- Trials with a EudraCT protocol (43,865)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)
Query did not match any clinical trials.
These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. |
Study title: Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. Ceftazidine/trobamycin in the treatment of acute pulmonary exacerbation. Pediatric Infections Disease Journal 1997; 16(1): 97-105Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. Ceftazidine/trobamycin in the treatment of acute pulmonary exacerbation. Pediatric Infections Disease Journal 1997; 16(1): 97-105 |
Active substance: CIPROFLOXACIN |
Study summary document link (including results): |
View full study record |
Document reference: 24211 |
Study title: The effect of topical ciprofloxacin on postoperative otorrhea after tympanostomy tube insertion. Zipfel TE, Wood WE, Street DF, Wulffman J, Tipirneni A, Frey C, Gibson WS. Am J Otol. 1999 Jul;20(4):416-20. The effect of topical ciprofloxacin on postoperative otorrhea after tympanostomy tube insertion. Zipfel TE, Wood WE, Street DF, Wulffman J, Tipirneni A, Frey C, Gibson WS. Am J Otol. 1999 Jul;20(4):416-20. |
Active substance: CIPROFLOXACIN |
Study summary document link (including results): |
View full study record |
Document reference: 24233 |
Study title: Khan SP et al, Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence, Mayo Clin Proc. 1994 Oct;69(10):949-54Khan SP et al, Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence, Mayo Clin Proc. 1994 Oct;69(10):949-54 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24958 |
Study title: Kharasch VS et al, Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and, cyclophosphamide in osteosarcoma survivors, Med Pediatr Oncol. 1996 Aug;27(2):85-91Kharasch VS et al, Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and, cyclophosphamide in osteosarcoma survivors, Med Pediatr Oncol. 1996 Aug;27(2):85-91 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24959 |
Study title: Kiss K et al Nephropathy in patients treated with ifosfamide Orv Hetil. 1994 May 8;135(19):1023-6. HungarianKiss K et al Nephropathy in patients treated with ifosfamide Orv Hetil. 1994 May 8;135(19):1023-6. Hungarian |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24960 |
Study title: Klingebiel T et al Treatment of children with relapsed soft tissue sarcoma: report of the German CESS/CWS REZ 91 trial.Med Pediatr Oncol 1998 May;30(5):269-75Klingebiel T et al Treatment of children with relapsed soft tissue sarcoma: report of the German CESS/CWS REZ 91 trial.Med Pediatr Oncol 1998 May;30(5):269-75 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24961 |
Study title: Kluin-Nelemans HC et al. Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study. J Natl Cancer Inst. 2001 Jan 3;93(1):22-30.Kluin-Nelemans HC et al. Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study. J Natl Cancer Inst. 2001 Jan 3;93(1):22-30. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24962 |
Study title: Koch Nogueira PC et al Long-term nephrotoxicity of cisplatin, ifosfamide, and methotrexate inoteosarcoma Pediatr Nephrol. 1998 Sep;12(7):572-5Koch Nogueira PC et al Long-term nephrotoxicity of cisplatin, ifosfamide, and methotrexate inoteosarcoma Pediatr Nephrol. 1998 Sep;12(7):572-5 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24963 |
Study title: Kolb EA et al Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults.J Clin Oncol 2003 Sep 15;21(18):3423-30Kolb EA et al Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults.J Clin Oncol 2003 Sep 15;21(18):3423-30 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24964 |
Study title: Kortmann RD et al Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91Int J Radiat Oncol Biol Phys 2000 Jan 15;46(2):269-79Kortmann RD et al Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91Int J Radiat Oncol Biol Phys 2000 Jan 15;46(2):269-79 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24965 |
Study title: Koscielniak E et al Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86 J Clin Oncol. 1999 Dec;17(12):3706-19Koscielniak E et al Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86 J Clin Oncol. 1999 Dec;17(12):3706-19 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24966 |
Study title: Köther M et al Abnormalities in serum osteocalcin values in children receiving chemotherapy including ifosfamide In Vivo. 1992 Mar-Apr;6(2):219-21Köther M et al Abnormalities in serum osteocalcin values in children receiving chemotherapy including ifosfamide In Vivo. 1992 Mar-Apr;6(2):219-21 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24967 |
Study title: Kovnar EH et al Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study J Clin Oncol. 1990 Feb;8(2):330-6. ReviewKovnar EH et al Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study J Clin Oncol. 1990 Feb;8(2):330-6. Review |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24968 |
Study title: Therapeutic management of chronic suppurative otitis media with otic drops. Merifield DO, Parker NJ, Nicholson NC. Otolaryngol Head Neck Surg. 1993 Jul;109(1):77-82Therapeutic management of chronic suppurative otitis media with otic drops. Merifield DO, Parker NJ, Nicholson NC. Otolaryngol Head Neck Surg. 1993 Jul;109(1):77-82 |
Active substance: CIPROFLOXACIN HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 24288 |
Study title: Topical ciprofloxacin for otorrhea after tympanostomy tube placement. Force RW, Hart MC, Plummer SA, Powell DA, Nahata MC. Arch Otolaryngol Head Neck Surg. 1995 Aug;121(8):880-4. Topical ciprofloxacin for otorrhea after tympanostomy tube placement. Force RW, Hart MC, Plummer SA, Powell DA, Nahata MC. Arch Otolaryngol Head Neck Surg. 1995 Aug;121(8):880-4. |
Active substance: CIPROFLOXACIN HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 24277 |
Study title: Bay b 5097 - 500-mg Vaginal Tablets. . Activity and Tolerability of Bay b 5097 500-mg Vaginal Tablets in Single or One-Day Treatment of Vaginal Candida Infections (Open, Mycologically Controlled Study) |
Active substance: CLOTRIMAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 24460 |
Study title: A single-dose, randomized, investigator-blinded trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile patients. Aug 1997. |
Active substance: CODEINE_AND_PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 24553 |
Study title: A single-dose, randomized, investigator-blinded trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile patients. Aug 1996. |
Active substance: CODEINE_AND_PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 24554 |
Study title: A study of the efficacy and side effects profile of sustained release acetaminophen pediatric chewable tablets compared to Children's Tylenol chewable tablets in the treatment of febrile children. Mar 1990. |
Active substance: CODEINE_AND_PARACETAMOL |
Study summary document link (including results): paracetamol 88-845.pdf |
View full study record |
Document reference: 24568 |
Study title: Agbolosu−N−B et al. Efficacy of tepid sponging versus paracetamol in reducing temperature in febrile children. {ANN−TROP−PAEDIATR}, 1997, Vol/Iss/Pg. 17/3 (283−288) |
Active substance: CODEINE_AND_PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 24528 |
Study title: Amdekar−Y−K, Desai−R−Z. Antipyretic activity of ibuprofen and paracetamol in children with pyrexia. {Br−J−Clin−Pract}, Apr 1985, vol. 39, no. 4, p. 140−3 |
Active substance: CODEINE_AND_PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 24544 |
Study title: An Assessment of the Safety of Pediatric Ibuprofen ("Boston University Fever Study"). Dec 1993. |
Active substance: CODEINE_AND_PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 24551 |
Study title: An evaluation of the efficacy and safety of C-14 elixir in pediatric patients with symptomatology requiring an analgesic and/or antipyretic. Jun 1981. |
Active substance: CODEINE_AND_PARACETAMOL |
Study summary document link (including results): paracetamol 0-206.pdf |
View full study record |
Document reference: 24572 |
Study title: An Evaluation of the Efficacy and Safety of C-30-13 Cough-Cold Formula in Adult and Pediatric Patients with Symptomatology of Upper Respiratory Infection or Allergic Rhinitis. May 1981. |
Active substance: CODEINE_AND_PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 24576 |
Study title: Autret, Reboul-Marty, Henry-Launois, Laborde,Courcier, Goehrs et al.; Eur J Clin Pharmacol 1997; |
Active substance: CODEINE_AND_PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 24578 |
Study title: Autret−E et al. Comparative efficacy and tolerance of ibuprofen syrup and acetaminophen syrup in children with pyrexia associated with infectious diseases and treated with antibiotics. {EUR−J−CLIN−PHARMACOL}, 1994, Vol/Iss/Pg. 46/3 (197−201) |
Active substance: CODEINE_AND_PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 24530 |
Study title: Autret−E et al. Evaluation of ibuprofen versus aspirin and paracetamol on efficacy and comfort in children with fever. {Eur−J−Clin−Pharmacol}, 1997, vol. 51, no. 5, p. 367−71 |
Active substance: CODEINE_AND_PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 24521 |
Study title: Autret−Leca−E et al. Ibuprofen versus paracetamol in pediatric fever: Objective and subjective findings from a randomized, blinded study. {CURR−MED−RES−OPIN}, 2007, Vol /Iss/Pg. 23/9 (2205−2211) |
Active substance: CODEINE_AND_PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 24501 |
Study title: Bernath−V−F et al. Tepid sponging and paracetamol for reduction of body temperature in febrile children. {MED−J−AUST}, 04 FEB 2002, Vol/Iss/Pg. 176/3 (130) |
Active substance: CODEINE_AND_PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 24517 |
Study title: Carabaño−Aguado−I et al. Antipyretic effectiveness of ibuprofen and paracetamol. {An−Pediatr−Barc}, Feb 2005, vol. 62, no. 2, p. 117−22 |
Active substance: CODEINE_AND_PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 24508 |
Study title: Cedrato−A−E et al. (Comparison of the antipyretic effect of a single dose of dipyrone, paracetamol and diclofenac resinate. A multicenter clinical trial). {Medicina−B−Aires}, 1989, vol. 49, no. 6, p. 635−6 |
Active substance: CODEINE_AND_PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 24537 |
Study title: Chastagner P et al Phase II study of ifosfamide in childhood brain tumors: a report by the French Society of Pediatric Oncology (SFOP) Med Pediatr Oncol. 1993;21(1):49-53Chastagner P et al Phase II study of ifosfamide in childhood brain tumors: a report by the French Society of Pediatric Oncology (SFOP) Med Pediatr Oncol. 1993;21(1):49-53 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24825 |
Study title: Ultralente Humulin vs Iletin I Ultralente in Diabetes |
Active substance: INSULIN (HUMAN) |
Study summary document link (including results): Human insulin - B5K-MC-IBCH redacted CSR.PDF |
View full study record |
Document reference: 30186 |
Study title: Gahlinger PM. A comparison of motion sickness remedies in severe sea conditions. Wilderness and Environmental Medicine 2000; 11: 136-137 |
Active substance: CINNARIZINE |
Study summary document link (including results): |
View full study record |
Document reference: 24192 |
Study title: Hargreaves J. A double-blind placebo controlled study of cinnarizine in the prophylaxis of seasickness. Practitioner 1980; 224: 547-50 |
Active substance: CINNARIZINE |
Study summary document link (including results): |
View full study record |
Document reference: 24198 |
Study title: Hargreaves J. The prophylaxis of seasickness; a comparison of cinnarizine with hyoscine Practitioner 1982; 226: 160 |
Active substance: CINNARIZINE |
Study summary document link (including results): |
View full study record |
Document reference: 24197 |
Study title: MacNair AL. Cinnarizine in the Prophylaxis of Car Sickness in Children. Curr Med Res Opin 1983; 8: 451-5 |
Active substance: CINNARIZINE |
Study summary document link (including results): |
View full study record |
Document reference: 24196 |
Study title: Pingree BJW & Pethybridge RJ. A Double-blind Placebo-controlled Comparison of Hyoscine with Early Administered Cinnarizine in Increasing Tolerance to a Nauseogenic Cross-coupled Motion Challenge. Pharmaceutical Medicine 1989; 4: 29-42 |
Active substance: CINNARIZINE |
Study summary document link (including results): |
View full study record |
Document reference: 24194 |
Study title: Schmid R et al. Comparison of Seven Commonly Used Agents for Prophylaxis of Seasickness. J Travel Med 1994; 1: 203-6 |
Active substance: CINNARIZINE |
Study summary document link (including results): |
View full study record |
Document reference: 24193 |
Study title: Van Driessche R. A Combiination of Cinnarizine and Domperidone for the Prevention of Motion Sickness: A Double-Blind Comparative Study Versus Cinnarizine. Curr Ther Res 1985; 38: 61-7 |
Active substance: CINNARIZINE |
Study summary document link (including results): |
View full study record |
Document reference: 24195 |
Study title: Open-label pilot study on use of clonidine in adolescent hypertensive Latin males |
Active substance: CLONIDINE |
Study summary document link (including results): clonidine hydrochloride_U87-0271_synopsis.pdf |
View full study record |
Document reference: 47128 |
Study title: Pharmacokinetics and hemodynamic response after an intravenous bolus injection of clonidine in children |
Active substance: CLONIDINE |
Study summary document link (including results): clonidine hydrochloride_U93-0224_synopsis.pdf |
View full study record |
Document reference: 47132 |
Study title: Spinal anaesthesia and Clonidin in premature infants preventing postoperative apnoea. |
Active substance: CLONIDINE |
Study summary document link (including results): clonidine hydrochloride_U02-1350_synopsis.pdf |
View full study record |
Document reference: 24408 |
Study title: The use of clonidine monotherapy in adolescent hypertension |
Active substance: CLONIDINE |
Study summary document link (including results): clonidine hydrochloride_U85-0798_synopsis.pdf |
View full study record |
Document reference: 47125 |
Study title: The use of clonidine monotherapy in adolescent hypertension |
Active substance: CLONIDINE |
Study summary document link (including results): clonidine hydrochloride_U85-0838_synopsis.pdf |
View full study record |
Document reference: 47126 |
Study title: A randomized, parallel, double-blind, placebo-controlled study to determine the onset of action and tolerability of PHZ 136 and Motrin IB in post-operative dental pain and a repeat dose evaluation |
Active substance: CLOPERASTINE |
Study summary document link (including results): |
View full study record |
Document reference: 24409 |
Study title: A randomized, parallel, single dose, double-blind, double-dummy multicentre study to assess the antipyretic activity and tolerability of ibuprofen-arginine drops, in comparison to paracetamol in the treatment of likely infectious pediatric fever. |
Active substance: CLOPERASTINE |
Study summary document link (including results): |
View full study record |
Document reference: 24410 |
Study title: Clinical assessment of Chlorchinaldin lozengesClinical Experience with antitussive Hustazol. Miyako M. et all. - 1967 - New Remedies & Clinics 16 (7): 819 |
Active substance: CLOPERASTINE |
Study summary document link (including results): |
View full study record |
Document reference: 24414 |
Study title: Minerva Pediatr. 1988 May;40(5):283-6. IT Cloperastine fendizoate in the treatment of cough-producing diseases in pediatrics. Scotti L, Borzani M Minerva Pediatr. 1988 May;40(5):283-6. IT Cloperastine fendizoate in the treatment of cough-producing diseases in pediatrics. Scotti L, Borzani M |
Active substance: CLOPERASTINE |
Study summary document link (including results): |
View full study record |
Document reference: 24411 |
Study title: The efficacy of topical ciprofloxacin in the treatment of chronic suppurative otitis media. Kiris M, Berktas M, Egeli E, Kutluhan A. Ear Nose Throat J. 1998 Nov;77(11):904-5, 909.The efficacy of topical ciprofloxacin in the treatment of chronic suppurative otitis media. Kiris M, Berktas M, Egeli E, Kutluhan A. Ear Nose Throat J. 1998 Nov;77(11):904-5, 909. |
Active substance: CIPROFLOXACIN |
Study summary document link (including results): |
View full study record |
Document reference: 24231 |
Study title: Topical ciprofloxacin for otorrhea after tympanostomy tube placement. Force RW, Hart MC, Plummer SA, Powell DA, Nahata MC. Arch Otolaryngol Head Neck Surg. 1995 Aug;121(8):880-4. Topical ciprofloxacin for otorrhea after tympanostomy tube placement. Force RW, Hart MC, Plummer SA, Powell DA, Nahata MC. Arch Otolaryngol Head Neck Surg. 1995 Aug;121(8):880-4. |
Active substance: CIPROFLOXACIN |
Study summary document link (including results): |
View full study record |
Document reference: 24228 |
Study title: Topical ciprofloxacin versus topical gentamicin for chronic otitis media. Nawasreh O, Fraihat A. East Mediterr Health J. 2001 Jan-Mar;7(1-2):26-30. Topical ciprofloxacin versus topical gentamicin for chronic otitis media. Nawasreh O, Fraihat A. East Mediterr Health J. 2001 Jan-Mar;7(1-2):26-30. |
Active substance: CIPROFLOXACIN |
Study summary document link (including results): |
View full study record |
Document reference: 24242 |
Study title: Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes. Roland PS, Anon JB, Moe RD, Conroy PJ, Wall GM, Dupre SJ, Krueger KA, Potts S, Hogg G, Stroman DW. Laryngoscope. 2003 Dec;113(12):2116-22. Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes. Roland PS, Anon JB, Moe RD, Conroy PJ, Wall GM, Dupre SJ, Krueger KA, Potts S, Hogg G, Stroman DW. Laryngoscope. 2003 Dec;113(12):2116-22. |
Active substance: CIPROFLOXACIN |
Study summary document link (including results): |
View full study record |
Document reference: 24246 |
Study title: Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. Roland PS, Kreisler LS, Reese B, Anon JB, Lanier B, Conroy PJ, Wall GM, Dupre SJ, Potts S, Hogg G, Stroman DW, McLean C. Pediatrics. 2004 Jan;113(1 Pt 1):e40-6. ... |
Active substance: CIPROFLOXACIN |
Study summary document link (including results): |
View full study record |
Document reference: 24226 |
Study title: Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of granulation tissue in children with acute otitis media with otorrhea through tympanostomy tubes. Roland PS, Dohar JE, Lanier BJ, Hekkenburg R, Lane EM, Conroy PJ, Wall GM, Dupre SJ, Potts SL; CIPRODEX AOMT Study Group. Otolaryngol Head Neck Surg. 2004 Jun;130(6):736-41. Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of granulation tissue in children with acute otitis media with otorrhea through tympanostomy tubes. Roland PS, Dohar JE, Lanier BJ, Hekkenburg R, Lane EM, Conroy PJ, Wall GM, Dupre SJ, Potts SL; CIPRODEX AOMT Study Group. Otolaryngol Head Neck Surg. 2004 Jun;130(6):736-41. |
Active substance: CIPROFLOXACIN |
Study summary document link (including results): |
View full study record |
Document reference: 24249 |
Study title: Artom G, Koren-Morag N,Spodick D, Brucato A, Guindo J, Bayes de Luna A, Brambilla G, Finkelstein Y, Granel B, Bayes Genis A, Schwammenthal E, Adler Y. Pretreatment with corticosteroids attenuates the efficacy of colchicines in preventing recurrent pericarditis: a multi-centre all-case analysis. Eur Heart J 2005;26:723-727Artom G, Koren-Morag N,Spodick D, Brucato A, Guindo J, Bayes de Luna A, Brambilla G, Finkelstein Y, Granel B, Bayes Genis A, Schwammenthal E, Adler Y. Pretreatment with corticosteroids attenuates the efficacy of colchicines in preventing recurrent pericarditis: a multi-centre all-case analysis. Eur Heart J 2005;26:723-727 |
Active substance: COLCHICINE |
Study summary document link (including results): |
View full study record |
Document reference: 24620 |
Study title: Banodkar D, Al-Suwaid A. Colchicine as a novel therapeutic agent in chronic bullous dermatosis of childhood. International Journal of Dermatology 1997; 36:213-216Banodkar D, Al-Suwaid A. Colchicine as a novel therapeutic agent in chronic bullous dermatosis of childhood. International Journal of Dermatology 1997; 36:213-216 |
Active substance: COLCHICINE |
Study summary document link (including results): |
View full study record |
Document reference: 24621 |
Study title: Ben-Chetrit E, Scherrmann J-M, Levy M. Colchicine in breast milk of patients with Familial Mediterranean Fever. Arthritis and Rheumatism 1996; 39, 7:1213-1217Ben-Chetrit E, Scherrmann J-M, Levy M. Colchicine in breast milk of patients with Familial Mediterranean Fever. Arthritis and Rheumatism 1996; 39, 7:1213-1217 |
Active substance: COLCHICINE |
Study summary document link (including results): |
View full study record |
Document reference: 24613 |
Study title: Topical ciprofloxacin versus topical gentamicin for chronic otitis media. Nawasreh O, Fraihat A. East Mediterr Health J. 2001 Jan-Mar;7(1-2):26-30. Topical ciprofloxacin versus topical gentamicin for chronic otitis media. Nawasreh O, Fraihat A. East Mediterr Health J. 2001 Jan-Mar;7(1-2):26-30. |
Active substance: CIPROFLOXACIN HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 24271 |
Study title: Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of granulation tissue in children with acute otitis media with otorrhea through tympanostomy tubes. Roland PS, Dohar JE, Lanier BJ, Hekkenburg R, Lane EM, Conroy PJ, Wall GM, Dupre SJ, Potts SL; CIPRODEX AOMT Study Group. Otolaryngol Head Neck Surg. 2004 Jun;130(6):736-41. Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of granulation tissue in children with acute otitis media with otorrhea through tympanostomy tubes. Roland PS, Dohar JE, Lanier BJ, Hekkenburg R, Lane EM, Conroy PJ, Wall GM, Dupre SJ, Potts SL; CIPRODEX AOMT Study Group. Otolaryngol Head Neck Surg. 2004 Jun;130(6):736-41. |
Active substance: CIPROFLOXACIN HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 24264 |
Study title: Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. Roland PS, Kreisler LS, Reese B, Anon JB, Lanier B, Conroy PJ, Wall GM, Dupre SJ, Potts S, Hogg G, Stroman DW, McLean C. Pediatrics. 2004 Jan;113(1 Pt 1):e40-6. Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. Roland PS, Kreisler LS, Reese B, Anon JB, Lanier B, Conroy PJ, Wall GM, Dupre SJ, Potts S, Hogg G, Stroman DW, McLean C. Pediatrics. 2004 Jan;113(1 Pt 1):e40-6. |
Active substance: CIPROFLOXACIN HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 24266 |
Study title: Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes. Dohar J, Giles W, Roland P, Bikhazi N, Carroll S, Moe R, Reese B, Dupre S, Wall M, Stroman D, McLean C, Crenshaw K. Pediatrics. 2006 Sep;118(3):e561-9;Epub 2006 Jul 31. Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes. Dohar J, Giles W, Roland P, Bikhazi N, Carroll S, Moe R, Reese B, Dupre S, Wall M, Stroman D, McLean C, Crenshaw K. Pediatrics. 2006 Sep;118(3):e561-9;Epub 2006 Jul 31. |
Active substance: CIPROFLOXACIN HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 24259 |
Study title: Topical quinolone vs. antiseptic for treating chronic suppurative otitis media: a randomized controlled trial. Macfadyen C, Gamble C, Garner P, Macharia I, Mackenzie I, Mugwe P, Oburra H, Otwombe K, Taylor S, Williamson P. Clin Otolaryngol. 2005 Apr;30(2):193-4. Topical quinolone vs. antiseptic for treating chronic suppurative otitis media: a randomized controlled trial. Macfadyen C, Gamble C, Garner P, Macharia I, Mackenzie I, Mugwe P, Oburra H, Otwombe K, Taylor S, Williamson P. Clin Otolaryngol. 2005 Apr;30(2):193-4. |
Active substance: CIPROFLOXACIN HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 24260 |
Study title: Topical quinolone vs. antiseptic for treating chronic suppurative otitis media: a randomized controlled trial. Macfadyen C, Gamble C, Garner P, Macharia I, Mackenzie I, Mugwe P, Oburra H, Otwombe K, Taylor S, Williamson P. Trop Med Int Health. 2005 Feb;10(2):190-7. Topical quinolone vs. antiseptic for treating chronic suppurative otitis media: a randomized controlled trial. Macfadyen C, Gamble C, Garner P, Macharia I, Mackenzie I, Mugwe P, Oburra H, Otwombe K, Taylor S, Williamson P. Trop Med Int Health. 2005 Feb;10(2):190-7. |
Active substance: CIPROFLOXACIN HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 24261 |
Study title: Treatment of chronic ear disease. Topical ciprofloxacin vs topical gentamicin. Tutkun A, Ozagar A, Koç A, Batman C, Uneri C, Sehitoglu MA. Arch Otolaryngol Head Neck Surg. 1995 Dec;121(12):1414-6. Treatment of chronic ear disease. Topical ciprofloxacin vs topical gentamicin. Tutkun A, Ozagar A, Koç A, Batman C, Uneri C, Sehitoglu MA. Arch Otolaryngol Head Neck Surg. 1995 Dec;121(12):1414-6. |
Active substance: CIPROFLOXACIN HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 24276 |
Study title: Water precautions in children with tympanostomy tubes. Salata JA, Derkay CS. Arch Otolaryngol Head Neck Surg. 1996 Mar;122(3):276-80. 9. Prophylactic antibiotic drops after tympanostomy tube placement. Hester TO, Jones RO, Archer SM, Haydon RC. Arch Otolaryngol Head Neck Surg. 1995 Apr;121(4):445-8. Water precautions in children with tympanostomy tubes. Salata JA, Derkay CS. Arch Otolaryngol Head Neck Surg. 1996 Mar;122(3):276-80. 9. Prophylactic antibiotic drops after tympanostomy tube placement. Hester TO, Jones RO, Archer SM, Haydon RC. Arch Otolaryngol Head Neck Surg. 1995 Apr;121(4):445-8. |
Active substance: CIPROFLOXACIN HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 24286 |
Study title: Margolis FJ, Rheames HR, Freshman E et al. Fluoride: ten year prospective study of deciduous teeth and permanent dentition. Am J Dis Child 1975; 129: 794-800. |
Active substance: COLECALCIFEROL AND SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24633 |
Study title: Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res. 2004 Aug;19(8):1221-30. |
Active substance: COLECALCIFEROL AND SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24637 |
Study title: Study Comparing Two Doses of Clarithromycin in Pediatric Tonsillitis |
Active substance: CLARITHROMYCIN |
Study summary document link (including results): clarithromycin-aca-grec-2001.pdf |
View full study record |
Document reference: 48061 |
Study title: Treatment of acute pharyngitis in children using clarithromycin under usual clinical practice conditions |
Active substance: CLARITHROMYCIN |
Study summary document link (including results): clarithromycin-fran03-004.pdf |
View full study record |
Document reference: 48063 |
Study title: Treatment of lower respiratory tract infections in children by clarithromycin under real practice conditions |
Active substance: CLARITHROMYCIN |
Study summary document link (including results): clarithromycin-fran03-005.pdf |
View full study record |
Document reference: 48064 |
Study title: |
Active substance: CLAVULANIC ACID AND TICARCILLIN |
Study summary document link (including results): Study BRL-028500-TIM-14 Ticarcillin (Timentin).xlsx |
View full study record |
Document reference: 24305 |
Study title: A pharmacokinetic evaluation of intravenously administered Timentin in paediatric patients. |
Active substance: CLAVULANIC ACID AND TICARCILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 24304 |
Study title: 2.3.9 Collins IS, Morton FJ (1968). Mecloprodin (Tavegyl) – a new antihistamine: clinical trials in Australia 1966-1967. 2.3.9 Collins IS, Morton FJ (1968). Mecloprodin (Tavegyl) – a new antihistamine: clinical trials in Australia 1966-1967. |
Active substance: CLEMASTINE |
Study summary document link (including results): 2011_EMAspreadsheet_Tavegil_1mg_Tablets_Collins IS_1968.xls |
View full study record |
Document reference: 24314 |
Study title: A comparative study of clemastine (Tavegil) and chlorpheniramine maleate in the treatment of hay fever.Curr Med Res Opin 1976;4:245-249A comparative study of clemastine (Tavegil) and chlorpheniramine maleate in the treatment of hay fever.Curr Med Res Opin 1976;4:245-249 |
Active substance: CLEMASTINE |
Study summary document link (including results): |
View full study record |
Document reference: 24326 |
Study title: A. Roncevich, Allergic rhinitis and its control by antihistaminics: clinical trial of Tavegyl (meclastine) Curr Ther Res Clin Exp 1968;8;373-81A. Roncevich, Allergic rhinitis and its control by antihistaminics: clinical trial of Tavegyl (meclastine) Curr Ther Res Clin Exp 1968;8;373-81 |
Active substance: CLEMASTINE |
Study summary document link (including results): |
View full study record |
Document reference: 24321 |
Study title: Carron (1967). Clinical study on clemastine capsules. |
Active substance: CLEMASTINE |
Study summary document link (including results): 2011_EMAspreadsheet_Tavegil_Carron_1967.xls |
View full study record |
Document reference: 21227 |
Study title: Castillo (1971). Clinical study on clemastine. |
Active substance: CLEMASTINE |
Study summary document link (including results): 2011_EMAspreadsheet_Tavegil_Castillo_1971.xls |
View full study record |
Document reference: 24319 |
Study title: Comparison of oxatomide and clemastine in the treatment of chronic urticaria. A double blind study.Dermatologica 1985; 171:49-51 Beck et al. |
Active substance: CLEMASTINE |
Study summary document link (including results): |
View full study record |
Document reference: 24308 |
Study title: De Nobrega (1971). Clinical study on clemastine syrup versus placebo.Report date: 1*71 |
Active substance: CLEMASTINE |
Study summary document link (including results): 2011_EMAspreadsheet_Tavegil_DeNobrega_1971.xls |
View full study record |
Document reference: 24322 |
Study title: Genovesi (1968). Clinical study on clemastine. |
Active substance: CLEMASTINE |
Study summary document link (including results): 2011_EMAspreadsheet_Tavegil_Genovesi_1968.xls |
View full study record |
Document reference: 24317 |
Study title: Investigator: B. Hazelman |
Active substance: CLEMASTINE |
Study summary document link (including results): |
View full study record |
Document reference: 24316 |
Study title: Investigator: F. Commandre et al. |
Active substance: CLEMASTINE |
Study summary document link (including results): |
View full study record |
Document reference: 24310 |
Study title: Platelet aggregation Inhibition in Children On Clopidogrel (PICOLO) – Doseranging pharmacodynamic assessment of platelet aggregation inhibition with clopidogrel in children of Blalock-Taussig shunt age categories (neonates and infants/toddlers) |
Active substance: CLOPIDROGEL |
Study summary document link (including results): Clopidogrel-Study 1.pdf |
View full study record |
Document reference: 47288 |
Study title: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Study of the Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for the Treatment of Increased Muscle Tone of the Lower Limb Resulting in Abnormal Gait A |
Active substance: CLOSTRIDIUM BOTULINUM TOXIN TYPE A |
Study summary document link (including results): |
View full study record |
Document reference: 24428 |
Study title: A Multicenter, Open-Label Study of the Safety and Efficacy of Repeated Treatments with BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Primary Axillary Hyperhidrosis in Adolescents |
Active substance: CLOSTRIDIUM BOTULINUM TOXIN TYPE A |
Study summary document link (including results): |
View full study record |
Document reference: 22689 |
Study title: An Evaluator-Blinded Randomized Pilot Study Comparing the Use of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin complex to Standard Care in the Management of the Hemiplegic Upper Limb in Paediatric Cerebral Palsy. 6-Month Report. |
Active substance: CLOSTRIDIUM BOTULINUM TOXIN TYPE A |
Study summary document link (including results): |
View full study record |
Document reference: 24429 |
Study title: Salmeterol versus sodium cromoglycate for the protection of exercise induced asthma in children - a randomised cross-over study - Zimmermann T, Gulyas A, Bauer CP, Steinkamp G, Trautmann M - 2003 (Eur J Med Res 2003 29;8:428-34) Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07Salmeterol versus sodium cromoglycate for the protection of exercise induced asthma in children - a randomised cross-over study - Zimmermann T, Gulyas A, Bauer CP, Steinkamp G, Trautmann M - 2003 (Eur J Med Res 2003 29;8:428-34) Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07 |
Active substance: CROMOGLICIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 24678 |
Study title: Sodium cromoglycate therapy in wheezing infant : preliminary evidence of beneficial outcome at early school age - Kotaniemi-Syrjanen A, Reijonen TM, Korhonen K, Korppi M - 2005 (Pediatr Int 2005; 627-34) Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07Sodium cromoglycate therapy in wheezing infant : preliminary evidence of beneficial outcome at early school age - Kotaniemi-Syrjanen A, Reijonen TM, Korhonen K, Korppi M - 2005 (Pediatr Int 2005; 627-34) Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07 |
Active substance: CROMOGLICIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 24679 |
Study title: The combination of nebulized sodium cromoglycate and salbutamol in the treatment of moderate-to-severe asthma in children - Furusho K, Nishikawa S, Akasaka T, Arita M, Edwards A - 2002 (Pediatr. Allergy Immunol. 2002;13:209-16) Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07The combination of nebulized sodium cromoglycate and salbutamol in the treatment of moderate-to-severe asthma in children - Furusho K, Nishikawa S, Akasaka T, Arita M, Edwards A - 2002 (Pediatr. Allergy Immunol. 2002;13:209-16) Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07 |
Active substance: CROMOGLICIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 24680 |
Study title: The effect of montelukast versus usual care on health care ressource utilization in children aged 2 to 5 years with asthma - 2004 - Davies GM, Dasbach EJ, Santanello NC, Knorr BA, Bratton DL (Clin. Ther. 2004;26:1895-904) Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07The effect of montelukast versus usual care on health care ressource utilization in children aged 2 to 5 years with asthma - 2004 - Davies GM, Dasbach EJ, Santanello NC, Knorr BA, Bratton DL (Clin. Ther. 2004;26:1895-904) Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07 |
Active substance: CROMOGLICIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 24681 |
Study title: Intraindividuelle, randomisierte, doppelblinde Provokationsstudie zwischen AARANE bzw. ALLERGOSPASMIN mit herkömmlichen Treibmittel (FCKW) im Vergleich zur gleichen Kombination mit neuen Treibmittel (HFA 227) bei Kindern mit Anstrengungsaathma |
Active substance: CROMOGLICIC ACID AND REPROTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 24686 |
Study title: Clinical study of the efficacy and tolerability of the preparation Tot'hema in the states of iron-defficiency in young children |
Active substance: CUPRIC AND FERROUS |
Study summary document link (including results): |
View full study record |
Document reference: 24687 |
Study title: Bibas R, Kalil Gaspar N, Ramos-e-Silva M. Colchicine for dermatologic diseases. Journal of drugs in dermatology 2005; 4:196-204Bibas R, Kalil Gaspar N, Ramos-e-Silva M. Colchicine for dermatologic diseases. Journal of drugs in dermatology 2005; 4:196-204 |
Active substance: COLCHICINE |
Study summary document link (including results): |
View full study record |
Document reference: 24614 |
Study title: Blanchette V, Freedman J, Garvey B. Management of Cronic Immune Thrombocytopenic Purpura in children and adults. Seminars in hematology 1998; 35,1, suppl 1:36-51Blanchette V, Freedman J, Garvey B. Management of Cronic Immune Thrombocytopenic Purpura in children and adults. Seminars in hematology 1998; 35,1, suppl 1:36-51 |
Active substance: COLCHICINE |
Study summary document link (including results): |
View full study record |
Document reference: 24615 |
Study title: Cacoub P, Sbai A, Wechsler B, Amoura Z, Godeau P, Piette J.C. Efficacité de la colchicine dans les péricardites aiguës récidivantes idiopathiques. Arch Mal Cœur 2000 ; 93 :1511-1514Cacoub P, Sbai A, Wechsler B, Amoura Z, Godeau P, Piette J.C. Efficacité de la colchicine dans les péricardites aiguës récidivantes idiopathiques. Arch Mal Cœur 2000 ; 93 :1511-1514 |
Active substance: COLCHICINE |
Study summary document link (including results): |
View full study record |
Document reference: 24616 |
Study title: Chapey O, Scherrmann J-M. La colchicine : données récentes sur sa pharmacocinétique et sa pharmacologie clinique. Rev Med Int 1995 ; 16 :782-789Chapey O, Scherrmann J-M. La colchicine : données récentes sur sa pharmacocinétique et sa pharmacologie clinique. Rev Med Int 1995 ; 16 :782-789 |
Active substance: COLCHICINE |
Study summary document link (including results): |
View full study record |
Document reference: 24617 |
Study title: Declèves X, Niel E, Debray M, Scherrmann J-M. Is P-glycoprotein (ABCB1) a phase 0 or a phase 3 colchicine transporter depending on colchicine exposure conditions? Toxicology and Applied Pharmacology 2006; 217:153-160Declèves X, Niel E, Debray M, Scherrmann J-M. Is P-glycoprotein (ABCB1) a phase 0 or a phase 3 colchicine transporter depending on colchicine exposure conditions? Toxicology and Applied Pharmacology 2006; 217:153-160 |
Active substance: COLCHICINE |
Study summary document link (including results): |
View full study record |
Document reference: 24618 |
Study title: Dinarello C, Wolff S, Goldfinger S, Dale D, Alling D. Colchicine therapy for Familial Mediterranean Fever: a double blind trial. N Eng J Med 1974; 291: 934-937Dinarello C, Wolff S, Goldfinger S, Dale D, Alling D. Colchicine therapy for Familial Mediterranean Fever: a double blind trial. N Eng J Med 1974; 291: 934-937 |
Active substance: COLCHICINE |
Study summary document link (including results): |
View full study record |
Document reference: 24583 |
Study title: Djian B, Santoni A, Guilhou JJ, Meynadier J, Michel B, Aliserai M, Guillot B. Traitement de l'aphtose vulgaire récidivante par la colchicine. La Nouvelle Presse Médicale 1982 ; 11, 51 :3799Djian B, Santoni A, Guilhou JJ, Meynadier J, Michel B, Aliserai M, Guillot B. Traitement de l'aphtose vulgaire récidivante par la colchicine. La Nouvelle Presse Médicale 1982 ; 11, 51 :3799 |
Active substance: COLCHICINE |
Study summary document link (including results): |
View full study record |
Document reference: 24584 |
Study title: Fonnesu C, Cerquaglia C, Giovinale M, Curigliano V, Verrecchia E, de Socio G, La Regina M, Gasbarrini G, Manna R. Familial Mediterranean Fever : a review for clinical management.Joint Bone Spine 2009; 76:227-233Fonnesu C, Cerquaglia C, Giovinale M, Curigliano V, Verrecchia E, de Socio G, La Regina M, Gasbarrini G, Manna R. Familial Mediterranean Fever : a review for clinical management.Joint Bone Spine 2009; 76:227-233 |
Active substance: COLCHICINE |
Study summary document link (including results): |
View full study record |
Document reference: 24585 |
Study title: Goldstein R, Schwabe A. Prophylactic colchicines therapy in familial Mediterranean Fever: a controlled, double blind study. Ann Intern Med 1974; 81:792-794Goldstein R, Schwabe A. Prophylactic colchicines therapy in familial Mediterranean Fever: a controlled, double blind study. Ann Intern Med 1974; 81:792-794 |
Active substance: COLCHICINE |
Study summary document link (including results): |
View full study record |
Document reference: 24587 |
Study title: Arndt C et al A feasibility, toxicity, and early response study of etoposide, ifosfamide, andvincristine for the treatment of children with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS) IV pilot study J Pediatr Hematol Oncol. 1997 Mar-Apr;19(2):124-9Arndt C et al A feasibility, toxicity, and early response study of etoposide, ifosfamide, andvincristine for the treatment of children with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS) IV pilot study J Pediatr Hematol Oncol. 1997 Mar-Apr;19(2):124-9 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24728 |
Study title: Arndt C et al Renal function following combination chemotherapy with ifosfamide and cisplatinin patients with osteogenic sarcoma Med Pediatr Oncol. 1999 Feb;32(2):93-6Arndt C et al Renal function following combination chemotherapy with ifosfamide and cisplatinin patients with osteogenic sarcoma Med Pediatr Oncol. 1999 Feb;32(2):93-6 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24729 |
Study title: Arndt C et al Renal function in children and adolescents following 72 g/m2 of ifosfamide Cancer Chemother Pharmacol. 1994;34(5):431-3Arndt C et al Renal function in children and adolescents following 72 g/m2 of ifosfamide Cancer Chemother Pharmacol. 1994;34(5):431-3 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24730 |
Study title: Nicolaidou P, Georgouli H, Kotsalis H, Matsinos Y, Papadopoulou A, Fretzayas A, Syriopoulou V, Krikos X, Karantana A, Karpathios T. Effects of anticonvulsant therapy on vitamin D status in children: prospective monitoring study. J Child Neurol. 2006 Mar;21(3):205-9. |
Active substance: COLECALCIFEROL AND SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24638 |
Study title: Specker BL, Ho ML, Oestreich A, Yin TA, Shui QM, Chen XC, Tsang RC.Prospective study of vitamin D supplementation and rickets in China.J Pediatr. 1992 May;120(5):733-9. |
Active substance: COLECALCIFEROL AND SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24639 |
Study title: A double-blind, randomized, placebo-controlled clinical trial on the use of cholestyramine in acute diarrhea in children |
Active substance: COLESTYRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24640 |
Study title: Rapport d'etude: evaluation des concentrations bronchiques de colistine apres administration en aerosol, a la posologie de 1 MUI 2 fois par jour et de la tolerance de cette voie d'administration chez des patients atteints de mucoviscidose. |
Active substance: COLISTIN |
Study summary document link (including results): Colistimethate sodium STUDY SAF-133.xls |
View full study record |
Document reference: 47977 |
Study title: Sputum concentrations and systemic availibilty of colistin after inhalation in patients with cystic fibrosis |
Active substance: COLISTIN |
Study summary document link (including results): GD-COL 01.pdf |
View full study record |
Document reference: 24649 |
Study title: Concurrent testing of the thyreotropic, somatotropic, gonadotropic, and corticotropic partial function of the anterior lobe of the pituitary gland in children and adolescents. |
Active substance: CORTICORELIN |
Study summary document link (including results): |
View full study record |
Document reference: 24653 |
Study title: Diagnostic use and tolerability testing of a combined pituitary gland function test in children with disturbances of development and growth. |
Active substance: CORTICORELIN |
Study summary document link (including results): |
View full study record |
Document reference: 24652 |
Study title: |
Active substance: CREATINE PHOSPHATE |
Study summary document link (including results): |
View full study record |
Document reference: 46920 |
Study title: Agnese L, Tarello M, Grazioli I. Efficacy of creatine phosphate in treating hypotonotrophy due to non-use of skeletal muscle. Ortop Traumatol Oggi 1992; 12(4):107-113 Agnese L, Tarello M, Grazioli I. Efficacy of creatine phosphate in treating hypotonotrophy due to non-use of skeletal muscle. Ortop Traumatol Oggi 1992; 12(4):107-113 |
Active substance: CREATINE PHOSPHATE |
Study summary document link (including results): |
View full study record |
Document reference: 46921 |
Study title: Cossolini M, Sonzogni V, Di Dedda G, Fruga F, Pansera C, Pirola C, et al. Paediatric cold heart surgery: experience with creatine phosphate added to cardioplegic solution heart surgery. Acts of 5th International Symposium on Cardiac Surgery - Rome (Italy), May 25-28, 1993: 442-443 Cossolini M, Sonzogni V, Di Dedda G, Fruga F, Pansera C, Pirola C, et al. Paediatric cold heart surgery: experience with creatine phosphate added to cardioplegic solution heart surgery. Acts of 5th International Symposium on Cardiac Surgery - Rome (Italy), May 25-28, 1993: 442-443 |
Active substance: CREATINE PHOSPHATE |
Study summary document link (including results): |
View full study record |
Document reference: 46923 |
Study title: Dal Monte A, Leonardi LM, Figura F, Cappozzo A, Marchetti M, De Santis AM. Effects of phosphocreatine administration on muscle strength in man. Gazz. Med. Ital. 1976; 135 (9): 439-448 Dal Monte A, Leonardi LM, Figura F, Cappozzo A, Marchetti M, De Santis AM. Effects of phosphocreatine administration on muscle strength in man. Gazz. Med. Ital. 1976; 135 (9): 439-448 |
Active substance: CREATINE PHOSPHATE |
Study summary document link (including results): |
View full study record |
Document reference: 46924 |
Study title: Bower M et al, Chemotherapy for ovarian germ cell tumours, Eur J Cancer. 1996 Apr;32A(4):593-7Bower M et al, Chemotherapy for ovarian germ cell tumours, Eur J Cancer. 1996 Apr;32A(4):593-7 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24790 |
Study title: Ahrendt HJ, Karck U, Pichl T, Mueller T, Ernst, U. The effects of an oestrogen-free, desogestrel-containing oral contraceptive in women with cyclical symptoms: Results from two studies on oestrogen-related symptoms and dysmenorrhoea. Eu J Contraception R |
Active substance: DESOGESTREL AND ETHINYLESTRADIOL |
Study summary document link (including results): |
View full study record |
Document reference: 25674 |
Study title: Arul GS, Dolan G, Rance CH, Singh SJ, Sommers J. Coeliac axis thrombosis associated with the combined oral contraceptive pill: a rare cause of an acute abdominal . Pediatr. Surg. Int. 1998;13/4:285-7.Arul GS, Dolan G, Rance CH, Singh SJ, Sommers J. Coeliac axis thrombosis associated with the combined oral contraceptive pill: a rare cause of an acute abdominal . Pediatr. Surg. Int. 1998;13/4:285-7. |
Active substance: DESOGESTREL AND ETHINYLESTRADIOL |
Study summary document link (including results): |
View full study record |
Document reference: 25671 |
Study title: From: "Aftonbladet" 3 November 1995 (Sweden).From: "Aftonbladet" 3 November 1995 (Sweden). |
Active substance: DESOGESTREL AND ETHINYLESTRADIOL |
Study summary document link (including results): |
View full study record |
Document reference: 25673 |
Study title: Marcel Bouvy. De pil en haaruitval (The pill and hair loss). Pharm Weekbl 1996;131, 33:950.Marcel Bouvy. De pil en haaruitval (The pill and hair loss). Pharm Weekbl 1996;131, 33:950. |
Active substance: DESOGESTREL AND ETHINYLESTRADIOL |
Study summary document link (including results): |
View full study record |
Document reference: 25672 |
Study title: Pelletier J, Cabanot C, Levrier O, Thuillier JN, Cherif AA. Angiodysplasia of Moya-Moya type disclosed by choreic unvoluntary abnormal movements during oral contraception. Rev Neurol (Paris) 1997;153:393-7.Pelletier J, Cabanot C, Levrier O, Thuillier JN, Cherif AA. Angiodysplasia of Moya-Moya type disclosed by choreic unvoluntary abnormal movements during oral contraception. Rev Neurol (Paris) 1997;153:393-7. |
Active substance: DESOGESTREL AND ETHINYLESTRADIOL |
Study summary document link (including results): |
View full study record |
Document reference: 25675 |
Study title: Scolding NJ, Gibby OM: Fatal pulmonary embolus in a patient treated with Marvelon. J Royal Coll Gen Pract 38, 568 (1988). Scolding NJ, Gibby OM: Fatal pulmonary embolus in a patient treated with Marvelon. J Royal Coll Gen Pract 38, 568 (1988). |
Active substance: DESOGESTREL AND ETHINYLESTRADIOL |
Study summary document link (including results): |
View full study record |
Document reference: 25670 |
Study title: BILATERAL REGIMEN EFFICACY COMPARISON OF DESOWEN (DESONIDE LOTION) LOTION, 0.05% VS DESOWEN (DESONIDE LOTION) LOTION, 0.05% PLUS CETAPHIL MOISTURIZING CREAM IN PATIENTS WITH ATOPIC DERMATITIS |
Active substance: DESONIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25676 |
Study title: EFFICACY AND SAFETY COMPARISON OF DESONIDE 0.05% LOTION (DESOWEN) VERSUS FLUOCORTOLONE 0.5% OINTMENT (ULTRALAN) IN THE TREATMENT OF ATOPIC DERMATITIS |
Active substance: DESONIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25677 |
Study title: Pickering DN, Beardsmore CS. Nasal flow limitation in children. Pediatr Pulmonol. 1999 Jan;27(1):32-6.Pickering DN, Beardsmore CS. Nasal flow limitation in children. Pediatr Pulmonol. 1999 Jan;27(1):32-6. |
Active substance: DESONIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25678 |
Study title: A double-blind comparison of 0.25% and 0.05% desoxymethasone, 0.1% betamethasone valerate and 1% hydroxycortisone creams in the treatment of eczema. Ashton et al. 1987 (The Journal of International Medical Research 15: 160-166) - Publication mentioned as part of CES on Desoximetasone Flubason - Sostens Ferrer F. - 09/1998 -A double-blind comparison of 0.25% and 0.05% desoxymethasone, 0.1% betamethasone valerate and 1% hydroxycortisone creams in the treatment of eczema. Ashton et al. 1987 (The Journal of International Medical Research 15: 160-166) - Publication mentioned as part of CES on Desoximetasone Flubason - Sostens Ferrer F. - 09/1998 - |
Active substance: DESOXYMETHASONE |
Study summary document link (including results): |
View full study record |
Document reference: 25680 |
Study title: Efficacy of Esperson (desoxymethasone 0.05% oily cream) in psoriasis, eczema and dermatitis |
Active substance: DESOXYMETHASONE |
Study summary document link (including results): |
View full study record |
Document reference: 25679 |
Study title: Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial.Lam DS, Fan DS, Ng JS, Yu CB, Wong CY, Cheung AY. Clin Experiment Ophthalmol. 2005 Jun;33(3):252-8. Comment in: Clin Experiment Ophthalmol. 2005 Jun;33(3):229-30. PMID: 15932523. Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial.Lam DS, Fan DS, Ng JS, Yu CB, Wong CY, Cheung AY. Clin Experiment Ophthalmol. 2005 Jun;33(3):252-8. Comment in: Clin Experiment Ophthalmol. 2005 Jun;33(3):229-30. PMID: 15932523. |
Active substance: DESOXYMETHASONE |
Study summary document link (including results): |
View full study record |
Document reference: 25681 |
Study title: |
Active substance: DEXAMETHASONE |
Study summary document link (including results): Ocular hypertensive.pdf |
View full study record |
Document reference: 47194 |
Study title: A. Glerek - Clinical investigations of the effectiveness and tolerance of the preparation dexamethasone 0.1 % solution - eye drops from the Institute of Ophtalmology, Medical Academy in Katowicw Institute Director: Professor A. Gierek, M.D. |
Active substance: DEXAMETHASONE |
Study summary document link (including results): |
View full study record |
Document reference: 25683 |
Study title: Efficacy of Tothema in iron defficiency anemia in children |
Active substance: CUPRIC AND FERROUS |
Study summary document link (including results): |
View full study record |
Document reference: 24688 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Cutis compositum (injection solution) [AWB-029] |
Active substance: Cutis compositum-Heel - Ampullen |
Study summary document link (including results): |
View full study record |
Document reference: 39836 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Cutis compositum (ampoules) [AWB-AT] |
Active substance: Cutis compositum-Heel - Ampullen |
Study summary document link (including results): |
View full study record |
Document reference: 39837 |
Study title: Kimball, F N Passenger comforts on the high seas. With special refernce to the clinical evaluation of anti-motion sickness drugs. International Record Medicine and General Practice Clinics, 1955: 168/2: 72-77. Kimball, F N Passenger comforts on the high seas. With special refernce to the clinical evaluation of anti-motion sickness drugs. International Record Medicine and General Practice Clinics, 1955: 168/2: 72-77. |
Active substance: CYCLIZINE |
Study summary document link (including results): |
View full study record |
Document reference: 24690 |
Study title: Lederer, L G, KIDERA, GJ Passenger comfort in commercial air travel with reference to motion sickness. International Record Medicine and General Practice Clinics, 1954: 167/12: 661-668 . Lederer, L G, KIDERA, GJ Passenger comfort in commercial air travel with reference to motion sickness. International Record Medicine and General Practice Clinics, 1954: 167/12: 661-668 . |
Active substance: CYCLIZINE |
Study summary document link (including results): |
View full study record |
Document reference: 24689 |
Study title: Wade, O L, Dundee, J W Antiemetic drugs, Prescribers Journal, 1969: 9/3: 69-74Wade, O L, Dundee, J W Antiemetic drugs, Prescribers Journal, 1969: 9/3: 69-74 |
Active substance: CYCLIZINE |
Study summary document link (including results): |
View full study record |
Document reference: 24691 |
Study title: Friedmann AM et al Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose, involved-field radiation.J Clin Oncol 2002 Jul 15;20(14):3088-94Friedmann AM et al Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose, involved-field radiation.J Clin Oncol 2002 Jul 15;20(14):3088-94 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24881 |
Study title: Frisk P et al Painful peripheral neuropathy after treatment with high-dose ifosfamide Med Pediatr Oncol. 2001 Oct;37(4):379-82Frisk P et al Painful peripheral neuropathy after treatment with high-dose ifosfamide Med Pediatr Oncol. 2001 Oct;37(4):379-82 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24882 |
Study title: Fröhlich B et al [High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma.(EI)CESS] Klin Padiatr 1999 Jul-Aug;211(4):284-90. GermanFröhlich B et al [High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma.(EI)CESS] Klin Padiatr 1999 Jul-Aug;211(4):284-90. German |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24883 |
Study title: Fryer CJ et al, Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: a report from the, Children's Cancer Study Group, J Clin Oncol. 1990 Dec;8(12):1971-80Fryer CJ et al, Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: a report from the, Children's Cancer Study Group, J Clin Oncol. 1990 Dec;8(12):1971-80 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24884 |
Study title: Fuchs J et al Cooperative Pediatric Liver Tumor Study Hb 94 for the German Society for Pediatric Oncology and Hematology.Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94 Cancer. 2002 Jul 1;95(1):172-82Fuchs J et al Cooperative Pediatric Liver Tumor Study Hb 94 for the German Society for Pediatric Oncology and Hematology.Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94 Cancer. 2002 Jul 1;95(1):172-82 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24885 |
Study title: Fuchs N et al Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs Ann Oncol. 1998 Aug;9(8):893-9Fuchs N et al Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs Ann Oncol. 1998 Aug;9(8):893-9 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24886 |
Study title: Gad-el-Mawla N et al Prolonged disease-free survival in pediatric non-Hodgkin's lymphoma using ifosfamide-containing combination chemotherapy Hematol Oncol. 1991 Jul-Oct;9(4-5):281-6Gad-el-Mawla N et al Prolonged disease-free survival in pediatric non-Hodgkin's lymphoma using ifosfamide-containing combination chemotherapy Hematol Oncol. 1991 Jul-Oct;9(4-5):281-6 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24887 |
Study title: Arndt CA et al Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group Pediatr Blood Cancer. 2008 Jan;50(1):33-6Arndt CA et al Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group Pediatr Blood Cancer. 2008 Jan;50(1):33-6 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24731 |
Study title: Arndt CA et al Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide Eur J Cancer. 1998 Jul;34(8):1224-9Arndt CA et al Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide Eur J Cancer. 1998 Jul;34(8):1224-9 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24732 |
Study title: Arya LS et al, Hodgkin's disease in Indian children: outcome with chemotherapy alone, Pediatr Blood Cancer. 2006 Jan;46(1):26-34Arya LS et al, Hodgkin's disease in Indian children: outcome with chemotherapy alone, Pediatr Blood Cancer. 2006 Jan;46(1):26-34 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24733 |
Study title: Ashraf MS et al Ifosfamide nephrotoxicity in paediatric cancer patients Eur J Pediatr. 1994 Feb;153(2):90-4Ashraf MS et al Ifosfamide nephrotoxicity in paediatric cancer patients Eur J Pediatr. 1994 Feb;153(2):90-4 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24734 |
Study title: Aung L et al Second malignant neoplasms in long-term survivors of osteosarcoma: Memorial Sloan-Kettering Cancer Center Experience Cancer. 2002 Oct 15;95(8):1728-34Aung L et al Second malignant neoplasms in long-term survivors of osteosarcoma: Memorial Sloan-Kettering Cancer Center Experience Cancer. 2002 Oct 15;95(8):1728-34 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24738 |
Study title: Bacci G et al Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report J Clin Oncol. 2000 Dec 15;18(24):4016-27Bacci G et al Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report J Clin Oncol. 2000 Dec 15;18(24):4016-27 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24739 |
Study title: Bacci G et al Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies Cancer 1998 Mar 15;82(6):1174-83Bacci G et al Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies Cancer 1998 Mar 15;82(6):1174-83 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24741 |
Study title: Bacci G et al Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases atpresentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide Ann Oncol. 2003 Jul;14(7):1126-34Bacci G et al Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases atpresentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide Ann Oncol. 2003 Jul;14(7):1126-34 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24742 |
Study title: Jones DP et al Renal toxicity of cancer chemotherapeutic agents in children: ifosfamide and cisplatin Curr Opin Pediatr. 1995 Apr;7(2):208-13. ReviewJones DP et al Renal toxicity of cancer chemotherapeutic agents in children: ifosfamide and cisplatin Curr Opin Pediatr. 1995 Apr;7(2):208-13. Review |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24941 |
Study title: Juergens C et al Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial Pediatr Blood Cancer 2006 Jul;47(1):22-9Juergens C et al Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial Pediatr Blood Cancer 2006 Jul;47(1):22-9 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24942 |
Study title: Jürgens H et al High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma Cancer Chemother Pharmacol. 1989;24 Suppl 1:S40-4Jürgens H et al High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma Cancer Chemother Pharmacol. 1989;24 Suppl 1:S40-4 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24943 |
Study title: Bramwell VH et al. Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group. Cancer Chemother Pharmacol. 1993;31 Suppl 2:S180-4.Bramwell VH et al. Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group. Cancer Chemother Pharmacol. 1993;31 Suppl 2:S180-4. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24791 |
Study title: Bramwell VH et al. Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group. Cancer Chemother Pharmacol. 1993;31 Suppl 2:S180-4.Bramwell VH et al. Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group. Cancer Chemother Pharmacol. 1993;31 Suppl 2:S180-4. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24792 |
Study title: Bramwell VH et al. Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group. Cancer Chemother Pharmacol. 1993;31 Suppl 2:S180-4.Bramwell VH et al. Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group. Cancer Chemother Pharmacol. 1993;31 Suppl 2:S180-4. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24793 |
Study title: Brecher ML et al. Fractionated cylophosphamide and back to back high dose methotrexate and cytosinearabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group. Med Pediatr Oncol. 1997 Dec;29(6):526-33.Brecher ML et al. Fractionated cylophosphamide and back to back high dose methotrexate and cytosinearabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group. Med Pediatr Oncol. 1997 Dec;29(6):526-33. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24794 |
Study title: Brecher ML et al. Fractionated cylophosphamide and back to back high dose methotrexate and cytosinearabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group. Med Pediatr Oncol. 1997 Dec;29(6):526-33.Brecher ML et al. Fractionated cylophosphamide and back to back high dose methotrexate and cytosinearabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group. Med Pediatr Oncol. 1997 Dec;29(6):526-33. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24795 |
Study title: Breitfeld PP et al Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.J Pediatr Hematol Oncol 2001 May;23(4):225-33Breitfeld PP et al Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.J Pediatr Hematol Oncol 2001 May;23(4):225-33 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24796 |
Study title: Brewer M et al, Outcome and reproductive function after chemotherapy for ovarian dysgerminoma, J Clin Oncol. 1999 Sep;17(9):2670-75Brewer M et al, Outcome and reproductive function after chemotherapy for ovarian dysgerminoma, J Clin Oncol. 1999 Sep;17(9):2670-75 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24797 |
Study title: Bruggers CS et al Cerebral atrophy in an infant following treatment with ifosfamide Med Pediatr Oncol. 1994;23(4):380-3Bruggers CS et al Cerebral atrophy in an infant following treatment with ifosfamide Med Pediatr Oncol. 1994;23(4):380-3 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24798 |
Study title: Buchanan GR et al. Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study. Cancer. 2000 Mar 1;88(5):1166-74.Buchanan GR et al. Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study. Cancer. 2000 Mar 1;88(5):1166-74. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24799 |
Study title: Buchanan GR et al. Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. A Pediatric Oncology group study. Cancer. 1991 Jul 1;68(1):48-55.Buchanan GR et al. Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. A Pediatric Oncology group study. Cancer. 1991 Jul 1;68(1):48-55. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24800 |
Study title: Rogers PC et al, Treatment of children and adolescents with stage II testicular and stages I and, II ovarian malignant germ cell tumors: A Pediatric Intergroup Study—Pediatric Oncology Group 9048 and Children's Cancer Group 8891, J Clin Oncol. 2004 Sep 1;22(17):3563-9, Rogers PC et al, Treatment of children and adolescents with stage II testicular and stages I and, II ovarian malignant germ cell tumors: A Pediatric Intergroup Study—Pediatric Oncology Group 9048 and Children's Cancer Group 8891, J Clin Oncol. 2004 Sep 1;22(17):3563-9, |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25087 |
Study title: Roguin A et al Ifosfamide in pediatric malignancy--experiences in the Northern Israel Oncology Center Harefuah. 1996 Apr 15;130(8):511-4, 584. HebrewRoguin A et al Ifosfamide in pediatric malignancy--experiences in the Northern Israel Oncology Center Harefuah. 1996 Apr 15;130(8):511-4, 584. Hebrew |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25088 |
Study title: Rosito P et al Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: a preliminary report of 6 years of experience Cancer 1999 Aug 1;86(3):421-8. Erratum in: Cancer. 2005 Aug 1;104(3):667. dosage error in textRosito P et al Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: a preliminary report of 6 years of experience Cancer 1999 Aug 1;86(3):421-8. Erratum in: Cancer. 2005 Aug 1;104(3):667. dosage error in text |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25089 |
Study title: AN 09890466 Medline 20070101. TI Abdominal migraine: prophylactic treatment and follow-up. SO Journal of pediatric gastroenterology and nutrition, {J-Pediatr- Gastroenterol-Nutr}, Jan 1999, vol. 28, no. 1, p. 37-40, ISSN: 0277-2116. AU Worawattanakul-M, Rhoads-J-M, Lichtman-S-N, Ulshen-M-H. IN Department of Pediatrics, University of North Carolina, Chapel Hill 27599-7220, USA. YR 1999.AN 09890466 Medline 20070101. TI Abdominal migraine: prophylactic treatment and follow-up. SO Journal of pediatric gastroenterology and nutrition, {J-Pediatr- Gastroenterol-Nutr}, Jan 1999, vol. 28, no. 1, p. 37-40, ISSN: 0277-2116. AU Worawattanakul-M, Rhoads-J-M, Lichtman-S-N, Ulshen-M-H. IN Department of Pediatrics, University of North Carolina, Chapel Hill 2759... |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25231 |
Study title: AN 10233642 Medline 20070101. TI Diffuse cutaneous mastocytosis responding to cyproheptadine. SO Clinical and experimental dermatology, {Clin-Exp-Dermatol}, Jan 1999, vol. 24, no. 1, p. 16-8, ISSN: 0307-6938. AU Enomoto-U, Kusakabe-H, Matsumura-T, Kuno-T, Tamai-H, Kiyokane-K. IN Department of Dermatology, Osaka Medical College, Osaka, Japan. YR 1999.AN 10233642 Medline 20070101. TI Diffuse cutaneous mastocytosis responding to cyproheptadine. SO Clinical and experimental dermatology, {Clin-Exp-Dermatol}, Jan 1999, vol. 24, no. 1, p. 16-8, ISSN: 0307-6938. AU Enomoto-U, Kusakabe-H, Matsumura-T, Kuno-T, Tamai-H, Kiyokane-K. IN Department of Dermatology, Osaka Medical College, Osaka, Japan. YR 1999. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25232 |
Study title: AN 15012660 Medline 20070101. TI Prophylactic treatment of pediatric migraine. SO Headache, {Headache}, Mar 2004, vol. 44, no. 3, p. 230-7, ISSN: 0017-8748. AU Lewis-Donald-W, Diamond-Sharon, Scott-David, Jones-Valarie. IN Department of Pediatrics, Division of Pediatric Neurology, Children's Hospital of the King's Daughters, Norfolk, Va 23510, USA. CM Comment in: Headache. 2004 Oct; 44(9):935. YR 2004.AN 15012660 Medline 20070101. TI Prophylactic treatment of pediatric migraine. SO Headache, {Headache}, Mar 2004, vol. 44, no. 3, p. 230-7, ISSN: 0017-8748. AU Lewis-Donald-W, Diamond-Sharon, Scott-David, Jones-Valarie. IN Department of Pediatrics, Division of Pediatric Neurology, Children's Hospital of the King's Daughters, Norfolk, Va 23510, USA. CM Comment in: Headache. 2004... |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25233 |
Study title: AN 15142393 Medline 20070101. TI A chart review of cyproheptadine for stimulant-induced weight loss. SO Journal of child and adolescent psychopharmacology, {J-Child-Adolesc- Psychopharmacol}, Spring 2004, vol. 14, no. 1, p. 65-73, ISSN: 1044-5463. AU Daviss-W-Burleson, Scott-John. IN Department of Psychiatry, Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, USA. YR 2004.AN 15142393 Medline 20070101. TI A chart review of cyproheptadine for stimulant-induced weight loss. SO Journal of child and adolescent psychopharmacology, {J-Child-Adolesc- Psychopharmacol}, Spring 2004, vol. 14, no. 1, p. 65-73, ISSN: 1044-5463. AU Daviss-W-Burleson, Scott-John. IN Department of Psychiatry, Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania... |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25234 |
Study title: Treatment of painful diabetic neuropathy with capsaicin 0.075%. Scheffler NM, Sheitel PL, Lipton MN. Journal of the American Podiatric Medical Association, Jun 1991, vol. 81, no. 6, p. 288−93.Treatment of painful diabetic neuropathy with capsaicin 0.075%. Scheffler NM, Sheitel PL, Lipton MN. Journal of the American Podiatric Medical Association, Jun 1991, vol. 81, no. 6, p. 288−93. |
Active substance: CAPSAICIN |
Study summary document link (including results): |
View full study record |
Document reference: 23226 |
Study title: Stöhr W et al Growth impairment after ifosfamide-induced nephrotoxicity in children Pediatr Blood Cancer. 2007 May;48(5):571-6Stöhr W et al Growth impairment after ifosfamide-induced nephrotoxicity in children Pediatr Blood Cancer. 2007 May;48(5):571-6 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25136 |
Study title: Stöhr W et al Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System Pediatr Blood Cancer. 2007 Apr;48(4):447-52Stöhr W et al Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System Pediatr Blood Cancer. 2007 Apr;48(4):447-52 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25137 |
Study title: Strauss SJ et al Single center experience of a new intensive induction therapy for ewing's family of tumors: feasibility, toxicity, and stem cell mobilization properties J Clin Oncol. 2003 Aug 1;21(15):2974-81Strauss SJ et al Single center experience of a new intensive induction therapy for ewing's family of tumors: feasibility, toxicity, and stem cell mobilization properties J Clin Oncol. 2003 Aug 1;21(15):2974-81 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25138 |
Study title: Suarez A et al Long-term follow-up of ifosfamide renal toxicity in children treated formalignant mesenchymal tumors: an International Society of Pediatric Oncology report J Clin Oncol. 1991 Dec;9(12):2177-82Suarez A et al Long-term follow-up of ifosfamide renal toxicity in children treated formalignant mesenchymal tumors: an International Society of Pediatric Oncology report J Clin Oncol. 1991 Dec;9(12):2177-82 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25139 |
Study title: AN 2003220170 20030626. TI Evaluation of tricyclic antidepressant false positivity in a pediatric case of cyproheptadine (periactin) overdose. AU Yuan-C-M, Spandorfer-P-R, Miller-S-L, Henretig-F-M, Shaw-L-M. IN Dr. L.M. Shaw, Clinical Toxicology Laboratory, Department of Pathology, Univ. of Pennsylvania Medical Center, 3400 Spruce Street, Philadelphia, PA 19104, United States e-mail: shawlmj@mail.med.upenn.edu. SO Therapeutic Drug Monitoring {THER-DRUG-MONIT}, 2003, Vol/Iss/Pg. 25/3 (299-304), ISSN: 0163-4356. YR 2003.AN 2003220170 20030626. TI Evaluation of tricyclic antidepressant false positivity in a pediatric case of cyproheptadine (periactin) overdose. AU Yuan-C-M, Spandorfer-P-R, Miller-S-L, Henretig-F-M, Shaw-L-M. IN Dr. L.M. Shaw, C... |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25263 |
Study title: AU Cortese-Samuele, Lecendreux-Michel, Mouren-Marie-Christine, Konofal-Eric CM Comment on: J Am Acad Child Adolesc Psychiatry. 2005 May; 44(5) :499-501. YR 2006.AU Cortese-Samuele, Lecendreux-Michel, Mouren-Marie-Christine, Konofal-Eric CM Comment on: J Am Acad Child Adolesc Psychiatry. 2005 May; 44(5) :499-501. YR 2006. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25264 |
Study title: AU Homnick-Douglas-N, Marks-John-H, Rubin-Bruce-K. IN Division of Pediatric Pulmonology, Michigan State University, Kalamazoo Center for Medical Studies, Kalamazoo, Michigan 49008, USA. homnick@kcms.msu.edu. YR 2007.AU Homnick-Douglas-N, Marks-John-H, Rubin-Bruce-K. IN Division of Pediatric Pulmonology, Michigan State University, Kalamazoo Center for Medical Studies, Kalamazoo, Michigan 49008, USA. homnick@kcms.msu.edu. YR 2007. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25265 |
Study title: AU Kratochvil-Christopher-J, Lake-Marybeth, Pliszka-Steven-R, Walkup- John-T. IN Department of Psychiatry, University of Nebraska Medical Center, Omaha, NE 68195-5581, USA. ckratoch@unmc.edu. CM Comment in: J Am Acad Child Adolesc Psychiatry. 2006 Apr; 45(4) :384-5. YR 2005.AU Kratochvil-Christopher-J, Lake-Marybeth, Pliszka-Steven-R, Walkup- John-T. IN Department of Psychiatry, University of Nebraska Medical Center, Omaha, NE 68195-5581, USA. ckratoch@unmc.edu. CM Comment in: J Am Acad Child Adolesc Psychiatry. 2006 Apr; 45(4) :384-5. YR 2005. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25266 |
Study title: AU Lewis-Donald-W, Yonker-Marcy, Winner-Paul, Sowell-Michael. IN Children's Hospital of the King's Daughters, Eastern Virginia Medical School, Norfolk, VA, USA. dlewis@chkd.com. YR 2005.AU Lewis-Donald-W, Yonker-Marcy, Winner-Paul, Sowell-Michael. IN Children's Hospital of the King's Daughters, Eastern Virginia Medical School, Norfolk, VA, USA. dlewis@chkd.com. YR 2005. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25267 |
Study title: Yalcin B et al High-dose ifosfamide with hematopoietic growth factor support in advanced bone and soft tissue sarcomas Exp Oncol. 2004 Dec;26(4):320-5Yalcin B et al High-dose ifosfamide with hematopoietic growth factor support in advanced bone and soft tissue sarcomas Exp Oncol. 2004 Dec;26(4):320-5 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25170 |
Study title: Yang CP et al. Treatment of childhood acute lymphoblastic leukemia with protocol TCL-842 inTaiwan: the Taiwan Children's Cancer Study Group. J Formos Med Assoc. 1993 May;92(5):431-9.Yang CP et al. Treatment of childhood acute lymphoblastic leukemia with protocol TCL-842 inTaiwan: the Taiwan Children's Cancer Study Group. J Formos Med Assoc. 1993 May;92(5):431-9. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25171 |
Study title: Yang CP et al. Treatment of childhood acute lymphoblastic leukemia with protocol TCL-842 inTaiwan: the Taiwan Children's Cancer Study Group. J Formos Med Assoc. 1993 May;92(5):431-9.Yang CP et al. Treatment of childhood acute lymphoblastic leukemia with protocol TCL-842 inTaiwan: the Taiwan Children's Cancer Study Group. J Formos Med Assoc. 1993 May;92(5):431-9. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25172 |
Study title: Yock TI et al Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group J Clin Oncol 2006 Aug 20;24(24):3838-43. Erratum in: J Clin Oncol 2006 Oct 20;24(30):4947Yock TI et al Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group J Clin Oncol 2006 Aug 20;24(24):3838-43. Erratum in: J Clin Oncol 2006 Oct 20;24(30):4947 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25173 |
Study title: Yock TI et al. Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group. J Clin Oncol. 2006 Aug 20;24(24):3838-43.Yock TI et al. Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group. J Clin Oncol. 2006 Aug 20;24(24):3838-43. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25174 |
Study title: Yule SM et al Ifosfamide-induced hyperpigmentation Cancer. 1994 Jan 1;73(1):240-1. No abstract availableYule SM et al Ifosfamide-induced hyperpigmentation Cancer. 1994 Jan 1;73(1):240-1. No abstract available |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25175 |
Study title: Zielinska E et al Growth retardation and osteomalacia as a result of ifosfamide nephrotoxicity in a 3-year-old boy whose genotype reveals the genes encoding glutathioneS-transferases GSTM1 and GSTT1 Cytobios. 2001;106(413):193-200Zielinska E et al Growth retardation and osteomalacia as a result of ifosfamide nephrotoxicity in a 3-year-old boy whose genotype reveals the genes encoding glutathioneS-transferases GSTM1 and GSTT1 Cytobios. 2001;106(413):193-200 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25176 |
Study title: Zielinska E et al Increased urinary excretion of the neurotoxic side-chain metabolites of ifosphamide in children with polymorphism of the glutathione S-transferases genes Med Wieku Rozwoj. 2005 Jul-Sep;9(3 Pt 2):579-92. PolishZielinska E et al Increased urinary excretion of the neurotoxic side-chain metabolites of ifosphamide in children with polymorphism of the glutathione S-transferases genes Med Wieku Rozwoj. 2005 Jul-Sep;9(3 Pt 2):579-92. Polish |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25177 |
Study title: Zielinska E et al Role of GSTM1, GSTP1, and GSTT1 gene polymorphism in ifosfamide metabolism affecting neurotoxicity and nephrotoxicity in children J Pediatr Hematol Oncol. 2005 Nov;27(11):582-9Zielinska E et al Role of GSTM1, GSTP1, and GSTT1 gene polymorphism in ifosfamide metabolism affecting neurotoxicity and nephrotoxicity in children J Pediatr Hematol Oncol. 2005 Nov;27(11):582-9 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25178 |
Study title: Zubizarreta PA et al, Nasopharyngeal carcinoma in childhood and adolescence: a single-institution experience with combined therapy, Cancer. 2000 Aug 1;89(3):690-5Zubizarreta PA et al, Nasopharyngeal carcinoma in childhood and adolescence: a single-institution experience with combined therapy, Cancer. 2000 Aug 1;89(3):690-5 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25179 |
Study title: Evaluation of intensified chemotherapy in children with advanced rhabdomyosarcoma (clinical groups III and IV).The Intergroup Rhabdomyosarcoma Study (IRS) Committee of the Cancer and Leukemia Group B Children's Cancer Study Group, Southwest Oncology Group. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25348 |
Study title: Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25349 |
Study title: Ewing tumours: Outcome in children, adolescents and adult patients |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25350 |
Study title: Ewing's sarcoma: treatment with high-dose radiation and adjuvant chemotherapy. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25351 |
Study title: Expression of the hepatic insulin receptor gene in the rat during postnatal development. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25352 |
Study title: Pediatr Med Chir. 1999 May-Jun;21(3):129-33. IT Evaluation of diosmectite in acute diarrhea in children. Milocco C, Bolis A, Rizzo V, Suprani T, Cerasoli G, Marani M, Pocecco M |
Active substance: DIOSMECTITE |
Study summary document link (including results): |
View full study record |
Document reference: 26170 |
Study title: MRL Clinical Study Report, Multicenter Study: A Randomized, Double-Blind, Parallel, Placebo-Controlled, Pilot Study, Comparing the Onset and Duration of Action of Famotidine 10-mg CCT (Coated-Chewable Tablets), Calcium Carbonate-Magnesium Hydroxide Chewable Antacid Tablets (42 mEq ANC), and Placebo on Symptoms Produced Following an Evening Provocative Meal. |
Active substance: FAMOTIDINE COMBINATIONS |
Study summary document link (including results): |
View full study record |
Document reference: 27011 |
Study title: MRL Clinical Study Report, Multicentre Study: A Double-Blind, Randomised, Parallel-Group, Multiple-Dose Study to Compare the Efficacy of Famotidine/Antacid Combination, Famotidine 10mg, Antacid and Placebo in Patients with frequent heartburn. |
Active substance: FAMOTIDINE COMBINATIONS |
Study summary document link (including results): |
View full study record |
Document reference: 27012 |
Study title: See MC et al. Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: Global and quantitative assessment. Dig Dis Sci 2001; 46(5):985-992 |
Active substance: FAMOTIDINE COMBINATIONS |
Study summary document link (including results): |
View full study record |
Document reference: 27008 |
Study title: Leeb B. Topisches Felbinac in der therapie von sportverletzungen. Fortschritte der Medizin 1994; 112(6): 77-80. |
Active substance: FELBINAC |
Study summary document link (including results): |
View full study record |
Document reference: 27018 |
Study title: McLatchie GR, McDonald M, Lawrence DF et al. Soft tissue trauma: a randomized controlled trial of the topical application of felbinac, a new NSAID. Br J Clin Pract 1989; 44: 277-80. |
Active substance: FELBINAC |
Study summary document link (including results): |
View full study record |
Document reference: 27015 |
Study title: Oakland C, Rapier C. A comparison of the efficacy of the topical NSAID felbinac and ultrasound in the treatment of acute ankle injuries. Br J Clin Res 1993; 4:89-96. |
Active substance: FELBINAC |
Study summary document link (including results): |
View full study record |
Document reference: 27017 |
Study title: Vandenhoven G, Wouters C, Slachmuylders P et al. Biphenylacetic acid (Felbinac) 3% gel t.i.d. in patients with acute soft tissue injuries. Acta Therapeutica 1995; 21(2): 155-66. |
Active substance: FELBINAC |
Study summary document link (including results): |
View full study record |
Document reference: 27016 |
Study title: Immunotherapy in children with allergic asthma: Effect on bronchial hyperreactivity and pharmacotherapy |
Active substance: Felis domesticus |
Study summary document link (including results): |
View full study record |
Document reference: 40001 |
Study title: Immunotherapy with partially purified and standardized animal dander extracts |
Active substance: FELIS DOMESTICUS |
Study summary document link (including results): |
View full study record |
Document reference: 27019 |
Study title: Immunotherapy with partially purified and standardized animal dander extracts |
Active substance: Felis domesticus |
Study summary document link (including results): |
View full study record |
Document reference: 40000 |
Study title: A multicenter, open-label, single-dose study of the safety, tolerability and pharmacokinetics of felodipine in pediatric subjects. |
Active substance: FELODIPINE |
Study summary document link (including results): US No. 235 (SH-FEH-0025) CSR Synopsis.pdf |
View full study record |
Document reference: 27020 |
Study title: A multicenter, open-label, single-dose study of the safety, tolerability and pharmacokinetics of felodipine in pediatric subjects |
Active substance: FELODIPINE |
Study summary document link (including results): US No. 235 (SH-FEH-0025) CSR Synopsis.pdf |
View full study record |
Document reference: 27023 |
Study title: Blowey DL et al . The pharmacokinetics of extended release felodipine in children Eur J Clin Pharmacol 1996; 50: 147-148 |
Active substance: FELODIPINE |
Study summary document link (including results): |
View full study record |
Document reference: 27024 |
Study title: Clinical trial of extended-release felodipine in pediatric essential hypertension - Trachtman H et al - 2003 (Pediatr Nephrol 18: 548-553) |
Active substance: FELODIPINE |
Study summary document link (including results): |
View full study record |
Document reference: 27021 |
Study title: Dose ranging, safety and tolerability trial of felodipine ER in pediatric patients; a multicenter, double-blind, placebo-controlled, randomized, parallel group trial with an open-label extension |
Active substance: FELODIPINE |
Study summary document link (including results): US No. 216 OL (SH-FEH-0024) CSR Synopsis.pdf |
View full study record |
Document reference: 27022 |
Study title: Moncica I et al. A crossover comparison of extended release felodipine with prolonged action nifedipine in hypertension Arch Dis Child 1995; 73: 154-156 |
Active substance: FELODIPINE |
Study summary document link (including results): |
View full study record |
Document reference: 27025 |
Study title: Long-term assessment of the safety and efficacy of fenofibrate in hypercholesterolemic children and adolescents. Analysis of a long-term registry. |
Active substance: FENOFIBRATE |
Study summary document link (including results): Fenofenofibrate-CFEN7301FR202.pdf |
View full study record |
Document reference: 27026 |
Study title: Steinmetz J, Morin C, Panek E, Siest G, Drouin P. Biological variations in hyperlipidemic children and adolescents treated with fenofibrate. Clinica Chimica Acta 1981; 112:43-53Steinmetz J, Morin C, Panek E, Siest G, Drouin P. Biological variations in hyperlipidemic children and adolescents treated with fenofibrate. Clinica Chimica Acta 1981; 112:43-53 |
Active substance: FENOFIBRATE |
Study summary document link (including results): |
View full study record |
Document reference: 27027 |
Study title: AN 15447711 Medline 20070101. TI Cyproheptadine's antiserotonin effects are responsible for its antimigraine activity. SO Headache, {Headache}, Oct 2004, vol. 44, no. 9, p. 935, ISSN: 0017-8748. AU Lehrer-Joel-F. CM Comment on: Headache. 2004 Mar; 44(3):230-7. YR 2004.AN 15447711 Medline 20070101. TI Cyproheptadine's antiserotonin effects are responsible for its antimigraine activity. SO Headache, {Headache}, Oct 2004, vol. 44, no. 9, p. 935, ISSN: 0017-8748. AU Lehrer-Joel-F. CM Comment on: Headache. 2004 Mar; 44(3):230-7. YR 2004. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25236 |
Study title: AN 15843773 Medline 20070101. TI Pharmacological management of treatment-induced insomnia in ADHD. SO Journal of the American Academy of Child and Adolescent Psychiatry, {J-Am-Acad-Child-Adolesc-Psychiatry}, May 2005, vol. 44, no. 5, p. 499-501, 3 refs, ISSN: 0890-8567.AN 15843773 Medline 20070101. TI Pharmacological management of treatment-induced insomnia in ADHD. SO Journal of the American Academy of Child and Adolescent Psychiatry, {J-Am-Acad-Child-Adolesc-Psychiatry}, May 2005, vol. 44, no. 5, p. 499-501, 3 refs, ISSN: 0890-8567. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25237 |
Study title: AN 16601641 Medline 20070101. TI ADHD and insomnia. SO Journal of the American Academy of Child and Adolescent Psychiatry, {J-Am-Acad-Child-Adolesc-Psychiatry}, Apr 2006, vol. 45, no. 4, p. 384-5, ISSN: 0890-8567.AN 16601641 Medline 20070101. TI ADHD and insomnia. SO Journal of the American Academy of Child and Adolescent Psychiatry, {J-Am-Acad-Child-Adolesc-Psychiatry}, Apr 2006, vol. 45, no. 4, p. 384-5, ISSN: 0890-8567. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25239 |
Study title: Chyatte SB et al.:The use of dantrolene sodium in disorders of the central nervous system; Southern Medical Journal 64, 830-834 (1971)Chyatte SB et al.:The use of dantrolene sodium in disorders of the central nervous system; Southern Medical Journal 64, 830-834 (1971) |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25535 |
Study title: Chyatte, S.B.:Double-blind controlled evaluation of the Safety and Efficacy of Dantrolene Sodium in Patients With Athetoid Cerebral Palsy;Chyatte, S.B.:Double-blind controlled evaluation of the Safety and Efficacy of Dantrolene Sodium in Patients With Athetoid Cerebral Palsy; |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25548 |
Study title: Ford F et al: Efficacy of dantrolene sodium in the treatment of spastic cerebral palsy; Dev. Med. Child. Neurol. 18, 770-783 (1976)Ford F et al: Efficacy of dantrolene sodium in the treatment of spastic cerebral palsy; Dev. Med. Child. Neurol. 18, 770-783 (1976) |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25538 |
Study title: Haslam RHA et al.:Dantrolene sodium in children with spasticity; Arch. Phys. Med. Rehabil. 55, 384-388 (1974)Haslam RHA et al.:Dantrolene sodium in children with spasticity; Arch. Phys. Med. Rehabil. 55, 384-388 (1974) |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25530 |
Study title: Kolb ME et al.: Dantrolene in Human Malignant Hyperthermia. A Multicenter Study; Anesthesiology 56 (4): 254-262 (1982)Kolb ME et al.: Dantrolene in Human Malignant Hyperthermia. A Multicenter Study; Anesthesiology 56 (4): 254-262 (1982) |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25544 |
Study title: Larach, DR et al.: Cardiopulmonary bypass interference with dantrolene prophylaxis of malignant hyperthermia. J. Cardiothoracic Anesthesia 1, 448-453 (1987)Larach, DR et al.: Cardiopulmonary bypass interference with dantrolene prophylaxis of malignant hyperthermia. J. Cardiothoracic Anesthesia 1, 448-453 (1987) |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25541 |
Study title: Lerman J. et.al.: Pharmacokinetics of intravenous dantrolene in children. Anaesthesiol. 70, 625-629 (1989)Lerman J. et.al.: Pharmacokinetics of intravenous dantrolene in children. Anaesthesiol. 70, 625-629 (1989) |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25540 |
Study title: Lewis, K.R.:Double-blind Controlled Evaluation of the Safety and Efficacy of Dantrolene Sodium in the Treatment of Moderate to Severe Skeletal Muscle Spasticity in a Pediatric Population;Lewis, K.R.:Double-blind Controlled Evaluation of the Safety and Efficacy of Dantrolene Sodium in the Treatment of Moderate to Severe Skeletal Muscle Spasticity in a Pediatric Population; |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25549 |
Study title: Lietman, P.S. et al.: Pharmacology of dantrolene sodium in children; Arch. Phys. Med. Rehabil. 55, 388-392 (1974)Lietman, P.S. et al.: Pharmacology of dantrolene sodium in children; Arch. Phys. Med. Rehabil. 55, 388-392 (1974) |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25526 |
Study title: Mahmoudian M, Skellern GG:Pharmacokinetics of dantrolene sodium in a patient suffering from malignant hyperpyrexia crisis; Iranian J. Med. Sci. 16, 82-86 (1991)Mahmoudian M, Skellern GG:Pharmacokinetics of dantrolene sodium in a patient suffering from malignant hyperpyrexia crisis; Iranian J. Med. Sci. 16, 82-86 (1991) |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25543 |
Study title: Multicenter, double-blind, double dummy, randomizedparallel group study to evaluate the safety of 0.030 mg ethinylestradiol / 2 mg dienogest for 6 treatment cycles in female patients with papulopustular acne in comparison to 0.035 mg ethinylestradiol / 2 mg cyproterone acetate and placeboTI (Efficacy of cyproheptadine in the therapy of essential headache in the developmental age). TT L'efficacia della ciproeptadina nella terapia delle cefalee essenziali in eta evolutiva. SO Minerva pediatrica, {Minerva-Pediatr}, 30 Apr 1984, vol. 36, no. 8, p. 431-7, ISSN: 0026-4946. AU Rosano-Burgio-F, Fazzi-E, Paglino-S, Lanzi-G. YR 1984. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25268 |
Study title: BAY b 5097 Spray Efficacy and Tolerance in Dermatomycoses. Open, Mycologically Controlled Study |
Active substance: CYPROTERONE + ETHINYLESTRADIOL |
Study summary document link (including results): |
View full study record |
Document reference: 25270 |
Study title: Multicenter, double-blind, randomized parallel group study on efficacy of 0.035 mg ethinylestradiol / 2 mg cyproterone acetate and of 0.035 mg ethinylestradiol / 2 mg cyproterone acetate in combination with 10 mg cyproterone acetate in comparison to triphasic ethinylestradiol / norgestimate over 6 cycles in women with acne papulopustulosa |
Active substance: CYPROTERONE + ETHINYLESTRADIOL |
Study summary document link (including results): |
View full study record |
Document reference: 25269 |
Study title: OPEN, MULTICENTER STUDY WITH INITIAL CYCLIC HIGH-DOSE HYDROXY-UREA THERAPY AND PROGNOSIS ORIENTED MAINTENANCE THERAPY IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA (CML) |
Active substance: CYTARABINE |
Study summary document link (including results): |
View full study record |
Document reference: 25273 |
Study title: PHASE I/II STUDY ON THE COMBINATION OF HIGH-DOSE CYTARABINE AND MITOXANTRONE IN REFRACTORY NONHODGKIN'S LYMPHOMAS (from Appendix)" |
Active substance: CYTARABINE |
Study summary document link (including results): |
View full study record |
Document reference: 25271 |
Study title: "TO DETERMINE THE REMISSION DURATION PRODUCED BY AN INTERMEDIATE DOSE ARAC CONTAINING CONSOLIDATION SCHEDULE FOLLOWED BY AUTOLOGOUS BONE MARROW TRANSPLANTATION IN PREVIOUSLY UNTREATED PATIENTS WITH ACUTE |
Active substance: CYTARABINE |
Study summary document link (including results): |
View full study record |
Document reference: 25272 |
Study title: Daunomycin in the treatment of acute leukaemia and neoplastic diseases in childhood - Massimo L., Fossati-Guglielmoni A. & Fortuna E. - 1968 - Publication in the dos. allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - Daunomycin in the treatment of acute leukaemia and neoplastic diseases in childhood - Massimo L., Fossati-Guglielmoni A. & Fortuna E. - 1968 - Publication in the dos. allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25579 |
Study title: Daunorubicin - prednisone treatment of erythroleukemia - Bloomfield, C. D., Brunning, R. D., Kennedy, B. J. - 1974 (Annals of Internal Medicin 81, 746 - 750) - Publication in the dos. Allemand jan 1981 - Daunorubicin - prednisone treatment of erythroleukemia - Bloomfield, C. D., Brunning, R. D., Kennedy, B. J. - 1974 (Annals of Internal Medicin 81, 746 - 750) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25580 |
Study title: Daunorubicin (DNR) cardiac toxicity in children with acute lymphocytic leukemia (A.L.L.) - J.F. Halazun, H.R. Wagner, J.F. Gaeta & coll. - 1973 - Publication in the dos. Français jan 1977 and in the dos. Allemand jan 1981 - Daunorubicin (DNR) cardiac toxicity in children with acute lymphocytic leukemia (A.L.L.) - J.F. Halazun, H.R. Wagner, J.F. Gaeta & coll. - 1973 - Publication in the dos. Français jan 1977 and in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25581 |
Study title: Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia - B. Jones, J.F. Holland, A.R. Morrison & coll. - 1971 - Publication in the dos. Français jan 1977 and in the dos. Allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia - B. Jones, J.F. Holland, A.R. Morrison & coll. - 1971 - Publication in the dos. Français jan 1977 and in the dos. Allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25582 |
Study title: Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia - B. Jones, J.F. Holland, A.R. Morrison & coll. - 1971 - Publication in the dos. Français jan 1977 and in the dos. Allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia - B. Jones, J.F. Holland, A.R. Morrison & coll. - 1971 - Publication in the dos. Français jan 1977 and in the dos. Allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25616 |
Study title: Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia - B. Jones, J.F. Holland, A.R. Morrison & coll. - 1971 - Publication in the dos. Français jan 1977 and in the dos. Allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia - B. Jones, J.F. Holland, A.R. Morrison & coll. - 1971 - Publication in the dos. Français jan 1977 and in the dos. Allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25620 |
Study title: Failure of high-dose alkylating agents in osteosarcoma. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25353 |
Study title: False-positive anti-Toxoplasma fluorescent-antibody tests in patients with antinuclear antibodies. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25354 |
Study title: Fibromatosis (desmoid tumor) involving the orbit and cheek. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25355 |
Study title: GAMEC--a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25356 |
Study title: Hematopathy-thrombocytopenia syndrome in children treated with dactinomycin |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25357 |
Study title: Hemophagocytic alveolar rhabdomyosarcoma |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25358 |
Study title: Hepatotoxicity in irradiated nephroblastoma patients during postoperative treatment according to SIOP9/GPOH. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25359 |
Study title: Hepatotoxicity in patients treated according to the nephroblastoma trial and study SIOP-9/GPOH. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25360 |
Study title: High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25361 |
Study title: Hourly monitoring of circulating CD34+ cells to optimize timing of autologous apheresis in pediatric patients |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25362 |
Study title: How to establish equivalence between treatments: a one-sided clinical trial in paediatric oncology. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25363 |
Study title: Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25364 |
Study title: Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25365 |
Study title: Ifosfamide in soft tissue sarcoma. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25366 |
Study title: Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25367 |
Study title: Importance of dactinomycin in the current therapy of tumors |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25368 |
Study title: Improving outcomes after relapse in Ewing's sarcoma: Analysis of 114 patients from a single institution |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25369 |
Study title: Increased systemic toxicity of sarcoma chemotherapy due to combination with the P-glycoprotein inhibitor cyclosporin. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25370 |
Study title: Initial chemotherapy including ifosfamide in the management of Ewing's sarcoma: preliminary results. A protocol of the French Pediatric Oncology Society (SFOP). |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25371 |
Study title: Integrated therapy for Ewing's sarcoma. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25372 |
Study title: Integrative tumor board: Pediatric synovial sarcoma |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25373 |
Study title: Controlled assessment of the effects of deflazacort hemisuccinate and methylprednisolone hemisuccinate in patients with acute bronchial asthma - McDermott J and Marsden J - 1 June 1995 - Report in the Clinical Documentation Deflazacort injectable 60 mg and 300mg vials - 06/1995 |
Active substance: DEFLAZACORT |
Study summary document link (including results): Deflazacort STUDY MMD01.xls |
View full study record |
Document reference: 25637 |
Study title: 0.5 % Th 1165a drops: report of a joint trial for therapeutic assessment in paediatric in-patients with bronchospasm. |
Active substance: FENOTEROL |
Study summary document link (including results): Fenoterol hydrobromide_U70-0179_synopsis.pdf |
View full study record |
Document reference: 27036 |
Study title: Treatment of acute bronchial asthma comparison between epinephrine (injections - subcutaneous) and fenoterol (inhalation). |
Active substance: FENOTEROL |
Study summary document link (including results): Fenoterol hydrobromide_U84-0556_synopsis.pdf |
View full study record |
Document reference: 27088 |
Study title: A 4-Week, Open-Label Extension Study of ACTIQ® (Oral Transmucosal Fentanyl Citrate [OTFC®]) Treatment for Opioid-Tolerant Children and Adolescents With Breakthrough Pain |
Active substance: FENTANYL |
Study summary document link (including results): Fentanyl_Actiq_C8278b_202BPUSCA and C8278b_2022BPUSCA.xls |
View full study record |
Document reference: 27124 |
Study title: A comparison of oral transmucosal fentanyl and oral midazolam for premedication in children. Howell TK, Smith S, Rushman SC, Walker RW, Radivan F. Anaesthesia. 2002 Aug;57(8):798-805. |
Active substance: FENTANYL |
Study summary document link (including results): |
View full study record |
Document reference: 27125 |
Study title: A comparison of oral transmucosal fentanyl citrate and oral hydromorphone for inpatient pediatric burn wound care analgesia; Journal of Burn Care &; Rehabilitation 1998, 19(6): 516-21 |
Active substance: FENTANYL |
Study summary document link (including results): |
View full study record |
Document reference: 27126 |
Study title: A comparison of oral transmucosal fentanyl citrate and oral oxycodone for pediatric outpatient wound care; J Burn Care Rehabil 2002, 23(1): 27-31 |
Active substance: FENTANYL |
Study summary document link (including results): |
View full study record |
Document reference: 27127 |
Study title: A double-blind study of the analgesic efficacy of oral transmucosal fentanyl citrate and oral morphine in pediatric patients undergoing burn dressing change and tubbing; Paediatric Anaesthesia 2004, 14(9): 759-67 |
Active substance: FENTANYL |
Study summary document link (including results): |
View full study record |
Document reference: 27128 |
Study title: A Double-Blind, Placebo-Comparison Study to Evaluate the Efficacy and Safety of ACTIQ® (Oral Transmucosal Fentanyl Citrate [OTFC®]) Treatment for Opioid-Tolerant Children and Adolescents With Breakthrough Pain |
Active substance: FENTANYL |
Study summary document link (including results): Fentanyl_Actiq_C8278b_202BPUSCA and C8278b_2022BPUSCA.xls |
View full study record |
Document reference: 27123 |
Study title: A randomized clinical trial of oral transmucosal fentanyl citrate versus intravenous morphine sulfate for initial control of pain in children with extremity injuries.Pediatric Emergency Care 2007, 23(8): 544-8 |
Active substance: FENTANYL |
Study summary document link (including results): |
View full study record |
Document reference: 27129 |
Study title: A randomized, clinical trial of oral midazolam plus placebo versus oral midazolam plus oral transmucosal fentanyl for sedation during laceration repair; Pediatrics,2002, 109(5): 894-897 |
Active substance: FENTANYL |
Study summary document link (including results): |
View full study record |
Document reference: 27130 |
Study title: Age and fentanyl pharmacokinetics. Bentley et al. Anesth. Analgesia 1982, 61, 968-971 |
Active substance: FENTANYL |
Study summary document link (including results): |
View full study record |
Document reference: 27131 |
Study title: Analgesia with oral transmucosal fentanyl citrate (OTFC) for painful pediatric procedures; Journal de Pharmacie Clinique 2006, 25(1): 9-15 |
Active substance: FENTANYL |
Study summary document link (including results): |
View full study record |
Document reference: 27132 |
Study title: Analgesia with oral transmucosal fentanyl citrate (OTFC) for painful pediatric procedures; Revista de la Sociedad Espanola del Dolor 2004, 11(7): 415-419 |
Active substance: FENTANYL |
Study summary document link (including results): |
View full study record |
Document reference: 27133 |
Study title: Assessment of small-dose fentanyl and sufentanil blunting the cardiovascular responses to laryngoscopy and intubation in children. Xue, F.S., et al., Paediatr Anaesth, 2007. 17(6): p. 568-74. |
Active substance: FENTANYL |
Study summary document link (including results): |
View full study record |
Document reference: 27134 |
Study title: Blunting of stress responses in the pulmonary circulation of infants by fentanyl. Hickey et al., Anaesth analg, 1985, 64 , 1137-1142. |
Active substance: FENTANYL |
Study summary document link (including results): |
View full study record |
Document reference: 27135 |
Study title: Cancer pain management in children; Agri 2004, 16(4): 31-34 |
Active substance: FENTANYL |
Study summary document link (including results): |
View full study record |
Document reference: 27137 |
Study title: Cancer pain management in children; Revista de la Sociedad Espanola del Dolor 2004, 11(7): 415-419 |
Active substance: FENTANYL |
Study summary document link (including results): |
View full study record |
Document reference: 27138 |
Study title: Clinical evaluation of oral transmucosal fentanyl citrate (OTFC) vs. Placebo as a premedication in children |
Active substance: FENTANYL |
Study summary document link (including results): Fentanyl Actiq 100-003.xls |
View full study record |
Document reference: 27108 |
Study title: Clinical evaluation of oral transmucosal fentanyl citrate (OTFC) vs. Placebo as a premedication in children with and without droperidol as a prophylactic anti-emetic |
Active substance: FENTANYL |
Study summary document link (including results): Fentanyl Actiq 100008A.xls |
View full study record |
Document reference: 27111 |
Study title: Mayer N. et al: Treatment of spasticity with dantrolene sodium; Am. J. Phys. Med. 52, 18 (1973)Mayer N. et al: Treatment of spasticity with dantrolene sodium; Am. J. Phys. Med. 52, 18 (1973) |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25553 |
Study title: Mejia, R.:Double-blind Controlled Evaluation of the Safety and Efficacy of Dantrolene Sodium in the Treatment of Moderate to Severe Skeletal Muscle Spasticity in a Pediatric Population;Mejia, R.:Double-blind Controlled Evaluation of the Safety and Efficacy of Dantrolene Sodium in the Treatment of Moderate to Severe Skeletal Muscle Spasticity in a Pediatric Population; |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25550 |
Study title: Meyler, W.J. et al: The effect of dantrolene sodium in relation to blood levels in spastic patients after prolonged administration; J. Neurol. Neurosurg. Psychiatry 44, 334-339 (1981)Meyler, W.J. et al: The effect of dantrolene sodium in relation to blood levels in spastic patients after prolonged administration; J. Neurol. Neurosurg. Psychiatry 44, 334-339 (1981) |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25528 |
Study title: Molnar GE et al.: Dantrolene sodium in spasticity. Long-term administration in children; N. Y. StateJ. Med. 78, 1233-1237 (1978)Molnar GE et al.: Dantrolene sodium in spasticity. Long-term administration in children; N. Y. StateJ. Med. 78, 1233-1237 (1978) |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25537 |
Study title: Murakawa, M. Et al.: Dantrolene plasma concentration during malignant hyperthermia crisis; Hiroshima J. Anesth. 24 (S19), 93-96 (1988)Murakawa, M. Et al.: Dantrolene plasma concentration during malignant hyperthermia crisis; Hiroshima J. Anesth. 24 (S19), 93-96 (1988) |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25542 |
Study title: Post-marketing surveillance study of Seractil 200 mg and 300 mg film-coated tablets involving 1400 patients with rheumatic diseases. Phelps W. et al.. (Nov 1994): Final report Gebro; English translation, original report (in German language).Post-marketing surveillance study of Seractil 200 mg and 300 mg film-coated tablets involving 1400 patients with rheumatic diseases. Phelps W. et al.. (Nov 1994): Final report Gebro; English translation, original report (in German language). |
Active substance: DEXAMETHASONE AND NEOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25750 |
Study title: Postoperative miotics for patients with infantile esotropia.Spierer A, Zeeli T. Ophthalmic Surg Lasers. 1997 Dec;28(12):1002-5. Postoperative miotics for patients with infantile esotropia.Spierer A, Zeeli T. Ophthalmic Surg Lasers. 1997 Dec;28(12):1002-5. |
Active substance: DEXAMETHASONE AND NEOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25744 |
Study title: Trimethoprim-polymyxin B ophthalmic solution in treatment of surface ocular bacterial infections. Nozik RA, Smolin G, Knowlton G, Austin R. Ann Ophthalmol. 1985 Dec;17(12):746-8. Trimethoprim-polymyxin B ophthalmic solution in treatment of surface ocular bacterial infections. Nozik RA, Smolin G, Knowlton G, Austin R. Ann Ophthalmol. 1985 Dec;17(12):746-8. |
Active substance: DEXAMETHASONE AND NEOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25748 |
Study title: Vernal keratoconjunctivitis in the black child and its response to therapy.Dahan E, Appel R. Br J Ophthalmol. 1983 Oct;67(10):688-92. Vernal keratoconjunctivitis in the black child and its response to therapy.Dahan E, Appel R. Br J Ophthalmol. 1983 Oct;67(10):688-92. |
Active substance: DEXAMETHASONE AND NEOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25747 |
Study title: A comparison of ciprofloxacin and tobramycin in bacterial conjunctivitis in children.Gross RD, Hoffman RO, Lindsay RN. Clin Pediatr (Phila). 1997 Aug;36(8):435-44 Comment in: Clin Pediatr (Phila). 1997 Aug;36(8):445-8. PMID: 9272317. A comparison of ciprofloxacin and tobramycin in bacterial conjunctivitis in children.Gross RD, Hoffman RO, Lindsay RN. Clin Pediatr (Phila). 1997 Aug;36(8):435-44 Comment in: Clin Pediatr (Phila). 1997 Aug;36(8):445-8. PMID: 9272317. |
Active substance: DEXAMETHASONE AND TOBRAMYCIN |
Study summary document link (including results): Comparison of ciprofloxacin and tobramycin in bacterial conj.pdf |
View full study record |
Document reference: 25753 |
Study title: Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia - B. Jones, J.F. Holland, A.R. Morrison & coll. - 1971 - Publication in the dos. Français jan 1977 and in the dos. Allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia - B. Jones, J.F. Holland, A.R. Morrison & coll. - 1971 - Publication in the dos. Français jan 1977 and in the dos. Allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25625 |
Study title: Daunorubicin (NSC 83142) in advanced childhood leukemia - N. Jaffe, D.G. Traggis & L. Das - 1974 - Publication in the dos. Français jan 1977 and in the dos. Allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - Daunorubicin (NSC 83142) in advanced childhood leukemia - N. Jaffe, D.G. Traggis & L. Das - 1974 - Publication in the dos. Français jan 1977 and in the dos. Allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25583 |
Study title: Daunorubicin and L-asparaginase therapy for relapse in acute childhood leukemia - H. Kaizer, A. Sigler, E.S. Buescher & coll. - 1976 - Publication in the dos. Français jan 1977 -Daunorubicin and L-asparaginase therapy for relapse in acute childhood leukemia - H. Kaizer, A. Sigler, E.S. Buescher & coll. - 1976 - Publication in the dos. Français jan 1977 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25584 |
Study title: Daunorubicin in the therapy of acute granulocytic leukaemia - Weil M. et al. - 1973 - Publication in Clinical Expert Report (J.K.H. Rees - 1989) and in the dos. Allemand jan 1981 - Daunorubicin in the therapy of acute granulocytic leukaemia - Weil M. et al. - 1973 - Publication in Clinical Expert Report (J.K.H. Rees - 1989) and in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25585 |
Study title: Daunorubicin in the treatment of acute myelocytic leukaemia - Boiron M. et al. - 1969 - Publication in Clinical Expert Report (J.K.H. Rees - 1989) -Daunorubicin in the treatment of acute myelocytic leukaemia - Boiron M. et al. - 1969 - Publication in Clinical Expert Report (J.K.H. Rees - 1989) - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25586 |
Study title: Daunorubicin therapy in advanced neuroblastoma - Samuels LD et al. - 1971 - Publication in the dos. Allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - Daunorubicin therapy in advanced neuroblastoma - Samuels LD et al. - 1971 - Publication in the dos. Allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25587 |
Study title: Paul IM et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007; 161(12):1140-1146Paul IM et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007; 161(12):1140-1146 |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 25800 |
Study title: Phase IV Safety and Efficacy Study of C-30 Liquid Cough-Cold FormulaPhase IV Safety and Efficacy Study of C-30 Liquid Cough-Cold Formula |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 25799 |
Study title: Taylor AJ et al. Efficacy of cough suppressants in children. J Pediatr 1993; 122(5 Pt 1):799-802 Taylor AJ et al. Efficacy of cough suppressants in children. J Pediatr 1993; 122(5 Pt 1):799-802 |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 25792 |
Study title: Yoder KE et al. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clin Pediatr 2006; 45(7):633-640Yoder KE et al. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clin Pediatr 2006; 45(7):633-640 |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 25788 |
Study title: Britton−M−G, Empey−D−W, John−G−C, Hodder−M, Hughes−D−T. Two doses of triprolidine for treatment of allergic rhinitis. Annals of allergy, {Ann−Allergy}, May 1979, vol. 42, no. 5, p. 330−2.Britton−M−G, Empey−D−W, John−G−C, Hodder−M, Hughes−D−T. Two doses of triprolidine for treatment of allergic rhinitis. Annals of allergy, {Ann−Allergy}, May 1979, vol. 42, no. 5, p. 330−2. |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 25818 |
Study title: Korppi M et al. Antitussives in the treatment of acute transient cough in children. Acta Paediatr Scand 1991; 80(10):969-71Korppi M et al. Antitussives in the treatment of acute transient cough in children. Acta Paediatr Scand 1991; 80(10):969-71 |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 25806 |
Study title: Lee PCL et al. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 2000; 52(9):1137-42Lee PCL et al. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 2000; 52(9):1137-42 |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 25804 |
Study title: Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: results of the International Society of Pediatric Oncology MMT 84 Study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25424 |
Study title: Primary chemotherapy in the treatment of rhabdomyosarcoma in children: trial of the International Society of Pediatric Oncology (SIOP) preliminary results. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25425 |
Study title: Primary chemotherapy with the Rosen T10 protocol before conservative surgery in limb primitive osteosarcomas: results about 56 cases |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25426 |
Study title: Primary osteogenic sarcoma of the femur: a model for the use of preoperative chemotherapy in high risk malignant tumors. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25427 |
Study title: Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25428 |
Study title: Probable cure of metastatic testicular tumors treated with sequential therapy. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25429 |
Study title: Prognosis in children with Wilms' tumor metastases prior to or following primary treatment: results from the first National Wilms' Tumor Study (NWTS-1). |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25430 |
Study title: Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study). |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25431 |
Study title: Prognostic factors in patients with localized Ewing's sarcoma: the effect on survival of actual received drug dose intensity and of histologic response to induction therapy. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25432 |
Study title: Prophylactic actinomycin D for high-risk complete hydatidiform mole. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25434 |
Study title: Radiation related toxicities in National Wilms' Tumor Study Number 1. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25435 |
Study title: Radiation therapy in the multimodal management of Ewing's sarcoma of bone: report of the Intergroup Ewing's Sarcoma Study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25437 |
Study title: Randomized study of systemic chemotherapy following complete excision of nonosseous sarcomas. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25438 |
Study title: Rarity of surgical complications after postchemotherapy nephrectomy for nephroblastoma. Experience of the International Society of Paediatric Oncology-Trial and Study 'SIOP-9'. International Society of Paediatric Oncology Nephroblastoma Trial and Study Committee. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25439 |
Study title: Recent trends in the medical treatment of Hodgkin's disease. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25440 |
Study title: Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25441 |
Study title: Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25442 |
Study title: Relationship between dose schedule and charges for treatment on National Wilms' Tumor Study-4. A report from the National Wilms' Tumor Study Group. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25443 |
Study title: Response and survival of patients with metastatic neuroblastoma after combination chemotherapy with adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and vincristine (NSC-67574). |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25444 |
Study title: Results of chemotherapy and salvage surgery for advanced testicular cancer |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25445 |
Study title: Results of intensive therapy in children with localized alveolar extremity rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25446 |
Study title: Results of the COSS-77 and COSS-80 studies on adjuvant chemotherapy in osteosarcoma of the extremities |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25447 |
Study title: Clinical evaluation of oral transmucosal fentanyl citrate vs. An oral solution of meperidine, diazepam and atropine as a premedication in pediatric patients undergoing cardiovascular surgery |
Active substance: FENTANYL |
Study summary document link (including results): Fentanyl Actiq 100011.xls |
View full study record |
Document reference: 27115 |
Study title: BIOAVAILABILITY OF DICLOFENAC-NA FROM VOLTAREN CHILDREN'S SUPPOSITORIES FOLLOWING A SINGLE ADMINISTRATION AND REPEATED ADMINISTRATION IN CHLIDRENBIOAVAILABILITY OF DICLOFENAC-NA FROM VOLTAREN CHILDREN'S SUPPOSITORIES FOLLOWING A SINGLE ADMINISTRATION AND REPEATED ADMINISTRATION IN CHLIDREN |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 26080 |
Study title: Bisacodyl and high-amplitude-propagating colonic contractions in children. Bisacodyl and high-amplitude-propagating colonic contractions in children. |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 26000 |
Study title: Borkar J, Dave N. Analgesic efficacy of caudal block versus diclofenac suppository and local anesthetic infiltration following pediatric laparoscopy. J Laparoendosc Adv Surg Tech A. 2005 Aug;15(4):415-8.Borkar J, Dave N. Analgesic efficacy of caudal block versus diclofenac suppository and local anesthetic infiltration following pediatric laparoscopy. J Laparoendosc Adv Surg Tech A. 2005 Aug;15(4):415-8. |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 25969 |
Study title: Borkar J, Dave N. Analgesic efficacy of caudal block versus diclofenac suppository and local anesthetic infiltration following pediatric laparoscopy. J Laparoendosc Adv Surg Tech A. 2005 Aug;15(4):415-8.Borkar J, Dave N. Analgesic efficacy of caudal block versus diclofenac suppository and local anesthetic infiltration following pediatric laparoscopy. J Laparoendosc Adv Surg Tech A. 2005 Aug;15(4):415-8. |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 25976 |
Study title: Borkar J, Dave N. Analgesic efficacy of caudal block versus diclofenac suppository and local anesthetic infiltration following pediatric laparoscopy. J Laparoendosc Adv Surg Tech A. 2005 Aug;15(4):415-8.Borkar J, Dave N. Analgesic efficacy of caudal block versus diclofenac suppository and local anesthetic infiltration following pediatric laparoscopy. J Laparoendosc Adv Surg Tech A. 2005 Aug;15(4):415-8. |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 25985 |
Study title: Borkar J, Dave N. Analgesic efficacy of caudal block versus diclofenac suppository and local anesthetic infiltration following pediatric laparoscopy. J Laparoendosc Adv Surg Tech A. 2005 Aug;15(4):415-8.Borkar J, Dave N. Analgesic efficacy of caudal block versus diclofenac suppository and local anesthetic infiltration following pediatric laparoscopy. J Laparoendosc Adv Surg Tech A. 2005 Aug;15(4):415-8. |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 25988 |
Study title: Cander B, et all.The effectiveness of analgesics in traumatic injuries of the extremities. Adv Ther. 2005 Sep-Oct;22(5):462-6.Cander B, et all.The effectiveness of analgesics in traumatic injuries of the extremities. Adv Ther. 2005 Sep-Oct;22(5):462-6. |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 25979 |
Study title: Cander B, et all.The effectiveness of analgesics in traumatic injuries of the extremities. Adv Ther. 2005 Sep-Oct;22(5):462-6.Cander B, et all.The effectiveness of analgesics in traumatic injuries of the extremities. Adv Ther. 2005 Sep-Oct;22(5):462-6. |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 25990 |
Study title: CATAFLAM DROPS (DICLOFENAC RESINATE) IN ACUTE PHARYNGOTONSILLITIS IN CHILDREN, AS AN ADJUVANT TO ANTIBIOTIC THERAPYCATAFLAM DROPS (DICLOFENAC RESINATE) IN ACUTE PHARYNGOTONSILLITIS IN CHILDREN, AS AN ADJUVANT TO ANTIBIOTIC THERAPY |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 26031 |
Study title: Cavalcanti A et al (1990) Estudo cooperativo multicêntrico com Cataflam Emulgel no tratamento das afecções músculo-esqueléticas. Observaçãoem 8957 pacientes. F méd (BR); 100(3-4): 91-110 Brazilian publication and English translation.Cavalcanti A et al (1990) Estudo cooperativo multicêntrico com Cataflam Emulgel no tratamento das afecções músculo-esqueléticas. Observaçãoem 8957 pacientes. F méd (BR); 100(3-4): 91-110 Brazilian publication and English translation. |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 26013 |
Study title: Clinical summary and Report on GP 45, 840 Voltaren Paediatric Indications (25 mg suppository and enteric coated tablet) |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 26048 |
Study title: Colonic manometry as predictor of cecostomy success in children with defecation disorders. Colonic manometry as predictor of cecostomy success in children with defecation disorders. |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 25995 |
Study title: COMMENTAIRES SUR LES ESSAIS EN PEDIATRIE. VOLTARENE SUPPOSITOIRES A 25 MGCOMMENTAIRES SUR LES ESSAIS EN PEDIATRIE. VOLTARENE SUPPOSITOIRES A 25 MG |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 26058 |
Study title: [Conjunctivitis of bacterial origin in children. Local antibiotic treatment with tobramycin collyrium] Fioretti GM, Campanari C. Pediatr Med Chir. 1989 Jul-Aug;11(4):421-3. [Conjunctivitis of bacterial origin in children. Local antibiotic treatment with tobramycin collyrium] Fioretti GM, Campanari C. Pediatr Med Chir. 1989 Jul-Aug;11(4):421-3. |
Active substance: DEXAMETHASONE AND TOBRAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25754 |
Study title: Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops. Jackson WB, Low DE, Dattani D, Whitsitt PF, Leeder RG, MacDougall R. Can J Ophthalmol. 2002 Jun;37(4):228-37; discussion 237. Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops. Jackson WB, Low DE, Dattani D, Whitsitt PF, Leeder RG, MacDougall R. Can J Ophthalmol. 2002 Jun;37(4):228-37; discussion 237. |
Active substance: DEXAMETHASONE AND TOBRAMYCIN |
Study summary document link (including results): Treatment of acute neonatal bacterial conjunctivitis.pdf |
View full study record |
Document reference: 25752 |
Study title: |
Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B |
Study summary document link (including results): Neomycin sulfate-polymixin B-Dexmthasone - C-94-28.xls |
View full study record |
Document reference: 47627 |
Study title: Rosito P et al Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: a preliminary report of 6 years of experience Cancer. 1999 Aug 1;86(3):421-8. Erratum in: Cancer. 2005 Aug 1;104(3):667. dosage error in textRosito P et al Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: a preliminary report of 6 years of experience Cancer. 1999 Aug 1;86(3):421-8. Erratum in: Cancer. 2005 Aug 1;104(3):667. dosage error in text |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25090 |
Study title: Rossi R et al Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 Patients Med Pediatr Oncol. 1999 Mar;32(3):177-82Rossi R et al Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 Patients Med Pediatr Oncol. 1999 Mar;32(3):177-82 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25091 |
Study title: Rossi R et al Ifosfamide-induced nephrotoxicity Monatsschr Kinderheilkd. 1993 Jul;141(7):594-601. GermanRossi R et al Ifosfamide-induced nephrotoxicity Monatsschr Kinderheilkd. 1993 Jul;141(7):594-601. German |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25092 |
Study title: Rossi R et al Partial and complete de Toni-Debré-Fanconi syndrome after ifosfamide chemotherapy of childhood malignancy Eur J Clin Pharmacol. 1993;44 Suppl 1:S43-5Rossi R et al Partial and complete de Toni-Debré-Fanconi syndrome after ifosfamide chemotherapy of childhood malignancy Eur J Clin Pharmacol. 1993;44 Suppl 1:S43-5 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25093 |
Study title: Rossi R et al Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-inducednephrotoxicity: analysis of 120 patients J Clin Oncol. 1994 Jan;12(1):159-65Rossi R et al Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-inducednephrotoxicity: analysis of 120 patients J Clin Oncol. 1994 Jan;12(1):159-65 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25094 |
Study title: Rousseau P et al Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: results of the International Society of Pediatric Oncology MMT 84 Study J Clin Oncol. 1994 Mar;12(3):516-21Rousseau P et al Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: results of the International Society of Pediatric Oncology MMT 84 Study J Clin Oncol. 1994 Mar;12(3):516-21 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25095 |
Study title: Sackmann-Muriel F et al. Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina. Med Pediatr Oncol. 1997 Dec;29(6):544-52.Sackmann-Muriel F et al. Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina. Med Pediatr Oncol. 1997 Dec;29(6):544-52. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25096 |
Study title: Maxilase syrup: final clinical report on child serous otitis - Bessede JP. Romanet P. - 23/04/88 |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 25825 |
Study title: Paul IM et al. Dose-response relationship with increasing doses of dextromethorphan for children with cough. Clin Ther 2004; 26(9):1508-1514 Paul IM et al. Dose-response relationship with increasing doses of dextromethorphan for children with cough. Clin Ther 2004; 26(9):1508-1514 |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 25802 |
Study title: Paul IM et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114(1):85-90 Paul IM et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114(1):85-90 |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 25803 |
Study title: Phase IV Safety and Efficacy Study of C-30 Liquid Cough-Cold FormulaPhase IV Safety and Efficacy Study of C-30 Liquid Cough-Cold Formula |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 25824 |
Study title: Purello−D−Ambrosio−F, Tigano−F, Gallesio−M−T, Chevallier−P, Janssens− M. Astemizole−D compared with triprolidine−D (Actifedregistered trade mark) for acute treatment of perennial allergic rhinitis. Journal of Pharmaceutical Medicine {J−PHARM−MED}, 1994, Vol/Iss/Pg. 4 /1 (15−22). Purello−D−Ambrosio−F, Tigano−F, Gallesio−M−T, Chevallier−P, Janssens− M. Astemizole−D compared with triprolidine−D (Actifedregistered trade mark) for acute treatment of perennial allergic rhinitis. Journal of Pharmaceutical Medicine {J−PHARM−MED}, 1994, Vol/Iss/Pg. 4 /1 (15−22). |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 25817 |
Study title: Taylor AJ et al. Efficacy of cough suppressants in children. J Pediatr 1993; 122(5 Pt 1):799-802 Taylor AJ et al. Efficacy of cough suppressants in children. J Pediatr 1993; 122(5 Pt 1):799-802 |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 25805 |
Study title: Sullivan MP et al. High-dose cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: results of a Pediatric Oncology Group study. Am J Pediatr Hematol Oncol. 1991 Fall;13(3):288-95. Sullivan MP et al. High-dose cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: results of a Pediatric Oncology Group study. Am J Pediatr Hematol Oncol. 1991 Fall;13(3):288-95. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25140 |
Study title: Sullivan MP et al. High-dose cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: results of a Pediatric Oncology Group study. Am J Pediatr Hematol Oncol. 1991 Fall;13(3):288-95. Sullivan MP et al. High-dose cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: results of a Pediatric Oncology Group study. Am J Pediatr Hematol Oncol. 1991 Fall;13(3):288-95. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25141 |
Study title: Tanaka K et al High-dose chemotherapy and autologous peripheral blood stem-cell transfusionafter conventional chemotherapy for patients with high-risk Ewing's tumors J Orthop Sci. 2002;7(4):477-82Tanaka K et al High-dose chemotherapy and autologous peripheral blood stem-cell transfusionafter conventional chemotherapy for patients with high-risk Ewing's tumors J Orthop Sci. 2002;7(4):477-82 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25143 |
Study title: Taylor RE et al. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study. J Clin Oncol. 2003 Apr 15;21(8):1581-91Taylor RE et al. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study. J Clin Oncol. 2003 Apr 15;21(8):1581-91 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25144 |
Study title: Teresi ME et al Ifosfamide-induced hyperpigmentation Cancer. 1993 May 1;71(9):2873-5. ReviewTeresi ME et al Ifosfamide-induced hyperpigmentation Cancer. 1993 May 1;71(9):2873-5. Review |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25146 |
Study title: Controlled study of the therapeutic activity of DL 458 IT compared with prednisone in rheumatoid arthritis - Gigante D - 13 March 1978 - Report (reference 31) in the Clinical Documentation Deflazacort 6 mg tablets April 1991 - |
Active substance: DEFLAZACORT |
Study summary document link (including results): Deflazacort STUDY Gigante.xls |
View full study record |
Document reference: 25638 |
Study title: Deflazacort in thrombocytopenia: a comparison with prednisone - Criscuolo D - November 1978 - Report in the Clinical Documentation Deflazacort 6 mg tablets April 1991 - |
Active substance: DEFLAZACORT |
Study summary document link (including results): Deflazacort STUDY report 161.xls |
View full study record |
Document reference: 25639 |
Study title: Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth - Balsan S, Lenoir G, Steru D, Bourdeau A and Grimberg R - 1987 - Report (reference 82) in the Clinical Documentation Deflazacort 6 mg tablets April 1991 - |
Active substance: DEFLAZACORT |
Study summary document link (including results): Deflazacort STUDY report Balsan.xls |
View full study record |
Document reference: 25643 |
Study title: Estimate of the potency ratio between DL 458 IT and prednisone in patients with rheumatoid arthritis using a direct biological test - Schiavetti L - 5 November 1975 - Report (reference 33) in the Clinical Documentation Deflazacort 6 mg tablets April 1991 - |
Active substance: DEFLAZACORT |
Study summary document link (including results): |
View full study record |
Document reference: 25641 |
Study title: In vitro and ex vivo effects of different corticosteroids on polymorphonuclear leukocyte functions - Marcolongo R, Lalumera M, Calabria A and Imbimbo B - 1984 - Report (reference 47) in the Clinical Documentation Defalzacort 6 mg tablets April 1991 - |
Active substance: DEFLAZACORT |
Study summary document link (including results): |
View full study record |
Document reference: 25642 |
Study title: Clinical evaluation in the treatment of Contact dermatitis, Atopic dermatitis, Seborrhoeic dermatitis, Eczema, Psoriasis and Neurodermatitis |
Active substance: DEQUALINIUM AND XYLOMETAZOLINE |
Study summary document link (including results): |
View full study record |
Document reference: 25645 |
Study title: Post-marketing study with NHD Mites cluster dose escalation regimen |
Active substance: DERMAPHAGOITES FARINAE AND DERMAPHAGOITES PTERONYSSIMUS |
Study summary document link (including results): |
View full study record |
Document reference: 25649 |
Study title: Post-marketing surveillance study:retrospective data collection Novo-Helisen® oral – preparations for mite allergy Report for PEI (renewal of marketing authorisation, PSUR) prepared Age of patients: 6 – 80 Years |
Active substance: DERMAPHAGOITES FARINAE AND DERMAPHAGOITES PTERONYSSIMUS |
Study summary document link (including results): |
View full study record |
Document reference: 25646 |
Study title: Retrospective Analysis about hypersensitation with NHD Mites, Allergologie, Jahrgang 17, Heft 4, S. 154-15 Age of patients: 9-81 Years, 494 Patients |
Active substance: DERMAPHAGOITES FARINAE AND DERMAPHAGOITES PTERONYSSIMUS |
Study summary document link (including results): |
View full study record |
Document reference: 25647 |
Study title: A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: Clinical efficacy and side effects |
Active substance: DERMATOPHAGIODES PTERONYSSIMUS |
Study summary document link (including results): |
View full study record |
Document reference: 25651 |
Study title: Depigoid D. pteronyssinus: Study title: "A monocenter observational cohort study on the efficacy and safety of a 6 months Depigoid® immunotherapy in patients with atopic eczema and sensitization against house dust mites" |
Active substance: DERMATOPHAGIODES PTERONYSSIMUS |
Study summary document link (including results): |
View full study record |
Document reference: 25653 |
Study title: Immunotherapy in children with allergic asthma: Effect on bronchial hyperreactivity and pharmacotherapy |
Active substance: DERMATOPHAGIODES PTERONYSSIMUS |
Study summary document link (including results): |
View full study record |
Document reference: 25650 |
Study title: MacDonald TJ et al Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933 Cancer. 2005 Dec 15;104(12):2862-71MacDonald TJ et al Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933 Cancer. 2005 Dec 15;104(12):2862-71 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24993 |
Study title: COMPARATIVE DOUBLE-BLIND STUDY WITH DICLOFENAC POTASSIUM DROPS VS BENZYDAMINE, COMBINED WITH AN ANTIBIOTIC, IN CHILDREN WITH UPPER RESPIRATORY TRACT INFECTIONSCOMPARATIVE DOUBLE-BLIND STUDY WITH DICLOFENAC POTASSIUM DROPS VS BENZYDAMINE, COMBINED WITH AN ANTIBIOTIC, IN CHILDREN WITH UPPER RESPIRATORY TRACT INFECTIONS |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 26025 |
Study title: Southeast Asian J Trop Med Public Health. 1994 Mar;25(1):157-62. Control randomized study of rehydration/rehydration with dioctahedral smectite in ambulatory Thai infants with acute diarrhea. Lexomboon U, Harikul S, Lortholary O |
Active substance: DIOSMECTITE |
Study summary document link (including results): |
View full study record |
Document reference: 26172 |
Study title: Evaluation of nasal congestion clinical efficacy for diphenhydramine 25 mg and diphenhydramine 50 mg in seasonal allergic rhinitis: a randomized, double-blind, placebo and pseudoephedrine controlled study |
Active substance: DIPHENHYDRAMINE |
Study summary document link (including results): diphenhydramine A2341002.pdf |
View full study record |
Document reference: 47890 |
Study title: Electrocardiographic Findings in Patients with Diphenhydramine Overdose, Zareba, W., Am. J. Cardiol. 1997; 80: 1168-1173Electrocardiographic Findings in Patients with Diphenhydramine Overdose, Zareba, W., Am. J. Cardiol. 1997; 80: 1168-1173 |
Active substance: DIPHENHYDRAMINE AND GUAIFENESIN AND L-MENTHOL |
Study summary document link (including results): |
View full study record |
Document reference: 26175 |
Study title: Outcome of prophylactic therapy for idiopathic anaphylaxis, Wong, S., Ann. Intern. Med. 1991; 114: 133-136Outcome of prophylactic therapy for idiopathic anaphylaxis, Wong, S., Ann. Intern. Med. 1991; 114: 133-136 |
Active substance: DIPHENHYDRAMINE AND GUAIFENESIN AND L-MENTHOL |
Study summary document link (including results): |
View full study record |
Document reference: 26174 |
Study title: Parvez−L, Vaidya−M, Sakhardande−A, Subburaj−S, Rajagopalan−T−G. Evaluation of antitussive agents in man. Pulmonary pharmacology, {Pulm−Pharmacol}, Oct−Dec 1996, vol. 9, no. 5−6, p. 299−308.Parvez−L, Vaidya−M, Sakhardande−A, Subburaj−S, Rajagopalan−T−G. Evaluation of antitussive agents in man. Pulmonary pharmacology, {Pulm−Pharmacol}, Oct−Dec 1996, vol. 9, no. 5−6, p. 299−308. |
Active substance: DIPHENHYDRAMINE AND GUAIFENESIN AND L-MENTHOL |
Study summary document link (including results): |
View full study record |
Document reference: 26180 |
Study title: Russo−R−M, Gururaj−V−J, Allen−J−E. The effectiveness of diphenhydramine HCI in pediatric sleep disorders. Journal of clinical pharmacology, {J−Clin−Pharmacol}, May−Jun 1976, vol. 16, no. 5−6, p. 284−8.Russo−R−M, Gururaj−V−J, Allen−J−E. The effectiveness of diphenhydramine HCI in pediatric sleep disorders. Journal of clinical pharmacology, {J−Clin−Pharmacol}, May−Jun 1976, vol. 16, no. 5−6, p. 284−8. |
Active substance: DIPHENHYDRAMINE AND GUAIFENESIN AND L-MENTHOL |
Study summary document link (including results): |
View full study record |
Document reference: 26177 |
Study title: Kuhn−J−J, Hendley−J−O, Adams−K−F, Clark−J−W, Gwaltney−J−M−Jr. Antitussive effect of guaifenesin in young adults with natural colds. Objective and subjective assessment. Chest, {Chest}, Dec 1982, vol. 82, no. 6, p. 713−8.Kuhn−J−J, Hendley−J−O, Adams−K−F, Clark−J−W, Gwaltney−J−M−Jr. Antitussive effect of guaifenesin in young adults with natural colds. Objective and subjective assessment. Chest, {Chest}, Dec 1982, vol. 82, no. 6, p. 713−8. |
Active substance: DIPHENHYDRAMINE AND MENTHOL |
Study summary document link (including results): |
View full study record |
Document reference: 26181 |
Study title: Moscati−R−M, Moore−G−P. Comparison of cimetidine and diphenhydramine in the treatment of acute urticaria. Annals of emergency medicine, {Ann−Emerg−Med}, Jan 1990, vol. 19, no. 1, p. 12−5.Moscati−R−M, Moore−G−P. Comparison of cimetidine and diphenhydramine in the treatment of acute urticaria. Annals of emergency medicine, {Ann−Emerg−Med}, Jan 1990, vol. 19, no. 1, p. 12−5. |
Active substance: DIPHENHYDRAMINE AND MENTHOL |
Study summary document link (including results): |
View full study record |
Document reference: 26185 |
Study title: Pujet−J−C, Keddad−K, Sévenier−F, Jolivet−Landreau−I. Comparative study of two antitussive drugs in the treatment of acute dry cough of infectious origin (prospective, randomized, single blind study). Thérapie, {Therapie}, Sep−Oct 2002, vol. 57, no. 5, p. 457−63.Pujet−J−C, Keddad−K, Sévenier−F, Jolivet−Landreau−I. Comparative study of two antitussive drugs in the treatment of acute dry cough of infectious origin (prospective, randomized, single blind study). Thérapie, {Therapie}, Sep−Oct 2002, vol. 57, no. 5, p. 457−63. |
Active substance: DIPHENHYDRAMINE AND MENTHOL |
Study summary document link (including results): |
View full study record |
Document reference: 26182 |
Study title: Bender BG, McCormick DR, Milgrom H. Children's school performance is not impaired by short-term administration of diphenhydramine or loratadine. J Pediatr. 2001 May;138(5):656-60.Bender BG, McCormick DR, Milgrom H. Children's school performance is not impaired by short-term administration of diphenhydramine or loratadine. J Pediatr. 2001 May;138(5):656-60. |
Active substance: DIPHENHYDRAMINE_OR DIPHENHYDRAMINE AND CHLORHEXIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 26193 |
Study title: Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Yoder KE, Shaffer ML, La Tournous SJ, Paul IM. Clin Pediatr (Phila). 2006 Sep;45(7):633-40.Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Yoder KE, Shaffer ML, La Tournous SJ, Paul IM. Clin Pediatr (Phila). 2006 Sep;45(7):633-40. |
Active substance: DIPHENHYDRAMINE_OR DIPHENHYDRAMINE AND CHLORHEXIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 26202 |
Study title: Sackmann-Muriel F et al. Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina. Med Pediatr Oncol. 1997 Dec;29(6):544-52.Sackmann-Muriel F et al. Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina. Med Pediatr Oncol. 1997 Dec;29(6):544-52. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25097 |
Study title: Sadowitz PD et al. Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood. 1993 Feb 1;81(3):602-9.Sadowitz PD et al. Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood. 1993 Feb 1;81(3):602-9. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25098 |
Study title: Sadowitz PD et al. Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood. 1993 Feb 1;81(3):602-9.Sadowitz PD et al. Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood. 1993 Feb 1;81(3):602-9. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25099 |
Study title: Salloum E et al Irreversible encephalopathy with ifosfamide/mesna J Clin Oncol. 1987 Aug;5(8):1303-4. No abstract availableSalloum E et al Irreversible encephalopathy with ifosfamide/mesna J Clin Oncol. 1987 Aug;5(8):1303-4. No abstract available |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25100 |
Study title: Sampi K et al Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia Gan To Kagaku Ryoho. 1986 Oct;13(10):3021-7. JapaneseSampi K et al Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia Gan To Kagaku Ryoho. 1986 Oct;13(10):3021-7. Japanese |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25101 |
Study title: Sandler E et al Efficacy of ifosfamide and doxorubicin given as a phase II "window" in children with newly diagnosed metastatic rhabdomyosarcoma: a report from the IntergroupRhabdomyosarcoma Study Group Med Pediatr Oncol. 2001 Nov;37(5):442-8Sandler E et al Efficacy of ifosfamide and doxorubicin given as a phase II "window" in children with newly diagnosed metastatic rhabdomyosarcoma: a report from the IntergroupRhabdomyosarcoma Study Group Med Pediatr Oncol. 2001 Nov;37(5):442-8 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25102 |
Study title: AN 17388752 Medline 20070507. TI The effect of a first-generation antihistamine on sputum viscoelasticity in cystic fibrosis. SO Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine, {J-Aerosol-Med}, Spring 2007, vol. 20, no. 1, p. 45-9, ISSN: 0894-2684.AN 17388752 Medline 20070507. TI The effect of a first-generation antihistamine on sputum viscoelasticity in cystic fibrosis. SO Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine, {J-Aerosol-Med}, Spring 2007, vol. 20, no. 1, p. 45-9, ISSN: 0894-2684. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25186 |
Study title: AN 17388752 Medline 20070507. TI The effect of a first-generation antihistamine on sputum viscoelasticity in cystic fibrosis. SO Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine, {J-Aerosol-Med}, Spring 2007, vol. 20, no. 1, p. 45-9, ISSN: 0894-2684.AN 17388752 Medline 20070507. TI The effect of a first-generation antihistamine on sputum viscoelasticity in cystic fibrosis. SO Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine, {J-Aerosol-Med}, Spring 2007, vol. 20, no. 1, p. 45-9, ISSN: 0894-2684. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25240 |
Study title: AN 1974035826 19740101. TI The anorexiant action of cyproheptadine hydrochloride and its influence on height and weight in growing children. AU Scorza-P, Baroncelli-G, Lombardi-S. IN Div. Ped., Osp. Maria Delle Croci, Ravenna, Italy. SO Clinica Pediatrica {CLIN-PEDIATR}, 1972, Vol/Iss/Pg. 54/6 (358-367). YR 1972.AN 1974035826 19740101. TI The anorexiant action of cyproheptadine hydrochloride and its influence on height and weight in growing children. AU Scorza-P, Baroncelli-G, Lombardi-S. IN Div. Ped., Osp. Maria Delle Croci, Ravenna, Italy. SO Clinica Pediatrica {CLIN-PEDIATR}, 1972, Vol/Iss/Pg. 54/6 (358-367). YR 1972. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25241 |
Study title: AN 1974155671 19740101. TI Effect of cyproheptadine on weight gain among convalescing children. AU Yap-L-C. IN Cent. Luzon Chapter, Philippine Ped. Soc., Manila, Philippines. SO Philippine Journal of Pediatrics {PHILIPP-J-PEDIATR}, 1973, Vol/Iss /Pg. 22/2 (60-69). YR 1973.AN 1974155671 19740101. TI Effect of cyproheptadine on weight gain among convalescing children. AU Yap-L-C. IN Cent. Luzon Chapter, Philippine Ped. Soc., Manila, Philippines. SO Philippine Journal of Pediatrics {PHILIPP-J-PEDIATR}, 1973, Vol/Iss /Pg. 22/2 (60-69). YR 1973. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25242 |
Study title: Thomson B et al Avramis V, Douglas JG, Loken MR, Hawkins DS.Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse Pediatr Blood Cancer. 2004 Oct;43(5):571-9Thomson B et al Avramis V, Douglas JG, Loken MR, Hawkins DS.Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse Pediatr Blood Cancer. 2004 Oct;43(5):571-9 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24764 |
Study title: Torres Valdivieso MJ et al Ifosfamide-induced renal tubular defect Med Pediatr Oncol. 1994;22(2):144-6Torres Valdivieso MJ et al Ifosfamide-induced renal tubular defect Med Pediatr Oncol. 1994;22(2):144-6 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25147 |
Study title: Tournade MF A phase II study of ifosfamide in the treatment of relapses in Wilms' tumor Cancer Chemother Pharmacol. 1989;24 Suppl 1:S31-3Tournade MF A phase II study of ifosfamide in the treatment of relapses in Wilms' tumor Cancer Chemother Pharmacol. 1989;24 Suppl 1:S31-3 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25148 |
Study title: Tubergen DG et al. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study. J Clin Oncol. 1995 Jun;13(6):1368-76Tubergen DG et al. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study. J Clin Oncol. 1995 Jun;13(6):1368-76 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24760 |
Study title: Tubergen DG et al. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study. J Clin Oncol. 1995 Jun;13(6):1368-76Tubergen DG et al. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study. J Clin Oncol. 1995 Jun;13(6):1368-76 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25149 |
Study title: Uchida A et al Neoadjuvant chemotherapy for pediatric osteosarcoma patients Cancer. 1997 Jan 15;79(2):411-5Uchida A et al Neoadjuvant chemotherapy for pediatric osteosarcoma patients Cancer. 1997 Jan 15;79(2):411-5 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24759 |
Study title: Depigoid D. pteronyssinus: Study title: "A monocenter observational cohort study on the efficacy and safety of a 6 months Depigoid® immunotherapy in patients with atopic eczema and sensitization against house dust mites" |
Active substance: D pt, depigmented/polymerised extract |
Study summary document link (including results): |
View full study record |
Document reference: 39838 |
Study title: Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin disease. Cancer, 46; 2349-55 - Rodgers - 1980 - Publication in the dossier Dacarbazine injectable 100 and 200 mg - Data on human (dossier B) - |
Active substance: DACARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 25274 |
Study title: Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide. Cancer. 30; 6:1632-38 - Gottlieb - Dec 1972 - Publication in the dossier Dacarbazine injectable 100 and 200 mg - Data on human (dossier B) - |
Active substance: DACARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 25275 |
Study title: Combined chemotherapy (MOPP or ABVD). Radiotherapy approach in Advanced Hodgkin's disease. Cancer Treat Rep. 61:769-777- Bonadonna - 1977 - Publication in the clinical dossierST/RD/RE NH/MFA - |
Active substance: DACARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 25276 |
Study title: DTIC (NSC-45388) and combination therapy for melanoma. I Studies with DTIC , BCNU (NSC 409962), CCNU (NSC-79037), Vincristine (NSC67-574), and Hydroxyurea (NSC-32065). Cancer Treat Rep. 60:601-609 - Carter - 1976 - Publication in the clinical expert report from G. Mathé - 06/1975 |
Active substance: DACARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 25277 |
Study title: Eight drug combination chemotherapy (MOPP and ABDV) and local radiotherapy for advanced Hodgkins' disease. Cancer Treat rep. 60; 1217-23 - Case - 1976 - Publication in the dossier Dacarbazine injectable 100 and 200 mg - Data on human (dossier B) - |
Active substance: DACARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 25278 |
Study title: Essai de D.T.I.C. (1513 R.B.) - Mathé - No date - In the clinical expert report from G. Mathé dated 6 June 1975 - |
Active substance: DACARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 25279 |
Study title: A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25280 |
Study title: A prospective, randomized, national trial for treatment of ovarian cancer: the role of chemotherapy and external irradiation. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25281 |
Study title: A randomized clinical trial of single-dose versus fractionated-dose dactinomycin in the treatment of Wilms' tumor. Results after extended follow-up. Brazilian Wilms' Tumor Study Group. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25282 |
Study title: Magrath I et al A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people Cancer Chemother Pharmacol. 1986;18 Suppl 2:S25-8Magrath I et al A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people Cancer Chemother Pharmacol. 1986;18 Suppl 2:S25-8 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24994 |
Study title: Magrath I et al. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol. 1996 Mar;14(3):925-34.Magrath I et al. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol. 1996 Mar;14(3):925-34. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24995 |
Study title: Magrath I et al. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol. 1996 Mar;14(3):925-34. Magrath I et al. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol. 1996 Mar;14(3):925-34. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24996 |
Study title: Mandell LR et al, Preliminary results of alternating combination chemotherapy (CT) and, hyperfractionated radiotherapy (HART) in advanced rhabdomyosarcoma (RMS), Int J Radiat Oncol Biol Phys. 1988 Jul;15(1):197-203Mandell LR et al, Preliminary results of alternating combination chemotherapy (CT) and, hyperfractionated radiotherapy (HART) in advanced rhabdomyosarcoma (RMS), Int J Radiat Oncol Biol Phys. 1988 Jul;15(1):197-203 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24997 |
Study title: Mann JR et al, Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies, Cancer. 1989 May 1;63(9):1657-67, Mann JR et al, Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies, Cancer. 1989 May 1;63(9):1657-67, |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24998 |
Study title: Mann JR et al, The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity, J Clin Oncol. 2000 Nov 15;18(22):3809-18, Mann JR et al, The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity, J Clin Oncol. 2000 Nov 15;18(22):3809-18, |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24999 |
Study title: Mann JR et al, UKCCSG's germ cell tumour (GCT) studies: improving outcome for children with malignant extracranial non-gonadal tumours--carboplatin, etoposide, and bleomycin, are effective and less toxic than previous regimens. United Kingdom Children's Cancer Study Group, Med Pediatr Oncol. 1998 Apr;30(4):217-27Mann JR et al, UKCCSG's germ cell tumour (GCT) studies: improving outcome for children with malignant extracranial non-gonadal tumours--carboplatin, etoposide, and bleomycin, are effective and less toxic than previous regimens. United Kingdom Children's Cancer Study Group, Med Pediatr Oncol. 1998 Apr;30(4):217-27 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25000 |
Study title: Mantadakis E et al Fractionated cyclophosphamide and etoposide for children with advanced or refractory solid tumors: a phase II window study J Clin Oncol 2000 Jul;18(13):2576-81Mantadakis E et al Fractionated cyclophosphamide and etoposide for children with advanced or refractory solid tumors: a phase II window study J Clin Oncol 2000 Jul;18(13):2576-81 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25001 |
Study title: Marina N et al, Treatment of childhood germ cell tumors. Review of the St. Jude experience from 1979 to 1988, Cancer. 1992 Nov 15;70(10):2568-75Marina N et al, Treatment of childhood germ cell tumors. Review of the St. Jude experience from 1979 to 1988, Cancer. 1992 Nov 15;70(10):2568-75 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25002 |
Study title: Marina NM et al Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital J Clin Oncol 1999 Jan;17(1):180-90Marina NM et al Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital J Clin Oncol 1999 Jan;17(1):180-90 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25003 |
Study title: Marina NM et al Comparative renal tubular toxicity of chemotherapy regimens including ifosfamide in patients with newly diagnosed sarcomas J Pediatr Hematol Oncol. 2000 Mar-Apr;22(2):112-8Marina NM et al Comparative renal tubular toxicity of chemotherapy regimens including ifosfamide in patients with newly diagnosed sarcomas J Pediatr Hematol Oncol. 2000 Mar-Apr;22(2):112-8 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25004 |
Study title: Children's school performance is not impaired by short-term administration of diphenhydramine or loratadine. Bender BG, McCormick DR, Milgrom H. J Pediatr. 2001 May;138(5):656-60.Children's school performance is not impaired by short-term administration of diphenhydramine or loratadine. Bender BG, McCormick DR, Milgrom H. J Pediatr. 2001 May;138(5):656-60. |
Active substance: DIPHENHYDRAMINE_OR DIPHENHYDRAMINE AND CHLORHEXIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 26201 |
Study title: Acute and therapeutic dose-response comparison of Th 1165a administered as a powder from a capsule via the CHBS inhaler to children. |
Active substance: FENOTEROL |
Study summary document link (including results): Fenoterol hydrobromide_U79-0178_synopsis.pdf |
View full study record |
Document reference: 27073 |
Study title: Acute and therapeutic dose-response comparison of Th 1165a administered with the CHBS powder inhaler in children. |
Active substance: FENOTEROL |
Study summary document link (including results): Fenoterol hydrobromide_U79-0177_synopsis.pdf |
View full study record |
Document reference: 27072 |
Study title: Acute and therapeutic dose-response comparison of Th 1165a administered with the CHBS powder inhaler to children. |
Active substance: FENOTEROL |
Study summary document link (including results): Fenoterol hydrobromide_U79-0179_synopsis.pdf |
View full study record |
Document reference: 27074 |
Study title: Acute asthma management of children in the emergency department. |
Active substance: FENOTEROL |
Study summary document link (including results): Fenoterol hydrobromide_U86-0564_synopsis.pdf |
View full study record |
Document reference: 27095 |
Study title: Assessment of the effect of 2.5 mg and 5 mg Th 1165a Linctus in school children compared with placebo. |
Active substance: FENOTEROL |
Study summary document link (including results): Fenoterol hydrobromide_U75-0098_synopsis.pdf |
View full study record |
Document reference: 27047 |
Study title: Assessment of the therapeutic effect and tolerance of Th 1165a Linctus in 12 infants and 12 school children at doses of 3 x 1.25 mg and 3 x 2.5 mg. |
Active substance: FENOTEROL |
Study summary document link (including results): Fenoterol hydrobromide_U75-0261_synopsis.pdf |
View full study record |
Document reference: 27048 |
Study title: Assessment of the therapeutic effect of Th 1165a-linctus with several days' administration in infants. |
Active substance: FENOTEROL |
Study summary document link (including results): Fenoterol hydrobromide_U76-0088_synopsis.pdf |
View full study record |
Document reference: 27030 |
Study title: Assessment of the therapeutical efficacy and tolerability of 7.5 mg Th 1165a-suppositories in school children. |
Active substance: FENOTEROL |
Study summary document link (including results): Fenoterol hydrobromide_U73-0098_synopsis.pdf |
View full study record |
Document reference: 27044 |
Study title: Assessment of therapeutic effect and tolerance of Th 1165a suppositories after repeated administration in infants and school children. |
Active substance: FENOTEROL |
Study summary document link (including results): Fenoterol hydrobromide_U76-0080_synopsis.pdf |
View full study record |
Document reference: 27054 |
Study title: Assessment of therapeutic efficacy and tolerance of Th 1165a 4.5 mg suppositories during administration for several days in infants. |
Active substance: FENOTEROL |
Study summary document link (including results): Fenoterol hydrobromide_U75-0664_synopsis.pdf |
View full study record |
Document reference: 27051 |
Study title: Assessment of therapeutic efficacy and tolerance of Th 1165a 4.5 mg suppositories in infants and small children during multiple dosing. |
Active substance: FENOTEROL |
Study summary document link (including results): Fenoterol hydrobromide_U76-0073_synopsis.pdf |
View full study record |
Document reference: 27052 |
Study title: Atrovent or Berotec mite in children with recurrent obstructive bronchitis. |
Active substance: FENOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 27099 |
Study title: Berotec solution statistical report, study no. E79-234 protocol designation: IIF I. |
Active substance: FENOTEROL |
Study summary document link (including results): Fenoterol hydrobromide_U80-0161_synopsis.pdf |
View full study record |
Document reference: 27075 |
Study title: Berotec solution summary of study - final report - phase III. |
Active substance: FENOTEROL |
Study summary document link (including results): Fenoterol hydrobromide_U77-0063_synopsis.pdf |
View full study record |
Document reference: 27061 |
Study title: Berotec tablets + Theophylline summary of study - interim report - phase II. |
Active substance: FENOTEROL |
Study summary document link (including results): Fenoterol hydrobromide_U77-0561_synopsis.pdf |
View full study record |
Document reference: 27063 |
Study title: Berotec tablets 2.5 mg summary of study - interim report - phase II. |
Active substance: FENOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 27062 |
Study title: AN 1975042349 19750101. TI Effect of a combination of DL carnitine and cyproheptadine on weight gain of anorexic children. AU Rodrigues-V-R. N Div. Ped., Osp. Univ., Oporto, Port Iugal. SO Gazzetta Medica Italiana {GAZZ-MED-ITAL}, 1974, Vol/Iss/Pg. 133/3 (107-109). YR 1974.AN 1975042349 19750101. TI Effect of a combination of DL carnitine and cyproheptadine on weight gain of anorexic children. AU Rodrigues-V-R. N Div. Ped., Osp. Univ., Oporto, Port Iugal. SO Gazzetta Medica Italiana {GAZZ-MED-ITAL}, 1974, Vol/Iss/Pg. 133/3 (107-109). YR 1974. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25243 |
Study title: AN 1975122205 19750101. TI Appetite stimulating action of cyproheptadine; clinical data. AU Lo-Iacono-F. IN Div. Ped., Ente Osp. Villa Sofia, Palermo, Italy. SO Clinica Terapeutica {CLIN-TER}, 1974, Vol/Iss/Pg. 70/2 sup 3 (119-126). YR 1974.AN 1975122205 19750101. TI Appetite stimulating action of cyproheptadine; clinical data. AU Lo-Iacono-F. IN Div. Ped., Ente Osp. Villa Sofia, Palermo, Italy. SO Clinica Terapeutica {CLIN-TER}, 1974, Vol/Iss/Pg. 70/2 sup 3 (119-126). YR 1974. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25244 |
Study title: AN 1976116858 19760101. TI Clinical and therapeutic study about cyproheptadine HCl and cobamamide association on weight gain in children. AU Pennachin-D-J. IN Dept. Assist. Inf. Matern., Pref. Sao Paulo, Brazil. SO Revista Brasileira de Clinica e Terapeutica {REV-BRAS-CLIN-TER}, 1975, Vol/Iss/Pg. 4/5 (161-166). YR 1975.AN 1976116858 19760101. TI Clinical and therapeutic study about cyproheptadine HCl and cobamamide association on weight gain in children. AU Pennachin-D-J. IN Dept. Assist. Inf. Matern., Pref. Sao Paulo, Brazil. SO Revista Brasileira de Clinica e Terapeutica {REV-BRAS-CLIN-TER}, 1975, Vol/Iss/Pg. 4/5 (161-166). YR 1975. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25245 |
Study title: AN 1977065371 19770101. TI Cyproheptadine modification of glucagon induced growth hormone release: possible hypothalamic site of glucagon action. AU AvRuskin-T-W, Lala-V-R, Onur-K, Juan-C-S. IN Dept. Ped., New York Univ. Sch. Med., Brookdale Hosp. Med. Cent., Brooklyn, N.Y., United States. SO Pediatric Research {PEDIATR-RES}, 1976, Vol/Iss/Pg. 10/4 (no.209). YR 1976.AN 1977065371 19770101. TI Cyproheptadine modification of glucagon induced growth hormone release: possible hypothalamic site of glucagon action. AU AvRuskin-T-W, Lala-V-R, Onur-K, Juan-C-S. IN Dept. Ped., New York Univ. Sch. Med., Brookdale Hosp. Med. Cent., Brooklyn, N.Y., United States. SO Pediatric Research {PEDIATR-RES}, 1976, Vol/Iss/Pg. 10/4 (no.209). YR 1976. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25246 |
Study title: Nogen AG: Medical treatment for spasticity in children with cerebral palsy; Childs Brain 2, 304-308 (1976)Nogen AG: Medical treatment for spasticity in children with cerebral palsy; Childs Brain 2, 304-308 (1976) |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25532 |
Study title: Paloucek, F.P. et al.:Oral dantrolene ingestion: a case series (Abstract); Vet. Human. Toxicol. 33, 362 (Abstract 43) (1991)Paloucek, F.P. et al.:Oral dantrolene ingestion: a case series (Abstract); Vet. Human. Toxicol. 33, 362 (Abstract 43) (1991) |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25527 |
Study title: Ploetz J. et al:Inhibitory Effect of Dantrolene on the Rise of Serum-Ck Activity After Combined Use of Halothane and Succinylcholine in Man; Anaesthesist 30 (7), 338-342 (1981)Ploetz J. et al:Inhibitory Effect of Dantrolene on the Rise of Serum-Ck Activity After Combined Use of Halothane and Succinylcholine in Man; Anaesthesist 30 (7), 338-342 (1981) |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25545 |
Study title: Pozonyi, J.:Double-blind Controlled Evaluation of the Safety and Efficacy of Dantrolene Sodium in the Treatment of Moderate to Severe Skeletal Muscle Spasticity in a Pediatric Population;Pozonyi, J.:Double-blind Controlled Evaluation of the Safety and Efficacy of Dantrolene Sodium in the Treatment of Moderate to Severe Skeletal Muscle Spasticity in a Pediatric Population; |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25551 |
Study title: Soboloff HR: A five-year study of cerebral-palsied children with the use of dantrium sodium; Dev. Med. Child. Neurol. 20, 241-242 (1978)Soboloff HR: A five-year study of cerebral-palsied children with the use of dantrium sodium; Dev. Med. Child. Neurol. 20, 241-242 (1978) |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25539 |
Study title: Soboloff, H.R.:Single-blind Controlled Evaluation of the Safety and Efficacy of Dantrolene Sodium in the Treatment of Moderate to Severe Skeletal Muscle Spasticity in a Pediatric Population;Soboloff, H.R.:Single-blind Controlled Evaluation of the Safety and Efficacy of Dantrolene Sodium in the Treatment of Moderate to Severe Skeletal Muscle Spasticity in a Pediatric Population; |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25552 |
Study title: Analyse de metaphases de lymphocytes de sujets traites par le Bendazac-lysine |
Active substance: DAPIPRAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 25556 |
Study title: Analyse de metaphases de lymphocytes de sujets traites par le Bendazac-lysine |
Active substance: DAPIPRAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 25557 |
Study title: Dapiprazolo: richiamo della midriasi da atropina nell'infanzia |
Active substance: DAPIPRAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 25558 |
Study title: Open study on the effect of dapiprazole eye-drops on the reversal of cyclopentolate Induced mydriasis; |
Active substance: DAPIPRAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 25554 |
Study title: A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25283 |
Study title: Abdominal irradiation in unilateral nephroblastoma and its impact on local control and survival. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25284 |
Study title: Actinomycin D--the drug of choice for initial therapy of gestational trophoblastic disease. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25285 |
Study title: Actinomycin-D plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamine (DTIC) with or without intravenous Corynebacterium parvum in metastatic malignant melanoma. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25286 |
Study title: Acupuncture against chemotherapy-induced nausea and vomiting in pediatric oncology: Interim results of a multicenter crossover study |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25287 |
Study title: Acute toxicities associated with radiation in the second National Wilms' Tumor Study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25288 |
Study title: Adjuvant chemotherapy with a nitrosourea-based protocol in advanced malignant melanoma. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25289 |
Study title: Advances in chemotherapy for gynecologic cancer. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25290 |
Study title: Age is a risk factor for chemotherapy-induced hepatopathy with vincristine, dactinomycin, and cyclophosphamide. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25291 |
Study title: Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25292 |
Study title: Alternative chemotherapy of malignant bone neoplasms in children |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25293 |
Study title: Alveolar soft-part sarcoma: A cardiac metastasis as a rare site of relapse |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25294 |
Study title: Daunorubicin VS - Daunorubicin + Prednisone VS - Daunorubicine + Vincristine + Prednisone in restistant childhood leukemia - B. Jones - 1970 - Publication in the dos. Français jan 1977 and in the dos. Allemand jan 1981 - Daunorubicin VS - Daunorubicin + Prednisone VS - Daunorubicine + Vincristine + Prednisone in restistant childhood leukemia - B. Jones - 1970 - Publication in the dos. Français jan 1977 and in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25588 |
Study title: Efficacy and morbidity of Daunomycin (NSC-82151) added to vincristine (NSC-67574) and Prednisone (NSC-10023) for remission induction of childhood acute lymphocytic leukemia - Verzosa, M., Fite, A. - 1971 (Cancer Chemotherapy Reports Part.1 Vol. 55 n°1, 79-82) - Publication in the dos. Allemand jan 1981 - Efficacy and morbidity of Daunomycin (NSC-82151) added to vincristine (NSC-67574) and Prednisone (NSC-10023) for remission induction of childhood acute lymphocytic leukemia - Verzosa, M., Fite, A. - 1971 (Cancer Chemotherapy Reports Part.1 Vol. 55 n°1, 79-82) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25589 |
Study title: Efficacy and morbidity of Daunomycin (NSC-82151) added to vincristine (NSC-67574) and Prednisone (NSC-10023) for remission induction of childhood acute lymphocytic leukemia - Verzosa, M., Fite, A. - 1971 (Cancer Chemotherapy Reports Part.1 Vol. 55 n°1, 79-82) - Publication in the dos. Allemand jan 1981 - Efficacy and morbidity of Daunomycin (NSC-82151) added to vincristine (NSC-67574) and Prednisone (NSC-10023) for remission induction of childhood acute lymphocytic leukemia - Verzosa, M., Fite, A. - 1971 (Cancer Chemotherapy Reports Part.1 Vol. 55 n°1, 79-82) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25621 |
Study title: Eosinophilic Leukaemia - Marcovitch, H., Cain, F., Havard, C.W.H. - 1973 (The British Journal of Clinical Pratice, Vol. 27 No 5, 185 - 188) - Publication in the dos. Allemand jan 1981 - Eosinophilic Leukaemia - Marcovitch, H., Cain, F., Havard, C.W.H. - 1973 (The British Journal of Clinical Pratice, Vol. 27 No 5, 185 - 188) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25590 |
Study title: Arndt CA et al Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide Eur J Cancer. 1998 Jul;34(8):1224-9Arndt CA et al Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide Eur J Cancer. 1998 Jul;34(8):1224-9 |
Active substance: CYCLOPHOSPHAMIDE AND ETOPOSIDE AND IFOSFAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25181 |
Study title: Arndt CA et al Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group Pediatr Blood Cancer. 2008 Jan;50(1):33-6Arndt CA et al Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group Pediatr Blood Cancer. 2008 Jan;50(1):33-6 |
Active substance: CYCLOPHOSPHAMIDE AND ETOPOSIDE AND IFOSFAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25180 |
Study title: Bacci G et al Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patientstreated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin,cyclophosphamide, dactinomycin, ifosfamide and etoposide) Minerva Pediatr. 1995 Nov;47(11):457-69. ItalianBacci G et al Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patientstreated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin,cyclophosphamide, dactinomycin, ifosfamide and etoposide) Minerva Pediatr. 1995 Nov;47(11):457-69. Italian |
Active substance: CYCLOPHOSPHAMIDE AND ETOPOSIDE AND IFOSFAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25183 |
Study title: Ferrari S et al Ifosfamide and actinomycin-D, added in the induction phase to vincristine,cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity J Chemother. 1998 Dec;10(6):484-91Ferrari S et al Ifosfamide and actinomycin-D, added in the induction phase to vincristine,cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity J Chemother. 1998 Dec;10(6):484-91 |
Active substance: CYCLOPHOSPHAMIDE AND IFOSFAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25184 |
Study title: AN 00264413 Medline 20070101. TI Toxic psychosis due to cyproheptadine in a child on hemodialysis: a case report. SO Clinical nephrology, {Clin-Nephrol}, Jan 1977, vol. 7, no. 1, p. 43-4, ISSN: 0301-0430. AU Berger-M, White-J, Travis-L-B, Brouhard-B-H, Cunningham-R-J-3rd, Patnode-R, Petrusick-T. YR 1977.AN 00264413 Medline 20070101. TI Toxic psychosis due to cyproheptadine in a child on hemodialysis: a case report. SO Clinical nephrology, {Clin-Nephrol}, Jan 1977, vol. 7, no. 1, p. 43-4, ISSN: 0301-0430. AU Berger-M, White-J, Travis-L-B, Brouhard-B-H, Cunningham-R-J-3rd, Patnode-R, Petrusick-T. YR 1977. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25187 |
Study title: AN 00324951 Medline 20070101. TI Prophylaxis of migraine in children. SO Headache, {Headache}, May 1977, vol. 17, no. 2, p. 61-3, ISSN: 0017-8748. AU Bille-B, Ludvigsson-J, Sanner-G. YR 1977.YR 1977.AN 00324951 Medline 20070101. TI Prophylaxis of migraine in children. SO Headache, {Headache}, May 1977, vol. 17, no. 2, p. 61-3, ISSN: 0017-8748. AU Bille-B, Ludvigsson-J, Sanner-G. YR 1977.YR 1977. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25188 |
Study title: AN 00334082 Medline 20070101. TI Primary acquired cold urticaria. Double-blind comparative study of treatment with cyproheptadine, chlorpheniramine, and placebo. SO Archives of dermatology, {Arch-Dermatol}, Oct 1977, vol. 113, no. 10, p. 1375-7, ISSN: 0003-987X. AU Wanderer-A-A, St-Pierre-J-P, Ellis-E-F. YR 1977.AN 00334082 Medline 20070101. TI Primary acquired cold urticaria. Double-blind comparative study of treatment with cyproheptadine, chlorpheniramine, and placebo. SO Archives of dermatology, {Arch-Dermatol}, Oct 1977, vol. 113, no. 10, p. 1375-7, ISSN: 0003-987X. AU Wanderer-A-A, St-Pierre-J-P, Ellis-E-F. YR 1977. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25189 |
Study title: AN 00349601 Medline 20070101. TI Cyproheptadine in anorexia nervosa (proceedings). SO Psychopharmacology bulletin, {Psychopharmacol-Bull}, Apr 1978, vol. 14, no. 2, p. 31-3, ISSN: 0048-5764. AU Halmi-K-A, Goldberg-S-C. YR 1978.AN 00349601 Medline 20070101. TI Cyproheptadine in anorexia nervosa (proceedings). SO Psychopharmacology bulletin, {Psychopharmacol-Bull}, Apr 1978, vol. 14, no. 2, p. 31-3, ISSN: 0048-5764. AU Halmi-K-A, Goldberg-S-C. YR 1978. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25190 |
Study title: AN 00632998 Medline 20070101. TI The effect of cyproheptadine and human growth hormone on adrenocortical function in children with hypopituitarism. SO The Journal of pediatrics, {J-Pediatr}, Mar 1978, vol. 92, no. 3, p. 491-4, ISSN: 0022-3476. AU Kenien-A-G, Zeidner-D-L, Pang-S-J, Becker-D-J, Postellon-D-C, Gutai- J-P, Foley-T-P-Jr, Drash-A-L. YR 1978.AN 00632998 Medline 20070101. TI The effect of cyproheptadine and human growth hormone on adrenocortical function in children with hypopituitarism. SO The Journal of pediatrics, {J-Pediatr}, Mar 1978, vol. 92, no. 3, p. 491-4, ISSN: 0022-3476. AU Kenien-A-G, Zeidner-D-L, Pang-S-J, Becker-D-J, Postellon-D-C, Gutai- J-P, Foley-T-P-Jr, Drash-A-L. YR 1978. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25191 |
Study title: Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25374 |
Study title: Berotec tablets 5 mg + Theophylline summary of study - final report - phase III. |
Active substance: FENOTEROL |
Study summary document link (including results): Fenoterol hydrobromide_U80-0164_synopsis.pdf |
View full study record |
Document reference: 27076 |
Study title: Berotec tablets summary of study - phase II - final report. |
Active substance: FENOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 27064 |
Study title: The intergroup rhabdomyosarcoma study: a preliminary report. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25471 |
Study title: The IVADo regimen--a pilot study with ifosfamide, vincristine, actinomycin D, and doxorubicin in children with metastatic soft tissue sarcoma: a pilot study of behalf of the European pediatric Soft tissue sarcoma Study Group. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25474 |
Study title: The multi-institutional osteosarcoma study: an update. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25475 |
Study title: The pharmacological management of aggressive and autoaggressive behaviour in mentally retarded patients with melperone |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25476 |
Study title: The relationship between microsubstaging variables, age at diagnosis, and tumor weight of children with stage I/favorable histology Wilms' tumor. A report from the National Wilms' Tumor study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25477 |
Study title: The role of chemotherapy in the management of soft tissue sarcomas. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25478 |
Study title: The role of radiation therapy in the management of non-metastatic Ewing's sarcoma of bone. Report of the Intergroup Ewing's Sarcoma Study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25479 |
Study title: The treatment of Wilms' tumor: Results of the national Wilms' tumor study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25480 |
Study title: The treatment of Wilms' tumour: Results of the United Kingdom children's cancer study group third Wilms' tumour Study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25481 |
Study title: Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25482 |
Study title: Treatment of childhood Wilms' tumor without radiotherapy in Nicaragua. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25483 |
Study title: Treatment of children with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25484 |
Study title: Treatment of children with stage IV favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25485 |
Study title: Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25486 |
Study title: Treatment of endodermal sinus tumor in children using a regimen that lacks bleomycin. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25487 |
Study title: Treatment of Ewing's sarcoma in children and adolescents: a cooperative study of the German society of pediatric oncology (author's transl)a |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25488 |
Study title: Treatment of Ewing's sarcoma with intensive initial chemotherapy. 1st evaluation of a French pediatric multicenter protocol |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25489 |
Study title: Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25490 |
Study title: Treatment of Kaposi's sarcoma by combination of actinomycin-D, vincristine and imidazole carboxamide (nsc-45388): results of a randomized clinical trial. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25491 |
Study title: Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25492 |
Study title: Treatment of metastatic Ewing's sarcoma with actinomycin D (NSC-3053). |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25493 |
Study title: Richiamo con dapiprazolo collirio della midriasi da fenilefrina in pazienti a rischio e non |
Active substance: DAPIPRAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 25559 |
Study title: Studio di valutazione dell'efficacia del dapiprazolo collirio nella preparazione del paziente da sottoporre all'intervento di yag-laser iridotomia e argon-laser trabeculoplastica |
Active substance: DAPIPRAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 25555 |
Study title: Studio di valutazione dell'efficacia del dapiprazolo collirio nella preparazione del paziente da sottoporre all'intervento di yag-laser iridotomia e argon-laser trabeculoplastica |
Active substance: DAPIPRAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 25560 |
Study title: A review of 110 cases - D.D. Von Hoff, M. Rosencweig, M. Layard & coll. - 1977 - Publication in the dos. Français jan 1977 - Daunomycin induced cardiotoxicity in children and adults - A review of 110 cases - D.D. Von Hoff, M. Rosencweig, M. Layard & coll. - 1977 - Publication in the dos. Français jan 1977 - Daunomycin induced cardiotoxicity in children and adults - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25561 |
Study title: Acute and Long-Term Cytogenetic Effects of Childhood Cancer Chemotherapy and Radiotherapy - Miller, RG., Hill, R.B., Nichols, W. W., et al. - 1978 (Cancer Res. 38 (10), 3241) - Publication in the dos. Allemand jan 1981 - Acute and Long-Term Cytogenetic Effects of Childhood Cancer Chemotherapy and Radiotherapy - Miller, RG., Hill, R.B., Nichols, W. W., et al. - 1978 (Cancer Res. 38 (10), 3241) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25562 |
Study title: Acute leukemia treatment - Bernard J. - 1967 - Publication in Clinical Expert Report (J.K.H. Rees - 1989) and in the dos. Allemand jan 1981 - Acute leukemia treatment - Bernard J. - 1967 - Publication in Clinical Expert Report (J.K.H. Rees - 1989) and in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25563 |
Study title: Acute Lymphoblastic Leukaemia treated with a combination of Prednisone, Vincristine, and Rubidomycin - Mathé, G., Schwarzenberg, L., Schneider, M., et al. - 1967 (The Lancet, 380 - 382) - Publication in the dos. Allemand jan 1981 -Acute Lymphoblastic Leukaemia treated with a combination of Prednisone, Vincristine, and Rubidomycin - Mathé, G., Schwarzenberg, L., Schneider, M., et al. - 1967 (The Lancet, 380 - 382) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25564 |
Study title: Acute lymphoblastic leukemia in adults and children. Differences in response with similar therapeutic regimens. - T.S. Gee, M. Haghbin, M.D. Dowling & coll. - 1976 - Publication in the dos. Français jan 1977 - Acute lymphoblastic leukemia in adults and children. Differences in response with similar therapeutic regimens. - T.S. Gee, M. Haghbin, M.D. Dowling & coll. - 1976 - Publication in the dos. Français jan 1977 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25565 |
Study title: A prospective randomized study of medications after silicone intubation. Liu D. Ophthalmic Surg Lasers. 1996 Jun;27(6):434-7. A prospective randomized study of medications after silicone intubation. Liu D. Ophthalmic Surg Lasers. 1996 Jun;27(6):434-7. |
Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B |
Study summary document link (including results): A prospective randomized study of medications.pdf |
View full study record |
Document reference: 25763 |
Study title: Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8. Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8. |
Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B |
Study summary document link (including results): |
View full study record |
Document reference: 25757 |
Study title: [Epidemic keratoconjunctivitis: treatment results during an epidemic] Hutter H. Klin Monatsbl Augenheilkd. 1990 Sep;197(3):214-7. [Epidemic keratoconjunctivitis: treatment results during an epidemic] Hutter H. Klin Monatsbl Augenheilkd. 1990 Sep;197(3):214-7. |
Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B |
Study summary document link (including results): |
View full study record |
Document reference: 25761 |
Study title: Ocular hypertensive response to topical dexamethasone in children: a dose-dependent phenomenon.Ng JS, Fan DS, Young AL, Yip NK, Tam K, Kwok AK, Lam DS. Ophthalmology. 2000 Nov;107(11):2097-100 Comment in: Ophthalmology. 2001 Oct;108(10):1715-6. PMID: 11581031. Ocular hypertensive response to topical dexamethasone in children: a dose-dependent phenomenon.Ng JS, Fan DS, Young AL, Yip NK, Tam K, Kwok AK, Lam DS. Ophthalmology. 2000 Nov;107(11):2097-100 Comment in: Ophthalmology. 2001 Oct;108(10):1715-6. PMID: 11581031. |
Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B |
Study summary document link (including results): |
View full study record |
Document reference: 25756 |
Study title: Ocular-hypertensive response to topical steroids in children. Kwok AK, Lam DS, Ng JS, Fan DS, Chew SJ, Tso MO. Ophthalmology. 1997 Dec;104(12):2112-6. Ocular-hypertensive response to topical steroids in children. Kwok AK, Lam DS, Ng JS, Fan DS, Chew SJ, Tso MO. Ophthalmology. 1997 Dec;104(12):2112-6. |
Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B |
Study summary document link (including results): |
View full study record |
Document reference: 25759 |
Study title: Postoperative miotics for patients with infantile esotropia.Spierer A, Zeeli T. Ophthalmic Surg Lasers. 1997 Dec;28(12):1002-5. Postoperative miotics for patients with infantile esotropia.Spierer A, Zeeli T. Ophthalmic Surg Lasers. 1997 Dec;28(12):1002-5. |
Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B |
Study summary document link (including results): |
View full study record |
Document reference: 25758 |
Study title: Evaluation of chemotherapy in children with metastatic ewing's sarcoma and osteogenic sarcoma - W.W. Sutow, T.J. Vietti, D.J. Fernbach & coll. - 1971 - Publication in the dos. Français jan 1977 -Evaluation of chemotherapy in children with metastatic ewing's sarcoma and osteogenic sarcoma - W.W. Sutow, T.J. Vietti, D.J. Fernbach & coll. - 1971 - Publication in the dos. Français jan 1977 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25591 |
Study title: Evolution des méthodes d'utilisation de la chimiothérapie dans les tumeurs solides de l'enfant - D. Olive - 1976 - Publication in the dos. Français jan 1977 - Evolution des méthodes d'utilisation de la chimiothérapie dans les tumeurs solides de l'enfant - D. Olive - 1976 - Publication in the dos. Français jan 1977 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25592 |
Study title: High dose daunorubicin (NSC-83142) in the treatment of advanced acute myelogenous leukemia - Lippmann M. et al. - 1972 - Publication in Clinical Expert Report (J.K.H. Rees - 1989) - High dose daunorubicin (NSC-83142) in the treatment of advanced acute myelogenous leukemia - Lippmann M. et al. - 1972 - Publication in Clinical Expert Report (J.K.H. Rees - 1989) - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25593 |
Study title: Improvement in remission induction therapy of acute myelocytic Leukemia - Rai, K. R., Holland, J. F., Glidewell, O. - 1975 (Proc. Amer. Cancer Res. Vol. 16 No. 1176, 265) - Publication in the dos. Allemand jan 1981 - Improvement in remission induction therapy of acute myelocytic Leukemia - Rai, K. R., Holland, J. F., Glidewell, O. - 1975 (Proc. Amer. Cancer Res. Vol. 16 No. 1176, 265) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25594 |
Study title: Induction and Maintenance of remission in acute Leukemia - Pavlowsky, S., Penalver, J., Eppinger-Helft, M., et al. - 1973 (Cancer 31, 273 - 279) - Publication in the dos. Allemand jan 1981 -Induction and Maintenance of remission in acute Leukemia - Pavlowsky, S., Penalver, J., Eppinger-Helft, M., et al. - 1973 (Cancer 31, 273 - 279) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25595 |
Study title: Intensive Chemotherapy in Children with acute lymphoblastic leukemia - Hagbin, M., Tan, C. C., Clarkson, B. D., Miké, V., et al. - 1974 (Cancer 33, 1491 - 1498) - Publication in the dos. Allemand jan 1981 -Intensive Chemotherapy in Children with acute lymphoblastic leukemia - Hagbin, M., Tan, C. C., Clarkson, B. D., Miké, V., et al. - 1974 (Cancer 33, 1491 - 1498) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25596 |
Study title: Les leucémie aigües lymphoblastiques de l'enfant - F. Lejeune - 1975 - Publication in the dos. Français jan 1977 - Les leucémie aigües lymphoblastiques de l'enfant - F. Lejeune - 1975 - Publication in the dos. Français jan 1977 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25597 |
Study title: Yoder KE et al. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clin Pediatr 2006; 45(7):633-640Yoder KE et al. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clin Pediatr 2006; 45(7):633-640 |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 25801 |
Study title: Abuse of coricidin HBP cough & cold tablets: episodes recorded by a poison center. -Banerji SN, Anderson BA.- 2001 (Am. J. Health Syst. Pharm.; 58/1811-4) - Publication of Part IV Dextromethorphan HBr Syrup 1% - |
Active substance: DEXTROMETHORPHAN |
Study summary document link (including results): |
View full study record |
Document reference: 25827 |
Study title: Abuse of dextromethorphan. - Cranston J.W.- 1999 (Arch. Fam. Med.; 8:99-100.) - Publication of Part IV Dextromethorphan HBr Syrup 1% - |
Active substance: DEXTROMETHORPHAN |
Study summary document link (including results): |
View full study record |
Document reference: 25828 |
Study title: Abuse of over-the-counter dextromethorphan by teenagers - Murray S. et al.- 1993 (South. Med. J.; 86: 1151-3.) - Publication of Part IV Dextromethorphan HBr Syrup 1% - |
Active substance: DEXTROMETHORPHAN |
Study summary document link (including results): |
View full study record |
Document reference: 25829 |
Study title: Antitussives in the treatment of acute transient cough in children. - Korppi M. et al. - 1991 (Acta Paediatr. Scand.; 80: 969-971.) - Publication of Part IV Dextromethorphan HBr Syrup 1% - |
Active substance: DEXTROMETHORPHAN |
Study summary document link (including results): |
View full study record |
Document reference: 25830 |
Study title: Britton−M−G, Empey−D−W, John−G−C, Hodder−M, Hughes−D−T. Two doses of triprolidine for treatment of allergic rhinitis. Annals of allergy, {Ann−Allergy}, May 1979, vol. 42, no. 5, p. 330−2.Britton−M−G, Empey−D−W, John−G−C, Hodder−M, Hughes−D−T. Two doses of triprolidine for treatment of allergic rhinitis. Annals of allergy, {Ann−Allergy}, May 1979, vol. 42, no. 5, p. 330−2. |
Active substance: DEXTROMETHORPHAN |
Study summary document link (including results): |
View full study record |
Document reference: 25844 |
Study title: Dextromethorphan: an overview of safety issues. - Bem J. L. et al. (Drug safety 7 (3): 190-199.) - Publication of Part IV Dextromethorphan HBr Syrup 1% - |
Active substance: DEXTROMETHORPHAN |
Study summary document link (including results): |
View full study record |
Document reference: 25831 |
Study title: Interferon alfa-2a in recurrent metastatic hemangiopericytoma. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25375 |
Study title: Intracranial germ cell tumors: analysis of the therapy study MAKEI 83/86 and changes in protocol for the follow-up study |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25376 |
Study title: Intraoperative radiotherapy in the multidisciplinary treatment of bone sarcomas in children and adolescents. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25377 |
Study title: Intrathoracic soft tissue sarcomas in children. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25378 |
Study title: Kidney tumors of children |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25379 |
Study title: Late malignant melanoma after treatment of rhabdomyosarcoma of the orbit during childhood. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25380 |
Study title: Late recurrence in children with Wilms' tumor |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25381 |
Study title: Local control and survival related to radiation dose and volume and to chemotherapy in non-metastatic Ewing's sarcoma of pelvic bones. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25382 |
Study title: Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25383 |
Study title: Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25384 |
Study title: Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25385 |
Study title: Long-term evaluation of single versus multiple courses of actinomycin D therapy of Wilm's tumor. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25386 |
Study title: Long-term results of two VAB-like regimens (vinblastine + actinomycin-D + bleomycin + cyclophosphamide + cisplatin) in malignant germ cell tumours of the ovary |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25387 |
Study title: Long-term survival following a phase I/II trial with VETOPEC for solid tumors in childhood |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25388 |
Study title: Long-term survival rates with various chemotherapeutic regimens in stages III and IV ovarian adenocarcinoma. The influence of optimum pretreatment surgical resection. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25389 |
Study title: Melperone in low doses in anxious neurotic patients. A double-blind placebo-controlled clinical study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25390 |
Study title: Metastatic soft tissue sarcomas in children - A remaining challenge for paediatric oncology. A retrospective multicenter study from the Polish Pediatric Solid Tumors' Group |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25391 |
Study title: Mirror-image osteosarcoma of the radius. A casea |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25392 |
Study title: Multicentre analysis of anthracycline-induced cardiotoxicity in children following treatment according to the nephroblastoma studies SIOP No.9/GPOH and SIOP 93-01/GPOH. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25393 |
Study title: Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25394 |
Study title: Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: an Intergroup Study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25395 |
Study title: Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25396 |
Study title: Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: the recent experience at the Rizzoli Institute. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25397 |
Study title: Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25398 |
Study title: Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25496 |
Study title: Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25494 |
Study title: Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25495 |
Study title: Diphenhydramine hydrochloride intoxication, Hestand, H.E., J. Paediatr. 1977; 90:1017-1018Diphenhydramine hydrochloride intoxication, Hestand, H.E., J. Paediatr. 1977; 90:1017-1018 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25705 |
Study title: Diphenhydramine toxicity from combined oral and topical use, Schunk, J.E., Am. J. Dis. Child. 1988; 142(19): 1020-1021Diphenhydramine toxicity from combined oral and topical use, Schunk, J.E., Am. J. Dis. Child. 1988; 142(19): 1020-1021 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25719 |
Study title: Diphenhydramine toxicity in a child with varicella. A case report, McGann, K.P., J. Fam. Pract. 1992 August; 35(2): 210, 213-214Diphenhydramine toxicity in a child with varicella. A case report, McGann, K.P., J. Fam. Pract. 1992 August; 35(2): 210, 213-214 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25701 |
Study title: Diphenhydramine toxicity in three children with varicella-zoster infection, Chan, C.Y.J., The Annals of Pharmacotherapy 1991; 25(2): 130-132Diphenhydramine toxicity in three children with varicella-zoster infection, Chan, C.Y.J., The Annals of Pharmacotherapy 1991; 25(2): 130-132 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25696 |
Study title: Diphenhydramine, Garnett, W.R., Am. Pharm. 1986; NS26: 35-40Diphenhydramine, Garnett, W.R., Am. Pharm. 1986; NS26: 35-40 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25702 |
Study title: Diphenhydramine, Martindale The complete drug reference, 33 edition, Sweetman, S.C., p.416Diphenhydramine, Martindale The complete drug reference, 33 edition, Sweetman, S.C., p.416 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25721 |
Study title: Dose-dependent toxicity of diphenhydramine overdose, Radovanovic, D., Numan and Exp. Tixicology 2000; 19: 489-495Dose-dependent toxicity of diphenhydramine overdose, Radovanovic, D., Numan and Exp. Tixicology 2000; 19: 489-495 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25717 |
Study title: Double-blind crossover study comparing doxepin with diphenhydramine for the reatment of chronic urticaria, Greene, S.L., J. Am. Acad. Dermatol. 1985; 12: 669-675Double-blind crossover study comparing doxepin with diphenhydramine for the reatment of chronic urticaria, Greene, S.L., J. Am. Acad. Dermatol. 1985; 12: 669-675 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25704 |
Study title: Effects of fexofenadine, diphenhydramine, and placebo on performance of the test of variables of attention, Mansfield, L., Ann. Allergy Asthma Immunol. 2003 May; 90(5): 554-559Effects of fexofenadine, diphenhydramine, and placebo on performance of the test of variables of attention, Mansfield, L., Ann. Allergy Asthma Immunol. 2003 May; 90(5): 554-559 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25710 |
Study title: Electrocardiographic Findings in Patients with Diphenhydramine Overdose, Zareba, W., Am. J. Cardiol. 1997; 80: 1168-1173Electrocardiographic Findings in Patients with Diphenhydramine Overdose, Zareba, W., Am. J. Cardiol. 1997; 80: 1168-1173 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25724 |
Study title: FDA, HHS. Labelling of diphenhydramine-containing drug products for over-the counter human use. Final rule, Fed. Regist 1997; 62(168): 45767-74.FDA, HHS. Labelling of diphenhydramine-containing drug products for over-the counter human use. Final rule, Fed. Regist 1997; 62(168): 45767-74. |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25700 |
Study title: Massive diphenhydramine poisoning resulting in a wide-complex tachycardia: successful treatment with sodium bicarbonate, Clark, R.F., Ann. Emerg. Med. 1992; 21: 318-320Massive diphenhydramine poisoning resulting in a wide-complex tachycardia: successful treatment with sodium bicarbonate, Clark, R.F., Ann. Emerg. Med. 1992; 21: 318-320 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25697 |
Study title: Micromedex. Dexamethasone. Thomson Healthcare. 1974-2005 medizinishes Informationssystem Vol.125 expires 9/2005, 2005Micromedex. Dexamethasone. Thomson Healthcare. 1974-2005 medizinishes Informationssystem Vol.125 expires 9/2005, 2005 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25713 |
Study title: Vernal keratoconjunctivitis in the black child and its response to therapy.Dahan E, Appel R. Br J Ophthalmol. 1983 Oct;67(10):688-92.. Vernal keratoconjunctivitis in the black child and its response to therapy.Dahan E, Appel R. Br J Ophthalmol. 1983 Oct;67(10):688-92.. |
Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B |
Study summary document link (including results): |
View full study record |
Document reference: 25760 |
Study title: Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8. |
Active substance: DEXAMETHASONE_OR_DEXAMETHASONE AND CHLORAMPHENICOL |
Study summary document link (including results): |
View full study record |
Document reference: 25768 |
Study title: [Epidemic keratoconjunctivitis: treatment results during an epidemic] Hutter H. Klin Monatsbl Augenheilkd. 1990 Sep;197(3):214-7. |
Active substance: DEXAMETHASONE_OR_DEXAMETHASONE AND CHLORAMPHENICOL |
Study summary document link (including results): |
View full study record |
Document reference: 25770 |
Study title: Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial.Lam DS, Fan DS, Ng JS, Yu CB, Wong CY, Cheung AY. Clin Experiment Ophthalmol. 2005 Jun;33(3):252-8. Comment in: Clin Experiment Ophthalmol. 2005 Jun;33(3):229-30. PMID: 15932523. 2. Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial.Lam DS, Fan DS, Ng JS, Yu CB, Wong CY, Cheung AY. Clin Experiment Ophthalmol. 2005 Jun;33(3):252-8. Comment in: Clin Experiment Ophthalmol. 2005 Jun;33(3):229-30. PMID: 15932523. 2. |
Active substance: DEXAMETHASONE_OR_DEXAMETHASONE AND CHLORAMPHENICOL |
Study summary document link (including results): |
View full study record |
Document reference: 25766 |
Study title: Ocular hypertensive response to topical dexamethasone in children: a dose-dependent phenomenon.Ng JS, Fan DS, Young AL, Yip NK, Tam K, Kwok AK, Lam DS. Ophthalmology. 2000 Nov;107(11):2097-100 Comment in: Ophthalmology. 2001 Oct;108(10):1715-6. PMID: 11581031. 3. |
Active substance: DEXAMETHASONE_OR_DEXAMETHASONE AND CHLORAMPHENICOL |
Study summary document link (including results): |
View full study record |
Document reference: 25767 |
Study title: Ocular-hypertensive response to topical steroids in children. Kwok AK, Lam DS, Ng JS, Fan DS, Chew SJ, Tso MO. Ophthalmology. 1997 Dec;104(12):2112-6. |
Active substance: DEXAMETHASONE_OR_DEXAMETHASONE AND CHLORAMPHENICOL |
Study summary document link (including results): |
View full study record |
Document reference: 25772 |
Study title: Postoperative miotics for patients with infantile esotropia.Spierer A, Zeeli T. Ophthalmic Surg Lasers. 1997 Dec;28(12):1002-5. |
Active substance: DEXAMETHASONE_OR_DEXAMETHASONE AND CHLORAMPHENICOL |
Study summary document link (including results): |
View full study record |
Document reference: 25769 |
Study title: Vernal keratoconjunctivitis in the black child and its response to therapy.Dahan E, Appel R. Br J Ophthalmol. 1983 Oct;67(10):688-92. |
Active substance: DEXAMETHASONE_OR_DEXAMETHASONE AND CHLORAMPHENICOL |
Study summary document link (including results): |
View full study record |
Document reference: 25771 |
Study title: Experience with dexibuprofen in infantile surgery; Alberto Abdulhadi; Pren.Med.Argent. 2001,88,499-503Experience with dexibuprofen in infantile surgery; Alberto Abdulhadi; Pren.Med.Argent. 2001,88,499-503 |
Active substance: DEXIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 25773 |
Study title: Studie mit Hydro-, Lipo- und Sebonorm Cordes |
Active substance: DEXIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 25774 |
Study title: Santana VM et al, MACOP-B treatment in children and adolescents with advanced diffuse large-cell non-Hodgkin's lymphoma, Leukemia. 1993 Feb;7(2):187-91Santana VM et al, MACOP-B treatment in children and adolescents with advanced diffuse large-cell non-Hodgkin's lymphoma, Leukemia. 1993 Feb;7(2):187-91 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25103 |
Study title: Santini G et al. VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group. J Clin Oncol. 1998 Aug;16(8):2796-802Santini G et al. VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group. J Clin Oncol. 1998 Aug;16(8):2796-802 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25104 |
Study title: Santini G et al. VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group. J Clin Oncol. 1998 Aug;16(8):2796-802.Santini G et al. VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group. J Clin Oncol. 1998 Aug;16(8):2796-802. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25105 |
Study title: Sawamura Y et al Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study Neurol Med Chir (Tokyo). 1996 Sep;36(9):632-8Sawamura Y et al Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study Neurol Med Chir (Tokyo). 1996 Sep;36(9):632-8 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25106 |
Study title: Sawamura Y et al Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma J Neurosurg. 1998 Jan;88(1):66-72Sawamura Y et al Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma J Neurosurg. 1998 Jan;88(1):66-72 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25107 |
Study title: Dose-dependent toxicity of dextromethorphan overdose. - Betschart T. et al. 2000 (J. Clin.Toxicol.; 38:190.) - Publication of Part IV Dextromethorphan HBr Syrup 1% - |
Active substance: DEXTROMETHORPHAN |
Study summary document link (including results): |
View full study record |
Document reference: 25832 |
Study title: "DWM": a new drug of abuse ? - Nordt SP.- 1998 (Ann. Emerg.; 31: 794-5.) - Publication of Part IV Dextromethorphan HBr Syrup 1% - |
Active substance: DEXTROMETHORPHAN |
Study summary document link (including results): |
View full study record |
Document reference: 25826 |
Study title: Efficacy of cough suppressants in children. - Taylor J.A.- 1993 (J. Pediatr. 122: 799-802.) - Publication of Part IV Dextromethorphan HBr Syrup 1% - |
Active substance: DEXTROMETHORPHAN |
Study summary document link (including results): |
View full study record |
Document reference: 25833 |
Study title: Intentional abuse of dextromethorphan products: 1985 to 1988 statewide data. -McElwee NE. et al.- 1990 (Vet. Hum. Toxicol.; 32: 355.) - Publication of Part IV Dextromethorphan HBr Syrup 1% - |
Active substance: DEXTROMETHORPHAN |
Study summary document link (including results): |
View full study record |
Document reference: 25834 |
Study title: Korppi M et al. Antitussives in the treatment of acute transient cough in children. Acta Paediatr Scand 1991; 80(10):969-71Korppi M et al. Antitussives in the treatment of acute transient cough in children. Acta Paediatr Scand 1991; 80(10):969-71 |
Active substance: DEXTROMETHORPHAN |
Study summary document link (including results): |
View full study record |
Document reference: 25842 |
Study title: Lee PCL et al. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 2000; 52(9):1137-42Lee PCL et al. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 2000; 52(9):1137-42 |
Active substance: DEXTROMETHORPHAN |
Study summary document link (including results): |
View full study record |
Document reference: 25840 |
Study title: Paul IM et al. Dose-response relationship with increasing doses of dextromethorphan for children with cough. Clin Ther 2004; 26(9):1508-1514 Paul IM et al. Dose-response relationship with increasing doses of dextromethorphan for children with cough. Clin Ther 2004; 26(9):1508-1514 |
Active substance: DEXTROMETHORPHAN |
Study summary document link (including results): |
View full study record |
Document reference: 25838 |
Study title: Paul IM et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114(1):85-90 Paul IM et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114(1):85-90 |
Active substance: DEXTROMETHORPHAN |
Study summary document link (including results): |
View full study record |
Document reference: 25839 |
Study title: Uderzo C et al. High-dose vincristine, fractionated total-body irradiation and cyclophosphamide as conditioning regimen in allogeneic and autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission: a 7-year Italian multicentre study. Br J Haematol. 1995 Apr;89(4):790-7.Uderzo C et al. High-dose vincristine, fractionated total-body irradiation and cyclophosphamide as conditioning regimen in allogeneic and autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission: a 7-year Italian multicentre study. Br J Haematol. 1995 Apr;89(4):790-7. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25150 |
Study title: Ungerleider RS et al Phase I trial of mitoxantrone in childrenCancer Treat Rep. 1985 Apr;69(4):403-7 Starling KA et al Mitoxantrone in refractory acute leukemia in children: a phase I study Invest New Drugs. 1985;3(2):191-5 Ungerleider RS et al Phase I trial of mitoxantrone in childrenCancer Treat Rep. 1985 Apr;69(4):403-7 Starling KA et al Mitoxantrone in refractory acute leukemia in children: a phase I study Invest New Drugs. 1985;3(2):191-5 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25151 |
Study title: van den Berg H et al, Treatment of Hodgkin's disease in children with alternating mechlorethamine,, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy, Med Pediatr Oncol. 1997 Jul;29(1):23-7van den Berg H et al, Treatment of Hodgkin's disease in children with alternating mechlorethamine,, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy, Med Pediatr Oncol. 1997 Jul;29(1):23-7 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25152 |
Study title: Van Gool S et al Reversible hypophosphatemic rickets following ifosfamide treatment Med Pediatr Oncol. 1992;20(3):254-7Van Gool S et al Reversible hypophosphatemic rickets following ifosfamide treatment Med Pediatr Oncol. 1992;20(3):254-7 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25153 |
Study title: Post-marketing surveillance study:retrospective data collection Novo-Helisen® oral – preparations for mite allergy Report for PEI (renewal of marketing authorisation, PSUR) prepared Age of patients: 6 – 80 Years |
Active substance: DERMATOPHAGIODES PTERONYSSIMUS |
Study summary document link (including results): |
View full study record |
Document reference: 25655 |
Study title: Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study |
Active substance: DERMATOPHAGIODES PTERONYSSIMUS |
Study summary document link (including results): |
View full study record |
Document reference: 25652 |
Study title: Specific immunotherapy with Novo-Helisen Depot Pollen and Mite Preparations in a cluster dose- escalation-regimen: safety data; Age of patients: 4 - 65 Years Report for PEI (PSUR) in progress |
Active substance: DERMATOPHAGIODES PTERONYSSIMUS |
Study summary document link (including results): |
View full study record |
Document reference: 25657 |
Study title: Successful specific subcutaneous immunotherapy (SCIT) with non modified semi-depot pollen and mite preparations. Results of a post-marketing surveillance study Allergo J. No. 16, 193-198 Age of patients: 5 -71 Years |
Active substance: DERMATOPHAGIODES PTERONYSSIMUS |
Study summary document link (including results): |
View full study record |
Document reference: 25656 |
Study title: Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study |
Active substance: Dermatophagoides farinae, Dermatophagoides pteronyssinus |
Study summary document link (including results): |
View full study record |
Document reference: 39839 |
Study title: NHD Mites in patients with periennal allergic rhinitis, conjunctivitis and possibly asthma symptoms, so far only statistical analysis, Publication scheduled Age of patients: 6 -62 Years |
Active substance: Dermatophagoides farinae;Dermatophagoides pteronyssinus |
Study summary document link (including results): |
View full study record |
Document reference: 39841 |
Study title: Results of a post-marketing surveillance study Allergo J. No. 16, 193-198 Age of patients: 5 -71 Years.; Post-marketing study 1998-2001 (year) |
Active substance: Dermatophagoides farinae;Dermatophagoides pteronyssinus |
Study summary document link (including results): |
View full study record |
Document reference: 39842 |
Study title: Retrospective Analysis about hypersensitation with NHD Mites, Allergologie, Jahrgang 17, Heft 4, S. 154-159 Age of patients: 9-81 Years, 494 Patients |
Active substance: Dermatophagoides farinae;Dermatophagoides pteronyssinus |
Study summary document link (including results): |
View full study record |
Document reference: 39840 |
Study title: Successful specific subcutaneous immunotherapy (SCIT) with non modified semi-depot pollen and mite preparations. |
Active substance: Dermatophagoides farinae;Dermatophagoides pteronyssinus |
Study summary document link (including results): |
View full study record |
Document reference: 47782 |
Study title: A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: Clinical efficacy and side effects |
Active substance: Dermatophagoides pteronyssinus |
Study summary document link (including results): |
View full study record |
Document reference: 39844 |
Study title: Immunotherapy in children with allergic asthma: Effect on bronchial hyperreactivity and pharmacotherapy |
Active substance: Dermatophagoides pteronyssinus |
Study summary document link (including results): |
View full study record |
Document reference: 39843 |
Study title: Novo-Helisen® oral mite preparationsReport for PEI (PSUR) prepared (renewal of marketing authorisation). Age of patients: 6 - 80 Years |
Active substance: Dermatophagoids farinae;Dermatophagoides pteronyssinus |
Study summary document link (including results): |
View full study record |
Document reference: 47929 |
Study title: Post-marketing surveillance study:Novo-Helisen® oral preparations for mite allergyReport for PEI (PSUR) prepared. Age of patients: 6 - 61 Years |
Active substance: Dermatophagoids farinae;Dermatophagoides pteronyssinus |
Study summary document link (including results): |
View full study record |
Document reference: 40156 |
Study title: A Multi-Center, Pediatric, Open-Label Preference Study of Desloratadine 2.5 mg RediTab and Zyrtec 5.0 mg Chewable Tablet Medications. |
Active substance: desloratadine |
Study summary document link (including results): |
View full study record |
Document reference: 39696 |
Study title: A Placebo Controlled Study of the Efficacy and Safety of Desloratadine vs. Fexofenadine 180mg in the Treatment of Subjects with Symptomatic Seasonal Allergic Rhinitis (SAR). |
Active substance: desloratadine |
Study summary document link (including results): |
View full study record |
Document reference: 39694 |
Study title: A Placebo Controlled Study of the Efficacy and Safety of Desloratadine vs. Fexofenadine 180mg in the Treatment of Subjects with Symptomatic Seasonal Allergic Rhinitis (SAR). |
Active substance: desloratadine |
Study summary document link (including results): |
View full study record |
Document reference: 39695 |
Study title: A RANDOMIZED DOUBLE-BLIND COMPARISON OF THE EFFECTS OF DESLORATADINE VS DIPHENHYDRAMINE VS PLACEBO ON MANAGERIAL PERFORMANCE IN SUBJECTS WITH SEASONAL ALLERGIC RHINITIS. |
Active substance: desloratadine |
Study summary document link (including results): |
View full study record |
Document reference: 39693 |
Study title: Outcome of prophylactic therapy for idiopathic anaphylaxis, Wong, S., Ann. Intern. Med. 1991; 114: 133-136Outcome of prophylactic therapy for idiopathic anaphylaxis, Wong, S., Ann. Intern. Med. 1991; 114: 133-136 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25723 |
Study title: Over-the counter topical antipruritic agents are commonly recommended by office-based physicians: an analysis of US practice patterns, Duque, M.I., J. Dermatol. Treatment 2004; 15: 185-188Over-the counter topical antipruritic agents are commonly recommended by office-based physicians: an analysis of US practice patterns, Duque, M.I., J. Dermatol. Treatment 2004; 15: 185-188 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25698 |
Study title: Patte C et al. FAB/LMB96 International Study Committee. Results of the randomized international FAB / LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood. 2007 Apr 1;109(7):2773-80Patte C et al. FAB/LMB96 International Study Committee. Results of the randomized international FAB / LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood. 2007 Apr 1;109(7):2773-80 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25055 |
Study title: Paulides M et al Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance System Clin Endocrinol (Oxf). 2007 May;66(5):727-31. Epub 2007 Mar 23Paulides M et al Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance System Clin Endocrinol (Oxf). 2007 May;66(5):727-31. Epub 2007 Mar 23 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25056 |
Study title: Paulussen M et al. EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study)-preliminary results Klin Padiatr. 1999 Jul-Aug;211(4):276-83Paulussen M et al. EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study)-preliminary results Klin Padiatr. 1999 Jul-Aug;211(4):276-83 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25057 |
Study title: Paulussen M et al. Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study. Ann Oncol. 2001 Nov;12(11):1619-30.Paulussen M et al. Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study. Ann Oncol. 2001 Nov;12(11):1619-30. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25058 |
Study title: Pein F et al Etoposide in relapsed or refractory Wilms' tumor: a phase II study by the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group.J Clin Oncol 1993 Aug;11(8):1478-81Pein F et al Etoposide in relapsed or refractory Wilms' tumor: a phase II study by the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group.J Clin Oncol 1993 Aug;11(8):1478-81 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25059 |
Study title: Pfreundschuh M et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomisedcontrolled trial by the MabThera International Trial (MInT) Group. Lancet Oncol. 2006 May;7(5):379-91Pfreundschuh M et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomisedcontrolled trial by the MabThera International Trial (MInT) Group. Lancet Oncol. 2006 May;7(5):379-91 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24713 |
Study title: Pfreundschuh M et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomisedcontrolled trial by the MabThera International Trial (MInT) Group. Lancet Oncol. 2006 May;7(5):379-91Pfreundschuh M et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomisedcontrolled trial by the MabThera International Trial (MInT) Group. Lancet Oncol. 2006 May;7(5):379-91 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25060 |
Study title: Philip T et al High-dose methotrexate and HELP [Holoxan (ifosfamide), eldesine (vindesine), platinum]--doxorubicin in non-metastatic osteosarcoma of the extremity: a French multicentre pilot study. Fédération Nationale des Centres de Lutte contre le Cancer and Société Française d'Oncologie Pédiatrique Ann Oncol. 1999 Sep;10(9):1065-71Philip T et al High-dose methotrexate and HELP [Holoxan (ifosfamide), eldesine (vindesine), platinum]--doxorubicin in non-metastatic osteosarcoma of the extremity: a French multicentre pilot study. Fédération Nationale des Centres de Lutte contre le Cancer and Société Française d'Oncologie Pédiatrique Ann Oncol. 1999 Sep;10(9):1065-71 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25061 |
Study title: Schellong G et al High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group.J Clin Oncol 1999 Dec;17(12):3736-44Schellong G et al High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group.J Clin Oncol 1999 Dec;17(12):3736-44 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25108 |
Study title: Schellong G et al, Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group, J Clin Oncol. 2005 Sep 1;23(25):6181-9Schellong G et al, Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group, J Clin Oncol. 2005 Sep 1;23(25):6181-9 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25109 |
Study title: Schmidt P et al Results of the German studies (MAHO) for treatment of testicular germ celltumors in children--an update Klin Padiatr. 2002 Jul-Aug;214(4):167-72. GermanSchmidt P et al Results of the German studies (MAHO) for treatment of testicular germ celltumors in children--an update Klin Padiatr. 2002 Jul-Aug;214(4):167-72. German |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25111 |
Study title: Schneider DT et al Acute myelogenous leukemia after treatment for malignant germ cell tumors in children J Clin Oncol. 1999 Oct;17(10):3226-33Schneider DT et al Acute myelogenous leukemia after treatment for malignant germ cell tumors in children J Clin Oncol. 1999 Oct;17(10):3226-33 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25112 |
Study title: Seibel NL et al Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma: children's Cancer Group (CCG) 7943 Cancer 2007 Apr 15;109(8):1646-53Seibel NL et al Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma: children's Cancer Group (CCG) 7943 Cancer 2007 Apr 15;109(8):1646-53 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25113 |
Study title: Shamberger RC et al. Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection. J Thorac Cardiovasc Surg. 2000 Jun;119(6):1154-61Shamberger RC et al. Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection. J Thorac Cardiovasc Surg. 2000 Jun;119(6):1154-61 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25114 |
Study title: AN 1978026986 19780101. TI Treatment of Cushing's disease in childhood with cyproheptadine. AU Connors-M-H, Golabi-M. IN Dept. Ped., Univ. California, Davis, Calif., United States. SO Clinical Research {CLIN-RES}, 1977, Vol/Iss/Pg. 25/2 (172A). YR 1977.AN 1978026986 19780101. TI Treatment of Cushing's disease in childhood with cyproheptadine. AU Connors-M-H, Golabi-M. IN Dept. Ped., Univ. California, Davis, Calif., United States. SO Clinical Research {CLIN-RES}, 1977, Vol/Iss/Pg. 25/2 (172A). YR 1977. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25247 |
Study title: AN 1978038953 19780101. TI Cushing's disease: failure of treatment with cyproheptadine. AU Allgrove-J, Husband-P, Brook-C-G-D. IN Dept. Paed., West Middlesex Hosp., Isleworth, Middlesex, United Kingdom. SO British Medical Journal {BR-MED-J}, 1977, Vol/Iss/Pg. 1/6062 (686-687). YR 1977.AN 1978038953 19780101. TI Cushing's disease: failure of treatment with cyproheptadine. AU Allgrove-J, Husband-P, Brook-C-G-D. IN Dept. Paed., West Middlesex Hosp., Isleworth, Middlesex, United Kingdom. SO British Medical Journal {BR-MED-J}, 1977, Vol/Iss/Pg. 1/6062 (686-687). YR 1977. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25248 |
Study title: AN 1978059362 19780101. TI Effects of fenfluramine and cyproheptadine on growth hormone secretion. AU Mazzi-C, Riva-L-P, Bernasconi-D. IN Div. Endocrinol. Med. Costituz., Osp. Gen. Prov. S. Antonio Abate, Gallarate, Italy. SO Annales d'Endocrinologie {ANN-ENDOCRINOL}, 1976, Vol/Iss/Pg. 37/5 (355-364). YR 1976.AN 1978059362 19780101. TI Effects of fenfluramine and cyproheptadine on growth hormone secretion. AU Mazzi-C, Riva-L-P, Bernasconi-D. IN Div. Endocrinol. Med. Costituz., Osp. Gen. Prov. S. Antonio Abate, Gallarate, Italy. SO Annales d'Endocrinologie {ANN-ENDOCRINOL}, 1976, Vol/Iss/Pg. 37/5 (355-364). YR 1976. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25249 |
Study title: AN 1978076994 19780101. TI Effect of cyproheptadine (CPH), a serotonin antagonist, on adrenocortical function in hypopituitary children. AU Kenien-A-C, Zeidner-D-L, Becker-D-J, et-al. IN Univ. Pittsburgh, Sch. Med., Pittsburgh, Pa., United States. SO Pediatric Research {PEDIATR-RES}, 1977, Vol/Iss/Pg. 11/4 (No.333). YR 1977.AN 1978076994 19780101. TI Effect of cyproheptadine (CPH), a serotonin antagonist, on adrenocortical function in hypopituitary children. AU Kenien-A-C, Zeidner-D-L, Becker-D-J, et-al. IN Univ. Pittsburgh, Sch. Med., Pittsburgh, Pa., United States. SO Pediatric Research {PEDIATR-RES}, 1977, Vol/Iss/Pg. 11/4 (No.333). YR 1977. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25250 |
Study title: van Hoff J et al Etoposide, ifosfamide, and cisplatin therapy for refractory childhood solid tumors. Response and toxicity.Cancer 1995 Jun 15;75(12):2966-70van Hoff J et al Etoposide, ifosfamide, and cisplatin therapy for refractory childhood solid tumors. Response and toxicity.Cancer 1995 Jun 15;75(12):2966-70 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24755 |
Study title: Van Winkle P et al Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience Pediatr Blood Cancer. 2005 Apr;44(4):338-47Van Winkle P et al Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience Pediatr Blood Cancer. 2005 Apr;44(4):338-47 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24754 |
Study title: Vecchi V et al, Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients, Cancer. 1993 Sep 15;72(6):2049-57Vecchi V et al, Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients, Cancer. 1993 Sep 15;72(6):2049-57 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24753 |
Study title: Verdeguer A et al Fatal encephalopathy with ifosfamide/mesna Pediatr Hematol Oncol. 1989;6(4):383-5. No abstract availableVerdeguer A et al Fatal encephalopathy with ifosfamide/mesna Pediatr Hematol Oncol. 1989;6(4):383-5. No abstract available |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25154 |
Study title: von Schweinitz D et al Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology Eur J Cancer. 1997 Jul;33(8):1243-9von Schweinitz D et al Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology Eur J Cancer. 1997 Jul;33(8):1243-9 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25155 |
Study title: Voûte PA et al A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma. European Osteosarcoma Intergroup (EOI) Ann Oncol. 1999 Oct;10(10):1211-8Voûte PA et al A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma. European Osteosarcoma Intergroup (EOI) Ann Oncol. 1999 Oct;10(10):1211-8 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24746 |
Study title: Walter AW et al A pilot study of vincristine, ifosfamide, and doxorubicin in the treatment of pediatric non-rhabdomyosarcoma soft tissue sarcomas Med Pediatr Oncol. 1998 Apr;30(4):210-6Walter AW et al A pilot study of vincristine, ifosfamide, and doxorubicin in the treatment of pediatric non-rhabdomyosarcoma soft tissue sarcomas Med Pediatr Oncol. 1998 Apr;30(4):210-6 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25156 |
Study title: Warner JT et al Relative osteopenia after treatment for acute lymphoblastic leukemia Pediatr Res. 1999 Apr;45(4 Pt 1):544-51Warner JT et al Relative osteopenia after treatment for acute lymphoblastic leukemia Pediatr Res. 1999 Apr;45(4 Pt 1):544-51 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25157 |
Study title: An alternative schedule based on ifosfamide (IFM) in combination with doxorubicin (ADM), vincristin (VCR) and actinomycin D (ACTD) in advanced soft tissue sarcomas (STS) of adults. A pilot study |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25295 |
Study title: An extensive Ewing's sarcoma of the left ischium treatment by optimal systemic chemotherapy, intra-arterial dactinomycin, and delayed irradiation |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25296 |
Study title: Analysis of local tumor control in Ewing's sarcoma: preliminary results of a cooperative intergroup study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25297 |
Study title: Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25298 |
Study title: Anaplastic nephrogenic rest 3 |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25299 |
Study title: Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25300 |
Study title: Biliary emesis as the presenting sign in a neonate with Wilms tumor. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25302 |
Study title: A six month study evaluating the suppression of wheal and flare following multiple dose administration of desloratadine (5 mg) to subjects with allergic conditions |
Active substance: desloratadine |
Study summary document link (including results): |
View full study record |
Document reference: 39689 |
Study title: Marina NM et al. Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital. J Clin Oncol. 1999 Jan;17(1):180-90.Marina NM et al. Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital. J Clin Oncol. 1999 Jan;17(1):180-90. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25005 |
Study title: Martelli H et al Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of thegenital tract: A report from the Study Committee of the International Society of Pediatric Oncology J Clin Oncol. 1999 Jul;17(7):2117-22. ReviewMartelli H et al Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of thegenital tract: A report from the Study Committee of the International Society of Pediatric Oncology J Clin Oncol. 1999 Jul;17(7):2117-22. Review |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25006 |
Study title: Mastrangelo S et al. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy. Br J Cancer. 2001 Feb;84(4):460-4Mastrangelo S et al. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy. Br J Cancer. 2001 Feb;84(4):460-4 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24726 |
Study title: Mastrangelo S et al. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy. Br J Cancer. 2001 Feb;84(4):460-4Mastrangelo S et al. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy. Br J Cancer. 2001 Feb;84(4):460-4 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25007 |
Study title: Mathew P et al Phase I study of oral etoposide in children with refractory solid tumors J Clin Oncol 1994 Jul;12(7):1452-7Mathew P et al Phase I study of oral etoposide in children with refractory solid tumors J Clin Oncol 1994 Jul;12(7):1452-7 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25008 |
Study title: Matsukado Y et al, Cisplatin, vinblastine and bleomycin (PVB) combination chemotherapy in the treatment of intracranial malignant germ cell tumors--a preliminary report of a, phase II study--The Japanese Intracranial Germ Cell Tumor Study Group, Gan No Rinsho. 1986 Sep;32(11):1387-93. JapaneseMatsukado Y et al, Cisplatin, vinblastine and bleomycin (PVB) combination chemotherapy in the treatment of intracranial malignant germ cell tumors--a preliminary report of a, phase II study--The Japanese Intracranial Germ Cell Tumor Study Group, Gan No Rinsho. 1986 Sep;32(11):1387-93. Japanese |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25009 |
Study title: Matsumoto S et al Ifosfamide-induced hemorrhagic cystitis and its prevention by mesna Gan To Kagaku Ryoho. 1995 Jun;22(7):965-8. Japanese. No abstract availableMatsumoto S et al Ifosfamide-induced hemorrhagic cystitis and its prevention by mesna Gan To Kagaku Ryoho. 1995 Jun;22(7):965-8. Japanese. No abstract available |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25010 |
Study title: McCune JS et al Influence of age upon Ifosfamide-induced nephrotoxicity Pediatr Blood Cancer. 2004 May;42(5):427-32McCune JS et al Influence of age upon Ifosfamide-induced nephrotoxicity Pediatr Blood Cancer. 2004 May;42(5):427-32 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25012 |
Study title: McTiernan A et al A phase I/II study of doxorubicin, ifosfamide, etoposide and interval methotrexate in patients with poor prognosis osteosarcoma Pediatr Blood Cancer 2006 Mar;46(3):345-50McTiernan A et al A phase I/II study of doxorubicin, ifosfamide, etoposide and interval methotrexate in patients with poor prognosis osteosarcoma Pediatr Blood Cancer 2006 Mar;46(3):345-50 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25013 |
Study title: McWilliams NB et al.Cyclophosphamide/doxorubicin vs. cisplatin/teniposide in the treatment of children older than 12 months of age with disseminated neuroblastoma: a Pediatric Oncology Group Randomized Phase II study. Med Pediatr Oncol. 1995 Mar;24(3):176-80McWilliams NB et al.Cyclophosphamide/doxorubicin vs. cisplatin/teniposide in the treatment of children older than 12 months of age with disseminated neuroblastoma: a Pediatric Oncology Group Randomized Phase II study. Med Pediatr Oncol. 1995 Mar;24(3):176-80 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25014 |
Study title: Mertens AC et al, Pulmonary complications in survivors of childhood and adolescent cancer. A report from the Childhood Cancer Survivor Study, Cancer. 2002 Dec 1;95(11):2431-41Mertens AC et al, Pulmonary complications in survivors of childhood and adolescent cancer. A report from the Childhood Cancer Survivor Study, Cancer. 2002 Dec 1;95(11):2431-41 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25016 |
Study title: Philip T et al High-dose methotrexate and HELP [Holoxan (ifosfamide), eldesine (vindesine), platinum]--doxorubicin in non-metastatic osteosarcoma of the extremity: a French multicentre pilot study. Fédération Nationale des Centres de Lutte contre le Cancer and Société Française d'Oncologie Pédiatrique Ann Oncol. 1999 Sep;10(9):1065-71Philip T et al High-dose methotrexate and HELP [Holoxan (ifosfamide), eldesine (vindesine), platinum]--doxorubicin in non-metastatic osteosarcoma of the extremity: a French multicentre pilot study. Fédération Nationale des Centres de Lutte contre le Cancer and Société Française d'Oncologie Pédiatrique Ann Oncol. 1999 Sep;10(9):1065-71 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25062 |
Study title: Phillips MB et al Phase II study of rapid-scheduled etoposide in paediatric soft tissue sarcomas Eur J Cancer 1995;31A(5):782-4Phillips MB et al Phase II study of rapid-scheduled etoposide in paediatric soft tissue sarcomas Eur J Cancer 1995;31A(5):782-4 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25063 |
Study title: Pinkerton CR et al Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). The European Neuroblastoma Study Group Br J Cancer. 1990 Aug;62(2):319-23Pinkerton CR et al Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). The European Neuroblastoma Study Group Br J Cancer. 1990 Aug;62(2):319-23 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25064 |
Study title: AN 05747744 Medline 20070101. TI (Thinness syndrome and cyproheptadine chlorhydrate). TT Sindrome de delgadez y clorhidrato de ciproheptadina. SO Prensa medica argentina, {Prensa-Med-Argent}, 28 Jun 1968, vol. 55,no. 18, p. 850-7, ISSN: 0032-745X. AU Gerosa-H-N, Bonet-J-A. YR 1968.AN 05747744 Medline 20070101. TI (Thinness syndrome and cyproheptadine chlorhydrate). TT Sindrome de delgadez y clorhidrato de ciproheptadina. SO Prensa medica argentina, {Prensa-Med-Argent}, 28 Jun 1968, vol. 55,no. 18, p. 850-7, ISSN: 0032-745X. AU Gerosa-H-N, Bonet-J-A. YR 1968. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25215 |
Study title: AN 05759652 Medline 20070101. TI (Use of an appetite stimulant in anorexia). TT Utilisation d'un atimulant de l'appetit dans l'anorexie. SO Therapeutique (La Semaine des hopitaux), {Therapeutique}, Nov 1968, vol. 44, no. 9, p. 570-1, ISSN: 0040-5922. AU Pariente-J. YR 1968.AN 05759652 Medline 20070101. TI (Use of an appetite stimulant in anorexia). TT Utilisation d'un atimulant de l'appetit dans l'anorexie. SO Therapeutique (La Semaine des hopitaux), {Therapeutique}, Nov 1968, vol. 44, no. 9, p. 570-1, ISSN: 0040-5922. AU Pariente-J. YR 1968. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25216 |
Study title: AN 05776055 Medline 20070101. TI (Weight increase induced with cyprohepadine). TT Aumento ponderale indotto dalla ciproeptadina. SO Minerva medica, {Minerva-Med}, 24 Feb 1969, vol. 60, no. 16, p. 694-9, ISSN: 0026-4806. AU Gionta-D. YR 1969.AN 05776055 Medline 20070101. TI (Weight increase induced with cyprohepadine). TT Aumento ponderale indotto dalla ciproeptadina. SO Minerva medica, {Minerva-Med}, 24 Feb 1969, vol. 60, no. 16, p. 694-9, ISSN: 0026-4806. AU Gionta-D. YR 1969. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25217 |
Study title: AN 05776077 Medline 20070101. TI (Action of cyproheptadine on the appetite of anorexic and normal children). TT Azione della ciproeptadina sull'appetito di bambini anoressici e normali. SO Minerva pediatrica, {Minerva-Pediatr}, 17 Mar 1969, vol. 21, no. 11, p. 465-9, ISSN: 0026-4946. AU Salvatori-A. YR 1969.AN 05776077 Medline 20070101. TI (Action of cyproheptadine on the appetite of anorexic and normal children). TT Azione della ciproeptadina sull'appetito di bambini anoressici e normali. SO Minerva pediatrica, {Minerva-Pediatr}, 17 Mar 1969, vol. 21, no. 11, p. 465-9, ISSN: 0026-4946. AU Salvatori-A. YR 1969. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25218 |
Study title: AN 05827600 Medline 20070101. TI (Periactine in pediatrics). TT La periactine en pediatrie. SO La Medecine infantile, {Med-Infant-Paris}, Apr 1965, vol. 72, no. 4, p. 265-77, ISSN: 0025-6773. AU Perelman-R. YR 1965.AN 05827600 Medline 20070101. TI (Periactine in pediatrics). TT La periactine en pediatrie. SO La Medecine infantile, {Med-Infant-Paris}, Apr 1965, vol. 72, no. 4, p. 265-77, ISSN: 0025-6773. AU Perelman-R. YR 1965. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25219 |
Study title: AN 06327962 Medline 20070101. TI Prolonged remission of Cushing disease after treatment with cyproheptadine. SO The Journal of pediatrics, {J-Pediatr}, Jun 1984, vol. 104, no. 6, p. 906-8, ISSN: 0022-3476. AU Couch-R-M, Smail-P-J, Dean-H-J, Winter-J-S. YR 1984.AN 06327962 Medline 20070101. TI Prolonged remission of Cushing disease after treatment with cyproheptadine. SO The Journal of pediatrics, {J-Pediatr}, Jun 1984, vol. 104, no. 6, p. 906-8, ISSN: 0022-3476. AU Couch-R-M, Smail-P-J, Dean-H-J, Winter-J-S. YR 1984. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25220 |
Study title: AN 06753477 Medline 20070101. TI Inhibition of the insulin response to glucose after treatment with cyproheptadine. SO Acta paediatrica Scandinavica, {Acta-Paediatr-Scand}, May 1982, vol. 71, no. 3, p. 485-7, ISSN: 0001-656X. AU Golander-A, Spirer-Z. YR 1982.AN 06753477 Medline 20070101. TI Inhibition of the insulin response to glucose after treatment with cyproheptadine. SO Acta paediatrica Scandinavica, {Acta-Paediatr-Scand}, May 1982, vol. 71, no. 3, p. 485-7, ISSN: 0001-656X. AU Golander-A, Spirer-Z. YR 1982. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25221 |
Study title: AN 1978153963 19780101. TI Suppression of human growth hormone secretion by cyproheptadine. AU Delitala-G, Devilla-L, Bionda-S, Franca-V. IN Catt. Semeiot. Med. II, Univ. Sassari, Italy. SO Metabolism: Clinical and Experimental {METAB-CLIN-EXP}, 1977, Vol/Iss /Pg. 26/8 (931-936). YR 1977.AN 1978153963 19780101. TI Suppression of human growth hormone secretion by cyproheptadine. AU Delitala-G, Devilla-L, Bionda-S, Franca-V. IN Catt. Semeiot. Med. II, Univ. Sassari, Italy. SO Metabolism: Clinical and Experimental {METAB-CLIN-EXP}, 1977, Vol/Iss /Pg. 26/8 (931-936). YR 1977. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25251 |
Study title: AN 1978208704 19780101. TI Effect of cyproheptadine (CPH), a serotonin antagonist, on adrenocortical function in children with hypopituitarism. AU Kenien-A-G, Zeidner-D-L, Becker-D-J, et-al. SO Journal of Pediatrics {J-PEDIATR}, 1977, Vol/Iss/Pg. 91/5 (836). YR 1977.AN 1978208704 19780101. TI Effect of cyproheptadine (CPH), a serotonin antagonist, on adrenocortical function in children with hypopituitarism. AU Kenien-A-G, Zeidner-D-L, Becker-D-J, et-al. SO Journal of Pediatrics {J-PEDIATR}, 1977, Vol/Iss/Pg. 91/5 (836). YR 1977. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25252 |
Study title: AN 1978276212 19780101. TI Cyproheptadine. SO Lancet {LANCET}, 1978, Vol/Iss/Pg. 2/8060 (367-368). YR 1978.AN 1978276212 19780101. TI Cyproheptadine. SO Lancet {LANCET}, 1978, Vol/Iss/Pg. 2/8060 (367-368). YR 1978. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25253 |
Study title: AN 1978307339 19780101. TI Toxicity of cyproheptadine side effects and accidental overdosage. AU Von-Muehlendahl-K-E, Krienke-E-G. IN Beratungsstelle Vergiftungserscheinungen, Univ. Kinderklin., Freie Univ., Berlin, Germany. SO Monatsschrift fur Kinderheilkunde {MONATSSCHR-KINDERHEILKD}, 1978, Vol/Iss/Pg. 126/3 (123-126). YR 1978.AN 1978307339 19780101. TI Toxicity of cyproheptadine side effects and accidental overdosage. AU Von-Muehlendahl-K-E, Krienke-E-G. IN Beratungsstelle Vergiftungserscheinungen, Univ. Kinderklin., Freie Univ., Berlin, Germany. SO Monatsschrift fur Kinderheilkunde {MONATSSCHR-KINDERHEILKD}, 1978, Vol/Iss/Pg. 126/3 (123-126). YR 1978. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25254 |
Study title: AN 1981016945 19810101. TI Effect of cyproheptadine on steroid hormone excretion by a young girl with Cushing's syndrome. AU Seaton-B, Johnston-P-G-B. IN Zool. Soc., London NW1 4RY, United Kingdom. SO Journal of Endocrinology {J-ENDOCRINOL}, 1980, Vol/Iss/Pg. 87/2 (61p-62p). YR 1980.AN 1981016945 19810101. TI Effect of cyproheptadine on steroid hormone excretion by a young girl with Cushing's syndrome. AU Seaton-B, Johnston-P-G-B. IN Zool. Soc., London NW1 4RY, United Kingdom. SO Journal of Endocrinology {J-ENDOCRINOL}, 1980, Vol/Iss/Pg. 87/2 (61p-62p). YR 1980. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25255 |
Study title: Acute promyelocytic leukaemia: results of treatment of daunorubicin - Bernard J. et al. - 1973 - Publication in the dos. Allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - Acute promyelocytic leukaemia: results of treatment of daunorubicin - Bernard J. et al. - 1973 - Publication in the dos. Allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25566 |
Study title: Chemotherapy of acute lymphocytic Leukemia of childhood - Holland, J. F., Glidewell, O. - 1972 (Cancer Vol. 30 No. 6, 1480 - 1487) - Publication in the dos. Allemand jan 1981 -Chemotherapy of acute lymphocytic Leukemia of childhood - Holland, J. F., Glidewell, O. - 1972 (Cancer Vol. 30 No. 6, 1480 - 1487) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25567 |
Study title: Clinical and Ultracytochemical observations on monocytic Leukemia in childhood - Komiyama, A., Eguchi, M., Tsukdada, M., Hanamura, K., Akabane, T. - 1973 (J. Shinshu Univ. 17, 115 - 125) - Publication in the dos. Allemand jan 1981 - Clinical and Ultracytochemical observations on monocytic Leukemia in childhood - Komiyama, A., Eguchi, M., Tsukdada, M., Hanamura, K., Akabane, T. - 1973 (J. Shinshu Univ. 17, 115 - 125) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25568 |
Study title: Clinical Expert Report - J.K.H. Rees - 1989Clinical Expert Report - J.K.H. Rees - 1989 |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25569 |
Study title: Clinical overview - Irène Eugène Jolchine - 20 February 2007Clinical overview - Irène Eugène Jolchine - 20 February 2007 |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25570 |
Study title: Clinical Study of Daunomycin (NSC-82151) in children with acute leukemia - Holton, C.P., Lonsdale, D., Nora, A. H., Thurman, W.G., Vietti, T.J. - 1968 (Cancer Vol. 22 N° 5, 1014 - 1017) - Publication in the dos. Allemand jan 1981 - Clinical Study of Daunomycin (NSC-82151) in children with acute leukemia - Holton, C.P., Lonsdale, D., Nora, A. H., Thurman, W.G., Vietti, T.J. - 1968 (Cancer Vol. 22 N° 5, 1014 - 1017) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25571 |
Study title: Clinical Study of Daunomycin and Prednisone for induction of remission in children with advanced leukemia - Holton, C.P., Vietti, T. J., Nora, A. H., Donaldson, M. H., Stuckey, W. J., Watkins, W. L., Lane, D. M. - 1969 (The New England Journal of Medicine Vol. 280, N°. 4, 171 - 174) - Publication in the dos. Allemand jan 1981 - Clinical Study of Daunomycin and Prednisone for induction of remission in children with advanced leukemia - Holton, C.P., Vietti, T. J., Nora, A. H., Donaldson, M. H., Stuckey, W. J., Watkins, W. L., Lane, D. M. - 1969 (The New England Journal of Medicine Vol. 280, N°. 4, 171 - 174) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25572 |
Study title: Bladder and prostatic tumors in the intergroup Rhabdomyosarcoma study (IRS-I): results of therapy. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25303 |
Study title: Bleomycin, actinomycin-D, and cisplatin treatment of ovarian germ-cell malignancies contributes to reducing adverse drug reactions. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25304 |
Study title: Bleomycin, cyclophosphamide, and dactinomycin in metastatic osteosarcoma: lack of tumor regression in previously treated patients. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25305 |
Study title: Carboplatin and etoposide (CarE) combined with radiotherapy and vincristine, doxorubicin and cyclophosphamide (VAC) in limited small cell lung cancer. A phase II study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25306 |
Study title: Chemotherapy for testicular cancer: current status of the National Cancer Institute Combined Modality Trial. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25307 |
Study title: Chemotherapy in osteogenic sarcoma: the experience of the Pediatric Department of the Gustave Roussy Institute. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25308 |
Study title: Chemotherapy of bladder and prostatic neoplasms in children |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25309 |
Study title: Chemotherapy of immature ovarian teratomas |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25310 |
Study title: Chemotherapy of sarcomas-a perspective. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25311 |
Study title: Chemotherapy-related toxicity in infants treated according to the Second National Wilms' Tumor Study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25312 |
Study title: Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25313 |
Study title: Clinical study of testicular cancer |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25314 |
Study title: Clinical trial of CCLSG OS-88 protocol in childhood osteosarcoma: Selection of postoperative chemotherapy based on histological tumor response. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25315 |
Study title: Clinical trial of chlorozotocin, DTIC, and dactinomycin in metastatic malignant melanoma. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25316 |
Study title: Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613). |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25317 |
Study title: Combined chemotherapy in childhood rhabdomyosarcoma. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25318 |
Study title: Combined chemotherapy of the metastases of testicular teratoblastomas |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25319 |
Study title: Comparative evaluation of three combination regimens for advanced malignant melanoma: results of an international cooperative study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25320 |
Study title: Leucémie myéloïde aigüe de l'enfant traité par un protocole d'induction bref - D. Fiere, G. Souillet, N. Philippe & coll. - 1976 - Publication in the dos. Français jan 1977 - Leucémie myéloïde aigüe de l'enfant traité par un protocole d'induction bref - D. Fiere, G. Souillet, N. Philippe & coll. - 1976 - Publication in the dos. Français jan 1977 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25598 |
Study title: Management of acute non-lymphocytic Leukemia - Fennelly, J. J., O'Connell, L. G., Cahalane, S. F., et al. - 1974 (Ir. Journal Med. Sci. 143, 129 - 136) - Publication in the dos. Allemand jan 1981 - Management of acute non-lymphocytic Leukemia - Fennelly, J. J., O'Connell, L. G., Cahalane, S. F., et al. - 1974 (Ir. Journal Med. Sci. 143, 129 - 136) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25599 |
Study title: Overall Clinical Summary and Evaluation for the application of CerubidineOverall Clinical Summary and Evaluation for the application of Cerubidine |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25600 |
Study title: Paediatric Phase I study in solid tumours Paediatric Phase I study in solid tumours |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25612 |
Study title: Peut-on guérir la leuncémie de l'enfant - M. Weil, Cl. Jacquillat & M.F. Gemon - 1974 - Publication in the dos. Français jan 1977 - Peut-on guérir la leuncémie de l'enfant - M. Weil, Cl. Jacquillat & M.F. Gemon - 1974 - Publication in the dos. Français jan 1977 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25601 |
Study title: AN 00853345 Medline 20070101. TI Treatment of Cushing disease in Childhood with cyproheptadine. SO The Journal of pediatrics, {J-Pediatr}, May 1977, vol. 90, no. 5, p. 834-5, ISSN: 0022-3476. AU D-Ercole-A-J, Morris-M-A, Underwood-L-E, Van-Wyk-J-J, Feldman-J-M. YR 1977.AN 00853345 Medline 20070101. TI Treatment of Cushing disease in Childhood with cyproheptadine. SO The Journal of pediatrics, {J-Pediatr}, May 1977, vol. 90, no. 5, p. 834-5, ISSN: 0022-3476. AU D-Ercole-A-J, Morris-M-A, Underwood-L-E, Van-Wyk-J-J, Feldman-J-M. YR 1977. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25192 |
Study title: AN 01379358 Medline 20070101. TI Palliative treatment of hyperinsulinism with cyproheptadine and diazoxide. SO Pediatrics, {Pediatrics}, Aug 1992, vol. 90, no. 2 Pt 1, p. 212-5, SSN: 0031-4005. AU Rotenstein-D, Serbin-S, Welsh-T. IN Department of Pediatrics, Medical College of Pennsylvania, Allegheny General Hospital, Pittsburgh 15212.YR 1992.AN 01379358 Medline 20070101. TI Palliative treatment of hyperinsulinism with cyproheptadine and diazoxide. SO Pediatrics, {Pediatrics}, Aug 1992, vol. 90, no. 2 Pt 1, p. 212-5, SSN: 0031-4005. AU Rotenstein-D, Serbin-S, Welsh-T. IN Department of Pediatrics, Medical College of Pennsylvania, Allegheny General Hospital, Pittsburgh 15212.YR 1992. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25193 |
Study title: AN 01424795 Medline 20070101. TI Aquagenic urticaria. SO Cutis; cutaneous medicine for the practitioner, {Cutis}, Oct 1992, vol. 50, no. 4, p. 283-4, ISSN: 0011-4162. AU Parker-R-K, Crowe-M-J, Guin-J-D. IN Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock 72205. YR 1992.AN 01424795 Medline 20070101. TI Aquagenic urticaria. SO Cutis; cutaneous medicine for the practitioner, {Cutis}, Oct 1992, vol. 50, no. 4, p. 283-4, ISSN: 0011-4162. AU Parker-R-K, Crowe-M-J, Guin-J-D. IN Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock 72205. YR 1992. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25194 |
Study title: AN 02596504 Medline 20070101. TI Nocturnal rhythm of growth hormone in Duchenne patients: effect of different doses of mazindol and/or cyproheptadine. SO American journal of medical genetics, {Am-J-Med-Genet}, Aug 1989, vol. 33, no. 4, p. 457-67, ISSN: 0148-7299. AU Zatz-M, Rapaport-D, Pavanello-R-C, Rocha-J-M, Vainzof-M, Nicolau-W. IN Departamento de Biologia, Universidade de Sao Paulo, Brazil. YR 1989.AN 02596504 Medline 20070101. TI Nocturnal rhythm of growth hormone in Duchenne patients: effect of different doses of mazindol and/or cyproheptadine. SO American journal of medical genetics, {Am-J-Med-Genet}, Aug 1989, vol. 33, no. 4, p. 457-67, ISSN: 0148-7299. AU Zatz-M, Rapaport-D, Pavanello-R-C, Rocha-J-M, Vainzof-M, Nicolau-W. IN Departamento de Biologia, Univer... |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25195 |
Study title: AN 03414615 Medline 20070101. TI Cyproheptadine and growth. SO American journal of diseases of children (1960), {Am-J-Dis-Child}, Sep 1988, vol. 142, no. 9, p. 914-5, ISSN: 0002-922X. AU Arisaka-O, Shimura-N, Nakayama-Y, Yabuta-K. YR 1988.AN 03414615 Medline 20070101. TI Cyproheptadine and growth. SO American journal of diseases of children (1960), {Am-J-Dis-Child}, Sep 1988, vol. 142, no. 9, p. 914-5, ISSN: 0002-922X. AU Arisaka-O, Shimura-N, Nakayama-Y, Yabuta-K. YR 1988. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25196 |
Study title: AN 03794875 Medline 20070101. TI Enhancement of linear growth and weight gain by cyproheptadine in children with hypopituitarism receiving growth hormone therapy. SO The Journal of pediatrics, {J-Pediatr}, Jan 1987, vol. 110, no. 1, p.140-3, ISSN: 0022-3476. AU Kaplowitz-P-B, Jennings-S. YR 1987.AN 03794875 Medline 20070101. TI Enhancement of linear growth and weight gain by cyproheptadine in children with hypopituitarism receiving growth hormone therapy. SO The Journal of pediatrics, {J-Pediatr}, Jan 1987, vol. 110, no. 1, p.140-3, ISSN: 0022-3476. AU Kaplowitz-P-B, Jennings-S. YR 1987. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25197 |
Study title: AN 04581629 Medline 20070101. TI (Effects of cyproheptadine in a sample of children in the second age of childhood). TT Osservazioni sugli effetti determinati dalla ciproeptadina su un campione di bambini della seconda infanzia. SO Minerva pediatrica, {Minerva-Pediatr}, 26 May 1973, vol. 25, no. 19, p. 833-43, ISSN: 0026-4946. AU Di-Marzo-G. YR 1973.AN 04581629 Medline 20070101. TI (Effects of cyproheptadine in a sample of children in the second age of childhood). TT Osservazioni sugli effetti determinati dalla ciproeptadina su un campione di bambini della seconda infanzia. SO Minerva pediatrica, {Minerva-Pediatr}, 26 May 1973, vol. 25, no. 19, p. 833-43, ISSN: 0026-4946. AU Di-Marzo-G. YR 1973. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25198 |
Study title: AN 04901745 Medline 20070101. TI Appetite and weight gain in children: a double-blind trial using cyproheptadine and methandrostenolone. SO The Central African journal of medicine, {Cent-Afr-J-Med}, Oct 1969, vol. 15, no. 11, p. 229-32, ISSN: 0008-9176. AU Kibel-M-A. YR 1969.AN 04901745 Medline 20070101. TI Appetite and weight gain in children: a double-blind trial using cyproheptadine and methandrostenolone. SO The Central African journal of medicine, {Cent-Afr-J-Med}, Oct 1969, vol. 15, no. 11, p. 229-32, ISSN: 0008-9176. AU Kibel-M-A. YR 1969. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25199 |
Study title: Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25399 |
Study title: AN 06954287 Medline 20070101. TI Benoxaprofen and cyproheptadine. SO The Journal of the Medical Society of New Jersey, {J-Med-Soc-N-J}, May 1982, vol. 79, no. 5, p. 413-4, ISSN: 0025-7524. AU Rosenberg-J-M, Kirschenbaum-H-L, Saleem-G, Ritz-J, Martino-F-P. YR 1982AN 06954287 Medline 20070101. TI Benoxaprofen and cyproheptadine. SO The Journal of the Medical Society of New Jersey, {J-Med-Soc-N-J}, May 1982, vol. 79, no. 5, p. 413-4, ISSN: 0025-7524. AU Rosenberg-J-M, Kirschenbaum-H-L, Saleem-G, Ritz-J, Martino-F-P. YR 1982 |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25222 |
Study title: AN 07278892 Medline 20070101. TI Pregnancy after cyproheptadine treatment for Cushing's disease. SO The New England journal of medicine, {N-Engl-J-Med}, 8 Oct 1981, vol.305, no. 15, p. 893-4, ISSN: 0028-4793. AU Griffith-D-N, Rose-E-J. YR 1981.AN 07278892 Medline 20070101. TI Pregnancy after cyproheptadine treatment for Cushing's disease. SO The New England journal of medicine, {N-Engl-J-Med}, 8 Oct 1981, vol.305, no. 15, p. 893-4, ISSN: 0028-4793. AU Griffith-D-N, Rose-E-J. YR 1981. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25223 |
Study title: Treatment of rhabdomyosarcoma and other malignant mesenchymal tumours of childhood with ifosfamide + vincristine + dactinomycin (IVA) as front-line therapy (a SIOP study). |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25497 |
Study title: Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25498 |
Study title: Treatment of soft tissue sarcomas in childhood and adolescence: results of the CWS-81 multicenter therapy study |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25499 |
Study title: Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: a Pediatric Oncology Group study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25500 |
Study title: Treatment outcomes in patients less than 2 years of age with small, stage I, favorable-histology Wilms' tumors: a report from the National Wilms' Tumor Study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25502 |
Study title: Treatment-related myelodysplastic syndrome after chemotherapy for childhood low-grade astrocytoma 2 |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25503 |
Study title: Trial and study on nephroblastomas S.I.O.P. No. 1. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25504 |
Study title: Tumor response and toxicity after single high-dose versus standard five-day divided-dose dactinomycin in childhood rhabdomyosarcoma. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25505 |
Study title: Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25506 |
Study title: VAB-3 combination chemotherapy of metastatic testicular cancer. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25507 |
Study title: VAB-4 combination chemotherapy in the treatment of metastatic testis tumors. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25508 |
Study title: Value of postchemotherapy bioptical verification of complete clinical remission in previously incompletely resected (stage I and II pT3) malignant mesenchymal tumors in children: International Society of Pediatric Oncology 1984 Malignant Mesenchymal Tumors Study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25509 |
Study title: Vascular-endothelial-growth-factor (VEGF) expression and possible response to angiogenesis inhibitor bevacizumab in metastatic alveolar soft part sarcoma |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25510 |
Study title: Vertebral abnormalities after treatment for Ewing sarcoma. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25511 |
Study title: Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25512 |
Study title: FRAGMIN P / - FORTE FOR RISK ADAPTED PERI- AND POSTOPERATIVE PROPHYLAXIS OF THROMBOSIS IN HOSPITALIZED PATIENT |
Active substance: DALTEPARIN |
Study summary document link (including results): Dalteparin Cover Letter Article 45 publ VP059498 Feb 12 (4).pdf |
View full study record |
Document reference: 25513 |
Study title: Clinical Study of Daunomycin and Prednisone for induction of remission in children with advanced leukemia - Holton, C.P., Vietti, T. J., Nora, A. H., Donaldson, M. H., Stuckey, W. J., Watkins, W. L., Lane, D. M. - 1969 (The New England Journal of Medicine Vol. 280, N°. 4, 171 - 174) - Publication in the dos. Allemand jan 1981 - Clinical Study of Daunomycin and Prednisone for induction of remission in children with advanced leukemia - Holton, C.P., Vietti, T. J., Nora, A. H., Donaldson, M. H., Stuckey, W. J., Watkins, W. L., Lane, D. M. - 1969 (The New England Journal of Medicine Vol. 280, N°. 4, 171 - 174) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25613 |
Study title: Clinical Study of Daunomycin and Prednisone for induction of remission in children with advanced leukemia - Holton, C.P., Vietti, T. J., Nora, A. H., Donaldson, M. H., Stuckey, W. J., Watkins, W. L., Lane, D. M. - 1969 (The New England Journal of Medicine Vol. 280, N°. 4, 171 - 174) - Publication in the dos. Allemand jan 1981 - Clinical Study of Daunomycin and Prednisone for induction of remission in children with advanced leukemia - Holton, C.P., Vietti, T. J., Nora, A. H., Donaldson, M. H., Stuckey, W. J., Watkins, W. L., Lane, D. M. - 1969 (The New England Journal of Medicine Vol. 280, N°. 4, 171 - 174) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25618 |
Study title: Clinical Study of Daunomycin and Prednisone for induction of remission in children with advanced leukemia - Holton, C.P., Vietti, T. J., Nora, A. H., Donaldson, M. H., Stuckey, W. J., Watkins, W. L., Lane, D. M. - 1969 (The New England Journal of Medicine Vol. 280, N°. 4, 171 - 174) - Publication in the dos. Allemand jan 1981 - Clinical Study of Daunomycin and Prednisone for induction of remission in children with advanced leukemia - Holton, C.P., Vietti, T. J., Nora, A. H., Donaldson, M. H., Stuckey, W. J., Watkins, W. L., Lane, D. M. - 1969 (The New England Journal of Medicine Vol. 280, N°. 4, 171 - 174) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25622 |
Study title: Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors. - A.E. Evans, R.L. Baehner, R.L. Chard & coll. - 1974 - Publication in the dos. Français jan 1977 and and in the dos. allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) -Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors. - A.E. Evans, R.L. Baehner, R.L. Chard & coll. - 1974 - Publication in the dos. Français jan 1977 and and in the dos. allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25573 |
Study title: A phase II clinical trial of cardioprotection with cardioxane (ICRF-187) in pediatric patients with Osteosarcoma. 30th November 1999. |
Active substance: DEXPANTHENOL AND POLYVINYLALCOHOL |
Study summary document link (including results): |
View full study record |
Document reference: 25776 |
Study title: Küchle H. J., Busse H., Augenerkrankungen im Kindesalter, Thieme Verlag Stuttgart New York 1985Küchle H. J., Busse H., Augenerkrankungen im Kindesalter, Thieme Verlag Stuttgart New York 1985 |
Active substance: DEXPANTHENOL AND POLYVINYLALCOHOL |
Study summary document link (including results): |
View full study record |
Document reference: 25775 |
Study title: EC-CX-012. A phase II clinical trial of cardioprotection with cardioxane (ICRF-187) in pediatric patients with Osteosarcoma. 30th November 1999. |
Active substance: DEXRAZONANE |
Study summary document link (including results): Cardioxane EC-CX-012.xls |
View full study record |
Document reference: 25777 |
Study title: A Factorially-Designed Analgesic Efficacy Study Comparing Combinations of Acetaminophen in Doses of 325 mg, 500 mg, and 1000 mg and Dextromethorphan Hydrobromide in Doses of 5 mg, 15 mg and 30 mg, with the Components Alone and Placebo in Post-Operative Dental Pain. |
Active substance: DEXTROMETHOPRHAN AND PARACETAMOL |
Study summary document link (including results): dextromethorphan_paracetamol 96-626.pdf |
View full study record |
Document reference: 47893 |
Study title: A Comparative Study Evaluating the Analgesic Efficacy of a Single Dose of Acetaminophen 1000 mg, Acetaminophen 1000 mg/Dextromethorphan Hydrobromide 30 mg, Ibuprofen 400 mg, Dextromethorphan Hydrobromide 30 mg, or Placebo in Post-Operative Dental Pain |
Active substance: DEXTROMETHOPRHAN AND PARACETAMOL AND IBUPROFEN |
Study summary document link (including results): dextromethorphan_ibuprofen_paracetamol 95-534.pdf |
View full study record |
Document reference: 47892 |
Study title: An Evaluation of the Efficacy and Safety of C-30-13 Cough-Cold Formula in Adult and Pediatric Patients with Symptomatology of Upper Respiratory Infection or Allergic Rhinitis. May 1981.An Evaluation of the Efficacy and Safety of C-30-13 Cough-Cold Formula in Adult and Pediatric Patients with Symptomatology of Upper Respiratory Infection or Allergic Rhinitis. May 1981. |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 25798 |
Study title: Jawad SS & Eccles R. Effect of pseudoephedrine on nasal airflow in patients with nasal congestion associated with common cold. Rhinology 1998; 36(2):73-6Jawad SS & Eccles R. Effect of pseudoephedrine on nasal airflow in patients with nasal congestion associated with common cold. Rhinology 1998; 36(2):73-6 |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 25782 |
Study title: Rapport d'expertise clinique - Résultats du traitement des hémopathies malignes et des cancers par le 13.057 R.P. (à propos de 168 observations) - Professeur Jean Bernard - 25 May 1967Rapport d'expertise clinique - Résultats du traitement des hémopathies malignes et des cancers par le 13.057 R.P. (à propos de 168 observations) - Professeur Jean Bernard - 25 May 1967 |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25602 |
Study title: Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children's Cancer Study Group - O'Brien TA, Russell SJ, Vowels MR, et al. - 15 October 2002 - Publication 4 in CES EXPCRC-CES0603-EN-E02 -Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children's Cancer Study Group - O'Brien TA, Russell SJ, Vowels MR, et al. - 15 October 2002 - Publication 4 in CES EXPCRC-CES0603-EN-E02 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25603 |
Study title: Rubidomycin. A new agent in the treatment of acute lymphoblastic leukaemia - Jacquillat .C et al. - 1966 - Publication in the dos. allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - Rubidomycin. A new agent in the treatment of acute lymphoblastic leukaemia - Jacquillat .C et al. - 1966 - Publication in the dos. allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25604 |
Study title: Sequential therapy for induction and maintenance of remission in acute myeloblastic Leukemia - Eppinger-Helft, M., Pavlovsky, S., Suarez, A., et al. - 1975 (Cancer 35, 347-353) - Publication in the dos. Allemand jan 1981 - Sequential therapy for induction and maintenance of remission in acute myeloblastic Leukemia - Eppinger-Helft, M., Pavlovsky, S., Suarez, A., et al. - 1975 (Cancer 35, 347-353) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25605 |
Study title: Tan, C., Tasaka, H. - 1965 (Proc. Amer. Assoc. Cancer Research N°. 6, 64) - Publication in the dos. Allemand jan 1981 - Clinical Studies of Daunomycin - Tan, C., Tasaka, H. - 1965 (Proc. Amer. Assoc. Cancer Research N°. 6, 64) - Publication in the dos. Allemand jan 1981 - Clinical Studies of Daunomycin - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25606 |
Study title: The Berlin Childhood Acute Lymphoblastic Leukaemia Therapy - Study:19170-17-976 - Amer. J. Ped. Hematol./Oncol. 2, 299-306 (1980)The Berlin Childhood Acute Lymphoblastic Leukaemia Therapy - Study:19170-17-976 - Amer. J. Ped. Hematol./Oncol. 2, 299-306 (1980) |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25611 |
Study title: The cardiotoxicity of adriamycin and daunomycin in children - A.C. Gilladoga, C. Manuel, C.T.C. Tan & coll. - 1976 - Publication in the dos. Français jan 1977 and in the dos. Allemand jan 1981 - The cardiotoxicity of adriamycin and daunomycin in children - A.C. Gilladoga, C. Manuel, C.T.C. Tan & coll. - 1976 - Publication in the dos. Français jan 1977 and in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25607 |
Study title: The use of Heparin in the Therapy of acute promyelocytic leukemia with Daunorubicin - Nomura T. et al. - 1974 - Publication in the dos. Allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) -The use of Heparin in the Therapy of acute promyelocytic leukemia with Daunorubicin - Nomura T. et al. - 1974 - Publication in the dos. Allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25608 |
Study title: Vincristine, Prednisone, and Daunomycin in acute Leukemia of childhood - Vietti, T. J., Starling, K., Wildbur, J. R., et al. - 1971 (Cancer Vol. 27, 602 - 607) - Publication in the dos. Allemand jan 1981 - Vincristine, Prednisone, and Daunomycin in acute Leukemia of childhood - Vietti, T. J., Starling, K., Wildbur, J. R., et al. - 1971 (Cancer Vol. 27, 602 - 607) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25609 |
Study title: Fatal diphenhydramine intoxication in infants, Baker, A.M., J. Forensic Sci. 2003 March; 48(2): 425-428 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25845 |
Study title: FDA, HHS. Labelling of diphenhydramine-containing drug products for over-the counter human use. Final rule, Fed. Regist 1997; 62(168): 45767-74. |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25853 |
Study title: Greene−S−L, Reed−C−E, Schroeter−A−L. Double−blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. Journal of the American Academy of Dermatology, {J−Am−Acad−Dermatol}, Apr 1985, vol. 12, no. 4, p. 669−75. |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25880 |
Study title: Lee PCL et al. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 2000; 52(9):1137-42 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25882 |
Study title: Massive diphenhydramine poisoning resulting in a wide-complex tachycardia: successful treatment with sodium bicarbonate, Clark, R.F., Ann. Emerg. Med. 1992; 21: 318-320 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25850 |
Study title: Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: A report from the late effects surveillance system |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25400 |
Study title: Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25402 |
Study title: Orbital rhabdomyosarcoma in Li-Fraumeni syndrome |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25403 |
Study title: Osteosarcoma in adolescents and young adults: new developments and controversies. The Childrens Cancer Group (CCG) studies. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25404 |
Study title: Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25405 |
Study title: Ovarian preservation with gonadotropin-releasing hormone analog during chemotherapy |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25406 |
Study title: Paratesticular rhabdomyosarcoma in children. Is retroperitoneal lymphadenectomy necessary in disease limited to the scrotum? |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25407 |
Study title: Pathology teach and tell: Solid variant alveolar rhabdomyosarcoma of the orbit |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25408 |
Study title: Pediatric oncology |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25409 |
Study title: Pediatric urologic oncology: bladder, prostate, testis |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25410 |
Study title: Perianal alveolar rhabdomyosarcoma in a child. Report of a long-term survival case. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25411 |
Study title: Perlman syndrome: Clinical report and nine-year follow-up |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25412 |
Study title: Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group Study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25413 |
Study title: Phase I study of tumor necrosis factor-alpha and actinomycin D in pediatric patients with cancer: a Children's Cancer Group study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25414 |
Study title: Phase II study demonstrating failure of both a five-drug continuous-therapy regimen and a two-drug pulse-therapy regimen in the treatment of metastatic neuroblastoma: Southwest Oncology Group Study 822. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25415 |
Study title: Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25416 |
Study title: Pleural effusion in wilms tumor after tru-cut biopsy 1 |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25417 |
Study title: POMB/ACE chemotherapy in non-seminomatous germ cell tumours: outcome and importance of dose intensity. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25418 |
Study title: PRE OPERATIVE VS POST OPERATIVE RADIO THERAPY SINGLE VS MULTIPLE COURSES OF ACTINOMYCIN D IN THE TREATMENT OF WILMS TUMOR PRELIMINARY RESULTS OF A CONTROLLED CLINICAL TRIAL CONDUCTED BY THE INTERNATIONAL SOCIETY OF PEDIATRIC ONCOLOGY |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25419 |
Study title: Preliminary evaluation of the toxicity and effectiveness of chemotherapy using the VAB-6 protocol in the treatment of non-seminoma of the testis |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25420 |
Study title: Preoperative chemotherapy of nephroblastoma. Preliminary results of the SIOP-9/GPO therapy study |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25421 |
Study title: Preoperative versus postoperative radiotherapy, single versus multiple courses of actinomycin D, in the treatment of Wilms' tumor. Preliminary results of a controlled clinical trial conducted by the International Society of Paediatric Oncology (S.I.O.P.). |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25422 |
Study title: RANDOMIZED COMPARISON OF LOW MOLECULAR WEIGHT HEPARIN VERSUS ORAL WARFARIN THERAPY FOR LONG TERM ANTICOAGULATION IN CANCER PATIENTS WITH VENOUS THROMBOEMBOLISM |
Active substance: DALTEPARIN |
Study summary document link (including results): |
View full study record |
Document reference: 25514 |
Study title: A comparison of danazol and placebo in the treatment of adult idiopathic gynecomastia : results of a prospective study in 55 patients - Investigators : David J Jones et al. - Ann. R. Coll. Surg. Engl. 1990, 72(5), 296-298 - Publication CER - No author - 06/1996A comparison of danazol and placebo in the treatment of adult idiopathic gynecomastia : results of a prospective study in 55 patients - Investigators : David J Jones et al. - Ann. R. Coll. Surg. Engl. 1990, 72(5), 296-298 - Publication CER - No author - 06/1996 |
Active substance: DANAZOL |
Study summary document link (including results): |
View full study record |
Document reference: 25515 |
Study title: Danazol prophylaxis for delivery in hereditary angioneurotic oedema (HAE) - Investigators : AN Boulos et al. - Br. J. Obstet. Gynaecol., 1994, 101(12), Dec. 1094-1095 - Publication in CER - No author - 06/1996 -Danazol prophylaxis for delivery in hereditary angioneurotic oedema (HAE) - Investigators : AN Boulos et al. - Br. J. Obstet. Gynaecol., 1994, 101(12), Dec. 1094-1095 - Publication in CER - No author - 06/1996 - |
Active substance: DANAZOL |
Study summary document link (including results): |
View full study record |
Document reference: 25523 |
Study title: Probable Benadryl withdrawal manifestations in a newborn infant, Parkin, D.E., J. Pediatr. 1974; 85: 580Probable Benadryl withdrawal manifestations in a newborn infant, Parkin, D.E., J. Pediatr. 1974; 85: 580 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25715 |
Study title: Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication, Ito, S., Am. J. Obstet. Gynecol. 1993; 168: 1393-1399Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication, Ito, S., Am. J. Obstet. Gynecol. 1993; 168: 1393-1399 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25707 |
Study title: Pruritus in burnd, Gordon, M.D., JBCR 1988; 9(3): 305-308Pruritus in burnd, Gordon, M.D., JBCR 1988; 9(3): 305-308 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25703 |
Study title: QT interval prolongation in diphenhydramine toxicity, Thakur, A.C., Int. J. Cardiol. 2005; 98 (2): 341-343QT interval prolongation in diphenhydramine toxicity, Thakur, A.C., Int. J. Cardiol. 2005; 98 (2): 341-343 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25722 |
Study title: Risk of developing life-threatening ventricular arrhythmia associated with terfenadine in comparison with over-the counter antihistamines, ibuprofen and clemasine, Pratt, C.M., Am. J. Cardiol. 1994; 73: 346-352Risk of developing life-threatening ventricular arrhythmia associated with terfenadine in comparison with over-the counter antihistamines, ibuprofen and clemasine, Pratt, C.M., Am. J. Cardiol. 1994; 73: 346-352 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25716 |
Study title: Sedation and performance impairment of diphenhydramine and secon-generation antihistamines: a meta-analysis, Bender, B.G., J. Allergy Clin. Immunol. 2003; 111:770-776Sedation and performance impairment of diphenhydramine and secon-generation antihistamines: a meta-analysis, Bender, B.G., J. Allergy Clin. Immunol. 2003; 111:770-776 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25694 |
Study title: Suspected fatal diphenhydramine toxicity by application to the skin of an infant with varicella, Maswoswe, J.J., Hosp. Pharm. 1994 January; 29: 26, 28-30, 53Suspected fatal diphenhydramine toxicity by application to the skin of an infant with varicella, Maswoswe, J.J., Hosp. Pharm. 1994 January; 29: 26, 28-30, 53 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25711 |
Study title: Topical diphenhydramine toxicity, Bernhardt, D.T., Wis. Med. J. 1991 August; 90(8): 469-471Topical diphenhydramine toxicity, Bernhardt, D.T., Wis. Med. J. 1991 August; 90(8): 469-471 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25695 |
Study title: Topically induced diphenhydramine toxicity, Reilly, J.F. Jr., J. Emerg. Med. 1990; 8(1): 59-61Topically induced diphenhydramine toxicity, Reilly, J.F. Jr., J. Emerg. Med. 1990; 8(1): 59-61 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25718 |
Study title: Toxic encephalopathy caused by topically applied diphenhydramine, Filloux, F., J. Pediatr. 1986, 108: 1018-1020Toxic encephalopathy caused by topically applied diphenhydramine, Filloux, F., J. Pediatr. 1986, 108: 1018-1020 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25699 |
Study title: Toxicity from topical administration of diphenhydramine in children, Huston, R.L., Clin. Pediatr. (Phila) 1990; 29(9): 542-545Toxicity from topical administration of diphenhydramine in children, Huston, R.L., Clin. Pediatr. (Phila) 1990; 29(9): 542-545 |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 25706 |
Study title: Brady K. M., Atkinson S., Kilty L. A., Hiles D. A., J Cataract Refract Surg 1997; 23 Suppl. 1: 669 |
Active substance: DEXAMETHASONE AND FRAMYCETIN AND GRAMICIDIN |
Study summary document link (including results): |
View full study record |
Document reference: 25731 |
Study title: Korppi M et al. Antitussives in the treatment of acute transient cough in children. Acta Paediatr Scand 1991; 80(10):969-71Korppi M et al. Antitussives in the treatment of acute transient cough in children. Acta Paediatr Scand 1991; 80(10):969-71 |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 25793 |
Study title: Lee PCL et al. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 2000; 52(9):1137-42Lee PCL et al. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 2000; 52(9):1137-42 |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 25791 |
Study title: Multiple-Dose Pharmacokinetic Study of an Ibuprofen-Pseudoephedrine HCl Suspension in Children. Aug 1999.Multiple-Dose Pharmacokinetic Study of an Ibuprofen-Pseudoephedrine HCl Suspension in Children. Aug 1999. |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 25796 |
Study title: Paul IM et al. Dose-response relationship with increasing doses of dextromethorphan for children with cough. Clin Ther 2004; 26(9):1508-1514 Paul IM et al. Dose-response relationship with increasing doses of dextromethorphan for children with cough. Clin Ther 2004; 26(9):1508-1514 |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 25789 |
Study title: Paul IM et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114(1):85-90 Paul IM et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114(1):85-90 |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 25790 |
Study title: Paul IM et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007; 161(12):1140-1146Paul IM et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007; 161(12):1140-1146 |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 25787 |
Study title: Shamberger RC et al. Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection. J Thorac Cardiovasc Surg. 2000 Jun;119(6):1154-61Shamberger RC et al. Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection. J Thorac Cardiovasc Surg. 2000 Jun;119(6):1154-61 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25115 |
Study title: Shields CL et al Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors Am J Ophthalmol 2004 Sep;138(3):329-37Shields CL et al Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors Am J Ophthalmol 2004 Sep;138(3):329-37 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25116 |
Study title: Shields CL et al Practical approach to management of retinoblastoma Arch Ophthalmol 2004 May;122(5):729-35Shields CL et al Practical approach to management of retinoblastoma Arch Ophthalmol 2004 May;122(5):729-35 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25117 |
Study title: Shore R et al Iphosphamide-induced nephrotoxicity in children Pediatr Nephrol. 1992 Mar;6(2):162-5Shore R et al Iphosphamide-induced nephrotoxicity in children Pediatr Nephrol. 1992 Mar;6(2):162-5 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25118 |
Study title: Simbre VC et al Cardiotoxicity of cancer chemotherapy: implications for children Paediatr Drugs. 2005;7(3):187-202. ReviewSimbre VC et al Cardiotoxicity of cancer chemotherapy: implications for children Paediatr Drugs. 2005;7(3):187-202. Review |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25119 |
Study title: Simon T et al. Topotecan, cyclophosphamide, and etoposide (TCE) in the treatment of high-risk neuroblastoma. Results of a phase-II trial. J Cancer Res Clin Oncol. 2007 Sep;133(9):653-61. Epub 2007 May 4.Simon T et al. Topotecan, cyclophosphamide, and etoposide (TCE) in the treatment of high-risk neuroblastoma. Results of a phase-II trial. J Cancer Res Clin Oncol. 2007 Sep;133(9):653-61. Epub 2007 May 4. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25120 |
Study title: Skinner R Chronic ifosfamide nephrotoxicity in children Med Pediatr Oncol. 2003 Sep;41(3):190-7. ReviewSkinner R Chronic ifosfamide nephrotoxicity in children Med Pediatr Oncol. 2003 Sep;41(3):190-7. Review |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25121 |
Study title: Skinner R et al Hypophosphataemic rickets after ifosfamide treatment in children BMJ. 1989 Jun 10;298(6687):1560-1. No abstract availableSkinner R et al Hypophosphataemic rickets after ifosfamide treatment in children BMJ. 1989 Jun 10;298(6687):1560-1. No abstract available |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25122 |
Study title: Skinner R et al Risk factors for ifosfamide nephrotoxicity in children Lancet. 1996 Aug 31;348(9027):578-80 Skinner R et al Risk factors for ifosfamide nephrotoxicity in children Lancet. 1996 Aug 31;348(9027):578-80 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25123 |
Study title: Micromedex. Dexamethasone. Thomson Healthcare. 1974-2005 medizinishes Informationssystem Vol.125 expires 9/2005, 2005 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25866 |
Study title: Micromedex. Diphenhydramine Hydrochloride. Thomson Healthcare. 1974-2005 medizinishes Informationssystem Vol.125 expires 9/2005, 2005 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25865 |
Study title: Moscati−R−M, Moore−G−P. Comparison of cimetidine and diphenhydramine in the treatment of acute urticaria. Annals of emergency medicine, {Ann−Emerg−Med}, Jan 1990, vol. 19, no. 1, p. 12−5. |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25879 |
Study title: Outcome of prophylactic therapy for idiopathic anaphylaxis, Wong, S., Ann. Intern. Med. 1991; 114: 133-136 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25876 |
Study title: Over-the counter topical antipruritic agents are commonly recommended by office-based physicians: an analysis of US practice patterns, Duque, M.I., J. Dermatol. Treatment 2004; 15: 185-188 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25851 |
Study title: Pharmacokinetics and Pharmacodynamics in Elderly Adults, Young Adults, and Children, Simons, K.J., J.Clin. Pharmacol. 1990; 30: 665-671 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25873 |
Study title: Probable Benadryl withdrawal manifestations in a newborn infant, Parkin, D.E., J. Pediatr. 1974; 85: 580 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25868 |
Study title: Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication, Ito, S., Am. J. Obstet. Gynecol. 1993; 168: 1393-1399 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25860 |
Study title: Pruritus in burnd, Gordon, M.D., JBCR 1988; 9(3): 305-308 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25856 |
Study title: QT interval prolongation in diphenhydramine toxicity, Thakur, A.C., Int. J. Cardiol. 2005; 98 (2): 341-343 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25875 |
Study title: Raphael−G−D, Angello−J−T, Wu−M−M, Druce−H−M. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate−to−severe seasonal allergic rhinitis. Annals of Allergy, Asthma and Immunology {ANN−ALLERGY−ASTHMA−IMMUNOL}, 2006, Vol/Iss/Pg. 96/4 (606−614). |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25878 |
Study title: Risk of developing life-threatening ventricular arrhythmia associated with terfenadine in comparison with over-the counter antihistamines, ibuprofen and clemasine, Pratt, C.M., Am. J. Cardiol. 1994; 73: 346-352 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25869 |
Study title: Sedation and performance impairment of diphenhydramine and secon-generation antihistamines: a meta-analysis, Bender, B.G., J. Allergy Clin. Immunol. 2003; 111:770-776 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25847 |
Study title: Weiner MA et al, Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study, J Clin Oncol. 1991 Sep;9(9):1591-8Weiner MA et al, Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study, J Clin Oncol. 1991 Sep;9(9):1591-8 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25158 |
Study title: Weiner MA et al, Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study, J Clin Oncol. 1997 Aug;15(8):2769-79Weiner MA et al, Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study, J Clin Oncol. 1997 Aug;15(8):2769-79 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25159 |
Study title: Wells RJ et al Cytosine arabinoside and mitoxantrone treatment of relapsed or refractory childhood leukemia: initial response and relationship to multidrug resistance gene 1 Med Pediatr Oncol. 1994;22(4):244-9Wells RJ et al Cytosine arabinoside and mitoxantrone treatment of relapsed or refractory childhood leukemia: initial response and relationship to multidrug resistance gene 1 Med Pediatr Oncol. 1994;22(4):244-9 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25160 |
Study title: A Study of the Effect of Desloratadine (5mg) and Pseudoephedrine 240 mg on Nasal Stuffiness in Subjects with Seasonal Allergic Rhinitis |
Active substance: desloratadine |
Study summary document link (including results): |
View full study record |
Document reference: 39690 |
Study title: AN OPEN LABEL TASTE EVALUATION OF DESLORATADINE 2.5MG RAPIDLY DISINTEGRATING TABLETS IN 6-11 YEAR OLD SUBJECTS WHO HAVE TAKEN CLARITIN REDITABS. |
Active substance: desloratadine |
Study summary document link (including results): |
View full study record |
Document reference: 39691 |
Study title: AN OPEN LABEL TASTE EVALUATION OF DESLORATADINE 2.5MG RAPIDLY DISINTEGRATING TABLETS IN 6-11 YEAR OLD SUBJECTS WHO HAVE NEVER TAKEN CLARITIN REDITABS. |
Active substance: desloratadine |
Study summary document link (including results): |
View full study record |
Document reference: 39692 |
Study title: Evaluation of the efficacy and the safety of DCL syrup in childhood atopic dermatitis. |
Active substance: desloratadine |
Study summary document link (including results): |
View full study record |
Document reference: 39698 |
Study title: Evaluation of the efficacy and the safety of desloratadine syrup in children suffering from seasonal allergic rhinitis with or without intermittent asthma. |
Active substance: desloratadine |
Study summary document link (including results): |
View full study record |
Document reference: 39699 |
Study title: Observational study evaluating the safety and efficacy of desloratadine for perennial allergic rhinitis in Indonesian paediatric patients. |
Active substance: desloratadine |
Study summary document link (including results): |
View full study record |
Document reference: 39700 |
Study title: |
Active substance: DESMOPRESSIN |
Study summary document link (including results): Desmopressin_ FE992026 CS002 (DRIP).pdf |
View full study record |
Document reference: 25659 |
Study title: A 6-week open label cross-over study with 2 different daily doses of Minirin® oral lyophilisate (120 µg and 240 µg) and 2 different daily doses of Minirin® tablet (0.2 mg and 2 x 0.2 mg) in children and adolescents with primary nocturnal enuresis (PNE) |
Active substance: DESMOPRESSIN |
Study summary document link (including results): Desmopressin_ FE992026 CS022.pdf |
View full study record |
Document reference: 25665 |
Study title: An explorative study of Octostim-spray (desmopressin) in children with bleeding disorder. |
Active substance: DESMOPRESSIN |
Study summary document link (including results): Desmopressin_45A05-122_clinical_synopsis.pdf |
View full study record |
Document reference: 25662 |
Study title: Desmopressin tablets in the treatment of severe nocturnal enuresis in adolescents. (Stenberg A, Läckgren G.) Pediatrics. 1994 Dec; 94(6 Pt 1):841-6.Desmopressin tablets in the treatment of severe nocturnal enuresis in adolescents. (Stenberg A, Läckgren G.) Pediatrics. 1994 Dec; 94(6 Pt 1):841-6. |
Active substance: DESMOPRESSIN |
Study summary document link (including results): |
View full study record |
Document reference: 25667 |
Study title: DRY : Desmopressin Response in the Young : A double-blind, randomised, placebo-controlled, dose-titration study with three different doses (120 µg, 240 µg and 360 µg) of desmopressin administered as a new melt tablet in children and adolescents with Prim&ry Nocturnal Enuresis (PNE) |
Active substance: DESMOPRESSIN |
Study summary document link (including results): Desmopressin_FE992026 CS026_DRY.pdf |
View full study record |
Document reference: 25666 |
Study title: EFFICACY OF DESMOPRESSIN IN COMBINATION WITH ALARM THERAPY IN A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY IN PATIENTS WITH PRIMARY NOCTURNAL ENURESIS |
Active substance: DESMOPRESSIN |
Study summary document link (including results): |
View full study record |
Document reference: 25660 |
Study title: Efficacy of desmopressin in combination with alarm therapy in patients with monosymptomatic nocturnal enuresis. |
Active substance: DESMOPRESSIN |
Study summary document link (including results): Desmopressin_MIN 95_07_NL.pdf |
View full study record |
Document reference: 25661 |
Study title: Etude de l'efficacité et de la tolérance à long terme de minirin spray dans l'énurésie nocturne de l'enfant. Essai ouvert non comparatif avec récherche de la dose efficace entre 10 et 40 mcg. |
Active substance: DESMOPRESSIN |
Study summary document link (including results): |
View full study record |
Document reference: 25663 |
Study title: Long-term efficacy of Minirin Spray in monosymptomatic nocturnal enuresis: a multicenter comparative double-blind crossover placebo-controlled study with double-blind continuation of effective treatment for 3 to 6 months. |
Active substance: DESMOPRESSIN |
Study summary document link (including results): |
View full study record |
Document reference: 25664 |
Study title: Ahrendt HJ, Karck U, Pichl T, Mueller T, Ernst, U. The effects of an oestrogen-free, desogestrel-containing oral contraceptive in women with cyclical symptoms: Results from two studies on oestrogen-related symptoms and dysmenorrhoea. Eu J Contraception R |
Active substance: DESOGESTREL |
Study summary document link (including results): |
View full study record |
Document reference: 25669 |
Study title: Clinical Expert Statement of Framycetin sulfate containing formulations. - Dr R. Ohlrogge - 7 Apr.2004 |
Active substance: DEXAMETHASONE AND FRAMYCETIN AND GRAMICIDIN |
Study summary document link (including results): |
View full study record |
Document reference: 25726 |
Study title: Küchle H. J., Busse H., Augenerkrankungen im Kindesalter, Thieme Verlag Stuttgart New York 1985Küchle H. J., Busse H., Augenerkrankungen im Kindesalter, Thieme Verlag Stuttgart New York 1985 |
Active substance: DEXAMETHASONE AND GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25733 |
Study title: Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial.Lam DS, Fan DS, Ng JS, Yu CB, Wong CY, Cheung AY. Clin Experiment Ophthalmol. 2005 Jun;33(3):252-8. Comment in: Clin Experiment Ophthalmol. 2005 Jun;33(3):229-30. PMID: 15932523. Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial.Lam DS, Fan DS, Ng JS, Yu CB, Wong CY, Cheung AY. Clin Experiment Ophthalmol. 2005 Jun;33(3):252-8. Comment in: Clin Experiment Ophthalmol. 2005 Jun;33(3):229-30. PMID: 15932523. |
Active substance: DEXAMETHASONE AND GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25734 |
Study title: Pinkerton CR et al, 'JEB'--a carboplatin based regimen for malignant germ cell tumours in children, Br J Cancer. 1990 Aug;62(2):257-62, Pinkerton CR et al, 'JEB'--a carboplatin based regimen for malignant germ cell tumours in children, Br J Cancer. 1990 Aug;62(2):257-62, |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25066 |
Study title: Pinkerton CR et al, High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy, J Clin Oncol. 1986 Feb;4(2):194-9, Pinkerton CR et al, High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy, J Clin Oncol. 1986 Feb;4(2):194-9, |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25065 |
Study title: Pinkerton CR et al, Response rates in relapsed Wilms' tumor. A need for new effective agents, Cancer. 1991 Feb 1;67(3):567-71Pinkerton CR et al, Response rates in relapsed Wilms' tumor. A need for new effective agents, Cancer. 1991 Feb 1;67(3):567-71 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25067 |
Study title: Popadiuk S et al, Testicular malignant tumours. Efficacy of germ cell and sex cord tumours, treatment protocol in Poland, Med Wieku Rozwoj. 2006 Jul-Sep;10(3 Pt 1):811-7. PolishPopadiuk S et al, Testicular malignant tumours. Efficacy of germ cell and sex cord tumours, treatment protocol in Poland, Med Wieku Rozwoj. 2006 Jul-Sep;10(3 Pt 1):811-7. Polish |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25068 |
Study title: Pratt CB Current studies of ifosfamide for pediatric solid tumors and leukemia in the United States Semin Oncol. 1992 Dec;19(6 Suppl 12):43-9. ReviewPratt CB Current studies of ifosfamide for pediatric solid tumors and leukemia in the United States Semin Oncol. 1992 Dec;19(6 Suppl 12):43-9. Review |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25069 |
Study title: Pratt CB et al A phase I study of ifosfamide given on alternate days to treat children withbrain tumors Cancer. 1993 Jun 1;71(11):3666-9Pratt CB et al A phase I study of ifosfamide given on alternate days to treat children withbrain tumors Cancer. 1993 Jun 1;71(11):3666-9 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25070 |
Study title: Pratt CB et al Ifosfamide neurotoxicity is related to previous cisplatin treatment for pediatric solid tumors J Clin Oncol. 1990 Aug;8(8):1399-401Pratt CB et al Ifosfamide neurotoxicity is related to previous cisplatin treatment for pediatric solid tumors J Clin Oncol. 1990 Aug;8(8):1399-401 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25071 |
Study title: Pratt CB et al Ifosfamide, Fanconi's syndrome, and rickets J Clin Oncol. 1991 Aug;9(8):1495-9Pratt CB et al Ifosfamide, Fanconi's syndrome, and rickets J Clin Oncol. 1991 Aug;9(8):1495-9 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25072 |
Study title: Pratt CB et al Novantrone for childhood malignant solid tumors. A pediatric oncology group phase II study Invest New Drugs. 1986;4(1):43-8Pratt CB et al Novantrone for childhood malignant solid tumors. A pediatric oncology group phase II study Invest New Drugs. 1986;4(1):43-8 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25073 |
Study title: Pratt CB et al. Role of adjuvant chemotherapy in the treatment of surgically resected pediatric non-rhabdomyosarcomatous soft tissue sarcomas: A Pediatric Oncology Group Study. J Clin Oncol. 1999 Apr;17(4):1219Pratt CB et al. Role of adjuvant chemotherapy in the treatment of surgically resected pediatric non-rhabdomyosarcomatous soft tissue sarcomas: A Pediatric Oncology Group Study. J Clin Oncol. 1999 Apr;17(4):1219 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25074 |
Study title: Pratt CB et al. Treatment of unresectable or metastatic pediatric soft tissue sarcomas withsurgery, irradiation, and chemotherapy: a Pediatric Oncology Group study. Med Pediatr Oncol. 1998 Apr;30(4):201-9.Pratt CB et al. Treatment of unresectable or metastatic pediatric soft tissue sarcomas withsurgery, irradiation, and chemotherapy: a Pediatric Oncology Group study. Med Pediatr Oncol. 1998 Apr;30(4):201-9. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25075 |
Study title: Skinner R et al Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group Br J Cancer. 2000 May;82(10):1636-45Skinner R et al Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group Br J Cancer. 2000 May;82(10):1636-45 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25124 |
Study title: Smeland S et al Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors foroutcome and the role of replacement salvage chemotherapy for poor histological responders Eur J Cancer. 2003 Mar;39(4):488-94Smeland S et al Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors foroutcome and the role of replacement salvage chemotherapy for poor histological responders Eur J Cancer. 2003 Mar;39(4):488-94 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25125 |
Study title: Smith SC et al Intensive induction chemotherapy and delayed irradiation in the management of parameningeal rhabdomyosarcoma.J Pediatr Hematol Oncol 2003 Oct;25(10):774-9Smith SC et al Intensive induction chemotherapy and delayed irradiation in the management of parameningeal rhabdomyosarcoma.J Pediatr Hematol Oncol 2003 Oct;25(10):774-9 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25126 |
Study title: Soft Tissue Sarcoma Committee of the Children's Oncology Group et al Pooled analysis of phase II window studies in children with contemporary high-risk metastatic rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group J Clin Oncol 2006 Jul 20;24(21):3415-22Soft Tissue Sarcoma Committee of the Children's Oncology Group et al Pooled analysis of phase II window studies in children with contemporary high-risk metastatic rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group J Clin Oncol 2006 Jul 20;24(21):3415-22 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25127 |
Study title: Sokolov T et al Treatment of Ewing's sarcoma with 2 different protocols Ann Med Interne (Paris). 2001 Dec;152(8):497-501. FrenchSokolov T et al Treatment of Ewing's sarcoma with 2 different protocols Ann Med Interne (Paris). 2001 Dec;152(8):497-501. French |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25128 |
Study title: AN 1985174711 19850101. TI Fatal poisoning with cyproheptadine. AU Bouju-P, Amiot-J-F, Palacci-J-H, et-al. IN Departement d'Anesthesie-Reanimation, Centre Hospitalier General Robert Ballanger, 93602 Aulnay-sous-Bois, France. SO Cahiers d'Anesthesiologie {CAH-ANESTHESIOL}, 1985, Vol/Iss/Pg. 33/3 (265-269). YR 1985.AN 1985174711 19850101. TI Fatal poisoning with cyproheptadine. AU Bouju-P, Amiot-J-F, Palacci-J-H, et-al. IN Departement d'Anesthesie-Reanimation, Centre Hospitalier General Robert Ballanger, 93602 Aulnay-sous-Bois, France. SO Cahiers d'Anesthesiologie {CAH-ANESTHESIOL}, 1985, Vol/Iss/Pg. 33/3 (265-269). YR 1985. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25256 |
Study title: AN 1988147856 19880101. TI Evaluation of the efficacy and tolerability of an association of cyproheptadine, carnitine and pantethine in the treatment of anorexia in children. Double blind clinical trial vs. cyproheptadine. AU Berni-Canani-M, Berni-Canani-R. IN 1 Divisione di Medicina Pediatrica, U.S.L. 40 della Regione Campania, Presidio Regionale Pediatrico, Santobono, Italy. SO Acta Toxicologica et Therapeutica {ACTA-TOXICOL-THER}, 1988, Vol/Iss /Pg. 9/1 (81-100), ISSN: 0393-635X. YR 1988.AN 1988147856 19880101. TI Evaluation of the efficacy and tolerability of an association of cyproheptadine, carnitine and pantethine in the treatment of anorexia in children. Double blind clinical trial vs. cyproheptadine. AU Berni-Canani-M, Berni-Canani-R. IN 1 Divisione di... |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25257 |
Study title: AN 1991233286 19910101. TI A comparative study of cyproheptadine, amitriptyline, and propranolol in the treatment of Pre adolescent migraine. AU Lavenstein-B. IN Georgetown University School of Medicine, Wash. DC, United States. SO Cephalalgia {CEPHALALGIA}, 1991, Vol/Iss/Pg. 11/SUPPL. 11 (122-123), ISSN: 0333-1024. YR 1991.AN 1991233286 19910101. TI A comparative study of cyproheptadine, amitriptyline, and propranolol in the treatment of Pre adolescent migraine. AU Lavenstein-B. IN Georgetown University School of Medicine, Wash. DC, United States. SO Cephalalgia {CEPHALALGIA}, 1991, Vol/Iss/Pg. 11/SUPPL. 11 (122-123), ISSN: 0333-1024. YR 1991. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25258 |
Study title: AN 1993195892 19930101. TI Controlled trial with clonidine, arginine asparate, ornithine, alpha- ketoglutarate and cyproheptadine as growth stimulants in healthy children of short stature. AU Herranz-Jordan-B, Moreno-Romero-F, Cardesa-Garcia-J-J, Santos- Hurtado-I, Aparicio-Palomino-A, Requena-Guerrero-F. IN C/Ecija, 101,28230 Las Rozas, Spain. SO Anales Espanoles de Pediatria {AN-ESP-PEDIATR}, 1993, Vol/Iss/Pg. 38 /6 (509-515), ISSN: 0302-4342. YR 1993.AN 1993195892 19930101. TI Controlled trial with clonidine, arginine asparate, ornithine, alpha- ketoglutarate and cyproheptadine as growth stimulants in healthy children of short stature. AU Herranz-Jordan-B, Moreno-Romero-F, Cardesa-Garcia-J-J, Santos- Hurtado-I, Aparicio-Palomino-A, Requena-Guerrero-F. I... |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25259 |
Study title: Weston CL et al Establishing long-term survival and cure in young patients with Ewing's sarcoma Br J Cancer. 2004 Jul 19;91(2):225-32Weston CL et al Establishing long-term survival and cure in young patients with Ewing's sarcoma Br J Cancer. 2004 Jul 19;91(2):225-32 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25161 |
Study title: Wexler LH et al Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors Cancer 1996 Aug 15;78(4):901-11. Erratum in: Cancer 1997 Feb 15;79(4):867Wexler LH et al Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors Cancer 1996 Aug 15;78(4):901-11. Erratum in: Cancer 1997 Feb 15;79(4):867 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25162 |
Study title: White L et al Dose-intensive cyclophosphamide with etoposide and vincristine for pediatric solid tumors: a phase I/II pilot study by the Australia and New Zealand Childhood Cancer Study Group J Clin Oncol 1994 Mar;12(3):522-31White L et al Dose-intensive cyclophosphamide with etoposide and vincristine for pediatric solid tumors: a phase I/II pilot study by the Australia and New Zealand Childhood Cancer Study Group J Clin Oncol 1994 Mar;12(3):522-31 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24736 |
Study title: Williamson SK et al Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group StudyCancer. 2000 Mar 1;88(5):1159-65Williamson SK et al Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group StudyCancer. 2000 Mar 1;88(5):1159-65 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24735 |
Study title: Wiltshaw E et al Ifosfamide plus mesna with and without adriamycin in soft tissue sarcoma Cancer Chemother Pharmacol. 1986;18 Suppl 2:S10-2Wiltshaw E et al Ifosfamide plus mesna with and without adriamycin in soft tissue sarcoma Cancer Chemother Pharmacol. 1986;18 Suppl 2:S10-2 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25163 |
Study title: Wimmer RS et al APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trialPediatr Blood Cancer 2006 Mar;46(3):320-4Wimmer RS et al APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trialPediatr Blood Cancer 2006 Mar;46(3):320-4 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25164 |
Study title: Winick NJ et al. Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study. J Clin Oncol. 1993 Feb;11(2):271-8Winick NJ et al. Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study. J Clin Oncol. 1993 Feb;11(2):271-8 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25165 |
Study title: Winkler K et al, Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative, trial (COSS-82) with salvage chemotherapy based on histological tumor response, J Clin Oncol. 1988 Feb;6(2):329-37Winkler K et al, Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative, trial (COSS-82) with salvage chemotherapy based on histological tumor response, J Clin Oncol. 1988 Feb;6(2):329-37 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25166 |
Study title: Wofford MM et al. Treatment of occult or late overt testicular relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol. 1992 Apr;10(4):624-30Wofford MM et al. Treatment of occult or late overt testicular relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol. 1992 Apr;10(4):624-30 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25167 |
Study title: Comparison of pulse methotrexate and pulse dactinomycin in the treatment of low-risk gestational trophoblastic neoplasia. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25321 |
Study title: Comparison of the efficacy of imidazole-carboxamide and of a combination of nitrosomethylurea, vincristine and dactinomycin in disseminated melanoma |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25322 |
Study title: Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25323 |
Study title: Concurrent combination chemotherapy of human solid tumors: experience with a three-drug regimen and review of the literature. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25324 |
Study title: Congenital disseminated malignant rhabdoid tumor of the soft tissue 2 |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25325 |
Study title: Congenital sacrococcygeal primitive neuroectodermal tumor. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25326 |
Study title: Conjunctival rhabdomyosarcoma presenting as a squamous papilloma 29 |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25327 |
Study title: Meyer RM et al. Escalated as compared with standard doses of doxorubicin in BACOP therapy for patients with non-Hodgkin's lymphoma. N Engl J Med. 1993 Dec 9;329(24):1770-6.Meyer RM et al. Escalated as compared with standard doses of doxorubicin in BACOP therapy for patients with non-Hodgkin's lymphoma. N Engl J Med. 1993 Dec 9;329(24):1770-6. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25017 |
Study title: Meyer WH et al Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial J Clin Oncol. 2001 Jan 1;19(1):171-82Meyer WH et al Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial J Clin Oncol. 2001 Jan 1;19(1):171-82 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25018 |
Study title: Meyer WH et al Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone J Clin Oncol. 1992 Nov;10(11):1737-42Meyer WH et al Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone J Clin Oncol. 1992 Nov;10(11):1737-42 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25019 |
Study title: Meyers PA et al Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate J Clin Oncol. 2005 Mar 20;23(9):2004-11Meyers PA et al Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate J Clin Oncol. 2005 Mar 20;23(9):2004-11 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25020 |
Study title: Meyers PA et al, Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol, J Clin Oncol. 1998 Jul;16(7):2452-8Meyers PA et al, Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol, J Clin Oncol. 1998 Jul;16(7):2452-8 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25021 |
Study title: Michel G et al. Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia. J Clin Oncol. 2000 Apr;18(7):1517-24Michel G et al. Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia. J Clin Oncol. 2000 Apr;18(7):1517-24 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25022 |
Study title: Michelagnoli MP et al Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma Br J Cancer. 1999 Mar;79(7-8):1174-8Michelagnoli MP et al Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma Br J Cancer. 1999 Mar;79(7-8):1174-8 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25023 |
Study title: Michon JM et al. An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma. Eur J Cancer. 1998 Jun;34(7):1063-9Michon JM et al. An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma. Eur J Cancer. 1998 Jun;34(7):1063-9 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25024 |
Study title: Milano GM et al High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experience.Cancer 2006 Apr 15;106(8):1838-45. Erratum in: Cancer 2006 Sep 15;107(6):1421Milano GM et al High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experience.Cancer 2006 Apr 15;106(8):1838-45. Erratum in: Cancer 2006 Sep 15;107(6):1421 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25025 |
Study title: Milpied N et al. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med. 2004 Mar 25;350(13):1287-95Milpied N et al. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med. 2004 Mar 25;350(13):1287-95 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25026 |
Study title: Milpied N et al. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med. 2004 Mar 25;350(13):1287-95Milpied N et al. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med. 2004 Mar 25;350(13):1287-95 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25027 |
Study title: Miser JS et al Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group Pediatr Blood Cancer. 2007 Dec;49(7):894-900Miser JS et al Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group Pediatr Blood Cancer. 2007 Dec;49(7):894-900 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25028 |
Study title: Pritchard J et al. High dose melphalan in the treatment of advanced neuroblastoma: results of arandomised trial (ENSG-1) by the European Neuroblastoma Study Group. Pediatr Blood Cancer. 2005 Apr;44(4):348-57.Pritchard J et al. High dose melphalan in the treatment of advanced neuroblastoma: results of arandomised trial (ENSG-1) by the European Neuroblastoma Study Group. Pediatr Blood Cancer. 2005 Apr;44(4):348-57. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24724 |
Study title: Pritchard J et al. High dose melphalan in the treatment of advanced neuroblastoma: results of arandomised trial (ENSG-1) by the European Neuroblastoma Study Group. Pediatr Blood Cancer. 2005 Apr;44(4):348-57.Pritchard J et al. High dose melphalan in the treatment of advanced neuroblastoma: results of arandomised trial (ENSG-1) by the European Neuroblastoma Study Group. Pediatr Blood Cancer. 2005 Apr;44(4):348-57. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25076 |
Study title: Provisor AJ et al, Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group, J Clin Oncol. 1997 Jan;15(1):76-84Provisor AJ et al, Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group, J Clin Oncol. 1997 Jan;15(1):76-84 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25077 |
Study title: AN 07416909 Medline 20070101. TI Effects of cyproheptadine on symptoms and attitudes in anorexia nervosa. SO Archives of general psychiatry, {Arch-Gen-Psychiatry}, Sep 1980, vol. 37, no. 9, p. 1083, ISSN: 0003-990X. AU Goldberg-S-C, Eckert-E-D, Halmi-K-A, Casper-R-C, Davis-J-M, Roper-M. YR 1980.AN 07416909 Medline 20070101. TI Effects of cyproheptadine on symptoms and attitudes in anorexia nervosa. SO Archives of general psychiatry, {Arch-Gen-Psychiatry}, Sep 1980, vol. 37, no. 9, p. 1083, ISSN: 0003-990X. AU Goldberg-S-C, Eckert-E-D, Halmi-K-A, Casper-R-C, Davis-J-M, Roper-M. YR 1980. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25224 |
Study title: AN 07880345 Medline 20070101. TI Episodic spontaneous hypothermia with hyperhidrosis. SO Pediatric neurology, {Pediatr-Neurol}, Oct 1994, vol. 11, no. 3, p. 266, ISSN: 0887-8994. AU Arroyo-H-A, Di-Blasi-M, Fejerman-N. YR 1994.AN 07880345 Medline 20070101. TI Episodic spontaneous hypothermia with hyperhidrosis. SO Pediatric neurology, {Pediatr-Neurol}, Oct 1994, vol. 11, no. 3, p. 266, ISSN: 0887-8994. AU Arroyo-H-A, Di-Blasi-M, Fejerman-N. YR 1994. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25225 |
Study title: AN 07930419 Medline 20070101. TI Infantile migraine presenting as colic. SO Journal of child neurology, {J-Child-Neurol}, Jul 1994, vol. 9, no. 3, p. 336-7, ISSN: 0883-0738. AU Katerji-M-A, Painter-M-J. IN Children's Hospital of Pittsburgh, Pennsylvania. YR 1994.AN 07930419 Medline 20070101. TI Infantile migraine presenting as colic. SO Journal of child neurology, {J-Child-Neurol}, Jul 1994, vol. 9, no. 3, p. 336-7, ISSN: 0883-0738. AU Katerji-M-A, Painter-M-J. IN Children's Hospital of Pittsburgh, Pennsylvania. YR 1994. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25226 |
Study title: AN 07994334 Medline 20070101. TI (Acute urine retention: a rare mode of revelation of cervico-dorsal syringomyelia caused by cyproheptadine). TT Retention aigue d'urines: un mode de revelation rare d'une syringomyelie cervicodorsale a l'occasion de la prise de cyproheptadine. SO Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, {Arch-Pediatr}, Mar 1994, vol. 1, no. 3, p. 260-3, ISSN: 0929-693X. AU Houang-M, Leroy-B, Forin-V, Sinnassamy-P, Bensman-A. IN Service de nephrologie pediatrique, hopital Trousseau, Paris, France. YR 1994.AN 07994334 Medline 20070101. TI (Acute urine retention: a rare mode of revelation of cervico-dorsal syringomyelia caused by cyproheptadine). TT Retention aigue d'urines: un mode de r... |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25227 |
Study title: AN 08532571 Medline 20070101. TI Cyproheptadine-induced central anticholinergic syndrome in a child: a case report. SO Pediatric emergency care, {Pediatr-Emerg-Care}, Aug 1995, vol. 11, no. 4, p. 235-7, ISSN: 0749-5161. AU Blaustein-B-S, Gaeta-T-J, Balentine-J-R, Gindi-M. IN Department of Emergency Medicine, St. Barnabas Hospital, Bronx, New York 10457, USA. YR 1995.AN 08532571 Medline 20070101. TI Cyproheptadine-induced central anticholinergic syndrome in a child: a case report. SO Pediatric emergency care, {Pediatr-Emerg-Care}, Aug 1995, vol. 11, no. 4, p. 235-7, ISSN: 0749-5161. AU Blaustein-B-S, Gaeta-T-J, Balentine-J-R, Gindi-M. IN Department of Emergency Medicine, St. Barnabas Hospital, Bronx, New York 10457, USA. YR 1995. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25228 |
Study title: AN 1995094011 19950101. TI Reversal of anorexia in a child with partial ornithine transcarbamylase deficiency by cyproheptadine therapy. AU Lerman-Sagie-T, Mimouni-M. IN Child Development Center, 14 Balfour Street, Tel Aviv, Israel. SO Clinical Pediatrics {CLIN-PEDIATR}, 1995, Vol/Iss/Pg. 34/3 (163-165), ISSN: 0009-9228. YR 1995.AN 1995094011 19950101. TI Reversal of anorexia in a child with partial ornithine transcarbamylase deficiency by cyproheptadine therapy. AU Lerman-Sagie-T, Mimouni-M. IN Child Development Center, 14 Balfour Street, Tel Aviv, Israel. SO Clinical Pediatrics {CLIN-PEDIATR}, 1995, Vol/Iss/Pg. 34/3 (163-165), ISSN: 0009-9228. YR 1995. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25260 |
Study title: AN 1999012398 19990205. TI A study of the effect of cyproheptadine on gait in hemiplegic children. AU Khodadadeh-S, Holstein-H, Purushotthaman-S, Patrick-J, IN S. Khodadadeh, Department of Computer Science, University of Wales, Aberystwyth, Ceredigion SY23 3DB, United Kingdom. SO Gait and Posture {GAIT-POSTURE}, 1998, Vol/Iss/Pg. 8/3 (205-213), ISSN: 0966-6362. YR 1998.AN 1999012398 19990205. TI A study of the effect of cyproheptadine on gait in hemiplegic children. AU Khodadadeh-S, Holstein-H, Purushotthaman-S, Patrick-J, IN S. Khodadadeh, Department of Computer Science, University of Wales, Aberystwyth, Ceredigion SY23 3DB, United Kingdom. SO Gait and Posture {GAIT-POSTURE}, 1998, Vol/Iss/Pg. 8/3 (205-213), ISSN: 0966-6362. YR 1998. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25261 |
Study title: AN 2001157844 20010517. TI Fixed drug eruption due to cyproheptadine hydrochloride (Periactin®). AU Tanaka-M, Yanaru-E, Hori-K. IN Dr. M. Tanaka, Division of Dermatology, Kobe National Hospital, 3-1-1, Nishiochiai, Suma-ku, Kobe 654-0155, Japan. SO Skin Research {SKIN-RES}, 2000, Vol/Iss/Pg. 42/6 (567-570), ISSN: 0018-1390. YR 2000.AN 2001157844 20010517. TI Fixed drug eruption due to cyproheptadine hydrochloride (Periactin®). AU Tanaka-M, Yanaru-E, Hori-K. IN Dr. M. Tanaka, Division of Dermatology, Kobe National Hospital, 3-1-1, Nishiochiai, Suma-ku, Kobe 654-0155, Japan. SO Skin Research {SKIN-RES}, 2000, Vol/Iss/Pg. 42/6 (567-570), ISSN: 0018-1390. YR 2000. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25262 |
Study title: Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors. - A.E. Evans, R.L. Baehner, R.L. Chard & coll. - 1974 - Publication in the dos. Français jan 1977 and and in the dos. allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) -Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors. - A.E. Evans, R.L. Baehner, R.L. Chard & coll. - 1974 - Publication in the dos. Français jan 1977 and and in the dos. allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25614 |
Study title: Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors. - A.E. Evans, R.L. Baehner, R.L. Chard & coll. - 1974 - Publication in the dos. Français jan 1977 and and in the dos. allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) -Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors. - A.E. Evans, R.L. Baehner, R.L. Chard & coll. - 1974 - Publication in the dos. Français jan 1977 and and in the dos. allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25619 |
Study title: Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors. - A.E. Evans, R.L. Baehner, R.L. Chard & coll. - 1974 - Publication in the dos. Français jan 1977 and and in the dos. allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) -Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors. - A.E. Evans, R.L. Baehner, R.L. Chard & coll. - 1974 - Publication in the dos. Français jan 1977 and and in the dos. allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25623 |
Study title: Complications and Total Care of a Child with Acute Leukemia - Vietti, T.J., and Ragab, A.H. - 1975 (Cancer 35(3), 1007) - Publication in the dos. Allemand jan 1981 - Complications and Total Care of a Child with Acute Leukemia - Vietti, T.J., and Ragab, A.H. - 1975 (Cancer 35(3), 1007) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25574 |
Study title: Cytosine arabinoside (NSC-63878) and Daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia - Yates, J. W., Wallace, H. J., Ellison, R. R., Holland, J. F. - 1973 (Cancer Chemotherapy Rep. Part 1 Vol. 57 No. 4, 485 - 488) - Publication in the dos. Allemand jan 1981 -Cytosine arabinoside (NSC-63878) and Daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia - Yates, J. W., Wallace, H. J., Ellison, R. R., Holland, J. F. - 1973 (Cancer Chemotherapy Rep. Part 1 Vol. 57 No. 4, 485 - 488) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25575 |
Study title: Cytosine arabinoside (NSC-63878) and Daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia - Yates, J. W., Wallace, H. J., Ellison, R. R., Holland, J. F. - 1973 (Cancer Chemotherapy Rep. Part 1 Vol. 57 No. 4, 485 - 488) - Publication in the dos. Allemand jan 1981 -Cytosine arabinoside (NSC-63878) and Daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia - Yates, J. W., Wallace, H. J., Ellison, R. R., Holland, J. F. - 1973 (Cancer Chemotherapy Rep. Part 1 Vol. 57 No. 4, 485 - 488) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25615 |
Study title: Coordinated treatment of childhood rhabdomyosarcoma with surgery, radiotherapy, and combination chemotherapy. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25328 |
Study title: Current phase III clinical trials investigating pediatric cancers |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25329 |
Study title: Cyclophosphamide dose escalation in combination with vincristine and actinomycin-D (VAC) in gross residual sarcoma. A pilot study without hematopoietic growth factor support evaluating toxicity and response. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25330 |
Study title: Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanoma. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25331 |
Study title: Desmoptastic small round cell tumor of meckels diverticulum |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25332 |
Study title: Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25334 |
Study title: Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25335 |
Study title: Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25337 |
Study title: Effectiveness of chemotherapy of advanced forms of neuroblastoma in children according to the program of the RWPG |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25338 |
Study title: Effectiveness of rhGM-CSF mouthwashes on chemotherapy induced mucositis in childhood solid tumors |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25339 |
Study title: Effects of different magnitudes of cyclic stretch on Na+-K+-ATPase in skeletal muscle cells in vitro. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25340 |
Study title: Effects of oral glutamine supplementation on children with solid tumors receiving chemotherapy |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25341 |
Study title: Efficacy of carboplatin given in a phase II window study to children and adolescents with newly diagnosed metastatic soft tissue sarcoma |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25342 |
Study title: Efficacy of topotecan and cyclophosphamide given in a phase II window trial in children with newly diagnosed metastatic rhabdomyosarcoma: a Children's Oncology Group study. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25343 |
Study title: EMA-EP regimen, as firstline multiple agent chemotherapy in high-risk GTT patients (stage II-IV). |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25344 |
Study title: Emergence of secondary acute lymphoblastic leukemia of Burkitt type after treatment of rhabdomyosarcoma. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25345 |
Study title: Endometrioid variant of yolk sac tumour 1 |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25346 |
Study title: ETV6-NTRK3 gene fusion in metastasizing congenital fibrosarcoma. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25347 |
Study title: W.W. Sutow, T.J. Vietti, D. Lonsdale & coll. - 1972 - Publication in the dos. Français jan 1977 - Daunomycin in the treatment of metastatic soft tissue sarcoma in children - W.W. Sutow, T.J. Vietti, D. Lonsdale & coll. - 1972 - Publication in the dos. Français jan 1977 - Daunomycin in the treatment of metastatic soft tissue sarcoma in children - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25610 |
Study title: |
Active substance: Deferiprone |
Study summary document link (including results): |
View full study record |
Document reference: 39688 |
Study title: A comparative study on the effects of L5458 and prednisone on the electrolyte and nitrogen balance and on oral glucose tolerance - Acocella G and Marchetti M - 5 March 1973 - Report in the Clinical Documentation Deflazacort 6 mg tablets April 1991 - |
Active substance: DEFLAZACORT |
Study summary document link (including results): Deflazacort STUDY report 57.xls |
View full study record |
Document reference: 25626 |
Study title: AN 04913572 Medline 20070101. TI (Anorexia nervosa. A general review of recent works). TT L'anorexie mentale. Revue generale des travaux recents. SO Annales medico-psychologiques, {Ann-Med-Psychol-Paris}, Mar 1969, vol. 1, no. 3, p. 375-93, 58 refs, ISSN: 0003-4487. AU Demoulin-C. YR 1969.AN 04913572 Medline 20070101. TI (Anorexia nervosa. A general review of recent works). TT L'anorexie mentale. Revue generale des travaux recents. SO Annales medico-psychologiques, {Ann-Med-Psychol-Paris}, Mar 1969, vol. 1, no. 3, p. 375-93, 58 refs, ISSN: 0003-4487. AU Demoulin-C. YR 1969. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25200 |
Study title: AN 04913983 Medline 20070101. TI Appetite stimulation and weight gain with cyproheptadine. A double- blind study in underweight children. blind study in underweight children. SO Journal of postgraduate medicine, {J-Postgrad-Med}, Jan 1970, vol. 16, no. 1, p. 12-5, ISSN: 0022-3859. AU Sanzgiri-R-R, Mohamad-H-A, Raja-Z. YR 1970.AN 04913983 Medline 20070101. TI Appetite stimulation and weight gain with cyproheptadine. A double- blind study in underweight children. blind study in underweight children. SO Journal of postgraduate medicine, {J-Postgrad-Med}, Jan 1970, vol. 16, no. 1, p. 12-5, ISSN: 0022-3859. AU Sanzgiri-R-R, Mohamad-H-A, Raja-Z. YR 1970. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25201 |
Study title: AN 04949071 Medline 20070101. TI (Stimulation of the appetite in children: comparison between the action of cyproheptadine and a placebo). TT Stimulation de l'appetit chez l'enfant: comparaison entre l'action de la cyproheptadine et d'un placebo. SO Revue medicale de la Suisse romande, {Rev-Med-Suisse-Romande}, Aug 1971, vol. 91, no. 8, p. 567-72, ISSN: 0035-3655. AU Juillard-E. YR 1971.AN 04949071 Medline 20070101. TI (Stimulation of the appetite in children: comparison between the action of cyproheptadine and a placebo). TT Stimulation de l'appetit chez l'enfant: comparaison entre l'action de la cyproheptadine et d'un placebo. SO Revue medicale de la Suisse romande, {Rev-Med-Suisse-Romande}, Aug 1971, vol. 91, no. 8, p. 567-72, ISSN: 0035-3655. AU Juillard-E. YR 1971. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25202 |
Study title: AN 05072673 Medline 20070101. TI (Evaluation of dexamethasone-cyproheptadine in children with allergic syndromes and reactive dermatitis). TT Evaluacion de la dexametasona-ciproheptadina en ninos con sindrome alergico y dermatitis reaccionales. SO Alergia, {Alergia}, May 1972, vol. 19, no. 4, p. 153-9, ISSN: 0002-5151. AU Perez-Martin-J. YR 1972.AN 05072673 Medline 20070101. TI (Evaluation of dexamethasone-cyproheptadine in children with allergic syndromes and reactive dermatitis). TT Evaluacion de la dexametasona-ciproheptadina en ninos con sindrome alergico y dermatitis reaccionales. SO Alergia, {Alergia}, May 1972, vol. 19, no. 4, p. 153-9, ISSN: 0002-5151. AU Perez-Martin-J. YR 1972. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25203 |
Study title: AN 05244349 Medline 20070101. TI (Cyproheptadine, an antihistamine and serotonin antagonist acting on body weight: preliminary report). TT La ciproeptadina, un antiistaminico e antiserotoninico con azione sul peso corporeo: rapporto preliminare. SO Minerva medica, {Minerva-Med}, 11 Jul 1968, vol. 59, no. 55, p. 3079-82, ISSN: 0026-4806. AU Francini-F, Santana-J-G, Kitrosen-J. YR 1968.AN 05244349 Medline 20070101. TI (Cyproheptadine, an antihistamine and serotonin antagonist acting on body weight: preliminary report). TT La ciproeptadina, un antiistaminico e antiserotoninico con azione sul peso corporeo: rapporto preliminare. SO Minerva medica, {Minerva-Med}, 11 Jul 1968, vol. 59, no. 55, p. 3079-82, ISSN: 0026-4806. AU Francini-F, Santana-J-G, Kitrosen-J. YR 1968. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25205 |
Study title: AN 05255351 Medline 20070101. TI (On the anti-anorexic and eutrophic activity of cyproheptadine in children). TT Sull'attivita antianoressica ed eutrofica della ciproeptadina nei bambini. SO Minerva medica, {Minerva-Med}, 6 Jun 1969, vol. 60, no. 45, p. 2254-8, ISSN: 0026-4806. AU Motta-W, Panzetti-G. YR 1969.AN 05255351 Medline 20070101. TI (On the anti-anorexic and eutrophic activity of cyproheptadine in children). TT Sull'attivita antianoressica ed eutrofica della ciproeptadina nei bambini. SO Minerva medica, {Minerva-Med}, 6 Jun 1969, vol. 60, no. 45, p. 2254-8, ISSN: 0026-4806. AU Motta-W, Panzetti-G. YR 1969. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25185 |
Study title: Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25423 |
Study title: AN 09374568 Medline 20070101. TI Effective prophylactic therapy for cyclic vomiting syndrome in children using amitriptyline or cyproheptadine. SO Pediatrics, {Pediatrics}, Dec 1997, vol. 100, no. 6, p. 977-81, ISSN: 1098-4275. AU Andersen-J-M, Sugerman-K-S, Lockhart-J-R, Weinberg-W-A. IN Department of Pediatrics, University of Texas Southwestern Medical Center and Children's Medical Center, Dallas, Texas, USA. YR 1997.AN 09374568 Medline 20070101. TI Effective prophylactic therapy for cyclic vomiting syndrome in children using amitriptyline or cyproheptadine. SO Pediatrics, {Pediatrics}, Dec 1997, vol. 100, no. 6, p. 977-81, ISSN: 1098-4275. AU Andersen-J-M, Sugerman-K-S, Lockhart-J-R, Weinberg-W-A. IN Department of Pediatrics, University of Texas Southwe... |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25229 |
Study title: AN 09628074 Medline 20070101. TI Nightmares treated with cyproheptadine. SO Journal of the American Academy of Child and Adolescent Psychiatry, {J-Am-Acad-Child-Adolesc-Psychiatry}, Jun 1998, vol. 37, no. 6, p. 570-2, ISSN: 0890-8567. AU Gupta-S, Austin-R, Cali-L-A, Bhatara-V. YR 1998.AN 09628074 Medline 20070101. TI Nightmares treated with cyproheptadine. SO Journal of the American Academy of Child and Adolescent Psychiatry, {J-Am-Acad-Child-Adolesc-Psychiatry}, Jun 1998, vol. 37, no. 6, p. 570-2, ISSN: 0890-8567. AU Gupta-S, Austin-R, Cali-L-A, Bhatara-V. YR 1998. |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25230 |
Study title: Danazol Therapy in Gynaecomastia ; Recent Experience and Indications for Therapy - Investigators : R Buckle - Postgrad. Med. J., 1979, 55(Suppl.5), 71-78 - Publication in CER - No author - 06/1996Danazol Therapy in Gynaecomastia ; Recent Experience and Indications for Therapy - Investigators : R Buckle - Postgrad. Med. J., 1979, 55(Suppl.5), 71-78 - Publication in CER - No author - 06/1996 |
Active substance: DANAZOL |
Study summary document link (including results): |
View full study record |
Document reference: 25516 |
Study title: Gynaecomastia of Puberty. Final Report on Drug Therapy with Danazol - Investigators : Dr Wolf Beck - Kinderarzt, 1986, 17(12), 1732-1738 - Publication in CER - No author - 06/1996Gynaecomastia of Puberty. Final Report on Drug Therapy with Danazol - Investigators : Dr Wolf Beck - Kinderarzt, 1986, 17(12), 1732-1738 - Publication in CER - No author - 06/1996 |
Active substance: DANAZOL |
Study summary document link (including results): |
View full study record |
Document reference: 25517 |
Study title: Long-term treatment of hereditary angiodema (HAE) with attenuated andogens : a survey of 13 years experience - Investigators : Marco Circadi et al. - J. Allergy Clin. Immunol. 1991, 87(4), Apr., 768-773 - Publication in CER - No author -06/1996Long-term treatment of hereditary angiodema (HAE) with attenuated andogens : a survey of 13 years experience - Investigators : Marco Circadi et al. - J. Allergy Clin. Immunol. 1991, 87(4), Apr., 768-773 - Publication in CER - No author -06/1996 |
Active substance: DANAZOL |
Study summary document link (including results): |
View full study record |
Document reference: 25518 |
Study title: Steroid Treatment of Puberty Gyneacomastia with Danazol - Investigators : W Swoboda and al. - P. Wein. Med. Woshr, 1981, (5), 127-132 - Publication in CER - No author - 06/1996Steroid Treatment of Puberty Gyneacomastia with Danazol - Investigators : W Swoboda and al. - P. Wein. Med. Woshr, 1981, (5), 127-132 - Publication in CER - No author - 06/1996 |
Active substance: DANAZOL |
Study summary document link (including results): |
View full study record |
Document reference: 25519 |
Study title: Treatment Dysfunctional Uterine Bleeding with Danazol - Investigators : IS Fraser - Aust N.Z.J. Obstet. Gynaecol., 1985, 25. Aug., 224-226 - Publication in CER - No author - 06/1996Treatment Dysfunctional Uterine Bleeding with Danazol - Investigators : IS Fraser - Aust N.Z.J. Obstet. Gynaecol., 1985, 25. Aug., 224-226 - Publication in CER - No author - 06/1996 |
Active substance: DANAZOL |
Study summary document link (including results): |
View full study record |
Document reference: 25520 |
Study title: Use of Danazol in hysteroscopic surgery for menorrhagia - Investigators : Milton H Goldrath - J. Reprod. Med., 1990, 35(1 suppl.), Janv. 91-96 - Publication CER - No author - No date -Use of Danazol in hysteroscopic surgery for menorrhagia - Investigators : Milton H Goldrath - J. Reprod. Med., 1990, 35(1 suppl.), Janv. 91-96 - Publication CER - No author - No date - |
Active substance: DANAZOL |
Study summary document link (including results): |
View full study record |
Document reference: 25521 |
Study title: Variable effects of Danazol on Endometriosis at 4 low-dose Levels - Investigators : Dr W. P. Dmowsky et al. - Obstetrics and Gynaecology, 1982, 59(4), 408-415 - Publication in CER - No author - 06/1996Variable effects of Danazol on Endometriosis at 4 low-dose Levels - Investigators : Dr W. P. Dmowsky et al. - Obstetrics and Gynaecology, 1982, 59(4), 408-415 - Publication in CER - No author - 06/1996 |
Active substance: DANAZOL |
Study summary document link (including results): |
View full study record |
Document reference: 25522 |
Study title: Adams, E.D.:Controlled evaluation of the Safety and Effectiveness of Dantrolene Sodium in a Pediatric Population;Adams, E.D.:Controlled evaluation of the Safety and Effectiveness of Dantrolene Sodium in a Pediatric Population; |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25546 |
Study title: Adams, E.D.:Double-blind controlled evaluation of the Safety and Effectiveness of Dantrolene Sodium in relieving Spasticity Associated with Dystonia in Children with Cerebral Palsy;Adams, E.D.:Double-blind controlled evaluation of the Safety and Effectiveness of Dantrolene Sodium in relieving Spasticity Associated with Dystonia in Children with Cerebral Palsy; |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25547 |
Study title: Cytosine arabinoside (NSC-63878) and Daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia - Yates, J. W., Wallace, H. J., Ellison, R. R., Holland, J. F. - 1973 (Cancer Chemotherapy Rep. Part 1 Vol. 57 No. 4, 485 - 488) - Publication in the dos. Allemand jan 1981 -Cytosine arabinoside (NSC-63878) and Daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia - Yates, J. W., Wallace, H. J., Ellison, R. R., Holland, J. F. - 1973 (Cancer Chemotherapy Rep. Part 1 Vol. 57 No. 4, 485 - 488) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25624 |
Study title: Daunomycin - induced cardiotoxicity in children and adults - Von Hoff, D. D., Rozencweig, M. Layard, M. Slavik, M. Muggia, A. M. - 1977 (The American Journal of Medicine Vol. 62, 200 - 208) - Publication in the dos. Allemand jan 1981 - Daunomycin - induced cardiotoxicity in children and adults - Von Hoff, D. D., Rozencweig, M. Layard, M. Slavik, M. Muggia, A. M. - 1977 (The American Journal of Medicine Vol. 62, 200 - 208) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25576 |
Study title: Daunomycin , an antitumour antibiotic in the treatment of neoplastic disease - Tan C. et al. - 1967 - Publication in Clinical Expert Report (J.K.H. Rees - 1989) and in the dos. Allemand jan 1981 - Daunomycin , an antitumour antibiotic in the treatment of neoplastic disease - Tan C. et al. - 1967 - Publication in Clinical Expert Report (J.K.H. Rees - 1989) and in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25578 |
Study title: Daunomycin (NSC - 82151) in the treatment of metastatic neuroblastoma - Sutow, W. W., Fernbach, D.J., Thurman, W. G., et al. - 1970 (Cancer Chemother. Reports Part 1 Vol. 54 No. 4, 283 - 289) - Publication in the dos. Allemand jan 1981 - Daunomycin (NSC - 82151) in the treatment of metastatic neuroblastoma - Sutow, W. W., Fernbach, D.J., Thurman, W. G., et al. - 1970 (Cancer Chemother. Reports Part 1 Vol. 54 No. 4, 283 - 289) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25577 |
Study title: Paul IM et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007; 161(12):1140-1146Paul IM et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007; 161(12):1140-1146 |
Active substance: DEXTROMETHORPHAN |
Study summary document link (including results): |
View full study record |
Document reference: 25836 |
Study title: Purello−D−Ambrosio−F, Tigano−F, Gallesio−M−T, Chevallier−P, Janssens− M. Astemizole−D compared with triprolidine−D (Actifedregistered trade mark) for acute treatment of perennial allergic rhinitis. Journal of Pharmaceutical Medicine {J−PHARM−MED}, 1994, Vol/Iss/Pg. 4 /1 (15−22). Purello−D−Ambrosio−F, Tigano−F, Gallesio−M−T, Chevallier−P, Janssens− M. Astemizole−D compared with triprolidine−D (Actifedregistered trade mark) for acute treatment of perennial allergic rhinitis. Journal of Pharmaceutical Medicine {J−PHARM−MED}, 1994, Vol/Iss/Pg. 4 /1 (15−22). |
Active substance: DEXTROMETHORPHAN |
Study summary document link (including results): |
View full study record |
Document reference: 25843 |
Study title: Taylor AJ et al. Efficacy of cough suppressants in children. J Pediatr 1993; 122(5 Pt 1):799-802 Taylor AJ et al. Efficacy of cough suppressants in children. J Pediatr 1993; 122(5 Pt 1):799-802 |
Active substance: DEXTROMETHORPHAN |
Study summary document link (including results): |
View full study record |
Document reference: 25841 |
Study title: Yoder KE et al. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clin Pediatr 2006; 45(7):633-640Yoder KE et al. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clin Pediatr 2006; 45(7):633-640 |
Active substance: DEXTROMETHORPHAN |
Study summary document link (including results): |
View full study record |
Document reference: 25837 |
Study title: Children's school performance is not impaired by short-term administration of diphenhydramine or loratadine, Bender, B.G., J. Pediatr. 2001; 138: 656-660 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25846 |
Study title: Clinical Symptomatology of diphenhydramine overdose: an evaluation of 136 cases in 1082 to 1985, Koeppel, C., Clinical Toxicology 1987; 25 (1,2): 53-70 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25862 |
Study title: Diphenhydramine drug monograph, Kasper, D.L., Harrison's Online - Harrison's princeples of internal medicine, 16th edition; 2007 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25861 |
Study title: Diphenhydramine hydrochloride intoxication, Hestand, H.E., J. Paediatr. 1977; 90:1017-1018 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25858 |
Study title: Diphenhydramine toxicity from combined oral and topical use, Schunk, J.E., Am. J. Dis. Child. 1988; 142(19): 1020-1021 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25872 |
Study title: Diphenhydramine toxicity in a child with varicella. A case report, McGann, K.P., J. Fam. Pract. 1992 August; 35(2): 210, 213-214 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25854 |
Study title: A double blind comparative trial of deflazacort and prednisone in juvenile chronic arthritis - Loftus J, Allen R, Hesp R, Reeve J and Ansell BM - June 1989 - Report (reference 83) in the Clinical Documentation Deflazacort 6 mg tablets April 1991 - |
Active substance: DEFLAZACORT |
Study summary document link (including results): Deflazacort STUDY Loftus.xls |
View full study record |
Document reference: 25627 |
Study title: A double blind controlled study of the therapeutic activity in rheumatoid arthritis of L 5458 given for one week in comparison with prednisone - Manzini A, Acocella B, Bonollo L and Marchetti M - 16 December 1971 - Report in the Clinical Documentation Deflazacort 6mg tablet - 04/1991 |
Active substance: DEFLAZACORT |
Study summary document link (including results): Deflazacort STUDY report 37.xls |
View full study record |
Document reference: 25628 |
Study title: An overall summary of the tolerability and safety of deflazacort injectable - McDermott J and Marsden J - 25 May 1995 - Report in the Clinical Documentation Deflazacort injectable 60 mg and 300 mg vials June 1995 - |
Active substance: DEFLAZACORT |
Study summary document link (including results): |
View full study record |
Document reference: 25629 |
Study title: Bone histomorphometry and biochemical data during glucocorticoid treatment - Bonucci E and Lo Cascio V - 1986 - Report (reference 78) in the Clinical Documentation Deflazacort 6 mg tablets April 1991 - |
Active substance: DEFLAZACORT |
Study summary document link (including results): Deflazacort STUDY MMD07.xls |
View full study record |
Document reference: 25630 |
Study title: Bone loss after glucocorticoid therapy - Lo Cascio V, Bonucci E, Imbimbo B, Ballanti P et al. - 1984 - Report in the Clinical Documentation Deflazacort 6 mg tablets April 1991 - |
Active substance: DEFLAZACORT |
Study summary document link (including results): |
View full study record |
Document reference: 25631 |
Study title: Comparative clinical study of the effects of two glucocorticoids (deflazacort and prednisone) in the combined chemotherapy of Hodgkin's lymphoma and chronic lymphocytic leukaemia - Tura S - 30 June 1979 - Report (reference 39) in the Clinical Documentation Deflazacort 6mg tablet - 04/1991 - |
Active substance: DEFLAZACORT |
Study summary document link (including results): |
View full study record |
Document reference: 25633 |
Study title: Comparative clinical trial of the effects of two steroids (DL 458 IT and prednisone) in acute and chronic skin diseases - Longhi A - 20 December 1978 - Report in the Clinical Documentation Deflazacort 6 mg tablets April 1991 - |
Active substance: DEFLAZACORT |
Study summary document link (including results): |
View full study record |
Document reference: 25634 |
Study title: Comparison of growth retarding effects induced by two different glucocorticoids in prepubertal sick children: an interim long-term analysis - AicardiG et al. - 1991 - Publication in Consolidated responses to questions Deflazacort 6 mg and 30 mg March 1992 - |
Active substance: DEFLAZACORT |
Study summary document link (including results): |
View full study record |
Document reference: 25636 |
Study title: Langer T et al Effects Working Group in the German Society of Pediatric Oncology and Hematology. Late effects surveillance system for sarcoma patients Pediatr Blood Cancer. 2004 Apr;42(4):373-9Langer T et al Effects Working Group in the German Society of Pediatric Oncology and Hematology. Late effects surveillance system for sarcoma patients Pediatr Blood Cancer. 2004 Apr;42(4):373-9 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24980 |
Study title: Laver JH et al. Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non-Hodgkin's lymphoma: a Pediatric Oncology Group study. Leuk Lymphoma. 2002 Jan;43(1):105-9Laver JH et al. Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non-Hodgkin's lymphoma: a Pediatric Oncology Group study. Leuk Lymphoma. 2002 Jan;43(1):105-9 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24981 |
Study title: Therapy with nebulised fenoterol 0.5% in asthmatic patients in the children's hospital Josefina Martinez de Ferrari. |
Active substance: FENOTEROL |
Study summary document link (including results): Fenoterol hydrobromide_U85-0530_synopsis.pdf |
View full study record |
Document reference: 27090 |
Study title: Studio clinico aperto sulla efficacia e tollerabilità dell'associazione 2-4 dicloro benzil alcool, amilmetacresolo e vitamina C (open clinical study on the effectiveness and tolerability of a combination of DCBA, AMC and vit C) |
Active substance: DICHLOROBENZYL-ALCOHOL AND LIDOCAINE |
Study summary document link (including results): |
View full study record |
Document reference: 25953 |
Study title: A CLINICAL COMPARATIVE ASSESSMENT OF DICLOFENAC RESINATE AND PARACETAMOL TOGETHER WITH ANTIBIOTIC IN THE TREATMENT OF PHARINGOTONSILLITIS IN CHILDRENA CLINICAL COMPARATIVE ASSESSMENT OF DICLOFENAC RESINATE AND PARACETAMOL TOGETHER WITH ANTIBIOTIC IN THE TREATMENT OF PHARINGOTONSILLITIS IN CHILDREN |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 26019 |
Study title: A clinical evaluation of piroxicam gel: an open comparative trial with diclofenac gel in the treatment of acute musculoskeletal disorders. A clinical evaluation of piroxicam gel: an open comparative trial with diclofenac gel in the treatment of acute musculoskeletal disorders. |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 26018 |
Study title: A CLINICAL TRIAL OF DICLOFENAC POTASSIUM RESINATE DROPS TOGETHER WITH AN ANTIBIOTIC IN THE TREATMENT OF ACUTE OTITIS MEDIA IN CHILDRENA CLINICAL TRIAL OF DICLOFENAC POTASSIUM RESINATE DROPS TOGETHER WITH AN ANTIBIOTIC IN THE TREATMENT OF ACUTE OTITIS MEDIA IN CHILDREN |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 26026 |
Study title: A comparative fully randomized clinical study of FZ1000 (diclofenac eye drops 0,1%)vs dexamethasone in the managment of uveitis and episcleritis of the anterior eye segment in two paralell groups of paediatric patients followed by open continuationA comparative fully randomized clinical study of FZ1000 (diclofenac eye drops 0,1%)vs dexamethasone in the managment of uveitis and episcleritis of the anterior eye segment in two paralell groups of paediatric patients followed by open continuation |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 26003 |
Study title: A prospective study comparing oral sodium phosphate solution to a bowel cleansing preparation with nutrition food package in children. A prospective study comparing oral sodium phosphate solution to a bowel cleansing preparation with nutrition food package in children. |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 25993 |
Study title: An assessment of bisacodyl-based bowel preparation for colonoscopy in children. An assessment of bisacodyl-based bowel preparation for colonoscopy in children. |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 25994 |
Study title: Antegrade continence enemas in the management of intractable faecal incontinence. Antegrade continence enemas in the management of intractable faecal incontinence. |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 26002 |
Study title: ANTI-INFLAMMATORY AND ANALGESIC EFFICACY, LOCAL AND SYSTEMIC TOLERABILITY OF GP 45,840 IN CHILDREN SUFFERING FROM VARIOUS DISEASES AND POSTOPERATIVE STATES WHO REQUIRE TREATMENT WITH A NON-STEROIDAL, ANTI-INFLAMMATORY PREPARATIONANTI-INFLAMMATORY AND ANALGESIC EFFICACY, LOCAL AND SYSTEMIC TOLERABILITY OF GP 45,840 IN CHILDREN SUFFERING FROM VARIOUS DISEASES AND POSTOPERATIVE STATES WHO REQUIRE TREATMENT WITH A NON-STEROIDAL, ANTI-INFLAMMATORY PREPARATION |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 26042 |
Study title: Atilla MK, et all. A nonsurgical approach to the treatment of phimosis: local nonsteroidal anti-inflammatory ointment application. J Urol. 1997 Jul;158(1):196-7.Atilla MK, et all. A nonsurgical approach to the treatment of phimosis: local nonsteroidal anti-inflammatory ointment application. J Urol. 1997 Jul;158(1):196-7. |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 25957 |
Study title: BIOAVAILABILITY OF DICLOFENAC-NA FROM VOLTAREN CHILDREN'S SUPPOSITORIES FOLLOWING A SINGLE ADMINISTRATION AND REPEATED ADMINISTRATION IN CHLIDREN |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 26047 |
Study title: BIOAVAILABILITY OF DICLOFENAC-NA FROM VOLTAREN CHILDREN'S SUPPOSITORIES FOLLOWING A SINGLE ADMINISTRATION AND REPEATED ADMINISTRATION IN CHLIDRENBIOAVAILABILITY OF DICLOFENAC-NA FROM VOLTAREN CHILDREN'S SUPPOSITORIES FOLLOWING A SINGLE ADMINISTRATION AND REPEATED ADMINISTRATION IN CHLIDREN |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 26060 |
Study title: BIOAVAILABILITY OF DICLOFENAC-NA FROM VOLTAREN CHILDREN'S SUPPOSITORIES FOLLOWING A SINGLE ADMINISTRATION AND REPEATED ADMINISTRATION IN CHLIDRENBIOAVAILABILITY OF DICLOFENAC-NA FROM VOLTAREN CHILDREN'S SUPPOSITORIES FOLLOWING A SINGLE ADMINISTRATION AND REPEATED ADMINISTRATION IN CHLIDREN |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 26062 |
Study title: Badell- Ribera et al.: Dantrolene sodium in cerebral palsy: Long-term administration to pre-school age children; Arch. Phys. Med. Rehabil. 59; 529 (1978)Badell- Ribera et al.: Dantrolene sodium in cerebral palsy: Long-term administration to pre-school age children; Arch. Phys. Med. Rehabil. 59; 529 (1978) |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25536 |
Study title: Bertorini, T.E. et al:Effect of dantrolene in Duchenne Muscular Dystrophy; Musc. Nerve. 14, 503-507 (1991Bertorini, T.E. et al:Effect of dantrolene in Duchenne Muscular Dystrophy; Musc. Nerve. 14, 503-507 (1991 |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25524 |
Study title: Carpenter, N.J. And J.D. Conklin: Blood and Urine Drug Concentrations in Pediatric Patients during the Oral Administration of Dantrolene Sodium (F-440) and PlaceboCarpenter, N.J. And J.D. Conklin: Blood and Urine Drug Concentrations in Pediatric Patients during the Oral Administration of Dantrolene Sodium (F-440) and Placebo |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25529 |
Study title: Chomiki, R. et al: Action of Dantrium on the speed of movement; Rev. Readat. Fonct. Prof. Soc. 17, 85-89 (1988)Chomiki, R. et al: Action of Dantrium on the speed of movement; Rev. Readat. Fonct. Prof. Soc. 17, 85-89 (1988) |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25525 |
Study title: Chyatte SB et al.: Dantrolene sodium in athetoid cerebral palsy; Arch. Phys. Med. Rehabil. 54, 365-368 (1973)Chyatte SB et al.: Dantrolene sodium in athetoid cerebral palsy; Arch. Phys. Med. Rehabil. 54, 365-368 (1973) |
Active substance: DANTROLENE |
Study summary document link (including results): |
View full study record |
Document reference: 25534 |
Study title: Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8. 4. Postoperative miotics for patients with infantile esotropia.Spierer A, Zeeli T. Ophthalmic Surg Lasers. 1997 Dec;28(12):1002-5. Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8. 4. Postoperative miotics for patients with infantile esotropia.Spierer A, Zeeli T. Ophthalmic Surg Lasers. 1997 Dec;28(12):1002-5. |
Active substance: DEXAMETHASONE AND GENTAMYCIN AND TETRYZOLINE |
Study summary document link (including results): |
View full study record |
Document reference: 25736 |
Study title: [Epidemic keratoconjunctivitis: treatment results during an epidemic] Hutter H. Klin Monatsbl Augenheilkd. 1990 Sep;197(3):214-7. [Epidemic keratoconjunctivitis: treatment results during an epidemic] Hutter H. Klin Monatsbl Augenheilkd. 1990 Sep;197(3):214-7. |
Active substance: DEXAMETHASONE AND GENTAMYCIN AND TETRYZOLINE |
Study summary document link (including results): |
View full study record |
Document reference: 25738 |
Study title: Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial.Lam DS, Fan DS, Ng JS, Yu CB, Wong CY, Cheung AY. Clin Experiment Ophthalmol. 2005 Jun;33(3):252-8. Comment in: Clin Experiment Ophthalmol. 2005 Jun;33(3):229-30. PMID: 15932523. Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial.Lam DS, Fan DS, Ng JS, Yu CB, Wong CY, Cheung AY. Clin Experiment Ophthalmol. 2005 Jun;33(3):252-8. Comment in: Clin Experiment Ophthalmol. 2005 Jun;33(3):229-30. PMID: 15932523. |
Active substance: DEXAMETHASONE AND GENTAMYCIN AND TETRYZOLINE |
Study summary document link (including results): |
View full study record |
Document reference: 25741 |
Study title: Ocular hypertensive response to topical dexamethasone in children: a dose-dependent phenomenon.Ng JS, Fan DS, Young AL, Yip NK, Tam K, Kwok AK, Lam DS. Ophthalmology. 2000 Nov;107(11):2097-100 Comment in: Ophthalmology. 2001 Oct;108(10):1715-6. PMID: 11581031. Ocular hypertensive response to topical dexamethasone in children: a dose-dependent phenomenon.Ng JS, Fan DS, Young AL, Yip NK, Tam K, Kwok AK, Lam DS. Ophthalmology. 2000 Nov;107(11):2097-100 Comment in: Ophthalmology. 2001 Oct;108(10):1715-6. PMID: 11581031. |
Active substance: DEXAMETHASONE AND GENTAMYCIN AND TETRYZOLINE |
Study summary document link (including results): |
View full study record |
Document reference: 25735 |
Study title: Ocular-hypertensive response to topical steroids in children. Kwok AK, Lam DS, Ng JS, Fan DS, Chew SJ, Tso MO. Ophthalmology. 1997 Dec;104(12):2112-6. Ocular-hypertensive response to topical steroids in children. Kwok AK, Lam DS, Ng JS, Fan DS, Chew SJ, Tso MO. Ophthalmology. 1997 Dec;104(12):2112-6. |
Active substance: DEXAMETHASONE AND GENTAMYCIN AND TETRYZOLINE |
Study summary document link (including results): |
View full study record |
Document reference: 25737 |
Study title: Single-dose kanamycin therapy of gonococcal ophthalmia neonatorum. Fransen L, Nsanze H, D'Costa L, Brunham RC, Ronald AR, Piot P. Lancet. 1984 Dec 1;2(8414):1234-7.Single-dose kanamycin therapy of gonococcal ophthalmia neonatorum. Fransen L, Nsanze H, D'Costa L, Brunham RC, Ronald AR, Piot P. Lancet. 1984 Dec 1;2(8414):1234-7. |
Active substance: DEXAMETHASONE AND GENTAMYCIN AND TETRYZOLINE |
Study summary document link (including results): |
View full study record |
Document reference: 25740 |
Study title: Vernal keratoconjunctivitis in the black child and its response to therapy.Dahan E, Appel R. Br J Ophthalmol. 1983 Oct;67(10):688-92. Vernal keratoconjunctivitis in the black child and its response to therapy.Dahan E, Appel R. Br J Ophthalmol. 1983 Oct;67(10):688-92. |
Active substance: DEXAMETHASONE AND GENTAMYCIN AND TETRYZOLINE |
Study summary document link (including results): |
View full study record |
Document reference: 25739 |
Study title: Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8. Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8. |
Active substance: DEXAMETHASONE AND NEOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25743 |
Study title: Diphenhydramine toxicity in three children with varicella-zoster infection, Chan, C.Y.J., The Annals of Pharmacotherapy 1991; 25(2): 130-132 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25849 |
Study title: Diphenhydramine, Garnett, W.R., Am. Pharm. 1986; NS26: 35-40 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25855 |
Study title: Diphenhydramine, Martindale The complete drug reference, 33 edition, Sweetman, S.C., p.416 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25874 |
Study title: Dose-dependent toxicity of diphenhydramine overdose, Radovanovic, D., Numan and Exp. Tixicology 2000; 19: 489-495 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25870 |
Study title: Double-blind crossover study comparing doxepin with diphenhydramine for the reatment of chronic urticaria, Greene, S.L., J. Am. Acad. Dermatol. 1985; 12: 669-675 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25857 |
Study title: Effects of fexofenadine, diphenhydramine, and placebo on performance of the test of variables of attention, Mansfield, L., Ann. Allergy Asthma Immunol. 2003 May; 90(5): 554-559 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25863 |
Study title: Electrocardiographic Findings in Patients with Diphenhydramine Overdose, Zareba, W., Am. J. Cardiol. 1997; 80: 1168-1173 |
Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
Study summary document link (including results): |
View full study record |
Document reference: 25877 |
Study title: Souhami RL et al, Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup, Lancet. 1997 Sep 27;350(9082):911-7Souhami RL et al, Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup, Lancet. 1997 Sep 27;350(9082):911-7 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25129 |
Study title: Spitzer TR et al Etoposide in combination with cyclophosphamide and total body irradiation or busulfan as conditioning for marrow transplantation in adults and children Int J Radiat Oncol Biol Phys 1994 Apr 30;29(1):39-44Spitzer TR et al Etoposide in combination with cyclophosphamide and total body irradiation or busulfan as conditioning for marrow transplantation in adults and children Int J Radiat Oncol Biol Phys 1994 Apr 30;29(1):39-44 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25130 |
Study title: Sposto R et al. Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group. Med Pediatr Oncol. 2001 Nov;37(5):432-41.Sposto R et al. Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group. Med Pediatr Oncol. 2001 Nov;37(5):432-41. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25131 |
Study title: Sripada PV et al, Hybrid (COPP/ABV) therapy in childhood Hodgkin's disease: a study of 53 cases during 1989-1993 at the Cancer Institute, Madras, Pediatr Hematol Oncol. 1995 Jul-Aug;12(4):333-41Sripada PV et al, Hybrid (COPP/ABV) therapy in childhood Hodgkin's disease: a study of 53 cases during 1989-1993 at the Cancer Institute, Madras, Pediatr Hematol Oncol. 1995 Jul-Aug;12(4):333-41 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25132 |
Study title: Steinherz PG et al. Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocol. Cancer. 1993 Nov 15;72(10):3120-30.Steinherz PG et al. Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocol. Cancer. 1993 Nov 15;72(10):3120-30. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25133 |
Study title: Stevens MC et al Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.J Clin Oncol 2005 Apr 20;23(12):2618-28. Epub 2005 Feb 22Stevens MC et al Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.J Clin Oncol 2005 Apr 20;23(12):2618-28. Epub 2005 Feb 22 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25134 |
Study title: Stewart RJ et al Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology J Clin Oncol. 2003 Mar 1;21(5):793-8Stewart RJ et al Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology J Clin Oncol. 2003 Mar 1;21(5):793-8 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25135 |
Study title: Le Deley MC et al SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients Eur J Cancer. 2007 Mar;43(4):752-61. Epub 2007 Jan 30Le Deley MC et al SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients Eur J Cancer. 2007 Mar;43(4):752-61. Epub 2007 Jan 30 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24982 |
Study title: Lee BS et al Ifosfamide nephrotoxicity in pediatric cancer patients Pediatr Nephrol. 2001 Oct;16(10):796-9Lee BS et al Ifosfamide nephrotoxicity in pediatric cancer patients Pediatr Nephrol. 2001 Oct;16(10):796-9 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24983 |
Study title: Link MP et al Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. N Engl J Med. 1997 Oct 30;337(18):1259-66Link MP et al Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. N Engl J Med. 1997 Oct 30;337(18):1259-66 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24984 |
Study title: Link MP, The multi-institutional osteosarcoma study: an update, Cancer Treat Res. 1993;62:261-7. No abstract availableLink MP, The multi-institutional osteosarcoma study: an update, Cancer Treat Res. 1993;62:261-7. No abstract available |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24985 |
Study title: Lo Curto M et al Malignant germ cell tumors in childhood: results of the first Italian cooperative study "TCG 91"Med Pediatr Oncol. 2003 Nov;41(5):417-25Lo Curto M et al Malignant germ cell tumors in childhood: results of the first Italian cooperative study "TCG 91"Med Pediatr Oncol. 2003 Nov;41(5):417-25 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24986 |
Study title: Longhi A et al Fertility in male patients treated with neoadjuvant chemotherapy for Osteosarcoma J Pediatr Hematol Oncol. 2003 Apr;25(4):292-6Longhi A et al Fertility in male patients treated with neoadjuvant chemotherapy for Osteosarcoma J Pediatr Hematol Oncol. 2003 Apr;25(4):292-6 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24987 |
Study title: López-Aguilar E et al Preirradiation ifosfamide, carboplatin and etoposide (ICE) for the treatment of high-grade astrocytomas in children Childs Nerv Syst. 2003 Dec;19(12):818-23. Epub 2003 Nov 12López-Aguilar E et al Preirradiation ifosfamide, carboplatin and etoposide (ICE) for the treatment of high-grade astrocytomas in children Childs Nerv Syst. 2003 Dec;19(12):818-23. Epub 2003 Nov 12 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24988 |
Study title: Loss JF et al Outcome of pediatric recurrent and refractory malignant solid tumors following ifosfamide/carboplatin/etoposide (ICE): A phase II study in a pediatric oncology centre in Brazil Pediatr Blood Cancer 2004 Feb;42(2):139-44Loss JF et al Outcome of pediatric recurrent and refractory malignant solid tumors following ifosfamide/carboplatin/etoposide (ICE): A phase II study in a pediatric oncology centre in Brazil Pediatr Blood Cancer 2004 Feb;42(2):139-44 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24989 |
Study title: Lowis SP et al A study of the feasibility and accuracy of pharmacokinetically guided etoposide dosing in children.Br J Cancer 1998 Jun;77(12):2318-23Lowis SP et al A study of the feasibility and accuracy of pharmacokinetically guided etoposide dosing in children.Br J Cancer 1998 Jun;77(12):2318-23 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24990 |
Study title: Lowis SP et al Prohibitive toxicity of a dose-intense regime for metastatic neuroblastoma containing ifosfamide, doxorubicin and cisplatin Cancer Chemother Pharmacol. 1993;31(5):415-8Lowis SP et al Prohibitive toxicity of a dose-intense regime for metastatic neuroblastoma containing ifosfamide, doxorubicin and cisplatin Cancer Chemother Pharmacol. 1993;31(5):415-8 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24991 |
Study title: Lund MB et al, Lung function impairment in long-term survivors of Hodgkin's disease, Ann Oncol. 1995 May;6(5):495-501Lund MB et al, Lung function impairment in long-term survivors of Hodgkin's disease, Ann Oncol. 1995 May;6(5):495-501 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24992 |
Study title: Wolff JE et al Simultaneous radiochemotherapy in pediatric patients with high-grade glioma: a phase I study Anticancer Res. 2002 Nov-Dec;22(6B):3569-72Wolff JE et al Simultaneous radiochemotherapy in pediatric patients with high-grade glioma: a phase I study Anticancer Res. 2002 Nov-Dec;22(6B):3569-72 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25168 |
Study title: Worden FP et al Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma J Clin Oncol. 2005 Jan 1;23(1):105-12. Erratum in: J Clin Oncol. 2006 Sep1;24(25):4223Worden FP et al Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma J Clin Oncol. 2005 Jan 1;23(1):105-12. Erratum in: J Clin Oncol. 2006 Sep1;24(25):4223 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25169 |
Study title: BIOAVAILABILITY OF DICLOFENAC-NA FROM VOLTAREN CHILDREN'S SUPPOSITORIES FOLLOWING A SINGLE ADMINISTRATION AND REPEATED ADMINISTRATION IN CHLIDRENBIOAVAILABILITY OF DICLOFENAC-NA FROM VOLTAREN CHILDREN'S SUPPOSITORIES FOLLOWING A SINGLE ADMINISTRATION AND REPEATED ADMINISTRATION IN CHLIDREN |
Active substance: DICLOFENAC |
Study summary document link (including results): |
View full study record |
Document reference: 26075 |
Study title: A multicenter comparative trial of cefprozil (500 mg QD) versus cefaclor (250 mg TID) in the treatment of tonsillopharyngitis in pediatric patients (final report on study AI414-015). |
Active substance: CEFPROZIL |
Study summary document link (including results): Protocol ai414-015 Cefprozil.pdf |
View full study record |
Document reference: 23574 |
Study title: Phase IV, double-blind, randomised, placebo controlled, multi-centre clinical trial in patients, three treatment groups (DMM 0.1 mg/kg per day vs. DMM 0.05 mg/kg x per day vs. placebo)Report Zy15050-DP-86-95-D |
Active substance: DIMETINDENE |
Study summary document link (including results): 2011_EMAspreadsheet_Fenistil oral_Report Zy15050-DP-86-95-D.xls |
View full study record |
Document reference: 48158 |
Study title: Uncontrolled, open-label; case series to evaluate symptomatic treatment of pruritus with oral dimethpyrindene maleate in children (case series) Juillard_1962 |
Active substance: DIMETINDENE |
Study summary document link (including results): 2011_EMAspreadsheet_Fenistil oral_Juillard_1962.xls |
View full study record |
Document reference: 48156 |
Study title: Uncontrolled, open-label; case series To evaluate symptomatic treatment of pruritus with oral dimethpyrindene maleate in children with pruritic dermatoses.Neyroud_1962 |
Active substance: DIMETINDENE |
Study summary document link (including results): Fenistil oral_Neyroud_1962.xls |
View full study record |
Document reference: 48166 |
Study title: Uncontrolled, open-label; case series; Antihistaminics with superior effect but less sideKaneko_1967 |
Active substance: DIMETINDENE |
Study summary document link (including results): 2011_EMAspreadsheet_Fenistil oral_Kaneko_1967.xls |
View full study record |
Document reference: 48157 |
Study title: Uncontrolled, open-label; case seriesHuberman_1962 |
Active substance: DIMETINDENE |
Study summary document link (including results): Fenistil oral_Huberman_1962.xls |
View full study record |
Document reference: 48164 |
Study title: Aliment Pharmacol Ther. 2006 Jan 15;23(2):217-27. Meta-analysis: Smectite in the treatment of acute infectious diarrhoea in children. Szajewska H, Dziechciarz P, Mrukowicz J |
Active substance: DIOSMECTITE |
Study summary document link (including results): |
View full study record |
Document reference: 26167 |
Study title: Efficacy and safety of Smecta in combination with Oral Rehydration in the treatment of acute watery diarrhoea in children. A placebo controlled, randomized, double-blind, parallel groups study. |
Active substance: DIOSMECTITE |
Study summary document link (including results): |
View full study record |
Document reference: 26164 |
Study title: Efficacy and safety of Smecta in combination with Oral Rehydration in the treatment of acute watery diarrhoea in infants and children. A phase IIIb study, placebo controlled, randomized, double blind, parallel groups, multicenter study. |
Active substance: DIOSMECTITE |
Study summary document link (including results): |
View full study record |
Document reference: 26165 |
Study title: Efficacy and safety of Smecta in combination with Oral Rehydration in the treatment of acute watery diarrhoea in infants and children. A phase IIIb study, placebo controlled, randomized, double blind, parallel groups, multicenter study. |
Active substance: DIOSMECTITE |
Study summary document link (including results): |
View full study record |
Document reference: 26166 |
Study title: Emerg Med J. 2006 Jan;23(1):65-6. Review. Best evidence topic report. Smectite for acute diarrhoea in children. Yen ZS, Lai MS |
Active substance: DIOSMECTITE |
Study summary document link (including results): |
View full study record |
Document reference: 26173 |
Study title: Fortschr Med. 1994 Aug 30;112(24):6p. Placebo-controlled, double-blind clinical trial of smectite in acute pediatric diarrhea. No authors listed |
Active substance: DIOSMECTITE |
Study summary document link (including results): |
View full study record |
Document reference: 26171 |
Study title: J Pediatr Gastroenterol Nutr. 2001 Jan;32(1):71-5. Smectite in the treatment of acute diarrhea: a nationwide randomized controlled study of the Italian Society of Pediatric Gastroenterology and Hepatology (SIGEP) in collaboration with primary care pediatricians. SIGEP Study Group for Smectite in Acute Diarrhea. Guarino A, Bisceglia M, Castellucci G, Iacono G, Casali LG, Bruzzese E, Musetta A, Greco L; Italian Society of Pediatric Gastroenterology and Hepatology Study Group for Smectite in Acute Diarrhea |
Active substance: DIOSMECTITE |
Study summary document link (including results): |
View full study record |
Document reference: 26169 |
Study title: Journal of Pediatric Gastroenterology and Nutrition 1993; 17:176-181 Smectite in acute diarrhea in children a double-blind placebo-controlled clinical trial. A.A. Madkour, E.M.H. Madina, O.E.Z. El-Azzouni, M.A. Amer, T.M.K. El-Walili, T. Abbass |
Active substance: DIOSMECTITE |
Study summary document link (including results): |
View full study record |
Document reference: 26168 |
Study title: [Epidemic keratoconjunctivitis: treatment results during an epidemic] Hutter H. Klin Monatsbl Augenheilkd. 1990 Sep;197(3):214-7. [Epidemic keratoconjunctivitis: treatment results during an epidemic] Hutter H. Klin Monatsbl Augenheilkd. 1990 Sep;197(3):214-7. |
Active substance: DEXAMETHASONE AND NEOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25746 |
Study title: Ocular hypertensive response to topical dexamethasone in children: a dose-dependent phenomenon.Ng JS, Fan DS, Young AL, Yip NK, Tam K, Kwok AK, Lam DS. Ophthalmology. 2000 Nov;107(11):2097-100 Comment in: Ophthalmology. 2001 Oct;108(10):1715-6. PMID: 11581031. Ocular hypertensive response to topical dexamethasone in children: a dose-dependent phenomenon.Ng JS, Fan DS, Young AL, Yip NK, Tam K, Kwok AK, Lam DS. Ophthalmology. 2000 Nov;107(11):2097-100 Comment in: Ophthalmology. 2001 Oct;108(10):1715-6. PMID: 11581031. |
Active substance: DEXAMETHASONE AND NEOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25742 |
Study title: Ocular-hypertensive response to topical steroids in children. Kwok AK, Lam DS, Ng JS, Fan DS, Chew SJ, Tso MO. Ophthalmology. 1997 Dec;104(12):2112-6. Ocular-hypertensive response to topical steroids in children. Kwok AK, Lam DS, Ng JS, Fan DS, Chew SJ, Tso MO. Ophthalmology. 1997 Dec;104(12):2112-6. |
Active substance: DEXAMETHASONE AND NEOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25745 |
Study title: Raney B et al Renal toxicity of ifosfamide in pilot regimens of the intergroup rhabdomyosarcoma study for patients with gross residual tumor Am J Pediatr Hematol Oncol. 1994 Nov;16(4):286-95Raney B et al Renal toxicity of ifosfamide in pilot regimens of the intergroup rhabdomyosarcoma study for patients with gross residual tumor Am J Pediatr Hematol Oncol. 1994 Nov;16(4):286-95 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25078 |
Study title: Rees JK et al. Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's AML9 study. MRC Leukaemia in Adults Working Party. Br J Haematol. 1996 Jul;94(1):89-98.Rees JK et al. Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's AML9 study. MRC Leukaemia in Adults Working Party. Br J Haematol. 1996 Jul;94(1):89-98. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25079 |
Study title: Rees JK et al. Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's AML9 study. MRC Leukaemia in Adults Working Party. Br J Haematol. 1996 Jul;94(1):89-98. Rees JK et al. Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's AML9 study. MRC Leukaemia in Adults Working Party. Br J Haematol. 1996 Jul;94(1):89-98. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25080 |
Study title: Reiter A et al Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients.Results and conclusions of the multicenter trial ALL-BFM 86 Blood. 1994 Nov 1;84(9):3122-33Reiter A et al Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients.Results and conclusions of the multicenter trial ALL-BFM 86 Blood. 1994 Nov 1;84(9):3122-33 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25081 |
Study title: Reiter A et al Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of theBerlin-Frankfurt-Münster Group J Clin Oncol. 1995 Feb;13(2):359-72Reiter A et al Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of theBerlin-Frankfurt-Münster Group J Clin Oncol. 1995 Feb;13(2):359-72 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25082 |
Study title: Reiter A et al Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies J Clin Oncol. 1994 May;12(5):899-908Reiter A et al Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies J Clin Oncol. 1994 May;12(5):899-908 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25083 |
Study title: Reiter A et al. NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 2: An intermediate term analysis of the non-B-NHL therapy group. BFM Study group Klin Padiatr. 1994 Jul-Aug;206(4):234-41.Reiter A et al. NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 2: An intermediate term analysis of the non-B-NHL therapy group. BFM Study group Klin Padiatr. 1994 Jul-Aug;206(4):234-41. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25084 |
Study title: Reiter A Therapy of B-cell acute lymphoblastic leukaemia in childhood: the BFM experience Baillieres Clin Haematol. 1994 Jun;7(2):321-37. ReviewReiter A Therapy of B-cell acute lymphoblastic leukaemia in childhood: the BFM experience Baillieres Clin Haematol. 1994 Jun;7(2):321-37. Review |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25085 |
Study title: Relf M et al Rickets--a complication of ifosfamide chemotherapy for Wilms tumor Pediatr Radiol. 1992;22(3):209-10Relf M et al Rickets--a complication of ifosfamide chemotherapy for Wilms tumor Pediatr Radiol. 1992;22(3):209-10 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 25086 |
Study title: TO ASSESS THE EFFICACY AND SAFETY OF FLUCONAZOLE I.V. (+ AMPHOTERICIN B BY ORAL ROUTE) VS. PLACEBO I.V. (+AMPHOTERICIN B BY ORAL ROUTE) TO PREVENT THE ONSET OF INFECTIONS WITH A MYCOTIC ETIOLOGY IN MULTICOLONIZED NEUTROPENIC PATIENTS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27825 |
Study title: TO ASSESS THE EFFICACY AND TOLERATION OF VIBRAMYCINE (DOXYCYCLIN) IN THE TREATMENT OF PATIENTS WITH ACUTE RESPIRATORY TRACT INFECTIONS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27334 |
Study title: Zuluaga A comparison of oral itraconazole with griseofulvin in the treaement of tinea corporis and tinea cruris. A double-blind study. Clinical summary on R51211, August 1987 (11-64 years, LMD56445)Zuluaga A comparison of oral itraconazole with griseofulvin in the treaement of tinea corporis and tinea cruris. A double-blind study. Clinical summary on R51211, August 1987 (11-64 years, LMD56445) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30787 |
Study title: |
Active substance: IVERMECTIN |
Study summary document link (including results): J21_507_ivermectin.pdf |
View full study record |
Document reference: 47780 |
Study title: A Multiclinic, Double-Blind Study of Ivermectin (MK-933) and Placebo in Patients with Onchocerciasis. |
Active substance: IVERMECTIN |
Study summary document link (including results): Stromectol_Ivermectin_519_Synopsis.pdf |
View full study record |
Document reference: 30824 |
Study title: A Single-Blind, Comparative Study of Ivermectin (MK-933) and Placebo on the Effect and Intake and Development of Onchocerca Volvulus Microfilariae in Simulium Sirbanum Fed on Patients with Onchocerciasis. |
Active substance: IVERMECTIN |
Study summary document link (including results): Stromectol_Ivermectin_517_Synopsis.pdf |
View full study record |
Document reference: 45274 |
Study title: An Open Study of the Tolerability, Safety, and Efficacy of Single Oral 150 mcg/kg Doses of Ivermectin in Children 5-12 Years of Age with Onchocerciasis. |
Active substance: IVERMECTIN |
Study summary document link (including results): Stromectol_Ivermectin_545_Synopsis.pdf |
View full study record |
Document reference: 30827 |
Study title: An Open, Randomized Study of Efficacy, Safety, and Tolerability of Ivermectin Single Dose (One or Two Day Course) vs. Thiabendazole (Three-Day Course) in the Treatment of Patients Infected With Strongyloides Stercoralis |
Active substance: IVERMECTIN |
Study summary document link (including results): J17_020_ ivermectin.pdf |
View full study record |
Document reference: 47779 |
Study title: Double-Blind Comparative Studies of Ivermectin, Diethylcarbamazine Citrate and Placebo in Patients with Onchocerciasis. |
Active substance: IVERMECTIN |
Study summary document link (including results): Stromectol_Ivermectin_514_Synopsis.pdf |
View full study record |
Document reference: 30823 |
Study title: Open, Randomized Trial in Otherwise Healthy Ambulatory Patients (children) to Compare the Efficacy, Safety, and Tolerability of Ivermectin versus Albendazole in the Treatment of Strongyloidiasis of the Gastrointestinal Tract |
Active substance: IVERMECTIN |
Study summary document link (including results): |
View full study record |
Document reference: 30820 |
Study title: Phase III Onchocerciasis - A Single-Blind, Placebo-Controlled Study of the Tolerability, Safety, and Efficacy of Successive Single Oral Doses of Ivermectin (MK-933). Approximately 150 to 220 mcg/kg in Adults with Onchocerciasis . |
Active substance: IVERMECTIN |
Study summary document link (including results): Stromectol_Ivermectin_548_Synopsis.pdf |
View full study record |
Document reference: 30825 |
Study title: To systematically document under practice conditions satisfactory tolerance, and accordingly the safety of therapy with Hedelix® s.a. drops in accordance with the manufacturer’s dosage recommendations, in children with respiratory tract catarrh and/or chronic inflammatory recidive bronchial disease. |
Active substance: IVY |
Study summary document link (including results): |
View full study record |
Document reference: 47263 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Kalmia compositum (drops) [AWB-AT] |
Active substance: Kalmia compositum |
Study summary document link (including results): |
View full study record |
Document reference: 40042 |
Study title: Non-interventional study on the use of Kanamycin-POS® in children; Küchle H. J., Busse H., Augenerkrankungen im Kindesalter, Thieme Verlag Stuttgart New York 1985 |
Active substance: KANAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 30828 |
Study title: EFFICACY AND SAFETY OF LACTEOL® SACHET IN THE TREATMENT OF ACUTE DIARRHEA IN CHILDREN |
Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30976 |
Study title: Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants – SZAJEWSKA H., KOTOWSKA M. and al. – 2001.Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants – SZAJEWSKA H., KOTOWSKA M. and al. – 2001. |
Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30982 |
Study title: Efficacy of probiotic use in acute diarrhea in children: a meta analysis – HUANG J.S., BOUSVAROS A. and al. – 2002.Efficacy of probiotic use in acute diarrhea in children: a meta analysis – HUANG J.S., BOUSVAROS A. and al. – 2002. |
Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30983 |
Study title: Infectodiarrstop LGG 2007: Observational post-marketing trial in children |
Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30977 |
Study title: Lactobacillus casei variety rhamnosus Lcr35 in children with chronic constipation – HUANG LN, CHANG MH and al – 2007Lactobacillus casei variety rhamnosus Lcr35 in children with chronic constipation – HUANG LN, CHANG MH and al – 2007 |
Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30979 |
Study title: A Multicenter, Double-Blind, Randomized, Parallel-Group Study Investigating the linical Effect of Combination Montelukast/Loratadine in Patients With Seasonal Allergic Rhinitis Who Have a History of Asthma |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32416 |
Study title: A multicenter, double-blind, randomized, placebo-controlled study to assess the clinical effect of montelukast in patients with seasonal allergic rhinitis |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32417 |
Study title: A multicenter, double-blind, randomized, placebo-controlled study to compare concomitant Montelukast and Loratadine with intranasal Beclomethasone in patients with seasonal allergic rhinitis |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32418 |
Study title: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Study Investigating the Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32419 |
Study title: A multicenter, open study to assess the safety, tolerability, performance, robustness, and acceptability of a new capsule powder device (E-haler) when delivering the dry powder formulation of sodium cromoglicate at a dose of 20 mg qid for four weeks treat |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32420 |
Study title: A multicenter, open-label study to confirm the ability of montelukast sodium to allow tapering of inhaled corticosteroids in asthmatic patients |
Active substance: MONTELUKAST |
Study summary document link (including results): 904 synopsis.pdf |
View full study record |
Document reference: 32421 |
Study title: A Multicenter, Open-label, Controlled, Extended Safety Study of Montelukast in Infants and Young Children With Chronic Asthma |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32422 |
Study title: A Multicenter, Randomized, Double-blind, Placebo-Controlled Parallel Group 8-Week Study to Evaluate the Efficacy and Safety of Chewable Montelukast When Initiated at the Start of the School Year in Pediatric Patients With Persistent Asthma |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32423 |
Study title: A Multicenter, Double-Blind, Randomized, Parallel-Group Study Comparing Montelukast With Placebo in Pediatric Patients Aged 2 Through 14 Years With Seasonal Allergic Rhinitis |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32408 |
Study title: A multicenter, randomized, double-blind, placebo-controlled, parallel study of the efficacy and safety of chlorofluorocarbon (CFC) and HFA-227 (non-CFC) formulations of Intal® (cromolyn sodium) metered dose inhaler (MDI) 2mg Qid in the treatment of asthma |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32424 |
Study title: DIECKMANN-K, MAURAGE-C, ROLLAND-J-C, RAMPONI-N, JONVILLE-A-P, ET-AL. CHU CLOCHEVILLE, TOURS, FRANCE. TORTICOLLIS AS A SIDE EFFECT OF CISAPRIDE TREATMENT IN AN INFANT. JOURNAL-OF-PEDIATRIC-GASTROENTEROLOGY-AND-NUTRITION (J-PEDIATR- GASTROENTEROL-NUTR). 22: 336-337, APR 1996.DIECKMANN-K, MAURAGE-C, ROLLAND-J-C, RAMPONI-N, JONVILLE-A-P, ET-AL. CHU CLOCHEVILLE, TOURS, FRANCE. TORTICOLLIS AS A SIDE EFFECT OF CISAPRIDE TREATMENT IN AN INFANT. JOURNAL-OF-PEDIATRIC-GASTROENTEROLOGY-AND-NUTRITION (J-PEDIATR- GASTROENTEROL-NUTR). 22: 336-337, APR 1996. |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46755 |
Study title: DUPONT C. EFFET DEBRIDAT (TRIMEBUTINE) DANS LES COLOPATHIES FONCTIONNELLES DE L'ENFANT MED. ENFANCE,2(6),2-5,1982DUPONT C. EFFET DEBRIDAT (TRIMEBUTINE) DANS LES COLOPATHIES FONCTIONNELLES DE L'ENFANT MED. ENFANCE,2(6),2-5,1982 |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46763 |
Study title: Espinazo-Ramos-O. O. Espinazo Ramos, Serv. de Gastroenterologia y Nutr., Hosp. Infantil Universitario La Paz, Madrid, Spain. Gastroesophageal reflux disease. Conservative and pharmacological treatment Pediatrika {PEDIATRIKA}, 2001, Vol/Iss/Pg. 21/8 (33-38) Espinazo-Ramos-O. O. Espinazo Ramos, Serv. de Gastroenterologia y Nutr., Hosp. Infantil Universitario La Paz, Madrid, Spain. Gastroesophageal reflux disease. Conservative and pharmacological treatment Pediatrika {PEDIATRIKA}, 2001, Vol/Iss/Pg. 21/8 (33-38) |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46749 |
Study title: FINESCHI-S, OKOLICSANYI-L. L. OKOLICSANYI, CATTEDRA DI GASTROENTEROLOGIA, ISTITUTO DI SEMEIOTICA MEDIC A, VIA A. GRAMSCI 14, 43100 PARMA, ITALY. PATHOPHYSIOLOGY AND TREATMENT OF IRRITABLE BOWEL SYNDROME. ARGOMENTI DI GASTROENTEROLOGIA CLINICA {ARGOMENTI-GASTROENTEROL- CLIN}, 1999 VOL/ISS/PG. 12/2 (49-59),FINESCHI-S, OKOLICSANYI-L. L. OKOLICSANYI, CATTEDRA DI GASTROENTEROLOGIA, ISTITUTO DI SEMEIOTICA MEDIC A, VIA A. GRAMSCI 14, 43100 PARMA, ITALY. PATHOPHYSIOLOGY AND TREATMENT OF IRRITABLE BOWEL SYNDROME. ARGOMENTI DI GASTROENTEROLOGIA CLINICA {ARGOMENTI-GASTROENTEROL- CLIN}, 1999 VOL/ISS/PG. 12/2 (49-59), |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46753 |
Study title: Francillon-J, Philippe-M-P. (Trial in abdominal surgery of a new molecule, trimebutine, in resumption of postoperative transit). Lyon medical, {Lyon-Med}, 28 Feb 1971, vol. 225, no. 4, p. 363-5,Francillon-J, Philippe-M-P. (Trial in abdominal surgery of a new molecule, trimebutine, in resumption of postoperative transit). Lyon medical, {Lyon-Med}, 28 Feb 1971, vol. 225, no. 4, p. 363-5, |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46767 |
Study title: Krymchantowski-A-V, Filho-P-F-M, Bigal-M-E. Instituto de Neurologia Deolindo Couto, Rio de Janeiro, Brazil. Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study. Cephalalgia : an international journal of headache, {Cephalalgia}, Jul 2006, vol. 26, no. 7, p. 871-4,Krymchantowski-A-V, Filho-P-F-M, Bigal-M-E. Instituto de Neurologia Deolindo Couto, Rio de Janeiro, Brazil. Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study. Cephalalgia : an international journal of headache, {Cephalalgia}, Jul 2006, vol. 26, no. 7, p. 871-4, |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46747 |
Study title: LEPERCQ G.,STEINSCHNEIDER R. L'EMPLOI DE LA TRIMEBUTINE SUSPENSION BUVABLE EN PRATIQUE PEDIATRIQUE COURANTE LA FEMME ET L'ENFANT,6(2),146-150,LEPERCQ G.,STEINSCHNEIDER R. L'EMPLOI DE LA TRIMEBUTINE SUSPENSION BUVABLE EN PRATIQUE PEDIATRIQUE COURANTE LA FEMME ET L'ENFANT,6(2),146-150, |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46768 |
Study title: LESTRADET H. UTILISATION THERAPEUTIQUE DE LA SUSPENSION BUVABLE DE TRIMEBUTINE EN PEDIATRIE GAZ.MED. FRANCE,30,16-19,1971LESTRADET H. UTILISATION THERAPEUTIQUE DE LA SUSPENSION BUVABLE DE TRIMEBUTINE EN PEDIATRIE GAZ.MED. FRANCE,30,16-19,1971 |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46766 |
Study title: AN OPEN NON-COMPARATIVE MULTICENTRE STUDY OF THE EFFICACY AND TOLERATION OF UNASYN (SULTAMICILLIN) ORAL IN THE TREATMENT OF COMMUNITY-ACQUIRED MILD-MODERATE BACTERIAL INFECTIONS IN GENERAL PRACTICE |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43041 |
Study title: AN OPEN NON-COMPARATIVE STUDY OF THE EFFICACY AND TOLERATION OF STM IN THE TREATMENT OF GENERAL BACTERIAL INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42994 |
Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN (25MG/KG) IN THE TREATMENT OF MILD TO MODERATE TONSILLITIS INFECTIONS BY STREPTOCOCCUS B HEMOLYTIC. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43026 |
Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN ) IN VARIOUS INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43049 |
Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42974 |
Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43050 |
Study title: The ocular manifestations of sickle-cell disease: a prevalence and natural history study. Clarkson JG. Trans Am Ophthalmol Soc. 1992;90:481-504. |
Active substance: FLUORESCEIN |
Study summary document link (including results): The Ocular manifestations of sickle-cell disease.pdf |
View full study record |
Document reference: 28248 |
Study title: Diclofenac vs oxybuprocaine eyedrops for analgesia in paediatric strabismus surgery. Morton NS, Benham SW, Lawson RA, McNicol LR. Paediatr Anaesth. 1997;7(3):221-6. |
Active substance: FLUORESCEIN AND OXYBUPRICAINE |
Study summary document link (including results): |
View full study record |
Document reference: 28249 |
Study title: A double-blind controlled trial of betamethasone dipropionate 0.05% (Diproderm) in comparison with fluocinolone acetonide 0.025% (Synalar) in psoriasis and other steroid-responsive dermatoses. |
Active substance: FLUOROCINONIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28253 |
Study title: Corticosteroid-induced glaucoma following treatment of the periorbital region. |
Active substance: FLUOROCINONIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28251 |
Study title: Fluocinonide in an adhesive base for treatment of oral lichen planus. A double-blind, placebo-controlled clinical study. |
Active substance: FLUOROCINONIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28252 |
Study title: Interval treatment with local corticosteroids and bases. |
Active substance: FLUOROCINONIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28250 |
Study title: Topical treatment of alopecia areata--a double blind test using 0.025 per cent and 1.2 per cent fluocinolone acetonide cream. |
Active substance: FLUOROCINONIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28254 |
Study title: |
Active substance: FLUOROMETHOLONE |
Study summary document link (including results): Fluorometholone_EUdraCT_reduced datafields for Interim publi.xls |
View full study record |
Document reference: 47211 |
Study title: A prospective study on ocular hypertensive and antiinflammatory response to different dosages of fluorometholone in children. Fan DS, Ng JS, Lam DS. Ophthalmology. 2001 Nov;108(11):1973-7. Comment in: Ophthalmology. 2003 Jun;110(6):1072-3; author reply 1073. PMID: 12799226. |
Active substance: FLUOROMETHOLONE |
Study summary document link (including results): A prospective study on ocular hypertensive.pdf |
View full study record |
Document reference: 28257 |
Study title: Efficacy of nedocromil 2% versus fluorometholone 0.1%: a randomised, double masked trial comparing the effects on severe vernal keratoconjunctivitis. Tabbara KF, al-Kharashi SA. Br J Ophthalmol. 1999 Feb;83(2):180-4. |
Active substance: FLUOROMETHOLONE |
Study summary document link (including results): |
View full study record |
Document reference: 28258 |
Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43051 |
Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43052 |
Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43053 |
Study title: Kaopectate: Comparison of the efficacy of Kao-Con, Kaolin, Pectin, Lomitil and Placebo in the treatment of Acute Diarrhea in a Pediatric - Consumer Product Study #291 |
Active substance: Kaolin, Pectin |
Study summary document link (including results): |
View full study record |
Document reference: 40043 |
Study title: OPEN LABEL RANDOMIZED, PARALLEL-GROUP STUDY TO COMPARE THE NEUROLOGICAL AND METABOLIC STATE OF THE NEW BORN CHILDREN AND THEIR MOTHERS HEMODYNAMIC PARAMETERS AFTER INDUCTION OF ANAESTHESIA FOR CAESARIAN SECTIONS WITH S-(+)- KETAMINE HYDROCHLORIDE (CI-9136) OR A COMBINATION OF S-(+)- KETAMINE HYDROCHLORIDE AND THIOPENTAL SODIUM (CI-653) (CT-9136-423010) |
Active substance: KETAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 30829 |
Study title: 2% ketoconazole in shampoo for treating seborrheic dermatitits of the scalp: clinical trial at the hospital San Juan De Dios |
Active substance: KETOCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30838 |
Study title: A Double-Blind, Placebo- Controlled Study of Ketoconazole 2% Shampoo in the Treatment of Pityriasis Versicolor in Adolescents. (Jun 1999)" |
Active substance: KETOCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30836 |
Study title: A new therapeutic way to treat pityriasis versicolor. The use of ketoconazole in a 2% shampoo. |
Active substance: KETOCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30837 |
Study title: An open study of 2% ketoconazole shampoo in corticodependent seborrhoeic dermatitis of the scalp |
Active substance: KETOCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30839 |
Study title: comparison of 4 concentrations of a ketoconazole shampoo with a placebo shampoo in dandruff and/or seborrheic dermatitits |
Active substance: KETOCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30832 |
Study title: Ketoconazole 2 % shampoo in the treatment of dandruff and/or seborrheic dermatitits: a double-blind placebo-controlled study |
Active substance: KETOCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30833 |
Study title: Ketoconazole 2 % shampoo in the treatment of seborrhoeic dermatitits: an open multicentre study in Belgium |
Active substance: KETOCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30834 |
Study title: Marshall, K.F. - Brit. Dental J. (1969) 139-140Marshall, K.F. - Brit. Dental J. (1969) 139-140 |
Active substance: CETALKONIUM AND CHOLINE SALICYLATE |
Study summary document link (including results): |
View full study record |
Document reference: 23635 |
Study title: Multi-centre (6 centres), randomised, double-blind, placebo-controlled study |
Active substance: KETOCONAZOLE |
Study summary document link (including results): LMD124740_Interventional_Ketoconazole.xls |
View full study record |
Document reference: 47252 |
Study title: Multi-centre (8 centres), parallel-group, randomised, double-blind, placebo-controlled clinical study. |
Active substance: KETOCONAZOLE |
Study summary document link (including results): LMD139895_Interventional_Ketoconazole.xls |
View full study record |
Document reference: 47254 |
Study title: Open, comparative, cross-over study lasting for 4-weeks. |
Active substance: KETOCONAZOLE |
Study summary document link (including results): LMD124799_Interventional_Ketoconazole.xls |
View full study record |
Document reference: 47253 |
Study title: Randomized, doble-blind, placebo-controlled evaluation in the treatment of moderate to severe dandruff |
Active substance: KETOCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30830 |
Study title: |
Active substance: KETOPROFEN |
Study summary document link (including results): Ketoprofen_synopsis.docx |
View full study record |
Document reference: 47537 |
Study title: Schang-J-C, Devroede-G, Pilote-M. Department of Surgery, Faculte de Medecine, Universite de Sherbrooke, Quebec, Canada. Effects of trimebutine on colonic function in patients with chronic idiopathic constipation: evidence for the need of a physiologic rather than clinical selection. Diseases of the colon and rectum, {Dis-Colon-Rectum}, Apr 1993, vol.36, no. 4, p. 330-6, Schang-J-C, Devroede-G, Pilote-M. Department of Surgery, Faculte de Medecine, Universite de Sherbrooke, Quebec, Canada. Effects of trimebutine on colonic function in patients with chronic idiopathic constipation: evidence for the need of a physiologic rather than clinical selection. Diseases of the colon and rectum, {Dis-Colon-Rectum}, Apr 1993, vol.36, no. 4, p. 330-6, |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46757 |
Study title: Teixeira-C-R, Kurban-A-C-A, Denicol-I-P, Coelho-N-H-V, Torresini-R-J-S, Petter-R-B, Saul-C. Fundacao Riograndense, Universitaria de Gastroenterologia, Rua Silva , Porto Alegre, Brazil. Randomized, double-blind study of functional dyspepsia with cisapride, trimebutine and placebo - Relationship with variation of the gastric emptying time. Revista Brasileira de Medicina {REV-BRAS-MED}, 2000, Vol/Iss/Pg. 57/7,(729-735),Teixeira-C-R, Kurban-A-C-A, Denicol-I-P, Coelho-N-H-V, Torresini-R-J-S, Petter-R-B, Saul-C. Fundacao Riograndense, Universitaria de Gastroenterologia, Rua Silva , Porto Alegre, Brazil. Randomized, double-blind study of functional dyspepsia with cisapride, trimebutine and placebo - Relationship with variation of the gastric emptying time. Revista Brasileira de M... |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46751 |
Study title: Walters-J-M, Crean-P, McCarthy-C-F. Trimebutine, a new antispasmodic in the treatment of dyspepsia. Irish medical journal, {Ir-Med-J}, Oct 1980, vol. 73, no. 10, p.380-1, ,Walters-J-M, Crean-P, McCarthy-C-F. Trimebutine, a new antispasmodic in the treatment of dyspepsia. Irish medical journal, {Ir-Med-J}, Oct 1980, vol. 73, no. 10, p.380-1, , |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46764 |
Study title: A bacteriological study of the middle ear and upper respiratory tract in children with chronic secretory otitis media.Mills et al., Clin Otolaryngol Allied Sci. 1985 Dec;10(6):335-41A bacteriological study of the middle ear and upper respiratory tract in children with chronic secretory otitis media.Mills et al., Clin Otolaryngol Allied Sci. 1985 Dec;10(6):335-41 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46818 |
Study title: A clinical and therapeutic study of 29 patients with infantile acne.Cunliffe et al., Br J Dermatol. 2001 Sep;145(3):463-6.A clinical and therapeutic study of 29 patients with infantile acne.Cunliffe et al., Br J Dermatol. 2001 Sep;145(3):463-6. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46793 |
Study title: Olives-J-P. J.-P. Olives, Gastro-enterologie et Nutrition, Hopital des Enfants, Toulouse, France. Medical treatment of gastroesophageal reflux. Medecine Therapeutique Pediatrie {MED-THER-PEDIATR}, 2000, Vol/Iss /Pg. 3/S PEC. ISS. 1 (27-32)Olives-J-P. J.-P. Olives, Gastro-enterologie et Nutrition, Hopital des Enfants, Toulouse, France. Medical treatment of gastroesophageal reflux. Medecine Therapeutique Pediatrie {MED-THER-PEDIATR}, 2000, Vol/Iss /Pg. 3/S PEC. ISS. 1 (27-32) |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46750 |
Study title: PARENT P.,LE FUR J.M.,CASTEL Y. EFFETS THERAPEUTIQUES DE DEBRIDAT CHEZ L'ENFANT OUEST MED.,35(12),781-783,1982PARENT P.,LE FUR J.M.,CASTEL Y. EFFETS THERAPEUTIQUES DE DEBRIDAT CHEZ L'ENFANT OUEST MED.,35(12),781-783,1982 |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46762 |
Study title: Paediatric nosocomial urinary tract infection at a regional hospital.Orrett et al., Int Urol Nephrol. 1999;31(2):173-9Paediatric nosocomial urinary tract infection at a regional hospital.Orrett et al., Int Urol Nephrol. 1999;31(2):173-9 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46799 |
Study title: Positive correlation between the age of patients and the degree of antimicrobial resistance among urinary strains of Escherichia coli.Arstila et al., J Infect. 1994 Jul;29(1):9-16Positive correlation between the age of patients and the degree of antimicrobial resistance among urinary strains of Escherichia coli.Arstila et al., J Infect. 1994 Jul;29(1):9-16 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46804 |
Study title: Prenatally diagnosed reflux: a follow-up study.Gordon et al., Br J Urol. 1990 Apr;65(4):407-12Prenatally diagnosed reflux: a follow-up study.Gordon et al., Br J Urol. 1990 Apr;65(4):407-12 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46809 |
Study title: Presence of bacteriuria caused by trimethoprim resistant bacteria in patients prescribed antibiotics: multilevel model with practice and individual patient data.Donnan et al., BMJ. 2004 May 29;328(7451):1297Presence of bacteriuria caused by trimethoprim resistant bacteria in patients prescribed antibiotics: multilevel model with practice and individual patient data.Donnan et al., BMJ. 2004 May 29;328(7451):1297 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46779 |
Study title: Prevalence of carriage of antimicrobial resistant strains of Streptococcus pneumoniae in primary school children in Hong Kong.Boost MV et al., Epidemiol Infect. 2001 Aug;127(1):49-55Prevalence of carriage of antimicrobial resistant strains of Streptococcus pneumoniae in primary school children in Hong Kong.Boost MV et al., Epidemiol Infect. 2001 Aug;127(1):49-55 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46792 |
Study title: Primary vesicoureteral reflux detected in neonates with a history of fetal renal pelvis dilatation: a prospective clinical and imaging study.Ismaili et al., J Pediatr. 2006 Feb;148(2):222-7.Primary vesicoureteral reflux detected in neonates with a history of fetal renal pelvis dilatation: a prospective clinical and imaging study.Ismaili et al., J Pediatr. 2006 Feb;148(2):222-7. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46774 |
Study title: Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case–control study with multivariate analysis for other risk factors.Steinke etal., Journal of Antimicrobial Chemotherapy (2001) 47, 781-787Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case–control study with multivariate analysis for other risk factors.Steinke etal., Journal of Antimicrobial Chemotherapy (2001) 47, 781-787 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46780 |
Study title: Response to antibiotics of women with symptoms of urinary tract infection but negative dipstick urine test results: double blind randomised controlled trial.Richards et al., BMJ. 2005 Jul 16;331(7509):143. Epub 2005 Jun 22.Response to antibiotics of women with symptoms of urinary tract infection but negative dipstick urine test results: double blind randomised controlled trial.Richards et al., BMJ. 2005 Jul 16;331(7509):143. Epub 2005 Jun 22. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46777 |
Study title: Risk factors for the nasopharyngeal carriage of respiratory pathogens by Portuguese children: phenotype and antimicrobial susceptibility of Haemophilus influenzae and Streptococcus pneumoniae.Neto et al., Microb Drug Resist. 2003 Spring;9(1):99-108Risk factors for the nasopharyngeal carriage of respiratory pathogens by Portuguese children: phenotype and antimicrobial susceptibility of Haemophilus influenzae and Streptococcus pneumoniae.Neto et al., Microb Drug Resist. 2003 Spring;9(1):99-108 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46785 |
Study title: Ocular-hypertensive and anti-inflammatory response to rimexolone therapy in children. Fan DS, Yu CB, Chiu TY, Wong CY, Ng JS, Pang CP, Lam DS. Arch Ophthalmol. 2003 Dec;121(12):1716-21. |
Active substance: FLUOROMETHOLONE |
Study summary document link (including results): Ocular-hypertensive and anti-inflammatory response.pdf |
View full study record |
Document reference: 28255 |
Study title: Ocular-hypertensive response to topical steroids in children. Kwok AK, Lam DS, Ng JS, Fan DS, Chew SJ, Tso MO. Ophthalmology. 1997 Dec;104(12):2112-6. |
Active substance: FLUOROMETHOLONE |
Study summary document link (including results): Ocular-hypertensive response to topical steroids in children.pdf |
View full study record |
Document reference: 28259 |
Study title: The role of aspirin in vernal keratoconjunctivitis. Anwar MS. J Coll Physicians Surg Pak. 2003 Mar;13(3):178-9. |
Active substance: FLUOROMETHOLONE |
Study summary document link (including results): The role of aspirin in vernal keratoconjunctivitis.pdf |
View full study record |
Document reference: 28256 |
Study title: |
Active substance: FLUOROMETHOLONE AND GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28261 |
Study title: Ruiz Alvez, M et al. Medical report of the clinical comparative study with 0.3% Gentamicin and 0.1% Fluorometholone eye drops in comparison with 0.35% Neomicine and 0.1% Fluorometholone eye drops in therapy of bacterial conjunctivitis. May 18, 1989. (age range 4-76 years) |
Active substance: FLUOROMETHOLONE AND GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28260 |
Study title: 3-year results of docetaxel-based sequential and combination regimens in theadjuvant therapy of node-positive breast cancer: a pilot study. Ferreira Filho AF et al. Anticancer Res. 2002 Jul-Aug;22(4):2471-6 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28306 |
Study title: 5-fluorouracil and beyond. Khaw PT et al. Br J Ophthalmol. 1991 Oct;75(10):577-8 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28319 |
Study title: 5-Fluorouracil and interferon-alpha-2a in advanced colorectal cancer: Results of two treatment schedules. John WJ et al. Cancer. December 22, 1993, 3191-5 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28290 |
Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42973 |
Study title: AN OPEN NON-COMPARATIVE STUDY, Q COMBINATION OF SULBACTAM SODIUM WITH AMPICILLIN IN SERIOUS INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42914 |
Study title: AN OPEN NONCOMPARATIVE STUDY OF UNASYN ORAL (BRAND OF STM) IN VARIOUS INFECTIONS |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42972 |
Study title: AN OPEN NONCOMPARATIVE STUDY OF UNASYN ORAL (BRAND OF STM) IN VARIOUS INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42996 |
Study title: AN OPEN STUDY OF THE EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN ADMINISTERED PARENTERALLY AND SULTAMICILLIN ADMINISTERED ORALLY IN CHILDHOOD SKELETAL INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42918 |
Study title: AN OPEN STUDY OF THE EFFICACY AND TOLERANCE OF SULTAMICILLIN IN THE IN THE TREATMENT OF PEDIATRIC PATIENTS WITH CHRONIC OTITIS MEDIA |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43014 |
Study title: AN OPEN STUDY OF THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN THE TREATMENT OF MILD TO MODERATE UPPER RESPIRATORY TRACT INFECTIONS IN ADULTS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43039 |
Study title: AN OPEN STUDY OF THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN THE TREATMENT OF MILD TO MODERATE URTI IN ADULTS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43040 |
Study title: AN OPEN, NON COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF SULTAMICILLIN FOR THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS IN CHILDREN. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42995 |
Study title: International ALL trial MRC UKALL XII/ECOG E2993 |
Active substance: ASPARAGINASE |
Study summary document link (including results): |
View full study record |
Document reference: 21921 |
Study title: CLINICAL EVALUATION OF STM FINE GRANULES FOR THE TREATMENT OF ACUTE SINUSITIS OF CHILDREN. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43009 |
Study title: CLINICAL EVALUATION OF STM FINE GRANULES FOR THE TREATMENT OF ACUTE SUPPURATIVE OTITIS MEDIA OF CHILDREN. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43008 |
Study title: A Multi-centre randomised , double masked, vehicle controlled parallel group study evaluating the safety and tolerability of Ketorolac Tromethamine 0.5 % ophthalmic solution used four times daily for 6 weeks in normal paediatric subjects. |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30889 |
Study title: An open, parallel group, comparative, multicentre, general practice study to assess the efficacy, safety and acceptability of oruvail, piroxicam and diclofenac gels in the management of acute soft tissue injury - Patel RK - 1991-1992. |
Active substance: KETOPROFEN |
Study summary document link (including results): Ketoprofen KGL-168.xls |
View full study record |
Document reference: 30841 |
Study title: Antila, H., T. Manner, et al. "Ketoprofen and tramadol for analgesia during early recovery after tonsillectomy in children." ; Paediatr Anaesth 16(5): 548-53, 2006 |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30878 |
Study title: Antipyretic therapy in the febrile child - Drwal-Klein L.A., Phelps S.J. - 1992 (Clin. Pharm., 1992, 11, p.1005) |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30842 |
Study title: Celecoxib and ketoprofen for pain management during tonsillectomy: a placebo-controlled clinical trial - Nikanne E. & al. - 2005 (Otolaryngol Head Neck Surg., 2005; 132:287-94) |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30843 |
Study title: Clinical studies on antipyretic efficacy and safety of ketoprofen suppositories - Kitawaga T. et al. - 1983 (J. Ped. Pract. 1983, 46 (11), p 122-134) |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30844 |
Study title: Comparative double-blind trial of the efficacy and toleration of ketoprofen gel 2,5% versus placebo gel in the local treatment of minor injuries in sports medicine - Verspeelt P. & Kockelbergh MAIGJ - 1983-1984. report DN 60.1, |
Active substance: KETOPROFEN |
Study summary document link (including results): Ketoprofen K304-DN-22-1.xls |
View full study record |
Document reference: 30840 |
Study title: Comparative efficacy and tolerance of ibuprofen syrup and acetaminophen syrup in children with pyrexia associated with infectious diseases and treated with antibiotics - Autret E., Breart G., Jonville A.P., Courcier S., Lassale C., Goehrs J.M. - 1994 (Eur. J. Clin. Pharmacol. 1994; 46:197-201) |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30845 |
Study title: Comparative parallel double-blind study of the efficacy and safety of ketoprofen and placebo in local treatment in sports traumatology - Perrigot M. & Rodineau J. - 1986. |
Active substance: KETOPROFEN |
Study summary document link (including results): Ketoprofen K314-DN-60-1.xls |
View full study record |
Document reference: 30846 |
Study title: Comparative study of plasma pharmacokinetics and urinary excretion of ketoprofen (19583 R.P) in adult and in young rat - Fournel M. & Heusse D, Note RP/DSPh 17 264, Vitry, 1973 |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30847 |
Study title: Comparison of peri operative ketoprofen 2,0 mg/kg with 0,5 mg/kg i.v. in samll children during adenoidectomy - Nikanne E, Kokki H., Tuovinen K. - 1997 (British Journal of Anaesthesia, 1997, 79, p 606-608) |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30848 |
Study title: Defining fever and other aspects of body temperature in infants and children - Bonadio W.A. - 1993 ( Pediatric Annals 1993, 22 (8), p.467) |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30849 |
Study title: Determination of ketoprofen by high performance liquid chromatography from serum and urine: clinical application in children with juvenile rheumatoid arthritis. - Lempiälnen M. and Mâkelâ A. L., 1987 (In J. Clin. Pharm. Res., VII (4), p.265) |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30850 |
Study title: Double-blind study of ketoprofen and indomethacin in juvenile chronic arthritis - Bhettay E., Thomson A.J. - 1978 (S. Afr. Med. J., 1978, 54, p. 276.) |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30851 |
Study title: A cross-national study of acute otitis media: risk factors, severity, and treatment at initial visit. Report from the International Primary Care Network (IPCN) and the Ambulatory Sentinel Practice Network (ASPN).Froom et al., J Am Board Fam Pract. 2001 Nov-Dec;14(6):406-17A cross-national study of acute otitis media: risk factors, severity, and treatment at initial visit. Report from the International Primary Care Network (IPCN) and the Ambulatory Sentinel Practice Network (ASPN).Froom et al., J Am Board Fam Pract. 2001 Nov-Dec;14(6):406-17 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46789 |
Study title: Acute lymphoblastic leukaemia: trimethoprim resistant organisms during treatment.McDowell et al., Arch Dis Child. 1987 Jun;62(6):573-5.Acute lymphoblastic leukaemia: trimethoprim resistant organisms during treatment.McDowell et al., Arch Dis Child. 1987 Jun;62(6):573-5. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46816 |
Study title: Age differences in trimethoprim pharmacokinetics: need for revised dosing in children?Hoppu K., Clin Pharmacol Ther. 1987 Mar;41(3):336-43.Age differences in trimethoprim pharmacokinetics: need for revised dosing in children?Hoppu K., Clin Pharmacol Ther. 1987 Mar;41(3):336-43. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46817 |
Study title: An open, comparative study on trimethoprim and doxycycline in the treatment of acute bronchitis.Haukijärvi et al., Br J Dermatol. 1989 Nov;121(5):623-8.J Chemother. 1989 Jul;1(4 Suppl):798-9An open, comparative study on trimethoprim and doxycycline in the treatment of acute bronchitis.Haukijärvi et al., Br J Dermatol. 1989 Nov;121(5):623-8.J Chemother. 1989 Jul;1(4 Suppl):798-9 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46811 |
Study title: Antibacterial prophylaxis in children with urinary tract infection.Bollgren I, Acta Paediatr Suppl. 1999 Nov;88(431):48-52.Antibacterial prophylaxis in children with urinary tract infection.Bollgren I, Acta Paediatr Suppl. 1999 Nov;88(431):48-52. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46798 |
Study title: Antibiotic failure in the treatment of urinary tract infections in young women.Lawrenson et al., J Antimicrob Chemother. 2001 Dec;48(6):895-901Antibiotic failure in the treatment of urinary tract infections in young women.Lawrenson et al., J Antimicrob Chemother. 2001 Dec;48(6):895-901 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46790 |
Study title: Antibiotic treatment for five days is effective in children with acute cystitis.Abrahamsson et al., Acta Paediatr. 2002;91(1):55-8.Antibiotic treatment for five days is effective in children with acute cystitis.Abrahamsson et al., Acta Paediatr. 2002;91(1):55-8. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46787 |
Study title: Antimicrobial resistance in Escherichia coli in urine samples from children and adults: a 12 year analysis.Abelson Storby et al., Acta Paediatr. 2004 Apr;93(4):487-91Antimicrobial resistance in Escherichia coli in urine samples from children and adults: a 12 year analysis.Abelson Storby et al., Acta Paediatr. 2004 Apr;93(4):487-91 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46778 |
Study title: Antimicrobial resistance in fecal flora: longitudinal community-based surveillance of children from urban Mexico.Calva et al., Antimicrob Agents Chemother. 1996 Jul;40(7):1699-702Antimicrobial resistance in fecal flora: longitudinal community-based surveillance of children from urban Mexico.Calva et al., Antimicrob Agents Chemother. 1996 Jul;40(7):1699-702 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46802 |
Study title: Antimicrobial resistance of Shigella spp isolated from diarrheal patients between 1989 and 1998 in Vietnam.Anh et al., Southeast Asian J Trop Med Public Health. 2001 Dec;32(4):856-62.Antimicrobial resistance of Shigella spp isolated from diarrheal patients between 1989 and 1998 in Vietnam.Anh et al., Southeast Asian J Trop Med Public Health. 2001 Dec;32(4):856-62. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46786 |
Study title: Percutaneous nephrostomy in children with ureteropelvic junction obstruction and poor renal function.Gupta et al., Urology. 2001 Mar;57(3):547-50.Percutaneous nephrostomy in children with ureteropelvic junction obstruction and poor renal function.Gupta et al., Urology. 2001 Mar;57(3):547-50. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46794 |
Study title: Skin reactions to antibacterial agents in general practice.van der Linden et al., J Clin Epidemiol. 1998 Aug;51(8):703-8Skin reactions to antibacterial agents in general practice.van der Linden et al., J Clin Epidemiol. 1998 Aug;51(8):703-8 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46800 |
Study title: Strategy of acne therapy with long-term antibiotics.Hughes et al., Br J Dermatol. 1989 Nov;121(5):623-8.Strategy of acne therapy with long-term antibiotics.Hughes et al., Br J Dermatol. 1989 Nov;121(5):623-8. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46810 |
Study title: [The treatment of uncomplicated lower-urinary tract infection: a single dose of trimethoprim as opposed to 10 days with pipemidic acid].Ponce de León Roca et al., Aten Primaria. 1992 Jan;9(1):53[The treatment of uncomplicated lower-urinary tract infection: a single dose of trimethoprim as opposed to 10 days with pipemidic acid].Ponce de León Roca et al., Aten Primaria. 1992 Jan;9(1):53 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46806 |
Study title: Transferable antibiotic resistance in Escherichia coli isolated from healthy Nigerian school children.Lamikanra et al., Int J Antimicrob Agents. 1996 May;7(1):59-64.Transferable antibiotic resistance in Escherichia coli isolated from healthy Nigerian school children.Lamikanra et al., Int J Antimicrob Agents. 1996 May;7(1):59-64. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46803 |
Study title: Trimethoprim in the treatment of acute urinary tract infections in children.Hoppu et al., Int J Clin Pharmacol Ther Toxicol. 1988 Feb;26(2):65-8.Trimethoprim in the treatment of acute urinary tract infections in children.Hoppu et al., Int J Clin Pharmacol Ther Toxicol. 1988 Feb;26(2):65-8. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46812 |
Study title: Trimethoprim pharmacokinetics in children with renal insufficiency.Hoppu et al., Clin Pharmacol Ther. 1987 Aug;42(2):181-6.Trimethoprim pharmacokinetics in children with renal insufficiency.Hoppu et al., Clin Pharmacol Ther. 1987 Aug;42(2):181-6. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46815 |
Study title: Uncomplicated urinary tract infections. Bacterial findings and efficacy of empirical antibacterial treatment.Grude et al., Scand J Prim Health Care. 2005 Jun;23(2):115-9.Uncomplicated urinary tract infections. Bacterial findings and efficacy of empirical antibacterial treatment.Grude et al., Scand J Prim Health Care. 2005 Jun;23(2):115-9. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46776 |
Study title: Urinary tract infections, antibiotic resistance and sales of antimicrobial drugs--an observational study of uncomplicated urinary tract infections in Icelandic women.Olafsson et al., Scand J Prim Health Care. 2000 Mar;18(1):35-8.Urinary tract infections, antibiotic resistance and sales of antimicrobial drugs--an observational study of uncomplicated urinary tract infections in Icelandic women.Olafsson et al., Scand J Prim Health Care. 2000 Mar;18(1):35-8. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46796 |
Study title: |
Active substance: TRIMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 46856 |
Study title: Single dose treatment of cystitis in children.Lidefelt et al., Acta Paediatr Scand. 1991 Jun-Jul;80(6-7):648-53Single dose treatment of cystitis in children.Lidefelt et al., Acta Paediatr Scand. 1991 Jun-Jul;80(6-7):648-53 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46807 |
Study title: CONCERNTRATIONS OF SULTAMICILLIN IN SERUM AND MIDDLE EAR FLUID OF CHILDREN WITH ACUTE SUPPURATIVE OTITIS MEDIA WITH EFFUSION. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42913 |
Study title: DOUBLE BLIND COMPARATIVE STUDY OF SULTAMICILLIN IN THE TREATMENT OF DERMAL INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42906 |
Study title: DOUBLE BLIND STUDY IN OTITIS MEDIA TREATED WITH SULTAMICILLIN VS. CEFACTOR. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42908 |
Study title: DOUBLE BLIND STUDY IN TONSILLITIS TREATED WITH SULTAMICILLIN VS. CEFACLOR. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42907 |
Study title: DOUBLE BLIND STUDY IN UTI TREATED WITH SULTAMICILLIN VS. CEFADROXIL. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42909 |
Study title: DRUG SURVEILLANCE STUDY OF ORAL SULTAMICILLIN VS. AMOXICILLIN-CLAVULANIC ACID IN THE TREATMENT OF PATIENTS WITH COMMUNITY-ACQUIRED INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42976 |
Study title: EFFICACY AND SAFETY OF SBT/AMP,STM IN PEDIATRIC PATIENTS WITH MOD-SEVERE INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42945 |
Study title: EFFICACY AND SAFETY OF STM IN CYSTIC FIBROSIS INFECTED WITH HAEMOPHILUS INFLUENZA AND/OR STAPHYLOCOCCUS AUREUS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43032 |
Study title: EFFICACY AND SAFETY OF SULTAMICILLIN (DUOCID ORAL) IN THE TREATMENT OF ACUTE SUPPURATIVE OTITIS MEDIA AN OPEN NON-COMPARATIVE, MULTICENTER (3 CENTERS) STUDY. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43056 |
Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN ACUTE URINARY INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43031 |
Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN ADULTS WITH NOSOCOMIAL ACUTE BACTERIA INFECTIONS OF LOWER RESPIRATORY TRACT. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43001 |
Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN CHILDREN WITH ARI. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43027 |
Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN CHILDREN WITH BACTERIAL INFECTIONS OF UPPER RESPIRATORY TRACT. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43003 |
Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN CHILDREN WITH NOT NOSOCOMIAL ACUTE BACTERIAL INFECTIONS OF LOWER RESPIRATORY TRACT. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43002 |
Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN CHILDREN WITH SLIGHT AND MODERATE URTI |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42967 |
Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN PATIENTS WITH ACUTE URINARY INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43029 |
Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN PATIENTS WITH ORAL INFECTIONS |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43028 |
Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN PEDIATRIC PATIENTS WITH UPPER RESPIRATORY TRACT INFECTION. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43000 |
Study title: COMPARATIVE STUDY OF SULTAMICILLIN WITH OR WITHOUT LACTOBACILLUS. TO GET A PREVENTIVE MEASURE OF DIARRHEA AND LOOSE STOOL IN PEDIATRICS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43005 |
Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN SKIN AND SOFT TISSUES INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43030 |
Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN THE TREATMENT OF PEDIATRIC INFECTIONS OF BACTERIAL ETIOLOGY--OPEN, NON-COMPARATIVE STUDY |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43055 |
Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN TREATMENT OF RESPIRATORY TRACT, SKIN AND SOFT TISSUE, UT AND ENT INFECTIONS OF BACTERIAL ETIOLOGY--OPEN PARALLEL COMPARATIVE STUDY VERSUS CLAVULANIC ACID + AMOXYCILLIN |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43054 |
Study title: Effecti di divetti dosaggi di ketoprofen sale di lisina in supposto nelle efffezioni flogistiche nel lattente di 6-36 mesi et nel bambino di 3-13 anni - Carnelli V.E., Mei V.A., Cera R., Clemente VE. - 1995 (Previtali M. Minerva Pediatr., 1995, 47, p 199-205) |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30852 |
Study title: Efficacy and tolerance of Ketum Gel 2.5% vs placebo in the treatment of pain in the Osgood-Schlatter disease. A comparative, multi-center, randomised, double blind study. |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30887 |
Study title: Eficacia y tolerancia del ketoprofen por vía tópica |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 45087 |
Study title: Ensaio clinico com o cetoprofeno em pacientes apresentando artrite reumatoide, artrite reumatoide juvenil e artrose - Goncalves (G.W.S.), Ribeiro (A.C.M.) - 1975 (Rev. Bras. Clin. Terap., 1976, 5, 141-146) |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30888 |
Study title: Evaluation of ibuprofen versus aspirin and paracetamol on efficacy and comfort in children with fever - Autret E., Reboul Marty J., Henry-Launois B., Laborde C., Courcier S., Goehrs J.M., Languillat G., Launois - 1997 (Eur. J. Clin Pharmacol., 1997, 51, p 367-371) |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30853 |
Study title: Excipients of ketoprofen (RP19583) pediatric syrup: 4-week oral toxicity study in young rats SA/CRVA 99-078 |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30854 |
Study title: Expert Report on Clinical documentation. - Pr. A. Bourrillon - 22/06/1998 |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30855 |
Study title: Expert Report on Preclinical documentation - Jean-Luc Delongeas, 10/06/1998 |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30856 |
Study title: Febrile seizures : the treatment controversy - Fishman M.A. - 1979 (Journal of Pediatrics, 1979, 94(2), p 177-184) |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30857 |
Study title: Hiller, A., O. A. Meretoja, et al. "The analgesic efficacy of acetaminophen, ketoprofen, or their combination for pediatric surgical patients having soft tissue or orthopedic procedures." ; Anesth Analg 102(5): 1365-71, 2006Hiller, A., O. A. Meretoja, et al. "The analgesic efficacy of acetaminophen, ketoprofen, or their combination for pediatric surgical patients having soft tissue or orthopedic procedures." ; Anesth Analg 102(5): 1365-71, 2006 |
Active substance: KETOPROFEN |
Study summary document link (including results): Hiller- 2006 (Free).pdf |
View full study record |
Document reference: 30879 |
Study title: I.V. peri operative ketoprofen in small children during adenoidectomy - Nikanne E., Kokki H., Tuovinen K. - 1997 (British journal of Anaesthesia, 1997, 78, p 24-27) |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30858 |
Study title: Ketoprofen (gel containing 2,5%): Double-blind comparative trial of local tolerance in comparison with a placebo - Benezis C. - 1984 |
Active substance: KETOPROFEN |
Study summary document link (including results): Ketoprofen K306-DN-21.xls |
View full study record |
Document reference: 30859 |
Study title: Ketoprofen (profenid, specia= 19583 R.P)-acute and sub-acute toxicity (5 days treatment) by the oral route in the newly weaned rat and the adult rat - Julou L., Pasquet J., and al. - 1973 (Note SUCRP/DSPh 17 036, Vitry) |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30860 |
Study title: Ketoprofen and tramadol for analgesia during early recovery after tonsillectomy in children - Antila H. & al. - 2006 ( Paediatric Anaesth., 2006; 16: 548) |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30861 |
Study title: Ketoprofen oral drops : pharmocokinetic studies after oral administration of ketoprofen solutions in healthy adult volunteers and febrile children. Final report - Darcy - 04/85 |
Active substance: KETOPROFEN |
Study summary document link (including results): Ketoprofen STUDY 2685.xls |
View full study record |
Document reference: 30862 |
Study title: Cephalosporin resistant urinary tract infections in young children. Mehr et al., J Paediatr Child Health. 2004 Jan-Feb;40(1-2):48-52.Cephalosporin resistant urinary tract infections in young children. Mehr et al., J Paediatr Child Health. 2004 Jan-Feb;40(1-2):48-52. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46782 |
Study title: Children with trimethoprim- and ampicillin-resistant fecal Escherichia coli in day care centers.Reves et al., J Infect Dis. 1987 Nov;156(5):758-62Children with trimethoprim- and ampicillin-resistant fecal Escherichia coli in day care centers.Reves et al., J Infect Dis. 1987 Nov;156(5):758-62 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46814 |
Study title: Cinoxacin vs trimethoprim--safety and efficacy in the prophylaxis of uncomplicated urinary tract infections.Seppänen J, Drugs Exp Clin Res. 1988;14(10):669-71Cinoxacin vs trimethoprim--safety and efficacy in the prophylaxis of uncomplicated urinary tract infections.Seppänen J, Drugs Exp Clin Res. 1988;14(10):669-71 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46813 |
Study title: Colonization and persistence of antibiotic-resistant Enterobacteriaceae strains in infants nursed in two neonatal intensive care units in East London, United Kingdom.Millar et al., J Clin Microbiol. 2008 Feb;46(2):560-7. Epub 2007 Nov 26.Colonization and persistence of antibiotic-resistant Enterobacteriaceae strains in infants nursed in two neonatal intensive care units in East London, United Kingdom.Millar et al., J Clin Microbiol. 2008 Feb;46(2):560-7. Epub 2007 Nov 26. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46771 |
Study title: Decision making, evidence, audit, and education: case study of antibiotic prescribing in general practice.Lipman et al., BMJ. 2000 Apr 22;320(7242):1114-8.Decision making, evidence, audit, and education: case study of antibiotic prescribing in general practice.Lipman et al., BMJ. 2000 Apr 22;320(7242):1114-8. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46797 |
Study title: Diagnosis-prescribing surveys in 2000, 2002 and 2005 in Swedish general practice: Consultations, diagnosis, diagnostics and treatment choices.Andre et al., Scand J Infect Dis. 2008 Apr 1:1-7. [Epub ahead of print]Diagnosis-prescribing surveys in 2000, 2002 and 2005 in Swedish general practice: Consultations, diagnosis, diagnostics and treatment choices.Andre et al., Scand J Infect Dis. 2008 Apr 1:1-7. [Epub ahead of print] |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46770 |
Study title: Difference in trimethoprim pharmacokinetics between children and adults.Hoppu et al., Chemotherapy. 1984;30(5):283-7.Difference in trimethoprim pharmacokinetics between children and adults.Hoppu et al., Chemotherapy. 1984;30(5):283-7. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46819 |
Study title: Distribution of patterns of sensitivity and associated phenotypes of resistance in nosocomial and community acquired Escherichia coli during 2005.García et al., Rev Esp Quimioter. 2008 Sep;21(3):157-65Distribution of patterns of sensitivity and associated phenotypes of resistance in nosocomial and community acquired Escherichia coli during 2005.García et al., Rev Esp Quimioter. 2008 Sep;21(3):157-65 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46769 |
Study title: Drug utilisation in outpatient children. A comparison among Tenerife, Valencia, and Barcelona (Spain), Toulouse (France), Sofia (Bulgaria), Bratislava (Slovakia) and Smolensk (Russia.Sanz et al., Eur J Clin Pharmacol. 2004 Apr;60(2):127-34. Epub 2004 Mar 12Drug utilisation in outpatient children. A comparison among Tenerife, Valencia, and Barcelona (Spain), Toulouse (France), Sofia (Bulgaria), Bratislava (Slovakia) and Smolensk (Russia.Sanz et al., Eur J Clin Pharmacol. 2004 Apr;60(2):127-34. Epub 2004 Mar 12 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46781 |
Study title: Treatment of itching in atopic eczema with antihistamines with a low sedative profile. Doherty V, Sylvester DG, Kennedy CT, Harvey SG, Calthrop JG, Gibson JR. BMJ. 1989 Jan 14;298(6666):96. Treatment of itching in atopic eczema with antihistamines with a low sedative profile. Doherty V, Sylvester DG, Kennedy CT, Harvey SG, Calthrop JG, Gibson JR. BMJ. 1989 Jan 14;298(6666):96. |
Active substance: TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 46857 |
Study title: |
Active substance: TRIPTORELIN |
Study summary document link (including results): DECAPEPTYL Synopsis 45C02-AD-P01 1992.pdf |
View full study record |
Document reference: 47465 |
Study title: A phase III, multicentre, non comparative, one single group, open study to assess the efficacy and tolerability of triptorelin 11,25 mg in children with puberty precocious |
Active substance: TRIPTORELIN |
Study summary document link (including results): |
View full study record |
Document reference: 46861 |
Study title: A STUDY ON THE EFFICACY OF THE COMBINATION OF GROWTH HORMONE AND GONADOTROPIN RELEASING HORMONE ANALOGUES (GNRH-A) ON ADULT HEIGHT IN CHILDREN WITH IDIOPATHIC SHORT STATURE |
Active substance: TRIPTORELIN |
Study summary document link (including results): |
View full study record |
Document reference: 46860 |
Study title: Retrospective study of triptorelin CR in central precocious puberty. |
Active substance: TRIPTORELIN |
Study summary document link (including results): DECAPEPTYL Synopsis Kauli 1994.pdf |
View full study record |
Document reference: 47466 |
Study title: STUDY OF THE EFFECT OF TREATMENT WITH LHRH-ANALOGUE (DECAPEPTYL) ALONE OR IN COMBINATION WITH BIOSYNTHETIC HUMAN GROWTH HORMONE (GENOTROPIN) IN ADOPTED CHILDREN WITH EARLY PUBERTY |
Active substance: TRIPTORELIN |
Study summary document link (including results): |
View full study record |
Document reference: 46859 |
Study title: Synopsis Sippell 1994 |
Active substance: TRIPTORELIN |
Study summary document link (including results): DECAPEPTYL Synopsis Sippell 1994.pdf |
View full study record |
Document reference: 47467 |
Study title: Assessment of the safety, reactogenicity and immunogenicity of two SmithKline Beecham Biologicals' live attenuated measles (Schwarz strain) - mumps (RIT 4385 and RIT 4386) - rubella (RA 27/3 strain) candidate vaccines. A single blind randomised, controlled clinical study in healthy 15- to 18- month-old children. |
Active substance: trivalent attenuated measles (Schwarz strain) - mumps (RIT 4385 and RIT 4386) - rubella (RA 27/3 strain) |
Study summary document link (including results): |
View full study record |
Document reference: 47871 |
Study title: Open, multicentre study to assess the safety, reactogenicity and immunogenicity of GlaxoSmithKline Biologicals’ live attenuated Measles-Mumps-Rubella vaccine (PriorixTM) given to healthy children at the age of 12 to 15 months or 4- 6 years |
Active substance: trivalent attenuated measles (Schwarz strain) - mumps (RIT 4385 and RIT 4386) - rubella (RA 27/3 strain) |
Study summary document link (including results): |
View full study record |
Document reference: 47874 |
Study title: Post-Marketing Surveillance Report of Priorix™ (Priorix™, Combined Measles-Mumps-Rubella vaccine) Surveillance period: (20 August 1999 ~ 19 August 2005) |
Active substance: trivalent attenuated measles (Schwarz strain) - mumps (RIT 4385 and RIT 4386) - rubella (RA 27/3 strain) |
Study summary document link (including results): |
View full study record |
Document reference: 47873 |
Study title: Assessment of safety and immunogenicity of Merieux Vero OPV in France (ASTER ref. JT1903/1) (1987) |
Active substance: Trivalent Oral Poliomyelitis Vaccine (Vero cells) |
Study summary document link (including results): |
View full study record |
Document reference: 41294 |
Study title: A Multicentre Study of D-TRP-6-LHRH Microspheres (Decapeptyl Controlled Release) in the Treatment of True Precocious Puberty |
Active substance: TRIPTORELIN |
Study summary document link (including results): |
View full study record |
Document reference: 46858 |
Study title: Assessment of safety and immunogenicity of Merieux Vero OPV in Morocco (ASTER ref. JT1903/2) (1987) |
Active substance: Trivalent Oral Poliomyelitis Vaccine (Vero cells) |
Study summary document link (including results): |
View full study record |
Document reference: 41296 |
Study title: Assessment of safety and immunogenicity of Merieux Vero OPV in Morocco (ASTER ref. JT1903/3) (1988) |
Active substance: Trivalent Oral Poliomyelitis Vaccine (Vero cells) |
Study summary document link (including results): |
View full study record |
Document reference: 41295 |
Study title: Assessment of the immunogenicity and safety of three different formulation F3, F3+alum and F3bis of a pneumococcal polysaccharide conjugate vaccine in healthy Chilean infants (PNF 30298) ( 2000) |
Active substance: Trivalent Oral Poliomyelitis Vaccine (Vero cells) |
Study summary document link (including results): |
View full study record |
Document reference: 41297 |
Study title: Immunogenicity and response to polysaccharide challenge following different schedules of a Neisseria meningitidis A/C diphtheria conjugate vaccine administered to infants in Niamey, Niger (MAK02297) (1997) |
Active substance: Trivalent Oral Poliomyelitis Vaccine (Vero cells) |
Study summary document link (including results): |
View full study record |
Document reference: 41298 |
Study title: EFFICACY AND SECURITY OF SULTAMICILLIN IN PATIENTS WITH MILD TO MODERATE INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42966 |
Study title: EFFICACY AND TOLERANCE OF PARENTERAL SULBACTAM/AMPICILLIN AND ORAL UNASYN IN CHILDREN AND ADULTS WITH MODERATE TO SEVERE INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43058 |
Study title: EFFICACY AND TOLERANCE OF SULTAMICILLIN IN THE TREATMENT OF MILD TO MODERATE INFECTIONS IN CHILDREN AND ADULTS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43057 |
Study title: EFFICACY AND TOLERANCE OF SULTAMICILLIN VS. AMPICILLIN IN CHILDREN WITH ACUTE DIARRHEA. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43013 |
Study title: EFFICACY AND TOLERATION OF SULBACTAM/AMPICILLIN IM FOLLOWED BY SULTAMICILLIN PO IN NON-SEVERE INFECTIONS IN GENERAL PRACTICE. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42946 |
Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN GIVEN ORALLY B.I.D. IN ADULTS WITH GYNECOLOGICAL OR OBSTETRIC INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42985 |
Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN GIVEN ORALLY IN PATIENTS WITH RESPIRATORY TRACT INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42984 |
Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN PO IN ADULTS WITH ENT INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42987 |
Study title: TO COMPARE DOXYCYCLINE 50 MG WITH OXYTETRACYCLINE 250 MG BID IN THE TREATMENT OF INFLAMMATORY ACNE VULGARIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27335 |
Study title: TO COMPARE THE CLINICAL AND MYCOLOGIC EFFECTIVENESS AND SAFETY OF A SINGLE 150 MG ORAL DOSE OF FLUCONAZOLE VS. 3 DAYS OF ORAL DOSES OF ITRACONAZOLE GIVEN AT 200 MG PER DAY IN THE TREATMENT OF VAGINAL |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27595 |
Study title: TO COMPARE THE CLINICAL AND MYCOLOGIC EFFECTIVENESS AND SAFETY OF A SINGLE 150 MG ORAL DOSE OF FLUCONAZOLE VS. 3 DAYS OF ORAL DOSES OF ITRACONAZOLE GIVEN AT 200 MG PER DAY IN THE TREATMENT OF VAGINAL |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27958 |
Study title: TO COMPARE THE EFFICACY AND SAFETY OF FLUCONAZOLE AND AMPHOTERICIN B IN THE PREVENTION OF FUNGAL INFECTIONS; WITH ACUTE LEUKEMIA DURING THE PERIOD OF APLASIA. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27450 |
Study title: TO COMPARE THE EFFICACY AND SAFETY OF FLUCONAZOLE AND AMPHOTERICIN B IN THE PREVENTION OF FUNGAL INFECTIONS; WITH ACUTE LEUKEMIA DURING THE PERIOD OF APLASIA. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27814 |
Study title: TO COMPARE THE EFFICACY AND SAFETY OF FLUCONAZOLE VS. AMPHOTERICIN IN THE TREATMENT OF CHRONIC ATROPHIC ERYTHEMATOUS CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27667 |
Study title: TO COMPARE THE EFFICACY AND SAFETY OF FLUCONAZOLE VS. AMPHOTERICIN IN THE TREATMENT OF CHRONIC ATROPHIC ERYTHEMATOUS CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28029 |
Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN PO IN ADULTS WITH SKIN AND SOFT TISSUE INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42986 |
Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN PO IN CHILDREN WITH BACTERIAL INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42988 |
Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN VS AMOXICILLIN IN PEDIATRIC INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42998 |
Study title: EFFICACY AND TOLERATION OF UNASYN IN PEDIATRIC INFECTIONS |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43015 |
Study title: Kokki, H., A. Salonen, et al. "Perioperative intravenous ketoprofen neither prolongs operation time nor delays discharge after adenoidectomy in children." ; Paediatr Anaesth 11(1): 59-64, 2001.Kokki, H., A. Salonen, et al. "Perioperative intravenous ketoprofen neither prolongs operation time nor delays discharge after adenoidectomy in children." ; Paediatr Anaesth 11(1): 59-64, 2001. |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30881 |
Study title: Kokki, H., A. Salonen, et al. "Perioperative intravenous ketoprofen neither prolongs operation time nor delays discharge after adenoidectomy in children." ; Paediatr Anaesth 11(1): 59-64, 2001.Kokki, H., A. Salonen, et al. "Perioperative intravenous ketoprofen neither prolongs operation time nor delays discharge after adenoidectomy in children." ; Paediatr Anaesth 11(1): 59-64, 2001. |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30886 |
Study title: Kokki, H., E. Nikanne, et al."The feasibility of pain treatment at home after adenoidectomy with ketoprofen tablets in small children." ; Paediatr Anaesth 10(5): 531-5, 2000Kokki, H., E. Nikanne, et al."The feasibility of pain treatment at home after adenoidectomy with ketoprofen tablets in small children." ; Paediatr Anaesth 10(5): 531-5, 2000 |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30880 |
Study title: Kokki, H., H. Tuomilehto, et al. "Pain management after adenoidectomy with ketoprofen: comparison of rectal and intravenous routes." ; Br J Anaesth 85(6): 836-40, 2000.Kokki, H., H. Tuomilehto, et al. "Pain management after adenoidectomy with ketoprofen: comparison of rectal and intravenous routes." ; Br J Anaesth 85(6): 836-40, 2000. |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30882 |
Study title: Multicentre, randomised, comparative double-blind and double placebo study in two parallel groups, of the efficacy and safety of ketoprofen (0.5 mg/kg/dose), versus ibuprofen (5 mg/kg/dose), in repeated doses, in the treatment of febrile conditions in children aged 1 year to 6 years. |
Active substance: KETOPROFEN |
Study summary document link (including results): Ketoprofen-Study 3.pdf |
View full study record |
Document reference: 30863 |
Study title: Pharmacokinetic study of ketoprofen in children during and after day-case surgery. |
Active substance: KETOPROFEN |
Study summary document link (including results): Ketoprofen-Study 5.pdf |
View full study record |
Document reference: 30869 |
Study title: Pharmacokinetic study of ketoprofen in children during and after day-case surgery - Kokki H. and Heikkinen M. - 15/05/1998. |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30871 |
Study title: Pharmacokinetics of a 24-hour intravenous ketoprofen infusion in children - Kokki H, Karvinen M, Jekunen - 2002, Acta Anaesthes Scand; 46/2: 194-198 |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30877 |
Study title: Rapport d'expert Profenid gélules 50 mg (extension des indications thérapeutiques (stomatologie)- Etude clinique du kétoprofène en pathologie dentaire - Pr. C. Lecointre - Oct. 1985 |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30872 |
Study title: RP19583: Gastro-Intestinal tolerance in young rats after a 4-week oral administration of ketoprofen pediatric syrup SA-CRVA 99-205 |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30873 |
Study title: Salonen, A., H. Kokki, et al. "The effect of ketoprofen on recovery after tonsillectomy in children: a 3-week follow-up study." Int J Pediatr Otorhinolaryngol 62(2): 143-50, 2002 |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30883 |
Study title: Subramaniam, R., B. Ghai, et al."A comparison of intravenous ketoprofen versus pethidine on peri-operative analgesia and post-operative nausea and vomiting in paediatric vitreoretinal surgery."; J Postgrad Med 49(2): 123-6, 2003. |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30884 |
Study title: Enterotoxigenic Escherichia coli causing cholerogenic syndrome during an interepidemic period of cholera in North India.Taneja et al., Jpn J Infect Dis. 2006 Aug;59(4):245-8Enterotoxigenic Escherichia coli causing cholerogenic syndrome during an interepidemic period of cholera in North India.Taneja et al., Jpn J Infect Dis. 2006 Aug;59(4):245-8 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46772 |
Study title: Factors associated with antibiotic resistance in coliform organisms from community urinary tract infection in Wales.Howard et al., J Antimicrob Chemother. 2001 Mar;47(3):305-13.Factors associated with antibiotic resistance in coliform organisms from community urinary tract infection in Wales.Howard et al., J Antimicrob Chemother. 2001 Mar;47(3):305-13. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46795 |
Study title: High rates of antibiotic resistance among normal fecal flora Escherichia coli isolates in children from Greece.Vatopoulos et al., Clin Microbiol Infect. 1998;4(10):563-569.High rates of antibiotic resistance among normal fecal flora Escherichia coli isolates in children from Greece.Vatopoulos et al., Clin Microbiol Infect. 1998;4(10):563-569. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46788 |
Study title: Incidence & enteropathogenicity of Aeromonas spp in children suffering from acute diarrhoea in Chennai.Komathi et al., Indian J Med Res. 1998 Jun;107:252-6Incidence & enteropathogenicity of Aeromonas spp in children suffering from acute diarrhoea in Chennai.Komathi et al., Indian J Med Res. 1998 Jun;107:252-6 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46801 |
Study title: Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern?Mangin et al., N Z Med J. 2005 Nov 11;118(1225):U1726Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern?Mangin et al., N Z Med J. 2005 Nov 11;118(1225):U1726 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46775 |
Study title: Increasing antibiotic resistance among urinary tract isolates.Ladhani et al., Arch Dis Child. 2003 May;88(5):444-5.Increasing antibiotic resistance among urinary tract isolates.Ladhani et al., Arch Dis Child. 2003 May;88(5):444-5. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46784 |
Study title: Long-term antibiotics for preventing recurrent urinary tract infection in children.(2)Williams et al., Cochrane Database Syst Rev. 2001;(4):CD001534.Long-term antibiotics for preventing recurrent urinary tract infection in children.(2)Williams et al., Cochrane Database Syst Rev. 2001;(4):CD001534. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46791 |
Study title: Long-term antibiotics for preventing recurrent urinary tract infection in children.Williams et al., Cochrane Database Syst Rev. 2006 Jul 19;3:CD001534Long-term antibiotics for preventing recurrent urinary tract infection in children.Williams et al., Cochrane Database Syst Rev. 2006 Jul 19;3:CD001534 |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46773 |
Study title: Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infection in children. A randomized, double-blind study.Brendstrup et al., Acta Paediatr Scand. 1990 Dec;79(12):1225-34.Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infection in children. A randomized, double-blind study.Brendstrup et al., Acta Paediatr Scand. 1990 Dec;79(12):1225-34. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46808 |
Study title: Occurrence of Salmonella typhi and Salmonella paratyphi in Jordan.Battikhi MN., New Microbiol. 2003 Oct;26(4):363-73.Occurrence of Salmonella typhi and Salmonella paratyphi in Jordan.Battikhi MN., New Microbiol. 2003 Oct;26(4):363-73. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46783 |
Study title: Oral trimethoprim as a third-line antibiotic in the management of acne vulgaris.Bottomley et al., Dermatology. 1993;187(3):193-6.Oral trimethoprim as a third-line antibiotic in the management of acne vulgaris.Bottomley et al., Dermatology. 1993;187(3):193-6. |
Active substance: TRIMETHOPRIM |
Study summary document link (including results): |
View full study record |
Document reference: 46805 |
Study title: Immunogenicity and safety of an inactivated Hepatitis A vaccine (80 AgU) after simultaneous administration with either Tetract-Hib+OPV or DtacP-IPC//Act-Hib vaccine in 16 to 19 month old toddlers (HAF29393) (1999) |
Active substance: Trivalent Oral Poliomyelitis Vaccine (Vero cells) |
Study summary document link (including results): |
View full study record |
Document reference: 41299 |
Study title: Immunogenicity study for Tetra and Penta component vaccines in infants (1999) |
Active substance: Trivalent Oral Poliomyelitis Vaccine (Vero cells) |
Study summary document link (including results): |
View full study record |
Document reference: 41300 |
Study title: A comparison of the pupillary and cardiovascular effects of various mydriatic agents in preterm infants. Sindel BD, Baker MD, Maisels MJ, Weinstein J. J Pediatr Ophthalmol Strabismus. 1986 Nov-Dec;23(6):273-6. A comparison of the pupillary and cardiovascular effects of various mydriatic agents in preterm infants. Sindel BD, Baker MD, Maisels MJ, Weinstein J. J Pediatr Ophthalmol Strabismus. 1986 Nov-Dec;23(6):273-6. |
Active substance: TROPICAMIDE |
Study summary document link (including results): A comparison of the pupillary and cardiovascular effects.pdf |
View full study record |
Document reference: 46880 |
Study title: Safety and efficacy of pressure limited power injection of iodinated contrast medium through central lines in childrenRIGSBY CK; AJR; 2007 vol.188 p.726 732Safety and efficacy of pressure limited power injection of iodinated contrast medium through central lines in childrenRIGSBY CK; AJR; 2007 vol.188 p.726 732 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30427 |
Study title: Short term pediatric renal transplant survival : blood pressure and allograft function; MITSNEFES MM; Pediatr. Transplantation; 2001 vol.5 p.160-165Short term pediatric renal transplant survival : blood pressure and allograft function; MITSNEFES MM; Pediatr. Transplantation; 2001 vol.5 p.160-165 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30428 |
Study title: Significance of 'blush' on computed tomography scan in children with liver injury; EUBANKS JW; J. Pediatr. Surg.; 2003 vol.38 n.3 p.363 366Significance of 'blush' on computed tomography scan in children with liver injury; EUBANKS JW; J. Pediatr. Surg.; 2003 vol.38 n.3 p.363 366 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30429 |
Study title: Suspected appendicitis in children : focused CT technique for evaluation; FEFFERMAN NR; Radiology; 2001 vol.220 p.691-695Suspected appendicitis in children : focused CT technique for evaluation; FEFFERMAN NR; Radiology; 2001 vol.220 p.691-695 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30430 |
Study title: Suspected appendicitis in children: rectal and intravenous contrast enhanced versus intravenous contrast-enhanced CT.; KHARBANDA AB; Radiology; 2007 vol.243 n.3 p.520 526Suspected appendicitis in children: rectal and intravenous contrast enhanced versus intravenous contrast-enhanced CT.; KHARBANDA AB; Radiology; 2007 vol.243 n.3 p.520 526 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30431 |
Study title: Symptomatic intracranial stenosis : cerebrovascular complication from elective stent placement; JIANG WJ; Radiology; 2007 vol.243 n.1 188 197Symptomatic intracranial stenosis : cerebrovascular complication from elective stent placement; JIANG WJ; Radiology; 2007 vol.243 n.1 188 197 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30432 |
Study title: The newer radiographic contrast media; EGGLI KD; Clin. Pediat.; 1992 vol.31 n.9 p.554 559The newer radiographic contrast media; EGGLI KD; Clin. Pediat.; 1992 vol.31 n.9 p.554 559 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30433 |
Study title: TO COMPARE THE EFFICACY AND SAFETY OF ORAL FLUCONAZOLE GIVEN AS A SINGLE ORAL DOSE OF 150 MG PER WEEK OR 50 MG 3 TIMES PER WEEK FOR THE PREVENTION OF ORO-PHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27451 |
Study title: TO COMPARE THE EFFICACY AND SAFETY OF ORAL FLUCONAZOLE GIVEN AS A SINGLE ORAL DOSE OF 150 MG PER WEEK OR 50 MG 3 TIMES PER WEEK FOR THE PREVENTION OF ORO-PHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27815 |
Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE TO ORAL AMPHOTERICIN AND NYSTATIN IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASE RECEIVING CHEMOTHERAPY. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27668 |
Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE TO ORAL AMPHOTERICIN AND NYSTATIN IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASE RECEIVING CHEMOTHERAPY. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28030 |
Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE VS. ORAL KETOCONAZOLE IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS RECEIVING CHEMOTHERAPY FOR HEMATOLOGICAL DISEASE. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27666 |
Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE VS. ORAL NYSTATIN IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS RECEIVING CHEMOTHERAPY FOR HEMATOLOGICAL DISEASE. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27665 |
Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE VS. ORAL NYSTATIN IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS RECEIVING CHEMOTHERAPY FOR HEMATOLOGICAL DISEASE. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28027 |
Study title: 5-Fluorouracil cardiotoxicity: a unique mechanism for ischaemic cardiopathy and cardiac failure? Lieutaud T et al. Eur J Cancer. 1996 Feb;32A(2):368-9 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28314 |
Study title: 5-Fluorouracil filtering surgery and neovascular glaucoma: Long-term follow-up of the original pilot study. Tsai JC et al. Ophthalmology. June 30, 1995, 887-93 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28286 |
Study title: 5-Fluorouracil in childhood solid tumors. Haggard ME et al. Cancer Treat Rep. 1977 Jan-Feb 1, 69-71 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28325 |
Study title: A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Hareyama M. Cancer. April 15, 2002, 2217-23 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28271 |
Study title: Adjuvant chemotherapy for colorectal cancer: A Malaysian experience. Lim GCC et al. Medical Journal of Malaysia. September 8, 1997, 117-23 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28283 |
Study title: Chemotherapy for unresectable pancreatoblastoma. Hord JD, Janco RL. Med Pediatr Oncol. 1996 Jun;26(6):432-3 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28313 |
Study title: Chemotherapy of brain tumors in childhood. Review of the literature and pilot protocol. Kühl J. Klin Padiatr. 1988 May-Jun;200(3):214-20 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28321 |
Study title: Chemotherapy-radiotherapy combination in lung neoplasms. Chenal C, Follezou JY, Fauchon F. Bull Cancer. 1979;66(2):189-90 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28324 |
Study title: Choledochal cyst and squamous-cell carcinoma of the biliary tract. Harris M, Angus P, Davis ID. September 24, 2002, 491 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28269 |
Study title: Tolerability of nimesulide and ketoprofen in paediatric patients with traumatic or surgical fracture - Facchini R., Selva G., Peretti G. - 1993 ( Drugs 1993, 46, Suppl. 1, p. 238) |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30874 |
Study title: Traitement anti-inflammatoire local par un gel de kétoprofène: données cliniques récentes |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 45088 |
Study title: Traitement de la fièvre chez l'enfant: faux problème ou vrai débat? - Bourrillon A. - 1991 (La Presse Médicale, 1991, 20(17), p.785) |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30875 |
Study title: Treatment of fever in childhood - Adam D. and Stankov G. - 1994 (Eur. J. Pediatr., 1994, 153, p 394-402) |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30876 |
Study title: Tuomilehto, H. and H. Kokki "Parenteral ketoprofen for pain management after adenoidectomy: comparison of intravenous and intramuscular routes of administration." ; Acta Anaesthesiol Scand 46(2): 184-9, 2002. |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30885 |
Study title: A Phase IV Comparative Study Evaluating the Onset and Total Analgesia Using a Single Dose of Acetaminophen 1000 mg, Ketoprofen 25 mg, Ketoprofen 12.5 mg, or Placebo in Post-Operative Dental Pain |
Active substance: KETOPROFEN AND PARACETAMOL |
Study summary document link (including results): ketoprofen_paracetamol 95-531.pdf |
View full study record |
Document reference: 47777 |
Study title: |
Active substance: KETOPROFEN AND SUCRALFATE |
Study summary document link (including results): |
View full study record |
Document reference: 30893 |
Study title: Kokki H, et all. The feasibility of pain treatment at home after adenoidectomy with ketoprofen tablets in small children. Paediatr Anaesth. 2000;10(5):531-5. Kokki H, et all. The feasibility of pain treatment at home after adenoidectomy with ketoprofen tablets in small children. Paediatr Anaesth. 2000;10(5):531-5. |
Active substance: KETOPROFEN AND SUCRALFATE |
Study summary document link (including results): |
View full study record |
Document reference: 30890 |
Study title: Nikanne E, et all. Postoperative pain after adenoidectomy in children. Br J Anaesth. 1999 Jun;82(6):886-9. Nikanne E, et all. Postoperative pain after adenoidectomy in children. Br J Anaesth. 1999 Jun;82(6):886-9. |
Active substance: KETOPROFEN AND SUCRALFATE |
Study summary document link (including results): |
View full study record |
Document reference: 30891 |
Study title: A double-blind, randomised study to compare the efficacy of intravenous ketorolac tromethamine with morphine in relieving post-operative pain in children |
Active substance: KETOROLAC |
Study summary document link (including results): |
View full study record |
Document reference: 30895 |
Study title: A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF INTRAVENOUS KETOROLAC TROMETHAMINE IN THE PREVENTION AND TREATMENT OF POST-OPERATIVE PAIN IN CHILDREN [Study ID: MRE/KETI500/EUR] |
Active substance: KETOROLAC |
Study summary document link (including results): |
View full study record |
Document reference: 30898 |
Study title: A Multi-centre randomised , double masked, vehicle controlled parallel group study evaluating the safety and tolerability of Ketorolac Tromethamine 0.5 % ophthalmic solution used four times daily for 6 weeks in normal paediatric subjects. |
Active substance: KETOROLAC |
Study summary document link (including results): |
View full study record |
Document reference: 45109 |
Study title: A. Chmielewska - Comperative trial on ketotifen table and sirup with Zaditernem |
Active substance: KETOROLAC |
Study summary document link (including results): |
View full study record |
Document reference: 30906 |
Study title: An open study to investigate the pharmacokinetics of intravenous ketorolac tromethamine, following intravenous administration to relieve post-operative pain in children |
Active substance: KETOROLAC |
Study summary document link (including results): |
View full study record |
Document reference: 30896 |
Study title: AN OPEN STUDY TO INVESTIGATE THE PHARMACOKINETICS OF KETOROLAC TROMETHAMINE, FOLLOWING INTRAVENOUS ADMINISTRATION TO RELIEVE POST-OPERATIVE PAIN IN CHILDREN [Study ID: CRE/ANL/058] |
Active substance: KETOROLAC |
Study summary document link (including results): |
View full study record |
Document reference: 30897 |
Study title: A multicenter, randomized, double-blind, placebo-controlled, parallel study of the efficacy and safety of chlorofluorocarbon (CFC) and HFA-227 (non-CFC) formulations of IntalR (cromolyn sodium) metered dose inhaler (MDI) 2mg Qid in the treatment of asthma |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32425 |
Study title: A Multicenter,Open-Label, Controlled, Extended Safety Study of Montelukast in Infants and Young Children With Chronic Asthma |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32426 |
Study title: A randomised , double blind, 3-Way Crossover study to compare the protective effect o single doses of an alternative propellanst (HFA-227) - Formulation of sodium Cromoglycate 2x5mg with Intal (Lomudal) MDI 2x5mg and HFA-227 placebo in asthmatic volunteer |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32427 |
Study title: A Randomized, 3-Period, Multiple-Dose, Multicenter Study to Evaluate the Safety, Tolerability, and Plasma Concentration Profile of Montelukast Administered Once Daily as Oral Granules in Children Aged Less 1 to 3 Months |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32428 |
Study title: A randomized, double-blind, multicenter study evaluating the effect of montelukast sodium as compared to salmeterol on the inhibition of exercise-induced bronchoconstriction in adult asthmatics |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32429 |
Study title: A Randomized, Double-Blind, Multicenter Study to Evaluate the Effect of Adding Either Montelukast Sodium or Salmeterol Xinafoate to Inhaled Fluticasone in Adult Asthmatics |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32430 |
Study title: A Randomized, Double-Blind, Multicenter Study to Evaluate the Effect of Adding Either Montelukast Sodium or Salmeterol Xinafoate to Inhaled Fluticasone in Adult Asthmatics (IMPACT Study – Investigation of Montelukast as a Partner Agent for Complementary Therapy) |
Active substance: MONTELUKAST |
Study summary document link (including results): 908.pdf |
View full study record |
Document reference: 32431 |
Study title: A Randomized, Double-Blind, Multicenter Study to Evaluate the Effect of Oral Montelukast Sodium Versus Inhaled Fluticasone Propionate in Patients With MIld Persistent Asthma |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32432 |
Study title: A Randomized, Double-Blind, Multicenter Study to Evaluate the Effect of Oral Montelukast Sodium versus inhaled Fluticasone Proportionate in Patients With Persistent Asthma |
Active substance: MONTELUKAST |
Study summary document link (including results): 905 synopsis.pdf |
View full study record |
Document reference: 32433 |
Study title: A randomized, multicenter, double blind study to evaluate the effect of adding montelukast sodium to inhaled budesonide compared to doubling the dose of inhaled budesonide in adult patients with asthma |
Active substance: MONTELUKAST |
Study summary document link (including results): 909.pdf |
View full study record |
Document reference: 47560 |
Study title: A Randomized, Open Label, Cross-Over Study Comparing Parent/Guardian Preference for Montelukast Sodium Tablets or Cromolyn Sodium Aerosol (MDI) Treatment in their Children ages 6 to 11 with Chronic Asthma |
Active substance: MONTELUKAST |
Study summary document link (including results): 065 Synopsis.pdf |
View full study record |
Document reference: 32405 |
Study title: Randomized, Open-label Pilot Study Comparing the Effects of Montelukast Sodium Tablets, Fluticasone Aerosol (MDI) or Budesonide Turbuhaler® on Asthma Control in Mild Adult Asthmatics |
Active substance: MONTELUKAST |
Study summary document link (including results): 076 CSR.pdf |
View full study record |
Document reference: 47559 |
Study title: Dr. M. Chelly. Essai controle en ouvert evaluant l'efficacitè et la tolèrance du morniflumate suppositoire enfant versus alpha-amylase sirop dans les angines. |
Active substance: MORNIFLUMATE |
Study summary document link (including results): |
View full study record |
Document reference: 32435 |
Study title: A double-blind, randomised parallel group comparison of the dose equivalence, clinical efficacy, safety and pharmacokinetics of controlled-release morphine tablets (MS Contin) and a continuous intravenous infusion of morphine in paediatric patients with severe pain of vaso-occlusive crisis. |
Active substance: MORPHINE |
Study summary document link (including results): |
View full study record |
Document reference: 32436 |
Study title: A mydriatic eye-drop combination without systemic effects for premature infants: a prospective double-blind study. Bolt B, Benz B, Koerner F, Bossi E. J Pediatr Ophthalmol Strabismus. 1992 May-Jun;29(3):157-62. Comment in: J Pediatr Ophthalmol Strabismus. 1994 Mar-Apr;31(2):130. PMID: 8014788. A mydriatic eye-drop combination without systemic effects for premature infants: a prospective double-blind study. Bolt B, Benz B, Koerner F, Bossi E. J Pediatr Ophthalmol Strabismus. 1992 May-Jun;29(3):157-62. Comment in: J Pediatr Ophthalmol Strabismus. 1994 Mar-Apr;31(2):130. PMID: 8014788. |
Active substance: TROPICAMIDE |
Study summary document link (including results): A mydriatic eye-drop combination without systemic effects.pdf |
View full study record |
Document reference: 46878 |
Study title: A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children. Gwiazda J, Hyman L, Hussein M, Everett D, Norton TT, Kurtz D, Leske MC, Manny R, Marsh-Tootle W, Scheiman M. Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1492-500. Comment in: Optom Vis Sci. 2003 May;80(5):327-8. PMID: 12771658. A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children. Gwiazda J, Hyman L, Hussein M, Everett D, Norton TT, Kurtz D, Leske MC, Manny R, Marsh-Tootle W, Scheiman M. Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1492-500. Comment in: Optom Vis Sci. 2003 May;80(5):327-8. PMID: 12771658. |
Active substance: TROPICAMIDE |
Study summary document link (including results): A random8ized clinical trial of progressive addition lenses.pdf |
View full study record |
Document reference: 46867 |
Study title: Accommodation and related risk factors associated with myopia progression and their interaction with treatment in COMET children. Gwiazda JE, Hyman L, Norton TT, Hussein ME, Marsh-Tootle W, Manny R, Wang Y, Everett D; COMET Group. Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2143-51. Accommodation and related risk factors associated with myopia progression and their interaction with treatment in COMET children. Gwiazda JE, Hyman L, Norton TT, Hussein ME, Marsh-Tootle W, Manny R, Wang Y, Everett D; COMET Group. Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2143-51. |
Active substance: TROPICAMIDE |
Study summary document link (including results): Accommodation and related risk factors associated with myopi.pdf |
View full study record |
Document reference: 46866 |
Study title: Additive mydriatic effect of 2.5% phenylephrine and 0.5% tropicamide eyedrops in premature babies. Fleck BW, Dhillon B, Mitchell A. J Pediatr Ophthalmol Strabismus. 1994 Mar-Apr;31(2):130. Comment on: J Pediatr Ophthalmol Strabismus. 1992 May-Jun;29(3):157-62. PMID: 1432499. Additive mydriatic effect of 2.5% phenylephrine and 0.5% tropicamide eyedrops in premature babies. Fleck BW, Dhillon B, Mitchell A. J Pediatr Ophthalmol Strabismus. 1994 Mar-Apr;31(2):130. Comment on: J Pediatr Ophthalmol Strabismus. 1992 May-Jun;29(3):157-62. PMID: 1432499. |
Active substance: TROPICAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 46876 |
Study title: [Cardiovascular and digestive effects of 2 mydriatics in the low-birth-weight newborn infant] Walti H, Daoud P, Broussin B, Ryzman P, Moriette G, Relier JP. Arch Fr Pediatr. 1987 Jan;44(1):31-3. [Cardiovascular and digestive effects of 2 mydriatics in the low-birth-weight newborn infant] Walti H, Daoud P, Broussin B, Ryzman P, Moriette G, Relier JP. Arch Fr Pediatr. 1987 Jan;44(1):31-3. |
Active substance: TROPICAMIDE |
Study summary document link (including results): Cardiovascular and digestive effects of 2 mydriatics.pdf |
View full study record |
Document reference: 46879 |
Study title: Aggressive Fibromatosis of the Neck in Two Brothers: Diagnostic and Therapeutic Implications. Ludemann JP, Hughes CA, Bouzoukis J, Maddalozzo J, Goldman S. Journal of Otolaryngology 1999;28(5):288-292 1999;(5):288-292.Aggressive Fibromatosis of the Neck in Two Brothers: Diagnostic and Therapeutic Implications. Ludemann JP, Hughes CA, Bouzoukis J, Maddalozzo J, Goldman S. Journal of Otolaryngology 1999;28(5):288-292 1999;(5):288-292. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43286 |
Study title: Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study. Douglass EC et al. J Clin Oncol. 1993 Jan;11(1):96-9 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28317 |
Study title: Clinical and histopathological characteristics of basal cell carcinoma in Korean patients. Cho S et al. J Dermatol. September 28, 1999, 494-501 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28278 |
Study title: Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma. Evans AE et al. Cancer. 1982 Sep 1;50(5):821-6 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28323 |
Study title: Effective adjuvant chemotherapy for advanced nasopharyngeal carcinoma in children: A final update of a long-term prospective study in a single institution. Ghim TT et al. J Pediatr Hematol Oncol. March 1, 1998, 131-5 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28280 |
Study title: Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children. Lee MJ et al. J Neuro-Oncol. December 1, 2006, 277-84 |
Active substance: FLUOROURACIL |
Study summary document link (including results): 16807782.pdf |
View full study record |
Document reference: 28263 |
Study title: Ewing's sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewing's sarcoma studies. Cangir A et al. Cancer. 1990 Sep 1;66(5):887-93 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28320 |
Study title: Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy. Leung TWT et al. Cancer, January 15, 2002, 421-7 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28272 |
Study title: Fibrolamellar hepatocellular carcinoma in children and adolescents. Katzenstein HM et al. Cancer. 2003 Apr 15;97(8):2006-12 |
Active substance: FLUOROURACIL |
Study summary document link (including results): 12673731.pdf |
View full study record |
Document reference: 28303 |
Study title: Hepatoblastoma in children: A review. Raney B. J Pediatr Hematol Oncol. September 1, 1997, 418-22 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28281 |
Study title: A phase IV comparative study evaluating the onset of analgesia using a single dose of acetaminophen 1000 mg, naproxen sodium 440 mg, naproxen sodium 220 mg or placebo in post-operative dental pain. |
Active substance: NAPROXEN PARACETAMOL |
Study summary document link (including results): naproxen_paracetamol 93-321.pdf |
View full study record |
Document reference: 47117 |
Study title: A phase IV comparative study evaluating the onset of analgesia using a single dose of acetaminophen 1000 mg, naproxen sodium 440 mg, naproxen sodium 220 mg or placebo in post-operative dental pain. |
Active substance: NAPROXEN PARACETAMOL |
Study summary document link (including results): naproxen_paracetamol 93-322.pdf |
View full study record |
Document reference: 47118 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Naso-Heel S (drops) [AWB-AT] |
Active substance: Naso-Heel - Tropfen |
Study summary document link (including results): |
View full study record |
Document reference: 40080 |
Study title: A comparative study of the efficacity of nedocromil sodium and placebo given by pressurised aerosol in inhibiting exercise-induced bronchoconstrictor responses in children - R. Dahl et al. - 1985 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children - clinical documentation- K. Rocchiccioli - 24/06/1994 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46957 |
Study title: A comparison of activityof a new pressurised aerosol formulation of Nedocromil Sodium and Placebo delivered by a standard Mouthpiece and a spacer device in Exercise challenge tests (Menthol/ Saccharin Formulation) - Dr M. Silvermann et al. - 1987 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46958 |
Study title: A double- blind group comparative study of nedocromil sodium 2% ophthalmic solution and placebo in the treatment of vernal keratoconjunctivitis - Bonini - 1988 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46959 |
Study title: Bullingham r,lloyd j,mroszczak e, an open study to investigate the pharmacokinetics of ketorolac tromethamine, following intravenous administration to relieve post-operative pain in children [study id: cre/anl/058] |
Active substance: KETOROLAC |
Study summary document link (including results): |
View full study record |
Document reference: 30903 |
Study title: Goswamy Sharma M*,Schuerch M,Vardar T, Review of Adverse Events Reported with the Use of Toradol (Ketorolac) in Children 18 and under [Status: Period: Since introduction to January 31, 2000; International Birth Date: April 1990] |
Active substance: KETOROLAC |
Study summary document link (including results): |
View full study record |
Document reference: 30905 |
Study title: Maunuksela EL, Kokki H, A double-blind, randomised study to compare the efficacy of intravenous ketorolac tromethamine with morphine in relieving post-operative pain in children |
Active substance: KETOROLAC |
Study summary document link (including results): |
View full study record |
Document reference: 30901 |
Study title: Maunuksela EL, Olkkola KT, An open study to investigate the pharmacokinetics of intravenous ketorolac tromethamine, following intravenous administration to relieve post-operative pain in children |
Active substance: KETOROLAC |
Study summary document link (including results): |
View full study record |
Document reference: 30902 |
Study title: Revell S,Review of adverse events associated with ketorolac (Toradol®) use in children, 1 January 1991 to 31 July 1995 |
Active substance: KETOROLAC |
Study summary document link (including results): |
View full study record |
Document reference: 30900 |
Study title: Review of adverse events associated with ketorolac (Toradol®) use in children, 1 January 1991 to 31 July 1995; Syntex Report CL5136, March 1990 |
Active substance: KETOROLAC |
Study summary document link (including results): |
View full study record |
Document reference: 30894 |
Study title: Review of Adverse Events Reported with the Use of Toradol (Ketorolac) in Children 18 and under [Status: Period: Since introduction to January 31, 2000; International Birth Date: April 1990] |
Active substance: KETOROLAC |
Study summary document link (including results): |
View full study record |
Document reference: 30899 |
Study title: Spyt m,chapman j, a double-blind, randomised, placebo-controlled study to investigate the safety and efficacy of intravenous ketorolac tromethamine in the prevention and treatment of post-operative pain in children [study id: mre/keti500/eur] |
Active substance: KETOROLAC |
Study summary document link (including results): |
View full study record |
Document reference: 30904 |
Study title: |
Active substance: KETOTIFEN |
Study summary document link (including results): Zaditen Ophtha Paediatric Studies_C-08-97-003_EMA spreadsheet.xls |
View full study record |
Document reference: 47297 |
Study title: |
Active substance: KETOTIFEN |
Study summary document link (including results): Zaditen Ophtha Paediatric Studies_C01-KETO-011_EMA spreadsheet.xls |
View full study record |
Document reference: 47298 |
Study title: |
Active substance: KETOTIFEN |
Study summary document link (including results): Zaditen Ophtha Paediatric Studies_SHDR 42000-97-2_EMA spreadsheet.xls |
View full study record |
Document reference: 47300 |
Study title: A multicentre , blinded group comparative study to demonstrate the safety of a flavoured alternative propellant (HFA 227) formulation of nedocromil sodium MDI 4mg qid compared with TILADE Mint (CFC propellant) 4 mg qid in adult and adolescent asthma - G. Huchon et al. - 09/04/1998 |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46978 |
Study title: A multicentre ouble-blind group comparative study nedocromil sodium 2% ophthalmic solution and oral Astemizole in the treatment of seasonal allergic conjunctivitis - Brovarone et al. - 1988 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46993 |
Study title: GL/MST/280294 Phase IV 23-Jan-1998 - Anwendung von MST bei Kindern mit Tumorschmerzen. (MST in children with cancer pain.) (Germany) |
Active substance: MORPHINE |
Study summary document link (including results): |
View full study record |
Document reference: 45147 |
Study title: Klifo/MST/160891 - Post marketing surveillance, Drug monitoring, 06-Jul-1998. Beurteilung der Lebensqualität bei Patienten mit Krebsschmerzen unter Berücksichtigung ihrer Schmerztherapie gemäß Stufenplan WHO. (MST Mundipharma for treatment of cancer pain in practices) (Germany) |
Active substance: MORPHINE |
Study summary document link (including results): |
View full study record |
Document reference: 45148 |
Study title: Bannikov, Mihail Y.; Vasilenko, Inna V.: Anwendung von homöopathischen Komplexmitteln in der Behandlungakuter kindlicher Speiseröhrenverätzungen. Biol Med 2000 (29):253-254 [IIT-publication] |
Active substance: Mucosa compositum |
Study summary document link (including results): |
View full study record |
Document reference: 40074 |
Study title: Kostromina V.P.et al: Estimation of detoxicational effects of antihomotoxic medicines in the treatment of children suffering from relapsing bronchitis and infected with mycobacteria. Biological Therapy (Ukraine), 2007, 3: 20-23 [IIT-publication] |
Active substance: Mucosa compositum |
Study summary document link (including results): |
View full study record |
Document reference: 40077 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Mucosa compositum (ampoules) [AWB-AT] |
Active substance: Mucosa compositum |
Study summary document link (including results): |
View full study record |
Document reference: 40076 |
Study title: Samoilenko I.G.,Yulish E.I., Gadetskaya S.G., Buchtiarov E.V.: New approach to treat pediatric patients suffering from bronchial asthma associated with intracellular infection. Biological Therapy (Ukraine), 2006, 4: 10-13 [IIT-publication] |
Active substance: Mucosa compositum |
Study summary document link (including results): |
View full study record |
Document reference: 40075 |
Study title: A 12-month, multicenter, open, single arm, pilot study to evaluate the safety, tolerability and efficacy of Myfortic® in combination with Neoral® and steroids in paediatric de novo renal transplant patients |
Active substance: MYCOPHENOLIC ACID |
Study summary document link (including results): Myfortic_publication of Article 45 result-related information_final Aug 2011.xls |
View full study record |
Document reference: 47289 |
Study title: A prospective, open label, multicenter, international protocol to assess the efficacy and safety of Myfortic® in kidney transplant recipients |
Active substance: MYCOPHENOLIC ACID |
Study summary document link (including results): Myfortic_publication of Article 45 result-related information_final Aug 2011.xls |
View full study record |
Document reference: 32437 |
Study title: Hanisch & Bock Title: Gelomyrtol forte in patients with acute and chronic bronchitis and sinusitis. A post-marketing surveillance study. |
Active substance: Myrtol (Destillat aus einer Mischung von rektifiziertem Eukalyptusöl, rektifiziertem Süßorangenöl, rektifiziertem Myrtenöl und rektifiziertem Zitronenöl im Verhältnis 66:32:1:1)(HERB) |
Study summary document link (including results): |
View full study record |
Document reference: 40079 |
Study title: Sengespeick Title: Gelomyrtol forte in patients with acute respiratory diseases. A post-marketing surveillance study. |
Active substance: Myrtol (Destillat aus einer Mischung von rektifiziertem Eukalyptusöl, rektifiziertem Süßorangenöl, rektifiziertem Myrtenöl und rektifiziertem Zitronenöl im Verhältnis 66:32:1:1)(HERB) |
Study summary document link (including results): |
View full study record |
Document reference: 40078 |
Study title: Open Label, Multicenter, Phase IIIB, Follow up Study to Investigate the Antibody Response to Hepatitis B, Acellular Pertussis and Inactivated Poliovirus Antigens one Month after the 4th Hexavac® Vaccination in Healthy Children, who Participated in the NeisVac-C Non-Interference Study 216 |
Active substance: N. meningitidis group C polysaccharide conjugated to tetanus toxoid adsorbed on Al3+ |
Study summary document link (including results): |
View full study record |
Document reference: 41293 |
Study title: Future of cannabis and cannabinoids in therapeutics |
Active substance: NABILONE |
Study summary document link (including results): |
View full study record |
Document reference: 32440 |
Study title: Nabilone vs. Compazine (Procloperazine) in the control of nausea and vomiting in cancer patients receiving chemotherapy |
Active substance: NABILONE |
Study summary document link (including results): |
View full study record |
Document reference: 32442 |
Study title: Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients |
Active substance: NABILONE |
Study summary document link (including results): |
View full study record |
Document reference: 32280 |
Study title: Nabilone: an alternative antiemetic for cancer chemotherapy |
Active substance: NABILONE |
Study summary document link (including results): |
View full study record |
Document reference: 32279 |
Study title: Use of cutoff pigtail catheters with intraluminal guidewires in interventional procedures in congenital heart disease; VERMA R; Cathet. Cardiovasc. Diagn.; 1994 vol.33 p.85 88Use of cutoff pigtail catheters with intraluminal guidewires in interventional procedures in congenital heart disease; VERMA R; Cathet. Cardiovasc. Diagn.; 1994 vol.33 p.85 88 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30434 |
Study title: Use of imaging for assessing anatomical relationships of tracheo bronchial anomalies associated with left pulmonary artery sling; LEE KH; Pediatr. Radiol.; 2001 vol.31 p.269 278Use of imaging for assessing anatomical relationships of tracheo bronchial anomalies associated with left pulmonary artery sling; LEE KH; Pediatr. Radiol.; 2001 vol.31 p.269 278 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30435 |
Study title: Use of oral contrast material in abdominal trauma CT scans : is it dangerous ?; FEDERLE MP; J. Trauma.; 1995 vol.38 n.1 p.51 53Use of oral contrast material in abdominal trauma CT scans : is it dangerous ?; FEDERLE MP; J. Trauma.; 1995 vol.38 n.1 p.51 53 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30436 |
Study title: Vena cavography with CO(2) versus with iodinated contrast material for inferior vena cava filter placement : a prospective evaluation; DEWALD CL; Radiology; 2000 vol.216 p.752 757Vena cavography with CO(2) versus with iodinated contrast material for inferior vena cava filter placement : a prospective evaluation; DEWALD CL; Radiology; 2000 vol.216 p.752 757 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30437 |
Study title: fehlermoglichkeit bei der ausscheidungsurographie; Klingmuller V., Wissensch. Inform.; 1981 vol.7 n.4 p.93-99fehlermoglichkeit bei der ausscheidungsurographie; Klingmuller V., Wissensch. Inform.; 1981 vol.7 n.4 p.93-99 |
Active substance: IOXAGLIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 30440 |
Study title: peritoneographie : utilisation d'un nouveau produit de contraste faiblement hyperosmolaire (AG 62-27)progres en peritoneographie grace a l'utilisationd'un nouveau produit de contraste faiblement hyperosmolaire (hexabrix); Rozenberg R., J. Radiol.; 1981 vol.62 n.2 p.123-126 J. Belge Radiol.; 1981 vol.64 p.151-155 peritoneographie : utilisation d'un nouveau produit de contraste faiblement hyperosmolaire (AG 62-27)progres en peritoneographie grace a l'utilisationd'un nouveau produit de contraste faiblement hyperosmolaire (hexabrix); Rozenberg R., J. Radiol.; 1981 vol.62 n.2 p.123-126 J. Belge Radiol.; 1981 vol.64 p.151-155 |
Active substance: IOXAGLIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 30441 |
Study title: "can duplex doppler ultrasound replace computerized tomography in staging patients with renal cell carcinoma ?; BOS SD; Scand. J. Urol. Nephrol.; 1998 vol.32 p.87 91" "can duplex doppler ultrasound replace computerized tomography in staging patients with renal cell carcinoma ?; BOS SD; Scand. J. Urol. Nephrol.; 1998 vol.32 p.87 91" |
Active substance: IOXITALAMIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 30512 |
Study title: Efficacy and tolerability of Ipratropium bromide solution in the prevention of exercise-induced bronchospasm in children. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U92-0573_synopsis.pdf |
View full study record |
Document reference: 30706 |
Study title: Efficacy and usability of Sch 1000 in capsules with powder inhalator in paediatrics (pilot study). Phase III. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U82-0222_synopsis.pdf |
View full study record |
Document reference: 30672 |
Study title: Efficacy of inhaled ipratropium bromide in acute bronchiolitis. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30555 |
Study title: Efficacy of inhaled ipratropium bromide in acute bronchiolitis. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U98-0091_synopsis.pdf |
View full study record |
Document reference: 30716 |
Study title: Evaluation of optimal effective dose and action duration of ipratropium bromide in reducing bronchospasm in children with reversible chronic obstructive airway disease. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30549 |
Study title: Evaluation of optimal effective dose and action duration of ipratropium bromide in reducing bronchospasm in children with reversible chronic obstructive airway disease. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U90-0054_synopsis.pdf |
View full study record |
Document reference: 30699 |
Study title: Evaluation of the therapeutic effect and tolerance of 4.5 mg Th 1165a suppositories in newborns and infants. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30587 |
Study title: Evaluation of the therapeutic effect of Th 1165a-suppositories in children during the night compared with placebo. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30592 |
Study title: Ipratropium bromide (Atrovent) maintenance therapy of bronchial asthma and spastic bronchitis: results of a multicenter study on 2557 cases. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30572 |
Study title: A double-blind group comparative study, comparing nedocromil sodium (4mg*4 daily) Minty flavoured formulation and placebo in the management of bronchial asthma in children - E. Weinberg - 1992 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46960 |
Study title: A double-blind comparative trial, placebo-controlled study to assess the efficacity of nedocromil sodium in the management of childhood grass-pollen asthma - L. Businco et al. - 1990 ( Clin Exp allergy vol 20) - Publication in Product licence application TILADE MINT AEROSOL (nedocromil sodium) -Clinical documentation -29/08/1995 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46961 |
Study title: A double-blind group comparative study nedocromil sodium 2% ophthalmic solution, 2% sodium cromoglycate eye drops and placebo in the treatment of vernal keratoconjunctivitis - Hennawi - 1988 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46962 |
Study title: A double-blind group comparative study of 2% nedocromil sodium eye drops and placebo in the treatment of perennial allergic conjunctivitis - Alexander et al. - no date - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46963 |
Study title: A double-blind group comparative study of 2% nedocromil sodium eye drops and placebo in the treatment of trachoma - El Mofti - 1988 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46964 |
Study title: A double-blind group comparative study of 2% nedocromil sodium eye drops and placebo in the treatment of vernal keratoconjunctivitis - Dahan -1988 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46965 |
Study title: A double-blind group comparative study of 2% nedocromil sodium eye drops in the treatment of seasonal allergic conjunctivitis - Easty et al. - 1986 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46966 |
Study title: A double-blind group comparative study of nedocromil sodium 2% ophthalmic solution and placebo in the treatment of chronic allergic conjunctivitis - El Guindi - 1988 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46967 |
Study title: A double-blind group comparative study of nedocromil sodium 2% ophthalmic solution and placebo in the treatment of vernal keratoconjunctivitis - Mostafa - 1989 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46968 |
Study title: A double-blind group comparative trial comparing nedocromil sodium 8 mg per day via metered dose inhaler and placebo in the management of bronchial asthma in children - L. Businco - 1990 (Clin Exp Allergy vol 20) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46969 |
Study title: A double-blind group comparative trial comparing nedocromil sodium and placebo in the management of bronchial asthma in children - G. Longo - 1986 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46970 |
Study title: A Double-Blind Group-Comparative Multicentre Trial of Nedocromil Sodium Metered-Dose 1% Aqueous Nasal Spray and Placebo in the Treatment of Children with Saesonal Allergic Rhinitis Caused by Polen, Kitchingman G.,1993, Medical Report |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 47016 |
Study title: A Double-Blind Multicenter Group Comparison Study of the Safety and Effectiveness of 0,5% Nedocromil Sodium Nebulizer Solution QID vs. Placebo in the Management of Bronchila Asthma in Children (6-12 Years old), 1993, Medical Report |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 47017 |
Study title: A double-blind multicentre group comparative study of efficacy and safety of TILADE (nedocromil sodium) QID vsPlacebo in the management of bronchial asthma in children (6-12 years old) - R. Biondi - 1990 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46971 |
Study title: A multicentre, open label assessment of the safety of flavoured non-CFC propellant (HFA-227) Formulation of necrodomil sodium 4 mg QID via metered dose inhaler over 40 weeks in adolescent and adult asthmatics - Claire Cutts et al. - 16/10/1996 |
Active substance: NEDOCROMIL |
Study summary document link (including results): Nedocromil-Study 3.pdf |
View full study record |
Document reference: 46995 |
Study title: A phase III multicentre open study to assess the safety of a flavoured alternative propellant (HFA-227) formulation of Nedocromil sodium 4 mg metered-dose inhaler and FISONAIR holding chamber, 4 times daily for one year in children with asthma |
Active substance: NEDOCROMIL |
Study summary document link (including results): Nedocromil-Study 2.pdf |
View full study record |
Document reference: 46996 |
Study title: A pilot assessor blind crossover randomised comparison of the relative efficacies of nedocromil sodium 2% eyes drops 1 drop QDS and fluorometholone 0,1% eye drops QDS in the treatment of vernal keratoconjunctivitis - Professor KF Tabbara et al. - 08/12/1996 |
Active substance: NEDOCROMIL |
Study summary document link (including results): Nedocromil-Study 1.pdf |
View full study record |
Document reference: 46997 |
Study title: A placebo-controlled comparison of ketotifen fumarate and nedocromil sodium ophthalmic solutions for the prevention of ocular itching wit-h the conjunctival allergen challenge model - JV. Greiner et al. - 2003 (Clin. Ther vol 25) - Publication in Clinical Expert Statement - Renewal of the Marketing Autorisation for Nedocromil eye drops in Turkey - DR. Bruno Verdoncq - 22/01/2007 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 47006 |
Study title: A placebo-controlled, blind comparison of nedocromil sodium and beclomethasone dipropionate in bronchial asthma - KC Bergmann et al. - 1989 (Curr Med Res Opin vol 11) - Publication in Product licence application TILADE MINT AEROSOL (nedocromil sodium) -Clinical documentation -29/08/1995 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 47023 |
Study title: A randomised, multicenter, double-blind, placebo controlled , group comparative study of TILADE (Necrodomil Sodium) 4 mg QID vs. Placebo administrated via metered dose inhaler (MDI) in the treatment of children with asthma which is exacerbated by ragweed pollen - Don Bukstein et al. - 05/12/1995 |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46998 |
Study title: A randomised, multicenter, double-blind, placebo controlled, group comparative study of the absolute efficacy and safety of Tilade (Nedocromil sodium) 4 mg QID in the treatment of children 6-11 years of age with bronchial asthma- Mark Ellis et al. - 4/07/1994 |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46999 |
Study title: A Randomized Double-Blind Multicenter Group Comparative Study in the Absolute Efficacy and Safety of Nedocromil Sodium 0,5% Nebulizer Solution TID in the Treatment of Children 2-4 Years of Age with Bronchial Asthma, 1993, Medical Report |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 47018 |
Study title: A Report of a Double-Blind Multicentre Group Comparative Study of the Efficacy and safety of Nedocromil Sodium in the Management of Asthma |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 47019 |
Study title: Multicentre, randomised, single-blind study in four parallel groups comparing the dose-response relation of ketoprofen (0,25 mg/kg/dose; 0,5 mg/kg/dose; 1 mg/kg/dose) against Paracetamol (15 mg/kg/dose) in the treatment of fever in children aged from 2 years to 6 years - Reinert Ph et al. - 06/1997 |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30867 |
Study title: Multicentre, randomised, single-dose single-blind study in four parallel groups comparing the dose-response relationship of ketoprofen (0,25 mg/kg/dose; 0,5 mg/kg/dose; 1 mg/kg/dose) against Paracetamol (15 mg/kg/dose) in the treatment of febrile diseases in the child age from 6 months to 24 months - Bourrillon A. et al. - 16/06/1997 |
Active substance: KETOPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30868 |
Study title: Multicentre, randomized, single-dose single-blind study in four parallel groups comparing the dose response relation of ketoprofen (0.25 mg/kg/dose; 0.5 mg/kg/dose; 1 mg/kg/dose) against paracetamol (15 mg/kg/dose) in the treatment of fever in children aged from 2 years to 6 years |
Active substance: KETOPROFEN |
Study summary document link (including results): Ketoprofen-Study 1.pdf |
View full study record |
Document reference: 30865 |
Study title: Multicentre, randomized, single-dose single-blind study in four parallel groups comparing the dose-response relationship of ketoprofen (0.25 mg/kg/dose; 0.5 mg/kg/dose; 1 mg/kg/dose) against paracetamol (15 mg/kg/dose) in the treatment of febrile diseases in child aged from 6 months to 24 months |
Active substance: KETOPROFEN |
Study summary document link (including results): Ketoprofen-Study 2.pdf |
View full study record |
Document reference: 30866 |
Study title: Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy |
Active substance: NABILONE |
Study summary document link (including results): |
View full study record |
Document reference: 32439 |
Study title: A Study of the Safety and Pharmacokinetics of Nabumetone and 6-MNA, and the Protein Binding of 6-MNA in Patients with Juvenile Rheumatoid Arthritis and in Healthy Adult Volunteers Following Repeated Oral Doses of Nabumetone (1000 mg) Chewable Tablets Report No. SB Document Number: BRL-014 117I RSD1- 00NTK/ |
Active substance: Nabumetone |
Study summary document link (including results): Study 222 Nabumetone.xls |
View full study record |
Document reference: 47216 |
Study title: An open-label study assessing the population pharmacokinetics, safety and efficacy of nabumetone in patients with juvenile rheumatoid arthritis (JRA) requiring NSAID therapy. |
Active substance: NABUMETONE |
Study summary document link (including results): Nabumetone-14777262-ICHE3.pdf |
View full study record |
Document reference: 32444 |
Study title: Laporte S, Mismetti P, Piquet P, Doubine S, Touchot A, Decousus H. Population pharmacokinetic of nadroparin calcium (Fraxiparine) in children hospitalised for open heart surgery. European Journal of Pharmaceutical Sciences 1999;8:119-25." EJPS 1999:8:119-25 |
Active substance: NADROPARIN |
Study summary document link (including results): |
View full study record |
Document reference: 32448 |
Study title: The use of CY216 (fraxiparine) in Paediatric haemodialysis Fraxiparine : premier symposium international; 01 Nov 1987-01 Nov 1987; Paris, France. 2005. 19-19. |
Active substance: NADROPARIN |
Study summary document link (including results): |
View full study record |
Document reference: 32449 |
Study title: Büttner-Nalbuphine and piritramid in the postoperative period in young children. |
Active substance: NALBUPHINE |
Study summary document link (including results): |
View full study record |
Document reference: 32453 |
Study title: Büttner-Nalbuphine and piritramid in the postoperative phase in young children. |
Active substance: NALBUPHINE |
Study summary document link (including results): |
View full study record |
Document reference: 32452 |
Study title: Habre-Analgesic and respiratory effect of nalbuphine and pethidine for adenotonsillectomy in children with obstructive sleep disorder. |
Active substance: NALBUPHINE |
Study summary document link (including results): |
View full study record |
Document reference: 32451 |
Study title: "A meta-analysisi of randomized, controlled trials comparing short and long-course antibiotic therapy for urinary tract infections in children - Keren R. - 2002 (Pediatrics, 109,5) - Publication in CES EXPCRC-CES0164-EN01 - Eugène D. - 25 Apr. 2003 -" |
Active substance: Nalidixic acid |
Study summary document link (including results): |
View full study record |
Document reference: 32455 |
Study title: Nalidixic acid : Critical assessment on the pharmacotoxicological documentation - Gouy D. - 23 May 2003 |
Active substance: NALIDIXIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 32454 |
Study title: Publication in the critical assessment on the pharmacotoxicological documentation - Gouy D. - 23 May 2003 : Quinolone arthropathy in juvenile New Zealand White rabbits.- Sharpnack DD. - 1994 |
Active substance: Nalidixic acid |
Study summary document link (including results): |
View full study record |
Document reference: 32456 |
Study title: Publication in the critical assessment on the pharmacotoxicological documentation - Gouy D. - 23 May 2003 : Review of quinolone arthropathy in the dog. - Burkhardt JE - 1996 (Chemotherapy Journal, 5, 13:14-18) |
Active substance: Nalidixic acid |
Study summary document link (including results): |
View full study record |
Document reference: 32457 |
Study title: B. Kamiński - ,,Clinical trial of Naloxone Polfa" |
Active substance: NALOXONE |
Study summary document link (including results): |
View full study record |
Document reference: 32459 |
Study title: Sandyk - Naloxone abolishes self-injuring in a mentally retarded child.Sandyk - Ann Neurol. 1985 May;17(5):520Sandyk - Naloxone abolishes self-injuring in a mentally retarded child.Sandyk - Ann Neurol. 1985 May;17(5):520 |
Active substance: NALOXONE |
Study summary document link (including results): |
View full study record |
Document reference: 32460 |
Study title: Deas - Naltrexone treatment of adolescent alcoholics: an open-label pilot study. Deas et al. J Child Adolesc Psycho-pharmacol. 2005; 15(5):723-8.Deas - Naltrexone treatment of adolescent alcoholics: an open-label pilot study. Deas et al. J Child Adolesc Psycho-pharmacol. 2005; 15(5):723-8. |
Active substance: NALTREXONE |
Study summary document link (including results): |
View full study record |
Document reference: 32461 |
Study title: Effects of Naltrexone on the Autistic Syndrome, Double-Blind, Placebo Controlled Crossover Design Study |
Active substance: NALTREXONE |
Study summary document link (including results): Protocol DuP 393-015 Naltrexone.pdf |
View full study record |
Document reference: 32462 |
Study title: Am J Roenge nol Radium Ther Nucl Med 1975;124:638-42. |
Active substance: NANDROLONE |
Study summary document link (including results): |
View full study record |
Document reference: 32447 |
Study title: An Open-label Trial Evaluating the Safety and Efficacy of NOLVADEX (tamoxifen citrate) in the Treatment of McCune-Albright SyndromeAn Open-label Trial Evaluating the Safety and Efficacy of NOLVADEX (tamoxifen citrate) in the Treatment of McCune-Albright Syndrome |
Active substance: TAMOXIFEN |
Study summary document link (including results): 6157US0013 CSR Synopsis[1].pdf |
View full study record |
Document reference: 43084 |
Study title: An update on the treatment of precocious puberty in McCune-Albright syndrome and testotoxicosis. Haddad NARA, E-mail: nhaddad@iupui.edu], Eugster E. Journal of Pediatric Endocrinology & Metabolism~ 20(6):653-661, JUN 2007 2007;(6):-661, JUN.An update on the treatment of precocious puberty in McCune-Albright syndrome and testotoxicosis. Haddad NARA, E-mail: nhaddad@iupui.edu], Eugster E. Journal of Pediatric Endocrinology & Metabolism~ 20(6):653-661, JUN 2007 2007;(6):-661, JUN. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43252 |
Study title: arcon-Vargas D, Zhang Z, Agarwal B, Challagulla K, Mani S, Kalpana GV. Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors. Oncogene 2006; 25(5):722-734.arcon-Vargas D, Zhang Z, Agarwal B, Challagulla K, Mani S, Kalpana GV. Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors. Oncogene 2006; 25(5):722-734. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43133 |
Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43108 |
Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43129 |
Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology 1999; 16(3):245-250.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology 1999; 16(3):245-250. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43148 |
Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43187 |
Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43197 |
Study title: A double-blind multicentre group comparative study of efficacy of TILADE (Nedocromil sodium, 4 mg QID) in the management of bronchial asthma in children - H. Eigen - 1989 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46972 |
Study title: A double-blind multicentre group comparative trial of the efficacy and safety of nedocromil sodium 4 mg four times daily and placebo by metered dose inhaler in the management of bronchial asthma in children - L. Armerio et al. - 1993 (Arch Dis Child vol 68) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46973 |
Study title: A double-blind parallel group study comparing the effect of nedocromil sodium (4 mg TID) via a Nebuhaler. Device and placebo on bronchial hyperreactivity and diurnal variation in PEFR in children with asthma - P. Sly - 1993 (J. Asthma vol 30) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46974 |
Study title: A double-blind randomised crossover investigation to compare the acceptability of Tiliade Mint 8 mg (4 puffs) twice saily taken by metered dose inhaler via the fusionair with Intal 20 mg (4 puffs) twice daily taken by metered dose inhaler via the fusionair in paediatric asthmatics aged 2-5 years - AJ. Williams - 1993 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46975 |
Study title: A double-blind study to assess the efficacy and duration of protection of nedocromil sodium given by pressurised aerosol in asthmatic children in exercise challenge tests - A. Boner - 1985 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46976 |
Study title: A double-blind, crossover trial comparing "Tilade" (Nedocromil sodium) 4 mg three times daily and "INTAL" (Sodium cromoglycate) 4 mg three times daily in the management of children with bronchial asthma, currently being treated with "INTAL", 2 mg three times daily but responding at a sub-optimal level - C. Mellis - 1990 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46977 |
Study title: Comparison of the curative effect of IK 6 metered aerosol and its individual constituents in a provocation test with antigen inhalation. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30567 |
Study title: Comparison of the curative effect of IK 6 metered aerosol and its individual constituents in a provocation test with antigen inhalation. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30668 |
Study title: Comparison of the efficacy of preservative free ipratropium bromide and Atrovent nebuliser solution in children with asthma (Should ipratropium bromide be preservative free ?). |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30644 |
Study title: Comparison of the efficacy of preservative free ipratropium bromide and Atrovent nebuliser solution in children with asthma (Should ipratropium bromide be preservative free ?). |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U88-0553 _synopsis.pdf |
View full study record |
Document reference: 30697 |
Study title: Comparison of the long term effect of Fenoterol hydrobromide and Theophylline syrups in pre-school asthmatic children. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30610 |
Study title: Comparison of the protective action of Berodual solution (IK 37) and Intal in cases of allergen-provoked bronchoconstriction in children. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30606 |
Study title: Comparison of the protective action of Berodual solution (IK 37) and Intal in cases of allergen-provoked bronchoconstriction in children. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30667 |
Study title: Comparison of the safety profile of fenoterol administered by Lactose inhalets (100 mcg/Inhalet) or by MDI (100 mcg/puff) in paediatric patients with asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30560 |
Study title: Comparison of treatment with IK 6 and SCH 1000 used as capsules by means of a powder inhaler in paediatrics. Phase III. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30570 |
Study title: "A placebo-controlled comparison of ketotifen fumarate and nedocromil sodium ophthalmic solutions for the prevention of ocular itching with the conjunctival allergen challenge model. Greiner JV, Minno G. Clin. Ther. 2003 Jul; 25(7): 1988-2005. " "A placebo-controlled comparison of ketotifen fumarate and nedocromil sodium ophthalmic solutions for the prevention of ocular itching with the conjunctival allergen challenge model. Greiner JV, Minno G. Clin. Ther. 2003 Jul; 25(7): 1988-2005. " |
Active substance: KETOTIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30953 |
Study title: A. Chmielewska - Comperative trial on ketotifen table and sirup with Zaditernem |
Active substance: KETOTIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30950 |
Study title: Abelson MB. Six-week safety trial of ketotifen fumarate 0.025% ophthalmic solution in volunteers with normal ocular health. CIBA Vision Corp., Duluth, Georgia, USA: 23.11.1998. Abelson MB. Six-week safety trial of ketotifen fumarate 0.025% ophthalmic solution in volunteers with normal ocular health. CIBA Vision Corp., Duluth, Georgia, USA: 23.11.1998. |
Active substance: KETOTIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 26056 |
Study title: DOSE RESPONSE STUDY OF EXERCISE-INDUCED ASTHMA IN ADOLESCENTS AND YOUNGADULTS. CONCENTRATIONS OF PRE-AND POST-EXERCISE PLASMA SAMPLES ATDIFFERENT DOSES OF CAPSULES, (KNGL 6604, BATCH NR. 001G7; 1MG). |
Active substance: KETOTIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30951 |
Study title: " Efficacy and safety of single- and multiple-dose ketotifen fumarate 0,025% ophthalmic solution in a pediatric population. Abelson MB, Ferzola NJ, McWhirter CL, Crampton HJ. Pediatr Allergy Immunol 2004 Dec; 15(6):551-7" " Efficacy and safety of single- and multiple-dose ketotifen fumarate 0,025% ophthalmic solution in a pediatric population. Abelson MB, Ferzola NJ, McWhirter CL, Crampton HJ. Pediatr Allergy Immunol 2004 Dec; 15(6):551-7" |
Active substance: KETOTIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30955 |
Study title: Multicentre, double-masked, parallel-group, prospective, balanced-randomized, comparative trial using a vehicle and an active control. |
Active substance: KETOTIFEN |
Study summary document link (including results): Zaditen Ophtha Paediatric Studies_NHDR 42000-97-3_ EMA spreadsheet.xls |
View full study record |
Document reference: 47299 |
Study title: Multicentre, randomised, double-dummy, controlled, dose-finding 120472 |
Active substance: KETOTIFEN |
Study summary document link (including results): Zaditen_TabulazioneReport_16Oct11.xls |
View full study record |
Document reference: 48187 |
Study title: "Ocular tolerability and safety of ketotifen fumarate ophthalmic solution. Abelson MB, Chapin MJ, Kapik BM, Shams NB. Adv. Ther. 2002 Jul-Aug; 19(4): 161-9 " "Ocular tolerability and safety of ketotifen fumarate ophthalmic solution. Abelson MB, Chapin MJ, Kapik BM, Shams NB. Adv. Ther. 2002 Jul-Aug; 19(4): 161-9 " |
Active substance: KETOTIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30954 |
Study title: A Report of a Double-Blind Multicentre Group Comparative Study of the Efficacy and safety of Nedocromil Sodium in the Management of Asthma |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 47951 |
Study title: A single-blind, multicentre, randomised, group comparative, 12- week post-marketing surveillance study demonstrate the safety of sodium cromoglycate 5 mg MDI versus INTAL 5 mg (5MG/10 mg q.i.d.) in 3600 adults, adolescent and paedriatric asthmatic patients - Domège N et al. - 31/05/2001 |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 47000 |
Study title: Accuracy of mini peak flow meters in indicating changes in lung function in children with asthma - PD Sly et al. -1994 (BMJ vol 308) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46956 |
Study title: Chronic cough in childhood : approch to diagnosis and treatment - DP. Parks et al. - 1988 (J. of pedriatrics vol 115) |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 47025 |
Study title: Comparison of nedocromil sodium and sodium cromoglycate administered by pressurised aerosol, with and without a spacer device in exercise-induced asthma in children - A. Comis et al. - 1993 (Eur Resp J vol 6) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 47026 |
Study title: J Clin Path 1976;29:626-33.; |
Active substance: NANDROLONE |
Study summary document link (including results): |
View full study record |
Document reference: 32446 |
Study title: J Paediatr 1974; 84:109-10.; |
Active substance: NANDROLONE |
Study summary document link (including results): |
View full study record |
Document reference: 32445 |
Study title: A Double Blind, Parallel, Multicentre Comparison of Tenoxicam with Naproxen in the Treatment of Children and Adolescents Suffering from Juvenile Chronic Arthritis (JCA). |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46953 |
Study title: A randomised double blind multiple dose study to compare the analgesic efficacy and safety of Naproxen Sodium 220 mg and Ibuprofen 200 mg for the treatment of dysmenorrhea |
Active substance: NAPROXEN |
Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-00138_study_synopsis.pdf |
View full study record |
Document reference: 47071 |
Study title: A single-dose efficacy and safety comparison of Aleve®, Tylenol® No.3, and Placebo in dental pain |
Active substance: NAPROXEN |
Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-01267_study_synopsis.pdf |
View full study record |
Document reference: 47143 |
Study title: An Efficacy and Safety Study Comparing Single Doses of Aleve®, Extended Release Tylenol® and Placebo in Dental Pain |
Active substance: NAPROXEN |
Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-01273_study_synopsis.pdf |
View full study record |
Document reference: 47146 |
Study title: An efficacy and safety study comparing single doses of Aleve®, extended-release Tylenol and placebo in dental pain. |
Active substance: NAPROXEN |
Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-01268_study_synopsis.pdf |
View full study record |
Document reference: 47144 |
Study title: Antipyretic activity of naproxen in children: Comparison with aspirin and placebo. |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46943 |
Study title: Antipyretic effect of naproxen in children. |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46935 |
Study title: Bioavailability and efficacy of naproxen suspension in children with postoperative pain. |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46940 |
Study title: Bioavailability of naproxen suspension in pain compared with fever in children. |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46946 |
Study title: Clinical assessment of the antipyretic efficacy of naproxen compared to paracetamol in paediatric patients. |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46954 |
Study title: Clinical assessment of the entipyretic efficacy of naproxen compared with paracetamol in paediatric patients. |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46951 |
Study title: Comparison of naproxen sodium, Advil® and placebo in subjects with acute ankle sprains. |
Active substance: NAPROXEN |
Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-01269_study_synopsis.pdf |
View full study record |
Document reference: 47145 |
Study title: Double-blind clinical trial - naproxen sodium suspension vs placebo in postoperative adeno-tonsillectomy in children. |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46934 |
Study title: II/NAPS011/GER: Clinical assessment of the antipyretic efficacy of naproxen compared to paracetamol in paediatric patients. |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46948 |
Study title: Methodology Study Comparing Naproxen, Ibuprofen and Placebo in Subjects with Acute Ankle Sprains |
Active substance: NAPROXEN |
Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-00919_study_synopsis.pdf |
View full study record |
Document reference: 47140 |
Study title: Multiple Dose Safety and Efficacy Comparison of Naproxen with Placebo in the Treatment of Pain Secondary to Dental Impaction Surgery |
Active substance: NAPROXEN |
Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-00976_study_synopsis.pdf |
View full study record |
Document reference: 47141 |
Study title: Multiple-dose safety and efficacy comparison of naproxen and placebo in the treatment of pain secondary to dental impaction surgery |
Active substance: NAPROXEN |
Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-00974_study_synopsis.pdf |
View full study record |
Document reference: 47072 |
Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43207 |
Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43211 |
Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43221 |
Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43231 |
Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43241 |
Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43324 |
Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000; 18(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000; 18(6):1246-1253. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43146 |
Study title: Comparison of treatment with IK 6 and SCH 1000 used as capsules by means of a powder inhaler in paediatrics. Phase III. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30673 |
Study title: Determination of an effective dose of fenoterol, as free as possible from side effects for regular therapeutic use in obstructive respiratory tract diseases. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30619 |
Study title: Dose and placebo comparison of Th 1165a suppositories (3.0 to 10.5 mg) in children with acute bronchospasm. Multicentre trial STK. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30582 |
Study title: Double-blind, controlled trial to assess the efficacy of ipratropium bromide associated with high dose salbutamol by repeated nebulisation versus repeated nebulisation of salbutamol alone, for 120 minutes, in acute asthmatic attacks in young children. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30554 |
Study title: Double-blind, controlled trial to assess the efficacy of ipratropium bromide associated with high dose salbutamol by repeated nebulisation versus repeated nebulisation of salbutamol alone, for 120 minutes, in acute asthmatic attacks in young children |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U00-0090_synopsis.pdf |
View full study record |
Document reference: 30627 |
Study title: Duovent inhalets compared with inhaler in asthmatic children. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30695 |
Study title: Durban trial of Atrovent: statistical analysis of results. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30571 |
Study title: Durban trial of Atrovent: statistical analysis of results. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U83-0398_synopsis.pdf |
View full study record |
Document reference: 30676 |
Study title: Effect of ipratropium bromide on the diurnal variation of asthma in children |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U85-0252_synopsis.pdf |
View full study record |
Document reference: 30620 |
Study title: Effect of ipratropium bromide on the diurnal variation of asthma in children. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30547 |
Study title: Efficacy and suitability of IK 6 as a capsule administered with a powder inhaler in children. Phase III. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30674 |
Study title: To evaluate, in an open pilot study, the effect on lungfunction of Ipratropium bromide inhalation solution and the additional effect of a beta 2-agonist (Salbutamol inhalation solution) in children with an acute attack of asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30542 |
Study title: To evaluate, in an open pilot study, the effect on lungfunction of Ipratropium bromide inhalation solution and the additional effect of a beta 2-agonist (Salbutamol inhalation solution) in children with an acute attack of asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30629 |
Study title: To evaluate, in an open pilot study, the effect on lungfunction of Ipratropium bromide inhalation solution and the additional effect of a beta 2-agonist (Salbutamol inhalation solution) in children with an acute attack of asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U93-0136_synopsis.pdf |
View full study record |
Document reference: 30708 |
Study title: Tolerability and acceptability of Ipratropium bromide - Dry powder form in children with asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U92-0812_synopsis.pdf |
View full study record |
Document reference: 30707 |
Study title: Treatment of acute bronchial asthma comparison between epinephrine (injections - subcutaneous) and fenoterol (inhalation). |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30616 |
Study title: A comparison of the safety profile of fenoterol |
Active substance: IPRATROPIUM AND FENOTEROL |
Study summary document link (including results): Fenoterol hydrobromide_U99-0056_synopsis.pdf |
View full study record |
Document reference: 30742 |
Study title: Duovent inhalets compared with inhaler in asthmatic children. |
Active substance: IPRATROPIUM AND FENOTEROL |
Study summary document link (including results): Fenoterol hydrobromide_U82-0226_synopsis.pdf |
View full study record |
Document reference: 30728 |
Study title: A multicentre double-blid group comparative study 2% nedocromil sodium eye drops and placebo in the treatment of seasonal allergic conjunctivitis - Kreindler et al. - 1987 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46979 |
Study title: A Multicentre double-blind group comparative study 2% nedocromil sodium eye drops and placebo in the treatment of seasonal allergic conjunctivitis - Leino et al. - 1987 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46980 |
Study title: A Multicentre double-blind group comparative study 2% nedocromil sodium eye drops and placebo in the treatment of seasonal allergic conjunctivitis- Blumenthal et al. - 1987 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46981 |
Study title: A multicentre double-blind group comparative study nedocromil sodium 2% ophthalmic solution, 2% sodium cromoglycate eye drops and placebo in the treatment of seasonal allergic conjunctivitis due to birch pollen - Posti et al. - 1989 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46982 |
Study title: A multicentre double-blind group comparative study of 2% nedocromil sodium eye drops and placebo in the treatment of seasonal alllergic conjunctivitis - Greenbaum et al. -1986 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46983 |
Study title: A multicentre double-blind group comparative study of 2% nedocromil sodium eye drops, 2% sodium cromoglycate and placebo in the treatment of seasonal Allergic conjunctivitis - Alexander et al. - 1987 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46984 |
Study title: A multicentre double-blind group comparative study of 2% nedocromil sodium ophthalmic solution and oral terfenadine in the treatment of seasonal allergic conjunctivitis - Stockwell et al. - 1987 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46985 |
Study title: A multicentre double-blind group comparative study of nedocromil sodium 2% ophthalmic solution and placebo in the treatment of seasonal allergic conjunctivitis - Bloch-Michel et al. - 1988 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46986 |
Study title: A multicentre double-blind group comparative study of nedocromil sodium 2% ophthalmic solution and placebo in the treatment of seasonal allergic conjunctivitis carried out in general practice - Rodgers et al. - 1988 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46987 |
Study title: A multicentre double-blind group comparative study of nedocromil sodium 2% ophthalmic solution and placebo in the treatment of seasonal allergic conjunctivitis in children - Berg et al. - 1989 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46988 |
Study title: A multicentre double-blind group comparative study of nedocromil sodium 2% ophthalmic solution and placebo in the treatment of vernal keratoconjunctivitis- Mala - 1987 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46989 |
Study title: A multicentre double-blind group comparative study of the efficacy and safety of nedocromil sodium 2% ophthalmic solution in the treatment of Ragweed-induced seasonal allergic conjunctivitis- Blumenthal et al. - 1986 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46991 |
Study title: A multicentre double-blind group coparative study of nedocromil sodium 2% ophthalmic solution QID, BD and placebo in the treatment of perennial allergic conjunctivitis - Adenis et al. - 1990 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
Active substance: NEDOCROMIL |
Study summary document link (including results): |
View full study record |
Document reference: 46992 |
Study title: Multiple-dose safety and efficacy comparison of naproxen and placebo in the treatment of pain secondary to dental impaction surgery |
Active substance: NAPROXEN |
Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-00975_study_synopsis.pdf |
View full study record |
Document reference: 47073 |
Study title: Naproxen in secretory diarrhea in children. |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46949 |
Study title: Naproxen in the treatment with juvenile rheumatoid arthritis. |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46938 |
Study title: Naproxen suspension compared with placebo suspension as adjuncts to antibiotics in the treatment of acute otitis media in children. |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46952 |
Study title: Naproxen suspension in juvenile rheumatoid arthritis and other rheumatic manifestations in children. |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46947 |
Study title: Naproxen suspension in the treatment of postoperative pain in children: a multiple dose study. |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46939 |
Study title: Naproxen versus aspirin in children. |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46937 |
Study title: Naproxen versus codeine in paediatric pain. |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46945 |
Study title: Naproxen versus paracetamol in paediatric pyrexia: a single blind parallel study. |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46950 |
Study title: Naproxen, Ibuprofen and Placebo Dosing Compliance Study in Natural Common Colds |
Active substance: NAPROXEN |
Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-01243_study_synopsis.pdf |
View full study record |
Document reference: 47074 |
Study title: Naproxen, Ibuprofen and Placebo dosing compliance study in natural common colds. |
Active substance: NAPROXEN |
Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-01244_study_synopsis.pdf |
View full study record |
Document reference: 47075 |
Study title: Naproxen, ibuprofen, and placebo dosing compliance study in natural common colds |
Active substance: NAPROXEN |
Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-01242_study_synopsis.pdf |
View full study record |
Document reference: 47142 |
Study title: Open study of the metabolism of naproxen in children. |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46936 |
Study title: Pharmacokinetics of naproxen tablets and naproxen suspension in febrile adults and children. |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46955 |
Study title: Richiamo con dapiprazolo collirio della midriasi da fenilefrina in pazienti a rischio e non |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46930 |
Study title: Single dose methodology pilot study comparing the safety and efficacy of naproxen, ibuprofen and placebo in treatment of pain secondary to dental impaction surgery |
Active substance: NAPROXEN |
Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-01519_study_synopsis.pdf |
View full study record |
Document reference: 47147 |
Study title: Single-dose efficacy comparison of Naproxen, ibuprofen and placebo in the treatment of pain secundary to dental impaction surgery |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46933 |
Study title: Single-Dose Safety and Efficacy Comparison of Naproxen and Ibuprofen with Placebo in the Treatment of Pain Secondary to Dental Impaction Surgery |
Active substance: NAPROXEN |
Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-01555_study_synopsis.pdf |
View full study record |
Document reference: 47148 |
Study title: Single-dose safety and efficacy comparison of Naproxen Sodium plus Caffeine to Naproxen Sodium, Caffeine and Placebo in Dental pain |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46932 |
Study title: Single-dose safety and efficacy comparison of naproxen, acetaminophen and aspirin with placebo in the treatment of pain secondary to dental impaction surgery |
Active substance: NAPROXEN |
Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-423289_study_synopsis.pdf |
View full study record |
Document reference: 47076 |
Study title: Studio di valutazione dell'efficacia del dapiprazolo collirio nella preparazione del paziente da sottoporre all'intervento di yag-laser iridotomia e argon-laser trabeculoplastica |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46931 |
Study title: Study of the plasma levels from a single dose of naproxen in children. |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46944 |
Study title: Use of naproxen in children. |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46942 |
Study title: Use of naproxen in children’s joint diseases. |
Active substance: NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 46941 |
Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000; 18(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000; 18(6):1246-1253. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43166 |
Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000; 18(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000; 18(6):1246-1253. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43171 |
Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000; 18(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000; 18(6):1246-1253. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43177 |
Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43185 |
Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43195 |
Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43205 |
Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43342 |
Study title: Effect of the combination of ipratropium bromide and fenoterol (berodual) in patients with asthmatic crises comparative study with fenoterol (Berotec). |
Active substance: IPRATROPIUM AND FENOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 30729 |
Study title: Efficacy and suitability of IK 6 as a capsule administered with a powder inhaler in children. Phase III. |
Active substance: IPRATROPIUM AND FENOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 30730 |
Study title: Evaluation of the therapeutic action and tolerance of IK 37 in infants and children up to six years of age. |
Active substance: IPRATROPIUM AND FENOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 30731 |
Study title: Report to Boehringer-Ingelheim, Australia on clinical trial to determine the optimum dose of nebulised ipratropium bromide (Atrovent) solution (0.020 %) in children with chronic asthma. |
Active substance: IPRATROPIUM AND FENOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 30732 |
Study title: Safety profile of the combination ipratropium bromide (20 mcg)/fenoterol hydrobromide (50 mcg) 2 puffs t.i.d. delivered by an MDI aerosol formulated with CFC propellants compared to an MDI formulation with the propellant HFA 134a, in pediatric patients in asthma |
Active substance: IPRATROPIUM AND FENOTEROL |
Study summary document link (including results): Fenoterol hydrobromide_U84-0885_synopsis.pdf |
View full study record |
Document reference: 30733 |
Study title: Statistical report - A dose response and duration of action study of Duovent nebuliser solution in paediatrics. |
Active substance: IPRATROPIUM AND FENOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 30734 |
Study title: Statistical report - A dose response and duration of action study of Duovent nebuliser solution in paediatrics. |
Active substance: IPRATROPIUM AND FENOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 30735 |
Study title: Statistical report: A dose response and duration of action study of Duovent nebuliser solution in paediatrics. |
Active substance: IPRATROPIUM AND FENOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 30736 |
Study title: Study of pharmacodynamic and clinical response to bronchodual of asthmatic children with obstruction during the intercritical period. Clinical correlations and fuctions. |
Active substance: IPRATROPIUM AND FENOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 30737 |
Study title: Study of pharmacodynamic and clinical response to bronchodual of asthmatic children with obstruction during the intercritical period. Clinical correlations and fuctions. |
Active substance: IPRATROPIUM AND FENOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 30738 |
Study title: Study of the action of Berodual as a chronic treatment on the non-specific bronchial hyper-reactivity in children. |
Active substance: IPRATROPIUM AND FENOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 30739 |
Study title: Study on the acceptance of the multicapsule inhalator Boehringer Ingelheim M. Berodual inhalets are used. |
Active substance: IPRATROPIUM AND FENOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 30740 |
Study title: De Beule K, Van Cutsem J, Cauwenbergh G, Wesel S, Herman PH, Baekelandt J, Houben PWM, Scheurwegh W, Godts P. Oral itraconazole versus topical clotrimazole in acute vulvovaginal candidosis: a randomized comparative trial. Clinical research report on R051211 no-101, May 1989.(16-65 years, LMD68115)De Beule K, Van Cutsem J, Cauwenbergh G, Wesel S, Herman PH, Baekelandt J, Houben PWM, Scheurwegh W, Godts P. Oral itraconazole versus topical clotrimazole in acute vulvovaginal candidosis: a randomized comparative trial. Clinical research report on R051211 no-101, May 1989.(16-65 years, LMD68115) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30816 |
Study title: De Beulke K, Van Cutsem J, Cauwenbergh G. Itraconazole: A one-day oral treatment for vaginal candidosis: results of an open multicentre study. Clinical research report on R051211 no-100, March 1989. (15-64 years, LMD65820)De Beulke K, Van Cutsem J, Cauwenbergh G. Itraconazole: A one-day oral treatment for vaginal candidosis: results of an open multicentre study. Clinical research report on R051211 no-100, March 1989. (15-64 years, LMD65820) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30815 |
Study title: Decroix J, et al Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manus. Clinical research report on R051211 no-70, May 1987. (10-75 years, LMD56441)Decroix J, et al Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manus. Clinical research report on R051211 no-70, May 1987. (10-75 years, LMD56441) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30786 |
Study title: Decroix J, et al Open evaluation of itraconazole at daily doses of 50, 100, and 150 mg in the treatment of dermatophyte infections of the skin. A study of the time to response. Clinical summary on R51211, August 1987. (6-81 years, LMD56453)Decroix J, et al Open evaluation of itraconazole at daily doses of 50, 100, and 150 mg in the treatment of dermatophyte infections of the skin. A study of the time to response. Clinical summary on R51211, August 1987. (6-81 years, LMD56453) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30795 |
Study title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of PROVIGIL® (Modafinil) Treatment (100, 200 and 400mg/day) in Children and Adolescents with Excessive Sleepiness Associated with Narcolepsy. |
Active substance: MODAFINIL |
Study summary document link (including results): EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls |
View full study record |
Document reference: 45275 |
Study title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of PROVIGIL® (Modafinil) Treatment (100,200 and 400mg/day) in Children and Adolescents with Excessive Sleepiness Associated with Obstructive Sleep Apnea/Hypopnea Syndrome. |
Active substance: MODAFINIL |
Study summary document link (including results): EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls |
View full study record |
Document reference: 45276 |
Study title: A Randomized Open-Label Study to Compare the Relative Bioavailability of 170 mg of Modafinil Film-Coated Tablets to 200 mg of PROVIGIL® and to Assess the Pharmacokinetic and Safety Profile of Multiple Doses of the Modafinil Film-Coated Tablets Administered at Doses of 340 and 425 mg to Children and Adolescents With Attention-Deficit/Hyperactivity Disorder. |
Active substance: MODAFINIL |
Study summary document link (including results): EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls |
View full study record |
Document reference: 45284 |
Study title: A randomized double-blind study comparing the efficacy of single doses of ibuprofen 200 mg, ibuprofen 400 mg, ibuprofen 200 mg plus caffeine 100 mg, ibuprofen 400 mg plus caffeine 200 mg, caffeine 100 mg, and placebo in the treatment of post-operative dental pain |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29566 |
Study title: "ADHD: new pharmacological treatments on the horizon. FA Lopez, Journal of Developmental and Behavioral Pediatrics - JDBP 2006, 27(5): 410-6 "ADHD: new pharmacological treatments on the horizon. FA Lopez, Journal of Developmental and Behavioral Pediatrics - JDBP 2006, 27(5): 410-6 |
Active substance: MODAFINIL |
Study summary document link (including results): |
View full study record |
Document reference: 45676 |
Study title: An 8-Week, Open-Label Study to Characterize the Response to Modasomil (85-mg Film-Coated Tablet) Treatment at Dosages Up to 425 mg/day in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD) (With an Open-Ended Extension Period). |
Active substance: MODAFINIL |
Study summary document link (including results): EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls |
View full study record |
Document reference: 45279 |
Study title: An open-label assessment of modafinil on attention and fatigue in adolescent and adult AD(H)D subjects.Duane D; Heimberger G; Welch A;Sleep 2004; 27(s)/A47 An open-label assessment of modafinil on attention and fatigue in adolescent and adult AD(H)D subjects.Duane D; Heimberger G; Welch A;Sleep 2004; 27(s)/A47 |
Active substance: MODAFINIL |
Study summary document link (including results): |
View full study record |
Document reference: 45667 |
Study title: "An open-label assessment of modafinil on attention and fatigue in adolescent and adult AD(H)D subjects.Duane D; Heimberger G; Welch A;Sleep 2004; 27(s)/A47 "An open-label assessment of modafinil on attention and fatigue in adolescent and adult AD(H)D subjects.Duane D; Heimberger G; Welch A;Sleep 2004; 27(s)/A47 |
Active substance: MODAFINIL |
Study summary document link (including results): |
View full study record |
Document reference: 45675 |
Study title: Double Blind Study on the Effect of Modafinil in Urinary Incontinence of Neurologic Origin. |
Active substance: MODAFINIL |
Study summary document link (including results): |
View full study record |
Document reference: 45285 |
Study title: "Effects of modafinil in children with attention-deficit/hyperactivity disorder: an open-label study. TA Rugino & TC Copley, Journal of the American Academy of Child and Adolescent Psychiatry 2001, 40(2): 230-5. "Effects of modafinil in children with attention-deficit/hyperactivity disorder: an open-label study. TA Rugino & TC Copley, Journal of the American Academy of Child and Adolescent Psychiatry 2001, 40(2): 230-5. |
Active substance: MODAFINIL |
Study summary document link (including results): |
View full study record |
Document reference: 45663 |
Study title: [Effects of modafinil on visual and auditory reaction abilities and subjective fatigue level during 48 h sleep deprivation] Y Li, et al., Hang Tian Yi Xue Yu Yi Xue Gong Cheng = Space Medicine & Medical Engineering 2003, 16(4): 277-80.[Effects of modafinil on visual and auditory reaction abilities and subjective fatigue level during 48 h sleep deprivation] Y Li, et al., Hang Tian Yi Xue Yu Yi Xue Gong Cheng = Space Medicine & Medical Engineering 2003, 16(4): 277-80. |
Active substance: MODAFINIL |
Study summary document link (including results): |
View full study record |
Document reference: 45660 |
Study title: Comparative study on the safety and efficacy of different cycloplegic agents in children with darkly pigmented irides. Fan DS, Rao SK, Ng JS, Yu CB, Lam DS. Clin Experiment Ophthalmol. 2004 Oct;32(5):462-7. Comparative study on the safety and efficacy of different cycloplegic agents in children with darkly pigmented irides. Fan DS, Rao SK, Ng JS, Yu CB, Lam DS. Clin Experiment Ophthalmol. 2004 Oct;32(5):462-7. |
Active substance: TROPICAMIDE |
Study summary document link (including results): Comparative study on the safety and efficacy.pdf |
View full study record |
Document reference: 46865 |
Study title: Comparison of cyclopentolate versus tropicamide cycloplegia in children. Egashira SM, Kish LL, Twelker JD, Mutti DO, Zadnik K, Adams AJ. Optom Vis Sci. 1993 Dec;70(12):1019-26. Comparison of cyclopentolate versus tropicamide cycloplegia in children. Egashira SM, Kish LL, Twelker JD, Mutti DO, Zadnik K, Adams AJ. Optom Vis Sci. 1993 Dec;70(12):1019-26. |
Active substance: TROPICAMIDE |
Study summary document link (including results): Comparison of cyclopentolate versus tropicamide cycloplegia .pdf |
View full study record |
Document reference: 46877 |
Study title: Comparison of mydriatic regimens used in screening for retinopathy of prematurity in preterm infants with dark irides. Chew C, Rahman RA, Shafie SM, Mohamad Z. J Pediatr Ophthalmol Strabismus. 2005 May-Jun;42(3):166-73. Comparison of mydriatic regimens used in screening for retinopathy of prematurity in preterm infants with dark irides. Chew C, Rahman RA, Shafie SM, Mohamad Z. J Pediatr Ophthalmol Strabismus. 2005 May-Jun;42(3):166-73. |
Active substance: TROPICAMIDE |
Study summary document link (including results): Comparison of mydriatic regimens used in screening for retin.pdf |
View full study record |
Document reference: 46863 |
Study title: Comparison of the effectiveness of a nondilated versus dilated fundus examination in the pediatric population. Parisi ML, Scheiman M, Coulter RS. J Am Optom Assoc. 1996 May;67(5):266-72. Comparison of the effectiveness of a nondilated versus dilated fundus examination in the pediatric population. Parisi ML, Scheiman M, Coulter RS. J Am Optom Assoc. 1996 May;67(5):266-72. |
Active substance: TROPICAMIDE |
Study summary document link (including results): Comparison of the effectiveness of a nondilated versus dilat.pdf |
View full study record |
Document reference: 46874 |
Study title: Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in nigerian children. Ebri A, Kuper H, Wedner S. Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1025-31. Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in nigerian children. Ebri A, Kuper H, Wedner S. Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1025-31. |
Active substance: TROPICAMIDE |
Study summary document link (including results): Cost-effectiveness of cycloplegic agents.pdf |
View full study record |
Document reference: 46862 |
Study title: Effect of mydriatics on blood pressure in premature infants. Merritt JC, Kraybill EN. J Pediatr Ophthalmol Strabismus. 1981 Sep-Oct;18(5):42-6. Effect of mydriatics on blood pressure in premature infants. Merritt JC, Kraybill EN. J Pediatr Ophthalmol Strabismus. 1981 Sep-Oct;18(5):42-6. |
Active substance: TROPICAMIDE |
Study summary document link (including results): Effect of mydriatics on blood pressure in premature infants.pdf |
View full study record |
Document reference: 46881 |
Study title: Combination cyclopentolate and phenylephrine for mydriasis in premature infants with heavily pigmented irides. Khoo BK, Koh A, Cheong P, Ho NK. J Pediatr Ophthalmol Strabismus. 2000 Jan-Feb;37(1):15-20. Combination cyclopentolate and phenylephrine for mydriasis in premature infants with heavily pigmented irides. Khoo BK, Koh A, Cheong P, Ho NK. J Pediatr Ophthalmol Strabismus. 2000 Jan-Feb;37(1):15-20. |
Active substance: TROPICAMIDE |
Study summary document link (including results): Combination Cyclopentolate and Phenylephrine for Mydriasis.pdf |
View full study record |
Document reference: 46873 |
Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43352 |
Study title: aTargeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors. arcon-Vargas D, Zhang Z, Agarwal B, Challagulla K, Mani S, Kalpana GV. Oncogene~ 25(5):722-734, FEB 2006 2006;(5):-734, FEB.aTargeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors. arcon-Vargas D, Zhang Z, Agarwal B, Challagulla K, Mani S, Kalpana GV. Oncogene~ 25(5):722-734, FEB 2006 2006;(5):-734, FEB. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43253 |
Study title: Baker SB, Burkey BA, Thornton P, LaRossa D, Disa J, Heckler FR. Juvenile gigantomastia: Presentation of four cases and review of the literature. Annals of Plastic Surgery 2001; 46(5) 517-526.Baker SB, Burkey BA, Thornton P, LaRossa D, Disa J, Heckler FR. Juvenile gigantomastia: Presentation of four cases and review of the literature. Annals of Plastic Surgery 2001; 46(5) 517-526. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43142 |
Study title: Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. Lawrence SE, Arnold FK, Vethamuthu J, Lawson ML. Journal of Pediatrics 145(1)()(pp 71-76), 2004 Date of Publication: Jul 2004 2004;(1):71-76.Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. Lawrence SE, Arnold FK, Vethamuthu J, Lawson ML. Journal of Pediatrics 145(1)()(pp 71-76), 2004 Date of Publication: Jul 2004 2004;(1):71-76. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43267 |
Study title: Braunstein GD. Current Concepts - Gynecomastia. New England Journal of Medicine 1993; 328(7):490-495.Braunstein GD. Current Concepts - Gynecomastia. New England Journal of Medicine 1993; 328(7):490-495. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43159 |
Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43106 |
Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43127 |
Study title: Khan AKA, Truelove SC, Aronson JK. The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. Br J Clin Pharmacol 13 (1982) 523-528.Khan AKA, Truelove SC, Aronson JK. The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. Br J Clin Pharmacol 13 (1982) 523-528. |
Active substance: SULFASALAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 42898 |
Study title: Degreef H, Marien K, De Veylder H, Duprez K, Borghys A, Verhoeve L Itraconazole in the treatment of dermatophytoses: A comparison of two daily dosages. Reviews of infectious diseases 9 suppl.1, p.S104-S108, 1987. (6-81 years, LMD45556)Degreef H, Marien K, De Veylder H, Duprez K, Borghys A, Verhoeve L Itraconazole in the treatment of dermatophytoses: A comparison of two daily dosages. Reviews of infectious diseases 9 suppl.1, p.S104-S108, 1987. (6-81 years, LMD45556) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30798 |
Study title: Del Palacio Hernanz A double-blind randomized comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manus. Clinical research report on R051211 no-62, May 1987. (17-54 years, LMD56440)Del Palacio Hernanz A double-blind randomized comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manus. Clinical research report on R051211 no-62, May 1987. (17-54 years, LMD56440) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30785 |
Study title: Del Palacio Hernanz A double-blind randomized comparison of itraconazole with griseofulvin in the treatment ot tinea corporis ans tinea cruris. Clinical research report on R051211 no-64, May 1987. (17-67 years, LMD56219)Del Palacio Hernanz A double-blind randomized comparison of itraconazole with griseofulvin in the treatment ot tinea corporis ans tinea cruris. Clinical research report on R051211 no-64, May 1987. (17-67 years, LMD56219) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30783 |
Study title: Del Palacio Hernanz A, Delgado Vicente S, Menendez Ramos F, Rodriquez-Noriega Belaustegui A. Radomized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis vesicolor. Reviews of infectious diseases 9 suppl.1, p.S121-S127, 1987. (17-63 years, LMD45550)Del Palacio Hernanz A, Delgado Vicente S, Menendez Ramos F, Rodriquez-Noriega Belaustegui A. Radomized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis vesicolor. Reviews of infectious diseases 9 suppl.1, p.S121-S127, 1987. (17-63 years, LMD45550) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30802 |
Study title: Del Palacio Hernanz A, Frias-Iniesta J, Gonzalez-Valle O, Borgers M, Van Cutsem J, Cauvwenbergh G. Itraconazole therapy in pityriasis versicolor. British journal of dermatology 115, p.217-225, 1986. (17-71 years, LMD45458)Del Palacio Hernanz A, Frias-Iniesta J, Gonzalez-Valle O, Borgers M, Van Cutsem J, Cauvwenbergh G. Itraconazole therapy in pityriasis versicolor. British journal of dermatology 115, p.217-225, 1986. (17-71 years, LMD45458) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30803 |
Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27422 |
Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27424 |
Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27787 |
Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27789 |
Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH SYSTEMIC CANDIDIASIS OR CRYPTOCOCCAL MENINGITIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27410 |
Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH SYSTEMIC CANDIDIASIS OR CRYPTOCOCCAL MENINGITIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27775 |
Study title: "Efficacy and safety of modafinil film-coated tablets in children and adolescents with or without prior stimulant treatment for attention-deficit/hyperactivity disorder: pooled analysis of 3 randomized, double-blind, placebo-controlled studies. SB Wigal, et al., Primary Care Companion to the Journal of Clinical Psychiatry 2006, 8(6): 352-60. " |
Active substance: MODAFINIL |
Study summary document link (including results): |
View full study record |
Document reference: 45290 |
Study title: "Efficacy and safety of modafinil film-coated tablets in children and adolescents with or without prior stimulant treatment for attention-deficit/hyperactivity disorder: pooled analysis of 3 randomized, double-blind, placebo-controlled studies. " "C1538d/312/AD/US et al. SB Wigal, et al., Primary Care Companion to the Journal of Clinical Psychiatry 2006, 8(6): 352-60. " "Efficacy and safety of modafinil film-coated tablets in children and adolescents with or without prior stimulant treatment for attention-deficit/hyperactivity disorder: pooled analysis of 3 randomized, double-blind, placebo-controlled studies. " "C1538d/312/AD/US et al. SB Wigal, et al., Primary Care Companion to the Journal of Clinical Psychiatry 2006, 8(6): 352-60. " |
Active substance: MODAFINIL |
Study summary document link (including results): |
View full study record |
Document reference: 45673 |
Study title: Modafinil as adjunctive therapy in depressed outpatients. S Nasr, Annals of Clinical Psychiatry - Official Journal of the American Academy of Clinical Psychiatrists 2004, 16(3): 133-8. Modafinil as adjunctive therapy in depressed outpatients. S Nasr, Annals of Clinical Psychiatry - Official Journal of the American Academy of Clinical Psychiatrists 2004, 16(3): 133-8. |
Active substance: MODAFINIL |
Study summary document link (including results): |
View full study record |
Document reference: 45671 |
Study title: Modafinil as therapy for ADHD in children: a 4-week, double blind, placebo controlled study. Swanson JM; Biederman J; Boelliner SW; Lopez FA; J Psychopharmacol 2004; 18(s3)/A53 |
Active substance: MODAFINIL |
Study summary document link (including results): EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls |
View full study record |
Document reference: 45659 |
Study title: "Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study. SW Boellner, et al., Current Medical Research and Opinion 2006, 22(12): 2457-65. " |
Active substance: MODAFINIL |
Study summary document link (including results): EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls |
View full study record |
Document reference: 45289 |
Study title: Modafinil in children with ADHD: a double-blind, placebo-controlled study; Rugino TA; Samsock TC; Adkins L; Annu Meet Amer Psychiatry Assoc 2002; 77/32 Modafinil in children with ADHD: a double-blind, placebo-controlled study; Rugino TA; Samsock TC; Adkins L; Annu Meet Amer Psychiatry Assoc 2002; 77/32 |
Active substance: MODAFINIL |
Study summary document link (including results): |
View full study record |
Document reference: 45669 |
Study title: Modafinil in children with attention-deficit hyperactivity disorder. TA Rugino & TC Samsock, Pediatric Neurology 2003, 29(2): 136-42. Modafinil in children with attention-deficit hyperactivity disorder. TA Rugino & TC Samsock, Pediatric Neurology 2003, 29(2): 136-42. |
Active substance: MODAFINIL |
Study summary document link (including results): |
View full study record |
Document reference: 45661 |
Study title: "Modafinil in diurnal sleepiness. A study of 123 patients. F Laffont, et al., Sleep 1994, 17(8 Suppl): pl) pS113-5. "Modafinil in diurnal sleepiness. A study of 123 patients. F Laffont, et al., Sleep 1994, 17(8 Suppl): pl) pS113-5. |
Active substance: MODAFINIL |
Study summary document link (including results): |
View full study record |
Document reference: 45666 |
Study title: PHARMACOKINETIC STUDY IN CHILDREN WITH HC 20-511 PAEDIATRIC SYRUP |
Active substance: KETOTIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 30952 |
Study title: F. Rosaschino, L. Cattaneo, Strategies for optimizing compliance of paediatric patients for seasonal antibacterial vaccination with sublingually administered Polyvalent Mechanical Bacterial Lysates (PMBL), ACTA BIO MEDICA ATENEO PARMENSE 2004; 75; 171-178, |
Active substance: Klebsiella pneumoniae;Streptococcus pyogenes;Diplococcus pneumoniae;Staphylococcus aureus;Neisseria catarrhalis;Streptococcus viridans;Haemophilus influenzae;Klebsiella ozaenae; |
Study summary document link (including results): |
View full study record |
Document reference: 41339 |
Study title: I. La Mantia, F. Nicolosi, L. Maiolino, A. Serra, Immunoprophylaxis of recurring bacterial infections of respiratory tracts in pediatric age: clinical experience through a new immunostimulating vaccine, GIMMOC Quaderni di Microbiologia e Clinica, Vol XI, Q2, 2007, p1-8. |
Active substance: Klebsiella pneumoniae;Streptococcus pyogenes;Diplococcus pneumoniae;Staphylococcus aureus;Neisseria catarrhalis;Streptococcus viridans;Haemophilus influenzae;Klebsiella ozaenae; |
Study summary document link (including results): |
View full study record |
Document reference: 41338 |
Study title: Effects and side effects of mydriatic eyedrops in neonates. O?üt MS, Bozkurt N, Ozek E, Birgen H, Kazoko?lú H, O?üt M. Eur J Ophthalmol. 1996 Apr-Jun;6(2):192-6. Effects and side effects of mydriatic eyedrops in neonates. O?üt MS, Bozkurt N, Ozek E, Birgen H, Kazoko?lú H, O?üt M. Eur J Ophthalmol. 1996 Apr-Jun;6(2):192-6. |
Active substance: TROPICAMIDE |
Study summary document link (including results): Effects and side effects of mydriatic eyedrops in neonates.pdf |
View full study record |
Document reference: 46875 |
Study title: Evaluation of potentiating effect of a drop of lignocaine on tropicamide-induced mydriasis. Ghose S, Garodia VK, Sachdev MS, Kumar H, Biswas NR, Pandey RM. Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1581-5. Evaluation of potentiating effect of a drop of lignocaine on tropicamide-induced mydriasis. Ghose S, Garodia VK, Sachdev MS, Kumar H, Biswas NR, Pandey RM. Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1581-5. |
Active substance: TROPICAMIDE |
Study summary document link (including results): Evaluation of potentiating effect of a drop of lignocaine.pdf |
View full study record |
Document reference: 46871 |
Study title: Myopia control trial with progressive addition lenses in Japanese schoolchildren: baseline measures of refraction, accommodation, and heterophoria. Hasebe S, Nonaka F, Nakatsuka C, Ohtsuki H. Jpn J Ophthalmol. 2005 Jan-Feb;49(1):23-30. Myopia control trial with progressive addition lenses in Japanese schoolchildren: baseline measures of refraction, accommodation, and heterophoria. Hasebe S, Nonaka F, Nakatsuka C, Ohtsuki H. Jpn J Ophthalmol. 2005 Jan-Feb;49(1):23-30. |
Active substance: TROPICAMIDE |
Study summary document link (including results): Myopia control trial with progressive addition lenses.pdf |
View full study record |
Document reference: 46864 |
Study title: Results of a monozygotic cotwin control study on a treatment for myopia. Schwartz JT. Prog Clin Biol Res. 1981;69 Pt C:249-58. Results of a monozygotic cotwin control study on a treatment for myopia. Schwartz JT. Prog Clin Biol Res. 1981;69 Pt C:249-58. |
Active substance: TROPICAMIDE |
Study summary document link (including results): Results of a monozygotic cotwin control study on a treatment.pdf |
View full study record |
Document reference: 46882 |
Study title: Retinoscopy in infants using a near noncycloplegic technique, cycloplegia with tropicamide 1%, and cycloplegia with cyclopentolate 1%. Twelker JD, Mutti DO. Optom Vis Sci. 2001 Apr;78(4):215-22. Retinoscopy in infants using a near noncycloplegic technique, cycloplegia with tropicamide 1%, and cycloplegia with cyclopentolate 1%. Twelker JD, Mutti DO. Optom Vis Sci. 2001 Apr;78(4):215-22. |
Active substance: TROPICAMIDE |
Study summary document link (including results): Retinoscopy in infants using a near noncycloplegic technique.pdf |
View full study record |
Document reference: 46872 |
Study title: Seasonal variation in myopia progression and ocular elongation. Fulk GW, Cyert LA, Parker DA. Optom Vis Sci. 2002 Jan;79(1):46-51. 9. Baseline refractive and ocular component measures of children enrolled in the correction of myopia evaluation trial (COMET). Gwiazda J, Marsh-Tootle WL, Hyman L, Hussein M, Norton TT; COMET Study Group. Invest Ophthalmol Vis Sci. 2002 Feb;43(2):314-21. Seasonal variation in myopia progression and ocular elongation. Fulk GW, Cyert LA, Parker DA. Optom Vis Sci. 2002 Jan;79(1):46-51. 9. Baseline refractive and ocular component measures of children enrolled in the correction of myopia evaluation trial (COMET). Gwiazda J, Marsh-Tootle WL, Hyman L, Hussein M, Norton TT; COMET Study Group. Invest Ophthalmol Vis Sci. 2002 Feb;43(2):314-21. |
Active substance: TROPICAMIDE |
Study summary document link (including results): Seasonal variation in myopia progression and ocular elongati.pdf |
View full study record |
Document reference: 46869 |
Study title: Systemic response to mydriatic eyedrops in neonates: mydriatics in neonates. Caputo AR, Schnitzer RE. J Pediatr Ophthalmol Strabismus. 1978 Mar-Apr;15(2):109-22.Systemic response to mydriatic eyedrops in neonates: mydriatics in neonates. Caputo AR, Schnitzer RE. J Pediatr Ophthalmol Strabismus. 1978 Mar-Apr;15(2):109-22. |
Active substance: TROPICAMIDE |
Study summary document link (including results): systemic response to mydriatic eyedrops in neonates.pdf |
View full study record |
Document reference: 46883 |
Study title: Kiron M. "Sulfasalazine Therapy in Inflammatory Bowel Disease" Gastroenterology Clinics of North Ameica - Vol. 18, No.1, March 1989 Kiron M. "Sulfasalazine Therapy in Inflammatory Bowel Disease" Gastroenterology Clinics of North Ameica - Vol. 18, No.1, March 1989 |
Active substance: SULFASALAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 42876 |
Study title: Kummerle-Deschner J, Dannecker G; Acta Paediatr (Norway), Aug 1995, 84(8) p952-4; sulphasalazine desensitization in a paediatric patient with juvenile chronic arthritis.Kummerle-Deschner J, Dannecker G; Acta Paediatr (Norway), Aug 1995, 84(8) p952-4; sulphasalazine desensitization in a paediatric patient with juvenile chronic arthritis. |
Active substance: SULFASALAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 42890 |
Study title: Ozdogan H, Turunc M, Deringol B, Yurdakul S, Yazici H.; J Rheumatol 1986 Feb;13(1):124-5 Sulphasalazine in the treatment of juvenile rheumatoid arthritis: a preliminary open trial.Ozdogan H, Turunc M, Deringol B, Yurdakul S, Yazici H.; J Rheumatol 1986 Feb;13(1):124-5 Sulphasalazine in the treatment of juvenile rheumatoid arthritis: a preliminary open trial. |
Active substance: SULFASALAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 42891 |
Study title: Rosenberg AM; J Pediatr (United States), Feb 1989, 114(2) p171-8; Advanced drug therapy for juvenile rheumatoid arthritis.Rosenberg AM; J Pediatr (United States), Feb 1989, 114(2) p171-8; Advanced drug therapy for juvenile rheumatoid arthritis. |
Active substance: SULFASALAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 42892 |
Study title: Suschke HJ.; Monatsschr Kinderheilkd 1992 Sep;140(9):658-60; Treatment of juvenile spondylarthritis and reactive arthritis with sulfasalazine Suschke HJ.; Monatsschr Kinderheilkd 1992 Sep;140(9):658-60; Treatment of juvenile spondylarthritis and reactive arthritis with sulfasalazine |
Active substance: SULFASALAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 42893 |
Study title: Taggart AJ, McDermott BJ, Roberts SD. The effect of age and acetylator phenotype on the pharmacokinetics of sulfasalazine in patients with rheumatoid arthritis. Clin Pharmacokinet 23 (1992) 311-320.Taggart AJ, McDermott BJ, Roberts SD. The effect of age and acetylator phenotype on the pharmacokinetics of sulfasalazine in patients with rheumatoid arthritis. Clin Pharmacokinet 23 (1992) 311-320. |
Active substance: SULFASALAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 42899 |
Study title: van Rossum MA, Fiselier TJ, Franssen MJ, et al.; Arthritis Rheum (United States), May 1998, 41(5) p808-16; Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. van Rossum MA, Fiselier TJ, Franssen MJ, et al.; Arthritis Rheum (United States), May 1998, 41(5) p808-16; Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. |
Active substance: SULFASALAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 42894 |
Study title: Varbanova BB, Dyankov ED; Adv Exp Med Biol (United States), 1999, 455 p331-6; Sulphasalazine. An alternative drug for second-line treatment of juvenile chronic arthritis.Varbanova BB, Dyankov ED; Adv Exp Med Biol (United States), 1999, 455 p331-6; Sulphasalazine. An alternative drug for second-line treatment of juvenile chronic arthritis. |
Active substance: SULFASALAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 42896 |
Study title: Efficacy and tolerability of Benzoyl peroxide and detergent soap (Acne Aid) in the treatment of acne vulgaris (used together). |
Active substance: SULFONATED SURFACTANT BLEND |
Study summary document link (including results): Article 45_Ref_C0193_Final for Submission_07Nov2011.xlsx |
View full study record |
Document reference: 48308 |
Study title: Assessment of the use of 3% Salicylic acid and 10% Sulphur soap in the treatment of Tinea versicolor. |
Active substance: SULFUR AND SALICYLIC ACID |
Study summary document link (including results): Article 45_Ref_C0192_Final For Submission_27 Oct 2011.xlsx |
View full study record |
Document reference: 48309 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Sulfur-Heel (tablets) [AWB-AT] |
Active substance: Sulfur comp.-Heel |
Study summary document link (including results): |
View full study record |
Document reference: 40247 |
Study title: SAFETY AND EFFICACY OF TWO DIFFERENT DOSAGE OF FLUCONAZOLE IN PATIENTS WITH TINEA VERSICOLOR. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27370 |
Study title: SAFETY AND EFFICACY OF TWO DIFFERENT DOSAGE OF FLUCONAZOLE IN PATIENTS WITH TINEA VERSICOLOR. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27735 |
Study title: SAFETY, ACCEPTANCE, TOLERATION AND EFFICACY OF FLUCONAZOLE IN COMPARISON WITH ORAL POLYENES IN PATIENTS ON ISOLATION. ALSO TO ESTIMATE FEASIBILITY OF SUCH A TRIAL IN MULTICENTER SETTING. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27395 |
Study title: SAFETY, ACCEPTANCE, TOLERATION AND EFFICACY OF FLUCONAZOLE IN COMPARISON WITH ORAL POLYENES IN PATIENTS ON ISOLATION. ALSO TO ESTIMATE FEASIBILITY OF SUCH A TRIAL IN MULTICENTER SETTING. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27760 |
Study title: SECONDARY PREVENTION OF OROPHARYNGEAL CANDIDIASIS IN HIV+ PATIENTS. A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY WITH FOCUS ON RESISTANCE TO FLUCONAZOLE THERAPY. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27402 |
Study title: SECONDARY PREVENTION OF OROPHARYNGEAL CANDIDIASIS IN HIV+ PATIENTS. A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY WITH FOCUS ON RESISTANCE TO FLUCONAZOLE THERAPY. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27767 |
Study title: SINGLE DOSE THERAPY FOR ORAL CANDIDIASIS WITH FCA IN HIV-INFECTED ADULTS: A PILOT STUDY. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27392 |
Study title: SINGLE DOSE THERAPY FOR ORAL CANDIDIASIS WITH FCA IN HIV-INFECTED ADULTS: A PILOT STUDY. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27757 |
Study title: STUDY TO ASSESS THE PHARMACOKINETICS OF A SINGLE ORAL OR INTRAVENOUS DOSE OF FLUCONAZOLE ADMINISTERED TO FULL TERM NEONATES |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27339 |
Study title: Di Fonzo EM, Biggio P, Tulli A, Binazzi M, Ippolito F Oral itraconazole in the treatment of dermatomycoses. August 1987. (12-68 years, LMD56449)Di Fonzo EM, Biggio P, Tulli A, Binazzi M, Ippolito F Oral itraconazole in the treatment of dermatomycoses. August 1987. (12-68 years, LMD56449) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30791 |
Study title: Dom J, Goyvaerts H, Moens M, Schuermans V, Cauwenbergh G. Itraconazole in the treatment of pityriasis versicolor. A combined analysis of 15 clinical trials including about 600 patients. Clinical research report on R051211 no-68, June 1987. (10-78 years, LMD56299)Dom J, Goyvaerts H, Moens M, Schuermans V, Cauwenbergh G. Itraconazole in the treatment of pityriasis versicolor. A combined analysis of 15 clinical trials including about 600 patients. Clinical research report on R051211 no-68, June 1987. (10-78 years, LMD56299) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30812 |
Study title: Dominguez L, Lavalle P, Peremans W, 'T Kint R, Willemsen M, Mertens RLJ. Itraconazole for 2 or 4 weeks in the treatment of dermatophyte infections of the skin: A combined analysis of double-blind placebo-controlled studies. Clinical research report on R051211 no-78, June 1987. (15-69 years, LMD56443)Dominguez L, Lavalle P, Peremans W, 'T Kint R, Willemsen M, Mertens RLJ. Itraconazole for 2 or 4 weeks in the treatment of dermatophyte infections of the skin: A combined analysis of double-blind placebo-controlled studies. Clinical research report on R051211 no-78, June 1987. (15-69 years, LMD56443) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30781 |
Study title: Duran de Rueda MM Oral itraconazole in the treatment of tinea pedis. Clinical summary on R51211, August 1987. (16-83 years, LMD56455)Duran de Rueda MM Oral itraconazole in the treatment of tinea pedis. Clinical summary on R51211, August 1987. (16-83 years, LMD56455) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30797 |
Study title: O. T.Aksic, F.Rosaschino, L. Cattaneo, The evaluation of the clinical efficacy of a Polyvalent Mechanical Bacterial Lysate (PMBL) in a sample of 180 children of school age with recurrent respiratory infections, European Journal of Aerobiology, Environmental Medicine and Air-borne Infections, Vol 1, number 1/2005, p3-7 |
Active substance: Klebsiella pneumoniae;Streptococcus pyogenes;Diplococcus pneumoniae;Staphylococcus aureus;Neisseria catarrhalis;Streptococcus viridans;Haemophilus influenzae;Klebsiella ozaenae; |
Study summary document link (including results): |
View full study record |
Document reference: 41340 |
Study title: Double-blind randomised and controlled clinical trial to assess the efficacy and safety of Symphytum herb extract cream 10% against 1% in the acceleration of wound healing |
Active substance: Kulturbeinwell / Preparation of fresh Symphytum x uplandicum herb (2-3:1) consisting of: 0.4 g of pressed juice of fresh Symphytum x uplandicum herb (3-8:1) and 0.6 g extract of the press residue of fresh Symphytum x uplandicum herb (3-10:1); solvent ethanol 30 % V/V - "HERB"/ Symphyti herbae recens succus liquidum (2-3:1), extr. solvent ethanol 30 % (Symphytum concentrat... |
Study summary document link (including results): |
View full study record |
Document reference: 40249 |
Study title: Effect of a Symphytum Ointment with Sports Injuries of the Knee Joint (Wirkung einer Symphytum-Salbe bei Sportver-letzungen des Kniegelenkes) |
Active substance: Kulturbeinwell / Preparation of fresh Symphytum x uplandicum herb (2-3:1) consisting of: 0.4 g of pressed juice of fresh Symphytum x uplandicum herb (3-8:1) and 0.6 g extract of the press residue of fresh Symphytum x uplandicum herb (3-10:1); solvent ethanol 30 % V/V - "HERB"/ Symphyti herbae recens succus liquidum (2-3:1), extr. solvent ethanol 30 % (Symphytum concentrat... |
Study summary document link (including results): |
View full study record |
Document reference: 40044 |
Study title: The Local Treatment of Acute Lateral Distortions of the Ankle Joint with an Ointment containing a Symphytum Active Substance complex ( Die Lokalbehandlung der akuten lateralen Distorsion des oberen Sprung-gelenkes mit einer Symphytum-Wirk-stoffkomplex-Salbe) |
Active substance: Kulturbeinwell / Preparation of fresh Symphytum x uplandicum herb (2-3:1) consisting of: 0.4 g of pressed juice of fresh Symphytum x uplandicum herb (3-8:1) and 0.6 g extract of the press residue of fresh Symphytum x uplandicum herb (3-10:1); solvent ethanol 30 % V/V - "HERB"/ Symphyti herbae recens succus liquidum (2-3:1), extr. solvent ethanol 30 % (Symphytum concentrat... |
Study summary document link (including results): |
View full study record |
Document reference: 40139 |
Study title: The Local Treatment of Contusions and Distortions of the Knee Joint with a Symphytum Active Substance Complex Ointment (Die Lokalbehandlung von Kontusionen und Distorsionen des Kniegelenkes mit einer Symphytum-Wirkstoffkomplex-Salbe) |
Active substance: Kulturbeinwell / Preparation of fresh Symphytum x uplandicum herb (2-3:1) consisting of: 0.4 g of pressed juice of fresh Symphytum x uplandicum herb (3-8:1) and 0.6 g extract of the press residue of fresh Symphytum x uplandicum herb (3-10:1); solvent ethanol 30 % V/V - "HERB"/ Symphyti herbae recens succus liquidum (2-3:1), extr. solvent ethanol 30 % (Symphytum concentrat... |
Study summary document link (including results): |
View full study record |
Document reference: 40248 |
Study title: |
Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30978 |
Study title: A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children – ISOLAURI E., JUNTUNEN M. and al. – 1991.A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children – ISOLAURI E., JUNTUNEN M. and al. – 1991. |
Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30980 |
Study title: A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children – OBERHELMAN R.A., GILMAN R.H. and al. – 1999.A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children – OBERHELMAN R.A., GILMAN R.H. and al. – 1999. |
Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30981 |
Study title: "Modafinil in diurnal sleepiness. A study of 123 patients. F Laffont, et al., Sleep 1994, 17(8 Suppl): pl) pS113-5. "Modafinil in diurnal sleepiness. A study of 123 patients. F Laffont, et al., Sleep 1994, 17(8 Suppl): pl) pS113-5. |
Active substance: MODAFINIL |
Study summary document link (including results): |
View full study record |
Document reference: 45674 |
Study title: Modafinil: a treatment alternative for children with attention-deficit/hyperactivity disorder (ADHD). Rugino T; Child Adolesc Psychopharmacol News 2002;7(6)/5-7 Modafinil: a treatment alternative for children with attention-deficit/hyperactivity disorder (ADHD). Rugino T; Child Adolesc Psychopharmacol News 2002;7(6)/5-7 |
Active substance: MODAFINIL |
Study summary document link (including results): |
View full study record |
Document reference: 45668 |
Study title: Non-stimulant treatment of attention-deficit/hyperactivity disorder. SR Pliszka, CNS Spectrums 2003, 8(4): 253-8. Non-stimulant treatment of attention-deficit/hyperactivity disorder. SR Pliszka, CNS Spectrums 2003, 8(4): 253-8. |
Active substance: MODAFINIL |
Study summary document link (including results): |
View full study record |
Document reference: 45672 |
Study title: 13C-Urea breath test threshold calculation and evaluation for the detection of Helicobacter pylori infection in childrenStudy of the efficacy and tolerability of sodium valproate in the treatment of partial seizure and generalized epilepsy - Bittencourt P.R.M. - 4/03/1996 |
Active substance: UREA |
Study summary document link (including results): |
View full study record |
Document reference: 39145 |
Study title: 13C-Urea Breath Test to Diagnose Helicobactyer Pylori Infection in Children Aged up to 6 Years |
Active substance: UREA |
Study summary document link (including results): |
View full study record |
Document reference: 39146 |
Study title: A 13C –urea breath test in children with Helicobacter pylori infection: assessment of eradication therapy and follow-up treatmentStatus Epilepticus in children. Experience with intravenous valproate. Update of treatment guidelines - Campistol and al. - 1999 ( Rev. Neurol.1999 - 29 : 359-65 ) Publication 1 in Ergenyl Via Expert report on the clinical documentation - Hufnagel A. - 14/11/2006 |
Active substance: UREA |
Study summary document link (including results): |
View full study record |
Document reference: 39144 |
Study title: A rapid lateral flow stool antigen immunoassay and 14C-urea breath test for the diagnosis and eradication of Helicobacter pylori infection in childrenSodium Vallproate in status epilepticus - S. JHA 2003 (Neurol. India - 2003 - 51:421-2) Publication in Epilim-Reports of clinical studies Vol II - E. TRINKA - 06/11/2006 |
Active substance: UREA |
Study summary document link (including results): |
View full study record |
Document reference: 39141 |
Study title: Biokenetics and radiation doses for carbon-14 urea in adults and children undergoing the Helicobacter pylori breath testSpecific cognitive dysfunction in children with epileptic mothers. - Gaily et al. - Dev Med Child Neurol 1990;32-403-414. |
Active substance: UREA |
Study summary document link (including results): |
View full study record |
Document reference: 39143 |
Study title: Diagnosis of Helicobacter pyloriThe longer term outcome of children born to mothers with epilepsy. - Adab et al. - J Neurol Neurosurg Psychiatry 2004;75:1575-83. |
Active substance: UREA |
Study summary document link (including results): |
View full study record |
Document reference: 39149 |
Study title: Diagnostic accuracy of the 13C-urea breath test in children: Adjustment of the cut-off value according to ageTeratogenic effects of antiepileptic drugs: use of an international database on malformations and drug exposure (MADRE). - Arpino C et al. - Epilepsia 2000;41(11):1436-43. |
Active substance: UREA |
Study summary document link (including results): |
View full study record |
Document reference: 39147 |
Study title: Frequency of Helicobacter Pylori infection in children under 4 years of ageThe epilepsies – febrile convulsions. - Trescher WH et al. - In : WG Bradley et al. Neurology in clinical practice. 4th edition. Elsevier edition 2004; vol II, chapter 73: 1963-64. |
Active substance: UREA |
Study summary document link (including results): |
View full study record |
Document reference: 39148 |
Study title: Helicobacter pylori Infection in Pediatrics |
Active substance: UREA |
Study summary document link (including results): |
View full study record |
Document reference: 39150 |
Study title: No radiation protection reasons for restrictions on 14C urea breath tests in childrenSodium Vallproate in status epilepticus - S. JHA 2003 (Neurol. India - 2003 - 51:421-2) Publication in Epilim-Reports of clinical studies Vol II - E. TRINKA - 06/11/2006 |
Active substance: UREA |
Study summary document link (including results): |
View full study record |
Document reference: 39142 |
Study title: A Multicentre, Randomised, Controlled Trail of Therapeutic Lung Lavage in Ventilated Infants with Meconium Aspiration SyndromeThe treatment of childhood epilepsy with sodium valproate. - Haigh D et al. - Develop Med Child Neurol 1975;17:743-8 |
Active substance: URINARY CONCREMENT SOLVENTS |
Study summary document link (including results): |
View full study record |
Document reference: 39151 |
Study title: Borgmann et al.Cystine Stones in a Tree-Year Old Boy; Zeitschr-Kinderderchirurgie 1978; 25 |
Active substance: URINARY CONCREMENT SOLVENTS |
Study summary document link (including results): |
View full study record |
Document reference: 39155 |
Study title: Breitwieser et al. Conservative treatment of uric acid sone diathesis; Med. Welt 1967, 8: 2130-2135 |
Active substance: URINARY CONCREMENT SOLVENTS |
Study summary document link (including results): |
View full study record |
Document reference: 39156 |
Study title: Efficacy and tolerability of Benzoyl peroxide and detergent soap (Acne Aid) in the treatment of acne vulgaris (used together).The use of Epilim at doses of greater than 1400 mg/day - Reckitt & Colman - 01/1975 |
Active substance: URINARY CONCREMENT SOLVENTS |
Study summary document link (including results): |
View full study record |
Document reference: 39152 |
Study title: Retrospective survey for documentation of appllication and dosage of Sulfur comp.-Heel (tablets) in children < 12 years of age [Bef-020] |
Active substance: Sulfur comp.-Heel |
Study summary document link (including results): |
View full study record |
Document reference: 40246 |
Study title: Dalery J., Maillet J., de Villard R. - Traitment de dix-sept adolescents psychotiques par le dogmatil - Se. Hôp. Paris, 1985, 61 (19) 1327-1330 |
Active substance: SULPIRIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42903 |
Study title: Ensaio com a associacao bromazepam sulpiride (RO 10 7122) no tratamento de disturbios de conduta e de personalidade em criancas e adolescentes - Sarmento De Barros D. - 28/07/1981 |
Active substance: SULPIRIDE |
Study summary document link (including results): SULPIRIDE Study 81-01171-PT.xls |
View full study record |
Document reference: 42901 |
Study title: Ensayo terapeutico con sulpiride en ninos con trastomos digestivos |
Active substance: SULPIRIDE |
Study summary document link (including results): SULPIRIDE Study 81-01233-ES.xls |
View full study record |
Document reference: 47997 |
Study title: Zur therapie von verhaltensgestorten kindern mit sulpirid - Hoppner L. - 15/07/1981 |
Active substance: SULPIRIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42902 |
Study title: A CLINICAL EVALUATION OF STM FINE GRANULES FOR SUPPURATIVE OTITIS MEDIA OF CHILDREN. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43007 |
Study title: A COMPARATIVE PHARMACOKINETIC STUDY OF SULTAMICILLIN (CP-49,952) AND AMPICILLIN IN INFANTS AND YOUNG CHILDREN. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42915 |
Study title: A COMPARATIVE STUDY OF STM IN THE TREATMENT OF ACUTE TONSILLITIS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42958 |
Study title: A COMPARATIVE STUDY OF STM IN THE TREATMENT OF SUPPURATIVE OTITIS MEDIA |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42959 |
Study title: A COMPARATIVE STUDY OF SULTAMICILLIN AND AUGMENTIN IN THE TREATMENT OF ACUTE SUPPURATIVE OTITIS MEDIA IN CHILDREN. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42911 |
Study title: A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH AMOXYCILLIN OR CLOXACILLIN, AS APPROPRIATE, IN THE TREATMENT OF INFECTION IN CHILDREN. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42938 |
Study title: A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH AMOXYCILLIN OR CLOXACILLIN, AS APPROPRIATE, IN THE TREATMENT OF INFECTION IN CHILDREN. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42939 |
Study title: A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH AMOXYCILLIN OR CLOXACILLIN, AS APPROPRIATE, IN THE TREATMENT OF INFECTION IN CHILDREN. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42940 |
Study title: A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH AMOXYCILLIN OR CLOXACILLIN, AS APPROPRIATE, IN THE TREATMENT OF INFECTION IN CHILDREN. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42941 |
Study title: A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH AMOXYCILLIN OR CLOXACILLIN, AS APPROPRIATE, IN THE TREATMENT OF INFECTION IN CHILDREN. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42942 |
Study title: A DOUBLE BLIND COMPARATIVE STUDY OF STM IN THE TREATMENT OF DERMAL INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42957 |
Study title: A DOUBLE-BLIND COMPARATIVE STUDY OF STM IN THE TREATMENT OF COMPLICATED URINARY TRACT INFECTIONS |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42960 |
Study title: A MULTICENTER NON-COMPARATIVE STUDY FOR THE TREATMENT OF MODERATE UPPER RESPIRATORY TRACT INFECTION IN ADULT PATIENTS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43045 |
Study title: A MULTICENTER NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF STM FOR THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS IN PEDIATRIC PATIENTS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43044 |
Study title: A MULTICENTER STUDY OF SULTAMICILLIN (CP-49,952) A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICLLIN COMPARED WITH FLUCLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42943 |
Study title: Evaluation of itraconazole oral solution in infants with oral thrush: an open trial comparing three, five or seven days of treatment with ten days of nystatin treatment. |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 45128 |
Study title: Evaluation of itraconazole solution in infants with oral thrush: a multicentre trial comparing four different treatment durations. |
Active substance: ITRACONAZOLE |
Study summary document link (including results): LMD129326_Interventional_Itraconazole.xls |
View full study record |
Document reference: 45127 |
Study title: Feuilhade M Oral itraconazole in the treatment of tinea pedis and tinea manus. Clinical summary on R51211, August 1987. (16-57 years, LMD56452)Feuilhade M Oral itraconazole in the treatment of tinea pedis and tinea manus. Clinical summary on R51211, August 1987. (16-57 years, LMD56452) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30794 |
Study title: Goyvaerts H, Dom J, De Dier AM, Schuermans V, Cauwenbergh G. Itraconazole in the treatment of vulvovaginal yeast infections. A combined analysis of 18 clinical trials in 1374 patients. Clinical research report on R051211 no-72, June 1987. (16-79 years, LMD56319)Goyvaerts H, Dom J, De Dier AM, Schuermans V, Cauwenbergh G. Itraconazole in the treatment of vulvovaginal yeast infections. A combined analysis of 18 clinical trials in 1374 patients. Clinical research report on R051211 no-72, June 1987. (16-79 years, LMD56319) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30814 |
Study title: Graybill J. Bone radiography and serum calcium and phosphorus levels during itraconazole treatment in a young patient with progressive coccidioidomycosis. Clinical research report on R051211 no-66, June 1987. (1.5 years, LMD56178)Graybill J. Bone radiography and serum calcium and phosphorus levels during itraconazole treatment in a young patient with progressive coccidioidomycosis. Clinical research report on R051211 no-66, June 1987. (1.5 years, LMD56178) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30806 |
Study title: Hay RJ, Clayton YM Treatment of chronic dermatophytosis and chronic oral candidosis with oral itraconazole. Reviews of infectious diseases 9 suppl.1, p.S114-S118, 1987. (16-52 years, LMD45551)Hay RJ, Clayton YM Treatment of chronic dermatophytosis and chronic oral candidosis with oral itraconazole. Reviews of infectious diseases 9 suppl.1, p.S114-S118, 1987. (16-52 years, LMD45551) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30799 |
Study title: Hay RJ, Clayton YM. Treatment of chronic dermatophytosis and chronic oral candidosis with itraconazole. Reviews of infectious diseases 9 suppl.1, p.S114-S118, 1987. (16-52 years, LMD45551)Hay RJ, Clayton YM. Treatment of chronic dermatophytosis and chronic oral candidosis with itraconazole. Reviews of infectious diseases 9 suppl.1, p.S114-S118, 1987. (16-52 years, LMD45551) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30801 |
Study title: Hull PR, Decroix J Double-blind comparison of itraconazole 100 MG o.d. with griseofulvin 500 mg o.d. in the treatment of dermatophyte infections of the skin. A combined analysis of two studies ot the time to negativation and time to response. Clinical research report on R051211 no-80, August 1987. (6-58 years, LMD56457)Hull PR, Decroix J Double-blind comparison of itraconazole 100 MG o.d. with griseofulvin 500 mg o.d. in the treatment of dermatophyte infections of the skin. A combined analysis of two studies ot the time to negativation and time to response. Clinical research report on R051211 no-80, August 1987. (6-58 years, LMD56457) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30782 |
Study title: Kamp H, et al Oral itraconazole in the treatment of dermatomycoses. Clinical summary on R51211, August 1987. (13-82 years, LMD56446)Kamp H, et al Oral itraconazole in the treatment of dermatomycoses. Clinical summary on R51211, August 1987. (13-82 years, LMD56446) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30788 |
Study title: Ketele A et al. Itraconazole in the treatment of dermatomycoses. A combined analysis of 18 clinical trials including over 1400 patients.Clinical research on R051211 no-70, May 1987. (10-75 years, LMD56441)Ketele A et al. Itraconazole in the treatment of dermatomycoses. A combined analysis of 18 clinical trials including over 1400 patients.Clinical research on R051211 no-70, May 1987. (10-75 years, LMD56441) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30776 |
Study title: Lachapelle JM et al. Itraconazole compared with griseofulvin in the treatment of Tinea corporis/cruris and Tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile. Dermatology 184:45, 1992. (6-58 years, LMD81740)Lachapelle JM et al. Itraconazole compared with griseofulvin in the treatment of Tinea corporis/cruris and Tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile. Dermatology 184:45, 1992. (6-58 years, LMD81740) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30780 |
Study title: Open Study of the Effect of Modafinil on Urinary Disorders in Relation to “Stress” Incontinence. |
Active substance: MODAFINIL |
Study summary document link (including results): EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls |
View full study record |
Document reference: 45286 |
Study title: Pharmacokinetics and effect of modafinil in children with ADHD.Labellarte MJ; 47th Meet Am Acad Child Adolesc Psychiatry 2000;116 |
Active substance: MODAFINIL |
Study summary document link (including results): |
View full study record |
Document reference: 45658 |
Study title: "Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy.C1538a/ 302/NA/US US Modafinil in Narcolepsy Multicenter Study Group. Neurology 2000, 54(5): 1166-75." |
Active substance: MODAFINIL |
Study summary document link (including results): EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls |
View full study record |
Document reference: 45292 |
Study title: Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil. Y Dauvilliers, et al., pharmacogenomics Journal 2002, 2(1): 65-8. Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil. Y Dauvilliers, et al., pharmacogenomics Journal 2002, 2(1): 65-8. |
Active substance: MODAFINIL |
Study summary document link (including results): |
View full study record |
Document reference: 45662 |
Study title: "Sleep latency on the maintenance of wakefulness test (MWT) for 530 patients with narcolepsy while free of psychoactive drugs. MM Mitler, et al., Electroencephalography and Clinical Neurophysiology 1998, 107(1): 33-8. "Sleep latency on the maintenance of wakefulness test (MWT) for 530 patients with narcolepsy while free of psychoactive drugs. MM Mitler, et al., Electroencephalography and Clinical Neurophysiology 1998, 107(1): 33-8. |
Active substance: MODAFINIL |
Study summary document link (including results): |
View full study record |
Document reference: 45665 |
Study title: Study of the Effect of Modafinil in Children Presenting Psycho-intellectual and Motor Retardation. |
Active substance: MODAFINIL |
Study summary document link (including results): EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls |
View full study record |
Document reference: 45287 |
Study title: Study with Modafinil in Child Psychiatry. |
Active substance: MODAFINIL |
Study summary document link (including results): |
View full study record |
Document reference: 45288 |
Study title: "Visual P300 latency predicts treatment response to modafinil in patients with narcolepsy. RB Sangal, et al., Clinical Neurophysiology - Official Journal of the International Federation of Clinical Neurophysiology 1999, 110(6): 1041-7. "Visual P300 latency predicts treatment response to modafinil in patients with narcolepsy. RB Sangal, et al., Clinical Neurophysiology - Official Journal of the International Federation of Clinical Neurophysiology 1999, 110(6): 1041-7. |
Active substance: MODAFINIL |
Study summary document link (including results): |
View full study record |
Document reference: 45664 |
Study title: Die Verträglichkeit von Purethal |
Active substance: Modified, adsorbed grass pollen |
Study summary document link (including results): |
View full study record |
Document reference: 40073 |
Study title: A comparison of once-daily application of mometasone furoate 0.1% cream compared with twice-daily hydrocortisone valerate 0.2% cream in pediatric atopic dermatitis patients who failed to respond to hydrocortisone. Lebwohl, Mark MD; The mometasone furoate study group. International Journal of Dermatology. 38(8):604-606, August 1999.A comparison of once-daily application of mometasone furoate 0.1% cream compared with twice-daily hydrocortisone valerate 0.2% cream in pediatric atopic dermatitis patients who failed to respond to hydrocortisone. Lebwohl, Mark MD; The mometasone furoate study group. International Journal of Dermatology. 38(8):604-606, August 1999. |
Active substance: MOMETAZONE |
Study summary document link (including results): |
View full study record |
Document reference: 32284 |
Study title: Assessment of Longitudinal Leg Growth Using Knemometry in Asthmatic Children 6-12 Years of Age During Treatment with Mometasone Furoate (SCH 32088) Dry Powder Inhaler or Placebo |
Active substance: MOMETAZONE |
Study summary document link (including results): I96-349_mometasone furoate.pdf |
View full study record |
Document reference: 48182 |
Study title: Tropicamide (1%): an effective cycloplegic agent for myopic children. Manny RE, Hussein M, Scheiman M, Kurtz D, Niemann K, Zinzer K; COMET Study Group. Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1728-35. Tropicamide (1%): an effective cycloplegic agent for myopic children. Manny RE, Hussein M, Scheiman M, Kurtz D, Niemann K, Zinzer K; COMET Study Group. Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1728-35. |
Active substance: TROPICAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 46870 |
Study title: |
Active substance: TROPISETRON |
Study summary document link (including results): Navoban 3901.xls |
View full study record |
Document reference: 47312 |
Study title: Gaedicke G, Erttmann R, Henze G, Hartmann W, Drechsler S, Grass P, Faerber L, Kutz K Pharmacokinetics of the 5HT3 receptor antagonist tropisetron in children. Pediatr Hematol Oncol. 1996 Sep-Oct;13(5):405-16. |
Active substance: TROPISETRON |
Study summary document link (including results): Navoban 301_302_303.xls |
View full study record |
Document reference: 46884 |
Study title: Suarez A, Stettler ER, Rey E, Pons G, Simonetta-Chateauneuf C, de Bruijn KM, Olive G, Lemerle J. "Safety, tolerability, efficacy and plasma concentrations of tropisetron after administration at five dose levels to children receiving cancer chemotherapy." Eur J Cancer. 1994;30A(10):1436-41 |
Active substance: TROPISETRON |
Study summary document link (including results): Navoban ICS3 512-E-00.xls |
View full study record |
Document reference: 47313 |
Study title: Danilov VV, Danilova TI, Clinical-urodynamic assessment of the efficacy of administration of Spasmex to children with neurogenic bladder dysfunction. Medical University of the Vladivostok Administration, Vladivostok 2001 |
Active substance: TROSPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 46885 |
Study title: Wastell-H-J, Bartlett-K, Dale-G, Shein-A. Department of Clinical Biochemistry, Newcastle General Hospital, Newcastle upon Tyne. Biotinidase deficiency: a survey of 10 cases. Archives of disease in childhood, {Arch-Dis-Child}, Oct 1988, vol. 63, no. 10, p. 1244-9, ISSN: 1468-2044.Wastell-H-J, Bartlett-K, Dale-G, Shein-A. Department of Clinical Biochemistry, Newcastle General Hospital, Newcastle upon Tyne. Biotinidase deficiency: a survey of 10 cases. Archives of disease in childhood, {Arch-Dis-Child}, Oct 1988, vol. 63, no. 10, p. 1244-9, ISSN: 1468-2044. |
Active substance: BIOTIN |
Study summary document link (including results): |
View full study record |
Document reference: 22567 |
Study title: Spasmo-lyt - Clinical trial for nocturnal and diurnal enuresis |
Active substance: TROSPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 46887 |
Study title: Therapie der kindlichen Harninkontinenz mit Trospiumchlorid; Urologe (B) 1998; 38: 531-534Therapie der kindlichen Harninkontinenz mit Trospiumchlorid; Urologe (B) 1998; 38: 531-534 |
Active substance: TROSPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 46888 |
Study title: Assessment of tolerance and immunogenicity of a ViCPs vaccine at 2 dosages |
Active substance: Typhoid Vi Polysaccharide Vaccine |
Study summary document link (including results): |
View full study record |
Document reference: 47480 |
Study title: Double blind, controlled trial testing the immunogenicity and side effects of parenteral Vi polysaccharide typhoid vaccine in Indonesian children and adults |
Active substance: Typhoid Vi Polysaccharide Vaccine |
Study summary document link (including results): |
View full study record |
Document reference: 47483 |
Study title: Effectiveness of a Vi capsular polysaccharide vaccine |
Active substance: Typhoid Vi Polysaccharide Vaccine |
Study summary document link (including results): |
View full study record |
Document reference: 47481 |
Study title: Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi |
Active substance: Typhoid Vi Polysaccharide Vaccine |
Study summary document link (including results): |
View full study record |
Document reference: 47479 |
Study title: Safety and dose related immunogenicity of the Vi capsular polysaccharide of Salmonella typhi (Pilot study) |
Active substance: Typhoid Vi Polysaccharide Vaccine |
Study summary document link (including results): |
View full study record |
Document reference: 47478 |
Study title: Safety and immunogenicity of Vi CPS vaccine in teenagers |
Active substance: Typhoid Vi Polysaccharide Vaccine |
Study summary document link (including results): |
View full study record |
Document reference: 47482 |
Study title: Muz V.A., Zubkova S.T., Bolshova-Zubkovskaya E.V: Ubichinon compositum preparation applied to optimize the treatment of ketoacidosis in children suffering from diabetes mellitus type 1. Biological Therapy (Ukraine), 2003, 3: 27-30 [IIT-publication]; |
Active substance: Ubichinon compositum |
Study summary document link (including results): |
View full study record |
Document reference: 40294 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Ubichinon compositum Ampullen (ampoules) [AWB-AT] |
Active substance: Ubichinon compositum |
Study summary document link (including results): |
View full study record |
Document reference: 40295 |
Study title: The effect of coenzyme Q10 in ideopathic dilated cardiomyopathy in children. |
Active substance: UBIDECARENONE (CO-ENZYME Q10) |
Study summary document link (including results): |
View full study record |
Document reference: 39140 |
Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42927 |
Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42928 |
Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42929 |
Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42930 |
Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42931 |
Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42932 |
Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42933 |
Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42934 |
Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42935 |
Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42936 |
Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42937 |
Study title: A MULTICENTER SULTAMICILLIN (CP-49,952-15) PHASE III STUDY. A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952-15) AND AUGMENTIN FOR THE ASSESSMENT OF EFFICACY IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42912 |
Study title: A NON COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF SULTAMICILLIN FOR THE TREATMENT OF SKIN AND SOFT TISSUE PEDIATRIC INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43037 |
Study title: A NON COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF SULTAMICILLIN FOR THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42971 |
Study title: A NON-COMPARATIVE SHORT-TERM, OPEN STUDY OF EFFICACY AND TOLERABILITY OF ORAL SULTAMICILLIN SUSPENSION IN THE TREATMENT OF VARIOUS INFECTIONS IN PEDIATRIC INPATIENTS/OUTPATIENTS |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42989 |
Study title: A NON-COMPARATIVE STUDY OF SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN THE TREATMENT OF MODERATE PEDIATRIC INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43042 |
Study title: A NON-COMPARATIVE STUDY OF SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN THE TREATMENT OF MODERATE PEDIATRIC INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43043 |
Study title: A NON-COMPARATIVE STUDY OF SULTAMICILLIN SUSPENSION IN THE TREATMENT OF ACUTE SUPPURATIVE OTITIS MEDIA IN CHILDREN. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42920 |
Study title: Månsson T., Blychert LO, Åberg Å. The efficacy of itraconazole in dermatophyte infections in comparison with griseofulvin. Clinical study report, Janssen Pharma, Sweden, 1993. (12-72 years, LMD102676)Månsson T., Blychert LO, Åberg Å. The efficacy of itraconazole in dermatophyte infections in comparison with griseofulvin. Clinical study report, Janssen Pharma, Sweden, 1993. (12-72 years, LMD102676) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30778 |
Study title: Mariano A, Rocha MM Oral itraconazole in the treatment of dermatomycoses. Clinical summary on R51211, August 1987. (10-84 years, LMD56450)Mariano A, Rocha MM Oral itraconazole in the treatment of dermatomycoses. Clinical summary on R51211, August 1987. (10-84 years, LMD56450) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30792 |
Study title: Moens M, Van Meensel A, Willems W, Schuermans V, Cauwenbergh G. Combined analyses of adverse experiences and clinical laboratory data related to safety in patients treated with itraconazole for vulvovaginal candidosis, pityriasis versicolor, dermatomycoses, oral candidosis and fungal keratitis. Clinical research report on R051211 no-87, September 1987. (<15->65 years, LMD56766).Moens M, Van Meensel A, Willems W, Schuermans V, Cauwenbergh G. Combined analyses of adverse experiences and clinical laboratory data related to safety in patients treated with itraconazole for vulvovaginal candidosis, pityriasis versicolor, dermatomycoses, oral candidosis and fungal keratitis. Clinical research report on R051211 no-87, September 1987. (<15->65 years, LMD56766). |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30817 |
Study title: Open-label, single-centre, active control (nystatin), four parallel group study. |
Active substance: ITRACONAZOLE |
Study summary document link (including results): LMD118956_Interventional_Itraconazole.xls |
View full study record |
Document reference: 47579 |
Study title: Panagiotidou D et al. A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study.The journal of international medical research 20, p.392-400, 1992. (17-70 years, LMD88424)Panagiotidou D et al. A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study.The journal of international medical research 20, p.392-400, 1992. (17-70 years, LMD88424) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30777 |
Study title: Panconesi E, Difonzo E Treatment of dermatophytoses and pityriasis versicolor with itraconazole. Reviews of infectious diseases 9 suppl.1, p.S109-S113, 1987. (15-45 years, LMD51772)Panconesi E, Difonzo E Treatment of dermatophytoses and pityriasis versicolor with itraconazole. Reviews of infectious diseases 9 suppl.1, p.S109-S113, 1987. (15-45 years, LMD51772) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30790 |
Study title: Pharmacokinetic study of itraconazole oral solution during chronic treatment in neutropenic children. (ITR-FRA-7) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): LMD129355_Interventional_Itraconazole.xls |
View full study record |
Document reference: 45126 |
Study title: Phillips P, Graybill JR, Fetchick R, Dunn JF. Adrenal response to corticotropin during therapy with itraconazole. Antimicrobial agents and chemotherapy 31 (4), p.647-649, 1987. (7-72 years, LMD54302)Phillips P, Graybill JR, Fetchick R, Dunn JF. Adrenal response to corticotropin during therapy with itraconazole. Antimicrobial agents and chemotherapy 31 (4), p.647-649, 1987. (7-72 years, LMD54302) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30807 |
Study title: Rees T, Phillips R. Multicenter comparison of one-day oral therapy with fluconazole or itraconazole in vaginal candidiasis. International journal of gynecology and obstetrics 37 (suppl.), p.33-38, 1992. (17-68 years, LMD95334)Rees T, Phillips R. Multicenter comparison of one-day oral therapy with fluconazole or itraconazole in vaginal candidiasis. International journal of gynecology and obstetrics 37 (suppl.), p.33-38, 1992. (17-68 years, LMD95334) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30800 |
Study title: Repeated-dose pharmacokinetics of itraconazole in oral solution, 5 mg/kg once daily for two weeks, in infants and children.(ITR-INT-21) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): LMD118873_Interventional_Itraconazole.xls |
View full study record |
Document reference: 45125 |
Study title: Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis. Vernon HJ, Lane AT, Weston W. J Am Acad Dermatol. 1991 Apr; 24(4):603-7.Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis. Vernon HJ, Lane AT, Weston W. J Am Acad Dermatol. 1991 Apr; 24(4):603-7. |
Active substance: MOMETAZONE |
Study summary document link (including results): |
View full study record |
Document reference: 32282 |
Study title: Efficacy and Safety of Nasonex vs. Placebo in Subjects with SAR and Concomitant Asthma |
Active substance: MOMETAZONE |
Study summary document link (including results): Nasonex_Mometasone furoate_P03280.pdf |
View full study record |
Document reference: 47645 |
Study title: Mometasone furoate in the treatment of atopic dermatitis in children; Publication on Journal of the European Academy of dermatology & Dermatology 2(1993)225 Mometasone furoate in the treatment of atopic dermatitis in children; Publication on Journal of the European Academy of dermatology & Dermatology 2(1993)225 |
Active substance: MOMETAZONE |
Study summary document link (including results): |
View full study record |
Document reference: 32281 |
Study title: Mometasone furoate nasal spray vs placebo in subjects with allergic rhinitis and cough. |
Active substance: MOMETAZONE |
Study summary document link (including results): P01970.pdf |
View full study record |
Document reference: 48186 |
Study title: One-Year, Double-Blind Safety Study of the Effects of Mometasone Furoate (SCH 32088) Dry Powder Inhaler (MF DPI) vs. Placebo on Growth of Children With Asthma |
Active substance: MOMETAZONE |
Study summary document link (including results): C97-384_mometasone furoate.pdf |
View full study record |
Document reference: 48178 |
Study title: One-Year, Open-Label Safety Study of Mometasone Furoate (SCH 32088) Dry Powder Inhaler (MF DPI) and Beclomethasone Dipropionate (Vanceril® 84 mcg Double Strength) in Children With Asthma Previously Maintained on Inhaled Corticosteroids |
Active substance: MOMETAZONE |
Study summary document link (including results): C97-385_mometasone furoate.pdf |
View full study record |
Document reference: 48180 |
Study title: Onset of Action of Mometasone Furoate Nasal Spray vs. Placebo in Induced Allergic Rhinitis in an Allergen Exposure Unit (AEU) |
Active substance: MOMETAZONE |
Study summary document link (including results): Nasonex_Mometasone furoate_P03431.pdf |
View full study record |
Document reference: 47646 |
Study title: Placebo-Controlled Efficacy and Safety Study of a Once-Daily, PM Regimen of Mometasone Furoate (SCH 32088) Dry Powder in Asthmatics Previously Maintained on Short-acting Inhaled Beta-agonists |
Active substance: MOMETAZONE |
Study summary document link (including results): C98-475_mometasone furoates.pdf |
View full study record |
Document reference: 48179 |
Study title: Placebo-Controlled Efficacy and Safety Study of Mometasone Furoate Administered Via Dry Powder Inhaler in the Treatment of Asthma in Children Previously Maintained on Inhaled Corticosteroids |
Active substance: MOMETAZONE |
Study summary document link (including results): P01431_mometasone furoate.pdf |
View full study record |
Document reference: 48183 |
Study title: Placebo-Controlled Efficacy and Safety Study of Mometasone Furoate Administered ViaDry Powder Inhaler in the Treatment of Asthma in Children Previously Maintained on Inhaled Corticosteroids |
Active substance: MOMETAZONE |
Study summary document link (including results): P02236_mometasone furoate.pdf |
View full study record |
Document reference: 48184 |
Study title: Marsden CD, et al. The treatment of severe dystonia in children and adults. J Neurol Neurosurg Psychiatry 1984 Nov; 47(11): 116-73.Marsden CD, et al. The treatment of severe dystonia in children and adults. J Neurol Neurosurg Psychiatry 1984 Nov; 47(11): 116-73. |
Active substance: TRIHEXYPHENIDYL |
Study summary document link (including results): |
View full study record |
Document reference: 46744 |
Study title: Nardocci N, et al. Acquired hemidystonia in childhood: a clinical and neuroradiological study of thirteen patients. Pediatr Neurol. 1996 Sep;15(2):108-13.Nardocci N, et al. Acquired hemidystonia in childhood: a clinical and neuroradiological study of thirteen patients. Pediatr Neurol. 1996 Sep;15(2):108-13. |
Active substance: TRIHEXYPHENIDYL |
Study summary document link (including results): |
View full study record |
Document reference: 46739 |
Study title: Reddihough D, et al. Use of benzhexol hydrochloride to control drooling of children with cerebral palsy. Dev Med Child Neurol 1990 Nov; 32(11): 985- 9.Reddihough D, et al. Use of benzhexol hydrochloride to control drooling of children with cerebral palsy. Dev Med Child Neurol 1990 Nov; 32(11): 985- 9. |
Active substance: TRIHEXYPHENIDYL |
Study summary document link (including results): |
View full study record |
Document reference: 46741 |
Study title: Rockland L, et al. Effects of trihexyphenidyl on plasma chlorpromazine in young schizophrenics. Can J Psychiatry 1990 Oct; 35(7): 604-7. Erratum Can J Psychiatry 1991 Feb;36(1):73Rockland L, et al. Effects of trihexyphenidyl on plasma chlorpromazine in young schizophrenics. Can J Psychiatry 1990 Oct; 35(7): 604-7. Erratum Can J Psychiatry 1991 Feb;36(1):73 |
Active substance: TRIHEXYPHENIDYL |
Study summary document link (including results): |
View full study record |
Document reference: 46742 |
Study title: Saletu B, et al. Behavioral and visual evoked potential investigations during trihexyphenidyl and thiothixene treatment in psychotic boys. Biol Psychiatry 1974 Apr; 8(2): 177-89.Saletu B, et al. Behavioral and visual evoked potential investigations during trihexyphenidyl and thiothixene treatment in psychotic boys. Biol Psychiatry 1974 Apr; 8(2): 177-89. |
Active substance: TRIHEXYPHENIDYL |
Study summary document link (including results): |
View full study record |
Document reference: 46746 |
Study title: Saletu, B., Simeon, J., Saletu, M., Itil, T. M., and DaSilva, J. Behavioral and visual evoked potential investigations during trihexyphenidyl and thiothixene treatment in psychotic boys Biol.Psychiatry 1974;8:177-189. Marsden CD The treatment of severe dystonia in children and adults. J.Neurol.Neurosurg.Psych. 1984;47:1166-1173.Saletu, B., Simeon, J., Saletu, M., Itil, T. M., and DaSilva, J. Behavioral and visual evoked potential investigations during trihexyphenidyl and thiothixene treatment in psychotic boys Biol.Psychiatry 1974;8:177-189. Marsden CD The treatment of severe dystonia in children and adults. J.Neurol.Neurosurg.Psych. 1984;47:1166-1173. |
Active substance: TRIHEXYPHENIDYL |
Study summary document link (including results): |
View full study record |
Document reference: 46735 |
Study title: Sanger TD, et al. Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy. J Child Neurol 2007 May; 22(5): 530-7.Sanger TD, et al. Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy. J Child Neurol 2007 May; 22(5): 530-7. |
Active substance: TRIHEXYPHENIDYL |
Study summary document link (including results): |
View full study record |
Document reference: 46736 |
Study title: Vogels OJ, et al. Focal dystonia and speech impairment responding to anticholinergic therapy. Pediatric Neurol 1994; 11(4): 346-8.Vogels OJ, et al. Focal dystonia and speech impairment responding to anticholinergic therapy. Pediatric Neurol 1994; 11(4): 346-8. |
Active substance: TRIHEXYPHENIDYL |
Study summary document link (including results): |
View full study record |
Document reference: 46740 |
Study title: 1989 1980 BOIGE N.,CARGILL G.,MASHAKO L.,CEZARD J.P.,NAVARRO J. TRIMEBUTINE INDUCED PHASE III LIKE ACTIVITY IN INFANTS WITH INTESTINAL MOTILITY DISORDERS J.PEDIATR.GASTROENTEROL.NUTR.,6,548-553,19871989 1980 BOIGE N.,CARGILL G.,MASHAKO L.,CEZARD J.P.,NAVARRO J. TRIMEBUTINE INDUCED PHASE III LIKE ACTIVITY IN INFANTS WITH INTESTINAL MOTILITY DISORDERS J.PEDIATR.GASTROENTEROL.NUTR.,6,548-553,1987 |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46759 |
Study title: A NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN PEDIATRIC PATIENTS WITH MODERATE RESPIRATORY TRACT OR SKIN/SOFT TISSUE INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43020 |
Study title: A NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN THE TREATMENT OF MODERATE PEDIATRIC INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43038 |
Study title: A PROSPECTIVE, RANDOMIZED, THIRD-PARTY BLINDED, PLACEBO CONTROLLED EVALUATION OF AMPICILLIN/SULBACTAM VERSUS CLINDAMYCIN AS ADJUNCTIVE TREATMENT FOR WOMEN EXPERIENCING PRETERM LABOR |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42944 |
Study title: A RANDOMIZED, OPEN LABEL, MULTICENTER TRIAL COMPARING ORAL SULTAMICILLIN 750 MG DAILY FOR 10 DAYS WITH AMOXICILLIN/CLAVULANIC 1500 MG DAILY FOR 10 DAYS FOR THE TREATMENT OF ACUTE EAR, NOSE AND THROAT INFECTIONS |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42919 |
Study title: A STUDY OF THE PENETRATION CHARACTERISTICS OF SULTAMICILLIN (CP-49,952) INTO THE MIDDLE EAR FLUID OF PEDIATRIC PATIENTS WITH CHRONIC SERIOUS OTITIS MEDIA. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42910 |
Study title: A THIRD PARTED BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952) AND PENICILLIN V-K FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF UPPER RESPIRATORY INFECTIONS IN PEDIATRIC PATIENTS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42926 |
Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMACILLIN (CP-49,952-15) AND PENICILLIN V-K FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42925 |
Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952-15) AND AMOXICILLIN FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT LOWER RESPIRATORY TRACT INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43063 |
Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952-15) AND CECLOR FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43064 |
Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952-15) AND CLOXACILLIN FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42923 |
Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952) AND CLOXICILLIN FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS IN PEDIATRIC PATIENTS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42924 |
Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952) AND PENICILLIN V-K FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF STREPTOCOCCAL PHARYNGITIS IN PEDIATRIC PATIENTS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42917 |
Study title: AN OPEN COMPARATIVE MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF STM VS. CEFACLOR IN THE TREATMENT OF ACUTE OTITIS MEDIA IN CHILDREN. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42997 |
Study title: AN OPEN COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL (STM 25-50MK)VS. ORAL AMOXYCILLIN (25-40 MK) IN THE TREATMENT OF MILD TO MODERATE UPPER RESPIRATORY TRACT INFECTIONS IN CHILDREN. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43004 |
Study title: AN OPEN COMPARATIVE STUDY TO COMPARE THE SAFETY AND EFFICACY OF A SINGLE ORAL DOSE OF SULTAMICILLIN VS DOUBLE STRENGTH OF TRIMETHOPRIM-SULF. TABLETS FOR UNCOMPLICATED LOWER URINARY TRACT INFECTIONS IN WOMEN. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43019 |
Study title: AN OPEN MULTICENTER NON-COMPARATIVE SHORT TERM STUDY OF EFFICACY AND TOLERABILITY OF ORAL SULTAMICILLIN SUSPENSION IN THE TREATMENT OF UPPER AND LOWER RESPIRATORY TRACT INFECTIONS IN PEDIATRIC INPATIENTS/ OUTPATIENTS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42990 |
Study title: AN OPEN NON COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42975 |
Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY ON THE EFFICACY AND TOLERABILITY OF SULTAMICILLIN (SULBACTAM/AMPICILLIN) IN THE TREATMENT OF PEDIATRIC PATIENTS WITH ACUTE OTITIS MEDIA. |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 42964 |
Study title: Saul A, Bonifaz A, Arias I Itraconazole in the treatment of superficial mycoses: an open trial of 40 cases. Reviews of infectious diseases 9 suppl.1, p.S100-S103, 1987. (13-74 years, LMD45549)Saul A, Bonifaz A, Arias I Itraconazole in the treatment of superficial mycoses: an open trial of 40 cases. Reviews of infectious diseases 9 suppl.1, p.S100-S103, 1987. (13-74 years, LMD45549) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30796 |
Study title: Thomas PA, Abraham DJ, Kalavathy CM, Rajasekaran J. Oral itraconazole therapy in keratomycosis. March 1986. (5-60 years, LMD45894)Thomas PA, Abraham DJ, Kalavathy CM, Rajasekaran J. Oral itraconazole therapy in keratomycosis. March 1986. (5-60 years, LMD45894) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30804 |
Study title: Thomas PA, Kalavathy CM, Abraham DJ, Rajasekaran J. Combined oral and topical itraconazole therapy in the treatment of keratomycosis. August 1986. (13-55 years, LMD51269)Thomas PA, Kalavathy CM, Abraham DJ, Rajasekaran J. Combined oral and topical itraconazole therapy in the treatment of keratomycosis. August 1986. (13-55 years, LMD51269) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30805 |
Study title: Van Peer A, Van de Velde V, Heykants J, Woestenborghs R, Meuldermans W, Cauwenbergh G. Itraconazole pharmacokinetics in healthy volunteers and patients. A review of the data available until August '90. Clinical Research report on R051211 no-79, revised August 1990. (4-78 years, LMD74817)Van Peer A, Van de Velde V, Heykants J, Woestenborghs R, Meuldermans W, Cauwenbergh G. Itraconazole pharmacokinetics in healthy volunteers and patients. A review of the data available until August '90. Clinical Research report on R051211 no-79, revised August 1990. (4-78 years, LMD74817) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30813 |
Study title: Viviani MA, Van de Velde V, Cilli P, Van de Poel S, Van Peer A, Woestenborghs R, Heykants J, Cauwenbergh G. Pharmacokinetics of itraconazole in patients with systemic mycoses. Clinical research report on R051211 no-112, January 1990. (4-66 years, LMD67873)Viviani MA, Van de Velde V, Cilli P, Van de Poel S, Van Peer A, Woestenborghs R, Heykants J, Cauwenbergh G. Pharmacokinetics of itraconazole in patients with systemic mycoses. Clinical research report on R051211 no-112, January 1990. (4-66 years, LMD67873) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30809 |
Study title: Wishart JM. The influence of food on the pharmacokinetics of itraconazole in patients with superficial fungal infection. Journal of the american academy of dermatology 17 (2) (part 1), p.220-223, 1987. (13-64 years, LMD49681)Wishart JM. The influence of food on the pharmacokinetics of itraconazole in patients with superficial fungal infection. Journal of the american academy of dermatology 17 (2) (part 1), p.220-223, 1987. (13-64 years, LMD49681) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30808 |
Study title: STUDY TO ASSESS THE PHARMACOKINETICS OF A SINGLE ORAL OR INTRAVENOUS DOSE OF FLUCONAZOLE ADMINISTERED TO FULL TERM NEONATES |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27705 |
Study title: SYSTEMIC TREATMENT OF INTRACTABLE ONYCHOMYCOSIS WITH FLUCONAZOLE. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27493 |
Study title: SYSTEMIC TREATMENT OF INTRACTABLE ONYCHOMYCOSIS WITH FLUCONAZOLE. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27857 |
Study title: THE PHARMACOKINETICS OF FCA DURING HEMODIALYSIS IN PATIENTS WITH CHRONIC RENAL DYSFUNCTION. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27503 |
Study title: THE PHARMACOKINETICS OF FCA DURING HEMODIALYSIS IN PATIENTS WITH CHRONIC RENAL DYSFUNCTION. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27867 |
Study title: THREE OPEN COMPARATIVE STUDIES OF THE EFFICAY AND SAFETY OF FLUCONAZOLE AND KETOCONAZOLE, ITRACONAZOLE OR CLOTRIMAZOLE IN THE TREATMENT OF PATIENTS WITH PITYRIASIS VERSICOLOR |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27578 |
Study title: TO ASSESS THE EFFICACY AND SAFETY OF FLUCONAZOLE I.V. (+ AMPHOTERICIN B BY ORAL ROUTE) VS. PLACEBO I.V. (+AMPHOTERICIN B BY ORAL ROUTE) TO PREVENT THE ONSET OF INFECTIONS WITH A MYCOTIC ETIOLOGY IN MULTICOLONIZED NEUTROPENIC PATIENTS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27461 |
Study title: Placebo-Controlled Efficacy and Safety Study of Mometasone Furoate Dry Powder Inhaler (MF DPI) in the Treatment of Asthma in Children Previously Maintained on Beclomethasone Dipropionate (Vanceril® 84 mcg Double Strength) |
Active substance: MOMETAZONE |
Study summary document link (including results): C97-380_mometasone furoate.pdf |
View full study record |
Document reference: 48177 |
Study title: Placebo-Controlled Efficacy and Safety Study of Mometasone Furoate Dry Powder Inhaler (MF DPI) in the Treatment of Asthma in Children Previously Maintained on Inhaled Corticosteroids |
Active substance: MOMETAZONE |
Study summary document link (including results): CI97-300_mometasone furoate.pdf |
View full study record |
Document reference: 48181 |
Study title: Primotic ring topical corticoid cream (0.1% mometasone furoate) treatment in children. Pileggi Fde O, Vicente YA. J Pediatr Surg. 2007 Oct; 42(10):1749-52.Primotic ring topical corticoid cream (0.1% mometasone furoate) treatment in children. Pileggi Fde O, Vicente YA. J Pediatr Surg. 2007 Oct; 42(10):1749-52. |
Active substance: MOMETAZONE |
Study summary document link (including results): |
View full study record |
Document reference: 32283 |
Study title: A Multicenter, Double-Blind, Crossover Study Comparing the Clinical Effect of Combination MK-0476/Loratadine to MK-0476 in Patients With Chronic Asthma |
Active substance: MONTELUKAST |
Study summary document link (including results): 0476_various_synopses.pdf |
View full study record |
Document reference: 47561 |
Study title: A multicenter, double-blind, randomized, crossover study comparing montelukast sodium to placebo in 6- to 14-year-old patients with chronic asthma currently using inhaled corticosteroids (ICS) |
Active substance: MONTELUKAST |
Study summary document link (including results): 906 synopsis.pdf |
View full study record |
Document reference: 32406 |
Study title: A Multicenter, Double-Blind, Randomized, Crossover Study Investigating the Clinical Effect of Montelukast in Patients With Concomitant Asthma and Allergic Rhinitis Upon Controlled Exposure to Cat Allergen |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32407 |
Study title: A Multicenter, Double-Blind, Randomized, Parallel-Group Study Comparing Montelukast With Placebo in Pediatrics Patients Aged 6 to 24 Months With Asthma |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32409 |
Study title: A Multicenter, Double-Blind, Randomized, Parallel-Group Study Comparing the Effect on Linear Growth of Montelukast with Placebo and Inhaled Beclomethasone in Pediatric Patients (Prepubertal, Tanner Stage I) With Mild Asthma |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32410 |
Study title: A Multicenter, Double-Blind, Randomized, Parallel-Group Study Investigating the Clinical Effect of Combination Montelukast/Loratadine in Patients With Seasonal Allergic Rhinitis (Fall Study) |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32411 |
Study title: a Multicenter, Double-blind, Randomized, Parallel-Group Study Investigating the Clinical Effect of Montelukast in Patients With Seasonal Allergic Rhinitis - Fall Study |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32412 |
Study title: A Multicenter, Double-Blind, Randomized, Parallel-Group Study Investigating the Clinical Effect of Montelukast in Patients With Seasonal Allergic Rhinitis-Spring 2001 Study " |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32413 |
Study title: A Multicenter, Double-Blind, Randomized, Parallel-Group Study Investigating the Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32414 |
Study title: EFFICACY AND SAFETY OF LACTEOL SACHET IN THE TREATMENT OF ACUTE DIARRHEA IN CHILDREN |
Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30975 |
Study title: A Multicenter, Double-Blind, Randomized, Parallel-Group Study Investigating the Clinical Effects of Montelukast in Patients With Seasonal Allergic Rhinitis Over a 4-Week Treatment Period-Fall 2001 |
Active substance: MONTELUKAST |
Study summary document link (including results): |
View full study record |
Document reference: 32415 |
Study title: 1999 - 1990 SPIROGLOU-K, PAROUTOGLOU-G. SPIROGLOU DYSPEPSIA IN CHILDREN - A REAL PROBLEM OF CHILDHOOD. HELLENIC JOURNAL OF GASTROENTEROLOGY {HELL-J-GASTROENTEROL}, 1999, VOL/ISS/PG. 12/2 (87-95)1999 - 1990 SPIROGLOU-K, PAROUTOGLOU-G. SPIROGLOU DYSPEPSIA IN CHILDREN - A REAL PROBLEM OF CHILDHOOD. HELLENIC JOURNAL OF GASTROENTEROLOGY {HELL-J-GASTROENTEROL}, 1999, VOL/ISS/PG. 12/2 (87-95) |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46752 |
Study title: ante 1980 TOURSEL F.,FONTAINE G. ETUDE DE LA TRIMEBUTINE EN PEDIATRIE PEDIAT. L'OMNIPATRICIEN,N.8,1972ante 1980 TOURSEL F.,FONTAINE G. ETUDE DE LA TRIMEBUTINE EN PEDIATRIE PEDIAT. L'OMNIPATRICIEN,N.8,1972 |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46765 |
Study title: ARMENGAUD.,LAGARDERE B. LE REFLUX GASTRO-OESOPHAGIEN DE L'ENFANT REV.PRAT.,34(29),1557-1565,1984ARMENGAUD.,LAGARDERE B. LE REFLUX GASTRO-OESOPHAGIEN DE L'ENFANT REV.PRAT.,34(29),1557-1565,1984 |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46761 |
Study title: Boige-N, Cargill-G, Mashako-L, Cezard-J-P, Navarro-J. Hop Bretonneau, Serv Gastroenterol Pediat, F-75018 Paris, France. Trimebutine Induces Migrating Motor Complexes In Infants. Pediatric-Research, 1986, V20, N7, P692-692.Boige-N, Cargill-G, Mashako-L, Cezard-J-P, Navarro-J. Hop Bretonneau, Serv Gastroenterol Pediat, F-75018 Paris, France. Trimebutine Induces Migrating Motor Complexes In Infants. Pediatric-Research, 1986, V20, N7, P692-692. |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46760 |
Study title: CHARRITAT J.L. MOTRICITE DIGESTIVE EN PEDIATRIE;UNE REALITE QUOTIDIENNE JAMA ED. FRANCAISE,238(SUPPL.),1992 MASHAKO M.N.L.,SONSINO E.,NAVARRO J.,MOUGENOT J.F.,GARGOURI A.,BOIGE N.,CEZ ARD J.P. MICROSCOPIC COLITIS: A NEW CAUSE OF CHRONIC DIARRHEA IN CHILDREN? J.PEDIAT.GASTROENTEROL.NUTR., 10(1),21-26,1990CHARRITAT J.L. MOTRICITE DIGESTIVE EN PEDIATRIE;UNE REALITE QUOTIDIENNE JAMA ED. FRANCAISE,238(SUPPL.),1992 MASHAKO M.N.L.,SONSINO E.,NAVARRO J.,MOUGENOT J.F.,GARGOURI A.,BOIGE N.,CEZ ARD J.P. MICROSCOPIC COLITIS: A NEW CAUSE OF CHRONIC DIARRHEA IN CHILDREN? J.PEDIAT.GASTROENTEROL.NUTR., 10(1),21-26,1990 |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46758 |
Study title: CHOURAQUI J.P. COLIQUES DU NOURRISSON;ELLES CONSERNENT PRES DE 10 A 20% DES BEBES DE MOINS DE 4 MOIS REV.PRATIC.MED.GENERALE,8(321),27-33,1995CHOURAQUI J.P. COLIQUES DU NOURRISSON;ELLES CONSERNENT PRES DE 10 A 20% DES BEBES DE MOINS DE 4 MOIS REV.PRATIC.MED.GENERALE,8(321),27-33,1995 |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46756 |
Study title: Czerwionka-Szaflarska-M, Sadowska-Krawczenko-I, Korbal-P. M. Czerwionka-Szaflarska, Katedra i Klinika Pediatrii, Alergologii i Gastroenterologii, Akademia Medyczna im. L. Rydygiera, Bydgoszcz, Poland. Gastroesophageal reflux in preterm infants. Pediatria Polska {PEDIATR-POL}, 2005, Vol/Iss/Pg. 80/9 (719-726),Czerwionka-Szaflarska-M, Sadowska-Krawczenko-I, Korbal-P. M. Czerwionka-Szaflarska, Katedra i Klinika Pediatrii, Alergologii i Gastroenterologii, Akademia Medyczna im. L. Rydygiera, Bydgoszcz, Poland. Gastroesophageal reflux in preterm infants. Pediatria Polska {PEDIATR-POL}, 2005, Vol/Iss/Pg. 80/9 (719-726), |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46748 |
Study title: DELVAUX-M, WINGATE-D. GASTROENTEROLOGY UNIT, CHU RANGUEIL, TOULOUSE, FRANCE. TRIMEBUTINE: MECHANISM OF ACTION, EFFECTS ON GASTROINTESTINAL FUNCTION AND CLINICAL RESULTS. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH {J-INT-MED-RES} 1997 SEP- OCT, VOL: 25 (5), P: 225-46.DELVAUX-M, WINGATE-D. GASTROENTEROLOGY UNIT, CHU RANGUEIL, TOULOUSE, FRANCE. TRIMEBUTINE: MECHANISM OF ACTION, EFFECTS ON GASTROINTESTINAL FUNCTION AND CLINICAL RESULTS. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH {J-INT-MED-RES} 1997 SEP- OCT, VOL: 25 (5), P: 225-46. |
Active substance: TRIMEBUTINE |
Study summary document link (including results): |
View full study record |
Document reference: 46754 |
Study title: Fluoxetine In The Treatment Of Premenstrual Dysphoric Disorder (Pmdd) In Adolescents : An Open-Label Pilot Study |
Active substance: FLUOXETINE |
Study summary document link (including results): Fluoxetine - B1Y-MC-HCLF Synopsis.pdf |
View full study record |
Document reference: 28329 |
Study title: Fluoxetine Major Depressive Disorder |
Active substance: FLUOXETINE |
Study summary document link (including results): Fluoxetine - B1Y-IT-M002 Summary.pdf |
View full study record |
Document reference: 28340 |
Study title: Fluoxetine V Mianserin D.B. Depressed Patients |
Active substance: FLUOXETINE |
Study summary document link (including results): Fluoxetine - B1Y-IT-M003 Summary.pdf |
View full study record |
Document reference: 28341 |
Study title: "Fluoxetine Versus Placebo in Adolescent Depressed Patients " |
Active substance: FLUOXETINE |
Study summary document link (including results): fluoxetine B1Y-MC-HCCJ Clinical Study Summary.pdf |
View full study record |
Document reference: 28334 |
Study title: Fluoxetine Versus Placebo in Childhood/Adolescent Depression |
Active substance: FLUOXETINE |
Study summary document link (including results): fluoxetine B1Y-MC-HCJE Clinical Study Summary.pdf |
View full study record |
Document reference: 47358 |
Study title: Fluoxetine Versus Placebo In Social Phobia |
Active substance: FLUOXETINE |
Study summary document link (including results): Fluoxetine - B1Y-MC-HCHP Synopsis.pdf |
View full study record |
Document reference: 28327 |
Study title: A double-blind, single oral dose study comparing the anti-pyretic properties of Ibuprofen, acetaminophen and placebo in the treatment of pyrexia associated with infectious disease in children and Pharmacodynamics of fever treatment with Ibuprofen |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29426 |
Study title: A double-blind, single oral dose study comparing the anti-pyretic property of Ibuprofen, Acetaminophen, and placebo in the treatment of pyrexia associated with infectious disease in children. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29400 |
Study title: Tan-C, Jereb-B, Exelby-P, et-al. Mem. Sloan-Kettering Cancer Cent., New York, NY 10021, United States. Experiences in the changing management of 143 children with Hodgkin's disease (HD). Proceedings of the American Association for Cancer Research {PROC-AM-ASSOC-CANCER-RES}, 1981, Vol/Iss/Pg. Vol. 22/- (C-711).Tan-C, Jereb-B, Exelby-P, et-al. Mem. Sloan-Kettering Cancer Cent., New York, NY 10021, United States. Experiences in the changing management of 143 children with Hodgkin's disease (HD). Proceedings of the American Association for Cancer Research {PROC-AM-ASSOC-CANCER-RES}, 1981, Vol/Iss/Pg. Vol. 22/- (C-711). |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34855 |
Study title: Tekinalp-G, Arat-O, Acar-S, et-al. Div. Ped., Sch. Med., Hacettepe Univ., Ankara, Turkey. Combination chemotherapy in Hodgkin's lymphoma: results in 63 adult and pediatric patients. Kanser {KANSER}, 1977, Vol/Iss/Pg. 7/1 (12-22).Tekinalp-G, Arat-O, Acar-S, et-al. Div. Ped., Sch. Med., Hacettepe Univ., Ankara, Turkey. Combination chemotherapy in Hodgkin's lymphoma: results in 63 adult and pediatric patients. Kanser {KANSER}, 1977, Vol/Iss/Pg. 7/1 (12-22). |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34857 |
Study title: Thomas-L, Andes-W-A. Dep. Med., Tulane Univ. Sch. Med., New Orleans, LA, United States. Fetal anomaly associated with successful chemotherapy for Hodgkin's disease during the first trimester of pregnancy. Clinical Research {CLIN-RES}, 1982, Vol/Iss/Pg. 30/2 (424A).Thomas-L, Andes-W-A. Dep. Med., Tulane Univ. Sch. Med., New Orleans, LA, United States. Fetal anomaly associated with successful chemotherapy for Hodgkin's disease during the first trimester of pregnancy. Clinical Research {CLIN-RES}, 1982, Vol/Iss/Pg. 30/2 (424A). |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34858 |
Study title: A single-dose, randomized, investigator-blinded trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile patients. Aug 1997. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29550 |
Study title: A single-dose, randomized, investigator-blinded trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile patients. Aug 1996. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29551 |
Study title: A single-dose, randomized, investigator-blinded trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile children. Aug 1996. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29628 |
Study title: A single-dose, randomized, investigator-blinded trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile patients. Aug 1997. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29630 |
Study title: A study comparing the efficacy and safety of ibuprofen sustained release to ibuprofen regular release in the treatment of pain secondary to post-operative foot surgery |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29504 |
Study title: A study comparing the efficacy and safety of ibuprofen sustained release to ibuprofen regular release in the treatment of pain secondary to post-operative foot surgery. CSR 201. Protocol 89-925, Unpublished Report 360. |
Active substance: IBUPROFEN |
Study summary document link (including results): ibuprofen 89-925.pdf |
View full study record |
Document reference: 47450 |
Study title: A study of the effects of Ibuprofen on post-operative pain in children undergoing adenotonsillectomy when given preoperative |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29416 |
Study title: A study to compare the efficacy and tolerance of Ibuprofen syrup vs Propyphenazone in the treatment of feverish children |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29415 |
Study title: A Twelve-week, Multicenter, Double-Blind, Parallel-Group Study Comparing the Action of Ibuprofen Suspension and Aspirin in the Treatment of Active Juvenile Rheumatoid Arthritis (JRA) |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-BPI301.pdf |
View full study record |
Document reference: 47543 |
Study title: Advil Liqui-Gel Migraine Headache Study I |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29521 |
Study title: Advil Liquigel Dental Pain Study I |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29522 |
Study title: Advil liquigel Dental pain study II |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29537 |
Study title: Advil Liquigel Dental Pain Study III |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29524 |
Study title: Advil Liquigel Headache Study II |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29523 |
Study title: Advil liquigel maximum use safety and tolerance study |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29532 |
Study title: An Assessment of the Safety of Pediatric Ibuprofen ("Boston University Fever Study"). Dec 1993.An Assessment of the Safety of Pediatric Ibuprofen ("Boston University Fever Study"). Dec 1993. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 33433 |
Study title: An open label actual use study of the safety of childrens advil ibuprofen suspension (10mg/kg) in children with various sources of discomfort requiring the use of an analgesic. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29468 |
Study title: An Open Label, Multicentre, Twenty-Four-Week, Dose-Ranging Study to Evaluate the Efficacy and Relative Long-Term Safety and Tolerability of Ibuprofen Suspension in the Treatment of ActiveJuvenile Rheumatoid Arthritis, as Compared with a Historical Control |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29402 |
Study title: Med Sci (Paris). 2005 Nov;21(11):981-6. [Radiological innovations in the screening and diagnosis of the inborn errors of metabolism] [Article in French] Boddaert N, Ribeiro M, Touati G, Mention K, Valayanopoulos V, Nihoul-F, Brunelle F, de Lonlay P. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28093 |
Study title: Ment Retard Dev Disabil Res Rev. 2000;6(3):220-6. Structural and functional imaging in children with partial epilepsy. Gaillard WD. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28174 |
Study title: Neuro Endocrinol Lett. 2006 Oct;27(5):587-94. Regional brain metabolism as the predictor of performance on the Trail Making Test in schizophrenia. A 18FDG PET covariation study. Horacek J, Dockery C, Kopecek M, Spaniel F, Novak T, Tislerova B, Klirova M, Palenicek T, HÃschl C. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28070 |
Study title: Neuroimage. 2000 Aug;12(2):129-38. Statistical parametric mapping of regional glucose metabolism in mesial temporal lobe epilepsy. Van Bogaert P, Massager N, Tugendhaft P, Wikler D, Damhaut P, Levivier M, Brotchi J, Goldman S. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28176 |
Study title: Neuroimaging Clin N Am. 2003 Nov;13(4):705-16, viii. Imaging the epileptic brain with positron emission tomography. Juhász C, Chugani HT. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28130 |
Study title: Neurology. 1994 Dec;44(12):2331-6. Predictors of outcome after anterior temporal lobectomy: positron emission tomography. Manno EM, Sperling MR, Ding X, Jaggi J, Alavi A, O'Connor MJ, Reivich M. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28203 |
Study title: Green JS, Morgan B, Lauder I, Finlay DB, Allen M, Belton I. The correlation of bone scintigraphy and histological findings in patellar tendinitis. Nucl Med Commun. 1996 Mar;17(3):231-4. Green JS, Morgan B, Lauder I, Finlay DB, Allen M, Belton I. The correlation of bone scintigraphy and histological findings in patellar tendinitis. Nucl Med Commun. 1996 Mar;17(3):231-4. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43569 |
Study title: Neurology. 2001 Nov 13;57(9):1629-36. Localizing value of alpha-methyl-L-tryptophan PET in intractable epilepsy of neocortical origin. Fedi M, Reutens D, Okazawa H, Andermann F, Boling W, Dubeau F, White C, Nakai A, Gross DW, Andermann E, Diksic M. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28165 |
Study title: Gregg PJ, Barsoum MK, Clayton CB. Scintigraphic appearance of the tibia in the early stages following fracture. Clin Orthop Relat Res. 1983 May;(175):139-46. Gregg PJ, Barsoum MK, Clayton CB. Scintigraphic appearance of the tibia in the early stages following fracture. Clin Orthop Relat Res. 1983 May;(175):139-46. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44039 |
Study title: Nuclear medicine studies of aging--IV. Femoral proximal to distal radionuclide uptake gradient. Grimmond AP, Hosain F, Spencer RP. Int J Rad Appl Instrum B. 1988;15(5):529-30. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43833 |
Study title: Groot RH, van Merkesteyn JP, Bras J. Diffuse sclerosing osteomyelitis and florid osseous dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Mar;81(3):333-42. Groot RH, van Merkesteyn JP, Bras J. Diffuse sclerosing osteomyelitis and florid osseous dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Mar;81(3):333-42. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43570 |
Study title: Groshar D, Alperson M, Liberson A. Bone scintigraphy in recurrent osteoid osteoma of the Talus. Clin Nucl Med. 1996 Oct;21(10):817-8. No abstract available. Groshar D, Alperson M, Liberson A. Bone scintigraphy in recurrent osteoid osteoma of the Talus. Clin Nucl Med. 1996 Oct;21(10):817-8. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43560 |
Study title: D'Angio GJ et al. Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer. 1989 Jul 15;64(2):349-60D'Angio GJ et al. Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer. 1989 Jul 15;64(2):349-60 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24838 |
Study title: D'Angio GJ et al. Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer. 1989 Jul 15;64(2):349-60 D'Angio GJ et al. Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer. 1989 Jul 15;64(2):349-60 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24839 |
Study title: Davidoff AM et al, Endodermal sinus tumor in children, J Pediatr Surg. 1996 Aug;31(8):1075-8; discussion 1078-9, Davidoff AM et al, Endodermal sinus tumor in children, J Pediatr Surg. 1996 Aug;31(8):1075-8; discussion 1078-9, |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24840 |
Study title: Acute oral toxicity of compound HOE 296 for neonatal rats - F.R Springman et al. - 6/02/1976 (Hoescht AG) - Publication in Part III - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24123 |
Study title: Avaliacao clinica de um novo antimicotico, piridonico topico, HOE 296, em dermatofitoses - Clinical evaluation of a new topical pyridonium antimycotic, HOE 296, in dermatophytoses -L.N. Ermetice et al. - 1973 (Rev bras. Clin Ter vol 2) - Publication in Part Clinical documentation Batrafen Losung -No author-11/1999 - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24134 |
Study title: Behandlung bakteriell superinfizierter hautpilzerkrankungen - K. Jablonski - 1987 (Kassenartz vol 27) - Publication in clinical studies (volume 6) - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24135 |
Study title: Behandlung von schimmelpliz-mykosen mit iclopiroxolamin - B. Deichmann - 1986 (Schwerpunktmedizin vol 9) - Publication in Part clinical documentation- Batrafen Losung Study CIOMS - No author -11/ 1999 - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24136 |
Study title: Bericht über eine doppleblind-studie mit HOE 296 -creme - und canesten- creme (clotrimazol) - W. Adam et al. - 03/03/1978 - Publication in clinical studies (volume 6) - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24124 |
Study title: Breite Praxis-Prufung (Phase III) mit HOE 296 (Ciclopirox -olamin) - H.G.Peil - No date - Publication in Part IV volume 3 - Batafren creme, Batafren Vaginalcreme, Batafren Duo klinische prufung - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24137 |
Study title: Childhood white superficial onychomycosis caused by Trichophyton rubrum: Repor tof seven cases and review of the literature, Tanusin Ploysangam, Anne W. Lucky, J Am Acad Dermatol, 1997;36:29 32 |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24138 |
Study title: Ciclopiroxolamin bei der Behandlundg von dermatomykosenbei kindern - E. Briscik et al. - 1988 (Min Ped vol 40) - Publication in Part clinical documentation- Batrafen Losung Study CIOMS - No author -11/ 1999 - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24139 |
Study title: Clinical results with the Antimycotic agent ciclopirox olamine - W. Adam et al. - No date - Publication in clinical studies (volume 6) - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24140 |
Study title: Clinical study of HOE 296 Solution in Trichophytia Superficialis- Espesially on systemic Influence after application - S. Yoshida - 1975 (Clinical Medecine vol 17) - Publication in Part clinical documentation- Batrafen Losung Study CIOMS- No author - 11/ 1999 - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24125 |
Study title: Clinical trial with ciclopirox vaginal cream in vulvovaginal candidiasis - José Leal de Queiroz et al . - september 1990 - Publication in Part clinical documentation - Batrafen Losung Study CIOMS - No author - 11/ 1999 - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24141 |
Study title: Clinical/statistical report for ciclopirox olamine ( Loprox, HOE296) - Humberto Bogaert et al. - No date - Publication in clinical studies ( volume 4)- a double blind multicentre parallel study group comparing ciclopirox olamine 1% cream and vehicle, cream base in the subjects with Tinea corporis or Tinea cruris - No author - 08/1988 - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24142 |
Study title: Consideracoes terapeuticas sobre o uso de um novo antimicotico piridonico, o HOE 296, no tratamento topico de dermatofitoses - Therapeutical considerations about the use of a new piridonic antimycotic, HOE 296, in the topical treatment of dermatophytoses - Jarbas Porto et al. - 1974 (Rev Bras Clin Ter vol 3, n°10, suppl 7) - Publication in Part clinical Documentation Batrafen Losung- No author - 11/1999 - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24145 |
Study title: Dopplelblind - Vergleichsstuddie mit Ciclopiroxolamin-und Plazebo -Creme bei dermatophytosen - T Fredriksson et al.- 1981 (Arzneim. Forsch/ Drug Res ) - Publication in clinical studies (volume 6) - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24146 |
Study title: Thompson-E, Smith-K-L, Wilimas-J, Kumar-M. St Jude Child. Res. Hosp., Memphis, Tenn. 38101, United States. Radiation, chemotherapy, or both in childhood and adolescent Hodgkin's disease (HD). Proceedings of the American Association for Cancer Research {PROC-AM- ASSOC-CANCER-RES}, 1977, Vol/Iss/Pg. Vol.18/- (No.881).Thompson-E, Smith-K-L, Wilimas-J, Kumar-M. St Jude Child. Res. Hosp., Memphis, Tenn. 38101, United States. Radiation, chemotherapy, or both in childhood and adolescent Hodgkin's disease (HD). Proceedings of the American Association for Cancer Research {PROC-AM- ASSOC-CANCER-RES}, 1977, Vol/Iss/Pg. Vol.18/- (No.881). |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34859 |
Study title: Tucker-M-A, Meadows-A-T, Boice-Jr-J-D, et-al. Epidemiology and Biostatistics Program, Division of Cancer Etiology, National Cancer Institute, National Institutes of Health, Public Health Service, U.S. Department of Health and Human Services, Bethesda, MD 20892, United States. Leukemia after therapy with alkylating agents for childhood cancer. Journal of the National Cancer Institute {J-NATL-CANCER-INST}, 1987, Vol/Iss/Pg. 78/3 (459-464).Tucker-M-A, Meadows-A-T, Boice-Jr-J-D, et-al. Epidemiology and Biostatistics Program, Division of Cancer Etiology, National Cancer Institute, National Institutes of Health, Public Health Service, U.S. Department of Health and Human Services, Bethesda, MD 20892, United States. Leukemia after therapy with alkylating agents for ... |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34860 |
Study title: Urban-Ch, Hackl-A, Kurz-R, et-al. Univ. Kinderklin., 8036 Graz, Austria. Hodgkin's disease. Problems in childhood. Onkologie {ONKOLOGIE}, 1981, Vol/Iss/Pg. 4/6 (331-341).Urban-Ch, Hackl-A, Kurz-R, et-al. Univ. Kinderklin., 8036 Graz, Austria. Hodgkin's disease. Problems in childhood. Onkologie {ONKOLOGIE}, 1981, Vol/Iss/Pg. 4/6 (331-341). |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34861 |
Study title: Neumann Y. Zur Prophylaxe bleibender Hirnschäden bei Risikoneugeborenen (Sozialpädiatrie 1980; 2: 52-56); Neumann Y. Zur Prophylaxe bleibender Hirnschäden bei Risikoneugeborenen (Sozialpädiatrie 1980; 2: 52-56); |
Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35148 |
Study title: Non-interventional study on the use of Proparakain-POS® in childrenNon-interventional study on the use of Proparakain-POS® in children |
Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35158 |
Study title: Open-label quetiapine in the treatment of children and adolescents with autistic disorder J Child Adolesc Psychopharmacol. 1999;9(2):99-107Open-label quetiapine in the treatment of children and adolescents with autistic disorder J Child Adolesc Psychopharmacol. 1999;9(2):99-107 |
Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35164 |
Study title: Petova J. Pyrithioxine in the prevention of late consequences of intrauterine and postnatal hypoxia and malnutrition in new-born babie (Med Welt 1965; 43: 2438-2444); Petova J. Pyrithioxine in the prevention of late consequences of intrauterine and postnatal hypoxia and malnutrition in new-born babie (Med Welt 1965; 43: 2438-2444); |
Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35147 |
Study title: Radmayr E. Zur Therapie der Entwicklungsretardierung mit Encephabol (Actic nerv sup 1978; 20: 85-8); Radmayr E. Zur Therapie der Entwicklungsretardierung mit Encephabol (Actic nerv sup 1978; 20: 85-8); |
Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35146 |
Study title: Rossignol Klinische und psychologische Langzeitprüfung der Wirkung von Encephabol (LC 9088) bei retardierten Kindern (Immex 1971; 1347-1359); Rossignol Klinische und psychologische Langzeitprüfung der Wirkung von Encephabol (LC 9088) bei retardierten Kindern (Immex 1971; 1347-1359); |
Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35155 |
Study title: An Open Multicenter Study in Pakistan to Investigate the Effects of Ibuprofen Syrup in Juvenile Pyrexia |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-MS85 592.pdf |
View full study record |
Document reference: 47556 |
Study title: Bush FM, Harrington WG, Harkins SW. Interexaminer comparison of bone scintigraphy and panoramic radiography of temporomandibular joints: correlation with signs and symptoms. J Prosthet Dent. 1992 Feb;67(2):246-51. Bush FM, Harrington WG, Harkins SW. Interexaminer comparison of bone scintigraphy and panoramic radiography of temporomandibular joints: correlation with signs and symptoms. J Prosthet Dent. 1992 Feb;67(2):246-51. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43710 |
Study title: Bushnell D, Shirazi P, Khedkar N, Blank J. Ewing's sarcoma seen as a "cold" lesion on bone scans. Clin Nucl Med. 1983 Apr;8(4):173-4. No abstract available. Bushnell D, Shirazi P, Khedkar N, Blank J. Ewing's sarcoma seen as a "cold" lesion on bone scans. Clin Nucl Med. 1983 Apr;8(4):173-4. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44040 |
Study title: Butler-Manuel PA, Justins D, Heatley FW. Sympathetically mediated anterior knee pain. Scintigraphy and anesthetic blockade in 19 patients. Acta Orthop Scand. 1992 Feb;63(1):90-3. Butler-Manuel PA, Justins D, Heatley FW. Sympathetically mediated anterior knee pain. Scintigraphy and anesthetic blockade in 19 patients. Acta Orthop Scand. 1992 Feb;63(1):90-3. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43705 |
Study title: Bylander B, Hansson LI, Kärrholm J, Naversten Y. Scintimetric evaluation of posttraumatic and postoperative growth disturbance using 99Tcm MDP. Acta Radiol Diagn (Stockh). 1983;24(1):85-96. Bylander B, Hansson LI, Kärrholm J, Naversten Y. Scintimetric evaluation of posttraumatic and postoperative growth disturbance using 99Tcm MDP. Acta Radiol Diagn (Stockh). 1983;24(1):85-96. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44058 |
Study title: Caglar M, Ceylan E, Ozyar E. Frequency of skeletal metastases in nasopharyngeal carcinoma after initiation of therapy: should bone scans be used for follow-up? Nucl Med Commun. 2003 Dec;24(12):1231-6. Caglar M, Ceylan E, Ozyar E. Frequency of skeletal metastases in nasopharyngeal carcinoma after initiation of therapy: should bone scans be used for follow-up? Nucl Med Commun. 2003 Dec;24(12):1231-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43409 |
Study title: Caluser CI, Abdel-Dayem HM, Macapinlac HA, Scott A, Healey JH, Huvos A, Kalaigian H, Yeh SD, Larson SM. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas. Eur J Nucl Med. 1994 Nov;21(11):1198-205. Caluser CI, Abdel-Dayem HM, Macapinlac HA, Scott A, Healey JH, Huvos A, Kalaigian H, Yeh SD, Larson SM. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas. Eur J Nucl Med. 1994 Nov;21(11):1198-205. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43610 |
Study title: Caniggia A, Vattimo A. Kinetics of 99mtechnetium-tin-methylene-diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism. Calcif Tissue Int. 1980;30(1):5-13. No abstract available. Caniggia A, Vattimo A. Kinetics of 99mtechnetium-tin-methylene-diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism. Calcif Tissue Int. 1980;30(1):5-13. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44144 |
Study title: Caravatti M, Wiesli P, Uebelhart D, Germann D, Welzl-Hinterkörner E, Schulthess G. Coincidence of Behçet's disease and SAPHO syndrome. Clin Rheumatol. 2002 Aug;21(4):324-7. Caravatti M, Wiesli P, Uebelhart D, Germann D, Welzl-Hinterkörner E, Schulthess G. Coincidence of Behçet's disease and SAPHO syndrome. Clin Rheumatol. 2002 Aug;21(4):324-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43442 |
Study title: Groshar D, Alperson M, Mendes DG, Barsky V, Liberson A. Bone scintigraphy findings in Lisfranc joint injury. Foot Ankle Int. 1995 Nov;16(11):710-1. Groshar D, Alperson M, Mendes DG, Barsky V, Liberson A. Bone scintigraphy findings in Lisfranc joint injury. Foot Ankle Int. 1995 Nov;16(11):710-1. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43577 |
Study title: Groshar D, Rozenbaum M, Rosner I. Enthesopathies, inflammatory spondyloarthropathies and bone scintigraphy. J Nucl Med. 1997 Dec;38(12):2003-5. No abstract available. Groshar D, Rozenbaum M, Rosner I. Enthesopathies, inflammatory spondyloarthropathies and bone scintigraphy. J Nucl Med. 1997 Dec;38(12):2003-5. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43539 |
Study title: Groves AM, Cheow H, Balan K, Courtney H, Bearcroft P, Dixon A. 16-MDCT in the detection of occult wrist fractures: a comparison with skeletal scintigraphy. AJR Am J Roentgenol. 2005 May;184(5):1470-4. Groves AM, Cheow H, Balan K, Courtney H, Bearcroft P, Dixon A. 16-MDCT in the detection of occult wrist fractures: a comparison with skeletal scintigraphy. AJR Am J Roentgenol. 2005 May;184(5):1470-4. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43388 |
Study title: Groves AM, Cheow HK, Balan KK, Housden BA, Bearcroft PW, Dixon AK. 16-Detector multislice CT in the detection of stress fractures: a comparison with skeletal scintigraphy. Clin Radiol. 2005 Oct;60(10):1100-5. Groves AM, Cheow HK, Balan KK, Housden BA, Bearcroft PW, Dixon AK. 16-Detector multislice CT in the detection of stress fractures: a comparison with skeletal scintigraphy. Clin Radiol. 2005 Oct;60(10):1100-5. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43384 |
Study title: Gruen GS, Mears DC, Tauxe WN. Distinguishing avascular necrosis from segmental impaction of the femoral head following an acetabular fracture: preliminary report. J Orthop Trauma. 1988;2(1):5-9. Gruen GS, Mears DC, Tauxe WN. Distinguishing avascular necrosis from segmental impaction of the femoral head following an acetabular fracture: preliminary report. J Orthop Trauma. 1988;2(1):5-9. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43829 |
Study title: Moral DA, Piulachs CJ, Targarona Soler EM, Combalia AA, Ramon SR, Trias FM. Treatment of desmoid tumor. Medicina Clinica 1994; 102(7):250-253.Moral DA, Piulachs CJ, Targarona Soler EM, Combalia AA, Ramon SR, Trias FM. Treatment of desmoid tumor. Medicina Clinica 1994; 102(7):250-253. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43157 |
Study title: Multimodal treatment of children with unresectable or recurrent desmoid tumors: An 11-year longitudinal observational study. Multimodal treatment of children with unresectable or recurrent desmoid tumors: An 11-year longitudinal observational study. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43266 |
Study title: Noga CM, Brainard JA, Goldblum JR. Pelvic Fibromatosis: Clinicopathologic Study of 10 Cases. American Journal of Clinical Pathology 1999; 112(4):545.Noga CM, Brainard JA, Goldblum JR. Pelvic Fibromatosis: Clinicopathologic Study of 10 Cases. American Journal of Clinical Pathology 1999; 112(4):545. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43149 |
Study title: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Harrison SA, Neuschwander Tetri BA. Clinics In Liver Disease 2004;8(4):861-879 2004;(4):861-879.Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Harrison SA, Neuschwander Tetri BA. Clinics In Liver Disease 2004;8(4):861-879 2004;(4):861-879. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43264 |
Study title: Noncytotoxic Drug Therapy in Children with Unresectable Desmoid Tumors. Noncytotoxic Drug Therapy in Children with Unresectable Desmoid Tumors. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43297 |
Study title: Double blind comparative study of 1% cicloprirox olamine (Batrafen) powder vs 2% Miconazole nitrate (Daktarin) powder in patients suffering from tinea pedis - F. Arreaza et al. - May 1991 - Publication in Part I -Expert report on clinical documentation- H |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24147 |
Study title: Double blind comparative study of 1% cicloprirox olamine (Batrafen) powder vs 2% Miconazole nitrate (Daktarin) powder in patients suffering from tinea pedis - F. Arreaza et al. - May 1991 - Publication in Part I -Expert report on clinical documentation- H.G Vogel - No date - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24148 |
Study title: Empleo de HOE 296 (ciclopirox) en micosis superficiales - Dr Mario Magana Lorenzo - 1976 (Sem Med (Mex) vol 88) - Publication in Part Clinical documentation Batrafen Losung - No author - 11/1999 - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24149 |
Study title: Emprego de novo antimicotico, HOE-296, no tratamento topico de micoses superficiais - A.F Defina et al. -1973 (Rev bras. Clin Ter vol 2) - Publication in Part Clinical documentation Batrafen Losung -No author - 11/1999 - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24150 |
Study title: A SINGLE-BLIND (EVALUATOR BLIND) COMPARATIVE STUDY OF ORAL CLINDAMYCIN HYDROCHLORIDE 300 MG BID COMPARED AGAINST ORAL AUGMENTIN 1G BID IN THE TREATMENT OF ACUTE RECURRENT TONSILLITIS/PHARYNGITIS DUE TO GROUP A-B HEMOLYTIC STREPTOCOCCI. A MULTINATIONAL MUL |
Active substance: CLINDAMYCIN |
Study summary document link (including results): 251F-INF-9052-0280 EMA Pediatrics Web Synopsis.pdf |
View full study record |
Document reference: 24363 |
Study title: A STUDY TO COMPARE THE EFFICACY AND TOLERANCE OF CLINDAMYCIN WITH ERYTHROMYCIN IN THE TREATMENT OF FEMALES WITH CONFIRMED CHLAMYDIA TRACHOMARIS CERVICITIS |
Active substance: CLINDAMYCIN |
Study summary document link (including results): M11200134 EMA Pediatrics Web Synopsis.pdf |
View full study record |
Document reference: 24373 |
Study title: COMPARATIVE EFFICACY AND TOLERANCE OF CLEOCIN T GEL VERSUS ORAL MINOCYCLINE IN THE TREATMENT OF ACNE VULGARIS (PROTOCOL M/1112/0005) |
Active substance: CLINDAMYCIN |
Study summary document link (including results): M11120005 EMA Pediatrics Web Synopsis.pdf |
View full study record |
Document reference: 24372 |
Study title: COMPARATIVE EVALUATION OF CLINDAMYCIN VS CLINDAMYCIN PLUS TOBRAMYCIN IN THE TREATMENT OF PELVIC INFLAMMATORY DISEASE |
Active substance: CLINDAMYCIN |
Study summary document link (including results): M11000093 EMA Pediatrics Web Synopsis.pdf |
View full study record |
Document reference: 24368 |
Study title: DOUBLE-BLIND RANDOMIZED COMPARISON OF 2% CLINDAMYCIN VAGINAL CREAM VS ORAL METRONIDAZOLE CAPSULES FOR THE TREATMENT OF BACTERIAL VAGINOSIS |
Active substance: CLINDAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 24367 |
Study title: EFFICACY & SAFETY OF DALACIN C (CLINIDAMYCIN) IN ACUTE OR RECURRENT PHARYNGO-TONSILLITIS |
Active substance: CLINDAMYCIN |
Study summary document link (including results): CLIND-9052-285-INDIA EMA Pediatrics Web Synopsis.pdf |
View full study record |
Document reference: 24366 |
Study title: INTERIM REPORT OF AN ON-GOING NON-COMPARATIVE INTERNATIONAL MULTICENTRE STUDY OF CEFOPERAZONE NA IN THE TREATMENT OF ORTHOPEDIC SURGICAL AND GENERAL MEDICAL INFECTIONS. |
Active substance: CLINDAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 24358 |
Study title: INTERIM REPORT OF AN ON-GOING NON-COMPARATIVE MULTICENTRE STUDY OF CEFOPERAZONE NA IN THE TREATMENT OF SKIN AND SKIN STRUCTURE INFECTIONS. |
Active substance: CLINDAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 24359 |
Study title: OPEN LABEL COMPARATIVE, RANDOMIZED STUDY ASSESSING USEFULNESS OF RAPID MICROBIOLOGICAL DIAGNOSTICS IN PATIENTS WITH TONSILLITIS/PHARYNGITIS TREATED WITH CLINDAMYCIN |
Active substance: CLINDAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 24364 |
Study title: PHASE IV CLINICAL STUDY OF CLINDAMYCIN PHAOSPHATE TOPICAL GEL IN THE TREATMENT OF ACNE VULGARIS |
Active substance: CLINDAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 24365 |
Study title: A study of clobazam as monotherapy for the treatment of epilepsy in children - HOECHST-ROUSSEL Canada Inc - 26/07/1996 |
Active substance: CLOBAZAM |
Study summary document link (including results): |
View full study record |
Document reference: 24375 |
Study title: Essai du Clobazam en psychiatrie chez l'enfant - Dr MISES - No date |
Active substance: CLOBAZAM |
Study summary document link (including results): Clobazam STUDY Mises.xls |
View full study record |
Document reference: 24376 |
Study title: Schreiber K. Pyrithioxin in der Behandlung Schädel-Hirn-Verletzter (Landarzt 1965; 41 (26): 1126-1128); Schreiber K. Pyrithioxin in der Behandlung Schädel-Hirn-Verletzter (Landarzt 1965; 41 (26): 1126-1128); |
Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35153 |
Study title: Weimann H.M. Erfahrung mit einem Neurodynamikum bei hirngeschädigten Kindern (Ärztl Praxis 1967; 38: 1437)Weimann H.M. Erfahrung mit einem Neurodynamikum bei hirngeschädigten Kindern (Ärztl Praxis 1967; 38: 1437) |
Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35156 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Psorinoheel (drops) [AWB-AT] |
Active substance: Psorinoheel |
Study summary document link (including results): |
View full study record |
Document reference: 40141 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Psorinoheel (ampoules) [AWB-AT] |
Active substance: Psorinoheel |
Study summary document link (including results): |
View full study record |
Document reference: 40142 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Psorinoheel (ampoules) [AWB-AT] |
Active substance: Psorinoheel |
Study summary document link (including results): |
View full study record |
Document reference: 40143 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Psorinoheel (drops) [AWB-AT] |
Active substance: Psorinoheel |
Study summary document link (including results): |
View full study record |
Document reference: 40144 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Pulsatilla compositum (ampoules) [AWB-AT] |
Active substance: Pulsatilla compositum |
Study summary document link (including results): |
View full study record |
Document reference: 40145 |
Study title: TO INVESTIGATE THE SAFETY AND EFFICACY OF A SINGLE ORAL DOSE OF FCA 150 MG CAPS FOR THE TX OF WOMEN WITH VAGINAL CANDIDIASIS |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28045 |
Study title: TO MAKE FLUCONAZOLE AVAILABLE FOR USE IN PATIENTS WITH NON-LIFE THREATENING MYCOSES, WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. ALSO SAFETY AND EFFICACY OF DRUG. THIS PROTOCOL NUMBER ORIGINALLY WAS FCA-BRA-90-002C. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27383 |
Study title: TO MAKE FLUCONAZOLE AVAILABLE FOR USE IN PATIENTS WITH NON-LIFE THREATENING MYCOSES, WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. ALSO SAFETY AND EFFICACY OF DRUG. THIS PROTOCOL NUMBER ORIGINALLY WAS FCA-BRA-90-002C. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27748 |
Study title: TO MAKE FLUCONAZOLE AVAILABLE IN PATIENTS WITH CRYPTOCOCCAL MENINGITIS WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. ALSO SAFETY AND EFFECTIVENESS OF THE DRUG. THIS PROTOCOL NUMBER WAS ORIGINALLY FCA-BRA-90-002A. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27381 |
Study title: Biebach und Kremer (2004): postmarketing-surveillance study |
Active substance: pulverized active substances: gentian root (Gentianae radix) primrose flowers (Primulae flos) common sorrel herb (Rumicis herba) elder flowers (Sambuci flos) shop vervain wort (Verbenae herba) |
Study summary document link (including results): |
View full study record |
Document reference: 40146 |
Study title: A Randomized, Double-Blind, Placebocontrolled, Multicenter, Parallel-Arm Study Assessing the Efficacy, Safety, and Doseresponse of Ramipril for the Treatment of Hypertension in Children and Adolescents |
Active substance: RAMIPRIL |
Study summary document link (including results): Ramipril-Study 2.pdf |
View full study record |
Document reference: 35272 |
Study title: A Randomized, Open-Label Study of the Pharmacokinetics and Safety of a Single Dose of Ramipril in Children and Adolescents |
Active substance: RAMIPRIL |
Study summary document link (including results): Ramipril-Study 1.pdf |
View full study record |
Document reference: 45718 |
Study title: Ameen VZ, Pobiner BF, Giguere GC, Carter EG. Ranitidine (Zantac) syrup versus Ranitidine effervescent tablets (Zantac) EFFERdose) in children: a single-center taste preference study. Paediatr Drugs. 2006;8(4):265-70.Ameen VZ, Pobiner BF, Giguere GC, Carter EG. Ranitidine (Zantac) syrup versus Ranitidine effervescent tablets (Zantac) EFFERdose) in children: a single-center taste preference study. Paediatr Drugs. 2006;8(4):265-70. |
Active substance: RANITIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35276 |
Study title: Three-phase radionuclide bone imaging and magnetic resonance imaging detection of occult knee fractures in athletes. Giammarile F, Masciocchi C, Barile A, di Pietro M, Carducci A, Baschieri I. Eur J Nucl Med. 1994 Jun;21(6):493-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43622 |
Study title: Intraoperative radioactive localization of osteoid osteomas: four case reports. Gille P, Nachin P, Aubert D, de la Salle R, Giordan H, Bidet R, Cardot JC. J Pediatr Orthop. 1986 Sep-Oct;6(5):596-9. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43895 |
Study title: Gille P, Nachin P, Laurain JM, Aubert D. [Peroperative isotope labeling in surgery for osteoid osteoma. Apropos of 2 case reports] Rev Chir Orthop Reparatrice Appar Mot. 1985;71(2):123-6. French. Gille P, Nachin P, Laurain JM, Aubert D. [Peroperative isotope labeling in surgery for osteoid osteoma. Apropos of 2 case reports] Rev Chir Orthop Reparatrice Appar Mot. 1985;71(2):123-6. French. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43963 |
Study title: Gips S, Ruchman RB, Groshar D. Bone imaging in Kohler's disease. Clin Nucl Med. 1997 Sep;22(9):636-7. No abstract available. Gips S, Ruchman RB, Groshar D. Bone imaging in Kohler's disease. Clin Nucl Med. 1997 Sep;22(9):636-7. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43543 |
Study title: Cerebral infarction in child abuse. Diagnosis by technetium-99m methylene diphosphonate skeletal scintigraphy. Glasier CM, Seibert JJ, Williamson SL. Clin Nucl Med. 1987 Nov;12(11):897-8. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43842 |
Study title: The gamut of increased whole bone activity in bone scintigraphy in children. Glasier CM, Seibert JJ, Williamson SL. Clin Nucl Med. 1987 Mar;12(3):192-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43872 |
Study title: Goddard P, Bell J, Jackson P, Pitcher E, Bullimore JA, Davies ER. Pulmonary uptake of MDP: demonstration of site by correlation of emission and transmission computed tomography. West Engl Med J. 1990 Jun;105(2):43-6. No abstract available. Goddard P, Bell J, Jackson P, Pitcher E, Bullimore JA, Davies ER. Pulmonary uptake of MDP: demonstration of site by correlation of emission and transmission computed tomography. West Engl Med J. 1990 Jun;105(2):43-6. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43762 |
Study title: Goh AS, Sundram FX, Kumar P. Radionuclide bone imaging in patients with low back pain presenting to the orthopaedic surgeon. Ann Acad Med Singapore. 1986 Oct;15(4):529-34. Goh AS, Sundram FX, Kumar P. Radionuclide bone imaging in patients with low back pain presenting to the orthopaedic surgeon. Ann Acad Med Singapore. 1986 Oct;15(4):529-34. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43892 |
Study title: Goldman AB, Pavlov H, Schneider R. Radionuclide bone scanning in subtalar coalitions: differential considerations. AJR Am J Roentgenol. 1982 Mar;138(3):427-32. Goldman AB, Pavlov H, Schneider R. Radionuclide bone scanning in subtalar coalitions: differential considerations. AJR Am J Roentgenol. 1982 Mar;138(3):427-32. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44089 |
Study title: Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975.Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43168 |
Study title: Novoa FJ, Boronat M, Carrillo A, Tapia M, Diaz CJ, Chirino R. Effects of tamoxifen on lipid profile and coagulation parameters in male patients with pubertal gynecomastia. Hormone Research 2002;57(5-6):187-91 2002;(5-6):187-191.Novoa FJ, Boronat M, Carrillo A, Tapia M, Diaz CJ, Chirino R. Effects of tamoxifen on lipid profile and coagulation parameters in male patients with pubertal gynecomastia. Hormone Research 2002;57(5-6):187-91 2002;(5-6):187-191. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43101 |
Study title: O'Day SJ, Boasberg PD, Kristedja TS, Martin M, Wang HJ, Fournier P et al. High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma. Cancer 2001; 92(3):609-19.O'Day SJ, Boasberg PD, Kristedja TS, Martin M, Wang HJ, Fournier P et al. High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma. Cancer 2001; 92(3):609-19. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43144 |
Study title: Okuno SH, Edmonson JH. Combination chemotherapy for desmoid tumors. Cancer 2003; 97(4):1134-1135.Okuno SH, Edmonson JH. Combination chemotherapy for desmoid tumors. Cancer 2003; 97(4):1134-1135. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43141 |
Study title: Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas. Hall WA, Doolittle ND, Daman M, Bruns PK, Muldoon L, Fortin D et al. Journal of Neuro-Oncology 2006; 77(3):279-284.Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas. Hall WA, Doolittle ND, Daman M, Bruns PK, Muldoon L, Fortin D et al. Journal of Neuro-Oncology 2006; 77(3):279-284. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43255 |
Study title: Pediatric desmoid tumor: Retrospective analysis of 63 cases. Faulkner LB, Hajdu SI, Kher U, La QM, Exelby PR, Heller G et al. Journal of Clinical Oncology 13(11)()(pp 2813-2818), 1995 Date of Publication: Nov 1995 1995;(11):2813-2818.Pediatric desmoid tumor: Retrospective analysis of 63 cases. Faulkner LB, Hajdu SI, Kher U, La QM, Exelby PR, Heller G et al. Journal of Clinical Oncology 13(11)()(pp 2813-2818), 1995 Date of Publication: Nov 1995 1995;(11):2813-2818. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43302 |
Study title: Pelvic Fibromatosis: Clinicopathologic Study of 10 Cases. Noga CM, Brainard JA, Goldblum JR. American Journal of Clinical Pathology 1999;112(4):545 1999;(4):545.Pelvic Fibromatosis: Clinicopathologic Study of 10 Cases. Noga CM, Brainard JA, Goldblum JR. American Journal of Clinical Pathology 1999;112(4):545 1999;(4):545. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43287 |
Study title: Clinically silent pulmonary embolism due to transient protein S deficiency. Buffaz PD, Brut A. Clin Nucl Med. 1995 Nov;20(11):1016-7. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48258 |
Study title: Comparative imaging. Septic pulmonary embolus. Sty JR, Lundeen BE, Friedberg DZ. Clin Nucl Med. 1993 Dec;18(12):1090-1. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48270 |
Study title: Comparison of SPECT lung perfusion with transbronchial lung biopsy after lung transplantation. Colt HG, Cammilleri S, Khelifa F, Dumon JF, Garbe L, Noirclerc M, Kaphan G Am J Respir Crit Care Med. 1994 Aug;150(2):515-20. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48267 |
Study title: Contribution of lymphoscintigraphy in the exploration of lymphedema in children Baulieu F 2003 J Mal Vasc. 2003 Dec; 28(5):269-76. Baulieu et al. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): Baulieu F 2003.pdf |
View full study record |
Document reference: 48219 |
Study title: Etude de tolérance et d'efficacité d'un anxiolytique chez l'enfant: le clobazam (Urbanyl). B. Grenier et J.C. Rolland 2/75 (Gazete Mèdicale de France; 82(8):861-864)Etude de tolérance et d'efficacité d'un anxiolytique chez l'enfant: le clobazam (Urbanyl). B. Grenier et J.C. Rolland 2/75 (Gazete Mèdicale de France; 82(8):861-864) |
Active substance: CLOBAZAM |
Study summary document link (including results): |
View full study record |
Document reference: 24377 |
Study title: A clinical comparison of topical clobetasone butyrate and sodium cromoglycate in allergic conjunctivitis.Frankland AW, Walker SR. Clin Allergy. 1981 Sep;11(5):473-8. A clinical comparison of topical clobetasone butyrate and sodium cromoglycate in allergic conjunctivitis.Frankland AW, Walker SR. Clin Allergy. 1981 Sep;11(5):473-8. |
Active substance: CLOBETASONE |
Study summary document link (including results): A clinical comparison of topical clobetasone butyrate and so.pdf |
View full study record |
Document reference: 24378 |
Study title: Clobetasone butyrate eye drops. Effect on ocular inflammation and intraocular pressure.Williamson J, Eilon LA, Walker SR. Trans Ophthalmol Soc U K. 1981;101(1):27-9Clobetasone butyrate eye drops. Effect on ocular inflammation and intraocular pressure.Williamson J, Eilon LA, Walker SR. Trans Ophthalmol Soc U K. 1981;101(1):27-9 |
Active substance: CLOBETASONE |
Study summary document link (including results): Clobetasone butyrate eye drops effect on ocular inflammation.pdf |
View full study record |
Document reference: 24379 |
Study title: AKUTE TOXIZITAET, KANINCHEN PER OS.; ORIGIN=PCS CH; CONTRACTOR=1; |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24391 |
Study title: multicentre study of the efficacy and tolerability of clotrimazole 10% vaginal cream in the treatment of vaginal candidosis |
Active substance: CLOTRIMAZOLE |
Study summary document link (including results): Bayer CC_Clotrimazole_0524_study_synopsis.pdf |
View full study record |
Document reference: 24447 |
Study title: safety and efficacy of bay b 5097 2vaginal cream in 3-day treatment as compared with 7-day treatment with econazole cream (gyno-pevaryl cream). |
Active substance: CLOTRIMAZOLE |
Study summary document link (including results): Bayer CC_Clotrimazole_0583_study_synopsis.pdf |
View full study record |
Document reference: 24454 |
Study title: Vergleichende Prüfung von vier Clotrimazol-Zubereitungen |
Active substance: CLOTRIMAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 24464 |
Study title: Essai randomisé, ouvert, en groupes parallèles, afin d'évaluer la non infériorité de la cloxacilline versus la pristinamycine en termes d'efficacité et de tolérance dans les infections cutanées à staphylocoque ou à streptocoque |
Active substance: CLOTRIMAZOLE + SALICYLIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 24467 |
Study title: "Essai randomisé, ouvert, en groupes parallèles, afin d'évaluer la non infériorité de la cloxacilline versus la pristinamycine en termes d'efficacité et de tolérance dans les infections cutanées à staphylocoque ou à streptocoque" |
Active substance: CLOXACILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 24468 |
Study title: "Evaluation de l'acceptabilité et de la tolérance de la cloxacilline poudre pédiatrique pour suspension buvable 250 mg, en sachets, dans les angines streptococciques et infections cutanées de l'enfant" |
Active substance: CLOXACILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 24469 |
Study title: |
Active substance: CLOZAPINE |
Study summary document link (including results): LEX123B 603-151 Art 45 listing 2011.xls |
View full study record |
Document reference: 24470 |
Study title: |
Active substance: CLOZAPINE |
Study summary document link (including results): LEX123B 50504 Art45 listing 2011.xls |
View full study record |
Document reference: 47361 |
Study title: |
Active substance: CLOZAPINE |
Study summary document link (including results): LEX123J 51-63 Art 45 listing 2011.xls |
View full study record |
Document reference: 47362 |
Study title: 48 hour human patch test for primary irritation of ciclopirox olamine shampoos (Tarmed included as a comparator). |
Active substance: COAL TAR |
Study summary document link (including results): |
View full study record |
Document reference: 24474 |
Study title: 48 hour human patch test for primary irritation of ciclopirox olamine shampoos (Tarmed included as a comparator). |
Active substance: Coal tar solution |
Study summary document link (including results): |
View full study record |
Document reference: 40134 |
Study title: TO MAKE FLUCONAZOLE AVAILABLE IN PATIENTS WITH CRYPTOCOCCAL MENINGITIS WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. ALSO SAFETY AND EFFECTIVENESS OF THE DRUG. THIS PROTOCOL NUMBER WAS ORIGINALLY FCA-BRA-90-002A. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27746 |
Study title: TO STUDY THE EFFICACY AND TOLERATION OF FCA WHEN GIVEN AT A SINGLE 400 MG DOSE IN THOSE PATIENTS WITH OP IN WHOM THE SINGLE 150 MG DOSE DID NOT INDUCE SYMPTOMS WITHIN 3-10 DAYS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27393 |
Study title: TO STUDY THE EFFICACY AND TOLERATION OF FCA WHEN GIVEN AT A SINGLE 400 MG DOSE IN THOSE PATIENTS WITH OP IN WHOM THE SINGLE 150 MG DOSE DID NOT INDUCE SYMPTOMS WITHIN 3-10 DAYS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27758 |
Study title: TO STUDY THE SAFETY AND EFFICACY OF ORAL IV FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH NON-CANDIDA MYCOSES. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27588 |
Study title: TO STUDY THE SAFETY AND EFFICACY OF ORAL IV FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH NON-CANDIDA MYCOSES. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27951 |
Study title: TOLERATION AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27376 |
Study title: TOLERATION AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27741 |
Study title: TOLERATION AND SAFETY OF ORAL FLUCONAZOLE IN THE PROPHYLAXIS OF FUNGAL COLONIZATION AND INFECTION IN PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27463 |
Study title: TOLERATION AND SAFETY OF ORAL FLUCONAZOLE IN THE PROPHYLAXIS OF FUNGAL COLONIZATION AND INFECTION IN PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27827 |
Study title: TREATMENT OF OROPHARYNGEAL CANDIDIASIS RESISTANT TO FLUCONAZOLE A DAILY DOSE OF 400 MG FOR 7 DAYS. A PILOT DOSE STUDY USING 800, 1200 AND 1600 MG DAILY TO 7 DAYS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27401 |
Study title: A double-blind, single oral dose study, comparing the anti-pyretic properties of Ibuprofen, Acetaminophen, and placebo in the treatment of pyrexia associated with infectious disease in children |
Active substance: IBUPROFEN |
Study summary document link (including results): ibuprofen-bpi302.pdf |
View full study record |
Document reference: 29399 |
Study title: A double-blind, single-dose analgesic study comparing the safety and effectiveness of ibuprofen lysine 200 mg, acetylsalicylic acid 500 mg and placebo for the treatment of outpatients experiencing moderate to severe postoperative dental pain / A double-blind, single-dose study to investigate plasma ibuprofen concentrations and their relationship to clinicalanalgesic response in patients treated with dexibuprofen lysine, ibuprofen lysinate, ibuprofen (Motrin) or placebo for the relief of moderate or severe postoperative dental pain / a double-blind single-dose, analgesic pilot study comparing the safety and effectiveness of dexiprofen lysine ((s)-ibuprofen lysinate) 400 mg, (R)-Ibuprofen Lysinate 400mg, and placebo for the treatment of outpatients experiencing moderate or severe postope... |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29608 |
Study title: Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518.Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43355 |
Study title: Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1429-39. Epub 2005 Aug 26. Respiration artifacts in whole-body (18)F-FDG PET/CT studies with combined PET/CT tomographs employing spiral CT technology with 1 to 16 detector rows. Beyer T, Rosenbaum S, Veit P, Stattaus J, Müller SP, Difilippo FP, SchÃder H, Mawlawi O, Roberts F, Bockisch A, Kühl H. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28099 |
Study title: Eur J Nucl Med Mol Imaging. 2005 Jan;32(1):92-7. Epub 2004 Aug 21. Validation of anatomical standardization of FDG PET images of normal brain: comparison of SPM and NEUROSTAT. Hosaka K, Ishii K, Sakamoto S, Sadato N, Fukuda H, Kato T, Sugimura K, Senda M; |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28119 |
Study title: Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):653-9. Epub 2005 Feb 15. [18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors. Choi SJ, Kim JS, Kim JH, Oh SJ, Lee JG, Kim CJ, Ra YS, Yeo JS, Ryu JS, Moon DH. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28110 |
Study title: Eur J Nucl Med Mol Imaging. 2005 May;32(5):541-8. Epub 2004 Dec 30. Comment in: Eur J Nucl Med Mol Imaging. 2006 Feb;33(2):228-9; author reply 230. Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes? Yen TC, Chang YC, Chan SC, Chang JT, Hsu CH, Lin KJ, Lin WJ, Fu YK, Ng SH. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28115 |
Study title: Eur J Nucl Med Mol Imaging. 2005 Oct;32(10):1152-9. Epub 2005 Jun 18. Early restaging whole-body (18)F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma. Yen RF, Chen TH, Ting LL, Tzen KY, Pan MH, Hong RL. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28101 |
Study title: Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):428-32. Epub 2006 Jan 11. Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours. Brenner W, Friedrich RE, Gawad KA, Hagel C, von Deimling A, de Wit M, Buchert R, Clausen M, Mautner VF. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28091 |
Study title: Eur J Nucl Med Mol Imaging. 2006 Jan;33(1):13-21. Epub 2005 Sep 9. Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer. Hellwig D, GrÃschel A, Graeter TP, Hellwig AP, Nestle U, Schäfers HJ, Sybrecht GW, Kirsch CM. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28096 |
Study title: Eur J Nucl Med Mol Imaging. 2006 Jun;33(6):683-91. Epub 2006 Feb 28. Glut-1 expression and enhanced glucose metabolism are associated with tumour grade in bone and soft tissue sarcomas: a prospective evaluation by [18F]fluorodeoxyglucose positron emission tomography. Tateishi U, Yamaguchi U, Seki K, Terauchi T, Arai Y, Hasegawa T. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28088 |
Study title: Eur J Nucl Med Mol Imaging. 2006 Jun;33(6):692-6. Epub 2006 Mar 3. Accuracy of transmission CT and FDG-PET in the detection of small pulmonary nodules with integrated PET/CT. Aquino SL, Kuester LB, Muse VV, Halpern EF, Fischman AJ. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28086 |
Study title: Eur J Nucl Med Mol Imaging. 2006 Sep;33(9):1025-31. Epub 2006 Mar 25. Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin's disease. Kabickova E, Sumerauer D, Cumlivska E, Drahokoupilova E, Nekolna M, Chanova M, Hladikova M, Kodet R, Belohlavek O. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28083 |
Study title: Eur J Nucl Med. 1998 Jul;25(7):721-8. Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography. Stumpe KD, Urbinelli M, Steinert HC, Glanzmann C, Buck A, von Schulthess GK. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28192 |
Study title: Eur J Nucl Med. 2000 May;27(5):590-4. Fluorodeoxyglucose PET in the initial staging of germ cell tumours. Hain SF, O'Doherty MJ, Timothy AR, Leslie MD, Partridge SE, Huddart RA. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28178 |
Study title: Eur J Nucl Med. 2001 Jun;28(6):704-10. Quantitative evaluation of skeletal tumours with dynamic FDG PET: SUV in comparison to Patlak analysis. Wu H, Dimitrakopoulou-Strauss A, Heichel TO, Lehner B, Bernd L, Ewerbeck V, Burger C, Strauss LG. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28170 |
Study title: Correlation of pulmonary 99mTc-DTPA ventilation and 99mTc-MAA perfusion scans with pulmonary function tests in asymptomatic asthmatic children. Dai ZK, Chen YW, Hsu JH, Huang MS, Chou SH, Wu JR. Nucl Med Commun. 2003 Jul;24(7):819-24 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48225 |
Study title: Delayed restoration of lung perfusion after removal of aspirated foreign body. Suga K, Nishigauchi K, Kume N, Uchisako H, Yoshimizu T, Nakanishi T. Clin Nucl Med. 1995 Nov;20(11):1032-3. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48257 |
Study title: Detection of multiple thromboembolism in congenital antithrombin III deficiency with indium-111-platelet scintigraphy. Kawasugi K, Gohchi K, Kuniyasu Y, Matsuda J, Kinoshita T J Nucl Med. 1994 Nov;35(11):1811-4. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): Kawasugi K 1994.pdf |
View full study record |
Document reference: 48263 |
Study title: Diagnosis of pulmonary embolus using ventilation/perfusion lung scintigraphy: more than 0.5 segment of ventilation/perfusion mismatch is sufficient. Howarth DM, Booker JA, Voutnis DD. Intern Med J. 2006 May;36(5):281-8 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48222 |
Study title: Diaphragmatic hernia producing a perfusion defect and diffuse pulmonary vascular hypoplasia on lung imaging. Siraj QH, Clarke SE. Clin Nucl Med. 1994 Oct;19(10):917-8. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48265 |
Study title: Distribution of radioactive aerosol in the airways of children and adolescents with bronchial hyper-responsiveness. Backer V, Mortensen J. Clin Physiol. 1992 Sep;12(5):575-85. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48276 |
Study title: Early decortication for postpneumonic empyema in children. Effect on pulmonary perfusion. Eren N, Ozçelic C, Ener BK, Ozgen G, Solak H, Balci AE, Tas S. Scand J Thorac Cardiovasc Surg. 1995;29(3):125-9. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48261 |
Study title: Early radionuclide detection of intrapulmonary shunts in children with liver disease. Grimon G, André L, Bernard O, Raffestin B, Desgrez A. J Nucl Med. 1994 Aug;35(8):1328-32. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48268 |
Study title: Coccaro G, Khedkar NY, Peller PJ, Martinez CJ. An early false-negative bone scan in a spiral fracture. Clin Nucl Med. 1994 Sep;19(9):818-9. No abstract available. Coccaro G, Khedkar NY, Peller PJ, Martinez CJ. An early false-negative bone scan in a spiral fracture. Clin Nucl Med. 1994 Sep;19(9):818-9. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43615 |
Study title: Stress fracture of the femoral neck in a child (stress fracture). Coldwell D, Gross GW, Boal DK. Pediatr Radiol. 1984;14(3):174-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44013 |
Study title: Asymmetrical closure of epiphyses in a patient with sickle cell anemia. Collett-Solberg PF, Ware RE, O'Hara SM. J Pediatr Endocrinol Metab. 2002 Sep-Oct;15(8):1207-12. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43433 |
Study title: Einfachblinde, randomisierte, Verum-kontrollierte, monozentrische Studie zum Nachweis der Nicht-Unterlegenheit von Leukichtan Gel vs. Betaisodona Salbe in der Behandlung von Schnitt-, Schürfwunden und Verbrennungen |
Active substance: COD LIVER OIL |
Study summary document link (including results): |
View full study record |
Document reference: 24475 |
Study title: Diaper dermatitis - Schanzer MC, Wilkin JK. - 1982 (Am Fam Physician 1982; 25(4):127-132) |
Active substance: COD LIVER OIL/ZINC OXIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24476 |
Study title: Diaper dermatitis. Value of Vitamin A topically applied - Bosch-Banyeras M, Catala M et al - 1988 (Clin. Pediat. 1988, 27, 9:448-450) |
Active substance: COD LIVER OIL/ZINC OXIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24477 |
Study title: Efficacy of topical application of eosin compared with zinc oxide paste and corticosteroid cream for diaper dermatitis - Arad A, Mimouni D, Ben Amitai D, Zeharia A, Mimouni M. - 1999 (Dermatology 1999; 199(4):319-322) |
Active substance: COD LIVER OIL/ZINC OXIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24478 |
Study title: Empfehlungen zur Lokaltherapie banaler Dermatosen im Kindesalter [Recommendations for local therapy of common dermatoses in children] - Stogmann W - 1984 (Wien Med.Wochenschr. 1984, 134(1):19-24) |
Active substance: COD LIVER OIL/ZINC OXIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24479 |
Study title: Monographie-Entwürfe für Arzneimittel zur Behandlung des Windelekzems - no autor - 1991 ((Sonderdruck). Pharm Ind 1991; 53(I):152-158) |
Active substance: COD LIVER OIL/ZINC OXIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24480 |
Study title: Davidson A et al Phase II study of 21 day schedule oral etoposide in children. New Agents Group of the United Kingdom Children's Cancer Study Group (UKCCSG) Eur J Cancer 1997 Oct;33(11):1816-22Davidson A et al Phase II study of 21 day schedule oral etoposide in children. New Agents Group of the United Kingdom Children's Cancer Study Group (UKCCSG) Eur J Cancer 1997 Oct;33(11):1816-22 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24841 |
Study title: Davies SM et al Toxicity of high-dose ifosfamide in children Cancer Chemother Pharmacol. 1989;24 Suppl 1:S8-10Davies SM et al Toxicity of high-dose ifosfamide in children Cancer Chemother Pharmacol. 1989;24 Suppl 1:S8-10 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24842 |
Study title: de Andrea ML et al. A new treatment protocol for childhood non-Hodgkin's lymphoma: preliminaryevaluation. J Clin Oncol. 1990 Apr;8(4):666-71de Andrea ML et al. A new treatment protocol for childhood non-Hodgkin's lymphoma: preliminaryevaluation. J Clin Oncol. 1990 Apr;8(4):666-71 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24843 |
Study title: De Schepper J et al Renal function abnormalities after ifosfamide treatment in children Acta Paediatr. 1993 Apr;82(4):373-6De Schepper J et al Renal function abnormalities after ifosfamide treatment in children Acta Paediatr. 1993 Apr;82(4):373-6 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24844 |
Study title: Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease Pediatr Blood Cancer. 2004 Mar;42(3):210-5Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease Pediatr Blood Cancer. 2004 Mar;42(3):210-5 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24845 |
Study title: Delépine N et al CNS-side effects induced by Ifosfamide-Mesna in children with osteosarcomas Biomed Pharmacother. 1986;40(5):173-5Delépine N et al CNS-side effects induced by Ifosfamide-Mesna in children with osteosarcomas Biomed Pharmacother. 1986;40(5):173-5 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24846 |
Study title: Dieckmann K et al Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90 Int J Radiat Oncol Biol Phys 2003 Jul 1;56(3):644-52Dieckmann K et al Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90 Int J Radiat Oncol Biol Phys 2003 Jul 1;56(3):644-52 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24847 |
Study title: A double-blind, single-dose comparison of ibuprofen vs. acetaminophen vs. placebo in the relief of post operative oral surgery pain. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29456 |
Study title: A Double-Blind, Single-Oral-Dose Study Comparing the Antipyretic Properties of Ibuprofen, Acetaminophen, and Placebo in the Treatment of Pyrexia Associated with Infectious Diseases in Children |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-BPI303.pdf |
View full study record |
Document reference: 47544 |
Study title: A multi-centre, double blind, parallel group, prospective, randomised study to compare the efficacy of a single dose of 10 mg/kg ibuprofen with 15 mg/kgparacetamol in febrile children aged from 3 months to 12 years followed by tolerability over up to three days of open label dosing |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29397 |
Study title: A Multicenter, Double-Blind, Single-Oral-Dose Study Comparing the Action of Ibuprofen, Acetaminophen, and Placebo in the Treatment of Pediatric Patients with Postoperative Pain |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-BPI304.pdf |
View full study record |
Document reference: 47545 |
Study title: A MULTICENTER, OPEN-LABEL, MULTIPLE-DOSE STUDY TO DETERMINE THE SAFETY AND TOLERABILITY OF IBUPROFEN SUSPENSION IN THE TREATMENT OF MILD TO MODERATE PAIN OF VARIOUS ETIOLOGIES IN CHILDREN. |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-BPI-320.pdf |
View full study record |
Document reference: 47547 |
Study title: A multicentre open label multiple dose study to determine the safety and tolerability of ibuprofen suspension in the treatment of mild to moderate pain of various etiologies in children. |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-BPI-320.pdf |
View full study record |
Document reference: 29461 |
Study title: A MULTICENTRE, DOUBLE-BLIND, SINGLE-ORAL-DOSE STUDY COMPARING THE ACTION OF IBUPROFEN, ACETAMINOPHEN AND PLACEBO IN THE TREATMENT OF PEDIATRIC PATIENTS WITH POST-OPERATIVE PAIN |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29401 |
Study title: A multicentre, open dose-response evaluation of the safety and efficacy of Ibuprofen syrup in children with juvenile chronic arthritis . |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29421 |
Study title: A multicentre, open dose-response evaluation of the safety and efficacy of Ibuprofen syrup in children with juvenile chronic arthritis . |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29436 |
Study title: A Multicentre, Open Dose-Response Evaluation of the Safety and Efficacy of Ibuprofen Syrup in Children with Juvenile Chronic Arthritis (XXM85101) |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-M85-101.pdf |
View full study record |
Document reference: 47552 |
Study title: A multicentre, open-label multiple-dose study to determine the safety and tolerability of Ibuprofen suspension in the treatment of mild to moderate pain of various aetiologies in children |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29429 |
Study title: Comparision of pirenzepine, RANITIDINE and pirenzepine-RANITIDINE combination for reducing preoperative gastric fluid acidity and volume in children. |
Active substance: RANITIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35275 |
Study title: Cothran DS, Borowitz SM, Sutphen JL, Dudley SM, Donowitz LG. Alteration of normal gastric flora in neonates receiving ranitidine. J Perinatol. 1997 Sep-Oct;17(5):383-8.Cothran DS, Borowitz SM, Sutphen JL, Dudley SM, Donowitz LG. Alteration of normal gastric flora in neonates receiving ranitidine. J Perinatol. 1997 Sep-Oct;17(5):383-8. |
Active substance: RANITIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35282 |
Study title: Kaufman SS, Loseke CA, Young RJ, Perry DA. Ranitidine therapy for esophagitis in children with developmental disabilities. Clin Pediatr (Phila). 1996 Sep;35(9):451-6.Kaufman SS, Loseke CA, Young RJ, Perry DA. Ranitidine therapy for esophagitis in children with developmental disabilities. Clin Pediatr (Phila). 1996 Sep;35(9):451-6. |
Active substance: RANITIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35284 |
Study title: Eur Neurol. 1989;29 Suppl 3:16-24. [18F]-fluorodeoxyglucose (FDG) and positron emission tomography (PET) in aging and dementia. A decade of studies. Hoffman JM, Guze BH, Baxter LR, Mazziotta JC, Phelps ME.Eur Neurol. 1989;29 Suppl 3:16-24. [18F]-fluorodeoxyglucose (FDG) and positron emission tomography (PET) in aging and dementia. A decade of studies. Hoffman JM, Guze BH, Baxter LR, Mazziotta JC, Phelps ME. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28209 |
Study title: Eur Spine J. 2001 Dec;10(6):534-9. Fluorine-18 fluorodeoxyglucose positron emission tomography findings in spondylodiscitis: preliminary results. Schmitz A, Risse JH, Grünwald F, Gassel F, Biersack HJ, Schmitt O. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28163 |
Study title: Gynecol Oncol. 1993 Nov;51(2):197-204. Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG). Hubner KF, McDonald TW, Niethammer JG, Smith GT, Gould HR, Buonocore E. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28205 |
Study title: An open multicentre study in Pakistan to investigate the effects of Ibuprofen syrup in juvenile pyrexia |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29424 |
Study title: An open multicentre study in Pakistan to investigate the effects of Ibuprofen syrup in juvenile pyrexia |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29439 |
Study title: An open study to evaluate the use of Ibuprofen suspension in the treatment of post-immunisation pyrexia in children |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29410 |
Study title: An open Study to Evaluate the Use of Ibuprofen Suspension in the Treatment of Post-Immunisation Pyrexia in Children |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29469 |
Study title: An open study to evaluate the use of ibuprofen suspension in the treatment of post-immunisation pyrexia in children (BR1148). |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-BR1148.pdf |
View full study record |
Document reference: 47550 |
Study title: An Open-Label Study of the Safety of an Ibuprofen-Pseudoephedrine HCl Suspension in Children. Sep 1999. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29559 |
Study title: An Open-Label, Multicentre, Twenty-Four Week Dose-Ranging Study to Evaluate the Efficacy and Relative Long-Term Safety and Tolerability of Ibuprofen Suspension in the Treatment of Active Juvenile Rheumatoid Arthritis as Compared to a Historical Control |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-BPI308.pdf |
View full study record |
Document reference: 47546 |
Study title: An open, multiple dose study of the efficacy and tolerability of ibuprofen suspension in the treatment of juvenile pain and pyrexia (BR01 18) |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-BR0118.pdf |
View full study record |
Document reference: 47549 |
Study title: an open, multiple dose study of the efficacy and tolerability of Ibuprofen syrup in the treatment of juvenile pyrexia |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29404 |
Study title: An open, multiple-dose study of the efficacy and tolerability of Ibuprofen suspension in the treatment of juvenile pain and pyrexia |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29408 |
Study title: An open, multipledose study of the efficacy and tolerabili of ibuprofen syrup in the treatment of juvenile pyrexia (BR0105). |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-BR0105.pdf |
View full study record |
Document reference: 47548 |
Study title: An open, parallel-group, multiple dose study to compare the efficacy and tolerability of Ibuprofen suspension (Junifen) and Paracetamol suspension (Calpol Infant) in the symptomatic treatment of juvenile teething pain |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen BR1147.pdf |
View full study record |
Document reference: 29409 |
Study title: Anti-pyretic activity of Ibuprofen and Paracetamol in children with pyrexia by Y K Amdekar, R Z Desai, India |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29446 |
Study title: Anti-pyretic activity of Ibuprofen suspension and Aspirin in children by Professor R S Satoskar, KEM hospital, Bombay, India |
Active substance: IBUPROFEN |
Study summary document link (including results): ibuprofen-m83079.pdf |
View full study record |
Document reference: 29447 |
Study title: Connolly LP, Drubach LA, Treves ST. Localization of Tc-99m MDP in the rectus abdominis muscle without associated symptoms. Clin Nucl Med. 2003 Sep;28(9):769-70. Connolly LP, Drubach LA, Treves ST. Localization of Tc-99m MDP in the rectus abdominis muscle without associated symptoms. Clin Nucl Med. 2003 Sep;28(9):769-70. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43415 |
Study title: Conrad GR, Sinha P. Severe bladder distortion mimics bone metastasis from pelvic rhabdomyosarcoma. Clin Nucl Med. 2002 Dec;27(12):929-31. No abstract available. Conrad GR, Sinha P. Severe bladder distortion mimics bone metastasis from pelvic rhabdomyosarcoma. Clin Nucl Med. 2002 Dec;27(12):929-31. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43426 |
Study title: Constantinesco A, Brunot B, Demangeat JL, Foucher G, Farcot JM. Three phase bone scanning as an aid to early diagnosis in reflex sympathetic dystrophy of the hand. A study of eighty-nine cases. Ann Chir Main. 1986;5(2):93-104. English, French. Constantinesco A, Brunot B, Demangeat JL, Foucher G, Farcot JM. Three phase bone scanning as an aid to early diagnosis in reflex sympathetic dystrophy of the hand. A study of eighty-nine cases. Ann Chir Main. 1986;5(2):93-104. English, French. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43920 |
Study title: Cory DA, Siddiqui AR, Cohen MD. Uptake of technetium 99m MDP by hepatoblastoma. Eur J Nucl Med. 1987;12(11):546-7. Cory DA, Siddiqui AR, Cohen MD. Uptake of technetium 99m MDP by hepatoblastoma. Eur J Nucl Med. 1987;12(11):546-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43885 |
Study title: Neurology. 2003 Mar 11;60(5):756-61. Comment in: Neurology. 2003 Mar 11;60(5):736-7. Alpha-[11C] methyl-L-tryptophan and glucose metabolism in patients with temporal lobe epilepsy. Natsume J, Kumakura Y, Bernasconi N, Soucy JP, Nakai A, Rosa P, Fedi M, Dubeau F, Andermann F, Lisbona R, Bernasconi A, Diksic M. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28150 |
Study title: Neurosci Lett. 2007 Jul 11;422(2):91-6. Epub 2007 Jun 2.Modafinil-induced hippocampal activation in narcolepsy.Kim YK, Yoon IY, Shin YK, Cho SS, Kim SE. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28066 |
Study title: Nippon Rinsho. 2000 Jan;58(1):204-11. [Drug-induced myocardial disease--adriamycin cardiotoxicity] [Article in Japanese] Wakasugi S. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28177 |
Study title: Nucl Med Commun. 1999 Mar;20(3):255-61. Positron emission tomography using 18F-fluorodeoxyglucose in advanced stages of malignant melanoma: a comparison of ultrasonographic and radiological methods of diagnosis. Dietlein M, Krug B, Groth W, Smolarz K, Scheidhauer K, Psaras T, Stützer H, Lackner K, Schicha H. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28185 |
Study title: Nucl Med Commun. 1999 Sep;20(9):845-8. Fluorodeoxyglucose PET in the evaluation of amputations for soft tissue sarcoma. Hain SF, O'Doherty MJ, Lucas JD, Smith MA. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28181 |
Study title: Nucl Med Commun. 2002 Aug;23(8):773-7. Cerebral metabolic changes associated with Lyme disease. Newberg A, Hassan A, Alavi A. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28157 |
Study title: Nucl Med Commun. 2002 Nov;23(11):1079-83. 18FDG PET versus high-dose 67Ga scintigraphy for restaging and treatment follow-up of lymphoma patients. Van Den Bossche B, Lambert B, De Winter F, Kolindou A, Dierckx RA, Noens L, Van De Wiele C. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28154 |
Study title: Nucl Med Commun. 2002 Oct;23(10):961-5. The influences of blood glucose and duration of fasting on myocardial glucose uptake of [18F]fluoro-2-deoxy-D-glucose. Ding HJ, Shiau YC, Wang JJ, Ho ST, Kao A. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28155 |
Study title: Nucl Med Commun. 2003 Dec;24(12):1225-30. Pathology results in [18F]fluorodeoxyglucose positron emission tomography of the thyroid gland. Wolf G, Aigner RM, Schaffler G, Schwarz T, Krippl P. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28139 |
Study title: Donfrancesco A et al Ifosfamide/carboplatin/etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of age Acta Paediatr Suppl. 2004 May;93(445):6-11Donfrancesco A et al Ifosfamide/carboplatin/etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of age Acta Paediatr Suppl. 2004 May;93(445):6-11 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24849 |
Study title: Dörffel W et al Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook.Klin Padiatr 2003 May-Jun;215(3):139-45Dörffel W et al Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook.Klin Padiatr 2003 May-Jun;215(3):139-45 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24850 |
Study title: Dufour C et al Ifosfamide induced encephalopathy: 15 observations Arch Pediatr. 2006 Feb;13(2):140-5. Epub 2005 Dec 20. FrenchDufour C et al Ifosfamide induced encephalopathy: 15 observations Arch Pediatr. 2006 Feb;13(2):140-5. Epub 2005 Dec 20. French |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24852 |
Study title: Dunkel IJ et al High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group J Clin Oncol 1998 Jan;16(1):222-8Dunkel IJ et al High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group J Clin Oncol 1998 Jan;16(1):222-8 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24853 |
Study title: Dunst J et al. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial. Int J Radiat Oncol Biol Phys. 1995 Jul 15;32(4):919-30.Dunst J et al. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial. Int J Radiat Oncol Biol Phys. 1995 Jul 15;32(4):919-30. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24854 |
Study title: Ensaio clinico e terapeutico com um novo antimicotico piridonico de emprego topico o HOE 296-Clinical and therapeutic trial with a new pyridonic anti-mycotic compound for topical use, the HOE 296 - Luiz Carlos Pereira et al. - 1974 (Rev Bras Clin Ter vol 3) - Publication in Part Clinical documentation Batrafen Losung-No author - 11/1999 - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24151 |
Study title: Estudo sobre o uso do ciclopirox (HOE 296) em Dermatologia : Resultados clinicos das micoses superficiais- Clinical effects of use of ciclopirox (HOE 296) in dermatology : therapeutic efficacy in superficial mycosis- Marcio lobo Jardim et al. - 1975 ( Rev Bras Clin Ter vol 4) - Publication in Part Clinical documentation Batrafen Losung - No author - 11/1999 - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24152 |
Study title: Estudo sobre o uso do ciclopirox (HOE 296) em Dermatologia : Resultados clinicos das micoses superficiais- Clinical effects of use of ciclopirox (HOE 296) in dermatology : therapeutic efficacy in superficial mycosis- Marcio lobo Jardim et al. - 1975 ( Rev Bras Clin Ter vol 4) - Publication in Part Clinical documentation Batrafen Losung -No author - 11/1999 - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24153 |
Study title: Evaluation of a new antifungal cream, ciclopirox alamine 1% in the treatment of cutaneous candidosis - Fillmore K. Bagatell et al. - 1985 (Clincals Therapeutics vol 8, N°1) -Publication in clinical studies (volume 5) - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24154 |
Study title: Evaluation of a new antifungal cream, ciclopirox alamine 1% in the treatment of cutaneous candidosis - Fillmore K. Bagatell et al. - 1985 (Clincals Therapeutics vol 8, N°1) -Publication in clinical studies (volume 5) - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24155 |
Study title: Evaluation of ciclopirox olamine for the treatment of tinea pedis : multicenter, double-blind comparatives studies - Albert M. Kligman et al.- 1985 (Clinical therapeutics vol 7, n°4) - Publication in clinical studies ( volume 4)- a double blind multicentre parallel study group comparing ciclopirox olamine 1% cream and vehicle, cream base in the subjects with Tinea corporis or Tinea cruris - No author - 08/1988 - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24156 |
Study title: Experiencia clinica com um novo antimicotico : HOE 296-Clinical experience with HOE 296, a new antimycotic agent- R.D Azulay et al. - 1973 (Rev bras. Clin Ter vol 2) - Publication in Part Clinical documentation Batrafen Losung - No author - 11/1999 - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24157 |
Study title: Fungal colonization in the very low birth weight infants - J.E Baley et al. - 1986 (Pedriatrics vol 78) - Publication in Part clinical documentation- Batrafen Losung Study CIOMS - No author -11/ 1999 - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24158 |
Study title: High prevalence of cervical dysplasia in female consorts of men with genital warts- T. Hockenstrom et al.- No date (Acta Derm Venereol vol 67) - Publication in clinical studies (volume 6) - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24159 |
Study title: Kuusela AL, Ruuska T, Karikoski R, Laippala P, Ikonen RS, Janas M, Mäki M. A randomized, controlled study of prophylactic ranitidine in preventing stress-induced gastric mucosal lesions in neonatal intensive care unit patients. Crit Care Med. 1997 Feb;25(2):346-51.Kuusela AL, Ruuska T, Karikoski R, Laippala P, Ikonen RS, Janas M, Mäki M. A randomized, controlled study of prophylactic ranitidine in preventing stress-induced gastric mucosal lesions in neonatal intensive care unit patients. Crit Care Med. 1997 Feb;25(2):346-51. |
Active substance: RANITIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35283 |
Study title: Kuusela AL.Long-term gastric pH monitoring for determining optimal dose of ranitidine for critically ill preterm and term neonates. Arch Dis Child Fetal Neonatal Ed. 1998 Mar;78(2):F151-3.Kuusela AL.Long-term gastric pH monitoring for determining optimal dose of ranitidine for critically ill preterm and term neonates. Arch Dis Child Fetal Neonatal Ed. 1998 Mar;78(2):F151-3. |
Active substance: RANITIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35281 |
Study title: Orenstein SR, Blumer JL, Faessel HM, McGuire JA, Fung K, Li BU, Lavine JE, Grunow JE, Treem WR, Ciociola AA. Ranitidine, 75 mg, over-the-counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro-oesophageal reflux. Aliment Pharmacol Ther. 2002 May;16(5):899-907.Orenstein SR, Blumer JL, Faessel HM, McGuire JA, Fung K, Li BU, Lavine JE, Grunow JE, Treem WR, Ciociola AA. Ranitidine, 75 mg, over-the-counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro-oesophageal reflux. Aliment Pharmacol Ther. 2002 May;16(5):899-907. |
Active substance: RANITIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35278 |
Study title: Ranitidine, 75 mg, over-the-counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro-oesophageal reflux. |
Active substance: RANITIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35274 |
Study title: A Dose-Escalation, Randomized Double-Blind Withdrawal Study of the Efficacy, Dose- Response, and Safety of Ramipril for the Treatment of Hypertension in Children and Adolescents |
Active substance: RAMIPRIL |
Study summary document link (including results): Ramipril-Study 3.pdf |
View full study record |
Document reference: 35271 |
Study title: Kolygin-B-A, Fedoreev-G-A. Combination chemotherapy of Hodgkin disease in children. Neoplasma, {Neoplasma}, 1975, vol. 22, no. 2, p. 225-30, ISSN: 0028-2685.Kolygin-B-A, Fedoreev-G-A. Combination chemotherapy of Hodgkin disease in children. Neoplasma, {Neoplasma}, 1975, vol. 22, no. 2, p. 225-30, ISSN: 0028-2685. |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34761 |
Study title: Komp-D-M, Britton-H-A, Vietti-T-J, Humphrey-G-B. Southwest Oncol. Group, Operations Office, 3500 Rainbow Blvd, Suite 201, Kansas City, Kans. 66103, United States. Response of childhood histiocytosis X to procarbazine (NSC 77213). CANCER-CHEMOTHER-REP, 1974, Vol/Iss/Pg. 58/5 (719-722). Komp-D-M, Britton-H-A, Vietti-T-J, Humphrey-G-B. Southwest Oncol. Group, Operations Office, 3500 Rainbow Blvd, Suite 201, Kansas City, Kans. 66103, United States. Response of childhood histiocytosis X to procarbazine (NSC 77213). CANCER-CHEMOTHER-REP, 1974, Vol/Iss/Pg. 58/5 (719-722). |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34762 |
Study title: Krischer-J-P, Steuber-C-P, Vietti-T-J, Culbert-S-J, Ragab-A-H, Morgan-S-K, Berry-D-H, Hvizdala-E, Thomas-P-J, Land-V-J, et al. Department of Pediatrics, University of Florida, Gainesville. Long-term results in the treatment of acute nonlymphocytic leukemia: a Pediatric Oncology Group Study. Medical and pediatric oncology, {Med-Pediatr-Oncol}, 1989, vol. 17, no. 5, p. 401-8, ISSN: 0098-1532.Krischer-J-P, Steuber-C-P, Vietti-T-J, Culbert-S-J, Ragab-A-H, Morgan-S-K, Berry-D-H, Hvizdala-E, Thomas-P-J, Land-V-J, et al. Department of Pediatrics, University of Florida, Gainesville. Long-term results in the treatment of acute nonlymphocytic leukemia: a Pediatric Oncology Group Study. Medical and pediatric oncology, {Med-Pediatr-Oncol}, 1989, vol. 17, no. 5, p. 401-8, ISSN: 0... |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34763 |
Study title: Antipyretic activity of ibuprofen and paracetamol in children with pyrexia. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29472 |
Study title: Antipyretic Activity of Ibuprofen Suspension and Paracetamol: Comparative Study in Children with Pyrexia. |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-M83-111.pdf |
View full study record |
Document reference: 29465 |
Study title: Autret−E et al. Comparative efficacy and tolerance of ibuprofen syrup and acetaminophen syrup in children with pyrexia associated with infectious diseases and treated with antibiotics. {EUR−J−CLIN−PHARMACOL}, 1994, Vol/Iss/Pg. 46/3 (197−201)Autret−E et al. Comparative efficacy and tolerance of ibuprofen syrup and acetaminophen syrup in children with pyrexia associated with infectious diseases and treated with antibiotics. {EUR−J−CLIN−PHARMACOL}, 1994, Vol/Iss/Pg. 46/3 (197−201) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29590 |
Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43096 |
Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43124 |
Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43182 |
Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43192 |
Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43202 |
Study title: Nucl Med Commun. 2003 Jun;24(6):643-9. Persistent vegetative state: evaluation of brain metabolism and brain perfusion with PET and SPECT. Beuthien-Baumann B, Handrick W, Schmidt T, Burchert W, Oehme L, Kropp J, Schackert G, Pinkert J, Franke WG. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28147 |
Study title: Nucl Med Commun. 2004 Feb;25(2):123-8. Subcortical [18F]fluorodeoxyglucose uptake in lesional epilepsy in patients with intracranial tumour. Novak L, Emri M, Molnar P, Balkay L, Lengyel Z, Tron L. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28124 |
Study title: Nucl Med Commun. 2004 May;25(5):439-43. 18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature. Gotthardt M, Battmann A, HÃffken H, Schurrat T, Pollum H, Beuter D, Gratz S, Béhé M, Bauhofer A, Klose KJ, Behr TM. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28125 |
Study title: Nucl Med Commun. 2006 Nov;27(11):893-9. Pre-surgical identification of epileptogenic areas in temporal lobe epilepsy by 123I-iomazenil SPECT: a comparison with IMP SPECT and FDG PET.Kaneko K, Sasaki M, Morioka T, Koga H, Abe K, Sawamoto H, Ohya N, Yoshiura T, Mihara F, Honda H. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28074 |
Study title: Nucl Med Commun. 2007 Apr;28(4):273-80.Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma.Falk MS, Truitt AK, Coakley FV, Kashani-Sabet M, Hawkins RA, Franc B. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28068 |
Study title: Oncol Rep. 2005 Nov;14(5):1209-14. 18FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long-term results. Rigacci L, Castagnoli A, Dini C, Carpaneto A, Matteini M, Alterini R, Carrai V, Nassi L, Bernardi F, Pieroni C, Bosi A. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28094 |
Study title: Ophthalmic Genet. 2004 Mar;25(1):31-5. Fluorine-18 fluorodeoxyglucose positron emission tomography (PET) to detect vital retinoblastoma in the eye: preliminary experience. Moll AC, Hoekstra OS, Imhof SM, Comans EF, Schouten-van Meeteren AY, van der Valk P, Boers M. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28121 |
Study title: Paediatr Anaesth. 2007 Jul;17(7):616-21.Congenital hyperinsulinism - a review of the disorder and a discussion of the anesthesia management.Hardy OT, Litman RS. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28067 |
Study title: Pediatr Neurosurg. 1997 Mar;26(3):144-56. Use of positron emission tomography for presurgical localization of eloquent brain areas in children with seizures. Duncan JD, Moss SD, Bandy DJ, Manwaring K, Kaplan AM, Reiman EM, Chen K, Lawson MA, Wodrich DL. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28194 |
Study title: Comparison of bone scan and radiograph sensitivity in the detection of steroid-induced ischemic necrosis of bone. Conklin JJ, Alderson PO, Zizic TM, Hungerford DS, Densereaux JY, Gober A, Wagner HN. Radiology. 1983 Apr;147(1):221-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44043 |
Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43212 |
Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43222 |
Study title: HOE 296 - Its safety evaluated by laboratory test and its clinical effect- Y. Watanabe - 1975 (Journal of new Remedies and Clinicals vol 24) - Publication in Part clinical documentation-Batrafen Losung Study CIOMS -No author - 11/1999 - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24160 |
Study title: HOE 296, um novo antimicotico piridonicode emprego topico,com atividade antibacteriana adicional - Ney Romiti - 1974 (Rev Bras Clin Ter vol 3, n°10, suppl 7) - Publication in Part clinical documentation Batrafen Losung - Study CIOMS - No author - 11/ 1999 - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24161 |
Study title: HOE 296, um novo antimicotico piridonicode emprego topico,com atividade antibacteriana adicional - Ney Romiti - 1974 (Rev Bras Clin Ter vol 3, n°10, suppl 7) - Publication in Part clinical documentation Batrafen Losung - Study CIOMS - No author - 11/ 1999 - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24162 |
Study title: Investigacion clinica sobre el HOE 296 en demafitosis de la piel lampina y en pitiriasis versicolor - Antonio Gonzalvez-Ochoa et al. - 1974 (Rev Int Salud publica vol 34) - Publication in Part clinical Documentation Batrafen Losung - No author - 11/ 1999 - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24163 |
Study title: La ciclopiroxolamina nel trattamento della pityriasis versicolor (Ciclopiroxolamine in the treatment of pityriasis versicolor) - G. Trevisan et al. - 1988 (Giornale Italiano Di Dermatologica e Venerologica vol 123) - Publication in Part clinical documenta |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24164 |
Study title: Multicentre Double-blind clinical trials of ciclopirox olamine cream 1%in the treatment of tinea corporis or tinea cruris -Humberto Bogaert et al. - 1986 (J Int Med Res vol 14) - Publication in clinical studies ( volume 3) - a double bind multicentre parallel study group comparing ciclopirox olamine 1% cream and vehicle, cream base in the subjects with Tinea corporis or Tinea cruris - No author - 08/ 1988 - |
Active substance: CICLOSPORIX |
Study summary document link (including results): |
View full study record |
Document reference: 24165 |
Study title: ANAFRANIL (G34586) 2 YR RAT 2 VOLS. RAW DATA - 11/28/73 |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24403 |
Study title: ANAFRANIL-BIP. (ANAFRANIL & ANAFRANIL SLOW RELEASE); ORIGIN=PCS CH; CONTRACTOR=1; |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24386 |
Study title: ANAFRANIL, TOFRANIL |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24404 |
Study title: AUSTRALIEN GESAMT STUDIE RESULTATE 1976/77/78 |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24392 |
Study title: AUSTRALIEN II ORD. IV OKTOBER 77, AUSTALIEN III PO./IV MAERZ 1978 |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24393 |
Study title: CLINICAL TRIAL TO EVALUATE THE THERAPEUTIC ACTIVITY AND TOLERABILITY OF ANAFRANIL 10MG DRAGEES IN CHILDREN SUFFERING FROM DEPRESSION, ANOREXIA, ENURESIS, SCHOOL-PHOBIA, PHOBIA AND OBSESSION OR ANXIETY |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24388 |
Study title: effects of anafranil 10 mg in enuresic children |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24389 |
Study title: G 34586, ANAFRANIL: PLASMA CONCENTRATIONS OF CLOMIPRAMINE AND DESMETHYL CLOMIPRAMINE IN CHILDREN AND ADOLESCENTS WITH OBSESSIVE COMPULSIVE DISORDER |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24387 |
Study title: PRUEBA SOBRE POSIBLES EFECTOS PERJUDICIALES EN EL EMBRION. RATON, VIA ORAL |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24380 |
Study title: PRUEFUNG AUF TERATOGENE WIRKUNG, RATTE.; ORIGIN=PCS CH; CONTRACTOR=1; |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24383 |
Study title: REPRODUCTION STUDY, SEGMENT II, MOUSE.; ORIGIN=PCS CH; CONTRACTOR=1; |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24394 |
Study title: REPRODUCTION STUDY, SEGMENT II, RAT.; ORIGIN=PCS CH; CONTRACTOR=1; |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24395 |
Study title: REVIEW OF REPRODUCTION STUDIES DATED 7.8.72. (FRA NR.1); ORIGIN=PCS CH; CONTRACTOR=1; |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24396 |
Study title: REVIEW OF REPRODUCTION STUDIES.; ORIGIN=PCS CH; CONTRACTOR=1; |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24397 |
Study title: Kuehner-U, Bleher-E-A, Gretillat-P, et-al. Inst. Klin. Exp. Tum. Forsch. Klin., Strahlenther., Univ. Bern, Switzerland. Diagnosis and treatment of Hodgkin's disease in children. Monatsschrift fur Kinderheilkunde {MONATSSCHR-KINDERHEILKD}, 1976, Vol/Iss/Pg. 124/5 (408-410).Kuehner-U, Bleher-E-A, Gretillat-P, et-al. Inst. Klin. Exp. Tum. Forsch. Klin., Strahlenther., Univ. Bern, Switzerland. Diagnosis and treatment of Hodgkin's disease in children. Monatsschrift fur Kinderheilkunde {MONATSSCHR-KINDERHEILKD}, 1976, Vol/Iss/Pg. 124/5 (408-410). |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34764 |
Study title: Lampkin-B-C, Wong-K-Y, Kalinyak-K-A, et-al. Hematology-Oncology Division, Children's Hospital Medical Center, Cincinnati, OH 45229, United States. Solid malignancies in children and adolescents. Surgical Clinics of North America {SURG-CLIN-NORTH-AM}, 1985, Vol/Iss /Pg. 65/6 (1351-1386).Lampkin-B-C, Wong-K-Y, Kalinyak-K-A, et-al. Hematology-Oncology Division, Children's Hospital Medical Center, Cincinnati, OH 45229, United States. Solid malignancies in children and adolescents. Surgical Clinics of North America {SURG-CLIN-NORTH-AM}, 1985, Vol/Iss /Pg. 65/6 (1351-1386). |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34765 |
Study title: Lange-B, Littman-P, Schnaufer-L, Evans-A. Child. Hosp. Cancer Res. Cent., Univ. Pennsylvania, Philadelphia, Pa. 19104, United States. Treatment of Hodgkin's disease (HD) in children, 1970-1980. Proceedings of the American Association for Cancer Research {PROC-AM-ASSOC-CANCER-RES}, 1981, Vol/Iss/Pg. Vol. 22/- (C-287).Lange-B, Littman-P, Schnaufer-L, Evans-A. Child. Hosp. Cancer Res. Cent., Univ. Pennsylvania, Philadelphia, Pa. 19104, United States. Treatment of Hodgkin's disease (HD) in children, 1970-1980. Proceedings of the American Association for Cancer Research {PROC-AM-ASSOC-CANCER-RES}, 1981, Vol/Iss/Pg. Vol. 22/- (C-287). |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34766 |
Study title: Lange-B, Littman-P, Schnaufer-L, Evans-A. Treatment of advanced Hodgkin's disease in pediatric patients. Cancer, {Cancer}, Sep 1978, vol. 42, no. 3, p. 1141-5, ISSN: 0008-543X.Lange-B, Littman-P, Schnaufer-L, Evans-A. Treatment of advanced Hodgkin's disease in pediatric patients. Cancer, {Cancer}, Sep 1978, vol. 42, no. 3, p. 1141-5, ISSN: 0008-543X. |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34767 |
Study title: Bozkurt MF, Uğur O. Intra-arterial Tc-99m MDP injection mimicking reflex sympathetic dystrophy. Clin Nucl Med. 2001 Feb;26(2):154-6. No abstract available. Bozkurt MF, Uğur O. Intra-arterial Tc-99m MDP injection mimicking reflex sympathetic dystrophy. Clin Nucl Med. 2001 Feb;26(2):154-6. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43462 |
Study title: Braga FJ, Arbex MA, Haddad J, Maes A. Bone scintigraphy in testicular tumors. Clin Nucl Med. 2001 Feb;26(2):117-8. Braga FJ, Arbex MA, Haddad J, Maes A. Bone scintigraphy in testicular tumors. Clin Nucl Med. 2001 Feb;26(2):117-8. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43463 |
Study title: TREATMENT OF OROPHARYNGEAL CANDIDIASIS RESISTANT TO FLUCONAZOLE A DAILY DOSE OF 400 MG FOR 7 DAYS. A PILOT DOSE STUDY USING 800, 1200 AND 1600 MG DAILY TO 7 DAYS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27766 |
Study title: TREATMENT OF SYSTEMIC MYCOSIS WITH FLUCONAZOLE AND ITS IN VITRO ANTIFUNGAL ACTIVITY |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27498 |
Study title: TREATMENT OF SYSTEMIC MYCOSIS WITH FLUCONAZOLE AND ITS IN VITRO ANTIFUNGAL ACTIVITY |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27862 |
Study title: TREATMENT OF VAGINAL CANDIDIASIS WITH A SINGLE ORAL DOSE OF FCA. MULTICENTER NON-COMPARATIVE OPEN STUDY. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27407 |
Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43217 |
Study title: Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251.Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43341 |
Study title: Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251.Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43351 |
Study title: Wudy SA, Rodens K, Homoki J, Teller WM. Tamoxifen for treatment of sexual precocity in girls with McCune-Albright syndrome. Pediatric Reviews and Communications 1993; 7(2):115-120.Wudy SA, Rodens K, Homoki J, Teller WM. Tamoxifen for treatment of sexual precocity in girls with McCune-Albright syndrome. Pediatric Reviews and Communications 1993; 7(2):115-120. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43161 |
Study title: Yaghan RJ, Bani-Hani KE. Male breast disorders in Jordan - Disease patterns and management problems. Saudi Medical Journal~ 25(12):1877-1883, December 2004 2004;(12):-1883, December.Yaghan RJ, Bani-Hani KE. Male breast disorders in Jordan - Disease patterns and management problems. Saudi Medical Journal~ 25(12):1877-1883, December 2004 2004;(12):-1883, December. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43097 |
Study title: A randomized, double blinded, parallel group, multicenter study to explore the pharmaco-kinetics, safety, tolerability and efficacy of tamsulosin in pediatric patients with signs and symptoms of dysfunctional voiding |
Active substance: TAMSULOSIN |
Study summary document link (including results): 617-CL-310 Study synopsis_Tamsulosin.pdf |
View full study record |
Document reference: 43356 |
Study title: Pharmacokinetics, safety, and tolerability of single oral doses (0.1, 0.2, 0.4 and 0.8 mg) of tamsulosin hydrochloride in children with voiding disorders |
Active substance: TAMSULOSIN |
Study summary document link (including results): Tamsulosin_U05-3269_synopsis.pdf |
View full study record |
Document reference: 43357 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Tanacet-Heel (drops) [AWB-037] |
Active substance: Tanacet-Heel |
Study summary document link (including results): |
View full study record |
Document reference: 40251 |
Study title: Double blind, placebo controlled study of the efficacy of polytar in treatment of seborrhoeic dermatitis and eczema of the scalp. |
Active substance: TAR AND ZINC |
Study summary document link (including results): |
View full study record |
Document reference: 43358 |
Study title: To study the effects of Fongitar (Polytar AF) in Pityriasis and squamous conditions of the scalp. |
Active substance: TAR AND ZINC |
Study summary document link (including results): Article 45_Ref_C0202_Final For Submission_27 Oct 2011.xlsx |
View full study record |
Document reference: 43359 |
Study title: Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43283 |
Study title: Dose-dependant Resoption of quinine after intrarectal administration to children with moderate Plasmodium falciparum Malaria - Eric Pussard et al. - 11/2004 (Antimicrobial agents and Chimiotherapy;vol. 48,No. 11:4422-4426)Dose-dependant Resoption of quinine after intrarectal administration to children with moderate Plasmodium falciparum Malaria - Eric Pussard et al. - 11/2004 (Antimicrobial agents and Chimiotherapy;vol. 48,No. 11:4422-4426) |
Active substance: QUININE |
Study summary document link (including results): |
View full study record |
Document reference: 45065 |
Study title: Effects of corticosteroid inhalation therapy on the deposition pattern of Tc-99m human serum albumin radioaerosols in asthma. Kao CH, Lin HT, Yu SL, Wang SJ, Lan JL. Lung. 1995;173(5):291-6. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48262 |
Study title: Esophageal bronchus in an infant diagnosed by fortuitous intubation of the esophagus during ventilation imaging. Kohne RE, McLeary MS, Kirk GA, Young LW. Clin Nucl Med. 1996 Dec;21(12):990-3. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48248 |
Study title: Esophageal dysmotility as a serendipitous observation on ventilation-perfusion imaging of the lungs. Moallem A, Hilfer C, Stein A. Clin Nucl Med. 1992 Jun;17(6):446-8. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48277 |
Study title: Eur J Radiol. 1990 Sep-Oct;11(2):131-7. Contrast venography: from gold standard to 'golden backup' in clinically suspected deep vein thrombosis. de Valois JC, van Schaik CC, Verzijlbergen F, van Ramshorst B, Eikelboom BC, Meuwissen OJ. Eur J Radiol. 1990 Sep-Oct;11(2):131-7. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): de valois JC 1990.pdf |
View full study record |
Document reference: 48282 |
Study title: Evaluation of the ventilation-perfusion ratio in lung diseases by simultaneous anterior and posterior image acquisition. Nakata Y, Narabayashi I, Sueyoshi K, Matsui R, Namba R, Tabuchi K. Ann Nucl Med. 1994 Nov;8(4):269-76. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48264 |
Study title: Gamma probe-guided thoracoscopic surgery of small pulmonary nodules. Boni G, Bellina CR, Grosso M, Lucchi M, Manca G, Ambrogi MC, Volterrani D, Menconi G, Melfi FM, Gonfiotti A, Davini F, Angeletti CA, Bianchi R, Chella A. http://www.tumorionline.it/advertising.php Tumori. 2000 Jul-Aug;86(4):364-6. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48231 |
Study title: Hepatopulmonary syndrome in Gaucher disease with right-to-left shunt: evaluation and measurement using Tc-99m MAA. Kim JH, Park CH, Pai MS, Hahn MH, Kim HJ. Clin Nucl Med. 1999 Mar;24(3):164-6. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48241 |
Study title: Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99m)Tc MAA lung scanning. Krowka MJ, Wiseman GA, Burnett OL, Spivey JR, Therneau T, Porayko MK, Wiesner RH. Chest. 2000 Sep;118(3):615-24. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48233 |
Study title: Fluoride concentration in plaque in adolescents after topical application of different fluoride varnishes. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42424 |
Study title: SEGMENT I, GENERAL REPRODUCTION PERFORMANCE, RATS.; ORIGIN=HAZLETON USA AND UK; CONTRACTOR=1; |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24384 |
Study title: SEGMENT I, REPRODUCTIVE STUDY IN MALE AND FEMALE RATS.; ORIGIN=PCS US / SU; CONTRACTOR=1; |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24398 |
Study title: SEGMENT III - PERINATAL WEANING STUDY, RATS.; ORIGIN=HAZLETON USA AND UK; CONTRACTOR=1; |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24385 |
Study title: TERATOLOGY, ORAL RABBITS ;ORIGIN=HUNTINGDON |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24390 |
Study title: TEST FOR TERATOGENIC EFFECT, MOUSE, ORALLY.; ORIGIN=PCS CH; CONTRACTOR=1; |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24399 |
Study title: TEST ON TERATOGENIC EFFECT - MICE, ORAL ADMINISTRATION |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24402 |
Study title: TEST ON TERATOGENIC EFFECT - RATS |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24382 |
Study title: THE EFFECT OF G34586 UPON PREGNANCY IN THE NEW ZEALAND WHITE RABBIT.; ORIGIN=HUNTINGDON LIFE SCIENCES; CONTRACTOR=1; |
Active substance: CLOMIPRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 24400 |
Study title: Clinical report on the efficacy and tolerability of Bromocodeina syrup in paediatric patients suffering from cough |
Active substance: CODEINE |
Study summary document link (including results): Codeine_Synopsis.doc |
View full study record |
Document reference: 47532 |
Study title: Greene−S−L, Reed−C−E, Schroeter−A−L. Double−blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. Journal of the American Academy of Dermatology, {J−Am−Acad−Dermatol}, Apr 1985, vol. 12, no. 4, p. 669−75. |
Active substance: CODEINE_AND_DIPHENHYDRAMINE_AND_L-MENTHOL |
Study summary document link (including results): |
View full study record |
Document reference: 24486 |
Study title: Moscati−R−M, Moore−G−P. Comparison of cimetidine and diphenhydramine in the treatment of acute urticaria. Annals of emergency medicine, {Ann−Emerg−Med}, Jan 1990, vol. 19, no. 1, p. 12−5. |
Active substance: CODEINE_AND_DIPHENHYDRAMINE_AND_L-MENTHOL |
Study summary document link (including results): |
View full study record |
Document reference: 24483 |
Study title: Moscati−R−M, Moore−G−P. Comparison of cimetidine and diphenhydramine in the treatment of acute urticaria. Annals of emergency medicine, {Ann−Emerg−Med}, Jan 1990, vol. 19, no. 1, p. 12−5. |
Active substance: CODEINE_AND_DIPHENHYDRAMINE_AND_L-MENTHOL |
Study summary document link (including results): |
View full study record |
Document reference: 24485 |
Study title: Raphael−G−D, Angello−J−T, Wu−M−M, Druce−H−M. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate−to−severe seasonal allergic rhinitis. Annals of Allergy, Asthma and Immunology {ANN−ALLERGY−ASTHMA−IMMUNOL}, 2006, Vol/Iss/Pg. 96/4 (606−614). |
Active substance: CODEINE_AND_DIPHENHYDRAMINE_AND_L-MENTHOL |
Study summary document link (including results): |
View full study record |
Document reference: 24484 |
Study title: Russo−R−M, Gururaj−V−J, Allen−J−E. The effectiveness of diphenhydramine HCI in pediatric sleep disorders. Journal of clinical pharmacology, {J−Clin−Pharmacol}, May−Jun 1976, vol. 16, no. 5−6, p. 284−8. |
Active substance: CODEINE_AND_DIPHENHYDRAMINE_AND_L-MENTHOL |
Study summary document link (including results): |
View full study record |
Document reference: 24482 |
Study title: Simons, K.J. et al.:Diphenhydramin: Pharmacokinetic and Pharmacodynamic in elderly Adults, Young Adults, and Children. J Clin Pharmacol 1990;30:665-671 |
Active substance: CODEINE_AND_DIPHENHYDRAMINE_AND_L-MENTHOL |
Study summary document link (including results): |
View full study record |
Document reference: 24487 |
Study title: Yoder−K−E, Shaffer−M−L, La−Tournous−S−J, Paul−I−M. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clinical Pediatrics {CLIN−PEDIATR}, 2006, Vol/Iss/Pg. 45/7 (633−640). |
Active substance: CODEINE_AND_DIPHENHYDRAMINE_AND_L-MENTHOL |
Study summary document link (including results): |
View full study record |
Document reference: 24481 |
Study title: A multi-centre, double blind, parallel group, prospective, randomised study to compare the efficacy of a single dose of 10 mg/kg ibuprofen with 15 mg/kgparacetamol in febrile children aged from 3 months to 12 years followed by tolerability over up to thre |
Active substance: CODEINE_AND_IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 24499 |
Study title: TREATMENT OF VAGINAL CANDIDIASIS WITH A SINGLE ORAL DOSE OF FCA. MULTICENTER NON-COMPARATIVE OPEN STUDY. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27772 |
Study title: USEFULNESS OF DIFLUCAN THERAPY FOR SYSTEMIC FUNGAL INFECTIONS ASSOCIATED WITH HEMATOLOGIC DISEASES |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27486 |
Study title: USEFULNESS OF DIFLUCAN THERAPY FOR SYSTEMIC FUNGAL INFECTIONS ASSOCIATED WITH HEMATOLOGIC DISEASES |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27850 |
Study title: Acta Neurochir Suppl. 2005;95:165-8. Glucose metabolism in traumatic brain injury: a combined microdialysis and [18F]-2-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET) study. O'Connell MT, Seal A, Nortje J, Al-Rawi PG, Coles JP, Fryer TD, Menon DK, Pickard JD, Hutchinson PJ. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28090 |
Study title: Acta Neurol Belg. 2001 Dec;101(4):196-209. Guidelines for brain radionuclide imaging. Perfusion single photon computed tomography (SPECT) using Tc-99m radiopharmaceuticals and brain metabolism positron emission tomography (PET) using F-18 fluorodeoxyglucose. The Belgian Society for Nuclear Medicine. Vander Borght T, Laloux P, Maes A, Salmon E, Goethals I, Goldman S; Belgian Society for Nuclear Medicine. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28162 |
Study title: Ann Acad Med Singapore. 2004 Mar;33(2):183-5. Semi-quantitative measurements of normal organs with variable metabolic activity on FDG PET imaging. Tan LT, Ong KL. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28126 |
Study title: Ann Nucl Med. 2004 Apr;18(2):131-6. Lesion detectability of a gamma camera based coincidence system with FDG in patients with malignant tumors: a comparison with dedicated positron emission tomography. Koga H, Sasaki M, Kuwabara Y, Nakagawa M, Hayashi K, Kaneko K, Chen T, Honda H. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28123 |
Study title: Ann Nucl Med. 2004 Oct;18(7):579-84. Semiquantitative analysis of interictal glucose metabolism between generalized epilepsy and localization related epilepsy. Hikima A, Mochizuki H, Oriuchi N, Endo K, Morikawa A. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28117 |
Study title: Ann Nucl Med. 2005 Apr;19(2):101-8. The effect of oral contrast on large bowel activity in FDG-PET/CT. Otsuka H, Graham MM, Kubo A, Nishitani H. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28103 |
Study title: Ann Nucl Med. 2006 Jan;20(1):79-82. FDG PET in solitary metastastic/secondary tumor of the kidney: a report of three cases and a review of the relevant literature. Kaneta T, Hakamatsuka T, Yamada T, Takase K, Sato A, Higano S, Kinomura S, Fukuda H, Takahashi S, Yamada S. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28089 |
Study title: Ann Oncol. 2005 Jul;16(7):1160-8. Epub 2005 Jun 6. Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma. Hutchings M, Mikhaeel NG, Fields PA, Nunan T, Timothy AR. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28102 |
Study title: Anticancer Res. 1998 May-Jun;18(3B):2011-3. Escalating dose of oral ondansetron in the prevention of radiation induced emesis. Maisano R, Pergolizzi S, Settineri N. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28190 |
Study title: A multiple dose study comparing the antipyretic efficacy and safety of 5-7 mg/kg of ibuprofen and 10-15 mg/kg of acetaminophen in febrile children. (Feb 1988) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29383 |
Study title: A multiple dose study comparing the antipyretic efficacy and safety of 5-7 mg/kg of ibuprofen and 10-15 mg/kg of acetaminophen in febrile children. Feb 1988. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29618 |
Study title: A phase III comparative study of the pharmacokinetic/pharmacodynamic and safety profiles of ibuprofen extended release, ibuprofen regular release and placebo during a 12 hour observation in post-extraction dental pain |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29494 |
Study title: Khan SA et al.The treatment of chronic psoriasis a two centre comparative study 1981;225;(1356):932-4Khan SA et al.The treatment of chronic psoriasis a two centre comparative study 1981;225;(1356):932-4 |
Active substance: TARS |
Study summary document link (including results): |
View full study record |
Document reference: 43362 |
Study title: Langner A et al. Treatment of psoriasis of the scalp with coal tar gel and shampoo preparations. Cutaneous medicine for the practitioner 1983;32;(3):290-1;295-6 Langner A et al. Treatment of psoriasis of the scalp with coal tar gel and shampoo preparations. Cutaneous medicine for the practitioner 1983;32;(3):290-1;295-6 |
Active substance: TARS |
Study summary document link (including results): |
View full study record |
Document reference: 43361 |
Study title: Carter NJ, Brown A, Barrington SF, O'Doherty MJ, Nunan TO, Coakley AJ. A one-hour walk-in service for wrist trauma imaging. Nucl Med Commun. 1999 Dec;20(12):1161-4. Carter NJ, Brown A, Barrington SF, O'Doherty MJ, Nunan TO, Coakley AJ. A one-hour walk-in service for wrist trauma imaging. Nucl Med Commun. 1999 Dec;20(12):1161-4. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43495 |
Study title: Haematologica. 2006 Apr;91(4):475-81. The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease. Gallamini A, Rigacci L, Merli F, Nassi L, Bosi A, Capodanno I, Luminari S, Vitolo U, Sancetta R, Iannitto E, Trentin L, Stelitano C, Tavera S, Biggi A, Castagnoli A, Versari A, Gregianin M, Pelosi E, Torchio P, Levis A. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28082 |
Study title: Hepatology. 2006 Dec;44(6):1572-80. Comment in: Liver Transpl. 2007 Apr;13(4):622-3. Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation.Prytz H, Keiding S, BjÃrnsson E, Broomé U, Almer S, Castedal M, Munk OL; Swedish Internal Medicine Liver Club. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28071 |
Study title: IEEE Trans Biomed Eng. 2005 Sep;52(9):1574-81. Application of an objective method for localizing bilateral cortical FDG PET abnormalities to guide the resection of epileptic foci. Muzik O, Pourabdollah S, Juhasz C, Chugani DC, Janisse J, Draghici S. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28095 |
Study title: Int J Nurs Stud. 2007 Aug;44(6):973-81. Epub 2006 Jun 16. Effects of acupressure on dysmenorrhea and skin temperature changes in college students: a non-randomized controlled trial. Jun EM, Chang S, Kang DH, Kim S. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28080 |
Study title: Isr J Med Sci. 1996 Oct;32(10):812-4. How to use information from echocardiography and magnetic resonance for diagnosing myocardial viability. Sechtem U. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28196 |
Study title: J Am Coll Cardiol. 2000 Nov 1;36(5):1676-83. Myocardial viability assessed by positron emission tomography in infants and children after the arterial switch operation and suspected infarction. Rickers C, Sasse K, Buchert R, Stern H, van den Hoff J, Lübeck M, Weil J. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28173 |
Study title: J Cardiovasc Pharmacol. 1996 Apr;27(4):563-70. Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia. Steinmetz A, Schwartz T, Hehnke U, Kaffarnik H. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28198 |
Study title: J Child Neurol. 1994 Apr;9(2):155-61. Neuroimaging in infantile autism. Schifter T, Hoffman JM, Hatten HP Jr, Hanson MW, Coleman RE, DeLong GR. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28204 |
Study title: J Child Neurol. 2006 Jun;21(6):456-62. Pilot study of positron emission tomography (PET) brain glucose metabolism to assess the efficacy of tongue and body acupuncture in cerebral palsy. Wong VC, Sun JG, Yeung DW. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28077 |
Study title: J Child Neurol. 2006 Jun;21(6):463-73. Pilot study of efficacy of tongue and body acupuncture in children with visual impairment. Wong VC, Sun JG, Yeung DW. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28076 |
Study title: J Clin Oncol. 2005 May 1;23(13):3030-7. Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion. Borgwardt L, Højgaard L, Carstensen H, Laursen H, Nowak M, Thomsen C, Schmiegelow K. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28104 |
Study title: J Clin Psychiatry. 2002;63 Suppl 12:29-35. Management of ADHD in adults. Adler LA, Chua HC. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28151 |
Study title: Crone-Münzebrock W, Heller M, Witte G. [The importance of circumscript activity concentrations of the frontobasal region of the skull in skeletal scintigraphy (author's transl)] Radiol Diagn (Berl). 1981;22(6):815-8. German. No abstract available. Crone-Münzebrock W, Heller M, Witte G. [The importance of circumscript activity concentrations of the frontobasal region of the skull in skeletal scintigraphy (author's transl)] Radiol Diagn (Berl). 1981;22(6):815-8. German. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44131 |
Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43340 |
Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43350 |
Study title: Chow PKH, Tai BC, Tan CK, Machin D, Win KM, Johnson PJ et al. High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial. Hepatology 2002;36(5):1221-6 2002;(5):1221-1226.Chow PKH, Tai BC, Tan CK, Machin D, Win KM, Johnson PJ et al. High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial. Hepatology 2002;36(5):1221-6 2002;(5):1221-1226. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43100 |
Study title: Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43285 |
Study title: Combination chemotherapy for desmoid tumors. Okuno SH, Edmonson JH. Cancer~ 97(4):1134-1135, February 15, 2003 2003;(4):-1135, February. Combination chemotherapy for desmoid tumors. Okuno SH, Edmonson JH. Cancer~ 97(4):1134-1135, February 15, 2003 2003;(4):-1135, February. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43273 |
Study title: Complementary and alternative medical therapies for children with cancer. Kelly KM. European Journal of Cancer 2004;40(14):2041-2046 2004;(14):2041-2046.Complementary and alternative medical therapies for children with cancer. Kelly KM. European Journal of Cancer 2004;40(14):2041-2046 2004;(14):2041-2046. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43265 |
Study title: Cuenca RE, Giachino J, Arredondo MA, Hempling R, Edge SB. Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use. Cancer 1996; 77(10):2058-2063.Cuenca RE, Giachino J, Arredondo MA, Hempling R, Edge SB. Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use. Cancer 1996; 77(10):2058-2063. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43117 |
Study title: Comparative study of ibuprofen syrup and paracetamol in soft tissue injuries in children. |
Active substance: CODEINE_AND_IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 24493 |
Study title: Final Report from the Post Marketing Surveillance Study (Nurofen fur Kinder Fiebersaft) |
Active substance: CODEINE_AND_IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 24498 |
Study title: Ibuprofen vs paracetamol in soft tissue injuries in children. |
Active substance: CODEINE_AND_IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 24494 |
Study title: Nurofen for Children in Febrile Children. Data held in Ukraine. Copy report, Protocol, Ethics and correspondence. |
Active substance: CODEINE_AND_IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 24495 |
Study title: Report on a comparative assessment of the antipyretic activity of ibuprofen and paracetamol suspensions in children. |
Active substance: CODEINE_AND_IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 24492 |
Study title: Treatment of Pyrexia Associated with Infectious Disease in Children |
Active substance: CODEINE_AND_IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 24497 |
Study title: A comparative dose range evaluation of the antipyretic efficacy and safety of ibuprofen liquid at three different doses in children. Jan 1988. |
Active substance: CODEINE_AND_PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 24562 |
Study title: A comparison of the efficacy and safety of ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg and acetaminophen elixir dosed at 12.5 mg/kg to placebo in children with ear pain. Dec 1992. |
Active substance: CODEINE_AND_PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 24548 |
Study title: Jenkin-D, Greenberg-M, Fitzgerald-A. Toronto-Sunnybrook Regional Cancer Centre, Princess Margaret Hospital, University of Toronto, Canada. Second malignant tumours in childhood Hodgkin's disease. Medical and pediatric oncology, {Med-Pediatr-Oncol}, Jun 1996, vol. 26, no. 6, p. 373-9, ISSN: 0098-1532.Jenkin-D, Greenberg-M, Fitzgerald-A. Toronto-Sunnybrook Regional Cancer Centre, Princess Margaret Hospital, University of Toronto, Canada. Second malignant tumours in childhood Hodgkin's disease. Medical and pediatric oncology, {Med-Pediatr-Oncol}, Jun 1996, vol. 26, no. 6, p. 373-9, ISSN: 0098-1532. |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34752 |
Study title: Hepatocellular carcinoma in children and adolescents: Results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study. Katzenstein HM et al. J Clin Oncol. June 15, 2002, 2789-97 |
Active substance: FLUOROURACIL |
Study summary document link (including results): 12065555.pdf |
View full study record |
Document reference: 28270 |
Study title: Improved long-term survival with preoperative chemotherapy for hepatoblastoma. Ehrlich PF, Greenberg ML, Filler RM. J Pediatr Surg. 1997 Jul;32(7):999-1002 |
Active substance: FLUOROURACIL |
Study summary document link (including results): 9247221.pdf |
View full study record |
Document reference: 28312 |
Study title: Kokki H. et al.: Cerebrospinal Fluid Distribution of Ibuprofen After Intravenous Administration in Children;PEDIATRICS Volume 120, Number 4, October 2007.Kokki H. et al.: Cerebrospinal Fluid Distribution of Ibuprofen After Intravenous Administration in Children;PEDIATRICS Volume 120, Number 4, October 2007. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29606 |
Study title: Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma. Malogolowkin MH et al. J Clin Oncol. 2006 Jun 20;24(18):2879-84 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28299 |
Study title: Intraarterial chemotherapy with Lipiodol for initially unresectable hepatoblastomas in children. Ogita S. Regional Cancer Treatment. December 1, 1992, 106-9 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28291 |
Study title: Intraoperative irradiation: Current and future status. Gunderson LL. Semin Oncol. December 1, 1997, 715-31 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28282 |
Study title: Late complications after glaucoma filtering surgery with adjunctive 5- fluorouracil. Ticho U, Ophir A. Am J Ophthalmol. May 3, 1993, 506-10 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28293 |
Study title: Management of a 16-year-old boy with adenocarcinoma at the esophageal gastric junction. Zotter H et al. Med Pediatr Oncol. 2001 Dec;37(6):557 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28307 |
Study title: A phase III comparative study of the pharmacokinetic/pharmacodynamic and safety profiles of ibuprofen extended release, ibuprofen regular release and placebo during a 12 hour observation in post-extraction dental pain. |
Active substance: IBUPROFEN |
Study summary document link (including results): ibuprofen 93-344.pdf |
View full study record |
Document reference: 47455 |
Study title: A phase III single dose study to compare the efficacy of ibuprofen chewable tablets to ibuprofen suspension in febrile children. Jun 1995 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29557 |
Study title: A phase III single dose study to compare the efficacy of ibuprofen chewable tablets to ibuprofen suspension in febrile children. Jun 1995 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29625 |
Study title: A phase III single dose study to compare the efficacy of ibuprofen chewable tablets to ibuprofen suspension in febrile children. |
Active substance: IBUPROFEN |
Study summary document link (including results): ibuprofen 93-330.pdf |
View full study record |
Document reference: 47453 |
Study title: A phase IV comparative study evaluating the onset of analgesia using a single dose of ibuprofen chewable tablets 400 mg, ibuprofen suspension 400 mg/20 ml or placebo in post-operative dental pain |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29496 |
Study title: A Phase IV Comparative Study Evaluating the Onset of Analgesia Using a Single Dose of Ibuprofen Chewable Tablets 400 mg, Ibuprofen Suspension 400 mg/20 mL, or Placebo in Post-Operative Dental Pain |
Active substance: IBUPROFEN |
Study summary document link (including results): ibuprofen 95-524.pdf |
View full study record |
Document reference: 47456 |
Study title: A phase IV multicenter clinical investigation of the safety and efficacy of APAP 1000 mg (total daily dose of 4 grams), ibuprofen 400 mg (total daily dose of 1200 mg), and placebo in the management of the symptoms of primary dysmenorrhea |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29479 |
Study title: A Phase IV Randomized, Double-Blind, Multicenter Trial to Compare the Safety and Efficacy of Acetaminophen Suspension and Ibuprofen Suspension in the Treatment of Febrile Children. Dec 2000. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29548 |
Study title: A Phase IV Randomized, Double-Blind, Multicenter Trial to Compare the Safety and Efficacy of Acetaminophen Suspension and Ibuprofen Suspension in the Treatment of Febrile Children. Dec 2000. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29627 |
Study title: A pilot comparative study evaluating the analgesic effect of using a single dose of an ibuprofen 200 mg / acetaminophen 650 mg combination or ibuprofen 400 mg in post-operative dental pain |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29491 |
Study title: A randomised double blind nultiple-dose study comparing the efficacy and tolerability of Iburprofen versus Paracetamol (both syrup formulations) in the treatment of fever in children known with febrile convulsions |
Active substance: IBUPROFEN |
Study summary document link (including results): ibuprofen- br1178-vanEsch.xls |
View full study record |
Document reference: 29414 |
Study title: A randomized double-blind single dose study comparing ibuprofen 200 mg, ibuprofen 200 mg plus caffeine 100 mg, ibuprofen 400 mg, ibuprofen 400 mg plus caffeine 200 mg, caffeine 100 mg, and placebo in the treatment of pain following orthopedic surgery |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29505 |
Study title: Brenner W, Sieweke N, Bohuslavizki KH, Kampen WU, Zuhayra M, Clausen M, Henze E. Age- and sex-related bone uptake of Tc-99m-HDP measured by whole-body bone scanning. Nuklearmedizin. 2000 Aug;39(5):127-32. Brenner W, Sieweke N, Bohuslavizki KH, Kampen WU, Zuhayra M, Clausen M, Henze E. Age- and sex-related bone uptake of Tc-99m-HDP measured by whole-body bone scanning. Nuklearmedizin. 2000 Aug;39(5):127-32. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43477 |
Study title: J Comput Assist Tomogr. 2003 Jul-Aug;27(4):525-9. Usefulness of semiquantitative FDG-PET in the prediction of brain tumor treatment response to gamma knife radiosurgery. Lee JK, Liu RS, Shiang HR, Pan DH. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28144 |
Study title: J Neurol Neurosurg Psychiatry. 1997 Dec;63(6):743-8. Comparison of [18F]FDG-PET, [99mTc]-HMPAO-SPECT, and [123I]-iomazenil-SPECT in localising the epileptogenic cortex. Lamusuo S, Ruottinen HM, Knuuti J, HärkÃnen R, Ruotsalainen U, Bergman J, Haaparanta M, Solin O, Mervaala E, Nousiainen U, Jääskeläinen S, Ylinen A, Kälviäinen R, Rinne JK, Vapalahti M, Rinne JO. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28193 |
Study title: J Neurooncol. 2007 Mar;82(1):95-101. Epub 2006 Sep 22. Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme. Turner CD, Chi S, Marcus KJ, MacDonald T, Packer RJ, Poussaint TY, Vajapeyam S, Ullrich N, Goumnerova LC, Scott RM, Briody C, Chordas C, Zimmerman MA, Kieran MW. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28073 |
Study title: J Neurosurg. 1995 Mar;82(3):445-52. Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose. Levivier M, Goldman S, Pirotte B, Brucher JM, Balériaux D, Luxen A, Hildebrand J, Brotchi J. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28199 |
Study title: J Neurosurg. 1999 Nov;91(5):797-803. Functional brain mapping using positron emission tomography scanning in preoperative neurosurgical planning for pediatric brain tumors. Kaplan AM, Bandy DJ, Manwaring KH, Chen K, Lawson MA, Moss SD, Duncan JD, Wodrich DL, Schnur JA, Reiman EM. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28180 |
Study title: Autret−E et al. Evaluation of ibuprofen versus aspirin and paracetamol on efficacy and comfort in children with fever. {Eur−J−Clin−Pharmacol}, 1997, vol. 51, no. 5, p. 367−71Autret−E et al. Evaluation of ibuprofen versus aspirin and paracetamol on efficacy and comfort in children with fever. {Eur−J−Clin−Pharmacol}, 1997, vol. 51, no. 5, p. 367−71 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29578 |
Study title: Autret−Leca−E et al. Ibuprofen versus paracetamol in pediatric fever: Objective and subjective findings from a randomized, blinded study. {CURR−MED−RES−OPIN}, 2007, Vol /Iss/Pg. 23/9 (2205−2211)Autret−Leca−E et al. Ibuprofen versus paracetamol in pediatric fever: Objective and subjective findings from a randomized, blinded study. {CURR−MED−RES−OPIN}, 2007, Vol /Iss/Pg. 23/9 (2205−2211) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29567 |
Study title: Brufen syrup in juvenile chronic polyarthritis, rheumatic fever soft tissue injuries and infectious disorders in children, The Boots Company, India |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29431 |
Study title: Brufen syrup in the treatment of juvenile pyrexia -expert report on the clinical documentation which is included in the product licence application |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29452 |
Study title: Children’s Advil ® Cold & Sinus Suspension Multiple-Dose Safety Study in Children 2 to <12 Years Old |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29541 |
Study title: Clark E. et al.: A Randomized, Controlled Traial of Acetaminophen, Ibuprofen, and Codeine for Acute Releif in children With Musculoskeletal Trauma; PAEDIATRICS Volume 119, Number 3, March 2007 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29546 |
Study title: Clark E. et al.: A Randomized, Controlled Traial of Acetaminophen, Ibuprofen, and Codeine for Acute Releif in children With Musculoskeletal Trauma; PAEDIATRICS Volume 119, Number 3, March 2007Clark E. et al.: A Randomized, Controlled Traial of Acetaminophen, Ibuprofen, and Codeine for Acute Releif in children With Musculoskeletal Trauma; PAEDIATRICS Volume 119, Number 3, March 2007 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29607 |
Study title: Clin Ther. 2007 Dec;29(12):2716-23. A review of ibuprofen and acetaminophen use in febrile children and the occurrence of asthma related symptoms. Kanabar D, Dale S, Rawat M.Clin Ther. 2007 Dec;29(12):2716-23. A review of ibuprofen and acetaminophen use in febrile children and the occurrence of asthma related symptoms. Kanabar D, Dale S, Rawat M. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29610 |
Study title: Clinical trials of Ibuprofen Syrup in the Treatment of Juvenile Arthritis by Dr P Boonchob, Thailand |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-M83-104.pdf |
View full study record |
Document reference: 29453 |
Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43232 |
Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43242 |
Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000; 18(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000; 18(6):1246-1253. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43314 |
Study title: Pediatr Radiol. 2004 Mar;34(3):190-8. Epub 2004 Jan 27. PET imaging in pediatric Hodgkin's lymphoma. Hudson MM, Krasin MJ, Kaste SC. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28137 |
Study title: Pediatr Radiol. 2005 Feb;35(2):141-54. Epub 2004 Nov 16. 18F-FDG-avid sites mimicking active disease in pediatric Hodgkin's. Kaste SC, Howard SC, McCarville EB, Krasin MJ, Kogos PG, Hudson MM. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28113 |
Study title: Pharmacotherapy. 1992;12(5):369-75. Comparative assessment of the effect of lomefloxacin, ciprofloxacin, and placebo on cerebral blood flow, and glucose and oxygen metabolism in healthy subjects by positron emission tomography. Bednarczyk EM, Green JA, Nelson AD, Leisure GP, Little D, Adler LP, Berridge MS, Panacek EA, Miraldi FD. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28206 |
Study title: Q J Nucl Med Mol Imaging. 2006 Mar;50(1):23-7. Cancer screening with FDG-PET. Ide M. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28085 |
Study title: Q J Nucl Med Mol Imaging. 2006 Mar;50(1):68-77. Clinical impact of fluorine-18 fluorodeoxyglucose positron emission tomography in cancer patients. A comparative study between dedicated camera and dual-head coincidence gamma camera. Andrieux A, Switsers O, Chajari MH, Jacob JH, Delozier T, Gervais R, Allouache N, Laurençon V, Henry-Amar M, Bardet S. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28084 |
Study title: Q J Nucl Med. 2003 Mar;47(1):41-5. Assessment of therapy response by FDG PET in pediatric patients. Franzius C, Schober O. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28148 |
Study title: Radiol Clin North Am. 2005 Jan;43(1):135-52. PET in pediatric diseases. Jadvar H, Alavi A, Mavi A, Shulkin BL. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28112 |
Study title: Radiology. 1996 Jun;199(3):743-50. Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy. Shulkin BL, Hutchinson RJ, Castle VP, Yanik GA, Shapiro B, Sisson JC. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28197 |
Study title: Radiology. 1998 Oct;209(1):253-8. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging? Hoegerle S, Juengling F, Otte A, Altehoefer C, Moser EA, Nitzsche EU. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28189 |
Study title: Nasopharyngeal carcinoma in childhood and adolescence: concept and preliminary results of the cooperative GPOH study NPC-91. Gesellschaft für Pädiatrische Onkologie und Hämatologie. Mertens R et al. Cancer. 1997 Sep 1;80(5):951-9 |
Active substance: FLUOROURACIL |
Study summary document link (including results): 9307197.pdf |
View full study record |
Document reference: 28311 |
Study title: Nasopharyngeal carcinomas: Analysis of patient, tumor and treatment characteristics determining outcome. Erkal HS et al. Radiother Oncol. December 27, 2001, 247-56 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28273 |
Study title: Neuroendocrine gastroenteropancreatic tumors: 11 Years of clinical experience. Cirillo F. Int J Med Biol Environ. July 1, 2001, 129-41 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28268 |
Study title: New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Asilian A, Darougheh A, Shariati F. Dermatol Surg. July 1, 2006, 907-15 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28266 |
Study title: Newer techniques in cancer chemotherapy. Markman M. Dis Mon. 1984 Jul;30(10):1-48 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28322 |
Study title: Opinion and evidence in cancer: From the world literature. Am J Cancer. December 1, 2002, 153-63 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28267 |
Study title: Paradigm shift in adjuvant treatment of receptor positive premenopausal breast cancer patients? Not yet! Samur M, Bozcuk HS. J Clin Oncol. 2003 Jun 15;21(12):2444 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28302 |
Study title: Pediatric phase I trials in oncology: An analysis of study conduct efficiency. Lee DP, Skolnik JM, Adamson PC. J Clin Oncol. December 1, 2005, 8431-41 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28295 |
Study title: Jenkin-R-D-T, Anderson-J-R, Chilcote-R-R, et-al. Children's Cancer Study Group, Los Angeles, CA 90031, United States. The treatment of localized non-Hodgkin's lymphoma in children: a report from the children's cancer study group. Journal of Clinical Oncology {J-CLIN-ONCOL}, 1984, Vol/Iss/Pg. 2/2 (88-97).Jenkin-R-D-T, Anderson-J-R, Chilcote-R-R, et-al. Children's Cancer Study Group, Los Angeles, CA 90031, United States. The treatment of localized non-Hodgkin's lymphoma in children: a report from the children's cancer study group. Journal of Clinical Oncology {J-CLIN-ONCOL}, 1984, Vol/Iss/Pg. 2/2 (88-97). |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34754 |
Study title: Jenkin-R-D-T, Berry-M-P. Dept. Radiat. Oncol., Ontario Cancer Inst., Toronto, Ontario, M4X 1K9, Canada. Hodgkin's disease in children. Seminars in Oncology {SEMIN-ONCOL}, 1980, Vol/Iss/Pg. 7/2 (202-211).Jenkin-R-D-T, Berry-M-P. Dept. Radiat. Oncol., Ontario Cancer Inst., Toronto, Ontario, M4X 1K9, Canada. Hodgkin's disease in children. Seminars in Oncology {SEMIN-ONCOL}, 1980, Vol/Iss/Pg. 7/2 (202-211). |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34755 |
Study title: Sposto-R, Ertel-I-J, Jenkin-R-D, Boesel-C-P, Venes-J-L, Ortega-J-A, Evans-A-E, Wara-W, Hammond-D. University of Southern California School of Medicine, Los Angeles. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. Journal of neuro-oncology, {J-Neurooncol}, Jul 1989, vol. 7, no. 2, p. 165-77, ISSN: 0167-594X.Sposto-R, Ertel-I-J, Jenkin-R-D, Boesel-C-P, Venes-J-L, Ortega-J-A, Evans-A-E, Wara-W, Hammond-D. University of Southern California School of Medicine, Los Angeles. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. Journal of neuro... |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34849 |
Study title: Brill DR. Sports nuclear medicine. Bone imaging for lower extremity pain in athletes. Clin Nucl Med. 1983 Mar;8(3):101-6. Brill DR. Sports nuclear medicine. Bone imaging for lower extremity pain in athletes. Clin Nucl Med. 1983 Mar;8(3):101-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44045 |
Study title: Brown CV, Miller JH. Extraskeletal localization of MDP in soft tissue secondary to methotrexate infiltration. Clin Nucl Med. 1994 Apr;19(4):357-8. No abstract available. Brown CV, Miller JH. Extraskeletal localization of MDP in soft tissue secondary to methotrexate infiltration. Clin Nucl Med. 1994 Apr;19(4):357-8. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43629 |
Study title: Brown JM. Berkey BD, Brooks JA. Discovery of a renal medullary carcinoma in an adolescent male with sickle cel l trait by Tc-99m methylene disphosponate bone scintigraphy. Clin Nucl Med 2008;33:896-900.Brown JM. Berkey BD, Brooks JA. Discovery of a renal medullary carcinoma in an adolescent male with sickle cel l trait by Tc-99m methylene disphosponate bone scintigraphy. Clin Nucl Med 2008;33:896-900. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 47917 |
Study title: Brown JN. The suspected scaphoid fracture and isotope bone imaging. Injury. 1995 Sep;26(7):479-82. Brown JN. The suspected scaphoid fracture and isotope bone imaging. Injury. 1995 Sep;26(7):479-82. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43590 |
Study title: Brunetti A, Tedeschi E, Belfiore G, Salvatore M. [Neuroblastoma metastasis to the falx cerebri. A case report] Radiol Med (Torino). 1992 Apr;83(4):467-70. Italian. No abstract available. Brunetti A, Tedeschi E, Belfiore G, Salvatore M. [Neuroblastoma metastasis to the falx cerebri. A case report] Radiol Med (Torino). 1992 Apr;83(4):467-70. Italian. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43699 |
Study title: Buck FM, Treumann TC, Winiker H, Strobel K. Chronic recurrent multifocal osteomyelitis (CRMO) with symmetric involvement of both femora: X-ray, bone scintigram, and MR imaging findings in one case. J Magn Reson Imaging. 2007 Aug;26(2):422-6. Buck FM, Treumann TC, Winiker H, Strobel K. Chronic recurrent multifocal osteomyelitis (CRMO) with symmetric involvement of both femora: X-ray, bone scintigram, and MR imaging findings in one case. J Magn Reson Imaging. 2007 Aug;26(2):422-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43363 |
Study title: Burke TS, Tatum JL, Fratkin MJ, Baker K. Radionuclide bone imaging findings in recurrent calvarial infarction in sickle cell disease. J Nucl Med. 1988 Mar;29(3):411-3. Burke TS, Tatum JL, Fratkin MJ, Baker K. Radionuclide bone imaging findings in recurrent calvarial infarction in sickle cell disease. J Nucl Med. 1988 Mar;29(3):411-3. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43825 |
Study title: The complementary role of sequential 99mTc-MDP and 67Ga-citrate scanning in the diagnosis and follow-up of neuroblastoma. Garty I, Koren A, Goshen Y, Siplovich L in the Eur J Nucl Med. 1985;11(6-7):224-9. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43959 |
Study title: Nearly total absence of pulmonary perfusion with corresponding technetium-99m MDP and gallium-67 uptake in a patient with mediastinal neuroblastoma. Garty I, Koren A, Moguilner G, Dharan M, Siplovitch L. Clin Nucl Med. 1985 Aug;10(8):579-82. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43934 |
Study title: Comparison of dextranomer and streptokinase-streptodornase in the treatment of venous leg ulcers and other infected wounds.Hulkko A, Holopainen YV, Orava S, Kangas J, Kuusisto P, Hyvärinen E, Ervasti E, Silvennoinen E. Ann Chir Gynaecol. 1981;70(2):65-70. |
Active substance: streptokinase and streptodornase |
Study summary document link (including results): |
View full study record |
Document reference: 48946 |
Study title: [Conservative treatment of anal cryptitis and fissure as well as anal thrombosis with a streptokinase-streptodornase gel]. [Article in German] Frank W, Wilhelm E, Bouillon M. ZFA (Stuttgart). 1982 Apr 30;58(12):713-6. |
Active substance: streptokinase and streptodornase |
Study summary document link (including results): |
View full study record |
Document reference: 48945 |
Study title: Cochrane Database Syst Rev. 2007 Oct 17;(4):CD001505. Update of: Cochrane Database Syst Rev. 2000;(2):CD001505. Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis. Lands LC, Stanojevic S.Cochrane Database Syst Rev. 2007 Oct 17;(4):CD001505. Update of: Cochrane Database Syst Rev. 2000;(2):CD001505. Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis. Lands LC, Stanojevic S. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29614 |
Study title: Comparative evaluation of anti-pyretic activity of Ibuprofen and Aspirin in children with pyrexia o varied aetiology - India. (By P W Kandoth, M K Joshi, V R Joshi, R S Satoskar) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29432 |
Study title: Comparative evaluation of anti-pyretic activity of Ibuprofen and Aspirin in children with pyrexia of varied aetiology by Prof P W Kandoth, M K Joshi, V R Joshi, R S Satoskar, India. J. Int. Med. Res. (1984) 12, 292 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29449 |
Study title: Comparative evaluation of antipyretic activity of ibuprofen and aspirin in children with pyrexia of varied aetiology. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29471 |
Study title: Comparative study of ibuprofen syrup and paracetamol in soft tissue injuries in children. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29391 |
Study title: COMPARATIVE STUDY OF IBUPROFEN SYRUP AND PARACETAMOL SYRUP IN SOFT TISSUE INJURIES IN CHILDREN |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-MS85-806-CSR.pdf |
View full study record |
Document reference: 47555 |
Study title: Casara D, Bonazza A. Rhabdomyosarcoma concentrating Tc-99m MDP. J Nucl Med. 1983 Nov;24(11):1082-3. No abstract available. Casara D, Bonazza A. Rhabdomyosarcoma concentrating Tc-99m MDP. J Nucl Med. 1983 Nov;24(11):1082-3. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44024 |
Study title: Cavailloles F, Bok B, Bensahel H. Bone scintigraphy in the diagnosis and follow up of Perthes' disease. Eur J Nucl Med. 1982;7(7):327-30. Cavailloles F, Bok B, Bensahel H. Bone scintigraphy in the diagnosis and follow up of Perthes' disease. Eur J Nucl Med. 1982;7(7):327-30. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44101 |
Study title: Cawley KA, Dvorak AD, Wilmot MD. Normal anatomic variant: scintigraphy of the ischiopubic synchondrosis. J Nucl Med. 1983 Jan;24(1):14-6. Cawley KA, Dvorak AD, Wilmot MD. Normal anatomic variant: scintigraphy of the ischiopubic synchondrosis. J Nucl Med. 1983 Jan;24(1):14-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44062 |
Study title: Celen Z, Zincirkeser S, Ozkiliç S, Nacar F. Evaluation of growth in children using quantitative bone scintigraphy. J Int Med Res. 1999;27(6):286-91. Celen Z, Zincirkeser S, Ozkiliç S, Nacar F. Evaluation of growth in children using quantitative bone scintigraphy. J Int Med Res. 1999;27(6):286-91. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43489 |
Study title: Cermik TF, Salan A, Firat MF, Berkarda S. Tc-99m MDP bone scintigraphy in a patient with multicentric osteosarcoma. Clin Nucl Med. 2003 Jul;28(7):599-600. No abstract available. Cermik TF, Salan A, Firat MF, Berkarda S. Tc-99m MDP bone scintigraphy in a patient with multicentric osteosarcoma. Clin Nucl Med. 2003 Jul;28(7):599-600. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43417 |
Study title: Cervelli V, Cipriani C, Migliano E, Giudiceandrea F, Cervelli G, Grimaldi M. SPECT in the long-term evaluation of osteointegration in intraoral and extraoral implantology. J Craniofac Surg. 1997 Sep;8(5):379-82. Cervelli V, Cipriani C, Migliano E, Giudiceandrea F, Cervelli G, Grimaldi M. SPECT in the long-term evaluation of osteointegration in intraoral and extraoral implantology. J Craniofac Surg. 1997 Sep;8(5):379-82. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43536 |
Study title: Radiother Oncol. 2004 Dec;73(3):277-83. Addition of 18F-FDG-PET scans to radiotherapy planning of thoracic lymphoma. Lee YK, Cook G, Flower MA, Rowbottom C, Shahidi M, Sharma B, Webb S. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28116 |
Study title: Respiration. 2006;73(5):634-41. Epub 2006 May 5. Comment in: Respiration. 2006;73(5):587-9. The solitary pulmonary nodule--is it malignant or benign? Diagnostic performance of Tc-depreotide SPECT. Naalsund A, Maublant J. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28081 |
Study title: Rofo. 1999 Aug;171(2):87-94. [The lymph node staging of malignant testicular germ-cell tumors] [Article in German] Krug B, Heidenreich A, Dietlein M, Lackner K. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28183 |
Study title: Semin Nucl Med. 1989 Oct;19(4):282-94. Monoclonal antibodies and neuroblastoma. Miraldi F. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28208 |
Study title: Semin Nucl Med. 2007 Sep;37(5):316-31.PET and PET/CT in pediatric oncology. Jadvar H, Connolly LP, Fahey FH, Shulkin BL. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28065 |
Study title: Semin Nucl Med. 2007 Sep;37(5):357-81.Nuclear medicine in pediatric neurology and neurosurgery: epilepsy and brain tumors. Patil S, Biassoni L, Borgwardt L. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28064 |
Study title: Stereotact Funct Neurosurg. 1995;64 Suppl 1:258-69. Early irradiation effects observed on magnetic resonance imaging and angiography, and positron emission tomography for arteriovenous malformations treated by Gamma Knife radiosurgery. Guo WY, Pan DH, Liu RS, Chung WY, Shiau CY, Cheng SS, Chang CY, Chen KY, Yeh SH, Lee LS. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28200 |
Study title: Thyroid. 2002 Feb;12(2):155-61. Implication of 2-18fluor-2-deoxyglucose positron emission tomography in the follow-up of Hürthle cell thyroid cancer. Plotkin M, Hautzel H, Krause BJ, Schmidt D, Larisch R, Mottaghy FM, Boemer AR, Herzog H, Vosberg H, Müller-Gärtner HW. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28160 |
Study title: |
Active substance: fluid extract derived from thyme (1 : 2-2.5); extracting agent: pursuant to DAB, tincture derived from ivy leaves (1 : 1); extracting agent: ethanol 70 vol. %. |
Study summary document link (including results): |
View full study record |
Document reference: 40002 |
Study title: Bentzinger C*,Biziere K,Plovin P,Dulac O,Chiron C,Girod R,Hewson G,Metcalfe S,Siegel J L, Clinical Final Study Report: Open-label exploratory study of the effects of acute i.v. flumazenil on interictal epileptic activity in pediatric patients with treated or untreated Lennox-Gastaut syndrome |
Active substance: FLUMAZENIL |
Study summary document link (including results): |
View full study record |
Document reference: 28213 |
Study title: Hepatopulmonary syndrome: a rare complication of chronic liver disease in children. Yap FK, Aw MM, Quek SC, Quak S Ann Acad Med Singapore. 1999 Mar;28(2):290-3. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48238 |
Study title: Hyperlucent lung secondary to homocystinuria. Herman J, Miller JH, Wang F. Pediatr Radiol. 1996 Sep;26(9):672-4. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48250 |
Study title: Intrapulmonary arteriovenous shunting may be a universal phenomenon in patients with the superior cavopulmonary anastomosis: a radionuclide study. Vettukattil JJ, Slavik Z, Lamb RK, Monro JL, Keeton BR, Tsang VT, Aldous AJ, Zivanovic A, Johns S, Lewington V, Salmon AP. Heart. 2000 Apr;83(4):425-8. Comment in: Heart. 2000 Nov;84(5):467-8. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48236 |
Study title: Localization of Tc-99m MDP in neuroblastoma metastases to the liver and lung. Connolly LP, Bloom DA, Kozakewich H, Hoffer FA, Treves ST. Clin Nucl Med. 1996 Aug;21(8):629-33. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43563 |
Study title: [Clinical evaluation of Kr-81m inhalation study through a dead space] [Article in Japanese]Kaku Igaku. 1990 Feb;27(2):125-31. Kurosawa H 1990 |
Active substance: krypton |
Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
View full study record |
Document reference: 48539 |
Study title: Echizenya M et al. The 32nd annual meeting of Japanese Society of Sleep Research (7-9 November, 2007).Echizenya M et al. The 32nd annual meeting of Japanese Society of Sleep Research (7-9 November, 2007). |
Active substance: MIANSERIN |
Study summary document link (including results): |
View full study record |
Document reference: 31985 |
Study title: Sullivan-M-P, Fuller-L-M, Chen-T, Fisher-R, Fryer-C, Gehan-E,Gilchrist-G-S, Hays-D, Hanson-W, Heller-R, Higgins-G, Jenkin-D, Kung-F, Sheehan-W, Tefft-M, Ternberg-J, Wharam-M. Intergroup Hodgkin's disease in children study of stages I and II: a preliminary report. Cancer treatment reports, {Cancer-Treat-Rep}, Apr 1982, vol. 66, no. 4, p. 937-47, ISSN: 0361-5960.Sullivan-M-P, Fuller-L-M, Chen-T, Fisher-R, Fryer-C, Gehan-E,Gilchrist-G-S, Hays-D, Hanson-W, Heller-R, Higgins-G, Jenkin-D, Kung-F, Sheehan-W, Tefft-M, Ternberg-J, Wharam-M. Intergroup Hodgkin's disease in children study of stages I and II: a preliminary report. Cancer treatment reports, {Cancer-Treat-Rep}, Apr 1982, vol. 66, no. 4, p. 937-47, ISSN: 0361-5960. |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34850 |
Study title: Sullivan-M-P, Fuller-L-M. A chemotherapy-radiotherapy Rx regimen for children with stage 3 Hodgkin's disease. CA: a cancer journal for clinicians, {CA-Cancer-J-Clin}, Jul-Aug 1973, vol. 23, no. 4, p. 232-41, ISSN: 0007-9235.Sullivan-M-P, Fuller-L-M. A chemotherapy-radiotherapy Rx regimen for children with stage 3 Hodgkin's disease. CA: a cancer journal for clinicians, {CA-Cancer-J-Clin}, Jul-Aug 1973, vol. 23, no. 4, p. 232-41, ISSN: 0007-9235. |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34851 |
Study title: Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy. A preliminary report. Cancer, {Cancer}, 15 Jul 1987, vol. 60, no. 2, p. 173-7, ISSN: 0008-543X.Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy. A preliminary report. Cancer, {Cancer}, 15 Jul 1987, vol. 60, no. 2, p. 173-7, ISSN: 0008-543X. |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34852 |
Study title: Tan-C-T. Hodgkin's disease in children and adolescents. Experiences from the Memorial Sloan-Kettering Cancer Center, New York. Cancer treatment and research, {Cancer-Treat-Res}, 1989, vol. 41, p. 291-302, ISSN: 0927-3042.Tan-C-T. Hodgkin's disease in children and adolescents. Experiences from the Memorial Sloan-Kettering Cancer Center, New York. Cancer treatment and research, {Cancer-Treat-Res}, 1989, vol. 41, p. 291-302, ISSN: 0927-3042. |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34856 |
Study title: Tan-C, D-angio-G-J, Exelby-P-R, Lieberman-P-H, Watson-R-C, Cham-W-C, Murphy-M-L. The changing management of childhood Hodgkin's disease. Cancer, {Cancer}, Mar 1975, vol. 35, no. 3, p. 808-16, ISSN: 0008-543X.Tan-C, D-angio-G-J, Exelby-P-R, Lieberman-P-H, Watson-R-C, Cham-W-C, Murphy-M-L. The changing management of childhood Hodgkin's disease. Cancer, {Cancer}, Mar 1975, vol. 35, no. 3, p. 808-16, ISSN: 0008-543X. |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34853 |
Study title: Tan-C, Jereb-B, Chan-K-W, et-al. Dep. Pediatr., Meml. Sloan-Kettering Cancer Cent., New York, NY 10021, United States. Hodgkin's disease in children. Results of management between 1970-1981. Cancer {CANCER}, 1983, Vol/Iss/Pg. 51/9 (1720-1725).Tan-C, Jereb-B, Chan-K-W, et-al. Dep. Pediatr., Meml. Sloan-Kettering Cancer Cent., New York, NY 10021, United States. Hodgkin's disease in children. Results of management between 1970-1981. Cancer {CANCER}, 1983, Vol/Iss/Pg. 51/9 (1720-1725). |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34854 |
Study title: 51. Hanck A. Verhuetung und Behandlung der postoperativen Daratonie und anderer Formen des paralytischen Ileus mit Bepanthen Roche. Therapiewoche 1977;27:6878, 1881-4, 6887.51. Hanck A. Verhuetung und Behandlung der postoperativen Daratonie und anderer Formen des paralytischen Ileus mit Bepanthen Roche. Therapiewoche 1977;27:6878, 1881-4, 6887. |
Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35143 |
Study title: 52. Afifi AK, Bell WE. Tests for juvenile myasthenia gravis: comparative diagnostic yield and prediction of outcome. J Child Neurol 1993;8:403-11. 52. Afifi AK, Bell WE. Tests for juvenile myasthenia gravis: comparative diagnostic yield and prediction of outcome. J Child Neurol 1993;8:403-11. |
Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35144 |
Study title: Garty I, Koren A. Simultaneous demonstration of photopenic ("cold") and osteoblastic ("hot") skull metastases in a patient with neuroblastoma. Clin Nucl Med. 1985 Jul;10(7):529. No abstract available. Garty I, Koren A. Simultaneous demonstration of photopenic ("cold") and osteoblastic ("hot") skull metastases in a patient with neuroblastoma. Clin Nucl Med. 1985 Jul;10(7):529. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43937 |
Study title: Pitfalls in the diagnosis of neuroblastoma by 99mTc-MDP scintigraphy: a case report. Garty I, Siplovich L, Moguilner J. Eur J Nucl Med. 1984;9(12):564-5. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44010 |
Study title: Garty I, Tanzman M, Reiner S. Accumulation of technetium-99m MDP in distended ureter. A potential error in diagnosing osteoblastic bone activity. Clin Nucl Med. 1985 Sep;10(9):667. No abstract available. PMID: 2933203 [PubMed - indexed for MEDLINE] Garty I, Tanzman M, Reiner S. Accumulation of technetium-99m MDP in distended ureter. A potential error in diagnosing osteoblastic bone activity. Clin Nucl Med. 1985 Sep;10(9):667. No abstract available. PMID: 2933203 [PubMed - indexed for MEDLINE] |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43933 |
Study title: Gellad FE, Haney PJ, Sun JC, Robinson WL, Rao KC, Johnston GS. Imaging modalities of craniosynostosis with surgical and pathological correlation. Pediatr Radiol. 1985;15(5):285-90. Gellad FE, Haney PJ, Sun JC, Robinson WL, Rao KC, Johnston GS. Imaging modalities of craniosynostosis with surgical and pathological correlation. Pediatr Radiol. 1985;15(5):285-90. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43962 |
Study title: Gerety E, Siegel A. Thoracic lymph node visualization after a peritoneal leak study. Clin Nucl Med. 2001 Feb;26(2):157-8. No abstract available. Gerety E, Siegel A. Thoracic lymph node visualization after a peritoneal leak study. Clin Nucl Med. 2001 Feb;26(2):157-8. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43461 |
Study title: Geusens E, Brys P, Ghekiere J, Samson I, Sciot R, Brock P, Baert AL. Langerhans cell histiocytosis of the cervical spine: case report of an unusual location. Eur Radiol. 1998;8(7):1142-4. Geusens E, Brys P, Ghekiere J, Samson I, Sciot R, Brock P, Baert AL. Langerhans cell histiocytosis of the cervical spine: case report of an unusual location. Eur Radiol. 1998;8(7):1142-4. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43526 |
Study title: Ghelman B, Vigorita VJ. Postoperative radionuclide evaluation of osteoid osteomas. Radiology. 1983 Feb;146(2):509-12. Ghelman B, Vigorita VJ. Postoperative radionuclide evaluation of osteoid osteomas. Radiology. 1983 Feb;146(2):509-12. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44050 |
Study title: Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518.Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43226 |
Study title: Biol Psychiatry. 2000 Mar 15;47(6):540-7. A fenfluramine-activated FDG-PET study of borderline personality disorder. Soloff PH, Meltzer CC, Greer PJ, Constantine D, Kelly TM. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28179 |
Study title: Chan WL, Carolan MG, Fernandes VB, Abbati DP. Planar versus SPET imaging in the assessment of condylar growth. Nucl Med Commun. 2000 Mar;21(3):285-90. Chan WL, Carolan MG, Fernandes VB, Abbati DP. Planar versus SPET imaging in the assessment of condylar growth. Nucl Med Commun. 2000 Mar;21(3):285-90. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43484 |
Study title: Charkes ND, Siddhivarn N, Schneck CD. Bone scanning in the adductor insertion avulsion syndrome ("thigh splints"). J Nucl Med. 1987 Dec;28(12):1835-8. Charkes ND, Siddhivarn N, Schneck CD. Bone scanning in the adductor insertion avulsion syndrome ("thigh splints"). J Nucl Med. 1987 Dec;28(12):1835-8. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43839 |
Study title: Visualization of the spleen with radiophosphate in severe combined immunodeficiency disease. Charron M, Rosenthall L. Visualization of the spleen with radiophosphate in severe combined immunodeficiency disease. Clin Nucl Med. 1988 May;13(5):339-41. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43816 |
Study title: Cheng TH, Holman BL. Increased skeletal:renal uptake ratio: etiology and characteristics. Radiology. 1980 Aug;136(2):455-9. Cheng TH, Holman BL. Increased skeletal:renal uptake ratio: etiology and characteristics. Radiology. 1980 Aug;136(2):455-9. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44142 |
Study title: Nuclear imaging and clinical features of childhood reflex neurovascular dystrophy: comparison with adults. Goldsmith DP, Vivino FB, Eichenfield AH, Athreya BH, Heyman S. Arthritis Rheum. 1989 Apr;32(4):480-5. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43789 |
Study title: Goodear M, Styles CB. Stress fractures of the thoracic spine transverse processes in a water skier. Clin Nucl Med. 1999 Apr;24(4):285-6. No abstract available. Goodear M, Styles CB. Stress fractures of the thoracic spine transverse processes in a water skier. Clin Nucl Med. 1999 Apr;24(4):285-6. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43500 |
Study title: The role of ultrasound and isotope scanning in the management of irritable hips. Gopakumar TS, Vaishya R, Klenerman L, Carty H. Eur J Radiol. 1992 Sep;15(2):113-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43690 |
Study title: Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans. Gordon I, Peters AM, Gutman A, Morony S, Dicks-Mireaux C, Pritchard J. J Nucl Med. 1990 Feb;31(2):129-34. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43769 |
Study title: Gordon I. Undeserved bad press for bone scans. Eur J Nucl Med. 1994 May;21(5):466. No abstract available. Gordon I. Undeserved bad press for bone scans. Eur J Nucl Med. 1994 May;21(5):466. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43625 |
Study title: Gorenberg M, Groshar D, Israel O, Ben-Arush MW, Kolodny GM, Front D. Stress fractures associated with osteosarcoma of the lower limb. J Nucl Med. 1992 Sep;33(9):1699-700. Gorenberg M, Groshar D, Israel O, Ben-Arush MW, Kolodny GM, Front D. Stress fractures associated with osteosarcoma of the lower limb. J Nucl Med. 1992 Sep;33(9):1699-700. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43688 |
Study title: [Postoperative care with varidase following phimosis surgery. A comparative study of various application forms]. [Article in German] Tuchen W, Inglis R. ZFA (Stuttgart). 1980 Dec 10;56(34):2419-22. |
Active substance: streptokinase and streptodornase |
Study summary document link (including results): |
View full study record |
Document reference: 48950 |
Study title: The effectiveness of Varidase was evaluated in the local treatment of skin lesions, particularly wounds with fibrinous or necrotic crusts.Luger et al. 1981 |
Active substance: streptokinase and streptodornase |
Study summary document link (including results): |
View full study record |
Document reference: 48949 |
Study title: Varidase topical (Streptokinase-Streptodornase) has been clinically evaluated in patients for its efficacy, tolerance, and side effects.Chang et al. 1980 |
Active substance: streptokinase and streptodornase |
Study summary document link (including results): |
View full study record |
Document reference: 48948 |
Study title: da Rocha AB, Mans DRA, Regner A, Schwartsmann G. Targeting protein kinase C: New therapeutic opportunities against high-grade malignant gliomas? Oncologist 2002; 7(1):17-33.da Rocha AB, Mans DRA, Regner A, Schwartsmann G. Targeting protein kinase C: New therapeutic opportunities against high-grade malignant gliomas? Oncologist 2002; 7(1):17-33. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43175 |
Study title: Davies SL, Moral MA. Peripheral precocious puberty. Drugs of the Future 2006; 31(8):713-718.Davies SL, Moral MA. Peripheral precocious puberty. Drugs of the Future 2006; 31(8):713-718. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43087 |
Study title: Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999;17(3):968-975 1999;(3):968-975.Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999;17(3):968-975 1999;(3):968-975. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43130 |
Study title: Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975.Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43150 |
Study title: Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975.Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43173 |
Study title: Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975.Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43179 |
Study title: Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders CNS Drugs. 2005;19(11):923-34. Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders CNS Drugs. 2005;19(11):923-34. |
Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35165 |
Study title: Bleckmann K.H. Erfahrungsbericht über die Anwendung von Pyrithioxin in der Kinderpraxis (Praxis der Kinderpsychologie und Kinderpsychiatrie 1965; 14(8): 316-7); Bleckmann K.H. Erfahrungsbericht über die Anwendung von Pyrithioxin in der Kinderpraxis (Praxis der Kinderpsychologie und Kinderpsychiatrie 1965; 14(8): 316-7); |
Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35150 |
Study title: Bönisch E. Erfahrungen mit Pyrithioxin bei hirngeschädigten Kindern mit autistischem Syndrom (3 Europ Kongress Pädopsychiatr 1967); Bönisch E. Erfahrungen mit Pyrithioxin bei hirngeschädigten Kindern mit autistischem Syndrom (3 Europ Kongress Pädopsychiatr 1967); |
Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35151 |
Study title: Bozzo TM. The Effect of Encephabol in School Children with States of Mental Exhaustion (Minerva Medicopsicologica 1970; 2 (12): 44-47); Bozzo TM. The Effect of Encephabol in School Children with States of Mental Exhaustion (Minerva Medicopsicologica 1970; 2 (12): 44-47); |
Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35145 |
Study title: Efficacy of sucrose to reduce pain in premature infants during eye examinations for retinopathy of prematurity. Gal P, Kissling GE, Young WO, Dunaway KK, Marsh VA, Jones SM, Shockley DH, Weaver NL, Carlos RQ, Ransom JL. Ann Pharmacother. 2005 Jun;39(6):1029-33;Epub 2005 Apr 26. Efficacy of sucrose to reduce pain in premature infants during eye examinations for retinopathy of prematurity. Gal P, Kissling GE, Young WO, Dunaway KK, Marsh VA, Jones SM, Shockley DH, Weaver NL, Carlos RQ, Ransom JL. Ann Pharmacother. 2005 Jun;39(6):1029-33;Epub 2005 Apr 26. |
Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35157 |
Study title: TO DETERMINE FLUCONAZOLE EFFICACY AND SAFETY IN AIDS PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27405 |
Study title: TO DETERMINE FLUCONAZOLE EFFICACY AND SAFETY IN AIDS PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27770 |
Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF A SINGLE ORAL DOSE OF FLUCONAZOLE (150 MG) IN THE TREATMENT OF NON-SEVERE ORAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27590 |
Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF A SINGLE ORAL DOSE OF FLUCONAZOLE (150 MG) IN THE TREATMENT OF NON-SEVERE ORAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27953 |
Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL AND/OR IV FLUCONAZOLE 100-400 MG ONCE A DAY IN THE TREATMENT OF CRYPTOCOCCAL MENINGITIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27592 |
Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL AND/OR IV FLUCONAZOLE 100-400 MG ONCE A DAY IN THE TREATMENT OF CRYPTOCOCCAL MENINGITIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27955 |
Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL AND/OR IV FLUCONAZOLE 200-400 MG ONCE A DAY IN THE TREATMENT OF SYSTEMIC CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27591 |
Study title: Biomed Pharmacother. 2006 Nov;60(9):593-606. Epub 2006 Sep 1.18F-FDG PET/CT fusion imaging in paediatric solid extracranial tumours.Nanni C, Rubello D, Castellucci P, Farsad M, Franchi R, Rampin L, Gross MD, Al-Nahhas A, Fanti S. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28075 |
Study title: Blood. 2005 Aug 15;106(4):1376-81. Epub 2005 Apr 28. [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Haioun C, Itti E, Rahmouni A, Brice P, Rain JD, Belhadj K, Gaulard P, Garderet L, Lepage E, Reyes F, Meignan M. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28105 |
Study title: Blood. 2006 Jan 1;107(1):52-9. Epub 2005 Sep 8. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Hutchings M, Loft A, Hansen M, Pedersen LM, Buhl T, Jurlander J, Buus S, Keiding S, D'Amore F, Boesen AM, Berthelsen AK, Specht L. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28097 |
Study title: Br J Cancer. 2000 Oct;83(7):863-9. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse. Hain SF, O'Doherty MJ, Timothy AR, Leslie MD, Harper PG, Huddart RA. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28175 |
Study title: Br J Cancer. 2004 Feb 9;90(3):620-5. Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma. Naumann R, Beuthien-Baumann B, Reiss A, Schulze J, Hänel A, Bredow J, Kühnel G, Kropp J, Hänel M, Laniado M, Kotzerke J, Ehninger G. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28136 |
Study title: Br J Surg. 2006 Feb;93(2):243-9. Impact of [18F]fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients. Bastiaannet E, Oyen WJ, Meijer S, Hoekstra OS, Wobbes T, Jager PL, Hoekstra HJ. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28092 |
Study title: Brain Dev. 2001 Dec;23 Suppl 1:S62-71. Neuroimaging studies in Rett syndrome. Naidu S, Kaufmann WE, Abrams MT, Pearlson GD, Lanham DC, Fredericksen KA, Barker PB, Horska A, Golay X, Mori S, Wong DF, Yablonski M, Moser HW, Johnston MV. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28164 |
Study title: Brain Res Cogn Brain Res. 2004 Jan;18(2):142-8. Hostility differentiates the brain metabolic effects of nicotine. Fallon JH, Keator DB, Mbogori J, Turner J, Potkin SG. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28138 |
Study title: Cancer Treat Rev. 2004 Feb;30(1):83-101. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Bastiaannet E, Groen H, Jager PL, Cobben DC, van der Graaf WT, Vaalburg W, Hoekstra HJ. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28134 |
Study title: Cancer. 2001 Jul 15;92(2):434-9. Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy. Kao CH, Tsai SC, Wang JJ, Ho YJ, Yen RF, Ho ST. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28169 |
Study title: Cancer. 2001 Mar 1;91(5):889-99. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Buchmann I, Reinhardt M, Elsner K, Bunjes D, Altehoefer C, Finke J, Moser E, Glatting G, Kotzerke J, Guhlmann CA, Schirrmeister H, Reske SN. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28172 |
Study title: Cancer. 2002 Feb 15;94(4):879-88. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. Kostakoglu L, Leonard JP, Kuji I, Coleman M, Vallabhajosula S, Goldsmith SJ |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28159 |
Study title: Cephalalgia. 1998 Dec;18(10):690-6. Migraine with aura: a review of 81 patients at 10-20 years' follow-up. Cologno D, Torelli P, Manzoni GC. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28187 |
Study title: Childs Nerv Syst. 2006 Aug;22(8):810-20. Epub 2006 Jun 24. Functional neuroimaging in the preoperative evaluation of children with drug-resistant epilepsy. Sood S, Chugani HT. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28079 |
Study title: Chin Med J (Engl). 1997 Nov;110(11):875-8. Early intervention improves intellectual development in asphyxiated newborn infants. Intervention of Asphyxiated Newborn Infants Cooperative Research Group. Bao X, Sun S, Yu R, Sun J. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28188 |
Study title: A Randomized, Double-Blind Study of Ibuprofen L-Lysine Intravenous Solution in Premature Infants for the Early Treatment of PDA |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-FC00-01-CB88.pdf |
View full study record |
Document reference: 47551 |
Study title: A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study of Acetaminophen 1000 mg and Ibuprofen 400 mg in Postoperative Dental Pain |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29481 |
Study title: Bilateral accessory iliac horns: pathognomonic findings in Nail-patella syndrome. Scintigraphic evidence on bone scan. Goshen E, Schwartz A, Zilka LR, Zwas ST. Clin Nucl Med. 2000 Jun;25(6):476-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43483 |
Study title: Gravili S, Bonazza A. [Multiple exostoses and bone scintigraphy. A clinical case] Radiol Med (Torino). 1990 Mar;79(3):258-9. Italian. No abstract available. Gravili S, Bonazza A. [Multiple exostoses and bone scintigraphy. A clinical case] Radiol Med (Torino). 1990 Mar;79(3):258-9. Italian. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43767 |
Study title: Gray RJ, Horner K, Testa HJ, Lloyd JJ, Sloan P. Condylar hyperplasia: correlation of histological and scintigraphic features. Dentomaxillofac Radiol. 1994 May;23(2):103-7. Gray RJ, Horner K, Testa HJ, Lloyd JJ, Sloan P. Condylar hyperplasia: correlation of histological and scintigraphic features. Dentomaxillofac Radiol. 1994 May;23(2):103-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43627 |
Study title: J Neurosurg. 2006 Feb;104(2):238-53. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures. Pirotte B, Goldman S, Dewitte O, Massager N, Wikler D, Lefranc F, Ben Taib NO, Rorive S, David P, Brotchi J, Levivier M. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28087 |
Study title: J Nucl Med. 1991 Apr;32(4):651-9. Epilepsy. Fisher RS, Frost JJ. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28207 |
Study title: J Nucl Med. 1998 Jul;39(7):1302-5. Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine. Schelbert HR, Hoh CK, Royal HD, Brown M, Dahlbom MN, Dehdashti F, Wahl RL. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28191 |
Study title: J Nucl Med. 1999 Mar;40(3):399-405. 18F alpha-methyl tyrosine PET studies in patients with brain tumors. Inoue T, Shibasaki T, Oriuchi N, Aoyagi K, Tomiyoshi K, Amano S, Mikuni M, Ida I, Aoki J, Endo K. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28186 |
Study title: J Nucl Med. 1999 Oct;40(10):1637-43. Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET. Schulte M, Brecht-Krauss D, Werner M, Hartwig E, Sarkar MR, Keppler P, Kotzerke J, Guhlmann A, Delling G, Reske SN. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28182 |
Study title: J Nucl Med. 2001 Aug;42(8):1139-43. Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma. SchÃder H, Meta J, Yap C, Ariannejad M, Rao J, Phelps ME, Valk PE, Sayre J, Czernin J. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28168 |
Study title: J Nucl Med. 2001 Aug;42(8):1158-65. The utility of a 3-dimensional, large-field-of-view, sodium iodide crystal--based PET scanner in the presurgical evaluation of partial epilepsy. O'Brien TJ, Hicks RJ, Ware R, Binns DS, Murphy M, Cook MJ. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28167 |
Study title: J Nucl Med. 2003 Aug;44(8):1200-9. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, Altman H, Keidar Z, Israel O. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28142 |
Study title: J Nucl Med. 2003 Jan;44(1):24-9. Comment on: J Nucl Med. 2003 Jan;44(1):30-2. Impact of whole-body 18F-FDG PET on staging and managing patients for radiation therapy. Dizendorf EV, Baumert BG, von Schulthess GK, Lütolf UM, Steinert HC. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28153 |
Study title: J Nucl Med. 2004 Apr;45(4):559-66. Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients. SchÃder H, Erdi YE, Chao K, Gonen M, Larson SM, Yeung HW. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28128 |
Study title: J Nucl Med. 2004 Aug;45(8):1293-8. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas. Pirotte B, Goldman S, Massager N, David P, Wikler D, Vandesteene A, Salmon I, Brotchi J, Levivier M. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28120 |
Study title: J Nucl Med. 2004 Jul;45(7):1146-54. Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors: clinical experience and proposed classification. Levivier M, Massager N, Wikler D, Lorenzoni J, Ruiz S, Devriendt D, David P, Desmedt F, Simon S, Van Houtte P, Brotchi J, Goldman S. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28122 |
Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43322 |
Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 200Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 200 |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43330 |
Study title: Penna C. Management of familial polyposis coli [French]. Journal de Chirurgie 2002; 139(5):260-267.Penna C. Management of familial polyposis coli [French]. Journal de Chirurgie 2002; 139(5):260-267. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43102 |
Study title: Peripheral precocious puberty. Davies SL, Moral MA. Drugs of the Future 2006; 31(8):713-718.Peripheral precocious puberty. Davies SL, Moral MA. Drugs of the Future 2006; 31(8):713-718. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43254 |
Study title: Phase I Study of High-Dose Tamoxifen for the Treatment of Refractory Malignant Gliomas of Childhood. Phase I Study of High-Dose Tamoxifen for the Treatment of Refractory Malignant Gliomas of Childhood. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43298 |
Study title: Pierzynski P, Swiatecka J, Oczeretko E, Laudanski P, Batra S, Laudanski T. Effect of short-term, low-dose treatment with tamoxifen in patients with primary dysmenorrhea. Gynecological Endocrinology 2006; 22(12):698-703.Pierzynski P, Swiatecka J, Oczeretko E, Laudanski P, Batra S, Laudanski T. Effect of short-term, low-dose treatment with tamoxifen in patients with primary dysmenorrhea. Gynecological Endocrinology 2006; 22(12):698-703. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43136 |
Study title: Pollack IF, DaRosso RC, Robertson PL, Jakacki RL, Mirro JR, Blatt J et al. A Phase I Study of High-Dose Tamoxifen for the Treatment of Refractory Malignant Gliomas of Childhood. Clinical Cancer Research 1997; 3(7):1109-1115.Pollack IF, DaRosso RC, Robertson PL, Jakacki RL, Mirro JR, Blatt J et al. A Phase I Study of High-Dose Tamoxifen for the Treatment of Refractory Malignant Gliomas of Childhood. Clinical Cancer Research 1997; 3(7):1109-1115. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43155 |
Study title: Preemptive surgery. McAuliffe PF, Cance WG. Surgery (St Louis)~ 140(1):1-5, JUL 2006 2006;(St Louis):140-5, JULPreemptive surgery. McAuliffe PF, Cance WG. Surgery (St Louis)~ 140(1):1-5, JUL 2006 2006;(St Louis):140-5, JUL |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43258 |
Study title: Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43288 |
Study title: Pubertal gynecomastia. Pubertal gynecomastia. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43310 |
Study title: Pulmonary lymphangioleiomyomatosis: A study of 69 patients. Pulmonary lymphangioleiomyomatosis: A study of 69 patients. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43291 |
Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL AND/OR IV FLUCONAZOLE 200-400 MG ONCE A DAY IN THE TREATMENT OF SYSTEMIC CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27954 |
Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL FLUCONAZOLE (CAPSULES AND SYRUP) ONCE DAILY IN THE TREATMENT OF PATIENTS SUFFERING FROM ORAL ATROPHIC CANDIDIASIS WITH DENTURES. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27439 |
Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL FLUCONAZOLE (CAPSULES AND SYRUP) ONCE DAILY IN THE TREATMENT OF PATIENTS SUFFERING FROM ORAL ATROPHIC CANDIDIASIS WITH DENTURES. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27804 |
Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FCA 50 TO 200 O.D. IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27418 |
Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FCA 50 TO 200 O.D. IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27783 |
Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 100-400 MG/DAY IN THE TREATMENT OF SYSTEMIC CANDIDIASIS/CRYPTOCOCCAL MENINGITIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27580 |
Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 100-400 MG/DAY IN THE TREATMENT OF SYSTEMIC CANDIDIASIS/CRYPTOCOCCAL MENINGITIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27943 |
Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG O.D. IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27420 |
Study title: Phase II study of 5-fluorouracil/leucovorin for pediatric patients with malignant solid tumors. Pratt CB et al. Cancer. November 4, 1994, 2593-8 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28287 |
Study title: Phase II study of 5-fluorouracil/leucovorin for pediatric patients with malignant solid tumors. Pratt CB et al. Cancer. November 4, 1994, 2593-8 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28298 |
Study title: Preoperative UFT and calcium folinate and radiotherapy in rectal cancer. Hoff PM et al. Oncology (Williston Park). 1999 Jul;13(7 Suppl 3):129-31 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28309 |
Study title: Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma. Rodriguez-Galindo C et al. Cancer. 2005 Feb 15;103(4):850-7. |
Active substance: FLUOROURACIL |
Study summary document link (including results): 15641027.pdf |
View full study record |
Document reference: 28301 |
Study title: Randomized com+K9parison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. Ortega JA et al. J Clin Oncol. 2000 Jul;18(14):2665-75 |
Active substance: FLUOROURACIL |
Study summary document link (including results): 10894865.pdf |
View full study record |
Document reference: 28308 |
Study title: Relevance of high-dose chemotherapy in solid tumours. Nieboer P et al. Cancer Treat. Rev May 1, 2005, 210-25 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28297 |
Study title: Robust Bayesian methods for monitoring clinical trials. Greenhouse JB, Wasserman L. Stat Med. 1995 Jun 30;14(12):1379-91 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28315 |
Study title: A Randomized, Double-Blind, Parallel-Group Study Comparing the Safety and Efficacy of Acetaminophen Extended Release (3900 mg/day) and Ibuprofen (1200 mg/day) in the Treatment of Ankle Sprains |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29480 |
Study title: A randomized, open label, parallel, single dose study of the antipyretic efficacy, safety, and blood levels of ibuprofen 6 mg/kg in febrile children with acetaminophen 10-15 mg/kg as a positive control for efficacy. Jun 1989. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29476 |
Study title: A single dose double-blind study comparing the efficacy of ibuprofen and children's Tylenol elixir. (Feb 1988) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29384 |
Study title: A single dose double-blind study comparing the efficacy of ibuprofen and children's Tylenol elixir. Feb 1988. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29616 |
Study title: A single dose study to compare the efficacy and side effects of ibuprofen suspension to placebo in children 5 through 11 years of age with post-operative pain secondary to either inguinal or umbilical herniorrhaphy. Jul 1995. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29556 |
Study title: A single dose study to compare the efficacy and side effects of ibuprofen suspension to placebo in children 5 through 11 years of age with post-operative pain secondary to either inguinal or umbilical herniorrhaphy. Jul 1995. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29626 |
Study title: A single dose study to compare the efficacy and side effects of ibuprofen suspension to placebo in children 5 through 11 years of age with post-operative pain secondary to either inguinal or umbilical herniorrhaphy. CSR 187 Revised. Protocol 90-048, Unpublished Report 385. |
Active substance: IBUPROFEN |
Study summary document link (including results): ibuprofen 90-048.pdf |
View full study record |
Document reference: 47451 |
Study title: A Single Dose, Randomized, Open-Label, Single Center, Three-Way Crossover Pharmacokinetic Study of Children’s Advil® Cold & Sinus Suspension in 6 To <12 Year Old Children |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29540 |
Study title: A single-blind, parallel-group, multiple dose study comparing the efficacy and tolerability of Ibuprofen suspension and Paracetamol suspension in the treatment of juvenile pain and pyrexia |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-BR1151.pdf |
View full study record |
Document reference: 29412 |
Study title: A single-dose, double-blind, placebo-controlled, randomized, 4 x 4 factorial study comparing combinations of ibuprofen in doses of 100 mg, 200 mg, and 400 mg and dextromethorphan hydrobromide in doses of 10 mg, 20 mg, and 40 mg with the components alone and placebo in postoperative dental pain |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29492 |
Study title: A single-dose, double-blind, placebo-controlled, randomized, 4 x 4 factorial study comparing combinations of ibuprofen in doses of 100 mg, 200 mg, and 400 mg and dextromethorphan hydrobromide in doses of 10 mg, 20 mg, and 40 mg with the components alone and placebo in postoperative dental pain |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29516 |
Study title: A single-dose, double-blind, placebo-controlled, randomized, 4 x 4 factorial study comparing combinations of ibuprofen in doses of 100 mg, 200 mg, and 400 mg and dextromethorphan hydrobromide in doses of 10 mg, 20 mg, and 40 mg with the components alone and placebo in postoperative dental pain |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29561 |
Study title: A single-dose, double-blind, placebo-controlled, randomized, 4 x 4 factorial study comparing combinations of ibuprofen in doses of 100 mg, 200 mg, and 400 mg and dextromethorphan hydrobromide in doses of 10 mg, 20 mg, and 40 mg with the components alone and placebo in postoperative dental pain |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29565 |
Study title: J Nucl Med. 2004 Oct;45(10):1669-76. Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence. Ng SH, Joseph CT, Chan SC, Ko SF, Wang HM, Liao CT, Chang YC, Lin WJ, Fu YK, Yen TC. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28118 |
Study title: J Nucl Med. 2005 Apr;46(4):560-6. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA. Ribeiro MJ, De Lonlay P, Delzescaux T, Boddaert N, Jaubert F, Bourgeois S, Dollé F, Nihoul-Fékété C, Syrota A, Brunelle F. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28106 |
Study title: J Nucl Med. 2005 Aug;46(8):1278-84. Association of vascular 18F-FDG uptake with vascular calcification. Dunphy MP, Freiman A, Larson SM, Strauss HW. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28100 |
Study title: J Nucl Med. 2005 Feb;46(2):283-91. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error? Yau YY, Chan WS, Tam YM, Vernon P, Wong S, Coel M, Chu SK. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28111 |
Study title: J Nucl Med. 2005 Jan;46(1):52-9. Solid splenic masses: evaluation with 18F-FDG PET/CT. Metser U, Miller E, Kessler A, Lerman H, Lievshitz G, Oren R, Even-Sapir E. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28114 |
Study title: J Nucl Med. 2005 Mar;46(3):405-10. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx. Yen TC, Chang JT, Ng SH, Chang YC, Chan SC, Lin KJ, Lin WJ, Fu YK, Lin CY. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28107 |
Study title: Gray RJ, Sloan P, Quayle AA, Carter DH. Histopathological and scintigraphic features of condylar hyperplasia. Int J Oral Maxillofac Surg. 1990 Apr;19(2):65-71. Gray RJ, Sloan P, Quayle AA, Carter DH. Histopathological and scintigraphic features of condylar hyperplasia. Int J Oral Maxillofac Surg. 1990 Apr;19(2):65-71. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43765 |
Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43227 |
Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43237 |
Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43247 |
Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43319 |
Study title: Acute hematogenous osteomyelitis of children: assessment of skeletal scintigraphy-based diagnosis in the era of MRI. Connolly LP, Connolly SA, Drubach LA, Jaramillo D, Treves ST. J Nucl Med. 2002 Oct;43(10):1310-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43434 |
Study title: Skeletal scintigraphy of young patients with low-back pain and a lumbosacral transitional vertebra. Connolly LP, d'Hemecourt PA, Connolly SA, Drubach LA, Micheli LJ, Treves ST. J Nucl Med. 2003 Jun;44(6):909-14. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43421 |
Study title: Young athletes with low back pain: skeletal scintigraphy of conditions other than pars interarticularis stress. Connolly LP, Drubach LA, Connolly SA, Treves ST. Clin Nucl Med. 2004 Nov;29(11):689-93. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43396 |
Study title: Yen TC, Chang YC, Chan SC, Chang JT, Hsu CH, Lin KJ, et al.. Epub 2004 Dec 30. Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes? [yen-2005-c]Eur J Nucl Med Mol Imaging. 2005 May;32(5):541-8. Yen TC 2005 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48717 |
Study title: Buccally administered streptokinase: a double blind study.Macalister AD. Aust Dent J. 1966 Jun;11(3):165-7. |
Active substance: streptokinase and streptodornase |
Study summary document link (including results): |
View full study record |
Document reference: 48957 |
Study title: Hoffman J, Stoll P, Yoo K, et al, An open-label study of the safety of flumazenil (Ro 15-1788) when used in children to reverse the residual CNS depressant effects of benzodiazepine-induced conscious sedation |
Active substance: FLUMAZENIL |
Study summary document link (including results): |
View full study record |
Document reference: 28211 |
Study title: Min B*,Song D,Khayksi V,Zhang S,Choma N,Koss-Twardy S, An Open-label Study of the Safety of Flumazenil when Used in Children to Reverse the Residual Effects of Benzodiazepine-Induced Conscious Sedation-Bioanalytical Results, 02.12.94 |
Active substance: FLUMAZENIL |
Study summary document link (including results): |
View full study record |
Document reference: 28214 |
Study title: NDA 20-073 (USA) Romazicon ® (flumazenil) injection, S-008 NDA 20-073 (USA) Pediatric labelling supplement December 12,1996 |
Active substance: FLUMAZENIL |
Study summary document link (including results): |
View full study record |
Document reference: 28212 |
Study title: Allen ED, Whitaker ER, Ryu G. Six-week trial of nebulized flunisolide nasal spray: efficacy in young children with moderately severe asthma. Pediatr Pulmonol. 1997 Dec;24(6):397-405. |
Active substance: FLUNISOLIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28237 |
Study title: Bodini A, Peroni DG, Zardini F, Corradi M, Alinovi R, Boner AL, Piacentini GL. Flunisolide decreases exhaled nitric oxide and nitrotyrosine levels in asthmatic children. Mediators Inflamm. 2006;2006(4):31919. |
Active substance: FLUNISOLIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28234 |
Study title: Gillman SA, Anolik R, Schenkel E, Newman K. One-year trial on safety and normal linear growth with flunisolide HFA in children with asthma. Clin Pediatr (Phila). 2002 Jun;41(5):333-40. |
Active substance: FLUNISOLIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28236 |
Study title: Nakanishi A.K. et al.: A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children. Chest 2003; 124: 790-795 |
Active substance: FLUNISOLIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28226 |
Study title: Nakanishi AK, Klasner AK, Rubin BK. A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children. Chest. 2003 Sep;124(3):790-4. |
Active substance: FLUNISOLIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28235 |
Study title: Efficacy and safety of Ro-1788 in reversing the central effects of flunitrazepam used for induction of anesthesia. A double blind comparative clinical study Ro 15-1788 versus placebo |
Active substance: FLUNITRAZEPAM |
Study summary document link (including results): |
View full study record |
Document reference: 28238 |
Study title: Multicenter Study for Controlling the Efficacy and Tolerability of Topsym Creme |
Active substance: FLUNITRAZEPAM |
Study summary document link (including results): |
View full study record |
Document reference: 28241 |
Study title: An open study to evaluate the efficacy, safety and tolerance of the topical application of Varidase to treat patients with various kinds of open wounds with problems of inflammation, excessive accumulation of clotted blood or exudates, and tissue with necrosis.Wang et al. |
Active substance: streptokinase and streptodornase |
Study summary document link (including results): |
View full study record |
Document reference: 48947 |
Study title: Screening and diagnosis of beta-ureidopropionase deficiency by gas chromatographic/mass spectrometric analysis of urine. Ohse M et al. J Mass Spectrom. 2002 Sep;37(9):954-62 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28304 |
Study title: Seventy-two patients' experience with an implantable drug delivery system for chimotherapy or total parenteral nutrition. Huang C-J. Chinese Medical Journal (Taipei). June 2, 1992, 158-63 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28294 |
Study title: Some actual issues in chemotherapy of brain tumors in children. Sterba J. Klin Onkol. October 17, 2000, 112-5 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28276 |
Study title: The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcninoma. Zhang Z, Wu M, Liu Q. Chin J Oncol. July 6, 1999, 214-6 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28279 |
Study title: The preventive effect of granisetron on digestive tract symptoms induced by arterial infusion of anticancer and hypertensive agents in combination with radiotherapy--a study of forty patients with bladder cancer. Hayashida S et al. Gan To Kagaku Ryoho. 1995 Apr;22(5):639-46 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28316 |
Study title: Thromboembolic complications in children with cancer. Wiernikowski JT, Athale UH. Thromb Res. August 31, 2006, 137-52 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28264 |
Study title: Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study. Katzenstein HM et al. J Clin Oncol. 2002 Aug 15;20(16):3438-44 |
Active substance: FLUOROURACIL |
Study summary document link (including results): 12177104.pdf |
View full study record |
Document reference: 28305 |
Study title: UFT plus calcium folinate/irinotecan in colorectal cancer. Twelves C. Oncology (Williston Park). 1999 Jul;13(7 Suppl 3):51-4 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28310 |
Study title: Update of the subconjunctival THC:YAG (holmium) laser sclerostomy Ab externo clinical trial: 30-Month report. Iwach AG et al. Ophthalmic Surgery. March 7, 1994, 13-21 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28289 |
Study title: Hoffecker E. Erfahrungen mit Encephabol in der kinderärztlichen Praxis (Ther d Gegenw1964: 913-917); Hoffecker E. Erfahrungen mit Encephabol in der kinderärztlichen Praxis (Ther d Gegenw1964: 913-917); |
Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35152 |
Study title: Logue G. The Effects of Pyrithioxine on the Behaviour and Intellectual Functioning of Learning-Disabled Children (S Afr Med J1974; 48: 2245-2246); Logue G. The Effects of Pyrithioxine on the Behaviour and Intellectual Functioning of Learning-Disabled Children (S Afr Med J1974; 48: 2245-2246); |
Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35149 |
Study title: Neu W. Erfahrungen mit Encephabol in der pädiatrischen Praxis (Landarzt 1965; 41 (12): 523-5245); Neu W. Erfahrungen mit Encephabol in der pädiatrischen Praxis (Landarzt 1965; 41 (12): 523-5245); |
Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35154 |
Study title: A phase IV, open, multicentre study of the efficacy and tolerance of pre-exposure treatment with PCEC-Rabies-vaccine (Rabipur®) |
Active substance: RABIES VACCINE FOR HUMAN USE PREPARED FROM CELL CULTURE (DIPLOID CELLS) |
Study summary document link (including results): |
View full study record |
Document reference: 48380 |
Study title: A Phase IV, randomized, single-blind, multicenter study with four vaccination groups: three different batches PCECV India, one batch PCECV Germany to compare immunogenicity and safety of PCEC Rabies Vaccine (PCECV) manufactured in Ankleshwar/India with PCECV manufactured in Marburg/Germany. |
Active substance: RABIES VACCINE FOR HUMAN USE PREPARED FROM CELL CULTURE (DIPLOID CELLS) |
Study summary document link (including results): |
View full study record |
Document reference: 48386 |
Study title: An open, controlled, randomized and single-centre study to evaluate the effectiveness of a new economical schedule of rabies postexposure prophylaxis using purified chick embryo cell tissue culture (PCEC) rabies vaccine (Rabipur®, Behring Vaccines; now Novartis Vaccines) in the patients of 1 to 61 years of age. |
Active substance: RABIES VACCINE FOR HUMAN USE PREPARED FROM CELL CULTURE (DIPLOID CELLS) |
Study summary document link (including results): |
View full study record |
Document reference: 48381 |
Study title: Clinical Documentation, other information. Geode ref. 920. March 1992 |
Active substance: RABIES VACCINE FOR HUMAN USE PREPARED FROM CELL CULTURE (DIPLOID CELLS) |
Study summary document link (including results): |
View full study record |
Document reference: 41431 |
Study title: Expert report on clinical documentation. Geode ref. 460. March 1992. |
Active substance: RABIES VACCINE FOR HUMAN USE PREPARED FROM CELL CULTURE (DIPLOID CELLS) |
Study summary document link (including results): |
View full study record |
Document reference: 41430 |
Study title: Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518.Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43236 |
Study title: Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518.Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43246 |
Study title: Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994; 79(2):51Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994; 79(2):51 |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43317 |
Study title: Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518.Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43327 |
Study title: Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):51Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):51 |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43334 |
Study title: Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518.Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43345 |
Study title: Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251.Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43323 |
Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: JMeza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: J |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43328 |
Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43337 |
Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43347 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Tartephedreel (drops) [AWB-072] |
Active substance: Tartephedreel |
Study summary document link (including results): |
View full study record |
Document reference: 40252 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Tartephedreel (drops) [AWB-AT] |
Active substance: Tartephedreel |
Study summary document link (including results): |
View full study record |
Document reference: 40253 |
Study title: 99Tcm-MAA lung scintigraphy in patients with Behçet's disease: its value and correlation with clinical course and other diagnostic modalities. Caglar M, Ergun E, Emri S. Nucl Med Commun. 2000 Feb;21(2):171-9. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48235 |
Study title: A pilot study of the role of TC-99 radionuclide in localization of pulmonary nodular lesions for thoracoscopic resection. Chella A, Lucchi M, Ambrogi MC, Menconi G, Melfi FM, Gonfiotti A, Boni G, Angeletti CA. Eur J Cardiothorac Surg. 2000 Jul;18(1):17-21. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48234 |
Study title: Abnormal brain perfusion demonstrated by Tc-99m MAA total-body scan in two children with complex congenital heart disease. Suga K, Kume N, Hirabayashi A, Kishimoto K, Hara A, Matsunaga N. Ann Nucl Med. 1998 Oct;12(5):297-302. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48242 |
Study title: Acute paraquat intoxication: using nuclear pulmonary studies to predict patient outcome. Kao CH, Hsieh JF, Ho YJ, Hung DZ, Lin TJ, Ding HJ. Chest. 1999 Sep;116(3):709-14. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48239 |
Study title: Alteration of pulmonary blood flow distribution in patients with congenital left to right cardiac shunt--pre- and postoperative study with macroaggregates of 99mTc-labeled human serum albumin. Hashimoto K, Nakamura Y, Matsui M, Suzuki K, Kurosawa H, Arai T. Jpn Circ J. 1993 Apr;57(4):291-8. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48272 |
Study title: Rohypnol drops: results of acceptance trial in 220 children |
Active substance: FLUNITRAZEPAM |
Study summary document link (including results): |
View full study record |
Document reference: 28240 |
Study title: Study of the efficacy and safety of Ro 15-1788 in reversing the central effects of flunitrazepam used to induce and maintain general anesthesia |
Active substance: FLUNITRAZEPAM |
Study summary document link (including results): |
View full study record |
Document reference: 28239 |
Study title: [Current therapy aspects of intraocular tumors] Schüler AO, Bornfeld N. Ophthalmologe. 2000 Mar;97(3):207-22. |
Active substance: FLUORESCEIN |
Study summary document link (including results): Current therapy aspects of intraocular tumors.pdf |
View full study record |
Document reference: 28244 |
Study title: Diabetic retinopathy in pediatric patients with type-1 diabetes: effect of diabetes duration, prepubertal and pubertal onset of diabetes, and metabolic control. Holl RW, Lang GE, Grabert M, Heinze E, Lang GK, Debatin KM. J Pediatr. 1998 May;132(5):790-4. Comment in: J Pediatr. 1998 May;132(5):760-2. PMID: 9602180. |
Active substance: FLUORESCEIN |
Study summary document link (including results): Diabetic retinopathy in pediatric patients with type-1 diabe.pdf |
View full study record |
Document reference: 28247 |
Study title: Long-term results of laser treatment for retinal angiomatosis in von Hippel-Lindau disease. Schmidt D, Natt E, Neumann HP. Eur J Med Res. 2000 Feb 28;5(2):47-58. |
Active substance: FLUORESCEIN |
Study summary document link (including results): Long-term results of laser treatment for retinal angiomatosi.pdf |
View full study record |
Document reference: 28245 |
Study title: Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. [No authors listed] Pediatrics. 2000 Feb;105(2):295-310. |
Active substance: FLUORESCEIN |
Study summary document link (including results): Supplemental therapeutic oxygen for prethreshold retinopathy.pdf |
View full study record |
Document reference: 28246 |
Study title: Collier BD, Carrera GF, Messer EJ, Ryan DE, Gingrass D, Angell D, Palmer DW, Isitman AT, Hellman RS. Internal derangement of the temporomandibular joint: detection by single-photon emission computed tomography. Work in progress. Radiology. 1983 Nov;149(2):557-61. Collier BD, Carrera GF, Messer EJ, Ryan DE, Gingrass D, Angell D, Palmer DW, Isitman AT, Hellman RS. Internal derangement of the temporomandibular joint: detection by single-photon emission computed tomography. Work in progress. Radiology. 1983 Nov;149(2):557-61. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44277 |
Study title: Collier BD, Johnson RP, Carrera GF, Akhtar K, Isitman AT. Scintigraphic diagnosis of stress-induced incomplete fractures of the proximal tibia. J Trauma. 1984 Feb;24(2):156-60. Collier BD, Johnson RP, Carrera GF, Akhtar K, Isitman AT. Scintigraphic diagnosis of stress-induced incomplete fractures of the proximal tibia. J Trauma. 1984 Feb;24(2):156-60. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44007 |
Study title: Colton CL, Hardy JG. Evaluation of a sterilizable radiation probe as an aid to the surgical treatment of osteoid-osteoma. Technical note. J Bone Joint Surg Am. 1983 Sep;65(7):1019-22. No abstract available. Colton CL, Hardy JG. Evaluation of a sterilizable radiation probe as an aid to the surgical treatment of osteoid-osteoma. Technical note. J Bone Joint Surg Am. 1983 Sep;65(7):1019-22. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44032 |
Study title: Comparison of bone and gallium-67 imaging in heroin users' arthritis. Bittini A, Dominguez PL, Martinez Pueyo ML, López Longo FJ, Monteagudo I, Carreño L. J Nucl Med. 1985 Dec;26(12):1377-81. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48464 |
Study title: Computerized skeletal scintigraphy for assessment of mandibular asymmetry. Charkes ND, Siddhivarn N, Schneck CD. J Nucl Med 1987 Dec;28{12):1835-8. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48470 |
Study title: Computerized skeletal scintigraphy for assessment of mandibular asymmetry. Cisneros GJ, Kaban LB. J Oral Maxillofac Surg 1984 Aug;42{8):513-20. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48471 |
Study title: Prospective study on immunogenicity of VERORAB® rabies vaccine administered by intramuscular or intradermal route concomitantly with TETRACOQ® to infants followed up at the Center of Pediatrics, Development and Health of Ho Chi Minh Ville, Vietnam |
Active substance: Rabies virus (Wistar rabies PM/WI38-1503-3M strain), grown on a continuous Vero cell line, inactivated with betapropiolactone |
Study summary document link (including results): |
View full study record |
Document reference: 47472 |
Study title: Double-Blind, Randomized Trial of the Pharmacokinetics of Dexecadotril (BP 1.01) and Racecadotril (BP 0.52) in Children One Month to Six Years Old Suffering From Acute Diarrhea (Ben Becher S) |
Active substance: RACECADOTRIL |
Study summary document link (including results): |
View full study record |
Document reference: 35261 |
Study title: ADAMSON P. PHARMACOLOGY OF ANTI-METABOLITES AND OTHER ANTI-LEUKEMIC AGENTS. 1999. Crisp Data Base National Institutes of Health. 2000. Ref Type: Report ADAMSON P. PHARMACOLOGY OF ANTI-METABOLITES AND OTHER ANTI-LEUKEMIC AGENTS. 1999. Crisp Data Base National Institutes of Health. 2000. Ref Type: Report |
Active substance: RALTITREXED |
Study summary document link (including results): |
View full study record |
Document reference: 35262 |
Study title: Beale P, Clarke S. Chapter 7: 'Tomudex': Clinical Development. In: Anticancer Drug Development Guide: Antifolate Drugs in Cancer Therapy 1999; Totowa:Humana-181.Beale P, Clarke S. Chapter 7: 'Tomudex': Clinical Development. In: Anticancer Drug Development Guide: Antifolate Drugs in Cancer Therapy 1999; Totowa:Humana-181. |
Active substance: RALTITREXED |
Study summary document link (including results): |
View full study record |
Document reference: 35263 |
Study title: Clarke SJ, Beale PJ, Rivory LP. Clinical and preclinical pharmacokinetics of raltitrexed. Clinical Pharmacokinetics 2000;39(6):429-43 2000;(6):429-443. Clarke SJ, Beale PJ, Rivory LP. Clinical and preclinical pharmacokinetics of raltitrexed. Clinical Pharmacokinetics 2000;39(6):429-43 2000;(6):429-443. |
Active substance: RALTITREXED |
Study summary document link (including results): |
View full study record |
Document reference: 35264 |
Study title: Van CE. Raltitrexed ('Tomudex'). (Review, 54 refs). Expert Opinion on Investigational Drugs 1998;7(5):823-834 1998;(5):823-834. Van CE. Raltitrexed ('Tomudex'). (Review, 54 refs). Expert Opinion on Investigational Drugs 1998;7(5):823-834 1998;(5):823-834. |
Active substance: RALTITREXED |
Study summary document link (including results): |
View full study record |
Document reference: 35265 |
Study title: WIDEMANN B. Clinical development of novel drugs for children with ca. 2003. Crisp Data Base National Institutes of Health. 2004. Ref Type: Report WIDEMANN B. Clinical development of novel drugs for children with ca. 2003. Crisp Data Base National Institutes of Health. 2004. Ref Type: Report |
Active substance: RALTITREXED |
Study summary document link (including results): |
View full study record |
Document reference: 35266 |
Study title: WIDEMANN B. Novel Drugs for Children With Cancer /Neurofibromatosis. 2001. Crisp Data Base National Institutes of Health. 2003. WIDEMANN B. Novel Drugs for Children With Cancer /Neurofibromatosis. 2001. Crisp Data Base National Institutes of Health. 2003. |
Active substance: RALTITREXED |
Study summary document link (including results): |
View full study record |
Document reference: 35267 |
Study title: Jenkin-R-D-T, Boesel-C, Ertel-I, et-al. Childrens Cancer Study Group, University of Southern California, Pasadena, CA, United States. Brain-stem tumors in childhood: A prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Children's Cancer Study Group. Journal of Neurosurgery {J-NEUROSURG}, 1987, Vol/Iss/Pg. 66/2 (227-233).Jenkin-R-D-T, Boesel-C, Ertel-I, et-al. Childrens Cancer Study Group, University of Southern California, Pasadena, CA, United States. Brain-stem tumors in childhood: A prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Children's Cancer Study Group. Journal of Neurosurgery {J-NEUROSURG}, 1987, Vol/Iss/Pg. 66/2... |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34756 |
Study title: Jenkin-R-D-T, Brown-T-C, Peters-M-V, Sonley-M-J. Princess Margaret Hosp., Toronto, Canada. Hodgkin's disease in children. A retrospective analysis: 1958-73. Cancer {CANCER}, 1975, Vol/Iss/Pg. 35/3 sup (979-990).Jenkin-R-D-T, Brown-T-C, Peters-M-V, Sonley-M-J. Princess Margaret Hosp., Toronto, Canada. Hodgkin's disease in children. A retrospective analysis: 1958-73. Cancer {CANCER}, 1975, Vol/Iss/Pg. 35/3 sup (979-990). |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34757 |
Study title: Immunogenicity and efficacy of PCECV in a population bitten by animals at high risk of rabies infection |
Active substance: RABIES VACCINE FOR HUMAN USE PREPARED FROM CELL CULTURE (DIPLOID CELLS) |
Study summary document link (including results): |
View full study record |
Document reference: 48383 |
Study title: Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247 |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43331 |
Study title: Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251.Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43220 |
Study title: Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251.Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43230 |
Study title: Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251.Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43240 |
Study title: Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251.Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43250 |
Study title: Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000; 22(3):247.Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000; 22(3):247. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43315 |
Study title: Burt RW, Matthews TJ. Aseptic necrosis of the knee: bone scintigraphy. AJR Am J Roentgenol. 1982 Mar;138(3):571-3. No abstract available. Burt RW, Matthews TJ. Aseptic necrosis of the knee: bone scintigraphy. AJR Am J Roentgenol. 1982 Mar;138(3):571-3. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44088 |
Study title: Arteriovenous shunt measurement during endovascular therapy for cerebrospinal lesions. Mariani L, Haldemann AR, Schroth G. AJNR Am J Neuroradiol. 1997 Oct;18(9):1679-89. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48246 |
Study title: Assessment of peanut aspiration by MRI and lung perfusion scintigram. Morijiri M, Seto H, Kageyama M, Shimizu M, Nagayoshi T, Watanabe N, Kakishita M. J Comput Assist Tomogr. 1994 Sep-Oct;18(5):836-8. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48266 |
Study title: Bilateral deep venous thrombosis in protein S deficiency. Detection by radionuclide venography. Wegener WA, Heyman S. Clin Nucl Med. 1990 Sep;15(9):618-22. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48283 |
Study title: Bilateral pulmonary artery aneurysms in a patient with Behcet syndrome: evaluation with radionuclide angiography and V/Q lung scanning. Basoglu T, Canbaz F, Bernay I, Danaci M. Clin Nucl Med. 1998 Nov;23(11):735-8. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48243 |
Study title: Changes in intracardiac shunt elicited by pneumonia. Caceres LJ, Khedkar NY, Martinez CJ, DuBrow I, Lakier J Clin Nucl Med. 1994 Apr;19(4):359-60. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48269 |
Study title: Clinical significance of nonfocal scintigraphic findings in suspected tibial stress fractures.Chisin R, Milgrom C, Giladi M, Stein M, Margulies J, Kashtan H. Clin Orthop Relat Res. 1987 Jul;(220):200-5. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43858 |
Study title: Chisin R, Noyek AM, Israel O, Witterick IJ, Front D, Kirsh JC. Contribution of nuclear medicine to the diagnosis and management of extracranial head and neck diseases (excluding thyroid and parathyroid). Isr J Med Sci. 1992 Mar-Apr;28(3-4):254-61. Review. Chisin R, Noyek AM, Israel O, Witterick IJ, Front D, Kirsh JC. Contribution of nuclear medicine to the diagnosis and management of extracranial head and neck diseases (excluding thyroid and parathyroid). Isr J Med Sci. 1992 Mar-Apr;28(3-4):254-61. Review. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44264 |
Study title: Chiu NT, Jou IM, Lee BF, Yao WJ, Tu DG, Wu PS. Symptomatic and asymptomatic accessory navicular bones: findings of Tc-99m MDP bone scintigraphy. Clin Radiol. 2000 May;55(5):353-5. Chiu NT, Jou IM, Lee BF, Yao WJ, Tu DG, Wu PS. Symptomatic and asymptomatic accessory navicular bones: findings of Tc-99m MDP bone scintigraphy. Clin Radiol. 2000 May;55(5):353-5. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43485 |
Study title: Choong KK, Gulenchyn KY, Chamberlain MJ. 'Vascular scalp lesion' from cardiac activity. Clin Nucl Med. 1994 Aug;19(8):744-5. No abstract available. Choong KK, Gulenchyn KY, Chamberlain MJ. 'Vascular scalp lesion' from cardiac activity. Clin Nucl Med. 1994 Aug;19(8):744-5. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43619 |
Study title: Chronic recurrent multifocal osteomyelitis (CRMO) with symmetric involvement of both femora: X-ray, bone scintigram, and MR imaging findings in one case. Buck FM, Treumann TC, Winiker H. Strobel K. J Mag Reson Imaging 2007;26:422-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48467 |
Study title: A DOUBLE-BLIND MULTICENTER COMPARATIVE STUDY OF TWO DOSE REGIMENS OF ORAL CLINDAMYCIN HYDROCHLORIDE IN THE TREATMENT OF ACUTE TONSILLITIS/PHARYNGITIS DUE TO GROUP A BETA-HEMOLYTIC STREPTOCOCCI. |
Active substance: CLINDAMYCIN |
Study summary document link (including results): 251F-INF-0496-001 EMA Pediatrics Web Synopsis.pdf |
View full study record |
Document reference: 24361 |
Study title: A PROSPECTIVE, STRATIFIED, RANDOMIZED, THIRD-PARTY BLINDED COMPARISON OF THE SAFETY AND EFFICACY OF CEFOPERAZONE PLUS PIPERACILLIN VERSUS CEFOPERAZONE PLUS AMIKACIN IN THERAPY OF INFECTED SOLID TUMOR PATIENTS RECEIVING CISPLATIN |
Active substance: CLINDAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 24360 |
Study title: bay b 5097 500 mg vaginal tablet: efficacy and tolerance of bay b 5097 500 mg vaginal tablet as single or one day therapy of vaginal yeast infections |
Active substance: CLOTRIMAZOLE |
Study summary document link (including results): Bayer CC_Clotrimazole_0420_study_synopsis.pdf |
View full study record |
Document reference: 24457 |
Study title: BAY b 5097 Solution N Activity and Tolerability in Dermatomycoses. |
Active substance: CLOTRIMAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 24441 |
Study title: BAY b 5097 Solution N Activity and Tolerance in Otomycoses. |
Active substance: CLOTRIMAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 24442 |
Study title: BAY b 5097 Solution N Activity and Tolerance in Otomycoses. |
Active substance: CLOTRIMAZOLE |
Study summary document link (including results): Bayer CC_Clotrimazole_0220_study_synopsis.pdf |
View full study record |
Document reference: 24443 |
Study title: Comparative study on the efficacy of clotrimazole vaginal cream 10 & econazole depot ovule 150 mg in the treatment of candida vaginitis. |
Active substance: CLOTRIMAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 24445 |
Study title: Comparative study on the efficacy of clotrimazole vaginal cream 10% and econazole depot ovule 150 mg in the treatment of Candida vaginitis |
Active substance: CLOTRIMAZOLE |
Study summary document link (including results): Bayer CC_Clotrimazole_0595_study_synopsis.pdf |
View full study record |
Document reference: 24448 |
Study title: effectiveness and tolerance of bay b 5097 2 per cent vaginal cream on therapy for 3 days compared to therapy for 7 days with econazole 1 per cent vaginal cream (gyno-pevaryl cream) |
Active substance: CLOTRIMAZOLE |
Study summary document link (including results): Bayer CC_Clotrimazole_0396_study_synopsis.pdf |
View full study record |
Document reference: 24455 |
Study title: Efficacy and tolerability of clotrimazole vaginal cream 10 in comparison with clotrimazole vaginal tablets 500 mg after a single application in patients with vaginal yeast infections |
Active substance: CLOTRIMAZOLE |
Study summary document link (including results): Bayer CC_Clotrimazole_0345_study_synopsis.pdf |
View full study record |
Document reference: 24444 |
Study title: Efficacy and tolerability of clotrimazole vaginal cream 10 in comparison with clotrimazole vaginal tablets 500 mg after a single application in patients with vaginal yeast infections |
Active substance: CLOTRIMAZOLE |
Study summary document link (including results): Bayer CC_Clotrimazole_0473_study_synopsis.pdf |
View full study record |
Document reference: 24462 |
Study title: efficacy and tolerability of clotrimazole vaginal tablets 100 mg (galenic formulation with lactic acid) in the 6-day-therapy in vaginal candida-infections |
Active substance: CLOTRIMAZOLE |
Study summary document link (including results): Bayer CC_Clotrimazole_0516_study_synopsis.pdf |
View full study record |
Document reference: 24451 |
Study title: efficacy and tolerance of bay b 5097 vaginal cream 2% in the 3-day therapy compared to a 6-day therapy with Canesten vaginal cream 1% |
Active substance: CLOTRIMAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 24453 |
Study title: efficacy and tolerance of two galenical product formulations of canesten vaginal tablets containing 500 mg of the active ingredient clotrimazole after a single administration to patients with vaginal yeast infections |
Active substance: CLOTRIMAZOLE |
Study summary document link (including results): Bayer CC_Clotrimazole_0444_study_synopsis.pdf |
View full study record |
Document reference: 24458 |
Study title: Gutachten über die klinische Prüfung von Mykichthol Paste |
Active substance: CLOTRIMAZOLE |
Study summary document link (including results): Bayer CC_Clotrimazole_0524_study_synopsis.pdf |
View full study record |
Document reference: 24465 |
Study title: Jenkin-R-D, Anderson-J-R, Chilcote-R-R, Coccia-P, Exelby-P, Kersey-J, Kjeldsberg-C-R, Kushner-J, Meadows-A-T, Siegel-S, et al. The treatment of diffuse undifferentiated non-Hodgkin's lymphoma in children: the Childrens Cancer Study Group experience. IARC scientific publications, {IARC-Sci-Publ}, 1985, no. 60, p. 399-404, ISSN: 0300-5038.Jenkin-R-D, Anderson-J-R, Chilcote-R-R, Coccia-P, Exelby-P, Kersey-J, Kjeldsberg-C-R, Kushner-J, Meadows-A-T, Siegel-S, et al. The treatment of diffuse undifferentiated non-Hodgkin's lymphoma in children: the Childrens Cancer Study Group experience. IARC scientific publications, {IARC-Sci-Publ}, 1985, no. 60, p. 399-404, ISSN: 0300-5038. |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34753 |
Study title: Jurgens-H, Distler-W. Abteilung fur Hamatologie und Onkologie, Universitats-Kinderklinik, Moorenstrasse 5, W-4000 Dusseldorf 1, Germany. Puberty development and gonad function after treatment with cytostatics during childhood. Gynakologe {GYNAKOLOGE}, 1991, Vol/Iss/Pg. 24/2 (114-118), ISSN: 0017-5994. Jurgens-H, Distler-W. Abteilung fur Hamatologie und Onkologie, Universitats-Kinderklinik, Moorenstrasse 5, W-4000 Dusseldorf 1, Germany. Puberty development and gonad function after treatment with cytostatics during childhood. Gynakologe {GYNAKOLOGE}, 1991, Vol/Iss/Pg. 24/2 (114-118), ISSN: 0017-5994. |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34758 |
Study title: Kiltie-A-E, Lashford-L-S, Gattamaneni-H-R. Dr. H.R. Gattamaneni, NHS Trust, Christie Hospital, Wilmslow Road, Manchester M20 9BX, United Kingdom. Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old. Medical and Pediatric Oncology {MED-PEDIATR-ONCOL}, 1997, Vol/Iss/Pg. 28/5 (348-354), ISSN: 0098-1532.Kiltie-A-E, Lashford-L-S, Gattamaneni-H-R. Dr. H.R. Gattamaneni, NHS Trust, Christie Hospital, Wilmslow Road, Manchester M20 9BX, United Kingdom. Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old. Medical and Pediatric Oncology {MED-PEDIATR-ONCOL}, 1997, Vol/Iss/Pg. 28/5 (348-354), ISSN: 0098-1532. |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34759 |
Study title: Knerich-R, Butti-G, Pezzotta-S, et-al. Universita di Pavia, Dipartimento di Chirurgia, Sezione di Clinica Neurochirurgica, 27100 Pavia, Italy. Chemotherapy of malignant brain tumors in children. Minerva Medica {MINERVA-MED}, 1984, Vol/Iss/Pg. 75/24 (1441-1444).Knerich-R, Butti-G, Pezzotta-S, et-al. Universita di Pavia, Dipartimento di Chirurgia, Sezione di Clinica Neurochirurgica, 27100 Pavia, Italy. Chemotherapy of malignant brain tumors in children. Minerva Medica {MINERVA-MED}, 1984, Vol/Iss/Pg. 75/24 (1441-1444). |
Active substance: PROCARBAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 34760 |
Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG O.D. IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27785 |
Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG/DAY IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27589 |
Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG/DAY IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27952 |
Study title: TO EVALUATE THE EFFICACY AND SAFETY OF FLUCONAZOLE IN THE TREATMENT OF DISSEMINATED CANDIDIASIS AND CRYPTOCOCCAL MENINGITIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27623 |
Study title: TO EVALUATE THE EFFICACY AND SAFETY OF FLUCONAZOLE IN THE TREATMENT OF DISSEMINATED CANDIDIASIS AND CRYPTOCOCCAL MENINGITIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27985 |
Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF A SINGLE 400 MG ORAL/IV DOSE OF FLUCONAZOLE IN PATIENTS SUFFERING FROM CANDIDAL ESOPHAGITIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27394 |
Study title: Chirurg. 2001 Sep;72(9):1071-7. [Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft tissue tumors. 3rd Interdisciplinary Consensus Conference "PET in Oncology": results of the Bone and Soft Tissue Study Group] [Article in German] Franzius C, Schulte M, Hillmann A, Winkelmann W, Jürgens H, Bockisch A, Schober O. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28166 |
Study title: Clin Nucl Med. 2002 Aug;27(8):572-7. F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease. Rini JN, Manalili EY, Hoffman MA, Karayalcin G, Mehrotra B, Tomas MB, Palestro CJ. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28156 |
Study title: Clin Nucl Med. 2003 Aug;28(8):648-51. Thymic uptake of radiopharmaceuticals. Connolly LP, Connolly SA. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28143 |
Study title: Clin Nucl Med. 2005 Mar;30(3):170-6. Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors. Uchida Y, Minoshima S, Kawata T, Motoori K, Nakano K, Kazama T, Uno T, Okamoto Y, Ito H. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28109 |
Study title: Diabetes Care. 2001 Mar;24(3):555-60. Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type 1 diabetes. Oxford Regional Prospective Study Group. Schultz CJ, Neil HA, Dalton RN, Konopelska Bahu T, Dunger DB; Oxford Regional Prospective Study Group. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28171 |
Study title: Endocr Pract. 2003 Jul-Aug;9(4):273-9. Comment in: Endocr Pract. 2003 Jul-Aug;9(4):324-6. [18F]fluorodeoxyglucose triple-head coincidence imaging as an adjunct to 131I scanning for follow-up of papillary thyroid carcinoma. Gonzalo IT, Itti E, Mlikotic A, Pham le H, Cesar RB, Meignan M, Mishkin FS. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28140 |
Study title: Epilepsia. 2006;47 Suppl 2:71-5. Neuropsychological findings in Rolandic epilepsy and Landau-Kleffner syndrome. Metz-Lutz MN, Filippini M. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28072 |
Study title: Eur J Appl Physiol Occup Physiol. 1995;70(5):442-50. Pulmonary gas exchange and ventilatory responses to brief intense intermittent exercise in young trained and untrained adults. Chamari K, Ahmaidi S, Fabre C, Ramonatxo M, Préfaut C. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28202 |
Study title: Eur J Haematol. 2007 Mar;78(3):206-12. Epub 2007 Jan 23. Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma. Hutchings M, Loft A, Hansen M, Berthelsen AK, Specht L. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28069 |
Study title: Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):346-50. CT vs 68Ge attenuation correction in a combined PET/CT system: evaluation of the effect of lowering the CT tube current. Kamel E, Hany TF, Burger C, Treyer V, Lonn AH, von Schulthess GK, Buck A. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28158 |
Study title: Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):581-7. Epub 2003 Jan 30. Extratemporal hypometabolism on FDG PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy. Choi JY, Kim SJ, Hong SB, Seo DW, Hong SC, Kim BT, Kim SE. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28152 |
Study title: Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):396-402. Epub 2003 Jan 9. Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours. Lassen U, Daugaard G, Eigtved A, Højgaard L, Damgaard K, Rørth M. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28149 |
Study title: Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1064-72. Epub 2004 Mar 11. Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors. Tian M, Zhang H, Oriuchi N, Higuchi T, Endo K. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28131 |
Study title: Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1073-80. Epub 2004 Mar 9. Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. Ng SH, Chang JT, Chan SC, Ko SF, Wang HM, Liao CT, Chang YC, Yen TC. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28133 |
Study title: Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1105-13. Epub 2004 Mar 9. Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT. Bar-Shalom R, Gaitini D, Keidar Z, Israel O. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28132 |
Study title: Eur J Nucl Med Mol Imaging. 2004 Jun;31(6):811-9. Epub 2004 Feb 5. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology. Amthauer H, Denecke T, Rau B, Hildebrandt B, Hünerbein M, Ruf J, Schneider U, Gutberlet M, Schlag PM, Felix R, Wust P. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28135 |
Study title: Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1422-8. Epub 2005 Aug 31. Respiratory motion artefact in the liver dome on FDG PET/CT: comparison of attenuation correction with CT and a caesium external source. Papathanassiou D, Becker S, Amir R, Menéroux B, Liehn JC. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28098 |
Study title: The role of bone scan in the diagnosis of Jaffé-Lichtenstein-Uehlinger syndrome. Chroustova D, Votruba M, Sprindrich J, Sosna B. Nucl Med Rev Cent East Eur. 2004;7(1):87-9. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43398 |
Study title: Computerized skeletal scintigraphy for assessment of mandibular asymmetry. Cisneros GJ, Kaban LB. J Oral Maxillofac Surg. 1984 Aug;42(8):513-20. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43992 |
Study title: Allograft bone in the treatment of desmoplastic fibroma. A case report. Clayer M, Oakeshott R. Clin Orthop Relat Res. 1994 Mar;(300):219-24. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43632 |
Study title: Camurati-Engelmann disease: contribution of bone scintigraphy to genetic counseling. Clybouw C, Desmyttere S, Bonduelle M, Piepsz A Genet Couns. 1994;5(2):195-8. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43638 |
Study title: Chew FS, Hudson TM. Radionuclide bone scanning of osteosarcoma: falsely extended uptake patterns. AJR Am J Roentgenol. 1982 Jul;139(1):49-54. Chew FS, Hudson TM. Radionuclide bone scanning of osteosarcoma: falsely extended uptake patterns. AJR Am J Roentgenol. 1982 Jul;139(1):49-54. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44078 |
Study title: J Pediatr Hematol Oncol. 2006 Aug;28(8):501-12. Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease. Furth C, Denecke T, Steffen I, Ruf J, Voelker T, Misch D, Vondran F, Plotkin M, StÃver B, Henze G, Lemke AJ, Amthauer H. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28078 |
Study title: Jpn Circ J. 1997 Mar;61(3):201-10. Myocardial blood flow and metabolism in patients with hypertrophic cardiomyopathy--a study with carbon-11 acetate and positron emission tomography. Ishiwata S, Maruno H, Senda M, Toyama H, Nishiyama S, Seki A. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28195 |
Study title: Klin Padiatr. 2003 May-Jun;215(3):146-50. [18-FDG-PET-findings in children and adolescents with Hodgkin's disease: retrospective evaluation of the correlation to other imaging procedures in initial staging and to the predictive value of follow up examinations] [Article in German] Wickmann L, Lüders H, DÃrffel W. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28146 |
Study title: Leuk Lymphoma. 1999 Aug;34(5-6):545-51. Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease. Wiedmann E, Baican B, Hertel A, Baum RP, Chow KU, Knupp B, Adams S, HÃr G, Hoelzer D, Mitrou PS. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28184 |
Study title: Leuk Lymphoma. 2004 Jan;45(1):85-92. FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison. Friedberg JW, Fischman A, Neuberg D, Kim H, Takvorian T, Ng AK, Mauch PM, Canellos GP, van den Abbeele AD. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28129 |
Study title: Leuk Lymphoma. 2007 Sep;48(9):1721-7. Comment in:Leuk Lymphoma. 2007 Sep;48(9):1667-9. Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans. Picardi M, De Renzo A, Pane F, Nicolai E, Pacelli R, Salvatore M, Rotoli B. Leuk Lymphoma. 2007 Sep;48(9):1721-7. Comment in:Leuk Lymphoma. 2007 Sep;48(9):1667-9. Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans. Picardi M, De Renzo A, Pane F, Nicolai E, Pacelli R, Salvatore M, Rotoli B. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28063 |
Study title: Lung Cancer. 2004 May;44(2):175-81. FDG-PET in staging lung cancer: how does it change the algorithm? Verhagen AF, Bootsma GP, Tjan-Heijnen VC, van der Wilt GJ, Cox AL, Brouwer MH, Corstens FH, Oyen WJ. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28127 |
Study title: Investigation of the effectiveness and tolerance of a single administration of clotrimazole vaginal tablet of 500 mg in cases of vaginal candida infection in comparison with a 6-day theraphy with clotrimazole vaginal tablets of 100 mg |
Active substance: CLOTRIMAZOLE |
Study summary document link (including results): Bayer CC_Clotrimazole_0581_study_synopsis.pdf |
View full study record |
Document reference: 24450 |
Study title: Investigation of the effectiveness and tolerance of a single administration of clotrImazole vaginal tablet of 500 mg in cases of vaginal candida infection in comparison with a 6-day theraphy with clotrimazole vaginal tablets of 100 mg |
Active substance: CLOTRIMAZOLE |
Study summary document link (including results): Bayer CC_Clotrimazole_0460_study_synopsis.pdf |
View full study record |
Document reference: 24461 |
Study title: Chou AJ et al Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience Cancer. 2005 Nov 15;104(10):2214-21Chou AJ et al Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience Cancer. 2005 Nov 15;104(10):2214-21 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24827 |
Study title: Chow LM et al, Survival and late effects in children with Hodgkin's lymphoma treated with, MOPP/ABV and low-dose, extended-field irradiation, J Clin Oncol. 2006 Dec 20;24(36):5735-41Chow LM et al, Survival and late effects in children with Hodgkin's lymphoma treated with, MOPP/ABV and low-dose, extended-field irradiation, J Clin Oncol. 2006 Dec 20;24(36):5735-41 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24828 |
Study title: Chow SN et al, Malignant ovarian germ cell tumors, Int J Gynaecol Obstet. 1996 May;53(2):151-8Chow SN et al, Malignant ovarian germ cell tumors, Int J Gynaecol Obstet. 1996 May;53(2):151-8 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24829 |
Study title: Coze C et al. NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology. Clin Oncol. 1997 Dec;15(12):3433-40Coze C et al. NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology. Clin Oncol. 1997 Dec;15(12):3433-40 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24830 |
Study title: Craft A et al Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study J Clin Oncol. 1998 Nov;16(11):3628-33Craft A et al Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study J Clin Oncol. 1998 Nov;16(11):3628-33 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24831 |
Study title: Crist W et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol. 1995 Mar;13(3):610-30Crist W et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol. 1995 Mar;13(3):610-30 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24832 |
Study title: Crist WM et a lIntergroup rhabdomyosarcoma study-IV: results for patients with nonmetastaticDiseaseJ Clin Oncol. 2001 Jun 15;19(12):3091-102Crist WM et a lIntergroup rhabdomyosarcoma study-IV: results for patients with nonmetastaticDiseaseJ Clin Oncol. 2001 Jun 15;19(12):3091-102 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24833 |
Study title: Crist WM et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol. 2001 Jun 15;19(12):3091-102Crist WM et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol. 2001 Jun 15;19(12):3091-102 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24834 |
Study title: Crooks GM et alI Ifosfamide and etoposide in recurrent childhood acute lymphoblastic leukemia J Pediatr Hematol Oncol. 1995 Feb;17(1):34-8Crooks GM et alI Ifosfamide and etoposide in recurrent childhood acute lymphoblastic leukemia J Pediatr Hematol Oncol. 1995 Feb;17(1):34-8 |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24835 |
Study title: Culbert SJ Remission induction and continuation therapy in children with their first relapse of acute lymphoid leukemia. A Pediatric Oncology Group study.Cancer. 1991 Jan 1;67(1):37-42.Culbert SJ Remission induction and continuation therapy in children with their first relapse of acute lymphoid leukemia. A Pediatric Oncology Group study.Cancer. 1991 Jan 1;67(1):37-42. |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24836 |
Study title: Cushing B et al, Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study—Pediatric Oncology Group 9049 and Children's Cancer Group 8882, J Clin Oncol. 2004 Jul 1;22(13):2691-700, Cushing B et al, Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study—Pediatric Oncology Group 9049 and Children's Cancer Group 8882, J Clin Oncol. 2004 Jul 1;22(13):2691-700, |
Active substance: CYCLOPHOSPHAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24837 |
Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF A SINGLE 400 MG ORAL/IV DOSE OF FLUCONAZOLE IN PATIENTS SUFFERING FROM CANDIDAL ESOPHAGITIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27759 |
Study title: TO EVALUATE THE PHARMACOKINETIC PARAMETERS AFTER IV FLUCONAZOLE IN PATIENTS WITH EITHER 1. AIDS WITHOUT LIVER DISEASE OR 2. LIVER CIRRHOSIS OR SEVERE HEPATIC DISEASE IN COMPARISON WITH HEALTHY SUBJECTS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27427 |
Study title: TO EVALUATE THE PHARMACOKINETIC PARAMETERS AFTER IV FLUCONAZOLE IN PATIENTS WITH EITHER 1. AIDS WITHOUT LIVER DISEASE OR 2. LIVER CIRRHOSIS OR SEVERE HEPATIC DISEASE IN COMPARISON WITH HEALTHY SUBJECTS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27792 |
Study title: TO EVALUATE THE SAFETY AND EFFICACY OF FLUCONAZOLE CAPSULES VS. NYSTATIN SUSPENSION IN THE PREVENTION OF CANDIDIASIS IN LEUKEMIC PATIENTS UNDERGOING CHEMOTHERAPY. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27593 |
Study title: TO EVALUATE THE SAFETY AND EFFICACY OF FLUCONAZOLE CAPSULES VS. NYSTATIN SUSPENSION IN THE PREVENTION OF CANDIDIASIS IN LEUKEMIC PATIENTS UNDERGOING CHEMOTHERAPY. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27956 |
Study title: TO GATHER ADDITIONAL DATA ON THE SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS CRYPTOCOCCAL MENINGITIS. TO MAKE FLUCONAZOLE AVAILABLE FOR USE IN PATIENTS WITH CRYPTOCOCCAL MENINGITIS WHO IN THE INVESTIGATOR JUDGEMENT WOULD BENEFIT FROM TREATMENT WITH THIS AGENT |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27594 |
Study title: TO GATHER ADDITIONAL DATA ON THE SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS CRYPTOCOCCAL MENINGITIS. TO MAKE FLUCONAZOLE AVAILABLE FOR USE IN PATIENTS WITH CRYPTOCOCCAL MENINGITIS WHO IN THE INVESTIGATOR JUDGEMENT WOULD BENEFIT FROM TREATMENT WITH THIS AGENT |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27957 |
Study title: TO INVESTIGATE THE SAFETY AND EFFICACY OF A SINGLE ORAL DOSE OF FCA 150 MG CAPS FOR THE TX OF WOMEN WITH VAGINAL CANDIDIASIS |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27683 |
Study title: Warts in children: Treatment with 5-fluorouracil 5% cream and other painless alternatives. Cunningham B.B. Cosmetic Dermatology ( Cosmet. Dermatol. ) (United States) , May 1, 2004 , 17/5 SUPPL. 1 (9-12) Warts in children: Treatment with 5-fluorouracil 5% cream and other painless alternatives. Cunningham B.B. Cosmetic Dermatology ( Cosmet. Dermatol. ) (United States) , May 1, 2004 , 17/5 SUPPL. 1 (9-12) |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28262 |
Study title: Young patient trabeculectomy: Assessment of risk factors for failure. Sturmer J. Ophthalmology. June 18, 1993, 928-39 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28292 |
Study title: A Double-Blind Placebo-Controlled Study of Fluoxetine and Clomipramine in the Treatment of Panic Disorder |
Active substance: FLUOXETINE |
Study summary document link (including results): Fluoxetine - B1Y-EW-HCHQ Synopsis.pdf |
View full study record |
Document reference: 28335 |
Study title: Discontinuation Of Fluoxetine In Ocd |
Active substance: FLUOXETINE |
Study summary document link (including results): Fluoxetine - B1Y-SZ-IS38 Synopsis.pdf |
View full study record |
Document reference: 28331 |
Study title: "Fluox20mg V Fluox40mg V Clomip75mg Out Pt. Maj. Depression |
Active substance: FLUOXETINE |
Study summary document link (including results): |
View full study record |
Document reference: 28339 |
Study title: Fluoxetine hydrocloride with enteric cover |
Active substance: FLUOXETINE |
Study summary document link (including results): |
View full study record |
Document reference: 28342 |
Study title: Chrisp P, Clissold SP. Foscarnet - a review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis.Chrisp P, Clissold SP. Foscarnet - a review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. |
Active substance: Foscarnet |
Study summary document link (including results): Chrisp P and Clissold SP 1992.pdf |
View full study record |
Document reference: 39630 |
Study title: Deruiter A, Thin RN. Genital herpes - a guide to pharmacological therapy. Drugs 1994; 47(2):297-304.Deruiter A, Thin RN. Genital herpes - a guide to pharmacological therapy. Drugs 1994; 47(2):297-304. |
Active substance: Foscarnet |
Study summary document link (including results): Deruiter A et al 1994.pdf |
View full study record |
Document reference: 39632 |
Study title: "Benitez JG, Swanson-Biearman B, Krenzelok EP. Nystagmus secondary to fomepizole administration in a pediatric patient. J Toxicol Clin Toxicol. 2000;38(7):795-8. " "Benitez JG, Swanson-Biearman B, Krenzelok EP. Nystagmus secondary to fomepizole administration in a pediatric patient. J Toxicol Clin Toxicol. 2000;38(7):795-8. " |
Active substance: FOMEPIZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28471 |
Study title: "Brown MJ, Shannon MW, Woolf A, Boyer EW. Childhood methanol ingestion treated with fomepizole and hemodialysis. Pediatrics. 2001 Oct;108(4):E77. " "Brown MJ, Shannon MW, Woolf A, Boyer EW. Childhood methanol ingestion treated with fomepizole and hemodialysis. Pediatrics. 2001 Oct;108(4):E77. " |
Active substance: FOMEPIZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28470 |
Study title: "Bucaretchi F, Baracat EC. [Acute toxic exposure in children: an overview] J Pediatr (Rio J). 2005 Nov;81(5 Suppl):S212-22. Review. Portuguese. " "Bucaretchi F, Baracat EC. [Acute toxic exposure in children: an overview] J Pediatr (Rio J). 2005 Nov;81(5 Suppl):S212-22. Review. Portuguese. " |
Active substance: FOMEPIZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28467 |
Study title: Diagnosis, clinical picture and treatment of cytomegaloviral infection in children. Rossiiskii Vestnik Perinatologii i Pediatrii 1994; 39(3):16-19.Bendel A, Gross T, Woods W, Edelman C, Balfour H.Diagnosis, clinical picture and treatment of cytomegaloviral infection in children. Rossiiskii Vestnik Perinatologii i Pediatrii 1994; 39(3):16-19.Bendel A, Gross T, Woods W, Edelman C, Balfour H. |
Active substance: FOSCARNET |
Study summary document link (including results): Bendel A et al 1993.pdf |
View full study record |
Document reference: 28569 |
Study title: Ding H, Ren H, Guo N, Huang X, Xu L, Zhang Y et al. [Risk factors of cytomegalovirus infection and antiviral efficacy in recipients of hematopoietic stem cell transplantation]. [Chinese]. Ding H, Ren H, Guo N, Huang X, Xu L, Zhang Y et al. [Risk factors of cytomegalovirus infection and antiviral efficacy in recipients of hematopoietic stem cell transplantation]. [Chinese]. |
Active substance: FOSCARNET |
Study summary document link (including results): Ding H et al 2003.pdf |
View full study record |
Document reference: 28592 |
Study title: Dini G, Castagnola E, Comoli P, van Tol MJD, Vossen JM. Infections after stem cell transplantation in children: state of the art and recommendations. Bone Marrow Transplantation. 2001; 28 (Suppl 1):S18-S21.Dini G, Castagnola E, Comoli P, van Tol MJD, Vossen JM. Infections after stem cell transplantation in children: state of the art and recommendations. Bone Marrow Transplantation. 2001; 28 (Suppl 1):S18-S21. |
Active substance: Foscarnet |
Study summary document link (including results): Dini G et al 2001.pdf |
View full study record |
Document reference: 39644 |
Study title: Douglas MW, Johnson RW, Cunningham AL. Tolerability of treatments for postherpetic neuralgia [Review]. Drug Safety 2004; 27(15):1217-1233.Douglas MW, Johnson RW, Cunningham AL. Tolerability of treatments for postherpetic neuralgia [Review]. Drug Safety 2004; 27(15):1217-1233. |
Active substance: FOSCARNET |
Study summary document link (including results): Douglas MW et al 2004.pdf |
View full study record |
Document reference: 28587 |
Study title: Dwyer DE, Kesson AM. Advances in antiviral therapy. Current Opinion in Pediatrics 1997; 9(1):24-30.Dwyer DE, Kesson AM. Advances in antiviral therapy. Current Opinion in Pediatrics 1997; 9(1):24-30. |
Active substance: Foscarnet |
Study summary document link (including results): Dwyer DE et al 1997.pdf |
View full study record |
Document reference: 39659 |
Study title: Eddleston M, Peacock S, Juniper M, Warrell DA. Severe cytomegalovirus infection in immunocompetent patients. Clinical Infectious Diseases 1997; 24(1):52-56.Eddleston M, Peacock S, Juniper M, Warrell DA. Severe cytomegalovirus infection in immunocompetent patients. Clinical Infectious Diseases 1997; 24(1):52-56. |
Active substance: Foscarnet |
Study summary document link (including results): Eddleston M et al 1997.pdf |
View full study record |
Document reference: 39660 |
Study title: Fucidin® ointment versus its vehicle and Bactroban® in the treatment of impetigoH Rockl. Unpublished. |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28646 |
Study title: Fucidin® ointment versus its vehicle in the treatment of impetigo |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28647 |
Study title: Open clinical studies with Gd-DTPA (dimeglumine gadopentetate) in cerebral and spinal diseases - Summary of studies at 22 hospitals. |
Active substance: GADOPENTETIC ACID |
Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_A23BSA_study_synopsis.pdf |
View full study record |
Document reference: 28835 |
Study title: Open clinical study in dynamic MRI in rheumatic arthritis and related disease |
Active substance: GADOPENTETIC ACID |
Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_88135_study_synopsis.pdf |
View full study record |
Document reference: 28824 |
Study title: Open clinical study in MRI (Magnetic Resonance Imaging) to demonstrate the tolerance and efficacy of Gd-DTPA (Gadolinium Diethylene triamine penta acetic Acid) in the whole body |
Active substance: GADOPENTETIC ACID |
Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_87054_study_synopsis.pdf |
View full study record |
Document reference: 28821 |
Study title: Open clinical study in MRI of intracranial and spinal tumors and other lesion of the CNS |
Active substance: GADOPENTETIC ACID |
Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_86224_study_synopsis.pdf |
View full study record |
Document reference: 28819 |
Study title: Open label study of Gadopentetate Dimeglumine as a magnetic resonance imaging (MRI) contrast agent in pediatric patients presenting with symptoms of central nervous system (CNS) lesions. |
Active substance: GADOPENTETIC ACID |
Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_88492_study_synopsis.pdf |
View full study record |
Document reference: 28831 |
Study title: Open label study of Gadopentetate Dimeglumine as an MRI contrast agent in pediatric patients presenting with symptoms of central nervous system lesions. |
Active substance: GADOPENTETIC ACID |
Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_88490_study_synopsis.pdf |
View full study record |
Document reference: 28828 |
Study title: Open uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging of musculo-skeletal lesions in children and teenage patients (6-18 years) |
Active substance: GADOPENTETIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28829 |
Study title: Open-Label Study of Gadopentetate Dimeglumine as an magnetic resonance imaging (MRI) contrast agent in pediatric patients presenting with symptoms of central nervous system lesions. |
Active substance: GADOPENTETIC ACID |
Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_88493_study_synopsis.pdf |
View full study record |
Document reference: 28832 |
Study title: Open-Label Study of Gadopentetate Dimeglumine as an MRI Contrast Agent in Pediatric Patients Presenting with Symptoms of Central Nervous System Lesions |
Active substance: GADOPENTETIC ACID |
Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_88488_study_synopsis.pdf |
View full study record |
Document reference: 28826 |
Study title: Open-Label study of Gadopentetate Dimeglumine as an MRI Contrast Agent in Pediatric Patients Presenting with Symptoms of Central Nervous System Lesions. |
Active substance: GADOPENTETIC ACID |
Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_88489_study_synopsis.pdf |
View full study record |
Document reference: 28827 |
Study title: AN OPEN-LABEL MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF GABAPENTIN AS ADD-ON THERAPY IN THE EXTENDED TREATMENT OF EPILEPTIC SEIZURES |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28764 |
Study title: AN OPEN-LABEL MULTICENTRE STUDY OF THE SAFETY AND EFFICACY OF GABAPENTIN AS AD-ON THERAPY AND MONOTHERAPY IN THE LONG-TERM TREATMENT OF EPILEPTIC SEIZURES |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28765 |
Study title: AN OPEN-LABEL, MULTICENTER STUDY TO DETERMINE THE SAFETY AND EFFICACY OF GABAPENTIN(NEURONTIN) IN COMPARISON WITH CARBAMAZEPINE IN THE LONG-TERM EXTENDED TREATMENT OF PATIENTS WITH NEWLY-DIAGNOSED EPILEPSY WHO ARE CONVERTED FROM PROTOCOL 945-077 |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28766 |
Study title: AN OPEN-LABEL, SAFETY STUDY OF GABAPENTIN (CI-945) AS ADJUNCT THERAPY IN CHILDREN AGED 1 MONTH THROUGH 4 YEARS WITH SEIZURES UNCONTROLLED BY CURRENT ANTIVONVULSANT DRUGS |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28767 |
Study title: AN OPEN-LABEL, UNCONTROLLED, MULTICENTER STUDY TO DETERMINE THE LONG TERM SAFETY AND EFFICACY OF GABAPENTIN (CI-945) ADMINISTERED AS MONOTHERAPY OR IN COMBINATION WITH OTHER ANTIEPILEPTIC DRUGS IN PATIENTS WITH MEDICALLY UNCONTROLLED PARTIAL OR GENERALIZED EPILEPTIC SEIZURES |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28768 |
Study title: AN ORAL, RISING SINGLE-DOSE TOLERANCE, PHARMACONETIC, AND PHARMACODYNAMIC STUDY OF PD 200390 CAPSULTE DOSES COMPARING HEALTHY ELDERLY VOLUNTEERS TO HEALTHY YOUNG VOLUNTEERS |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28769 |
Study title: COMPARATIVE CLINICAL TRIAL OF GABAPENTIN AND SODIUM VALPROATE AS ADD-ON THERAPY IN REFRACTORY PARTIAL EPILEPSIES: OPEN RANDOMIZED MULTICENTER TRIAL |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28770 |
Study title: COMPARATIVE NEURONTIN TRIAL: RESPONSE ON LONG TERM ASSESSMENT |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28771 |
Study title: Time resolved contrast enhanced MR angiography of the hand with parallel imaging and view sharing: initial experience; Brauck K; Eur. Radiol.; 2007 vol.17 p.183-192Time resolved contrast enhanced MR angiography of the hand with parallel imaging and view sharing: initial experience; Brauck K; Eur. Radiol.; 2007 vol.17 p.183-192 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28867 |
Study title: Utilization of gadolinium DOTA in the diagnosis of tumors of the central nervous system of the child;Lipski S; Diagn. Interv. Radiol.; 1990 vol.2 p.163-167Utilization of gadolinium DOTA in the diagnosis of tumors of the central nervous system of the child;Lipski S; Diagn. Interv. Radiol.; 1990 vol.2 p.163-167 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28842 |
Study title: Wirksamkeit und Verträglichkeit von Aknichthol N Lotio bei 40 Patienten mit leichter und mittelschwerer Akne vulgaris |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28878 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to the treatment of Galium-Heel (drops) [AWB-055] |
Active substance: Galium-Heel /Galium-Heel - Tropfen |
Study summary document link (including results): |
View full study record |
Document reference: 40004 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Galium-Heel (drops) [AWB-AT] |
Active substance: Galium-Heel/ Galium-Heel - Tropfen |
Study summary document link (including results): |
View full study record |
Document reference: 40003 |
Study title: Pharmacokinetics and tolerability of i.v. ganciclovir and oral valganciclovir syrup formulation in paediatric renal transplant recipients. |
Active substance: GANCICLOVIR |
Study summary document link (including results): |
View full study record |
Document reference: 28879 |
Study title: Safety and pharmacokinetics of i.v. ganciclovir and valganciclovir oral solution formulation in paediatric liver transplant recipients receiving treatment with i.v. ganciclovir for prevention of cytomegalovirus disease. |
Active substance: GANCICLOVIR |
Study summary document link (including results): |
View full study record |
Document reference: 28880 |
Study title: Prospective, multicenter, reference-controlled observational study for the documentation of therapeutic efficay and tolerability in the use of Gastricumeel (tablets) or proton pump inhibitors in the treatment of gastritis or heartburn [AWB-502] |
Active substance: Gastricumeel |
Study summary document link (including results): |
View full study record |
Document reference: 40005 |
Study title: Final Report from the Post Marketing Surveillance Study (Nurofen fur Kinder Fiebersaft) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29396 |
Study title: Final Study Report A Comparative Pharmacodynamic Evaluation of the Antipyretic Efficacy and Safety of Ibuprofen Liquid Vs Acetaminophen in children |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29458 |
Study title: Renn−E. The antipyretic use of acetaminophen versus ibuprofen in a pediatric care setting. {P−T}, 2000, Vol/Iss/Pg. 25/8 (395−397)Renn−E. The antipyretic use of acetaminophen versus ibuprofen in a pediatric care setting. {P−T}, 2000, Vol/Iss/Pg. 25/8 (395−397) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29579 |
Study title: Report on a comparative assessment of the anti-pyretic activity of Ibuprofen and Paracetamol suspensions in children. Prof T I Bhutta, Nishta Medical College, Multan |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29451 |
Study title: Roth RP et al. Nasal decongestant activity of pseudoephedrine. Ann Otol Rhinol Laryngol 1977; 86(2 pt. 1):235-42 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29515 |
Study title: Sarrell−E−M et al. Antipyretic treatment in young children with fever: Acetaminophen, ibuprofen, or both alternating in a randomized, double−blind study. {ARCH−PEDIATR−ADOLESC− MED}, 2006, Vol/Iss/Pg. 160/2 (197−202)Sarrell−E−M et al. Antipyretic treatment in young children with fever: Acetaminophen, ibuprofen, or both alternating in a randomized, double−blind study. {ARCH−PEDIATR−ADOLESC− MED}, 2006, Vol/Iss/Pg. 160/2 (197−202) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29569 |
Study title: Single parallel group study investigating the antipyretic properties of ibuprofen syrup vs acetylsalicylic acid syrup in febrile children. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29467 |
Study title: Single-blind parallel group study investigating the antipyretic properties of Ibuprofen syrup versus Acetylsalicylic acid syrup in febrile children |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29420 |
Study title: Single-Blind Parallel Group Study Investigating the Antipyretic Properties of Ibuprofen Syrup Versus Acetylsalicylic Acid Syrup in Febrile Children |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-MS83-078.pdf |
View full study record |
Document reference: 47553 |
Study title: single-dose open study comparing Ibuprofen suspension and Paracetamol suspension in symptomatic therapy of juvenile pyrexia |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-BR9083.pdf |
View full study record |
Document reference: 29417 |
Study title: Sperber SJ et al. Effectiveness of pseudoephedrine plus acetaminophen for treatment of symptoms attributed to the paranasal sinuses associated with the common cold. Arch Fam Med 2000; 9(10):979-85 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29510 |
Study title: St. Charles CS et al.: A comparison of ibuprofen versus acetaminophen with codeine in the young tonsillectomy. PubMed. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29544 |
Study title: St. Charles CS et al.: A comparison of ibuprofen versus acetaminophen with codeine in the young tonsillectomy. PubMed. St. Charles CS et al.: A comparison of ibuprofen versus acetaminophen with codeine in the young tonsillectomy. PubMed. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29605 |
Study title: Starha−J et al. Ibuprofen as an antipyretic drug in childhood. {CESKO−SLOV−PEDIATR}, 1994, Vol/Iss/Pg. 49/7 (424−427)Starha−J et al. Ibuprofen as an antipyretic drug in childhood. {CESKO−SLOV−PEDIATR}, 1994, Vol/Iss/Pg. 49/7 (424−427) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29589 |
Study title: Study 1 - Ibuprofen in the treatment of postoperative pain in small children. A randomised double-blind-placebo controlled parallel group study |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29517 |
Study title: Study of the efficacy and tolerance of Ibuprofen on hectic fever in systemic juvenile chronic arthritis (JCA) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29406 |
Study title: Enright AM, Prober C. Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections. [Review] [99 refs]. Herpes 2003; 10(2):32-37.Enright AM, Prober C. Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections. [Review] [99 refs]. Herpes 2003; 10(2):32-37. |
Active substance: FOSCARNET |
Study summary document link (including results): Enright AM et al 2003.pdf |
View full study record |
Document reference: 28594 |
Study title: Franca IE, Poiaresbaptista A, Araujo CO, Borges FC, Lerias MG, Melo EL et Verrucous herpetic disseminated lesions in AIDS patients. European-Journal-of- Dermatology 1995; 5(3):212-215.Franca IE, Poiaresbaptista A, Araujo CO, Borges FC, Lerias MG, Melo EL et Verrucous herpetic disseminated lesions in AIDS patients. European-Journal-of- Dermatology 1995; 5(3):212-215. |
Active substance: Foscarnet |
Study summary document link (including results): Franca IE et al 1995.pdf |
View full study record |
Document reference: 39670 |
Study title: Frangoul H, Wills M, Crossno C, Engel M, Domm J. Acyclovir-resistant herpes simplex virus pneumonia post-unrelated stem cell transplantation: a word of caution. Pediatr Transplant. 2007 Dec;11(8):942-4.Frangoul H, Wills M, Crossno C, Engel M, Domm J. Acyclovir-resistant herpes simplex virus pneumonia post-unrelated stem cell transplantation: a word of caution. Pediatr Transplant. 2007 Dec;11(8):942-4. |
Active substance: Foscarnet |
Study summary document link (including results): Frangoul H et al 2007.pdf |
View full study record |
Document reference: 39617 |
Study title: Freifeld A. 1993. The antimicrobial armamentarium. Hematology-Oncology Clinics of North America 1993; 7(4):813-839.Freifeld A. 1993. The antimicrobial armamentarium. Hematology-Oncology Clinics of North America 1993; 7(4):813-839. |
Active substance: Foscarnet |
Study summary document link (including results): Freifeld A. et al 1993.pdf |
View full study record |
Document reference: 39620 |
Study title: Gambertoglio JG, Lilleby K, Meyers JD, Reusser P. 1992.Phase i-ii trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients. Journal of Infectious Diseases 1992;166(3):473-9 1992;(3):473-479.Gambertoglio JG, Lilleby K, Meyers JD, Reusser P. 1992.Phase i-ii trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients. Journal of Infectious Diseases 1992;166(3):473-9 1992;(3):473-479. |
Active substance: Foscarnet |
Study summary document link (including results): Reusser et al 1992.pdf |
View full study record |
Document reference: 39626 |
Study title: Gershon AA. Prevention and treatment of VZV infections in patients with HIV. Herpes. 2001; 8(2):32-36.Gershon AA. Prevention and treatment of VZV infections in patients with HIV. Herpes. 2001; 8(2):32-36. |
Active substance: Foscarnet |
Study summary document link (including results): Gershon AA 2001.pdf |
View full study record |
Document reference: 39645 |
Study title: Glassner CL, Noormohamed SE. Pediatric HIV infection: a primer for pharmacists. Journal of the American Pharmaceutical Association (1996) 1996;36(10):580-95 1999;(1996):580-595.Glassner CL, Noormohamed SE. Pediatric HIV infection: a primer for pharmacists. Journal of the American Pharmaceutical Association (1996) 1996;36(10):580-95 1999;(1996):580-595. |
Active substance: Foscarnet |
Study summary document link (including results): Glassner CL et al 1996.pdf |
View full study record |
Document reference: 39648 |
Study title: Griffiths PD. Progress in the clinical management of herpes virus infections. Antiviral-Chemistry- Chemotherapy 1995; 6(4):191-209.Griffiths PD. Progress in the clinical management of herpes virus infections. Antiviral-Chemistry- Chemotherapy 1995; 6(4):191-209. |
Active substance: Foscarnet |
Study summary document link (including results): Griffiths PD 1995.pdf |
View full study record |
Document reference: 39671 |
Study title: Grose C. Childhood infections with human herpesviruses types 6, 7, and 8. Advances in Pediatric Infectious Diseases 1996; 12:181-208.Grose C. Childhood infections with human herpesviruses types 6, 7, and 8. Advances in Pediatric Infectious Diseases 1996; 12:181-208. |
Active substance: Foscarnet |
Study summary document link (including results): Grose C. 1996.pdf |
View full study record |
Document reference: 39666 |
Study title: Gross G, Braun D. 2006. [Efficacy and tolerability of topical foscarnet sodium in treatment of herpes labialis. Results of postmarketing surveillance]. Hautarzt 2006; 57(1):40-46.Gross G, Braun D. 2006. [Efficacy and tolerability of topical foscarnet sodium in treatment of herpes labialis. Results of postmarketing surveillance]. Hautarzt 2006; 57(1):40-46. |
Active substance: FOSCARNET |
Study summary document link (including results): Gross G, Braun D 2006.pdf |
View full study record |
Document reference: 39590 |
Study title: Haas H. 2005. Antiviral treatment in chickenpox. Antibiotiques. 7(3):171-176, SEP 2005 2005;(3):-176, Sep. 2005.Haas H. 2005. Antiviral treatment in chickenpox. Antibiotiques. 7(3):171-176, SEP 2005 2005;(3):-176, Sep. 2005. |
Active substance: FOSCARNET |
Study summary document link (including results): Haas H. 2005.pdf |
View full study record |
Document reference: 39591 |
Study title: Open-Label Study of Gadopentetate Dimeglumine as an MRI Contrast Agent in Pediatric patients Presenting with Symptoms of Central Nervous System Lesions. |
Active substance: GADOPENTETIC ACID |
Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_88491_study_synopsis.pdf |
View full study record |
Document reference: 28830 |
Study title: Open-label, multicenter trial of Magnevist® enteral in magnetic resonance imaging of patients = 16 years of age |
Active substance: GADOPENTETIC ACID |
Study summary document link (including results): ME90095 ME91005 ME91006.pdf |
View full study record |
Document reference: 28825 |
Study title: Rapporto su uno studio non controllato con Kryptocur (denominazione sperimentale HOE 471) nel criptorchidismo. Prof. Hadziselimovic (Clinical study) 25/9/1981 |
Active substance: GONADORELIN |
Study summary document link (including results): |
View full study record |
Document reference: 28997 |
Study title: Aguiar AL, Couto-Silva AC, Vicente EJ, Freitas IC, Cruz T, Adan LF. Weight evolution in girls treated for idiopathic central precocious puberty with GnRH analogues. Journal of Pediatric Endocrinology and Metabolism 19(11)()(pp 1327-1334), 2006 Date of Publication: Nov 2006 2006;(11):1327-1334.Aguiar AL, Couto-Silva AC, Vicente EJ, Freitas IC, Cruz T, Adan LF. Weight evolution in girls treated for idiopathic central precocious puberty with GnRH analogues. Journal of Pediatric Endocrinology and Metabolism 19(11)()(pp 1327-1334), 2006 Date of Publication: Nov 2006 2006;(11):1327-1334. |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 28999 |
Study title: Albano MCC, Latronico AC, Arnhold IJP, Domenice S, Bloise W, Mendonca BB. Long-acting gonadotropin-releasing hormone agonists in the differential diagnosis of male precocious puberty. Journal of Pediatric Endocrinology and Metabolism 10(5)()(pp 499-503), 1997 Date of Publication: 1997 1997;(5):499-503.Albano MCC, Latronico AC, Arnhold IJP, Domenice S, Bloise W, Mendonca BB. Long-acting gonadotropin-releasing hormone agonists in the differential diagnosis of male precocious puberty. Journal of Pediatric Endocrinology and Metabolism 10(5)()(pp 499-503), 1997 Date of Publication: 1997 1997;(5):499-503. |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 29000 |
Study title: Antoniazzi F, Zamboni G. Central precocious puberty: Current treatment options. Pediatric Drugs 2004;6(4):211-231 2004;(4):211-231.Antoniazzi F, Zamboni G. Central precocious puberty: Current treatment options. Pediatric Drugs 2004;6(4):211-231 2004;(4):211-231. |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 29001 |
Study title: Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty. Paterson WF, McNeill E, Young D, Donaldson MDC. Clinical Endocrinology 2004;61(5)(Suppl 2):626-34 2004;(5):626-634.Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty. Paterson WF, McNeill E, Young D, Donaldson MDC. Clinical Endocrinology 2004;61(5)(Suppl 2):626-34 2004;(5):626-634. |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 29002 |
Study title: Breyer P, Haider A, Pescovitz O. Gonadotropin-releasing hormone agonists in the treatment of girls with central precocious puberty. Clinical Obstetrics and Gynecology 1993; 36(3):764-772.Breyer P, Haider A, Pescovitz O. Gonadotropin-releasing hormone agonists in the treatment of girls with central precocious puberty. Clinical Obstetrics and Gynecology 1993; 36(3):764-772. |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 29004 |
Study title: De B, V, Latronico AC, Arnhold IJP, Lo LSS, Domenice S, Albano MCC et al. Treatment of gonadotropin dependent precocious puberty due to hypothalamic hamartoma with gonadotropin releasing hormone agonist depot. Archives of Disease in Childhood 1999; 80(3):2.De B, V, Latronico AC, Arnhold IJP, Lo LSS, Domenice S, Albano MCC et al. Treatment of gonadotropin dependent precocious puberty due to hypothalamic hamartoma with gonadotropin releasing hormone agonist depot. Archives of Disease in Childhood 1999; 80(3):2. |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 29005 |
Study title: Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 29006 |
Study title: A Phase I study of gemcitabine in children with refractory solid tumours |
Active substance: GEMCITABINE |
Study summary document link (including results): |
View full study record |
Document reference: 28883 |
Study title: A Phase I study of gemcitabine in children with relapsed or refactory leukemia and non-Hodgkin's lymphoma |
Active substance: GEMCITABINE |
Study summary document link (including results): |
View full study record |
Document reference: 28882 |
Study title: A phase II study of Gemcitabine in Children with Relapsed Acute Lymphoblastic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) |
Active substance: GEMCITABINE |
Study summary document link (including results): |
View full study record |
Document reference: 28881 |
Study title: A phase II study of Gemcitabine in Children with Relapsed Acute Lymphoblastic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) |
Active substance: GEMCITABINE |
Study summary document link (including results): |
View full study record |
Document reference: 28884 |
Study title: A PHASE II STUDY OF GEMCITABINE IN CHILDREN WITH SOLID TUMOURS OF MESENCHYMAL AND EMBRYONAL ORIGIN |
Active substance: GEMCITABINE |
Study summary document link (including results): Gemcitabine - B9E-SB-0325.pdf |
View full study record |
Document reference: 47212 |
Study title: Phase II Study of Gemcitabine in Children with Relapsed Leukemia |
Active substance: GEMCITABINE |
Study summary document link (including results): Gemcitabine - B9E-SB-0350.pdf |
View full study record |
Document reference: 47213 |
Study title: Phase III, controlled, open-label, randomized, single-center study to evaluate the safety and immunogenicity using four different vaccination schedules of tick-borne encephalitis (TBE) - polygeline free vaccine in adolescents and adults. |
Active substance: Tick-Borne Encephalitis Virus |
Study summary document link (including results): |
View full study record |
Document reference: 48397 |
Study title: Bronchial secretion and serum levels in children with cystic fibrosis treated with gentamicin. - Vogt E. - 1973 ( Praxis, 62 : 444-447) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28891 |
Study title: Clinical an dLaboratory evaluation of Gentaimicin in Infants and Children. - Riley HD. & Al - 1971 (J. of infectious Dis. 124 Suppl: S236) - Publication in Gentamicin Registration Dossier - No author - 1977 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28892 |
Study title: A double blind dose-ranging study of the efficacy and safety of prophylactic BRL-043694-A in controlling cytotoxic drug induced nausea and vomiting in paediatric patients with malignant disease |
Active substance: GRANISETRON |
Study summary document link (including results): |
View full study record |
Document reference: 29022 |
Study title: Physiologic changes induced by theophylline in the treatment of apnea in preterm infants.Davi MJ, Sankaran K, Simons KJ, Simons FE, Seshia MM, Rigatto H. J Pediatr. 1978 Jan;92(1):91-5. |
Active substance: THEOPHYLLINE |
Study summary document link (including results): |
View full study record |
Document reference: 48958 |
Study title: Continuation study for the prophylactic use of intravenous BRL-043694-A in controlling cytotoxic drug induced nausea and vomiting in paediatric patients with malignant disease |
Active substance: GRANISETRON |
Study summary document link (including results): |
View full study record |
Document reference: 29023 |
Study title: Pellier P, Wells K, Singh Saggu P, Bartlett J: A double blind dose ranging study comparing the efficacy and safety of two oral doses of Granisetron solution 20 mcg/kg bd and 40 mcg/kg bd for prophylaxis of cytotoxic induced emesis in paediatric patients with malignant disease |
Active substance: GRANISETRON |
Study summary document link (including results): |
View full study record |
Document reference: 29026 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Graphites-Homaccord (drops) [AWB-AT] |
Active substance: Graphites-Homaccord |
Study summary document link (including results): |
View full study record |
Document reference: 40014 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Graphites-Homaccord (ampoules) [AWB-AT] |
Active substance: Graphites-Homaccord |
Study summary document link (including results): |
View full study record |
Document reference: 40015 |
Study title: A short notice and intermediateterm control of success after triennial hypersensitation with Graminea Pollen-Depot- Allergoid (Allergovit); Age of patients: 6-67 Years |
Active substance: Grasses |
Study summary document link (including results): |
View full study record |
Document reference: 47784 |
Study title: In-vitro determination of Interleukin-5, Interferongamma as well as IgG4 and IgG1 as monitor parameters in correlation with their clinical course during the first 2 years of preseasonal immunotherapy with a grass allergoid 10.04.01 Age of patients:6-49 Years, 27 Patients. |
Active substance: Grasses |
Study summary document link (including results): |
View full study record |
Document reference: 47783 |
Study title: |
Active substance: TIAGABINE |
Study summary document link (including results): |
View full study record |
Document reference: 38444 |
Study title: Taste Test Study by RSSL Pharma A taste testing study in healthy volunteers to investigate preference for Nurofen for Children Project Scrumptious |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29520 |
Study title: The gas chromatographic determination of 2(4-isobutylphenyl )- propionic acid in Brufen suspension - paediatric ( modified formula ) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29433 |
Study title: Pharmacovigilance of AlphanineSD; affinity purified, solvent detergent treated: An open label study of viral safety in previously untreated subjects with Haemophilia B. |
Active substance: HUMAN COAGULATION FACTOR IX |
Study summary document link (including results): 02 ATC 96-04 (synopsis).pdf |
View full study record |
Document reference: 47317 |
Study title: 'Post marketing study in haemophilia B patients using Nonafact® 100 IU/ml powder and solvent for solution for injection (human coagulation factor IX) |
Active substance: HUMAN COAGULATION FACTOR IX |
Study summary document link (including results): |
View full study record |
Document reference: 29134 |
Study title: Post-marketing authorisation study of the efficacy and safety of coagulation factors FACTANE, BETAFACT, WILFACTIN/WILSTART |
Active substance: HUMAN COAGULATION FACTOR IX |
Study summary document link (including results): |
View full study record |
Document reference: 29135 |
Study title: Summary of Clinical Data on Children Treated with Nanotiv |
Active substance: HUMAN COAGULATION FACTOR IX |
Study summary document link (including results): |
View full study record |
Document reference: 29132 |
Study title: A Postlicensing Study to Determine Long-Term Safety of Alphanate® in Previously-Treated Patients Diagnosed with Severe Hemophilia A |
Active substance: HUMAN COAGULATION FACTOR VII |
Study summary document link (including results): |
View full study record |
Document reference: 29144 |
Study title: Clinical Study of Recovery and Half-Life of Factor VII Concentrate (Human Immuno 1988-1991) |
Active substance: HUMAN COAGULATION FACTOR VII |
Study summary document link (including results): |
View full study record |
Document reference: 29142 |
Study title: Compassionate Use of Factor VII, VH |
Active substance: HUMAN COAGULATION FACTOR VII |
Study summary document link (including results): |
View full study record |
Document reference: 29141 |
Study title: Low risk if viral infection after administration of vapor heated factor VII concentrate or factor IX complex in first time recipients of blood components |
Active substance: HUMAN COAGULATION FACTOR VII |
Study summary document link (including results): |
View full study record |
Document reference: 29140 |
Study title: Open-Label Clinical Study of Long-Term Treatment and Prophylaxis with Factor VII Concentrate (Human) Immuno, Vapor Heated" |
Active substance: HUMAN COAGULATION FACTOR VII |
Study summary document link (including results): |
View full study record |
Document reference: 29138 |
Study title: Single Patient Use of Factor VII Concentrate |
Active substance: HUMAN COAGULATION FACTOR VII |
Study summary document link (including results): |
View full study record |
Document reference: 29143 |
Study title: Study to determine the safety of virus inactivated factor concentrates in hemophiliacs naive to blood product administration (IFSS) |
Active substance: HUMAN COAGULATION FACTOR VII |
Study summary document link (including results): |
View full study record |
Document reference: 29139 |
Study title: A study on the safety and efficacy of FEIBA VH Immuno in Hemophilia Patients with Inhibitors Hemophiliac Treatment Research Study |
Active substance: HUMAN COAGULATION FACTOR VIII |
Study summary document link (including results): 05 ATG95-03 (full).pdf |
View full study record |
Document reference: 29148 |
Study title: Clinical study to investigate the efficacy, safety and immunogenicity of Wilate in children < 6 years of age with inherited von willebrand disease. |
Active substance: HUMAN COAGULATION FACTOR VIII |
Study summary document link (including results): |
View full study record |
Document reference: 29157 |
Study title: Efficacy and safety in children with severe Haemophilia A treated with OCTANATE (Phase III) |
Active substance: HUMAN COAGULATION FACTOR VIII |
Study summary document link (including results): |
View full study record |
Document reference: 29156 |
Study title: Efficacy of factor VIII/von Willebrand factor concentrate Alphanate in preventing excessive bleeding during surgery or invasive procedures in subjects with congenital von Willebrand disease |
Active substance: HUMAN COAGULATION FACTOR VIII |
Study summary document link (including results): |
View full study record |
Document reference: 29146 |
Study title: Efficacy Study of FEIBA IMMUNO Vapor Heated Versus Factor IX Complex (Human) IMMUNO, Vapor Heated, in the Management of Patients with Hemophilia A with Inhibitors |
Active substance: HUMAN COAGULATION FACTOR VIII |
Study summary document link (including results): |
View full study record |
Document reference: 29150 |
Study title: Evaluation of the Pharmacokinetic, Clinical Efficacyand Safety of the Concentrate of Factor VIII, Emoclot D.I., in patients affected by Haemophilia A |
Active substance: HUMAN COAGULATION FACTOR VIII |
Study summary document link (including results): 06 IG95-01B (full).pdf |
View full study record |
Document reference: 29154 |
Study title: Han YX, Xue R, Zhao W, Zhou ZX, Li JN, Chen HS et al. 2005.Antiviral therapeutic efficacy of foscarnet in hepatitis B virus infection.Antiviral Research. 68(3):147-153, DEC 2005 2005;(3):-153, Dec.2005.Han YX, Xue R, Zhao W, Zhou ZX, Li JN, Chen HS et al. 2005.Antiviral therapeutic efficacy of foscarnet in hepatitis B virus infection.Antiviral Research. 68(3):147-153, DEC 2005 2005;(3):-153, Dec.2005. |
Active substance: FOSCARNET |
Study summary document link (including results): |
View full study record |
Document reference: 39592 |
Study title: Hatchette T, Tipples GA, Peters G, Alsuwaidi A, Zhou J, Mailman TL. Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature. Pediatr Infect Dis J. 2008 Jan;27(1):75-7.Hatchette T, Tipples GA, Peters G, Alsuwaidi A, Zhou J, Mailman TL. Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature. Pediatr Infect Dis J. 2008 Jan;27(1):75-7. |
Active substance: Foscarnet |
Study summary document link (including results): Hatchette T et al 2008.pdf |
View full study record |
Document reference: 39615 |
Study title: Hick RW, Prose N. 2010. Penile erosions associated with foscarnet therapy in a child. Pediatr Dermatol. 2010 May-Jun;27(3):302-3.Hick RW, Prose N. 2010. Penile erosions associated with foscarnet therapy in a child. Pediatr Dermatol. 2010 May-Jun;27(3):302-3. |
Active substance: FOSCARNET |
Study summary document link (including results): Hick RW et al 2010.pdf |
View full study record |
Document reference: 39601 |
Study title: Hubacek P, Keslova P, Formankova R, Pochop P, Cinek O, Zajac M, Lochmanova J, Stary J, Sedlacek P. Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet. Pediatr Transplant. 2009 Nov;13(7):919- 22.Hubacek P, Keslova P, Formankova R, Pochop P, Cinek O, Zajac M, Lochmanova J, Stary J, Sedlacek P. Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet. Pediatr Transplant. 2009 Nov;13(7):919- 22. |
Active substance: Foscarnet |
Study summary document link (including results): Hubacek P et al 2009.pdf |
View full study record |
Document reference: 39609 |
Study title: Idanpaan H, Aranko K. Miscellaneous antibacterial and antiviral drugs. In: Side effects of drugs. MNG Dukes & JK Aronsen (ed). Elsevier Science Publishers. 1992;322- 340.Idanpaan H, Aranko K. Miscellaneous antibacterial and antiviral drugs. In: Side effects of drugs. MNG Dukes & JK Aronsen (ed). Elsevier Science Publishers. 1992;322- 340. |
Active substance: Foscarnet |
Study summary document link (including results): Idanpaan H et al 1992.pdf |
View full study record |
Document reference: 39627 |
Study title: Ippoliti C, Morgan A, Warkentin D, Van BK, Mehra R, Khouri I. Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir.Ippoliti C, Morgan A, Warkentin D, Van BK, Mehra R, Khouri I. Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir. |
Active substance: Foscarnet |
Study summary document link (including results): Ippoliti C et al 1997.pdf |
View full study record |
Document reference: 39661 |
Study title: Jacobson MA, Kramer F, Bassiakos Y, Hooton T, Polsky B, Geheb H et al. Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS Clinical Trial Group Protocol 151. Journal-of-Infectious- Diseases 1994; 170 (July): 189-193.Jacobson MA, Kramer F, Bassiakos Y, Hooton T, Polsky B, Geheb H et al. Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS Clinical Trial Group Protocol 151. Journal-of-Infectious- Diseases 1994; 170 (July): 189-193. |
Active substance: Foscarnet |
Study summary document link (including results): Jacobson MA _Kramer F et al 1994.pdf |
View full study record |
Document reference: 39633 |
Study title: Jacobson MA,Causey D, Polsky B, Hardy D, Chown M, Davis R. A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS. Journal of Infectious Diseases 1993; 168(2):444-448.Jacobson MA,Causey D, Polsky B, Hardy D, Chown M, Davis R. A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS. Journal of Infectious Diseases 1993; 168(2):444-448. |
Active substance: Foscarnet |
Study summary document link (including results): Jacobson MA et al 1993.pdf |
View full study record |
Document reference: 39622 |
Study title: Kawamura Y, Yoshikawa T. 2011. HHV-6 encephalopathy. Nippon Rinsho. 2011 Mar;69(3):423-8.Kawamura Y, Yoshikawa T. 2011. HHV-6 encephalopathy. Nippon Rinsho. 2011 Mar;69(3):423-8. |
Active substance: FOSCARNET |
Study summary document link (including results): Kawamura Y 2011.pdf |
View full study record |
Document reference: 39598 |
Study title: Keating MR. Antiviral agents. Mayo-clinic-proceedings 1992; 67(2):160-178.Keating MR. Antiviral agents. Mayo-clinic-proceedings 1992; 67(2):160-178. |
Active substance: Foscarnet |
Study summary document link (including results): Keating MR et al 1992.pdf |
View full study record |
Document reference: 39628 |
Study title: Isaac H, Patel L, Meyer S, Hall CM, Cusick C, Price DA et al. Efficacy of a monthly compared to 3-monthly depot GnRH analogue (goserelin) in the treatment of children with central precocious puberty. Hormone Research 2007; 68(4):157-163.Isaac H, Patel L, Meyer S, Hall CM, Cusick C, Price DA et al. Efficacy of a monthly compared to 3-monthly depot GnRH analogue (goserelin) in the treatment of children with central precocious puberty. Hormone Research 2007; 68(4):157-163. |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 28998 |
Study title: Lebrethon M-C, Grossman AB, Afshar F, Plowman PN, Besser GM, Savage MO. Linear Growth and Final Height after Treatment for Cushing's Disease in Childhood. Journal of Clinical Endocrinology and Metabolism 2000; 85(9):3262-3265.Lebrethon M-C, Grossman AB, Afshar F, Plowman PN, Besser GM, Savage MO. Linear Growth and Final Height after Treatment for Cushing's Disease in Childhood. Journal of Clinical Endocrinology and Metabolism 2000; 85(9):3262-3265. |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 29007 |
Study title: Untersuchung der Wirkamkeit einer neuen oralen Dareichungsform von Furosemid bei herinsuffizienten Kindern (abs) - Vogel M. et al. - 1990 (Monatschr Kinderheilkd, 138:488, abs 036) Publication in Clinical Expert Report - Dr Matti VERHO - 05/1995 - Volume 2 |
Active substance: FUROSEMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28642 |
Study title: |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28723 |
Study title: |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28724 |
Study title: |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28725 |
Study title: 4A. A report of patients with superficial skin sepsis treated with fucidin cream. An open assessment of Fucidin Cream as a treatment for superficial sepsis (Newby) |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28669 |
Study title: A clinical investigation of the pharmacokinetics of MULTIHANCE in healthy normal subjects from two to fifteen years of age. |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28720 |
Study title: A comparative study of Fucidin® ointment (sodium fusidate 2%) and Cicatrin cream (neomycin sulphate 0.5%, bacitracin zinc 250u/g |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28692 |
Study title: A comparison of Fucidin tablets and Flucloxacillin in skin and soft-tissue infections |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28694 |
Study title: A comparison of Fucithalmic® eye drops and Chloramphenicol® eye ointment as single treatment in brasion corneae, corpus alieni corneae |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28650 |
Study title: A comparison of Fusidic acid 1% viscous eye drops (Fucithalmic LEO) and neosporin eye ointment (Wellcome) in patients with external eye infections; Yacinto U Dy, Llacco Int. J. of clinical practices, Vol 7., No. 3., 1991 82 pts (4-75) |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28708 |
Study title: A comparison of fusidic acid gel 1% (Fucithalmic®) and chloramphenicol 0.5% in acute bacterial conjunctivits Carr WD, Journal Clin Research 1998;1:403-411 |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28713 |
Study title: A comparison of fusidic acid viscous eye drops and Chloramphenicol eye ointment in acute conjunctivitis |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28697 |
Study title: A comparison of low dose and standard dose systemic Fucidin® in skin and soft tissue infections |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28716 |
Study title: A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28693 |
Study title: A comparison of the efficacy of Fucidin® H cream(2% fusidic acid/1%hydrocortisone acetate) with Fucidin® cream(2% fusidic acid) in the management of patients with mild to moderate atopic eczema |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28672 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Gripp-Heel (tablets) in children aged up to 11 years old [AWB-063] |
Active substance: Gripp-Heel |
Study summary document link (including results): |
View full study record |
Document reference: 40018 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to the treatment of Gripp-Heel (tablets) [AWB-056] |
Active substance: Gripp-Heel |
Study summary document link (including results): |
View full study record |
Document reference: 40016 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to the treatment of Gripp-Heel (injection solution) [AWB-056] |
Active substance: Gripp-Heel |
Study summary document link (including results): |
View full study record |
Document reference: 40020 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Gripp-Heel (ampoules) [AWB-AT] |
Active substance: Gripp-Heel |
Study summary document link (including results): |
View full study record |
Document reference: 40017 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Gripp-Heel (tablets) [AWB-AT] |
Active substance: Gripp-Heel |
Study summary document link (including results): |
View full study record |
Document reference: 40019 |
Study title: Korppi M et al. Antitussives in the treatment of acute transient cough in children. Acta Paediatr Scand 1991; 80(10):969-71Korppi M et al. Antitussives in the treatment of acute transient cough in children. Acta Paediatr Scand 1991; 80(10):969-71 |
Active substance: GUAIFENESIN |
Study summary document link (including results): |
View full study record |
Document reference: 29027 |
Study title: Lee PCL et al. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 2000; 52(9):1137-42Lee PCL et al. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 2000; 52(9):1137-42 |
Active substance: GUAIFENESIN |
Study summary document link (including results): |
View full study record |
Document reference: 29028 |
Study title: Parvez−L, Vaidya−M, Sakhardande−A, Subburaj−S, Rajagopalan−T−G. Evaluation of antitussive agents in man. Pulmonary pharmacology, {Pulm−Pharmacol}, Oct−Dec 1996, vol. 9, no. 5−6, p. 299−308. Parvez−L, Vaidya−M, Sakhardande−A, Subburaj−S, Rajagopalan−T−G. Evaluation of antitussive agents in man. Pulmonary pharmacology, {Pulm−Pharmacol}, Oct−Dec 1996, vol. 9, no. 5−6, p. 299−308. |
Active substance: GUAIFENESIN |
Study summary document link (including results): |
View full study record |
Document reference: 45237 |
Study title: Open clinical study to evaluate the reactogenicity of SmithKline Beecham Biologicals' Hib conjugate vaccine mixed with SmithKline Beecham Biologicals' DTPa vaccine when given as a booster dose to children at 15 to 18 months of age, previously primed with SB Bio's Hib tetanus conjugate and DTPa vaccines in study HIB-012. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41133 |
Study title: Open label, randomised comparative assessment of the immunogenicity and reactogenicity of SmithKline Beecham's (SB's) diphteria/tetanus/acellular pertussis (DTPa) vaccine and SB's Hib with commercially available diphtheria/tetanus/whole cell pertussis (DTPw) and SB's Hib. Vaccines to be combined in the same syringe and administered to healthy infants as three consecutive doses at 2, 3 and 4 months of age. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41137 |
Study title: Open randomised clinical study to evaluate the immunogenicity and reactogenicity of SB Biologicals' Hib tetanus conjugate vaccine, co-administered with SB Biologicals' DTPa vaccine either mixed in one syringe, or in two separate injections into opposite limbs, to healthy children around two years of age. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41141 |
Study title: Open study to assess the immunogenicity and reactogenicity of a three-dose primary vaccination course against Haemophilus influenzae type b, diphtheria, tetanus, pertussis and hepatitis B in healthy infants at 6, 10 and 14 weeks of age. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41155 |
Study title: Open, phase II clinical trial to assess long-term antibody persistence, before Td booster vaccination, in healthy children 5 to 6 years old, previously vaccinated with 4 doses of SB Biologicals¿ DTPa vaccine mixed with SB Biologicals¿ Hib conjugate vaccine in primary vaccination study Hib-006 (208108/005) and in booster vaccination study Hib-017 (208108/017). |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41156 |
Study title: Familiarization Phase of FEIBA Immuno Study (Hilgartner) |
Active substance: HUMAN COAGULATION FACTOR VIII |
Study summary document link (including results): 03 IG405 (synopsis).pdf |
View full study record |
Document reference: 29149 |
Study title: Human Plasma derived Antihemophilic Factor VIII: Evaluation of Efficacy, Tolerability and Safety in Previously Treated Severe Hemophilia A Patients. An Open non-Comparative Phase III Study. |
Active substance: HUMAN COAGULATION FACTOR VIII |
Study summary document link (including results): |
View full study record |
Document reference: 29153 |
Study title: A dose-ranging study of Ibuprofen syrup in pyrexia in chlidren |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29427 |
Study title: A dose-ranging study of Ibuprofen syrup in pyrexia in chlidren |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29440 |
Study title: A double blind single-dose, Parallel study comparing Advil Liquigel to Excedrin Extra-Strength /Excedrin Migraine and to Placebo in Migraine Headache |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29527 |
Study title: A double blind, single oral dose study, comparing the antipyretic properties of ibuprofen, acetaminophen and placebo in the treatment of pyrexia associated with infectious disease in children. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29464 |
Study title: A double blind, single-dose, parallel group study comparing Advil Liquigel to Extra Strength Excedrin/Excedrin Migraine and to Placebo in Dental Pain |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29525 |
Study title: A double-blind comparison of Ibuprofen and Paracetamol in juvenile pyrexia |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29423 |
Study title: A double-blind comparison of Ibuprofen and Paracetamol in juvenile pyrexia |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29438 |
Study title: A DOUBLE-BLIND COMPARISON OF IBUPROFEN AND PARACETAMOL IN JUVENILE PYREXIA |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-MS85-526.pdf |
View full study record |
Document reference: 47554 |
Study title: A double-blind comparison of the safety and efficacy of a single dose of Children's Advil Ibuprofen suspension (10mg.kg~1), Acetaminophen (15mg.kg~1), and suspension (10mg.kg~1), Acetaminophen (15mg.kg~1), and a control vehicle in the relief of sore throat pain in children. |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-WM-366.pdf |
View full study record |
Document reference: 29434 |
Study title: A double-blind comparison of the safety and efficacy of a single dose of Children's Advil Ibuprofen uspension (10mg.kg~1), Acetaminophen (15mg.kg~1), and suspension (10mg.kg~1), Acetaminophen (15mg.kg~1), and a control vehicle in the relief of sore throat pain in children. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29454 |
Study title: A double-blind multicentre, multiple dose, parrallel group study comparing the efficacy of thre dose levels of Ibuprofen versus Acetaminophen in the Treatment of Pyrexia in Children |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29394 |
Study title: A Double-Blind Parallel Study to Compare the Efficacy and Side Effects of an Ibuprofen 400 mg/Pseudoephedrine 60 mg Combination, an Ibuprofen 200 mg/Pseudoephedrine 30 mg Combination, and Placebo in the Treatment of Sinus Headache |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29502 |
Study title: A double-blind placebo controlled study comparing the safety and efficacy of ibuprofen 600 mg sustained release to ibuprofen 200 mg regular release, in the treatment of post-operative dental pain |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29497 |
Study title: A double-blind placebo controlled study comparing the safety and efficacy of ibuprofen 600 mg sustained release to ibuprofen 200 mg regular release, administered every four hours, in the treatment of post-operative dental pain |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29499 |
Study title: Kimberlin DW. Antiviral therapy for cytomegalovirus infections in pediatric patients. Seminars in Pediatric Infectious Diseases. 2002; 13(1):22-30.Kimberlin DW. Antiviral therapy for cytomegalovirus infections in pediatric patients. Seminars in Pediatric Infectious Diseases. 2002; 13(1):22-30. |
Active substance: Foscarnet |
Study summary document link (including results): Kimberlin DW. et al 2002.pdf |
View full study record |
Document reference: 39637 |
Study title: Kist-van Holthe JE, Goedvolk CA, Brand R, van Weel MH, Bredius RG, van Oostayen JA et al. Prospective study of renal insufficiency after bone marrow transplantation. Pediatric Nephrology. 2002; 17(12):1032-1037.Kist-van Holthe JE, Goedvolk CA, Brand R, van Weel MH, Bredius RG, van Oostayen JA et al. Prospective study of renal insufficiency after bone marrow transplantation. Pediatric Nephrology. 2002; 17(12):1032-1037. |
Active substance: Foscarnet |
Study summary document link (including results): Kist-van Holthe JE et al 2002.pdf |
View full study record |
Document reference: 39638 |
Study title: Leport C, Perronne C, Vilde JL. Antiviral treatment of varicella in adults and immunocompromised hosts (adults and children). Medecine et Maladies Infectieuses 1998; 28(Special Issue SI):837-842.Leport C, Perronne C, Vilde JL. Antiviral treatment of varicella in adults and immunocompromised hosts (adults and children). Medecine et Maladies Infectieuses 1998; 28(Special Issue SI):837-842. |
Active substance: Foscarnet |
Study summary document link (including results): Leport C et al 1998.pdf |
View full study record |
Document reference: 39652 |
Study title: Ljungman P, Oberg G, Aschan J, Ehrnst A, Lonnqvist B, Pauksen K et al. Foscarnet for pre-emptive therapy of cmv infection detected by a leukocyte-based nested pcr in allogeneic bone marrow transplant patients. Bone Marrow Transplantation 1996;18(3):565-56Ljungman P, Oberg G, Aschan J, Ehrnst A, Lonnqvist B, Pauksen K et al. Foscarnet for pre-emptive therapy of cmv infection detected by a leukocyte-based nested pcr in allogeneic bone marrow transplant patients. Bone Marrow Transplantation 1996;18(3):565-56 |
Active substance: Foscarnet |
Study summary document link (including results): Ljungman P et al 1996.pdf |
View full study record |
Document reference: 39667 |
Study title: Ljungman P. 1995 Cytomegalovirus pneumonia: presentation, diagnosis, and treatment. Seminars in Respiratory Infections 1995; 10(4):209-215. Ljungman P. 1995 Cytomegalovirus pneumonia: presentation, diagnosis, and treatment. Seminars in Respiratory Infections 1995; 10(4):209-215. |
Active substance: Foscarnet |
Study summary document link (including results): Ljungman P 1995.pdf |
View full study record |
Document reference: 39672 |
Study title: Ma C, Wong CK, Wong BC, Chan KC, Lun SW, Lee N, Wu J, Cockram CS, Chan PK, Tang JW.Cytokine responses in a severe case of glandular fever treated successfully with foscarnet combined with prednisolone and intravenous immunoglobulin.J Med Virol. 2009 Jan;81(1):99-105.Ma C, Wong CK, Wong BC, Chan KC, Lun SW, Lee N, Wu J, Cockram CS, Chan PK, Tang JW.Cytokine responses in a severe case of glandular fever treated successfully with foscarnet combined with prednisolone and intravenous immunoglobulin.J Med Virol. 2009 Jan;81(1):99-105. |
Active substance: Foscarnet |
Study summary document link (including results): Ma C et al 2009.pdf |
View full study record |
Document reference: 39610 |
Study title: Marshall BC, Koch WC. Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events.Paediatr Drugs. 2009;11(5):309-21.Marshall BC, Koch WC. Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events.Paediatr Drugs. 2009;11(5):309-21. |
Active substance: Foscarnet |
Study summary document link (including results): Marshall BC et al 2009.pdf |
View full study record |
Document reference: 39606 |
Study title: Mattes FM, Hainsworth EG, Geretti AM, Nebbia G, Prentice G, Potter M et al. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients. Journal of Infectious Diseases 189(8), 1355-1361. 2004. Mattes FM, Hainsworth EG, Geretti AM, Nebbia G, Prentice G, Potter M et al. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients. Journal of Infectious Diseases 189(8), 1355-1361. 2004. |
Active substance: FOSCARNET |
Study summary document link (including results): Mattes FM et al 2004.pdf |
View full study record |
Document reference: 28588 |
Study title: Mazeron MC, Alain S. Active antiviral agents against human cytomegalovirus and their use in pediatrics. Archives de Pediatrie 1996; 3:Suppl-311s.Mazeron MC, Alain S. Active antiviral agents against human cytomegalovirus and their use in pediatrics. Archives de Pediatrie 1996; 3:Suppl-311s. |
Active substance: Foscarnet |
Study summary document link (including results): Mazeron MC et al 1996.pdf |
View full study record |
Document reference: 39668 |
Study title: Mindel A. Recent advances in genital herpes. Annals of the Academy of Medicine, Singapore 1995; 24(4):584-592.Mindel A. Recent advances in genital herpes. Annals of the Academy of Medicine, Singapore 1995; 24(4):584-592. |
Active substance: Foscarnet |
Study summary document link (including results): Mindel A 1995.pdf |
View full study record |
Document reference: 39673 |
Study title: A Prospective Blinded Read to Explore the Efficacy of MULTIHANCE and MAGNEVIST (0.10 mmol/kg) in Magnetic Resonance Imaging (MRI) of Brain and Spine Tumors in Pediatric Population |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28722 |
Study title: Long-acting gonadotropin-releasing hormone agonists in the differential diagnosis of male precocious puberty. .Long-acting gonadotropin-releasing hormone agonists in the differential diagnosis of male precocious puberty. . |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 29008 |
Study title: Nikolov A, Burdarova I, Kolarov G, Veltova L. The use of GnRH agonists in severe uterine hemorrhages in adolescence caused by congenital aplastic and hypoplastic anemias. Akusherstvo i Ginekologiia 1999;38(2):46-8.Nikolov A, Burdarova I, Kolarov G, Veltova L. The use of GnRH agonists in severe uterine hemorrhages in adolescence caused by congenital aplastic and hypoplastic anemias. Akusherstvo i Ginekologiia 1999;38(2):46-8. |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 29009 |
Study title: Fucidin® tablets in cutaneous infection in comparison with pristinamycin tablets |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28695 |
Study title: Fucithalmic in external eye infections. Fucithalmic in The Baltic States (adults & children) |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28648 |
Study title: Fucithalmic viscous eye drops in acute conjunctivitis Single-Blind, Ramdomized Comparison with Chloramphenicol Eye Drops ; J. Hvidberg Acta Ophthalmologica, vol 65, no 1. 1987 |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28699 |
Study title: Fucithalmic viscous eye drops in superficial eye infections Open non-comparative study |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28652 |
Study title: Fucithalmic, chloramphenicol or no treatment after squint surgery in children: a single blind randomised study |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28719 |
Study title: Fucithalmic® versus 1% rifamycin in acute conjunctivitis.Adenis J P, Arrata M, Gastaud P, Limon S, Massin M. J. Fr Ophtalmol 1989; 12(4): 317-322 |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28653 |
Study title: Fusidic Acid and the Treatment of Patients with Skin and Soft Tissue Infections |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28698 |
Study title: Fusidic acid versus tobramycin in suspected bacterial conjunctivitis |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28680 |
Study title: Garborg-O, Nyjordet-R. Pyogenic Cutaneous Infections In East African Children Treated With Fucidin Ointment. Journal of Tropical Pediatrics and Environmental Child Health, 1971, vol. 17, no. 4, p. 153-157. |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28663 |
Study title: Garborg-O. Cutaneous staphylococcal infections in children treated by 2 per cent sodium fusidate ointment. Bruxelles medical, {Brux-Med}, Jun 1968, vol. 48, no. 6, p. 377-82, ISSN: 0068-3027. |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28664 |
Study title: Koning-S, van-Suijlekom-Smit-LWA, Nouwen-JL, Verduin-CM, Bernsen-RMD, et-al. Erasmus University and University Hospital Rotterdam, Rotterdam, The Netherlands. Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial. BMJ, {BMJ}, 26 Jan 2002, vol. 324, p. 203-206, ISSN: 0959-8138. |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28656 |
Study title: Koning-S, van-Suijlekom-Smit-LWA, Nouwen-JL, Op-t-Veld-Mulders-M, Snijders-S, et-al. Erasmus University Medical Center, Rotterdam, The Netherlands. Fusidic acid cream versus placebo in the treatment of impetigo: a double blind placebo controlled randomized trial. 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, {41st-ICAAC}, 22 Sep 2001, p. 269. |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28657 |
Study title: Liddy-N. Intravenous fusidic acid in the newborn. Lancet, {Lancet}, 17 Mar 1973, vol. 1, no. 7803, p. 621, ISSN: 0140-6736. |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28662 |
Study title: Gentamycin in the treatment of infections in the premature infant. - Forti G. - 1968 (Antibiotica, Dec, 4:255)- Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28925 |
Study title: Germs of the serratia genus as etiological agents in septicemic syndroms in children. - Negut M. -1972 (Arch. Roum. Path. Exp. Microbiol. 31,2: 225) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28926 |
Study title: Intérêt de la gentalline 10mg en pédiatrie. Orsini A. - 1972 (Marseille Medical, 109, 12: 836-866) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28927 |
Study title: Intravenous Gentamicin for infections complications in children wth acute leukemia. - Haghbin M. -1971 (J. Infectious Dis. Dec. Suppl 124:192) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28928 |
Study title: Is the primary suture indicated in infected wounds in pediatric surgery?Is the primary suture indicated in infected wounds in pediatric surgery? |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28887 |
Study title: La Gentamicine en pédiatrie - Dachy A. & Al. - 1972 (Medecine et Hygiène 1034: 1831-2) - Publication in Gentamicin Registration Dossier - No author - 1977 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28929 |
Study title: La Gentamycine en pédiatrie - utilisation de la forme 10mg/1ml - Monnet P. -1970 (Lyon Medical, 224, 34: 432-439) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28930 |
Study title: La pharmacocinetique de la gentamicine chez l'adulte et chez des enfants d'ages divers. - Simon C. - 1973 (Dec. Med. Welt, 16, 73 : 626-630) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28931 |
Study title: Perinatal pharmacology of gentamicin. - Salvador G. - 1972 (Clinical research, 20,2: 252) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28932 |
Study title: Pharmacokinetics of gentamicin during peritoneal dialysis in children - Juskon WJ. - 1976 (Kidney, 9, 5 : 430-8) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28933 |
Study title: Pharmacokinetics of gentamicin in children and adults. - Siber GR. - 1975 (J. Infect. Dis., 132, 6: 637-631) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28934 |
Study title: Pharmacologic evaluation of gentamicin in newborn infants. - McCracken - 1971 (J. of Infectious Dis. 124, Suppl: S214) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28935 |
Study title: Serratia marcescens osteomyelitis in an infant. - Nelms DK. - 1968 (J. Pediat., 72: 222) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28937 |
Study title: Single-dose kanamycin therapy of gonococcal ophthalmia neonatorum. Fransen L, Nsanze H, D'Costa L, Brunham RC, Ronald AR, Piot P. Lancet. 1984 Dec 1;2(8414):1234-7. Single-dose kanamycin therapy of gonococcal ophthalmia neonatorum. Fransen L, Nsanze H, D'Costa L, Brunham RC, Ronald AR, Piot P. Lancet. 1984 Dec 1;2(8414):1234-7. |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28885 |
Study title: Study of a new antibiotic: injectable gentamicin therapy in paediatrics. - D'Oelsnitz M. - 1967 - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28938 |
Study title: Wolfson MR, Bhutani VK, Shaffer TH, Bowen FW. Mechanics and energetics of breathing helium in infants with bronchopulmonary dysplasia. J Pediatr 1984;104:752-757.Wolfson MR, Bhutani VK, Shaffer TH, Bowen FW. Mechanics and energetics of breathing helium in infants with bronchopulmonary dysplasia. J Pediatr 1984;104:752-757. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29114 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Hepar compositum (ampoules) [AWB-AT] |
Active substance: Hepar compositum-Heel - Ampullen |
Study summary document link (including results): |
View full study record |
Document reference: 40024 |
Study title: Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis - Greinacher A. et al. - 2005 (Thromb Haemost 2005; 94; 132-5) Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis - Greinacher A. et al. - 2005 (Thromb Haemost 2005; 94; 132-5) |
Active substance: HEPARIN |
Study summary document link (including results): |
View full study record |
Document reference: 29116 |
Study title: Heparin-induced thrombocytopenia associated thrombosis in pediatric intensive care patients - Schmugge M. et Al. - 2002 (Pediatrics, vol 109, No.1, January 2002, 1-4) Heparin-induced thrombocytopenia associated thrombosis in pediatric intensive care patients - Schmugge M. et Al. - 2002 (Pediatrics, vol 109, No.1, January 2002, 1-4) |
Active substance: HEPARIN |
Study summary document link (including results): |
View full study record |
Document reference: 29115 |
Study title: Prospective, bicenter, randomised, placebo-controlled, parallel group comparison trial to investigate the antiphlogistic efficacy and tolerance of a fixed combination of levomenol and heparin (Sensicutan ointment) in patients with atopic eczema |
Active substance: HEPARIN AND LEVOMENOL |
Study summary document link (including results): |
View full study record |
Document reference: 29118 |
Study title: A double-blind placebo controlled study comparing the safety and efficacy of ibuprofen 600 mg sustained release to ibuprofen 200 mg regular release, in the treatment of post-operative dental pain. |
Active substance: IBUPROFEN |
Study summary document link (including results): ibuprofen 87-732.pdf |
View full study record |
Document reference: 47446 |
Study title: A double-blind placebo controlled study comparing the safety and efficacy of ibuprofen 600 mg sustained release to ibuprofen 200 mg regular release, administered every four hours, in the treatment of post-operative dental pain. CSR 116. Protocol 87-759, Unpublished Report 242. |
Active substance: IBUPROFEN |
Study summary document link (including results): ibuprofen 87-759.pdf |
View full study record |
Document reference: 47448 |
Study title: Heremans−G et al. A single−blind parallel group study investigating the antipyretic properties of ibuprofen syrup versus acetylsalicylic acid syrup in febrile children. {Br−J−Clin−Pract}, Jun 1988, vol. 42, no. 6, p. 245−7Heremans−G et al. A single−blind parallel group study investigating the antipyretic properties of ibuprofen syrup versus acetylsalicylic acid syrup in febrile children. {Br−J−Clin−Pract}, Jun 1988, vol. 42, no. 6, p. 245−7 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29594 |
Study title: Ibuprofen and other NSAID usage in juvenile arthritis - a review of clinical data |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29443 |
Study title: Ibuprofen in children with infective disorders - anti-pyretic efficacy - M A Phadke, P V Paranjape and,A S Joshi, B.J. Medical, College, India |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29450 |
Study title: IBUPROFEN IN THE TREATMENT OF POSTOPERATIVE PAIN IN SMALL CHILDREN. A RANDOMISED CDOUBLE-BLIND-PLACEBO CONTROLLED PARALLEL GROUP STUDY |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29473 |
Study title: Ibuprofen vs paracetamol in soft tissue injuries in children. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29392 |
Study title: Int J Clin Pract Suppl. 2003 Apr;(135):50-3. The safety of ibuprofen suspension in children. Lesko SMInt J Clin Pract Suppl. 2003 Apr;(135):50-3. The safety of ibuprofen suspension in children. Lesko SM |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29611 |
Study title: JAMA. 1995 Mar 22-29;273(12):929-33.Links Comment in: JAMA. 1996 Apr 3;275(13):986. An assessment of the safety of pediatric ibuprofen. A practitioner-based randomized clinical trial. Lesko SM, Mitchell AAJAMA. 1995 Mar 22-29;273(12):929-33.Links Comment in: JAMA. 1996 Apr 3;275(13):986. An assessment of the safety of pediatric ibuprofen. A practitioner-based randomized clinical trial. Lesko SM, Mitchell AA |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29612 |
Study title: Jawad SS & Eccles R. Effect of pseudoephedrine on nasal airflow in patients with nasal congestion associated with common cold. Rhinology 1998; 36(2):73-6 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29511 |
Study title: Joshi−Y−M et al. Comparative evaluation of the antipyretic efficacy of ibuprofen and paracetamol. {Indian−Pediatr}, Aug 1990, vol. 27, no. 8, p. 803−6Joshi−Y−M et al. Comparative evaluation of the antipyretic efficacy of ibuprofen and paracetamol. {Indian−Pediatr}, Aug 1990, vol. 27, no. 8, p. 803−6 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29591 |
Study title: Kandoth−P−W et al. Comparative evaluation of antipyretic activity of ibuprofen and aspirin in children with pyrexia of varied aetiology. {J−Int−Med−Res}, 1984, vol. 12, no. 5, p. 292−7Kandoth−P−W et al. Comparative evaluation of antipyretic activity of ibuprofen and aspirin in children with pyrexia of varied aetiology. {J−Int−Med−Res}, 1984, vol. 12, no. 5, p. 292−7 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29601 |
Study title: Kauffman−R−E et al. Antipyretic efficacy of ibuprofen vs acetaminophen. {AM−J−DIS−CHILD}, 1992, Vol /Iss/Pg. 146/5 (622−625)Kauffman−R−E et al. Antipyretic efficacy of ibuprofen vs acetaminophen. {AM−J−DIS−CHILD}, 1992, Vol /Iss/Pg. 146/5 (622−625) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29595 |
Study title: Kokki H. et al.: Cerebrospinal Fluid Distribution of Ibuprofen After Intravenous Administration in Children;PEDIATRICS Volume 120, Number 4, October 2007. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29545 |
Study title: Mocroft A, Youle M, Gazzard B, Morcinek J, Halai R, Phillips AN. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.Mocroft A, Youle M, Gazzard B, Morcinek J, Halai R, Phillips AN. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. |
Active substance: Foscarnet |
Study summary document link (including results): Mocroft A et al 1996.pdf |
View full study record |
Document reference: 39669 |
Study title: Morel C, Metge F, Roman S, Scheer S, Larricart P, Monin C et al. [Acute retinal necrosis: clinical presentation, treatment, and prognosis in a series of 22 patients]. [French]. Journal Francais d Opthalmologie 2004; 27(1):7-13.Morel C, Metge F, Roman S, Scheer S, Larricart P, Monin C et al. [Acute retinal necrosis: clinical presentation, treatment, and prognosis in a series of 22 patients]. [French]. Journal Francais d Opthalmologie 2004; 27(1):7-13. |
Active substance: FOSCARNET |
Study summary document link (including results): Morel C et al 2004.pdf |
View full study record |
Document reference: 28589 |
Study title: Moretti S, Zikos P, Van Lint MT, Tedone E, Oochini D, Gualandi F. Foscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (hsct): a randomised study. Bone Marrow Transplantation 1998;22(2):175-180Moretti S, Zikos P, Van Lint MT, Tedone E, Oochini D, Gualandi F. Foscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (hsct): a randomised study. Bone Marrow Transplantation 1998;22(2):175-180 |
Active substance: Foscarnet |
Study summary document link (including results): Moretti S et al 1998.pdf |
View full study record |
Document reference: 39653 |
Study title: Naik HR, Siddique N, Chandrasekar PH. Foscarnet therapy for acyclovir resistant herpes simplex virus 1 infection in allogeneic bone marrow transplant recipients. Clinical Infectious Diseases 1995; 21(6):1514-1515. Naik HR, Siddique N, Chandrasekar PH. Foscarnet therapy for acyclovir resistant herpes simplex virus 1 infection in allogeneic bone marrow transplant recipients. Clinical Infectious Diseases 1995; 21(6):1514-1515. |
Active substance: Foscarnet |
Study summary document link (including results): Naik HR et al 1995.pdf |
View full study record |
Document reference: 39674 |
Study title: Narimatsu H, Kami M, Kato D, Matsumura T, Murashige N, Kusumi E et al. 2007; Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation. Transplant Infectious Disease 2007; 9(1):11-15.Narimatsu H, Kami M, Kato D, Matsumura T, Murashige N, Kusumi E et al. 2007; Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation. Transplant Infectious Disease 2007; 9(1):11-15. |
Active substance: FOSCARNET |
Study summary document link (including results): Narimatsu H et al. 2007.pdf |
View full study record |
Document reference: 39588 |
Study title: New approaches to drug therapy in HIV infection and AIDS. AIDS-Forschung 1994; 9(6):283-294.Tabolin VA, Volodin NN, Geras k, V, Il i, I, Tikhonov VV.New approaches to drug therapy in HIV infection and AIDS. AIDS-Forschung 1994; 9(6):283-294.Tabolin VA, Volodin NN, Geras k, V, Il i, I, Tikhonov VV. |
Active substance: FOSCARNET |
Study summary document link (including results): Tabolin VA et al 1994.pdf |
View full study record |
Document reference: 28570 |
Study title: Numazaki K, Chiba S. Current aspects of diagnosis and treatment of cytomegalovirus infections in infants. Clinical & Diagnostic Virology 1997; 8(3):169-181.Numazaki K, Chiba S. Current aspects of diagnosis and treatment of cytomegalovirus infections in infants. Clinical & Diagnostic Virology 1997; 8(3):169-181. |
Active substance: Foscarnet |
Study summary document link (including results): Numazaki K et al 1997.pdf |
View full study record |
Document reference: 39662 |
Study title: Numazaki K. Cytomegalovirus infection.Nippon Rinsho - Japanese Journal of Clinical Medicine. 2001; 59:Suppl-8.Numazaki K. Cytomegalovirus infection.Nippon Rinsho - Japanese Journal of Clinical Medicine. 2001; 59:Suppl-8. |
Active substance: Foscarnet |
Study summary document link (including results): Numazaki K 2001.pdf |
View full study record |
Document reference: 39646 |
Study title: Ongrádi J, Kövesdi V, Medveczky GP. Human herpesvirus 6; Orv Hetil. 2010 Mar 28;151(13):523-32.Ongrádi J, Kövesdi V, Medveczky GP. Human herpesvirus 6; Orv Hetil. 2010 Mar 28;151(13):523-32. |
Active substance: Foscarnet |
Study summary document link (including results): |
View full study record |
Document reference: 39604 |
Study title: Paris C, Kopp K, King A, Santolaya ME, Zepeda AJ, Palma J. Cytomegalovirus infection in children undergoing hematopoietic stem cell transplantation in Chile.Pediatr Blood Cancer. 2009 Sep;53(3):453-8.Paris C, Kopp K, King A, Santolaya ME, Zepeda AJ, Palma J. Cytomegalovirus infection in children undergoing hematopoietic stem cell transplantation in Chile.Pediatr Blood Cancer. 2009 Sep;53(3):453-8. |
Active substance: Foscarnet |
Study summary document link (including results): Paris C et al 2009.pdf |
View full study record |
Document reference: 39607 |
Study title: Occella-C, Schiazza-L, Nemelka-O, Persi-A, Rampini-E. Ist.Sci. "G.Gaslini", Div.Dermatologica, Genova, Italia. Garze medicate con acido fusidico nella terapia topica Rassegna di Dermatologia e Sifilografia, vol.XXXV, n.unico, genn-dic 1982. |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28660 |
Study title: Perianal streptococcal dermatitis treated with oral fusidic acid: report of two cases |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28718 |
Study title: Pharmacokinetics of fusidic acid given as an oral suspension to children |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28687 |
Study title: Pharmacokinetics of fusidic acid in children after single dose administration |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28689 |
Study title: Pyogenic cutaneous infections in east African children treated with Fucidin® ointment; Garborg O and Nyjordet R. 1971 J Trop Pediatr. Child Health, 17: 153-157 |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28677 |
Study title: Open, uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging (MRI) of CNS lesions in children (6 to 12 years) |
Active substance: GADOPENTETIC ACID |
Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_86238_study_synopsis.pdf |
View full study record |
Document reference: 28820 |
Study title: Open, uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging of musculo-skeletal lesions in children and teenage patients, 16-18 years (phase III) |
Active substance: GADOPENTETIC ACID |
Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_87191_study_synopsis.pdf |
View full study record |
Document reference: 28822 |
Study title: Open, uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging (MRI) of brain lesions in children (2-6 years) (phase III). |
Active substance: GADOPENTETIC ACID |
Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_87224_study_synopsis.pdf |
View full study record |
Document reference: 28823 |
Study title: Phase II study with Gd-DTPA in body trunk and extremities |
Active substance: GADOPENTETIC ACID |
Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_A23CQB_study_synopsis.pdf |
View full study record |
Document reference: 28836 |
Study title: Tolerance and diagnostic quality of Gd-DTPA (SH L 451 AA) in MR tomography for the demonstration and demarcation of lesions in the region of the cranium and trunk |
Active substance: GADOPENTETIC ACID |
Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_86144_study_synopsis.pdf |
View full study record |
Document reference: 28817 |
Study title: Uncontrolled multicentre study for the further demonstration of the tolerance and efficacy of dimeglumine gadopentatate on intravenous use in magnetic resonance imaging in adults |
Active substance: GADOPENTETIC ACID |
Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_86110_study_synopsis.pdf |
View full study record |
Document reference: 28816 |
Study title: A vein of galen aneurysm with an abnormal drain system: MRI findings;Desprechins B; Pediatr. Radiol.; 1995 vol.25 p.442-443A vein of galen aneurysm with an abnormal drain system: MRI findings;Desprechins B; Pediatr. Radiol.; 1995 vol.25 p.442-443 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28851 |
Study title: Abdominale tumoren beim kind;Muller MF; ROFO; 1993 vol.158 n.1 p.9-14Abdominale tumoren beim kind;Muller MF; ROFO; 1993 vol.158 n.1 p.9-14 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28839 |
Study title: Accoustic schwannoma: MR findings in 84 tumors;Mulkens TH; AJR; 1993 vol.160 p.395-398Accoustic schwannoma: MR findings in 84 tumors;Mulkens TH; AJR; 1993 vol.160 p.395-398 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28844 |
Study title: Adrenoleucodystrophie: intérêt de l'IRM avec gadolinium;Romero C; J. Neuroradiol.; 1990 vol.17 p.267-276Adrenoleucodystrophie: intérêt de l'IRM avec gadolinium;Romero C; J. Neuroradiol.; 1990 vol.17 p.267-276 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28837 |
Study title: Anwendungsbeobachtung zur Überprüfung der Wirksamkeit und Verträglichkeit von Leukichtan N 10 % Gel bei Patienten mit Schnittwunden, Schürfwunden oder Verbrennungen |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28877 |
Study title: Chu WCW 2000; INCIDENCE OF ADVERSE EVENTS AFTER I.V. INJECTION OF MR CONTRAST AGENTS IN A CHINESE POPULATIONChu WCW 2000; INCIDENCE OF ADVERSE EVENTS AFTER I.V. INJECTION OF MR CONTRAST AGENTS IN A CHINESE POPULATION |
Active substance: GADODIAMIDE |
Study summary document link (including results): Chu WCW 2000.pdf |
View full study record |
Document reference: 47567 |
Study title: Contrast Enhanced Magnetic Resonance Imaging of the Central Nervous System in Patients Between 2 and 18 Years of Age by Intravenous Administration: A Randomized Double-Blind Comparison of Gadodiamide Injection (Gd DTPA BMA) 0.1 mmol/kg with MAGNEVIST®(G d DTPA) 0.1 mmol/kg |
Active substance: GADODIAMIDE |
Study summary document link (including results): SW1357 Redacted.pdf |
View full study record |
Document reference: 47577 |
Study title: Contrast Enhanced Magnetic Resonance Imaging of the Central Nervous System in Patients Between 2 and 18 Years of Age by Intravenous Administration: A Randomized Double-Blind Comparison of Gadodiamide Injection (Gd DTPA BMA) 0.1 mmol/kg with MAGNEVIST® (Gd DTPA) 0.1 mmol/kg (Protocol 50678-005, Study B) |
Active substance: GADODIAMIDE |
Study summary document link (including results): SW1358 Redacted.pdf |
View full study record |
Document reference: 47578 |
Study title: Contrast Enhanced Magnetic Resonance Imaging of the Central Nervous System in Patients Less Than 2 Years of Age by Intravenous Administration: An Open Label Study of Gadodiamide Injection (Gd DTPA BMA) 0.1 mmol/kg |
Active substance: GADODIAMIDE |
Study summary document link (including results): SW1356 Redacted.pdf |
View full study record |
Document reference: 47576 |
Study title: Effectiveness and tolerance in the MRT of pediatric patients with CNS lesions; 1X I.V. PH. III - Berlex Report No. 88 488Radiology. 1994 Apr;191(1):155-64.Gadolinium-enhanced MR aortography. Prince MR. |
Active substance: GADODIAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28813 |
Study title: Effectiveness and tolerance in the MRT of pediatric patients with CNS lesions; 1X I.V. PH. III - Berlex Report No. 88 489 |
Active substance: GADODIAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28814 |
Study title: Effectiveness and tolerance in the MRT of pediatric patients with CNS lesions; 1X I.V. PH. III - Berlex Report No. 88 490 |
Active substance: GADODIAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28815 |
Study title: Int J Cardiovasc Imaging. 2005 Apr-Jun;21(2-3):313-22. Comment in: Int J Cardiovasc Imaging. 2005 Apr-Jun;21(2-3):323-4. Contrast-enhanced magnetic resonance angiography of the great arteries in patients with congenital heart disease: an accurate tool for planning catheter-guided interventions. Valsangiacomo Büchel ER, DiBernardo S, Bauersfeld U, Berger F. Int J Cardiovasc Imaging. 2005 Apr-Jun;21(2-3):313-22. Comment in: Int J Cardiovasc Imaging. 2005 Apr-Jun;21(2-3):323-4. Contrast-enhanced magnetic resonance angiography of the great arteries in patients with congenital heart disease: an accurate tool for planning catheter-guided interventions. Valsangiacomo Büchel ER, DiBernardo S, Bauersfeld U, Berger F. |
Active substance: GADODIAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28808 |
Study title: Invest Ophthalmol Vis Sci. 2001 Jan;42(1):17-22. Structure-function correlation of laminar vascularity in human rectus extraocular muscles. Oh SY, Poukens V, Cohen MS, Demer JL. Invest Ophthalmol Vis Sci. 2001 Jan;42(1):17-22. Structure-function correlation of laminar vascularity in human rectus extraocular muscles. Oh SY, Poukens V, Cohen MS, Demer JL. |
Active substance: GADODIAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28804 |
Study title: J Magn Reson Imaging. 2002 Jan;15(1):31-8. Magnetic resonance imaging of pulmonary parenchymal disease using a modified breath-hold 3D gradient-echo technique: initial observations. Bader TR, Semelka RC, Pedro MS, Armao DM, Brown MA, Molina PL. J Magn Reson Imaging. 2002 Jan;15(1):31-8. Magnetic resonance imaging of pulmonary parenchymal disease using a modified breath-hold 3D gradient-echo technique: initial observations. Bader TR, Semelka RC, Pedro MS, Armao DM, Brown MA, Molina PL. |
Active substance: GADODIAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28809 |
Study title: The current status of Gentamicin for the neonate and young infant. - Nelson JD. - 1972 (Amer. J. Dis. 124 1: 13-14) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28939 |
Study title: The influence of locally implanted high doses of gentamicin on hearing and renal function of newborns treated for acute hematogenous osteomyelitis.The influence of locally implanted high doses of gentamicin on hearing and renal function of newborns treated for acute hematogenous osteomyelitis. |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28886 |
Study title: The rate of bacteriologic response to antimicrobial therapy in neonatal meningitis. - McCracken -1972 (Amer. J. Dis. 123: 547) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28940 |
Study title: The treatment of pyoderma in children. Esterly NB. - 1970 (JAMA, 212,10: 1667-70) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28941 |
Study title: Timewell R. M., Rosenthal A. L., Smith J. P., Cagle G. D., J Ped Opht & Strab 1983; 20, 1: 22-26; Timewell R. M., Rosenthal A. L., Smith J. P., Cagle G. D., J Ped Opht & Strab 1983; 20, 1: 22-26; |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25732 |
Study title: To compare the antipyretic activity of ibuprofen suspension and paracetamol suspension. To evaluate the tolerability of ibuprofen suspension and paracetamol suspension. |
Active substance: IBUPROFEN |
Study summary document link (including results): Iboprofen-BR0115.pdf |
View full study record |
Document reference: 29405 |
Study title: Treatment of Pyrexia Associated with Infectious Disease in Children |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29395 |
Study title: Vauzelle−Kervroedan−F et al. Equivalent antipyretic activity of ibuprofen and paracetamol in febrile children. {J−PEDIATR}, 1997, Vol/Iss/Pg. 131/5 (683−687)Vauzelle−Kervroedan−F et al. Equivalent antipyretic activity of ibuprofen and paracetamol in febrile children. {J−PEDIATR}, 1997, Vol/Iss/Pg. 131/5 (683−687) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29585 |
Study title: Williams BO et al. Efficacy of acrivastine plus pseudoephedrine for symptomatic relief of seasonal allergic rhinitis due to mountain cedar. Ann Allergy Asthma Immunol 1996; 76(5):432-438 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29513 |
Study title: Wilson−J−T et al. Single−dose, placebo−controlled comparative study of ibuprofen and acetaminophen antipyresis in children. {J−Pediatr}, Nov 1991, vol. 119, no. 5, p. 803−11Wilson−J−T et al. Single−dose, placebo−controlled comparative study of ibuprofen and acetaminophen antipyresis in children. {J−Pediatr}, Nov 1991, vol. 119, no. 5, p. 803−11 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29586 |
Study title: Xiao Z. An open label multi-center clinical trial to evaluate the efficacy of compound pseudoephedrine (corrected) hydrochloride sustained release capsules in patients with nasal symptoms associated with common cold. Chinese journal of internal medicine 2002; 41(8):547-9 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29509 |
Study title: Yilmaz−H−L et al. Intramuscular dipyrone versus oral ibuprofen or nimesulide for reduction of fever in the outpatient setting. {CLIN−DRUG−INVEST}, 2003, Vol/Iss/Pg. 23/8 (519−526)Yilmaz−H−L et al. Intramuscular dipyrone versus oral ibuprofen or nimesulide for reduction of fever in the outpatient setting. {CLIN−DRUG−INVEST}, 2003, Vol/Iss/Pg. 23/8 (519−526) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29573 |
Study title: A double-blind single dose evaluation of the comparative analgesic efficacy of aspirin 1000 mg/caffeine 64 mg, ibuprofen 400 mg, and placebo in the treatment of post-operative pain following third molar extraction. Stat Rpt 81. Protocol 7-714B, Unpublished Report 206. |
Active substance: IBUPROFEN + CAFFEINE + ACETYLSALICYLIC ACID |
Study summary document link (including results): acetylsalicylic acid_ caffeine_ibuprofen 7-714B.pdf |
View full study record |
Document reference: 47431 |
Study title: A double-blind single dose evaluation of the comparative analgesic efficacy of aspirin 800 mg/caffeine 64 mg, ibuprofen 400 mg, and placebo in the treatment of post-operative pain following third molar extraction. Stat Rpt 87. Protocol 7-713B, Unpublished Report 212. |
Active substance: IBUPROFEN + CAFFEINE + ACETYLSALICYLIC ACID |
Study summary document link (including results): acetylsalicylic acid_ caffeine_ibuprofen 7-713B.pdf |
View full study record |
Document reference: 47430 |
Study title: A double-blind, multi-clinic, single dose evaluation of the comparative analgesic efficacy of aspirin 1000 mg plus caffeine 64 mg, ibuprofen 400 mg and placebo in the treatment of post-operative pain following third molar extraction. CSR 92. Protocol 87-714A, Unpublished Report 218. |
Active substance: IBUPROFEN + CAFFEINE + ACETYLSALICYLIC ACID |
Study summary document link (including results): acetylsalicylic acid_ caffeine_ibuprofen 87-714A.pdf |
View full study record |
Document reference: 47433 |
Study title: Patel SR, Ridwan RU, Ortin M. Cytomegalovirus reactivation in pediatric hemopoietic progenitors transplant: a retrospective study on the risk factors and the efficacy of treatment.Journal of Pediatric Hematology/Oncology. 2005; 27(8):411-415.Patel SR, Ridwan RU, Ortin M. Cytomegalovirus reactivation in pediatric hemopoietic progenitors transplant: a retrospective study on the risk factors and the efficacy of treatment.Journal of Pediatric Hematology/Oncology. 2005; 27(8):411-415. |
Active substance: FOSCARNET |
Study summary document link (including results): Patel SR 2005.pdf |
View full study record |
Document reference: 39594 |
Study title: Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). |
Active substance: FOSCARNET |
Study summary document link (including results): |
View full study record |
Document reference: 28573 |
Study title: Rachlis A. 1993. Mortality with foscarnet or ganciclovir for retinitis in AIDS. ACP Journal Club 1993;116(3):74 1993;(3):74.Rachlis A. 1993. Mortality with foscarnet or ganciclovir for retinitis in AIDS. ACP Journal Club 1993;116(3):74 1993;(3):74. |
Active substance: Foscarnet |
Study summary document link (including results): Rachlis A. 1993.pdf |
View full study record |
Document reference: 39624 |
Study title: Reusser P, Einsele H, Lee J, Volin L, Rovira M, Engelhard D et al. Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood. 2002; 99(4):1159- 1164.Reusser P, Einsele H, Lee J, Volin L, Rovira M, Engelhard D et al. Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood. 2002; 99(4):1159- 1164. |
Active substance: Foscarnet |
Study summary document link (including results): Reusser P Einsele H et al 2002.pdf |
View full study record |
Document reference: 39639 |
Study title: Reusser P. 2002 Challenges and options in the management of viral infections after stem cell transplantation. Supportive Care in Cancer. 2002; 10(3):197-203.Reusser P. 2002 Challenges and options in the management of viral infections after stem cell transplantation. Supportive Care in Cancer. 2002; 10(3):197-203. |
Active substance: Foscarnet |
Study summary document link (including results): Reusser P et al 2002..pdf |
View full study record |
Document reference: 39640 |
Study title: Reusser PE. 2002 Management of viral infections in immunocompromised cancer patients. Swiss Medical Weekly. 2002; 132(27-28):374- 378.Reusser PE. 2002 Management of viral infections in immunocompromised cancer patients. Swiss Medical Weekly. 2002; 132(27-28):374- 378. |
Active substance: Foscarnet |
Study summary document link (including results): Reusser PE 2002.pdf |
View full study record |
Document reference: 39641 |
Study title: Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J et al. A controlled trial comparing foscarnet with vidarabine for acyclovir- resistant mucocutaneous herpes-simplex in the acquired- immunodeficiencysyndrome. New-England-Journalof- Medicine 325 (8): 551-555.Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J et al. A controlled trial comparing foscarnet with vidarabine for acyclovir- resistant mucocutaneous herpes-simplex in the acquired- immunodeficiencysyndrome. New-England-Journalof- Medicine 325 (8): 551-555. |
Active substance: Foscarnet |
Study summary document link (including results): Safrin S et al 1991.pdf |
View full study record |
Document reference: 39631 |
Study title: Sarin P. GENITAL HERPES-SIMPLEX INFECTIONS IN PATIENTS WITH THE ACQUIRED- IMMUNODEFICIENCY-SYNDROME. Pharmacotherapy 1994; 14(5):529-542.Sarin P. GENITAL HERPES-SIMPLEX INFECTIONS IN PATIENTS WITH THE ACQUIRED- IMMUNODEFICIENCY-SYNDROME. Pharmacotherapy 1994; 14(5):529-542. |
Active substance: FOSCARNET |
Study summary document link (including results): Sarin P. 1994.pdf |
View full study record |
Document reference: 28571 |
Study title: Satwani P, Baldinger L, Freedman J, Jacobson JS, Guerra J, van de Ven C, Morris E, Garvin J, George D, Bradley MB, Bhatia M, Tallamy B, Schwartz J, Jin Z, Cairo MS.Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients. Biol Blood Marrow Transplant. 2009 Dec;15(12):1587-95.Satwani P, Baldinger L, Freedman J, Jacobson JS, Guerra J, van de Ven C, Morris E, Garvin J, George D, Bradley MB, Bhatia M, Tallamy B, Schwartz J, Jin Z, Cairo MS.Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients. Biol Blood Marrow Transplant. 2009 Dec;15(12):1587-95. |
Active substance: Foscarnet |
Study summary document link (including results): Satwani P et al 2009.pdf |
View full study record |
Document reference: 39605 |
Study title: Schleiss MR, McVoy MA. Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy. [Review] [109 refs]. Expert Review of Antiinfective Therapy 2004; 2(3):389-403.Schleiss MR, McVoy MA. Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy. [Review] [109 refs]. Expert Review of Antiinfective Therapy 2004; 2(3):389-403. |
Active substance: FOSCARNET |
Study summary document link (including results): Schleiss MR and McVoy MA 2004.pdf |
View full study record |
Document reference: 28590 |
Study title: Assessment of vascular invasion by musculoskeletal tumors of the limbs: use of contrast enhanced angiography; Feydy A; Radiology; 2006 vol.238 n.2 p.611-621Assessment of vascular invasion by musculoskeletal tumors of the limbs: use of contrast enhanced angiography; Feydy A; Radiology; 2006 vol.238 n.2 p.611-621 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28869 |
Study title: AWB bei gastrointestinalen MykosenA large number of publications mentioning gadolinium without mentioning any commercial product name are available and can be provided upon request. |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28875 |
Study title: Begutachtung der Dermichthol -fest und -flüssig bei einem ausgewählten dermatologischen Krankengut unter besonderer Berücksichtigung der Rasur mit Dermichthol-fest bei männlichen Patienten.Wrist ligament tears: evaluation of MRI and combined MDCT and MR arthrography; Moser T; AJR; 2007 vol.188 p.1278-1286 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28876 |
Study title: Clinical safety and diagnostic value of the gadolinium chelate gadoterate meglumine (Gd-DOTA); Herborn CU; Invest. Radiol.; 2007 vol.42 p.58-62Clinical safety and diagnostic value of the gadolinium chelate gadoterate meglumine (Gd-DOTA); Herborn CU; Invest. Radiol.; 2007 vol.42 p.58-62 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28872 |
Study title: EUV07: A phase III, open, randomized, controlled, primary vaccination study to assess the immunogenicity and the safety of CP20/20/5/3DT-IPV-PRP~T and ACTAcel given concomitantly with OPV vaccine and TETRAct-Hib given concomitantly with OPV vaccine at 6, 10, 14 weeks of age. All infants receiving hepatitis B vaccine (Recomvax B) at 0, 6, 14 weeks of age EUV06: Safety and immunogenicity of hepatitis B vaccine distributed by Aventis Pasteur Korea administered at 0-1-6 months when given in association with three Aventis Pasteur pertussis combination (1 whole cell and 2 acellular) vaccines administered at 2, 4 and 6 months in Mexican infants |
Active substance: Hepatitis B Surface Antigen |
Study summary document link (including results): |
View full study record |
Document reference: 47181 |
Study title: Open, parallel group. Active controlled study to evaluate immunogenicity and safety of Euvax B. |
Active substance: Hepatitis B Surface Antigen |
Study summary document link (including results): |
View full study record |
Document reference: 47180 |
Study title: Open, parallel group. Active controlled. To compare immunogenicity of Euvax B with other palsma-derived heptitis B vaccines according to vaccination schedule. |
Active substance: Hepatitis B Surface Antigen |
Study summary document link (including results): |
View full study record |
Document reference: 47184 |
Study title: Open, parallel group. Active controlled. To evaluate immunogenicity and safety of Euvax B |
Active substance: Hepatitis B Surface Antigen |
Study summary document link (including results): |
View full study record |
Document reference: 47179 |
Study title: Open, uncontrolled. To compare immunogenicity and safety of Eivax B according to vaccination schedules. |
Active substance: Hepatitis B Surface Antigen |
Study summary document link (including results): |
View full study record |
Document reference: 47178 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Hepeel (tablets) [AWB-AT] |
Active substance: Hepeel |
Study summary document link (including results): |
View full study record |
Document reference: 40025 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Hepeel (ampoules) [AWB-AT] |
Active substance: Hepeel |
Study summary document link (including results): |
View full study record |
Document reference: 40026 |
Study title: Three randomized, double blind, placebo-controlled clinical trials: Efficacy and tolerability of Pelargonium extract EPs® 7630 in patients (1-18 resp. 6-18 years old) with acute bronchitis. |
Active substance: HERB: 800 mg ethanolic extract (1+10) from the roots of Pelargonium reniforme/sidoides. |
Study summary document link (including results): |
View full study record |
Document reference: 21222 |
Study title: Three randomized, double blind, placebo-controlled clinical trials: Efficacy and tolerability of Pelargonium extract EPs® 7630 in patients (1-18 resp. 6-18 years old) with acute bronchitis. |
Active substance: HERB: 800 mg ethanolic extract (1+10) from the roots of Pelargonium reniforme/sidoides./ HERB: extract from the roots of Pelargonium sidoides (1 : 8 - 10)./ HERB: extract from the roots of Pelargonium sidoides (1 : 8 - 10); extraction agent: ethanol 11% (m/m)./ HERB: extract from the roots of Pelargonium sidoides (1 : 9 - 11); extraction agent: ethanol 11% (m/m). |
Study summary document link (including results): |
View full study record |
Document reference: 21218 |
Study title: Three randomized, double blind, placebo-controlled clinical trials: Efficacy and tolerability of Pelargonium extract EPs® 7630 in patients (1-18 resp. 6-18 years old) with acute bronchitis. |
Active substance: HERB: 800 mg ethanolic extract (1+10) from the roots of Pelargonium reniforme/sidoides./ HERB: extract from the roots of Pelargonium sidoides (1 : 8 - 10)./ HERB: extract from the roots of Pelargonium sidoides (1 : 8 - 10); extraction agent: ethanol 11% (m/m)./ HERB: extract from the roots of Pelargonium sidoides (1 : 9 - 11); extraction agent: ethanol 11% (m/m). |
Study summary document link (including results): |
View full study record |
Document reference: 21219 |
Study title: Three randomized, double blind, placebo-controlled clinical trials: Efficacy and tolerability of Pelargonium extract EPs® 7630 in patients (1-18 resp. 6-18 years old) with acute bronchitis. |
Active substance: HERB: 800 mg ethanolic extract (1+10) from the roots of Pelargonium reniforme/sidoides./ HERB: extract from the roots of Pelargonium sidoides (1 : 8 - 10)./ HERB: extract from the roots of Pelargonium sidoides (1 : 8 - 10); extraction agent: ethanol 11% (m/m)./ HERB: extract from the roots of Pelargonium sidoides (1 : 9 - 11); extraction agent: ethanol 11% (m/m). |
Study summary document link (including results): |
View full study record |
Document reference: 21220 |
Study title: Serrano A.C. Haloperidol. Its use in children.J Clin Psychiat. 1984, 141, 1195Serrano A.C. Haloperidol. Its use in children.J Clin Psychiat. 1984, 141, 1195 |
Active substance: HALOPERIDOL |
Study summary document link (including results): serrano_haloperidol.pdf |
View full study record |
Document reference: 29066 |
Study title: A double-blind single dose within patient comparison of Optrex against control solution in volunteers with eye irritation after swimming |
Active substance: Hamamelis water |
Study summary document link (including results): |
View full study record |
Document reference: 40022 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Hamamelis-Salbe-Heel (ointment) [AWB-AT] |
Active substance: Hamamelis-Salbe-Heel S |
Study summary document link (including results): |
View full study record |
Document reference: 40021 |
Study title: Abd-Allah SA, Rogers MS, Terry M, Gross M, Perkin RM. Helium-oxygen therapy for pediatric acute severe asthma requiring mechanical ventilation. Pediatr Crit Care Med 2003;4(3):353-7.Abd-Allah SA, Rogers MS, Terry M, Gross M, Perkin RM. Helium-oxygen therapy for pediatric acute severe asthma requiring mechanical ventilation. Pediatr Crit Care Med 2003;4(3):353-7. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29068 |
Study title: BREATHE study |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): BREATHE -Heliox(Final-110804).xls |
View full study record |
Document reference: 45120 |
Study title: Brown L, Sherwin T, Perez JE, Perez DU. Heliox as a temporizing measure for pediatric foreign body aspiration. Acad Emerg Med 2002;9(4):346-347.Brown L, Sherwin T, Perez JE, Perez DU. Heliox as a temporizing measure for pediatric foreign body aspiration. Acad Emerg Med 2002;9(4):346-347. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29069 |
Study title: Bucci G, Cook CD. Studies of respiratory physiology in children. VI. Lung diffusing capacity, diffusing capacity of the pulmonary membrane and pulmonary capillary blood volume in congenital heart disease. J Clin Invest 1961 Aug;40(8 Pt 1-2):1431-41.Bucci G, Cook CD. Studies of respiratory physiology in children. VI. Lung diffusing capacity, diffusing capacity of the pulmonary membrane and pulmonary capillary blood volume in congenital heart disease. J Clin Invest 1961 Aug;40(8 Pt 1-2):1431-41. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29070 |
Study title: Butt WW, Koren G, England S, Shear NH, Whyte H, Bryan CA, Swyer PR. Hypoxia associated with helium-oxygen therapy in neonates. J Pediatr 1985;106(3):474-477.Butt WW, Koren G, England S, Shear NH, Whyte H, Bryan CA, Swyer PR. Hypoxia associated with helium-oxygen therapy in neonates. J Pediatr 1985;106(3):474-477. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29071 |
Study title: Piva JP, Amantea S, Barreto SS, Zelmanovitz F. The use of helium-oxygen mixture in the ventilation study of children with chronic obstructive lung disease. J Pediatr (Rio J) 2000 Jan-Feb;76(1):17-26.Piva JP, Amantea S, Barreto SS, Zelmanovitz F. The use of helium-oxygen mixture in the ventilation study of children with chronic obstructive lung disease. J Pediatr (Rio J) 2000 Jan-Feb;76(1):17-26. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29099 |
Study title: Piva JP, Menna Barreto SS, Zelmanovitz F, Amantea S, Cox P. Heliox versus oxygen for nebulized aerosol therapy in children with lower airway obstruction. Pediatr Crit Care Med 2002;3(1):6-10.Piva JP, Menna Barreto SS, Zelmanovitz F, Amantea S, Cox P. Heliox versus oxygen for nebulized aerosol therapy in children with lower airway obstruction. Pediatr Crit Care Med 2002;3(1):6-10. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29100 |
Study title: Prefaut C, Lloret MC, Tronc JF, Michel FB, Chardon G. Density dependence of the maximal expiratory flow curves in normal and asthmatic children. Scand J Respir Dis 1979;60:109-118.Prefaut C, Lloret MC, Tronc JF, Michel FB, Chardon G. Density dependence of the maximal expiratory flow curves in normal and asthmatic children. Scand J Respir Dis 1979;60:109-118. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29101 |
Study title: Rivera ML, Kim TY, Stewart GM, Minasyan L, Brown L. Albuterol nebulized in heliox in the initial ED treatment of pediatric asthma: a blinded, randomized controlled trial. Am J Emerg Med 2006 Jan;24(1):38-42. Rivera ML, Kim TY, Stewart GM, Minasyan L, Brown L. Albuterol nebulized in heliox in the initial ED treatment of pediatric asthma: a blinded, randomized controlled trial. Am J Emerg Med 2006 Jan;24(1):38-42. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29102 |
Study title: Rodeberg DA, Easter AJ, Washam MA, Housinger TA, Greenhalgh DG, Warden GD. Use of Helium-Oxygen Mixture in the Treatment of Postextubation Stridor in Pediatric Patients with Burns. J Burn Care Rehabil 1995;16:476-80.Rodeberg DA, Easter AJ, Washam MA, Housinger TA, Greenhalgh DG, Warden GD. Use of Helium-Oxygen Mixture in the Treatment of Postextubation Stridor in Pediatric Patients with Burns. J Burn Care Rehabil 1995;16:476-80. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29103 |
Study title: IG 95-01B: Retrospective pharmacovilance study. Safety study on the double-inactivated human antihaemophilic factor concentrate (Fanhdi) Grifols, during prophylaxis and/or treatment of patients with haemophilia A. |
Active substance: HUMAN COAGULATION FACTOR VIII |
Study summary document link (including results): |
View full study record |
Document reference: 29151 |
Study title: Incidence of inhibitors in previously untreated patients with severe haemophilia A treated with Octanate |
Active substance: HUMAN COAGULATION FACTOR VIII |
Study summary document link (including results): 04 UK95-02 (full).pdf |
View full study record |
Document reference: 29155 |
Study title: Post Marketing Pharmacovigilance Study (ATC 9503) with Profilate (SD, HT) |
Active substance: HUMAN COAGULATION FACTOR VIII |
Study summary document link (including results): |
View full study record |
Document reference: 29145 |
Study title: Report UK 95-02: Retrospective review of inhibitor formation in a cohort of haemophilia A patients who received Alphanate (Alpha 8 ST) prophylactically |
Active substance: HUMAN COAGULATION FACTOR VIII |
Study summary document link (including results): |
View full study record |
Document reference: 29152 |
Study title: |
Active substance: HUMAN COAGULATION FACTOR VIII AND HUMAN VON WILLEBRAND FACTOR |
Study summary document link (including results): |
View full study record |
Document reference: 29159 |
Study title: International clinical study to investigate the incidence of inhibitors in previously untreated patients with severe haemophilia A treated with Octate (=Wilate). |
Active substance: HUMAN COAGULATION FACTOR VIII AND HUMAN VON WILLEBRAND FACTOR |
Study summary document link (including results): |
View full study record |
Document reference: 29158 |
Study title: Baker CJ, Melish NM, Hall RT, et al. and the multicenter group for the study of immune globulin in neonates. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. N Engl J Med 1992; 327 (4): 213-219Baker CJ, Melish NM, Hall RT, et al. and the multicenter group for the study of immune globulin in neonates. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. N Engl J Med 1992; 327 (4): 213-219 |
Active substance: HUMAN NORMAL IMMUNOGLOBULIN |
Study summary document link (including results): |
View full study record |
Document reference: 29161 |
Study title: Clinical Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of IGIV3I GRIFOLS [Immune Globulin Intravenous (Human)] for Replacement Therapy in Primary Immunodeficiency Diseases (PID) |
Active substance: HUMAN NORMAL IMMUNOGLOBULIN |
Study summary document link (including results): IG201 (synopsis).pdf |
View full study record |
Document reference: 45137 |
Study title: Evaluation of prophylactic passive immunization using IGIV to prevent late onset neonatal infection among low birth weight(< 1750 grams) neonates. Baxter Internal ReportBB IND 1628: June, 1992Evaluation of prophylactic passive immunization using IGIV to prevent late onset neonatal infection among low birth weight(< 1750 grams) neonates. Baxter Internal ReportBB IND 1628: June, 1992 |
Active substance: HUMAN NORMAL IMMUNOGLOBULIN |
Study summary document link (including results): |
View full study record |
Document reference: 45133 |
Study title: Monocenter Post Marketing Observation Study Alphaglobin@ ATG 9304 |
Active substance: HUMAN NORMAL IMMUNOGLOBULIN |
Study summary document link (including results): 05 ATG9304(full).pdf |
View full study record |
Document reference: 47751 |
Study title: Monocenter Post Marketing Observation Study Alphaglobin@ ATG 9410 |
Active substance: HUMAN NORMAL IMMUNOGLOBULIN |
Study summary document link (including results): 06 ATG9410(full).pdf |
View full study record |
Document reference: 47752 |
Study title: MUL TICENTRE POST MARKETING OBSERVATION STUDY ALPHAGLOBIN@ AWB 9401 (PMOS 9401) |
Active substance: HUMAN NORMAL IMMUNOGLOBULIN |
Study summary document link (including results): 04 AWB9401(full).pdf |
View full study record |
Document reference: 47750 |
Study title: Multicentric post marketing observation study Alphaglobin’ 9301 |
Active substance: HUMAN NORMAL IMMUNOGLOBULIN |
Study summary document link (including results): 03 AGL9301(full).pdf |
View full study record |
Document reference: 45253 |
Study title: Schleiss MR. 2005. Antiviral therapy of congenital cytomegalovirus infection.Seminars in Pediatric Infectious Diseases. 2005; 16(1):50-59.Schleiss MR. 2005. Antiviral therapy of congenital cytomegalovirus infection.Seminars in Pediatric Infectious Diseases. 2005; 16(1):50-59. |
Active substance: FOSCARNET |
Study summary document link (including results): Schleiss MR 2005.pdf |
View full study record |
Document reference: 39595 |
Study title: Schuster FR, Simon A, Laws HJ, Beutel K, Groll AH, Jager G et al. 2005. Viral infections in pediatric cancer patients. Klinische Padiatrie. 2005; 217(Suppl 1):S67-S84.Schuster FR, Simon A, Laws HJ, Beutel K, Groll AH, Jager G et al. 2005. Viral infections in pediatric cancer patients. Klinische Padiatrie. 2005; 217(Suppl 1):S67-S84. |
Active substance: FOSCARNET |
Study summary document link (including results): Schuster FR et al 2005.pdf |
View full study record |
Document reference: 39596 |
Study title: Shapira MY, Resnick IB, Chou S, Neumann AU, Lurain NS, Stamminger T, Caplan O, Saleh N, Efferth T, Marschall M, Wolf DG. Artesunate as a potent antiviral agent in a patient with late drug resistant cytomegalovirus infection after hematopoietic stem cell transplantation. Clin Infect Dis. 2008 May 1;46(9):1455-7.Shapira MY, Resnick IB, Chou S, Neumann AU, Lurain NS, Stamminger T, Caplan O, Saleh N, Efferth T, Marschall M, Wolf DG. Artesunate as a potent antiviral agent in a patient with late drug resistant cytomegalovirus infection after hematopoietic stem cell transplantation. Clin Infect Dis. 2008 May 1;46(9):1455-7. |
Active substance: Foscarnet |
Study summary document link (including results): Shapira MY et al 2008.pdf |
View full study record |
Document reference: 39613 |
Study title: Sharland M, Luck S, Griffiths P, Cotton M. 2011. Antiviral therapy of CMV disease in children. Adv Exp Med Biol. 2011;697:243-60.Sharland M, Luck S, Griffiths P, Cotton M. 2011. Antiviral therapy of CMV disease in children. Adv Exp Med Biol. 2011;697:243-60. |
Active substance: FOSCARNET |
Study summary document link (including results): Sharland M 2011.pdf |
View full study record |
Document reference: 39599 |
Study title: Snoeck R, Andrei G, De CE. Current pharmacological approaches to the therapy of varicella zoster virus infections - A guide to treatment. Drugs 1999; 57(2):187-206.Snoeck R, Andrei G, De CE. Current pharmacological approaches to the therapy of varicella zoster virus infections - A guide to treatment. Drugs 1999; 57(2):187-206. |
Active substance: Foscarnet |
Study summary document link (including results): Snoeck R et al 1999.pdf |
View full study record |
Document reference: 39649 |
Study title: Snoeck R, Andrei G, De CE. Novel agents for the therapy of varicella-zoster virus infections. Expert Opinion on Investigational Drugs. 2000; 9(8):1743-1751.Snoeck R, Andrei G, De CE. Novel agents for the therapy of varicella-zoster virus infections. Expert Opinion on Investigational Drugs. 2000; 9(8):1743-1751. |
Active substance: Foscarnet |
Study summary document link (including results): Snoeck R et al 2000.pdf |
View full study record |
Document reference: 39647 |
Study title: SOCA, Lewis RA, Clogston P, Fainstein V, Gross R, Samo T Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trial Group. Arch. Intern. Med. 1995; 155: 65-74.SOCA, Lewis RA, Clogston P, Fainstein V, Gross R, Samo T Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trial Group. Arch. Intern. Med. 1995; 155: 65-74. |
Active substance: Foscarnet |
Study summary document link (including results): SOCA, Lewis RA et al 1995.pdf |
View full study record |
Document reference: 39675 |
Study title: Sohal A, Riordan A, Mallewa M, Solomon T, Kneen R. Successful treatment of cytomegalovirus polyradiculopathy in a 9-year-old child with congenital human immunodeficiency virus infection. J Child Neurol. 2009 Feb;24(2):215-8. Sohal A, Riordan A, Mallewa M, Solomon T, Kneen R. Successful treatment of cytomegalovirus polyradiculopathy in a 9-year-old child with congenital human immunodeficiency virus infection. J Child Neurol. 2009 Feb;24(2):215-8. |
Active substance: Foscarnet |
Study summary document link (including results): Sohal etal 2009.pdf |
View full study record |
Document reference: 39608 |
Study title: Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O et al. 2005. Viral encephalitis: a review of diagnostic methods and guidelines for management. European Journal of Neurology. 2005; 12(5):331-343.Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O et al. 2005. Viral encephalitis: a review of diagnostic methods and guidelines for management. European Journal of Neurology. 2005; 12(5):331-343. |
Active substance: FOSCARNET |
Study summary document link (including results): Steiner I 2005.pdf |
View full study record |
Document reference: 39597 |
Study title: Stocchi R, Ward KN, Fanin R, Baccarani M, Apperley JF. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation. Haematologica 1999; 84(1):71-79.Stocchi R, Ward KN, Fanin R, Baccarani M, Apperley JF. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation. Haematologica 1999; 84(1):71-79. |
Active substance: Foscarnet |
Study summary document link (including results): Stocchi R et al 1999.pdf |
View full study record |
Document reference: 39650 |
Study title: Efficacy and tolerability of Hametum® wound and healing ointment in children with superficial skin injuries and local inflammation of skin and mucosa |
Active substance: HERB: aqueous distillate from fresh leaves and twigs of Hamamelis virginiana./ HERB: distillate from fresh leaves and twigs of Hamamelis virginiana (1 : 1.6)/ HERB: distillate from fresh leaves and twigs of Hamamelis virginiana (1 : 1.6), corresponding to 0.64 mg Hamamelis ketones./ HERB: distillate from fresh leaves and twigs of Hamamelis virginiana (1 : 1.6)./ HERB: Distillate from fresh leav... |
Study summary document link (including results): |
View full study record |
Document reference: 40027 |
Study title: Post-marketing surveillance study on the treatment of restlessness and nervous sleep disorder in children under 14 years of age (Euvegal® forte) |
Active substance: HERB: dry extract from Valerian root (3 - 6 : 1), extraction agent: ethanol 62 % (w/w); dry extract from Balm leaves (4 - 6 : 1), extraction agent: ethanol 30 % (w/w)./ HERB: dry extract from Valerian root (4 - 5 : 1), dry extract from Balm leaves (4 - 6 : 1)./ HERB: Extract of Valerian root, corresp. to 640-800 mg drug; + Extract of Melissa leaf, corresp. 60 320-480 mg drug./ HERB: dry extract... |
Study summary document link (including results): |
View full study record |
Document reference: 21221 |
Study title: Götte and Roschke; päd (7) 2001 A supportive measure in the treatment of acute infections of the respiratory tract in children with recurring infections of the upper respiratory tract |
Active substance: (HERB) Purple cone flower, pressed juice, 1.7 - 2.5 : 1 |
Study summary document link (including results): |
View full study record |
Document reference: 39727 |
Study title: Künzer Th., Retrospective investigation on children (0-12 years) concerning safety and tolerability and dosage of Echinacin Liquidum |
Active substance: (HERB) Purple cone flower, pressed juice, 1.7 - 2.5 : 1 |
Study summary document link (including results): |
View full study record |
Document reference: 39730 |
Study title: A phase IIb randomised, multi-site clinical study to assess the immunogenicity and reactogenicity of formulation B of SB Biologicals¿ Hib conjugate vaccine administered mixed as single injection with SB Biologicals¿ DTPa vaccine versus formulation A of SB Biologicals¿ Hib conjugate vaccine administered either mixed as single injection or separately into opposite thighs with SB Biologicals¿ DTPa vaccine as a three-dose primary vaccination course in healthy infants at 3, 4, and 5 months of age. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41147 |
Study title: A post-marketing surveillance study of GlaxoSmithKline Biologicals¿ Haemophilus influenzae type b (Hib) tetanus conjugate vaccine in 3,000 Filipino subjects. Phase IV single-blind randomised study to assess the feasibility of syringe mixing of combined diphtheria, tetanus, whole cell Bordetella pertussis (DTPw) vaccine and Haemophilus influenzae type b (Hib) conjugate vaccine as a three dose primary vaccination course in healthy infants. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41151 |
Study title: An open multicentric post marketing surveillance study of SmithKline Beecham haemophilus influenzae type B tetanus conjugate vaccine-Hiberix- administered according to local recommendations in infants and children up to the age of 5 years. Only Korean version-English title to be provided. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41157 |
Study title: An open, parallel, randomised clinical study to assess the reactogenicity of SB Biologicals¿ Hib conjugate vaccine mixed with SB Biologicals¿ DTPa vaccine in comparison to the Pasteur-Mérieux´s Hib conjugate vaccine mixed with Pasteur-Mérieux´s DTPw vaccine as a booster vaccination to healthy children at 15 to 20 months, previously primed with three doses of commercially available DTPw and Hib conjugate vaccines. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41154 |
Study title: An open, parallel, randomized clinical study to assess the reactogenicity of SmithKline Beecham (SB) Biologicals¿ Hib conjugate vaccine mixed with SB Biologicals¿ DTPa vaccine in comparison to Pasteur-Mérieux Connaught¿s (PMC) Hib conjugate vaccine mixed with PMCs¿ DTPw vaccine, as a three-dose primary vaccination course to healthy infants at 2, 4 and 6 months of age. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41153 |
Study title: An open, randomised clinical study to assess the reactogenicity of SB Biologicals¿ Hib conjugate vaccine administered mixed as single injection with SB Biologicals¿ DTPa vaccine in comparison to commercially available Hib conjugate vaccine and DTPw vaccine administered separately into opposite limbs as a booster vaccination in healthy infants at 18 months of age, previously primed with three doses of DTPw and Hib conjugate vaccines. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41149 |
Study title: Timewell R. M., Rosenthal A. L., Smith J. P., Cagle G. D., J Ped Opht & Strab 1983; 20, 1: 22-26; Küchle H. J., Busse H., Augenerkrankungen im Kindesalter, Thieme Verlag Stuttgart New York 1985Timewell R. M., Rosenthal A. L., Smith J. P., Cagle G. D., J Ped Opht & Strab 1983; 20, 1: 22-26; Küchle H. J., Busse H., Augenerkrankungen im Kindesalter, Thieme Verlag Stuttgart New York 1985 |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28888 |
Study title: Treatment of meningitis in children with intrathecal gentamicin. - Newman RL - 1967 (Vth Intern. Of Chemotherapy, Vienna, Vol 1/2: 895) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28943 |
Study title: Treatment of urinary tract infection with gentamicin once or three times daily - Chong CY. - 2003 (Acta Paediatr 2003;92:291-6) - Publication in CES Renewal Application for Gentamicin sulfate - T. Darragon - 13 Sept. 2004 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28944 |
Study title: Treatment of ventriculitis with gentamicin and cloxacillin in infants born with spina bifida - Lorber J. -1970 (Arch. Dis. Childhood, 45, 178) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28945 |
Study title: Trial of a new antibiotic (gentamicin) in the treatment of diarrhea in infants. - Satge P. - No date - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28946 |
Study title: Use of antibiotics in acute gastroenteritis among infants in hospital. - Valmon HB. - 1969 ( Lancet, 1 : 1122-3) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28947 |
Study title: Zur Therapie der bakteriellen Wundinfektion von ulcera cruris. - Elle-broek U. - 1966 (Arztliche Praxis, XVIII, 27:1066-7) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28949 |
Study title: Acta Psychiatr Scand. 2004 Feb;109(2):140-6. Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP-CIT/SPECT study. Serra-Mestres J, Ring HA, Costa DC, Gacinovic S, Walker Z, Lees AJ, Robertson MM, Trimble MR.Acta Psychiatr Scand. 2004 Feb;109(2):140-6. Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP-CIT/SPECT study. Serra-Mestres J, Ring HA, Costa DC, Gacinovic S, Walker Z, Lees AJ, Robertson MM, Trimble MR. |
Active substance: Gentian (root |
Study summary document link (including results): |
View full study record |
Document reference: 41500 |
Study title: Biebach und Kremer (2004): postmarketing-surveillance study |
Active substance: Gentian (root), powdered Common Sorrel (herb), powdered European Elder (flower), powdered pimrose (flower with calyx), powdered |
Study summary document link (including results): |
View full study record |
Document reference: 40007 |
Study title: Dadamyan Z.S. Aflubin in the treatment and prophylaxis of influenza and other ARVIs in children, Moscow |
Active substance: Gentiana D1, Aconitum D6, Bryonia D6, Ferrum phosphoricum D12, Acidum sarcolacticum D12 |
Study summary document link (including results): |
View full study record |
Document reference: 40008 |
Study title: Petukhova Z.N., Yablonskaya L.V., Burakhova S.V. Clinical effectiveness of Aflubin in the treatment of ARVI and influenza in children with joint diseases, Novosibirsk |
Active substance: Gentiana D1, Aconitum D6, Bryonia D6, Ferrum phosphoricum D12, Acidum sarcolacticum D12 |
Study summary document link (including results): |
View full study record |
Document reference: 40011 |
Study title: Sitnikow I., Kisseljow W., Fjodeorow W., Alexandrowa E., Kremnowa N., Sitnikowa E., Marenko E. The pathogenic mechanisms of Aflubin in children with ARVI, Jaroslawl, 1999 |
Active substance: Gentiana D1, Aconitum D6, Bryonia D6, Ferrum phosphoricum D12, Acidum sarcolacticum D12 |
Study summary document link (including results): |
View full study record |
Document reference: 40010 |
Study title: Utschajkin W.F., Charlamowa F.S., Sawenkowa M.S., Afanassjewa A.A. Aflubin in the treatment of ARVI associated with stenosing laryngotracheitis in children, Moscow, 2000 |
Active substance: Gentiana D1, Aconitum D6, Bryonia D6, Ferrum phosphoricum D12, Acidum sarcolacticum D12 |
Study summary document link (including results): |
View full study record |
Document reference: 40009 |
Study title: Kuhn−J−J, Hendley−J−O, Adams−K−F, Clark−J−W, Gwaltney−J−M−Jr. Antitussive effect of guaifenesin in young adults with natural colds. Objective and subjective assessment. Chest, {Chest}, Dec 1982, vol. 82, no. 6, p. 713−8.Kuhn−J−J, Hendley−J−O, Adams−K−F, Clark−J−W, Gwaltney−J−M−Jr. Antitussive effect of guaifenesin in young adults with natural colds. Objective and subjective assessment. Chest, {Chest}, Dec 1982, vol. 82, no. 6, p. 713−8. |
Active substance: GUAIFENESIN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 29052 |
Study title: Latte J & Taverner D. Clinical trial of 3 days of treatment with oral pseudoephedrine for the common cold in the southern hemisphere. Am J Rhinol 2007; 21(4):452-5Latte J & Taverner D. Clinical trial of 3 days of treatment with oral pseudoephedrine for the common cold in the southern hemisphere. Am J Rhinol 2007; 21(4):452-5 |
Active substance: GUAIFENESIN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 29041 |
Study title: Parvez−L, Vaidya−M, Sakhardande−A, Subburaj−S, Rajagopalan−T−G. Evaluation of antitussive agents in man. Pulmonary pharmacology, {Pulm−Pharmacol}, Oct−Dec 1996, vol. 9, no. 5−6, p. 299−308.Parvez−L, Vaidya−M, Sakhardande−A, Subburaj−S, Rajagopalan−T−G. Evaluation of antitussive agents in man. Pulmonary pharmacology, {Pulm−Pharmacol}, Oct−Dec 1996, vol. 9, no. 5−6, p. 299−308. |
Active substance: GUAIFENESIN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 29051 |
Study title: A double-blind placebo-controlled crossover study comparing the safety and efficacy of ibuprofen sustained release 600 mg and ibuprofen regular release 400 mg in the treatment of primary dysmenorrhea |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29563 |
Study title: A double-blind placebo-controlled crossover study comparing the safety and efficacy of ibuprofen sustained release 600 mg and ibuprofen regular release 400 mg in the treatment of primary dysmenorrhea. |
Active substance: IBUPROFEN |
Study summary document link (including results): ibuprofen 87-752.pdf |
View full study record |
Document reference: 47447 |
Study title: A double-blind single dose evaluation of the comparative analgesic efficacy of aspirin 1000 mg/caffeine 64 mg, ibuprofen 400 mg, and placebo in the treatment of post-operative pain following third molar extraction. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29501 |
Study title: A double-blind single dose evaluation of the efficacy and safety of acetaminophen 1000 mg, ibuprofen 200 mg, ibuprofen 400 mg, and placebo in the treatment of pain following oral surgery |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29490 |
Study title: A double-blind single dose evaluation of the efficacy and safety of acetaminophen 650 mg, ibuprofen 200 mg, and placebo in the treatment of pain following oral surgery |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29489 |
Study title: A double-blind single dose evaluation of the efficacy and safety of ibuprofen 400 mg, ibuprofen 200 mg, APAP 1000 mg, and placebo in the treatment of pain following removal of the impacted third molars |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29487 |
Study title: A double-blind single dose study comparing the safety and efficacy of ibuprofen 200 mg, ibuprofen 400 mg, naproxen 200 mg, naproxen 400 mg and placebo in the treatment of post-operative dental pain |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29498 |
Study title: A double-blind single-dose of Advil 400 vs. APAP 1000 vs. Placebo in the relief of post operative oral surgery pain. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29530 |
Study title: A double-blind, multi-clinic single dose evaluation of the comparative analgesic efficacy of acetaminophen 650 mg, ibuprofen 200 mg, and placebo in the treatment of pain following oral surgery |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29485 |
Study title: a double-blind, multicentre multiple-dose, parallel-group study comparing the efficacy of three dose levels of Ibuprofen versus acetaminophen in the treatment of pyrexia in children. |
Active substance: IBUPROFEN |
Study summary document link (including results): ibuprofen-bpi310.pdf |
View full study record |
Document reference: 29403 |
Study title: A double-blind, Multiple Dose Parallel group study Comparing Advil Liquigels to Celebrex and to Placebo in Dental Pain. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29528 |
Study title: A double-blind, multiple-dose study of the anti-pyretic activity and tolerability of Ibuprofen and Paracetamol in burns pyrexia in children |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29428 |
Study title: A double-blind, multiple-dose study of the anti-pyretic activity and tolerability of Ibuprofen and Paracetamol in burns pyrexia in children |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29441 |
Study title: A DOUBLE-BLIND, MULTIPLE-DOSE STUDY OF THE ANTIPYRETIC ACTIVITY AND TOLERABILITY OF IBUPROFEN AND PARACETAMOL IN BURNS PYREXIA IN CHILDREN. |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-MS87-515.pdf |
View full study record |
Document reference: 47558 |
Study title: A Double-Blind, Parallel Study to Compare the Efficacy and Side Effects of an Ibuprofen 400 mg/Pseudoephedrine 60 mg Combination, An Ibuprofen 200 mg/Pseudoephedrine 30 mg Combination, and Placebo in the Treatment of Sinus Headache |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29562 |
Study title: A double-blind, parallel-group, multiple-dose study to compare the efficacy and tolerability of Ibuprofen suspension (Junifen) and Paracetamol suspension in the treatment of children undergoing tonsillectomy |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29411 |
Study title: A double-blind, placebo-controlled crossover study comparing the safety and efficacy of ibuprofen sustained release 600 mg and ibuprofen regular release 400 mg in the treatment of primary dysmenorrhea |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29503 |
Study title: Teich SA, Cheung TW, Friedman AH. Systemic antiviral drugs used in ophthalmology. Survey-of- Ophthalmology 1992; 37(1):19-53.Teich SA, Cheung TW, Friedman AH. Systemic antiviral drugs used in ophthalmology. Survey-of- Ophthalmology 1992; 37(1):19-53. |
Active substance: Foscarnet |
Study summary document link (including results): Teich et al 1992.pdf |
View full study record |
Document reference: 39629 |
Study title: Zerr DM, Gupta D, Huang ML, Carter R, Corey L. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clinical Infectious Diseases. 2002; 34(3):309-317.Zerr DM, Gupta D, Huang ML, Carter R, Corey L. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clinical Infectious Diseases. 2002; 34(3):309-317. |
Active substance: Foscarnet |
Study summary document link (including results): Zerr DM et al 2002.pdf |
View full study record |
Document reference: 39643 |
Study title: Ambrosioni G. - Activity and Tollerability of FZ 588 (Monuril) in the Treatment of Uncomplicated Low Internal Clinical Report, 1984 Varese L.A. et al.- Z1282 (Monuril) by Zambon Farmaceutici S.p.A. Internal clinical Report 1984 Ambrosioni G. - Activity and Tollerability of FZ 588 (Monuril) in the Treatment of Uncomplicated Low Internal Clinical Report, 1984 Varese L.A. et al.- Z1282 (Monuril) by Zambon Farmaceutici S.p.A. Internal clinical Report 1984 |
Active substance: FOSFOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 45048 |
Study title: Brunelli A. - Children's Recurrent Urinary Tract Infections. Single -Dose Therapy with Fosfomycin Trometamol In: Neu, Williams (eds), New Trends in Urinary Tract Infections. Int Symp., Rome 1987 Karger, Basel, pp. 307-311, 1988 Brunelli A. - Children's Recurrent Urinary Tract Infections. Single -Dose Therapy with Fosfomycin Trometamol In: Neu, Williams (eds), New Trends in Urinary Tract Infections. Int Symp., Rome 1987 Karger, Basel, pp. 307-311, 1988 |
Active substance: FOSFOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 45047 |
Study title: Careddu et al. Treatment of lower Urinary Tract infections in Children: single Dose Fosfomycin Trometamol Versus Pipemidic Acid. Chemioterapia, 6 pp 290-294, 1987Careddu et al. Treatment of lower Urinary Tract infections in Children: single Dose Fosfomycin Trometamol Versus Pipemidic Acid. Chemioterapia, 6 pp 290-294, 1987 |
Active substance: FOSFOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 45045 |
Study title: Principi N. et al. Fosfomycin Trometamol versus Netilmicin in Children's Lower Urinary Tract Infections. Chemotherapy, 36 suppl. 1 pp 41-45 1990 Principi N. et al. Fosfomycin Trometamol versus Netilmicin in Children's Lower Urinary Tract Infections. Chemotherapy, 36 suppl. 1 pp 41-45 1990 |
Active substance: FOSFOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 45046 |
Study title: Tumbarello R., Chessa M. - Terapia Antibiotica Monodose nel Trattamento delle infezioni delle Basse Vie Urinarie in età pediatrica- Atti del Congresso Internazionale della Società Italiana di Pediatria, 25-28 settembre 1986- Capo Boi, Villasimius (CA), ppTumbarello R., Chessa M. - Terapia Antibiotica Monodose nel Trattamento delle infezioni delle Basse Vie Urinarie in età pediatrica- Atti del Congresso Internazionale della Società Italiana di Pediatria, 25-28 settembre 1986- Capo Boi, Villasimius (CA), pp |
Active substance: FOSFOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 45049 |
Study title: Varese L.A., et al. - Z1282 (Fosfomycin Trometamol) an Antibacterial Agent as a single-Dose Therapy of lower Uncomplicated Urinary Tract Infection in Children - In: Joji Ishigami ed Recent advances in chemotherapy, Kyoto 1985. Tokyo University of Tokyo PrVarese L.A., et al. - Z1282 (Fosfomycin Trometamol) an Antibacterial Agent as a single-Dose Therapy of lower Uncomplicated Urinary Tract Infection in Children - In: Joji Ishigami ed Recent advances in chemotherapy, Kyoto 1985. Tokyo University of Tokyo Pr |
Active substance: FOSFOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 45050 |
Study title: Study of Blood Pressure Reduction with Fosinopril in Children and Adolescent |
Active substance: FOSINOPRIL |
Study summary document link (including results): Protocol CV118-028 Fosinopril.pdf |
View full study record |
Document reference: 45146 |
Study title: The Pharmacokinetics of Fosinopril in Children and Adolescent |
Active substance: FOSINOPRIL |
Study summary document link (including results): Protocol CV118-027 Fosinopril.pdf |
View full study record |
Document reference: 28600 |
Study title: A DOUBLE-BLIND, PARALLEL-GROUP, SINGLE-DOSE, MULTICENTER, STUDY COMPARING THE SAFETY AND TOLERANCE OF INTRAVENOUSLY ADMINISTERED FOSPHENYTOIN VERSUS DILANTIN PARENTERAL IN THE TREATMENT OF PATIENTS REQUIRING A LOADING DOSE OF PHENYTOIN |
Active substance: FOSPHENYTOIN |
Study summary document link (including results): PhRMA Web Synopsis_2.pdf |
View full study record |
Document reference: 28609 |
Study title: A DOUBLE-BLIND, RANDOMIZED, PARALLEL-GROUP, MULTICENTER CLINICAL STUDY OF TOLERANCE AND SAFETYOF MULTIPLE DOSES OF INTRAVENOUSLY ADMINISTERED FOSPHENYTOIN SODIUM VERSUS DILANTIN PARENTERAL IN NEUROSURGERY PATIENTS |
Active substance: FOSPHENYTOIN |
Study summary document link (including results): |
View full study record |
Document reference: 28607 |
Study title: A DOUBLE-BLIND, RANDOMIZED, PARALLEL-GROUP, SINGLE-DOSE, MULTICENTER, SAFTEY, TOLERANCE AND PHARMACOKINETIC STUDY OF INTRAVENOUS FOSPHENYTOIN (CEREBYX) VERSUS INTRAVENOUS DILANTIN IN PATIENTS REQUIRING A LOADING DOSE OF PHENYTOIN |
Active substance: FOSPHENYTOIN |
Study summary document link (including results): |
View full study record |
Document reference: 28613 |
Study title: An open, randomised post-marketing clinical trial to assess the safety and reactogenicity of GlaxoSmithKline Biologicals¿ Haemophilus influenzae type b (Hib) tetanus conjugate vaccine (Hiberix¿) co-administered with Chinese local DTPw vaccine when compared to Chinese local DTPw vaccine administered alone, in healthy infants at 3, 4 and 5 months of age. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41128 |
Study title: Clinical study to assess the immunogenicity and reactogenicity of a booster dose of formulation B of SB Biologicals¿ Hib conjugate vaccine administered either mixed as a single injection or separate into opposite sites with SB Biologicals¿ DTPa vaccine, or formulation A of SB Biologicals¿ Hib conjugate vaccine separately into opposite sites with SB Biologicals¿ DTPa vaccine at 13 months of age in infants primed in study 208108/032 (Hib-032). |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41150 |
Study title: Clinical study to assess the immunological memory induced by a primary course using different formulations of Hib conjugate vaccines in several combinations with acellular pertussis vaccines by giving one dose of unconjugated PRP co-administered with SB Biologicals¿ DTPa-HBV combined vaccine at 12-24 months of age in infants primed in study DTPa-HBV-037. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41146 |
Study title: Report on clinical study with iv fucidin in the treatment of severe staphylococcal infection |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28686 |
Study title: Sputum penetration of fusidic acid in patients with cystic fibrosis |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28717 |
Study title: Staemmler-H-G, Rodeck-H, Linzenmeier-G. On the treatment of superficial staphylococcal diseases in childhood with Fucidin-gel. Deutsche medizinische Wochenschrift (1946), {Dtsch-Med-Wochenschr}, 6 Sep 1968, vol. 93, no. 36, p. 1714-6, ISSN: 0012-0472. |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28665 |
Study title: Staemmler-H-G, Rodeck-H, Loss-G. The Effect Of Fusidic-Acid Anti Infect On Staphylococcus Infections In Children Abstract From Deutsch-Med-Wschr 91-45 2013-2017 November 11 1996 |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28666 |
Study title: Study of fusidic acid administered intravenously for the treatment of severe staphylococcus infection |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28685 |
Study title: Systemic or Local Treatment of Erythrasma. Thorn P Scand J Prim Health Care 1991 9 35-39 |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28671 |
Study title: Therapeutic assessment of application of calcipotriol ointment (Daivonex®) in children with psoriasis |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28704 |
Study title: Treatment of skin infections with two dosages of fusidic acid (500 mg/day and 1 g/day) compared with pristinamycin 2 g/day : a multicentre randomised study; L. Machet, A. Puissant, L. Vaillant t le groupe d’étude des infections cutanéesNouvelles Dermatologiques 1994; 13: 512-9 |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28683 |
Study title: A comparative study of Fucidin H cream and Hydrocortisone cream in children (4-17 years) with a flare-up of atopic dermatitis. A study using non-invasive bioengineering techniques. |
Active substance: FUSIDIC ACID AND HYDROCORTISONE |
Study summary document link (including results): |
View full study record |
Document reference: 28726 |
Study title: 945-405 GABAPENTIN PEDIATRIC ADD-ON TRIAL: K RANDOMIZED, DOOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP MULTICENTER STUDY IN PATIENTS WITH PARTIAL SEIZURES. (945-305). |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28730 |
Study title: A 12 WEEK, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL GROUP MULTICENTER STUDY TO DETERMINE THE EFFICACY OF GABAPENTIN (CI-945) 900MG DAILY AND THE DOSE RESPONSE CHARACTERISTICS AND SAFETY OF GABAPENTIN 900MG AND 1200MG ORAL DAILY DOSES AS ADD ON THERAPY IN PATIENTS WITH MEDICALLY REFRACTORY SEIZURES |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28731 |
Study title: Open, randomised, clinical study to evaluate the interference on the immunogenicity of vaccine antigens, when Haemophilus influenzae type b tetanus conjugate and combined diphtheria, tetanus, acellular pertussis vaccines are co-administered, either in one single or two separate injections as a primary vaccination course to healthy infants at 2, 4 and 6 months of age. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41136 |
Study title: Open, randomized clinical study of the immunogenicity and reactogenicity of the SB Biologicals¿ DTPa and Hib conjugate vaccines, either mixed in one syringe or given in two separate injections, to healthy infants at the age of 2, 4, 6 and 18 months, or the administration of a dose of plain PRP at the age of 12 months in infants primed with Hib conjugate vaccine. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41135 |
Study title: Phase II open randomized primary vaccination study to assess the immunogenicity and reactogenicity of GlaxoSmithKline Biologicals (GSK) Haemophilus influenzae type b (Hib) conjugate vaccine administered either mixed or in two separated injections with commercially available DTPw vaccine (Government Pharmaceutical Organization: GPO) as compared to GSK Biologicals¿ Hib administered mixed with GSK Biologicals¿ DTPw vaccine in healthy infants, aged 2, 4 and 6 months. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41158 |
Study title: Phase IV primary vaccination study to assess the immunogenicity and reactogenicity of concomitant administration of Haemophilus influenzae type b (Hib) vaccine with either diphtheria-tetanus-whole cell pertussis vaccine and hepatitis B vaccine or with quadrivalent diphtheria-tetanus-whole cell pertussis-hepatitis B vaccine |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41152 |
Study title: DOUBLE-BLIND, DOSE CONTROLLED, MULTICENTER STUDY TO DETERMINE THE SAFETY AND EFFICACY OF THREE DOSES OF GABAPENTIN IN COMPARISON WITH OPEN-LABEL CARBAMAZEPINE AS MONOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED EPILEPSY. |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28772 |
Study title: DOUBLE-BLIND, PARALLEL GROUP COMPARISON OF GABAPENTIN VERSUS PLACEBO AS ADD-ON THERAPY FOR EPILEPSY IN CHILDREN |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28773 |
Study title: DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDIES OF THE SAFETY AND EFFICACY OF GABAPENTIN MONOTHERAPY IN PATIENTS WITH CHILDHOOD ABSENCE EPILEPSY NAIVE TO ANTIEPILEPTIC DRUG THERAPY (945-19 & 945-20) |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28774 |
Study title: DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER TRIAL TO DETERMINE THE EFFICACY AND SAFETY OF NEURONTIN (GABAPENTIN) IN MIGRAINE PROPHYLAXIS ADMINISTERED IN DOSES DIVIDED THREE TIMES A DAY (TID) PROTOCOL 945-400193) |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28775 |
Study title: GABAPENTIN ADJUNCTIVE TREATMENT IN PATIENTS WITH BIPOLAR DISORDER |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28776 |
Study title: GABAPENTIN AS ADD-ON THERAPY IN PATIENTS WITH EPILEPSY. |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28777 |
Study title: GABAPENTIN IN PATIENT MONOTHERAPY TRIAL: A DOUBLE-BLIND, DOSE-CONTROLLED, MULTICENTER STUDY IN PATIENTS WITH REFRACTORY PARTIAL EPILEPSY. |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28778 |
Study title: GABAPENTIN MONOTHERAPY TRIAL: A 36-WEEK, DOUBLE-BLIND, PARALLEL-GROUP, MULTICENTER, COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF GABAPENTIN VERSUS CARBAMAZEPINE IN PPATIENTS WITH PARTIAL EPILEPSY |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28779 |
Study title: GABAPENTIN OPEN-LABEL, FOLLOW-ON TRIAL IN PATIENTS WITH REFRACTORY PARTIAL EPILEPSY. |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28780 |
Study title: Kraemer C. und Evers S.: Eine randomisierte, doppelblinde, placebokontrollierte, Crossover Studie zur Wirksamkeit von Ibuprofen und Zolmitriptan akuten Migräneattacke bei Kindern; Neurology 2006;67;497-499; original published online Jun 14, 2006. Lewis D. et al.: Children`s Ibuprofen Suspension for the Acute Treatment of Pediatirc Migraine; Headache September 2002. pp:780-786.St. Charles CS et al.: A comparison of ibuprofen versus acetaminophen with codein in the young tonsillectomy. PubMed. Bennie RE et al.: Postoperative analgesia with preoperative oral ibuprofen or acetaminophen in children undergoing myringotomy. PubMed. Kokki H. et al.: Cerebrospinal Fluid Distribution of Ibuprofen After Intravenous Administration in Children;PEDIATRICS Volume 120, Number 4, October 2007. Clark E.... |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29609 |
Study title: Kraemer C. und Evers S.: Eine randomisierte, doppelblinde, placebokontrollierte, Crossover-Studie zur Wirksamkeit von Ibuprofen und Zolmitriptan akuten Migräneattacke bei Kindern; Neurology 2006;67;497-499; original published online Jun 14, 2006. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29542 |
Study title: Kraemer C. und Evers S.: Eine randomisierte, doppelblinde, placebokontrollierte, Crossover-Studie zur Wirksamkeit von Ibuprofen und Zolmitriptan akuten Migräneattacke bei Kindern; Neurology 2006;67;497-499; original published online Jun 14, 2006. Kraemer C. und Evers S.: Eine randomisierte, doppelblinde, placebokontrollierte, Crossover-Studie zur Wirksamkeit von Ibuprofen und Zolmitriptan akuten Migräneattacke bei Kindern; Neurology 2006;67;497-499; original published online Jun 14, 2006. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29603 |
Study title: Latte J & Taverner D. Clinical trial of 3 days of treatment with oral pseudoephedrine for the common cold in the southern hemisphere. Am J Rhinol 2007; 21(4):452-5 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29506 |
Study title: Latte J et al. A randomized, double-blind, placebo-controlled trial of pseudoephedrine in coryza. Clin Exp Pharmacol Physiol 2004; 31(7): 429-32 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29508 |
Study title: Lewis D. et al.: Children`s Ibuprofen Suspension for the Acute Teratment of Pediatirc Migraine; Headache September 2002. pp:780-786. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29543 |
Study title: Lewis D. et al.: Children`s Ibuprofen Suspension for the Acute Teratment of Pediatirc Migraine; Headache September 2002. pp:780-786. Lewis D. et al.: Children`s Ibuprofen Suspension for the Acute Teratment of Pediatirc Migraine; Headache September 2002. pp:780-786. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29604 |
Study title: Marchetti−F. Ibuprofene in pediatrics. {MED−BAMBINO}, 30 JUN 2001, Vol/Iss/Pg. 20/6 (387−391)Marchetti−F. Ibuprofene in pediatrics. {MED−BAMBINO}, 30 JUN 2001, Vol/Iss/Pg. 20/6 (387−391) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29576 |
Study title: Marriott−S−C et al. A dose ranging study of ibuprofen suspension as an antipyretic. {Arch−Dis−Child}, Sep 1991, vol. 66, no. 9, p. 1037−41Marriott−S−C et al. A dose ranging study of ibuprofen suspension as an antipyretic. {Arch−Dis−Child}, Sep 1991, vol. 66, no. 9, p. 1037−41 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29587 |
Study title: Marriott−S−C, Stephenson−T−J. A double−blind dose−ranging trial with paediatric ibuprofen. {BR−J−CLIN−PRACT}, 1990, Vol/Iss /Pg. 44/8 SUPPL. 70 (15−18)Marriott−S−C, Stephenson−T−J. A double−blind dose−ranging trial with paediatric ibuprofen. {BR−J−CLIN−PRACT}, 1990, Vol/Iss /Pg. 44/8 SUPPL. 70 (15−18) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29599 |
Study title: An analgesic combination. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29813 |
Study title: Meran A et al. A cross-over comparison of acrivastine, pseudoephedrine and their combination in seasonal allergic rhinitis. Rhinology 1990; 28(1): 33-40 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29514 |
Study title: A PHASE IV RANDOMIZED STUDY OF THE USE OF FLUCONAZOLE AS CHRONIC SUPPRESSIVE THERAPY VERSUS EPISODIC THERAPY IN HIV POSITIVE SUBJECTS WITH RECURRENT OROPHARYNGEAL CANDIDIASIS. |
Active substance: FOSPHENYTOIN |
Study summary document link (including results): |
View full study record |
Document reference: 28603 |
Study title: A RANDOMIZED, DOUBLE-BLIND COMPARATIVE MULTICENTER STUDY OF FLUCONAZOLE PLUS AMPHOTERICIN B VERSUS FLUCONAZOLE PLUS PLACEBO IN THE TREATMENT OF CANDIDEMIA AND ITS CONSEQUENCES IN NON-NEUTROPENIC PATIENTS |
Active substance: FOSPHENYTOIN |
Study summary document link (including results): |
View full study record |
Document reference: 28602 |
Study title: AN OPEN-LABEL STUDY OF INTRAVENOUS FOSPHENYTOIN (CEREBYX) ON PLASMA FORMATE, PHOSPHATE, AND CALCIUM CONCENTRATIONS IN NEONATAL PEDIATRIC PATIENTS |
Active substance: FOSPHENYTOIN |
Study summary document link (including results): |
View full study record |
Document reference: 28605 |
Study title: AN OPEN-LABEL, MULTICENTER STUDY ASSESSING THE SAFETY AND TOLERANCE OF AN INTRAMUSCULARLY ADMINISTERED LOADING DOSE OF FOSPHENYTOIN IN PATIENTS REQUIRING A LOADING DOSE OF PHENYTOIN. |
Active substance: FOSPHENYTOIN |
Study summary document link (including results): EMA Pediatrics Web Synopsis.pdf |
View full study record |
Document reference: 28610 |
Study title: AN OPEN-LABEL, SAFETY, TOLERANCE AND PHARMACOKINETIC STUDY OF INTRAVENOUS AND INTRAMUSCULAR FOSPHENYTOIN (CEREBYX) IN CHILDREN |
Active substance: FOSPHENYTOIN |
Study summary document link (including results): 982-028 EMA Pediatrics Web Synopsis.pdf |
View full study record |
Document reference: 28612 |
Study title: OPEN LABEL STUDY OF CEREBYX IN PEDIATRIC PATIENTS WITH SEIZURES |
Active substance: FOSPHENYTOIN |
Study summary document link (including results): |
View full study record |
Document reference: 28611 |
Study title: OPEN LABELLED, MULTICENTER STUDY OF THE SAFETY AND TOLERANCE OF INTRAMUSCULARLY-ADMINISTRED, MULTIDOSE FOSPHENYTOIN IN HOSPITALIZED NEUROSURGERY PATIENTS. |
Active substance: FOSPHENYTOIN |
Study summary document link (including results): 982-014 EMA Pediatrics Web Synopsis.pdf |
View full study record |
Document reference: 28606 |
Study title: OPEN-LABEL, RATE-ESCALATION, MULTICENTER STUDY TO ASSESS SAFETY, TOLERANCE AND PHARMACOKINETICS OF INTRAVENOUSLY ADMINISTERED FOSPHENYTOIN SODIUM IN THE ACUTE TREATMENT OG GENERALIZED CONVULSIVE STATUS EPILEPTICUS. |
Active substance: FOSPHENYTOIN |
Study summary document link (including results): PhRMA Web Synopsis.pdf |
View full study record |
Document reference: 28608 |
Study title: PILOT STUDY TO DETERMINE THE FEASIBILITY OF FLUCONAZOLE FOR INDUCTION TREATMENT AND SUPPRESSION OF RELAPSE OF HISTOPLASMOSIS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME |
Active substance: FOSPHENYTOIN |
Study summary document link (including results): |
View full study record |
Document reference: 28601 |
Study title: Phase I-II study of high-dose fotemustine followed by autologous peripheral blood stem-cell transplant in children and adolescents with relapsed or refractory malignant solid tumours |
Active substance: FOTEMUSTINE |
Study summary document link (including results): fotemustine_CL1-10036-305_spreadsheet.xls |
View full study record |
Document reference: 28614 |
Study title: Safety and pharmacokinetic profile of the pasteurized purified antitetanus serum (pasteurized pats) associated with adsorbed Td vaccine |
Active substance: Fragments F(ab')2 of Antitetanus Immunoglobulins (Pasteurized) |
Study summary document link (including results): |
View full study record |
Document reference: 41392 |
Study title: A randomized clinical trial of two topical preparations (framycitin/gramicidin and oxytetracycline/hydrocortisone with polymyxin B) in the treatment of external otitis. Wadsten CJ, Bertilsson CA, Sieradzki H, Edström S. Arch Otorhinolaryngol. 1985;242(2):135-9. |
Active substance: FRAMYCETIN |
Study summary document link (including results): A randomized clinical trial of two topical preparations.pdf |
View full study record |
Document reference: 28623 |
Study title: Clinical Expert Statement of Framycetin sulfate containing formulations. - Dr R. Boyer - 21 Feb. 2002 |
Active substance: FRAMYCETIN |
Study summary document link (including results): |
View full study record |
Document reference: 45272 |
Study title: Comparative clinical trial of anti-diarrhoeal drugs. - Gupta S. - 1977 (14:639-644) - Micromedex ref. in CES - Ohlrogge R. - 24 July 2004 - |
Active substance: FRAMYCETIN |
Study summary document link (including results): |
View full study record |
Document reference: 28621 |
Study title: A 12 WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTI-CENTER STUDY TO DETERMINE THE EFFICACY OF GABAPENTIN (CI-945) 900-MG DAILY AND THE DOSE RESPONSE CHARACTERISTICS AND SAFETY OF GABAPENTIN 900-MG AND 1200-MG ORAL DAILY DOSES AS ADD-ON THERAPY IN PATIENTS WITH MEDICALLY REFRACTORY PARTIAL SEIZURES. |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28732 |
Study title: A 26 WEEK DOUBLE-BLIND, DOSE-CONTROLLED, MULTICENTER STUDY OFCONVERSION FROM MARKETED ANTIEPILEPTIC DRUG THERAPY TO GABAPENTIN MONOTHERAPY IN PATIENTS W/ COMPLEX PARTIAL OR SECONDARILY GENERALIZED SEIZURES: . |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28733 |
Study title: A 3 WEEK, DOUBLE BLIND, PILOT STUDY OF THE SAFETY AND TOLERANCE OF GABAPENTIN (CI-945) ADMINISTERED AS ADD-ON THERAPY WITHOUT TITRATION TO PATIENTS WITH REFRACTORY EPILEPSY. |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28734 |
Study title: A 3-MONTH, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, SINGLE CENTER STUDY, TO EVALUATE THE EFFICACY AND SAFETY OF GABAPENTIN (CI-945) IN PATIENTS WITH SPASTICITY. |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28735 |
Study title: A DOUBLE BLIND PLACEBO CONTROLLED, PARALLEL GROUP, MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF GABAPENTIN (CI-945) AS ADD-ON THERAPY IN PATIENTS WITH MEDICALLY UNCONTROLLED PARTIAL EPILEPSY |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28736 |
Study title: Coarctation of the aorta: pre and postoperative evaluation with MRI and MR angiography: correlation with echocardiography and surgery; Didier D; Int. J. Cardiovasc. Imaging.; 2006 vol.22 p.457-475Coarctation of the aorta: pre and postoperative evaluation with MRI and MR angiography: correlation with echocardiography and surgery; Didier D; Int. J. Cardiovasc. Imaging.; 2006 vol.22 p.457-475 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28871 |
Study title: Collateral flow in coarctation of the aorta with magnetic resonance velocity mapping: correlation to morphological imaging of collateral vessels; Holmqvist C; JMRI; 2002 vol.15 p.39-46Collateral flow in coarctation of the aorta with magnetic resonance velocity mapping: correlation to morphological imaging of collateral vessels; Holmqvist C; JMRI; 2002 vol.15 p.39-46 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28861 |
Study title: Contrast-enhanced thoracic 3D-MR angiography in infants and children;Holmqvist C; Acta Radiol.; 2001 vol.42 p.50-58Contrast-enhanced thoracic 3D-MR angiography in infants and children;Holmqvist C; Acta Radiol.; 2001 vol.42 p.50-58 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28854 |
Study title: Diffusion weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma; Dubrulle F; Radiology; 2006 vol.238 n.2 p.604-610Diffusion weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma; Dubrulle F; Radiology; 2006 vol.238 n.2 p.604-610 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28868 |
Study title: Doppelblinde, randomisierte, Placebo-kontrollierte, monozentrische Studie zum Nachweis der therapeutischen Wirksamkeit und Verträglichkeit von Ichthraletten® gegenüber Placebo bei Akne papulopustulosaSAPHO syndrome: MR appearance of vertebral involvement; Laredo JD; Radiology; 2007 vol.242 n.3 p.825-831 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28874 |
Study title: Dynamic gadolinium enhanced subtraction MR imaging a simple technique for the early diagnosis of Legg-Calve-Perthes disease: preliminary results;Sebag G; Pediatr. Radiol.; 1997 vol.27 p.216-220Dynamic gadolinium enhanced subtraction MR imaging a simple technique for the early diagnosis of Legg-Calve-Perthes disease: preliminary results;Sebag G; Pediatr. Radiol.; 1997 vol.27 p.216-220 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28852 |
Study title: Femoral head vascularisation in Legg-Calve-Perthes disease: comparison of dynamic gadolinium-enhanced subtraction MRI with bone scintigraphy; Lamer S; Pediatr. Radiol.; 2002 vol.32 p.580-585Femoral head vascularisation in Legg-Calve-Perthes disease: comparison of dynamic gadolinium-enhanced subtraction MRI with bone scintigraphy; Lamer S; Pediatr. Radiol.; 2002 vol.32 p.580-585 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28862 |
Study title: Gadolinium DOTA enhanced MRI of painful osseous crises in children with sickle-cell anemia;Bonnerot V; Pediatr. Radiol.; 1994 vol.24 p.92-95Gadolinium DOTA enhanced MRI of painful osseous crises in children with sickle-cell anemia;Bonnerot V; Pediatr. Radiol.; 1994 vol.24 p.92-95 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28841 |
Study title: Gd-DOTA enhanced MR imaging in two cases of Sturge-Weber syndrome;Lipski S; AJNR; 1990 vol.11 p.690-692Gd-DOTA enhanced MR imaging in two cases of Sturge-Weber syndrome;Lipski S; AJNR; 1990 vol.11 p.690-692 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28840 |
Study title: Gd-DOTA: chemistry toxicity and clinical results;Bonnemain B; Liver imaging current trends and new techniques; Ferruci J.T. Stark D.D.; Andiver Medical Publishers Boston 1990; p.349-357Gd-DOTA: chemistry toxicity and clinical results;Bonnemain B; Liver imaging current trends and new techniques; Ferruci J.T. Stark D.D.; Andiver Medical Publishers Boston 1990; p.349-357 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28843 |
Study title: Sauder RA, Rafferty JF, Bilenki AL, Berkowitz ID. Helium-oxygen and conventional mechanical ventilation in the treatment of large airway obstruction and respiratory failure in an infant. South Med J 1991 May;84(5):646-8.Sauder RA, Rafferty JF, Bilenki AL, Berkowitz ID. Helium-oxygen and conventional mechanical ventilation in the treatment of large airway obstruction and respiratory failure in an infant. South Med J 1991 May;84(5):646-8. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29104 |
Study title: Smith SW, Biros M. Relief of imminent respiratory failure from upper airway obstruction by use of helium-oxygen: a case series and brief review. Acad Emerg Med 1999 Sep;6(9):953-6.Smith SW, Biros M. Relief of imminent respiratory failure from upper airway obstruction by use of helium-oxygen: a case series and brief review. Acad Emerg Med 1999 Sep;6(9):953-6. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29106 |
Study title: Stucki P, Scalfaro P, de Halleux Q, Vermeulen F, Rappaz I, Cotting J. Successful management of severe respiratory failure combining helium/oxygen gas mixture with non-invasive high-frequency percussive ventilation. Crit Care Med 2002;30(3):692-694.Stucki P, Scalfaro P, de Halleux Q, Vermeulen F, Rappaz I, Cotting J. Successful management of severe respiratory failure combining helium/oxygen gas mixture with non-invasive high-frequency percussive ventilation. Crit Care Med 2002;30(3):692-694. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29107 |
Study title: Tepper RS, Asdell S. Comparison of helium dilution and nitrogen washout measurements of functional residual capacity in infants and very young children. Pediatric pulmonology. 1992;13(4):250-4.Tepper RS, Asdell S. Comparison of helium dilution and nitrogen washout measurements of functional residual capacity in infants and very young children. Pediatric pulmonology. 1992;13(4):250-4. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29108 |
Study title: Terregino C, Nairn S, Chansky M. The effect of heliox on croup: a pilot study. Acad Emerg Med 1998;5:1130 1133.Terregino C, Nairn S, Chansky M. The effect of heliox on croup: a pilot study. Acad Emerg Med 1998;5:1130 1133. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29109 |
Study title: Ulhoa CAG, Larner L. Helium-oxygen (Heliox) mixture in airway obstruction. J Pediatr (Rio J) 2000 Jan-Feb;76(1):73-8.Ulhoa CAG, Larner L. Helium-oxygen (Heliox) mixture in airway obstruction. J Pediatr (Rio J) 2000 Jan-Feb;76(1):73-8. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29110 |
Study title: Weber JE, Chudnofsky CR, Younger JG, Larkin L, Boczar M, Wilkerson MD, Zuriekat GY, Nolan B, Eicke DM. A randomized comparison of helium-oxygen mixture (heliox) and racemic epinephrine for the treatment of moderate to severe croup. Pediatrics 2001;107(6):1-4.Weber JE, Chudnofsky CR, Younger JG, Larkin L, Boczar M, Wilkerson MD, Zuriekat GY, Nolan B, Eicke DM. A randomized comparison of helium-oxygen mixture (heliox) and racemic epinephrine for the treatment of moderate to severe croup. Pediatrics 2001;107(6):1-4. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29111 |
Study title: Weir M. Vocal cord dysfunction mimics asthma and may respond to heliox. Clin Pediatr 2002;41(1):37-41.Weir M. Vocal cord dysfunction mimics asthma and may respond to heliox. Clin Pediatr 2002;41(1):37-41. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29112 |
Study title: Williams J, Stewart K, Tobias JD, Berkenbosch JW. Therapeutic benefits of helium-oxygen delivery to infants via nasal cannula. Pediatr Emerg Care 2004 Sep;20(9):574-8.Williams J, Stewart K, Tobias JD, Berkenbosch JW. Therapeutic benefits of helium-oxygen delivery to infants via nasal cannula. Pediatr Emerg Care 2004 Sep;20(9):574-8. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29113 |
Study title: OPEN-LABEL MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF GABAPENTIN AS MONOTHERAPY OR ADD-ON THERAPY IN THE LONG-TERM TREATMENT OF EPILEPTIC SEIZURES |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28790 |
Study title: OPEN-LABEL, LONG-TERM EXTENSION, MULTI-CENTER STUDY TO DETERMINE SAFETY OF GABAPENTIN AS ADD-ON THERAPY IN PATIENTS WITH MEDICALLY REFRACTORY PARTIAL SEIZURE |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28791 |
Study title: OPEN-LABEL, MULTICENTER STUDY TO DETERMINE THE PERCENTAGE OF PATIENTS WITH FOCAL ( PARTIAL ONSET) SEIZURES, WHO ARE INSUFFICIENTLY CONTROLLED BY ANTIEPILEPTIC MONOTHERAPY, BECOMING SEIZURE-FREE IN AT LEAST ONE FOCAL SEIZURE TYPE UNDER ADD-ON THERPAY WITH GABAPENTIN (NEURONTIN) |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28792 |
Study title: PATIENTS WITH PARTIAL SEIZURES (WITH OUR WITHOUT SECONDARY GENERALIZATION. "AUS-STEPS". DOUBLE BLIND |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28793 |
Study title: PHASE IIA, OPEN-LABEL, MULTICENTER STUDY TO DETERMINE THE EFFICACY AND SAFETY OF GABAPENTIN 600 MG TO 1800 MG DAILY AS ADD-ON THERAPY IN PATIENTS WITH MEDICALLY REFRACTORY PARTIAL EPILEPSY |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28794 |
Study title: PK IN CHILDREN |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28795 |
Study title: Multiple-Dose Pharmacokinetic Study of an Ibuprofen-Psuedoephedrine HCl Suspension in Children. Aug 1999. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29560 |
Study title: A double-blind, single dose evaluation of the comparative analgesic efficacy of aspirin 800 mg plus caffeine 64 mg, ibuprofen 400 mg and placebo in the treatment of post-operative pain following third molar extraction. CSR 103. Protocol 87-713A, Unpublished Report 229. |
Active substance: IBUPROFEN + CAFFEINE + ACETYLSALICYLIC ACID |
Study summary document link (including results): acetylsalicylic acid_ caffeine_ibuprofen 87-713A.pdf |
View full study record |
Document reference: 47432 |
Study title: A randomized double-blind study comparing the efficacy of single doses of ibuprofen 200 mg, ibuprofen 400 mg, ibuprofen 200 mg plus caffeine 100 mg, ibuprofen 400 mg plus caffeine 200 mg, caffeine 100 mg, and placebo in the treatment of post-operative dental pain. CSR 112. |
Active substance: IBUPROFEN AND CAFFEINE |
Study summary document link (including results): caffeine_ibuprofen 87-731B.pdf |
View full study record |
Document reference: 47261 |
Study title: |
Active substance: IBUPROFEN AND DEXTROMETHOPRHAN |
Study summary document link (including results): dextromethorphan_ibuprofen 96-617.pdf |
View full study record |
Document reference: 47891 |
Study title: A double-blind single dose study comparing the safety and efficacy of ibuprofen 200 mg, ibuprofen 400 mg, naproxen 200 mg, naproxen 400 mg and placebo in the treatment of post-operative dental pain. CSR 122. Protocol 89-907, Unpublished Report 248. |
Active substance: IBUPROFEN AND NAPROXEN |
Study summary document link (including results): |
View full study record |
Document reference: 47888 |
Study title: |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 11-201.pdf |
View full study record |
Document reference: 47397 |
Study title: A comparative dose range evaluation of the antipyretic efficacy and safety of ibuprofen liquid at three different doses in children. Stat Rpt 84. Protocol 6-639, Unpublished Report 209. |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 6-639.pdf |
View full study record |
Document reference: 47396 |
Study title: A comparison of the efficacy and safety of ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg and acetaminophen elixir dosed at 12.5 mg/kg to placebo in children with sore throat pain. CSR 162. Protocol 89-949, 90-001, Unpublished Report 288. |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 89-949_90-001.pdf |
View full study record |
Document reference: 47404 |
Study title: A comparison of the efficacy and safety of ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg and acetaminophen elixir dosed at 12.5 mg/kg to placebo in children with ear pain. CSR 161. Protocol 90-002, 90-003, Unpublished Report 287. |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 90-002_3.pdf |
View full study record |
Document reference: 47405 |
Study title: A dose range study of the antipyretic efficacy and safety of ibuprofen pediatric suspension in febrile children. CSR 136. Protocol 88-828, Unpublished Report 262. |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 88-828.pdf |
View full study record |
Document reference: 47401 |
Study title: A double-blind single dose evaluation of the efficacy and safety of acetaminophen 1000 mg, ibuprofen 200 mg, ibuprofen 400 mg, and placebo in the treatment of pain following oral surgery. Stat Rpt 52. Protocol 4-403, Unpublished Report 164. |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 4-403.pdf |
View full study record |
Document reference: 47392 |
Study title: A double-blind single dose evaluation of the efficacy and safety of acetaminophen 650 mg, ibuprofen 200 mg, and placebo in the treatment of pain following oral surgery. Stat Rpt 51. Protocol 4-411, Unpublished Report 163. |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 4-411.pdf |
View full study record |
Document reference: 47394 |
Study title: Treatment of acute tonsillo−pharyngitis: a comparative study of spiramycin and erythromycin. Suprihati, Noersinggih, Hoedijono R. Current medical research and opinion, {Curr−Med−Res−Opin}, 1984, vol. 9, no. 3, p. 192−6. |
Active substance: ERYTHROMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 26523 |
Study title: Micromedex ref. in CES - Ohlrogge R. - 24 July 2004 : Comparative clinical trial of anti-diarrhoeal drugs. - Gupta S. - 1977 (14:639-644) |
Active substance: FRAMYCETIN |
Study summary document link (including results): |
View full study record |
Document reference: 28617 |
Study title: Open dose finding study on effects and tolerability of Egb 761 in children with attention deficit/hyperactovity syndrome (ADHS) |
Active substance: Ginkgo biloba (herb)/ Ginkgo biloba leaves (35-67:1), (herb)/ HERB: 40 mg Ginkgo bilobae fol. extr. sicc. (35 - 67 : 1), corresponding to 9.6 mg ginkgo flavone glycosides and 2.4 mg terpene lactones./ HERB: Dry extract of Ginkgo biloba leaves 40 mg, standardized to 9.6 mg (24%) Ginkgo flavone glycosides and 2.4 mg (6%) terpene lactones (ginkgolides and bilobalide)./ HERB: extract (50:1) from Gi... |
Study summary document link (including results): |
View full study record |
Document reference: 40012 |
Study title: Glatiramer acetate treatment in patients with childhood juvenile onset multiple sclerosis - Kornek B, Bernert G, Balassy C, et al. - 2003 (Neuropediatrics 2003; 34: 120-126) Glatiramer acetate treatment in patients with childhood juvenile onset multiple sclerosis - Kornek B, Bernert G, Balassy C, et al. - 2003 (Neuropediatrics 2003; 34: 120-126) |
Active substance: GLATITRAMER |
Study summary document link (including results): |
View full study record |
Document reference: 28958 |
Study title: An open-label, multicenter, single-dose study to evaluate the pharmacokinetics of glimepiride (Amaryl®) in pediatric patients with type 2 diabetes mellitus - Sponsor Sanofi - 26/02/2004 |
Active substance: GLIMEPIRIDE |
Study summary document link (including results): Glimepiride-Study 2.pdf |
View full study record |
Document reference: 28971 |
Study title: Glimipiride versus Metformin as Monotherapy in Paediatric Subject with Type 2 Diabetes Mellitus : A Single Bind Comparaison Study - sponsor sanofi - 15/11/2004 |
Active substance: GLIMEPIRIDE |
Study summary document link (including results): Glimepiride-Study 1.pdf |
View full study record |
Document reference: 28972 |
Study title: Clinical trial of a new oral antidiabetic agent: gliquidone or ARDF-26. |
Active substance: GLIQUIDONE |
Study summary document link (including results): Gliquidone_U77-0366_synopsis.pdf |
View full study record |
Document reference: 28973 |
Study title: Böhmer D., Ambrus P., Szögy A. and Haralambie G. Chondropathia patellae of young sportsmen Therapiewoche 1982; 32(41): 4897-901Böhmer D., Ambrus P., Szögy A. and Haralambie G. Chondropathia patellae of young sportsmen Therapiewoche 1982; 32(41): 4897-901 |
Active substance: GLUCOSAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 28975 |
Study title: Rovati L.C., Giacovelli G. and Setnikar I. A multicenter clinical trial on the efficacy and tolerability of glucosamine sulphate (DONA®) in the treatment of osteoarthritis. (1989)Rovati L.C., Giacovelli G. and Setnikar I. A multicenter clinical trial on the efficacy and tolerability of glucosamine sulphate (DONA®) in the treatment of osteoarthritis. (1989) |
Active substance: GLUCOSAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 28976 |
Study title: Souschek K. Efficacy of glucosamine in juvenile osteochondrosis Ortopädische Praxis 1973; 9(11): 383-6Souschek K. Efficacy of glucosamine in juvenile osteochondrosis Ortopädische Praxis 1973; 9(11): 383-6 |
Active substance: GLUCOSAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 28974 |
Study title: BSS Alcon Studies: Clinical Evaluation of the Safety of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus for Use During Cataract Extraction in Pediatric Patients. |
Active substance: GLUCOSE AND GLUTATHIONE AND SODIUM BICARBONATE |
Study summary document link (including results): |
View full study record |
Document reference: 28977 |
Study title: Prospective investigation to assess the efficacy of one monotherapy (NAAGA) versus one bitherapy (NAAGA + Levocabastine) in the treatment of mild and moderate seasonal and intra-annual allergic conjunctivitis. Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA |
Active substance: GLUTAMIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28978 |
Study title: Study of the clinical and biological efficacity of NAAXIA SINE® in vernal keratoconjunctivitis |
Active substance: GLUTAMIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28979 |
Study title: Bieber T; Randomised, placebo-controlled, double-blind efficacy study of the emollient V0034CR in addition to a moderately potent corticosteroid in the acute phase of treatment of atopic dermatitis in infants. |
Active substance: GLYCEROL AND LIQUID PARAFFIN |
Study summary document link (including results): V0034CR3041B.xls |
View full study record |
Document reference: 28980 |
Study title: Blanchet-Bardon C; Efficacité et tolérance de la préparation RD 569B – NY2903 dans le traitement symptomatique des ichtyoses modérées. 1995 |
Active substance: GLYCEROL AND LIQUID PARAFFIN |
Study summary document link (including results): RD569B94CR301.xls |
View full study record |
Document reference: 28981 |
Study title: Imaging of cervico-thoracic lymphangiomas in children;Borecky N; Pediatr. Radiol.; 1995 vol.25 p.127-130Imaging of cervico-thoracic lymphangiomas in children;Borecky N; Pediatr. Radiol.; 1995 vol.25 p.127-130 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28850 |
Study title: Intersticial MR lymphography with gadoterate meglumine: initial experience in humans;Ruehm SG; Radiology; 2001 vol.220 p.816-821Intersticial MR lymphography with gadoterate meglumine: initial experience in humans;Ruehm SG; Radiology; 2001 vol.220 p.816-821 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28860 |
Study title: Intraarticular diffusion of Gd-DOTA after intravenous injection in the knee: MR imaging evaluation;Drape JL; Radiology; 1993 vol.188 p.227-234Intraarticular diffusion of Gd-DOTA after intravenous injection in the knee: MR imaging evaluation;Drape JL; Radiology; 1993 vol.188 p.227-234 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28847 |
Study title: Juvenil spondylodiscitis: the value of magnetic resonance imaging a report of two cases; Plasschaert H; Acta. Othop. Belg.; 2004 vol.70 p.627-631Juvenil spondylodiscitis: the value of magnetic resonance imaging a report of two cases; Plasschaert H; Acta. Othop. Belg.; 2004 vol.70 p.627-631 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28866 |
Study title: Juvenile rheumatoid arthritis of the knee: MR evaluation with Gd-DOTAHerve Somma C; Radiology; 1992 vol.182 p.93-98Juvenile rheumatoid arthritis of the knee: MR evaluation with Gd-DOTAHerve Somma C; Radiology; 1992 vol.182 p.93-98 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28845 |
Study title: Double-blind, randomised clinical study to evaluate the consistency of the immunogenicity and reactogenicity of three consecutive production lots of SB Biologicals¿ Hib formulation B vaccine, co-administered with SB Biologicals¿ DTPa vaccine into opposite limbs, and in comparison to the SB Biologicals¿ Hib formulation A vaccine co-administered with SB Biologicals¿ DTPa vaccine into opposite limbs, as a primary vaccination course to healthy infants at 3, 4 and 5 months of age. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41140 |
Study title: Double-blind, randomised clinical study to evaluate the immunogenicity and reactogenicity of four different lots of SB Biologicals' Hib vaccine co-administered with SB Biologicals¿ DTPa vaccine into opposite limbs, as a primary vaccination course to healthy infants at the age of 3, 4½ and 6 months. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41138 |
Study title: Double-blind, randomised, comparative, multicentre, clinical study to assess the immunogenicity and reactogenicity of three lots of SmithKline Beecham Biologicals' Haemophilus influenzae type b (Hib) tetanus conjugate vaccine when administered simultaneously with SmithKline Beecham Biologicals' tricomponent DTPa vaccine, reconstituted in one single injection, as a primary vaccination course in healthy infants at the age of 3 and 5 months (referred to in this report as Hib-10). |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41131 |
Study title: Open clinical study to assess the immunogenicity and reactogenicity of a booster dose of formulation B of SB Biologicals¿ Hib conjugate vaccine mixed with SB Biologicals¿ DTPa vaccine as a single injection at 12 or 15-18 months of age in healthy children primed with SB Biologicals¿ Hib conjugate vaccines co-administrated with DTPa-HBV vaccine in study DTPa-HBV-038 |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41144 |
Study title: Open clinical study to assess the immunogenicity and reactogenicity of a dose of SB Biologicals¿ plain PRP vaccine at 12 months of age followed by SB Biologicals¿ DTPa-HBV vaccine at 15 to 18 months of age in children primed with a new formulation of SB Biologicals¿ Hib conjugate vaccine mixed with DTPa-HBV combined vaccine as a single injection (group 5 of study DTPa-HBV-023). |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41143 |
Study title: Open clinical study to assess the safety of SmithKline Beecham Biologicals' Haemophilus influenzae type b conjugate vaccine mixed with SmithKline Beecham Biologicals' diphtheria, tetanus, tricomponent acellular pertussis vaccine and administered in one single injection, given as a primary vaccination course to healthy infants at 3, 4 and 5 months of age. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41132 |
Study title: Clinical Safety Evaluation Study of sanofi pasteur’s AVAXIM 80U Pediatric Administered, at a First Step in 20 Healthy Adolescents, and at a Second Step in 20 Healthy Toddlers in China |
Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
Study summary document link (including results): |
View full study record |
Document reference: 47490 |
Study title: Comparative immunogenicity trial of Avaxim 80 vs Havrix 720 and Vaqta in 1-15 years old children |
Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
Study summary document link (including results): |
View full study record |
Document reference: 47488 |
Study title: Comparative study of two vaccination schedules of an inactivated Hepatitis A vaccine (80U) in Argentinean infants |
Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
Study summary document link (including results): |
View full study record |
Document reference: 47486 |
Study title: Immunogenicity and safety of an inactivated hepatitis A vaccine (80 AgU) after simultaneous administration with either TETRAct-HIB + OPV or DTacP-IPV//Act-HIB vaccine in 16 to 19 month-old toddlers |
Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
Study summary document link (including results): |
View full study record |
Document reference: 40918 |
Study title: Immunogenicity and safety of AVAXIM-Pediatric and HAVRIX 720, in chilean subjects from 1 to 15 years of age |
Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
Study summary document link (including results): |
View full study record |
Document reference: 47489 |
Study title: Large scale multicentre safety study of inactivated hepatitis A vaccine (80 U) in children - ASIA |
Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
Study summary document link (including results): |
View full study record |
Document reference: 40914 |
Study title: Large scale multicentre safety study of inactivated hepatitis A vaccine (80 U) in children - EUROPE |
Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
Study summary document link (including results): |
View full study record |
Document reference: 40913 |
Study title: Large scale multicentre safety study of inactivated hepatitis A vaccine (80 U) in children - SOUTH AMERICA Immunogenicity on a subgroup of Argentinean children |
Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
Study summary document link (including results): |
View full study record |
Document reference: 47484 |
Study title: Open study of immunogenicity and safety of the P.M. sv. hepatitis A vaccine (80 Antigen Units) in children - ISRAEL |
Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
Study summary document link (including results): |
View full study record |
Document reference: 40912 |
Study title: Open study of safety and immunogenicity of the P.M. sv. hepatitis A vaccine (80 U) in Brasilian children |
Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
Study summary document link (including results): |
View full study record |
Document reference: 47485 |
Study title: Randomised open study of immunogenicity and safety of inactivated hepatitis a vaccine (80 U) in children: comparison of three vaccination shedules (0-6 months / 0-12 months / 0-18 months) |
Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
Study summary document link (including results): |
View full study record |
Document reference: 40917 |
Study title: Safety and immunogenicity study of 3 consistency batches of inactivated hepatitis A vaccine (80 U) in children |
Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
Study summary document link (including results): |
View full study record |
Document reference: 40916 |
Study title: Safety and immunogenicity study of a new paediatric inactivated Hepatitis A vaccine (80 U) in Taiwanese children |
Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
Study summary document link (including results): |
View full study record |
Document reference: 47487 |
Study title: |
Active substance: Hepatitis B Surface Antigen |
Study summary document link (including results): |
View full study record |
Document reference: 47185 |
Study title: An open label, prospective, post-marketing surveillance study to evaluate the safety of Euvax B inj. |
Active substance: Hepatitis B Surface Antigen |
Study summary document link (including results): |
View full study record |
Document reference: 47186 |
Study title: Comparative study of the immunogenicity and safety of the Lucky Goldstar hepatitis B vaccine versus SmithKline Beecham hepatitis B vaccine in Argentinian newborns |
Active substance: Hepatitis B Surface Antigen |
Study summary document link (including results): |
View full study record |
Document reference: 47183 |
Study title: Comparative study of the immunogenicity and safety of two recombinant Hepatitis B vaccines : Euvax B and Engerix B in European adolescents. |
Active substance: Hepatitis B Surface Antigen |
Study summary document link (including results): |
View full study record |
Document reference: 47182 |
Study title: Paul IM et al. Dose-response relationship with increasing doses of dextromethorphan for children with cough. Clin Ther 2004; 26(9):1508-1514 Paul IM et al. Dose-response relationship with increasing doses of dextromethorphan for children with cough. Clin Ther 2004; 26(9):1508-1514 |
Active substance: GUAIFENESIN |
Study summary document link (including results): |
View full study record |
Document reference: 29029 |
Study title: Paul IM et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114(1):85-90 Paul IM et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114(1):85-90 |
Active substance: GUAIFENESIN |
Study summary document link (including results): |
View full study record |
Document reference: 29030 |
Study title: Paul IM et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007; 161(12):1140-1146Paul IM et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007; 161(12):1140-1146 |
Active substance: GUAIFENESIN |
Study summary document link (including results): |
View full study record |
Document reference: 29031 |
Study title: Taylor AJ et al. Efficacy of cough suppressants in children. J Pediatr 1993; 122(5 Pt 1):799-802 Taylor AJ et al. Efficacy of cough suppressants in children. J Pediatr 1993; 122(5 Pt 1):799-802 |
Active substance: GUAIFENESIN |
Study summary document link (including results): |
View full study record |
Document reference: 29032 |
Study title: A double-blind, multi-clinic single dose evaluation of the comparative analgesic efficacy of acetaminophen 650 mg, ibuprofen 200 mg, and placebo in the treatment of pain following oral surgery. Stat Rpt 67. Protocol 4-406, Unpublished Report 186 |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 4-406.pdf |
View full study record |
Document reference: 47393 |
Study title: Indomethacin treatment in patent ductus arteriosus. A double-blind study utilizing indomethacin plasma levels. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29941 |
Study title: Noya F, Rench MA, Garcia-Prats JA, et al. Disposition of an immunoglobulin in very low birth weight neonates. J Ped, 1988; 112: 278-283Noya F, Rench MA, Garcia-Prats JA, et al. Disposition of an immunoglobulin in very low birth weight neonates. J Ped, 1988; 112: 278-283 |
Active substance: HUMAN NORMAL IMMUNOGLOBULIN |
Study summary document link (including results): |
View full study record |
Document reference: 29160 |
Study title: Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IGIV3I 10% Grifols [Immune Globulin Intravenous (Human)] for Replacement Therapy in Primary Immunodeficiency Diseases (PID) |
Active substance: Human normal immunoglobulin |
Study summary document link (including results): IG304 (synopsis).pdf |
View full study record |
Document reference: 45252 |
Study title: An immunogenicity and safety study in females 9-23 years of age in Korea |
Active substance: human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed) |
Study summary document link (including results): |
View full study record |
Document reference: 39682 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Husteel (drops) [AWB-AT] |
Active substance: Husteel |
Study summary document link (including results): |
View full study record |
Document reference: 40028 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Husteel (drops) [AWB-085] |
Active substance: Husteel |
Study summary document link (including results): |
View full study record |
Document reference: 40029 |
Study title: 4th ed. American Medical Association - AMA Departement of Drugs: AMA Drug Evaluation - 1980 - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29164 |
Study title: A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome. - Baden M et al - 1972 (Pediatrics 1972; 50: 526-34) - In publication Martindale The extra pharmacopoeia in dossier 01353 - |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29165 |
Study title: A general practitioner study to evaluate the efficacy of Proctossedyl Ointment in the treatment of acute fissure-in-ano - No author - 1970 ( The British journal of Clinical Practice 1970;24 N°7) - Compilation of clinical papers for the UK review of Medicines in 1983 - |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29166 |
Study title: A Randomized, Double-Blind, Vehicle-Controlled Clinical Trial of the Efficacy and Safety of 1.0% Hydrocortisone and a Mixture of Antioxidants, Separately and in Combination, in Reducing the Severity of Disease Symptoms in Children, Aged 2 to 6 Years, with Atopic Dermatitis |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): hydrocortisone 957-010.pdf |
View full study record |
Document reference: 47742 |
Study title: Butenandt O. "Kinderkrankheiten" in: Kaiser H., Kley H. K. "Cortisontherapie", 11th ed. Thieme Verlag Stuttgart New York 2002; Küchle H. J., Busse H., Augenerkrankungen im Kindesalter, Thieme Verlag Stuttgart New York 1985 |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29167 |
Study title: Carbohydrate Metabolism in the Newborn - Creery RDG - 1968 (Lancet 1968; 291: 594-595 in Extracts from Martindale - 28th Edition - No author - 1982 (Hydrocortisone p 473-474)) - Compilation of clinical papers for the UK review of Medicines in 1983 - |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29168 |
Study title: Chronic topical corticosteroid use simulating congenital glaucoma - Kass MA et al - 1972 ( Journal of Pediatric 1972; 81: 1175-1177) - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29169 |
Study title: Blanchet-Bardon C; Efficacy and tolerance of the emollient cream V0034 CR in the symptomatic treatment of ichthyosis in children. International, multicentric, randomised, controlled, double blind study, in parallel groups V0034 CR versus vehicle. Study Report ongoing. |
Active substance: GLYCEROL AND LIQUID PARAFFIN |
Study summary document link (including results): V0034CR3091B.xls |
View full study record |
Document reference: 28982 |
Study title: The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. American Journal of Opthalmology 1997; 124(2): 141-157.The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. American Journal of Opthalmology 1997; 124(2):... |
Active substance: Foscarnet |
Study summary document link (including results): SOCA studies 1997 (B).pdf |
View full study record |
Document reference: 39655 |
Study title: The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. American Journal of Opthalmology 1997; 124(1): 61-70.The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. American Journal of Opthalmology 1997; 124(1): 61-70. |
Active substance: Foscarnet |
Study summary document link (including results): SOCA studies 1997 (a).pdf |
View full study record |
Document reference: 39654 |
Study title: Tomasik T, Opozda A, Pietrzyk JJ. 2010.Cytomegalovirus infection-- diagnostic and therapeutic difficulties in neonatal intensive care unit. Przegl Lek. 2010;67(1):18-24.Tomasik T, Opozda A, Pietrzyk JJ. 2010.Cytomegalovirus infection-- diagnostic and therapeutic difficulties in neonatal intensive care unit. Przegl Lek. 2010;67(1):18-24. |
Active substance: FOSCARNET |
Study summary document link (including results): Tomasik T et al 2010.pdf |
View full study record |
Document reference: 39603 |
Study title: Tomonari A, Takahashi S, Ooi J, Tsukada N, Konuma T, Kobayashi T, Takasugi K, Iseki T, Tojo A, Asano S.Preemptive therapy with ganciclovir 5 mg/kg once daily for cytomegalovirus infection after unrelated cord blood transplantation. Bone Marrow Transplant. 2008 Feb;41(4):371-6.Tomonari A, Takahashi S, Ooi J, Tsukada N, Konuma T, Kobayashi T, Takasugi K, Iseki T, Tojo A, Asano S.Preemptive therapy with ganciclovir 5 mg/kg once daily for cytomegalovirus infection after unrelated cord blood transplantation. Bone Marrow Transplant. 2008 Feb;41(4):371-6. |
Active substance: Foscarnet |
Study summary document link (including results): Tomonari A et al 2008.pdf |
View full study record |
Document reference: 39616 |
Study title: Tran TH, Stanescu D, Caspers-Velu L, Rozenberg F, Liesnard C, Gaudric A et al. Clinical characteristics of acute HSV-2 retinal necrosis. [Review] [42 refs]. American Journal of Ophthalmology 2004; 137(5):872-879.Tran TH, Stanescu D, Caspers-Velu L, Rozenberg F, Liesnard C, Gaudric A et al. Clinical characteristics of acute HSV-2 retinal necrosis. [Review] [42 refs]. American Journal of Ophthalmology 2004; 137(5):872-879. |
Active substance: FOSCARNET |
Study summary document link (including results): Tran TH et al 2004.pdf |
View full study record |
Document reference: 28591 |
Study title: Treatment of congenital cytomegalovirus: where are we now? Expert Review of Antiinfective Therapy 2007; 5(3):441-448Treatment of congenital cytomegalovirus: where are we now? Expert Review of Antiinfective Therapy 2007; 5(3):441-448 |
Active substance: FOSCARNET |
Study summary document link (including results): Michaels MG 2007.pdf |
View full study record |
Document reference: 39587 |
Study title: Trizna Z Viral diseases of the skin: diagnosis and antiviral treatment. Paediatric Drugs. 2002; 4(1):9-19.Trizna Z Viral diseases of the skin: diagnosis and antiviral treatment. Paediatric Drugs. 2002; 4(1):9-19. |
Active substance: Foscarnet |
Study summary document link (including results): Trizna Z 2002.pdf |
View full study record |
Document reference: 39642 |
Study title: Walton RC,Whitcup SM,Mueller BU, LewisLL, Pizzo PA,Nussenblatt RB. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis. Ophthalmology 1995;102(12):1865- 1870 1995;(12):1865- 1870. Walton RC,Whitcup SM,Mueller BU, LewisLL, Pizzo PA,Nussenblatt RB. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis. Ophthalmology 1995;102(12):1865- 1870 1995;(12):1865- 1870. |
Active substance: Foscarnet |
Study summary document link (including results): Walton RC et al 1995.pdf |
View full study record |
Document reference: 39676 |
Study title: Open clinical study to evaluate persistence of antibodies induced by a primary vaccination course using SmithKline Beecham Biologicals¿ Hib vaccine mixed with SmithKline Beecham Biologicals' DTPa vaccine, and to assess immunogenicity and reactogenicity of a booster dose of the same vaccines at 15-20 months of age (referred to in this report as Hib-21). |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41134 |
Study title: Open clinical study to evaluate the immunogenicity and reactogenicity of SB Biologicals' Hib vaccine, co-administered with routine DTPw vaccine into opposite limbs, as a primary vaccination course to healthy infants at the age of 2, 4 and 6 months. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41142 |
Study title: Open clinical study to evaluate the priming, in terms of antibody persistence and immunological memory, induced by the administration of SB Biologicals¿ Hib conjugate vaccine administered with DTPa-HBV vaccine in study DTPa-HBV-039 and to evaluate the immunogenicity and reactogenicity of a booster dose of SB Biologicals¿ Hib conjugate vaccine when administered mixed with DTPa-HBV combined vaccine. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41145 |
Study title: Open clinical study to evaluate the priming, in terms of antibody persistence and immunological memory, induced by the administration of SB Biologicals¿ Hib conjugate vaccine administered with DTPa-HBV vaccine in study DTPa-HBV-043 and to evaluate the immunogenicity and reactogenicity of a booster dose of SB Biologicals¿ Hib conjugate vaccine when administered either mixed or separately with DTPa-HBV combined vaccine. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41148 |
Study title: Connolly KN, McGuirt WF. Avoiding intubation in the injured subglottis: the role of helium/oxygen gas mixture therapy. Ann Otol Rhinol Layrngol 2001;110(8):713-717.Connolly KN, McGuirt WF. Avoiding intubation in the injured subglottis: the role of helium/oxygen gas mixture therapy. Ann Otol Rhinol Layrngol 2001;110(8):713-717. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29072 |
Study title: Corcoran TE, Shortall BP, Kim IK, Meza MP, Chigier N. Aerosol drug delivery using heliox and nebulizer reservoirs: results from an MRI-based pediatric model. J Aerosol Med 2003;16(3):263-71.Corcoran TE, Shortall BP, Kim IK, Meza MP, Chigier N. Aerosol drug delivery using heliox and nebulizer reservoirs: results from an MRI-based pediatric model. J Aerosol Med 2003;16(3):263-71. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29073 |
Study title: Curtis JL, Mahlmeister M, Fink JB, Lampe G, Matthay MA, Stulbarg MS. Helium-oxygen gas therapy. Use and availability for the emergency treatment of inoperable airway obstruction. Chest 1986 Sep;90(3):455-7.Curtis JL, Mahlmeister M, Fink JB, Lampe G, Matthay MA, Stulbarg MS. Helium-oxygen gas therapy. Use and availability for the emergency treatment of inoperable airway obstruction. Chest 1986 Sep;90(3):455-7. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29074 |
Study title: de Gamarra E, Moriette G, Farhat M, Walti H. Heliox tolerance in spontaneously breathing neonates with bronchopulmonary dysplasia. Biol Neonate 1998;74(3):193-9. de Gamarra E, Moriette G, Farhat M, Walti H. Heliox tolerance in spontaneously breathing neonates with bronchopulmonary dysplasia. Biol Neonate 1998;74(3):193-9. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29075 |
Study title: DiCecco RJ, Rega PP. The application of heliox in the management of croup by an air ambulance service. Air Med J 2004;23(2):910-26.DiCecco RJ, Rega PP. The application of heliox in the management of croup by an air ambulance service. Air Med J 2004;23(2):910-26. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29076 |
Study title: Duncan PG. Efficacy of helium-oxygen mixtures in the management of severe viral and post-intubation croup. Can Anaesth Soc J 1979 May;26(3):206-12.Duncan PG. Efficacy of helium-oxygen mixtures in the management of severe viral and post-intubation croup. Can Anaesth Soc J 1979 May;26(3):206-12. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29077 |
Study title: Elleau C, Galperine R, Guenard H, Demarquez J. Helium-oxygen mixture in respiratory distress syndrome: A double blind study. J Pediatrics 1993;122:132-136.Elleau C, Galperine R, Guenard H, Demarquez J. Helium-oxygen mixture in respiratory distress syndrome: A double blind study. J Pediatrics 1993;122:132-136. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29078 |
Study title: George R, Berkenbosch JW, Fraser RF 2nd, Tobias JD. Mechanical ventilation during pregnancy using a helium-oxygen mixture in a patient with respiratory failure due to status asthmaticus. J Perinatol 2001;21(6):395-398.George R, Berkenbosch JW, Fraser RF 2nd, Tobias JD. Mechanical ventilation during pregnancy using a helium-oxygen mixture in a patient with respiratory failure due to status asthmaticus. J Perinatol 2001;21(6):395-398. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29079 |
Study title: GABAPENTIN PEDIATRIC MONOTHERAPY TRIAL: A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY IN PEDIATRIC PATIENTS WITH BENIGN CHILDHOOD EPILEPSY WITH CENTROTEMPORAL SPIKES (BECTS) (PROTOCOL 945-094). |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28781 |
Study title: NEURONTIN VS LAMOTRIGINE: A DOUBLE-BLIND MONOTHERAPY, PARALLEL-GROUP, MULTICENTER, COMPARATIVE STUDY IN PATIENTS WITH PARTIAL AND/OR GENERALIZED TONIC-CLONIC SEIZURES |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28782 |
Study title: NONINTERVENTIONAL STUDY IN PATIENTS WITH PARTIAL SEIZURES TREATED WITH NEURONTIN |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28783 |
Study title: OPEN LABEL MULTICENTRE STUDY OF THE EFFICACY AND SAFETY OF GABAPENTIN AS ADD-ON THERAPY IN THE TREATMENT OF EPILEPTIC PATIENTS WITH PARTIALSEIZURES |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28784 |
Study title: OPEN LABEL PILOT STUDY OF GABAPENTIN IN JUVENILES WITH CEREBRAL SEIZURES |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28785 |
Study title: OPEN LABEL, MULTICENTER, UNCONTROLLED 12 WEEK STUDY OF EFFICACY AND SAFETY OF GABAPENTIN AS ADD-ON THERAPY IN REFRACTORY PARTIAL EPILESPY WITH OR WITHOUT SECONDARY GENERALIZATION. |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28786 |
Study title: OPEN MULTICENTRE OBSERVATIONNAL STUDY IN TWO GROUPS OF PATIENTS (FIRST LINE THERAPY OR SUBSTITUTION) AIMED TO OPTIMIZE THE USE OF GABAPENTIN ® AS A MONOTHERAPY IN PATIENTS SUFFERING FROM FOCAL EPILEPSY TO BECOME SEIZURE-FREE |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28787 |
Study title: OPEN-LABEL ADD-ON COMPARISON OF GABAPENTIN AND LAMOTRIGINE IN ADULT PATIENTS WITH LEARNING DISABILITIES WHO HAVE REFRACTORY EPILEPSY |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28788 |
Study title: OPEN-LABEL EXTENSION OF A DOUBLE-BLIND, PLACEBO CONTROLLED, MULTICENTER STUDY OF GABAPENTIN AS ADD-ON THERAPY IN CHILDREN WITH PARTIAL SEIZURES (945-87/187) |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28789 |
Study title: Clinical experience with gentamicin in neonates. - Sila R. - 1973 (Acta Pat. Microbiol. Scand. 81? sUPPL; 241: 130-136) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28894 |
Study title: Clinical Expert Statement - Renewal Application for Gentamicin sulfate (all strengths in EU) - T. Darragon - 13 Sept. 2004 Clinical Expert Statement - Renewal Application for Gentamicin sulfate (all strengths in EU) - T. Darragon - 13 Sept. 2004 |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28895 |
Study title: Clinical Pharmacology evaluation of gentamicin in newborn infants. - McCracken - 1972 (J. of Infectious Dis. 124 : 884) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28896 |
Study title: Comparative in-vitro studies of Knamycin and gentamicin : E-coli isolated from newborn infants -Backer CJ. - 1970 (Clin Res. Vol. 20 :1) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28897 |
Study title: Consideration of Gentamicin for therapy of neonatal sepsis. - Klein JO. - 1969 (J. Infectious Dis. 119,4-5:361) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28898 |
Study title: Diffusion dans le liquide céphalorachidien de gentamycine injectée par voie IM. Etude chez 5 enfants attents de méningite purulente. - Mariel C - 1971 (Therapie, 26:511-6) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28899 |
Study title: Emploi de la gentamicine dans les infections graves du nouveau né. - Raynaud EJ. - 1971 (Gaz. Med. De France, 79, 38: 133-9) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28900 |
Study title: Emploi de la Gentamicine dans les infections graves du nouveau-né - Raynaud EJ. & Al. - 1971 (Gazette Médicale de France) - Publication in Gentamicin Registration Dossier - No author - 1977 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28901 |
Study title: Essai therapeutique en pédiatrie d'un nouvel antibiotique : la gentamicine. - Thieffry S. - 1968 (Medecine Infantile, 6 : 444-52) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28902 |
Study title: Disorders of the adrenal gland - New et al - 1986 (In Gellis SS & Kayan BM (Ed): Current Pediatric Therapy, 12th ed., WB saundres, Philadelphia, 1986; pp 308-312) - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29170 |
Study title: Drug Interactions 4th ed - Hansten PD - 1979 (Lea & Frebiger, Philadelphia, PA, 1979) - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29171 |
Study title: A multi-centre, randomised, double-blind, double-dummy, parallel-group study to determine the clinical equivalence between fluticasone propionate 50μg twice daily delivered via a multidose powder inhaler (MDPI) and the Diskhaler™ in children aged 4-11 years with reversible airways disease |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FMDT01-ICHE3.pdf |
View full study record |
Document reference: 28432 |
Study title: A multi-centre, randomised, double-blind, parallel group study to validate the changes in tidal breathing lung function parameters versus FEV1 and PD20 assessments due to anti-inflammatory treatment in 5 to 10 years old mild to moderately symptomatic children with asthma. Extensive searching has revealed that no clinical report is available for this study. The clinical trial results were reported via publications; see citation below. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FMS30002-ICHE3.pdf |
View full study record |
Document reference: 28397 |
Study title: A Multi-centre, Randomised, Parallel-Group, Open-Label Study to Assess the Long-Term Safety (Including Growth) of Fluticasone Propionate 100mcg bd via the Metered-Dose Inhaler and BabyhalerTM Spacer Device Compared With Sodium Cromoglycate 5mg qds Delivered via Metered Dose Inhaler and NebuhalerTM Spacer Device in Children aged 12-47 Months With Documented Evidence of Recurrent/Persistent Asthma-Like Symptoms over a 52-Week Treatment Period |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FAS30009-ICHE3.pdf |
View full study record |
Document reference: 28394 |
Study title: A multicenter, randomized, double-blind, parallel group vehicle-controlled study of the efficacy and safety of fluticasone propionate lotion 0.05% applied once daily for four weeks in the treatment of adult and pediatric subjects with moderate to severe atopic dermatitis Report No. NI1999/00008/00 |
Active substance: FLUTICASONE |
Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FPL30003.pdf |
View full study record |
Document reference: 45116 |
Study title: A multicentre, blinded, parallel group, randomized study to compare the efficacy and tolerability of nebulised Fluticasone propionate 0.25mg administered twice daily versus nebulised Budesonide 0.5mg administered twice daily in children with mild asthma.. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLIC12-ICHE3.pdf |
View full study record |
Document reference: 28419 |
Study title: A multicentre, randomised, double-blind, parallel group clinical trial to determine the safety and efficacy of nebulised fluticasone propionate 1mg twice daily compared with oral soluble prednisolone administered for 7 days to children aged 4 to 16 years with an acute asthma exacerbation. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLTB3002-ICHE3.pdf |
View full study record |
Document reference: 28420 |
Study title: A multicentre, randomised, double-blinded, parallel-group comparison of the efficacy and tolerability of fluticasone propionate 100mcg bid with nedocromil MDI 4mg bid in mild-moderate asthmatic children |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLIC16-ICHE3.pdf |
View full study record |
Document reference: 28374 |
Study title: A multiple-dose, open-label, 2-way crossover study in pediatric subjects with asthma aged 1 to < 4 years to compare the systemic exposure of fluticasone propionate 88mcg administered via the hydrofluoroalkane metered-dose inhaler using the valved holding chambers, Aerochamber Plus™ and Babyhaler™, with face-masks |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FAS10002-ICHE3.pdf |
View full study record |
Document reference: 28438 |
Study title: A phase III multicentre, open, parallel-group, randomised study to compare the efficacy and tolerability of fluticasone propionate 50 micrograms bd via the Diskhaler™ with inhaled sodium cromoglycate (Intal) 20 milligrams qds via the Spinhaler in asthmatic children with a clinic requirement for inhaled prophylactic therapy. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLUPD-AH90-N081-ICHE3.pdf |
View full study record |
Document reference: 28383 |
Study title: Williams DN, Rehm SJ, Tice AD, Bradley JS, Kind AC, Craig WA. Practice guidelines for communitybased parenteral anti-infective therapy. Clinical Infectious Diseases 1997; 25(4):787-801.Williams DN, Rehm SJ, Tice AD, Bradley JS, Kind AC, Craig WA. Practice guidelines for communitybased parenteral anti-infective therapy. Clinical Infectious Diseases 1997; 25(4):787-801. |
Active substance: Foscarnet |
Study summary document link (including results): Williams DN et al 1997.pdf |
View full study record |
Document reference: 39663 |
Study title: Wittek M, Doerr HW, Allwinn R. Varicella and herpes zoster. Part 2: therapy and prevention Med Klin (Munich). 2010 Jun;105(6):399- 403.Wittek M, Doerr HW, Allwinn R. Varicella and herpes zoster. Part 2: therapy and prevention Med Klin (Munich). 2010 Jun;105(6):399- 403. |
Active substance: FOSCARNET |
Study summary document link (including results): Wittek M et al 2010.pdf |
View full study record |
Document reference: 39602 |
Study title: Belkum-A, Snijders-S, van-leeuwen-W, Verbrugh-H, NouwenJ, Op--t-Veld- Koning-S, Van-M, van-Suijlekom-Smit-LW, van-der-Wouden-JC, Verduin-C. Severity of nonbullous Staphylococcus aureus impetigo in children is associated with strains harboring genetic markers for exfoliative toxin B, Panton-Valentine leukocidin, and the multidrug resistance plasmid pSK41. Journal of Clinical Microbiology, {J-Clin-Microbiol}, 1 Jul 2003, vol. 41, p. 3017-3021, ISSN: 0095-1137. |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28667 |
Study title: Bourget-P, Duhamel-J-F, Soerensen-H, Roiron-R. Clinical Pharmacy Department, Antoine Beclere Hospital, Clamart, France. Pharmacokinetics of fusidic acid after a single dose of a new paediatric suspension. Journal of clinical pharmacy and therapeutics, {J-Clin-Pharm-Ther}, Jun 1993, vol. 18, no. 3, p. 171-7, ISSN: 0269-4727. |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28659 |
Study title: Cannarozzo-C, Zagni-G-F. Osp.Gen.Reg. "Vittorio Emanuele II", Div.Dermatologica, Catania, Italia. Studio clinico sul fusidato di sodio in polvere per uso topico. Clin.Europea, anno xx, n.3, maggio-giugno 1981. |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28661 |
Study title: Chu-AC. Imperial College of Science, London, England. Incidence of resistance to fusidic acid in atopic eczema patients treated with topical fusidic acid, with or without topical steroid. 59th Annual Meeting American Academy of Dermatology, {59th-AAD}, 2 Mar 2001, p. abstr. 091. |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28658 |
Study title: Clinical study report Fucidin Creme Vol II (Efficacy and compatibility of Fucidin Crème)West German trial. 337 patients. 90 patients were under the age of 10, 63 patients aged 11-20. |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28709 |
Study title: Clinical trial of fusidic acid for lepromatous leprosy Franzblau S.G. et al ACC 1994; 38(7):1651-1654 LEO provided tablets |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28710 |
Study title: Comparative effect of fusidic acid (Fucithalmic®) and ofloxacin (tarivid®) eye drops in acute conjunctivitis. |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28649 |
Study title: Comparative effect of fusidic acid gel 1% (Fucithalmic®) and norfloxacin 0.3% (Noroxin®) in acute bacterial conjunctivitis |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28681 |
Study title: Comparative effects of fusidic acid (1%) viscous eye drops (Fucithalmic® Unit Dose) and Chloramphenicol (0.5% ) eye drops (Minims® Chloramphenicol) in acute neonatal bacterial conjunctivitis |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28679 |
Study title: Comparative trial of Fucidin ointment and Fucidin cream in skin sepsis; Pakrooh H. J Int Med Res 1980; 8(6): 425-429 (LEO sponsored) |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28644 |
Study title: Comparison of Fusidic acid and Oxacillin in bacterial skin infections |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28711 |
Study title: Comparison of Safety and Efficacy of Gadobenate Dimeglumine and Gadopentetate Dimeglumine in Magnetic Resonance Imaging of Central Nervous System Disorders in Pediatric Patients. |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28721 |
Study title: Data collection and treatment of children with Daivonex® ointment |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28706 |
Study title: Efficacy and acceptability of Fusidic acid cream and mupirocin ointment in acute skin sepsis |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28700 |
Study title: Gross MF, Spear RM, Peterson BM. Helium-oxygen mixture does not improve gas exchange in mechanically ventilated children with bronchiolitis. Crit Care 2000;4(3):188-92.Gross MF, Spear RM, Peterson BM. Helium-oxygen mixture does not improve gas exchange in mechanically ventilated children with bronchiolitis. Crit Care 2000;4(3):188-92. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29080 |
Study title: Grosz AH, Jacobs IN, Cho C, Schears GJ. Use of helium-oxygen mixtures to relieve upper airway obstruction in a pediatric population. Laryngoscope 2001;111(9):1512-1514.Grosz AH, Jacobs IN, Cho C, Schears GJ. Use of helium-oxygen mixtures to relieve upper airway obstruction in a pediatric population. Laryngoscope 2001;111(9):1512-1514. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29081 |
Study title: Habib DM, Garner SS, Brandeburg S. Effect of Helium-Oxygen on Delivery of Albuterol in a Pediatric, Volume-Cycled, Ventilated Lung Model. Pharmacotherapy 1999;19(2):143-149.Habib DM, Garner SS, Brandeburg S. Effect of Helium-Oxygen on Delivery of Albuterol in a Pediatric, Volume-Cycled, Ventilated Lung Model. Pharmacotherapy 1999;19(2):143-149. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29082 |
Study title: Haynes JM, Sargent RJ, Sweeney EL. Use of heliox to avoid intubation in a child with acute severe asthma and hypercapnia. Am J Crit Care 2003;12(1):28-30.Haynes JM, Sargent RJ, Sweeney EL. Use of heliox to avoid intubation in a child with acute severe asthma and hypercapnia. Am J Crit Care 2003;12(1):28-30. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29083 |
Study title: Henchey K. Use of heliox therapy to relieve acute respiratory distress in an adolescent with cystic fibrosis: a case report. Am J Crit Care 2003;12(6):556-7.Henchey K. Use of heliox therapy to relieve acute respiratory distress in an adolescent with cystic fibrosis: a case report. Am J Crit Care 2003;12(6):556-7. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29084 |
Study title: Hollman G, Shen G, Zeng L, Yngsdal-Krenz R, Perloff W, Zimmerman J, Strauss R. Helium-oxygen improves Clinical Asthma Scores in children with acute bronchiolitis. Crit Care Med 1998 Oct;28(10):1731-6.Hollman G, Shen G, Zeng L, Yngsdal-Krenz R, Perloff W, Zimmerman J, Strauss R. Helium-oxygen improves Clinical Asthma Scores in children with acute bronchiolitis. Crit Care Med 1998 Oct;28(10):1731-6. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29085 |
Study title: A DOUBLE BLIND, PLACEBO CONTROLLED, MULTICENTER STUDY TO DETERMINE THE SAFETY AND EFFICACY OF GABAPENTIN AS ADD-ON THERAPY IN THE TREATMENT OF PARTIAL SEIZURES |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28737 |
Study title: A DOUBLE-BLIND BRIDGING STUDY FOR THE EXTRAPOLATION OF DATA FROM OVERSEAS CLINICAL STUDIES; A STUDY IN REFRACTORY EPILEPSY (PARTIAL SEIZURE) USING AN ADD-ON THERAPY METHOD |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28738 |
Study title: A DOUBLE-BLIND PARALLEL GROUP COMPARISON OF GABAPENTIN VS PLACEBO AS ADD-ON THERAPY FOR EPILEPSY IN CHILDREN |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28739 |
Study title: A DOUBLE-BLIND PARALLEL GROUP COMPARISON OF GABAPENTIN VS SODIUM VALPROATE AS ADD-ON THERAPY IN EPILEPSY |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28740 |
Study title: A DOUBLE-BLIND, DOSE-CONTROLLED, MULTICENTER STUDY TO DETERMINE THE SAFETY AND EFFICACY OF THREE DOSES OF GABAPENTIN (NEURONTIN) IN COMPARISON WITH OPEN-LABEL CARBAMAZEPINE AS MONOTHERAPY IN PATIENTS WITH NEWLY-DIAGNOSED EPILEPSY. |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28741 |
Study title: A DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO DETERMINE THE SAFETY AND EFFICACY OF GABAPENTIN AS ADD-ON THERAPY IN THE TREATMENT OF PARTIAL SEIZURES |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28742 |
Study title: A DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY, WITH AN OPEN-LABEL EXTENSION, OF THE SAFETY AND EFFICACY OF GABAPENTIN AS ADD-ON THERAPY IN THE TREATMENT OF PHARMACOTHERAPY-RESISTANT CHILDHOOD SYMPTOMATIC EPILEPSIES |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28743 |
Study title: A LONG-TERM OPEN-LABEL STUDY IN CASES MIGRATED FROM AN EARLY PHASE II STUDY TO DETERMINE THE EFFICACY AND SAFETY OF GABAPENTIN AS ADD-ON THERAPY IN PATIENTS WITH MEDICALLY REFRACTORY PARTIAL SEIZURE |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28744 |
Study title: A LONG-TERM, MULTICENTER, OPEN LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF GABAPENTIN AS ADD-ON THERAPY IN SUBJECTS WITH REFRACTORY EPILEPSY (PARTIAL SEIZURE) AND WHO TRANSFERRED FROM A DOUBLE BLIND BRIDGING STUDY |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28745 |
Study title: A MC TO ASSEST EFFICACY AND SAFTEY OF CI-945 IN CHILDREN AND ADOLESCENT WITH PARTIAL SEIZURES (MANET) |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28746 |
Study title: POST MARKETING SURVEILLANCE(PMS) STUDY OF NEURONTIN |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28796 |
Study title: THE LONG TERM PHASE OF AN OPEN LABEL, UNCONTROLLED STUDY TO DETERMINE THE EFFICACY, SAFETY AND TOLERANCE OF ORALLY ADMINITERED GABAPENTIN AS ADD-ON THERAPY IN PATIENTS WITH MEDICALLY REFRACTORY UNCONTROLLED EPILEPTIC SEIZURES. |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28797 |
Study title: A clinical investigation of the pharmacokinetics of MULTIHANCE in healthy normal subjects from two to fifteen years of age. |
Active substance: GADOBENIC ACID |
Study summary document link (including results): EUdraCT-datafields for publication-Bracco-MultiHance_43779_10.xls |
View full study record |
Document reference: 28799 |
Study title: Comparison of Safety and Efficacy of Gadobenate Dimeglumine and Gadopentetate Dimeglumine in Magnetic Resonance Imaging of Central Nervous System Disorders in Pediatric Patients. |
Active substance: GADOBENIC ACID |
Study summary document link (including results): EUdraCT-datafields for publication-Bracco-MultiHance_B19036036.xls |
View full study record |
Document reference: 28800 |
Study title: Multicentre, within patient controlled trial to assess the efficacy of the contrast agent MultiHance, at a dose of 0.1 mmol/kg in MRI of the CNS in paediatric patients. |
Active substance: GADOBENIC ACID |
Study summary document link (including results): EUdraCT-datafields for publication-Bracco-MultiHanceMH110.xls |
View full study record |
Document reference: 28801 |
Study title: Single Centre, open label, pharmacokinetic study; To obtain pharmacokinetic information in patients from 2-5 years of age. |
Active substance: GADOBENIC ACID |
Study summary document link (including results): EUdraCT-datafields for publication-Bracco-MultiHance_MH119.xls |
View full study record |
Document reference: 47524 |
Study title: A phase III, double-blind, parallel-group, randomized, comparative, two-centre study on gadodiamide injection (Omniscan) and Magnevist® at 0.1 mmol/kg b.w. in MR examinations of the CNS in children and adolescents in a 0.5 T Philips Gyroscan MR unit at the University Hospital Eppendorf, Hamburg, Germany, and in a 1.5T Philips Gyroscan S15 MR unit at the Department of Diagnostic Radiology, University of Cologne, Cologne, Germany |
Active substance: GADODIAMIDE |
Study summary document link (including results): SOV033 Redacted.pdf |
View full study record |
Document reference: 47574 |
Study title: A phase IVIII open study of gadodiamide injection (OMNISCAN(D) 0.3 mmol/kg b.w. used for MR examinations of patients with bone or soft tissue tumours |
Active substance: GADODIAMIDE |
Study summary document link (including results): ISOV026 Redacted.pdf |
View full study record |
Document reference: 47568 |
Study title: Gentamicin in the neonatal period. - McCracken GH. (Amer. J. Dis. Child, Dec. 120: 524-533) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28917 |
Study title: Gentamicin in the newborn - Milner RDG - 1974 (Postgraduate Medical Journal 50 (Suppl 7):40-44) - Publication in Gentamicin Registration Dossier - No author - 1977 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28918 |
Study title: Gentamicin in the newborn - Milner RSC - 1974 (Postgraduate Med. J., 50, Suppl 7: 40-44) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28919 |
Study title: Gentamicin in the treatment of acute infantile enteritis. - Panero C. - 1966 (Minerva Pediatrica, 18, 204) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28920 |
Study title: Gentamicin in the treatment of meningitis in neonates. Leelom JM. - 1969 (J. Infectious Dis., 119,4-5: 476) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28921 |
Study title: Gentamicin in the treatment of sepsis in new born infants. - Elfving L. - 1973 (Acta path; microbio. Scand., section B 81 Suppl. 241: 124-129) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28922 |
Study title: Gentamicin in urinary infections of children. - Holt RJ. - 1968 (Arch. Dis. Childhood, 43:329) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28923 |
Study title: Gentamicin therapy for the neonate and young infant. - Nelson JD. - 1973 (Drugs, 6, 1: 56-57) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28924 |
Study title: A phase III, randomised, double-blind, parallel group study to compare the efficacy of inhaled fluticasone propionate 100μg given once daily and fluticasone propionate 50μg given twice daily, both delivered via the multi-dose powder inhaler, in children aged 4–16 years with mild to moderate, stable asthma. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLTB3049-ICHE3.pdf |
View full study record |
Document reference: 28379 |
Study title: Summary of the efficacy and safety and safety of salmeterol 50mcg and fluticasone propionate 100mcg administered in Diskus Dry Powder Inhaler twice daily in steroid experienced children with reversible airways obstruction |
Active substance: FLUTICASONE AND SALMETEROL |
Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAM40121-ICHE3.pdf |
View full study record |
Document reference: 28449 |
Study title: A prospective dose titration study of the efficay and safety (fluvastatin sodium) in the treatment of children with heterozygous familial hypercholesterolemia |
Active substance: FLUVASTATIN |
Study summary document link (including results): |
View full study record |
Document reference: 28455 |
Study title: "Open label, phase III, dose titration, multicenter study to assess the efficacy and safety of fluvastatin sodium capsules and fluvastatin sodium extended-release tablets (20, 40 and 80 mg) given orally at bedtime for 114 weeks in pediatric patiens with heterozygous familial hypercholesterolemia" |
Active substance: FLUVASTATIN |
Study summary document link (including results): |
View full study record |
Document reference: 28456 |
Study title: Fluvoxamine for Children and Adolescents With Obsessive-Compulsive Disorder: A Randomized, Controlled, Multicenter Trial.(Statistical Data Included) Article from: Journal of the American Academy of Child and Adolescent Psychiatry,2001 | RIDDLE, MARK A.; REEVE, ELIZABETH A.; YARYURA-TOBIAS,JOSE A.; YANG, HWA MING; CLAGHORN, JAMES L.; GAFFNEY, GARY; GREIST,JOHN H.; HOLLAND, DONNA; McCONVILLE, BRIAN J.; PIGOTT, TERESA; WALKUP, JOHN T. |
Active substance: FLUVOXAMINE |
Study summary document link (including results): Bayer Pharma_Fluvoxamine Maleate_Riddle MA_2001_publication.pdf |
View full study record |
Document reference: 28457 |
Study title: FLUVOXAMINE IN THE TREATMENT OF OBSESSIVE COMPULSIVE DISORDER: A MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED STUDY IN OUTPATIENT CHILDREN AND ADOLESCENTS |
Active substance: FLUVOXAMINE |
Study summary document link (including results): Fluvoxamine-RH.114.02.01.pdf |
View full study record |
Document reference: 47713 |
Study title: Multiple-Dose Pharmacokinetics of Fluvoxamine in Children and Adolescents;J . AM. ACAD. CHILD ADOLESC. PSYCHIATRY, 43:12, DECEMBER 2004 |
Active substance: FLUVOXAMINE |
Study summary document link (including results): A9R1546.pdf |
View full study record |
Document reference: 28458 |
Study title: The Multiple-Dose Pharmacokinetics of Fluvoxamine in Children and Adolescents |
Active substance: FLUVOXAMINE |
Study summary document link (including results): Fluvoxamine-S114.1.102.pdf |
View full study record |
Document reference: 47714 |
Study title: Clin Pharmacol Ther. 2007 May;81(5):685-91. Review. Prenatal multivitamin supplementation and rates of pediatric cancers: a meta-analysis. Goh YI, Bollano E, Einarson TR, Koren G. |
Active substance: FOLIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28461 |
Study title: Haematologica. 2006 Aug;91(8):1113-6. Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leucemia. Costea I, Moghrabi A, Laverdiere C, Graziani A, Krajinovic M. |
Active substance: FOLIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28464 |
Study title: J Child Neurol. 2007 Dec;22(12):1389-92. Homocysteine levels in epileptic children receiving antiepileptic drugs. Kurul S, Unalp A, Yiş U |
Active substance: FOLIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28459 |
Study title: Monaldi Arch Chest Dis. 2006 Dec;66(4):275-85. Review.IT Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor. Caramia G, Belardinelli R. |
Active substance: FOLIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28462 |
Study title: Pediatr Hematol Oncol. 2007 Sep;24(6):417-30. Clinical characteristics and treatment results of pediatric B-cell non-Hodgkin lymphoma patients in a single center. Karadeniz C, Oguz A, Citak EC, Uluoglu O, Okur V, Demirci S, Okur A, Aksakal N |
Active substance: FOLIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28460 |
Study title: Efficacy and acceptability of fusidic acid cream and mupirocin ointment in facial impetigo |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28701 |
Study title: Efficacy and acceptability of fusidic acid cream and mupirocin ointment in facial impetigo. Sutton J.B. Curr Ther Res 1992; 51(5): 673-678 |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28670 |
Study title: Efficacy and safety of calcipotriol ointment in treating children (2-14 years) with psoriasis vulgaris |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28705 |
Study title: J Neurosurg. 2004 Feb;100(2 Suppl Pediatrics):150-5. Use of gadolinium as an intraarterial contrast agent for pediatric neuroendovascular procedures. Burry MV, Cohen J, Mericle RA. J Neurosurg. 2004 Feb;100(2 Suppl Pediatrics):150-5. Use of gadolinium as an intraarterial contrast agent for pediatric neuroendovascular procedures. Burry MV, Cohen J, Mericle RA. |
Active substance: GADODIAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28802 |
Study title: J Pediatr Surg. 1998 Jan;33(1):123-6. Gadolinium-infusion magnetic resonance angiogram: a new, noninvasive, and accurate method of preoperative localization of impalpable undescended testes. Lam WW, Tam PK, Ai VH, Chan KL, Cheng W, Chan FL, Leong L J Pediatr Surg. 1998 Jan;33(1):123-6. Gadolinium-infusion magnetic resonance angiogram: a new, noninvasive, and accurate method of preoperative localization of impalpable undescended testes. Lam WW, Tam PK, Ai VH, Chan KL, Cheng W, Chan FL, Leong L |
Active substance: GADODIAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28807 |
Study title: Lauenstein TC 2007Lauenstein TC 2007 |
Active substance: GADODIAMIDE |
Study summary document link (including results): Lauenstein TC 2007.pdf |
View full study record |
Document reference: 47569 |
Study title: Lundby B 1996; MRI in children given gadodiamide injection: safety and efficacy in CNS and body indicationsLundby B 1996; MRI in children given gadodiamide injection: safety and efficacy in CNS and body indications |
Active substance: GADODIAMIDE |
Study summary document link (including results): Lundby B 1996.pdf |
View full study record |
Document reference: 47570 |
Study title: Magn Reson Imaging. 1999 Feb;17(2):229-35. Effect of a gadodiamide contrast agent on the reliability of brain tissue T1 measurements. Steen RG, Reddick WE, Ogg RJ, Langston JW. Magn Reson Imaging. 1999 Feb;17(2):229-35. Effect of a gadodiamide contrast agent on the reliability of brain tissue T1 measurements. Steen RG, Reddick WE, Ogg RJ, Langston JW. |
Active substance: GADODIAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28806 |
Study title: Martin DR 2010; Decreased Incidence of NSF in Patients on Dialysis After Changing Gadolinium Contrast-Enhanced MRI ProtocolsMartin DR 2010; Decreased Incidence of NSF in Patients on Dialysis After Changing Gadolinium Contrast-Enhanced MRI Protocols |
Active substance: GADODIAMIDE |
Study summary document link (including results): Martin DR 2010.pdf |
View full study record |
Document reference: 47571 |
Study title: Open clinical studies with Gd-DTPA (dimeglumine gadopentetate) in cerebral and spinal diseases - summary of studies at 22 hoospitalsJ Mol Neurosci. 1996 Summer;7(2):87-90.Early diagnosis of Nelson's syndrome. Kasperlik-Zaluska AA, Walecki J, Jeske W, Migdalska B, Janik J, Bonicki W, Brzeziński J, Makowska A, Brzezińska A. |
Active substance: GADODIAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28812 |
Study title: Open Clinical study in MRI to demonstrate the tolerance and efficacy of Gd-DTPA in the whole bodyPediatr Radiol. 1999 Nov;29(11):856-62. Potential utility of MRI in the evaluation of children at risk of renal scarring. Chan YL, Chan KW, Yeung CK, Roebuck DJ, Chu WC, Lee KH, Metreweli C. |
Active substance: GADODIAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28810 |
Study title: Pediatr Int. 2000 Jun;42(3):285-8. Assessment of disease activity and extent by magnetic resonance imaging in ulcerative colitis. Nozue T, Kobayashi A, Takagi Y, Okabe H, Hasegawa M. Pediatr Int. 2000 Jun;42(3):285-8. Assessment of disease activity and extent by magnetic resonance imaging in ulcerative colitis. Nozue T, Kobayashi A, Takagi Y, Okabe H, Hasegawa M. |
Active substance: GADODIAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28805 |
Study title: |
Active substance: GADOPENTETIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28834 |
Study title: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, COMPARATIVE STUDY OF GABAPENTIN (CI-945) ADMINISTERED AS AN INITIAL DOSAGE OF 900 MG/DAY VERSUS A DOSAGE TITRATED TO 900 MG/DAY OVER THREE DAYS |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28747 |
Study title: A MULTICENTER,DOUBLE-BLIND, DOUBLE-DUMMY RANDOMIZED, PARALLEL GROUP COMPARISON OF GABAPENTIN (CI945) AND AND SODIUM VALPROATE SR AS AS ADD-ON AND MONOTHERAPY IN PATIENTS WITH PARTIAL EPILEPSY UNCONTOLLED BY CARBAMAZAPINE THERAPY |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28748 |
Study title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER ACTUAL USE STUDY OF THE SAFETY AND TOLERABILITY OF GABAPENTIN 500 MG IN A POTENTIAL OTC POPULATION |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28749 |
Study title: A REPORT OF A SINGLE-CENTER, PILOT STUDY COMPRISING A 12-WEEK, PLACEBO CONTROLLED, PARALLEL GROUP, DOUBLE BLIND PHASE, FOLLOWED BY A LONG-TERM, OPEN LABEL PHASE, TO DETERMINE THE EFFICACY AND SAFETY OF GABAPENTIN (CI-945) TAKEN AS ORAL DAILY DOSES AS ADD-ON THERAPY IN JUVENILE PATIENTS WITH MEDICALLY REFRACTORY PARTIAL SEIZURES |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28750 |
Study title: A SAFETY AND EFFICACY STUDY OF EXTENDED OPEN-LABEL GABAPENTIN MONOTHERAPY FOLLOWING A DOUBLE-BLIND STUDY IN PATIENTS WITH COMPLEX PARTIAL OR SECONDARILY GENERALIZED SEIZURES |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28751 |
Study title: A SINGLE DOSE BIOEQUIVALENCE STUDY COMPARING GABAPENTIN SYRUP FORMULATION TO 300MG NEURONTIN CAPSULES. |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28752 |
Study title: A SINGLE DOSE STUDY OF GABAPENTIN SYRUP (CI-945) PHARMACOKINETICS IN HEALTHY NEONATES, INFANTS AND CHILDREN. |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28753 |
Study title: Kawasaki disease associated coronary artery lesions with navigator echo-based respiratory gated three dimensional coronary magnetic resonance angiography compared with achocardiography in young children;Amino M; J. Tokyo Med. Univ.; 2004 vol.62 n.2 p.146-152Kawasaki disease associated coronary artery lesions with navigator echo-based respiratory gated three dimensional coronary magnetic resonance angiography compared with achocardiography in young children;Amino M; J. Tokyo Med. Univ.; 2004 vol.62 n.2 p.146-152 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28864 |
Study title: Legg-Perthes-Calve diseases: staging by MRI using gadolinium;Ducou Le Pointe H; Pediatr. Radiol.; 1994 vol.24 p.88-91Legg-Perthes-Calve diseases: staging by MRI using gadolinium;Ducou Le Pointe H; Pediatr. Radiol.; 1994 vol.24 p.88-91 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28848 |
Study title: Magnetic resonance findings in 92 acoustic neuromas;Duvoisin B; Eur. J. Radiol.; 1991 vol.13 p.96-102Magnetic resonance findings in 92 acoustic neuromas;Duvoisin B; Eur. J. Radiol.; 1991 vol.13 p.96-102 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28846 |
Study title: MR to assess renal function in children; Rohrschneider WK; Eur. Radiol.; 2003 vol.13 p.1033-1045MR to assess renal function in children; Rohrschneider WK; Eur. Radiol.; 2003 vol.13 p.1033-1045 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28863 |
Study title: MRI and clinical differences between optic pathway tumours in children with and without neurofibromatosis; Chateil JF; Br. J. Radiol.; 2001 vol.74 p.24-31MRI and clinical differences between optic pathway tumours in children with and without neurofibromatosis; Chateil JF; Br. J. Radiol.; 2001 vol.74 p.24-31 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28859 |
Study title: MRI and ultrasound in children with juvenile chronic arthritis; Lamer S; Eur. J. Radiol.; 2000 vol.33 p.85-93MRI and ultrasound in children with juvenile chronic arthritis; Lamer S; Eur. J. Radiol.; 2000 vol.33 p.85-93 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28856 |
Study title: Neuroradiologic findings in leptomeningeal carcinomatosis: the value interest of gadolinium-enhanced MRI;Rodesch G; Neuroradiology; 1990 vol.32 p.26-32Neuroradiologic findings in leptomeningeal carcinomatosis: the value interest of gadolinium-enhanced MRI;Rodesch G; Neuroradiology; 1990 vol.32 p.26-32 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28838 |
Study title: Oral contraceptive use and focal nodular hyperplasia of the liver;Mathieu D; Gastroenterology; 2000 vol.118 p.560-564Oral contraceptive use and focal nodular hyperplasia of the liver;Mathieu D; Gastroenterology; 2000 vol.118 p.560-564 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28855 |
Study title: Perfusion weighted MR imaging studies in brain hypervascular diseases: comparison of arterial input function extractions for perfusion measurement;Ducreux D; AJNR; 2006 vol.27 p.1059-1069Perfusion weighted MR imaging studies in brain hypervascular diseases: comparison of arterial input function extractions for perfusion measurement;Ducreux D; AJNR; 2006 vol.27 p.1059-1069 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28870 |
Study title: Yoder KE et al. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clin Pediatr 2006; 45(7):633-640Yoder KE et al. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clin Pediatr 2006; 45(7):633-640 |
Active substance: GUAIFENESIN |
Study summary document link (including results): |
View full study record |
Document reference: 29033 |
Study title: Bjerre I, Blennow G. Methocarbamol in the treatment of cerebral palsy in children. Neuropadiatrie. 1971 Oct;3(2):140-6.Bjerre I, Blennow G. Methocarbamol in the treatment of cerebral palsy in children. Neuropadiatrie. 1971 Oct;3(2):140-6. |
Active substance: GUAIFENESIN AND CHLOROCYCLINE |
Study summary document link (including results): |
View full study record |
Document reference: 29038 |
Study title: Chakrabarti A, Pandhi P, Jindal SK, Malik SK, Sharma PL. A comparative randomized doubleblind clinical trial of hexapneumine and clistine as antitussive agents. Int J Clin Pharmacol Ther Toxicol. 1987 Jun;25(6):310-2.Chakrabarti A, Pandhi P, Jindal SK, Malik SK, Sharma PL. A comparative randomized doubleblind clinical trial of hexapneumine and clistine as antitussive agents. Int J Clin Pharmacol Ther Toxicol. 1987 Jun;25(6):310-2. |
Active substance: GUAIFENESIN AND CHLOROCYCLINE |
Study summary document link (including results): |
View full study record |
Document reference: 29035 |
Study title: Falliers CJ, Cato AE, Harris JR. Controlled assessment of oral bronchodilators for asthmatic children. J Int Med Res. 1978;6(4):326-36.Falliers CJ, Cato AE, Harris JR. Controlled assessment of oral bronchodilators for asthmatic children. J Int Med Res. 1978;6(4):326-36. |
Active substance: GUAIFENESIN AND CHLOROCYCLINE |
Study summary document link (including results): |
View full study record |
Document reference: 29036 |
Study title: Jayaram S, Desai A. Efficacy and safety of Ascoril expectorant and other cough formula in the treatment of cough management in paediatric and adult patients--a randomised double-blind comparative trial. J Indian Med Assoc.2000 Feb;98(2):68-70.Jayaram S, Desai A. Efficacy and safety of Ascoril expectorant and other cough formula in the treatment of cough management in paediatric and adult patients--a randomised double-blind comparative trial. J Indian Med Assoc.2000 Feb;98(2):68-70. |
Active substance: GUAIFENESIN AND CHLOROCYCLINE |
Study summary document link (including results): |
View full study record |
Document reference: 29034 |
Study title: Lall JC, Gupta HL. Therapeutic trial of methocarbamol (Robinax) in tetanus neonatorum. Indian Pediatr. 1975 Jun;12(6):503-4.Lall JC, Gupta HL. Therapeutic trial of methocarbamol (Robinax) in tetanus neonatorum. Indian Pediatr. 1975 Jun;12(6):503-4. |
Active substance: GUAIFENESIN AND CHLOROCYCLINE |
Study summary document link (including results): |
View full study record |
Document reference: 29037 |
Study title: Taylor WF, Siegel SC, Busser RJ, Strick L, Heimlich EM. A controlled evaluation of oral theophylline in asthmatic children. Ann Allergy. 1968 Oct;26(10):523-30.Taylor WF, Siegel SC, Busser RJ, Strick L, Heimlich EM. A controlled evaluation of oral theophylline in asthmatic children. Ann Allergy. 1968 Oct;26(10):523-30. |
Active substance: GUAIFENESIN AND CHLOROCYCLINE |
Study summary document link (including results): |
View full study record |
Document reference: 29039 |
Study title: Unger DL, Unger L, Temple DE. Double-blind evaluation of an antiasthmatic agent. Ann Allergy. 1967 Oct;25(10):575-7.Unger DL, Unger L, Temple DE. Double-blind evaluation of an antiasthmatic agent. Ann Allergy. 1967 Oct;25(10):575-7. |
Active substance: GUAIFENESIN AND CHLOROCYCLINE |
Study summary document link (including results): |
View full study record |
Document reference: 29040 |
Study title: Britton−M−G, Empey−D−W, John−G−C, Hodder−M, Hughes−D−T. Two doses of triprolidine for treatment of allergic rhinitis. Annals of allergy, {Ann−Allergy}, May 1979, vol. 42, no. 5, p. 330−2.Britton−M−G, Empey−D−W, John−G−C, Hodder−M, Hughes−D−T. Two doses of triprolidine for treatment of allergic rhinitis. Annals of allergy, {Ann−Allergy}, May 1979, vol. 42, no. 5, p. 330−2. |
Active substance: GUAIFENESIN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 29055 |
Study title: An open label, phase II/III, non-drug comparative study of gadodiamide injection (Omniscan*) at 0.1 mmol/kg b.w. in MR examinations of the body (excluding the CNS) in children and adolescents at the University Hospital Eppendorf, Hamburg, Germany |
Active substance: GADODIAMIDE |
Study summary document link (including results): SOV035 Redacted.pdf |
View full study record |
Document reference: 47575 |
Study title: An open phase III study of gadodiamide injection (Omniscan®) 0.1 mmol/kg b.w. used for MR examinations of the body (including the CNS) in children |
Active substance: GADODIAMIDE |
Study summary document link (including results): SOV032 Redacted.pdf |
View full study record |
Document reference: 47573 |
Study title: An open, non-comparative, phase III study of gadodiamide injection (Omniscan®) 0.1 mmol/kg b.w. used for magnetic resonance examinations of the CNS in children from 6 months to 14 years of age in a 0.5 T Esaote MR unit |
Active substance: GADODIAMIDE |
Study summary document link (including results): SOV031 Redacted.pdf |
View full study record |
Document reference: 47572 |
Study title: Pediatr Res. 2007 Feb;61(2):209-14. Cytogenetic damage in blood lymphocytes and exfoliated epithelial cells of children with inflammatory bowel disease. Holland N, Harmatz P, Golden D, Hubbard A, Wu YY, Bae J, Chen C, Huen K, Heyman MB. |
Active substance: FOLIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28463 |
Study title: Pediatrics. 2006 Jul;118(1):180-8. A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity. Haiden N, Klebermass K, Cardona F, Schwindt J, Berger A, Kohlhauser-Vollmuth C, Jilma B, Pollak A. |
Active substance: FOLIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28465 |
Study title: CLINICAL EXPERIENCES WITH FORMOTEROL DRY SYRUP AGAINST PEDIATRIC BRONCHIAL ASTHMA - REVIEW ON ONE-TIME DOSAGE EFFICACY & DOSES |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 YBDG-3-4 Art45 listing 2011.xls |
View full study record |
Document reference: 47823 |
Study title: CLINICAL RESULTS OF REPEATED ADMINISTRATION OF FORMOTEROL (BD 40A) DRY SYRUP IN THE PEDIATRIC PATIENTS WITH BRONCHIAL ASTHMA |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 YBD G-3-5 Art45 listing 2011.xls |
View full study record |
Document reference: 47824 |
Study title: CLINICAL RESULTS WITH BD 40A (FORMOTEROL) DRY SYRUP IN CHILD BRONCHIAL ASTHMA. |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 YBDG 3-19 Art45 listing 2011.xls |
View full study record |
Document reference: 47825 |
Study title: CLINICAL STUDIES ON FORMOTEROL (BD 40A) IN PEDIATRIC PATIENTS WITH BRONCHIAL ASTHMA. |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 YBDG 3-2 Art45 listing 2011.xls |
View full study record |
Document reference: 47826 |
Study title: CLINICAL STUDIES ON FORMOTEROL (BD 40A) IN PEDIATRIC PATIENTS WITH BRONQUITIS. |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 YBD G-5-2 Art45 listing 2011.xls |
View full study record |
Document reference: 47827 |
Study title: CLINICAL STUDY ON FORMOTEROL (BD 40A) IN PEDIATRIC PATIENTS WITH BRONCHITIS. |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 YBDG 5-3 Art45 listing 2011.xls |
View full study record |
Document reference: 47828 |
Study title: CLINICAL TRIAL OF FORMOTEROL (BD 40A) FOR BRONCHIAL ASTHMA IN CHILDREN. |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 YBD G-3-1 Art45 listing 2011.xls |
View full study record |
Document reference: 47829 |
Study title: CLINICAL TRIAL TO COMPARE THE DURATION OF BRONCHODILATOR EFFECT OF FORMOTEROL METERED DOSE AEROSOL WITH SALBUTAMOL METERED DOSE AEROSOL IN CHILDREN WITH PERENNIAL ASTHMA. CLINICAL TRIAL SUMMARY AND REPORT |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 GS 20-GS20 Art45 listing 2011.xls |
View full study record |
Document reference: 47830 |
Study title: DOSE FINDING STUDY WITH 6, 12 AND 24 MCG INHALED FORMOTEROL IN CHILDREN WITH EXERCISE-INDUCED ASTHMA |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 DFORD5 Art45 listing 2011.xls |
View full study record |
Document reference: 47831 |
Study title: DOUBLE-BLIND, 12-WEEK, PARALLEL-GROUP, MULTI-CENTRE TRIAL TO ASSESS FORMOTEROL DRY POWDER 12 UG AND 24 UG DAILY VS. SALBUTAMOL DRY POWDER 1200 UG DAILY IN CHILDREN WITH REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASES |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 DP_PD2 Art45 listing 2011.xls |
View full study record |
Document reference: 47832 |
Study title: Double-blind, within-patient placebo-controlled trial comparing the effect of inhalation of formoterol dry powder capsules 12 ug at two different flow rates on the time-course of protection against exercise-induced bronchoconstriction in children with asthma |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 DP-FL2 Art45 listing 2011.xls |
View full study record |
Document reference: 47833 |
Study title: DOUBLE-BLIND, WITHIN-PATIENT, PLACEBO-CONTROLLED STUDY TO EVALUATE THE ONSET AND DURATION OF THE PROTECTIVE EFFECT OF A SINGLE DOSE OF INHALED FORMOTEROL DRY POWDER AGAINST EXERCISE-INDUCED ASTHMA IN ADOLESCENT AND ADULT ATHLETES. |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 25827 02 069 Art45 listing 2011.xls |
View full study record |
Document reference: 47834 |
Study title: An open, multicenter clinical trial of Magnevist® in newborns and infants up to the second year of life in CNS indications |
Active substance: GADOPENTETIC ACID |
Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_90104_study_synopsis.pdf |
View full study record |
Document reference: 28833 |
Study title: Effectiveness and tolerance in the MRT of pediatric patients with CNS lesions; 1X I.V. PH. III - Berlex Report No. 88 493 |
Active substance: GADOPENTETIC ACID |
Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_88493_study_synopsis.pdf |
View full study record |
Document reference: 28818 |
Study title: Cambazard; Double blind, randomised, parallel group. Study of V0034CR cream versus vehicle in the management of atopic dermatitis in infants aged from 3 months to 24 months. |
Active substance: GLYCEROL AND LIQUID PARAFFIN |
Study summary document link (including results): V0034CR201.xls |
View full study record |
Document reference: 28983 |
Study title: Stalder; A multicentre, parallel group, double blind versus vehicle study, to evaluate the benefit of topical V0034CR compared to the vehicle in the treatment of atopic dermatitis in children between 4 and 24 months. Study Report 2004 |
Active substance: GLYCEROL AND LIQUID PARAFFIN |
Study summary document link (including results): V0034CR301.xls |
View full study record |
Document reference: 28984 |
Study title: Szepietowski J; Efficacy, local tolerance and patient acceptability of an moisturising emollient on xerosis with or without pruritus, in patients undergoing maintenance renal dialysis (MRD). Study Report 2006 |
Active substance: GLYCEROL AND LIQUID PARAFFIN |
Study summary document link (including results): V0034CR302.xls |
View full study record |
Document reference: 28986 |
Study title: Taieb A; Long term management of atopic dermatitis with the emollient V0034CR. A randomised, placebo-controlled, parallel groups, double-blind study in infants and children. |
Active substance: GLYCEROL AND LIQUID PARAFFIN |
Study summary document link (including results): V0034CR3071B.xls |
View full study record |
Document reference: 28985 |
Study title: Bettinger-J et al. Comparison of different non-invasive test methods with respect to the effect of different moisturisers on the skin. Skin Research and Technology 1999;5;(1):21-27 |
Active substance: GLYCEROL OR GLYCEROL AND LIQUID SUGAR |
Study summary document link (including results): |
View full study record |
Document reference: 28987 |
Study title: Tilt testing potentiated with sublingual nitroglycerin in children with unexplained syncope Foglia - Manzillo G, Giada F, Fteita N, Nessi I, Santarone M, Raviele A. Eur Heart J. 2007 Nov;28(21) : 2605-9. Epub 2007 Oct 2.Tilt testing potentiated with sublingual nitroglycerin in children with unexplained syncope Foglia - Manzillo G, Giada F, Fteita N, Nessi I, Santarone M, Raviele A. Eur Heart J. 2007 Nov;28(21) : 2605-9. Epub 2007 Oct 2. |
Active substance: GLYCERYL TRINITRATE |
Study summary document link (including results): |
View full study record |
Document reference: 28989 |
Study title: Vascular endothelial and smooth muscle function relates to body mass index and glucose in obese and nonobese children PENA Alexia Sophie, WILTSHIRE Esko, MACKENZIE Karen. GENT Roger. PIOTTO Lino. HIRTE Craig. COUPER Jennifer. The Journal of clinical endocrinology and metabolism. 2006; 91 (11) : 4467 - 4471Vascular endothelial and smooth muscle function relates to body mass index and glucose in obese and nonobese children PENA Alexia Sophie, WILTSHIRE Esko, MACKENZIE Karen. GENT Roger. PIOTTO Lino. HIRTE Craig. COUPER Jennifer. The Journal of clinical endocrinology and metabolism. 2006; 91 (11) : 4467 - 4471 |
Active substance: GLYCERYL TRINITRATE |
Study summary document link (including results): |
View full study record |
Document reference: 28988 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Glyoxal compositum (ampoules) [AWB-AT] |
Active substance: Glyoxal compositum-Heel - apmpoules |
Study summary document link (including results): |
View full study record |
Document reference: 40013 |
Study title: Klinisches Gutachten gem. § 24 AMG über Kryptocur (HOE 471) zur Behandlung des Kryptorchismus mit verbesserter Dosierung - Prof. Dr. Seidel, 21.10.1981 Perizia clinica secondo § 24 della legge sui medicinali su Kryptocur per il trattamento del criptorchidismo con posologia migliorata. Prof. Seidel - (Exp.Report) 21/10/1981 |
Active substance: GONADORELIN |
Study summary document link (including results): |
View full study record |
Document reference: 28991 |
Study title: Rapporto su uno studio con Kryptocur (denominazione sperimentale HOE 471) nel criptorchidismo. Prof. Hocht (Clinical study) 30/9/1981 |
Active substance: GONADORELIN |
Study summary document link (including results): |
View full study record |
Document reference: 28992 |
Study title: Rapporto su uno studio non controllato con Kryptocur (denominazione sperimentale HOE 471) nel criptorchidismo. Dr. Borkenstein (Clinical study) 25/9/1981 |
Active substance: GONADORELIN |
Study summary document link (including results): |
View full study record |
Document reference: 28993 |
Study title: PMID = 20945944; DOI = 10.2165/11539140-000000000-00000PMID = 20945944; DOI = 10.2165/11539140-000000000-00000 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication.xls |
View full study record |
Document reference: 47122 |
Study title: Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging; Stikkelbroeck NMML; Eur. Radiol.; 2004 vol.14 p.1802-1806Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging; Stikkelbroeck NMML; Eur. Radiol.; 2004 vol.14 p.1802-1806 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28865 |
Study title: Safety of approved MR contrast media for intravenous injection; Runge VM; JMRI; 2000 vol.12 p.205-213Safety of approved MR contrast media for intravenous injection; Runge VM; JMRI; 2000 vol.12 p.205-213 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28857 |
Study title: Sinus pericranii: advantages of MR imaging; Bigot JL; Pediatr. Radiol.; 2000 vol.30 p.710-712Sinus pericranii: advantages of MR imaging; Bigot JL; Pediatr. Radiol.; 2000 vol.30 p.710-712 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28858 |
Study title: Soft tissue signal abnormality associated with eosinophilic granuloma correlation of MR imaging with pathologic findings;Monroc M; Pediatr. Radiol.; 1994 vol.24 p.328-332Soft tissue signal abnormality associated with eosinophilic granuloma correlation of MR imaging with pathologic findings;Monroc M; Pediatr. Radiol.; 1994 vol.24 p.328-332 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28849 |
Study title: Subjective and objective image qualities: a comparison of sagittal T2-weighted spin-echo and turbo-spin-echo sequences in magnetic resonance imaging of the spine by use of a subjective ranking system;Gorres G; Rontgenpraxis; 1998 vol.51 p.258-265Subjective and objective image qualities: a comparison of sagittal T2-weighted spin-echo and turbo-spin-echo sequences in magnetic resonance imaging of the spine by use of a subjective ranking system;Gorres G; Rontgenpraxis; 1998 vol.51 p.258-265 |
Active substance: GADOTERIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28853 |
Study title: Kemper KJ, Ritz RH, Benson MS, Bishop MS. Helium-oxygen mixture in the treatment of postextubation stridor in pediatric trauma patients. Crit Care Med 1991;19(3):356-359Kemper KJ, Ritz RH, Benson MS, Bishop MS. Helium-oxygen mixture in the treatment of postextubation stridor in pediatric trauma patients. Crit Care Med 1991;19(3):356-359 |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29086 |
Study title: Kim IK, Phrampus E, Venkataraman S, Pitetti R, Saville A, Corcoran T, Gracely E, Funt N, Thompson A. Helium/oxygen-driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: a randomized, controlled trial. Pediatrics 2005 Nov;116(5):1127-33.Kim IK, Phrampus E, Venkataraman S, Pitetti R, Saville A, Corcoran T, Gracely E, Funt N, Thompson A. Helium/oxygen-driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: a randomized, controlled trial. Pediatrics 2005 Nov;116(5):1127-33. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29087 |
Study title: Liet JM, Millotte B, Tucci M, Laflammme S, Hutchison J, Creery D, Cucruet T, Lacroix J; Canadian Critical Care Trials Group. Noninvasive therapy with helium-oxygen for severe bronchiolitis. J Pediatr 2005 Dec;147(6):812-7.Liet JM, Millotte B, Tucci M, Laflammme S, Hutchison J, Creery D, Cucruet T, Lacroix J; Canadian Critical Care Trials Group. Noninvasive therapy with helium-oxygen for severe bronchiolitis. J Pediatr 2005 Dec;147(6):812-7. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29089 |
Study title: Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005 Oct;26(4):720-35.Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005 Oct;26(4):720-35. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29090 |
Study title: Martin D, Day J, Ward G, Carter E, Chesrown S. Effects of breathing a normoxic helium mixture on exercise tolerance of patients with cystic fibrosis. Pediatr Pulmonol 1994 Oct;18(4):206-10.Martin D, Day J, Ward G, Carter E, Chesrown S. Effects of breathing a normoxic helium mixture on exercise tolerance of patients with cystic fibrosis. Pediatr Pulmonol 1994 Oct;18(4):206-10. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29091 |
Study title: Martinón-Torres F, Rodriguez-Nuñez A, Martinón-Sánchez JM. Heliox therapy in Infants with Acute bronchiolitis. Pediatrics 2002;109(1):68-73.Martinón-Torres F, Rodriguez-Nuñez A, Martinón-Sánchez JM. Heliox therapy in Infants with Acute bronchiolitis. Pediatrics 2002;109(1):68-73. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29092 |
Study title: Essai therapeutique en pédiatrie d'un nouvel antibiotique : La Gentamycine - Thieffry s; 1 Al - 1968 (Medecine infantile) - Publication in Gentamicin Registration Dossier - No author - 1977 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28903 |
Study title: Gentamicin : Clinical and laboratory studies in Infants and children - Nunnery AW - 1969 (J. Infect. Dis., 119, 4-5 : 460) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28904 |
Study title: Gentamicin : Laboratory and clinical studies in infants and children - Nunnery AW - 1965 (4th Congr. Chemotherapy on Antimicrobial Agents and Chemotherapy, Oct. 17-21) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28905 |
Study title: Gentamicin : Pharmacologic observations in newborns and infants. - Nunnery AW - 1969 (J. Infect. Dis., 119, 4-5 : 402) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28906 |
Study title: Gentamicin in childhood infections - Marsden HB. & Al - 1970 - Publication in Gentamicin Registration Dossier - No author - 1977 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28907 |
Study title: Gentamicin in Childhood infections. 6 Marsden HB. - 1970 (Curr. Ther. Res, 12 : 353) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28908 |
Study title: Gentamicin in infections in infants with low birthweights. - Howard J. - 1971 (J. Infectious Dis. Dec. Suppl 124:232) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28909 |
Study title: Gentamicin in neonatal period. - McCracken - 1971 (Amer. J. Dis. 120: 524-33) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28910 |
Study title: Gentamicin In Newborn infants. - Paisley JW. - 1973 (Am. J. Dis. Child, 126, oct: 473) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28911 |
Study title: Gentamicin in Pediatric Infections caused by Gram-Negative Organisms. - Del Valle - 1969 (J. of Infectious Dis. 119, 4-5 : 453) - Publication in Gentamicin Registration Dossier - 1978 - |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28913 |
Study title: Gentamicin in Pediatrics. II. Treatment of severe urinary-tract infections caused by Gram-negative Bacilli and of Staphylococcal infections - Holt RJ. Al. - 1971 (J. of Infectious Dis. 124 Suppl.: S257) - Publication in Gentamicin Registration Dossier - N |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28916 |
Study title: Randomised comparative assessment of the immunogenicity and reactogenicity of three different lots of SmithKline Beecham Biologicals' Haemophilus influenzae type b vaccine and the Pasteur/Mérieux Haemophilus influenzae type b vaccine. The vaccines were administered to healthy infants as a primary vaccination course of three consecutive doses at 2, 4 and 6 months of age. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41130 |
Study title: Randomised, double-blind clinical study to evaluate and compare the immunogenicity and reactogenicity of a booster dose of two formulations of SB Biologicals' Hib conjugate vaccine, when administered mixed in one syringe with SB Biologicals' DTPa vaccine to healthy children in their 2nd year of life. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41139 |
Study title: Phase III Clinical Study of DF-098 (Bridging Study) |
Active substance: HaemophilusType b Vaccine Conjugated to Tetanus Protein |
Study summary document link (including results): |
View full study record |
Document reference: 47491 |
Study title: Placebo controlled randomised study of Haemophilus lnfluenzae type b capsular polysaccharide tetanus conjugate vaccine (PRP-T) associated with Diphtheria-Tetanus-Pertussis and Inactivated Poliomyelitis vaccine (DTP-IPV). |
Active substance: HaemophilusType b Vaccine Conjugated to Tetanus Protein |
Study summary document link (including results): |
View full study record |
Document reference: 47493 |
Study title: Placebo controlled randomized study of Haemophilus influenzae type b capsular polysaccharide tetanus conjugate vaccine (PRP-T) combined with Diphtheria-Tetanus-Pertussis and Inactivated Poliomyelitis vaccine (DTP-IPV). |
Active substance: HaemophilusType b Vaccine Conjugated to Tetanus Protein |
Study summary document link (including results): |
View full study record |
Document reference: 47492 |
Study title: Anderson L.T. Campbell M. et al. Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms AM J Psychiat. 1984, 141, 1195Anderson L.T. Campbell M. et al. Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms AM J Psychiat. 1984, 141, 1195 |
Active substance: HALOPERIDOL |
Study summary document link (including results): andersonabstract_haloperiol.pdf |
View full study record |
Document reference: 29065 |
Study title: DOUBLE-BLIND, WITHIN-PATIENT, SINGLE-CENTRE, PLACEBO-CONTROLLED TRIAL OF TWO DOSES OF INHALED FORMOTEROL (12, 24 UG) AND 200 UG INHALED SALBUTAMOL IN CHILDREN WITH BRONCHIAL ASTHMA |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 BA-AP1 Art45 listing 2011.xls |
View full study record |
Document reference: 47835 |
Study title: Duration of effects of inhaled formoterol versus salbutamol. |
Active substance: FORMOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 47836 |
Study title: Asakura M, Ikegame K, Yoshihara S,Taniguchi S, Mori T, Etoh T, Takami A, Yoshida T, Fukuda T, Hatanaka K, Kanamori H, Yujiri T, Atsuta Y, Sakamaki H, Suzuki R, Ogawa H. 2010. Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor. Int J Hematol. 2010 Sep;92(2):351-9.Asakura M, Ikegame K, Yoshihara S,Taniguchi S, Mori T, Etoh T, Takami A, Yoshida T, Fukuda T, Hatanaka K, Kanamori H, Yujiri T, Atsuta Y, Sakamaki H, Suzuki R, Ogawa H. 2010. Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor. Int J Hematol. 2010 Sep;92(2):351-9. |
Active substance: FOSCARNET |
Study summary document link (including results): Asakura M et al 2010.pdf |
View full study record |
Document reference: 39600 |
Study title: Aschan J, Ringden O, Ljungman P, Lonnqvist B, Ohlman S. 1992. Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients. Scandinavian Journal of Infectious Diseases 1992; 24(2):143-150.Aschan J, Ringden O, Ljungman P, Lonnqvist B, Ohlman S. 1992. Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients. Scandinavian Journal of Infectious Diseases 1992; 24(2):143-150. |
Active substance: Foscarnet |
Study summary document link (including results): Aschan J et al 1992.pdf |
View full study record |
Document reference: 39625 |
Study title: Bacigalupo A, Bregante S, Tedone E, Isaza A, Van Lint MT, Moro F. Combined foscarnet - ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation (hsct). Bone Marrow Transplantation 1996;18SUPPL:110-4 1996.Bacigalupo A, Bregante S, Tedone E, Isaza A, Van Lint MT, Moro F. Combined foscarnet - ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation (hsct). Bone Marrow Transplantation 1996;18SUPPL:110-4 1996. |
Active substance: Foscarnet |
Study summary document link (including results): Bacigalupo A et al 1996 supplement.pdf |
View full study record |
Document reference: 39665 |
Study title: Bacigalupo A, Bregante S, Tedone E, Isaza A, Van Lint MT,Trespi G et al. Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation. Transplantation 1996;62(3):376-380 1996;(3):376-380.Bacigalupo A, Bregante S, Tedone E, Isaza A, Van Lint MT,Trespi G et al. Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation. Transplantation 1996;62(3):376-380 1996;(3):376-380. |
Active substance: Foscarnet |
Study summary document link (including results): Bacigalupo A et al 1996.pdf |
View full study record |
Document reference: 39664 |
Study title: Beijing da Xue Xue Bao 2003; Yi(6):596-599.Eksborg S. The pharmacokinetics of antiviral therapy in paediatric patients. [Review] [42 refs]. Herpes 2003; 10(3):66-71.Beijing da Xue Xue Bao 2003; Yi(6):596-599.Eksborg S. The pharmacokinetics of antiviral therapy in paediatric patients. [Review] [42 refs]. Herpes 2003; 10(3):66-71. |
Active substance: FOSCARNET |
Study summary document link (including results): |
View full study record |
Document reference: 28593 |
Study title: Bendel A, Gross T, Woods W, Edelman C, Balfour H. 1993. Failure of foscarnet in disseminated herpes zoster. Lancet (North American Edition) 1993; 341(8856):1342.Bendel A, Gross T, Woods W, Edelman C, Balfour H. 1993. Failure of foscarnet in disseminated herpes zoster. Lancet (North American Edition) 1993; 341(8856):1342. |
Active substance: Foscarnet |
Study summary document link (including results): Bendel A et al 1993.pdf |
View full study record |
Document reference: 39619 |
Study title: Bernstein DI, Schleupner CJ, Evans TG, Blumberg DA, Bryson Y, Grafford K et al. Effect of foscarnet cream on experimental UV radiation-induced herpes labialis. Antimicrobial Agents & Chemotherapy 1997; 41(9):1961-1964.Bernstein DI, Schleupner CJ, Evans TG, Blumberg DA, Bryson Y, Grafford K et al. Effect of foscarnet cream on experimental UV radiation-induced herpes labialis. Antimicrobial Agents & Chemotherapy 1997; 41(9):1961-1964. |
Active substance: Foscarnet |
Study summary document link (including results): Bernstein DI et al 1997.pdf |
View full study record |
Document reference: 39656 |
Study title: Biron KK. 2006. Antiviral drugs for cytomegalovirus diseases. Antiviral Research 2006; 71(2-3):154- 163.Biron KK. 2006. Antiviral drugs for cytomegalovirus diseases. Antiviral Research 2006; 71(2-3):154- 163. |
Active substance: FOSCARNET |
Study summary document link (including results): Biron KK..pdf |
View full study record |
Document reference: 39589 |
Study title: Clinical efficacy of dirithromycin in pharyngitis and tonsillitis. Müller O, Wettich K. The Journal of antimicrobial chemotherapy, { Mar 1993, vol. 31 Suppl C, p. 97−102. |
Active substance: ERYTHROMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 26472 |
Study title: Protection against the common cold in a boys' school |
Active substance: DICHLOROBENZYL-ALCOHOL AND LIDOCAINE |
Study summary document link (including results): |
View full study record |
Document reference: 25949 |
Study title: Rapporto su uno studio non controllato con Kryptocur (denominazione sperimentale HOE 471) nel criptorchidismo. Dr. Borkenstein (Clinical study) 25/9/1981 |
Active substance: GONADORELIN |
Study summary document link (including results): |
View full study record |
Document reference: 28994 |
Study title: Rapporto su uno studio non controllato con Kryptocur (denominazione sperimentale HOE 471) nel criptorchidismo. Dr. M von der Ohe (Clinical study) 25/9/1981 |
Active substance: GONADORELIN |
Study summary document link (including results): |
View full study record |
Document reference: 28995 |
Study title: Rapporto su uno studio non controllato con Kryptocur (denominazione sperimentale HOE 471) nel criptorchidismo. Dr. Pankrath (Clinical study) 25/9/1981 |
Active substance: GONADORELIN |
Study summary document link (including results): |
View full study record |
Document reference: 28996 |
Study title: Noncontrolled clinical trial of framycetin sulphate (sofrakay) bacterial diarrhoea and cholera in children. - Praharaj SC. - 1977 (Indian J. Pediatr. 44: 39-44) - Micromedex ref. in CES - Ohlrogge R. - 24 July 2004 - |
Active substance: FRAMYCETIN |
Study summary document link (including results): |
View full study record |
Document reference: 28618 |
Study title: Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukemia. - Storring RA -1977 (Lancet, 837-840) - Micromedex ref. in CES - Ohlrogge R. - 24 July 2004 - |
Active substance: FRAMYCETIN |
Study summary document link (including results): |
View full study record |
Document reference: 28619 |
Study title: Which dressing ? - Gough DCS - 1990 (Br. J. Urol. 65: 418-419) - Micromedex ref. in CES - Ohlrogge R. - 24 July 2004 - |
Active substance: FRAMYCETIN |
Study summary document link (including results): |
View full study record |
Document reference: 28620 |
Study title: [Clinical trials of a collyrium associating desoxymethasone, framycetin and gramicidin] Ingignoli B, Bronner A. Bull Soc Ophtalmol Fr. 1971 Apr;71(4):433-44. |
Active substance: FRAMYCETIN AND POLYMYXIN B/ FRAMYCETIN + OXEDRINE + POLYMYXIN B |
Study summary document link (including results): Clinical trials of a collyrium associating desoxymethasone,.pdf |
View full study record |
Document reference: 28627 |
Study title: Clinical Expert report – Dr Th. DOBMEYER – 27/09/2001 |
Active substance: FUROSEMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28632 |
Study title: Continuous versus intermittent furosemide infusion in critically ill infants after open heart operations - Luciani G.B. et al. - 1997 (Ann. Thorac. Surg. 64, 1133-1139) - Publication in Clinical Expert Report - Dr. Med. Th. DOBMEYER - 27/08/2001 - |
Active substance: FUROSEMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28630 |
Study title: Furosemide Pharmacokinetics and Pharmacodynamics in health and disease – An Update - Hammarlund-Udenaes M. et al. - 1989 (Journal of pharmacokinetics and biopharmaceutics, Vol 17, No.1) Publication in Clinical Expert Report - Dr Matti VERHO 05/1999 - Volume 18 |
Active substance: FUROSEMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28641 |
Study title: Furosemide-associated fever - Amir J. et al. - 1996 (J Pediatr 128 : 163-164) - Publication in Clinical Expert Report - Dr. Med. Th. DOBMEYER - 27/08/2001 - |
Active substance: FUROSEMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28631 |
Study title: International PHVD Drug Trial Group;International randomized controlled trial of acetazolamide and furosemide in posthaemorrhagic ventricular dilatation in infancy; Lancet 352, 433-440 (1998) |
Active substance: FUROSEMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28633 |
Study title: Intratracheal furosemide in infants after cardiac surgery : its effects on lung mechanics and urinary output, and its levels in plasma and tracheal aspirate - Aufricht C. et AL. - 1997 ( Intensive Care Med. 23, 992-997) Publication in Clinical Expert Report - Dr. Med. Th. DOBMEYER - 27/08/2001 |
Active substance: FUROSEMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28634 |
Study title: Klinge J.M, Schsrf J et al., Intermittent administration of furosemide versus continuous infusion in the postoperative management of children following open heart surgery;Intensive Care Med, 23, 693-697 (1997) |
Active substance: FUROSEMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28635 |
Study title: Lochan S.R. et al., Coadministration of theophylline enhances diuretic response to furosemide in infants during extracoproreal membrane oxygenation:a a randomized controlled pilot study; J.Pediatr. 133, 86-89(1998)Lochan S.R. et al., Coadministration of theophylline enhances diuretic response to furosemide in infants during extracoproreal membrane oxygenation:a a randomized controlled pilot study; J.Pediatr. 133, 86-89(1998) |
Active substance: FUROSEMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28636 |
Study title: Melo R.E, Sole D. et al., Comparative efficacy of inhaled furosemide and disodium cromoglycate in the treatment of exercise-induced asthma in children; J.Allergy Clin.Immunol. 99, 204-209 (1997)Melo R.E, Sole D. et al., Comparative efficacy of inhaled furosemide and disodium cromoglycate in the treatment of exercise-induced asthma in children; J.Allergy Clin.Immunol. 99, 204-209 (1997) |
Active substance: FUROSEMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28637 |
Study title: Martinón-Torres F, Rodriguez-Nuñez A, Martinón-Sánchez JM. Nasal continuous positive airway pressure with heliox in infants with acute bronchiolitis. Respir Med 2006 Jan; Article in press.Martinón-Torres F, Rodriguez-Nuñez A, Martinón-Sánchez JM. Nasal continuous positive airway pressure with heliox in infants with acute bronchiolitis. Respir Med 2006 Jan; Article in press. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29093 |
Study title: Martinón-Torres R, Crespo Suarez PA, Silvia Barbara C, Castello Munoz A, Rodriguez Nuñez A, Martinón-Sanchez JM. Noninvasive ventilation with heliox in an infant with acute respiratory distress syndrome. An Pediatr (Barc) 2005 Jan;62(1):64-7.Martinón-Torres R, Crespo Suarez PA, Silvia Barbara C, Castello Munoz A, Rodriguez Nuñez A, Martinón-Sanchez JM. Noninvasive ventilation with heliox in an infant with acute respiratory distress syndrome. An Pediatr (Barc) 2005 Jan;62(1):64-7. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29094 |
Study title: McCoy KS, Castile RG, Allen ED, Filbrun DA, Flucke RL, Bar-Yishay E. Functional residual capacity (FRC) measurements by plethysmography and helium dilution in normal infants. Pediatric pulmonology. 1995;19(5):282-90.McCoy KS, Castile RG, Allen ED, Filbrun DA, Flucke RL, Bar-Yishay E. Functional residual capacity (FRC) measurements by plethysmography and helium dilution in normal infants. Pediatric pulmonology. 1995;19(5):282-90. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29095 |
Study title: Nasr SZ, Amato P, Wilmott RW. Predicted values for lung diffusing capacity in healthy children. Pediatr Pulmonol 1991;10(4):267-72.Nasr SZ, Amato P, Wilmott RW. Predicted values for lung diffusing capacity in healthy children. Pediatr Pulmonol 1991;10(4):267-72. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29096 |
Study title: Nelson DS, McClellan L. Helium-oxygen mixtures as adjunctive support for refractory viral croup. Ohio State Med J 1982;78:729-30.Nelson DS, McClellan L. Helium-oxygen mixtures as adjunctive support for refractory viral croup. Ohio State Med J 1982;78:729-30. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29097 |
Study title: Paret G. Dekel B, Vardi A, Szeinberg A, Lotan D, Barzilay Z. Helium/oxygen gas mixture in respiratory failure secondary to bronchiolitis: a new therapy. Pediatric Pulmonology 1996;22:322-323.Paret G. Dekel B, Vardi A, Szeinberg A, Lotan D, Barzilay Z. Helium/oxygen gas mixture in respiratory failure secondary to bronchiolitis: a new therapy. Pediatric Pulmonology 1996;22:322-323. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29098 |
Study title: Nikolov A, Burdarova I, Kolarov G, Veltova L. The use of GnRH agonists in severe uterine hemorrhages in adolescence caused by congenital aplastic and hypoplastic anemias. Akusherstvo i Ginekologiia 1999;38(2):46-8.Nikolov A, Burdarova I, Kolarov G, Veltova L. The use of GnRH agonists in severe uterine hemorrhages in adolescence caused by congenital aplastic and hypoplastic anemias. Akusherstvo i Ginekologiia 1999;38(2):46-8. |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 29010 |
Study title: Paterson WF, McNeill E, Reid S, Hollman AS, Donaldson MDC. Efficacy of 'Zoladez LA' (goserelin) in the treatment of girls with central precocious or early puberty. Archives of Disease in Childhood 1998; 79(4):323-327.Paterson WF, McNeill E, Reid S, Hollman AS, Donaldson MDC. Efficacy of 'Zoladez LA' (goserelin) in the treatment of girls with central precocious or early puberty. Archives of Disease in Childhood 1998; 79(4):323-327. |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 29011 |
Study title: Stanhope R, Brook CCD. Thelarche variant: A new syndrome of precocious sexual maturation? Acta Endocrinologica 1990; 123(5):481-486.Stanhope R, Brook CCD. Thelarche variant: A new syndrome of precocious sexual maturation? Acta Endocrinologica 1990; 123(5):481-486. |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 29012 |
Study title: Suppression of puberty with long-acting goserelin (Zoladex-LA): effect on gonadotrophin response to GnRH in the first treatment cycle.Breyer P, Haider A, Pescovitz O. Clinical Obstetrics and Gynecology 1993; 36(3):764-772.Suppression of puberty with long-acting goserelin (Zoladex-LA): effect on gonadotrophin response to GnRH in the first treatment cycle.Breyer P, Haider A, Pescovitz O. Clinical Obstetrics and Gynecology 1993; 36(3):764-772. |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 29013 |
Study title: The use of GnRH agonists in severe uterine hemorrhages in adolescence caused by congenital aplastic and hypoplastic anemias]. [Review] [21 refs] Stanhope R, Brook CCD. Acta Endocrinologica 1990;123(5):481-486 1990;(5):481-486.The use of GnRH agonists in severe uterine hemorrhages in adolescence caused by congenital aplastic and hypoplastic anemias]. [Review] [21 refs] Stanhope R, Brook CCD. Acta Endocrinologica 1990;123(5):481-486 1990;(5):481-486. |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 29014 |
Study title: Thelarche variant: A new syndrome of precocious sexual maturation? Thelarche variant: A new syndrome of precocious sexual maturation? |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 29015 |
Study title: A dose range study of the antipyretic efficacy and safety of ibuprofen pediatric suspension in febrile children. Mar 1991.A dose range study of the antipyretic efficacy and safety of ibuprofen pediatric suspension in febrile children. Mar 1991. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29668 |
Study title: A Dose-Ranging Study of Ibuprofen Syrup in Pyrexia in Children |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-MS86-534.pdf |
View full study record |
Document reference: 47557 |
Study title: Comparison of ibuprofen, acetaminophen and placebo treatment of fever in children |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29462 |
Study title: Comparison of the anti-pyretic activity of Ibuprofen and Paracetamol in children with pyrexia |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-BR9095.pdf |
View full study record |
Document reference: 29418 |
Study title: Demonstration of the analgesic efficacy and safety of liquid formulation of ibuprofen (10 mg/kg), acetaminophen (15 mg/kg) and placebo in the relief of orthodontic pain in children (WM-390) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29534 |
Study title: Dockhorn RJ et al. Efficacy of acrivastine with pseudoephedrine in treatment of allergic rhinitis due to ragweed. Ann Allergy Asthma Immunol 1996; 76(2):204-8 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29512 |
Study title: Dose response study of Ibuprofen syrup in juvenile chronic arthritis (AMDBA83008) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29444 |
Study title: Dose-response study of ibuprofen syrup in juvenile chronic arthritis (JCA). |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen-AMDBA83008.pdf |
View full study record |
Document reference: 47542 |
Study title: Double blind, single dose study of the safety and analgesic efficacy of ibuprofen liquid, and placebo (liquid vehicle) following orthodontic treatment" (WM-402) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29535 |
Study title: Double-Blind, Placebo-controlled, Maximum Use Safety and Tolerance Study of Advil Liquigel and Celebrex |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29526 |
Study title: Efficacy and pharmacokinetic/pharmacodynamic profile of ibuprofen chewable tablets versus ibuprofen suspension in febrile children. Apr 1994. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29558 |
Study title: Efficacy and pharmacokinetic/pharmacodynamic profile of ibuprofen chewable tablets versus ibuprofen suspension in febrile children. Apr 1994. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29624 |
Study title: Efficacy and pharmacokinetic/pharmacodynamic profile of ibuprofen chewable tablets versus ibuprofen suspension in febrile children. CSR 167S. Protocol 91-113, Unpublished Report 293A and Unpublished Report 1475. |
Active substance: IBUPROFEN |
Study summary document link (including results): ibuprofen 91-113.pdf |
View full study record |
Document reference: 47452 |
Study title: Efficacy and tolerance of Ibuprofen Syrup in juvenile chronic arthritis evaluation on joint involvement in patients weighting 10-25 kg. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29407 |
Study title: Efficacy of rectal ibuprofen in controlling postoperative pain in children |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29518 |
Study title: Evaluation of Ibuprofen and Paracetamol in Infective Disorders of Children. |
Active substance: IBUPROFEN |
Study summary document link (including results): ibuprofen-m83081.pdf |
View full study record |
Document reference: 48089 |
Study title: Evaluation of the efficacy and safety of tramadol/APAP in oral surgical pain |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29482 |
Study title: Evid Based Med. 2007 Oct;12(5):144. Ibuprofen was more effective than codeine or acetaminophen for musculoskeletal pain in children. Ali S, Klassen TPEvid Based Med. 2007 Oct;12(5):144. Ibuprofen was more effective than codeine or acetaminophen for musculoskeletal pain in children. Ali S, Klassen TP |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29615 |
Study title: Biron P, Bosi A, Cahn JY, Goldstone AH, Gorin NC, Link H Cytomegalovirus interstitial pneumonia in autologous bone marrow transplant recipients. Bone Marrow Transplantation 1994;13(2):209-12 1994;(2):209-212.Biron P, Bosi A, Cahn JY, Goldstone AH, Gorin NC, Link H Cytomegalovirus interstitial pneumonia in autologous bone marrow transplant recipients. Bone Marrow Transplantation 1994;13(2):209-12 1994;(2):209-212. |
Active substance: Foscarnet |
Study summary document link (including results): Biron P et al 1994.pdf |
View full study record |
Document reference: 39677 |
Study title: Brady RC, Bernstein DI. Treatment of herpes simplex virus infections. Antiviral Research~ 61(2):73-81, February 2004 2004;(2):-81, February. 2004. Brady RC, Bernstein DI. Treatment of herpes simplex virus infections. Antiviral Research~ 61(2):73-81, February 2004 2004;(2):-81, February. 2004. |
Active substance: FOSCARNET |
Study summary document link (including results): Brady RC et al 2004.pdf |
View full study record |
Document reference: 28586 |
Study title: Bryan CJ, Prichard MN, Daily S, Jefferson G, Hartline C, Cassady KA, Hilliard L, Shimamura M. Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastoma.Pediatr Infect Dis J. 2008 Oct;27(10):946- 8.Bryan CJ, Prichard MN, Daily S, Jefferson G, Hartline C, Cassady KA, Hilliard L, Shimamura M. Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastoma.Pediatr Infect Dis J. 2008 Oct;27(10):946- 8. |
Active substance: Foscarnet |
Study summary document link (including results): Bryan CJ et al 2008.pdf |
View full study record |
Document reference: 39611 |
Study title: Bueno J, Ramil C, Green M. Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients. Paediatric Drugs. 2002; 4(5):279-290.Bueno J, Ramil C, Green M. Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients. Paediatric Drugs. 2002; 4(5):279-290. |
Active substance: Foscarnet |
Study summary document link (including results): Bueno J et al 2002.pdf |
View full study record |
Document reference: 39635 |
Study title: Carbon C. New anti-VZV drugs: Perspectives. Medecine et Maladies Infectieuses 1998; 28(Special Issue SI):924-927.Carbon C. New anti-VZV drugs: Perspectives. Medecine et Maladies Infectieuses 1998; 28(Special Issue SI):924-927. |
Active substance: Foscarnet |
Study summary document link (including results): Carbon C 1998.pdf |
View full study record |
Document reference: 39651 |
Study title: Castelli F, Tomasoni L, Zeroli C, Suter F, Trespi G, Carosi G Comparison of pharmacokinetics and dynamics of two dosage regimens of foscarnet in AIDS patients with Cytomegalovirus retinitis. European Journal of Clinical Pharmacology 1997;52(5):397-401.Castelli F, Tomasoni L, Zeroli C, Suter F, Trespi G, Carosi G Comparison of pharmacokinetics and dynamics of two dosage regimens of foscarnet in AIDS patients with Cytomegalovirus retinitis. European Journal of Clinical Pharmacology 1997;52(5):397-401. |
Active substance: Foscarnet |
Study summary document link (including results): Castelli F et al 1997.pdf |
View full study record |
Document reference: 39657 |
Study title: Caumes E, Bricaire F. Prevention of herpes simplex and varicella zoster infections in hiv infected patients. Annales de Medecine Interne 1997; 148(3):255-257.Caumes E, Bricaire F. Prevention of herpes simplex and varicella zoster infections in hiv infected patients. Annales de Medecine Interne 1997; 148(3):255-257. |
Active substance: Foscarnet |
Study summary document link (including results): Caumes E et al 1997.pdf |
View full study record |
Document reference: 39658 |
Study title: Causey D, Davis R, Duppermann BD, Feinberg J, Heinemann MH, Jacobson MA et al. 1994. Pharmacodynamic relationship of pharmacokinetic parameters of maintenance doses of foscarnet and clinical outcome of cytomegalovirus reninitis. Antimicrobial Agents and Chemotherapy 1994; 38(5): 1190- 1193Causey D, Davis R, Duppermann BD, Feinberg J, Heinemann MH, Jacobson MA et al. 1994. Pharmacodynamic relationship of pharmacokinetic parameters of maintenance doses of foscarnet and clinical outcome of cytomegalovirus reninitis. Antimicrobial Agents and Chemotherapy 1994; 38(5): 1190- 1193 |
Active substance: Foscarnet |
Study summary document link (including results): |
View full study record |
Document reference: 39678 |
Study title: Cesaro S, Boaro MP, Pillon M, Calore E, Cermakova I, Perruccio K, Mengoli C, Messina C. Immune reconstitution complicated by CMV retinitis in a pediatric patient who underwent haploidentical CD34+-selected hematopoietic stem cell transplant for acute lymphoblastic leukemia.Int J Hematol. 2008 Sep;88(2):145-8.Cesaro S, Boaro MP, Pillon M, Calore E, Cermakova I, Perruccio K, Mengoli C, Messina C. Immune reconstitution complicated by CMV retinitis in a pediatric patient who underwent haploidentical CD34+-selected hematopoietic stem cell transplant for acute lymphoblastic leukemia.Int J Hematol. 2008 Sep;88(2):145-8. |
Active substance: Foscarnet |
Study summary document link (including results): Cesaro S et al 2008.pdf |
View full study record |
Document reference: 39612 |
Study title: Part IC - Clinical Expert report (volume 2) – Dr Matti VERHO – 05/1995 |
Active substance: FUROSEMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28638 |
Study title: Reiter P.D. Makhlof R., et al., Comparison of 6-hour infusion versus bolus furosemide in premature infants. Pharmacotherapy 18, 63-68 (1998) |
Active substance: FUROSEMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28639 |
Study title: Romagnoli C, Zecca E at al., Furosemide does not prevent indomethacin-induced renal side effects in preterm infants, Clin.Pharmacol.Ther. 62, 181-186 (1997) |
Active substance: FUROSEMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 28640 |
Study title: Experience with Fucidin® Gel preparations in general practice |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28690 |
Study title: Final report for a trial of Fucidin® cream using both photographic and clinical assessments (Fucidin® cream in the treatment of superficial skin sepsis) |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28673 |
Study title: Final report for a trial of Fucidin® cream using both photographic and clinical assessments (Fucidin® cream in the treatment of superficial skin sepsis). |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28645 |
Study title: Fucidin eye drops in acute, bacterial eye infections; Thanpaichitra, Bangkok Thailland |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28654 |
Study title: Fucidin H Gel in acne |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28691 |
Study title: Fucidin in various eye infections Open evaluation with fucidin eye drops and fucithalmic viscous eye drops |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28651 |
Study title: Fucidin Ointment and Fucidin tablets in various indications |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28696 |
Study title: Fucidin treatment of soft tissue infections in children: comparison of two dosages |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28688 |
Study title: Fucidin versus erythromycin in skin and soft tissue infection |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28714 |
Study title: Fucidin versus flucloxacillin in skin and soft tissue infection |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28715 |
Study title: Fucidin® cream in the treatment of impetigo |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28682 |
Study title: Fucidin® cream versus its vehicle and Bactroban® in the treatment of impetigo |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28675 |
Study title: Fucidin® cream versus its vehicle in the treatment of impetigo |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28668 |
Study title: Fucidin® cream versus its vehicle in the treatment of impetigo |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28674 |
Study title: Fucidin® cream versus its vehicle in the treatment of impetigo |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28702 |
Study title: Fucidin® levels in osteomyelitis. E H Chater et al. J Ir. Med. Assoc. 1972; 65: 506 -508 Note this study is included for suspension, tablets and iv reports Study includes pts from 2-72. |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28712 |
Study title: Fucidin® levels in osteomyelitis.E H Chater et al. J Ir. Med. Assoc. 1972; 65: 506 -508 |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28684 |
Study title: Fucidin® ointment versus its vehicle and Bactroban® in the treatment of impetigo |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28703 |
Study title: Thomas BC, Stanhope R, Leiper AD. Gonadotropin Releasing Hormone Analogue and Growth Hormone Therapy in Precocious and Premature Puberty following Cranial Irradiation for Acute Lymphoblastic Leukaemia. Hormone Research 1993; 39(1/2):25-29.Thomas BC, Stanhope R, Leiper AD. Gonadotropin Releasing Hormone Analogue and Growth Hormone Therapy in Precocious and Premature Puberty following Cranial Irradiation for Acute Lymphoblastic Leukaemia. Hormone Research 1993; 39(1/2):25-29. |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 29016 |
Study title: Trueman JA, Tillmann V, Cusick CF, Foster P, Patel L, Hall CM et al. Suppression of puberty with long-acting goserelin (Zoladex-LA): effect on gonadotrophin response to GnRH in the first treatment cycle. Clinical Endocrinology 2002; 57(2):223-30.Trueman JA, Tillmann V, Cusick CF, Foster P, Patel L, Hall CM et al. Suppression of puberty with long-acting goserelin (Zoladex-LA): effect on gonadotrophin response to GnRH in the first treatment cycle. Clinical Endocrinology 2002; 57(2):223-30. |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 29017 |
Study title: Tuvemo T. Treatment of central precocious puberty [Review]. Expert Opinion on Investigational Drugs 2006; 15(5):495-505.Tuvemo T. Treatment of central precocious puberty [Review]. Expert Opinion on Investigational Drugs 2006; 15(5):495-505. |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 29018 |
Study title: Tuvemo T. Treatment of central precocious puberty. Expert Opinion on Investigational Drugs 2006; 15(5):495-505.Tuvemo T. Treatment of central precocious puberty. Expert Opinion on Investigational Drugs 2006; 15(5):495-505. |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 29019 |
Study title: Waller KG, Shaw RW. Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Fertility & Sterility 1993; 59(3):511-515.Waller KG, Shaw RW. Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Fertility & Sterility 1993; 59(3):511-515. |
Active substance: GOSERELIN |
Study summary document link (including results): |
View full study record |
Document reference: 29020 |
Study title: A clinical study to evaluate the safety, tolerance, antiemetic efficacy and pharmacokinetic profile of BRL 43694A in paediatric patients receiving chemotherapy for malignant disease |
Active substance: GRANISETRON |
Study summary document link (including results): |
View full study record |
Document reference: 29025 |
Study title: A SINGLE-CENTER, NON-RANDOMIZED, OPEN-LABEL STUDY OF THE EFFICACY OF ORAL GABAPENTIN(CI-945) IN THE TREATMENT OF PATIENTS WITH GENERALIZED OR SYNPTOMATIC EPILEPSY |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28754 |
Study title: A SINGLE-DOSE STUDY OF NEURONTIN® (GABAPENTIN; CI-945) PHARMACOKINETICS IN HEALTHY PEDIATRIC SUBJECTS |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28755 |
Study title: A STUDY IN HEALTHY VOLUNTEERS TO DETERMINE THE TASTE ACCEPTABILITY OF THREE GABAPENTIN (CI-945) LIQUID FORMULATIONS |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28756 |
Study title: A STUDY IN PATIENTS WITH REFRACTORY PARTIAL SEIZURES TO DETERMINE THE EFFICACY AND SAFETY OF GABAPENTIN MONOTHERAPY COMPARED WITH CARBAMAZEPINE MONOTHERAPY AND COMBINATION THERAPY |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28757 |
Study title: A STUDY OF POTENTIAL INTERACTION BETWEEN VALPROIC ACID AND GABAPENTIN IN EPILEPTIC PATIENTS MAINTAINED ON VALPROIC ACID. |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28758 |
Study title: AN EXTENDED OPEN-LABEL GABAPENTIN (CI-945) PEDIATRIC MONOTHERAPY TRIAL FOLLOWING A DOUBLE-BLIND STUDY (945-094) IN PEDIATRIC PATIENTS WITH BENIGN CHILDHOOD EPILEPSY WITH CENTROTEMPORAL SPIKES (BECTS) (PROTOCOL 945-095). |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28759 |
Study title: AN OPEN LABEL EXTENSION STUDY OF GABAPENTIN IN CHILDREN WITH EPILEPSY WHO HAVE PARTICIPATED IN THE DOUBLE-BLIND STUDY GA 001 (945-430001) |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28760 |
Study title: AN OPEN LABEL MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF GABAPENTIN AS ADD-ON THERAPY IN THE EXTENDED TREATMENT OF EPILEPTIC SEIZURES. |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28761 |
Study title: AN OPEN LABEL, UNCONTROLLED PILOT STUDY OF THE SAFETY, TOLERANCE, AND EFFICACY OF GABAPENTIN (CI-945) AS ADD-ON THERAPY IN PATIENTS WITH MEDICALLY UNCONTROLLED SEIZURES. |
Active substance: GABAPENTIN |
Study summary document link (including results): |
View full study record |
Document reference: 28762 |
Study title: Our experiences with indocin in the treatment of postoperative pain and postoperative edemaa |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29981 |
Study title: Outcome of children in the indomethacin intraventricular hemorrhage prevention trial. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29982 |
Study title: The treatment of acute fissure-in-ano in children : evaluation of the efficacy of the Proctossedyl - No author - 1971 (Clinical Trials Journal 1971; 4: 9-13) - Compilation of clinical papers for the UK review of Medicines in 1983 - |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29184 |
Study title: Topical Corticosteroids: Clinical Pharmacology and Therapeutic Use - Miller JA et al - 1980 (Drugs 1980; 19: 119-134) - Publication in Application for a reviewed license - |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29185 |
Study title: Treatment of haemorrhoids with Proctossedyl - Soegaard PK - No date (private communication) - Compilation of clinical papers for the UK review of Medicines in 1983 - |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29186 |
Study title: Watterberg, K.L., et al., Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants. Pediatrics, 2007. 120(1): p. 40-8. |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29187 |
Study title: Peripherally inserted central venous catheters : success of scalp-vein access in infants and newborns;RACADIO JM; Radiology; 1999 vol.210 p.858 860Peripherally inserted central venous catheters : success of scalp-vein access in infants and newborns;RACADIO JM; Radiology; 1999 vol.210 p.858 860 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30424 |
Study title: Khan, S. A. and Williamson, D. M. A double-blind comparison of 1% hydrocortisone plus 10% urea ('Alphaderm') and 0.1% betamethasone 17-valerate in the treatment of non-infective inflammatory dermatoses Curr.Med.Res.Opin. 1977;5:354-358. |
Active substance: HYDROCORTIZONE AND UREA |
Study summary document link (including results): |
View full study record |
Document reference: 29189 |
Study title: Effect on gingivitis of daily rinsing with 1.5 percent h2O2Boyd 1989 |
Active substance: HYDROGEN PEROXIDE |
Study summary document link (including results): Boyd_1989_effect on gingivitis of daily rinsing with 1.5 percent h2o2.pdf |
View full study record |
Document reference: 48175 |
Study title: Efficacy and safety of stabilised hydrogen peroxide cream (crystacide) in mild to moderate acne vulgaris: a randomised, controlled trial versus benzoyl peroxide gel. |
Active substance: HYDROGEN PEROXIDE |
Study summary document link (including results): |
View full study record |
Document reference: 29191 |
Study title: skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparasion with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial. |
Active substance: HYDROGEN PEROXIDE |
Study summary document link (including results): |
View full study record |
Document reference: 29190 |
Study title: Succesful treatment of molluscum contagiosum skin infection with hydrogen peroxide 1% cream. in the management of patients with psoriasis.; 12th congress of the European Academy of Dermatology & venerology |
Active substance: HYDROGEN PEROXIDE |
Study summary document link (including results): |
View full study record |
Document reference: 29192 |
Study title: Topical oral antiseptics, mouthwashes and throat remediesDarlington 1973 |
Active substance: HYDROGEN PEROXIDE |
Study summary document link (including results): Darlington_1973_Topical oral antiseptics, mouthwashes and throat remedies.pdf |
View full study record |
Document reference: 48176 |
Study title: HDM9007 - Clinical observation to evaluate the patient oriented dosages of Palladon® retard with respect to circadian variations in pain intensity (0.1% of patients 10-19 years) (Germany); Protocol No.011-004: Open label, preliminary evaluation of the clinical effectiveness and steady state pharmacokinetics of a controlled release sprinkle formulation of hydromorphone in pediatric patients with chronic cancer pain. (terminated - lack of recruitment) |
Active substance: HYDROMORPHONE |
Study summary document link (including results): |
View full study record |
Document reference: 29193 |
Study title: "An overview of the treatment of Childhood SLE - E.D. Silverman and B. Lang- 1997 - Publication in CES 0533 - H. Dennequin - 28 Sept 2006 -" |
Active substance: HYDROXYCHLOROQUINE |
Study summary document link (including results): |
View full study record |
Document reference: 29206 |
Study title: Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30053 |
Study title: Urinary metabolites of oxidative stress and nitric oxide in preterm and term infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30054 |
Study title: Use of chlorbutin in the complex treatment of systemic forms of juvenile rheumatoid arthritisa |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30055 |
Study title: Use of indomethacin in patients with a gastrointestinal form of salmonellosisa |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30056 |
Study title: Virilization in a child with pseudohypoaldosteronism treated with indometacin |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30057 |
Study title: When to treat the patent ductus arteriosus with indomethacin in very-low-birth-weight infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30058 |
Study title: Worldwide experience with etodolac (Lodine) 300 mg b.i.d. in the treatment of osteoarthritis. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30059 |
Study title: A Multicenter Study of Anti-TNFα Chimeric Monoclonal Antibody (Infliximab) in the Treatment of Pediatric Patients with Active Crohn’s Disease • 20 week report synopsis |
Active substance: Infliximab |
Study summary document link (including results): |
View full study record |
Document reference: 47434 |
Study title: A Multicenter Study of Anti-TNFα Chimeric Monoclonal Antibody (Infliximab) in the Treatment of Pediatric Patients with Active Crohn’s Disease • 48 week report synopsis |
Active substance: Infliximab |
Study summary document link (including results): |
View full study record |
Document reference: 47435 |
Study title: Comparison of chloral hydrate, meperidine, and hydroxyzine to midazolam regimens for oral sedation of pediatric dental patients. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE06B2013.pdf |
View full study record |
Document reference: 29239 |
Study title: Comparison of hydroxyzine and cyproheptadine as antipruri- tics for atopic dermatitis in children. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29370 |
Study title: Comparison of oral midazolam with and without hydroxyzine in the sedation of pediatric dental patients. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE05B1415.pdf |
View full study record |
Document reference: 29339 |
Study title: Comparison of three conscious sedation regimens for pediatric dental patients. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE07G0921.pdf |
View full study record |
Document reference: 29355 |
Study title: Comparison of triazolam to a chloral hydrate / hydroxyzine combination in the sedation of pediatric dental patients. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE92B1305.pdf |
View full study record |
Document reference: 29303 |
Study title: Comparison of two different dosages of hydroxyzine for sedation in the paediatric dental patient |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE07H2209.pdf |
View full study record |
Document reference: 29254 |
Study title: Concerning the side effects of hydroxyzine. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE96J0916-translation.pdf |
View full study record |
Document reference: 29314 |
Study title: Confronto clinico statistico fra tre farmaci nella preanesthesia del paziente pediatrico. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPI97B1125.pdf |
View full study record |
Document reference: 29324 |
Study title: Conscious sedation and pulse oximetry: false alarms? |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE91G3031.pdf |
View full study record |
Document reference: 29364 |
Study title: Cruzado D, Masserey-Spicher V, Roux L, Delavelle J, Picard F, Haenggeli CA. Eur J Pediatr. 2002 Aug;161(8):438-41. Early onset and rapidly progressive subacute sclerosing panencephalitis after congenital measles infection.Cruzado D, Masserey-Spicher V, Roux L, Delavelle J, Picard F, Haenggeli CA. Eur J Pediatr. 2002 Aug;161(8):438-41. Early onset and rapidly progressive subacute sclerosing panencephalitis after congenital measles infection. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30094 |
Study title: Delogu C, Lozzi A, Campanelli A, De Ritis G, Pietropaoli P, Balbi P, Signore L.. Italian Journal of Anesthesiology [Italy]. 1982; 33(4):619-625. Cell- mediated immunity and immunomodulatory drugs in critically ill patientsDelogu C, Lozzi A, Campanelli A, De Ritis G, Pietropaoli P, Balbi P, Signore L.. Italian Journal of Anesthesiology [Italy]. 1982; 33(4):619-625. Cell- mediated immunity and immunomodulatory drugs in critically ill patients |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30096 |
Study title: Di Blasi F, Ruvolo F, D'Amico P, Basile MI, Torre S, Violi L. Archivo di Medicina Interna. July-August, 1981; 33(4):1457-1467. Considerations on the use of methisoprinol: the treatment of acute viral hepatitisDi Blasi F, Ruvolo F, D'Amico P, Basile MI, Torre S, Violi L. Archivo di Medicina Interna. July-August, 1981; 33(4):1457-1467. Considerations on the use of methisoprinol: the treatment of acute viral hepatitis |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30097 |
Study title: Dimova PS, Bojinova VS. J Child Neurol. 2004 Jul;19(7):548-52. Case of subacute sclerosing panencephalitis with atypical absences and myoclonic-atonic seizures as a first symptom.Dimova PS, Bojinova VS. J Child Neurol. 2004 Jul;19(7):548-52. Case of subacute sclerosing panencephalitis with atypical absences and myoclonic-atonic seizures as a first symptom. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30098 |
Study title: Duman O, Balta G, Metinsoy M, Haspolat S.J Child Neurol. 2004 Jul;19(7):552-5. Unusual manifestation of subacute sclerosing panencephalitis: case with intracranial high-pressure symptoms.Duman O, Balta G, Metinsoy M, Haspolat S.J Child Neurol. 2004 Jul;19(7):552-5. Unusual manifestation of subacute sclerosing panencephalitis: case with intracranial high-pressure symptoms. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30099 |
Study title: DuRant RH, Dyken PR, Swift AV. J Pediatr Aug 1982;101(2):288-93 [Abstract]. The influence of inosiplex treatment on the neurological disability of patients with subacute sclerosing panencephalitisDuRant RH, Dyken PR, Swift AV. J Pediatr Aug 1982;101(2):288-93 [Abstract]. The influence of inosiplex treatment on the neurological disability of patients with subacute sclerosing panencephalitis |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30100 |
Study title: Feldman S, Hayes FA, Chaudhary S, Ossi M.. Antimicrob Agents Chemother. 1978 Sep;14(3):495-7. Inosiplex for localized herpes zoster in childhood cancer patients: preliminary controlled studyFeldman S, Hayes FA, Chaudhary S, Ossi M.. Antimicrob Agents Chemother. 1978 Sep;14(3):495-7. Inosiplex for localized herpes zoster in childhood cancer patients: preliminary controlled study |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30101 |
Study title: Filipowicz A, Grudzinska B. Neurol Neurochir Pol. 1987 Jul-Aug;21(4-5):352-6. Evaluation of the results of treatment of SSPE (subacute sclerosing panencephalitis) with isoprinosine.Filipowicz A, Grudzinska B. Neurol Neurochir Pol. 1987 Jul-Aug;21(4-5):352-6. Evaluation of the results of treatment of SSPE (subacute sclerosing panencephalitis) with isoprinosine. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30102 |
Study title: Preoperative preparation for tonsillectomy with hydroxyzine hydrochloride in pediatric patients. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE91G2920.pdf |
View full study record |
Document reference: 29348 |
Study title: Quelques indications de l’ »Atarax » en pediatrie. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPS92C2407.pdf |
View full study record |
Document reference: 29302 |
Study title: Re-evaluation of hydroxyzine, droperidol,diazepam and pentazocine as premedicants in pediatric anesthesia. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE92D2136.pdf |
View full study record |
Document reference: 29368 |
Study title: Repigmentacion de vitiligo y otras leucodermias con antihistaminicos h1 (estudio prospectivo 1983-1988). |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPS91H0201.pdf |
View full study record |
Document reference: 29234 |
Study title: Routine preoperative medication in dentistry for children. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE92D1339.pdf |
View full study record |
Document reference: 29351 |
Study title: Effect of topically applied fluorides in dental caries experiences on children residing in fluoride areas1951-Downs |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1951-Downs-Effect of topically applied fluorides in dental caries experiences on children residing in fluoride areas.pdf |
View full study record |
Document reference: 49131 |
Study title: Enamel opacities in the incisors of school children in a community in the canton of ZurichSteiner 1984 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Steiner 1984 Enamel opacities in the incisors of school children.pdf |
View full study record |
Document reference: 49180 |
Study title: Evaluation of a practise based preventative programme for adolescentsBlinkhorn et. al. Community Dent. Oral Epidemiol. 1981: 9: 275-279 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1981-blinkhorn-Evaluation of a Practice Basedpreventive programme for adolescents.pdf |
View full study record |
Document reference: 48771 |
Study title: Fluoride - Ten year prospective study of deciduous and permanent dentitionFrederick J Margolis, Harold R Reames, Ernest Freshman, John C Macauley, Howard Mehaffey. Am J Dis Child - Vol 129. July 1975 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1975-margolis-Fluoride-tenyear prospective study of decidous and permanent dentition.pdf |
View full study record |
Document reference: 48768 |
Study title: Fluoride absorption after the local applicationEinwag 1987 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Einwag 1987 Fluoride absorption after the local application.pdf |
View full study record |
Document reference: 49162 |
Study title: Fluoride excretion in the urine of childrenFeuerle 1989 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Feuerle 1989 Fluoride excretion in the urine of children.pdf |
View full study record |
Document reference: 49164 |
Study title: Fluoride level in surface enamelHotz 1987 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Hotz 1987 Fluoride level in surface enamel.pdf |
View full study record |
Document reference: 49168 |
Study title: "cardiopathies congenitales et produits de contraste : essais d'un nouvel opacifiant; LERICHE H; Coeur; 1981 vol.2 n.3 p.261 264 " "cardiopathies congenitales et produits de contraste : essais d'un nouvel opacifiant; LERICHE H; Coeur; 1981 vol.2 n.3 p.261 264 " |
Active substance: IOXITALAMIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 30514 |
Study title: "Correlation between the adverse reactions to intravenous iodinated contrast media and IgE levels; GURSES C; Diagn. Interv. Radiol.; 2005 vol.11 p.74 76" "Correlation between the adverse reactions to intravenous iodinated contrast media and IgE levels; GURSES C; Diagn. Interv. Radiol.; 2005 vol.11 p.74 76" |
Active substance: IOXITALAMIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 30510 |
Study title: "etude comparative : ioxitalamate et ioxaglate en angiocardiographie : a propos de 50 enfants de moins de 5kg; HUGUET JF; in : contrast media in radiology ; numero special hexabrix ; AMIEL M MOREAU JF ; Springer Verlag berlin 1982 ; p.127 " "etude comparative : ioxitalamate et ioxaglate en angiocardiographie : a propos de 50 enfants de moins de 5kg; HUGUET JF; in : contrast media in radiology ; numero special hexabrix ; AMIEL M MOREAU JF ; Springer Verlag berlin 1982 ; p.127 " |
Active substance: IOXITALAMIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 30513 |
Study title: "focal nodular hyperplasia : natural course observed with ct and mri; LECONTE I; J. Comput. Assist. Tomogr.; 2000 vol.24 n.1 p.61 66" "focal nodular hyperplasia : natural course observed with ct and mri; LECONTE I; J. Comput. Assist. Tomogr.; 2000 vol.24 n.1 p.61 66" |
Active substance: IOXITALAMIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 30511 |
Study title: 0.5 % Th 1165a drops: report of a joint trial for therapeutic assessment in paediatric in-patients with bronchospasm. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30581 |
Study title: A dose response study of Ipatropium bromide and Fenoterol nebuliser solution in asthmatic children |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30685 |
Study title: A double-blind, vehicle-controlled pharmacokinetic study of Atrovent nasal spray 0.06 % in children with naturally acquired common colds. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30557 |
Study title: An overview of the treatment of Childhood SLE - E.D. Silverman and B. Lang- 1997 - Publication in CES 0533 - H. Dennequin - 28 Sept 2006 - |
Active substance: HYDROXYCHLOROQUINE |
Study summary document link (including results): |
View full study record |
Document reference: 29202 |
Study title: An overview of the treatment of Childhood SLE - E.D. Silverman and B. Lang- 1997 Publication in CES 0635 - H. Dennequin - 14 May 2007 - |
Active substance: HYDROXYCHLOROQUINE |
Study summary document link (including results): |
View full study record |
Document reference: 29205 |
Study title: A single dose study to compare the efficacy of acetaminophen elixir dosed at 10-15 mg/kg and ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg in febrile children. CSR 155. Protocol 89-945, Unpublished Report 281. |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 89-945.pdf |
View full study record |
Document reference: 47403 |
Study title: A single dose study to compare the efficacy of acetaminophen elixir dosed at 12.5 mg/kg and 25 mg/kg and ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg in febrile children. CSR 149. Protocol 89-932, Unpublished Report 275. |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 89-932.pdf |
View full study record |
Document reference: 47402 |
Study title: A single dose study to compare the efficacy of acetaminophen sustained release pediatric chewable tablets to ibuprofen suspension in febrile children. |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 91-140.pdf |
View full study record |
Document reference: 47408 |
Study title: A single dose, randomized, investigator-blinded trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile children. |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 94-437.pdf |
View full study record |
Document reference: 47409 |
Study title: A Single-Dose, Randomized, Double-Blind Trial to Compare the Efficacy and Safety of Ibuprofen Suspension 7.5 mg/kg with Acetaminophen Suspension 12.5 mg/kg for the Treatment of Febrile Children |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 96-608.pdf |
View full study record |
Document reference: 47411 |
Study title: A single-dose, randomized, investigator-blinded trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile patients |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 95-516.pdf |
View full study record |
Document reference: 47410 |
Study title: An Assessment of the Safety of Pediatric Ibuprofen (The Boston University Fever Study). |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 90-056 231.pdf |
View full study record |
Document reference: 47406 |
Study title: Carabaño−Aguado−I et al. Antipyretic effectiveness of ibuprofen and paracetamol. {An−Pediatr−Barc}, Feb 2005, vol. 62, no. 2, p. 117−22Carabaño−Aguado−I et al. Antipyretic effectiveness of ibuprofen and paracetamol. {An−Pediatr−Barc}, Feb 2005, vol. 62, no. 2, p. 117−22 |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 29706 |
Study title: double-blind single dose evaluation of the efficacy and safety of ibuprofen 400 mg, ibuprofen 200 mg, APAP 1000 mg, and placebo in the treatment of pain following removal of impacted third molars. Stat Rpt 60. Protocol 3-259, Unpublished Report 177. |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 3-259.pdf |
View full study record |
Document reference: 47388 |
Study title: No author. Ibuprofen versus paracetamol in febrile asthmatic children. {MED−TODAY}, 2002, Vol/Iss/Pg. 3/4 (10)No author. Ibuprofen versus paracetamol in febrile asthmatic children. {MED−TODAY}, 2002, Vol/Iss/Pg. 3/4 (10) |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 29574 |
Study title: Phase IV Randomized, Double-Blind, Multicenter Trial to Compare the Safety and Efficacy of Acetaminophen Suspension and Ibuprofen Suspension in the Treatment of Febrile Children. |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 96-619.pdf |
View full study record |
Document reference: 47412 |
Study title: The Safety of Antipyretic Medication Use Among Children Less Than Two Years of Age: A Subgroup Analysis of the Boston University Fever Study Data. Protocol 90-056, Unpublished Report CSR231S1. |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 90-056 231S1.pdf |
View full study record |
Document reference: 47407 |
Study title: Conscious sedation of pediatric dental patients using chloral hydrate, hydroxyzine, and nitrous oxide: a retrospective study of 382 sedations. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE96C0601.pdf |
View full study record |
Document reference: 29310 |
Study title: Conscious sedation of pediatric dental patients: an investigation of chloral hydrate, hydroxyzine pamoate, and meperidine vs. chloral hydrate and hydroxyzine pamoate. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE92F0401.pdf |
View full study record |
Document reference: 29270 |
Study title: De l’emploi de l’atarax dans la dyspepsie transitoire du nourrisson |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29264 |
Study title: Degree of sedation. Incidence of vomiting and time of postoperative sleep with 3 different oral administration schedules of hydroxyzine chlorhydrate and chloral hydrate |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPS91G3005.pdf |
View full study record |
Document reference: 29247 |
Study title: Effect of hydroxyzine as a bronchodilator in asthmatic children |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE91B1207.pdf |
View full study record |
Document reference: 29260 |
Study title: Effect of premedication with hydroxyzine on the behavior of child patients |
Active substance: HYDROXYZINE |
Study summary document link (including results): DS87A301P.pdf |
View full study record |
Document reference: 29224 |
Study title: Effect of tranquillizers on the end-results of operations for muscle elongation by the method of Madroszkiewicz. |
Active substance: HYDROXYZINE |
Study summary document link (including results): DPL78F181P.pdf |
View full study record |
Document reference: 29296 |
Study title: Effectiveness of midazolam/hydroxyzine compared to chloral hydrate/hydroxyzine in sedating pedodontic patients |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE02H2305.pdf |
View full study record |
Document reference: 29276 |
Study title: A Single Dose, Randomized, Open-Label, Single Center, Three-Way Crossover Pharmacokinetic Study of Children’s Advil® Cold & Sinus Suspension in 6 To <12 Year Old Children |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29660 |
Study title: A Single Dose, Randomized, Open-Label, Single Center, Two-Way Crossover Pharmacokinetic Study of Advil® Cold & Sinus Tablets in Children |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29659 |
Study title: A single-dose, double-blind, placebo-controlled, randomized, 4 x 4 factorial study comparing combinations of ibuprofen in doses of 100 mg, 200 mg, and 400 mg and dextromethorphan hydrobromide in doses of 10 mg, 20 mg, and 40 mg with the components alone and placebo in postoperative dental painA single-dose, double-blind, placebo-controlled, randomized, 4 x 4 factorial study comparing combinations of ibuprofen in doses of 100 mg, 200 mg, and 400 mg and dextromethorphan hydrobromide in doses of 10 mg, 20 mg, and 40 mg with the components alone and placebo in postoperative dental pain |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29695 |
Study title: A single-dose, randomized, double-blind trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile children. Dec 2000.A single-dose, randomized, double-blind trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile children. Dec 2000. |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29696 |
Study title: A single-dose, randomized, investigator-blinded trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile patients. Aug 1997.A single-dose, randomized, investigator-blinded trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile patients. Aug 1997. |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29697 |
Study title: A study comparing the efficacy and safety of ibuprofen sustained release to ibuprofen regular release in the treatment of pain secondary to post-operative foot surgeryA study comparing the efficacy and safety of ibuprofen sustained release to ibuprofen regular release in the treatment of pain secondary to post-operative foot surgery |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29699 |
Study title: Sedation of children undergoing CT and MR imaging: the association of oral hydroxyzine and rectal chloral hydrate. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPF97B1206.pdf |
View full study record |
Document reference: 29243 |
Study title: Sensory response of schizophrenic children under atarax: a new method of measurement |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE92B0513.pdf |
View full study record |
Document reference: 29258 |
Study title: Serial neurologic examination of hyperactive children. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29301 |
Study title: Sur le traitement a l’hydroxyzine des etats nerveux de l’enfance |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29229 |
Study title: Symptomatic and physiologic effects of sedatives in anti- asthmatic preparations in children. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29308 |
Study title: The antipruritic effect of placebo versus hydroxyzine versus astemizole in children with severe atopic dermatitis. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29322 |
Study title: The effect of metoclopramide and hydroxyzine in sedation of infants undergoing dental treatment. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE99H1813.pdf |
View full study record |
Document reference: 29320 |
Study title: The effect of sleep on conscious sedation: a follow-up study. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE98J3001.pdf |
View full study record |
Document reference: 29328 |
Study title: The effect of sleep on conscious sedation. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE95C1702.pdf |
View full study record |
Document reference: 29327 |
Study title: The effect of tranquilizers on the immediate skin wheal reaction. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29367 |
Study title: The effectiveness of midazolam and hydroxyzine as sedative agents for young pediatric dental patients. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE97G1128.pdf |
View full study record |
Document reference: 29338 |
Study title: The effects of nitrous oxide on behavior and physiological parameters during conscious sedation with a moderate dose of chloral hydrate and hydroxyzine. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE96L1315.pdf |
View full study record |
Document reference: 29300 |
Study title: The efficacy of midazolam-famotidine suppository for premedication in children |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPZ96D2915.pdf |
View full study record |
Document reference: 29274 |
Study title: The evaluation of child behavior during dental examination and treatment using premedication and placebo. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE94G2807.pdf |
View full study record |
Document reference: 29352 |
Study title: Überprüfung der Wirksamkeit und Verträglichkeit von Ichthocortin® Gel und Elidel® 1% Creme bei Kindern mit leichter bis mittelschwerer atopischer Dermatitis |
Active substance: ICHTASOL |
Study summary document link (including results): |
View full study record |
Document reference: 29758 |
Study title: EFFICACY AND SAFETY COMPARISON OF IDARUBICIN LOCAL PRODUCT AND IMPORT PRODUCT IN PATIENTS WITH AML AND ALL: A PROSPECTIVE, CONTROLLED, RANDOMIZED, OPEN-LABLE AND MULTI-CENTER STUDY |
Active substance: IDARUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 29768 |
Study title: THERAPY OF 'DE NOVO' ACUTE MYELOBLASTIC LEUKEMIA IN PEDIATRIC PATIENTS WITH AN I.V. IDARUBICIN COMBINATION |
Active substance: IDARUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 29769 |
Study title: Stevens MC et al Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89 J Clin Oncol. 2005 Apr 20;23(12):2618-28. Epub 2005 Feb 22Stevens MC et al Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89 J Clin Oncol. 2005 Apr 20;23(12):2618-28. Epub 2005 Feb 22 |
Active substance: IFOSFAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 29770 |
Study title: A double-blind, vehicle-controlled pharmacokinetic study of Atrovent nasal spray 0.06 % in children with naturally acquired common colds. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U97-3023_synopsis.pdf |
View full study record |
Document reference: 30714 |
Study title: A four-way, single-dose crossover, dose-ranging study of inhaled Atrovent and placebo in children with chronic asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U93-0304_synopsis.pdf |
View full study record |
Document reference: 30709 |
Study title: A multiple dose comparison of ipratropium bromide HFA-MDI and Atrovent MDI in a 12-week, double-blind, parallel group study in paediatric patients with bronchial asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U98-0129_synopsis.pdf |
View full study record |
Document reference: 30717 |
Study title: A Phase IV Safety Trial in Pediatric Patients (Ages 2-5) with Rhinorrhea Associated with a Common Cold or Allergy |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30559 |
Study title: A Phase IV Safety Trial in Pediatric Patients (Ages 2-5) with Rhinorrhea Associated with a Common Cold or Allergy |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U03-3585_synopsis.pdf |
View full study record |
Document reference: 30662 |
Study title: A retrospective study of Atrovent nebuliser solution in wheezy infants. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30650 |
Study title: A retrospective study of Atrovent nebuliser solution in wheezy infants. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U91-0623_synopsis.pdf |
View full study record |
Document reference: 30703 |
Study title: A safety comparison of fenoterol hydrobromide HFA-MDI and Berotec MDI in a 12 week, double-blind, parallel group study in paediatric patients with bronchial asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30544 |
Study title: A safety comparison of fenoterol hydrobromide HFA-MDI and Berotec MDI in a 12 week, double-blind, parallel group study in paediatric patients with bronchial asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30561 |
Study title: A single-blind, placebo-controlled safety evaluation of Atrovent nasal spray 0.06 %, administered alone or in combination with over-the-counter cold therapies, in children with naturally acquired common colds. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30558 |
Study title: A single-blind, placebo-controlled safety evaluation of Atrovent nasal spray 0.06 %, administered alone or in combination with over-the-counter cold therapies, in children with naturally acquired common colds. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U97-3216_synopsis.pdf |
View full study record |
Document reference: 30715 |
Study title: Randomized, double-blind, parallel comparison of Atrovent Nasal Spray 0.03 % (42 mcg/nostril) versus placebo administered twice a day in pediatric patients with allergic or nonallergic perennial rhinitis with an optional six-month treatment comparison ... |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30556 |
Study title: Randomized, double-blind, parallel comparison of Atrovent nasal spray 0.03% (42 mcg/nostril) versus placebo administered twice a day in pediatric patients with allergic or nonallergic perennial rhinitis with an optional 6 month treatment comparison of ... |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30636 |
Study title: Randomized, double-blind, parallel comparison of Atrovent nasal spray 0.03% (42 mcg/nostril) versus placebo administered twice a day in pediatric patients with allergic or nonallergic perennial rhinitis with an optional 6 month treatment comparison of ... |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U95-3002_synopsis.pdf |
View full study record |
Document reference: 30711 |
Study title: Report on an open therapeutical study of Berocillin suspension (pivampicillin-base) in pediatrics. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30589 |
Study title: Report on the use of Berotec in children. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30584 |
Study title: Report to Boehringer-Ingelheim, Australia on clinical trial to determine the optimum dose of nebulised ipratropium bromide (Atrovent) solution (0.020 %) in children with chronic asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30573 |
Study title: Results of a study concerning children with an asthmatic syndrome treated with a parasymphathicolytic agent, the Sch 1000. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30575 |
Study title: Wahba−H. The Antipyretic Effect of Ibuprofen and Acetaminophen in Children. {PHARMACOTHERAPY}, 2004, Vol/Iss/Pg. 24/2 I (280−284) Wahba−H. The Antipyretic Effect of Ibuprofen and Acetaminophen in Children. {PHARMACOTHERAPY}, 2004, Vol/Iss/Pg. 24/2 I (280−284) |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 29571 |
Study title: |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41118 |
Study title: |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41120 |
Study title: |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 47325 |
Study title: A comparative study of the safety and immunogenicity of two dosing schedules of an inactivated Hepatitis A vaccine in healthy infants. |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41121 |
Study title: A comparative, double-blind, randomized study to compare the immunogenicity and reactogenicity of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine containing 360 EL.U injected according to a 0, 1 and 6 month schedule in healthy children. |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 47329 |
Study title: A comparative, double-blind, randomized study to compare the immunogenicity and reactogenicity of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine containing 360 EL.U injected according to a 0, 1 and 6 month schedule in healthy children. |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 47330 |
Study title: A comparative, double-blind, randomized study to compare the immunogenicity and reactogenicity of SmithKline Beecham Biologicals’ inactivated hepatitis A vaccine containing 360EL.U injected according to 0, 1 and 6 month schedule in healthy children. |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 47328 |
Study title: A comparative, double-blind, randomizes study of two different lots of SmithKline Beecham Biologicals’ inactivated hepatitis A vaccine (360 EL.U) administered to healthy children according to a primary vaccination course at 0, 1 months and a booster at month 6. |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41119 |
Study title: A comparative, double-blind, randomizes study of two different lots of SmithKline Beecham Biologicals’ inactivated hepatitis A vaccine (360 EL.U) administered to healthy children according to a primary vaccination course at 0, 1 months and a booster at month 6. |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 47327 |
Study title: A dose-ranging study to evaluate the safety, tolerability, and immunogenicity of formalin inactivate, alum adjuvanted Hepatitis A vaccine administered as a single dose plus a booster to healthy young infants |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41461 |
Study title: A dose-ranging study to evaluate the safety, tolerability, and immunogenicity of formalin inactivate, alum adjuvanted Hepatitis A vaccine administered as a single dose plus a booster to healthy young infants |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41467 |
Study title: A double-blind randomized, placebo-controlled study of the protective efficacy of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine in healthy children. |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41116 |
Study title: A double-blind randomized, placebo-controlled study of the protective efficacy of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine in healthy children. |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 47333 |
Study title: A double-blind randomized, placebo-controlled study of the protective efficacy of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine in healthy children. |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 47334 |
Study title: A double-blind, randomised, controlled protective efficacy study of a primary course of an inactivated hepatitis A vaccine in healthy children. |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 47331 |
Study title: A double-blind, randomized, controlled protective efficacy study of a primary course of an inactivated hepatitis A vaccine in healthy children. |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 47332 |
Study title: Acetaminophen and ibuprofen : Fever and control - Kathleen A. Murphy - No date (Updates &Kidbits) - Publication in Rhinathiol tablets (ibuprofen/ pseudoephredin) Pharmaco-toxicological & clinical documentation- Poulain Dominique - 04/2001 - |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29639 |
Study title: An assessment of the safety of pediatric ibuprofen : A practioner - based randomized Clinical trial - Samuel M. Lesko et al. - 22/03/1995 ( JAMA vol 273 n°12) |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29641 |
Study title: An Assessment of the Safety of Pediatric Ibuprofen ("Boston University Fever Study"). Dec 1993.An Assessment of the Safety of Pediatric Ibuprofen ("Boston University Fever Study"). Dec 1993. |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29701 |
Study title: An Open-Label Study of the Safety of an Ibuprofen-Pseudoephedrine HCl Suspension in Children |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): ibuprofen_pseudoephedrine 99-086.pdf |
View full study record |
Document reference: 29649 |
Study title: Children’s Advil ® Cold & Sinus Suspension Multiple-Dose Safety Study in Children 2 to <12 Years Old |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): Ibuprofen and Pseudoephedrine Clinical Trial Summaries.pdf |
View full study record |
Document reference: 29661 |
Study title: A functional magnetic resonance imaging study of the long-term influences of early indomethacin exposure on language processing in the brains of prematurely born children. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29804 |
Study title: A preliminary report--heparin counteracts indomethacin effect on ductus arteriosus in very low birthweight infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29805 |
Study title: A study of indomethacin combined with ritodrine in threatened preterm labor. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29806 |
Study title: A three-month trial of indomethacin in rheumatoid arthritis, with special reference to analysis and inference. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29807 |
Study title: Action of the anti-inflammatory agent Lonazolac on experimentally-induced acute inflammation of human skina |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29808 |
Study title: Acute effects of indomethacin on cerebral hemodynamics and oxygenation |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29809 |
Study title: Administration of indomethacin for the prevention of periventricular-intraventricular hemorrhage in high-risk neonates. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29810 |
Study title: Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29811 |
Study title: Aguiar T. Acta Med Port Jul-Aug 2000;13(4):193-8 Panencephalite esclerosante subagudaAguiar T. Acta Med Port Jul-Aug 2000;13(4):193-8 Panencephalite esclerosante subaguda |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30065 |
Study title: Alternatives in drug treatment of chronic paroxysmal hemicrania. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29812 |
Study title: Open Label clinical study of prophylaxis with Factor IX Concentrate (Human) vapor Heated, IMMUNO, in patients with hemophilia B |
Active substance: HUMAN COAGULATION FACTOR IX |
Study summary document link (including results): |
View full study record |
Document reference: 29126 |
Study title: Pharmacokinetic + safety profile study of Nanotiv |
Active substance: HUMAN COAGULATION FACTOR IX |
Study summary document link (including results): |
View full study record |
Document reference: 29131 |
Study title: A comparative dose range evaluation of the antipyretic efficacy and safety of ibuprofen liquid at three different doses in children. Jan 1988. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29617 |
Study title: A comparative pharmacodynamic evaluation of the antipyretic efficacy and safety of ibuprofen liquid vs acetaminophen in children. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29460 |
Study title: A comparative study evaluating the analgesic effect of using MagnaBloc therapy, a single dose of ibuprofen 400 mg, or placebo in post-operative dental pain |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29495 |
Study title: A comparative study evaluating the analgesic effect of using MagnaBloc therapy, a single dose of ibuprofen 400 mg, or placebo in post-operative dental pain. CSR 227. Protocol 96-614, Unpublished Report 670. |
Active substance: IBUPROFEN |
Study summary document link (including results): ibuprofen 96-614.pdf |
View full study record |
Document reference: 47457 |
Study title: A comparative study evaluating the analgesic efficacy of a single dose of acetaminophen 1000 mg, acetaminophen 1000 mg/dextromethorphan hydrobromide 30 mg, ibuprofen 400 mg, dextromethorphan hydrobromide 30 mg, or placebo in post-operative dental pain |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29483 |
Study title: A comparative study of Ibuprofen and Paracetamol in pyrexia in children by Dr Y K Amdekar, Institute of Child Health, Bombay India |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29430 |
Study title: A comparative study of ibuprofen and paracetamol in pyrexia in children. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29470 |
Study title: A comparative study of the pharmacokinetic/pharmacodynamic and safety profiles of ibuprofen extended release, ibuprofen regular release and placebo during a 12-hour observation in post-extraction dental pain |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29493 |
Study title: A comparative study of the pharmacokinetic/pharmacodynamic and safety profiles of ibuprofen extended release, ibuprofen regular release and placebo during a 12 hour observation in post-extraction dental pain. |
Active substance: IBUPROFEN |
Study summary document link (including results): ibuprofen 93-343.pdf |
View full study record |
Document reference: 47454 |
Study title: A comparative study of two dosage levels of Ibuprofen syrup in children with pyrexia A Kotob, Egypt |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29445 |
Study title: A Comparative Study of Two Dosage Levels of Ibuprofen Syrup in Chidren with PyrexiaKotob−A. A comparative study of two dosage levels of ibuprofen syrup in children with pyrexia. {J−Int−Med−Res}, 1985, vol. 13, no. 2, p. 122−6 |
Active substance: IBUPROFEN |
Study summary document link (including results): ibuprofen-kotob.xls |
View full study record |
Document reference: 29600 |
Study title: a comparative two dosage level study of ibuprofen syrup in children with pyrexia. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29466 |
Study title: A comparison of the efficacy and safety of ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg and acetaminophen elixir dosed at 12.5 mg/kg to placebo in children with ear pain. Dec 1992. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29547 |
Study title: A controlled double blind study to evaluate the analgesic efficacy of Ibuprofen following tonsillectomy in children from 5 to 13 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29413 |
Study title: A dose range study of the antipyretic efficacy and safety of ibuprofen pediatric suspension in febrile children. Mar 1991. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29475 |
Study title: Results of a study concerning children with an asthmatic syndrome treated with a parasymphathicolytic agent, the Sch 1000. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30665 |
Study title: Statistical evaluation of a controlled double-blind cross-over study in children with exercise included asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30605 |
Study title: Statistical report - A dose response and duration of action study of Duovent nebuliser solution in paediatrics. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30683 |
Study title: Statistical report fenoterol by inhalation in asthmatic children: a dose-response study. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30612 |
Study title: Statistical report: Atrovent by inhalation in asthmatic children, a dose response study. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30649 |
Study title: Statistical report: Atrovent by inhalation in asthmatic children, a dose response study. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U86-0925_synopsis.pdf |
View full study record |
Document reference: 30687 |
Study title: Statistical report: Fenoterol By Inhalation in Asthmatic Children - A Dose-Response Study (Low Dose). |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30646 |
Study title: Statistical report: Fenoterol by inhalation in asthmatic children: A dose-response study (Low dose). |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30614 |
Study title: Study of bronchospasmolytic action of ipratropium bromide in asthmatic children in intercritic period: dose action curve. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30631 |
Study title: Study of bronchospasmolytic action of ipratropium bromide in asthmatic children in intercritic period: dose action curve. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U87-0945_synopsis.pdf |
View full study record |
Document reference: 30692 |
Study title: Study of the action of Berodual as a chronic treatment on the non-specific bronchial hyper-reactivity in children. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30693 |
Study title: Study of the efficacy and tolerance of ipratropium bromide solution adminstered by nebulisation in children during an asthma attack and with a theophylline infusion. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30550 |
Study title: Study of the efficacy and tolerance of ipratropium bromide solution adminstered by nebulisation in children during an asthma attack and with a theophylline infusion. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U90-0055_synopsis.pdf |
View full study record |
Document reference: 30700 |
Study title: A multi-centre assessment of acne vulgaris treated with topical isotretinoin. |
Active substance: ISOTRETINOIN |
Study summary document link (including results): Article 45_Ref_C0626_Final For Submission_27 Oct 2011.xls |
View full study record |
Document reference: 48306 |
Study title: An Open Clinical and Photographic Evaluation of the Safety and Efficacy of Isotrex gel (0.05% isotretinoin) in the Treatment of Acne Vulgaris. |
Active substance: ISOTRETINOIN |
Study summary document link (including results): Article 45_Ref_C0625_Final For Submission_27 Oct 2011.xls |
View full study record |
Document reference: 48305 |
Study title: Bernstein A B, Benefit Risk Summary for Accutane for Pediatric Patients |
Active substance: ISOTRETINOIN |
Study summary document link (including results): |
View full study record |
Document reference: 30766 |
Study title: Frederick A*,Eberhardt D,Mcgarry C,Mclane J, Final Study Report: Efficacy and Safety of Accutane in Pediatric Patients versus Adult Patients-A Subgroup Analysis (Study NR15645) of Patients with Severe Recalcitrant Nodular Acne Treated with Accutane [Ident No: NR15645] |
Active substance: ISOTRETINOIN |
Study summary document link (including results): |
View full study record |
Document reference: 30771 |
Study title: A Phase IIIb, open, randomized, controlled, multicenter study of the immunogenicity and safety of GSK Biologicals' inactivated hepatitis A vaccine (Havrix¿) [720 El.U/ 0.5 mL dose] administered on a 0, 6-month schedule concomitantly with Wyeth Lederle's pneumococcal. |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41126 |
Study title: Piroxicam in acute musculoskeletal disorders and sports injuries. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29983 |
Study title: Piroxicam in acute musculoskeletal disorders and sports injuries. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29984 |
Study title: Plasma and cerebrospinal fluid concentrations of indomethacin in children after intravenous administration. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29985 |
Study title: Population pharmacokinetics of intravenous indomethacin in neonates with symptomatic patent ductus arteriosus. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29986 |
Study title: Pre-pubertal growth in the hyperprostaglandin E syndrome. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29989 |
Study title: Prednisone administration in recent onset type I diabetes. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29987 |
Study title: Prenatal administration of indomethacin as a tocolytic agent: effect on neonatal renal function. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29988 |
Study title: Presumed photic retinopathy after cataract surgery: an angiographic study. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29990 |
Study title: Prevention of brain hemorrhage in infants with low and extremely low birth weight and infants treated with surfactants. Late observation |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29991 |
Study title: Prevention of intraventricular hemorrhage by indomethacin in male preterm infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29992 |
Study title: Prevention of symptomatic patent ductus arteriosus with a single dose of indomethacin. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29993 |
Study title: Preventive management of hypoglycemia in very low-birthweight infants following indomethacin therapy for patent ductus arteriosus. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29994 |
Study title: Primary dysmenorrhea treated with indomethacin. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29995 |
Study title: Prolonged indomethacin therapy for the prevention of recurrences of patent ductus arteriosus. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29996 |
Study title: Prolonged low dose indomethacin for persistent ductus arteriosus of prematurity. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29997 |
Study title: Prolonged low-dose indomethacin therapy for patent ductus arteriosus in very low birthweight infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29998 |
Study title: Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29999 |
Study title: Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30000 |
Study title: Prophylactic indomethacin in the very low birth weight infant |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30001 |
Study title: An evidence-based approach to predicting low IQ in very preterm infants from the neurological examination: outcome data from the indomethacin Indomethacin Intraventricular Hemorrhage Prevention Trial. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29814 |
Study title: An open trial of indomethacin therapy in exacerbated phases of lepromatous leprosy. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29815 |
Study title: Analgesic action of clometacin in ophthalmologya |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29816 |
Study title: Analgesic and antiinflammatory effects of glucamethacin (a nonsteroidal antiinflammatory analgesic) after the removal of impacted third molars. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29817 |
Study title: Antecedents of cerebral palsy in a multicenter trial of indomethacin for intraventricular hemorrhage. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29818 |
Study title: Antenatal exposure to steroids and the additional prophylaxis effect of indomethacin to prevent intraventricular hemorrhage. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29819 |
Study title: Antenatal steroids, delivery mode, and intraventricular hemorrhage in preterm infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29820 |
Study title: Anti-inflammatory treatment of lumbago? |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29821 |
Study title: Burlo C, RotondoAggiornamento Pediatrico ; 1981. Methisoprinol in infantile viral infectionsBurlo C, RotondoAggiornamento Pediatrico ; 1981. Methisoprinol in infantile viral infections |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30079 |
Study title: Caksen H, Odabas D, Atas B. Pediatr Neurol Jul 2002;27(1):75 [Abstract]. Seizures in a boy with subacute sclerosing panencephalitis during high-dose intrathecal interferon-alpha therapyCaksen H, Odabas D, Atas B. Pediatr Neurol Jul 2002;27(1):75 [Abstract]. Seizures in a boy with subacute sclerosing panencephalitis during high-dose intrathecal interferon-alpha therapy |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30080 |
Study title: Calonghi GF, Sueri L, Cadeo GP, Del Massa M. Presented at del Convegno Internazionale sulla Isoprinosina®; April 28, 1979; Rome, Italy; 75-77. Treatment of acute viral hepatitis with Isoprinosine: double-blind clinical studyCalonghi GF, Sueri L, Cadeo GP, Del Massa M. Presented at del Convegno Internazionale sulla Isoprinosina®; April 28, 1979; Rome, Italy; 75-77. Treatment of acute viral hepatitis with Isoprinosine: double-blind clinical study |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30081 |
Study title: Campbell C, Levin S, Humphreys P, Walop W, Brannan R. BMC Pediatr. 2005 Dec 15;5:47. Review. Subacute sclerosing panencephalitis: results of the Canadian Paediatric Surveillance Program and review of the literature.Campbell C, Levin S, Humphreys P, Walop W, Brannan R. BMC Pediatr. 2005 Dec 15;5:47. Review. Subacute sclerosing panencephalitis: results of the Canadian Paediatric Surveillance Program and review of the literature. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30082 |
Study title: Catania S, Ginanni-Corradini S, Monacelli M, et al Eur Rev Med Pharmacol Sci. 1982; 4:353-356. Methisoprinol in the therapy of herpes zosterCatania S, Ginanni-Corradini S, Monacelli M, et al Eur Rev Med Pharmacol Sci. 1982; 4:353-356. Methisoprinol in the therapy of herpes zoster |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30083 |
Study title: Catania S, Vittucci P, Monaceli M, et al.. Presented at the 7th International Congress of Infectious and Parasitic Diseases; June 7-11, 1982; Stockholm, Sweden; 203. Abstract 13:8. Antiviral treatment of chicken-pox and varicella-zoster in normal and compromised patientsCatania S, Vittucci P, Monaceli M, et al.. Presented at the 7th International Congress of Infectious and Parasitic Diseases; June 7-11, 1982; Stockholm, Sweden; 203. Abstract 13:8. Antiviral treatment of chicken-pox and varicella-zoster in normal and compromised patients |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30084 |
Study title: Antman KH et al Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma J Clin Oncol. 1989 Jan;7(1):126-31. Erratum in: J Clin Oncol 1989 Sep;7(9):1369Antman KH et al Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma J Clin Oncol. 1989 Jan;7(1):126-31. Erratum in: J Clin Oncol 1989 Sep;7(9):1369 |
Active substance: IFOSFAMIDE AND MESNA |
Study summary document link (including results): |
View full study record |
Document reference: 29776 |
Study title: Wiltshaw E et al Ifosfamide plus mesna with and without adriamycin in soft tissue sarcoma Cancer Chemother Pharmacol. 1986;18 Suppl 2:S10-2Wiltshaw E et al Ifosfamide plus mesna with and without adriamycin in soft tissue sarcoma Cancer Chemother Pharmacol. 1986;18 Suppl 2:S10-2 |
Active substance: IFOSFAMIDE AND MESNA |
Study summary document link (including results): |
View full study record |
Document reference: 29777 |
Study title: A Study of the Efficacy, Pharmaco-kinetics, Safety and Tolerability of Intravenously Administered Multiple doses of MK-787/MK-791 in Neonates, including Premature Infants. |
Active substance: IMIPENEM |
Study summary document link (including results): |
View full study record |
Document reference: 29774 |
Study title: Humanitarian Use of Imipenem/Cilastatin Sodium in Neonates. |
Active substance: IMIPENEM AND CILASTATIN |
Study summary document link (including results): |
View full study record |
Document reference: 29775 |
Study title: A multicentre, open, prospective study investigating clinical efficacy, safety, and pharmacokinetic properties of the human normal immunoglobulin for intravenous administration BT681 with intraindividual comparisons to previous standard treatment in patients with primary immunodeficiency disease (PID). |
Active substance: IMMUNOGLOBULINS |
Study summary document link (including results): |
View full study record |
Document reference: 29782 |
Study title: A single-centre, non-blinded, randomised, parallel comparison of the efficacy and safety of intravenous versus rapid subcutaneous infusion of immunoglobulin in paediatric patients with Primary Immunodeficiency Disease |
Active substance: IMMUNOGLOBULINS |
Study summary document link (including results): 02 IG704 (synopsis).pdf |
View full study record |
Document reference: 29781 |
Study title: Clinical study to demonstrate the efficacy of Octagam for replacement therapy in primary immunodeficiency syndromes (PID) |
Active substance: IMMUNOGLOBULINS |
Study summary document link (including results): |
View full study record |
Document reference: 29778 |
Study title: Clinical study to evaluate the safety, efficacy and pharmacokinetics of Octagam for replacement therapy in primary immunodeficiency diseases (PID) |
Active substance: IMMUNOGLOBULINS |
Study summary document link (including results): |
View full study record |
Document reference: 29779 |
Study title: Intravenous immunoglobuline in the treatment of Rhesus disease of the neonate. A randomized double blind placebo controlled trial |
Active substance: IMMUNOGLOBULINS |
Study summary document link (including results): |
View full study record |
Document reference: 29780 |
Study title: A Phase 4 study to evaluate the safety and Immunogenicity of Imovax Polio in Korean Healthy Infants after primary immunization at 2, 4, and 6 months of age |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41199 |
Study title: Antibody persistence in five-year old children who received a pentavalent combination vaccine in infancy |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41206 |
Study title: Assessment of tolerance and immunogenicity of a ViCPs vaccine at 2 dosages |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41208 |
Study title: Effect of indomethacin on cerebral blood flow velocities in very low birth weight neonates with a patent ductus arteriosus. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29882 |
Study title: Effect of indomethacin phonophoresis on the relief of temporomandibular joint pain. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29883 |
Study title: Effect of inhaled indomethacin on exercise-induced bronchoconstriction in children with asthma. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29884 |
Study title: Effect of intravenous diclofenac or indomethacin on the emergence from anaesthesia for tonsillectomy. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29885 |
Study title: McLane J A*, Liss C, Leach E, Eberhardt D R, Bryce G F, Khoo K-C, Final Study Report / Open label extension of Protocol NR15645 to evaluate the efficacy and safety of a second course of Accutane for severe recalcitrant nodular acne in pediatric patients experiencing recurrence between 36 and 72 weeks of previous isotretinoin treatment |
Active substance: ISOTRETINOIN |
Study summary document link (including results): |
View full study record |
Document reference: 30762 |
Study title: McLane J A*, Mues B, Bryce G F, Khoo K-C, Evaluation of available post-marketing safety reports and published literature regarding epiphyseal closure in Accutane-treated pediatric patients with severe recalcitrant nodular acne |
Active substance: ISOTRETINOIN |
Study summary document link (including results): |
View full study record |
Document reference: 30764 |
Study title: Ondovik M S*, Eberhardt D R, Liss C, Khoo K-C, Clinical Study Report (Protocol NR 15806): Evaluation of the pharmacokinetics and safety of Accutane in pediatric and adult patients with severe recalcitrant nodular acne |
Active substance: ISOTRETINOIN |
Study summary document link (including results): |
View full study record |
Document reference: 30763 |
Study title: Ondovik M S*, Jackson K, Pentikis H S, Khoo K-C, Evaluation of the Pharmacokinetics of Isotretinoin in Pediatric and Adult Patients |
Active substance: ISOTRETINOIN |
Study summary document link (including results): |
View full study record |
Document reference: 30767 |
Study title: Shah L P*, Wu E, Eberhardt D R, Ondovik M, Bryce G F, Khoo K-C, An open-label study to evaluate the effect of a single course of Accutane therapy on bone mineral density in pediatric patients with severe recalcitrant nodular acne |
Active substance: ISOTRETINOIN |
Study summary document link (including results): |
View full study record |
Document reference: 30765 |
Study title: Shiomos C, Bebeau P, Smith R A, Drug Safety Report Roaccutane - Pediatric Report |
Active substance: ISOTRETINOIN |
Study summary document link (including results): |
View full study record |
Document reference: 30768 |
Study title: Shiomos C, Bebeau P, Smith R A, Drug Safety Report Roaccutane (isotretinoin) - Adverse Events reported for Roaccutane during the time period 1-June-2004 to 30-June 2005 in children and adolescents under 18 years old. |
Active substance: ISOTRETINOIN |
Study summary document link (including results): |
View full study record |
Document reference: 30769 |
Study title: Treatment of acne vulgaris with topical isotretinoin |
Active substance: ISOTRETINOIN |
Study summary document link (including results): |
View full study record |
Document reference: 30760 |
Study title: Nolan T et al. Randozimed trial of laxatives in treatment of childhood encopresis. The Lancet 338, 1991, 8766: 523-527. |
Active substance: Ispaghula mucilage;Ispaghula seed;Cassia angustifolia (fruit) |
Study summary document link (including results): |
View full study record |
Document reference: 40041 |
Study title: Sölter et al. Summary of clinical results with Prodiem Plain, a bowel-regulation agent. Today's Therapeutic Trends (1983); 1(1): 45-59. |
Active substance: Ispaghula mucilage;Ispaghula seed;Cassia angustifolia (fruit) |
Study summary document link (including results): |
View full study record |
Document reference: 40040 |
Study title: PROPHYLAXIS OF FUNGAL INFECTION WITH DIFLUCAN IN PATIENTS WITH COLLAGEN DISEASE ON THE LONG TERM, AND LARGE-DOSAGE STEROID THERAPY. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27865 |
Study title: Prophylaxis, costs and effectiveness of gram positive therapy in neatropenic children |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27454 |
Study title: Prophylaxis, costs and effectiveness of gram positive therapy in neatropenic children |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27818 |
Study title: PROSPECTIVE COMPARATIVE TRIAL OF AMPHOTERICIN B VS. FCA IN NEONATAL SYSTEMIC FUNGAL INFECTIONS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27643 |
Study title: PROSPECTIVE COMPARATIVE TRIAL OF AMPHOTERICIN B VS. FCA IN NEONATAL SYSTEMIC FUNGAL INFECTIONS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28005 |
Study title: Serum mepivacaine concentrations after intraoral injection in young children. Chin, K.L. et al, J. Calif.Dent. Assoc. 2003Serum mepivacaine concentrations after intraoral injection in young children. Chin, K.L. et al, J. Calif.Dent. Assoc. 2003 |
Active substance: MEPIVACAINE |
Study summary document link (including results): |
View full study record |
Document reference: 31606 |
Study title: "Combination therapy of juvenile rheumatoid arthritis with hydroxychloroquine-gold-methotrexate: a pilot study - Lomater C, Gattinara M, Gerloni V, Zeni S. Fantini F.-1994 - Publication in CES 0035 - ML BORG - 11 Jul 2002 -" |
Active substance: HYDROXYCHLOROQUINE |
Study summary document link (including results): |
View full study record |
Document reference: 29204 |
Study title: "Combination therapy of juvenile rheumatoid arthritis with hydroxychloroquine-gold-methotrexate: a pilot study - Lomater C, Gattinara M, Gerloni V, Zeni S. Fantini F.-1994 - Publication in CES 0318 - J. Klausner - 10 Nov 2004 -" |
Active substance: HYDROXYCHLOROQUINE |
Study summary document link (including results): |
View full study record |
Document reference: 29207 |
Study title: "Lupus profundus in chidren: treatment with hydroxychloroquine - Fox JN, Klapman MH, Rowe L - 1987 - Publication in expert report on the clinical documentation N° 639.6.002 -" |
Active substance: HYDROXYCHLOROQUINE |
Study summary document link (including results): |
View full study record |
Document reference: 29203 |
Study title: Non-interventional study |
Active substance: HYDROXYETHYLSTARCH |
Study summary document link (including results): |
View full study record |
Document reference: 29216 |
Study title: A Controlled Study on the Effect of an Absorbable Sustained Release Artificial Tear Substitute on the Dry Eye Syndrome Frequently Associated with Familial Dysautonomia. |
Active substance: HYDROXYPROPYL CELLULOSE |
Study summary document link (including results): |
View full study record |
Document reference: 29218 |
Study title: Long Term Study of the Effect of a Sustained Release Artificial Tear Substitute (SR-AT) on Keratoconjunctivitis Sicca. |
Active substance: HYDROXYPROPYL CELLULOSE |
Study summary document link (including results): |
View full study record |
Document reference: 29217 |
Study title: Clinical response and adverse events in young patients with sickle cell disease treated with hydroxyurea2004 |
Active substance: HYDROXYUREA |
Study summary document link (including results): 15205096.pdf |
View full study record |
Document reference: 48360 |
Study title: Clinical response of patients with Sickle Cell Anemia to Cromolyn Sodium Nasal Spray2006 |
Active substance: HYDROXYUREA |
Study summary document link (including results): 16941613.pdf |
View full study record |
Document reference: 48365 |
Study title: Comparaison of busulfan, hydroxyurea and BMT in CML: BMT prolongs survival2004 |
Active substance: HYDROXYUREA |
Study summary document link (including results): 15570285.pdf |
View full study record |
Document reference: 48362 |
Study title: Comparative analysis of the impact of risk profile and drug therapy on survival in CML using Sokal's index and new score1997 |
Active substance: HYDROXYUREA |
Study summary document link (including results): 9136944.pdf |
View full study record |
Document reference: 48356 |
Study title: Hydroxyurea therapy in 49 patients with major beta thalassemia2009 |
Active substance: HYDROXYUREA |
Study summary document link (including results): 19400608.pdf |
View full study record |
Document reference: 48368 |
Study title: Hypereosinophilic syndrome: a multicentre, retrospective analysis of clinical characteristics and response to therapy2009 |
Active substance: HYDROXYUREA |
Study summary document link (including results): 19910029.pdf |
View full study record |
Document reference: 48369 |
Study title: Imatinib and hydroxyurea in pretreated progressive glioblastoma multiforme: a patient series2005 |
Active substance: HYDROXYUREA |
Study summary document link (including results): 16033874.pdf |
View full study record |
Document reference: 48364 |
Study title: Intensive treatment and stem cell transplantation in chronic myelogenous leukaemia: long term follow up2004 |
Active substance: HYDROXYUREA |
Study summary document link (including results): 15870485.pdf |
View full study record |
Document reference: 48363 |
Study title: Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in CML II study1997 |
Active substance: HYDROXYUREA |
Study summary document link (including results): 12886239.pdf |
View full study record |
Document reference: 48357 |
Study title: Response to hydroxyurea treatment in Iranian transfusion dependent beta thalassemia patients2004 |
Active substance: HYDROXYUREA |
Study summary document link (including results): 15477200.pdf |
View full study record |
Document reference: 48361 |
Study title: Steroid treatment in children with Sickle Cell Disease2007 |
Active substance: HYDROXYUREA |
Study summary document link (including results): 17339198.pdf |
View full study record |
Document reference: 48366 |
Study title: The presence of alpha thalassemia trait blunts the response of hydroxycarbamide in patients with Sickle Cell Disease2008 |
Active substance: HYDROXYUREA |
Study summary document link (including results): 18764867.pdf |
View full study record |
Document reference: 48367 |
Study title: A clinical trial with hydroxyzine on a group of maladjusted educationally subnormal children. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29332 |
Study title: Cazzola G, Cavalieri S, Solbiati M. (1978) Presented at del Convegno Nazionale della Societa Italiana per lo Studio delle Malattie Infettive e Parassitarie; September 16-17, Ancona, Italy; 1-23. Study of the activity of Isoprinosine® in herpes virus infections.Cazzola G, Cavalieri S, Solbiati M. (1978) Presented at del Convegno Nazionale della Societa Italiana per lo Studio delle Malattie Infettive e Parassitarie; September 16-17, Ancona, Italy; 1-23. Study of the activity of Isoprinosine® in herpes virus infections. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30086 |
Study title: Chang TW, Heel RC. Drugs. Aug 1981;22(2):111-28. Ribavirin and inosiplex: a review of their present status in viral diseases.Chang TW, Heel RC. Drugs. Aug 1981;22(2):111-28. Ribavirin and inosiplex: a review of their present status in viral diseases. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30087 |
Study title: Charieras JL, Plassart H. Medecine Tropicale. May-June, 1982; 42(3):316-318. Double-blind study of 59 cases of severe measles treated with IsoprinosineCharieras JL, Plassart H. Medecine Tropicale. May-June, 1982; 42(3):316-318. Double-blind study of 59 cases of severe measles treated with Isoprinosine |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30088 |
Study title: Ciaula V, Miani F, Fenizi G, Giglio G. Rass Dermatol Sifilogr. Additional clinical studies on activity and curative capability of methisoprinolCiaula V, Miani F, Fenizi G, Giglio G. Rass Dermatol Sifilogr. Additional clinical studies on activity and curative capability of methisoprinol |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30089 |
Study title: Clinical and histological results obtained in the treatment of chronic hepatitis Clinical and histological results obtained in the treatment of chronic hepatitis |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30090 |
Study title: Cohen AL, Antonini GM, Stefano JC La Prensa Medica Argentina. 1973; 60(8):267-278. A clinical study of various viral infections treated with methisoprinol syrup.Cohen AL, Antonini GM, Stefano JC La Prensa Medica Argentina. 1973; 60(8):267-278. A clinical study of various viral infections treated with methisoprinol syrup. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30091 |
Study title: Effects of dextroamphetamine, chlorpromazine, and hydroxy- zine on behavior and performance in hyperactive children |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE92B1901.pdf |
View full study record |
Document reference: 29266 |
Study title: Effects of hydroxyzine hydrochloride on the reaction time performance of schizophrenic children |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE92B0504.pdf |
View full study record |
Document reference: 29257 |
Study title: Efficacy of hydroxyzine vs diphenhydramine in atopic dermatitis. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29345 |
Study title: Electromyography: its potential as an adjunct to other monitored parameters during conscious sedation in children receiving dental treatment. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE91B1826.pdf |
View full study record |
Document reference: 29365 |
Study title: Empleo del clorhidrato de hidroxicina en el tratamiento de la urticaria cronica. |
Active substance: HYDROXYZINE |
Study summary document link (including results): DS76H021P.pdf |
View full study record |
Document reference: 29312 |
Study title: Enuresis – a comparative study of imipramine and tranquillisers in its management |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE01A1818.pdf |
View full study record |
Document reference: 29272 |
Study title: Erfahrungen mit dem ataraktikum masmoran in der paediatrie |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPD95A2602.pdf |
View full study record |
Document reference: 29275 |
Study title: Evaluation of an alphaprodine-hydroxyzine combination as a sedative agent in the treatment of the pediatric dental patient |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29250 |
Study title: Evaluation of an ataractic (hydroxyzine) in 2025 patients as an adjunct in oral surgery |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29223 |
Study title: Evaluation of analgesic, sedative, antipyretic effects of the combination acetaminophen plus hydroxyzine in pediatrics. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPP92K0719.pdf |
View full study record |
Document reference: 29341 |
Study title: Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosus. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29886 |
Study title: Effects of early indomethacin administration on oxygenation and surfactant requirement in low birth weight infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29887 |
Study title: Effects of early therapy with indomethacin on the manifestation of a persistent ductus arteriosus in extremely underweight premature infants |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29888 |
Study title: Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29889 |
Study title: Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29890 |
Study title: Effects of indomethacin on cerebral haemodynamics in very preterm infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29891 |
Study title: Effects of indomethacin on cerebral hemodynamics at rest and during endotracheal suctioning in preterm neonates. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29892 |
Study title: Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29893 |
Study title: Effects of prenatal exposure to betamethasone and indomethacin on the glomerular filtration rate in the preterm infant. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29894 |
Study title: Effects of prolonged versus acute indomethacin therapy in very low birth-weight infants with patent ductus arteriosus. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29895 |
Study title: Effects of repeated indomethacin administration on cerebral oxygenation and haemodynamics in preterm infants: combined near infrared spectrophotometry and Doppler ultrasound study. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29896 |
Study title: Effects on cerebral blood flow velocities of slow and rapid infusion of indomethacin. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29897 |
Study title: Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor: a randomized study. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29898 |
Study title: Efficacy of oxybutynin, pseudoephedrine and indomethacin in the treatment of primary nocturnal enuresis. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29899 |
Study title: Evaluation of bioequivalence of highly variable drugs using Monte Carlo simulations. I. Estimation of rate of absorption for single and multiple dose trials using Cmax. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29900 |
Study title: Künzer Th., Retrospective investigation on children (2-12 years) concerning safety and tolerability and dosage of Echinacin Lozenges; unpublished report (1997) |
Active substance: (HERB) Purple cone flower, pressed juice, 1.7 - 2.5 : 1 |
Study summary document link (including results): |
View full study record |
Document reference: 39726 |
Study title: Taylor et al.JAMA December 3, 2003-Vol 290, No. 21 Efficacy and Safety of Echinacea in Treating Upper Respiratory Tract Infections in Children |
Active substance: (HERB) Purple cone flower, pressed juice, 1.7 - 2.5 : 1 |
Study summary document link (including results): |
View full study record |
Document reference: 39728 |
Study title: Weber et al. THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 11, Number 6, 2005, pp. 1021–1026 Echinacea purpurea for Prevention of Upper Respiratory Tract Infections in Children |
Active substance: (HERB) Purple cone flower, pressed juice, 1.7 - 2.5 : 1 |
Study summary document link (including results): |
View full study record |
Document reference: 39729 |
Study title: PROSPECTIVE OPEN PILOT COMPARATIVE STUDY OF SAFETY & EFFICACY OF FCA PARENTERAL/ORAL VS STANDARD PROPHYLACTIC REGIMEN IN PREVENTION OF FUNGAL INFECTIONS IN PTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY OR IN PTS SUFFERING FROM APLASTIC ANEMIA |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27396 |
Study title: PROSPECTIVE OPEN PILOT COMPARATIVE STUDY OF SAFETY & EFFICACY OF FCA PARENTERAL/ORAL VS STANDARD PROPHYLACTIC REGIMEN IN PREVENTION OF FUNGAL INFECTIONS IN PTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY OR IN PTS SUFFERING FROM APLASTIC ANEMIA |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27761 |
Study title: RANDOMIZED CONTROLLED STUDY COMPARING ORAL FLUCONAZOLE TO TOPICAL CLOTRIMAZOLE IN THE TREATMENT OF VAGINAL CANDIDIASIS |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27648 |
Study title: RANDOMIZED CONTROLLED STUDY COMPARING ORAL FLUCONAZOLE TO TOPICAL CLOTRIMAZOLE IN THE TREATMENT OF VAGINAL CANDIDIASIS |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28010 |
Study title: RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF THE EFFICACY OF FLUCONAZOLE PARENTERAL/ORAL IN THE PREVENTION OF FUNGAL INFECTIONS IN PATIENTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML). |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27397 |
Study title: RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF THE EFFICACY OF FLUCONAZOLE PARENTERAL/ORAL IN THE PREVENTION OF FUNGAL INFECTIONS IN PATIENTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML). |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27762 |
Study title: RETROSPECTIVE CONTROLLED ANALYSIS OF FLUCONAZOLE PROPHYLAXIS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27619 |
Study title: RETROSPECTIVE CONTROLLED ANALYSIS OF FLUCONAZOLE PROPHYLAXIS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27981 |
Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN CRYPTOCOCCAL MENINGITIS IN PATIENTS WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27677 |
Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN CRYPTOCOCCAL MENINGITIS IN PATIENTS WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28039 |
Study title: A study of the efficacy and safety of repeated nebulized therapy combining ipratropium bromide 0.25 mg plus salbutamol sulphate 3.0 mg versus salbutamol sulphate 3.0 mg alone in children with acute asthma |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U94-0664_synopsis.pdf |
View full study record |
Document reference: 30635 |
Study title: A study of the efficacy and safety of repeated nebulized therapy combining ipratropium bromide 0.25 mg plus salbutamol sulphate 3.0 mg versus salbutamol sulphate 3.0 mg alone in children with acute asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30710 |
Study title: Acute and therapeutic dose-response comparison of Th 1165a administered with the CHBS powder inhaler to children. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U80-0167_synopsis.pdf |
View full study record |
Document reference: 30671 |
Study title: Acute asthma management of children in the emergency department. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30701 |
Study title: A comparison of the antipruritic efficacy of hydroxyzine and cyproheptadine in children with atopic dermatitis. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29282 |
Study title: A comparative dose range evaluation of the antipyretic efficacy and safety of ibuprofen liquid at three different doses in children. Jan 1988.A comparative dose range evaluation of the antipyretic efficacy and safety of ibuprofen liquid at three different doses in children. Jan 1988. |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29665 |
Study title: A Comparative Study of Coadministered Doses of Ibuprofen and Pseudoephedrine HCl and Each Drug Alone in the Treatment of Primary Nocturnal Enuresis in Children. Dec 2003 |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): ibuprofen_pseudoephedrine 00-131.pdf |
View full study record |
Document reference: 29477 |
Study title: A Comparative Study of Coadministered Doses of Ibuprofen and Pseudoephedrine HCl and Each Drug Alone in the Treatment of Primary Nocturnal Enuresis in Children. Dec 2003A Comparative Study of Coadministered Doses of Ibuprofen and Pseudoephedrine HCl and Each Drug Alone in the Treatment of Primary Nocturnal Enuresis in Children. Dec 2003 |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29666 |
Study title: A comparison of the efficacy and safety of ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg and acetaminophen elixir dosed at 12.5 mg/kg to placebo in children with ear pain. Dec 1992.A comparison of the efficacy and safety of ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg and acetaminophen elixir dosed at 12.5 mg/kg to placebo in children with ear pain. Dec 1992. |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29667 |
Study title: A Double-Blind Parallel Study to Compare the Efficacy and Side Effects of an Ibuprofen 400 mg/Pseudoephedrine 60 mg Combination, an Ibuprofen 200 mg/Pseudoephedrine 30 mg Combination, and Placebo in the Treatment of Sinus HeadacheA Double-Blind Parallel Study to Compare the Efficacy and Side Effects of an Ibuprofen 400 mg/Pseudoephedrine 60 mg Combination, an Ibuprofen 200 mg/Pseudoephedrine 30 mg Combination, and Placebo in the Treatment of Sinus Headache |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29669 |
Study title: A double-blind placebo controlled study comparing the safety and efficacy of ibuprofen 600 mg sustained release to ibuprofen 200 mg regular release, administered every four hours, in the treatment of post-operative dental painA double-blind placebo controlled study comparing the safety and efficacy of ibuprofen 600 mg sustained release to ibuprofen 200 mg regular release, administered every four hours, in the treatment of post-operative dental pain |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29670 |
Study title: A double-blind single dose evaluation of the comparative analgesic efficacy of aspirin 1000 mg/caffeine 64 mg, ibuprofen 400 mg, and placebo in the treatment of post-operative pain following third molar extraction. A double-blind single dose evaluation of the comparative analgesic efficacy of aspirin 1000 mg/caffeine 64 mg, ibuprofen 400 mg, and placebo in the treatment of post-operative pain following third molar extraction. |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29662 |
Study title: A double-blind single dose evaluation of the comparative analgesic efficacy of aspirin 800 mg/caffeine 64 mg, ibuprofen 400 mg, and placebo in the treatment of post-operative pain following third molar extractionA double-blind single dose evaluation of the comparative analgesic efficacy of aspirin 800 mg/caffeine 64 mg, ibuprofen 400 mg, and placebo in the treatment of post-operative pain following third molar extraction |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29671 |
Study title: A double-blind single dose evaluation of the efficacy and safety of acetaminophen 1000 mg, ibuprofen 200 mg, ibuprofen 400 mg, and placebo in the treatment of pain following oral surgeryA double-blind single dose evaluation of the efficacy and safety of acetaminophen 1000 mg, ibuprofen 200 mg, ibuprofen 400 mg, and placebo in the treatment of pain following oral surgery |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29672 |
Study title: Evaluation of the effect of nitrous oxide and hydroxyzine in controlling the behavior of the pediatric dental patient. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE93B0817.pdf |
View full study record |
Document reference: 29337 |
Study title: Exercise-induced asthma. Pharmacological assessment of single drugs and drug combinations |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29231 |
Study title: Fixed drug eruption in the genital area in 15 boys. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE02G2901.pdf |
View full study record |
Document reference: 29311 |
Study title: Hydroxyzine (HXZ) monotherapy or combination of hydroxyzine (HXZ) and ranitidine (R) for anaesthesia premedication in allergic children. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPG92A0801.pdf |
View full study record |
Document reference: 29350 |
Study title: Hydroxyzine by the i.m. or oral route in anaesthesia premedication of children. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADAE92D1006.pdf |
View full study record |
Document reference: 29335 |
Study title: Hydroxyzine for postoperative nausea and vomiting following ophthalmologic surgery. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29346 |
Study title: Hydroxyzine HCl in the management of allergic conditions. |
Active substance: HYDROXYZINE |
Study summary document link (including results): CE67J301P.pdf |
View full study record |
Document reference: 29279 |
Study title: Clinical Pharmacokinetics of Ibuprofen - Neal M. Davies - 02/1998 (Clin Pharmacokinet : 34 (2)) - Publication in Rhinathiol tablets (ibuprofen/ pseudoephredin) Pharmaco-toxicological & clinical documentation- Poulain Dominique - 04/2001 - |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29643 |
Study title: Comparative Evaluation of antipyretic activity of ibuprofenand aspirin in children with pyrexia of varied aetiology - P W . Kandoth et al. - 1984 (J Int Med Res vol 12) - Publication in Rhinathiol tablets (ibuprofen/ pseudoephredin) Pharmaco-toxicological documentation- Poulain Dominique - 04/2001 - |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29644 |
Study title: Díez−Domingo−J et al. Evaluation of the antipyretic safety and accuracy of two pediatric ibuprofen formulations. {An−Esp−Pediatr}, Nov 2000, vol. 53, no. 5, p. 436−40Díez−Domingo−J et al. Evaluation of the antipyretic safety and accuracy of two pediatric ibuprofen formulations. {An−Esp−Pediatr}, Nov 2000, vol. 53, no. 5, p. 436−40 |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29707 |
Study title: Efficacy and pharmacokinetic/pharmacodynamic profile of ibuprofen chewable tablets versus ibuprofen suspension in febrile children. Apr 1994.Efficacy and pharmacokinetic/pharmacodynamic profile of ibuprofen chewable tablets versus ibuprofen suspension in febrile children. Apr 1994. |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29709 |
Study title: Evaluation of the efficacy and safety of tramadol/APAP in oral surgical painEvaluation of the efficacy and safety of tramadol/APAP in oral surgical pain |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29711 |
Study title: Heremans−G et al. A single−blind parallel group study investigating the antipyretic properties of ibuprofen syrup versus acetylsalicylic acid syrup in febrile children. {Br−J−Clin−Pract}, Jun 1988, vol. 42, no. 6, p. 245−7Heremans−G et al. A single−blind parallel group study investigating the antipyretic properties of ibuprofen syrup versus acetylsalicylic acid syrup in febrile children. {Br−J−Clin−Pract}, Jun 1988, vol. 42, no. 6, p. 245−7 |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29712 |
Study title: Kotob−A. A comparative study of two dosage levels of ibuprofen syrup in children with pyrexia. {J−Int−Med−Res}, 1985, vol. 13, no. 2, p. 122−6Kotob−A. A comparative study of two dosage levels of ibuprofen syrup in children with pyrexia. {J−Int−Med−Res}, 1985, vol. 13, no. 2, p. 122−6 |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29717 |
Study title: Efficacy and safety of echinacea in treating upper respoiratory tract infections in children. A randomized controlled trial.Taylor JA, Weber W, Standish L et al. JAMA 2003;290: 2824-2830Efficacy and safety of echinacea in treating upper respoiratory tract infections in children. A randomized controlled trial.Taylor JA, Weber W, Standish L et al. JAMA 2003;290: 2824-2830 |
Active substance: (HERB) Echinacea purpurea L extract |
Study summary document link (including results): |
View full study record |
Document reference: 39702 |
Study title: Open non-randomised investigator-initiated study with EGb 761 + reading/spelling training vs. reading/spelling trainin |
Active substance: (HERB) Dry extract from Ginkgo biloba leaves (35-67 :1), extraction solvent: acetone 60% (w/w). The extract is adjusted to 22.0 - 27.0 % ginkgo flavonoids calculated as ginkgo flavone glycosides and 5.0 - 7.0 % terpene lactones consisting of 2.8 - 3.4 % ginkgolides A, B, C and 2.6 - 3.2 % bilobalide and contains less than 5 ppm ginkgolic acids. |
Study summary document link (including results): |
View full study record |
Document reference: 39703 |
Study title: Nesbit ME et al. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study. J Clin Oncol. 1990 Oct;8(10):1664-74Nesbit ME et al. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study. J Clin Oncol. 1990 Oct;8(10):1664-74 |
Active substance: MITOXANTRONE |
Study summary document link (including results): |
View full study record |
Document reference: 32190 |
Study title: An open label pilot study of St John's wort in juvenile depression; Findling, RL,; McNamara, NK et al.J Am Acad Child Adolesc Psychiatry 2003;42(8):908-914 |
Active substance: (HERB) Hypericum perforatum L extract |
Study summary document link (including results): |
View full study record |
Document reference: 39705 |
Study title: Symptoms of depression and psychovegatative disturbances in children under 12 years.; Hubner WD; Kirste T. Schweiz. Z. Ganzheitsmed. 2002;14(6): 318-324 |
Active substance: (HERB) Hypericum perforatum L extract |
Study summary document link (including results): |
View full study record |
Document reference: 39706 |
Study title: Nolan T et al., Randomized trial of laxatives in treatment of childhood encopresis. The Lancet 338, 1991, 8766: 523-52 |
Active substance: (HERB) Ispaghula husk Ispaghula seed Senna pods, Tinnevelly_and_(HERB) Ispaghula seed Ispaghula husk/ Plantago Ovata Tinnevelly Senna Pods/ |
Study summary document link (including results): |
View full study record |
Document reference: 39710 |
Study title: Roth OA.:Therapeutic observations on constipation.; Med. Welt 1969;20:536-7 |
Active substance: (HERB) Ispaghula husk Ispaghula seed Senna pods, Tinnevelly_and_(HERB) Ispaghula seed Ispaghula husk/ Plantago Ovata Tinnevelly Senna Pods/ |
Study summary document link (including results): |
View full study record |
Document reference: 39709 |
Study title: Sölter et al., Summary of clinical results with Prodiem Plain, a bowel-regulating agent. Today´s Therapeutic Trends (1983);1(1):45-59 |
Active substance: (HERB) Ispaghula husk Ispaghula seed Senna pods, Tinnevelly_and_(HERB) Ispaghula seed Ispaghula husk/ Plantago Ovata Tinnevelly Senna Pods/ |
Study summary document link (including results): |
View full study record |
Document reference: 39707 |
Study title: Zawodsky L., Problems of a double-blind trial, as exemplified by a laxative; Der Praktische Arzt 1976;30:1182-92 |
Active substance: (HERB) Ispaghula husk Ispaghula seed Senna pods, Tinnevelly_and_(HERB) Ispaghula seed Ispaghula husk/ Plantago Ovata Tinnevelly Senna Pods/ |
Study summary document link (including results): |
View full study record |
Document reference: 39708 |
Study title: Albrecht M./Strenge-Hesse et al: The treatment of Toxic liver damage with legalon; Z Klin Med;1992,47(2):87-92 |
Active substance: (HERB) Milk thistle fruit, dry extract, 36 - 44 : 1 (Silymarin 77.5 %) (Legalon) |
Study summary document link (including results): |
View full study record |
Document reference: 39714 |
Study title: Grüngreiff K./Strenge-Hesse et al.:Nutzen der medikamentösen Lebertherpaie in der hausärztlichen Praxis. The Value of a drug therapy for liver disease in general practice. Die Medizinishe Welt 1995;46(4):222-227 |
Active substance: (HERB) Milk thistle fruit, dry extract, 36 - 44 : 1 (Silymarin 77.5 %) (Legalon) |
Study summary document link (including results): |
View full study record |
Document reference: 39713 |
Study title: Hruby K et al., Pharmacotherapy of Amanita phalloides Poisoning with Silibinin.Wiener klin.Wochenschrift (and Human Toxicology); 1983; 7 (and 2 (2): 183-95 ) |
Active substance: (HERB) Milk thistle fruit, dry extract, 36 - 44 : 1 (Silymarin 77.5 %) (Legalon) |
Study summary document link (including results): |
View full study record |
Document reference: 39711 |
Study title: Jodl J et al, Therapeutische Mög-lichkeiten mit Legalon in der Pädiatrie. Therapeutic uses of Legalon in paediatrics.Medica 1983; 4 (11): 3-6 |
Active substance: (HERB) Milk thistle fruit, dry extract, 36 - 44 : 1 (Silymarin 77.5 %) (Legalon) |
Study summary document link (including results): |
View full study record |
Document reference: 39715 |
Study title: The physiological effects of supplemental oxygen versus nitrous oxide/oxygen during conscious sedation of pediatric dental patients. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE00L1003.pdf |
View full study record |
Document reference: 29290 |
Study title: The preoperative sedation of children. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADRE92D1302.pdf |
View full study record |
Document reference: 29349 |
Study title: Acute asthma management of children in the emergency department. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30545 |
Study title: Assessment of the effect of 2.5 mg and 5 mg Th 1165a Linctus in school children compared with placebo. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30590 |
Study title: Assessment of the therapeutic effect and tolerance of Th 1165a Linctus in 12 infants and 12 school children at doses of 3 x 1.25 mg and 3 x 2.5 mg. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30591 |
Study title: Assessment of the therapeutic effect of Th 1165a-linctus with several days' administration in infants. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30601 |
Study title: Assessment of the therapeutical efficacy and tolerability of 7.5 mg Th 1165a-suppositories in school children. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30586 |
Study title: Assessment of therapeutic effect and tolerance of Th 1165a suppositories after repeated administration in infants and school children. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30597 |
Study title: Assessment of therapeutic efficacy and tolerance of Th 1165a 4.5 mg suppositories during administration for several days in infants. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30594 |
Study title: Assessment of therapeutic efficacy and tolerance of Th 1165a 4.5 mg suppositories in infants and small children during multiple dosing. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30595 |
Study title: Atrovent and Berotec in children with recurrent obstructive bronchitis |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U89-0249_synopsis.pdf |
View full study record |
Document reference: 30698 |
Study title: Atrovent maintenance therapy of asthma and spastic bronchitis |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U84-0774_synopsis.pdf |
View full study record |
Document reference: 30677 |
Study title: Berotec solution statistical report, study no. E79-234 protocol designation: IIF I. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30657 |
Study title: Berotec solution summary of study - final report - phase III. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30656 |
Study title: Berotec tablets + Theophylline summary of study - interim report - phase II. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30655 |
Study title: Berotec tablets 2.5 mg summary of study - interim report - phase II. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30653 |
Study title: Berotec tablets 5 mg + Theophylline summary of study - final report - phase III. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30658 |
Study title: Berotec tablets summary of study - phase II - final report. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30654 |
Study title: Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30553 |
Study title: Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U92-0221_synopsis.pdf |
View full study record |
Document reference: 30705 |
Study title: Buccally administered fenoterol aerosol in acute childhood asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30638 |
Study title: Study on the acceptance of the multicapsule inhalator Boehringer Ingelheim M. Berodual inhalets are used. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30702 |
Study title: Study on the obstruction in small airways. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30604 |
Study title: Study on the response to fenoterol metered aerosol in a 14 day comparison with placebo. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30599 |
Study title: Study on the therapeutic efficacy and tolerability of Th 1165a-suppositories in infants and school children, applied for several days in the evening. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30598 |
Study title: Study on the therapeutic efficacy and tolerability of Th 1165a-suppositories in infants, applied for several days. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30596 |
Study title: Study on the therapeutic efficacy and tolerability of Th 1165a-suppositories in school-children administered for several days. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30593 |
Study title: A double-blind single dose evaluation of the efficacy and safety of ibuprofen 400 mg, ibuprofen 200 mg, APAP 1000 mg, and placebo in the treatment of pain following removal of the impacted third molarsA double-blind single dose evaluation of the efficacy and safety of ibuprofen 400 mg, ibuprofen 200 mg, APAP 1000 mg, and placebo in the treatment of pain following removal of the impacted third molars |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29674 |
Study title: A randomized open study to investigate the boosting effect of VAQTA and AVAXIM following a single dose of AVAXIM (PM-MSD U98-XQ-003) |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41464 |
Study title: A single-center, pilot study of the safety, tolerability, and immunogenicity of VAQTA in healthy infants ~6 months of age |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41463 |
Study title: A study to assess the immunogenicity and reactogenicity of a Hepatitis A vaccine administered subcutaneously to patients with congenital coagulation disorders using a single primary dose and a booster dose at 6 months at a dose of 1440 ElU (in 1 ml) to adults and 720 ElU (in 0.5ml) in children. |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41124 |
Study title: Administration of an Inactivated Hepatitis A Vaccine to Healthy Children Attending Day Care Centers |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41111 |
Study title: Comparison of anti-IgE and anti-HLA immune responses after HAVRIX versus VAQTA inactivated Hepatitis A vaccine - "Comparison of immunogenicity of two hepatitis A vaccines - VAQTA® and HAVRIX® - in young adults." Ashur, Y., et al., Vaccine 17: 2290-2296, 1999 ) |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41465 |
Study title: Evaluation of the safety, immunogenicity and protective efficacy of an inactivated hepatitis A vaccine in healthy children. |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41115 |
Study title: Hepatitis A vaccine versus immune globulin for postexposure prophylaxis; Hepatitis A vaccine versus immune globulin for postexposure prophylaxisUniversity of Michigan sponsored study performed in Kazakhstan Publication Citation: Hepatitis A Vaccine versus Immune Globulin for Postexposure Prophylaxis. Victor, J.C., et al., N. Engl. J. Med. 357 (17): 1685-1694, 2007 |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41468 |
Study title: Letson GW et al. Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infantsJ Pediatr 2004;144:327-32Letson GW et al. Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infantsJ Pediatr 2004;144:327-32 |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41112 |
Study title: Local Registration Study - Russia |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41462 |
Study title: Open multicentric study of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine in healthy children. |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41109 |
Study title: Open study of the immunogenicity and reactogenicity of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine administered to hemophiliac patients following the schedule 0, 1 months with a booster at 6 months.. |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41122 |
Study title: Open study of the immunogenicity and reactogenicity of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine administered to hemophilic patients following the schedule 0, 1 months with a booster at 6 months. |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41123 |
Study title: Open study to evaluate the immunogenicity and reactogenicity of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per ml dose injected according to a 0, 12 month schedule in healthy adolescents. |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 21206 |
Study title: Randomised clinical study to assess immunogenicity and reactogenicity of SmithKline Beecham¿s inactivated Hepatitis A-Vaccine Havrix 1440 in healthy adolescents from their completed 14th to their completed 17th year of life, administered according to the schedule 0-6 or 0-12 months, |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 21207 |
Study title: Marchetti−F. Ibuprofene in pediatrics. {MED−BAMBINO}, 30 JUN 2001, Vol/Iss/Pg. 20/6 (387−391)Marchetti−F. Ibuprofene in pediatrics. {MED−BAMBINO}, 30 JUN 2001, Vol/Iss/Pg. 20/6 (387−391) |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29720 |
Study title: Marriott−S−C et al. A dose ranging study of ibuprofen suspension as an antipyretic. {Arch−Dis−Child}, Sep 1991, vol. 66, no. 9, p. 1037−41Marriott−S−C et al. A dose ranging study of ibuprofen suspension as an antipyretic. {Arch−Dis−Child}, Sep 1991, vol. 66, no. 9, p. 1037−41 |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29721 |
Study title: Marriott−S−C, Stephenson−T−J. A double−blind dose−ranging trial with paediatric ibuprofen. {BR−J−CLIN−PRACT}, 1990, Vol/Iss /Pg. 44/8 SUPPL. 70 (15−18)Marriott−S−C, Stephenson−T−J. A double−blind dose−ranging trial with paediatric ibuprofen. {BR−J−CLIN−PRACT}, 1990, Vol/Iss /Pg. 44/8 SUPPL. 70 (15−18) |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29722 |
Study title: Mise au point sur la sécurité de l'ibuproféne à dose antalgique - N. Moore et al. - 1996 (Thérapie vol 51) - Publication in Rhinathiol tablets (ibuprofen/ pseudoephredin) Pharmaco-toxicological & clinical documentation - Poulain Dominique - 04/2001 - |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29652 |
Study title: Multiple-Dose Pharmacokinetic Study of an Ibuprofen-Pseudoephedrine HCl Suspension in Children |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): ibuprofen_pseudoephedrine 97-024.pdf |
View full study record |
Document reference: 29648 |
Study title: Multiple-Dose Pharmacokinetic Study of an Ibuprofen-Psuedoephedrine HCl Suspension in Children. Aug 1999.Multiple-Dose Pharmacokinetic Study of an Ibuprofen-Psuedoephedrine HCl Suspension in Children. Aug 1999. |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29725 |
Study title: Antipyretic effects of indomethacin in acute infectious diseases--a double blind testa |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29822 |
Study title: Aspirin versus indomethacin treatment of patent ductus arteriosus in preterm infants with respiratory distress syndrome. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29823 |
Study title: Asymptomatic reopening of ductus arteriosus after successful closure by indomethacin in premature infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29824 |
Study title: Azapropazone versus indomethacin in a double blind test with patients with ankylosing spondylitisa |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29825 |
Study title: Calcium homeostasis and hypercalciuria in hyperprostaglandin E syndrome. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29826 |
Study title: Can dopamine prevent the renal side effects of indomethacin? A prospective randomized clinical study. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29827 |
Study title: Changes in cerebral, renal and mesenteric blood flow velocity during continuous and bolus infusion of indomethacin. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29828 |
Study title: Cimetidine decreases indomethacin induced duodenal mucosal damage in patients with acute musculoskeletal disorders. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29829 |
Study title: Clinical and laboratory observations: Successful treatment of Finnish congenital nephrotic syndrome with captopril and indomethacin. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29830 |
Study title: Clinical and objective assessments of naproxen through 5 years of clinical experience. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29831 |
Study title: The spectrum of antihistamines adversely affecting pulmonary function in asthmatic children. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29330 |
Study title: The therapeutic effectiveness of nitrous oxide and chloral hydrate administered orally, rectally, and combined with hydroxyzine for pediatric dentistry. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29305 |
Study title: The use of a tranquilizer in the management of behavior problems in a private pediatric practice. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29309 |
Study title: The use of hydroxyzine hydrochloride (atarax) as a sedative agent in paediatric dentistry. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE91B0814.pdf |
View full study record |
Document reference: 29269 |
Study title: The use of Marax in the treatment of bronchial asthma. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE92B2841.pdf |
View full study record |
Document reference: 29283 |
Study title: Tranquilisers – their present status in therapeutics. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE92D1513.pdf |
View full study record |
Document reference: 29359 |
Study title: Treatment of arrhythmias during cardiac catheterisation of children |
Active substance: HYDROXYZINE |
Study summary document link (including results): RAD90J0513P.pdf |
View full study record |
Document reference: 29233 |
Study title: Treatment of asthma with combined hydroxyzine-theophylline- ephedrine |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29256 |
Study title: Treatment of secretory otitis media with local instillation of hydroxyzine. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE94C2105.pdf |
View full study record |
Document reference: 29353 |
Study title: Uber die klinische bedeutung der ataraktika “tranquillanten” unter besonderer berucksichtigung ihrer anwendung in der kinderheilkunde |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29222 |
Study title: Urticaria cronica. Caracteristicas, diagnostico y tratamiento. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPS92M2124.pdf |
View full study record |
Document reference: 29360 |
Study title: Urticaria in thai children. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE92D1427.pdf |
View full study record |
Document reference: 29357 |
Study title: Use of intravenously given hydroxyzine for simple pain-pro- ducing office procedures |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE92A2427.pdf |
View full study record |
Document reference: 29241 |
Study title: Visual compatibility of hydroxyzine hydrochloride with various antineoplastic agents. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29299 |
Study title: Zur pharmakotherapie kindlicher verhaltensstorungen. |
Active substance: HYDROXYZINE |
Study summary document link (including results): CD59M152P.pdf |
View full study record |
Document reference: 29267 |
Study title: Buscopan plus (Buscopan-paracetamol-combinations film-coated tablets, suppositories, paediatric solution IK 19, IK 26). |
Active substance: HYOSCINE BUTYLBROMIDE AND PARACETAMOL |
Study summary document link (including results): Hyoscine Butylbromide+Paracetamol_U82-0481_synopsis.pdf |
View full study record |
Document reference: 47385 |
Study title: Comparative safety and immunogenicity study of diphtheria, tetanus, acellular pertussis, poliomyelitis vaccine (DTacP-IPV) and diphtheria, tetanus, whole-cell pertussis, poliomyelitis vaccine (TETRACOQ®) given as a second booster to 4- to 7-year-old children |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41193 |
Study title: Ketoconazole shampoo in the treatment of dandruff and/or seborrheic dermatitits: a randomized, double-blind placebo-controlled comparison of different concentrations |
Active substance: KETOCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30831 |
Study title: Th 1165a a metered aerosol. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30576 |
Study title: Th 1165a metered aerosol (0.2 mg/puff): therapeutic assessment in children with bronchial asthma and spastic bronchitis. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30579 |
Study title: Th 1165a metered aerosol: pediatrics / therapeutic observations. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30578 |
Study title: Th 1165a metered aerosol: therapy. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30580 |
Study title: TH 1165a metered dose aerosol 0.2 mg per spray - F 9123538 Therapeutic observations in pediatrics. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30577 |
Study title: Th 1165a suppositories 7.5 mg. An assessment of the effect of Th 1165a suppositories in school children during the night on the frequency of acute attacks of bronchospasm, on chronic dyspnoea, and the necessity for adjunctive therapy. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30585 |
Study title: Th 1165a suppositories: Summary of the results of clinical trial. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30602 |
Study title: Th-1165a-suppositories: summary of results of the clinical trial for medical approval. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30583 |
Study title: The bronchodilator efficacy of Berotec or ephedrine. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30652 |
Study title: The bronchodilator efficacy of Berotec tablets as measured after single doses (day 1) by comparison with the standard therapeutic agent (ephedrine) with particular emphasis on onset of action and duration of action. 2. The persistence of bronchodila... |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30651 |
Study title: The clinical comparison of Fenoterol and salbutamol administered by inhalation. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30607 |
Study title: The effect of administration technique on bronchodilator response to fenoterol in a metered dose inhaler. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30613 |
Study title: The site of obstruction in exercise-induced asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30669 |
Study title: Therapeutic testing for several weeks in bronchospastic children: daily use of Sch 1000 metered dose aerosol. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30564 |
Study title: Therapeutic testing for several weeks in bronchospastic children: daily use of Sch 1000 metered dose aerosol. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U72-0222_synopsis.pdf |
View full study record |
Document reference: 30663 |
Study title: Therapeutic testing of several days' duration, in bronchospastic children: daily administration of multiple doses of Sch 1000 metered-dose aerosol. Duration of study: 1 - 20 days. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30565 |
Study title: Therapeutic testing of several days' duration, in bronchospastic children: daily administration of multiple doses of Sch 1000 metered-dose aerosol. Duration of study: 1 - 20 days. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U72-0227_synopsis.pdf |
View full study record |
Document reference: 30664 |
Study title: Therapy with nebulised fenoterol 0.5% in asthmatic patients in the children's hospital Josefina Martinez de Ferrari. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30639 |
Study title: Cavadini C, Siega-Riz AM, Popkin BM. US adolescent food intake trends from 1965 to 1996. Arch Dis Child. 2000 Jul; 83(1):18-24. |
Active substance: Ispaghula seed |
Study summary document link (including results): |
View full study record |
Document reference: 21223 |
Study title: Cavadini C, Siega-Riz AM, Popkin BM. US adolescent food intake trends from 1965 to 1996. Arch Dis Child. 2000 Jul; 83(1):18-24. |
Active substance: Ispaghula seed |
Study summary document link (including results): |
View full study record |
Document reference: 40032 |
Study title: .Hampl JS, Betts NM, Benes BA. The "age+5" rule: comparasion of dietery fiber intake among 4- to 10-year-old children. J Am Diet Assoc. 1998 Dec; 98(12):1418-23. |
Active substance: Ispaghula seed |
Study summary document link (including results): |
View full study record |
Document reference: 40033 |
Study title: Leis R, Pavon P, Queiro T, Recarey D, Tojo R. Atherogenic diet and blood lipidprofile in children and adolescents from Galicia, NW Spain. The Galinut Study. Acta Paediatr. 1999 Jan; 88(1):19-23. |
Active substance: Ispaghula seed |
Study summary document link (including results): |
View full study record |
Document reference: 21224 |
Study title: Randomized clinical study to assess immunogenicity and reactogenicity of SmithKline Beecham¿s inactivated Hepatitis A-Vaccine Havrix 720 in healthy adolescents from their completed 12th to their completed 15th year of life, administered according to the schedule 0-6 or 0-12 months. |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41125 |
Study title: A Phase III randomised, open, controlled study to assess the safety and immunogenicity of concomitant administration of virosomal hepatitis A vaccine (Epaxal®) with DTPaHibIPV, OPV and MMR vaccines vs. non-concomitant administration in 12-15 month old children. |
Active substance: Inactivated hepatitis A virus (strain RG-SB). |
Study summary document link (including results): |
View full study record |
Document reference: 41087 |
Study title: Prophylactic indomethacin therapy in the first twenty-four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30003 |
Study title: Prophylactic indomethacin: factors determining permanent ductus arteriosus closure. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30004 |
Study title: Prostaglandin synthetase inhibitors and dysmenorrhea. A survey and personal clinical experience. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30005 |
Study title: Prostaglandin synthetase inhibitors in treatment of primary dysmenorrheaa |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30006 |
Study title: Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30007 |
Study title: Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30008 |
Study title: Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30009 |
Study title: Randomized trial of prolonged low-dose versus conventional-dose indomethacin for treating patent ductus arteriosus in very low birth weight infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30010 |
Study title: Regional hemodynamic effects of dopamine in the indomethacin-treated preterm infant |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30011 |
Study title: Renal functional impairment in preterm neonates related to intrauterine indomethacin exposure |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30012 |
Study title: Results of two year use of dipyridamole and metindol in patients with primary focal and (or) segmental glomerulosclerosis |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30014 |
Study title: Retinopathy of prematurity (ROP) and indomethacin therapy in premature infants with patent ductus arteriosus (PDA). |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30015 |
Study title: Retrospective economic evaluation of a controlled trial of indomethacin prophylaxis for patent ductus arteriosus in premature infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30016 |
Study title: Risk period for intraventricular hemorrhage of the preterm neonate is independent of gestational age. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30017 |
Study title: Clinical course to 1 year of age in premature infants with patent ductus arteriosus: results of a multicenter randomized trial of indomethacin. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29832 |
Study title: Clinical evaluation of indomethacin-containing patches for osteoarthritis and extremity trauma. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29833 |
Study title: Clinical trials of intravenous indomethacin for closure of the patent ductus arteriosus |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29835 |
Study title: Clinical trials with acemetacin on children and adolescents (author's transl)a |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29836 |
Study title: Closure of the arterial canal induced by indometacin in premature neonates with severe congestive heart failure |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29837 |
Study title: Cognitive outcome at 4 1/2 years of very low birth weight infants enrolled in the multicenter indomethacin intraventricular hemorrhage prevention trial. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29838 |
Study title: Combined treatment with a nonselective nitric oxide synthase inhibitor (l-NMMA) and indomethacin increases ductus constriction in extremely premature newborns. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29839 |
Study title: Comparative effectiveness of voltaren and indomethacin in rheumatoid arthritis (according to the data of a double-blind study)a |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29840 |
Study title: A Phase 1, Open-label Study Evaluating the Safety and Pharmacokinetics of a Single Intravenous Infusion of a Chimeric Monoclonal Antibody to Human TNFα (Infliximab) in Pediatric Inflammatory Bowel Disease Subjects Receiving Maintenance Treatment with Infliximab |
Active substance: Infliximab |
Study summary document link (including results): |
View full study record |
Document reference: 47439 |
Study title: A Randomized, Double-blind Study of Anti-TNFα Chimeric Monoclonal Antibody (Infliximab) in Combination with Methotrexate for the Treatment of Subjects with Polyarticular Juvenile Rheumatoid Arthritis |
Active substance: Infliximab |
Study summary document link (including results): |
View full study record |
Document reference: 47436 |
Study title: A Randomized, Double-blind Study of Anti-TNFα Chimeric Monoclonal Antibody (Infliximab) in Combination with Methotrexate for the Treatment of Subjects with Polyarticular Juvenile Rheumatoid Arthritis • OLE study report synopsis |
Active substance: Infliximab |
Study summary document link (including results): |
View full study record |
Document reference: 47437 |
Study title: A Randomized, Multicenter, Open-label Study to Evaluate the Safety and Efficacy of Anti-TNFα Chimeric Monoclonal Antibody (Infliximab, REMICADE®) in Pediatric Subjects with Moderate to Severe Crohn’s Disease |
Active substance: Infliximab |
Study summary document link (including results): |
View full study record |
Document reference: 47438 |
Study title: A phase III double-blind, randomized, multicentric, comparative vaccination study of the immunogenicity and reactogenicity of a thiomersal-free formulation of Influsplit SSW® 2003/2004 versus the standard formulation of Influsplit SSW® 2003/2004 in children aged from 6 months to <6 years. |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): 100351 (FLU-056) synopsis.pdf |
View full study record |
Document reference: 48371 |
Study title: A phase III, open-label, multi-centre study to evaluate the safety, tolerability an immunogenicity of CSL´s influenza vaccine in two paediatric populations, Group A (≥ 6 month to ≥ 3 years) and Group B (≥ 3 years to < 9 years). |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): |
View full study record |
Document reference: 47149 |
Study title: A phase III, open-label, multi-centre study to evaluate the safety, tolerability and immunogenicity of CSL´s influenza vaccine in two paediatric populations, Group A (≥ 6 month to ≥ 3 years) and Group B (≥ 3 years to < 9 years). |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): |
View full study record |
Document reference: 47150 |
Study title: Comparative safety and immunogenicity study of diphtheria, tetanus, acellular pertussis, poliomyelitis vaccine (DTacP-IPV) and diphtheria, tetanus, poliomyelitis vaccine (DT POLIO®) administered as a booster in children aged 8 to 12 years |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41197 |
Study title: Comparison of antibody response to killed Poliovirus (KPV) produced on vero cell substrate (MERIEUX) and reference standard KPV produced on monkey kidney cell substrate (RIJKS) |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41200 |
Study title: Comparison of antibody response to killed poliovirus (KPV) produced on Verol cell substrate (Merieux) and reference standard KPV produced on monkey kidney cell substrate (RIJKS) |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41185 |
Study title: Comparison of immungenicity of oral and inactivated polio vaccines in Indian infants |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41186 |
Study title: Comparison of immunogenicity of oral and inactivated polio vaccines in Indian infants |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41201 |
Study title: Comparison of the immunogenicity of an adsorbed tetanus diphtheria (low toxoid content) poliomyelitis (inactivated viruses) vaccine with that of an adsorbed tetanus-diphtheria (low toxoid content) vacine administered as boosters to healthy children aged 6 to 9 years |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41198 |
Study title: Concomitant administration of a Haemophilus influenzae type b - Hepatitis b vaccine with a diphtheria, tetanus, acellular pertussis, inactivated polio combination vaccine in healthy infants |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41191 |
Study title: Diminution of the anti-polyribosylribito phosphate response to a combined diphtheria-tetanus-acellular pertussis/Haemophilus influenzae Type b vaccine by concurrent inactivated poliovirus vaccination |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41205 |
Study title: Double blind, controlled trial testing the immunogenicity and side effects of parenteral Vi polysaccharide typhoid vaccine in Indonesian children and adults |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41210 |
Study title: Evaluation of long-term treatment with indomethacin in hereditary hypokalemic salt-losing tubulopathies. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29901 |
Study title: Salbutamol Powder, Administered via a Multidose and a Single-Dose Powder Inhaler, in the Prevention of Exercise-Induced Asthma in ChildrenPEDIATRIC ASTHMA, ALLERGY & IMMUNOLOGY Volume 9, Number 3, 1995, Col et al. |
Active substance: SALBUTAMOL |
Study summary document link (including results): 15.01-CT-02-92 publication.pdf |
View full study record |
Document reference: 49210 |
Study title: Leis R, Pavon P, Queiro T, Recarey D, Tojo R. Atherogenic diet and blood lipidprofile in children and adolescents from Galicia, NW Spain. The Galinut Study. Acta Paediatr. 1999 Jan; 88(1):19-23. |
Active substance: Ispaghula seed |
Study summary document link (including results): |
View full study record |
Document reference: 40034 |
Study title: Saldanha LG. Fiber in the diet of US children: results of national surveys. Paediatrics. 1995 Nov; 96 (5 Pt 2): 994-7. |
Active substance: Ispaghula seed |
Study summary document link (including results): |
View full study record |
Document reference: 40035 |
Study title: Initial experience with Isradipine for the treatment of hypertension in children Strauser LM et al, South Med J; 93: 287-293; 2000Initial experience with Isradipine for the treatment of hypertension in children Strauser LM et al, South Med J; 93: 287-293; 2000 |
Active substance: ISRAPIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 30774 |
Study title: Isradipine therapy in hypertensive pediatric patients Johnson CE et al, Ann Pharmacother; 31: 704-707; 1997Isradipine therapy in hypertensive pediatric patients Johnson CE et al, Ann Pharmacother; 31: 704-707; 1997 |
Active substance: ISRAPIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 30773 |
Study title: Isradipine treatment of hypertension in children: a single-center experience Flynn JT, Pediatr Nephrol.; 17 (9): 748-53; 2002Isradipine treatment of hypertension in children: a single-center experience Flynn JT, Pediatr Nephrol.; 17 (9): 748-53; 2002 |
Active substance: ISRAPIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 30775 |
Study title: Adame G Oral itraconazole in the treatment of tinea manus and tinea pedis. Clinical summary on R51211, August 1987. (14-54 years, LMD56451)Adame G Oral itraconazole in the treatment of tinea manus and tinea pedis. Clinical summary on R51211, August 1987. (14-54 years, LMD56451) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30793 |
Study title: Alcantara R. Treatment of dermatomycosis with 100 mg itraconazole o.d. during fifteen or thirty days. Janssen Research Foundation Products Information service. Clinical research report, February 1988. (5-90 years, LMD59929)Alcantara R. Treatment of dermatomycosis with 100 mg itraconazole o.d. during fifteen or thirty days. Janssen Research Foundation Products Information service. Clinical research report, February 1988. (5-90 years, LMD59929) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30779 |
Study title: An open evaluation of itraconazole oral solution in paediatric patients undergoing treatment for haematological malignancy or solid tumour. Safety findings. |
Active substance: ITRACONAZOLE |
Study summary document link (including results): LMD129189_Interventional_Itraconazole.xls |
View full study record |
Document reference: 45124 |
Study title: An open study on the pharmacokinetics and safety of itraconazole oral solution in 24 cystic fibrosis subjects |
Active substance: ITRACONAZOLE |
Study summary document link (including results): LMD172168_Interventional_Itraconazole.xls |
View full study record |
Document reference: 47581 |
Study title: Boogaerts MA, Verhoef GE, Zachee P, Demuynck H, Verbist L, De Beulke K. Antifungal prophylaxis with itraconazole in prolonged neutropenia: Correlation with plasma levels. Proceedings of the 2nd internationa symposium on itraconazole, Antwerp, Belgium, June 22-23, 1989. Mycoses 32 (suppl.1), p.103-108, 1989. (9-78 years, LMD69411)Boogaerts MA, Verhoef GE, Zachee P, Demuynck H, Verbist L, De Beulke K. Antifungal prophylaxis with itraconazole in prolonged neutropenia: Correlation with plasma levels. Proceedings of the 2nd internationa symposium on itraconazole, Antwerp, Belgium, June 22-23, 1989. Mycoses 32 (suppl.1), p.103-108, 1989. (9-78 years, LMD69411) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30811 |
Study title: Coninx S, et al Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea Corporis and tinea cruris. Clinical research report on R051211 no-71, May 1987. (2-78 years, LMD56442)Coninx S, et al Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea Corporis and tinea cruris. Clinical research report on R051211 no-71, May 1987. (2-78 years, LMD56442) |
Active substance: ITRACONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 30784 |
Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN LIFE THREATENING DEEP MYCOSES |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27674 |
Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN LIFE THREATENING DEEP MYCOSES |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28036 |
Study title: Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30018 |
Study title: School-age outcomes of very low birth weight infants in the indomethacin intraventricular hemorrhage prevention trial. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30019 |
Study title: Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30020 |
Study title: Short versus prolonged indomethacin therapy for patent ductus arteriosus in preterm infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30021 |
Study title: A comparison of the child’s behavior between two groups of oral sedative drugs. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPZ92F0536.pdf |
View full study record |
Document reference: 29347 |
Study title: A double-blind, placebo-controlled, crossover trial of ketotifen versus hydroxyzine in the treatment of pediatric mastocytosis. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29280 |
Study title: A prospective study of 2 sedation regimens in children: chloral hydrate, meperidine, and hydroxyzine versus midazolam, meperidine, and hydroxyzine. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE07C2107.pdf |
View full study record |
Document reference: 29340 |
Study title: A randomized double-blind trial of chloral hydrate/ hydroxyzine versus midazolam/acetaminophen in the sedation of pediatric dental outpatients. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE97G2901.pdf |
View full study record |
Document reference: 29321 |
Study title: A randomized, controlled, crossover trial of oral midazolam and hydroxyzine for pediatric dental sedation. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE04B1014.pdf |
View full study record |
Document reference: 29244 |
Study title: A retrospective study of chloral hydrate, meperidine, hydroxyzine, and midazolam regimens used to sedate children for dental care. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE01A1503.pdf |
View full study record |
Document reference: 29366 |
Study title: A specific antihistaminic premedication anti H1 and anti H2 for pediatric anesthesia. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29292 |
Study title: A study of 3 preoperative sedative combinations. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29354 |
Study title: A study of quadriceps contracture-causing factor by the analysis of muscle injection according to medical records. |
Active substance: HYDROXYZINE |
Study summary document link (including results): RACH90J0558P.pdf |
View full study record |
Document reference: 29306 |
Study title: A study to compare the effectiveness of temazepam and a chloral hydrate/hydroxyzine combination in sedating paediatric dental patients. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE94F2815.pdf |
View full study record |
Document reference: 29356 |
Study title: Acute urticaria in infancy and early childhood: a prospective study. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE99E3106.pdf |
View full study record |
Document reference: 29307 |
Study title: Adverse central nervous system effects of older antihistamines in children. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE96K0715.pdf |
View full study record |
Document reference: 29344 |
Study title: Adverse events and outcomes of conscious sedation for pediatric patients – study of an oral sedation regimen. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE02A0402.pdf |
View full study record |
Document reference: 29289 |
Study title: A phase IV, open study to evaluate the reactogenicity and immunogenicity of SmithKline Beecham Biologicals' influenza split vaccine in children aged 6-36 months |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): 218352-003 (FLUARIX-003) synopsis.pdf |
View full study record |
Document reference: 48372 |
Study title: Clinical Analysis of Influsplit SSW® 94 1 Fluarix in children of the ages of 3-6 years |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): Influ 02 94 _Synopsis.pdf |
View full study record |
Document reference: 48375 |
Study title: Clinical Trial of the Reactogenicity and Immunogenicity of INFLUSPLIT SSW®92 in children aged from 1 to 4 years |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): INFLU 03 92 INFLU 04 92 synopsis.pdf |
View full study record |
Document reference: 48376 |
Study title: Open immunization study to determine the reactogenicity and immunogenicity of Influsplit SSW® 2000/2001 in children aged from 6 month to <6 years |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): 218352-044 (Influ 03-2000) synopsis.pdf |
View full study record |
Document reference: 48374 |
Study title: Open immunization study to determine the reactogenicity and immunogenicity of Influsplit SSW® 98/99 in children upon completion of 6 month of live till completion of 18 years |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): 218352-031 (Influ 02-98) synopsis.pdf |
View full study record |
Document reference: 48373 |
Study title: A Randomized, Endpoint-blind, Parallel Group Study to Demonstrate the Non-inferiority of the Subunit Influenza Vaccine Influvac® to the Subunit Influenza Vaccine Agrippal® in Healthy Children, Adults and Elderly in China |
Active substance: influenza vaccine (subunit, inactivated) |
Study summary document link (including results): |
View full study record |
Document reference: 47501 |
Study title: Reactogenicity and Immunogenicity of InfluvacR in high-risk children between 6 months and 4 years of age. |
Active substance: influenza vaccine (subunit, inactivated) |
Study summary document link (including results): |
View full study record |
Document reference: 47502 |
Study title: Hydroxyzine hydrochloride (Atarax). A new tranquilizer. |
Active substance: HYDROXYZINE |
Study summary document link (including results): CE56L121.pdf |
View full study record |
Document reference: 29323 |
Study title: Hydroxyzine hydrochloride and methylphenidate hydrochloride in the management of enuresis |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29232 |
Study title: Hydroxyzine hydrochloride in the management of children with behavior problems. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29298 |
Study title: Hydroxyzine hydrochloride in treatment of behavioral disturbances in mentally retarded children |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29262 |
Study title: Hydroxyzine in anaesthesia premedication |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29315 |
Study title: Hydroxyzine in the treatment and management of institutio- nalized mental patients. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE92A2108.pdf |
View full study record |
Document reference: 29236 |
Study title: Hydroxyzine in the treatment of rheumatic chorea in children |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29252 |
Study title: Hydroxyzine prevents isolation-induced vocalization in guinea pig pups: comparison with chlorpheniramine and immepip. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE04K0103.pdf |
View full study record |
Document reference: 29287 |
Study title: Hydroxyzine syrup (atarax) in the management of pediatric behavior problems |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29251 |
Study title: Hydroxyzine versus cetirizine in the treatment of atopic dermatitis in children |
Active substance: HYDROXYZINE |
Study summary document link (including results): DIE90J061 - Cetirizine.pdf |
View full study record |
Document reference: 29220 |
Study title: Factors influencing successful closure with indomethacin of the patent ductus arteriosus in premature infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29903 |
Study title: Failure of prophylactic indomethacin to improve the outcome of the very low birth weight infant. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29904 |
Study title: Flurbiprofen in the treatment of ankylosing spondylitis. A comparison with indomethacin. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29905 |
Study title: Furosemide does not prevent indomethacin-induced renal side effects in preterm infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29906 |
Study title: Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29907 |
Study title: Growth and development until 18 months of children exposed to tocolytics indomethacin or nylidrin. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29908 |
Study title: High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29909 |
Study title: Ibuprofen versus indomethacin in the treatment of patent ductus arteriosus in preterm infants |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29910 |
Study title: Ibuprofen vs indomethacin for treatment of PDA in preterm infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29911 |
Study title: Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29912 |
Study title: Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29914 |
Study title: Increase in serum digoxin concentrations after indomethacin therapy in a full-term neonate |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29915 |
Study title: Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29916 |
Study title: Indometacin as prophylaxis for heterotopic ossification after the operative treatment of fractures of the acetabulum. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29917 |
Study title: Indometacin therapy for idiopathic dysmenorrhea (author's transl)a |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29918 |
Study title: Indomethacin and corticosteroids: an additive constrictive effect on the fetal ductus arteriosus. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29919 |
Study title: Götte and Roschke A supportive measure in the treatment of acute infections of the respiratory tract in children with recurring infections of the upper respiratory tract; päd (7) 2001 |
Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1 |
Study summary document link (including results): |
View full study record |
Document reference: 39716 |
Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS WITH NON-LIFE THREATENING MYCOSIS WHO CANNOT BE TREATED ADEQUATELY TREATED WITH AVAILABLE AGENTS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27676 |
Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS WITH NON-LIFE THREATENING MYCOSIS WHO CANNOT BE TREATED ADEQUATELY TREATED WITH AVAILABLE AGENTS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28038 |
Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN CANCER PATIENTS WITH OROPHARYNGEAL AND OESOPHAGEAL CANDIDIASIS |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27651 |
Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN CANCER PATIENTS WITH OROPHARYNGEAL AND OESOPHAGEAL CANDIDIASIS |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28013 |
Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE THREATENING DEEP MYCOSES. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27675 |
Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE THREATENING DEEP MYCOSES. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28037 |
Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE-THREATENING DEEP MYCOSES, WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27449 |
Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE-THREATENING DEEP MYCOSES, WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27813 |
Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27426 |
Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27791 |
Study title: SAFETY AND EFFICACY OF FLUCONAZOLE PO VS. AMPHOTERICIN B SUSPENSION IN PREVENTION OF CANDIDIASIS IN LEUKEMIC PATIENTS UNDERGOING CHEMOTHERAPY. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27961 |
Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH GASTRO-INTESTINAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27419 |
Study title: Fluoride tablets in prevention of tooth decayG. Stolte, Aus dem Gesundheitsamt der Stadt SolingenM.Hoskova 1968. Ceskoslovenska pediatrie praha |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1968-hoscowa-Fluoride tablets in prevertion od tooth decay.pdf |
View full study record |
Document reference: 48784 |
Study title: Fluoride toothpastes for preventing dental caries in children and adolescents2009-marinho, the cochrane collaboration |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 2009-marinho-fluoride toothpastes for preventing dental caries in children and adolescents.pdf |
View full study record |
Document reference: 49091 |
Study title: Clinical and spirometric evaluation of ipratropium bromide and salbutamol in children with bronchitis and preceding asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U87-0035_synopsis.pdf |
View full study record |
Document reference: 30689 |
Study title: Alphaprodine-hydroxyzine sedation technique for children: a conservative approach. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29295 |
Study title: An evaluation of hydroxyzine hydrochloride as a preopera- tive and post-operative adjunct in dental procedures. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29235 |
Study title: An evaluation of the efficacy of hydroxyzine (Atarax-Vistaril) in controlling the behavior of child patients. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29288 |
Study title: An investigation into the therapeutic action of hydroxyzine (atarax) in the treatment of nervous disorders and the control of the tobacco-habit. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE92D1425.pdf |
View full study record |
Document reference: 29358 |
Study title: Antihistamine selection in patients with allergic rhinitis. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29361 |
Study title: A double-blind single dose study comparing the safety and efficacy of ibuprofen 200 mg, ibuprofen 400 mg, naproxen 200 mg, naproxen 400 mg and placebo in the treatment of post-operative dental painA double-blind single dose study comparing the safety and efficacy of ibuprofen 200 mg, ibuprofen 400 mg, naproxen 200 mg, naproxen 400 mg and placebo in the treatment of post-operative dental pain |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29675 |
Study title: A Double-Blind, Parallel Study to Compare the Efficacy and Side Effects of an Ibuprofen 400 mg/Pseudoephedrine 60 mg Combination, An Ibuprofen 200 mg/Pseudoephedrine 30 mg Combination, and Placebo in the Treatment of Sinus Headache. Protocol 86-638A, Unpublished Report TA93. |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): ibuprofen_pseudoephedrine 86-638A.pdf |
View full study record |
Document reference: 29645 |
Study title: A Double-Blind, Parallel Study to Compare the Efficacy and Side Effects of an Ibuprofen 400 mg/Pseudoephedrine 60 mg Combination, An Ibuprofen 200 mg/Pseudoephedrine 30 mg Combination, and Placebo in the Treatment of Sinus Headache. Protocol 86-638B, Unpublished Report TA94. |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): ibuprofen_pseudoephedrine 86-638B.pdf |
View full study record |
Document reference: 29646 |
Study title: A Double-Blind, Parallel Study to Compare the Efficacy and Side Effects of an Ibuprofen 400 mg/Pseudoephedrine 60 mg Combination, An Ibuprofen 200 mg/Pseudoephedrine 30 mg Combination, and Placebo in the Treatment of Sinus Headache. Protocol 86-638C, Unpublished Report TA95 |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): ibuprofen_pseudoephedrine 86-638C.pdf |
View full study record |
Document reference: 29647 |
Study title: A double-blind, placebo-controlled crossover study comparing the safety and efficacy of ibuprofen sustained release 600 mg and ibuprofen regular release 400 mg in the treatment of primary dysmenorrheaA double-blind, placebo-controlled crossover study comparing the safety and efficacy of ibuprofen sustained release 600 mg and ibuprofen regular release 400 mg in the treatment of primary dysmenorrhea |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29676 |
Study title: A double-blind, single dose evaluation of the comparative analgesic efficacy of acetaminophen 1000 mg, ibuprofen 400 mg, ibuprofen 200 mg, and placebo in the treatment of pain following oral surgeryA double-blind, single dose evaluation of the comparative analgesic efficacy of acetaminophen 1000 mg, ibuprofen 400 mg, ibuprofen 200 mg, and placebo in the treatment of pain following oral surgery |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29677 |
Study title: A double-blind, single dose evaluation of the comparative efficacy of acetaminophen 1000 mg, ibuprofen 200 mg, ibuprofen 400 mg, and placebo in the treatment of pain following periodontal surgeryA double-blind, single dose evaluation of the comparative efficacy of acetaminophen 1000 mg, ibuprofen 200 mg, ibuprofen 400 mg, and placebo in the treatment of pain following periodontal surgery |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29678 |
Study title: Hydroxyzine: pharmacokinetics and antipruritic effect in children with atopic dermatitis. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29342 |
Study title: Idiopathic anaphylaxis: a series of 325 cases. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE95L1361.pdf |
View full study record |
Document reference: 29248 |
Study title: Interaction between sedative premedicants and ketamine in man and in isolated perfused rat livers. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29294 |
Study title: Interaction of ephedrine and theophylline. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29362 |
Study title: Intranasal midazolam better at effecting amnesia after sedation than oral hydroxyzine: a pilot study. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE96L1314.pdf |
View full study record |
Document reference: 29285 |
Study title: Is chloral hydrate/hydroxyzine a good option for paediatric dental outpatient sedation ? |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE99C1134.pdf |
View full study record |
Document reference: 29227 |
Study title: L’hydroxyzine dans la therapeutique des begaiements. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPF92D2132.pdf |
View full study record |
Document reference: 29369 |
Study title: L’hydroxyzine dans le traitement des affections allergiques. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPS92D0750.pdf |
View full study record |
Document reference: 29326 |
Study title: L’idroxizina cloridrato nella pratica anestesiologica |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPI92A2223.pdf |
View full study record |
Document reference: 29240 |
Study title: Nahata−M−C et al. Efficacy of ibuprofen in pediatric patients with fever. {Int−J−Clin−Pharmacol−Ther−Toxicol}, Mar 1992, vol. 30, no. 3, p. 94−6Nahata−M−C et al. Efficacy of ibuprofen in pediatric patients with fever. {Int−J−Clin−Pharmacol−Ther−Toxicol}, Mar 1992, vol. 30, no. 3, p. 94−6 |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29726 |
Study title: Olive−G et al. Randomized, double−blind, multicenter controlled trial of ibuprofen for tonsillitis and pharyngitis in children. {EUR−J−PHARMACOL}, 1990, Vol/Iss/Pg. 183/3 (1042−1043)Olive−G et al. Randomized, double−blind, multicenter controlled trial of ibuprofen for tonsillitis and pharyngitis in children. {EUR−J−PHARMACOL}, 1990, Vol/Iss/Pg. 183/3 (1042−1043) |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29729 |
Study title: Over - the - counter Analgesics and Antipyretics : A critical Assessment - Elliot V. Hersh et al. - 16/02/2000 (Clinical Therapeutics / vol. 22, n°5) - Publication in Rhinathiol tablets (ibuprofen/ pseudoephredin) Pharmaco-toxicological & clinical documentation - Poulain Dominique - 04/2001 - |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29654 |
Study title: Pardo−J et al. Antipyretic efficacy and tolerability of oral ibuprofen, oral dipyrone and intramuscular dipyrone in children: A randomized controlled trial. {SAO−PAULO−MED−J}, 2006, Vol/Iss/Pg. 124/3 (135−140)Pardo−J et al. Antipyretic efficacy and tolerability of oral ibuprofen, oral dipyrone and intramuscular dipyrone in children: A randomized controlled trial. {SAO−PAULO−MED−J}, 2006, Vol/Iss/Pg. 124/3 (135−140) |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29730 |
Study title: Pelen−F et al. Treatment of fever: Monotherapy with ibuprofen. Ibuprofen pediatric suspension containing 100 mg/5 ml(*), multicentre acceptability study conducted in hospital. {ANN−PEDIATR}, 1998, Vol/Iss/Pg. 45/10 (719−728)Pelen−F et al. Treatment of fever: Monotherapy with ibuprofen. Ibuprofen pediatric suspension containing 100 mg/5 ml(*), multicentre acceptability study conducted in hospital. {ANN−PEDIATR}, 1998, Vol/Iss/Pg. 45/10 (719−728) |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29731 |
Study title: Taylor et al. Efficacy and Safety of Echinacea in Treating Upper Respiratory Tract Infections in Children.; JAMA December 3, 2003-Vol 290, No. 21 |
Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1 |
Study summary document link (including results): |
View full study record |
Document reference: 39717 |
Study title: Wber et al. Echinacea purpurea for Prevention of Upper Respiratory Tract Infections in Children; THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 11, Number 6, 2005, pp. 1021–1026 |
Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1 |
Study summary document link (including results): |
View full study record |
Document reference: 39718 |
Study title: Künzer,Retrospective investigation on children (2-12 years) concerning safety and tolerability and dosage of Echinacin Lozenges; unpublished report (1997) |
Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1, 85 % |
Study summary document link (including results): |
View full study record |
Document reference: 39722 |
Study title: Schöneberger Einfluß der immunstimulierenden Wirkung von Preßsaft aus Herba Echinaceae purpureae auf Verlauf und Schweregrad von Erkältungskrankheiten (EC31J0.05)Z. für Immunbiologie in der Praxis, 2 (8), 1992, 18-22 |
Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1, 85 % |
Study summary document link (including results): |
View full study record |
Document reference: 39721 |
Study title: Taylor et al. Efficacy and Safety of Echinacea in Treating Upper Respiratory Tract Infections in Children; JAMA December 3, 2003-Vol 290, No. 21 |
Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1, 85 % |
Study summary document link (including results): |
View full study record |
Document reference: 39719 |
Study title: Weber et al. Echinacea purpurea for Prevention of Upper Respiratory Tract Infections in Children; THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 11, Number 6, 2005, pp. 1021–1026 |
Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1, 85 % |
Study summary document link (including results): |
View full study record |
Document reference: 39720 |
Study title: Effect of valerian, Valeriana edculis, on sleep difficulties in children with intellectual deficits: randomised trial.; Francis AJ, Dempster RJ. Phytomedicine 2002 May; 9(4): 273-279 |
Active substance: (HERB) Valeriana officinalis L. extract |
Study summary document link (including results): |
View full study record |
Document reference: 39723 |
Study title: Sleep disorders in Children. Observational study with a high dosage valerian extract.; Hintelmann C. Schweiz. Z. Ganzheitsmed. 2002;14( ): 404-407 |
Active substance: (HERB) Valeriana officinalis L. extract |
Study summary document link (including results): |
View full study record |
Document reference: 39724 |
Study title: A combination of valerian and lemon balm is effective in the treatment of restlessness and dyssomnia in children; Article published: Mueller SF; Klement S. Phytomedicine (Jena) 2006;13(6): 383-387 |
Active substance: (HERB) Valeriana officinalis L. extract Melissa officinalis L. extract |
Study summary document link (including results): |
View full study record |
Document reference: 39725 |
Study title: HX181-Appréciation en ouvert de l'activité et de la tolérance héxomedine solution chez l'enfant (dossier de modification de formule du 30/10/87) -partie IVB - Paupe and Prost - 27/04/1986Kettelhut, B. V., Berkebile, C., Bradley, D., and Metcalfe, D. D. Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Disease, Bethesda, Md 20892 A double-blind, placebo-controlled, crossover trial of ketotifen versus hydroxyzine in the treatment of pediatric mastocytosis J.Allergy Clin.Immunol. 1989;83:866-870. |
Active substance: HEXAMIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 29119 |
Study title: HX181-Open study to assess the activity and tolerance of hexomedine solution in children (french dossier-change in formulation-30/10/87)-partie IVB - Paupe and Prost - 27/04/1986Simons, F. E., Simons, K. J., Becker, A. B., and Haydey, R. P. Pharmacokinetics and antipruritic effects of hydroxyzine in children with atopic dermatitis J.Pediatr. 1984;104:123-127. |
Active substance: HEXAMIDINE |
Study summary document link (including results): Hexamidine STUDY 0000103117.xls |
View full study record |
Document reference: 29120 |
Study title: Prevention of nosocomial infection in a pediatric intensive care unit (PICU) through the use of selective digestive decontamination. Ruza F, Alvarado F, Herruzo R, Delgado MA, García S, Dorao P, Goded F. Eur J Epidemiol. 1998 Oct;14(7):719-27.Prevention of nosocomial infection in a pediatric intensive care unit (PICU) through the use of selective digestive decontamination. Ruza F, Alvarado F, Herruzo R, Delgado MA, García S, Dorao P, Goded F. Eur J Epidemiol. 1998 Oct;14(7):719-27. |
Active substance: HEXETIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 29121 |
Study title: Thomas JG et al. Managing the complexity of a dynamic biofilm. J Am Dent Assoc 2006; 137: 10s-15sThomas JG et al. Managing the complexity of a dynamic biofilm. J Am Dent Assoc 2006; 137: 10s-15s |
Active substance: HEXETIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 29122 |
Study title: Observational study Angina-Gastreu N R1 |
Active substance: (HMP) Apis D4, Belladonna D4, Calcium iodatum D4, Hepar sulfuris D12, Kalium bichromicum D4, Lachesis D12, Marum verum D6, Mercurius sublimatus corrosivus D5, Phytolacca D4 |
Study summary document link (including results): |
View full study record |
Document reference: 39731 |
Study title: Clinical trial of a new bronchodilator fenoterol (Berotec) administered by inhalation to asthmatic children. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30588 |
Study title: Clinical trial on Berotec syrup for bronchial Asthma in children (well-controlled comparative trial). |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30609 |
Study title: Clinical trial on Berotec syrup in children with bronchial asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30608 |
Study title: Clinical trial with Th 1165a metered aerosol in children. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30600 |
Study title: Combivent vs. salbutamol in patients with metacholine-induced bronchospasm |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_salbutamol sulphate_U00-0040_synopsis.pdf |
View full study record |
Document reference: 30659 |
Study title: Comparative double-blind study of the bronchodilating effect of ipratropium bromide administered as inhalation powder with two different powder inhalators in children with bronchial asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30552 |
Study title: Comparative double-blind study of the bronchodilating effect of ipratropium bromide administered as inhalation powder with two different powder inhalators in children with bronchial asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U97-0051_synopsis.pdf |
View full study record |
Document reference: 30713 |
Study title: Comparative study of ipratropium bromide and salbutamol in children with chronic bronchitis and / or asthmatic bronchitis. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30551 |
Study title: Comparative study of ipratropium bromide and salbutamol in children with chronic bronchitis and / or asthmatic bronchitis. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U87-0397_synopsis.pdf |
View full study record |
Document reference: 30690 |
Study title: Comparative study with Ipratropium bromide versus Salbutamol in 30 asymptomatiy asthmatic children. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30574 |
Study title: Comparative study with Ipratropium bromide versus Salbutamol in 30 asymptomatiy asthmatic children. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U84-0911_synopsis.pdf |
View full study record |
Document reference: 30679 |
Study title: Comparison of 2 weeks of therapy with IK 6 and fenoterol administered as a capsule with the aid of a powder inhaler in children with bronchial asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30611 |
Study title: Comparison of 2 weeks of therapy with IK 6 and fenoterol administered as a capsule with the aid of a powder inhaler in children with bronchial asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30675 |
Study title: Comparison of Ba-253 and Atrovent metered aerosol in exercise-induced asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30566 |
Study title: Comparison of Ba-253 and Atrovent metered aerosol in exercise-induced asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U78-0018_synopsis.pdf |
View full study record |
Document reference: 30666 |
Study title: Comparison of nebulised fenoterol with that delivered by metered aerosol in children with asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30562 |
Study title: Comparison of the bronchodilatory effect of nebulised ipratropium bromide and fenoterol in children with acute crisis of asthma. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30632 |
Study title: Comparison of the bronchospasmolytic action of Berotec and Atrovent inhalation solution in infants |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U86-0413_synopsis.pdf |
View full study record |
Document reference: 30618 |
Study title: Comparison of the bronchospasmolytic action of Berotec and Atrovent inhalation solution in infants. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30684 |
Study title: Nahata−M−C et al. Efficacy of ibuprofen in pediatric patients with fever. {Int−J−Clin−Pharmacol−Ther−Toxicol}, Mar 1992, vol. 30, no. 3, p. 94−6Nahata−M−C et al. Efficacy of ibuprofen in pediatric patients with fever. {Int−J−Clin−Pharmacol−Ther−Toxicol}, Mar 1992, vol. 30, no. 3, p. 94−6 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29583 |
Study title: A double-blind, single dose parallel study to compare analgesic efficacy and side effects profile of acetaminophen 1000 mg, ibuprofen 400 mg, ibuprofen 200 mg, and placebo in the treatment of muscle contraction ('tension') headacheA double-blind, single dose parallel study to compare analgesic efficacy and side effects profile of acetaminophen 1000 mg, ibuprofen 400 mg, ibuprofen 200 mg, and placebo in the treatment of muscle contraction ('tension') headache |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29679 |
Study title: A multiple dose study comparing the antipyretic efficacy and safety of 5-7 mg/kg of ibuprofen and 10-15 mg/kg of acetaminophen in febrile children. Feb 1988.A multiple dose study comparing the antipyretic efficacy and safety of 5-7 mg/kg of ibuprofen and 10-15 mg/kg of acetaminophen in febrile children. Feb 1988. |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29680 |
Study title: Fluoride tablets in pre-school age - effect on primary and permanent teethRoland Andersson, Hans Grahnen. Swed Dent J69 137 - 143 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1969-anderesson-Fluoride Tablets in Preschool Age - Effect on Primary and Permanent Teeth.pdf |
View full study record |
Document reference: 48767 |
Study title: Open randomised controlled study to evaluate the safety and immunogenicity of a paediatric dose (0.25 mL) and the standard dose (0.5 mL) of Epaxal® with reference to Havrix Juniror® in healthy children and adolescents (³ 1-16 years) using a 0/6 month schedule. |
Active substance: Inactivated hepatitis A virus (strain RG-SB). |
Study summary document link (including results): |
View full study record |
Document reference: 21201 |
Study title: Open randomised controlled study to evaluate the safety and immunogenicity of a paediatric dose (0.25 mL) and the standard dose (0.5 mL) of Epaxal® with reference to Havrix Juniror® in healthy children and adolescents (³ 1-16 years) using a 0/6 month schedule. |
Active substance: Inactivated hepatitis A virus (strain RG-SB). |
Study summary document link (including results): |
View full study record |
Document reference: 21202 |
Study title: Open randomised controlled study to evaluate the safety and immunogenicity of a paediatric dose (0.25 mL) and the standard dose (0.5 mL) of Epaxal® with reference to Havrix Juniror® in healthy children and adolescents (³ 1-16 years) using a 0/6 month schedule. |
Active substance: Inactivated hepatitis A virus (strain RG-SB). |
Study summary document link (including results): |
View full study record |
Document reference: 41086 |
Study title: Open, controlled randomised multi-centre study to assess and compare local reactions of a single dose of Epaxal® to Havrix Monodose® and Havrix Junior® (where applicable) in parallel-groups. |
Active substance: Inactivated hepatitis A virus (strain RG-SB). |
Study summary document link (including results): |
View full study record |
Document reference: 41088 |
Study title: HAB-051 |
Active substance: inactivated hepatitis a virus and hepatitis b surface antigen (rdna) |
Study summary document link (including results): |
View full study record |
Document reference: 41480 |
Study title: HAB-052 |
Active substance: inactivated hepatitis a virus and hepatitis b surface antigen (rdna) |
Study summary document link (including results): |
View full study record |
Document reference: 41481 |
Study title: HAB-164 Ext:038 Y10 |
Active substance: inactivated hepatitis a, hepatitis b recombinant, adsorbed, vaccine |
Study summary document link (including results): |
View full study record |
Document reference: 41612 |
Study title: Evaluation of safety and immunogenicity of inactivated flu vaccine in children with underlying disease |
Active substance: INACTIVATED INFLUENZA SPLIT VIRION VACCINE (TRITON X 100) |
Study summary document link (including results): |
View full study record |
Document reference: 41289 |
Study title: Immunogenicity and safety of the inactivated, split virion influenza vaccine in high risk children aged from 3 to 8 years |
Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) |
Study summary document link (including results): |
View full study record |
Document reference: 41221 |
Study title: Immunogenicity and safety of the inactivated, split virion influenza vaccine in high risk children aged from 3 to 8 years |
Active substance: INACTIVATED INFLUENZA SPLIT VIRION VACCINE (TRITON X 100) |
Study summary document link (including results): |
View full study record |
Document reference: 41290 |
Study title: Immunogenicity and safety of the inactivated, split virion influenza vaccine in high risk children aged from 6 to 35 months |
Active substance: INACTIVATED INFLUENZA SPLIT VIRION VACCINE (TRITON X 100) |
Study summary document link (including results): |
View full study record |
Document reference: 41291 |
Study title: Evaluation of safety and immunogenicity of inactivated flu vaccine in children with underlying disease |
Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) without Thiomersal |
Study summary document link (including results): |
View full study record |
Document reference: 41217 |
Study title: Phadke−M−A et al. Ibuprofen in children with infective disorders−−antipyretic efficacy. {Br−J−Clin−Pract}, Nov−Dec 1985, vol. 39, no. 11−12, p. 437−40Phadke−M−A et al. Ibuprofen in children with infective disorders−−antipyretic efficacy. {Br−J−Clin−Pract}, Nov−Dec 1985, vol. 39, no. 11−12, p. 437−40 |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29733 |
Study title: Pharmacokinetics of oral decongestants - Isadore Kanfer et al. - 1993 (Pharmacotherapy ; 13) - Publication in Rhinathiol tablets (ibuprofen/ pseudoephredin) Pharmaco-toxicological & clinical documentation- Poulain Dominique - 04/2001 - |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29655 |
Study title: Renal excretion of pseudoephedrine - D. Craig Brater et al - November 1980 ( Clin .Pharmacol.Ther/vol 28, n°5) - Publication in Rhinathiol tablets (ibuprofen/ pseudoephredin) Pharmaco-toxicological documentation- Poulain Dominique - 04/2001 - |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29656 |
Study title: Starha−J et al. Ibuprofen as an antipyretic drug in childhood. {CESKO−SLOV−PEDIATR}, 1994, Vol/Iss/Pg. 49/7 (424−427)Starha−J et al. Ibuprofen as an antipyretic drug in childhood. {CESKO−SLOV−PEDIATR}, 1994, Vol/Iss/Pg. 49/7 (424−427) |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29739 |
Study title: The Safety of Antipyretic Medication Use Among Children Less Than Two Years of Age: A Subgroup Analysis of the Boston University Fever Study Data. Dec 1997.The Safety of Antipyretic Medication Use Among Children Less Than Two Years of Age: A Subgroup Analysis of the Boston University Fever Study Data. Dec 1997. |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29740 |
Study title: The safety profile of nonprescription ibuprofen in multiple-dose use : a meta-analysis - David E Kellstein- 1999 (J clin Pharmacol vol 39) - Publication in Rhinathiol tablets (ibuprofen/ pseudoephredin) Pharmaco-toxicological & clinical documentation- Poulain Dominique - 04/2001 - |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29657 |
Study title: Visual hallucinations in a toddler : accidental ingestion of a sympathomimetic over-the-counter nasal decongestant - Kurtis L. Sauder et al. 19/09/1999 ( American journal of emergency medecine vol 15 n°5) - Publication in Rhinathiol tablets (ibuprofen/ pseudoephredin) Pharmaco-toxicological & clinical documentation- Poulain Dominique - 04/2001 - |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29658 |
Study title: Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29841 |
Study title: Comparative study of the clinical effects of ibuprofen and indomethacin in rheumatoid arthritis. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29842 |
Study title: Comparison between fluproquazone and indomethacin in treatment of primary dysmenorrhoea. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29843 |
Study title: Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29844 |
Study title: Comparison of piroxicam with indomethacin in ankylosing spondylitis: a double-blind crossover trial. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29845 |
Study title: Comparison of single and multiple dose pharmacokinetics using clinical bioequivalence data and Monte Carlo simulations. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29846 |
Study title: Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29847 |
Study title: Complex treatment of acne with lipoic acida |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29848 |
Study title: Clinical trial of IK-26. |
Active substance: HYOSCINE BUTYLBROMIDE AND PARACETAMOL |
Study summary document link (including results): Hyoscine Butylbromide+Paracetamol_U80-0288_synopsis.pdf |
View full study record |
Document reference: 23094 |
Study title: Open study with IK19 in 50 children and 50 adults. |
Active substance: HYOSCINE BUTYLBROMIDE AND PARACETAMOL |
Study summary document link (including results): Hyoscine Butylbromide+Paracetamol_U79-0384_synopsis.pdf |
View full study record |
Document reference: 23092 |
Study title: Spasmolytic-analgesic efficacy of the substance IK-26 in pediatry. |
Active substance: HYOSCINE BUTYLBROMIDE AND PARACETAMOL |
Study summary document link (including results): Hyoscine Butylbromide+Paracetamol_U80-0287_synopsis.pdf |
View full study record |
Document reference: 23093 |
Study title: Commentary on the dosage of Buscopan® injection solution in children and juveniles. Boehringer Ingelheim in-house files, May 1995. |
Active substance: HYOSCINE-N-BUTYLBROMIDE |
Study summary document link (including results): Hyoscine Butylbromide_U96-0263_synopsis.pdf |
View full study record |
Document reference: 47311 |
Study title: Expert clinical statement on Buscopan® liquid (hyoscine-N-butylbromide). |
Active substance: HYOSCINE-N-BUTYLBROMIDE |
Study summary document link (including results): Hyoscine Butylbromide_U95-0207_synopsis.pdf |
View full study record |
Document reference: 47310 |
Study title: BIOKID: Randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solution in children |
Active substance: HYPERTONIC SOLUTIONS |
Study summary document link (including results): |
View full study record |
Document reference: 29376 |
Study title: Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children, 2002 |
Active substance: HYPERTONIC SOLUTIONS |
Study summary document link (including results): |
View full study record |
Document reference: 29378 |
Study title: Improved Acidosis Correction and Recovery of Mesothelial Cell Mass with Neutral-pH Bicarbonate Dialysis Solution among Children Undergoing Automated Peritoneal Dialysis, 2003 |
Active substance: HYPERTONIC SOLUTIONS |
Study summary document link (including results): |
View full study record |
Document reference: 29377 |
Study title: Reduced Advanced Glycation Endproduct (AGE) Levels in Children on Automated Peritoneal Dialysis (PD) with PD-Fluids Containing Less Glucose Degradation Products (GDPs), 2003 |
Active substance: HYPERTONIC SOLUTIONS |
Study summary document link (including results): |
View full study record |
Document reference: 29379 |
Study title: 4. Arch Pediatr Adolesc Med. 2006 Feb;160(2):197-202. Comment in: Arch Pediatr Adolesc Med. 2006 Jul;160(7):757; Antipyretic treatment in young children with fever: acetaminophen, ibuprofen, or both alternating in a randomized, double-blind study. Sarrell EM, Wielunsky E, Cohen HA4. Arch Pediatr Adolesc Med. 2006 Feb;160(2):197-202. Comment in: Arch Pediatr Adolesc Med. 2006 Jul;160(7):757; Antipyretic treatment in young children with fever: acetaminophen, ibuprofen, or both alternating in a randomized, double-blind study. Sarrell EM, Wielunsky E, Cohen HA |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29613 |
Study title: A 12-week multicentre double-blind parallel group study comparing the action of Ibuprofen suspension and aspirin in the treatment of active juvenile rheumatoidarthritis. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29398 |
Study title: A blinded, single-dose, parallel study comparing the antipyretic afficacy and safety of ibuprofen pediatric suspension and acetaminophen suspension in children with fever (AF 96-01) |
Active substance: IBUPROFEN |
Study summary document link (including results): Ibuprofen Clinical Trial Summaries.pdf |
View full study record |
Document reference: 29533 |
Study title: A Blinded, Single-Dose, Parallel Study Comparing the Antipyretic Efficacy and Safety of Ibuprofen Paediatric Suspension in Children with Fever |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29538 |
Study title: A clinical trial to evaluate the efficacy and safety of compound pseudoephedrine hydrochloride sustained release capsule in patients with seasonal allergic rhinitis. Zhonghua Er Bi Yan Hou Ke Za Zhi 2004; 39(9):549-53 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29507 |
Study title: Nurofen for Children in Febrile Children. Data held in Ukraine. Copy report, Protocol, Ethics and correspondence. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29393 |
Study title: Olive−G et al. Randomized, double−blind, multicenter controlled trial of ibuprofen for tonsillitis and pharyngitis in children. {EUR−J−PHARMACOL}, 1990, Vol/Iss/Pg. 183/3 (1042−1043)Olive−G et al. Randomized, double−blind, multicenter controlled trial of ibuprofen for tonsillitis and pharyngitis in children. {EUR−J−PHARMACOL}, 1990, Vol/Iss/Pg. 183/3 (1042−1043) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29602 |
Study title: Open dose response study of Ibuprofen in juvenile chronic arthritis Dr P Manners of University of Western Australia, Perth, Australia |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29422 |
Study title: Open dose response study of Ibuprofen in juvenile chronic arthritis Dr P Manners of University of Western Australia, Perth, Australia |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29437 |
Study title: Open label pharmacokinetic study of a single dose ibuprofen suppository in children with fever |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29474 |
Study title: Open label pharmacokinetic study of a single dose ibuprofen suppository in children with fever |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29519 |
Study title: Open Label Pharmacokinetic Study of a Single Dose Ibuprofen Suppository in Children with Fever |
Active substance: IBUPROFEN |
Study summary document link (including results): ibuprofen 573-CHC-9127-001.pdf |
View full study record |
Document reference: 47458 |
Study title: Pardo−J et al. Antipyretic efficacy and tolerability of oral ibuprofen, oral dipyrone and intramuscular dipyrone in children: A randomized controlled trial. {SAO−PAULO−MED−J}, 2006, Vol/Iss/Pg. 124/3 (135−140)Pardo−J et al. Antipyretic efficacy and tolerability of oral ibuprofen, oral dipyrone and intramuscular dipyrone in children: A randomized controlled trial. {SAO−PAULO−MED−J}, 2006, Vol/Iss/Pg. 124/3 (135−140) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29568 |
Study title: Pelen−F et al. Treatment of fever: Monotherapy with ibuprofen. Ibuprofen pediatric suspension containing 100 mg/5 ml(*), multicentre acceptability study conducted in hospital. {ANN−PEDIATR}, 1998, Vol/Iss/Pg. 45/10 (719−728)Pelen−F et al. Treatment of fever: Monotherapy with ibuprofen. Ibuprofen pediatric suspension containing 100 mg/5 ml(*), multicentre acceptability study conducted in hospital. {ANN−PEDIATR}, 1998, Vol/Iss/Pg. 45/10 (719−728) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29584 |
Study title: Perrott−D−A et al. Efficacy and safety of acetaminophen vs ibuprofen for treating children's pain or fever: A Meta−analysis. {ARCH−PEDIATR−ADOLESC− MED}, 2004, Vol/Iss/Pg. 158/6 (521−526)Perrott−D−A et al. Efficacy and safety of acetaminophen vs ibuprofen for treating children's pain or fever: A Meta−analysis. {ARCH−PEDIATR−ADOLESC− MED}, 2004, Vol/Iss/Pg. 158/6 (521−526) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29570 |
Study title: Phadke−M−A et al. Ibuprofen in children with infective disorders−−antipyretic efficacy. {Br−J−Clin−Pract}, Nov−Dec 1985, vol. 39, no. 11−12, p. 437−40Phadke−M−A et al. Ibuprofen in children with infective disorders−−antipyretic efficacy. {Br−J−Clin−Pract}, Nov−Dec 1985, vol. 39, no. 11−12, p. 437−40 |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29596 |
Study title: Pharmacodynamics of fever treatment with ibuprofen, acetaminophen and placebo in children. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29459 |
Study title: Population pk study in premature infants for Ibuprofen Lysine IV |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29419 |
Study title: Product-Ibuprofen Pediatric 03.88-05.90 Memos, Correspondence, IND memos, AMA Press release (03.21.95), Confidential Inv. Brochure chewable Tablet, Protocol Review (P/2750/0003, P/3100/0162, P/2000/0430), NDA 19-833, NDA 19-842, NDA-833, Arthritis and Rheumatism Journals (01.89) |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29564 |
Study title: Relazione sullo studio di palatabilità di Moment gocce. Valutazione comparativa a Novalgina gocce in soggetti volontari. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29455 |
Study title: Indomethacin treatment of children suffering from nephrogenic diabetes insipidus or secondary tubulopathy associated with severe polyuria |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29942 |
Study title: Immunogenicity and safety of P.M.sv, inactivated split influenza vaccine in children between 6 months and 3 years old |
Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) without Thiomersal |
Study summary document link (including results): |
View full study record |
Document reference: 41477 |
Study title: Immunogenicity and safety of the inactivated, split virion influenza vaccine in high risk children aged from 3 to 8 years |
Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) without Thiomersal |
Study summary document link (including results): |
View full study record |
Document reference: 41474 |
Study title: Immunogenicity and tolerability of the Aventis Pasteur inactivated flu vaccine (IMOVAX GRIPE) in high risk and healthy children aged from 6 to 35 months |
Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) without Thiomersal |
Study summary document link (including results): |
View full study record |
Document reference: 41476 |
Study title: Safety of inactivated split-virion influenza vaccine administered by the intradermal route in healthy children |
Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) without Thiomersal |
Study summary document link (including results): |
View full study record |
Document reference: 45254 |
Study title: Immunogenicity and safety of the inactivated, split virion influenza vaccine in high risk children aged from 6 to 35 months |
Active substance: Inactivated Influenzae Split Virion Vaccine |
Study summary document link (including results): |
View full study record |
Document reference: 41475 |
Study title: EVALUATION OF A NEW COMBINED INACTIVATED DTP-POLIO VACCINE |
Active substance: Inactivated Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41181 |
Study title: Successful treatment with indomethacin of three children with Bartter's syndrome |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30022 |
Study title: Sulglycotide in the prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal mucosal injury. A controlled double-blind, double-dummy, randomized endoscopic study versus placebo in rheumatic patients. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30023 |
Study title: Sulglycotide in the prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal mucosal injury. A controlled double-blind, double-dummy, randomized endoscopic study versus placebo in rheumatic patients. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30024 |
Study title: Surgical closure of patent ductus arteriosus in 268 preterm infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30025 |
Study title: Symptomatic patent ductus arteriosus following prophylactic indomethacin. A clinical and biochemical appraisal. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30026 |
Study title: Systematic review: intravenous Ibuprofen in preterm newborns. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30027 |
Study title: The effect of antenatal dexamethasone administration on the fetal and neonatal ductus arteriosus. A randomized double-blind study. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30028 |
Study title: The effect of indomethacin on renal function in children with congenital nephrogenic diabetes insipidus |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30029 |
Study title: The effects of indomethacin on refractoriness following exercise both with and without a bronchoconstrictor response. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30030 |
Study title: The hemodynamic effects of antenatal indomethacin and a beta-sympathomimetic agent on the fetus and the newborn: a randomized study. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30031 |
Study title: The hemodynamically significant ductus arteriosus in critically ill full-term neonates - Two case reports? |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30032 |
Study title: The patent ductus arteriosus. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30033 |
Study title: Congenital heart disease and respiratory distress syndrome. Reversal of indomethacin closure of patent ductus arteriosus by prostaglandin therapy in a preterm infant |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29849 |
Study title: Continuous versus multiple rapid infusions of indomethacin: effects on cerebral blood flow velocity. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29850 |
Study title: Controlled clinical trial of parsalmide in patients with subacute and chronic arthro-neuro-mypathiesa |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29851 |
Study title: Controlled study of the effects of indomethacin on cerebral blood flow velocities in newborn infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29852 |
Study title: Controlled therapeutic trial in IgA glomerulonephritisa |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29853 |
Study title: Decreased plasma glucose after indomethacin therapy in premature infants with patent ductus anteriosus. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29854 |
Study title: Demographic and therapeutic determinants of pain reactivity in very low birth weight neonates at 32 Weeks' postconceptional Age. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29855 |
Study title: Digoxin-indomethacin interaction |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29856 |
Study title: Does furosemide prevent the indomethacin induced changes in renal function in prematures? |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29857 |
Study title: Does indomethacin prophylaxis benefit extremely low birth weight infants? Results of a placebo-controlled multicenter trial. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29858 |
Study title: Does indomethacin reduce heterotopic bone formation after operations for acetabular fractures? A prospective randomised study. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29859 |
Study title: Does prophylactic intravenous infusion of indomethacin improve the management of postoperative pain in children? |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29860 |
Study title: Almishari MA. (1994). The Gulf Journal of Dermatology [Kuwait]. February,1(1):30-31. Isoprinosine® therapy in varicellaAlmishari MA. (1994). The Gulf Journal of Dermatology [Kuwait]. February,1(1):30-31. Isoprinosine® therapy in varicella |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30066 |
Study title: Angioni G, Monni A, Piro S, Serru G. ]. Rassegna Medica Sarda. May 26, 1979; 82(5):1-19. Isoprinosina in the treatment of acute viral hepatitis Angioni G, Monni A, Piro S, Serru G. ]. Rassegna Medica Sarda. May 26, 1979; 82(5):1-19. Isoprinosina in the treatment of acute viral hepatitis |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30067 |
Study title: Anlar B, Guven A, Kose G, Okur H, Kose O, Aydin OF, Kabakus N, Altunbasak S, Herguner O, Sonmez M, Serdaroglu A. J Neuroimmunol. 2005 Jun;163(1-2):195-8. Lymphocyte subsets, TNF alpha and interleukin-4 levels in treated and untreated subacute sclerosing panencephalitis patients.Anlar B, Guven A, Kose G, Okur H, Kose O, Aydin OF, Kabakus N, Altunbasak S, Herguner O, Sonmez M, Serdaroglu A. J Neuroimmunol. 2005 Jun;163(1-2):195-8. Lymphocyte subsets, TNF alpha and interleukin-4 levels in treated and untreated subacute sclerosing panencephalitis patients. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30068 |
Study title: Anlar B, Yalaz K, Imir T, Turanli G. Eur Neurol. 1994;34(1):44-7. The effect of inosiplex in subacute sclerosing panencephalitis: a clinical and laboratory study.Anlar B, Yalaz K, Imir T, Turanli G. Eur Neurol. 1994;34(1):44-7. The effect of inosiplex in subacute sclerosing panencephalitis: a clinical and laboratory study. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30069 |
Study title: Anlar B, Yalaz K, Oktem F, Kose G. Neurology. 1997 Feb;48(2):526-8. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon.Anlar B, Yalaz K, Oktem F, Kose G. Neurology. 1997 Feb;48(2):526-8. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30070 |
Study title: Inactivated poliovirus vaccine clinical expertise |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41184 |
Study title: Large scale safety study of the DTacP-IPV {acellular TETRACOQ®) vaccine, administered in combination (one injection site) or in assocation two injection sites) with Haemophilus influenzae Type b vaccine (Act-HIB®) for primary and booster immunisation |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41203 |
Study title: Merieux inactivated poliovirus vaccine Final report of clinical studies at Suny/Children's hospital, Buffalo, New York & John Hopkins University, Baltimore, Maryland |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41187 |
Study title: Merieux inactivated poliovirus vaccine Final report of clinical studies at Suny/Children's hospital, Buffalo, New York & John Hopkins University, Baltimore, Maryland |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 47469 |
Study title: Phase III trial on the persistence of antibodies 5 years after a primo-vaccination and 4 years after a first booster with PENTAVAC® vaccine and the immunogenicity and safery of a second booster with TETRAVAC-ACELLULAIRE® vaccine at the ager of 5-6 years |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41194 |
Study title: Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41207 |
Study title: Randomised open trial of the safety and the immunogenicity of a combined dihtheria, tetanus, acellular pertussis and inactivated polio vaccine (DTacP-IPV) mixed with Haemophilus influenzae type b vaccine (Act-HIB®) given either at 3-5 and 12 or 2-4-6 and 13 months of age |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41190 |
Study title: Safety and dose-escalation of a tetravalent Meningococcal polysaccharide diphtheria conjugate (A, C, Y AND W-135) vaccine adults, toodlers and infants |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41204 |
Study title: Safety and dose-escalation of a tetravalent meningococcal polysaccharide diphtheria conjugate (A, C, Y and W-135) vaccine in adults, toddlers and infants |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 47470 |
Study title: Safety and immunogenicity of a diphteria, tetanus, acellular pertussis, enhanced inactivated trivalent poliovirus vaccine administered separately or combined with Haemophilus influenzae type b vaccine, to healthy Chilean infants |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41188 |
Study title: Double-blind, multinational, multicentre, parallel-group, placebo-controlled design clinical trial of the efficacy and safety of nebulized beclomethasone dipropionate (400 mcg b.i.d.) plus as needed salbutamol versus as needed salbutamol or as needed salbutamol/beclomethasone fixed combination, in the 12-week treatment of young childrem with asthma symptoms.please see report |
Active substance: SALBUTAMOL AND BECLOMETHASONE DIPROPIONATE |
Study summary document link (including results): MC.PR.1404.002.05 publication.pdf |
View full study record |
Document reference: 49209 |
Study title: On the use of a Beclometasone Dipropionate-Salbutamol combination in powder form in the topical treatment of allergic bronchial asthma in children: comparison with metered aerosol.Clin .Ped.,1982,64(3),102-116. G.Baldini et al |
Active substance: SALBUTAMOL AND BECLOMETHASONE DIPROPIONATE |
Study summary document link (including results): Art 45 EMA Chiesi Paediatric Studies.xls |
View full study record |
Document reference: 48879 |
Study title: A Stratified, Multicenter, Randomized, Double-Blind, Parallel Group, 4-Week Comparison of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg BID versus Fluticasone Propionate DISKUS 100mcg in Pediatric and in Adolescent Subjects with Activity-Induced Bronchospasm. Report No. RM2005/00345/00 |
Active substance: SALMETEROL |
Study summary document link (including results): |
View full study record |
Document reference: 35593 |
Study title: Indomethacin versus radiation therapy for prophylaxis against heterotopic ossification in acetabular fractures: a randomised, prospective study. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29943 |
Study title: Indomethacin, patent ductus arteriosus, and cerebral blood flow |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29944 |
Study title: Indomethacin. Clinical and biologic study conducted with 73 patients |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29945 |
Study title: Infantile cystinosis: A 3-year indomethacin (IDM) treatment |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29946 |
Study title: Inhaled indomethacin prevents bronchoconstrictive response to distilled water but not to histamine in children with asthma. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29947 |
Study title: Interaction between flurbiprofen and indomethacin in rheumatoid arthritis. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29948 |
Study title: Intestinal perforation after intravenous indomethacin in a premature infant |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29949 |
Study title: Intestinal perforation following indomethacin therapy for patent ductus arteriosus |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29950 |
Study title: Intravenous indometacin in preterm infants with symptomatic patent ductus arteriosus. A population pharmacokinetic study. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29951 |
Study title: Intravenous indomethacin as postoperative analgesic in children: acute effects on blood pressure, heart rate, body temperature and bleeding. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29952 |
Study title: Intravenous indomethacin in the treatment of ureteric colic. A clinical multicentre study with pethidine and metamizol as the control preparations. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29953 |
Study title: Intravenous indomethacin therapy in infants with a patent ductus arteriosus complicating other congenital heart defects. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29954 |
Study title: Intravenous indomethacin therapy in premature infants with patent ductus arteriosus. Causes of death and one-year follow-up. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29955 |
Study title: Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus--a double-blind controlled study. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29956 |
Study title: Intravenous indomethacin therapy in preterm neonates with patent ductus arteriosus. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29957 |
Study title: Intraventricular hemorrhage of the preterm neonate: prevention studies. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29958 |
Study title: Intraventricular hemorrhage of the preterm neonate: prevention studies. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29959 |
Study title: Irreversible renal failure after indomethacin in steroid-resistant nephrosis. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29960 |
Study title: Is there a relationship between indomethacin-induced reduction in neonatal cerebral blood flow velocity and prostaglandin production? |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29961 |
Study title: The response of normal and asthmatic subjects to prostaglandins E2 and F2alpha by different routes, and their significance in asthma. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30035 |
Study title: The silent ductus: its precursors and its aftermath. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30036 |
Study title: The therapy with indomethacin in the Bartter's syndrome interferes with the height growth? |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30037 |
Study title: The use of dopamine for the prevention of the renal side effects of indomethacin in premature infants with patent ductus arteriosus. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30038 |
Study title: The use of indomethacin for the prevention of intraventricular brain hemorrhage in high-risk neonates. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30039 |
Study title: The use of indomethacin in the treatment of pericarditis in childhood |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30040 |
Study title: Arrhythmias during right heart catheterization |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE92B2815.pdf |
View full study record |
Document reference: 29281 |
Study title: Assessment of the effects of 2 sedation regimens on cardiopulmonary parameters in pediatric dental patients: a retrospective study. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE06J1502.pdf |
View full study record |
Document reference: 29238 |
Study title: Ataraktika in der padiatrie |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPD92A0705.pdf |
View full study record |
Document reference: 29228 |
Study title: Bullous mastocytosis : diffuse cutaneous mastocytosis with extensive blisters mimicking scalded skin syndrome or erythema multiforme |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29263 |
Study title: Cetirizine vs hydroxyzine. Atopic dermatitis in children. Statistical report |
Active substance: HYDROXYZINE |
Study summary document link (including results): 9039 - Cetirizine - MRCE91M1101.pdf |
View full study record |
Document reference: 29221 |
Study title: Cleft lip repair using intramuscular hydroxyzine sedation and local anesthesia |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE93L0414.pdf |
View full study record |
Document reference: 29277 |
Study title: Clinical evaluation of hydroxyzine hydrochloride in pediatric anesthesia and its effect on arousal time. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29304 |
Study title: Clinical evaluation of parenteral hydroxyzine for preoperative medication |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29265 |
Study title: Clinical experience with hydroxyzine in preanesthetic medication. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE92D2157.pdf |
View full study record |
Document reference: 29371 |
Study title: Clinical impressions of hydroxyzine and other tranquilizers in a child guidance clinic. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29317 |
Study title: Clinical observation to evaluate the patient oriented dosages of Palladon® retard with respect to circadian variations in pain intensity (0.1% of patients 10-19 years) (Germany) |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29374 |
Study title: Clinical observation utilizing morphine sulfate and hydroxyzine pamoate for sedating apprehensive children for dental procedures: a nine-year report. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE91B2604.pdf |
View full study record |
Document reference: 29329 |
Study title: Antonini G, Stefano GM, Spataro R, Coronel N, Andres FJ, Ink, RL, Scarpiello V, Genoves MH, Natelli C, Buey O, Ink JJornada Medica Argentina. January 27, 1971; 3(343):4-8. NPT10381 and bronchiolitis: new antiviral agentAntonini G, Stefano GM, Spataro R, Coronel N, Andres FJ, Ink, RL, Scarpiello V, Genoves MH, Natelli C, Buey O, Ink JJornada Medica Argentina. January 27, 1971; 3(343):4-8. NPT10381 and bronchiolitis: new antiviral agent |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30071 |
Study title: Asawanonda P.. 1990. Graduate School of Chulalongkorn University Treatment of multiple warts with Isoprinosine: an open studyAsawanonda P.. 1990. Graduate School of Chulalongkorn University Treatment of multiple warts with Isoprinosine: an open study |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30072 |
Study title: Aydin OF, Senbil N, Gurer YK. J Child Neurol. 2006 Mar;21(3):256-60. Nonconvulsive status epilepticus on electroencephalography in a case with subacute sclerosing PanencephalitisAydin OF, Senbil N, Gurer YK. J Child Neurol. 2006 Mar;21(3):256-60. Nonconvulsive status epilepticus on electroencephalography in a case with subacute sclerosing Panencephalitis |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30073 |
Study title: Aydin OF, Senbil N, Kuyucu N, Gurer YK. J Child Neurol. 2003 Feb;18(2):104-8. Combined treatment with subcutaneous interferon-alpha, oral isoprinosine, and lamivudine for subacute sclerosing panencephalitis.Aydin OF, Senbil N, Kuyucu N, Gurer YK. J Child Neurol. 2003 Feb;18(2):104-8. Combined treatment with subcutaneous interferon-alpha, oral isoprinosine, and lamivudine for subacute sclerosing panencephalitis. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30074 |
Study title: Azzara A, Meozzi A, Carulli G, Margelli A, Tangheroni F, Serravalle E, Ambrogi F. Presented at Session 18: Italian Society of Chemotherapy, 13th National Congress; June 9-11, 1983; Catania, Italy; 2(3):399-400. Normalization of neutrophilic functions in children suffering from recurrent chronic infections after cyclic therapy with methisoprinol.Azzara A, Meozzi A, Carulli G, Margelli A, Tangheroni F, Serravalle E, Ambrogi F. Presented at Session 18: Italian Society of Chemotherapy, 13th National Congress; June 9-11, 1983; Catania, Italy; 2(3):399-400. Normalization of neutrophilic functions in children suffering from recurrent chronic infections after cyclic therapy with methisoprinol. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30075 |
Study title: Berker N, Batman C, Guven A, Ozalp S, Aslan O, Zilelioglu O.Am J Ophthalmol. 2004 Nov;138(5):879-81. Optic atrophy and macular degeneration as initial presentations of subacute sclerosing PanencephalitisBerker N, Batman C, Guven A, Ozalp S, Aslan O, Zilelioglu O.Am J Ophthalmol. 2004 Nov;138(5):879-81. Optic atrophy and macular degeneration as initial presentations of subacute sclerosing Panencephalitis |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30076 |
Study title: Berth-Jones J, Hutchinson PE. Brit J Derm 1992;127:262-265. Modern treatment of warts: cure rates at 3 and 6 months.Berth-Jones J, Hutchinson PE. Brit J Derm 1992;127:262-265. Modern treatment of warts: cure rates at 3 and 6 months. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30077 |
Study title: Bowszyc J et al. Przegl Dermatol. Jun 1983;60(3):283-290. Isoprinosine in the treatment of viral skin diseases.Bowszyc J et al. Przegl Dermatol. Jun 1983;60(3):283-290. Isoprinosine in the treatment of viral skin diseases. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30078 |
Study title: Le chlorhydrate d’hydroxyzine comme medicament adjuvant dans l’anesthesie generale. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPI92D0131.pdf |
View full study record |
Document reference: 29318 |
Study title: Les essais cliniques avec l’hydroxyzine sur un groupe d’enfants arrieres. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPF92D1019.pdf |
View full study record |
Document reference: 29333 |
Study title: Maladjusted young social wards treated with hydroxyzine hydrochloride |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29259 |
Study title: Management of tension and anxiety states with hydroxyzine hydrochloride |
Active substance: HYDROXYZINE |
Study summary document link (including results): CE60H151P.pdf |
View full study record |
Document reference: 29261 |
Study title: Mast cell quantification in the skin of children with atopic dermatitis : its value in diagnosis and in assessing the effctiveness of therapy |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE97H2007.pdf |
View full study record |
Document reference: 29268 |
Study title: Methylpentynol and hydroxyzine as oral premedicants in children |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29230 |
Study title: Monitoring of sedated pediatric dental patients. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE92G0330.pdf |
View full study record |
Document reference: 29363 |
Study title: Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29920 |
Study title: Indomethacin and the stress response to hysterectomy. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29921 |
Study title: Indomethacin as an analgesic after hysterectomy. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29922 |
Study title: Indomethacin for prevention of intraventricular hemorrhage. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29923 |
Study title: Indomethacin in extra-articular lesions. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29924 |
Study title: Indomethacin in soft-tissue sports injuries. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29925 |
Study title: Indomethacin in superficial thrombophlebitis. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29926 |
Study title: Indomethacin in the management of erythema nodosum leprosum--a double-blind controlled trial. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29927 |
Study title: Indomethacin in the prevention of subependymal-intraventricular hemorrhage in preterm newborns with conventional mechanical ventilationa |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29928 |
Study title: Indomethacin in the treatment of primary dysmenorrhoea. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29929 |
Study title: Indomethacin in the treatment of rheumatic diseases |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29930 |
Study title: Indomethacin in the treatment of uveitis. A double-blind trial. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29931 |
Study title: Indomethacin in urticaria and histamine induced wealing. A double-blind evaluation. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29932 |
Study title: Indomethacin prophylaxis for intraventricular hemorrhage in very low birth weight babies. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29933 |
Study title: Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants? |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29935 |
Study title: Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29936 |
Study title: Indomethacin reduces the risks of severe intraventricular hemorrhage. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29937 |
Study title: Indomethacin the treatment of glomerular nephropathies |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29938 |
Study title: Indomethacin therapy on the first day of life in infants with very low birth weight. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29939 |
Study title: Drug Therapy in Infants: Pharmacologic Principles and Clinical Experience - Roberts RJ - 1984 (WB Saunders, Philadelphia, 1984) - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29172 |
Study title: Drugs in Pregnancy. The Royal Women's Hospital - No author - 1993 (Batagol R (Ed) CSL Limited, Victoria, Australia, 1993) - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29173 |
Study title: Einfachblinde randomisierte Studie zur Wirksamkeit und Verträglichkeit eines Gels mit 2 % Ichthyol Natrium, hell und 0,2 % Hydrocortisonacetat bei Patienten mit mittelschwerer Neurodermitis. |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29174 |
Study title: Endocrine disorders in newborn - Bongiovanni AM et al - 1981 - In Avery GB (Ed): Neonatalogy: Pathophysiology and Management of the Newborn, 2nd Ed. JB Lippincott, Philadelphia, 1981; pp 1104-1127) - Publication in the Comprehensive Summary of Hydrocortison in dated 27/06/1995 - |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29162 |
Study title: Guidelines for Administration in Intravenous Medications to Pediatric Patients - No author - 1984 (2nd ed American Society of Hospital Pharmacists, Bethesda, MD, 1984) - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29175 |
Study title: Increase in proteinuria due to steroid medicatio in chronic renal disease - Heymann W et al - 1969 ( Journal of Pediatric 1969; 72: 356) - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29176 |
Study title: Maguire, A.M., et al., Prolonged hypocortisolemia in hydrocortisone replacement regimens in adrenocorticotrophic hormone deficiency. Pediatrics, 2007. 120(1): p. e164-71. |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29177 |
Study title: Neonatology: Pathophysiology and Management of the Newborn - Avery GB - 1981 (2nd ed. JB Lippincott Company, Philadelphia, PA, 1981) - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29163 |
Study title: No title - Harvey D - 1972 (Br. J. Hosp. Med. 1972; 8: 65 in Extracts from Martindale - 28th Edition - No author - 1982 (Hydrocortisone p 473-474)) - Compilation of clinical papers for the UK review of Medicines in 1983 - |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29179 |
Study title: Premiloc |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29180 |
Study title: Problems in Pediatric Drug Therapy - Pagliaro LA et al. - 1979 (Drug Intelligence Publications, Hamilton, Illinois 1979) - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29181 |
Study title: Prophylactic corticosteroids for pretherm birth -Crowley p - 2004 (in the Cochrane Library, Issue 2, 2004) - Publication in Hydrocortisone CES juillet 2004 all form - Bouvet A - 2004 - |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29182 |
Study title: The Pediatric Drug handbook - Benitz WE - 1981 (Year Book Medical Publishers, Chicago, 1981) - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
Active substance: HYDROCORTIZONE |
Study summary document link (including results): |
View full study record |
Document reference: 29183 |
Study title: Fluoride varnish for community based caries prevention in children1997-peterson |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1997-peterson-Fluoride varnish for community based caries prevention in children.pdf |
View full study record |
Document reference: 49124 |
Study title: Fluoride varnish versus acidulated phosphate fluoride gel1995-seppa |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1995-seppa-Fluoride varnish versus acidulated phosphate fluoride gel.pdf |
View full study record |
Document reference: 49120 |
Study title: Fluoride varnishes in caries prevention. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42420 |
Study title: Clinical observations on the use of hydroxyzine in anxiety- tension states and senile agitation. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29334 |
Study title: Clinical pediatric experience with ataractic agent in less severe emotional states. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29293 |
Study title: Clinical studies on hydroxyzine in childrens’ premedication in adenoidectomy and tonsillectomy. |
Active substance: HYDROXYZINE |
Study summary document link (including results): DID89A026P-ADPD94M1940.pdf |
View full study record |
Document reference: 29331 |
Study title: Clinical study of hydroxyzine pamoate in pedodontics. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPS95H3104.pdf |
View full study record |
Document reference: 29245 |
Study title: Comparative evaluation of combined preoperative medications for pediatric surgery. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29278 |
Study title: Comparison between per os diazepam and hydroxyzine, as premedication in children undergoing ent operations. |
Active substance: HYDROXYZINE |
Study summary document link (including results): MDPG93B1801.pdf |
View full study record |
Document reference: 29316 |
Study title: Comparison of a chloral hydrate / hydroxyzine combination with and without meperidine in the sedation of pediatric dental patients. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE92B1304.pdf |
View full study record |
Document reference: 29319 |
Study title: A phase III single dose study to compare the efficacy of ibuprofen chewable tablets to ibuprofen suspension in febrile children. Jun 1995A phase III single dose study to compare the efficacy of ibuprofen chewable tablets to ibuprofen suspension in febrile children. Jun 1995 |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29682 |
Study title: A phase IV comparative study evaluating the onset of analgesia using a single dose of ibuprofen chewable tablets 400 mg, ibuprofen suspension 400 mg/20 ml or placebo in post-operative dental painA phase IV comparative study evaluating the onset of analgesia using a single dose of ibuprofen chewable tablets 400 mg, ibuprofen suspension 400 mg/20 ml or placebo in post-operative dental pain |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29683 |
Study title: A phase IV multicenter clinical investigation of the safety and efficacy of APAP 1000 mg (total daily dose of 4 grams), ibuprofen 400 mg (total daily dose of 1200 mg), and placebo in the management of the symptoms of primary dysmenorrheaA phase IV multicenter clinical investigation of the safety and efficacy of APAP 1000 mg (total daily dose of 4 grams), ibuprofen 400 mg (total daily dose of 1200 mg), and placebo in the management of the symptoms of primary dysmenorrhea |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29684 |
Study title: A pilot comparative study evaluating the analgesic effect of using a single dose of an ibuprofen 200 mg / acetaminophen 650 mg combination or ibuprofen 400 mg in post-operative dental pain A pilot comparative study evaluating the analgesic effect of using a single dose of an ibuprofen 200 mg / acetaminophen 650 mg combination or ibuprofen 400 mg in post-operative dental pain |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29663 |
Study title: A randomized double-blind single dose study comparing ibuprofen 200 mg, ibuprofen 200 mg plus caffeine 100 mg, ibuprofen 400 mg, ibuprofen 400 mg plus caffeine 200 mg, caffeine 100 mg, and placebo in the treatment of pain following orthopedic surgeryA randomized double-blind single dose study comparing ibuprofen 200 mg, ibuprofen 200 mg plus caffeine 100 mg, ibuprofen 400 mg, ibuprofen 400 mg plus caffeine 200 mg, caffeine 100 mg, and placebo in the treatment of pain following orthopedic surgery |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29686 |
Study title: A randomized double-blind study comparing the efficacy of single doses of ibuprofen 200 mg, ibuprofen 400 mg, ibuprofen 200 mg plus caffeine 100 mg, ibuprofen 400 mg plus caffeine 200 mg, caffeine 100 mg, and placebo in the treatment of post-operative dental painA randomized double-blind study comparing the efficacy of single doses of ibuprofen 200 mg, ibuprofen 400 mg, ibuprofen 200 mg plus caffeine 100 mg, ibuprofen 400 mg plus caffeine 200 mg, caffeine 100 mg, and placebo in the treatment of post-operative dental pain |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29687 |
Study title: Narcotic sedation: an evaluation of cardiopulmonary para- meters and behavior modification in pediatric dental patients. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29242 |
Study title: Negative effect on the electroencephalogram of hydroxyzine pamoate at therapeutic dosage. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29225 |
Study title: On the use of an ataractic (hydroxyzine hydrochloride) in the treatment of enuresis. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29297 |
Study title: Paediatric mastocytosis : retrospective study of 15 cases |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPP02J2001.pdf |
View full study record |
Document reference: 29237 |
Study title: Pediatric idiopathic anaphylaxis : experience with 22 patients |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE99H0215.pdf |
View full study record |
Document reference: 29249 |
Study title: Pediatric premedication with diazepam or hydroxyzine. Oral versus intramuscular route. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29325 |
Study title: Pharmacokinetics and antipruritic effects of hydroxyzine in children with atopic dermatitis. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29343 |
Study title: Phenytoin-induced choreoathetosis in infancy: case reports and a review. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29284 |
Study title: Pre-anaesthetic medication in paediatric day-care surgery |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29246 |
Study title: Preanesthetic supplementation with hydroxyzine in the pediatric patient. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE95A2403.pdf |
View full study record |
Document reference: 29372 |
Study title: Prednisolone alone and in combination with hydroxyzine |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29226 |
Study title: Preliminary study on the use of hydroxyzine in psychosomatic affections |
Active substance: HYDROXYZINE |
Study summary document link (including results): CE56F151P.pdf |
View full study record |
Document reference: 29253 |
Study title: Preliminary survey of results obtained in infantile psychiatrics with a derivative of chlorobenzhydryl. |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE92B2101-translation.pdf |
View full study record |
Document reference: 29271 |
Study title: Premedication anti histaminique specifique anti H1 anti H2 en anesthesie pediatrique. |
Active substance: HYDROXYZINE |
Study summary document link (including results): |
View full study record |
Document reference: 29291 |
Study title: Xiao Z. An open label multi-center clinical trial to evaluate the efficacy of compound pseudoephedrine (corrected) hydrochloride sustained release capsules in patients with nasal symptoms associated with common cold. Chinese journal of internal medicine 2002; 41(8):547-9Xiao Z. An open label multi-center clinical trial to evaluate the efficacy of compound pseudoephedrine (corrected) hydrochloride sustained release capsules in patients with nasal symptoms associated with common cold. Chinese journal of internal medicine 2002; 41(8):547-9 |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29750 |
Study title: Yilmaz−H−L et al. Intramuscular dipyrone versus oral ibuprofen or nimesulide for reduction of fever in the outpatient setting. {CLIN−DRUG−INVEST}, 2003, Vol/Iss/Pg. 23/8 (519−526)Yilmaz−H−L et al. Intramuscular dipyrone versus oral ibuprofen or nimesulide for reduction of fever in the outpatient setting. {CLIN−DRUG−INVEST}, 2003, Vol/Iss/Pg. 23/8 (519−526) |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29751 |
Study title: A Study of the Pharmacology Profile, Safety and Tolerability of Intravenously Administered Single Doses of MK0787/MK0791 in Neonates. |
Active substance: ICHTASOL |
Study summary document link (including results): |
View full study record |
Document reference: 29752 |
Study title: A Study of the Pharmacology Profile, Safety and Tolerability of Intravenously Administered Single and Multiple Doses of MK0787/MK0791 in Neonates. |
Active substance: ICHTASOL |
Study summary document link (including results): |
View full study record |
Document reference: 29753 |
Study title: Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29940 |
Study title: Observational study Jutussin N R9 |
Active substance: (HMP) Belladonna D4, Bryonia D3, Coccus cacti D6, Corallium rubrum D12, Cuprum aceticum D12, Drosera D4, Ipecacuanha D6, Spongia D6, Sticta D4 |
Study summary document link (including results): |
View full study record |
Document reference: 39732 |
Study title: Observational study Cysto-Gastreu R18 |
Active substance: (HMP) Berberis vulgaris D4, Cantharis D4, Dulcamara D4, Equisetum hiemale D6, Eupatorium purpureum D6 |
Study summary document link (including results): |
View full study record |
Document reference: 39733 |
Study title: Observational study Hypotonie-Gastreu R44 |
Active substance: (HMP) Crataegus D1, Laurocerasus D3, Oleander D3, Spartium scoparium D2 |
Study summary document link (including results): |
View full study record |
Document reference: 39734 |
Study title: Status of cyclopentolate as a cycloplegic in children: a comparison with atropine and homatropine. Khurana AK, Ahluwalia BK, Rajan C. Acta Ophthalmol (Copenh). 1988 Dec;66(6):721-4.Status of cyclopentolate as a cycloplegic in children: a comparison with atropine and homatropine. Khurana AK, Ahluwalia BK, Rajan C. Acta Ophthalmol (Copenh). 1988 Dec;66(6):721-4. |
Active substance: HOMATROPIN |
Study summary document link (including results): Status of cyclopentolate as a cycloplegic in children.pdf |
View full study record |
Document reference: 29123 |
Study title: Efficacy of Tonsilotren in the treatment of acute angina catarrhalis. |
Active substance: (Homeopathic) Per tablet: Atropinum sulfuricum D5 12,5 mg Hepar sulfuris D3 10,0 mg Kalium bichromicum D4 50,0 mg Silicea D2 5,0 mg Mercurius bijodatus D8 25,0 mg |
Study summary document link (including results): |
View full study record |
Document reference: 39745 |
Study title: HPV-033 |
Active substance: hpv-16 and hpv-18 l1 proteins |
Study summary document link (including results): |
View full study record |
Document reference: 41497 |
Study title: A study to determine the safety of IMMUNO's virus-inactivated plasma derivatives in patients naive to blodd product administration Efficacy and Safety of Immunine in Continuous Infusion in patients with hemophilia B undergoing surgery Single Patient use of Factor IX Concentrates |
Active substance: HUMAN COAGULATION FACTOR IX |
Study summary document link (including results): |
View full study record |
Document reference: 29127 |
Study title: Clinical safety + efficacy study of Nanotiv during long-term prophylaxis and/or on demand treatment… |
Active substance: HUMAN COAGULATION FACTOR IX |
Study summary document link (including results): |
View full study record |
Document reference: 29133 |
Study title: Clinical study of recovery and half life of factor VII concentrate |
Active substance: HUMAN COAGULATION FACTOR IX |
Study summary document link (including results): |
View full study record |
Document reference: 29137 |
Study title: Coagulation Factor IX (Human) AlphaNine® SD Affinity Purified, Solvent Detergent Treated, An Open Label Study if Viral Safety in Previously Untreated Individuals with Hemophilia B |
Active substance: HUMAN COAGULATION FACTOR IX |
Study summary document link (including results): |
View full study record |
Document reference: 29125 |
Study title: Coagulation Factor IX (human) AlphanineSD affinity purified, solvent detergent treated, an open label study of viral safety in previously untreated subjects with Haemophilia B. |
Active substance: HUMAN COAGULATION FACTOR IX |
Study summary document link (including results): 01 ATC 91-11(synopsis).pdf |
View full study record |
Document reference: 47316 |
Study title: Efficacy and safety in children with Haemophilia B treated with OCTANINE F |
Active substance: HUMAN COAGULATION FACTOR IX |
Study summary document link (including results): |
View full study record |
Document reference: 29129 |
Study title: Efficacy and safety of BETAFACT® in previously untreated haemophilia B patients |
Active substance: HUMAN COAGULATION FACTOR IX |
Study summary document link (including results): |
View full study record |
Document reference: 29136 |
Study title: Efficacy and safety of Factor IX (FIX) contained in FIX-GRIFOLS in patients with severe hereditary haemophilia B. |
Active substance: HUMAN COAGULATION FACTOR IX |
Study summary document link (including results): 03 IG104 (synopsis).pdf |
View full study record |
Document reference: 47318 |
Study title: Efficacy and Safety of Immunine in Continuous Infusion in patients with hemophilia B undergoing surgery Single Patient use of Factor IX Concentrates |
Active substance: HUMAN COAGULATION FACTOR IX |
Study summary document link (including results): |
View full study record |
Document reference: 29128 |
Study title: Evaluation of Immunogenicity, Tolerability and Viral Safety in Haemophilia B Patients under Therapy with OCTANINE F |
Active substance: HUMAN COAGULATION FACTOR IX |
Study summary document link (including results): |
View full study record |
Document reference: 29130 |
Study title: A double-blind, placebo-controlled crossover study comparing the safety and efficacy of ibuprofen sustained release 600 mg and ibuprofen regular release 400 mg in the treatment of primary dysmenorrhea. CSR 130S. Protocol 88-852, Unpublished Report 256A. |
Active substance: IBUPROFEN |
Study summary document link (including results): ibuprofen 88-852.pdf |
View full study record |
Document reference: 47449 |
Study title: A double-blind, single dose comparison of Advil (ibuprofen) vs Tylenul plus codeine vs. Placebo in the relief of post operative surgery pain" |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29531 |
Study title: A double-blind, single dose comparison of ibuprofen vs. Acetaminophen vs. Placebo in the relief of post operative oral surgery pain |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29529 |
Study title: A double-blind, single dose evaluation of the comparative analgesic efficacy of acetaminophen 1000 mg, ibuprofen 400 mg, ibuprofen 200 mg, and placebo in the treatment of pain following oral surgery |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29488 |
Study title: A double-blind, single dose evaluation of the comparative analgesic efficacy of aspirin 800 mg plus caffeine 64 mg, ibuprofen 400 mg and placebo in the treatment of post-operative pain following third molar extraction |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29500 |
Study title: A double-blind, single dose evaluation of the comparative efficacy of acetaminophen 1000 mg, ibuprofen 200 mg, ibuprofen 400 mg, and placebo in the treatment of pain following periodontal surgery |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29486 |
Study title: A double-blind, single dose evaluation of the comparative efficacy of acetaminophen 1000 mg, ibuprofen 200 mg, ibuprofen 400 mg, and placebo in the treatment of pain following periodontal surgery. Stat Rpt 66. Protocol 3-279, Unpublished Report 185. |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 3-279.pdf |
View full study record |
Document reference: 47390 |
Study title: A double-blind, single dose parallel study to compare analgesic efficacy and side effects profile of acetaminophen 1000 mg, ibuprofen 400 mg, ibuprofen 200 mg, and placebo in the treatment of muscle contraction ('tension') headache. Stat Rpt 77. Protocol 84-462, Unpublished Report 201. |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 84-462.pdf |
View full study record |
Document reference: 47399 |
Study title: A phase IV multicenter clinical investigation of the safety and efficacy of APAP 1000 mg (total daily dose of 4 grams), ibuprofen 400 mg (total daily dose of 1200 mg), and placebo in the management of the symptoms of primary dysmenorrhea. Stat Rpt 73. Protocol 4-400, Unpublished Report 193. |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 4-400.pdf |
View full study record |
Document reference: 47391 |
Study title: A Phase IV Randomized, Double-Blind, Multicenter Trial to Compare the Safety and Efficacy of Acetaminophen Suspension and Ibuprofen Suspension in the Treatment of Febrile Children. Dec 2000.A Phase IV Randomized, Double-Blind, Multicenter Trial to Compare the Safety and Efficacy of Acetaminophen Suspension and Ibuprofen Suspension in the Treatment of Febrile Children. Dec 2000. |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 29685 |
Study title: A Pilot Comparative Study Evaluating the Analgesic Effect of Using a Single Dose of an Ibuprofen 200 mg / Acetaminophen 650 mg Combination or Ibuprofen 400 mg in Post-Operative Dental Pain. |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 98-053.pdf |
View full study record |
Document reference: 47413 |
Study title: A Randomized, Double-Blind, Parallel-Group Study Comparing the Safety and Efficacy of Acetaminophen Extended Release (3900 mg/day) and Ibuprofen (1200 mg/day) in the Treatment of Ankle Sprains |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 11-301.pdf |
View full study record |
Document reference: 47398 |
Study title: A randomized, open label, parallel, single dose study of the antipyretic efficacy, safety, and blood levels of ibuprofen 6 mg/kg in febrile children with acetaminophen 10-15 mg/kg as a positive control for efficacy. CSR 106. Protocol 86-642, Unpublished Report 232. |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 86-642.pdf |
View full study record |
Document reference: 47400 |
Study title: A single dose double-blind study comparing the efficacy of ibuprofen and children's Tylenol elixir. Stat Rpt 80. Protocol 5-535, Unpublished Report 205. |
Active substance: IBUPROFEN AND PARACETAMOL |
Study summary document link (including results): ibuprofen_paracetamol 5-535.pdf |
View full study record |
Document reference: 47395 |
Study title: A Randomized, Double-Blind, Parallel-Group Study Comparing the Safety and Efficacy of Acetaminophen Extended Release (3900 mg/day) and Ibuprofen (1200 mg/day) in the Treatment of Ankle SprainsA Randomized, Double-Blind, Parallel-Group Study Comparing the Safety and Efficacy of Acetaminophen Extended Release (3900 mg/day) and Ibuprofen (1200 mg/day) in the Treatment of Ankle Sprains |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29688 |
Study title: A randomized, open label, parallel, single dose study of the antipyretic efficacy, safety, and blood levels of ibuprofen 6 mg/kg in febrile children with acetaminophen 10-15 mg/kg as a positive control for efficacy. Jun 1989.A randomized, open label, parallel, single dose study of the antipyretic efficacy, safety, and blood levels of ibuprofen 6 mg/kg in febrile children with acetaminophen 10-15 mg/kg as a positive control for efficacy. Jun 1989. |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29689 |
Study title: A single dose study to compare the efficacy and side effects of ibuprofen suspension to placebo in children 5 through 11 years of age with post-operative pain secondary to either inguinal or umbilical herniorrhaphy. Jul 1995.A single dose study to compare the efficacy and side effects of ibuprofen suspension to placebo in children 5 through 11 years of age with post-operative pain secondary to either inguinal or umbilical herniorrhaphy. Jul 1995. |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29691 |
Study title: A single dose study to compare the efficacy of acetaminophen elixir dosed at 12.5 mg/kg and 25 mg/kg and ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg in febrile children. Oct 1991.A single dose study to compare the efficacy of acetaminophen elixir dosed at 12.5 mg/kg and 25 mg/kg and ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg in febrile children. Oct 1991. |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 29693 |
Study title: Safety and immunogenicity of Imovax Polio vaccine in Korean infants, when given at 2,4 and 6 months of age |
Active substance: Inactivated Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 47471 |
Study title: |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30060 |
Study title: |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30061 |
Study title: |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30062 |
Study title: |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30063 |
Study title: A case of haemorrhagic lung edema treated by indomethacin in a term infantBaker CJ, Melish NM, Hall RT, et al. and the multicenter group for the study of immune globulin in neonates. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. N Engl J Med 1992; 327 (4): 213-219 |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29790 |
Study title: A clinical trial of indomethacin and ibuprofen in dysmenorrhea.Evaluation of prophylactic passive immunization using IGIV to prevent late onset neonatal infection among low birth weight(< 1750 grams) neonates. Baxter Internal ReportBB IND 1628: June, 1992 |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29791 |
Study title: A clinical trial with indomethacin (indomee(R)) in low back pain and sciatica. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29792 |
Study title: A comparative clinical trial of fenbufen and indomethacin in patients with rheumatoid arthritis. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29793 |
Study title: A comparative evaluation of indomethacin, acetaminophen and placebo as antipyretic agents in children. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29794 |
Study title: A comparative study of benoxaprofen and indomethacin in ankylosing spondylitis. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29795 |
Study title: Anwendungsbeobachtung Aknichthol soft N Lotio |
Active substance: ICHTASOL |
Study summary document link (including results): |
View full study record |
Document reference: 29757 |
Study title: Anwendungsbeobachtung zu Natriumbituminosulfonat 20% (Ichtholan T) bei Neurodermitis |
Active substance: ICHTASOL |
Study summary document link (including results): |
View full study record |
Document reference: 29762 |
Study title: Anwendungsbeobachtung zum Nachweis der Wirksamkeit und Verträglichkeit von Ichthoseptal® Creme bei Patienten mit Acne papulo-pustulosa bzw. entzündlicher Acne comedonica |
Active substance: ICHTASOL |
Study summary document link (including results): |
View full study record |
Document reference: 29763 |
Study title: AWB bei Neurodermitis |
Active substance: ICHTASOL |
Study summary document link (including results): |
View full study record |
Document reference: 29764 |
Study title: AWB bei Psoriasis bzw. seborrh. Ekzem |
Active substance: ICHTASOL |
Study summary document link (including results): |
View full study record |
Document reference: 29760 |
Study title: Doppelblinde, kontrollierte klinische Prüfung zum Wirksamkeits- und Verträglichkeitsnachweis von Akne-Lotion I bei Patienten mit mittelschwererer Akne vulgaris |
Active substance: ICHTASOL |
Study summary document link (including results): |
View full study record |
Document reference: 29756 |
Study title: Monozentrische, prospektive, randomisierte, kontrollierte Doppelblindstudie zum Nachweis der Wirksamkeit und Verträglichkeit von 4 % Natriumbituminosulfonat, hell in einer O/W-Emulsion versus der (angefärbten) Grundlage bei Kindern mit leichter bis mittelschwerer Neurodermitis |
Active substance: ICHTASOL |
Study summary document link (including results): |
View full study record |
Document reference: 29765 |
Study title: Monozentrische, prospektive, randomisierte, kontrollierte, observer-blind Studie zum Nachweis der Wirksamkeit und Verträglichkeit von Natriumbituminosulfonat, hell (20 %ig) in einer Gelgrundlage (Ichtholan® T Gel) versus Fusidinsäure (2 %ig) in einer Cremegrundlage (Fucidine® Creme) bei Patienten mit bakteriell-bedingten Hauterkrankungen im Alter vom 4. Lebensmonat bis zum 18. Lebensjahr |
Active substance: ICHTASOL |
Study summary document link (including results): |
View full study record |
Document reference: 29761 |
Study title: Überprüfung der Wirksamkeit und Verträglichkeit einer Milchschorf Creme bei Säuglingen und Kleinkindern bis zum vollendeten 2. Lebensjahr |
Active substance: ICHTASOL |
Study summary document link (including results): |
View full study record |
Document reference: 29759 |
Study title: Überprüfung der Wirksamkeit und Verträglichkeit einer Neurodermitis Creme bei Säuglingen und Kindern bis zum vollendeten 6. Lebensjahr |
Active substance: ICHTASOL |
Study summary document link (including results): |
View full study record |
Document reference: 29766 |
Study title: Double-blind comparison of tolmetin sodium and indomethacin in ankylosing spondylitis. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29861 |
Study title: Double-blind cross-over comparison of flurbiprofen and indomethacin in osteoarthritis of the knee and hip |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29862 |
Study title: Double-blind crossover comparison of naproxen and indomethacin in rheumatoid arthritis. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29863 |
Study title: Double-blind evaluation of intravenous indomethacin and oxycone-papaverine in the treatment of acute biliary pain. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29864 |
Study title: Double-blind study of ketoprofen and indomethacin in juvenile chronic arthritis. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29865 |
Study title: Ductal patency in neonates with respiratory distress syndrome. A randomized surfactant trial. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29866 |
Study title: Long term safety of ipratropium bromide in children with reversible obstructive pulmonary disease in stable period. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30634 |
Study title: Long term safety of ipratropium bromide in children with reversible obstructive pulmonary disease in stable period. |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U88-0151_synopsis.pdf |
View full study record |
Document reference: 30694 |
Study title: Mechanisms of bronchial hyper-reactivity in cystic fibrosis |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U86-0564_synopsis.pdf |
View full study record |
Document reference: 30648 |
Study title: Mechanisms of bronchial hyper-reactivity in cystic fibrosis. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30643 |
Study title: Mechanisms of bronchial hyper-reactivity in cystic fibrosis. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30647 |
Study title: NA 872: final report of the respiratory distress syndrome in premature infants. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30603 |
Study title: Phase IV safety trial in pediatric patients (age 2-5) |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30661 |
Study title: Pilot assessment of the effect and tolerability of Th 1165a as a capsule administered with a powder inhaler and assessment of the powder inhaler. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30568 |
Study title: Pilot assessment of the effect and tolerability of Th 1165a as a capsule administered with a powder inhaler and assessment of the powder inhaler. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30670 |
Study title: Prophylactic treatment of wheezing in infants with hyper-reactive airways by oral Berotec solution. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30640 |
Study title: Prospective study with fenoterol mdi in patients with bronchoconstrictions. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30617 |
Study title: Randomized, Double-Blind, Parallel Comparison of Atrovent Nasal Spary 0.03% (42 μg/nostril) Versus Placebo Administered Twice a Day in Pediatric Patients with Allergic or Nonallergic Perennial Rhinitis with an Optional 6- Month Treatment Comparison of Atrovent Nasal Spray 0.03% (42 μg/nostril) Versus Beconase AQ (84 μg/nostril) |
Active substance: IPRATROPIUM |
Study summary document link (including results): Ipratropium bromide_U96-3125_synopsis.pdf |
View full study record |
Document reference: 30712 |
Study title: The site of obstruction in exercise-induced asthma. |
Active substance: IPRATROPIUM AND FENOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 30741 |
Study title: A comparison of a combination of Ipratropium bromide and Salbutamol with Salbutamol alone in acute severe asthma. |
Active substance: IPRATROPIUM AND SALBUTAMOL |
Study summary document link (including results): Ipratropium bromide_salbutamol sulphate_U91-0747_synopsis.pdf |
View full study record |
Document reference: 30747 |
Study title: A comparison of a combination of Ipratropium bromide and Salbutamol with Salbutamol alone in acute severe asthma. |
Active substance: IPRATROPIUM AND SALBUTAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 30752 |
Study title: A study of nebulised Ventolin versus nebulised Ventolin plus Atrovent in acute childhood asthma. |
Active substance: IPRATROPIUM AND SALBUTAMOL |
Study summary document link (including results): Ipratropium bromide_salbutamol sulphate_U88-0360_synopsis.pdf |
View full study record |
Document reference: 30746 |
Study title: A study of nebulised Ventolin versus nebulised Ventolin plus Atrovent in acute childhood asthma. |
Active substance: IPRATROPIUM AND SALBUTAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 30751 |
Study title: Combined treatment with ipratropium bromide and beta-2 adrenoceptor stimulating agents in chronic childhood asthma |
Active substance: IPRATROPIUM AND SALBUTAMOL |
Study summary document link (including results): Ipratropium bromide_salbutamol sulphate_U85-0434_synopsis.pdf |
View full study record |
Document reference: 30681 |
Study title: Combined treatment with ipratropium bromide and beta-2 adrenoceptor stimulating agents in chronic childhood asthma. |
Active substance: IPRATROPIUM AND SALBUTAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 30749 |
Study title: safety and immunogenicity of immovax polio vaccine in Korean infants, whn given at 2, 4 and 6 months of age |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41182 |
Study title: Safety and immunogenicity of PMSV diphtheria, tetanus, acellular pertussis, polio (DTacP-IPV) vaccine given mixed or separately with Haemophilus influenzae type b (Act-HIB®) vaccine, as a primary series. Comparison of three lots of DTacP-IPV vaccine given combined or separately with Act-HIB® |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41189 |
Study title: Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen-to nineteen-month-old infants |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41192 |
Study title: Safety and immunogenicity of Vi CPS vaccine in teenagers |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 21209 |
Study title: Safety of IPV of one or two doses in chinese infants |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41183 |
Study title: Study of the booster effect of IPV vaccination on children |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41196 |
Study title: The immune response after two doses of a new killed poliomyelitis vaccine |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41202 |
Study title: Trial on the persistence of antibodies 4 years after a first booster with PENTAVAC® vaccine and the immunogenicity and safety of a second booster with TETRAVAC ACELLULAIRE® vaccine at the age of 5-6 years |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41195 |
Study title: Open label study to evaluate the safety and immunogenicity of a hepatitis A vaccine (Avaxim 160U) |
Active substance: Inactivated Hepatitis A vaccine adsorbed for adults (160 U) |
Study summary document link (including results): |
View full study record |
Document reference: 47625 |
Study title: OPEN STUDY OF IMMUNOGENICITY AND SAFETY OF THE P.M.sv. (160 U) HEPATlTlS A VACCINE ON CHILDREN AND ADULTS |
Active substance: Inactivated Hepatitis A vaccine adsorbed for adults (160 U) |
Study summary document link (including results): |
View full study record |
Document reference: 47624 |
Study title: Open study of immunogenicity and safety of the P.M.sv. Hepatitis A vaccine (160 antigen units) in children |
Active substance: Inactivated Hepatitis A vaccine adsorbed for adults (160 U) |
Study summary document link (including results): |
View full study record |
Document reference: 47623 |
Study title: |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41107 |
Study title: |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41108 |
Study title: |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41110 |
Study title: |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41113 |
Study title: |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41114 |
Study title: A comparative study of fenbufen and indomethacin in patients with rheumatoid arthritis. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29796 |
Study title: A comparative trial of large doses of ketoprofen and indomethacin in the treatment of rheumatoid arthritis. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29797 |
Study title: A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29798 |
Study title: A comparison of indoprofen and indomethacin in the supportive treatment of soft-tissue injuries in football players: a pilot study. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29799 |
Study title: A controlled clinical trial of TAI-284 acid in rheumatoid arthritis (author's transl)a |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29800 |
Study title: A controlled clinical trial with indomethacin as an antipyretic in children. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29801 |
Study title: A double-blind cross-over study of niflumic acid and indomethacin in rheumatoid arthritis. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29802 |
Study title: Therapeutic effect of non-steroidal anti-inflammatory agents in eye disease |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30041 |
Study title: Therapeutic effectiveness of paracetamol in rheumatoid arthritis. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30042 |
Study title: Therapeutic interventions to prevent intracerebral hemorrhage in preterm infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30043 |
Study title: Tocolysis in advanced preterm labor: impact on neonatal outcome. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30044 |
Study title: Treatment of acute pain due to ureteral calculi with intravenous indomethacin or pethidine |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30045 |
Study title: Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30046 |
Study title: Treatment of patent ductus arteriosus with ibuprofen. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30047 |
Study title: Treatment of premature labor with indomethacin. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30048 |
Study title: Treatment of renal colic by prostaglandin synthetase inhibitors and avafortan (analgesic antispasmodic). |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30049 |
Study title: Treatment of renal colic by prostaglandin synthetase inhibitors and avafortan (analgesic antispasmodic). |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30050 |
Study title: Treatment of ureteral and biliary pain with an injectable salt of indomethacin. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30051 |
Study title: Treatment of ureteric colic. Intravenous versus rectal administration of indomethacin. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30052 |
Study title: Early administration of indomethacin to preterm infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29867 |
Study title: Early closure of ductus arteriosus with indomethacina |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29868 |
Study title: Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29869 |
Study title: Early closure of the patent ductus arteriosus in very low-birth-weight infants: a controlled trial. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29870 |
Study title: Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29872 |
Study title: Early-onset intraventricular hemorrhage in preterm neonates: incidence of neurodevelopmental handicap. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29873 |
Study title: Echocardiographic flow pattern of patent ductus arteriosus: a guide to indomethacin treatment in premature infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29874 |
Study title: Effect in man of aspirin, standard indomethacin, and sustained release indomethacin preparations on gastric bleeding. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29875 |
Study title: Effect of dopamine on failure of indomethacin to close the patent ductus arteriosus. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29876 |
Study title: Effect of early targeted indomethacin on the ductus arteriosus and blood flow to the upper body and brain in the preterm infant. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29877 |
Study title: Effect of graduated intravenous and standard rectal doses of indomethacin on cerebral blood flow in healthy volunteers. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29878 |
Study title: Effect of high dose ramipril with or without indomethacin on glomerular selectivity. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29879 |
Study title: Effect of indometacin in a child with pseudohypoaldosteronism |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29880 |
Study title: Effect of indomethacin on adenosine-induced bronchoconstriction. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29881 |
Study title: Cornaglia-Farraris P, Pasino M, Maggio A, Barabino A, Perlino GF, Massimo L. In: Le immunodeficienze primitive in Italia. Rome, Italy: Acta Medica, Field Educational Italia SpA; 1982. Chapter 4. Therapeutic success with methisoprinol in a case of congenital immune deficiency: clinical and immunological observations after one year of clinical therapy.Cornaglia-Farraris P, Pasino M, Maggio A, Barabino A, Perlino GF, Massimo L. In: Le immunodeficienze primitive in Italia. Rome, Italy: Acta Medica, Field Educational Italia SpA; 1982. Chapter 4. Therapeutic success with methisoprinol in a case of congenital immune deficiency: clinical and immunological observations after one year of clinical therapy. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30092 |
Study title: Cornaglia-Ferraris P, Koverech A.. International Journal of Immunopharmacology. [UK]. 1980; 2(3):193. (Abstract No. 23). Successful treatment with methisoprinol in a case of congenital immunodeficiencyCornaglia-Ferraris P, Koverech A.. International Journal of Immunopharmacology. [UK]. 1980; 2(3):193. (Abstract No. 23). Successful treatment with methisoprinol in a case of congenital immunodeficiency |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30093 |
Study title: Correlation between the adverse reactions to intravenous iodinated contrast media and IgE levels; Gurses C et al; Diagn. Interv. Radiol.; 2005 vol.11 p.74 76Correlation between the adverse reactions to intravenous iodinated contrast media and IgE levels; Gurses C et al; Diagn. Interv. Radiol.; 2005 vol.11 p.74 76 |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30181 |
Study title: Combined treatment with ipratropium bromide and beta-2 adrenoceptor stimulating agents in chronic childhood asthma. |
Active substance: IPRATROPIUM AND SALBUTAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 30753 |
Study title: Combivent vs. salbutamol in patients with metacholine-induced bronchospasm. |
Active substance: IPRATROPIUM AND SALBUTAMOL |
Study summary document link (including results): Ipratropium bromide_salbutamol sulphate_U00-0040_synopsis.pdf |
View full study record |
Document reference: 30748 |
Study title: Statistical report: Comparison of the use of salbutamol solution and the combination of salbutamol and ipratropium solution in the treatment of acute asthma attacks in children. |
Active substance: IPRATROPIUM AND SALBUTAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 30750 |
Study title: Effectiveness and Safety of the Angiotensin II Antagonist Irbesartan in Children With Chronic Kidney Diseases |
Active substance: irbesartan |
Study summary document link (including results): |
View full study record |
Document reference: 41533 |
Study title: Experience with Irbesartan Use in Children 16 Years of Age and Younger: A Descriptive Study in Two Medical Claims Databases |
Active substance: irbesartan |
Study summary document link (including results): |
View full study record |
Document reference: 45089 |
Study title: Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children, 2002 Reduced Advanced Glycation Endproduct (AGE) Levels in Children on Automated Peritoneal Dialysis (PD) with PD-Fluids Containing Less Glucose Degradation Products (GDPs), 2003 |
Active substance: ISOTONIC SOLUTIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30758 |
Study title: Statistical report: A dose response and duration of action study of Duovent nebuliser solution in paediatrics. |
Active substance: ISOTONIC SOLUTIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30759 |
Study title: A double-blind, placebo-controlled trial to evaluate the efficacy and safety of topically applied 0.1% isotretinoin cream for the treatment of acne vulgaris. |
Active substance: ISOTRETINOIN |
Study summary document link (including results): |
View full study record |
Document reference: 30761 |
Study title: Open-label, Randomized, Dose Ranging Study of Three Different Doses of Ritonavir in Combination with 3TC+d4T in Children Infected with HIV |
Active substance: ritonavir |
Study summary document link (including results): |
View full study record |
Document reference: 41580 |
Study title: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Cholesterol-Lowering Efficacy and Safety of Simvastatin as an Adjunct to Diet in Children and Adolescents With Familial Hypercholesterolemia |
Active substance: SIMVASTATIN |
Study summary document link (including results): |
View full study record |
Document reference: 42224 |
Study title: Double blind comparison of Sertraline and Placebo in children and adolescents with obsessive compulsive disorder. |
Active substance: SERTRALINE |
Study summary document link (including results): |
View full study record |
Document reference: 42126 |
Study title: Duraphat varnish a 2 year clinical trial in 5 year old childeren1977-murray, Brit. Dental J |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1977-murray-Duraphat varnish a 2 year clinical trial in 5 year old childeren.pdf |
View full study record |
Document reference: 49103 |
Study title: Effect of a partial substitution of invert sugar for surcose in combination with Duraphat treatment in caries development in pre-school children1991-frostell |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1991-frostell-Effect of a partial substitution of invert sugar for surcose in combination with Duraphat treatment in caries development in pre-scho... |
View full study record |
Document reference: 49116 |
Study title: Effect of fluoride varnish (Duraphat) treatment every 6 months compared with weekly mouthrinsing with 02 percent NaF solution on dental caries1979-koch |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1979-koch-Effect of fluoride varnish (Duraphat) treatment every 6 months compared with weekly mouthrinsing with 02 percent NaF solution on dental c... |
View full study record |
Document reference: 49105 |
Study title: Effect of topical applied stannous fluoride on dental caries experience children1955-Howell |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1955-Howell-Effect of topical applied stannous fluoride on dental caries experience children.pdf |
View full study record |
Document reference: 49132 |
Study title: |
Active substance: Inactivated hepatitis A virus |
Study summary document link (including results): |
View full study record |
Document reference: 41117 |
Study title: Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)a |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29962 |
Study title: Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29963 |
Study title: Long-term variability of heart rate increases with successful closure of patent ductus arteriosus in preterm infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29964 |
Study title: Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29965 |
Study title: Low-dose indomethacin therapy and extension of intraventricular hemorrhage: a multicenter randomized trial. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29966 |
Study title: Low-dose irradiation and indomethacin prevent heterotopic ossification after acetabular fracture surgery. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29967 |
Study title: Mannheimer lecture. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29968 |
Study title: Modification by drugs of urinary fibrin/fibrinogen degradation products in glomerulonephritis. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29969 |
Study title: Modulation of the immediate allergic wheal reaction in the skin by drugs inhibiting the effects of leukotriene C4 and prostaglandin D2. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29970 |
Study title: Near-infrared spectroscopy as a screening tool for patent ductus arteriosus in extremely low birth weight infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29972 |
Study title: Neonatal consequences of the use of indomethacin during pregnancy. A prospective study of 83 pregnant women and 115 neonates |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29973 |
Study title: Neonatal limb ischemia following maternal indomethacin treatment in twin pregnancies. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29974 |
Study title: Neurodevelopmental follow-up at 36 months' corrected age of preterm infants treated with prophylactic indomethacin. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29975 |
Study title: Neurodevelopmental outcome at 36 months' corrected age of preterm infants in the Multicenter Indomethacin Intraventricular Hemorrhage Prevention Trial. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29976 |
Study title: Neurodevelopmental outcome with early indomethacin. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29977 |
Study title: Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29978 |
Study title: Night medication in rheumatoid arthritis. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29979 |
Study title: Oligohydramnios, renal insufficiency, and ileal perforation in preterm infants after intrauterine exposure to indomethacin |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29980 |
Study title: A non-randomised, single-centre, retrospective, controlled trial using stored serum samples to investigate the immunogenicity of NovoRapid® and Actrapid® in children and adolescents from onset of Type 1 diabetes. |
Active substance: insulin detemir |
Study summary document link (including results): ANA-1676 synopsis.pdf |
View full study record |
Document reference: 47338 |
Study title: A single-centre, randomised, double-blind, cross-over trial comparing the within-subject variability of the pharmacokinetic profiles of insulin detemir and insulin glargine in children and adolescents with type 1 diabetes, LPLV October 2005 |
Active substance: insulin detemir |
Study summary document link (including results): NN304-1633-synopsis.pdf |
View full study record |
Document reference: 41577 |
Study title: 28-Week multicenter, controlled, randomized, open clinical trial comparing HOE 901 insulin with NPH human insulin in children with type 1 diabetes mellitus |
Active substance: INSULIN GLARGINE |
Study summary document link (including results): |
View full study record |
Document reference: 47339 |
Study title: Invest Radiol. 1984 Nov-Dec;19(6 Suppl):S301-5 Low-osmolality contrast media in cardiac radiology. Cumberland DC Invest Radiol. 1984 Nov-Dec;19(6 Suppl):S301-5 Low-osmolality contrast media in cardiac radiology. Cumberland DC |
Active substance: IOHEXOL |
Study summary document link (including results): |
View full study record |
Document reference: 30375 |
Study title: Invest Radiol. 1991 Jul;26(7):665-70 A comparison of iohexol and diatrizoate-meglumine in children undergoing cardiac catheterization. Pelech AN, Allard SM, Hurd RT, Giddins NG, Collins GF Invest Radiol. 1991 Jul;26(7):665-70 A comparison of iohexol and diatrizoate-meglumine in children undergoing cardiac catheterization. Pelech AN, Allard SM, Hurd RT, Giddins NG, Collins GF |
Active substance: IOHEXOL |
Study summary document link (including results): |
View full study record |
Document reference: 30376 |
Study title: J Comput Assist Tomogr. 2000 Mar-Apr;24(2):327-31 Gadolinium-enhanced magnetic resonance dacryocystography in patients with epiphora. Kirchhof K, Hähnel S, Jansen O, Zake S, Sartor K. J Comput Assist Tomogr. 2000 Mar-Apr;24(2):327-31 Gadolinium-enhanced magnetic resonance dacryocystography in patients with epiphora. Kirchhof K, Hähnel S, Jansen O, Zake S, Sartor K. |
Active substance: IOHEXOL |
Study summary document link (including results): |
View full study record |
Document reference: 30377 |
Study title: J Comput Assist Tomogr. 2007 Jul-Aug;31(4):493-8. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations. Cheruvu B, Henning K, Mulligan J, Klippenstein D, Lawrence D, Gurtoo L, Gottlieb RH. J Comput Assist Tomogr. 2007 Jul-Aug;31(4):493-8. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations. Cheruvu B, Henning K, Mulligan J, Klippenstein D, Lawrence D, Gurtoo L, Gottlieb RH. |
Active substance: IOHEXOL |
Study summary document link (including results): |
View full study record |
Document reference: 30378 |
Study title: Open uncontrolled clinical trial of iotrolan 300 for gastrointestinal diagnosis in childrenTurk J Pediatr. 1995 Oct-Dec;37(4):305-13 The effects of contrast media on renal function in children: comparison of ionic and non-ionic agents. Buyan N, Arab M, Hasanoğlu E, Gökçora N, Ercan S |
Active substance: IOHEXOL |
Study summary document link (including results): |
View full study record |
Document reference: 30382 |
Study title: A comparision of Iopromide and Iopamidol in computer tomography (CT) scanning of pediatric patients |
Active substance: IOPROMIDE |
Study summary document link (including results): Bayer Pharma_Iopromide_1114_study_synopsis.pdf |
View full study record |
Document reference: 46898 |
Study title: A comparison of iopromide and iopamidol in CT scanning of pediatric patients |
Active substance: IOPROMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 30385 |
Study title: Effect of oral iodized oil on thyroid size and thyroid hormone metabolism in children with concurrent selenium and iodine deficiency. ; Zimmermann-M-B. European Journal of Clinical Nutrition, 2000, Vol /Iss/Pg. 54/3 (209-213)Effect of oral iodized oil on thyroid size and thyroid hormone metabolism in children with concurrent selenium and iodine deficiency. ; Zimmermann-M-B. European Journal of Clinical Nutrition, 2000, Vol /Iss/Pg. 54/3 (209-213) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30234 |
Study title: Effect of supplementing iodine on child intellectual development in iodine deficient areas. ;Chen-Z-H. Chinese Journal of Endemiology, 2006, Vol/Iss/Pg. 25 /1 (75-77)Effect of supplementing iodine on child intellectual development in iodine deficient areas. ;Chen-Z-H. Chinese Journal of Endemiology, 2006, Vol/Iss/Pg. 25 /1 (75-77) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30235 |
Study title: Effectiveness of preoperative transarterial chemoembolization in presumed inoperable hepatoblastoma. Han-Y-M. Journal of Vascular and Interventional Radiology, 1999, Vol/Iss/Pg. 10/9 (1275-1280)Effectiveness of preoperative transarterial chemoembolization in presumed inoperable hepatoblastoma. Han-Y-M. Journal of Vascular and Interventional Radiology, 1999, Vol/Iss/Pg. 10/9 (1275-1280) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30236 |
Study title: Effects of salt iodization in the treatment of endemic goiter in school children of rural origin in Cameroon. ;Ngogang-J. Annales d'Endocrinologie, 1993, Vol/Iss/Pg. 54/3 (191-196)Effects of salt iodization in the treatment of endemic goiter in school children of rural origin in Cameroon. ;Ngogang-J. Annales d'Endocrinologie, 1993, Vol/Iss/Pg. 54/3 (191-196) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30237 |
Study title: Effects on school children of prophylaxis of mothers with iodized oil in an area of iodine deficiency. ; Fierro-Benitez-R. Journal of Endocrinological Investigation, 1988, Vol/Iss/Pg. 11/5 (327-335)Effects on school children of prophylaxis of mothers with iodized oil in an area of iodine deficiency. ; Fierro-Benitez-R. Journal of Endocrinological Investigation, 1988, Vol/Iss/Pg. 11/5 (327-335) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30238 |
Study title: Efficacy of oral iodised oil is associated with anthropometric status in severely iodine-deficient schoolchildren in rural Malawi. ; Furnee-C-A. British Journal of Nutrition, 2000, Vol/Iss/Pg. 84/3 (345-352)Efficacy of oral iodised oil is associated with anthropometric status in severely iodine-deficient schoolchildren in rural Malawi. ; Furnee-C-A. British Journal of Nutrition, 2000, Vol/Iss/Pg. 84/3 (345-352) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30239 |
Study title: Embolization and intra-vascular therapy in thoracic, abdominal and peripheral pediatric diseases. ; Brunelle-F. Annales de Pediatrie, 1983, Vol/Iss/Pg. 30/3 (189-193)Embolization and intra-vascular therapy in thoracic, abdominal and peripheral pediatric diseases. ; Brunelle-F. Annales de Pediatrie, 1983, Vol/Iss/Pg. 30/3 (189-193) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30240 |
Study title: Embolization of arteriovenous malformations of the brain: Preliminary experience. ;Wilms-G. Journal Belge de Radiologie, 1993, Vol/Iss/Pg. 76/5 (299-303)Embolization of arteriovenous malformations of the brain: Preliminary experience. ;Wilms-G. Journal Belge de Radiologie, 1993, Vol/Iss/Pg. 76/5 (299-303) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30241 |
Study title: Embolization of rolandic cortex arteriovenous malformations. ;Paulsen-R-D. Neurosurgery, 1999, Vol/Iss/Pg. 44/3 (479-486)Embolization of rolandic cortex arteriovenous malformations. ;Paulsen-R-D. Neurosurgery, 1999, Vol/Iss/Pg. 44/3 (479-486) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30242 |
Study title: Emergency endovascular embolization of traumatic intrarenal arterial pseudoaneurysms with N-Butyl cyanoacrylate. 02/12/2010Emergency endovascular embolization of traumatic intrarenal arterial pseudoaneurysms with N-Butyl cyanoacrylate. 02/12/2010 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30243 |
Study title: Emergent embolization for control of massive hemorrhage from a splanchnic artery with a new coaxial catheter system. ;Okazaki-M. Acta Radiologica, 1992, Vol/Iss/Pg. 33/1 (57-62)Emergent embolization for control of massive hemorrhage from a splanchnic artery with a new coaxial catheter system. ;Okazaki-M. Acta Radiologica, 1992, Vol/Iss/Pg. 33/1 (57-62) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30244 |
Study title: Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains: a randomized, double-blind, placebo-controlled trial – SZYMANSKI H., PEJCZ J. and al. – 2006.Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains: a randomized, double-blind, placebo-controlled trial – SZYMANSKI H., PEJCZ J. and al. – 2006. |
Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30973 |
Study title: “Clinical report on the effect of lactitol for the treatment of intestinal stasis in newborns and toddlers" Investigator: Prof. M. T. Duillo Report date: 23.05.1986“Clinical report on the effect of lactitol for the treatment of intestinal stasis in newborns and toddlers" Investigator: Prof. M. T. Duillo Report date: 23.05.1986 |
Active substance: LACTITOL |
Study summary document link (including results): |
View full study record |
Document reference: 30986 |
Study title: Comparative study beween lactitol and placebo in infants less than 2 years presenting constipationBaudon, J.J :, Bouillie, C. et al. (1995) A controlled study of lactitol in the treatment of constipation in dhildren. Rev. Pediatr., 4, 1-8. |
Active substance: LACTITOL |
Study summary document link (including results): |
View full study record |
Document reference: 30984 |
Study title: Piepsz A, Hahn K, Roca I, Ciofetta G, Toth G, Gordon I et al. A radiopharmaceuticals schedale for imaging in paediatrics. [piepsz-1990]Eur J Nucl Med 1990;17 : 127 – 129. Piepsz A 1990 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48690 |
Study title: Pirotte B, Goldman S, Dewitte O, Massager N, Wikler D, Lefranc F, et al.. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures. [pirotte-2006]J Neurosurg. 2006 Feb;104(2):238-53. Pirotte B 2006 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48691 |
Study title: Procedure Guideline for Tumor Imaging Using Fluorine- 1 8-FDGJ Nucl Med 1998; 3&13&1305. Heinrich R. Schelbert, Carl K. Hoh, Henry D. Royal, Manuel Brown, Magnus N. Dahlbom, Farrokh Dehdashti and Richard L. Wahl |
Active substance: Steripet |
Study summary document link (including results): schelbert-1998.pdf |
View full study record |
Document reference: 48744 |
Study title: Mirmiran-P. International Journal for Vitamin and Nutrition Research, 2003, Vol/Iss/Pg. 73/3 (187-191)Mirmiran-P. International Journal for Vitamin and Nutrition Research, 2003, Vol/Iss/Pg. 73/3 (187-191) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30289 |
Study title: Monographie Jod, Bundesanzeiger Nr. 236 vom 16.12.1989; Azizi-F. Journal of Endocrinological Investigation, 2001, Vol/Iss/Pg. 24/2 (72-77)Monographie Jod, Bundesanzeiger Nr. 236 vom 16.12.1989; Azizi-F. Journal of Endocrinological Investigation, 2001, Vol/Iss/Pg. 24/2 (72-77) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30290 |
Study title: Multidetector CT in evaluating blood supply of hepatocellular carcinoma after transcatheter arterial chemoembolization. ; Guan-Y-S. World Journal of Gastroenterology, 15 JUL 2004, Vol/Iss/Pg. 10/14 (2127-2129)Multidetector CT in evaluating blood supply of hepatocellular carcinoma after transcatheter arterial chemoembolization. ; Guan-Y-S. World Journal of Gastroenterology, 15 JUL 2004, Vol/Iss/Pg. 10/14 (2127-2129) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30291 |
Study title: Neonatal screening for congenital hypothyroidism results and perspectives; François Delange. Horm Res 1997; 48:51-61Neonatal screening for congenital hypothyroidism results and perspectives; François Delange. Horm Res 1997; 48:51-61 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30292 |
Study title: Nervous endemic cretinism in Eastern Nepal. ; White-N-J. Developmental Medicine and Child Neurology, 1977, Vol/Iss/Pg. 19/2 (208-212).Nervous endemic cretinism in Eastern Nepal. ; White-N-J. Developmental Medicine and Child Neurology, 1977, Vol/Iss/Pg. 19/2 (208-212). |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30293 |
Study title: Notwendigkeit einer individuelen Jodprophylaxe, Ranke, M.; Kinderarzt 22, 617-622, 1991Notwendigkeit einer individuelen Jodprophylaxe, Ranke, M.; Kinderarzt 22, 617-622, 1991 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30294 |
Study title: Optimal Strategy of Preoperative Transcatheter Arterial Chemoembolization for Hepatoblastoma. ; Ohtsuka-Y. Surgery Today, 2004, Vol/Iss/Pg. 34/2 (127-133)Optimal Strategy of Preoperative Transcatheter Arterial Chemoembolization for Hepatoblastoma. ; Ohtsuka-Y. Surgery Today, 2004, Vol/Iss/Pg. 34/2 (127-133) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30295 |
Study title: Pediatric thoraco-lumbar paraspinal arteriovenous fistulas along the segmental nerve: Diagnosis and endovascular treatment. ; Niimi-Y. Interventional Neuroradiology, 2006, Vol/Iss /Pg. 12/SUPPL. 1 (158-162)Pediatric thoraco-lumbar paraspinal arteriovenous fistulas along the segmental nerve: Diagnosis and endovascular treatment. ; Niimi-Y. Interventional Neuroradiology, 2006, Vol/Iss /Pg. 12/SUPPL. 1 (158-162) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30296 |
Study title: Percutaneous direct puncture glue embolization of high-flow craniofacial arteriovenous lesions: A new circular ring compression device with a beveled edge. ; Ryu-C-W. American Journal of Neuroradiology, 2007, Vol/Iss /Pg. 28/3 (528-530)Percutaneous direct puncture glue embolization of high-flow craniofacial arteriovenous lesions: A new circular ring compression device with a beveled edge. ; Ryu-C-W. American Journal of Neuroradiology, 2007, Vol/Iss /Pg. 28/3 (528-530) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30297 |
Study title: Percutaneous embolization of a scalp arteriovenous malformation: Case report. ; Nistri-M. Rivista di Neuroradiologia, 2002, Vol/Iss/Pg. 15/6 (773-778)Percutaneous embolization of a scalp arteriovenous malformation: Case report. ; Nistri-M. Rivista di Neuroradiologia, 2002, Vol/Iss/Pg. 15/6 (773-778) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30298 |
Study title: Percutaneous embolization with Ethiblocregistered trade mark of lymphatic cystic malformations with a review of the experience in 70 patients. ;Herbreteau-D. International Angiology, 1993, Vol/Iss/Pg. 12/1 (34-39)Percutaneous embolization with Ethiblocregistered trade mark of lymphatic cystic malformations with a review of the experience in 70 patients. ;Herbreteau-D. International Angiology, 1993, Vol/Iss/Pg. 12/1 (34-39) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30299 |
Study title: The dental caries experience of 12 year old children in England and Wales2002-Pitts, Community Dental Health 2002 19, 46-53 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 2002-Pitts-the dental caries experience of 12 year old children in England and Wales.pdf |
View full study record |
Document reference: 49089 |
Study title: The effect of a fluoride gel used for supervising toothbrushing 15 to 30 times per yearMarthaler 1970 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Marthaler 1970 The effect of a fluoride gel.pdf |
View full study record |
Document reference: 49172 |
Study title: The effect on human dental caries of weekly oral rinsing with a sodium fluoride mouth wash duraphat rinse clinical1971-Horowitz |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1971-Horowitz-the effect on human dental caries of weekly oral rinsing with a sodium fluoride mouthwashduraphat rinse clinical.pdf |
View full study record |
Document reference: 49127 |
Study title: The effects of aminfluoride on nibition of caries in pre-school children and school children in rijekaOstric 1977 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Ostric 1977 The effects of aminfluoride.pdf |
View full study record |
Document reference: 49173 |
Study title: The rationale for the administration of a NaF tablet supplement during pregnancy and postnatally in a private practice setting.Frances B. Glenn 1981, Journal of Dentistry for Children |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1981-Glenn-The Rationale for the Administration od a NaF Tablet Supple,ment during Pregnancy and Postnatally in a private practice setting.pdf |
View full study record |
Document reference: 48778 |
Study title: The reduction of dental caries through use of a sodium fluoride mouthwash1960-Weisz |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1960-Weisz-the reduction of deental caries through use of a sodium fluoride mouthwash.pdf |
View full study record |
Document reference: 49125 |
Study title: The relative anticaries effectiveness of three fluoride-containing dentifrices in Puerto Rico2004-stookey, caries research |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 2004-stookey-the relative anticaries effectiveness of three fluoride-containing dentifrices in Puerto Rico.pdf |
View full study record |
Document reference: 49090 |
Study title: The results of 3 year prophylaxis of caries through fluoride preparations in a solinger kindergarden G. Stolte, Aus dem Gesundheitsamt der Stadt Solingen |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1968-stolte-Ergebnisse dreijähriger Kariesprophylaxe durch orale Fluoridgaben in Solinger Kindergarten.pdf |
View full study record |
Document reference: 48783 |
Study title: Use of fluorides by Finnish adolescentsHonkala ., Nyssonen V, Rimpela A, Scand J Dent Res 1984; 92: 517-23 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1984-honkala-Use of fluoride by finnish adolescents.pdf |
View full study record |
Document reference: 48769 |
Study title: use of professionally administered flouride among Danish children1992-ambjerg |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1992-ambjerg-use of professionally administered flouride among Danish children.pdf |
View full study record |
Document reference: 49118 |
Study title: Variation in caries prevalence related to combinations of dietary andoral hygiene habits and chewing fluoride tablets in 4 year old childrenLars-Eric Granath, Holger Rootzen, Elso Liljegren, Kerstin Hoist, Lennart Kohler 1978. Caries Res 12: 83-92 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1978-granath-Caries prevalence related to combinations of dietary and oral hygiene habits and chewing fluoride tablets in 4 years old children.pdf |
View full study record |
Document reference: 48781 |
Study title: Bowel preparation for colonoscopy with sodium picosulphate and magnesium citrate in children and adolescentsKawakami E, Portorreal A, Scuissiatto ML, Machado RS, Raguza D, Lozano L. , 2004, Arq Gastroenterol 2004; 41: 33 – 36 |
Active substance: SODIUM PICOPSULPHATE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48902 |
Study title: Is Bowel Preparation Required Before Cystoplasty in Children?Gundeti MS, Godpol PP, Wilcox DT. , 2006, The Journal of Urology 2006; 176: 1574 – 1577 |
Active substance: SODIUM PICOPSULPHATE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48901 |
Study title: Double-blind comparative study of Ultravist®, Solutrast® and Omnipaque® in excretory urography in children. |
Active substance: IOPROMIDE |
Study summary document link (including results): Bayer Pharma_Iopromide_85205_study_synopsis.pdf |
View full study record |
Document reference: 46900 |
Study title: IOPROMIDE (SH L 414 C) in excretion urography in children. |
Active substance: IOPROMIDE |
Study summary document link (including results): Bayer Pharma_Iopromide_83111_study_synopsis.pdf |
View full study record |
Document reference: 46899 |
Study title: Contrast quality and tolerability of iotrolan 300 in the diagnostic work-up of the upper gastrointestinal tract of infants and toddlers |
Active substance: IOTROLAN |
Study summary document link (including results): Bayer Pharma_Iotrolan_88058_study_synopsis.pdf |
View full study record |
Document reference: 30390 |
Study title: Non-comparative open-label study of iotrolan 320 in angiocardiography in children up to 12 years of age |
Active substance: IOTROLAN |
Study summary document link (including results): Bayer Pharma_Iotrolan_94063_study_synopsis.pdf |
View full study record |
Document reference: 30389 |
Study title: Open uncontrolled clinical trial of iotrolan 300 for gastrointestinal diagnosis in children |
Active substance: IOTROLAN |
Study summary document link (including results): Bayer Pharma_Iotrolan_86180_study_synopsis.pdf |
View full study record |
Document reference: 30388 |
Study title: Open-label clinical study of iotrolan for assessment of subarachnoidal space in children |
Active substance: IOTROLAN |
Study summary document link (including results): Bayer Pharma_Iotrolan_85332_study_synopsis.pdf |
View full study record |
Document reference: 30391 |
Study title: |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30393 |
Study title: Evaluation of the accuracy of steady-state krypton-81m method for calculating right ventricular ejection fraction.Ham HR 1986, J Nucl Med. 1986 May;27(5):593-601. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): Ham 1986.pdf |
View full study record |
Document reference: 48787 |
Study title: Evaluation of the effects of nasal septal deviation and its surgery on nasal mucociliary clearance in both nasal cavities.Am J Rhinol. 2007 Mar-Apr;21(2):180-3. Ulusoy B 2007 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48790 |
Study title: Evaluation of the ventilation-perfusion ratio in lung diseases by simultaneous anterior and posterior image acquisition. Ann Nucl Med. 1994 Nov;8(4):269-76. Nakata Y 1994 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48818 |
Study title: Excretion of radionuclides in human breast milk after the administration of radiopharmaceuticals. J Nucl Med. 1985 Sep;26(9): 1085-90. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): Ahlgren 1985.pdf |
View full study record |
Document reference: 48786 |
Study title: Extravasation from venous catheter: a serious complication potentially missed by lung imaging.Spicer KM 1983 J Nucl Med. 1983Nov;24(11):1023-6. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): Spicer 1983.pdf |
View full study record |
Document reference: 48788 |
Study title: Fatality immediately following rapid infusion of macroaggregates of 99mTc albumin (MAA) for lung scan. Radiology. 1968 Dec;91(6):1180-4 Vincent WR 1968 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48831 |
Study title: Hepatopulmonary syndrome in Gaucher disease with right-to-left shunt: evaluation and measurement using Tc-99m MAA. Clin Nucl Med. 1999 Mar;24(3):164-6. Kim JH 1999 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48809 |
Study title: Bone scanning in the adductor insertion avulsion syndrome ("thigh splints"). Charkes ND, Siddhivarn N, Schneck CD. J Nucl Med. 1987 Dec;28(12):1835-8. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48839 |
Study title: Bone scans in neuroblastoma.Bhogate BM, Samuel AM, Ramanathan P. Indian J Cancer 1993 Mar;30(1):5-9. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48571 |
Study title: "Controlled, randomised, parallel-group, single-centre clinical trial in patients; Duration: Expected treatment duration was 15 days. " Durand 1986 |
Active substance: Lactitol |
Study summary document link (including results): 2011_EMAspreadsheet_Importal_Durand 1986.xls |
View full study record |
Document reference: 48149 |
Study title: Controlled, randomised, single-blind, parallel-group, single-centre clinical trial in patients; Duration: Treatment was 4 weeks (28 consecutive days). Report 1744 |
Active substance: Lactitol |
Study summary document link (including results): 2011_EMAspreadsheet_Importal_Report 1744.xls |
View full study record |
Document reference: 48152 |
Study title: Gallet, J.P. (1990) Lactitol monohydrate (Importal) for treatment of constipation in children. Results of a clinical investigation. Rev. Pediatr, 26 (8), 1-8.Gallet, J.P. (1990) Lactitol monohydrate (Importal) for treatment of constipation in children. Results of a clinical investigation. Rev. Pediatr, 26 (8), 1-8. |
Active substance: LACTITOL |
Study summary document link (including results): |
View full study record |
Document reference: 30987 |
Study title: Kokki H, Tuomilehto H, Karvinen M. Pharmacokinetics of ketoprofen following oral and intramuscular administration in young children. Eur J Clin Pharmacol. 2001 Nov;57(9):643-7.Kokki H, Tuomilehto H, Karvinen M. Pharmacokinetics of ketoprofen following oral and intramuscular administration in young children. Eur J Clin Pharmacol. 2001 Nov;57(9):643-7. |
Active substance: LACTITOL |
Study summary document link (including results): |
View full study record |
Document reference: 30988 |
Study title: “Metabolism of lactitol” Investigator: Prof. H. Doorenbos Report date: NR“Metabolism of lactitol” Investigator: Prof. H. Doorenbos Report date: NR |
Active substance: LACTITOL |
Study summary document link (including results): |
View full study record |
Document reference: 30985 |
Study title: Open-label, non-comparative clinical trial in patients and healthy subjects. Doorenbos H |
Active substance: Lactitol |
Study summary document link (including results): 2011_EMAspreadsheet_Importal_Doorenbos H.xls |
View full study record |
Document reference: 48147 |
Study title: Open-label, non-comparative clinical trial in patients Gallet JP 1990 |
Active substance: Lactitol |
Study summary document link (including results): Importal_Gallet JP_1990.xls |
View full study record |
Document reference: 48155 |
Study title: Open-label, non-comparative clinical trial in patients Duillo MT 1986 |
Active substance: Lactitol |
Study summary document link (including results): 2011_EMAspreadsheet_Importal_Duillo MT_1986.xls |
View full study record |
Document reference: 48148 |
Study title: Open-label, non-comparative clinical trial in patients. D'Apuzzo 1986 |
Active substance: Lactitol |
Study summary document link (including results): 2011_EMAspreadsheet_Importal_D'Apuzzo V_1986.xls |
View full study record |
Document reference: 48146 |
Study title: Open-label, non-comparative clinical trial in patients. Gallet 1986 |
Active substance: Lactitol |
Study summary document link (including results): 2011_EMAspreadsheet_Importal_Gallet_JP_1986.xls |
View full study record |
Document reference: 48150 |
Study title: Open-label, non-comparative clinical trial in patients. Giambonini S_1986 |
Active substance: Lactitol |
Study summary document link (including results): 2011_EMAspreadsheet_Importal_Giambonini S_1986.xls |
View full study record |
Document reference: 48151 |
Study title: Placebo controlled, randomised, double-blind, parallel-group, multicentre clinical trial in patients; Duration: Treatment was 14 consecutive days;Medication: Sachets containing 2.5 g lactitol or 2.5 g placebo. Report Zy 15060 BG-95-F7 |
Active substance: Lactitol |
Study summary document link (including results): 2011_EMAspreadsheet_Importal_Report Zy 15060 BG-95-F7.xls |
View full study record |
Document reference: 48153 |
Study title: Experimental use of macrodex as a prophylaxis against post-operative thrombo-embolism.KOEKENBERG LJ. Bull Soc Int Chir. 1962 Sep-Oct;21:501-12. |
Active substance: Dextran |
Study summary document link (including results): |
View full study record |
Document reference: 48938 |
Study title: Prevention of dextran-induced anaphylactic reactions by hapten inhibition. III. A Scandinavian multicenter study on the effects of 20 ml dextran 1, 15%, administered before dextran 70 or dextran 40.Renck H, Ljungström KG, Hedin H, Richter W. Acta Chir Scand. 1983;149(4):355-60. |
Active substance: Dextran |
Study summary document link (including results): |
View full study record |
Document reference: 48941 |
Study title: Percutaneous puncture and pre-operative cyanoacrylate obliteration of a traumatic false aneurysm of an angular artery branch. ;Huang-F. British Journal of Radiology, 2003, Vol/Iss/Pg. 76/910 (746-749)Percutaneous puncture and pre-operative cyanoacrylate obliteration of a traumatic false aneurysm of an angular artery branch. ;Huang-F. British Journal of Radiology, 2003, Vol/Iss/Pg. 76/910 (746-749) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30300 |
Study title: Percutaneous sclerotherapy for lymphatic malformations: A retrospective analysis of patient-evaluated improvement. Alomari-A-I. Journal of Vascular and Interventional Radiology, 2006, Vol/Iss/Pg. 17/10 (1639-1648), 0443.Percutaneous sclerotherapy for lymphatic malformations: A retrospective analysis of patient-evaluated improvement. Alomari-A-I. Journal of Vascular and Interventional Radiology, 2006, Vol/Iss/Pg. 17/10 (1639-1648), 0443. |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30301 |
Study title: Persistence of goiter despite oral iodine supplementation in goitrous children with iron deficiency anemia in Cote d'Ivoire. ;Zimmermann-M. American Journal of Clinical Nutrition, 2000, Vol/Iss /Pg. 71/1 (88-93)Persistence of goiter despite oral iodine supplementation in goitrous children with iron deficiency anemia in Cote d'Ivoire. ;Zimmermann-M. American Journal of Clinical Nutrition, 2000, Vol/Iss /Pg. 71/1 (88-93) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30302 |
Study title: Persistence of lipiodol for 13 months in metastatic deposits in the liver on computed tomography. ;Fairlie-N-C. Clinical Radiology, 1991, Vol/Iss/Pg. 44/4 (273-274)Persistence of lipiodol for 13 months in metastatic deposits in the liver on computed tomography. ;Fairlie-N-C. Clinical Radiology, 1991, Vol/Iss/Pg. 44/4 (273-274) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30303 |
Study title: Efficacy and safety of loratadina-betamethasone combination in the initial treatment of severe perennial allergic rhinitis in children |
Active substance: LARATADINE |
Study summary document link (including results): |
View full study record |
Document reference: 31019 |
Study title: Efficacy and Safety of SCH 29851 8 mg in Subjects with Allergic Rhinitis |
Active substance: LARATADINE |
Study summary document link (including results): |
View full study record |
Document reference: 31017 |
Study title: Efficacy and Safety of SCH 29851 in 8 mg in Subjects with Allergic Rhinitis |
Active substance: LARATADINE |
Study summary document link (including results): |
View full study record |
Document reference: 31015 |
Study title: Efficacy and Safety of SCH 29851 in 8 mg in Subjects with Allergic Rhinitis |
Active substance: LARATADINE |
Study summary document link (including results): |
View full study record |
Document reference: 31018 |
Study title: HEALTH ECONOMIC DRUG UTILIZATION OBSERVATION "XPENSE" FOR COMPARISON OF THE COSTS OF DIFFERENT MEDICAL GLAUCOMA THERAPIES |
Active substance: LATANOPROST/LATANOPROST AND TIMOLOL |
Study summary document link (including results): |
View full study record |
Document reference: 31021 |
Study title: Björklund SI. Miniture enema in children’s practice. The Swedish Medical Journal 1961:58:2763-2766. Devaux j, Bernard JL, Mouly-Bandini a, Raybaud CI. Use of a peptisant gel in a pediatric ward. Méditerranée Médicale 1975:3:65-68 No.67 (English translation). Björklund SI. Miniture enema in children’s practice. The Swedish Medical Journal 1961:58:2763-2766. Devaux j, Bernard JL, Mouly-Bandini a, Raybaud CI. Use of a peptisant gel in a pediatric ward. Méditerranée Médicale 1975:3:65-68 No.67 (English translation). |
Active substance: LAURYL SULPHATE AND SORBITOL |
Study summary document link (including results): |
View full study record |
Document reference: 31024 |
Study title: Grosse K-P, Keller KM, Behrens R, Becker M. Chronische Obstipation im Kindesalter. Monatsschr Kinderheilk 1990:138:231-233. Grosse K-P, Keller KM, Behrens R, Becker M. Chronische Obstipation im Kindesalter. Monatsschr Kinderheilk 1990:138:231-233. |
Active substance: LAURYL SULPHATE AND SORBITOL |
Study summary document link (including results): |
View full study record |
Document reference: 31026 |
Study title: Nolan T, Debelle G, Oberklaid F, Coffey C. Randomised trial of laxatives in treatment of childhood encopresis. Lancet 1991:338:523-527. Nolan T, Debelle G, Oberklaid F, Coffey C. Randomised trial of laxatives in treatment of childhood encopresis. Lancet 1991:338:523-527. |
Active substance: LAURYL SULPHATE AND SORBITOL |
Study summary document link (including results): |
View full study record |
Document reference: 31025 |
Study title: Pharmacia Consumer Pharma report on the Clinical Documenation on Microlax Enema; Helsingborg May 1995, Jan RundegrenPharmacia Consumer Pharma report on the Clinical Documenation on Microlax Enema; Helsingborg May 1995, Jan Rundegren |
Active substance: LAURYL SULPHATE AND SORBITOL |
Study summary document link (including results): |
View full study record |
Document reference: 31027 |
Study title: Rett A. Die Obstipaton als Klinisch-terapeutishes Problem hirngeschädigter Kinder. Therapeutische Umschau 1996:23:165-169. Rett A. Die Obstipaton als Klinisch-terapeutishes Problem hirngeschädigter Kinder. Therapeutische Umschau 1996:23:165-169. |
Active substance: LAURYL SULPHATE AND SORBITOL |
Study summary document link (including results): |
View full study record |
Document reference: 31022 |
Study title: Strauss P. Die Behandlung der kindlichen Obstipation unter Verwendung eies neuen Mikroklistiers. Deut Med J 1965:16:476-478. Strauss P. Die Behandlung der kindlichen Obstipation unter Verwendung eies neuen Mikroklistiers. Deut Med J 1965:16:476-478. |
Active substance: LAURYL SULPHATE AND SORBITOL |
Study summary document link (including results): |
View full study record |
Document reference: 31023 |
Study title: |
Active substance: LEFLUNOMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 47352 |
Study title: Randomised trial of two pharmacological methods of bowel preparation for day case colonoscopyPinfield A, Stringer MD., 1999, Arch Dis child 1999; 80: 181 - 183 |
Active substance: SODIUM PICOPSULPHATE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48903 |
Study title: Safety of Picolax in inflammatory bowel disease.Evans M, Walker-Smith J, Williams Ch., 1989, BMJ 1989; 299: 1101 – 1102 |
Active substance: SODIUM PICOPSULPHATE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48900 |
Study title: The superiority of topical application of stannous fluoride on primary teeth1957-McDonald |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1957-McDonald-the superiority of topical application of stannous fluoride on primary teeth.pdf |
View full study record |
Document reference: 49135 |
Study title: The use of a sodium fluoride mouthwash in reducing the dental caries increment in eleven year old english school children1972-Brandt |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1972-Brandt-the use of a sodium fluoride mouthwash in reducing the dental caries increment in eleven year old english school children.pdf |
View full study record |
Document reference: 49128 |
Study title: Three year report on caries prevention using I fluoride varnish for caries risk children in a community with fluoridated water1982-seppa |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1982-seppa-Three year report on caries prevention using I fluoride varnish for caries risk children in a community with fluoridated water.pdf |
View full study record |
Document reference: 49109 |
Study title: Topical application of a fluoride protective varnish for caries prophylaxis1973-maiwald |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1973-maiwald-Topical application of a fluoride protective varnish for caries prophylaxis.pdf |
View full study record |
Document reference: 49101 |
Study title: Trends in total caries experience2000-Brown |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 2000-Brown-trends in total caries experience.pdf |
View full study record |
Document reference: 49097 |
Study title: Two-year clinical tests with different methods of local caries-preventive fluorine application in swedish school-children1965-Torell |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1965-Torell-two-year clinical tests with different methods of local caries-preventive fluorine application in swedish school-children.pdf |
View full study record |
Document reference: 49126 |
Study title: Fluorine concentration in primary tooth enamel in 6 year olds after 3 years of daily intake of fluoride-containing tablets.J. Widenheim, Lars G Petersson, Goran Koch 1984, Swed Dent J |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1984-widenheim-Fluoide concentration in primary tooth enamel in 6 years oldy after 3 years of daily intake of fluoridecontaining tablets.pdf |
View full study record |
Document reference: 48777 |
Study title: Fluroide in the prevention of caries in the pre-school childRugg 19990. J. Dent |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1990-Rugg_Gunn-Fluoride in the Prevention of Caries in the Pre-school Child.pdf |
View full study record |
Document reference: 48774 |
Study title: Four year study of caries inhibition of intensive Duraphat application in 11-15 year old children1994-skold, Community Dent. Oral Epidemiol. 1994 22:18-24 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1994-skold-Four year study of caries inhibition of intensive Duraphat application in 11-15 year old children.pdf |
View full study record |
Document reference: 49119 |
Study title: Gingival recession and wedge-shaped defects with regular use of an amine fluoride-containing gel applied with a toothbrushSchiffner 1995 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Schiffner 1995 Gingival recession and wedge-shaped.pdf |
View full study record |
Document reference: 49177 |
Study title: High-fluoride toothpaste and no post-brushing water rinsing on enamel demineralization using an in-sit caries model with orthodontic bands2010-AlMulla |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 2010-AlMulla-high-fluoride toothpaste and no post-brushing water rinsing on enamel demineralization using an in-sit caries model with orthodontic b... |
View full study record |
Document reference: 49098 |
Study title: Bone scintigraphy in calcific discitis of childhood. Delpassand ES, Barron BJ, Gundzik JM. J Nucl Med. 1990 Feb;31(2):234-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48843 |
Study title: Bone scintigraphy in testicular tumors.Braga FJ, Arbex MA, Haddad J, Maes A. Clin Nucl Med 2001 Feb;26(2):117-8. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48577 |
Study title: K.E.E.P.E.R. (KEPPRA(R) EPILEPSY EVALUATION OF PATIENT TIME TO RESPONSE). A PHASE IV, OPEN-LABEL, MULTI-CENTER, COMMUNITY-BASED TRIAL STUDYING THE SAFETY AND EFFICACY OF LEVETIRACETAM AS ADD-ON THERAPY IN ADULT PATIENTS WITH TREATMENT-RESISTANT, PARTIAL-ONSET EPILEPSY. |
Active substance: levetiracetam |
Study summary document link (including results): N01030 - Levetiracetam - RRCE02E1301.pdf |
View full study record |
Document reference: 31147 |
Study title: Bone scintigraphy in the diagnosis and follow up of Perthes' disease.Cavailloles F, Bok B, Bensahel H. Eur J Nucl Med 1982;7(7):327-30. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48588 |
Study title: Gallium-67 and technetium-99m-methylene diphosphonate skeletal scintigraphy in determining prognosis for children with stage IV neuroblastomaMacdonald WB. Stevens MM. Dalla Pozza L. Bergin M. Menser MA. Howman-Giles R. et al. J Nucl Med 1993Jul;34(7):1082-6 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48502 |
Study title: Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99m)Tc MAA lung scanning. Chest. 2000 Sep;118(3):615-24. Krowka MJ 2000 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48803 |
Study title: Irreversible long-term pulmonary functional impairments after adenovirus type-7 pneumonia: assessment with xenon-133 ventilation and Tc-99m MAA perfusion studies. Eur Radiol. 2000;10(9):1411-5. Suga K 2000 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48802 |
Study title: Krypton-81m ventilation and technetium-99m macroaggregated albumin perfusion scintigraphy for detection of pulmonary embolism: the first experience in Taiwan. Zhonghua Yi Xue Za Zhi (Taipei). 2000 Dec;63(12):876-84. Cherng SC 2000 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48801 |
Study title: Late pulmonary scintigraphic defects after uneventful recovery from focal pneumonia in children: comparison with initial radiograph. Med Sci. 2002 Jul;18(7):334-9. Kaohsiung J 2002 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48798 |
Study title: Late pulmonary scintigraphic defects after uneventful recovery from simple focal pneumonia of childhood. Br J Radiol. 1993 Nov;66(791):1031-4. Kenney IJ 1993 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48819 |
Study title: Gastric uptake of Tc-99m MDP in a child treated with isotretinoin.Franco A, Hampton WR, Greenspan BS, Holm AL, O'Mara RE. Clin Nucl Med 1993 18(6):510-1. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48723 |
Study title: Acute asthma management of children in the emergency department. |
Active substance: IPRATROPIUM |
Study summary document link (including results): |
View full study record |
Document reference: 30563 |
Study title: Low dose oral iodized oil for control of iodine deficiency in children. ; Zimmermann-M. British Journal of Nutrition, 2000, Vol/Iss/Pg. 84/2 (139-141)Low dose oral iodized oil for control of iodine deficiency in children. ; Zimmermann-M. British Journal of Nutrition, 2000, Vol/Iss/Pg. 84/2 (139-141) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30283 |
Study title: Dal Monte. Gastroenterology Dept Bellaria Hospital, Regional Hospital Institution-Hospital of Bologna Dal Monte. Gastroenterology Dept Bellaria Hospital, Regional Hospital Institution-Hospital of Bologna |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30095 |
Study title: AN 05134405 Medline 20070101. TI (Use of cyproheptadine to obtain recovery of the weight curve after tonsillectomy. Clinico-statistical observations on 91 cases). TT Sull'impiego della ciproeptadina per l'ottenimento di una ripresa della curva ponderale dopo l'intervento di tonsillectomia. Osservazioni clinico-statistich su 91 casi. SO Minerva otorinolaringologica, {Minerva-Otorinolaringol}, Sep-Oct 1971, vol. 21, no. 5, p. 191-5, ISSN: 0026-4938. AU Fior-R. YR 1971.AN 05134405 Medline 20070101. TI (Use of cyproheptadine to obtain recovery of the weight curve after tonsillectomy. Clinico-statistical observations on 91 cases). TT Sull'impiego della ciproeptadina per l'ottenimento di una ripresa della curva ponderale dopo l'intervento di... |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25204 |
Study title: Phase IV Efficacy and Safety Study of Reformulated CoTylenol Tablets. Nov 1978. |
Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 25797 |
Study title: Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25301 |
Study title: Efficacy and morbidity of Daunomycin (NSC-82151) added to vincristine (NSC-67574) and Prednisone (NSC-10023) for remission induction of childhood acute lymphocytic leukemia - Verzosa, M., Fite, A. - 1971 (Cancer Chemotherapy Reports Part.1 Vol. 55 n°1, 79-82) - Publication in the dos. Allemand jan 1981 - Efficacy and morbidity of Daunomycin (NSC-82151) added to vincristine (NSC-67574) and Prednisone (NSC-10023) for remission induction of childhood acute lymphocytic leukemia - Verzosa, M., Fite, A. - 1971 (Cancer Chemotherapy Reports Part.1 Vol. 55 n°1, 79-82) - Publication in the dos. Allemand jan 1981 - |
Active substance: DAUNORUBICIN |
Study summary document link (including results): |
View full study record |
Document reference: 25617 |
Study title: No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25401 |
Study title: Paul IM et al. Dose-response relationship with increasing doses of dextromethorphan for children with cough. Clin Ther 2004; 26(9):1508-1514 |
Active substance: Dextromethorphan + GUAFENESIN |
Study summary document link (including results): |
View full study record |
Document reference: 25913 |
Study title: Gikas P, Mokbel K. Management of gynaecomastia: an update [Review]. International Journal of Clinical Practice 2007; 61(7):1209-1215.Gikas P, Mokbel K. Management of gynaecomastia: an update [Review]. International Journal of Clinical Practice 2007; 61(7):1209-1215. |
Active substance: TAMOXIFEN |
Study summary document link (including results): |
View full study record |
Document reference: 43085 |
Study title: AN OPEN STUDY OF CEFOPERAZONE PLUS SULBACTAM IN THE TREATMENT OF SEVERE SKIN AND SKIN STRUCTURE INFECTIONS OF BACTERIAL ETIOLOGY |
Active substance: SULBACTAM |
Study summary document link (including results): |
View full study record |
Document reference: 42638 |
Study title: CLINICAL USEFULNESS OF SULTAMICILLIN FINE GRANULES FOR TONSILLITIS AND ACUTE BRONCHITIS OF CHILDREN |
Active substance: SULTAMICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 43006 |
Study title: Addition of 18F-FDG-PET scans to radiotherapy planning of thoracic lymphomaRadiotherapy and Oncology 73 (2004) 277–283. Young K. Leea,e,*, Gary Cookb, Maggie A. Flowera, Carl Rowbottomc, Mehdi Shahidid, Bhupinder Sharmab, Steve Webba |
Active substance: Steripet |
Study summary document link (including results): lee-2004.pdf |
View full study record |
Document reference: 48736 |
Study title: Application of Intravenous Contrast in PET/CT:Does It Really Introduce Significant Attenuation Correction Error?J Nucl Med 2005; 46:283–291. Yat-Yin Yau, MD1; Wing-Sze Chan, BSc1; Yat-Man Tam, MSc1; Phil Vernon, PhD2; So Wong1; Marc Coel, MD3; and Simon Kwok-Fai Chu1 |
Active substance: Steripet |
Study summary document link (including results): yau-2005.pdf |
View full study record |
Document reference: 48747 |
Study title: ARSAC (Administration of Radioactive Substances Advisory Committee). Notes for Guidance on the Clinical Administration of Radiopharmaceuticals and Use of Sealed Radioactive Sources.Chilton, Didcot, 2006. [arsac-2006]. ARSAC 2006 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48626 |
Study title: |
Active substance: LEFLUNOMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 47353 |
Study title: |
Active substance: LEFLUNOMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 47354 |
Study title: Double-blind, eight-month extension study to collect durability of efficacy data and additional safety data in patients with juvenile rheumatoid arthritis completing the double-blind comparison study HWA486/3503 of leflunomide versus methotrexate |
Active substance: LEFLUNOMIDE |
Study summary document link (including results): Leflunomide-Study 3.pdf |
View full study record |
Document reference: 47350 |
Study title: Efficacy and safety of leflunomide versus methotrexate in the treatment of pediatric patients with juvenile rheumatoid arthritis (JRA) |
Active substance: LEFLUNOMIDE |
Study summary document link (including results): Leflunomide-Study 2.pdf |
View full study record |
Document reference: 47349 |
Study title: Phase IB Trial of Leflunomide in Pediatric Subjects with Polyarticular Course Juvenile Rheumatoid Arthritis (JRA) |
Active substance: LEFLUNOMIDE |
Study summary document link (including results): Leflunomide-Study 1.pdf |
View full study record |
Document reference: 47348 |
Study title: Population pharmacokinetics of A77 1726 (M1) after oral administration of leflunomide in pediatric subjects with polyarticular course juvenile rheumatoid arthritis |
Active substance: LEFLUNOMIDE |
Study summary document link (including results): Leflunomide-Study 4.pdf |
View full study record |
Document reference: 47351 |
Study title: Compatibility of Lomaherpan Cream in children with herpes simplex labialis 1995 |
Active substance: Lemon balm dry extract |
Study summary document link (including results): |
View full study record |
Document reference: 40047 |
Study title: Q Clinical impact of fluorine-18fluorodeoxyglucose positron emission tomography in cancer patients. A comparative study between dedicated camera and dual-head coincidence gamma camera.JNucl Med Mol Imaging. 2006 Mar;50(1):68-77. Andrieux A 2006 |
Active substance: SteriPET |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48624 |
Study title: Rigacci L, Castagnoli A, Dini C, Carpaneto A, Matteini M, Alterini R. FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long-term results. [rigacci-2005]Oncol Rep. 2005 Nov;14(5):1209-14. 18. Rigacci L 2005 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48692 |
Study title: Rini JN, Manalili EY, Hoffman MA, Karayalcin G, Mehrotra B, Tomas MB, et alFDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease. [rini-2002]Clin Nucl Med. 2002 Aug;27(8):572-7. F-18. Rini JN 2002 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48693 |
Study title: Rixham PA, Roberts G. The new EANM paediatric dosage card : how does it affect UK centres working under the ARSAC guidelines? [rixham-2009]Nucl Med Comm 2009; 319 – 321. Rixham PA 2009 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48694 |
Study title: Schifter T, Hoffman JM, Hatten HP Jr, Hanson MW, Coleman RE, DeLong GR.. Neuroimaging in infantile autism. [schifter-1994]J Child Neurol. 1994 Apr;9(2):155-61. Schifter T 1994 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48695 |
Study title: Schmitz A, Risse JH, Grünwald F, Gassel F, Biersack HJ, Schmitt O.. Fluorine-18 fluorodeoxyglucose positron emission tomography findings in spondylodiscitis: preliminary results. [schmitz-2001]Eur Spine J. 2001 Dec;10(6):534-9. Schmitz A 2001 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48696 |
Study title: Shulkin BL, Goodin GS, McCarville MB, Kaste SC, Krasin MJ, Hudson MM, Metzger M.. Bone and [18F]fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults. [shulkin-2009 Leuk Lymphoma. 2009 Nov;50(11):1794-802. Shulkin BL 2009 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48698 |
Study title: Shulkin BL, Hutchinson RJ, Castle VP, Yanik GA, Shapiro B, Sisson JC.. Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy. [shulkin-1996]Radiology. 1996 Jun;199(3):743-50. Shulkin BL 1996 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48697 |
Study title: Incremental rates of dental caries after repeated topical sodium fluoride applications in children with lifelong consumption of fluoridated water1971-Englander |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1971-Englander-incremental rates of dental caries after repeated topical sodium fluoride applications in children with lifelong consumption of fluo... |
View full study record |
Document reference: 49093 |
Study title: Jarman underproveleged area scores, tooth decay and the effect of water fluoridation1997-jones |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1997-jones-Jarman underproveleged area scores, tooth decay and the effect of water fluoridation.pdf |
View full study record |
Document reference: 49123 |
Study title: Kollective Karies pravention in Vorchulatter unter Verwendung eines Fluoridhaltingen lackes1980-treide |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1980-treide-Kollective Karies pravention in Vorchulatter unter Verwendung eines Fluoridhaltingen lackes.pdf |
View full study record |
Document reference: 49107 |
Study title: Kollektive VorbeugungsprogrammeMagri 1986 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Magri 1986 Kollektive Vorbeugungsprogramme.pdf |
View full study record |
Document reference: 49169 |
Study title: Long term evaluation of a SnF2 gel for control of gingivitis and decalcification in adolescent orthodontic patients1994-boyd |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1994-boyd - long term evaluation of a SnF2 gel for control of gingivitis and decalcification in adolescent orthodontic patients.pdf |
View full study record |
Document reference: 49157 |
Study title: NHS dental epidemology programme for England2010-Rooney |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 2010-Rooney-NHS dental epidemology programme for England.pdf |
View full study record |
Document reference: 49092 |
Study title: Perspectives on the use of Prenatal Fluoride Administration for Prevention of Dental Caries: a reactors comments1981-Stamm. Journal of Dentistry for Children, March - April, 1951 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1981-Stamm-Perspectives on the use of Prenatal Fluoride Administration for Prevention of Dental Caries.pdf |
View full study record |
Document reference: 48772 |
Study title: Pharmacokinetics of Fluoride gelsEkstrand 1981, Caries Res 15:213 - 220 (1981) |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Ekstrand 1981 Pharmacokinetics of Fluoride gels.pdf |
View full study record |
Document reference: 49163 |
Study title: Pilot caries prevention- Modellversuch der KariesprophylaxeStöhr 1979 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Steiner 1984 Enamel opacities in the incisors of school children.pdf |
View full study record |
Document reference: 49181 |
Study title: Plasma fluoride concentration and urinary fluoride excretion in children following application of the fluoride containing varnish Duraphat1980-ekstrand, Caries Res, 14: 185-189 1980 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1980-ekstrand-Plasma fluoride concentration and urinary fluoride excretion in children following application of the fluoride containing varnish Dur... |
View full study record |
Document reference: 49106 |
Study title: Pre-eruptive effect of NaF tablets on caries in children from 12 to 17 years of ageJ. Widenheim, Dowen Birked, Lars Granath, Georg Lindgren 1986. Community Dent Oral Epidemiol |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1986-Widenheim-Preeruptive effect of NaF Tablets on Caries in Children from 12 to 17 years of age.pdf |
View full study record |
Document reference: 48776 |
Study title: Pretreatment of teeth with sodium fluoride prior to stannous fluoride applications1959-Abdul-Gaffar, J DENT RES 1959 38: 901 H. Abdul-Ghaffar and Joseph C. Muhler |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1959-Abdul-Gaffar- Pretreatment of teeth with sodium fluoride prior to stannous fluoride applications.pdf |
View full study record |
Document reference: 49136 |
Study title: Prevention of caries progress in xerostomic patients by topical fluoride applicationsMarkitziu 1982 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Markitziu 1982 Prevention of caries progress.pdf |
View full study record |
Document reference: 49171 |
Study title: L'Ipratropium bromide in the treatment of asthma-like bronchitis in babies.Clin.Ped. 1981,63,1-7Corrias A. et al ClinPed 1981, Corrias |
Active substance: IPRATROPIUM |
Study summary document link (including results): ClinPed 1981, Corrias.pdf |
View full study record |
Document reference: 48889 |
Study title: Measurements on the rapid and medium-acting bronchodilating effect of ipratropium bromide administered by aerosol in children with allergic bronchial asthma. Arch Med Int 1981,33,25-40Capristo A. et al ArchMedInterna 1981, Capristo |
Active substance: IPRATROPIUM |
Study summary document link (including results): ArchMedInterna 1981, Capristo.pdf |
View full study record |
Document reference: 48888 |
Study title: Role of buclizine hydrochloride in promoting weight gain in children |
Active substance: Buclizine |
Study summary document link (including results): DE81G307P - Buclizine hydrochloride.pdf |
View full study record |
Document reference: 42007 |
Study title: A comparison of iohexol and diatrizoate-meglumine in children undergoing cardiac catheterization. Investigative radiology (1991), 26(7), 665-70 Pelech AN 1991 |
Active substance: IOHEXOL |
Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
View full study record |
Document reference: 48863 |
Study title: A) Open non-comparative pilot study B) randomized, double-blind, parallel study using Amipaque (metrizamide) 300 mgI/ml as comparison in pediatric urography to assess the safety, tolerability and image effectiveness of iohexol 300 mgI/ml firstly in an open study and later compared to Amipaque 300 mgI/ml.Applicant's study report |
Active substance: IOHEXOL |
Study summary document link (including results): Copy of List of studies Omnipaque- pediatric.xls |
View full study record |
Document reference: 48887 |
Study title: Impact of ibuprofen administration on renal drug clearance in the first weeks of life. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29913 |
Study title: A comparative study to compare the effects of BDP and BUD of symptoms, peak-flow diaries. Lung function and hypothalamic-adrenal function |
Active substance: BUDESONIDE |
Study summary document link (including results): |
View full study record |
Document reference: 48892 |
Study title: Comparison of the risk of nocturnal hypoglycemia in adolescents with type 1 diabetes mellitus given either HOE901 with lispro or NPH insulin with regular human insulin, as multiple injection regimens |
Active substance: INSULIN GLARGINE |
Study summary document link (including results): |
View full study record |
Document reference: 47341 |
Study title: Morning Lantus® (insulin glargine [rDNA origin] injection) vs. intermediateacting insulin twice daily as basal insulin in a multiple daily injection regimen with Humalog® (insulin lispro injection [rDNA Origin]) in pediatrics with type 1 diabetes mellitus: an activeontrolled, open, randomized, gender-stratified, two arm, parallel-group study. |
Active substance: INSULIN GLARGINE |
Study summary document link (including results): |
View full study record |
Document reference: 47342 |
Study title: Multicenter, open, uncontrolled clinical extension trial of HOE901 in type 1 diabetic children previously participating in study HOE901/3003. |
Active substance: INSULIN GLARGINE |
Study summary document link (including results): |
View full study record |
Document reference: 47340 |
Study title: Lai C.L. Open, pilot (phase II) study comparing patients treated with interferon alfa-2a with an untreated control group, in chinese chidren with chronic hepatitis B (Protocol 0-10002); 30th May 1988 (Leitz G.J., Rochefort E., Ryff J.C.) |
Active substance: INTERFERON ALPHA (2A) |
Study summary document link (including results): |
View full study record |
Document reference: 30188 |
Study title: V. Carreno M.D. Open, single centre pilot (phase II) study comparing patients treated with interferon alfa-2a with an untreated control group in children with chronic hepatitis B (Protocol 0-10002); 30th May 1988 (Leitz G.J., Rochefort E., Ryff J.C.) |
Active substance: INTERFERON ALPHA (2A) |
Study summary document link (including results): |
View full study record |
Document reference: 30189 |
Study title: Treatment of Early Onset Mulitple Sclerosis with Suboptimal Dose of Interferon Beta-1a (Pakdaman et al) |
Active substance: Interferon beta-1a |
Study summary document link (including results): |
View full study record |
Document reference: 41483 |
Study title: |
Active substance: INTERFERON GAMMA (1B |
Study summary document link (including results): |
View full study record |
Document reference: 47176 |
Study title: 107.162, 107.235 - A Population pharmacokinetic analysis for meloxicam in pediatric juvenile rheumatoid arthritis patients – A combined analysis of pharmacokinetic data obtained in studies 107.162 and 107.235 |
Active substance: INTERFERON GAMMA (1B) |
Study summary document link (including results): |
View full study record |
Document reference: 30200 |
Study title: 137158 - Clinical efficacy of recombinant human interferon-gamma in chronic granulomatous disease. |
Active substance: INTERFERON GAMMA (1B) |
Study summary document link (including results): |
View full study record |
Document reference: 30192 |
Study title: ARSAC website http://www.arsac.org.uk/newsletter/newsletters.htm ; accessed 27 January 2010 [arsac-2009]ARSAC 2009 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48627 |
Study title: Bar-Shalom R, Gaitini D, Keidar Z, Israel O.. Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT. [bar-shalam-2004Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1105-13. Epub 2004 Mar 9. Bar-Shalom R 2004 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48628 |
Study title: Barrington SF, Begent J, Lynch T, Schleyer P, Biassoni L, Ramsden W, et al.. Guidelines for the use of PET–CT in children. [barrington-2008]Nucl Med Commun 2008; 29:418–424. Barrington SF 2008 |
Active substance: Steripet |
Study summary document link (including results): |
View full study record |
Document reference: 48629 |
Study title: Bastiaannet E, Oyen WJ, Meijer S, Hoekstra OS, Wobbes T, Jager PL, et al.. Impact of 18F] fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients. [bastiaannet-2006]Br J Surg. 2006 Feb;93(2):243-9. Bastiaannet E 2006 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48631 |
Study title: Bestic JM, Peterson JJ, Bancroft LW.. Review. Erratum in: Radiographics. 2010 Jan-Feb;30(1):301. Pediatric FDG PET/CT: Physiologic uptake, normal variants, and benign conditions [corrected]. [bestic-2009] Radiographics. 2009 Sep-Oct;29(5):1487-500. Bestic JM 2009 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48632 |
Study title: Boellaard R, Oyen WJ, Hoekstra CJ, Hoekstra OS, Visser EP, Willemsen AT, Arends B, Verzijlbergen FJ, Zijlstra J, Paans AM, Comans EF,. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. [boellaard-2008]Pruim J Eur J Nucl Med Mol Imaging 2008 12:2320–2333. Boellaard R 2008 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48633 |
Study title: Borgwardt L, Højgaard L, Carstensen H, Laursen H, Nowak M, Thomsen C, et al.. Increased fluorine-18 2-fluoro-2-deoxy-Dglucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion. [borgwardt-2005]J Clin Oncol. 2005 May 1;23(13):3030-7. Borgwardt L 2005 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48634 |
Study title: Brenner W, Friedrich RE, Gawad KA, Hagel C, von Deimling A, de Wit M, et al.. Epub 2006 Jan 11. Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours. [brenner-2006]Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):428-32. Brenner W 2006 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48635 |
Study title: Buchmann I, Reinhardt M, Elsner K, Bunjes D, Altehoefer C, Finke J, et al.. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. [buchmann-2001]Cancer. 2001 Mar 1;91(5):889-99. Buchmann I, 2001 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48636 |
Study title: Endemic goiter in rural peru: Effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitres populations; E.A. Pretell. Pan American Health Organization: Chapter 34 :419-437Endemic goiter in rural peru: Effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitres populations; E.A. Pretell. Pan American Health Organization: Chapter 34 :419-437 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30245 |
Study title: Endoscopic sclerotherapy of gastric variceal bleeding with N-butyl-2- cyanoacrylate. ; Dhiman-R-K. Journal of Clinical Gastroenterology, 2002, Vol /Iss/Pg. 35/3 (222-227)Endoscopic sclerotherapy of gastric variceal bleeding with N-butyl-2- cyanoacrylate. ; Dhiman-R-K. Journal of Clinical Gastroenterology, 2002, Vol /Iss/Pg. 35/3 (222-227) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30246 |
Study title: Strategy of goitre and cretinism control in Central Africa; C H Thilly. International journal of epidemiology Vol. 6 n0. 1: 43-54Strategy of goitre and cretinism control in Central Africa; C H Thilly. International journal of epidemiology Vol. 6 n0. 1: 43-54 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30325 |
Study title: Strumatherapie heute, Köbberling; Med. Klein. 87, 374-377, 1992Strumatherapie heute, Köbberling; Med. Klein. 87, 374-377, 1992 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30326 |
Study title: Successful left hepatectomy for hepatocellular carcinoma in a child after transcatheter arterial chemoembolization: Report of a survival. ; Uemura-S, T. European Journal of Pediatric Surgery, 1993, Vol /Iss/Pg. 3/1 (54-56)Successful left hepatectomy for hepatocellular carcinoma in a child after transcatheter arterial chemoembolization: Report of a survival. ; Uemura-S, T. European Journal of Pediatric Surgery, 1993, Vol /Iss/Pg. 3/1 (54-56) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30327 |
Study title: Successful left trisegmentectomy for ruptured hepatoblastoma using intraoperative transarterial embolization. ; Kitahara-S. Journal of Pediatric Surgery, 1995, Vol/Iss/Pg. 30/12 (1709-1712)Successful left trisegmentectomy for ruptured hepatoblastoma using intraoperative transarterial embolization. ; Kitahara-S. Journal of Pediatric Surgery, 1995, Vol/Iss/Pg. 30/12 (1709-1712) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30328 |
Study title: Technique of the lipiodol test in pediatrics (Russian). ; Livshitz-E-G. LAB-DELO, 1973, Vol/Iss/Pg. 12/- (740-741). Technique of the lipiodol test in pediatrics (Russian). ; Livshitz-E-G. LAB-DELO, 1973, Vol/Iss/Pg. 12/- (740-741). |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30329 |
Study title: Techniques and Applications of Transcatheter Embolization Procedures in Pediatric Cardiology. ; Sim-J-Y. Journal of Interventional Cardiology, 2003, Vol /Iss/Pg. 16/5 (425-448)Techniques and Applications of Transcatheter Embolization Procedures in Pediatric Cardiology. ; Sim-J-Y. Journal of Interventional Cardiology, 2003, Vol /Iss/Pg. 16/5 (425-448) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30330 |
Study title: The effect of varying doses of oral iodized oil in the prophylaxis of endemic goitre in elementary schools children. ; Abuye-C. Ethiopian Medical Journal, 1995, Vol/Iss/Pg. 33/2 (115-123)The effect of varying doses of oral iodized oil in the prophylaxis of endemic goitre in elementary schools children. ; Abuye-C. Ethiopian Medical Journal, 1995, Vol/Iss/Pg. 33/2 (115-123) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30331 |
Study title: The huon peninsula endemic: The effectiveness of an intramuscular depot of iodized oil in the control of endemic goitre.;Mc Cullagh. The medicinal journal of Australia 769-777The huon peninsula endemic: The effectiveness of an intramuscular depot of iodized oil in the control of endemic goitre.;Mc Cullagh. The medicinal journal of Australia 769-777 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30332 |
Study title: A dose-finding study of a super-long acting luteinizing hormone releasing hormone analogue in the treatment of central precocious puberty |
Active substance: LEUPRORELIN |
Study summary document link (including results): |
View full study record |
Document reference: 31052 |
Study title: A study of clinical utility of a sustained release injection of leuprorelin acetate in the treatment of patients with central precocious puberty |
Active substance: LEUPRORELIN |
Study summary document link (including results): |
View full study record |
Document reference: 31051 |
Study title: Clinical trial to evaluate efficacy and tolerability of subcutaneously administered leuprorelin acetate as a 1-month depot in a weight-dependent dosage in female patients with central precocious puberty + Biometrical report- interim results on bone metabolism |
Active substance: LEUPRORELIN |
Study summary document link (including results): 2011-08-11 Leuprorelin EC08(128)_EC108 Synopsis.pdf |
View full study record |
Document reference: 31043 |
Study title: Efficacy and safety of leuprorelin 3.75 mg administered by subcutanous injection every 28 days in the treatment of central precocious puberty |
Active substance: LEUPRORELIN |
Study summary document link (including results): 2011-08-11 Leuprorelin TAP-III-90-004 Synopsis.pdf |
View full study record |
Document reference: 31050 |
Study title: Leuproreline acetate in the treatment of central precocious puberty: a 12-month, multicenter, randomised, equivalence trial of two different depot formulations |
Active substance: LEUPRORELIN |
Study summary document link (including results): Leuprorelin_LEUb_CPP3M14_Synopsis.pdf |
View full study record |
Document reference: 31048 |
Study title: Leuproreline acetate in the treatment of central precocious puberty: a 12-month, multicenter, randomised, equivalence trial of two different depot formulations |
Active substance: LEUPRORELIN |
Study summary document link (including results): Leuprorelin_LEUb_CPP3M14_Synopsis.pdf |
View full study record |
Document reference: 31045 |
Study title: Lupron Injection (Lupron depot) combined results of independent investigators' studies of Leuprolide acetate in the treatment of central precocious puberty |
Active substance: LEUPRORELIN |
Study summary document link (including results): 2011-08-11 Leuprorelin P-90-053 Synopsis.pdf |
View full study record |
Document reference: 31049 |
Study title: Prevention of decalcification in orthodontic patients by daily self treatment with 0.4 percent SnF2 gel1979-shannon |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1979-shannon - prevention of decalcification in orthodontic patients by daily self treatment with 0.4 percent SnF2 gel.pdf |
View full study record |
Document reference: 49154 |
Study title: Preventive effect of high-fluoride dentifrice in caries-active adolescents2010-Nordstrom |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 2010-Nordstrom-preventive effect of high-fluoride dentifrice in caries-active adolescents.pdf |
View full study record |
Document reference: 49099 |
Study title: Reduction in dental caries with four concentrations of sodium fluoride in a dentifrice: a meta-analysis evaluation2001-Bartizek, The journal of clinical dentistry |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 2001-Bartizek-reduction in dental caries with four concentrations of sodium fluoride in a dentifrice.pdf |
View full study record |
Document reference: 49087 |
Study title: Relative anti-caries efficacy of 1100, 1700, 2200 and 2800 ppm fluoride ion in a sodium fluoride dentifrice over 1 year2001-Biesbrock, Community dentistry and oral epidemiology |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 2001-Biesbrock-relative anti-caries efficacy of 1100, 1700, 2200 and 2800 ppm fluoride ion in a sodium fluoride dentifrice over 1 year.pdf |
View full study record |
Document reference: 49088 |
Study title: Results of a 3-year oral hygiene programmeDénes 1991, european Journal of Orthodontics 13 (1991) 129-133 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Dénes 1991 Results of a 3-year oral hygiene programme.pdf |
View full study record |
Document reference: 49161 |
Study title: Results of a group prophylaxis programmeBüttner 1985 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Büttner 1985 Results of a group prophylaxis programme.pdf |
View full study record |
Document reference: 49158 |
Study title: Results of a three-year investigation about Zahneputzen with an amine fluoride gels - Ergebnisse einer dreijährigen untersuchung uber Zahneputzen mit einem Aminfluorid-geleSzöke 1989 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Szöke 1989 Ergebnisse einer dreijährigen.pdf |
View full study record |
Document reference: 49182 |
Study title: Results of the Sherbrooke-Lac Megtanic fluoride varnish study after 20 months1985-clark |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1985-clark-Results of the Sherbrooke-Lac Megtanic fluoride varnish study after 20 months.pdf |
View full study record |
Document reference: 49112 |
Study title: Sodium fluoride tablets for childrenFrancis A. Arnold, F.J. McClure, Carl. L. White. Dental Vol 1. No. 1. October 1960 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1960-Arnold-Sodium fluoride tablets for children.pdf |
View full study record |
Document reference: 48766 |
Study title: stannous fluoride topically applied os effective-data at the end of a five years study1965-Rothhaar |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1965-Gish-Effect on dental caries in children in a natural fluoride area of combined use of three agents containing stannous fluoride.pdf |
View full study record |
Document reference: 49148 |
Study title: Stannous fluoride versus sodium fluoride in preventive treatment of orthodontic patients1977-shannon |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1977-shannon - stannous fluoride versus sodium fluoride in preventive treatment of orthodontic patients.pdf |
View full study record |
Document reference: 49153 |
Study title: No title |
Active substance: Somatropin |
Study summary document link (including results): |
View full study record |
Document reference: 41752 |
Study title: Rovamycine (Spiramycine) RP5337 - Etude clinique nationale de la rovamycine sirop pediatrique |
Active substance: SPIRAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 42590 |
Study title: A TWO YEAR MULTI-CENTRE STUDY OF GENOTROPIN TREATMENT OF SHORT PUBERTAL CHILDREN WITH INTRAUTERINE GROWTH RETARDATION |
Active substance: Somatropin |
Study summary document link (including results): 93-8122-002 EMA Pediatrics Web Synopsis.pdf |
View full study record |
Document reference: 41681 |
Study title: 137163 - To study the effect duration of two different doses of IFN-gamma in patients with chronic granulomatous disease (CGD) on functional responses of neutrophils (PMN). |
Active substance: INTERFERON GAMMA (1B) |
Study summary document link (including results): |
View full study record |
Document reference: 30193 |
Study title: 137177 - The immunomodulatory impact of Imukin (IFNgamma-1b) on clinical and laboratory data in the treatment of atopic dermatitis. |
Active substance: INTERFERON GAMMA (1B) |
Study summary document link (including results): |
View full study record |
Document reference: 30194 |
Study title: A phase III randomized, controlled open label trial of actimmune (Interferon gamma-1b, rIFN-alpha1b) in patients with severe, congenital (malignant) osteopetrosis. |
Active substance: INTERFERON GAMMA (1B) |
Study summary document link (including results): |
View full study record |
Document reference: 30205 |
Study title: An open phase III follow-up (5 years) trial of recombinant human interferon gamma-1b in patients with chronic granulomatous disease (CGD) to evaluate safety and efficacy of long-term interferon gamma-1b treatment - 5-year-follow-up safety report. |
Active substance: INTERFERON GAMMA (1B) |
Study summary document link (including results): |
View full study record |
Document reference: 30191 |
Study title: BL 103836,GCGD4-002 - Long-term safety and efficacy of Actimmune therapy in children with chronic granulomatous disease (CGD): Summary of data from the National Institutes of Health cohort in children initiating Actimmune prior to 1 year of age and prior to 3 years of age, respectively. |
Active substance: INTERFERON GAMMA (1B) |
Study summary document link (including results): |
View full study record |
Document reference: 30198 |
Study title: Clinical efficacy of recombinant human interferon-gamma in chronic granulomatous disease. |
Active substance: INTERFERON GAMMA (1B) |
Study summary document link (including results): |
View full study record |
Document reference: 30202 |
Study title: EBI 4.20,IP 137.3,137.3 - Interferon gamma-1b (IF-RC 1001 XX G): Safety, Efficacy and Pharmacokinetics of 0.1 mg/sqm, 0.25 mg/sqm and 0.5 mg/sqm Interferon gamma-1b for 2 or more Weeks Subcutaneaously Administered to Patients with Lymphomas, Plasmocytomas and Solid Tumors. |
Active substance: INTERFERON GAMMA (1B) |
Study summary document link (including results): |
View full study record |
Document reference: 30199 |
Study title: I0016g(A),CH 9903,137.41 - An open phase III follow-up (5 years) trial of recombinant human interferon gamma-1b in patients with chronic granulomatous disease (CGD) to evaluate safety and efficacy of long-term interferon gamma-1b treatment - 5-year-follow-up safety report. |
Active substance: INTERFERON GAMMA (1B) |
Study summary document link (including results): |
View full study record |
Document reference: 30196 |
Study title: I0286n - Post marketing surveillance study of Actimmune (recombinant human interferon gamma-Ib) in patients with chronic granulomatous disease. |
Active substance: INTERFERON GAMMA (1B) |
Study summary document link (including results): |
View full study record |
Document reference: 30195 |
Study title: I0681s - A phase III randomized, controlled open label trial of actimmune (Interferon gamma-1b, rIFN-alpha1b) in patients with severe, congenital (malignant) osteopetrosis. |
Active substance: INTERFERON GAMMA (1B) |
Study summary document link (including results): |
View full study record |
Document reference: 30197 |
Study title: |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30394 |
Study title: |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30395 |
Study title: 3 D CT angiography for detection of vascular complications in pediatric liver transplantation; CHENG YF; C Liver Transplant.; 2004 vol.10 n.2 p.248 2523 D CT angiography for detection of vascular complications in pediatric liver transplantation; CHENG YF; C Liver Transplant.; 2004 vol.10 n.2 p.248 252 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30402 |
Study title: Appendicitis in children : low dose CT with a phantom based simulation technique initial observations; FEFFERMAN NR; Radiology; 2005 vol.237 p.641 646Appendicitis in children : low dose CT with a phantom based simulation technique initial observations; FEFFERMAN NR; Radiology; 2005 vol.237 p.641 646 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30396 |
Study title: Benefit of fluoroscopically guided intraarticular, long-acting corticosteroid injection for subtalar arthritis in juvenile idiopathic arthritis.; CAHILL AM; Pediatr. Radiol.; 2007 vol.37 p544 548Benefit of fluoroscopically guided intraarticular, long-acting corticosteroid injection for subtalar arthritis in juvenile idiopathic arthritis.; CAHILL AM; Pediatr. Radiol.; 2007 vol.37 p544 548 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30397 |
Study title: Blunt trauma in intoxicated patients: is computed tomography of the abdomen always necessary?; MAVRIDIS SP; South. Med. J.; 2000 vol.93 n.4 p.403 405Blunt trauma in intoxicated patients: is computed tomography of the abdomen always necessary?; MAVRIDIS SP; South. Med. J.; 2000 vol.93 n.4 p.403 405 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30398 |
Study title: Children with macrocrania : clinical and imaging predictors of disorders requiring surgery; MEDINA LS; AJNR; 2001 vol.22 p.564 570Children with macrocrania : clinical and imaging predictors of disorders requiring surgery; MEDINA LS; AJNR; 2001 vol.22 p.564 570 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30399 |
Study title: Endovascular Therapy for Priapism Secondary to Perineal Trauma; Ayrton C. J Trauma. 2001;50:571-584Endovascular Therapy for Priapism Secondary to Perineal Trauma; Ayrton C. J Trauma. 2001;50:571-584 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30247 |
Study title: Endovascular treatment in vein of Galen aneurysms. Case report. ;Battistella-P-A. Rivista di Neuroradiologia, 1994, Vol/Iss/Pg. 7/4 (671-681)Endovascular treatment in vein of Galen aneurysms. Case report. ;Battistella-P-A. Rivista di Neuroradiologia, 1994, Vol/Iss/Pg. 7/4 (671-681) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30248 |
Study title: Endovascular treatment of arteriovenous fistulas complicating percutaneous renal biopsy in three paediatric cases. ;Bilge-I. Nephrology Dialysis Transplantation, 1999, Vol/Iss/Pg. 14/11 (2726-2730)Endovascular treatment of arteriovenous fistulas complicating percutaneous renal biopsy in three paediatric cases. ;Bilge-I. Nephrology Dialysis Transplantation, 1999, Vol/Iss/Pg. 14/11 (2726-2730) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30250 |
Study title: Endovascular treatment of spinal arteriovenous fistula in a young child with hereditary hemorrhagic telangiectasia. Case report. ;Stephan-M-J. Journal of Neurosurgery, 2005, Vol/Iss/Pg. 103 PEDIATRICS/SUPPL. 5 (462-465)Endovascular treatment of spinal arteriovenous fistula in a young child with hereditary hemorrhagic telangiectasia. Case report. ;Stephan-M-J. Journal of Neurosurgery, 2005, Vol/Iss/Pg. 103 PEDIATRICS/SUPPL. 5 (462-465) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30251 |
Study title: Etude de deux foyers d’endémie goitreuse au Niger : Belley-Koira et Tiguey-Tallawal; R. Aquaron. Annales d’Endocrinologie (Paris) 1990, 51, 231-240Etude de deux foyers d’endémie goitreuse au Niger : Belley-Koira et Tiguey-Tallawal; R. Aquaron. Annales d’Endocrinologie (Paris) 1990, 51, 231-240 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30252 |
Study title: Evaluation of the intra-hepatic arterial injection therapy of cisplatin (CDDP)-Lipiodol suspension in a child with hepatoblastoma. Ohtsubo-K. Journal of Japan Society for Cancer Therapy, 1990, Vol/Iss/Pg. 25/1 (31-39)Evaluation of the intra-hepatic arterial injection therapy of cisplatin (CDDP)-Lipiodol suspension in a child with hepatoblastoma. Ohtsubo-K. Journal of Japan Society for Cancer Therapy, 1990, Vol/Iss/Pg. 25/1 (31-39) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30253 |
Study title: Facial intraosseous arteriovenous malformations: CT and MR features. ; Remonda-L. Journal of Computer Assisted Tomography, 1995, Vol/Iss/Pg. 19/2 (277-281)Facial intraosseous arteriovenous malformations: CT and MR features. ; Remonda-L. Journal of Computer Assisted Tomography, 1995, Vol/Iss/Pg. 19/2 (277-281) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30254 |
Study title: Goitre and cretinism in the high Himalayas; H.K Ibbertson. NZ med. J 1974, 80: 484-488Goitre and cretinism in the high Himalayas; H.K Ibbertson. NZ med. J 1974, 80: 484-488 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30255 |
Study title: Guidelines For Iodine Prophylaxis Following Nuclear Accidents, WHO 1989Guidelines For Iodine Prophylaxis Following Nuclear Accidents, WHO 1989 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30256 |
Study title: Hemobilia: Transcatheter Occlusive Therapy and Long-term Follow-up;Renan Uflacker. Cardiovasc Intervent Radiol (1989) 12:136-141Hemobilia: Transcatheter Occlusive Therapy and Long-term Follow-up;Renan Uflacker. Cardiovasc Intervent Radiol (1989) 12:136-141 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30257 |
Study title: Hepatocellular carcinoma after transcatheter hepatic arterial embolization: A histopathologic study of 84 resected cases. Higuchi-T. Cancer , 1994, Vol/Iss/Pg. 73/9 (2259-2267)Hepatocellular carcinoma after transcatheter hepatic arterial embolization: A histopathologic study of 84 resected cases. Higuchi-T. Cancer , 1994, Vol/Iss/Pg. 73/9 (2259-2267) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30258 |
Study title: Hepatocellular carcinoma and portal vein invasion: Results of treatment with transcatheter oily chemoembolization. ;Jin-Wook-Chung, J. American Journal of Roentgenology, 1995, Vol/Iss/Pg. 165/2 (315-321)Hepatocellular carcinoma and portal vein invasion: Results of treatment with transcatheter oily chemoembolization. ;Jin-Wook-Chung, J. American Journal of Roentgenology, 1995, Vol/Iss/Pg. 165/2 (315-321) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30259 |
Study title: Hepatocellular carcinoma outcomes based on indicated treatment strategy. ; Rose-A-T. American Surgeon, 1998, Vol/Iss/Pg. 64/12 (1128-1135)Hepatocellular carcinoma outcomes based on indicated treatment strategy. ; Rose-A-T. American Surgeon, 1998, Vol/Iss/Pg. 64/12 (1128-1135) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30260 |
Study title: "Randomised, multi-centric, open-label, comparative clinical trial in patients; Duration: Treatment was 3 weeks." Baudon JJ 1995 |
Active substance: Lactitol |
Study summary document link (including results): Importal_Baudon JJ_1995-OK.xls |
View full study record |
Document reference: 48154 |
Study title: Tuomilehto H, et all. Comparison of intravenous and oral ketoprofen for postoperative pain after adenoidectomy in children. Br J Anaesth. 2000 Aug;85(2):224-7. Tuomilehto H, et all. Comparison of intravenous and oral ketoprofen for postoperative pain after adenoidectomy in children. Br J Anaesth. 2000 Aug;85(2):224-7. |
Active substance: LACTITOL |
Study summary document link (including results): |
View full study record |
Document reference: 30989 |
Study title: Husz S, Kriza J, Dobozy A Presented at the Roundtable Symposium on Immunology, Hungarian Immunology Congress; October 25-28, 1989; Szeged, Hungary. (English translation) . Immunological studies in atopic dermatitis before and after Isoprinosine® treatmentHusz S, Kriza J, Dobozy A Presented at the Roundtable Symposium on Immunology, Hungarian Immunology Congress; October 25-28, 1989; Szeged, Hungary. (English translation) . Immunological studies in atopic dermatitis before and after Isoprinosine® treatment |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30122 |
Study title: Husz S, Kriza J, Kiss M, Oobozy A Gygyszereink [Hungary]; 1991; 41 :217-220. Prolonged Isoprinosine® treatment in atopic dermatitisHusz S, Kriza J, Kiss M, Oobozy A Gygyszereink [Hungary]; 1991; 41 :217-220. Prolonged Isoprinosine® treatment in atopic dermatitis |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30123 |
Study title: Huttenlocher, P:. Subacute Sclerosing Panencephalitis, 2nd Inti. Symp. SSPE, 1985:176-184. Follow-up of SSPE Patients on Long- Term Therapy with InosiplexHuttenlocher, P:. Subacute Sclerosing Panencephalitis, 2nd Inti. Symp. SSPE, 1985:176-184. Follow-up of SSPE Patients on Long- Term Therapy with Inosiplex |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30124 |
Study title: Ink J, Andres FJ, Antonini GM, Scarpiello V, Stefano JC, Coronel N, Genoves MH, Spataro R, Natelli C, Buey O, Ink RL, Goijman I, Pernas N, Andres RJ, Sumay OR, Casal I, Cudemo OLa Prensa Medica Argentina; January 8, 1971; 45(57):2050-2064. NPT10.381 Antiviral AgentInk J, Andres FJ, Antonini GM, Scarpiello V, Stefano JC, Coronel N, Genoves MH, Spataro R, Natelli C, Buey O, Ink RL, Goijman I, Pernas N, Andres RJ, Sumay OR, Casal I, Cudemo OLa Prensa Medica Argentina; January 8, 1971; 45(57):2050-2064. NPT10.381 Antiviral Agent |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30125 |
Study title: Ink J, Antonini GM. NPT10381: Prensa Universitaria [Argentina]. September 8, 1970; 324:6121-6124.Ink J, Antonini GM. NPT10381: Prensa Universitaria [Argentina]. September 8, 1970; 324:6121-6124. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30126 |
Study title: Ink J. Buenos Aires, Argentina: Teodoro Alvarez Hospital and Del Carmen Hospital. 1972. (Summary expert clinical report to Newport Pharmaceuticals International, Inc.) Isoprinosine® syrup against different acute viral diseasesInk J. Buenos Aires, Argentina: Teodoro Alvarez Hospital and Del Carmen Hospital. 1972. (Summary expert clinical report to Newport Pharmaceuticals International, Inc.) Isoprinosine® syrup against different acute viral diseases |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30127 |
Study title: Janeczko J, Baranowska M, Romanowska B. (1991) Przeglad Epidemiologiczny.; 45(4):267-271. Effect of Isoprinosine® and acyclovir on the clinical course of chickenpox and herpes zosterJaneczko J, Baranowska M, Romanowska B. (1991) Przeglad Epidemiologiczny.; 45(4):267-271. Effect of Isoprinosine® and acyclovir on the clinical course of chickenpox and herpes zoster |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30128 |
Study title: The role and limitation of living donor liver transplantation for hepatocellular carcinoma. ; Lo-C-M. Liver Transplantation, 2004, Vol/Iss/Pg. 10/3 (440-447)The role and limitation of living donor liver transplantation for hepatocellular carcinoma. ; Lo-C-M. Liver Transplantation, 2004, Vol/Iss/Pg. 10/3 (440-447) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30333 |
Study title: The use of iodized oil in goiter prevention.;John Kevany. American Journal of Public Health 1970 60 919-925The use of iodized oil in goiter prevention.;John Kevany. American Journal of Public Health 1970 60 919-925 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30334 |
Study title: The value of embolization in the prognosis of renal cell carcinoma.; Basche-S. Annales de Radiologie, 1988, Vol/Iss/Pg. 31/6 (333-336) The value of embolization in the prognosis of renal cell carcinoma.; Basche-S. Annales de Radiologie, 1988, Vol/Iss/Pg. 31/6 (333-336) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30335 |
Study title: Therapeutic arterial embolization of tumors and vascular lesions in the maxillofacial region and skull base. ; Heuser-L. RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Neuen Bildgebenden Verfahren, 1990, Vol/Iss/Pg. 152/5 (544-549)Therapeutic arterial embolization of tumors and vascular lesions in the maxillofacial region and skull base. ; Heuser-L. RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Neuen Bildgebenden Verfahren, 1990, Vol/Iss/Pg. 152/5 (544-549) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30336 |
Study title: Transarterial chemoembolization in the treatment of hepatoblastoma in children.; Vogl-T-J. European Radiology, 2006, Vol/Iss/Pg. 16/6 (1393-1396) Transarterial chemoembolization in the treatment of hepatoblastoma in children.; Vogl-T-J. European Radiology, 2006, Vol/Iss/Pg. 16/6 (1393-1396) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30337 |
Study title: Transarterial embolization of aneurysms associated with spinal cord arteriovenous malformations. Report of four cases. ; Konan-A-V. Journal of Neurosurgery, 1999, Vol/Iss/Pg. 90/1 SUPPL. (148-154)Transarterial embolization of aneurysms associated with spinal cord arteriovenous malformations. Report of four cases. ; Konan-A-V. Journal of Neurosurgery, 1999, Vol/Iss/Pg. 90/1 SUPPL. (148-154) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30338 |
Study title: Transcatheter arterial chemoembolization in the treatment of hepatoblastoma. ; Oue-T. Journal of Pediatric Surgery, 1998, Vol/Iss/Pg. 33/12 (1771-1775)Transcatheter arterial chemoembolization in the treatment of hepatoblastoma. ; Oue-T. Journal of Pediatric Surgery, 1998, Vol/Iss/Pg. 33/12 (1771-1775) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30339 |
Study title: Optimal imaging strategy for community-acquired Staphylococcus aureus musculoskeletal infections in children.Browne LP, Mason EO, Kaplan SL, Cassady CI, Krishnamurthy R, Guillerman RP. Pediatr Radiol 2008;38:841-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48583 |
Study title: Osteoma: a diagnoiss for radicular pain of extremities.Ebrahimzadeh MH, Ahmadzadeh-Chabock H, Ebrahimzadeh AR. Osteoid Orthopedics 2009; 32(11):821. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48718 |
Study title: Osteosarcoma of the proximal humerus.Belasco J, Watts H. Med Pediatr Oncol 1983;11(1):46-8. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48569 |
Study title: Peroperative isotopic detection in the treatment of osteoid osteoma in childrenLacheretz M, Herbaux B. Hossein-Foucher C. Lecouffe P. Richir M. Chirurgie 1989;115(7):413-6 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48494 |
Study title: Pitfalls and solutions in neuroblastoma diagnosis using radioiodine MIBG: our experience about 50 cases.Bouvier JF, Philip T, Chauvot P, Brunat Mentigny M, Ducrettet F, Maïassi N, et al. Prog Clin Biol Res 1988;271:707-20. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48575 |
Study title: Potentially misleading bone scan findings in patients with hepatoblastoma.Archer D, Babyn P, Gilday D, Greenberg MA. Clin Nucl Med 1993 Dec;18(12):1026-31 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48529 |
Study title: Presacral tumor associated with the Currarino triad in an adolescent.Horii T. Tsuchiya H. Tomita K. Surg 2001;121{1-2):114-6 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48488 |
Study title: Primary septic arthritis in heroin users: early diagnosis by radioisotopic imaging and geographic variations in the causative agentsLopez-Longo FJ. Menard HA. Carreno L. eosin J. Ballesteros R. Monteagudo I. J Rheumatol 1987 Oct;14(5):991-4 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48499 |
Study title: Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in prim ry osteosarcoma.Franzius C. Bielack S. Flege S, Sciuk J, Jurgens H. Schober 0. Nucl Med 2002 Aug;43(8):1012-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48483 |
Study title: Publication 53: Radiation dose to patients from radiopharmaceuticalsICRP (lnternation Commission on Radiological Protection). Pergamon Press 1987 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48489 |
Study title: Publication 80: Radiation dose to patients from radiopharmaceuticalsICRP (lnternation Commission on Radiological Protection). Addendum to ICRP Publication 53. Pergamon Press 1998 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48490 |
Study title: Publication of result-related information on paediatric studies submitted under Article 45 of the Regulation (EC) No 1901/2006 (‘Paediatric Regulation’) Amerscan Medronate ra.gehealthcare@ge.com |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48833 |
Study title: Pyogenic sacroiliitis - a comparison between paediatric and adult patientsWu M-S, Chang S-S, Lee S-H, Lee C-C. Rheumatology 2007;46:1684-7 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48765 |
Study title: Pyogenic sacroiliitis, the missed diagnosis?Abbott GT, Carty H. Br J Radiol 1993 Feb;66(782):120-2. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48520 |
Study title: Lytic bone lesion in a 12-year-old.Blackmore CC, Perkins A. Acad Radiol 1995 Jun;2(6):541-3. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48573 |
Study title: Lytic Bone Lesion in a 12-Year-OldC. Craig Blackmore, MD, and Anthony Perkins, MD Acad Radiol. 1995 Jun;2(6):541-3. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48835 |
Study title: Chronic inflammatory appendiceal conditions that mimic acute appendicitis on helical CT; CHECKOFF JL; AJR; 2002 vol.179 p.731 734Chronic inflammatory appendiceal conditions that mimic acute appendicitis on helical CT; CHECKOFF JL; AJR; 2002 vol.179 p.731 734 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30400 |
Study title: Clinical doses of contrast media; OLDER RA in : trends in contrast media; springer; berlin; 1999 p.75 80Clinical doses of contrast media; OLDER RA in : trends in contrast media; springer; berlin; 1999 p.75 80 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30401 |
Study title: Computed tomographic findings of distensible orbital venous anomalies; WOO KI; Ophtalm. Plast. Reconstr. Surg.; 2002 vol.18 n.2 p.114 120Computed tomographic findings of distensible orbital venous anomalies; WOO KI; Ophtalm. Plast. Reconstr. Surg.; 2002 vol.18 n.2 p.114 120 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30403 |
Study title: Contrast agents in neuroimaging; BYRD SE; Neuroimaging Clinics North America; 1994 vol.4 n.1 p.9 26Contrast agents in neuroimaging; BYRD SE; Neuroimaging Clinics North America; 1994 vol.4 n.1 p.9 26 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30404 |
Study title: Contrast media use in paediatrics; BABYN PS; Adv. X Ray Contrast; 1993 vol.1 p.74 85Contrast media use in paediatrics; BABYN PS; Adv. X Ray Contrast; 1993 vol.1 p.74 85 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30405 |
Study title: CT depiction of portal vein thrombi after creation of ileal pouch-anal anastomosis; BAKER ME; Radiology; 2003 vol.227 p.73 79CT depiction of portal vein thrombi after creation of ileal pouch-anal anastomosis; BAKER ME; Radiology; 2003 vol.227 p.73 79 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30406 |
Study title: CT of appendicitis in children; CALLAHAN MJ; Radiology; 2002 vol.224 p.325 332CT of appendicitis in children; CALLAHAN MJ; Radiology; 2002 vol.224 p.325 332 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30407 |
Study title: CT of small bowel ischemia associated with obstruction in emergency department patients ; diagnostic performance evaluation; SHEEDY SP; Radiology; 2006 vol.241 n.3 p.729 736CT of small bowel ischemia associated with obstruction in emergency department patients ; diagnostic performance evaluation; SHEEDY SP; Radiology; 2006 vol.241 n.3 p.729 736 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30408 |
Study title: Double Blind, parallel group study to compare the efficacy and safety of Ioversol 350 and Iohexol 350 in Pediatric Patients undergoing Angiocardiography |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30392 |
Study title: Acta Radiol. 1989 Nov-Dec;30(6):643-6 Influence of urography on renal function in children. A double blind study with metrizoate and iohexol. Stake G, Monn E, Rootwelt K, Golman K, Monclair T Acta Radiol. 1989 Nov-Dec;30(6):643-6 Influence of urography on renal function in children. A double blind study with metrizoate and iohexol. Stake G, Monn E, Rootwelt K, Golman K, Monclair T |
Active substance: IOHEXOL |
Study summary document link (including results): |
View full study record |
Document reference: 30362 |
Study title: Can plasma iohexol disappearance be used to measure GFR in children with chronic kidney disease? Nature Clinical Practice Nephrology (2006), 2(11), 608- 609, Schwartz GJ 2006 |
Active substance: IOHEXOL |
Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
View full study record |
Document reference: 48861 |
Study title: Comparative evaluation of iohexol and inulin clearance for glomerular filtration rate determinations Acta paediatrica (1994), 83(4), 418-22 Lindblad HG 1994 |
Active substance: IOHEXOL |
Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
View full study record |
Document reference: 48859 |
Study title: Comparison of intravenous contrast agents for CT studies in children Acta radiologica (Stockholm, Sweden : 1987) (1992), 33(6), 592-5 Cohen MD 1987 |
Active substance: IOHEXOL |
Study summary document link (including results): Cohen MD 1987.pdf |
View full study record |
Document reference: 48868 |
Study title: A comparative study: the efficacy of liquid paraffin and lactulose in management of chronic functional constipation. Urganci N, Akyildiz B, Polat TB. Pediatr Int. 2005 Feb;47(1):15-9.A comparative study: the efficacy of liquid paraffin and lactulose in management of chronic functional constipation. Urganci N, Akyildiz B, Polat TB. Pediatr Int. 2005 Feb;47(1):15-9. |
Active substance: LACTULOSE |
Study summary document link (including results): |
View full study record |
Document reference: 30997 |
Study title: A DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY OF LACTULOSE IN THE TREATMENT OF ENCOPRESIS IN CHILDREN WITH CHRONIC CONSTIPATION |
Active substance: LACTULOSE |
Study summary document link (including results): Lactulose-RH105.0101.pdf |
View full study record |
Document reference: 31005 |
Study title: A pilot, open, parallel group study of the effect of lactulose on stool bacterial composition in children suffering from cystic fibrosis (antibiotic-treated and untreated) and healthy childrenConstipation in childood: a controlled comparison between lactulose and standardized senna.; Perkin J.M. - Current Medical Research and Opinion, 1977; 4(8): 540-543 |
Active substance: LACTULOSE |
Study summary document link (including results): lactulose-s1053101.pdf |
View full study record |
Document reference: 30991 |
Study title: An open, group comparative study with Duphalac syrup versus lactulose crystalline in constipated children |
Active substance: LACTULOSE |
Study summary document link (including results): |
View full study record |
Document reference: 30990 |
Study title: An open, randomized group comparative study with lactulose syrup (Duphalac~ versus lactulose crystalline in constipated children. |
Active substance: LACTULOSE |
Study summary document link (including results): Lactulose-H.105.910NL.pdf |
View full study record |
Document reference: 31006 |
Study title: Clinical efficacy of duphalac in the treatment of functional constipations. Shevtsov SA. Eksp Klin Gastroenterol. 2005;(6):58-60.Clinical efficacy of duphalac in the treatment of functional constipations. Shevtsov SA. Eksp Klin Gastroenterol. 2005;(6):58-60. |
Active substance: LACTULOSE |
Study summary document link (including results): |
View full study record |
Document reference: 30994 |
Study title: Comparison of polyethylene glycol 3350 and lactulose for treatment of chronic constipation in children. Gremse DA, Hixon J, Crutchfield A. Clin Pediatr (Phila). 2002 May;41(4):225-9.Comparison of polyethylene glycol 3350 and lactulose for treatment of chronic constipation in children. Gremse DA, Hixon J, Crutchfield A. Clin Pediatr (Phila). 2002 May;41(4):225-9. |
Active substance: LACTULOSE |
Study summary document link (including results): |
View full study record |
Document reference: 30999 |
Study title: Double blind randomised controlled trial of topical glyceryl trinitrate in anal fissure. Kenny SE, Irvine T, Driver CP, Nunn AT, Losty PD, Jones MO, Turnock RR, Lamont; GL, Lloyd DA. Arch Dis Child. 2001 Nov;85(5):404-7.Double blind randomised controlled trial of topical glyceryl trinitrate in anal fissure. Kenny SE, Irvine T, Driver CP, Nunn AT, Losty PD, Jones MO, Turnock RR, Lamont; GL, Lloyd DA. Arch Dis Child. 2001 Nov;85(5):404-7. |
Active substance: LACTULOSE |
Study summary document link (including results): |
View full study record |
Document reference: 31004 |
Study title: Double-blind randomized evaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children. Dupont C, Leluyer B, Maamri N, Morali A, Joye JP, Fiorini JM, Abdelatif A, Baranes C, Benoît S, Benssoussan A, Boussioux JL, Boyer P, Brunet E, Delorme J, François-Cecchin S, Gottrand F, Grassart M, Hadji S, Kalidjian A, Languepin J, Leissler C, Lejay D, Livon D, Lopez JP, Mougenot JF, Risse JC, Rizk C, Roumaneix D, Schirrer J, Thoron B, Kalach N. J Pediatr Gastroenterol Nutr. 2005 Nov;41(5):625-33.Double-blind randomized evaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children. Dupont C, Leluyer B, Maamri N, Morali A, Joye JP, Fiorini JM, Abdelatif A, Baranes C, Benoît S, Benssoussan A, ... |
Active substance: LACTULOSE |
Study summary document link (including results): |
View full study record |
Document reference: 30996 |
Study title: Effects of early enteral feeding on the prevention of enterogenic infection in severely burned patients. Peng YZ, Yuan ZQ, Xiao GX. Burns. 2001 Mar;27(2):145-9.Effects of early enteral feeding on the prevention of enterogenic infection in severely burned patients. Peng YZ, Yuan ZQ, Xiao GX. Burns. 2001 Mar;27(2):145-9. |
Active substance: LACTULOSE |
Study summary document link (including results): |
View full study record |
Document reference: 31002 |
Study title: Choi SJ, Kim JS, Kim JH, Oh SJ, Lee JG, Kim CJ, et al.. Epub 2005 Feb 15. [18F]3'-deoxy-3'- fluorothymidine PET for the diagnosis and grading of brain tumors. [choi-2005]Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):653-9. Choi SJ 2005 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48637 |
Study title: Clinical Implications of Different Image Reconstruction Parameters for Interpretation of Whole-Body PET Studies in Cancer Patients.J Nucl Med 2004; 45:559–566. Heiko Scho¨der, MD1; Yusuf E. Erdi, DSc2; Kenneth Chao, BS1; Mithat Gonen, PhD3; Steven M. Larson, MD1; and Henry W.D. Yeung, MD1. |
Active substance: Steripet |
Study summary document link (including results): schulte-1999.pdf |
View full study record |
Document reference: 48746 |
Study title: Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia - Kojima S. et al - 2000 (Blood 96: 2049 - 2054) - Publication - Ref18 of Clinical Expert Report - |
Active substance: LENOGRASTIM |
Study summary document link (including results): |
View full study record |
Document reference: 31034 |
Study title: Limited mobilization effect of G-CSF (Lenograstim) for blood stem cells in children with solid tumors - Kawano Y. et al (Eur J Cancer - 31:238)Limited mobilization effect of G-CSF (Lenograstim) for blood stem cells in children with solid tumors - Kawano Y. et al (Eur J Cancer - 31:238) |
Active substance: LENOGRASTIM |
Study summary document link (including results): |
View full study record |
Document reference: 31041 |
Study title: Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia - Ohara A. et al - 1997 (Blood 90: 1009 - 1013) - Publication - Ref22 of Clinical Expert Report - |
Active substance: LENOGRASTIM |
Study summary document link (including results): |
View full study record |
Document reference: 31035 |
Study title: rG-CSF injection. Protocol for double blind controlled clinical trial. Bone Marow Transplantation - by The Japanese rG-CSF clinical study group. |
Active substance: LENOGRASTIM |
Study summary document link (including results): |
View full study record |
Document reference: 31036 |
Study title: rG-CSF injection. Protocol for phase II clinical trial. Bone Marow Transplantation - by The Japanese rG-CSF clinical study group. |
Active substance: LENOGRASTIM |
Study summary document link (including results): |
View full study record |
Document reference: 31037 |
Study title: Toxicity study by intravenous administration to rhesus Monkey for 13 weeks |
Active substance: LENOGRASTIM |
Study summary document link (including results): |
View full study record |
Document reference: 31038 |
Study title: Retrospective survey for documentation of appllication and dosage of CM Leptandra comp. (drops) in children < 12 years of age [Bef-016] |
Active substance: Leptandra compositum |
Study summary document link (including results): |
View full study record |
Document reference: 40046 |
Study title: A Dose Finding Study of a Super Long-Acting Luteinizing Hormone-Releasing Hormone Analog (Leuprolide Acetate Depot, TAP-144-SR) in the Treatment of Central Precocious Puberty |
Active substance: LEUPRORELIN |
Study summary document link (including results): |
View full study record |
Document reference: 31046 |
Study title: Fluorides in community programms-A study of four years of various fluorides applied topically to the teeth of children in fluoridated communities1972-Swejda |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1972-Swejda-Fluorides in community programms-A study of four years of various fluorides applied topically to the teeth of children in fluoridated c... |
View full study record |
Document reference: 49150 |
Study title: Fluorine concentration in primary tooth enamel in 6 year old after 3 years of daily intake1984-Widenheim |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1984-Widenheim-Fluorine concentration in primary tooth enamel in 6 year old after 3 years of daily intake.pdf |
View full study record |
Document reference: 49155 |
Study title: Effect on a 30 second topical stannous fluoride treatement on dental caries reductions in children1964-Mercer |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1964-Mercer-Effect on a 30 second topical stannous fluoride treatement on dental caries reductions in children.pdf |
View full study record |
Document reference: 49146 |
Study title: Effect on dental caries in children in a natural fluoride area of combined use of three agents containing stannous fluoride1965-Gish |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1965-Gish-Effect on dental caries in children in a natural fluoride area of combined use of three agents containing stannous fluoride.pdf |
View full study record |
Document reference: 49147 |
Study title: Effect on dental caries in children in a non fluoride area of combined use of three agents containing stannous fluoride1964-Bixler |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1964-Bixler-Effect on dental caries in children in a non fluoride ares of combined use of three agents containing stannous fluoride.pdf |
View full study record |
Document reference: 49145 |
Study title: Effectiveness of fornightly tooth brushing with amine fluorides in caries-prone subjectsRan 1991 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Ran 1991 Effectiveness of fornightly tooth brushing.pdf |
View full study record |
Document reference: 49176 |
Study title: Effectiveness of visible light fissure sealant (Delton) versus fluoride varnish (Duraphat) 24 month clinical trial1996-bravo, Community Dent. Oral Epidemiol. 1996: 24: 42-6 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1995-seppa-Fluoride varnish versus acidulated phosphate fluoride gel.pdf |
View full study record |
Document reference: 49121 |
Study title: Neuroblastoma presenting clinically as hip osteomyelitis: a "signature" diagnosis on skeletal scintigraphy.Applegate K, Connolly LP, Treves ST. Pediatr Radiol 1995 Nov;25 Suppl 1:S93-6 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48528 |
Study title: Nonspecific osteomyelitis in childhood and adolescence. The contribution of imaging diagnosisUrso S, Pacciani E, Fariello G, Colajacomo M, Fassari FM, Randisi F, et al. Radiol Med 1995 Sep;90(3):212-8 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48763 |
Study title: Normal anatomic variant: scintigraphy of the ischiopubic synchondrosis. Kevin A. Cawley, Allen D. Dvorak, and Michael D. Wilmot J NucÃMed 24: 14-16,1983 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48838 |
Study title: Normal anatomic variant: scintigraphy of the ischiopubic synchondrosis.Cawley KA, Dvorak AD, Wilmot MD. J Nucl Med 1983 Jan;24(1):14-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48589 |
Study title: Nuclear medicine studies of aging--IV. Femoral proximal to distal radionuclide uptake gradientGrimmond AP. Hosain F. Spencer RP. lnt J Rod Appllnstrum B 1988;15(5):529-30 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48486 |
Study title: Nonsurgical rapid maxillary expansion effects on craniofacial structures in young adult females.Baydas B, Yavuz I, Uslu H, Dagsuyu IM, Ceylan I. Angle Ortho 2006;76:759-67. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48568 |
Study title: Wu PS, Chiu NT, Lee BF, Yao WJ, W Chen HH. Clinical significance of solitary rib hot spots on bone scans in patients with extraskeletal cancer: correlation with other clinical manifestations. Clin Nucl Med. 2002 Aug;27(8):567-71. Wu PS, Chiu NT, Lee BF, Yao WJ, W Chen HH. Clinical significance of solitary rib hot spots on bone scans in patients with extraskeletal cancer: correlation with other clinical manifestations. Clin Nucl Med. 2002 Aug;27(8):567-71. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43444 |
Study title: Kokyu To Junkan. 1989 Sep;37(9):1003-7. [Significance of decreased washout rate in hypertrophic cardiomyopathy by exercise Tl-201 myocardial scintigraphy] [Article in Japanese] Inoue S, Nezuo S, Tadaoka S, Hasegawa K, Kawahara Y, Kakumae S, Nakamura T,Kokyu To Junkan. 1989 Sep;37(9):1003-7. [Significance of decreased washout rate in hypertrophic cardiomyopathy by exercise Tl-201 myocardial scintigraphy] [Article in Japanese] Inoue S, Nezuo S, Tadaoka S, Hasegawa K, Kawahara Y, Kakumae S, Nakamura T, |
Active substance: THALLIUM 201T1 CHLORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 44656 |
Study title: Quantitative bone SPECT in young males with delayed puberty and hypogonadism: implications for treatment of low bone mineral densityLubushitzky R. Front D. losi levsky G. Bettman L. Frenkel A. Kolodny GM. et al. J Nucl Med 1998 Jan;39(1):104-7 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48500 |
Study title: Radionuclide imaging in bilateral os trigonum syndrome in a young athlete. Minoves M, Company A, Ardevol J, Matas RB, Costansa JM, Setoain J, Domenech-Torné FM. Clin Nucl Med. 2001 Mar;26(3):237-8. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43458 |
Study title: Radionuclide imaging in the evaluation of osteomyelitis and septic arthritis.Kim EE, Haynie TP, Lowry PA, Harle TS. Crit Rev Diagn Imaging 1989; 29(3):257-305 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48751 |
Study title: Tc-99m MDP, thallium- 201 chloride and Tc-99m MAG3 renal uptake in subacute and chronic radiation nephritis compared.Degirmenci B, Uysal K, Bekis R, Cetingoz R, Kaya GC, Durak H. Ann Nucl Med 2001 Oct;15(5):447-9. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48599 |
Study title: Natural history and distribution of bone and bone marrow infarction in sickle hemoglobinopathiesKim SK. Miller JH. J Nucl Med 2002 Jul;43(7):896-900 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48493 |
Study title: COMPARISON OF INTRAVENOUS CONTRAST AGENTS FOR CT STUDIES IN CHILDRENM.D. CoHEN, E. HERMAN, D. HERRON, S. J. WHITE and J. A. SMITH Acta Radiol. 1992 Nov;33(6):592-5. |
Active substance: IOHEXOL |
Study summary document link (including results): |
View full study record |
Document reference: 48851 |
Study title: Comparison of low-osmolar contrast media in paediatric cardiac angiography. The British journal of radiology (1987), 60(710), 133-5 Rubin CME 1987 |
Active substance: IOHEXOL |
Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
View full study record |
Document reference: 48865 |
Study title: Comparison of iohexol with barium in gastrointestinal studies of infants and children Am J Roentgenol. 1991 Feb; 156(2): 345-50 Cohen MD 1991 |
Active substance: IOHEXOL |
Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
View full study record |
Document reference: 48855 |
Study title: Excretory urography with iohexol: evaluation in children Radiology (1986), 161(3), 625-30 Magill HL 1986 |
Active substance: IOHEXOL |
Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
View full study record |
Document reference: 48860 |
Study title: Experiences with iohexol (Omnipaque) at urography Pediatr Radio! (1987) 17: 491-492 Fjelldal A 1987 Pediatr Radio! (1987) 17: 491-492 Fjelldal A 1987 |
Active substance: IOHEXOL |
Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
View full study record |
Document reference: 48867 |
Study title: Phase 1 Pilot Trial of Interferon alfa-2a in Children with Japanese Viral Encephalitis |
Active substance: INTERFERON ALPHA (2A) |
Study summary document link (including results): |
View full study record |
Document reference: 30187 |
Study title: HyRhabdomyolysis after intraoperative myelography Paediatr Anaesth 2004 Jun; 14(6):509-13 Canbay O 2004 |
Active substance: IOHEXOL |
Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
View full study record |
Document reference: 48853 |
Study title: Influence of urography on renal function in children. A double blind study with metrizoate and iohexol. Acta Radiol. 1989 Nov-Dec; 30(6):643-6 Stake G 1989 |
Active substance: IOHEXOL |
Study summary document link (including results): Stake G 1989.pdf |
View full study record |
Document reference: 48872 |
Study title: Iodine in contrast agents and skin disinfectants is the major cause for hypothyroidism in premature infants during intensive care Horm Res. 1987;28(1):42-9 l'Allemand D 1987 |
Active substance: IOHEXOL |
Study summary document link (including results): l'Allemand D 1987.pdf |
View full study record |
Document reference: 48869 |
Study title: Hypothyroidism in neonates post-iodinated contrast media: a systematic review. Acta Paediatrica (Oxford, United Kingdom) (2009), 98(10), 1568-1574 Ahmet A 2009 |
Active substance: IOHEXOL |
Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
View full study record |
Document reference: 48852 |
Study title: Iohexol and metrizamide for urography in infants and children. Acta Radiol Suppl. 1983; 366: 39-41 Stake G 1983 |
Active substance: IOHEXOL |
Study summary document link (including results): Stake G 1983.pdf |
View full study record |
Document reference: 48871 |
Study title: Iohexol for contrast enhancement of bowel in paediatric abdominal CT. Acta Radiol. 1990 Nov; 31(6): 601-4 Smevik B 1990 |
Active substance: IOHEXOL |
Study summary document link (including results): Smevik B 1990.pdf |
View full study record |
Document reference: 48870 |
Study title: Iohexol in paediatric myelography. An open non-comparative trial Neuroradiology (1986), 28(1), 65-8 Kendall B 1986 |
Active substance: IOHEXOL |
Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
View full study record |
Document reference: 48858 |
Study title: Myelography with iohexol (Omnipaque); a clinical report with special reference to the adverse effects. Neuroradiology. 1988; 30(2):169-74 Skalpe IO 1988 |
Active substance: IOHEXOL |
Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
View full study record |
Document reference: 48866 |
Study title: Myelography with Omnipaque (Iohexol) using basic radiographic facilities: the main adverse effects. The Central African journal of medicine (1996), 42(7), 192-5. Ndosi BN 1996 |
Active substance: IOHEXOL |
Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
View full study record |
Document reference: 48862 |
Study title: Open, non-comparative study in angiocardiography in children, Angiocardiography: evaluate safety, tolerance and the radiographic properties of of iohexol in pediatric use. Systolic blood pressure, ECG parameters, body temperature, visualization and adverse reactions were recorded.Applicant's study report |
Active substance: IOHEXOL |
Study summary document link (including results): Copy of List of studies Omnipaque- pediatric.xls |
View full study record |
Document reference: 48882 |
Study title: Clinical Performance of PET/CT in Evaluation of Cancer: Additional Value for Diagnostic Imaging and Patient ManagementRachel Bar-Shalom, MD1; Nikolai Yefremov, MD1; Ludmila Guralnik, MD2; Diana Gaitini, MD2,3; Alex Frenkel, DSc1; Abraham Kuten, MD3,4; Hernan Altman, MBA5; Zohar Keidar, MD, PhD1; and Ora Israel, MD1,3. THE JOURNAL OF NUCLEAR MEDICINE • Vol. 44 • No. 8 • August 2003 |
Active substance: Steripet |
Study summary document link (including results): bar-shalom-2003.pdf |
View full study record |
Document reference: 48623 |
Study title: Clinical Usefulness of 18F-FDG PET in Nasopharyngeal Carcinoma Patients with Questionable MRI Findings for Recurrence Biomedicine & Pharmacotherapy 60 (2006) 593–606. C. Nannia, D. Rubellob,*, P. Castelluccia, M. Farsada, R. Franchia, L. Rampinb M.D. Grossc, A. Al-Nahhasd, S. Fantia |
Active substance: Steripet |
Study summary document link (including results): ng-2004-b.pdf |
View full study record |
Document reference: 48739 |
Study title: Comparison of 18F-FDG and 11C-Methionine for PET-Guided Stereotactic Brain Biopsy of GliomasJ Nucl Med 2004; 45:1293–1298. Benoit Pirotte, MD1; Serge Goldman, MD, PhD2; Nicolas Massager, MD1; Philippe David, MD3; David Wikler, MS1; Arlette Vandesteene, MD, PhD4; Isabelle Salmon, MD, PhD5; Jacques Brotchi, MD, PhD1; and Marc Levivier, MD, PhD1 |
Active substance: Steripet |
Study summary document link (including results): pirotte-2004.pdf |
View full study record |
Document reference: 48742 |
Study title: Connolly LP, Connolly SA.. Thymic uptake of radiopharmaceuticals. [connolly-2003]Clin Nucl Med. 2003 Aug;28(8):648-51. Connolly LP 2003 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48638 |
Study title: De González AB, Mahesh M, Kim K-P, Bhargavan M, Lewis R, Mettler F, Land C. Arch Projected cancer risks from computed tomographic scans performed in the United States in 2007. [de-gonzalez-2009]Intern Med 2009; 169 : 2071 - 2077. De González AB 2009 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48639 |
Study title: Developmental hemispheric asymmetry of interregional metabolic correlation of the auditory cortex in deaf subjects.NeuroImage 19 (2003) 777–783 .E. Kang,a D.S. Lee,a,* J.S. Lee,a H. Kang,a C.H. Hwang,b S.H. Oh,b C.S. Kim,b J.-K. Chung,a M.C. Lee,a M.J. Jang,a,c Y.J. Lee,c P. Morosan,d and K. Zillesd |
Active substance: Steripet |
Study summary document link (including results): kang-2003.pdf |
View full study record |
Document reference: 48734 |
Study title: Dietlein M, Krug B, Groth W, Smolarz K, Scheidhauer K, Psaras T, et al.. Positron emission tomography using 18Ffluorodeoxyglucose in advanced stages of malignant melanoma: a comparison of ultrasonographic and radiological methods of diagnosis. [dietlein-1999]Nucl Med Commun. 1999 Mar;20(3):255-61. Dietlein M 1999 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48640 |
Study title: Dizendorf EV, Baumert BG, von Schulthess GK, Lütolf UM, Steinert HC.. Impact of whole-body 18F-FDG PET on staging and managing patients for radiation therapy. [dizendorf-2003]J Nucl Med. 2003 Jan;44(1):24-9. Dizendorf EV 2003 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48641 |
Study title: Dobbeleir A, Ham H, Goethals I, Keppens J, D'Asseler Y, Van de Wiele C.. F-18 FDG-PET in children: do we have enough counts? [dobbeleir-2010]Nucl Med Commun. 2010 Mar;31(3):190-4. Dobbeleir A 2010 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48642 |
Study title: Early Irradiation Effects Observed on Magnetic Resonance Imaging and Angiography, and Positron Emission Tomography for Arteriovenous Malformations Treated by Gamma Knife Radiosurgery. Stereotact Funct Neurosurg 1995;61(suppl1):25S-269. 1VY Glio? D.H.C. Pollb, R.S. Lilic, 1VY Cll~i~lCg.Y~ ,S llio1~~, S.S. Cllalgc, C.Y Cllo~lgK~;,Y CIze~zS~.,H . Yellc, L.S. Leeb |
Active substance: Steripet |
Study summary document link (including results): guo-1994.pdf |
View full study record |
Document reference: 48730 |
Study title: Effect of Whole-Body 18F-FDG PET Imaging on Clinical Staging and Management of Patients with Malignant LymphomaJ Nucl Med 2001; 42:1139–1143. Heiko Scho¨der, Joubin Meta, Cecilia Yap, Maryam Ariannejad, Jyotsna Rao, Michael E. Phelps, Peter E. Valk, Jim Sayre, and Johannes Czernin |
Active substance: Steripet |
Study summary document link (including results): schoder-2001.pdf |
View full study record |
Document reference: 48745 |
Study title: Treatment of goitrous hypothyroidism with iodized oil supplementation in an area of iodine deficiency. ; Azizi-F. Experimental and Clinical Endocrinology and Diabetes, 1996, Vol/Iss/Pg. 104/5 (387-391)Treatment of goitrous hypothyroidism with iodized oil supplementation in an area of iodine deficiency. ; Azizi-F. Experimental and Clinical Endocrinology and Diabetes, 1996, Vol/Iss/Pg. 104/5 (387-391) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30340 |
Study title: Treatment of IDJWI Island endemic goiter by iodized oil; F. Delange. In. Endemic goiter. J.B Stanbury Ed. Pan American Health Organization. Scientific publication n° 193 : 118-131, 1968Treatment of IDJWI Island endemic goiter by iodized oil; F. Delange. In. Endemic goiter. J.B Stanbury Ed. Pan American Health Organization. Scientific publication n° 193 : 118-131, 1968 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30341 |
Study title: Treatment of Unresectable Primary Liver Cancer: With Reference to Cytoreduction and Sequential Resection.; Zhao-You Tang. World J. Surg. 19, 47-52, 1995.Treatment of Unresectable Primary Liver Cancer: With Reference to Cytoreduction and Sequential Resection.; Zhao-You Tang. World J. Surg. 19, 47-52, 1995. |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30342 |
Study title: Uptake of Lipiodol(trademark) -cytotoxic conjugates by hepatoblastoma cells. ;Towu-E. British Journal of Surgery, 2002, Vol/Iss/Pg. 89/4 (437-441)Uptake of Lipiodol(trademark) -cytotoxic conjugates by hepatoblastoma cells. ;Towu-E. British Journal of Surgery, 2002, Vol/Iss/Pg. 89/4 (437-441) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30343 |
Study title: Use of lipiodol, an iodinated oil preparation, in regions with moderate iodine deficiency. ; Sviridenko-Yu-N. Problemy Endokrinologii, 1995, Vol/Iss/Pg. 41/6 (8-11)Use of lipiodol, an iodinated oil preparation, in regions with moderate iodine deficiency. ; Sviridenko-Yu-N. Problemy Endokrinologii, 1995, Vol/Iss/Pg. 41/6 (8-11) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30344 |
Study title: A bi-centre randomised, parallel group, double-blind phase III comparison between iodixanol (VISIPAQUE) 150 mg I/ml and 270 mg I/ml and iohexal (Omnipaque) 140 mg I/ml and 300 mg I/ml Report DXC064 (date Jun 1999) |
Active substance: IODIXANOL |
Study summary document link (including results): DXC064 Redacted.pdf |
View full study record |
Document reference: 48211 |
Study title: A comparison of iopromide and iopamidol in CT scanning of pediatric patientsJ Radiol. 1999 Jul;80(7):727-32. [Comparison of iodixanol (Visipaque) and ioxaglate (Hexabrix) in coronary angiography and ventriculography: a double-blind randomized study] [Article in French] Roriz R, de Gevigney G, Finet G, Nantois-Collet C, Borch KW, Amiel M, Beaune J. |
Active substance: IODIXANOL |
Study summary document link (including results): |
View full study record |
Document reference: 30380 |
Study title: A PHASE IV, OPEN-LABEL, MULTI-CENTER COMMUNITY-BASED TRIAL STUDYING THE SAFETY AND EFFICACY OF KEPPRA. AS ADJUNCTIVE THERAPY IN ADULT PATIENTS WITH UNCONTROLLED PARTIAL EPILEPSY. S.K.A.T.E. : SAFETY OF KEPPRA. AS ADJUNCTIVE THERAPY IN EPILEPSY. |
Active substance: levetiracetam |
Study summary document link (including results): N01031 - Levetiracetam - RRCE04G2602.pdf |
View full study record |
Document reference: 41540 |
Study title: ANWENDUNG DER IN DEUTSCHLAND ZUGELASSENEN KEPPRA(R) - TABLETTEN ALS ZUSATZBEHANDLUNG BEI ERWACHSENEN PATIENTEN MIT FOKALEN EPILEPSIEN. |
Active substance: levetiracetam |
Study summary document link (including results): ARVD02L1406 - Levetiracetam.pdf |
View full study record |
Document reference: 41539 |
Study title: BRIDGING STUDY OF L059 (LEVETIRACETAM) IN PATIENTS WITH EPILEPSY BY DOUBLE BLIND METHOD. |
Active substance: levetiracetam |
Study summary document link (including results): N165 - Levetiracetam - RRCE04C3001.pdf |
View full study record |
Document reference: 41541 |
Study title: A study to compare the efficacy and safety of 0.0625% Levobupivacaine, 1 IJg.mr1 fentanyl, 0.0625% levobupivacaine plus1 IJg.mr1 fentanyl and 0.125% Levobupivacaine when administered as an extradural infusion in paediatric patients undergoing elective abdominal or urological surgery |
Active substance: LEVOBUVICAINE HCL |
Study summary document link (including results): Levobupivacaine-30716.pdf |
View full study record |
Document reference: 47651 |
Study title: Reflex sympathetic dystrophy associated with deep peroneal nerve entrapment.Para no E. Pavone V. Greco F. Majorana M. Trifiletti RR. Brain Dev 1998 Mar;20(2):80-2 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48509 |
Study title: Reiman RE, Rosen G, Gelbard AS, Benua RS, Laughlin JS. Imaging of primary Ewing sarcoma with 13N-L-glutamate. Radiology. 1982 Feb;142(2):495-500. Reiman RE, Rosen G, Gelbard AS, Benua RS, Laughlin JS. Imaging of primary Ewing sarcoma with 13N-L-glutamate. Radiology. 1982 Feb;142(2):495-500. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44093 |
Study title: Clin Nucl Med. 1999 Jun;24(6):435-9. Tc-99m DTPA used as reference imaging to evaluate the distribution of other tumor-seeking tracers in tumors associated with neurofibromatosis. Suga K, Hirabayashi A, Kishimoto K, Kume N, Matsumoto T, Matsunaga N. Clin Nucl Med. 1999 Jun;24(6):435-9. Tc-99m DTPA used as reference imaging to evaluate the distribution of other tumor-seeking tracers in tumors associated with neurofibromatosis. Suga K, Hirabayashi A, Kishimoto K, Kume N, Matsumoto T, Matsunaga N. |
Active substance: THALLIUM 201T1 CHLORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 44556 |
Study title: Technetium 99m-methylene diphosphonate bone scans in children with reflex neurovascular dystrophy.Laxer RM. Allen RC. Malleson PN. Morrison RT. Petty RE. J Pediatr 1985Mar;106(3):437-40 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48496 |
Study title: Technetium-99 m-MDP scintigraphy and long-term follow-up of musculoskeletal sarcoma reconstructed with pasteurized autologous bone graft.Ahmed AR. Arch Orthop Trauma Surg 2009;129:475-482 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48524 |
Study title: Technetium-99m-methylene diphosphonate uptake in the fetal skeleton at 30 weeks gestationMcKenzie AF. Budd RS. Yang C. Shapiro B. Hicks RJ. J Nucl Med 1994 Aug;35(8):1338-41 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48506 |
Study title: Thallium-201 scintigraphy in childhood osteosarcoma: Comparison with Technituim-99m MDP and magnetic resonance imaging in the evaluation of chemotherapeutic response.Ilhan IE, Gulin V, Berberoglu S, Kapucuoglu N, Cila A, Eke S. Quantitative Hematol Oncol 2005;22(2):153-62 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48725 |
Study title: The bone scan in desseminated BCGitis.Alavi M, Safavi S. Hell J Nucl Med 2008;11(1):46-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48526 |
Study title: Role of skeletal scintigraphy in soft tissue sarcoma: Improving the diagnostic yieldBarai S, Bandopadhayaya GP, Chumber S, Gupta DK, Patel CD, Dhanpati H. J Postgrad Med 2004a Jul-Sep;50(3):180-3; discussion 183-4. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48562 |
Study title: [The diagnostic importance of a quantitative evaluation of gamma scintigraphy in Perthes' disease in children]. Russian. Dmitrienkov BN, Fedin AV, Zhvaniia TG, Subbotina EN. Med Radiol (Mosk). 1989 Jul;34(7):19-23. Russian. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43784 |
Study title: The role of 99Tcmsestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: comparison with 131I-MIBG and 99Tcm-MDP scintigraphy.Burak Z, Yuksel DA, Cetingul N, Kantar M, Ozkilic H, Moretti JL. Nucl Med Comm 1999; 20(11):991-1000. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48586 |
Study title: Open Study to determine the concentration of telithromycin in middle ear fluid and plasma in infants/children with acute otitis media or otitis media with effusion after single oral administration of 20mg/kg or 30mg/kg of a telithromycin pediatric suspension |
Active substance: telithromycin |
Study summary document link (including results): |
View full study record |
Document reference: 41566 |
Study title: Sacro-iliitis in infants: a difficult diagnosis. 4 casesPratte L. Docquier P- L. Joint Bone Spine 2009: 76:313 -5 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48510 |
Study title: The role of ultrasound and isotope scanning in the management of irritable hipsGopakumar TS. Vaishya R. Klenerman L. Carty H. Eur J Radiol 1992 Sep;15(2):113-7 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48484 |
Study title: Open, non-comparative study in the GI tract in children and infants to evaluate the suitability/tolerability of iohexol in the GI tract in infants/children by monitoring patient reactions, taste acceptance and visualization.Applicant's study report |
Active substance: IOHEXOL |
Study summary document link (including results): Copy of List of studies Omnipaque- pediatric.xls |
View full study record |
Document reference: 48885 |
Study title: Open, non-comparative study Myelography study: evaluate safety, tolerance and image quality of iohexol in pediatric use.Applicant's study report |
Active substance: IOHEXOL |
Study summary document link (including results): Copy of List of studies Omnipaque- pediatric.xls |
View full study record |
Document reference: 48884 |
Study title: Open, non-comparative study to evaluate the suitability/tolerability of iohexol in abdominal CT in infants/children by monitoring patient reactions, taste acceptance and image qualityApplicant's study report |
Active substance: IOHEXOL |
Study summary document link (including results): Copy of List of studies Omnipaque- pediatric.xls |
View full study record |
Document reference: 48886 |
Study title: Paediatric angiocardiography with iohexol Invest Radiol 1985 Jan-Feb; 20(1 Suppl): S75-8 Carlsson EC 1985 |
Active substance: IOHEXOL |
Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
View full study record |
Document reference: 48854 |
Study title: Paediatric myelography with iohexol Paediatric radiology (1992), 22(4), 290-2. Fjelldal et al. Experiences with iohexol (Omnipaque) at urography Paediatric radiology (1987), 17(6), 491-2 Dube LJ 1987 |
Active substance: IOHEXOL |
Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
View full study record |
Document reference: 48857 |
Study title: Randomized double-blind, parallel study(open two-group comparison on consecutive patients) in pediatric angiography. Angiocardiography: the aim of the study was to compare iohexol to the best tolerated contrast medium in angiocardiography at present approved for routing use.Applicant's study report |
Active substance: IOHEXOL |
Study summary document link (including results): Copy of List of studies Omnipaque- pediatric.xls |
View full study record |
Document reference: 48883 |
Study title: Randomized, single-blind, parallel study in pediatric urography to study the safety, tolerance and radiographic properties of iohexol 300 mg I/ml compared to a conventional ionic CM, Urografin 290 mg I/ml, in pediatric urography.Applicant's study report |
Active substance: IOHEXOL |
Study summary document link (including results): Copy of List of studies Omnipaque- pediatric.xls |
View full study record |
Document reference: 48880 |
Study title: The use of low osmolality water soluble (LOWS) contrast media in the paediatric gastro-intestinal tract. A report of 115 examinations Paediatric radiology (1986), 16(1), 47-52 Ratcliffe JF 1986 |
Active substance: IOHEXOL |
Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
View full study record |
Document reference: 48864 |
Study title: Tracheobronchography in children Laryngoscope. 1996 Oct; 106(10): 1248-54 Deutsch ES 1996 |
Active substance: IOHEXOL |
Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
View full study record |
Document reference: 48856 |
Study title: Renal prostaglandin E |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 30013 |
Study title: Interferon gamma-1b (IF-RC 1001 XX G): Safety, Efficacy and Pharmaco- kinetics of 0.1 mg/sqm, 0.25 mg/sqm and 0.5 mg/sqm Interferon gamma-1b for 2 or more Weeks Sub- cutaneaously Administered to Patients with Lympho- mas, Plasmo- cytomas and Solid Tumors. |
Active substance: INTERFERON GAMMA (1B) |
Study summary document link (including results): |
View full study record |
Document reference: 30201 |
Study title: Long-term safety and efficacy of Actimmune therapy in children with chronic granulomatous disease (CGD): Summary of data from the National Institutes of Health cohort in children initiating Actimmune prior to 1 year of age and prior to 3 years of age, respectively. |
Active substance: INTERFERON GAMMA (1B) |
Study summary document link (including results): |
View full study record |
Document reference: 30206 |
Study title: Long-term safety and efficay of Actimmune therapy in young children with chronic granulomatous disease (CGD): An integrated summary of data extracted from Studies I0016g, I0016g(A),I0034g, and I0286n in children initiating Actimmune therapy prior to 1 year of age and prior to 3 years of age, respectively. |
Active substance: INTERFERON GAMMA (1B) |
Study summary document link (including results): |
View full study record |
Document reference: 30207 |
Study title: Post marketing surveillance study of Actimmune (recombinant human interferon gamma-Ib) in patients with chronic granulomatous disease. |
Active substance: INTERFERON GAMMA (1B) |
Study summary document link (including results): |
View full study record |
Document reference: 30190 |
Study title: The immunomodulatory impact of Imukin (IFNgamma-1b) on clinical and laboratory data in the treatment of atopic dermatitis. |
Active substance: INTERFERON GAMMA (1B) |
Study summary document link (including results): |
View full study record |
Document reference: 30204 |
Study title: Falk MS, Truitt AK, Coakley FV, Kashani-Sabet M, Hawkins RA, Franc B.. Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma. [falk-2007]Nucl Med Commun. 2007 Apr;28(4):273-80. Falk MS 2007 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48643 |
Study title: Fisher RS, Frost JJ. J Nucl Med.. [fisher-1991]1991 Apr;32(4):651-9. Epilepsy. Fisher RS 1991 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48644 |
Study title: Franzius C, Daldrup-Link HE, Wagner-Bohn A, Sciuk J, Heindel WL, Jurgens H, et al.. FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging. [franzius-2002]Franzius C 2002. Ann Oncol. 2002 Jan;13(1):157-60 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48645 |
Study title: Franzius C, Schober O.. Assessment of therapy response by FDG PET in pediatric patients. [franzius-2003]Q J Nucl Med. 2003 Mar;47(1):41-5. Franzius C 2003 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48646 |
Study title: Franzius C, Schulte M, Hillmann A, Winkelmann W, Jürgens H, Bockisch A, et al.. [Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft tissue tumors. 3rd Interdisciplinary Consensus Conference "PET in Oncology": results of the Bone and Soft Tissue Study Group] [Article in German] [franzius-2001]Chirurg. 2001 Sep;72(9):1071-7. Franzius C 2001 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48647 |
Study title: Friedberg JW, Fischman A, Neuberg D, Kim H, Takvorian T, Ng AK, et al.. FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison. [friedberg-2004]Leuk Lymphoma. 2004 Jan;45(1):85-92. Friedberg JW 2004 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48650 |
Study title: RM2002/00111/00 An open label long term observational study of the safety and tolerability of sumatriptan nasal spray in the treatment of migraine in adolescents. |
Active substance: SUMATRIPTAN |
Study summary document link (including results): Sumatriptan-SUM40276-ICHE3.pdf |
View full study record |
Document reference: 43075 |
Study title: Furth C, Denecke T, Steffen I, Ruf J, Voelker T, Misch D, et al.. Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease. [furth-2006]J Pediatr Hematol Oncol. 2006 Aug;28(8):501-12. Furth C 2006 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48652 |
Study title: Furth C, Steffen IG, Amthauer H, Ruf J, Misch D, Schönberger S, Kobe C, Denecke T, Stöver B, Hautzel H, Henze G, Hundsdoerfer P.. Epub 2009 Aug 10.Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial. [furth-2009]J Clin Oncol. 2009 Sep 10;27(26):4385-91. Furth C 2009 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48651 |
Study title: Gaillard WD, Bhatia S, Bookheimer SY, Fazilat S, Sato S, Theodore WH.. FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy. [gaillard-1995]Neurology. 1995 Jan;45(1):123-6. Gaillard WD 1995 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48653 |
Study title: Hypothyroid patients showing shortened responsiveness to oral iodized oil have paradoxically low serum thyroglobulin and low thyroid reserve. Thyroglobulin/thyrotropin ratio as a measure of thyroid damage. ;Contempre-B. European Journal of Endocrinology, 1996, Vol/Iss /Pg. 134/3 (342-351)Hypothyroid patients showing shortened responsiveness to oral iodized oil have paradoxically low serum thyroglobulin and low thyroid reserve. Thyroglobulin/thyrotropin ratio as a measure of thyroid damage. ;Contempre-B. European Journal of Endocrinology, 1996, Vol/Iss /Pg. 134/3 (342-351) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30261 |
Study title: effects of self-applied topical fluoride preparations in orthodontic patients2000-alexander |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 2000-alexander-effects of self-applied topical fluoride preparations in orthodontic patients.pdf |
View full study record |
Document reference: 49096 |
Study title: Enamel changes and dental caries in 7 years old children given fluoride tablets from shortly after birthA. Thylstrup, O. Fejerskov, C. Brunn, J. Kann 1979. Brit Dent. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1979-thylstrup-Enamel Changes and Dental Caries in 7-Year-Old children fiven fluoride tablets from shortly after birth.pdf |
View full study record |
Document reference: 48779 |
Study title: A 3 year oral health dose response study of sodium monofluorophosphate dentifrices with and without zinc citrate1988-Stephen, Community Dent Oral Epidemiology 16:321-5 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1988-Stephen-a 3 year oral health dose response study of sodium monofluorophosphate dentifrices with and without zinc citrate.pdf |
View full study record |
Document reference: 49085 |
Study title: A 48-month survival analysis comparing sealant (Delton) with fluoride varnish (Duraphat) in 6-8 year old children1997-bravo |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1996-bravo-Effectiveness of visible light fissure sealant (Delton) versus fluoride varnish (Duraphat) 24 month clinical trial.pdf |
View full study record |
Document reference: 49122 |
Study title: A Community Study of Fluoride Tablets for School Children in Portsmouth1982-Allmark. Br Dent J 1982: 153: 426 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1982-Allmark-A Community Study od Fluoride Tablets for School Children in Portsmouth.pdf |
View full study record |
Document reference: 48773 |
Study title: A home care program of chemical preventive dentistry for orthodontic patients1973-landry |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1973-landry-a home care program of chemical preventive dentistry for orthodontic patients.pdf |
View full study record |
Document reference: 49151 |
Study title: a new approach to the topical application of fluorides for the reduction od dental caries in children-results at the end of five years1962-Gish |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1962-Gish-a new approach to the topical application of fluorides for the reduction od dental caries in children-results at the end of five years.pdf |
View full study record |
Document reference: 49143 |
Study title: A new approach to the topical application of fluorides for the reduction of dental caries in children1957-gish |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1957-gish-a new approach to the topical application of fluorides for the reduction of dental caries in children.pdf |
View full study record |
Document reference: 49133 |
Study title: A new approach to the topical application of fluorides in children with results at the end of four years1959-Gish |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1959-Gish-A new approach to the topical application of fluorides in children with results at the end of four years.pdf |
View full study record |
Document reference: 49137 |
Study title: A newapproach to the topical application of fluorides in children with results at the end of two years1957-gish |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1957-Gish-A newapproach to the topical application of fluorides in children with results at the end of two years.pdf |
View full study record |
Document reference: 49134 |
Study title: A study of a single application of eight persent stannous fluoride1959-Jordan |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1959-Jordan-A study of a single application of eight persent stannous fluoride.pdf |
View full study record |
Document reference: 49138 |
Study title: A three year clinical comparison of a sodium monofluorophosphate dentifrice with sodium fluoride dentifrices on dental caries in children1987-Lu, Journal of dentistry for children, July-August 1987 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1987-Lu-a three year clinical comparison of a sodium monofluorophosphate dentifrice with sodium fluoride dentifrices on dental caries in children.pdf |
View full study record |
Document reference: 49083 |
Study title: The suspected scaphoid fracture and isotope bone imaging. Brown JN. Injury. 1995 Sep;26(7):479-82. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48836 |
Study title: The suspected scaphoid fracture and isotope bone imaging.Brown JN. Injury 1995 Sep;26(7):479-82. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48582 |
Study title: The symptomatic hip in childhood: scintigraphic findings in the presence of a normal radiograph. Gordon I, Peters AM, Nunn R. Skeletal Radiol. 1987;16(5):383-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43880 |
Study title: Three-phase radionuclide bone imaging in stress injury of the anterior iliac crestRockett JF. J Nucl Med 1990 Sep;31(9):1554-6 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48512 |
Study title: Scintigraphic and radiographic findings in eosinophilic granuloma.Benz-Bohm G, Georgi P. Radiologe 1981 Apr;21(4):195-8. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48570 |
Study title: Scintigraphic differentiation of bone infarction from osteomyelitis in children with sickle cell diseaseRoo S. Solomon N. MillerS. Dunn E. J Pediatr 1985 Nov;107(5):685-8 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48511 |
Study title: Scintigraphic evaluation of calcinosis in juvenile dermatomyositis with Tc-99m MDP.Bar-Sever Z, Mukamel M, Harel L, Hardoff R. Clin Nucl Med 2000 Dec;25(12):1013-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48565 |
Study title: Scintigraphic findings in progressive diaphyseal dysplasiaLundy MM. Billingsley JL. Redwine MD. Turnbull GL. Brown T J. J Nucl Med 1982 Apr;23(4):324-5 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48501 |
Study title: Scintigraphic findings of osteomyelitis after intraosseous infusion in a child.Barron BJ, Tran HD, Lamki LM. Clin Nucl Med 1994 Apr;19(4):307-8. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48564 |
Study title: Unexpected stomach uptake of technetium-99m-MDPSpicer JA. Slaton CK. Raveill TG. Baxter KG. Preston DF. Hladik WB. J Nucl Med Tech 1999 27(1):43-4 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48517 |
Study title: Unusual Tc-99m MDP and I-123 MIBG images in focal pyelonephritisJacobs A, Lenoir P, Delree M, Ramet J, Piepsz A. Clin Nucl Med 1990 15(11):821-4 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48749 |
Study title: Scintigraphy of lower extremity cadaveric bone allografts in osteosarcoma patients.Bar-Sever Z, Connolly LP, Gebhardt MC, Treves ST. Clin Nucl Med 1997 Aug;22(8):532-5. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48567 |
Study title: Scintigraphy of Toddler's FractureJohn H. Miller and Ronald A. Sanderson. J Nucl Med 29:2001-2003,1988 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48846 |
Study title: Scintigraphy of toddler's fractureMiller JH. Sanderson RA. J Nucl Med 1988 Dec;29(12):2001-3 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48507 |
Study title: Scintimetric evaluation of posttraumatic and postoperative growth disturbance using 99Tcm MDP.Bylander B, Hansson LI, Kärrholm J, Naversten Y. Acta Radiol Diagn 1983;24(1):85-96. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48587 |
Study title: Serum osteocalcin and other indices of bone formation: an 8-decade population study in healthy men and womenWorsfold M. Sharp CA. Davie MW. Clinica Chimica Acta 1988 178(2):225-35 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48518 |
Study title: Use of 99m-Tc-MDP Spect for assessment of mandibular growth: development of normal values.Fahey FH, Abramson ZR, Padwa BL, Zimmerman RE, Zurakowski D, Nissenbaum M, et al. Eur J Nucl Med Mol Imaging 2010;37:1002-10. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48722 |
Study title: International Commission on Radiological Protection, Radiation Dose to Patients from RadiopharmaceuticalsICRP Pergamon Press 1998) - Publication 80 |
Active substance: Iobenguane |
Study summary document link (including results): ICPR-1998.pdf |
View full study record |
Document reference: 48116 |
Study title: A case of postoperative recurrence of fibrolamellar hepatocellular carcinoma with increased vitamin B(12) binding capacity in a young Japanese female. ; Kanai-T. Japanese Journal of Clinical Oncology, 01 JUN 2004, Vol/Iss/Pg. 34/6 (346-351)A case of postoperative recurrence of fibrolamellar hepatocellular carcinoma with increased vitamin B(12) binding capacity in a young Japanese female. ; Kanai-T. Japanese Journal of Clinical Oncology, 01 JUN 2004, Vol/Iss/Pg. 34/6 (346-351) |
Active substance: IOBITRITOL |
Study summary document link (including results): |
View full study record |
Document reference: 30213 |
Study title: Detection of coronary complications after the arterial switch operation for transposition of the great arteries : first experience with multislice computed tomography in children; Ou P et al; Thorac.Cardiovasc. Surg.; 2006 vol.131 p.639 643Detection of coronary complications after the arterial switch operation for transposition of the great arteries : first experience with multislice computed tomography in children; Ou P et al; Thorac.Cardiovasc. Surg.; 2006 vol.131 p.639 643 |
Active substance: IOBITRITOL |
Study summary document link (including results): |
View full study record |
Document reference: 30211 |
Study title: Intravenous contrast media in uroradiology : evaluation of safety and tolerability in almost 50,000 patients; Wendt M. et al; Med. Princ. Pract.; 2006 vol.15 p.358 361Intravenous contrast media in uroradiology : evaluation of safety and tolerability in almost 50,000 patients; Wendt M. et al; Med. Princ. Pract.; 2006 vol.15 p.358 361 |
Active substance: IOBITRITOL |
Study summary document link (including results): |
View full study record |
Document reference: 30210 |
Study title: Iodine supplementation improves cognition in iodine-deficient schoolchildren in Albania: A randomized, controlled, double-blind study. ; Zimmermann-M-B.American Journal of Clinical Nutrition, 01 JAN 2006, Vol/Iss/Pg. 83/1 (108-114)Iodine supplementation improves cognition in iodine-deficient schoolchildren in Albania: A randomized, controlled, double-blind study. ; Zimmermann-M-B.American Journal of Clinical Nutrition, 01 JAN 2006, Vol/Iss/Pg. 83/1 (108-114) |
Active substance: IOBITRITOL |
Study summary document link (including results): |
View full study record |
Document reference: 30212 |
Study title: Results of the Safety and Efficiency of Iobitridol in more than 61,000 Patients; Petersein J. et al. / Eur Radiol (2003) 13: 2006-2011Results of the Safety and Efficiency of Iobitridol in more than 61,000 Patients; Petersein J. et al. / Eur Radiol (2003) 13: 2006-2011 |
Active substance: IOBITRITOL |
Study summary document link (including results): |
View full study record |
Document reference: 30209 |
Study title: Safety of iobitridol in the general population and at-risk patients; Hammerstingl RM et al; Eur. Radiol.; 2006 vol.16 n.6 p.1288 1297Safety of iobitridol in the general population and at-risk patients; Hammerstingl RM et al; Eur. Radiol.; 2006 vol.16 n.6 p.1288 1297 |
Active substance: IOBITRITOL |
Study summary document link (including results): |
View full study record |
Document reference: 30208 |
Study title: A case of undifferentiated sarcoma of the liver in which chemo- embolization with cisplatin-lipiodol suspension was effective. ; Araki-T. Japanese Journal of Clinical Radiology, 1994, Vol /Iss/Pg. 39/3 (419-422)A case of undifferentiated sarcoma of the liver in which chemo- embolization with cisplatin-lipiodol suspension was effective. ; Araki-T. Japanese Journal of Clinical Radiology, 1994, Vol /Iss/Pg. 39/3 (419-422) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30214 |
Study title: erste erfahrungen mit hexabrix bei der ausscheidungsurographie im kindesalter; Reither M., Fortschr. Med.; 1981 vol.99 n.20 p.771 773erste erfahrungen mit hexabrix bei der ausscheidungsurographie im kindesalter; Reither M., Fortschr. Med.; 1981 vol.99 n.20 p.771 773 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30438 |
Study title: Evaluation de l'efficacite diagnostique et de la tolerance clinique du ioversol en tomodensitometrie "corps entier" chez l'enfant : essai non comparatif de phase III; PANUEL M; Ann. Radiol.; 1992 vol.35 n.4 bis p.280-283Evaluation de l'efficacite diagnostique et de la tolerance clinique du ioversol en tomodensitometrie "corps entier" chez l'enfant : essai non comparatif de phase III; PANUEL M; Ann. Radiol.; 1992 vol.35 n.4 bis p.280-283 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30409 |
Study title: Evaluation of the post-shunt status with electron beam computed tomography in cyanotic congenital heart disease; CHOI BW; Yonsei Med. J.; 2003 vol.44 n.2 p.249 258Evaluation of the post-shunt status with electron beam computed tomography in cyanotic congenital heart disease; CHOI BW; Yonsei Med. J.; 2003 vol.44 n.2 p.249 258 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30410 |
Study title: Extrahepatic metastases of hepatocellular carcinoma; KATYAL S; Radiology; 2000 vol.216 p.698 703Extrahepatic metastases of hepatocellular carcinoma; KATYAL S; Radiology; 2000 vol.216 p.698 703 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30411 |
Study title: Interpreting the results of pediatric central venous catheter studies; KIM FM; Radiographics; 1996 vol.16 n.4 p.747 754Interpreting the results of pediatric central venous catheter studies; KIM FM; Radiographics; 1996 vol.16 n.4 p.747 754 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30412 |
Study title: Hypothyroidism in an area of endemic goiter and cretinism in Central Java, Indonesia;G. Hennemann. J. Clin. Endocrinology metabolism 1997 44 3 481-490Hypothyroidism in an area of endemic goiter and cretinism in Central Java, Indonesia;G. Hennemann. J. Clin. Endocrinology metabolism 1997 44 3 481-490 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30262 |
Study title: Hypothyroidism in cretins and non-cretinous subjects in an area of severe iodine deficiency in Central Java;Robbins J. et Coll. Thyroid research. Amsterdam excerpta medica 1975 378: 501-504Hypothyroidism in cretins and non-cretinous subjects in an area of severe iodine deficiency in Central Java;Robbins J. et Coll. Thyroid research. Amsterdam excerpta medica 1975 378: 501-504 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30263 |
Study title: Infant Survivals is improved by Oral Iodine supplementation; Claudine Cobra. J. Nutr. 127 : 574-578, 1997Infant Survivals is improved by Oral Iodine supplementation; Claudine Cobra. J. Nutr. 127 : 574-578, 1997 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30264 |
Study title: Influence of iodine supplementation on serum insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) levels in severe iodine deficiency. ;Özön-A. Turkish Journal of Pediatrics, 2004, Vol/Iss/Pg. 46/4 (303-308)Influence of iodine supplementation on serum insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) levels in severe iodine deficiency. ;Özön-A. Turkish Journal of Pediatrics, 2004, Vol/Iss/Pg. 46/4 (303-308) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30265 |
Study title: Influence of nutritional state on the disposal of orally and intramuscularly administered iodized oil to iodine repleted older children and adult women. Fierro-Benitez-R. Journal of Endocrinological Investigation, 1989, Vol/Iss/Pg. 12/6 (405-407)Influence of nutritional state on the disposal of orally and intramuscularly administered iodized oil to iodine repleted older children and adult women. Fierro-Benitez-R. Journal of Endocrinological Investigation, 1989, Vol/Iss/Pg. 12/6 (405-407) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30266 |
Study title: Intraarterial chemotherapy with Lipiodol for initially unresectable hepatoblastomas in children. ;Ogita-S. Regional Cancer Treatment, 1992, Vol/Iss/Pg. 5/3-4 (106-109)Intraarterial chemotherapy with Lipiodol for initially unresectable hepatoblastomas in children. ;Ogita-S. Regional Cancer Treatment, 1992, Vol/Iss/Pg. 5/3-4 (106-109) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30267 |
Study title: Intrahepatic Arterial Injections of Cisplatin-Phosphatidylcholine-Lipiodol Suspension in Two Unresectable Hepatoblastoma Cases;Kohji Sue. Medical and Pediatric Oncology 17:496-500 (1989)Intrahepatic Arterial Injections of Cisplatin-Phosphatidylcholine-Lipiodol Suspension in Two Unresectable Hepatoblastoma Cases;Kohji Sue. Medical and Pediatric Oncology 17:496-500 (1989) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30268 |
Study title: Investigation report of iodine deficiency disorders in Linxia, Gansu Province. Su-X-H. Chinese Journal of Endemiology , 2005, Vol/Iss/Pg. 24 /3 (297-299)Investigation report of iodine deficiency disorders in Linxia, Gansu Province. Su-X-H. Chinese Journal of Endemiology , 2005, Vol/Iss/Pg. 24 /3 (297-299) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30269 |
Study title: Iodine supplementation in a goitre endemic area.;Babikir Elnagar. Comprehensive summaries of Uppsala Dissertations from the Faculty of Medicines 608: 20-26Iodine supplementation in a goitre endemic area.;Babikir Elnagar. Comprehensive summaries of Uppsala Dissertations from the Faculty of Medicines 608: 20-26 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30270 |
Study title: Iodine supplementation: A comparison of oral and intramuscular methods in the improvement of thyroid function and prophylaxis of goitre. ; Malone-F-J. Trace Elements and Electrocytes, 1996, Vol /Iss/Pg. 13/3 (133-135)Iodine supplementation: A comparison of oral and intramuscular methods in the improvement of thyroid function and prophylaxis of goitre. ; Malone-F-J. Trace Elements and Electrocytes, 1996, Vol /Iss/Pg. 13/3 (133-135) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30271 |
Study title: Iodine-induced hypothyroidism and goiter following lipiodol(TM) lymphography. ;Heidemann-P-H. European Journal of Pediatrics, 1982, Vol/Iss/Pg. 138 /1 (82-83)Iodine-induced hypothyroidism and goiter following lipiodol(TM) lymphography. ;Heidemann-P-H. European Journal of Pediatrics, 1982, Vol/Iss/Pg. 138 /1 (82-83) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30272 |
Study title: Iodine-induced hypothyroidism following lymphography. ;Heidemann-P. Pediatric Research, 1981, Vol/Iss/Pg. 15/12 (No. 192)Iodine-induced hypothyroidism following lymphography. ;Heidemann-P. Pediatric Research, 1981, Vol/Iss/Pg. 15/12 (No. 192) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30273 |
Study title: Iodized oil as a complement to iodized salt in schoolchildren in endemic goiter in Romania. ;Simescu-M Hormone Research, 2002, Vol/Iss/Pg. 58/2 (78-82)Iodized oil as a complement to iodized salt in schoolchildren in endemic goiter in Romania. ;Simescu-M Hormone Research, 2002, Vol/Iss/Pg. 58/2 (78-82) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30275 |
Study title: Amounts of fluorides in self administered dental products: safety considerations for childrenStanley B Heifetz, Herschel S Horowitz. Pediatrics Vol 77No. 6 June 1986 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1986-heifetz-Amounts of fluoride in self-administered dental products-safety consideration for children.pdf |
View full study record |
Document reference: 48770 |
Study title: An assessment of two dental health education programmes for school children in the Lothian region of ScotlandC. Wight, A.S. Blinkhorn 1988. Journal of Pediatric Dentistry |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1988-wight-An Assessment of Two Dental Health Education programmes for school children in the lothian region of scotland.pdf |
View full study record |
Document reference: 48775 |
Study title: An open study to investigate what happens with a lozenge that is given to a 3-5 year old child that are told to leave it be in their mouth.Mejàre et al. (1987-09-23) |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 48943 |
Study title: Assessment of the effectiveness of supervised oral hygiene programmes by means of different indicesMaiwald 1993 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Maiwald 1993 Assessment of the effectiveness.pdf |
View full study record |
Document reference: 49170 |
Study title: Caries epidemiological studies- Kariesepidemiologische UntersuchungenBüttner 1995 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Büttner 1995 Kariesepidemiologische Untersuchungen.pdf |
View full study record |
Document reference: 49160 |
Study title: Caries increment in primary teeth after application of Duraphat fluoride varnish1982-grogzka |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1982-grogzka-Caries increment in primary teeth after application of Duraphat fluoride varnish.pdf |
View full study record |
Document reference: 49108 |
Study title: Fries P.. Final Report. Munich, Germany; Dermatological Clinic and Polyclinic of Technical University of Munich; 04 February.1985. Treatment of herpes simplex virus infection with Delimmun®. Fries P.. Final Report. Munich, Germany; Dermatological Clinic and Polyclinic of Technical University of Munich; 04 February.1985. Treatment of herpes simplex virus infection with Delimmun®. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30103 |
Study title: Fukuyama Y, Nihei K, Matsumoto S, Ebina T, Kamoshita S, Sato T et al. Brain and Development. 1987; 9(3):270-282. Clinical effects of MND-19 (inosiplexl on subacute sclerosing panencephalitis: a multi-institutional collaborative study.Fukuyama Y, Nihei K, Matsumoto S, Ebina T, Kamoshita S, Sato T et al. Brain and Development. 1987; 9(3):270-282. Clinical effects of MND-19 (inosiplexl on subacute sclerosing panencephalitis: a multi-institutional collaborative study. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30104 |
Study title: Gadoth M et al. Beilinson Hospital 1980. . Stimulation of interferon production by inospilex in SSPEGadoth M et al. Beilinson Hospital 1980. . Stimulation of interferon production by inospilex in SSPE |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30105 |
Study title: Gallais H, Kadio A, Odehouri K, Moreau J, Bertrand EDBulletin of the Society of Exotic Pathology. September- October, 1981; 74(5):553-561. . Effect of Isoprinosine in tropical measles: double-blind study (200 cases)Gallais H, Kadio A, Odehouri K, Moreau J, Bertrand EDBulletin of the Society of Exotic Pathology. September- October, 1981; 74(5):553-561. . Effect of Isoprinosine in tropical measles: double-blind study (200 cases) |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30106 |
Study title: Gallet J-P. Bulletin Officiel du Ministere de la Sante [Official gazette of the Ministry ofHealth, Paris]. June 3, 1986; 86(19): 1-12. Expert Clinician in Pediatrics report. Endorsement report concerning double-blind study of Isoprinosine and a placebo for the treatment of severe or complicated measles Gallet J-P. Bulletin Officiel du Ministere de la Sante [Official gazette of the Ministry ofHealth, Paris]. June 3, 1986; 86(19): 1-12. Expert Clinician in Pediatrics report. Endorsement report concerning double-blind study of Isoprinosine and a placebo for the treatment of severe or complicated measles |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30107 |
Study title: Galli M, Lazzarin A, Moroni M, Zanussi C. In: Immunomodulation: New Frontiers and Advances. Fudenberg HH, Whitten HD, Ambrogi F, eds. New York, New York, USA; Plenum Press; 1984; 385-397. Treatment of recurrent viral infectious diseases by methisoprinol.Galli M, Lazzarin A, Moroni M, Zanussi C. In: Immunomodulation: New Frontiers and Advances. Fudenberg HH, Whitten HD, Ambrogi F, eds. New York, New York, USA; Plenum Press; 1984; 385-397. Treatment of recurrent viral infectious diseases by methisoprinol. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30108 |
Study title: Uterine blush in multiphase bone imaging.Mandell GA. Harcke HT. Sharkey C. Brooks K. J Nucl Med 1986a Jan;27(1):51-5 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48503 |
Study title: Utility of delayed whole-body bone scintigraphy after directed three-phase scintigraphyDavenport MS, Brown RKJ, Frey KA. AJR 2009;193:338-42. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48596 |
Study title: Shoulder Pain in a young break-dancer evaluated with bone scintigraphy.Khoury JJ, Laberant N, Jerushalmi J. Clin Nucl Med 2009;34:916-7 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48750 |
Study title: A report on the method of treatment of chronic osteomyelitis at the Clinic of Infectious Diseases in Lund, which is both general and local in antibiotics administration. Comparisons are made with reports on the same general, but without the local treatment.Moilanen et al. |
Active substance: testa triticum |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Testa triticum tricum_1.xlsx |
View full study record |
Document reference: 49079 |
Study title: A report on the method of treatment of chronic osteomyelitis at the Clinic of Infectious Diseases in Lund, which is both general and local in antibiotics administration. Comparisons are made with reports on the same general, but without the local treatment.Moilanen et al. |
Active substance: testa triticum |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Testa triticum tricum_1.xlsx |
View full study record |
Document reference: 49080 |
Study title: Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.Gordon I. Peters AM. Gutman A, Morony S. Dicks-Mireaux C. Pritchard J. J Nucl Med 1990Feb;31(2):129-34 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48485 |
Study title: Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scansGordon I, Peters AM, Gutman A, Morony S, Dicks-Mireaux C, Pritchard J. J Nucl Med 1990Feb;31(2):129-34 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48724 |
Study title: Skeletal scintigraphy of young patients with low-back pain and a lumbosacral transitional vertebra. Connolly LP, d'Hemecourt PA, Connolly SA, Drubach LA, Micheli LJ, Treves ST. J Nucl Med. 2003 Jun;44(6):909-14. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48842 |
Study title: Small rounded B-cell lymphoma of bone presented by limp, with a positive multifocal 99mTC MDP bone scintigraphy pattern and a negative 99mTc HMPAO-labled leukocytes studyPerez RH, Farto JCA, Arias IA, Regi AR, Vazquez JMP. J Pediatr Hematol Oncol 2008:30:443-446 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48753 |
Study title: Adrenocortical suppression increases the risk of relapse in nephrotic syndromeAdrenocortical suppression increases the risk of relapse in nephrotic syndrome |
Active substance: TETRACOSACTIDE |
Study summary document link (including results): |
View full study record |
Document reference: 44459 |
Study title: Prediction of myocutaneous adverse side effect due to intra-arterial chemotherapy by intra-arterial (99m)Tc-macroaggregated albumin administration in patients with bone and soft-tissue tumors. J Nucl Med. 2002 Nov;43(11):1452-6. Taki J 2002 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48797 |
Study title: Preoperative diagnosis of bronchial atresia presenting with recurrent respiratory symptoms in an infant. Turk J Pediatr. 2000 Oct-Dec;42(4):348-51. Yüksel H 2000 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48800 |
Study title: Prevalence of deep venous thrombosis in the lower limbs and the pelvis and pulmonary embolism in patients with positive antiphospholipid antibodies. Ann Nucl Med. 2001 Dec;15(6):495-7. Kinuya K 2001 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48799 |
Study title: Pulmonary perfusion after endovascular stenting of pulmonary artery stenosis. J Nucl Med. 1995 Nov;36(11):2006-8. Oyen WJ 2006 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48817 |
Study title: Intravenous digital subtraction angiography for the evaluation of renal artery blood flow following the removal of a neuroblastoma; YAMAGIWA I; Surg. Today; 1994 vol.24 p.973-977Intravenous digital subtraction angiography for the evaluation of renal artery blood flow following the removal of a neuroblastoma; YAMAGIWA I; Surg. Today; 1994 vol.24 p.973-977 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30413 |
Study title: Intravenous use of ionic and nonionic contrast agents in children; COHEN MD; Radiology; 1994 vol.191 p.793-794Intravenous use of ionic and nonionic contrast agents in children; COHEN MD; Radiology; 1994 vol.191 p.793-794 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30414 |
Study title: Iodine and hypothyroidism in neonates with congenital heart disease; LINDER N; Arch. Dis. Child.; 1997 vol.77 p.239 240Iodine and hypothyroidism in neonates with congenital heart disease; LINDER N; Arch. Dis. Child.; 1997 vol.77 p.239 240 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30415 |
Study title: Ioversol (optiray) a new contrast media in the pediatric praxis; LOMBAY B; in : year book of pediatric radiology ; current problems of pediatric radiology ; Borsod County Teaching Hospital Hongrie ; 1994 vol.6 p.43 47Ioversol (optiray) a new contrast media in the pediatric praxis; LOMBAY B; in : year book of pediatric radiology ; current problems of pediatric radiology ; Borsod County Teaching Hospital Hongrie ; 1994 vol.6 p.43 47 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30416 |
Study title: Ioversol 300 : etude clinique en urographie intraveineuse pediatrique; MONTAGNE JP; Ann. Radiol.; 1992 vol.35 n.4 bis p.307-310Ioversol 300 : etude clinique en urographie intraveineuse pediatrique; MONTAGNE JP; Ann. Radiol.; 1992 vol.35 n.4 bis p.307-310 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30417 |
Study title: Is administration of enteric contrast material safe before abdominal CT in children who require sedation ? experience with chloral hydrate and pentobarbital; ZIEGLER MA; AJR; 2003 vol.180 p.13 15Is administration of enteric contrast material safe before abdominal CT in children who require sedation ? experience with chloral hydrate and pentobarbital; ZIEGLER MA; AJR; 2003 vol.180 p.13 15 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30418 |
Study title: Mechanisms of severe immediate reactions to iodinated contrast material; LAROCHE D; Radiology; 1998 vol.209 p.183 190Mechanisms of severe immediate reactions to iodinated contrast material; LAROCHE D; Radiology; 1998 vol.209 p.183 190 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30419 |
Study title: Nonoperative management of blunt liver trauma : the value of follow-up abdominal computed tomography scans; CUFF RF; Am. Surg.; 2000 vol.66 p.332 336Nonoperative management of blunt liver trauma : the value of follow-up abdominal computed tomography scans; CUFF RF; Am. Surg.; 2000 vol.66 p.332 336 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30420 |
Study title: Oral contrast agents for CT of abdominal trauma in pediatric patients : a comparison of dilute hypaque and water; HALSTED MJ; AJR; 2004 vol.182 p.1555 1559Oral contrast agents for CT of abdominal trauma in pediatric patients : a comparison of dilute hypaque and water; HALSTED MJ; AJR; 2004 vol.182 p.1555 1559 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30421 |
Study title: Pediatr cardiol. 2005 Jul-Aug: 26(4):413-7: Safety and Efficacy of Itravenous Contrast Imaging in Pediatrich Echocardiography.Pediatr cardiol. 2005 Jul-Aug: 26(4):413-7: Safety and Efficacy of Itravenous Contrast Imaging in Pediatrich Echocardiography. |
Active substance: Perflutren |
Study summary document link (including results): |
View full study record |
Document reference: 41585 |
Study title: Controlling conditioning-related emesis in children undergoing bone marrow transplantationOncol Nurs Forum 1997; 24 (9): 1539-44; Mehta NH., 1997 |
Active substance: PERPHENAZINE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48910 |
Study title: Preoperative oral antiemetics for reducing postoperative vomiting after tonsillectomy in childrenFujii Y., 1999, Anesth Analg. 1999 Jun; 88 (6): 1298-30 |
Active substance: PERPHENAZINE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48911 |
Study title: A controlled clinical comparison of nasal decongestants in acute rhinitis.Curr Ther Res 1966; 8: 91-3, Haines HL., 1966 |
Active substance: OXYMETAZOLINE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48916 |
Study title: Intestinal permeability and effects of Lactobacillus rhamnosus therapy in children with short bowel syndrome.Sentongo TA, Cohran V, Korff S, Sullivan C, Iyer K, Zheng X. J Pediatr Gastroenterol Nutr. 2008 Jan;46(1):41-7.Intestinal permeability and effects of Lactobacillus rhamnosus therapy in children with short bowel syndrome.Sentongo TA, Cohran V, Korff S, Sullivan C, Iyer K, Zheng X. J Pediatr Gastroenterol Nutr. 2008 Jan;46(1):41-7. |
Active substance: LACTULOSE |
Study summary document link (including results): |
View full study record |
Document reference: 30992 |
Study title: Intestinal permeability in newborns with necrotizing enterocolitis and controls: Does the sugar absorption test provide guidelines for the time to (re-)introduce enteral nutrition? Piena-Spoel M, Albers MJ, ten Kate J, Tibboel D. J Pediatr Surg. 2001 Apr;36(4):587-92.Intestinal permeability in newborns with necrotizing enterocolitis and controls: Does the sugar absorption test provide guidelines for the time to (re-)introduce enteral nutrition? Piena-Spoel M, Albers MJ, ten Kate J, Tibboel D. J Pediatr Surg. 2001 Apr;36(4):587-92. |
Active substance: LACTULOSE |
Study summary document link (including results): |
View full study record |
Document reference: 31001 |
Study title: PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. Voskuijl W, de Lorijn F, Verwijs W, Hogeman P, Heijmans J, Mäkel W, Taminiau J, Benninga M. Gut. 2004 Nov;53(11):1590-4.PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. Voskuijl W, de Lorijn F, Verwijs W, Hogeman P, Heijmans J, Mäkel W, Taminiau J, Benninga M. Gut. 2004 Nov;53(11):1590-4. |
Active substance: LACTULOSE |
Study summary document link (including results): |
View full study record |
Document reference: 30998 |
Study title: Polyethylene glycol 4000 vs. lactulose for the treatment of neurogenic constipation in myelomeningocele children: a randomized-controlled clinical trial.Rendeli C, Ausili E, Tabacco F, Focarelli B, Pantanella A, Di Rocco C, Genovese O, Fundarò C. Aliment Pharmacol Ther. 2006 Apr 15;23(8):1259-65.Polyethylene glycol 4000 vs. lactulose for the treatment of neurogenic constipation in myelomeningocele children: a randomized-controlled clinical trial.Rendeli C, Ausili E, Tabacco F, Focarelli B, Pantanella A, Di Rocco C, Genovese O, Fundarò C. Aliment Pharmacol Ther. 2006 Apr 15;23(8):1259-65. |
Active substance: LACTULOSE |
Study summary document link (including results): |
View full study record |
Document reference: 30995 |
Study title: Simultaneous HPLC determination with light-scattering detection of lactulose and mannitol in studies of intestinal permeability in pediatrics.Marsilio R, D'Antiga L, Zancan L, Dussini N, Zacchello F. Clin Chem. 1998 Aug;44(8 Pt 1):1685-91.Simultaneous HPLC determination with light-scattering detection of lactulose and mannitol in studies of intestinal permeability in pediatrics.Marsilio R, D'Antiga L, Zancan L, Dussini N, Zacchello F. Clin Chem. 1998 Aug;44(8 Pt 1):1685-91. |
Active substance: LACTULOSE |
Study summary document link (including results): |
View full study record |
Document reference: 31003 |
Study title: The sugar absorption test in the evaluation of the gastrointestinal intolerance to bisphosphonates: studies with oral pamidronate.Twiss IM, Burggraaf J, Schoemaker RC, van Elburg RM, den Hartigh J, Cohen AF, Vermeij P. Clin Pharmacol Ther. 2001 Jun;69(6):431-7.The sugar absorption test in the evaluation of the gastrointestinal intolerance to bisphosphonates: studies with oral pamidronate.Twiss IM, Burggraaf J, Schoemaker RC, van Elburg RM, den Hartigh J, Cohen AF, Vermeij P. Clin Pharmacol Ther. 2001 Jun;69(6):431-7. |
Active substance: LACTULOSE |
Study summary document link (including results): |
View full study record |
Document reference: 31000 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Lamioflur (drops) [AWB-AT] |
Active substance: Lamioflur |
Study summary document link (including results): |
View full study record |
Document reference: 40045 |
Study title: A Multi-Center, Double-blind, Placebo-controlled, Parallel Evaluation of LAMICTAL as Add-on Therapy with Valproic Acid for the Treatment of Generalized Seizures in Paediatric and Adult Patients. |
Active substance: LAMOTRIGINE |
Study summary document link (including results): Study SCAA3001-Lamotrigine.xls |
View full study record |
Document reference: 31009 |
Study title: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Evaluation of Lamotrigine Adjunctive Therapy in Subjects with Primary Generalized Tonic-Clonic Seizures [Data from the Open-label Continuation Phase] |
Active substance: LAMOTRIGINE |
Study summary document link (including results): Lamotrigine-Lamotrigine-LAM40097-ICHE3.pdf |
View full study record |
Document reference: 31007 |
Study title: A multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the safety and efficacy of lamotrigine in subjects with neuropathic pain and inadequate pain relief with gabapentin, tricyclic antidepressants or non-narcotic analgesics. |
Active substance: LAMOTRIGINE |
Study summary document link (including results): Lamotrigine-Lamotrigine-NPP30010-ICHE3.pdf |
View full study record |
Document reference: 31008 |
Study title: Lamotrigine: a single-blind dose-ranging study in patients with epilepsy. |
Active substance: LAMOTRIGINE |
Study summary document link (including results): Lamotrigine-Lamotrigine-UK25-ICHE3.pdf |
View full study record |
Document reference: 31010 |
Study title: Open, multicentre study to evaluate the efficacy and tolerability of leuprorelin acetate 3,75 mg (enantone depot) in central precocious puberty treatment |
Active substance: LEUPRORELIN |
Study summary document link (including results): |
View full study record |
Document reference: 31054 |
Study title: Open, multicentre, study to evaluate the efficacy and tolerability of leuprorelin acetate 3,75 mg (enantone depot) in central precocious puberty treatment |
Active substance: LEUPRORELIN |
Study summary document link (including results): |
View full study record |
Document reference: 31044 |
Study title: Study of Lupron Depot in the treatment of central precocious puberty, interim summary |
Active substance: LEUPRORELIN |
Study summary document link (including results): Leuprorelin_M90-516_synopsis.pdf |
View full study record |
Document reference: 31053 |
Study title: A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY: 16-WEEK EVALUATION OF THE EFFICACY AND SAFETY OF LEVETIRACETAM (LEV) AS ADD-ON THERAPY IN ADULTS AND ADOLESCENTS OLDER THAN 16 YEARS SUFFERING FROM PARTIAL SEIZURES. |
Active substance: levetiracetam |
Study summary document link (including results): N01102 - Levetiracetam - RRCE05F1502.pdf |
View full study record |
Document reference: 41537 |
Study title: A KOREAN OPEN-LABEL, MULTI-CENTER, COMMUNITY-BASED TRIAL ASSESSING THE EFFICACY AND SAFETY OF LEVETIRACETAM AS ADJUNCTIVE THERAPY IN ADULT SUBJECTS WITH UNCONTROLLED PARTIAL EPILEPSY FOR BRIDGING PURPOSE WITH A SIMILAR STUDY ON CAUCASIAN EPILEPTIC SUBJECTS. |
Active substance: levetiracetam |
Study summary document link (including results): N01099 - Levetiracetam - RRCE05B2803.pdf |
View full study record |
Document reference: 41536 |
Study title: A MULTICENTER, DOUBLE-BLIND, FOLLOW-UP TRIAL EVALUATING THE LONG-TERM SAFETY OF LEVETIRACETAM (1000 TO 3000 MG/DAY B.I.D.) AND CARBAMAZEPINE (400 TO 1200 MG/DAY ORAL B.I.D.), USED AS MONOTHERAPY IN SUBJECTS ( 16 YEARS) COMING FROM THE N01061 TRIAL. |
Active substance: levetiracetam |
Study summary document link (including results): N01093 - Levetiracetam - RRCE05L2109.pdf |
View full study record |
Document reference: 41534 |
Study title: A PHASE IV - PHARMACOVIGILANCE STUDY OF KEPPRA(R) GREECE - S.K.A.T.E. : SAFETY OF KEPPRA(R) AS ADJUNCTIVE THERAPY IN EPILEPSY. |
Active substance: levetiracetam |
Study summary document link (including results): N01035 - Levetiracetam - RRCE05J1501.pdf |
View full study record |
Document reference: 41535 |
Study title: Caries increments-tooth discoloration-and state of oral hygiene in children1965-Wellock |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1965-Wellock-Caries increments-tooth discoloration-and state of oral hygiene in children.pdf |
View full study record |
Document reference: 49149 |
Study title: Caries inhibiting effect of different modes of Duraphat reapplication-A three year radiographic study1991-peterson, Caries Res. 1991:25:70-73 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1991-peterson-Caries inhibiting effect of different modes of Duraphat reapplication-A three year radiographic study.pdf |
View full study record |
Document reference: 49117 |
Study title: Caries inhibition of mixed NaF-Na2PO3F dentifrices containing 1000 and 2500 ppmF1988-Ripa- JADA Volume 116, January 1988 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1988-Ripa-caries inhibition of mixed NaF-Na2PO3F dentifrices containing 1000 and 2500 ppmF.pdf |
View full study record |
Document reference: 49084 |
Study title: Caries prevention by daily fluoride mouthrinsingRugg-Gunn 1973 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Rugg-Gunn 1973 Caries prevention by daily fluoride mouthrinsing.pdf |
View full study record |
Document reference: 49129 |
Study title: Caries preventive effect of Duraphat Varnish versus fluoride mouthrinses-5 year data1986-kirkegaard |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1986-kirkegaard-Caries preventive effect of Duraphat Varnish versus fluoride mouthrinses-5 year data.pdf |
View full study record |
Document reference: 49113 |
Study title: Caries preventive effect of fluoride varnish application performed two or four times a year1990-seppa |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1990-seppa-Caries preventive effect of fluoride varnish application performed two or four times a year.pdf |
View full study record |
Document reference: 49115 |
Study title: Pulmonary scintigraphic findings in children with pectus excavatum by the comparison of chest radiograph indices. Clin Nucl Med. 1992 Nov;17(11):874-6 Kao CH 1992 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48820 |
Study title: Pulmonary ventilation/perfusion and reverse mismatches in an infant. Clin Nucl Med. 1985 Oct;10(10):708-9. Slavin JD 1985 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48828 |
Study title: Quantitative lung perfusion scintigraphy in postoperative evaluation of congenital right ventricular outflow tract obstructive lesions. Clin Nucl Med. 1996 Jun;21(6):471-6. Kim JH 1996 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48814 |
Study title: Radioimmunodetection of melanoma: preliminary results of a prospective study. Int J Biol Markers. 1986 Jan-Apr;1(1):47-54. Buraggi G 1986 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48827 |
Study title: Guidelines for paediatric bone scanning with 99mTc-labelled radiopharmaceuticals and 18F-fluoride. Stauss J, Hahn K, Mann M, De Palma D. Eur J Nucl Med Mol Imaging. (8 pages) Published online: www.eanm.org/scientific_info/guidelines/EJNMMI_Bone_Scintigraphy_in_Children.pdf |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48759 |
Study title: Renal uptake on lung perfusion scintigraphy in a patient with primary pulmonary hypertension. Clin Nucl Med. 2005 May;30(5):329-30. Kaya M 2005 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48792 |
Study title: Reversal of intrapulmonary shunting in cirrhosis after liver transplantation demonstrated by perfusion lung scan. J Nucl Med. 1991 May;32(5):862-4. Levin DP 1991 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48823 |
Study title: Reversed intrapulmonary right-to-left shunt after banding of the patent ductus venosus. Clin Nucl Med. 2003 Oct;28(10):827-33. Suga K 2003 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48795 |
Study title: Scintigraphic evaluation of the Eustachian tube functions. Rev Laryngol Otol Rhinol (Bord). 1999;120(2):123-5. Celen Z 1999 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48807 |
Study title: Spontaneous abrupt changes in the distribution of ventilation: a cause for apparent mismatching on ventilation/perfusion scintigraphy. Br J Radiol. 1989 Jun;62(738):536-43. Peters AM 1989 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48825 |
Study title: Surgery of congenital heart disease assessed by radionuclide scintigraphy. J Thorac Cardiovasc Surg. 1975 May;69(5):767-75. Gates GF 1975 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48830 |
Study title: Tc-99m MAA perfusion lung scanning in hepatopulmonary syndrome. Clin Nucl Med. 1999 Aug;24(8):616-7. Nishiyama Y 1999 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48808 |
Study title: Reflux of nasopharyngeal content into middle ear through the eustachian tube Eur Arch Otorhinolaryngol. 2004 Sep;261(8):439-44. Epub 2003 Nov 18. Ayanoglu E 2003 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48794 |
Study title: Chapter 7: Radionuclide techniques. In: Resnick D and Kransdorf MJ eds. Bone and joint imaging. 3rd Ed. Philidelphia. PA.Schneider R. Elsevier Saunders; 2005:86-117 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48515 |
Study title: A topical decongestant for children.The Eye, Ear, Nose and Throat Monthly 1968; 47: 121-3, Neffson AH., 1976 |
Active substance: OXYMETAZOLINE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48923 |
Study title: A topical nasal decongestant for children.J Med Soc New Jersey 1976; 64: 260-1, Weimann ML., 1976 |
Active substance: OXYMETAZOLINE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48924 |
Study title: Aikman PM, Bremner AD, de Burca B, et al.,1975, The Practitioner 1975; 214: 685-8 |
Active substance: OXYMETAZOLINE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48913 |
Study title: An open, not-controlled study to assess the safety and efficacy of oxymetazoline 0.01 % in infants suffering from rhinitisPlease see report |
Active substance: OXYMETAZOLINE |
Study summary document link (including results): 6529-660-59-190375 - Nasivin 0.01% (Oxymetazoline hydrochloride) - Semmelmayer 1972 - EUdraCT_reduced datafields for Interim publication.xls |
View full study record |
Document reference: 48992 |
Study title: Clinical note: Double-blind comparison of the duration of effect of oxymetazoline and phenylephrine in children..Ann Allergy 1966; 24: 250-1, Neidorff AH., 1966 |
Active substance: OXYMETAZOLINE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48919 |
Study title: Double-blind study of nasal decongestion with oxymetazoline and phenylephrine in asthmatic children with rhinitis.Rev Allergy 1966; 20: 863-8, Green M., 1966 |
Active substance: OXYMETAZOLINE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48918 |
Study title: En klinisk prövning av näsdroppar för spädbarn. (Clinical trials of nosedrops for infants).Z Allg Med 1974; 11: 535-7, Rüggeberg F., 1974 |
Active substance: OXYMETAZOLINE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48926 |
Study title: Essais cliniques du chlorhydrate d’oxymétazoline. (Clinical trials with oxymetazoline hydrochloride).Le Progrès Medical. 1965; 93: 321-3, Chatelet J., 1965 |
Active substance: OXYMETAZOLINE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48921 |
Study title: Evaluation of oxymetazoline paediatric in the treatment of congestion.J Matern Child Health 1976; 1: 32-3, Cannon NL., Dalgleisch J., Franks HL. et al., 1976 |
Active substance: OXYMETAZOLINE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48920 |
Study title: A single-blind trial to investigate the ethiology of bacterial respiratory tract infections and the efficacy of penicillin V (Kåvepenin) and erythromycin (Ery-Max) in these infections.Hovelius et al |
Active substance: PHENOXYMETHYLPENICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_10.xlsx |
View full study record |
Document reference: 49041 |
Study title: An open, randomized trila to evaluate if dose and frequency given bt American Heart Association coul be reduced (250 000 units x3 for 10 days)for streptococcal pharyngitis.Breese et al |
Active substance: PHENOXYMETHYLPENICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_3.xlsx |
View full study record |
Document reference: 49034 |
Study title: Compare the effect of treatment with penicillin V in children with AOM for 5 and 10 days respectively and to investigate whether a higher dose of penicillin V is associated with a beneficial result.Ingvarsson et al |
Active substance: PHENOXYMETHYLPENICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_11.xlsx |
View full study record |
Document reference: 49042 |
Study title: Gaillard WD. Ment Retard Dev Disabil Res. Structural and functional imaging in children with partial epilepsy. [gaillard-2000]Rev. 2000;6(3):220-6. Gaillard WD 2000 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48654 |
Study title: Gallamini A, Rigacci L, Merli F, Nassi L, Bosi A, Capodanno I et al.. The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advance stage Hodgkin's disease. [gallamini-2006]Haematologica 2006 Apr;91(4):475-81. Gallamini A 2006 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48655 |
Study title: Hain SF, O'Doherty MJ, Lucas JD, Smith MA. Nucl Med Commun. 1999 Sep;20(9):845-8. Fluorodeoxyglucose PET in the evaluation of amputations for soft tissue sarcoma. [hain-1999] Hain SF, O'Doherty MJ, Timothy AR, Leslie MD, Harper PG,. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse. [hain-2000]Huddart RA. Br J Cancer. 2000 Oct;83(7):863-9. Hain SF 2000 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48656 |
Study title: Hikima A, Mochizuki H, Oriuchi N, Endo K, Morikawa A..Semiquantitative analysis of interictal glucose metabolism between generalized epilepsy and localization related epilepsy. [hikima-2004]Ann Nucl Med. 2004 Oct;18(7):579-84. Hikima A 2004 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48657 |
Study title: Hoegerle S, Juengling F, Otte A, Altehoefer C, Moser EA, Nitzsche EU.. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging? [hoegerle 1998]Radiology. 1998 Oct;209(1):253-8. Hoegerle S 1998 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48658 |
Study title: Holm S, Borgwardt L, Loft A, Graff J, Law I, Højgaard L. Paediatric doses – a critical appraisal of the EANM paediatric dosage card. [holm-2007]Eur J Nucl Med Mol Imaging 2007; 34 : 1713 - 1718. Holm S 2007 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48659 |
Study title: Hostility differentiates the brain metabolic effects of nicotine.Cognitive Brain Research 18 (2004) 142–148. James H. Fallona, David B. Keatorb, James Mbogoric, Jessica Turnerd, Steven G. Potkine. |
Active substance: Steripet |
Study summary document link (including results): fallon-2004.pdf |
View full study record |
Document reference: 48728 |
Study title: Hudson MM, Krasin MJ, Kaste SC.. Epub 2004 Jan 27. PET imaging in pediatric Hodgkin's lymphoma. [hudson-2004]Pediatr Radiol. 2004 Mar;34(3):190-8. Hudson MM 2004 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48660 |
Study title: Hutchings M, Mikhaeel NG, Fields PA, Nunan T, Timothy AR.. Epub 2005 Jun 6. Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma. [hutchings-2005]Ann Oncol. 2005 Jul;16(7):1160-8. Hutchings M 2005 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48661 |
Study title: COMPARISON OF AMPICILLIN PLUS SULBACTAM VS CEFOXITIN/DOXYCYCLINE OR CLINDAMYCIN/GENTAMICIN IN THE TREATMENT OF GYNECOLOGICAL OR OBSTETRICAL INFECTIONS OF BACTERIAL ETIOLOGY |
Active substance: SULBACTAM |
Study summary document link (including results): |
View full study record |
Document reference: 42626 |
Study title: Imaging the epileptic brain with positron emission tomography.Neuroimag Clin N Am 13 (2003) 705– 716. Csaba Juha´sz, MD, PhDa,b,*, Harry T. Chugani, MDa,b |
Active substance: Steripet |
Study summary document link (including results): juhasz-2003.pdf |
View full study record |
Document reference: 48733 |
Study title: Jacobs F, Thierens H, Piepsz A, Bacher K, van de Wiele C, Ham H et al. Optimised tracer-dependent dosage cards to obtain weight-independent effective doses. [jacobs 2005Eur J Nucl Med Mol Imaging 2005; 32 : 581 - 588. Jacobs F 2005 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48662 |
Study title: Jasper N, Däbritz J, Frosch M, Loeffler M, Weckesser M, Foell D.. Epub. Diagnostic value of [(18)F]-FDG PET/CT in children with fever of unknown origin or unexplained signs of inflammation. [jasper-2010] Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):136-45. Jasper N 2010 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48663 |
Study title: Caries preventive effect of high fluoride and xylitol containing dentifrices1992-Cutress- |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1992-Cutress-caries preventive effect of high fluoride and xylitol containing dentifrices.pdf |
View full study record |
Document reference: 49094 |
Study title: Caries preventive effect of three topical fluorides_1% years clinical trial in Chandigarh schoolchildren of North India1984-tewari- |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1984-tewari-Caries preventive effect of three topical fluorides_1% years clinical trial in Chandigarh schoolchildren of North India.pdf |
View full study record |
Document reference: 49111 |
Study title: Caries preventive effect of two fluoride varnishes and a fluoride mouthrinse1987-seppa, Caries Res. 1987:21: 375-379 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1987-seppa-Caries preventive effect of two fluoride varnishes and a fluoride mouthrinse.pdf |
View full study record |
Document reference: 49114 |
Study title: Caries preventive effort of a fluoride-containing varnish (Duraphat) after 1 year s study1975-koch, Community Dentl Oral Epidemiol, 1975: 3: 262-266 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1975-koch-Cariespreventive effort of a fluoride-containing varnish (Duraphat) after 1 year s study.pdf |
View full study record |
Document reference: 49102 |
Study title: Caries rate, enamel fluoride concentration after fortnightly brushing with aminfluoride gelRan 1987 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Ran 1987 Caries rate, enamel fluoride concentration.pdf |
View full study record |
Document reference: 49175 |
Study title: Postoperative adjuvant locoregional chemotherapy in patients with hepatocellular carcinoma. ; Izumi-R. Hepato-Gastroenterology, 1996, Vol/Iss/Pg. 43/12 (1415-1420)Postoperative adjuvant locoregional chemotherapy in patients with hepatocellular carcinoma. ; Izumi-R. Hepato-Gastroenterology, 1996, Vol/Iss/Pg. 43/12 (1415-1420) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30304 |
Study title: Preliminary experience with arterial chemoembolization for hepatoblastoma and hepatocellular carcinoma in children. ;Czauderna-P. Pediatric Blood and Cancer, 2006, Vol/Iss/Pg. 46/7 (825-828)Preliminary experience with arterial chemoembolization for hepatoblastoma and hepatocellular carcinoma in children. ;Czauderna-P. Pediatric Blood and Cancer, 2006, Vol/Iss/Pg. 46/7 (825-828) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30306 |
Study title: Preoperative Chemoembolization for Hepatocellular Carcinoma.02/12/2010Mario Morino. Journal of Surgical Oncology Supplement 3:91-93 (1993)Preoperative Chemoembolization for Hepatocellular Carcinoma.02/12/2010Mario Morino. Journal of Surgical Oncology Supplement 3:91-93 (1993) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30307 |
Study title: Preoperative percutaneous portal vein embolization: Evaluation of adverse events in 188 patients. ; Di-Stefano-D-R. Radiology, 2005, Vol/Iss/Pg. 234/2 (625-630)Preoperative percutaneous portal vein embolization: Evaluation of adverse events in 188 patients. ; Di-Stefano-D-R. Radiology, 2005, Vol/Iss/Pg. 234/2 (625-630) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30308 |
Study title: Preoperative Porgal Vein Embolization for Extension of Hepatectomy Indications.;Thierry de Baere. Hepatology Vol. 24, No. 6, 1996.Preoperative Porgal Vein Embolization for Extension of Hepatectomy Indications.;Thierry de Baere. Hepatology Vol. 24, No. 6, 1996. |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30309 |
Study title: Preparation of two dosage forms containing antitumor prostaglandin and their antitumor effect in vitro and in vivo: Lipiodol solution for I.A. administration and lipid microspheres for I.P. or I.V. administration.;Fukushima Shoji. Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury 2, Edited by K.V. Honn et al., Plenum Press, New York 1997Preparation of two dosage forms containing antitumor prostaglandin and their antitumor effect in vitro and in vivo: Lipiodol solution for I.A. administration and lipid microspheres for I.P. or I.V. administration.;Fukushima Shoji. Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury 2, Edited by K.V. Honn et al., Plenum Press, New York 1997 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30310 |
Study title: Prevalence of goitre and hypothyroidism in Southern Tanzania: Effect of iodised oil on thyroid hormone deficiency. ; Wachter-W. Journal of Epidemiology and Community Health, 1986, Vol/Iss/Pg. 40/1 (86-91)Prevalence of goitre and hypothyroidism in Southern Tanzania: Effect of iodised oil on thyroid hormone deficiency. ; Wachter-W. Journal of Epidemiology and Community Health, 1986, Vol/Iss/Pg. 40/1 (86-91) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30311 |
Study title: Caries reduction and cost benefit after 3 years of sucking fluoride tablets daily at schoolK.W. Stephen, D. Campbell 1978. Brit Dent J 1978 144, 202 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1978-stephen-Caries Reduction and Cost Benefit After 3 Years of Sucking Fluoride Tablets Daily at school.pdf |
View full study record |
Document reference: 48780 |
Study title: Cherubism: diagnostic imaging and review of the literature in JapanHitomi G. Nishide N. Mitsui K. Ora l Surg Oral Med Oral Pathol Oral Radial Endod 1996 May;81(5):623-8 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48487 |
Study title: Tc-99m MAA total-body imaging to detect intrapulmonary right-to-left shunts and to evaluate the therapeutic effect in pulmonary arteriovenous shunts. Clin Nucl Med. 1996 Mar;21(3):197-202. Lu G 1996 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48815 |
Study title: The contribution of perfusion scintigraphy in the evaluation of children suffering from recurrent localized pneumonia. Eur J Nucl Med. 1990;17(3-4):152-5. Hardoff R 1990 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48824 |
Study title: The incidence and severity of hypoxia associated with 99Tcm Technegas ventilation scintigraphy and 99Tcm MAA perfusion scintigraphy. Br J Radiol. 1992 May;65(773):403-8. James JM 1992 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48821 |
Study title: Transcatheter infusion of 99mTc MAA for predicting response of intra-arterial chemotherapy in osteogenic sarcoma. Eur J Cancer Clin Oncol. 1985 Jan;21(1):35-42. Kim EE 1985 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48829 |
Study title: Tc-99m MAA SPECT in pectus excavatum: assessment of perfusion volume changes after correction by the Nuss procedure. Clin Nucl Med. 2005 Dec;30(12):779-82. Kinuya K 2005 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48791 |
Study title: Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology. 1998 Feb;114(2):305-10. Abrams GA 1998 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48812 |
Study title: Chronic recurrent multifocal osteomyelitis (CRMO) with symmetric involvement of both femora: X-ray, bone scintigram, and MR imaging findings in one case. Buck FM, Treumann TC, Winiker H, Strobel K. J Magn Reson Imaging. 2007 Aug;26(2):422-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48837 |
Study title: Chronic recurrent multifocal osteomyelitis involving the mandible in a 4-year-old girl: a case report and a review of the literatureOtsuka K. Hamakawa H. Kayahara H. Tanioka H. J Oral Maxillofac Surg 1999 Aug;57(8):1013-6 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48508 |
Study title: Hematogenous pyogenic vertebral osteomyelitis: diagnostic value of radionuclide bone imaging.Adatepe MH, Powell OM, Isaacs GH, Nichols K, Cefola R. J Nucl Med 1986 Nov;27(11):1680-5. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48523 |
Study title: |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48495 |
Study title: |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48504 |
Study title: 131I-MIBG in the diagnosis of primary and metastatic neuroblastoma.El-Maghraby T. Gulf J Oncol 2007 (2):33-41. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48720 |
Study title: 201Tl scintigraphic evaluation of tumor mass and viability of bone and soft-tissue tumors.Tsuda T, Kubota M, Yoshida S, Shibata M, Wakabayashi J, Obata H, et al. Kaku Igaku 1994 Dec;31(12):1477-94 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48762 |
Study title: (99m)Tc-MDP scintigraphic findings in children with leukemia: value of early and delayed whole-body imagingShalaby-Rana E, Majd M. J Nucl Med 2001 Jun;42(6):878-83 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48514 |
Study title: "Cold spots" in pediatric bone imagingRosovsky M. Goldfarb CR. Finestone H. Ongseng F. Semin Nucl Med 1994 Apr;24(2):184-6 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48513 |
Study title: Determine concentration of pcV in serum and in middle ear exudate and to isolate bacteria in the ear exsudate during the course of treatment with penicillin V in acute otitis media in children.Ingvarsson et al |
Active substance: PHENOXYMETHYLPENICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_15.xlsx |
View full study record |
Document reference: 49046 |
Study title: determine concentration of pcV in serum and in middle ear exudate at various intervals of administration of different doses and to correlate the susceptibility in vitro of H Infl to pcVKamme et al |
Active substance: PHENOXYMETHYLPENICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_5.xlsx |
View full study record |
Document reference: 49036 |
Study title: Double-blinded, Randomized parallel groups design trial, the primary objective of the study was to evaluate the taste of two formulations of phenoxymethylpenicillin suspension in children. The secondary objectives were to study age-related differences in taste perception, to evaluate the acceptability of the suspensions, and to determine patient compliance.Bagger-Sjöbäck et al |
Active substance: PHENOXYMETHYLPENICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_12.xlsx |
View full study record |
Document reference: 49043 |
Study title: Klinische Prüfung von Oxymetazolin-HCl-Nasentropfen für Säuglinge (Nasivin™ 0.01 %). (Clinical trials of oxymetazoline hydrochloride nasal drops for babies (Nasivin™ 0.01 %)).Draco por Medico 1968; 9: 6-8, Svenningsen N., 1968 |
Active substance: OXYMETAZOLINE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48925 |
Study title: Oxymetazoline spray in otorhinolaryngology.Curr Ther Res 1966; 8: 91-3, Haines HL., 1966 |
Active substance: OXYMETAZOLINE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48915 |
Study title: Physiological and clinical estimate of the relief of nasal flow obstruction in allergic rhinitis: effects of topical decongestant (oxymetazoline).J Asthma Res 1969; 7: 65-73, Cohen BM, Duffy EP., 1969 |
Active substance: OXYMETAZOLINE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48922 |
Study title: A novel approach to flow quantification in brain arteriovenous malformations prior to enbucrilate embolization: Use of insoluble contrast (Ethiodol droplet) angiography. ; Wakhloo-A-K. Journal of Neurosurgery, 1998, Vol/Iss/Pg. 89/3 (395-404)A novel approach to flow quantification in brain arteriovenous malformations prior to enbucrilate embolization: Use of insoluble contrast (Ethiodol droplet) angiography. ; Wakhloo-A-K. Journal of Neurosurgery, 1998, Vol/Iss/Pg. 89/3 (395-404) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30215 |
Study title: Accidental successful treatment of a rare case of diffuse peritoneal lymphangiomatosis; G. Silecchia. British Journal of Surgery 1994, 81, 1286-1289Accidental successful treatment of a rare case of diffuse peritoneal lymphangiomatosis; G. Silecchia. British Journal of Surgery 1994, 81, 1286-1289 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30216 |
Study title: Accurate preoperative evaluation of liver mass lesions without fine- needle biopsy. ; Torzilli-G. Hepatology, 1999, Vol/Iss/Pg. 30/4 (889-893)Accurate preoperative evaluation of liver mass lesions without fine- needle biopsy. ; Torzilli-G. Hepatology, 1999, Vol/Iss/Pg. 30/4 (889-893) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30217 |
Study title: Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial. ; Lau-W-Y. Lancet, 06 MAR 1999, Vol/Iss/Pg. 353/9155 (797-801)Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial. ; Lau-W-Y. Lancet, 06 MAR 1999, Vol/Iss/Pg. 353/9155 (797-801) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30218 |
Study title: Kabickova E, Sumerauer D, Cumlivska E, Drahokoupilova E, Nekolna M, ChanovaM, et al.. The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease. [kabickova-2006]Haematologica. 2006 Apr;91(4):475-81. Kabickova E 2006 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48664 |
Study title: Kamel E, Hany TF, Burger C, Treyer V, Lonn AH, von Schulthess GK, et al.. CT vs 68Ge attenuation correction in a combined PET/CT system: evaluation of the effect of lowering the CT tube current. [kamel-2002]Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):346-50. Kamel E 2002 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48665 |
Study title: Kaneta T, Hakamatsuka T, Yamada T, Takase K, Sato A, Higano S, et al.. FDG PET in solitary metastastic/secondary tumor of the kidney: a report of three cases and a review of the relevant literature. [kaneta-2006]Ann Nucl Med. 2006 Jan;20(1):79-82. Kaneta T 2006 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48666 |
Study title: Kaplan AM, Bandy DJ, Manwaring KH, Chen K, Lawson MA, Moss SD, et al.. Functional brain mapping using positron emission tomography scanning in preoperative neurosurgical planning for pediatric brain tumors. [kaplan-1999]J Neurosurg. 1999 Nov;91(5):797-803. Kaplan AM 1999 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48667 |
Study title: Kaste SC, Howard SC, McCarville EB, Krasin MJ, Kogos PG, Hudson MM.. Epub 2004 Nov 16. 18F-FDG-avid sites mimicking active disease in pediatric Hodgkin's. [kaste-2005]Pediatr Radiol. 2005 Feb;35(2):141-54. Kaste SC 2005 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48668 |
Study title: Koga H, Sasaki M, Kuwabara Y, Nakagawa M, Hayashi K, Kaneko K, et al.. Lesion detectability of a gamma camera based coincidence system with FDG in patients with malignant tumors: a comparison with dedicated positron emission tomography. [koga-2004]Ann Nucl Med. 2004 Apr;18(2):131-6. Koga H 2004 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48669 |
Study title: Kostakoglu L, Leonard JP, Kuji I, Coleman M, Vallabhajosula S, Goldsmith SJ.. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. [kostakaglu-2002]Cancer. 2002 Feb 15;94(4):879-88. Kostakoglu L 2002 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48670 |
Study title: Krug B, Heidenreich A, Dietlein M, Lackner K. Rofo.. [The lymph node staging of malignant testicular germ-cell tumors] [Translated] [krug-1999-en]1999 Aug;171(2):87-94. Krug B 1999 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48671 |
Study title: Lamusuo S, Ruottinen HM, Knuuti J, Härkönen R, Ruotsalainen U, Bergman J, et al.. Comparison of [18F]FDGPET, [99mTc]-HMPAO-SPECT, and [123I]-iomazenil-SPECT in localising the epileptogenic cortex. [lamusuo-1997]J Neurol Neurosurg Psychiatry. 1997 Dec;63(6):743-8. Lamusuo S 1997 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48672 |
Study title: Lassmann M, Biassoni L, Monsieurs M, Franzius C, Jacobs F, EANM Dosimetry and Paediatrics Committees.. The new EANM paediatric dosage card. [lassman-2007]Eur J Nucl Med Mol Imaging 2007; 34:796–798. Lassmann M 2007 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48673 |
Study title: Galli V, Canonaco F, Rozzi N.(1980) Clinica Pediatrica.; 62:1-11. Therapy with methisoprinol in pediatric pathologiesGalli V, Canonaco F, Rozzi N.(1980) Clinica Pediatrica.; 62:1-11. Therapy with methisoprinol in pediatric pathologies |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30109 |
Study title: Gascon G, Yamani S, Crowell J, Stigsby B, Nester M, Kanaan I, Jallu A. Brain Dev. 1993 Sep-Oct;15(5):346-55. Combined oral isoprinosine-intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis.Gascon G, Yamani S, Crowell J, Stigsby B, Nester M, Kanaan I, Jallu A. Brain Dev. 1993 Sep-Oct;15(5):346-55. Combined oral isoprinosine-intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30110 |
Study title: Gascon GG, Yamani S, Cafege A, Flock L, al-Sedairy S, Parhar RS, Crowell J, Nester M, Kanaan I, Jallu MA. Ann Neurol. 1991 Aug;30(2):227-8. Treatment of subacute sclerosing panencephalitis with alpha interferon.Gascon GG, Yamani S, Cafege A, Flock L, al-Sedairy S, Parhar RS, Crowell J, Nester M, Kanaan I, Jallu MA. Ann Neurol. 1991 Aug;30(2):227-8. Treatment of subacute sclerosing panencephalitis with alpha interferon. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30111 |
Study title: Geiger S, Peuten M. Inform Artz 1985;2:30-35. Treatment of herpetic and recurrent apthae with inosiplex.Geiger S, Peuten M. Inform Artz 1985;2:30-35. Treatment of herpetic and recurrent apthae with inosiplex. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30112 |
Study title: Ginsberg T. Third Int Symposium on SSPE, India 30-31 Oct 1989. Isoprinosine in subacute sclerosing panencephalitis: Confirmation and extension of beneficial clinical results in the US and Canada by a recent study in Japan.Ginsberg T. Third Int Symposium on SSPE, India 30-31 Oct 1989. Isoprinosine in subacute sclerosing panencephalitis: Confirmation and extension of beneficial clinical results in the US and Canada by a recent study in Japan. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30113 |
Study title: Grasso E. (1979) Isoprinosina; April 28,; Rome, Italy; 87-93. Isoprinosina treatment in viral mononucleosis and epidemic parotitis [in English]. Presented at del Convegno Internazionale sullaGrasso E. (1979) Isoprinosina; April 28,; Rome, Italy; 87-93. Isoprinosina treatment in viral mononucleosis and epidemic parotitis [in English]. Presented at del Convegno Internazionale sulla |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30114 |
Study title: Gross G, Jogerst C, Schőpf.. Acta Derm Venereol. 1986;66(1):76-80. Systemic treatment of mollusca contagiosa with inosiplexGross G, Jogerst C, Schőpf.. Acta Derm Venereol. 1986;66(1):76-80. Systemic treatment of mollusca contagiosa with inosiplex |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30115 |
Study title: Radiological aspects of a case of Waldmann's disease. ; Guery-V. Journal de Radiologie, 1990, Vol/Iss/Pg. 71/10 (535-538)Radiological aspects of a case of Waldmann's disease. ; Guery-V. Journal de Radiologie, 1990, Vol/Iss/Pg. 71/10 (535-538) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30319 |
Study title: Radiological aspects of a case of Waldmann's disease. Guery-V. Journal de Radiologie, 1990, Vol/Iss/Pg. 71/10 (535-538)Radiological aspects of a case of Waldmann's disease. Guery-V. Journal de Radiologie, 1990, Vol/Iss/Pg. 71/10 (535-538) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30318 |
Study title: Randomized clinical trial comparing different iodine interventions in school children. ; Zhao-J. Public Health Nutrition, 1999, Vol/Iss/Pg. 2/2 (173-178)Randomized clinical trial comparing different iodine interventions in school children. ; Zhao-J. Public Health Nutrition, 1999, Vol/Iss/Pg. 2/2 (173-178) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30320 |
Study title: Reversibility of severe hypothyroidism with supplementary iodine in patients with endemic cretinism. ; Vanderpas-J-B. New England Journal of Medicine, 1986, Vol/Iss/Pg. 315/13 (791-795).Reversibility of severe hypothyroidism with supplementary iodine in patients with endemic cretinism. ; Vanderpas-J-B. New England Journal of Medicine, 1986, Vol/Iss/Pg. 315/13 (791-795). |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30321 |
Study title: Selenium deficiency mitigates hypothyroxinemia in iodine-deficient subjects; Jean B Vanderpas. Am J Clin Nutr Suppl 1993 ;57 :271S-5S.Selenium deficiency mitigates hypothyroxinemia in iodine-deficient subjects; Jean B Vanderpas. Am J Clin Nutr Suppl 1993 ;57 :271S-5S. |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30322 |
Study title: Serum thyroglobulin and urinary iodine concentration are the most appropriate indicators of iodine status and thyroid function under conditions of increasing iodine supply in schoolchildren in Benin. ; Briel-T-V-D. Journal of Nutrition, 2001, Vol/Iss/Pg. 131/10 (2701-2706), ISSN: 0022-3166Serum thyroglobulin and urinary iodine concentration are the most appropriate indicators of iodine status and thyroid function under conditions of increasing iodine supply in schoolchildren in Benin. ; Briel-T-V-D. Journal of Nutrition, 2001, Vol/Iss/Pg. 131/10 (2701-2706), ISSN: 0022-3166 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30323 |
Study title: Spontaneous scalp arteriovenous fistula in a child with Hartnup disease. ; Kim-D-M. Journal of Endovascular Therapy, 2004, Vol/Iss/Pg. 11/3 (348-350)Spontaneous scalp arteriovenous fistula in a child with Hartnup disease. ; Kim-D-M. Journal of Endovascular Therapy, 2004, Vol/Iss/Pg. 11/3 (348-350) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30324 |
Study title: Comparison of bone and gallium-67 imaging in heroin users' arthritis.Bittini A, Dominguez PL, Martinez Pueyo ML, López Longo FJ, Monteagudo I, Carreño L. J Nucl Med 1985 Dec;26(12):1377-81. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48572 |
Study title: Comparison of planar scintigraphy alone and with SPECT for the initial evaluation of femoral neck stress fracture.Bryant LR, Song WS, Banks KP, Bui-Mansfield LT, Bradley YC. AJR 2008;191:1010-1015. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48584 |
Study title: Hip pain in an 18-year-old manRajaram A, Tamurian RM, Reith JD, Bush CH. Clin Orthop Relat Res 2008;466:248-54 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48754 |
Study title: Hematogenous Pyogenic Vertebral Osteomyelitis:Diagnostic Value of Radionucide Bone ImagingMustafa H. Adatepe, Oscar M. Powell, Gilbert H. Isaacs, Kenneth Nichols, and Raymond Cefola. J Nucl Med 27:1680-1685, 1986 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48832 |
Study title: A protocol of plain radiographs, hip ultrasound, and triple phase bone scans in the evaluation of the painful pediatric hip.Alexander JE, Seibert JJ, Aronson J, Williamson SL, Glasier CM, Rodgers AB, et al. Clin Pediatr 1988 Apr;27(4):175-81. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48527 |
Study title: A report of two cases of brucellar sacroiliitis without systematic manifestations in GreeceThoma S, Patsiogiannis N, Dempegiotis P, Filiopoulos K. J Pediatr Orthop 2009 29:375-79 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48761 |
Study title: Accumulation of Tc-99m MDP in diaphragm and retroperitoneum of a battered child. Sty JR, Carmody TJ, Ruiz ME. Clin Nucl Med. 1995 Oct;20(10):931. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43583 |
Study title: Computerized blood flow analysis for decision making in the treatment of osteochondritis dissecansLitchman HM, McCullough RW, Gandsman EJ, Schatz SL. J Pediatr Orthop 1988 Mar;8(2):208-12 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48752 |
Study title: Computerized skeletal scintigraphy for assessment of mandibular asymmetry. Cisneros GJ, Kaban LB. J Oral Maxillofac Surg. 1984 Aug;42(8):513-20. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): cisneros-1984.pdf |
View full study record |
Document reference: 48840 |
Study title: Acute hematogenous osteomyelitis of children: assessment of skeletal scintigraphy-based diagnosis in the era of MRI. Connolly LP, Connolly SA, Drubach LA, Jaramillo D, Treves ST. J Nucl Med. 2002 Oct;43(10):1310-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48841 |
Study title: Activation of the growth plates on three-phase bone scintigraphy: the explanation for the overgrowth of fractured femurs.Elba CSC, Etchebehere EC, Caron M, Pereira JA, Lima MC, Santos AO, et al. Eur J Nucl Med 2001 Jan;28(1):72-80. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48719 |
Study title: Age- and sex-related bone uptake of Tc-99m-HDP measured by whole-body bone scanning.Brenner W, Sieweke N, Bohuslavizki KH, Kampen WU, Zuhayra M, Clausen M, et al. Nuklearmedizin 2000 Aug;39(5):127-32. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48578 |
Study title: Age-related changes in skull uptake on bone scintigraphy: a quantitative study.Sadeghi R, Zakavi SR, Ghasemov M, Kakhki VRD. Nucl Med Rev 2008; 11 (2):67-69 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48756 |
Study title: DECREASED TRACER UPTAKE IN BONE TISSUE IN PAEDIATRIC REFLEX SYMPATHETIC DYSTROPHYX. Le Loet, J. Lefort, A. Daragon, B. Derumeaux, P. Deshayes Rheumatology Department, La Prévotière, Hôpital de Bois Guillaume, BP 100, F 76230 Bois Guillaume |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48845 |
Study title: Assessment of an intervention study on iodine deficiency in Burkina Faso (1990-1993). ; Casas-C-A. Atencion Primaria, 30 APR 1998, Vol/Iss/Pg. 21/7 (462-465)Assessment of an intervention study on iodine deficiency in Burkina Faso (1990-1993). ; Casas-C-A. Atencion Primaria, 30 APR 1998, Vol/Iss/Pg. 21/7 (462-465) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30219 |
Study title: Äthiopathogenese und Therapie der Jodmangelstruma, Gärtner, R.; Z. ärtzl. Fortbildung 89, 27-31, 1995Äthiopathogenese und Therapie der Jodmangelstruma, Gärtner, R.; Z. ärtzl. Fortbildung 89, 27-31, 1995 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30220 |
Study title: Cerebral av angiomas: 3-dimensional demonstration by spiral CT. ; Rieger-J. RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Neuen Bildgebenden Verfahren, 1994, Vol/Iss/Pg. 161/6 (489-494)Cerebral av angiomas: 3-dimensional demonstration by spiral CT. ; Rieger-J. RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Neuen Bildgebenden Verfahren, 1994, Vol/Iss/Pg. 161/6 (489-494) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30221 |
Study title: Chemical pneumonitis with iodoliposputosis following lymphangiography in children.; Stoegmann-W. Fortschritte auf den Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1974, Vol/Iss/Pg. 121/1 (43-48). Chemical pneumonitis with iodoliposputosis following lymphangiography in children.; Stoegmann-W. Fortschritte auf den Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1974, Vol/Iss/Pg. 121/1 (43-48). |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30222 |
Study title: Cognitive and motor functions of iodine-deficient but euthyroid children in Bangladesh do not benefit from iodized poppy seed oil (Lipiodol). ; Huda-S-N. Journal of Nutrition, 2001, Vol/Iss/Pg. 131/1 (72-77)Cognitive and motor functions of iodine-deficient but euthyroid children in Bangladesh do not benefit from iodized poppy seed oil (Lipiodol). ; Huda-S-N. Journal of Nutrition, 2001, Vol/Iss/Pg. 131/1 (72-77) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30223 |
Study title: Combination therapy consisting of arterial infusion chemotherapy (EPF, EAP) and transcatheter arterial embolization (TAE). ; Yodono-H. Cancer Chemotherapy and Pharmacology, Supplement, 1994, Vol/Iss/Pg. 33/- (S79-S83)Combination therapy consisting of arterial infusion chemotherapy (EPF, EAP) and transcatheter arterial embolization (TAE). ; Yodono-H. Cancer Chemotherapy and Pharmacology, Supplement, 1994, Vol/Iss/Pg. 33/- (S79-S83) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30224 |
Study title: Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression: a case report; K. Tanaka. J Clin Pathol 2005;58:884-887.Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression: a case report; K. Tanaka. J Clin Pathol 2005;58:884-887. |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30225 |
Study title: Coverage and cost of iodized oil capsule distribution in Tanzania. ;Peterson-S. Health Policy and Planning, 1999, Vol/Iss/Pg. 14 /4 (390-399)Coverage and cost of iodized oil capsule distribution in Tanzania. ;Peterson-S. Health Policy and Planning, 1999, Vol/Iss/Pg. 14 /4 (390-399) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30226 |
Study title: Craniofacial cavernous venous malformations: Percutaneous sclerotherapy with use of ethanolamine oleate. ;Choi-Y-H. Journal of Vascular and Interventional Radiology, 2002, Vol/Iss/Pg. 13/5 (475-482)Craniofacial cavernous venous malformations: Percutaneous sclerotherapy with use of ethanolamine oleate. ;Choi-Y-H. Journal of Vascular and Interventional Radiology, 2002, Vol/Iss/Pg. 13/5 (475-482) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30227 |
Study title: Diagnosis and management of vein of Galen aneurysmal malformations. ; Gailloud-P. Journal of Perinatology, 2005, Vol/Iss/Pg. 25/8 (542-551)Diagnosis and management of vein of Galen aneurysmal malformations. ; Gailloud-P. Journal of Perinatology, 2005, Vol/Iss/Pg. 25/8 (542-551) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30228 |
Study title: Diagnostic and therapeutic value of lymphography in persistent postoperative chylothorax. ; Thambo-J-B. Archives des Maladies du Coeur et des Vaisseaux, 2004, Vol/Iss/Pg. 97/5 (546-548)Diagnostic and therapeutic value of lymphography in persistent postoperative chylothorax. ; Thambo-J-B. Archives des Maladies du Coeur et des Vaisseaux, 2004, Vol/Iss/Pg. 97/5 (546-548) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30229 |
Study title: Pediatric hepatic CT : an injection protocol;ROCHE KJ; Pediatr. Radiol.; 1996 vol.26 p.502 507Pediatric hepatic CT : an injection protocol;ROCHE KJ; Pediatr. Radiol.; 1996 vol.26 p.502 507 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30422 |
Study title: Perforated versus non perforated acute appendicitis : accuracy of multidetector CT detection; BIXBY SD; Radiology ; 2006 vol.241 n.3 p.780 786Perforated versus non perforated acute appendicitis : accuracy of multidetector CT detection; BIXBY SD; Radiology ; 2006 vol.241 n.3 p.780 786 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30423 |
Study title: Iodized oil in the prophylaxis of endemic goiter in Argentina;Tomas Watanabe. Reprint from Endemic Goiter and cretinism: continuing threats to world health PAHO scientific publication 292, 1974: 231-240 Iodized oil in the prophylaxis of endemic goiter in Argentina;Tomas Watanabe. Reprint from Endemic Goiter and cretinism: continuing threats to world health PAHO scientific publication 292, 1974: 231-240 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30276 |
Study title: Iron supplementation in goitrous, iron-deficient children improves their response to oral iodized oil. ;Zimmermann-M. European Journal of Endocrinology, 2000, Vol/Iss /Pg. 142/3 (217-223)Iron supplementation in goitrous, iron-deficient children improves their response to oral iodized oil. ;Zimmermann-M. European Journal of Endocrinology, 2000, Vol/Iss /Pg. 142/3 (217-223) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30277 |
Study title: J Comput Assist Tomogr. 2007 Jul-Aug;31(4):493-8. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations. Cheruvu B, Henning K, Mulligan J, Klippenstein D, Lawrence D, Gurtoo L, Gottlieb RH. J Comput Assist Tomogr. 2007 Jul-Aug;31(4):493-8. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations. Cheruvu B, Henning K, Mulligan J, Klippenstein D, Lawrence D, Gurtoo L, Gottlieb RH. |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30345 |
Study title: J Invasive Cardiol. 2003 Mar;15(3):133-8. Early and late reactions following the use of iopamidol 340, iomeprol 350 and iodixanol 320 in cardiac catheterization. Sutton AG, Finn P, Campbell PG, Price DJ, Hall JA, Stewart MJ, Davies A, Linker NJ, De Belder MA. J Invasive Cardiol. 2003 Mar;15(3):133-8. Early and late reactions following the use of iopamidol 340, iomeprol 350 and iodixanol 320 in cardiac catheterization. Sutton AG, Finn P, Campbell PG, Price DJ, Hall JA, Stewart MJ, Davies A, Linker NJ, De Belder MA. |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30346 |
Study title: Jodblockade der Schilddrüse, Schicha H.; Gustav Fischer Verlag, 1994Jodblockade der Schilddrüse, Schicha H.; Gustav Fischer Verlag, 1994 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30278 |
Study title: Jodmangelstruma: Medikamentöse Therapie bei Kindern, Jugendlichen, jungen Erwachsenen und Schwangeren, Hehrmann, R.; Apotheker J. 8, 29-34, 1994Jodmangelstruma: Medikamentöse Therapie bei Kindern, Jugendlichen, jungen Erwachsenen und Schwangeren, Hehrmann, R.; Apotheker J. 8, 29-34, 1994 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30279 |
Study title: Jodprophylaxe und Strumatherapie mit Jodid, Finke R. et al.; Z.Allg. Med. 68, 984-989, 1992Jodprophylaxe und Strumatherapie mit Jodid, Finke R. et al.; Z.Allg. Med. 68, 984-989, 1992 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30280 |
Study title: Lipiodol computerized tomography: How sensitive and specific is the technique in the diagnosis of hepatocellular carcinoma? ; Ngan-H. British Journal of Radiology, 1990, Vol/Iss/Pg. 63/754 (771-775)Lipiodol computerized tomography: How sensitive and specific is the technique in the diagnosis of hepatocellular carcinoma? ; Ngan-H. British Journal of Radiology, 1990, Vol/Iss/Pg. 63/754 (771-775) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30281 |
Study title: Liver transplantation in the therapy of hepatocellular carcinoma: A revision of our series. ; Lucena-de-la-Poza-J-L. Transplantation Proceedings, 2002, Vol/Iss/Pg. 34/1 (260-261)Liver transplantation in the therapy of hepatocellular carcinoma: A revision of our series. ; Lucena-de-la-Poza-J-L. Transplantation Proceedings, 2002, Vol/Iss/Pg. 34/1 (260-261) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30282 |
Study title: Lymphangiography, therapeutic method of a surgical wound of the thoracic canal: Report of a case (1). ; Tiemtaoure-B. Journal de Radiologie, 2007, Vol/Iss/Pg. 88/1 C1 (69-71)Lymphangiography, therapeutic method of a surgical wound of the thoracic canal: Report of a case (1). ; Tiemtaoure-B. Journal de Radiologie, 2007, Vol/Iss/Pg. 88/1 C1 (69-71) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30284 |
Study title: Lymphography in primary lymphooedema of the leg in children. With reference to seven lymphographies. Manlot-G. Annales de Radiologie, 1976, Vol/Iss/Pg. 19/1 (41-55)Lymphography in primary lymphooedema of the leg in children. With reference to seven lymphographies. Manlot-G. Annales de Radiologie, 1976, Vol/Iss/Pg. 19/1 (41-55) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30285 |
Study title: Clinical assessment of the latrogenicGatto 1988 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Gatto 1988 Clinical assessment of the latrogenic.pdf |
View full study record |
Document reference: 49166 |
Study title: Clinical evaluations on the biocompatibility- Valutazioni cliniche sulla biocompatibilitaGatto 1989 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Gatto 1989 Valutazioni cliniche sulla biocompatibilita.pdf |
View full study record |
Document reference: 49167 |
Study title: Clinical study of an amine fluoride gel and acidulated phosphate fluoride gelShern 1976 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Shern 1976 Clinical study of an amine fluoride.pdf |
View full study record |
Document reference: 49178 |
Study title: Collective preschool caries prevention using a fluoride-containing varnish] [Article in German] |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42543 |
Study title: Comments on the biocompatibility - Osservazioni sulla biocompatibilitaGallusi 1988 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Gallusi 1988 Osservazioni sulla biocompatibilita.pdf |
View full study record |
Document reference: 49165 |
Study title: Comparision of a single application of stannous fluoride with a single application of sodium fluoride or two applications of stannous fluoride1961-Mercer |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1961-Mercer-Comparision of a single application of stannous fluoride with a single application of sodium fluoride or two applications of stannous f... |
View full study record |
Document reference: 49141 |
Study title: Comparision of three self applied topical fluoride preparationsfor control of decalcification1993-boyd |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1993-boyd - comparision of three self applied topical fluoride preparationsfor control of decalcification.pdf |
View full study record |
Document reference: 49156 |
Study title: Comparison of three prevention programs -Vergleich dreier Prophylaxe ProgrammeBüttner 1987 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Büttner 1987 Vergleich dreier Prophylaxe Programme.pdf |
View full study record |
Document reference: 49159 |
Study title: Haddad FS, Dhib-Jalbut S.. 1986 Elsevier Science Publishers Inopsiplex in the treatment of SSPEHaddad FS, Dhib-Jalbut S.. 1986 Elsevier Science Publishers Inopsiplex in the treatment of SSPE |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30117 |
Study title: Han CY, Lin HF, Shin PY, Liu CK, Liu CS. Kaohsiung J Med Sci. 2003 Aug;19(8):416-20. Combined interferon-alpha and inosiplex treatment of subacute sclerosing panencephalitis: a case report Han CY, Lin HF, Shin PY, Liu CK, Liu CS. Kaohsiung J Med Sci. 2003 Aug;19(8):416-20. Combined interferon-alpha and inosiplex treatment of subacute sclerosing panencephalitis: a case report |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30118 |
Study title: Himawan T, Kho LKAbstracts of Scientific Papers: Asian Congress of Pediatrics; May 1-2, 1974; Manila, Philippines: Philippines Pediatric Society; 1974. Abstract 64. Experiences in the treatment of dengue hemorrhagic fever with Isoprinosine.Himawan T, Kho LKAbstracts of Scientific Papers: Asian Congress of Pediatrics; May 1-2, 1974; Manila, Philippines: Philippines Pediatric Society; 1974. Abstract 64. Experiences in the treatment of dengue hemorrhagic fever with Isoprinosine. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30119 |
Study title: Horiguchi Y, Ohya T. No To Hattatsu. 1995 May;27(3):231-7. Successful treatment of subacute sclerosing panencephalitis with long-term intrathecal large dose of alpha-interferon--a case reportHoriguchi Y, Ohya T. No To Hattatsu. 1995 May;27(3):231-7. Successful treatment of subacute sclerosing panencephalitis with long-term intrathecal large dose of alpha-interferon--a case report |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30120 |
Study title: Hosoya M, Shigeta S et alAntimicrob Agents Chemother Mar 2001;45(3):943-5. High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis.Hosoya M, Shigeta S et alAntimicrob Agents Chemother Mar 2001;45(3):943-5. High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30121 |
Study title: Hypertrophic osteoarthropathy in a child with follicular bronchiolitis.Boas SR, Charron M, Ledesma-Medina J, Noyes BE, Kurland G. Clin Nucl Med 1995 Jan;20(1):49- 51. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48574 |
Study title: I-131 MIBG imaging after bone marrow transplantation for neuroblastoma.Englaro EE, Gelfand MJ, Harris RE, Smith HS. Radiology 1992 182(2):515-20 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48721 |
Study title: Detection of adrenal metastasis from osteosarcoma by Tc-99m MOP scintigraphyKauffman WM. Winer-Muram H. Sandlund JT. Clin Nucl Med 1995 20(8):741 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48492 |
Study title: Diffuse femoral uptake on bone scan after fracture in an infantRoach J, Höschl R. Q J Nucl Med 1996 Jun;40(2):194-6 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48755 |
Study title: Diffuse hepatic uptake of technetium-99m methylene diphosphonate in a patient receiving high dose methotrexate.Flynn BM. Treves ST. J Nucl Med 1987 Apr;28(4):532-4. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48482 |
Study title: Discovery of a renal medullary carcinoma in an adolescent male with sickle cell trait by Tc-99m methylene disphosponate bone scintigraphy.Brown JM, Berkey BD, Brooks JA. Clin Nucl Med 2008;33:896-900. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48581 |
Study title: Does I- 131-MIBG underestimate skeletal disease burden in neuroblastoma?Barai S, Bandopadhayaya GP, Malhotra A, Agarwal S, Kumar R, Dhanapathi H. J Postgrad Med 2004b Oct-Dec;50(4):257-61. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48563 |
Study title: Increased activity on immediate phase of bone imaging does not always indicate increased blood volume.Webster DL, Hurwitz GA, DeVeber LL, Troster M, Driedger AA. Clin Nucl Med 1986 Nov;11(11):749-50 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48764 |
Study title: Intense muscle uptake of Ga-67 citrate and Tc-99m MDP in a patient with aplastic anemia.Batte WG Jr., Yeh SD, Rosenblum MK, Larson SM. Clin Nucl Med 1991 Jun;16(6):421-4. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48566 |
Study title: Intraoperative radionuclide detection in the treatment of paediatric osteoid osteoma.M. Lacheretz, B. Herbaux, C. Hossein-Foucher, P. Lecouffe, M. Richir. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48844 |
Study title: Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastomaShulkin BL. Shapiro B. Hutchinson RJ. J Nucl Med 1992 Oct;33(10):1735-40 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48516 |
Study title: Ishii C, Mori Y, Hata Y, Katsuyama N, Fujioka M, Fukazawa W, Hashimoto H, Horiuchi T, Fujioka M, Kawakami K. [Clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)] Radioisotopes. 1981 Jul;30(7):401-3. Japanese. No abstract available. Ishii C, Mori Y, Hata Y, Katsuyama N, Fujioka M, Fukazawa W, Hashimoto H, Horiuchi T, Fujioka M, Kawakami K. [Clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)] Radioisotopes. 1981 Jul;30(7):401-3. Japanese. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44191 |
Study title: Assessment of mandibular growth by skeletal scintigraphyKaban LB. Cisneros GJ. Heyman S. Treves S. J Oral Maxillofac Surg 1982 Jan;40(1):18-22 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48491 |
Study title: Bandopadhyaya G. Malhotra A. Soft tissue uptake of Tc99m-MDP in acute lymphoblastic leukemia.Marwah A. Kumar R. Dasan J B. Choudhury S. Bandopadhyaya G. Malhotra A. Cl in Imaging 2002 May-Jun;26(3):206-8 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48505 |
Study title: Effects of renal failure and metabolic diseases upon bone scanning in children.Schumichen C. Annales de Radiologie 1983 26(6):498-504 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48758 |
Study title: peritoneographie : utilisation d'un nouveau produit de contraste faiblement hyperosmolaire (AG 62-27)progres en peritoneographie grace a l'utilisationd'un nouveau produit de contraste faiblement hyperosmolaire (hexabrix); Rozenberg R., J. Radiol.; 1981 vol.62 n.2 p.123-126 J. Belge Radiol.; 1981 vol.64 p.151-155peritoneographie : utilisation d'un nouveau produit de contraste faiblement hyperosmolaire (AG 62-27)progres en peritoneographie grace a l'utilisationd'un nouveau produit de contraste faiblement hyperosmolaire (hexabrix); Rozenberg R., J. Radiol.; 1981 vol.62 n.2 p.123-126 J. Belge Radiol.; 1981 vol.64 p.151-155 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30439 |
Study title: Reduced radiation dose helical chest CT : effect on reader evaluation of structures and lung findings;MAYO JR; Radiology; 2004 vol.232 p.749 756Reduced radiation dose helical chest CT : effect on reader evaluation of structures and lung findings;MAYO JR; Radiology; 2004 vol.232 p.749 756 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30425 |
Study title: Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children – VANDERHOOF J.A., WHITNEY D.B. and al. – 1999.Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children – VANDERHOOF J.A., WHITNEY D.B. and al. – 1999. |
Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30966 |
Study title: Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children – SHORNIKOVA A.V., CASAS I.A. and al. – 1997. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children – SHORNIKOVA A.V., CASAS I.A. and al. – 1997. |
Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30967 |
Study title: Lactobacillus therapy for acute infectious diarrhea in children: a meta analysis – VAN NIEL C.W., FEUDTNER C. and al. – 2005. Lactobacillus therapy for acute infectious diarrhea in children: a meta analysis – VAN NIEL C.W., FEUDTNER C. and al. – 2005. |
Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30968 |
Study title: Limitations of probiotic therapy in acute, severe dehydrating diarrhea – COSTA-RIBEIRO H., RIBEIRO T.C. and al. – 2003. Limitations of probiotic therapy in acute, severe dehydrating diarrhea – COSTA-RIBEIRO H., RIBEIRO T.C. and al. – 2003. |
Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30969 |
Study title: Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea – GUARINO A., BERNI CANANI R. and al. – 1997.Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea – GUARINO A., BERNI CANANI R. and al. – 1997. |
Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30970 |
Study title: Prevention of diarrhea by the probiotic, Lactobacillus GG – DUPONT H. – 1999Prevention of diarrhea by the probiotic, Lactobacillus GG – DUPONT H. – 1999 |
Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30974 |
Study title: Probiotics for pediatric antibiotic-associated diarrhea: a meta analysis of randomized placebo-controlled trials – JOHNSTON B.C., SUPINA A.L. and al. – 2006.Probiotics for pediatric antibiotic-associated diarrhea: a meta analysis of randomized placebo-controlled trials – JOHNSTON B.C., SUPINA A.L. and al. – 2006. |
Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30971 |
Study title: Short report: a placebo-controlled study of Lactobacillus GG colonization in one-to-three-year-old Peruvian children – SHEEN P., OBERHELMAN R.A. and al. – 1995.Short report: a placebo-controlled study of Lactobacillus GG colonization in one-to-three-year-old Peruvian children – SHEEN P., OBERHELMAN R.A. and al. – 1995. |
Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30972 |
Study title: Vergleichende Doppel-Blindprüfung zwischen Neseril™, einem neuen Nasentropfenpräparat, und Ephedrin. (Comparative double-blind trial between Neseril™ (Nasivin), a new nasal-drop formulation, and ephedrine).Särtryck ur Svenska Läkartidningen 1964; 61: 3204-13, Thulin A, Walther BW., 1964 |
Active substance: OXYMETAZOLINE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48917 |
Study title: Management of pediatric liver tumors. ; Bowman-L-C. Surgical Oncology Clinics of North America, 1996, Vol/Iss/Pg. 5/2 (451-459)Management of pediatric liver tumors. ; Bowman-L-C. Surgical Oncology Clinics of North America, 1996, Vol/Iss/Pg. 5/2 (451-459) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30286 |
Study title: Management of Pericentral Arteriovenous Malformations; James I. Ausman. Neurol Med Chir Suppl (Tokyo) 38, 208 ~ 216, 1998Management of Pericentral Arteriovenous Malformations; James I. Ausman. Neurol Med Chir Suppl (Tokyo) 38, 208 ~ 216, 1998 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30287 |
Study title: Mild iodine deficiency is associated with elevated hearing thresholds in children in Benin. ; Van-den-Briel-T European Journal of Clinical Nutrition, 2001, Vol /Iss/Pg. 55/9 (763-768)Mild iodine deficiency is associated with elevated hearing thresholds in children in Benin. ; Van-den-Briel-T European Journal of Clinical Nutrition, 2001, Vol /Iss/Pg. 55/9 (763-768) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30288 |
Study title: A study to test the efficacy of E45 Cream on nappy rash |
Active substance: LANOLIN SOFT PARAFFIN AND FAT PRODUCTS |
Study summary document link (including results): |
View full study record |
Document reference: 31012 |
Study title: Efficacy and tolerability of lactitol solution versus lactulose syrup in patients (children) suffering from chronic functional constipation. Investigator: Dr. Med. A.C. Douwes Report date: 04.11.1996 |
Active substance: LANREOTIDE |
Study summary document link (including results): |
View full study record |
Document reference: 31014 |
Study title: Evaluation of the efficacy and safety of Somatuline sustained release form in adolescent with constitutive tall stature |
Active substance: LANREOTIDE |
Study summary document link (including results): |
View full study record |
Document reference: 31013 |
Study title: A double blind, multi-centre, randomised, placebo-controlled study to assess the efficacy,tolerability and compliance profile of a triple therapy regimen (lansoprazole, amoxicilline and tinidazole) in comparison with the standard double therapy (amoxicilline and tinidazole), given for one week to children with Hpylori gastritis. |
Active substance: LANSOPRAZOLE |
Study summary document link (including results): Lansoprazole_HP-AG-97-01-EC428-Synopsis.pdf |
View full study record |
Document reference: 47614 |
Study title: A phase I, multi-centre, double-blind, randomized study consisting of a 7-day pre-treatment period and a 5-day treatment period of either lansoprazole 15mg or 30mg (capsules) in 12-17 year-olds with symptomatic, endoscopically (oesophagitis grade ³1) and/or histologically proven (borderline or abnormal from oesophageal biopsies) GERD. |
Active substance: LANSOPRAZOLE |
Study summary document link (including results): Lansoprazole_M97-640-Synopsis.pdf |
View full study record |
Document reference: 47612 |
Study title: A phase I, multi-centre, randomised, parallel group, open-label, single- and repeated-dose studies to evaluate the pharmacokinetic and pharmacodynamic profile of lansoprazole in neonates with clinically-evident GERD |
Active substance: LANSOPRAZOLE |
Study summary document link (including results): Lansoprazole_c03-042-synopsis.pdf |
View full study record |
Document reference: 47606 |
Study title: A Phase II, open-label, parallel group, 8-12 weeks study to assess the safety and efficacy of once daily administration of lansoprazole 15 mg or 30 mg in male and female adolescents aged 12 to 17 years with GERD including non-erosive GERD and erosive oesophagitis. |
Active substance: LANSOPRAZOLE |
Study summary document link (including results): Lansoprazole_M00-158-Synopsis.pdf |
View full study record |
Document reference: 47613 |
Study title: A phase II, single-centre, open-label pharmacokinetic and pharmacodynamic study of lansoprazole 30mg/1.73m2 in children aged 18 days to 14 years who required anti-secretory treatment |
Active substance: LANSOPRAZOLE |
Study summary document link (including results): Lansoprazole_FH-93-749-54 Synopsis _EC430__English.pdf |
View full study record |
Document reference: 47609 |
Study title: A phase II, two-centre, open-label study in patients aged 3 months to 13 years with endoscopically-proven reflux oesophagitis. |
Active substance: LANSOPRAZOLE |
Study summary document link (including results): Lansoprazole_AG-II-95-028-Synopsis.pdf |
View full study record |
Document reference: 47610 |
Study title: "Four- week intraveinous study of AG-1749 in rats - H. Miajyiama et al. - 25/07/1990 - Lanzor 30 mg-preclinical studies-" |
Active substance: LANSOPRAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 47616 |
Study title: Intravenous single dose toxicology study of AG-1749 - IV Formulation in mice and rats - H. Miajyima et al. - 19/08/1991 - Lanzor 30 mg-preclinical studies-" |
Active substance: LANSOPRAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 47615 |
Study title: Prevention and control of iodine deficiency: A review of a study on the effectiveness of oral iodized oil in Malawi. ;Furnee-C-A. European Journal of Clinical Nutrition, 1997, Vol /Iss/Pg. 51/SUPPL. 4 (9-10)Prevention and control of iodine deficiency: A review of a study on the effectiveness of oral iodized oil in Malawi. ;Furnee-C-A. European Journal of Clinical Nutrition, 1997, Vol /Iss/Pg. 51/SUPPL. 4 (9-10) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30312 |
Study title: Prophylaxis and treatment of endemic goiter in Peru with iodized oil; E. A. Pretell. J. Clin Endocr 29: 1586-1969Prophylaxis and treatment of endemic goiter in Peru with iodized oil; E. A. Pretell. J. Clin Endocr 29: 1586-1969 |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30313 |
Study title: Pulmonary complications after hepatic artery chemoembolization or infusion via the inferior phrenic artery for primary liver cancer. ; Tajima-T. Journal of Vascular and Interventional Radiology, 01 SEP 2002, Vol/Iss/Pg. 13/9 I (893-900)Pulmonary complications after hepatic artery chemoembolization or infusion via the inferior phrenic artery for primary liver cancer. ; Tajima-T. Journal of Vascular and Interventional Radiology, 01 SEP 2002, Vol/Iss/Pg. 13/9 I (893-900) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30314 |
Study title: Pulmonary embolism: A fatal complication of arterial chemoembolization for advanced hepatocellular carcinoma. ;Czauderna-P. Journal of Pediatric Surgery, 2005, Vol/Iss/Pg. 40/10 (1647-1650)Pulmonary embolism: A fatal complication of arterial chemoembolization for advanced hepatocellular carcinoma. ;Czauderna-P. Journal of Pediatric Surgery, 2005, Vol/Iss/Pg. 40/10 (1647-1650) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30315 |
Study title: Pulmonary lesions following lymphography in childhood. ;Pollak-A. Rontgen-Blatter, 1973, Vol/Iss/Pg. 26/7 (296-300). Pulmonary lesions following lymphography in childhood. ;Pollak-A. Rontgen-Blatter, 1973, Vol/Iss/Pg. 26/7 (296-300). |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30316 |
Study title: Pulmonary lipiodol embolism during transcatheter arterial chemoembolization for hepatoblastoma under general anaesthesia. Yamaura-K. European Journal of Anaesthesiology 2000, Vol /Iss/Pg. 17/11 (704-708)Pulmonary lipiodol embolism during transcatheter arterial chemoembolization for hepatoblastoma under general anaesthesia. Yamaura-K. European Journal of Anaesthesiology 2000, Vol /Iss/Pg. 17/11 (704-708) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30317 |
Study title: A Multi-Institutional Study of Optimal Use of Recombinant Granulocyte Colony Stimulating Factor (Lenograstim) in Pediatric Malignancies-III - Kawa K. et al - 1999 (Biotherapy - 13(4):361-367)A Multi-Institutional Study of Optimal Use of Recombinant Granulocyte Colony Stimulating Factor (Lenograstim) in Pediatric Malignancies-III - Kawa K. et al - 1999 (Biotherapy - 13(4):361-367) |
Active substance: LENOGRASTIM |
Study summary document link (including results): |
View full study record |
Document reference: 31040 |
Study title: A multicenter European randomized parallel-group phase III study to evaluate safety and efficacy of rHuG-CSF (lenograstim) in the first 12 weeks of the treatment of de novo severe aplastic anemia - 1998 (Blood, 92 (10) suppl 1 : abs 1551, p 376 a) |
Active substance: LENOGRASTIM |
Study summary document link (including results): |
View full study record |
Document reference: 31028 |
Study title: A multicenter non-randomized open-label dose-escalating phase I-II study (pharmakokinetic and dose-ranging) of intravenous or subcutaneous administration of rG-CSF for a maximum of 21 days to reduce duration of neutropenia in children having received COPAdM1 and / or COPAdM2 chemotherapy course for advanced lymphoma |
Active substance: LENOGRASTIM |
Study summary document link (including results): |
View full study record |
Document reference: 31029 |
Study title: A Phase III multicenter, double blind, randomized, parallel-group, vehicle controlled study to evaluate the safety and efficacy of 5µg/kg/day recombinant Granulocyte Colony Stimulating Factor (rHuG-CSF) in the treatment of patients who have undergone bone marrow transplantation (BMT). |
Active substance: LENOGRASTIM |
Study summary document link (including results): |
View full study record |
Document reference: 31030 |
Study title: An open label, multicenter study to evaluate the pharmacokinetics of 5uG / KG / day of recombinant granulocyte colony stimulating factor (rHuG-CSF) in the treatment of pediatric patients who have undergone bone marrow transplantation (BMT) - No author - No date - Clinical study documentation GHBA 271 study - Vol. 6 - |
Active substance: LENOGRASTIM |
Study summary document link (including results): |
View full study record |
Document reference: 31031 |
Study title: Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO / EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). - Bacigalupo A. et al - 2000 (Blood 95: 1931 - 1931) - Publication - Ref17 of Clinical Expert Report - |
Active substance: LENOGRASTIM |
Study summary document link (including results): |
View full study record |
Document reference: 31032 |
Study title: European Pjhase II study of open label administration of subcutaneous rHuG-CSF treatment in congenital agranulocytosis in children. |
Active substance: LENOGRASTIM |
Study summary document link (including results): |
View full study record |
Document reference: 31033 |
Study title: Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: a randomized study of the French Society of Pediatric Oncology - Patte C. et al - 2002 (J Clin Oncol. Jan 15;20(2):441-8)Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: a randomized study of the French Society of Pediatric Oncology - Patte C. et al - 2002 (J Clin Oncol. Jan 15;20(2):441-8) |
Active substance: LENOGRASTIM |
Study summary document link (including results): |
View full study record |
Document reference: 31039 |
Study title: Efficiency of the bone scan for occult limping toddlers.Aronson J, Garvin K, Seibert J, Glasier C, Tursky EA. J Pediatr Orthop 1992 Jan;12(1):38-44 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48530 |
Study title: Isotope bone scans in the assessment of children with hip pain or limp.Bower GD, Sprague P, Geijsel H, Holt K, Lovegrove FT. Pediatr Radiol 1985;15(5):319-23. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48576 |
Study title: Esthesioneuroblastoma imaged with bone scintigraphy.Acker R, Leonard JC. Clin Nucl Med 1986 Sep;11(9):670-1. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48522 |
Study title: 99Tcm-MAA lung scintigraphy in patients with Behçet's disease: its value and correlation with clinical course and other diagnostic modalities. Nucl Med Commun. 2000 Feb;21(2):171-9. Caglar M 2000 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48804 |
Study title: Abnormal brain perfusion demonstrated by Tc-99m MAA total-body scan in two children with complex congenital heart disease. Ann Nucl Med. 1998 Oct;12(5):297-302. Suga K 1998 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48810 |
Study title: Acute paraquat intoxication: using nuclear pulmonary studies to predict patient outcome. Chest. 1999 Sep;116(3):709-14. Kao CH 1999 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48806 |
Study title: Arteriovenous shunt measurement during endovascular therapy for cerebrospinal lesions. AJNR Am J Neuroradiol. 1997 Oct;18(9):1679-89. Mariani L 1997 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48813 |
Study title: Aspiration of nasal secretions into the lungs in patients with acute sinonasal infections. Laryngoscope. 2000 Jan;110(1):107-10. Ozagar A 2000 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48805 |
Study title: Evaluation of growth in children using quantitative bone scintigraphy.Celen Z, Zincirkeser S, Ozkiliç S, Nacar F. J Int Med Res 1999;27(6):286-91. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48590 |
Study title: Extraosseous accumulation of (99m)Tc-HMDP to radiation nephropathy, mimicking recurrent neuroblastoma.Abe K, Sasaki M, Kuwabara Y, Koga H, Baba S, Kaneko K, et al. Ann Nucl Med 2005 Feb;19(1):35-40. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48521 |
Study title: Bilateral pulmonary artery aneurysms in a patient with Behcet syndrome: evaluation with radionuclide angiography and V/Q lung scanning. Clin Nucl Med. 1998 Nov;23(11):735-8. Basoglu T 1998 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48811 |
Study title: Clinical studies of alveolar-capillary permeability using technetium-99m DTPA aerosol. Ann Nucl Med. 1995 Nov;9(4):171-8. Sundram FX 1995 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48816 |
Study title: Correlation of diagnostic imaging and subsequent autopsy findings in patients with pulmonary embolism. Patriquin L, Khorasani R, Polak JF. AJR Am J Roentgenol. 1998 Aug;171(2):347-9 Comment in: AJR Am J Roentgenol. 1998 Aug;171(2):293. AJR Am J Roentgenol. 1999 Jun;172(6):1691-3. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
View full study record |
Document reference: 48244 |
Study title: Bhogate BM, Samuel AM, Ramanathan P. Bone scans in neuroblastoma. Indian J Cancer. 1993 Mar;30(1):5-9. Bhogate BM, Samuel AM, Ramanathan P. Bone scans in neuroblastoma. Indian J Cancer. 1993 Mar;30(1):5-9. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43671 |
Study title: Wirksames und sicheres Rhinologikum für Säuglinge. (Effective and safe rhinological agent for infants).Pädiatrische Nachrichten 2000; 3: 14-15, Teichmann B, Tschaikin M., 2000 |
Active substance: OXYMETAZOLINE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48927 |
Study title: Klinische Erfahrungen mit Nasivin. (Clinical experience with Nasivin)..,The Practitioner 1975; 214: 685-8, Aikman PM, Bremner AD, de Burca B, et al., 1975 |
Active substance: OXYMETAZOLINE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48914 |
Study title: Evaluate in children the taste of two different phenoxymethylpenicillins, one containing aspartame.Norstedt |
Active substance: PHENOXYMETHYLPENICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_13.xlsx |
View full study record |
Document reference: 49044 |
Study title: Investigate how absorption is influenced by volume, composition and food intake.Forsman et al |
Active substance: PHENOXYMETHYLPENICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_1.xlsx |
View full study record |
Document reference: 49031 |
Study title: Investigate how absorption is influenced by volume, composition and food intake.Forsman et al |
Active substance: PHENOXYMETHYLPENICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_1.xlsx |
View full study record |
Document reference: 49032 |
Study title: investigate serum concentrations achieved with potassium salt of penicillin V i n2 different galenic forms.Perlhagen et al |
Active substance: PHENOXYMETHYLPENICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_2.xlsx |
View full study record |
Document reference: 49033 |
Study title: Investigate the minimum age limit in children accepting penicillin administered as tablets instead of mixture.Edvardsson et al |
Active substance: PHENOXYMETHYLPENICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_14.xlsx |
View full study record |
Document reference: 49045 |
Study title: Investigate the possibility to administer penicillin V in a twice daily dosage regimen.Edlund et al |
Active substance: PHENOXYMETHYLPENICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_6.xlsx |
View full study record |
Document reference: 49037 |
Study title: "Infantile anorexia treated with degreased whole bone substance", Vidal Perez Fernandez, Medicina, 1969, 49 : 169-171"Infantile anorexia treated with degreased whole bone substance", Vidal Perez Fernandez, Medicina, 1969, 49 : 169-171 |
Active substance: OSSEIN HYDROXYAPATITE COMPOUND |
Study summary document link (including results): Ossopan nr1.xls |
View full study record |
Document reference: 47590 |
Study title: Open-label, single-arm, multicenter study to evaluate the efficacy and tolerability of Creon for children in infants with pancreatic exocrine insufficiency caused by cystic fibrosis |
Active substance: Pancreatin |
Study summary document link (including results): Pancreatin-S248-3003.pdf |
View full study record |
Document reference: 47673 |
Study title: Efficacy of acrivastine with pseudoephedrine in treatment of allergic rhinitis due to ragweed. Ann Allergy Asthma Immunol 1996; 76(2):204-8 Efficacy of acrivastine with pseudoephedrine in treatment of allergic rhinitis due to ragweed. Ann Allergy Asthma Immunol 1996; 76(2):204-8 |
Active substance: PARACETAMOL AND PSEUDOEPHEDRINE |
Study summary document link (including results): |
View full study record |
Document reference: 33636 |
Study title: Valuatazioni su pazienti pediatrici recoverati per diarrea acuta dal 1990 al 1996 (valuations about paeditric admissions inhospital for acute diarrhea from 1990 to 1996) - Casini T. and al. - 1997 (Ped. Med. Chir., 1997, 19: 31-5)Valuatazioni su pazienti pediatrici recoverati per diarrea acuta dal 1990 al 1996 (valuations about paeditric admissions inhospital for acute diarrhea from 1990 to 1996) - Casini T. and al. - 1997 (Ped. Med. Chir., 1997, 19: 31-5) |
Active substance: NIFUROXAZIDE |
Study summary document link (including results): |
View full study record |
Document reference: 47064 |
Study title: Phase I, multi-centre, randomised, parallel group, open-label, single- and repeated-dose studies to evaluate the pharmacokinetic and pharmacodynamic profile of lansoprazole in infants with clinically-evident GERD |
Active substance: LANSOPRAZOLE |
Study summary document link (including results): Lansoprazole_c03-043-synopsis.pdf |
View full study record |
Document reference: 47608 |
Study title: Assessment of the efficacy and safety of Somatuline sustained release form in adolescent with constitutive tall stature |
Active substance: LARATADINE |
Study summary document link (including results): |
View full study record |
Document reference: 31020 |
Study title: Lee JK, Liu RS, Shiang HR, Pan DH.. Usefulness of semiquantitative FDG-PET in the prediction of brain tumor treatment response to gamma knife radiosurgery. [lee-2003]J Comput Assist Tomogr. 2003 Jul-Aug;27(4):525-9. Lee JK 2003 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48674 |
Study title: Levivier M, Goldman S, Pirotte B, Brucher JM, Balériaux D, Luxen A, et al.. Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose. [levivier-1995]J Neurosurg. 1995 Mar;82(3):445-52. Levivier M 1995 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48675 |
Study title: McCarville MB.. Review. PET-CT imaging in pediatric oncology. [mccarville-2009]Cancer Imaging. 2009 Jun 29;9:35-43. McCarville MB 2009 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48676 |
Study title: Metz-Lutz MN, Filippini M.. Neuropsychological findings in Rolandic epilepsy and Landau-Kleffner syndrome. [metz-lutz-2006]Epilepsia. 2006;47 Suppl 2:71-5. Metz-Lutz MN 2006 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48677 |
Study title: Modafinil-induced hippocampal activation in narcolepsyNeuroscience Letters 422 (2007) 91–96. Yu Kyeong Kima, In-Young Yoon b,∗, Yoon-Kyung Shin b, Sang Soo Choa, Sang Eun Kima. |
Active substance: Steripet |
Study summary document link (including results): kim-2007.pdf |
View full study record |
Document reference: 48735 |
Study title: Mody RJ, Bui C, Hutchinson RJ, Yanik GA, Castle VP, Frey KA, Shulkin BL.. FDG PET imaging of childhood sarcomas. [mody-2010]Pediatr Blood Cancer. 2010 Feb;54(2):222-7. Mody RJ 2010 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48678 |
Study title: Moll AC, Hoekstra OS, Imhof SM, Comans EF, Schouten-van Meeteren AY, van der Valk P, et al. Ophthalmic Genet. 2004 Mar;25(1):31-5. Fluorine-18 fluorodeoxyglucose positron emission tomography (PET) to detect vital retinoblastoma in the eye: preliminary experience. [moll-2004]Moll AC 2004 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48679 |
Study title: Muzik O, Pourabdollah S, Juhasz C, Chugani DC, Janisse J, Draghici S.. Application of an objective method for localizing bilateral cortical FDG PET abnormalities to guide the resection ofepileptic foci. [muzik-2005]IEEE Trans Biomed Eng. 2005 Sep;52(9):1574-81. Muzik O 2005 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48680 |
Study title: Myocardial Viability Assessed by Positron Emission Tomography in Infants and Children After the Arterial Switch Operation and Suspected Infarction(J Am Coll Cardiol 2000;36:1676–83). Carsten Rickers, MD,* Karin Sasse, MD,* Ralph Buchert, PHD,† Heiko Stern, MD,* Jo¨rg van den Hoff, PHD,‡ Martin Lu¨beck, MD,† Jochen Weil, MD* |
Active substance: Steripet |
Study summary document link (including results): rickers-2000.pdf |
View full study record |
Document reference: 48743 |
Study title: Natsume J, Kumakura Y, Bernasconi N, Soucy JP, Nakai A, Rosa P, et al.. Alpha-[11C] methyl-L-tryptophan and glucose metabolism in patients with temporal lobe epilepsy. [natsume-2003]Neurology. 2003 Mar 11;60(5):756-61. Natsume J 2003 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48681 |
Study title: Control of decalcification in orthodontic patients by daily self administered application of a water free 0.4 percent stannous fluoride gel1974-stratemann |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1974-stratemann - control of decalcification in orthodontic patients by daily self administered application of a water free 0.4 percent stannous fl... |
View full study record |
Document reference: 49152 |
Study title: Controlled trial of fluoride in vitamin drops for prevention of caries in childrenLars-Eric Granath, Holger Rootzen, Elso Liljegren, Kerstin Hoist, Lennart Kohler 1978. Caries Res 12: 83-92lENNART hAMBERG 1971, THE LANCET, February 27 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1971-hamberg-Controlled trial of Fluoride in Vitamins Drops for Prevention od Caries in Children.pdf |
View full study record |
Document reference: 48782 |
Study title: Djelovanje aminofluorida - elmex gelee na: Effect of amine fluorideRajic 1977 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Rajic 1977 Djelovanje aminofluorida - elmex gelee na.pdf |
View full study record |
Document reference: 49174 |
Study title: Decrease in DMF tooth numbersSigrist 1975 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Sigrist 1975 Decrease in DMF tooth numbers.pdf |
View full study record |
Document reference: 49179 |
Study title: The anticariogenic effectiveness od a single application of stannous fluoride in children residing in an optimum fluoride area1960-Muhler |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1960-Muhler-The anticariogenic effectiveness od a single application of stannous fluoride in children residing in an optimum fluoride area.pdf |
View full study record |
Document reference: 49140 |
Study title: the anticariogenic effects of one and two X application of stannous fluoride on the deciduous and permanent teeth of children1962-Salter |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 49144 |
Study title: The caries inhibitory effect of a fluoride gel (PreviDent) ina self-brushing home based programm for shoolchildren1994-DePaola |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1994-DePaola-the caries inhibitory effect of a fluoride gel (PreviDent) ina self-brushing home based programm for shoolchildren.pdf |
View full study record |
Document reference: 49095 |
Study title: The caries preventing effect of mouthrinsing with 0.025 percent sodium fluoride solution in Swedish children. Forsman B. Community Dent Oral Epidemiol. 1974;2(2):58-65. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 48944 |
Study title: The caries preventive effect of a fluoride varnish in the fissures of the first permanent molar1984-holm |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1984-holm-The caries preventive effect of a fluoride varnish in the fissures of the first permanent molar.pdf |
View full study record |
Document reference: 49110 |
Study title: The caries prophylactic effect of Fluorlack after years of use in paediatric/adolescent dental care: Karies prophylaktische Wirkung von Fluorlack nach mehrjahriger Anwendung in der Jugendzahnpflege1978-leiser |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1978-leiser-Karies prophylaktische Wirkung von Fluorlack nach mehrjahriger Anwendung in der Jugendzahnpflege.pdf |
View full study record |
Document reference: 49104 |
Study title: The caries-preventive effect of a fluoride varnish in the fissures of the first permanent molar. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42369 |
Study title: The clinical anticariogenic effectiveness of supplementary fluoride vitamin preparations - result at the end of four yearsDavid K. Hennon, Georg K Stookey, Joseph C Muhler 1967. Journal of dentistry for children. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1967-hennon-Ciinical Anticariogenic Effectivenoss of Supplementary Fluoride-Vitamin Preparations-Results at the end of four years.pdf |
View full study record |
Document reference: 48785 |
Study title: The combined antocariogenic effeccts of a single stannous fluoride treatement and the unsupervised use of stannous fluoride dentifrice1959-Muhler, J DENT RES 1959 38: 994 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1959-Muhler-The combined antocariogenic effeccts of a single stannous fluoride treatement and the unsupervised use of stannous fluoride dentifrice.pdf |
View full study record |
Document reference: 49139 |
Study title: Correlation of pulmonary 99mTc-DTPA ventilation and 99mTc-MAA perfusion scans with pulmonary function tests in asymptomatic asthmatic children. Nucl Med Commun. 2003 Jul;24(7):819-24. Dai ZK 2003 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48796 |
Study title: Diagnosis of thrombosis of the deep veins of the lower extremities and pelvis and pulmonary thromboembolism using 99Tcm human serum albumin macroaggregates. Nucl Med Commun. 1989 Mar;10(3):141-7. Stevan M 1989 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48826 |
Study title: Diffusing capacity is not measurably affected by routine lung perfusion scanning.Morris T A 1988, J Nucl Med. 1988 Jul;29(7):1268-71. |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): Morris 1988.pdf |
View full study record |
Document reference: 48789 |
Study title: Bone imaging for lower extremity pain in athletes.Brill DR. Clin Nucl Med 1983 Mar;8(3):101-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48579 |
Study title: The Therapeutic Efficacy of Human Insulin (recombinant DNA) in Patients with Insulin-dependent Diabetes Mellitus: A Comparative Study with Purified Porcine Insulin |
Active substance: INSULIN (HUMAN) |
Study summary document link (including results): |
View full study record |
Document reference: 30182 |
Study title: Use of Biosynthetic Human Insulin (BHI), Mixed Beef-Pork (MBP) or Purified Pork (PPI), NPH or Lente Alone, or in Combination with Neutral Regular Insulin in Type I and Type II Diabetic Patients |
Active substance: INSULIN (HUMAN) |
Study summary document link (including results): Human insulin - B5K-MC-IBAL redacted CSR.PDF |
View full study record |
Document reference: 30185 |
Study title: A 24-week, randomised, multi-centre, open-labelled, parallel-group trial to investigate the safety of NN304 (insulin detemir) and Neutral protamine hagedorn (NPH) human insulin in children with type 1 diabetes on a basal-bolus regimen |
Active substance: insulin detemir |
Study summary document link (including results): NN304-1604 ICTR Synopsis.pdf |
View full study record |
Document reference: 47337 |
Study title: A 32 Week, Open-labelled, Randomised, Cross-over Trial comparing Efficacy and Safety of Insulin Detemir and Insulin Semilente, both administered at bedtime, in Children, Adolescents and Young Adults with Type 1 Diabetes on Basal-Bolus Regimen, LPLV November 2005 |
Active substance: insulin detemir |
Study summary document link (including results): NN304-1630-synopsis.pdf |
View full study record |
Document reference: 41576 |
Study title: [Bone isotope hypofixation in algodystrophy in children]Le Loet X, Lefort J, Daragon A, Derumeaux B, Deshayes P. Rev Rhum Mal Osteoartic. 1987 Jan;54(1):53. French. No abstract available |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43881 |
Study title: Bone isotope hypofixation in algodystrophy in childrenLe Loet X. Lefort J. Daragon A. Derumeaux B. Deshayes P. Rev Rhum Mal Osteoartic 1987 Jan;54(1):53 |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48497 |
Study title: Fone-scan-like pattern with 99TcM(V)-DMSA scintigraphy in patients with osteomalacia and primary hyperparathyroidism.Akbunar AT, Orhan B, Alper E. Nucl Med Commun 2000;21:181-5. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48525 |
Study title: "Oxybutynin Chlorhydrate for the Treatment of Urinary Incontinence and Hyperactive Bladder in Children. - Aubert D et al. - Ann Pediatr (Paris). 1986 (33 (7): 629-634) - Publication in UK registration file -" "Oxybutynin Chlorhydrate for the Treatment of Urinary Incontinence and Hyperactive Bladder in Children. - Aubert D et al. - Ann Pediatr (Paris). 1986 (33 (7): 629-634) - Publication in UK registration file -" |
Active substance: OXYBUTYNIN |
Study summary document link (including results): |
View full study record |
Document reference: 32987 |
Study title: The comparative antipyretic efffect of N-acetyl-P-aminophenol and acetylsalicylic acid" - Margaret T. Colgan and A.A. Mitz, Houston, Texas, USA - The Journal of PediatricsThe comparative antipyretic efffect of N-acetyl-P-aminophenol and acetylsalicylic acid" - Margaret T. Colgan and A.A. Mitz, Houston, Texas, USA - The Journal of Pediatrics |
Active substance: PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 45755 |
Study title: Use of the antiseptic Octenisept in children at the Fachklinik Hornheide.1996. |
Active substance: OCTENIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 32736 |
Study title: Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group. |
Active substance: DACTINOMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 25501 |
Study title: EA O'Neil, WJ Chwals, MD O'Shea, CS Turner. Dexamethasone Treatment During Ventilator Dependency: Possible Life Threatening Gastrointestinal Complications. Archives of Disease in Childhood 1992 67:10-11 USA |
Active substance: DEXAMETHASONE |
Study summary document link (including results): |
View full study record |
Document reference: 25690 |
Study title: An open study to Investigating the safety and efficiacy of Dextran-Ringer after blood loss during surgery.Zetterström et al. (1986-03-09) |
Active substance: Dextran |
Study summary document link (including results): |
View full study record |
Document reference: 48940 |
Study title: Clinical evaluation of priming solutions for pump oxygenator perfusion. Ann Thorac Surg. 1975 May;19(5):529-36. Lee WH Jr, Rubin JW, Huggins MP. |
Active substance: Dextran |
Study summary document link (including results): |
View full study record |
Document reference: 48899 |
Study title: Dextran therapy for pregnancy-associated deep thrombophlebitis.Wallach RC. Am J Obstet Gynecol. 1972 Mar;112(5):613-8. |
Active substance: Dextran |
Study summary document link (including results): |
View full study record |
Document reference: 48939 |
Study title: Effect of dextran on blood volume and interactions with volume regulatory systems.Haldemann G, Schaer H, Spring C, Frey P, Gebauer U, Hossli G. Intensive Care Med. 1979 Mar;5(1):11-4. |
Active substance: Dextran |
Study summary document link (including results): |
View full study record |
Document reference: 48937 |
Study title: Diffuse lymphatic dysplasia with hepatic oil embolism. Tatezawa-T. American Journal of Roentgenology, 1978, Vol/Iss/Pg. 131/5 (898-900)Diffuse lymphatic dysplasia with hepatic oil embolism. Tatezawa-T. American Journal of Roentgenology, 1978, Vol/Iss/Pg. 131/5 (898-900) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30230 |
Study title: Effect of 10 yr of the iodine supplementation on the hearing threshold of iodine deficient schoolchildren. ; Azizi-F. Journal of Endocrinological Investigation, 2005, Vol/Iss/Pg. 28/7 (595-598)Effect of 10 yr of the iodine supplementation on the hearing threshold of iodine deficient schoolchildren. ; Azizi-F. Journal of Endocrinological Investigation, 2005, Vol/Iss/Pg. 28/7 (595-598) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30231 |
Study title: Effect of intestinal parasite treatment on the efficacy of oral iodized oil for correcting iodine deficiency in schoolchildren. ; Furnee-C-A. American Journal of Clinical Nutrition, 1997, Vol/Iss /Pg. 66/6 (1422-1427)Effect of intestinal parasite treatment on the efficacy of oral iodized oil for correcting iodine deficiency in schoolchildren. ; Furnee-C-A. American Journal of Clinical Nutrition, 1997, Vol/Iss /Pg. 66/6 (1422-1427) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30232 |
Study title: Effect of iodized oil treatment on the development of thyroid autoimmunity in adolescent females. ; Hashim-F-A Annals of Saudi Medicine, 2000, Vol/Iss/Pg. 20/5-6 (445-446)Effect of iodized oil treatment on the development of thyroid autoimmunity in adolescent females. ; Hashim-F-A Annals of Saudi Medicine, 2000, Vol/Iss/Pg. 20/5-6 (445-446) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30233 |
Study title: Naumann R, Beuthien-Baumann B, Reiß A, Schulze J, Hänel A, Bredow J, et al.. Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma. [naumann-2004]BrJ Cancer. 2004 Feb 9;90(3):620-5. Naumann R 2004 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48682 |
Study title: Newberg A, Hassan A,. Cerebral metabolic changes associated with Lyme disease. [newberg-2002]Alavi A. Nucl Med Commun. 2002 Aug;23(8):773-7. Newberg A 2002 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48683 |
Study title: Ng SH, Chang JT, Chan SC, Ko SF, Wang HM, Liao CT, et al.. Epub 2004 Mar 9. Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. [ng-2004-a]Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1073-80. Ng SH 2004 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48684 |
Study title: Novak L, Emri M, Molnar P, Balkay L, Lengyel Z. Subcortical [18F]fluorodeoxyglucose uptake in lesional epilepsy in patients with intracranial tumour. [novak-2004]Tron L. Nucl Med Commun. 2004 Feb;25(2):123-8. Novak L 2004 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48685 |
Study title: Nuclear Medicine in Pediatric Neurology and Neurosurgery: Epilepsy and Brain Tumors.Semin Nucl Med 37:357-381. Shekhar Patil, MD,* Lorenzo Biassoni, MD,† and Lise Borgwardt, MD, PhD |
Active substance: Steripet |
Study summary document link (including results): patil-2007.pdf |
View full study record |
Document reference: 48741 |
Study title: O'Connell MT, Seal A, Nortje J, Al-Rawi PG, Coles JP, Fryer TD, et al.. Glucose metabolism in traumatic brain injury: a combined microdialysis and [18F]-2-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET) study. [oconnell-2005]Acta Neurochir Suppl. 2005;95:165-8. O'Connell MT 2005 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48686 |
Study title: Otsuka H, Graham MM, Kubo A, Nishitani H.. The effect of oral contrast on large bowel activity in FDG-PET/CT. [otsuka-2005]Ann Nucl Med. 2005 Apr;19(2):101- 8. Otsuka H 2005 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48687 |
Study title: Papathanassiou D, Becker S, Amir R, Menéroux B, Liehn JC.. Epub 2005 Aug 31. Respiratory motion artefact n the liver dome on FDG PET/CT: comparison of attenuation correction with CT and a caesium external source. [papathanassiou-2005]Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1422-8. Papathanassiou D 2005 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48688 |
Study title: PET and PET/CT in Pediatric Oncology.Semin Nucl Med 37:316-331. Hossein Jadvar, MD, PhD, MPH, MBA,* Leonard P. Connolly, MD,† Frederic H. Fahey, DSc,† and Barry L. Shulkin, MD, MBA‡ |
Active substance: Steripet |
Study summary document link (including results): jadvar-2007.pdf |
View full study record |
Document reference: 48732 |
Study title: PET in pediatric diseasesRadiol Clin N Am 43 (2005) 135 – 152 .Hossein Jadvar, MD, PhDa,b,*, Abass Alavi, MDc, Ayse Mavi, MDd, Barry L. Shulkin, MD, MBAe |
Active substance: Steripet |
Study summary document link (including results): jadvar-2005.pdf |
View full study record |
Document reference: 48731 |
Study title: Picardi M, De Renzo A, Pane F, Nicolai E, Pacelli R, Salvatore M, et al.. Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans. [picardi-2007]Leuk Lymphoma. 2007 Sep;48(9):1721-7. Picardi M 2007 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48689 |
Study title: Chicaud P, Demange J, Drouin P, Debry G. Action du fénofibrate chez des enfants hypercholestérolémiques. Recul de 18 mois. La Presse médicale 1984; 13:417-419Chicaud P, Demange J, Drouin P, Debry G. Action du fénofibrate chez des enfants hypercholestérolémiques. Recul de 18 mois. La Presse médicale 1984; 13:417-419 |
Active substance: FENOFIBRATE |
Study summary document link (including results): |
View full study record |
Document reference: 27028 |
Study title: Hamada S, Miyamura T, Okimura T, Yamamoto T, Nishiki M, Miyatani H, Kobayashi M, Tonami H, Takarada A, Yamagishi T, Higashi K, Chatani T. [A case of melorheostosis-correlation with sclerotome map and bone scan image (author's transl)] Rinsho Hoshasen. 1981 Aug 26;26(8):897-900. Japanese. No abstract available. Hamada S, Miyamura T, Okimura T, Yamamoto T, Nishiki M, Miyatani H, Kobayashi M, Tonami H, Takarada A, Yamagishi T, Higashi K, Chatani T. [A case of melorheostosis-correlation with sclerotome map and bone scan image (author's transl)] Rinsho Hoshasen. 1981 Aug 26;26(8):897-900. Japanese. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44113 |
Study title: Hamada S, Miyamura T, Okimura T, Yamamoto T, Nishiki M, Miyatani H, Kobayashi M, Tonami H, Takarada A, Yamagishi T, Higashi K, Chatani T. [A case of melorheostosis-correlation with sclerotome map and bone scan image (author's transl)] Rinsho Hoshasen. 1981 Aug 26;26(8):897-900. Japanese. No abstract available. Hamada S, Miyamura T, Okimura T, Yamamoto T, Nishiki M, Miyatani H, Kobayashi M, Tonami H, Takarada A, Yamagishi T, Higashi K, Chatani T. [A case of melorheostosis-correlation with sclerotome map and bone scan image (author's transl)] Rinsho Hoshasen. 1981 Aug 26;26(8):897-900. Japanese. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44190 |
Study title: Smith MA, Jones EA, Strachan RK, Nicoll JJ, Best JJ, Tothill P, Hughes SP. Prediction of fracture healing in the tibia by quantitative radionuclide imaging. J Bone Joint Surg Br. 1987 May;69(3):441-7. Smith MA, Jones EA, Strachan RK, Nicoll JJ, Best JJ, Tothill P, Hughes SP. Prediction of fracture healing in the tibia by quantitative radionuclide imaging. J Bone Joint Surg Br. 1987 May;69(3):441-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43863 |
Study title: So Y, Chung JK, Seong SC, Sohn YJ, Kang HS, Lee DS, Lee MC. Usefulness of 99Tcm-MDP knee SPET for pre-arthroscopic evaluation of patients with internal derangements of the knee. Nucl Med Commun. 2000 Jan;21(1):103-9. So Y, Chung JK, Seong SC, Sohn YJ, Kang HS, Lee DS, Lee MC. Usefulness of 99Tcm-MDP knee SPET for pre-arthroscopic evaluation of patients with internal derangements of the knee. Nucl Med Commun. 2000 Jan;21(1):103-9. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43490 |
Study title: Tc-99m MDP bone and Ga-67 citrate scintigraphy of Erdheim-Chester disease in a child. Sohn MH, Kim MW, Kang YH, Jeong HJ. Clin Nucl Med. 2006 Feb;31(2):90-2. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43379 |
Study title: Solav S. Bone scintiscanning in osteolytic lesions. Clin Nucl Med. 2004 Jan;29(1):12-20. Solav S. Bone scintiscanning in osteolytic lesions. Clin Nucl Med. 2004 Jan;29(1):12-20. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43407 |
Study title: Sommer HJ, Knop J, Heise U, Winkler K, Delling G. Histomorphometric changes of osteosarcoma after chemotherapy. Correlation with 99mTc methylene diphosphonate functional imaging. Cancer. 1987 Jan 15;59(2):252-8. Sommer HJ, Knop J, Heise U, Winkler K, Delling G. Histomorphometric changes of osteosarcoma after chemotherapy. Correlation with 99mTc methylene diphosphonate functional imaging. Cancer. 1987 Jan 15;59(2):252-8. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43876 |
Study title: Spencer JD, Maisey M. A prospective scintigraphic study of avascular necrosis of bone in renal transplant patients. Clin Orthop Relat Res. 1985 Apr;(194):125-35. Spencer JD, Maisey M. A prospective scintigraphic study of avascular necrosis of bone in renal transplant patients. Clin Orthop Relat Res. 1985 Apr;(194):125-35. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43948 |
Study title: Magill HL, Strang MS. Paraspinal metastasis of Wilm's tumor visualized on bone imaging. J Nucl Med. 1981 May;22(5):481-2. No abstract available. Magill HL, Strang MS. Paraspinal metastasis of Wilm's tumor visualized on bone imaging. J Nucl Med. 1981 May;22(5):481-2. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44126 |
Study title: Ultrasonic signs of pelvic osteomyelitis in children. Mah ET, LeQuesne GW, Gent RJ, Paterson DC. Pediatr Radiol. 1994;24(7):484-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43639 |
Study title: Mahan S, Jolles PR. MAI osteomyelitis. 18-year scintigraphic follow-up. Clin Nucl Med. 1995 Jul;20(7):594-8. Mahan S, Jolles PR. MAI osteomyelitis. 18-year scintigraphic follow-up. Clin Nucl Med. 1995 Jul;20(7):594-8. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43597 |
Study title: Maigne JY, Boulahdour H, Chatellier G. Value of quantitative radionuclide bone scanning in the diagnosis of sacroiliac joint syndrome in 32 patients with low back pain. Eur Spine J. 1998;7(4):328-31. Maigne JY, Boulahdour H, Chatellier G. Value of quantitative radionuclide bone scanning in the diagnosis of sacroiliac joint syndrome in 32 patients with low back pain. Eur Spine J. 1998;7(4):328-31. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43524 |
Study title: Malik MH. Simultaneous dual isotope studies in the diagnosis of infection. J Nucl Med. 1985 Jul;26(7):722-5. Malik MH. Simultaneous dual isotope studies in the diagnosis of infection. J Nucl Med. 1985 Jul;26(7):722-5. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43938 |
Study title: Malizos KN, Soucacos PN, Vragalas V, Dailiana ZH, Schina I, Fotopoulos A. Three phase bone scanning and digital arteriograms for monitoring vascularized fibular grafts in femoral head necrosis. Int Angiol. 1995 Sep;14(3):319-26. Malizos KN, Soucacos PN, Vragalas V, Dailiana ZH, Schina I, Fotopoulos A. Three phase bone scanning and digital arteriograms for monitoring vascularized fibular grafts in femoral head necrosis. Int Angiol. 1995 Sep;14(3):319-26. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43586 |
Study title: [Osteochondrosis deformans coxae juvenilis (Legg-Calvé-Perthes disease) in the MR tomogram: diagnosis and follow-up assessment correlated with x-rays and skeletal scintigraphy] Ranner G. Rofo. 1990 Aug;153(2):124-30. German. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43757 |
Study title: Scintigraphic differentiation of bone infarction from osteomyelitis in children with sickle cell disease. Rao S, Solomon N, Miller S, Dunn E. J Pediatr. 1985 Nov;107(5):685-8. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43929 |
Study title: Raymond J, Dumas JM, Lisbona R. Nuclear imaging as a screening test for patients referred for intraarticular facet block. J Can Assoc Radiol. 1984 Sep;35(3):291-2. Raymond J, Dumas JM, Lisbona R. Nuclear imaging as a screening test for patients referred for intraarticular facet block. J Can Assoc Radiol. 1984 Sep;35(3):291-2. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43984 |
Study title: Reddy MS, Palcanis KG, Barnett ML, Haigh S, Charles CH, Jeffcoat MK. Efficacy of meclofenamate sodium (Meclomen) in the treatment of rapidly progressive periodontitis. J Clin Periodontol. 1993 Oct;20(9):635-40. Reddy MS, Palcanis KG, Barnett ML, Haigh S, Charles CH, Jeffcoat MK. Efficacy of meclofenamate sodium (Meclomen) in the treatment of rapidly progressive periodontitis. J Clin Periodontol. 1993 Oct;20(9):635-40. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43649 |
Study title: [Metastatic calcifications detected by Tc-99m MDP bone scanning in patients with hypercalcemia: case report] Japanese. Sugita R, Nakamura M, Sakamoto K, Watabe N. Rinsho Hoshasen. 1990 Mar;35(3):419-22. Japanese. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43766 |
Study title: Sun SS, Tsai SC, Su CC, Kao CH. Diffuse liver and spleen accumulation on Tc-99m methylene diphosphonate bone scan. Semin Nucl Med. 2001 Jul;31(3):253-4. No abstract available. Sun SS, Tsai SC, Su CC, Kao CH. Diffuse liver and spleen accumulation on Tc-99m methylene diphosphonate bone scan. Semin Nucl Med. 2001 Jul;31(3):253-4. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43451 |
Study title: Sundram FX, Chua ET, Goh AS, Toh HJ, Khor TH, Chua EJ. Bone scintigraphy in nasopharyngeal carcinoma. Clin Radiol. 1990 Sep;42(3):166-9. Sundram FX, Chua ET, Goh AS, Toh HJ, Khor TH, Chua EJ. Bone scintigraphy in nasopharyngeal carcinoma. Clin Radiol. 1990 Sep;42(3):166-9. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43755 |
Study title: Sternal uptake on bone scintigraphy: age-related variants. Syed GM, Fielding HW, Collier BD. Nucl Med Commun. 2005 Mar;26(3):253-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43390 |
Study title: Sziklas JJ, Vento JA, Spencer RP, Rosenberg RJ. Radiogallium accumulation in heterotopic bone. Clin Nucl Med. 1985 May;10(5):376. No abstract available. Sziklas JJ, Vento JA, Spencer RP, Rosenberg RJ. Radiogallium accumulation in heterotopic bone. Clin Nucl Med. 1985 May;10(5):376. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43945 |
Study title: Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74. Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44228 |
Study title: Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74. Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44275 |
Study title: Kroiss A, Böck F, Perneczky G, Auinger C, Weidlich G, Kleinpeter G, Brenner H. [Immunoscintigraphy for the detection of inflammation foci in bone and joint diseases] Wien Klin Wochenschr. 1990 Dec 21;102(24):713-7. German. Kroiss A, Böck F, Perneczky G, Auinger C, Weidlich G, Kleinpeter G, Brenner H. [Immunoscintigraphy for the detection of inflammation foci in bone and joint diseases] Wien Klin Wochenschr. 1990 Dec 21;102(24):713-7. German. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43751 |
Study title: Prolonged low-back pain in young athletes: a prospective case series study of findings and prognosis. Kujala UM, Kinnunen J, Helenius P, Orava S, Taavitsainen M, Karaharju E. Eur Spine J. 1999;8(6):480-4. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43496 |
Study title: A randomized, double-blind, double dummy, parallel group comparison of fluticasone propionate inhalation powder (50mcg BID) via DiskusTM with oral montelukast (5mg QD) chewable tablets in children 6–12 years of age with persistent asthma |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FPD40013-ICHE3.pdf |
View full study record |
Document reference: 28428 |
Study title: A Randomized, Double-Blind, Double-Dummy, Parallel-Group Trial Assessing the Efficacy and Safety of Fluticasone Propionate 50 or 100mcg BID via the Multi-Dose Powder Inhaler, Fluticasone Propionate 50 or 100mcg BID via the Diskhaler and Placebo in Subjects Aged 4 to 11 Years with Chronic Asthma |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLTA2006-ICHE3.pdf |
View full study record |
Document reference: 28423 |
Study title: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, 12-Week Trial of Inhaled Fluticasone Propionate 88mcg BID versus Placebo in Propellant GR106642X in Pediatric Subjects 4 to 11 Years of Age With Asthma |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FAP30010-ICHE3.pdf |
View full study record |
Document reference: 28391 |
Study title: A randomized, double-blind, placebo-controlled study examining the effect of fluticasone propionate aqueous nasal spray in antibiotic therapy in the treatment of chronic rhinosinusitis in paediatric patients. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FNS30003-ICHE3.pdf |
View full study record |
Document reference: 28368 |
Study title: A Randomized, Open-Label, 2-Way Crossover, Repeat-Dose Study in Pediatric Subjects with Asthma, Age 4-11 Years, to Compare Systemic Exposure of Fluticasone Propionate 2x44mcg Following Administration by Metered-Dose Inhalers Containing Hydrofluoroalkane or Chlorofluorocarbon Propellants |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FAP10006-ICHE3.pdf |
View full study record |
Document reference: 28417 |
Study title: A Randomized, Open-Label, 2-Way Crossover, Repeat-Dose Study in Pediatric Subjects with Asthma, Age 4-11 Years, to Compare Systemic Exposure of Fluticasone Propionate 2x44mcg Following Administration by Metered-Dose Inhalers Containing Hydrofluoroalkane or Chlorofluorocarbon Propellants |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FAP10006-ICHE3.pdf |
View full study record |
Document reference: 28441 |
Study title: A single centre, randomised, double blind, cross over study to investigate longitudinal growth using knemometry in children with seasonal and perennial rhinitis during treatment with fluticasone propionate aqueous nasal spray (FPANS) 100mcg/day and placebo. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FNM40181-ICHE3.pdf |
View full study record |
Document reference: 28415 |
Study title: A Study to Determine the Systemic Activity of a Single Dose of Fluticasone Propionate via the Diskus in Asthmatic Children Inhaling at Different Inspiratory Flows |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLTB4009-ICHE3.pdf |
View full study record |
Document reference: 28382 |
Study title: Comparison of fluticasone powder 1mg/day to budesonide powder 1mg/day in deterioration of severe asthma in children: a double-blind, randomised, multicentre study with parallel groups. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone -Propionate-FLPB0145-ICHE3.pdf |
View full study record |
Document reference: 28404 |
Study title: "Calello DP, Osterhoudt KC, Henretig FM.New and novel antidotes in pediatrics.Pediatr Emerg Care. 2006 Jul;22(7):523-30. Review. Erratum in: Pediatr Emerg Care. 2007 Feb;23(2):82. " "Calello DP, Osterhoudt KC, Henretig FM.New and novel antidotes in pediatrics.Pediatr Emerg Care. 2006 Jul;22(7):523-30. Review. Erratum in: Pediatr Emerg Care. 2007 Feb;23(2):82. " |
Active substance: FOMEPIZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28466 |
Study title: "Caravati EM, Heileson HL, Jones M. Treatment of severe pediatric ethylene glycol intoxication without hemodialysis. J Toxicol Clin Toxicol. 2004;42(3):255-9. " "Caravati EM, Heileson HL, Jones M. Treatment of severe pediatric ethylene glycol intoxication without hemodialysis. J Toxicol Clin Toxicol. 2004;42(3):255-9. " |
Active substance: FOMEPIZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28469 |
Study title: "Casavant MJ. Fomepizole in the treatment of poisoning. Pediatrics. 2001 Jan;107(1):170. " "Casavant MJ. Fomepizole in the treatment of poisoning. Pediatrics. 2001 Jan;107(1):170. " |
Active substance: FOMEPIZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28472 |
Study title: Pan MH, Wu YW, Yen RF, Tzen KY, Liao SL, Kao CH. Different fibrovascularization rate between coralline hydroxyapatite and high density porous polyethylene (Medpore) measured by 99mTc-MDP bone scintigraphy 6 months after intraorbital implantation. Nucl Med Commun. 2003 Dec;24(12):1237-41. Pan MH, Wu YW, Yen RF, Tzen KY, Liao SL, Kao CH. Different fibrovascularization rate between coralline hydroxyapatite and high density porous polyethylene (Medpore) measured by 99mTc-MDP bone scintigraphy 6 months after intraorbital implantation. Nucl Med Commun. 2003 Dec;24(12):1237-41. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44245 |
Study title: Panoutsopoulos G, Ilias I, Parcharidou A, Christakopoulou I. [Intense uptake of 99mTc-MDP in primary abdominal neuroblastoma] Rev Esp Med Nucl. 2002 Jul;21(4):294-5. Spanish. No abstract available. Panoutsopoulos G, Ilias I, Parcharidou A, Christakopoulou I. [Intense uptake of 99mTc-MDP in primary abdominal neuroblastoma] Rev Esp Med Nucl. 2002 Jul;21(4):294-5. Spanish. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43437 |
Study title: Ibis E, Erbay G, Aras G, Isitman AT, Krasnow AZ, Collier BD. Three-phase bone scintigraphy in Maffucci's syndrome. Clin Nucl Med. 1992 Jun;17(6):505-6. No abstract available. Ibis E, Erbay G, Aras G, Isitman AT, Krasnow AZ, Collier BD. Three-phase bone scintigraphy in Maffucci's syndrome. Clin Nucl Med. 1992 Jun;17(6):505-6. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43696 |
Study title: ICRP (lnternation Commission on Radiological Protection). Publication 53: Radiation dose to patients from radiopharmaceuticals.ICRP (lnternation Commission on Radiological Protection). Publication 53: Radiation dose to patients from radiopharmaceuticals. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 47920 |
Study title: ICRP Publication 80: Radiation dose to patients from radiopharmaceuticals (Addendum to ICRP Publication 53)..ICRP Publication 80: Radiation dose to patients from radiopharmaceuticals (Addendum to ICRP Publication 53).. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 47921 |
Study title: Ikawa G, dos Santos PA, Yamaguchi KT, Stroh-Recor C, Ibello R. Frostbite and bone scanning: the use of 99m-labeled phosphates in demarcating the line of viability in frostbite victims. Orthopedics. 1986 Sep;9(9):1257-61. Ikawa G, dos Santos PA, Yamaguchi KT, Stroh-Recor C, Ibello R. Frostbite and bone scanning: the use of 99m-labeled phosphates in demarcating the line of viability in frostbite victims. Orthopedics. 1986 Sep;9(9):1257-61. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43897 |
Study title: A follow-up study using iodine-131 metaiodobenzylguanidine imaging in a patient with neuroblastoma. Ikekubo K, Habuchi Y, Jeong S, Yamaguchi H, Saiki Y, Ito H, Hino M, Higa T. Clin Nucl Med. 1986 Nov;11(11):777-80. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43888 |
Study title: Findings on magnetic resonance imaging of the spine and femur in a case of McCune-Albright syndrome. Inamo Y, Hanawa Y, Kin H, Okuni M. Pediatr Radiol. 1993;23(1):15-8. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43674 |
Study title: Efficacy of Ambroxol (Surbronc) in acute respiratory exacerbation in cystic fibrosis. |
Active substance: AMBROXOL |
Study summary document link (including results): Ambroxol Hydrochloride_U92-0170_Synopsis.pdf |
View full study record |
Document reference: 46548 |
Study title: Miraglia del Giudice et al On the use of an extemporary combination of ambroxol and beclometasone dipropionate by aerosol in childhood allergic asthma. Comparative measurements. Riv.Pat.Clin.Tuberc.Pneumol.1985,56,37-48RivPatClinTub Pneumol 1985, Miraglia del Giudice. RivPatClinTub Pneumol 1985, Miraglia del Giudice |
Active substance: AMBROXOL |
Study summary document link (including results): RivPatClinTub Pneumol 1985, Miraglia del Giudice.pdf |
View full study record |
Document reference: 48875 |
Study title: Reinert S, Widlitzek H, Venderink DJ. The value of magnetic resonance imaging in the diagnosis of mandibular osteomyelitis. Br J Oral Maxillofac Surg. 1999 Dec;37(6):459-63. Reinert S, Widlitzek H, Venderink DJ. The value of magnetic resonance imaging in the diagnosis of mandibular osteomyelitis. Br J Oral Maxillofac Surg. 1999 Dec;37(6):459-63. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43493 |
Study title: Rencus T, Smith J, Munn S, Elgazzar A. Displaced uterus simulating aneurysm on a multiphase bone scan. Clin Nucl Med. 2003 Jul;28(7):574-6. No abstract available. Rencus T, Smith J, Munn S, Elgazzar A. Displaced uterus simulating aneurysm on a multiphase bone scan. Clin Nucl Med. 2003 Jul;28(7):574-6. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43418 |
Study title: Rhoad RC, Davidson RS, Heyman S, Dormans JP, Drummond DS. Pretreatment bone scan in SCFE: a predictor of ischemia and avascular necrosis. J Pediatr Orthop. 1999 Mar-Apr;19(2):164-8. Rhoad RC, Davidson RS, Heyman S, Dormans JP, Drummond DS. Pretreatment bone scan in SCFE: a predictor of ischemia and avascular necrosis. J Pediatr Orthop. 1999 Mar-Apr;19(2):164-8. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43511 |
Study title: Riebel T, Knop J, Winkler K, Delling G. [Comparative x-ray and nuclear medical studies of osteosarcomas to evaluate the effectiveness of preoperative chemotherapy] Rofo. 1986 Oct;145(4):365-72. German. Riebel T, Knop J, Winkler K, Delling G. [Comparative x-ray and nuclear medical studies of osteosarcomas to evaluate the effectiveness of preoperative chemotherapy] Rofo. 1986 Oct;145(4):365-72. German. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43891 |
Study title: Quantitative sacroiliac joint scintigraphy in normal subjects and patients with sacroiliitis. Kaçar G, Kaçar C, Karayalçin B, Güngör F, Tuncer T, Erkiliç M. Ann Nucl Med. 1998 Jun;12(3):169-73. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43530 |
Study title: Imaging of McCune-Albright syndrome using bone single photon emission computed tomography. Kairemo KJ, Verho S, Dunkel L. Eur J Pediatr. 1999 Feb;158(2):123-6. Review. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43513 |
Study title: Specific or superfluous? Doubtful clinical value of granulocyte scintigraphy in osteomyelitis in children. Kaiser S, Jacobsson H, Hirsch G. J Pediatr Orthop B. 2001 Apr;10(2):109-12. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43453 |
Study title: Early detection of subperiosteal abscesses by ultrasonography. A means for further successful treatment in pediatric osteomyelitis. Kaiser S, Rosenborg M. Pediatr Radiol. 1994;24(5):336-9. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43641 |
Study title: Estimate plasma peak concentrations of ampicillin obtained after rectal administration of single doses of ampicillin suppositories given to children.Movin et al. (1987-06-15) |
Active substance: AMPICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_25.xlsx |
View full study record |
Document reference: 49024 |
Study title: Evaluate the safety of ampicillin suppositories with special emphasis on local intolerance reactions in pediatric patients. The secondary objective was to evaluate the short term efficiacy in the treatment of acute otitis media. The study was comparative against amoxycillin suspension.Bagger-Sjöbäck et al. (1986-11-28) |
Active substance: AMPICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_19.xlsx |
View full study record |
Document reference: 49018 |
Study title: Investigate the rapidity of change in excretion rate of Ampicillin and Methicillin in the days after birth and demonstrate the effect of premature birth upon the excretion rates.Boe et al. (Pediatrics, vol. 39, no. 2, Feb 1967) |
Active substance: AMPICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_8.xlsx |
View full study record |
Document reference: 49001 |
Study title: The role of bone scintigraphy in osteogenic sarcoma. Rees CR, Siddiqui AR, duCret R. Skeletal Radiol. 1986;15(5):365-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43924 |
Study title: Progressive diaphyseal dysplasia (Engelmann disease(: scintigraphic-radiographic-clinical correlations. Kumar B, Murphy WA, Whyte MP. Radiology. 1981 Jul;140(1):87-92. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44121 |
Study title: Multifocal non-Hodgkin lymphoma in an infant with cardiac involvement: whole-body MR imaging. Kumar J, Seith A, Bakhshi S, Sharma R, Kumar A. Pediatr Radiol. 2007 Mar;37(3):321-4. Epub 2007 Jan 30. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43367 |
Study title: Kumar R, Balachandran S. Unilateral septic sacro-iliitis. Importance of the anterior view of the bone scan. Clin Nucl Med. 1983 Sep;8(9):413-5. Kumar R, Balachandran S. Unilateral septic sacro-iliitis. Importance of the anterior view of the bone scan. Clin Nucl Med. 1983 Sep;8(9):413-5. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44031 |
Study title: Kumar R, Dilip S, Padhy AK, Malhotra R, Malhotra A, Machineni S, Sharma R. Three-phase bone imaging in the early diagnosis of osteochondritis dissecans of the patella. Clin Nucl Med. 1998 Aug;23(8):540-1. No abstract available. Kumar R, Dilip S, Padhy AK, Malhotra R, Malhotra A, Machineni S, Sharma R. Three-phase bone imaging in the early diagnosis of osteochondritis dissecans of the patella. Clin Nucl Med. 1998 Aug;23(8):540-1. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43528 |
Study title: Nielsen PT, Hedeboe J, Thommesen P. Bone scintigraphy in the evaluation of fracture of the carpal scaphoid bone. Acta Orthop Scand. 1983 Apr;54(2):303-6. Nielsen PT, Hedeboe J, Thommesen P. Bone scintigraphy in the evaluation of fracture of the carpal scaphoid bone. Acta Orthop Scand. 1983 Apr;54(2):303-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44042 |
Study title: Nishiyama Y, Yamamoto Y, Toyama Y, Satoh K, Ohkawa M, Tanabe M. Diagnostic value of TI-201 and three-phase bone scintigraphy for bone and soft-tissue tumors. Clin Nucl Med. 2000 Mar;25(3):200-5. Nishiyama Y, Yamamoto Y, Toyama Y, Satoh K, Ohkawa M, Tanabe M. Diagnostic value of TI-201 and three-phase bone scintigraphy for bone and soft-tissue tumors. Clin Nucl Med. 2000 Mar;25(3):200-5. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43491 |
Study title: Nishiyama Y, Yamamoto Y, Yokoe K, Kawaguchi Y, Toyama Y, Satoh K, Ohkawa M. A comparative study of 201Tl scintigraphy and three-phase bone scintigraphy following therapy in patients with bone and soft-tissue tumors. Ann Nucl Med. 2004 May;18(3):235-41. Nishiyama Y, Yamamoto Y, Yokoe K, Kawaguchi Y, Toyama Y, Satoh K, Ohkawa M. A comparative study of 201Tl scintigraphy and three-phase bone scintigraphy following therapy in patients with bone and soft-tissue tumors. Ann Nucl Med. 2004 May;18(3):235-41. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43402 |
Study title: Noel AW, Heyman S. Scintigraphic findings in infantile hemangioendothelioma. Clin Nucl Med. 1986 Jun;11(6):413-6. Noel AW, Heyman S. Scintigraphic findings in infantile hemangioendothelioma. Clin Nucl Med. 1986 Jun;11(6):413-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43908 |
Study title: Normal anatomic variant: scintigraphy of the ischiopubic synchondrosis. Cawley KA, Dvorak AD. Wilmot MD. Nucl Med 1983 Jan;24{1):14-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48468 |
Study title: Isotope scanning with Tc99m-MDP of the spine and the costosternal junctions of patients with idiopathic scoliosis. Normelli H, Lewander R. Acta Radiol Diagn (Stockh). 1985 Jul-Aug;26(4):397-401. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43936 |
Study title: "De Brabander N, Wojciechowski M, De Decker K, De Weerdt A, Jorens PG. Fomepizole as a therapeutic strategy in paediatric methanol poisoning. A case report and review of the literature. Eur J Pediatr. 2005 Mar;164(3):158-61. Epub 2004 Dec 1. Review. " "De Brabander N, Wojciechowski M, De Decker K, De Weerdt A, Jorens PG. Fomepizole as a therapeutic strategy in paediatric methanol poisoning. A case report and review of the literature. Eur J Pediatr. 2005 Mar;164(3):158-61. Epub 2004 Dec 1. Review. " |
Active substance: FOMEPIZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28468 |
Study title: "Harry P, Jobard E, Briand M, Caubet A, Turcant A. Ethylene glycol poisoning in a child treated with 4-methylpyrazole. Pediatrics. 1998 Sep;102(3):E31. " "Harry P, Jobard E, Briand M, Caubet A, Turcant A. Ethylene glycol poisoning in a child treated with 4-methylpyrazole. Pediatrics. 1998 Sep;102(3):E31. " |
Active substance: FOMEPIZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28475 |
Study title: "Shannon M. Toxicology reviews: fomepizole--a new antidote. Pediatr Emerg Care. 1998 Apr;14(2):170-2. " "Shannon M. Toxicology reviews: fomepizole--a new antidote. Pediatr Emerg Care. 1998 Apr;14(2):170-2. " |
Active substance: FOMEPIZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28476 |
Study title: "Tenenbein M. Recent advancements in pediatric toxicology. Pediatr Clin North Am. 1999 Dec;46(6):1179-88, vii. Review. " "Tenenbein M. Recent advancements in pediatric toxicology. Pediatr Clin North Am. 1999 Dec;46(6):1179-88, vii. Review. " |
Active substance: FOMEPIZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28473 |
Study title: "Wiley JF 2nd. Novel therapies for ethylene glycol intoxication. Curr Opin Pediatr. 1999 Jun;11(3):269-73. Review. " "Wiley JF 2nd. Novel therapies for ethylene glycol intoxication. Curr Opin Pediatr. 1999 Jun;11(3):269-73. Review. " |
Active substance: FOMEPIZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28474 |
Study title: A 12 month multi-center, randomized, dbdd trial to examine the long-term tolerability of formoterol 1mg via the mddpi, both as b.i.d maintenance therapy and as on-demand-use on top of maintenane, in patients with persistent asthma. |
Active substance: FORMOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 47791 |
Study title: A 12 week randomized, double-blind, double-dummy, placebo controlled, parallel group study in adolescents and adults with persistent asthma comparing the safety and efficacy of two doses of formoterol fumarate b.i.d. administered from the multi-dose powder |
Active substance: FORMOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 47792 |
Study title: A 12-month comparison of Oxis® (formoterol) Turbuhaler® and Bricanyl® (terbutaline)Turbuhaler both used as needed in subjects with asthma not using anti-inflammatory treatment |
Active substance: FORMOTEROL |
Study summary document link (including results): SD-037-0716 Study Synopsis.pdf |
View full study record |
Document reference: 47793 |
Study title: A 12-month comparison of Oxis® (formoterol) Turbuhaler® and Bricanyl®(terbutaline) Turbuhaler® both used as needed in patients with asthma on anti-inflammatory treatment |
Active substance: FORMOTEROL |
Study summary document link (including results): SD-037-0714 Study Synopsis.pdf |
View full study record |
Document reference: 47794 |
Study title: A 12-week randomized, multicenter, double-blind, double-dummy, placebo and active controlled, parallel group study evaluating the safety and efficacy of Formoterol fumarate (10 µg b.i.d.) delivered by the multi-dose dry powder inhaler (MDDPI) versus place |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258F2302 Art45 listing 2011.xls |
View full study record |
Document reference: 47795 |
Study title: A 12-week randomized, multicenter, double-blind, double-dummy, placebo and active controlled, parallel group study evaluating the safety, efficacy, and pharmacokinetics of Foradil (formoterol fumarate) (10 mg bid) delivered by the multi-dose dry powder in |
Active substance: FORMOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 47796 |
Study title: Effects on the respiratory tract and male reproductive organs in young rats given formoterol fumarate (D2522) in lactose by the inhalation route for 3 months |
Active substance: FORMOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 47838 |
Study title: Efficacy and safety of budesonide/formoterol Turbuhaler in a fixed combination in steroid-using asthmatic children – COMIC. |
Active substance: FORMOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 47839 |
Study title: Efficacy and tolerability of four single doses of formoterol Turbuhaler compared to salmeterol Diskhaler 50μg and placebo in children with bronchial asthma. |
Active substance: FORMOTEROL |
Study summary document link (including results): SD-037-0002 Study Synopsis.pdf |
View full study record |
Document reference: 47840 |
Study title: Intenzo C, Kim S, Millin J, Park C. Scintigraphic patterns of the reflex sympathetic dystrophy syndrome of the lower extremities. Clin Nucl Med. 1989 Sep;14(9):657-61. Intenzo C, Kim S, Millin J, Park C. Scintigraphic patterns of the reflex sympathetic dystrophy syndrome of the lower extremities. Clin Nucl Med. 1989 Sep;14(9):657-61. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43780 |
Study title: Ishibashi K, Miyamae T. [Classification of bone scintigrams in hemodialysis patients] Kaku Igaku. 1985 Mar;22(3):367-76. Japanese. No abstract available. Ishibashi K, Miyamae T. [Classification of bone scintigrams in hemodialysis patients] Kaku Igaku. 1985 Mar;22(3):367-76. Japanese. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43952 |
Study title: Septic arthritis of a lumbar facet joint due to pyonex. Ishibe M, Inoue M, Saitou K. Arch Orthop Trauma Surg. 2001;121(1-2):90-2. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43464 |
Study title: Isotope bone scanning for acute osteomyelitis and septic arthritis in children. Tuson CE, Hoffman EB, Mann MD. J Bone Joint Surg Br. 1994 Mar;76(2):306-10. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43633 |
Study title: Uterine blush mimicking a hypervascular tumour in the pelvis as demonstrated by a triple-phase bone scan. Tzen KY, Yen TC. Nucl Med Commun. 1998 Jun;19(6):605-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43509 |
Study title: Uno K, Uchida Y, Sakata S, Minoshima S, Okada J, Yoshikawa K, Arimizu N, Karikomi M, Kitakata Y, Suzuki Y. [Visualization of the female breast in bone scintigraphy] Kaku Igaku. 1992 Oct;29(10):1201-6. Japanese. Uno K, Uchida Y, Sakata S, Minoshima S, Okada J, Yoshikawa K, Arimizu N, Karikomi M, Kitakata Y, Suzuki Y. [Visualization of the female breast in bone scintigraphy] Kaku Igaku. 1992 Oct;29(10):1201-6. Japanese. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43685 |
Study title: Uren RF, Howman-Giles R. The 'cold hip' sign on bone scan. A retrospective review. Clin Nucl Med. 1991 Aug;16(8):553-6. PMID: 1934806 [PubMed - indexed for MEDLINE] 372: Caner BE, Ercan MT, Bekdik CF, Varoğlu E, Müezzinoğlu S, Duman Y, Erbengi GF. Visualization of bone pathologies and lung cancer with 99mTc-glucose phosphate: a comparative study. Nuklearmedizin. 1991 Aug;30(4):132-6. Uren RF, Howman-Giles R. The 'cold hip' sign on bone scan. A retrospective review. Clin Nucl Med. 1991 Aug;16(8):553-6. PMID: 1934806 [PubMed - indexed for MEDLINE] 372: Caner BE, Ercan MT, Bekdik CF, Varoğlu E, Müezzinoğlu S, Duman Y, Erbengi GF. Visualization of bone pathologies and lung cancer with 99mTc-glucose phosphate: a comparative study. Nuklearmedizin. 1991 Aug;30(4):132-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43732 |
Study title: Uren RF, Howman-Giles R. The 'cold hip' sign on bone scan. A retrospective review. Clin Nucl Med. 1991 Aug;16(8):553-6. PMID: 1934806 [PubMed - indexed for MEDLINE] 372: Caner BE, Ercan MT, Bekdik CF, Varoğlu E, Müezzinoğlu S, Duman Y, Erbengi GF. Visualization of bone pathologies and lung cancer with 99mTc-glucose phosphate: a comparative study. Nuklearmedizin. 1991 Aug;30(4):132-6. Uren RF, Howman-Giles R. The 'cold hip' sign on bone scan. A retrospective review. Clin Nucl Med. 1991 Aug;16(8):553-6. PMID: 1934806 [PubMed - indexed for MEDLINE] 372: Caner BE, Ercan MT, Bekdik CF, Varoğlu E, Müezzinoğlu S, Duman Y, Erbengi GF. Visualization of bone pathologies and lung cancer with 99mTc-glucose phosphate: a comparative study. Nuklearmedizin. 1991 Aug;30(4):132-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44173 |
Study title: Assessment of growth activity in the mandibular condyles by single-photon emission computed tomography (SPECT). Kajan ZD, Motevasseli S, Nasab NK, Ghanepour H, Abbaspur F. Aust Orthod J. 2006 Nov;22(2):127-30. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43368 |
Study title: Age-related normal variants of sternal uptake on bone scintigraphy.Kakhki VD, Zakavi SR. Clin Nucl Med. 2006 Feb;31(2):63-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43380 |
Study title: Kaneda K, Kurakami C, Minami A. Free vascularized fibular strut graft in the treatment of kyphosis. Spine. 1988 Nov;13(11):1273-7. Kaneda K, Kurakami C, Minami A. Free vascularized fibular strut graft in the treatment of kyphosis. Spine. 1988 Nov;13(11):1273-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43804 |
Study title: Kantarjian HM, Bledin AG, Kim EE, Gutierrez CR, Haynie TP. Uptake of 99mTc-methylene disphosphonate in calcinosis cutis. J Am Acad Dermatol. 1982 Dec;7(6):804-6. No abstract available. Kantarjian HM, Bledin AG, Kim EE, Gutierrez CR, Haynie TP. Uptake of 99mTc-methylene disphosphonate in calcinosis cutis. J Am Acad Dermatol. 1982 Dec;7(6):804-6. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44065 |
Study title: Kao PF, Tzen KY, Chang LY, You DL, Yang JY. 99Tcm-MDP scintigraphy in high-voltage electrical burn patients. Nucl Med Commun. 1997 Sep;18(9):846-52. Erratum in: Nucl Med Commun 1998 Jan;19(1):90. Kao PF, Tzen KY, Chang LY, You DL, Yang JY. 99Tcm-MDP scintigraphy in high-voltage electrical burn patients. Nucl Med Commun. 1997 Sep;18(9):846-52. Erratum in: Nucl Med Commun 1998 Jan;19(1):90. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43541 |
Study title: Safety and Immunogenicity of Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis (TdcP) Vaccine Compared to Tetanus and Diphtheria Toxoids Adsorbed (Td) in Adolescents and Adults 11-64 Years of Age |
Active substance: purif tetan toxoid,purif dipht toxoid,purif pert toxoid,purif filamentous haemaggl,purif fimbriae (agglutinogens 2 & 3),purif pertactin (69kda membrane protein)-inact polio vacc |
Study summary document link (including results): |
View full study record |
Document reference: 41432 |
Study title: Safety of four acellular pertussis combination vaccines (Infantrix-IPV, Boostrix, Covaxis and repevax) given a booster dose to six-year-old Finnish children |
Active substance: purif tetan toxoid,purif dipht toxoid,purif pert toxoid,purif filamentous haemaggl,purif fimbriae (agglutinogens 2 & 3),purif pertactin (69kda membrane protein)-inact polio vacc |
Study summary document link (including results): |
View full study record |
Document reference: 41433 |
Study title: Double blind, controlled trial testing the immunogenicity and side effects of parenteral Vi polysaccharide typhoid vaccine in Indonesian children and adults |
Active substance: Purified Vi capsular polysaccharide of Salmonella typhi (Ty2 strain) |
Study summary document link (including results): |
View full study record |
Document reference: 21216 |
Study title: Effectiveness of a Vi capsular polysaccharide vaccine |
Active substance: Purified Vi capsular polysaccharide of Salmonella typhi (Ty2 strain) |
Study summary document link (including results): |
View full study record |
Document reference: 41448 |
Study title: Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi |
Active substance: Purified Vi capsular polysaccharide of Salmonella typhi (Ty2 strain) |
Study summary document link (including results): |
View full study record |
Document reference: 41447 |
Study title: Safety and immunogenicity of Vi CPS vaccine in teenagers |
Active substance: Purified Vi capsular polysaccharide of Salmonella typhi (Ty2 strain) |
Study summary document link (including results): |
View full study record |
Document reference: 21215 |
Study title: ANTHELMINTIC EFFICACY OF PYRANTEL PAMOATE VS. MEBENDAZOLE IN PATIENTS WITH ASCARIASIS. |
Active substance: PYRANTEL PAMOATE |
Study summary document link (including results): PRT-II-84-001-002-003 EMA Paediatrics Web Synopsis.pdf |
View full study record |
Document reference: 46148 |
Study title: EFFICACY AND SAFETY OF OXANTEL-PYRANTEL PAMOATE TAB. AGAINST MULTIPLE INTESTINAL HELNINTHIC/NEMATODE INFECTIONS WITH TRICHURIS TRICHURIA. |
Active substance: PYRANTEL PAMOATE |
Study summary document link (including results): |
View full study record |
Document reference: 46146 |
Study title: EFFICACY AND SAFETY OF OXANTEL/PYRANTEL PAMOATE TABLET AGAINST MULTIPLE INTESTINAL HELMINTHIC/NEMATODE INFECTIONS WITH TRICHURIS TRICHURIA. |
Active substance: PYRANTEL PAMOATE |
Study summary document link (including results): |
View full study record |
Document reference: 46145 |
Study title: Fibrodysplasia ossificans progressiva: case report. Nucci A, Queiroz LD, Santos AD, Camargo EE, Moura-Ribeiro MV. Arq Neuropsiquiatr. 2000 Jun;58(2A):342-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43482 |
Study title: Bone stress lesions in ballet dancers: scintigraphic assessment. Nussbaum AR, Treves ST, Micheli L. AJR Am J Roentgenol. 1988 Apr;150(4):851-5. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43821 |
Study title: Nuti R, Vattimo A, Turchetti V, Righi G. 25-Hydroxycholecalciferol as an antagonist of adverse corticosteroid effects on phosphate and calcium metabolism in man. J Endocrinol Invest. 1984 Oct;7(5):445-8. Nuti R, Vattimo A, Turchetti V, Righi G. 25-Hydroxycholecalciferol as an antagonist of adverse corticosteroid effects on phosphate and calcium metabolism in man. J Endocrinol Invest. 1984 Oct;7(5):445-8. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43980 |
Study title: O'Duffy EK, Clunie GP, Gacinovic S, Edwards JC, Bomanji JB, Ell PJ. Foot pain: specific indications for scintigraphy. Br J Rheumatol. 1998 Apr;37(4):442-7. O'Duffy EK, Clunie GP, Gacinovic S, Edwards JC, Bomanji JB, Ell PJ. Foot pain: specific indications for scintigraphy. Br J Rheumatol. 1998 Apr;37(4):442-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43533 |
Study title: Herndon WA, Alexieva BT, Schwindt ML, Scott KN, Shaffer WO. Nuclear imaging for musculoskeletal infections in children. J Pediatr Orthop. 1985 May-Jun;5(3):343-7. Herndon WA, Alexieva BT, Schwindt ML, Scott KN, Shaffer WO. Nuclear imaging for musculoskeletal infections in children. J Pediatr Orthop. 1985 May-Jun;5(3):343-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43946 |
Study title: Herrera M, Silverman ED, Cole RL. Hepatic abscess detected on a three-phase bone scan. Clin Nucl Med. 2002 Apr;27(4):307-8. No abstract available. Herrera M, Silverman ED, Cole RL. Hepatic abscess detected on a three-phase bone scan. Clin Nucl Med. 2002 Apr;27(4):307-8. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43449 |
Study title: Hersek N, Canay S, Caner B, Ulutuncel N. Bone SPECT imaging of patients with internal derangement of temporomandibular joint before and after splint therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Nov;94(5):576-80. Hersek N, Canay S, Caner B, Ulutuncel N. Bone SPECT imaging of patients with internal derangement of temporomandibular joint before and after splint therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Nov;94(5):576-80. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43431 |
Study title: Hervás Benito I, González Cabezas P, Saura Quiles A, Pérez Velasco R, Bello Arques P, Mateo Navarro A. [Visualization of pulmonary metastasis of osteosarcoma with 99mTc-HMDP] Rev Esp Med Nucl. 2001 Dec;20(7):558-9. Spanish. No abstract available. Hervás Benito I, González Cabezas P, Saura Quiles A, Pérez Velasco R, Bello Arques P, Mateo Navarro A. [Visualization of pulmonary metastasis of osteosarcoma with 99mTc-HMDP] Rev Esp Med Nucl. 2001 Dec;20(7):558-9. Spanish. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43450 |
Study title: Cherubism: diagnostic imaging and review of the literature in Japan. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 May;81(5):623-8. Review. Hitomi G, Nishide N, Mitsui K. Cherubism: diagnostic imaging and review of the literature in Japan. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 May;81(5):623-8. Review. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43567 |
Study title: Hod N, Horne T. "Cold" and "hot" osteomyelitis on bone scintigraphy. Clin Nucl Med. 2003 Nov;28(11):927-8. Hod N, Horne T. "Cold" and "hot" osteomyelitis on bone scintigraphy. Clin Nucl Med. 2003 Nov;28(11):927-8. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43412 |
Study title: EFFICACY AND TOLERABILITY STUDY IN CHILDREN OVER A 15 DAY PERIOD |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 DFOR C6 II (DFORC6Y) Art45 listing 2011.xls |
View full study record |
Document reference: 47841 |
Study title: EFFICACY OF FORMOTEROL (BD 40A) WITH SINGLE DOSE FOR BRONCHIAL ASTHMA IN CHILDREN: CLINICAL RESULTS IN 8 INSTITUTIONS |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 YBDG 3-3 Art45 listing 2011.xls |
View full study record |
Document reference: 47842 |
Study title: Eformoterol versus salmeterol: reduction in short acting bronchodilator usage in asthmatic children treated with inhaled steroids: FACT. |
Active substance: FORMOTEROL |
Study summary document link (including results): BU-037-0004 Study Synopsis.pdf |
View full study record |
Document reference: 47843 |
Study title: INFLUENCE ON BRONCHIAL HYPERRESPONSIVENESS USING A LONG ACTING (FORMOTEROL) AND A SHORT ACTING (SALBUTAMOL) BETA-2 SYMPATHOMIMETIC IN CHILDREN WITH BRONCHIAL ASTHMA |
Active substance: FORMOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 45268 |
Study title: INFLUENCE ON BRONCHIAL HYPERRESPONSIVENESS USING A LONG ACTING (FORMOTEROL) AND A SHORT ACTING (SALBUTAMOL) BETA-2 SYMPATHOMIMETIC IN CHILDREN WITH BRONCHIAL ASTHMA |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 DFORD2 Art45 listing 2011.xls |
View full study record |
Document reference: 47845 |
Study title: Investigation on the safety and efficacy of miflonide together with foradil in patients with moderate to severe asthma bronchiale which is not adequately controlled by other inhalative combinations of long-acting beta 2-agonists and corticosteroids. |
Active substance: FORMOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 45269 |
Study title: Investigation on the safety and efficacy of miflonide together with foradil in patients with moderate to severe asthma bronchiale which is not adequately controlled by other inhalative combinations of long-acting beta 2-agonists and corticosteroids. |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258DDE03 Art45 listing 2011.xls |
View full study record |
Document reference: 47846 |
Study title: MULTI-CENTRE, DOUBLE-BLIND, BETWEEN-PATIENT COMPARISON OF MULTIPLE DOSES OF 12 UG FORMOTEROL METERED DOSE AEROSOL VERSUS MULTIPLE DOSES OF 200 MYG SALBUTAMOL METERED-DOSE AEROSOL IN CHILDREN WITH BRONCHIAL ASTHMA |
Active substance: FORMOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 45270 |
Study title: MULTI-CENTRE, DOUBLE-BLIND, BETWEEN-PATIENT COMPARISON OF MULTIPLE DOSES OF 12 UG FORMOTEROL METERED DOSE AEROSOL VERSUS MULTIPLE DOSES OF 200 MYG SALBUTAMOL METERED-DOSE AEROSOL IN CHILDREN WITH BRONCHIAL ASTHMA |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 BA-RP1 Art45 listing 2011.xls |
View full study record |
Document reference: 47847 |
Study title: MULTI-CENTRE, DOUBLE-BLIND, THREE-MONTH, BETWEEN-PATIENT COMPARISON OF 6 UG B.I.D. AND 12 UG B.I.D. DAILY FORMOTEROL AEROSOL VERSUS 200 UG T.I.D. DAILY SALBUTAMOL AEROSOL IN CHILDREN WITH REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASES (E.G. BRONCHIAL ASTHMA) |
Active substance: FORMOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 45271 |
Study title: MULTI-CENTRE, DOUBLE-BLIND, THREE-MONTH, BETWEEN-PATIENT COMPARISON OF 6 UG B.I.D. AND 12 UG B.I.D. DAILY FORMOTEROL AEROSOL VERSUS 200 UG T.I.D. DAILY SALBUTAMOL AEROSOL IN CHILDREN WITH REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASES (E.G. BRONCHIAL ASTHMA) |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 SP PD2 Art45 listing 2011.xls |
View full study record |
Document reference: 47848 |
Study title: Report on an Open Cross-Over Comparison of Flurbiprofen and Naproxen in Juvenile Spondylitis, Definite and Probable |
Active substance: FLURBIPROFEN |
Study summary document link (including results): Flurbiprofen-M84-121.pdf |
View full study record |
Document reference: 47461 |
Study title: Serum Concentrations of Flurbiprofen in Children After a Single Oral Dose of 22.5 mg or 27 mg of the Drug, following a Multidose Regime |
Active substance: FLURBIPROFEN |
Study summary document link (including results): flurbiprofen-dm7620.pdf |
View full study record |
Document reference: 48075 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28346 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28347 |
Study title: Uren RF, Howman-Giles R. The 'cold hip' sign on bone scan. A retrospective review. Clin Nucl Med. 1991 Aug;16(8):553-6. PMID: 1934806 [PubMed - indexed for MEDLINE] 372: Caner BE, Ercan MT, Bekdik CF, Varoğlu E, Müezzinoğlu S, Duman Y, Erbengi GF. Visualization of bone pathologies and lung cancer with 99mTc-glucose phosphate: a comparative study. Nuklearmedizin. 1991 Aug;30(4):132-6. Uren RF, Howman-Giles R. The 'cold hip' sign on bone scan. A retrospective review. Clin Nucl Med. 1991 Aug;16(8):553-6. PMID: 1934806 [PubMed - indexed for MEDLINE] 372: Caner BE, Ercan MT, Bekdik CF, Varoğlu E, Müezzinoğlu S, Duman Y, Erbengi GF. Visualization of bone pathologies and lung cancer with 99mTc-glucose phosphate: a comparative study. Nuklearmedizin. 1991 Aug;30(4):132-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44220 |
Study title: Levine E, De Smet AA, Neff JR, Martin NL. Scintigraphic evaluation of giant cell tumor of bone. AJR Am J Roentgenol. 1984 Aug;143(2):343-8. Levine E, De Smet AA, Neff JR, Martin NL. Scintigraphic evaluation of giant cell tumor of bone. AJR Am J Roentgenol. 1984 Aug;143(2):343-8. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43991 |
Study title: Levinsohn EM, Sternick A, Echeverria TS, Yuan HA. Acute hematogenous osteomyelitis of the rib. Skeletal Radiol. 1982;8(4):291-3. Levinsohn EM, Sternick A, Echeverria TS, Yuan HA. Acute hematogenous osteomyelitis of the rib. Skeletal Radiol. 1982;8(4):291-3. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44097 |
Study title: Acute osteomyelitis in children: combined Tc-99m and Ga-67 imaging. Lewin JS, Rosenfield NS, Hoffer PB, Downing D. Radiology. 1986 Mar;158(3):795-804. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43915 |
Study title: A "harness" distribution pattern on pediatric Ga-67 scintigraphy. Lewis GW, Mansberg R, Howman-Giles R. Clin Nucl Med. 1999 Jul;24(7):527-8. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43505 |
Study title: [The application radionuclide bone imaging in the treatment of hallux valgus] Li W, Peng JJ, Zhou YX. Zhonghua Wai Ke Za Zhi. 1994 Dec;32(12):757-9. Chinese. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43607 |
Study title: Lim ST, Sohn MH, Park SA. Tc-99m MDP three-phase bone scintigraphy in disciplinary exercise-induced rhabdomyolysis. Clin Nucl Med. 2000 Jul;25(7):558-9. No abstract available. Lim ST, Sohn MH, Park SA. Tc-99m MDP three-phase bone scintigraphy in disciplinary exercise-induced rhabdomyolysis. Clin Nucl Med. 2000 Jul;25(7):558-9. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43480 |
Study title: Lin D, Alavi A, Dalinka M. Bone scan evaluation of patellar activity. Int J Nucl Med Biol. 1981;8(1):105-9. No abstract available. Lin D, Alavi A, Dalinka M. Bone scan evaluation of patellar activity. Int J Nucl Med Biol. 1981;8(1):105-9. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44135 |
Study title: Lin D, Alavi A, Dalinka M. Scintigraphic evaluation of the hyoid bone and the thyroid--cricoid cartilage. Int J Nucl Med Biol. 1981;8(1):96-104. No abstract available. Lin D, Alavi A, Dalinka M. Scintigraphic evaluation of the hyoid bone and the thyroid--cricoid cartilage. Int J Nucl Med Biol. 1981;8(1):96-104. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44133 |
Study title: Open comparative trial to evaluate the effectiveness of gonorrhae in males.Fluker |
Active substance: AMOXICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Amoxillin_9.xlsx |
View full study record |
Document reference: 48999 |
Study title: Open multicentre trial to evaluate the efficacy of amoxicllin in GP.Leigh et al |
Active substance: AMOXICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Amoxillin_10.xlsx |
View full study record |
Document reference: 48996 |
Study title: Open parallell group to evalutate the efficacy for 2 different dose regimens for untreated maxillar sinuitis.Sydow et al. |
Active substance: AMOXICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Amoxillin_13.xlsx |
View full study record |
Document reference: 48998 |
Study title: TO ASSESS THE COMPARATIVE ANTHELMINTIC EFFICACY OF PYRANTEL PAMOATE AND MEBENDAZOLE IN ENTEROBIASIS AND ASCARIASIS. |
Active substance: PYRANTEL PAMOATE |
Study summary document link (including results): PRT-II-84-001-002-003 EMA Paediatrics Web Synopsis.pdf |
View full study record |
Document reference: 46149 |
Study title: TO ASSESS THE EFFECT OF QUARTERLY TREATMENTS OVER A PERIOD OF ONE YEAR ON THE PREVALENCE OF ASCARIASIS, ANCYLOSTOMIASIS AND ENTEROBIASIS IN A RESIDENTIAL INSTITUTE FOR CHILDREN. |
Active substance: PYRANTEL PAMOATE |
Study summary document link (including results): |
View full study record |
Document reference: 46151 |
Study title: TO ESTIMATE THE PERCENTAGE OF AT-RISK FAMILIES IN A HIGH-PREVALENCE AREA HAVING TWO OR MORE MEMBERS WITH ROUND-WORM HOOKWORM INFECTION. "AT-RISK" FAMILIES HAS ONE MEMBER INFECTED. "AFFECTED" FAMILIES HAS 2 OR MORE INFECTED MEMBERS. |
Active substance: PYRANTEL PAMOATE |
Study summary document link (including results): PRT-II-85-002 EMEA Pediatric Web Synopsis.pdf |
View full study record |
Document reference: 46150 |
Study title: R.Ammer, Penka Demirova Drumeva, A.Völp: Nicht toxische Alternative zur Behandlung von Kopfläusen, päd (9) 2003 |
Active substance: Pyrethrum extract, Pyrethrins content 25% (m/m) (HERB) |
Study summary document link (including results): |
View full study record |
Document reference: 40147 |
Study title: Afifi AK, Bell WE: Tests for juvenile myastenia gravis: comparative diagnostic yield and prediction of outcome. J Child Neurol 8, 403 – 411 (1993) Afifi AK, Bell WE: Tests for juvenile myastenia gravis: comparative diagnostic yield and prediction of outcome. J Child Neurol 8, 403 – 411 (1993) |
Active substance: PYRIDOSTIGMINE |
Study summary document link (including results): |
View full study record |
Document reference: 35224 |
Study title: Afifi AK, Bell WE. Tests for juvenile myasthenia gravis: comparative diagnostic yield and prediction of outcome. J Child Neurol 1993;8:403-11.Afifi AK, Bell WE. Tests for juvenile myasthenia gravis: comparative diagnostic yield and prediction of outcome. J Child Neurol 1993;8:403-11. |
Active substance: PYRIDOSTIGMINE |
Study summary document link (including results): |
View full study record |
Document reference: 35228 |
Study title: Alhalel A et al. Ocular effects of hyoscine in double dose transdermal administration and its reversal by low dose pyridostigmine. Aviat Space Environ Med. 1995 Nov;66(11):1037-40Alhalel A et al. Ocular effects of hyoscine in double dose transdermal administration and its reversal by low dose pyridostigmine. Aviat Space Environ Med. 1995 Nov;66(11):1037-40 |
Active substance: PYRIDOSTIGMINE |
Study summary document link (including results): |
View full study record |
Document reference: 35198 |
Study title: Tam YH, Yeung CK, Lee KH. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study. Aliment Pharmacol Ther. 2006 Jul 1;24(1):81-6.Tam YH, Yeung CK, Lee KH. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study. Aliment Pharmacol Ther. 2006 Jul 1;24(1):81-6. |
Active substance: RANITIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35277 |
Study title: Wells TG, Heulitt MJ, Taylor BJ, Fasules JW, Kearns GL. Pharmacokinetics and pharmacodynamics of ranitidine in neonates treated with extracorporeal membrane oxygenation. J Clin Pharmacol. 1998 May;38(5):402-7.Wells TG, Heulitt MJ, Taylor BJ, Fasules JW, Kearns GL. Pharmacokinetics and pharmacodynamics of ranitidine in neonates treated with extracorporeal membrane oxygenation. J Clin Pharmacol. 1998 May;38(5):402-7. |
Active substance: RANITIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 35280 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Ranunculus-Homaccord (drops) [AWB-AT] |
Active substance: Ranunculus-Homaccord |
Study summary document link (including results): |
View full study record |
Document reference: 40150 |
Study title: A Multicenter Safety Study of SR29142 in Cancer Patients (LTS3025). |
Active substance: rasburicase |
Study summary document link (including results): |
View full study record |
Document reference: 47279 |
Study title: A Phase II, Open-Label, Multicenter Study of SR29142 as a Uricolytic Therapy for the Prophylaxis and Treatment of Hyperuricemia in Patients With Leukemias or Lymphomas (ACT2511) |
Active substance: rasburicase |
Study summary document link (including results): |
View full study record |
Document reference: 47275 |
Study title: A Phase II, Open-Label, Multicenter Study of SR29142 as a Uricolytic Therapy for the Prophylaxis and Treatment of Hyperuricemia in Patients with Leukemias or Lymphomas (ACT2694) |
Active substance: rasburicase |
Study summary document link (including results): |
View full study record |
Document reference: 47276 |
Study title: An open-label, randomized, multicenter comparison of SR29142 versus allopurinol for the prophylaxis and treatment of hyperuricemia in pediatric patients with leukemia or lymphoma (EFC2975) |
Active substance: rasburicase |
Study summary document link (including results): |
View full study record |
Document reference: 47277 |
Study title: Hod N, Horne T. Interesting presentation of renal and adjacent rib infection on bone scintigraphy: the additive value of tissue phase images. Clin Nucl Med. 2004 Nov;29(11):720-2. No abstract available. Hod N, Horne T. Interesting presentation of renal and adjacent rib infection on bone scintigraphy: the additive value of tissue phase images. Clin Nucl Med. 2004 Nov;29(11):720-2. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43395 |
Study title: Hodder SC, Rees JI, Oliver TB, Facey PE, Sugar AW. SPECT bone scintigraphy in the diagnosis and management of mandibular condylar hyperplasia. Br J Oral Maxillofac Surg. 2000 Apr;38(2):87-93. Hodder SC, Rees JI, Oliver TB, Facey PE, Sugar AW. SPECT bone scintigraphy in the diagnosis and management of mandibular condylar hyperplasia. Br J Oral Maxillofac Surg. 2000 Apr;38(2):87-93. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43481 |
Study title: Hoefnagel CA, Bruning PF, Cohen P, Marcuse HR, van der Schoot JB. Detection of lung metastases from osteosarcoma by scintigraphy using 99mTc-methylene diphosphonate. Diagn Imaging. 1981;50(5):277-84. Hoefnagel CA, Bruning PF, Cohen P, Marcuse HR, van der Schoot JB. Detection of lung metastases from osteosarcoma by scintigraphy using 99mTc-methylene diphosphonate. Diagn Imaging. 1981;50(5):277-84. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44132 |
Study title: [Scintigraphic aspect of infantile cortical hyperostosis (Caffey's disease)] French. Taillefer R, Danais S, Marton D. J Can Assoc Radiol. 1983 Mar;34(1):12-5. French. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44046 |
Study title: Takahashi T, Kakuhara N, Katsuragawa S, Kojima Y, Hirose A, Nakasato T, Yoshioka K, Kato K, Yanagisawa T. [Quantitative study of diffuse increased 99mTc-methylene diphosphonate accumulation of both kidneys] Radioisotopes. 1987 Oct;36(10):519-22. Japanese. Takahashi T, Kakuhara N, Katsuragawa S, Kojima Y, Hirose A, Nakasato T, Yoshioka K, Kato K, Yanagisawa T. [Quantitative study of diffuse increased 99mTc-methylene diphosphonate accumulation of both kidneys] Radioisotopes. 1987 Oct;36(10):519-22. Japanese. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43847 |
Study title: Takahashi T, Kakuhara N, Katsuragawa S, Kojima Y, Hirose A, Nakasato T, Yoshioka K, Kato K, Yanagisawa T. [Quantitative study of diffuse increased 99mTc-methylene diphosphonate accumulation of both kidneys] Radioisotopes. 1987 Oct;36(10):519-22. Japanese. Takahashi T, Kakuhara N, Katsuragawa S, Kojima Y, Hirose A, Nakasato T, Yoshioka K, Kato K, Yanagisawa T. [Quantitative study of diffuse increased 99mTc-methylene diphosphonate accumulation of both kidneys] Radioisotopes. 1987 Oct;36(10):519-22. Japanese. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44180 |
Study title: Takahashi T, Kakuhara N, Katsuragawa S, Kojima Y, Hirose A, Nakasato T, Yoshioka K, Kato K, Yanagisawa T. [Quantitative study of diffuse increased 99mTc-methylene diphosphonate accumulation of both kidneys] Radioisotopes. 1987 Oct;36(10):519-22. Japanese. Takahashi T, Kakuhara N, Katsuragawa S, Kojima Y, Hirose A, Nakasato T, Yoshioka K, Kato K, Yanagisawa T. [Quantitative study of diffuse increased 99mTc-methylene diphosphonate accumulation of both kidneys] Radioisotopes. 1987 Oct;36(10):519-22. Japanese. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44227 |
Study title: Takahashi T, Kakuhara N, Katsuragawa S, Kojima Y, Hirose A, Nakasato T, Yoshioka K, Kato K, Yanagisawa T. [Quantitative study of diffuse increased 99mTc-methylene diphosphonate accumulation of both kidneys] Radioisotopes. 1987 Oct;36(10):519-22. Japanese. Takahashi T, Kakuhara N, Katsuragawa S, Kojima Y, Hirose A, Nakasato T, Yoshioka K, Kato K, Yanagisawa T. [Quantitative study of diffuse increased 99mTc-methylene diphosphonate accumulation of both kidneys] Radioisotopes. 1987 Oct;36(10):519-22. Japanese. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44274 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28348 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28349 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28350 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28351 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28352 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28353 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28354 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28355 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28356 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28357 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28358 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28359 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28360 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28361 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FPO40003.pdf |
View full study record |
Document reference: 28362 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-DENB4016-ICHE3.pdf |
View full study record |
Document reference: 28369 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Study FAD101-Fluticasone Propionate-Flixotide Diskus.xls |
View full study record |
Document reference: 28370 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Study FAD102-Fluticasone Propionate-Flixotide Diskus.xls |
View full study record |
Document reference: 28371 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FAS30006-ICHE3.pdf |
View full study record |
Document reference: 28372 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FAS40019-ICHE3.pdf |
View full study record |
Document reference: 28373 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Study Fluticasone_Propionate-PED-FLTA2008.xlsx |
View full study record |
Document reference: 28377 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28378 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28381 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Study FMS40016-Fluticasone.xls |
View full study record |
Document reference: 28385 |
Study title: Due to the lack of good diagnostic techniques it can be difficult to diagnose asthma in young children. The symptoms can be such that anti-inflammatory medication is given as test medication; however there is a lack of clinical data in a large group of wheezy infants using objective endpoints. The aim of this study was to evaluate the effects of fluticasone propionate on lung function and symptom scores in infants with recurrent and persistent wheeze. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FMS30060-ICHE3.pdf |
View full study record |
Document reference: 28398 |
Study title: Lin DS, Alavi A. Bone scan evaluation of degenerative joint disease of the spine. Int J Nucl Med Biol. 1982;9(1):63-4. No abstract available. Lin DS, Alavi A. Bone scan evaluation of degenerative joint disease of the spine. Int J Nucl Med Biol. 1982;9(1):63-4. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44104 |
Study title: Evaluation of arthritis in Reiter's disease by bone scintigraphy and radiography. Lin WY, Wang SJ, Lan JL. Clin Rheumatol. 1995 Jul;14(4):441-4. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43596 |
Study title: Lin WY, Wang SJ, Lang JL, Hsu CY, Kao CH, Liao SQ, Yeh HW. Bone scintigraphy in evaluation of heel pain in Reiter's disease: compared with radiography and clinical examination. Scand J Rheumatol. 1995;24(1):18-21. Lin WY, Wang SJ, Lang JL, Hsu CY, Kao CH, Liao SQ, Yeh HW. Bone scintigraphy in evaluation of heel pain in Reiter's disease: compared with radiography and clinical examination. Scand J Rheumatol. 1995;24(1):18-21. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43605 |
Study title: Papanicolaou N. Osteoid osteoma: operative confirmation of complete removal by bone scintigraphy. Radiology. 1985 Mar;154(3):821-2. Papanicolaou N. Osteoid osteoma: operative confirmation of complete removal by bone scintigraphy. Radiology. 1985 Mar;154(3):821-2. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43957 |
Study title: Paramsothy M, Peng LH, Samuel D. Diagnostic value of radionuclide technetium 99m-MDP skeletal survey in acute leukaemia. Australas Radiol. 1983 Nov;27(3):295-6. No abstract available. Paramsothy M, Peng LH, Samuel D. Diagnostic value of radionuclide technetium 99m-MDP skeletal survey in acute leukaemia. Australas Radiol. 1983 Nov;27(3):295-6. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44023 |
Study title: Reflex sympathetic dystrophy associated with deep peroneal nerve entrapment. Parano E, Pavone V, Greco F, Majorana M, Trifiletti RR. Brain Dev. 1998 Mar;20(2):80-2. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43534 |
Study title: Park CH, Kapadia D, O'Hara AE. Three phase bone scan findings in stress fracture. Clin Nucl Med. 1981 Dec;6(12):587-8. No abstract available. Park CH, Kapadia D, O'Hara AE. Three phase bone scan findings in stress fracture. Clin Nucl Med. 1981 Dec;6(12):587-8. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44106 |
Study title: Park HM, Hunt-Reimann A, Appledorn CR, Siddiqui A. A comet-tail imaging artifact. Due to a "hot" point source and faulty electronics. Clin Nucl Med. 1993 Apr;18(4):341-2. No abstract available. Park HM, Hunt-Reimann A, Appledorn CR, Siddiqui A. A comet-tail imaging artifact. Due to a "hot" point source and faulty electronics. Clin Nucl Med. 1993 Apr;18(4):341-2. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43669 |
Study title: Early scintigraphic findings of occult femoral and tibial fractures in infants. Park HM, Kernek CB, Robb JA. Clin Nucl Med. 1988 Apr;13(4):271-5. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43819 |
Study title: Scintigraphic evaluation of extremity pain in children: its efficacy and pitfalls. Park HM, Rothschild PA, Kernek CB. AJR Am J Roentgenol. 1985 Nov;145(5):1079-84. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43930 |
Study title: Open pilot study to evaluate different dosages in various infections.Murdoch |
Active substance: AMOXICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Amoxillin_8.xlsx |
View full study record |
Document reference: 48997 |
Study title: Open single centertrial to evaluate efficacy and safety of amoxicillin for treatment of UTIParsons et al |
Active substance: AMOXICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Amoxillin_11.xlsx |
View full study record |
Document reference: 48995 |
Study title: Role of bone scans in assessment of skeletal age. Spencer RP, Sami S, Karimeddini M, Sziklas JJ, Rosenberg R. Int J Nucl Med Biol. 1981;8(1):33-8. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44134 |
Study title: Spencer RP, Sziklas JJ, Rosenberg R, Yoo JH, Weidner FA. Hemivertebral "disappearance" on bone scan. J Nucl Med. 1981 May;22(5):454-6. Spencer RP, Sziklas JJ, Rosenberg R, Yoo JH, Weidner FA. Hemivertebral "disappearance" on bone scan. J Nucl Med. 1981 May;22(5):454-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44125 |
Study title: Long-term scintigraphic appearance of extremities following bone tumor resection and allograft reconstruction. Smith JT, Smith LM, Rinsky L, Goris ML. Clin Nucl Med. 1991 Dec;16(12):907-9. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43722 |
Study title: Effect of growth hormone on metaphyseal uptake of 99mTc-methylene diphosphonate. Klingensmith WC 3rd, Klingensmith GJ, Tollefsen SE, Schalch DS. J Clin Endocrinol Metab. 1981 Jun;52(6):1162-4. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44123 |
Study title: Kloos RT, Rufini V, Gross MD, Shapiro B. Bone scans in neurofibromatosis: neurofibroma, plexiform neuroma and neurofibrosarcoma. J Nucl Med. 1996 Nov;37(11):1778-83. Kloos RT, Rufini V, Gross MD, Shapiro B. Bone scans in neurofibromatosis: neurofibroma, plexiform neuroma and neurofibrosarcoma. J Nucl Med. 1996 Nov;37(11):1778-83. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43558 |
Study title: Knop J, Delling G, Heise U, Winkler K. Parametric imaging of 99mTc methylene diphosphonate biokinetics in osteosarcoma for preoperative evaluation of chemotherapy-induced necrosis. Chir Organi Mov. 1990;75(1 Suppl):36-7. No abstract available. Knop J, Delling G, Heise U, Winkler K. Parametric imaging of 99mTc methylene diphosphonate biokinetics in osteosarcoma for preoperative evaluation of chemotherapy-induced necrosis. Chir Organi Mov. 1990;75(1 Suppl):36-7. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43773 |
Study title: Knop J, Delling G, Heise U, Winkler K. Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology. Skeletal Radiol. 1990;19(3):165-72. Knop J, Delling G, Heise U, Winkler K. Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology. Skeletal Radiol. 1990;19(3):165-72. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43774 |
Study title: Knop J, Delling G, Heise U, Winkler K. Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology. Skeletal Radiol. 1990;19(3):165-72. Knop J, Delling G, Heise U, Winkler K. Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology. Skeletal Radiol. 1990;19(3):165-72. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44176 |
Study title: Takebayashi S, Ono Y, Matsui K. [The changes in renal uptake of 99mTc-MDP after radiotherapy in the neuroblastoma (author's transl)] Kaku Igaku. 1981 Jul;18(6):859-62. Japanese. No abstract available. Takebayashi S, Ono Y, Matsui K. [The changes in renal uptake of 99mTc-MDP after radiotherapy in the neuroblastoma (author's transl)] Kaku Igaku. 1981 Jul;18(6):859-62. Japanese. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44120 |
Study title: Battered child syndrome. Uncommon pelvic fractures detected by bone scintigraphy. Tan TX, Gelfand MJ. Clin Nucl Med. 1997 May;22(5):321-2. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43552 |
Study title: Craniofacial fibrous dysplasia showing marked involution postoperatively. Tanaka Y, Tajima S, Maejima S, Umebayashi M. Ann Plast Surg. 1993 Jan;30(1):71-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43678 |
Study title: Osteoid osteoma of the proximal femur: new techniques in diagnosis and treatment. Kumar SJ, Harcke HT, MacEwen GD, Ger E. J Pediatr Orthop. 1984 Nov;4(6):669-72. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43978 |
Study title: [Algodystrophy, a little known disease in children. General review apropos of 4 cases] French. Labenne M, Bertrand AM, Wendling D, Onimus M, Laurain JM, Amsallem D. Ann Pediatr (Paris). 1987 Oct;34(8):603-8. Review. French. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43850 |
Study title: [Peroperative isotopic detection in the treatment of osteoid osteoma in children] French. Lacheretz M, Herbaux B, Hossein-Foucher C, Lecouffe P, Richir M. Chirurgie. 1989;115(7):413-6. French. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43798 |
Study title: Lagard D, Dupont S, Boutry N, Delfaut E, Cotten A. [Cortical septic osteitis: two cases] J Radiol. 2000 Jan;81(1):54-8. French. Lagard D, Dupont S, Boutry N, Delfaut E, Cotten A. [Cortical septic osteitis: two cases] J Radiol. 2000 Jan;81(1):54-8. French. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43494 |
Study title: Lamki L, Willis RB. Radionuclide findings of pyomyositis. Clin Nucl Med. 1982 Oct;7(10):465-7. No abstract available. Lamki L, Willis RB. Radionuclide findings of pyomyositis. Clin Nucl Med. 1982 Oct;7(10):465-7. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44073 |
Study title: Lammer J, Fueger GF, Fotter R, Nicoletti R. [A computer macro-programme for osteoscintimetry and activity profile in Perthe's disease (author's transl)] Rofo. 1982 Jan;136(1):14-21. German. Lammer J, Fueger GF, Fotter R, Nicoletti R. [A computer macro-programme for osteoscintimetry and activity profile in Perthe's disease (author's transl)] Rofo. 1982 Jan;136(1):14-21. German. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44103 |
Study title: To determine the blood and tonsil levels of ampicillin after rectal and oral administration.Baba et al. (1983-05-04) |
Active substance: AMPICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_9.xlsx |
View full study record |
Document reference: 49009 |
Study title: To investigate the absorption and excretion of ampicillin from supporitories given to children.Iwai et al. (1983-05-04) |
Active substance: AMPICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_12.xlsx |
View full study record |
Document reference: 49010 |
Study title: To investigate the absorption and excretion of ampicillin from supporitories given to children.Nakazawa et al. (1983-05-16) |
Active substance: AMPICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_16.xlsx |
View full study record |
Document reference: 49015 |
Study title: To investigate the absorption of ampicillin from suppositories in children.Motohiro et al. (1983-05-09) |
Active substance: AMPICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_15.xlsx |
View full study record |
Document reference: 49012 |
Study title: Effect of long-term treatment with fluticasone propionate on bone density, growth and lung function in childhood asthma. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FMS40175-ICHE3.pdf |
View full study record |
Document reference: 28388 |
Study title: Efficacy of treatment with inhaled fluticasone and the effect of priming and activation of PMN cells in children with allergy and asthma. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FMS40229-ICHE3.pdf |
View full study record |
Document reference: 28405 |
Study title: FLU9705: a multi-centre, parallel group, randomised, double-blind study to investigate the efficacy of fluticasone propionate 100 mcg MDI bd versus placebo MDI bd both via Babyhaler™ spacer in 1 to 5 year old children with asthma or asthma-like symptoms during a 6 months study period. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FMS40256-ICHE3.pdf |
View full study record |
Document reference: 28395 |
Study title: Nebulised Fluticasone propionate in an upper respiratory tract inflammatory disorder (rhinopharyngitis): a multicentre, randomised, blinded, parallel group study of the efficacy and safety of nebulised fluticasone propionate 0.5mg daily compared with nebulised beclomethasone dipropionate 0.8mg daily in children suffering from acute rhinopharyngitis. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLIC09-ICHE3.pdf |
View full study record |
Document reference: 28422 |
Study title: Pharmacodynamics of the 88mcg BID dose of the Hydrofluoroalkane propellant formulation of inhaled Fluticasone Propionate following Administration via the Metered-dose Inhaler in Pediatric Subjects 4 to 11 years of age with Asthma |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FAP19052-ICHE3.pdf |
View full study record |
Document reference: 28390 |
Study title: Prevention of Otitis media in children." 6) "A randomized, double-blind, placebo-controlled study examining the effect of fluticasone propionate aqueous nasal spray in antibiotic therapy in the treatment of chronic rhinosinusitis in paediatric patients." |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FNM40083-ICHE3.pdf |
View full study record |
Document reference: 28367 |
Study title: Report on a multicentre, randomised, double-blind, parallel-group clinical trial to compare the efficacy and safety of the dry powder formulation of fluticasone proprionate (FP) 200μg/day with fluticasone proprionate 400μg/day administered for 6 weeks from a multidose powder device (Diskus™) to paediatric patients with chronic asthma. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLTB3051-ICHE3.pdf |
View full study record |
Document reference: 28380 |
Study title: Systemic exposure of the fluticasone propionate from the hydrofluoroalkane propellant formulation via the metered-dose inhaler with and without a spacer in pediatric subjects 4 to 11 years of age with asthma. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FAP19058-ICHE3.pdf |
View full study record |
Document reference: 28418 |
Study title: Treatment with inhaled corticosteroids in wheezing pre-school children: is there a predictable effect? |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone -Propionate-FMS40257-ICHE3.pdf |
View full study record |
Document reference: 28396 |
Study title: A multi-centre, randomised, open-label, parallel group clinical trial to assess the efficacy and safety of Salmeterol/Fluticasone Propionate combination product (2x 25/125μg/actuation, bd) via a hydrofluoroalkane metereddose inhaler compared with Salmeterol/Fluticasone Propionate Accuhaler™ (50/250μg bd) in adult Chinese patients with mild to moderate asthma. |
Active substance: FLUTICASONE AND SALMETEROL |
Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAS30021-ICHE3.pdf |
View full study record |
Document reference: 28452 |
Study title: A 12-week randomized, multicenter, double-blind, placebo controlled, parallel group study in children (aged 5-12, inclusive) with persistent asthma evaluating the safety, efficacy and pharmacokinetics of Foradil (formoterol fumarate) 10 mg bid delivered b |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 0604 Art45 listing 2011.xls |
View full study record |
Document reference: 47797 |
Study title: Paulsen HU, Rabøl A, Sørensen SS. Bone scintigraphy of human temporomandibular joints during Herbst treatment: a case report. Eur J Orthod. 1998 Aug;20(4):369-74. Paulsen HU, Rabøl A, Sørensen SS. Bone scintigraphy of human temporomandibular joints during Herbst treatment: a case report. Eur J Orthod. 1998 Aug;20(4):369-74. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43525 |
Study title: Paulus G, Hirschfelder U, Feistel H. [Computer-assisted quantitative bone scintigraphy in the treatment planning of condylar hyperplasia] Fortschr Kiefer Gesichtschir. 1987;32:180-1. German. No abstract available. Paulus G, Hirschfelder U, Feistel H. [Computer-assisted quantitative bone scintigraphy in the treatment planning of condylar hyperplasia] Fortschr Kiefer Gesichtschir. 1987;32:180-1. German. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43884 |
Study title: Ishii C, Mori Y, Hata Y, Katsuyama N, Fujioka M, Fukazawa W, Hashimoto H, Horiuchi T, Fujioka M, Kawakami K. [Clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)] Radioisotopes. 1981 Jul;30(7):401-3. Japanese. No abstract available. Ishii C, Mori Y, Hata Y, Katsuyama N, Fujioka M, Fukazawa W, Hashimoto H, Horiuchi T, Fujioka M, Kawakami K. [Clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)] Radioisotopes. 1981 Jul;30(7):401-3. Japanese. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44118 |
Study title: Ishii C, Mori Y, Hata Y, Katsuyama N, Fujioka M, Fukazawa W, Hashimoto H, Horiuchi T, Fujioka M, Kawakami K. [Clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)] Radioisotopes. 1981 Jul;30(7):401-3. Japanese. No abstract available. Ishii C, Mori Y, Hata Y, Katsuyama N, Fujioka M, Fukazawa W, Hashimoto H, Horiuchi T, Fujioka M, Kawakami K. [Clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)] Radioisotopes. 1981 Jul;30(7):401-3. Japanese. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44238 |
Study title: Ishii C, Mori Y, Hata Y, Katsuyama N, Fujioka M, Fukazawa W, Hashimoto H, Horiuchi T, Fujioka M, Kawakami K. [Clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)] Radioisotopes. 1981 Jul;30(7):401-3. Japanese. No abstract available. Ishii C, Mori Y, Hata Y, Katsuyama N, Fujioka M, Fukazawa W, Hashimoto H, Horiuchi T, Fujioka M, Kawakami K. [Clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)] Radioisotopes. 1981 Jul;30(7):401-3. Japanese. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44285 |
Study title: Ishine M, Kawamura M, Koizumi M, Itoh H, Murase K, Inatsuki S, Iio A, Hamamoto K. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 Apr 25;42(4):389-97. Japanese. No abstract available. Ishine M, Kawamura M, Koizumi M, Itoh H, Murase K, Inatsuki S, Iio A, Hamamoto K. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 Apr 25;42(4):389-97. Japanese. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44086 |
Study title: Ishine M, Kawamura M, Koizumi M, Itoh H, Murase K, Inatsuki S, Iio A, Hamamoto K. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 Apr 25;42(4):389-97. Japanese. No abstract available. Ishine M, Kawamura M, Koizumi M, Itoh H, Murase K, Inatsuki S, Iio A, Hamamoto K. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 Apr 25;42(4):389-97. Japanese. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44187 |
Study title: Parker BR. Neuroblastoma with extraosseous uptake of bone-seeking radionuclide. AJR Am J Roentgenol. 1981 May;136(5):1032-4. No abstract available. Parker BR. Neuroblastoma with extraosseous uptake of bone-seeking radionuclide. AJR Am J Roentgenol. 1981 May;136(5):1032-4. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44124 |
Study title: Knop J, Delling G, Heise U, Winkler K. Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology. Skeletal Radiol. 1990;19(3):165-72. Knop J, Delling G, Heise U, Winkler K. Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology. Skeletal Radiol. 1990;19(3):165-72. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44223 |
Study title: Knop J, Delling G, Heise U, Winkler K. Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology. Skeletal Radiol. 1990;19(3):165-72. Knop J, Delling G, Heise U, Winkler K. Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology. Skeletal Radiol. 1990;19(3):165-72. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44270 |
Study title: Minoves M, Bassa P, Clemente A, Rivas A, Riera E, Setoain J, Costansa JM. Incidental finding of varicocele detected on a blood-pool image on Tc-99m HMDP bone scintigraphy. Clin Nucl Med. 2000 Nov;25(11):947-8. No abstract available. Minoves M, Bassa P, Clemente A, Rivas A, Riera E, Setoain J, Costansa JM. Incidental finding of varicocele detected on a blood-pool image on Tc-99m HMDP bone scintigraphy. Clin Nucl Med. 2000 Nov;25(11):947-8. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43472 |
Study title: Becker muscular dystrophy associated with focal myositis on bone scintigraphy. Minshew PT, Silverman ED, Samuels-Botts C. Clin Nucl Med. 2000 Dec;25(12):1010-2. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43470 |
Study title: Sacroiliitis as a sole manifestation of Brucella melitensis infection in a child. Miron D, Garty I, Tal I, Horovitz Y, Kedar A. Clin Nucl Med. 1987 Jun;12(6):466-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43860 |
Study title: The value of quantitative sacroiliac scintigraphy in detection of sacroiliitis. Miron SD, Khan MA, Wiesen EJ, Kushner I, Bellon EM. Clin Rheumatol. 1983 Dec;2(4):407-14. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44020 |
Study title: Osteomyelitis in the neonate. Clinical aspects and the role of radiography and scintigraphy in diagnosis and management. Mok PM, Reilly BJ, Ash JM. Radiology. 1982 Dec;145(3):677-82. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44066 |
Study title: Mondal A, Bhatnagar A, Sharma R, Behari V, Sawroop K, Khanna CM. Evaluation of the healing process in fractures using early and delayed bone scanning. Australas Radiol. 1994 Nov;38(4):284-7. Mondal A, Bhatnagar A, Sharma R, Behari V, Sawroop K, Khanna CM. Evaluation of the healing process in fractures using early and delayed bone scanning. Australas Radiol. 1994 Nov;38(4):284-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43608 |
Study title: Investigate the relationship between relapses in H. influenzae meningitis and the ability of ampicillin to penetrate to the CSF.Coleman et al. (The journal of pediatrics May 1969) |
Active substance: AMPICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_7.xlsx |
View full study record |
Document reference: 49008 |
Study title: Single-blind trial to evaluate the efficacy and safety of ampicillin suppositories in bacterial pneumonia in children using i.v. ampicillin as reference drug.Motohiro et al. (1983-05-09) |
Active substance: AMPICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_21.xlsx |
View full study record |
Document reference: 49020 |
Study title: Study plasma concentrations after rectal administration of ampicillin suppositories to children.Movin et al. (1987-06-15) |
Active substance: AMPICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_23.xlsx |
View full study record |
Document reference: 49022 |
Study title: Lammer J, Nicoletti R, Fueger GF, Fink W. Osteoscintimetry--a method of semiquantitative evaluation of skeletal scintigrams by use of profiles and a macro function for computer processing. Eur J Nucl Med. 1982;7(8):364-9. Lammer J, Nicoletti R, Fueger GF, Fink W. Osteoscintimetry--a method of semiquantitative evaluation of skeletal scintigrams by use of profiles and a macro function for computer processing. Eur J Nucl Med. 1982;7(8):364-9. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44099 |
Study title: LaMont RL, Muz J, Heilbronner D, Bouwhuis JA. Quantitative assessment of femoral head involvement in Legg-Calvé-Perthes disease. J Bone Joint Surg Am. 1981 Jun;63(5):746-52. LaMont RL, Muz J, Heilbronner D, Bouwhuis JA. Quantitative assessment of femoral head involvement in Legg-Calvé-Perthes disease. J Bone Joint Surg Am. 1981 Jun;63(5):746-52. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44122 |
Study title: Transient severe metastatic calcification in acute renal failure. Landau D, Krymko H, Shalev H, Agronovich S. Pediatr Nephrol. 2007 Apr;22(4):607-11. Epub 2006 Dec 21. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43369 |
Study title: O'Reilly RJ, Cook DJ, Gaffney RD, Angel KR, Paterson DC. Can serial scintigraphic studies detect delayed fracture union in man? Clin Orthop Relat Res. 1981 Oct;(160):227-32. O'Reilly RJ, Cook DJ, Gaffney RD, Angel KR, Paterson DC. Can serial scintigraphic studies detect delayed fracture union in man? Clin Orthop Relat Res. 1981 Oct;(160):227-32. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44110 |
Study title: Review of spondylolisthesis and spondylolysis in paediatric practice. Oakley RH, Carty H. Br J Radiol. 1984 Oct;57(682):877-85. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43981 |
Study title: Oates E, Sarno RC. Imaging of pelvic rhabdomyosarcoma by bone scintigraphy. Eur J Nucl Med. 1987;13(6):297-9. Oates E, Sarno RC. Imaging of pelvic rhabdomyosarcoma by bone scintigraphy. Eur J Nucl Med. 1987;13(6):297-9. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43879 |
Study title: Oesterreich FU, Jend-Rossmann I, Jend HH, Triebel HJ. [Semiquantitative SPECT of anterior dislocation of the temporomandibular joint disk] Rofo. 1987 Jan;146(1):13-7. German. Erratum in: ROFO 1987 Apr;146(4):487. Oesterreich FU, Jend-Rossmann I, Jend HH, Triebel HJ. [Semiquantitative SPECT of anterior dislocation of the temporomandibular joint disk] Rofo. 1987 Jan;146(1):13-7. German. Erratum in: ROFO 1987 Apr;146(4):487. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43886 |
Study title: Oesterreich FU, Jend-Rossmann I, Jend HH, Triebel HJ. Semiquantitative SPECT imaging for assessment of bone reactions in internal derangements of the temporomandibular joint. J Oral Maxillofac Surg. 1987 Dec;45(12):1022-8. Oesterreich FU, Jend-Rossmann I, Jend HH, Triebel HJ. Semiquantitative SPECT imaging for assessment of bone reactions in internal derangements of the temporomandibular joint. J Oral Maxillofac Surg. 1987 Dec;45(12):1022-8. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43840 |
Study title: Oh SN, Jee WH, Cho SM, Kim SH, Kang HS, Ryu KN, Cho CS. Osteonecrosis in patients with systemic lupus erythematosus: MR imaging and scintigraphic evaluation. Clin Imaging. 2004 Jul-Aug;28(4):305-9. Oh SN, Jee WH, Cho SM, Kim SH, Kang HS, Ryu KN, Cho CS. Osteonecrosis in patients with systemic lupus erythematosus: MR imaging and scintigraphic evaluation. Clin Imaging. 2004 Jul-Aug;28(4):305-9. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43400 |
Study title: A 3-month, placebo-controlled efficacy study of formoterol Turbuhaler 4.5μg and 9μg b.i.d. (corresponding to the metered doses 6μg and 12μg, respectively) in asthmatic children aged 6 to 17 years. |
Active substance: FORMOTEROL |
Study summary document link (including results): SD-037-0003 Study Synopsis.pdf |
View full study record |
Document reference: 47798 |
Study title: A 3-week, multicenter study investigating patient use and functionality of the Foradil Certihaler device in patients with asthma. |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258F2309 Art45 listing 2011.xls |
View full study record |
Document reference: 47799 |
Study title: A 3-week, open-label, uncontrolled, multicenter study evaluating the functionality of the Foradil Certihaler device in patients with Asthma. |
Active substance: FORMOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 47801 |
Study title: A 6 months comparison of the safety and efficacy profiles of OXIS (formoterol) Turbuhaler as needed and BRICANYL (terbutaline) Turbuhaler as needed in children with asthma on anti-inflammatory treatment. |
Active substance: FORMOTEROL |
Study summary document link (including results): SD-037-0695 Study Synopsis.pdf |
View full study record |
Document reference: 47802 |
Study title: A double-blind, placebo-controlled efficacy study of formoterol Turbuhaler 4.5μg and 9μg (corresponding to the metered doses of 6μg and 12μg, respectively) in asthmatic children. |
Active substance: FORMOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 47803 |
Study title: A NEW BRONCHODILATOR, IN THE PEDIATRIC PATIENTS WITH NON-ASTHMATIC RESPIRATORY DISORDERS. |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 YBDG 5-4 Art45 listing 2011.xls |
View full study record |
Document reference: 47804 |
Study title: A RANDOMISED, DOUBLE-BLIND, CROSS-OVER, MULTI-CENTRE STUDY COMPARING THE EFFICACY AND TOLERABILITY OF FORMOTEROL 12 UG INHALED TWICE DAILY WITH SALBUTAMOL 100 UG INHALED FOUR TIMES DAILY IN THE TREATMENT OF ASTHMA IN CHILDREN |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 NBG 8937 Art45 Listing.xls |
View full study record |
Document reference: 47805 |
Study title: A randomized double-blind, cross-over comparison of inhaled formoterol 12 ug and salbutamol 200 ug in children with exercise induced asthma |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 FO-DK1Art45 listing 2011.xls |
View full study record |
Document reference: 47807 |
Study title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, MULTIPLE DOSE (1 WEEK) FINDING, MULTICENTER, CROSSOVER STUDY IN CHILDREN AGED 5 TO 12 WITH PERSISTENT ASTHMA COMPARING 4 DOSES (5, 10, 15 AND 30 UG) OF FORMOTEROL BID ADMINISTERED FROM THE MULTIPLE DOSE DRY |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 0602 Art45 listing 2011.xls |
View full study record |
Document reference: 47808 |
Study title: A randomized, multi-centre, double-blind, double-dummy placebo controlled single-dose cross-over study to demonstrate that 12 and 24 mg of formoterol delivered by concept1 has a bronchodilator efficacy which is equivalent to the same dose of formoterol de |
Active substance: FORMOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 47811 |
Study title: A randomized, multicenter, double-blind, double-dummy, placebo controlled, cross-over dose ranging study to evaluate the safety and efficacy of single doses of formoterol fumarate (6,12 and 24 ug) via an hfa pmdi versus placebo and versus formoterol fumar |
Active substance: FORMOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 47809 |
Study title: MULTI-CENTRE, OPEN LABEL, NON COMPARATIVE STUDY OF MULTIPLEDOSES OF 12 MYG FORMOTEROL METERED DOSE AEROSOL IN CHILDREN WITH BROCHIAL ASTHMA |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 BA-RP1F Art45 listing 2011.xls |
View full study record |
Document reference: 47849 |
Study title: Ishine M, Kawamura M, Koizumi M, Itoh H, Murase K, Inatsuki S, Iio A, Hamamoto K. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 Apr 25;42(4):389-97. Japanese. No abstract available. Ishine M, Kawamura M, Koizumi M, Itoh H, Murase K, Inatsuki S, Iio A, Hamamoto K. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 Apr 25;42(4):389-97. Japanese. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44234 |
Study title: Ishine M, Kawamura M, Koizumi M, Itoh H, Murase K, Inatsuki S, Iio A, Hamamoto K. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 Apr 25;42(4):389-97. Japanese. No abstract available. Ishine M, Kawamura M, Koizumi M, Itoh H, Murase K, Inatsuki S, Iio A, Hamamoto K. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 Apr 25;42(4):389-97. Japanese. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44281 |
Study title: Uren RF, Howman-Giles R. The 'cold hip' sign on bone scan. A retrospective review. Clin Nucl Med. 1991 Aug;16(8):553-6. PMID: 1934806 [PubMed - indexed for MEDLINE] 372: Caner BE, Ercan MT, Bekdik CF, Varoğlu E, Müezzinoğlu S, Duman Y, Erbengi GF. Visualization of bone pathologies and lung cancer with 99mTc-glucose phosphate: a comparative study. Nuklearmedizin. 1991 Aug;30(4):132-6. Uren RF, Howman-Giles R. The 'cold hip' sign on bone scan. A retrospective review. Clin Nucl Med. 1991 Aug;16(8):553-6. PMID: 1934806 [PubMed - indexed for MEDLINE] 372: Caner BE, Ercan MT, Bekdik CF, Varoğlu E, Müezzinoğlu S, Duman Y, Erbengi GF. Visualization of bone pathologies and lung cancer with 99mTc-glucose phosphate: a comparative study. Nuklearmedizin. 1991 Aug;30(4):132-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44267 |
Study title: Urman M, Ammann W, Sisler J, Lentle BC, Llyod-Smith R, Loomer R, Fisher C. The role of bone scintigraphy in the evaluation of talar dome fractures. J Nucl Med. 1991 Dec;32(12):2241-4. Urman M, Ammann W, Sisler J, Lentle BC, Llyod-Smith R, Loomer R, Fisher C. The role of bone scintigraphy in the evaluation of talar dome fractures. J Nucl Med. 1991 Dec;32(12):2241-4. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43720 |
Study title: [Nonspecific osteomyelitis in childhood and adolescence. The contribution of imaging diagnosis] Italian. Urso S, Pacciani E, Fariello G, Colajacomo M, Fassari FM, Randisi F, Certo A, Liberatore M, Pagnotta G. Radiol Med (Torino). 1995 Sep;90(3):212-8. Italian. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43589 |
Study title: Usui K, Yamamoto W, Shuke N, Aburano T, Yamanaka Y, Tokusashi Y, Miyokawa N. Scintigraphic findings of tibial adamantinoma on a three-phase bone scan. Clin Nucl Med. 2000 Dec;25(12):1057-8. No abstract available. Usui K, Yamamoto W, Shuke N, Aburano T, Yamanaka Y, Tokusashi Y, Miyokawa N. Scintigraphic findings of tibial adamantinoma on a three-phase bone scan. Clin Nucl Med. 2000 Dec;25(12):1057-8. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43467 |
Study title: Vade A, Jeske J. Infiltrating lipoma of the chest wall. Pediatr Radiol. 1993;23(6):469-70. No abstract available. Vade A, Jeske J. Infiltrating lipoma of the chest wall. Pediatr Radiol. 1993;23(6):469-70. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43679 |
Study title: Moore AE, Blake GM, Fogelman I. A study to determine the dependence of 99mTc-MDP protein binding on plasma clearance and serum albumin concentration. Nucl Med Commun. 2007 Mar;28(3):187-92. Moore AE, Blake GM, Fogelman I. A study to determine the dependence of 99mTc-MDP protein binding on plasma clearance and serum albumin concentration. Nucl Med Commun. 2007 Mar;28(3):187-92. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43366 |
Study title: Moragas M, Lomeña F, Herranz R, García A, Piera C, Muxí A, Bassa P, Catafau A, Pavía A, Setoain J. 99Tcm-HMPAO leucocyte scintigraphy in the diagnosis of bone infection. Nucl Med Commun. 1991 May;12(5):417-27. Moragas M, Lomeña F, Herranz R, García A, Piera C, Muxí A, Bassa P, Catafau A, Pavía A, Setoain J. 99Tcm-HMPAO leucocyte scintigraphy in the diagnosis of bone infection. Nucl Med Commun. 1991 May;12(5):417-27. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43736 |
Study title: Morrison SC, Makley JT, O'Donnell J. Skeletal scintigraphic appearance of an auto-transplanted osteoarticular plug: epiphyseal transplant. Pediatr Radiol. 2003 Jul;33(7):482-4. Epub 2003 Apr 26. Morrison SC, Makley JT, O'Donnell J. Skeletal scintigraphic appearance of an auto-transplanted osteoarticular plug: epiphyseal transplant. Pediatr Radiol. 2003 Jul;33(7):482-4. Epub 2003 Apr 26. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43423 |
Study title: Hamada S, Miyamura T, Okimura T, Yamamoto T, Nishiki M, Miyatani H, Kobayashi M, Tonami H, Takarada A, Yamagishi T, Higashi K, Chatani T. [A case of melorheostosis-correlation with sclerotome map and bone scan image (author's transl)] Rinsho Hoshasen. 1981 Aug 26;26(8):897-900. Japanese. No abstract available. Hamada S, Miyamura T, Okimura T, Yamamoto T, Nishiki M, Miyatani H, Kobayashi M, Tonami H, Takarada A, Yamagishi T, Higashi K, Chatani T. [A case of melorheostosis-correlation with sclerotome map and bone scan image (author's transl)] Rinsho Hoshasen. 1981 Aug 26;26(8):897-900. Japanese. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44237 |
Study title: Hamada S, Miyamura T, Okimura T, Yamamoto T, Nishiki M, Miyatani H, Kobayashi M, Tonami H, Takarada A, Yamagishi T, Higashi K, Chatani T. [A case of melorheostosis-correlation with sclerotome map and bone scan image (author's transl)] Rinsho Hoshasen. 1981 Aug 26;26(8):897-900. Japanese. No abstract available. Hamada S, Miyamura T, Okimura T, Yamamoto T, Nishiki M, Miyatani H, Kobayashi M, Tonami H, Takarada A, Yamagishi T, Higashi K, Chatani T. [A case of melorheostosis-correlation with sclerotome map and bone scan image (author's transl)] Rinsho Hoshasen. 1981 Aug 26;26(8):897-900. Japanese. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44284 |
Study title: Age-related changes in the hemodynamics of the femoral head as evaluated by early phase of bone scintigraphy. Hamaguchi H, Fujioka M, Takahashi KA, Hirata T, Ishida M, Sakao K, Ushijima Y, Kubota T, Nishimura T, Kubo T. Ann Nucl Med. 2006 Jan;20(1):35-40. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43378 |
Study title: Ohta H, Hojo M, Shintaku M, Komibuchi T, Okamoto S. Tc-99m HMDP and Ga-67 imaging along with CT and MRI in fibrous dysplasia of the temporal bone. Clin Nucl Med. 1997 May;22(5):328-30. No abstract available. Ohta H, Hojo M, Shintaku M, Komibuchi T, Okamoto S. Tc-99m HMDP and Ga-67 imaging along with CT and MRI in fibrous dysplasia of the temporal bone. Clin Nucl Med. 1997 May;22(5):328-30. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43551 |
Study title: Okimura T, Higashi K, Nakagawa T, Kobayashi S, Tohda N. [A case of myositis ossificans with abnormal uptake of 99mTc-MDP and 67Ga-citrate] Rinsho Hoshasen. 1985 Jan;30(1):157-9. Japanese. No abstract available. Okimura T, Higashi K, Nakagawa T, Kobayashi S, Tohda N. [A case of myositis ossificans with abnormal uptake of 99mTc-MDP and 67Ga-citrate] Rinsho Hoshasen. 1985 Jan;30(1):157-9. Japanese. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43968 |
Study title: Okuyama T, Suzuki H, Nakamoto K, Suzuki S. [Evaluation of bone scintigraphy in differential diagnosis of benign bone tumors] Kaku Igaku. 1982 Dec;19(10):1519-30. Japanese. No abstract available. Okuyama T, Suzuki H, Nakamoto K, Suzuki S. [Evaluation of bone scintigraphy in differential diagnosis of benign bone tumors] Kaku Igaku. 1982 Dec;19(10):1519-30. Japanese. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44063 |
Study title: Holder LE, Michael RH. The specific scintigraphic pattern of "shin splints in the lower leg": concise communication. J Nucl Med. 1984 Aug;25(8):865-9. Holder LE, Michael RH. The specific scintigraphic pattern of "shin splints in the lower leg": concise communication. J Nucl Med. 1984 Aug;25(8):865-9. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43988 |
Study title: Honda H, Oshiumi Y, Kamoi I, Ichiya Y, Wada M, Matsuura K. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)] Kaku Igaku. 1981 Nov;18(9):1315-9. Japanese. No abstract available. Honda H, Oshiumi Y, Kamoi I, Ichiya Y, Wada M, Matsuura K. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)] Kaku Igaku. 1981 Nov;18(9):1315-9. Japanese. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44107 |
Study title: Honda H, Oshiumi Y, Kamoi I, Ichiya Y, Wada M, Matsuura K. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)] Kaku Igaku. 1981 Nov;18(9):1315-9. Japanese. No abstract available. Honda H, Oshiumi Y, Kamoi I, Ichiya Y, Wada M, Matsuura K. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)] Kaku Igaku. 1981 Nov;18(9):1315-9. Japanese. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44188 |
Study title: Honda H, Oshiumi Y, Kamoi I, Ichiya Y, Wada M, Matsuura K. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)] Kaku Igaku. 1981 Nov;18(9):1315-9. Japanese. No abstract available. Honda H, Oshiumi Y, Kamoi I, Ichiya Y, Wada M, Matsuura K. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)] Kaku Igaku. 1981 Nov;18(9):1315-9. Japanese. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44235 |
Study title: Honda H, Oshiumi Y, Kamoi I, Ichiya Y, Wada M, Matsuura K. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)] Kaku Igaku. 1981 Nov;18(9):1315-9. Japanese. No abstract available. Honda H, Oshiumi Y, Kamoi I, Ichiya Y, Wada M, Matsuura K. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)] Kaku Igaku. 1981 Nov;18(9):1315-9. Japanese. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44282 |
Study title: ONSET OF ACTION IN CHILDREN WITH REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASE |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 DFORC3 Art45 listing 2011.xls |
View full study record |
Document reference: 47851 |
Study title: OPEN LONG TERM TRIAL ON FORMOTEROL METERED DOSE AEROSOL IN CHILDREN WITH REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASE |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 DFORE6 - D 042 Art45 listing 2011.xls |
View full study record |
Document reference: 47852 |
Study title: Open-label, multi-center, non-controlled follow-up study over 3 months on the safety of Formoterol Easyhaler in approximately 35 asthmatic pediatric patients initially treated in study |
Active substance: FORMOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 47855 |
Study title: Open, 12-month, follow-up of a 3-month, comparative, multi-centre, double-blind trial to assess the long-term tolerability and efficacy of formoterol 12 ug dry powder capsules in children with reversible obstructive airways diseases |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 DP-PD2F Art45 listing 2011.xls |
View full study record |
Document reference: 47853 |
Study title: Open, multi-center, randomized, two fold crossover safety study comparing Formoterol Easyhaler vs. Foradil Aerolizer over a treatment period comprising two times 3-months in 70 asthmatic pediatric patients. |
Active substance: FORMOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 47854 |
Study title: PLACEBO-CONTROLLED, COMPARATIVE, SINGLE-CENTER, DOUBLE-BLIND, WITHIN-PATIENT, TRIAL TO COMPARE THE MAGNITUDE AND DURATION OF PROTECTION AGAINST EXERCISE-INDUCED BRONCHOCONSTRICTION OF INHALED FORMOTEROL DRY POWDER CAPSULES 12 UG WITH THAT OF SALBUTAMOL DR |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 DPPD3 Art45 listing 2011.xls |
View full study record |
Document reference: 47856 |
Study title: PLACEBO-CONTROLLED, COMPARATIVE, SINGLE-CENTRE, DOUBLE-BLIND, WITHIN-PATIENT TRIAL TO COMPARE THE EXTENT AND DURATION OF PROTECTION AGAINST EXERCISE-INDUCED BRONCHOCONSTRICTION OF 12 UG INHALED FORMOTEROL AEROSOL WITH THAT OF 200 UG INHALED SALBUTAMOL AER |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 SP PD4 Art45 listing 2011.xls |
View full study record |
Document reference: 47857 |
Study title: PLACEBO-CONTROLLED, DOSE-FINDING, SINGLE-CENTRE, DOUBLE-BLIND, WITHIN-PATIENT TRIAL OF DIFFERENT DOSES OF INHALED FORMOTEROL DRY POWDER (6, 12, 24 UG) AND 400 UG INHALED SALBUTAMOL DRY POWDER IN CHILDREN WITH REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASE |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 DP-PD6 Art45 listing 2011.xls |
View full study record |
Document reference: 47858 |
Study title: Preliminary 14 day pilot inhalation study of an HFA-propelled Foradil inhalation aerosol in juvenile beagle dogs |
Active substance: FORMOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 47859 |
Study title: PREVENTIVE EFFECT AND TOLERABILITY OF FORMOTEROL COMPARED WITH THAT OF SALBUTAMOL IN CHILDREN WITH EXERCISE-INDUCED ASTHMA |
Active substance: FORMOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 47860 |
Study title: Protective effect of single doses of formoterol Turbuhaler 4.5μg and 9μg (corresponding to the metered doses 6μg and 12μg, respectively) compared with terbutaline Turbuhelr 0.5mg and placebo in children with exercise-induced bronchoconstriction (EIB). |
Active substance: FORMOTEROL |
Study summary document link (including results): SD-037-0149 Study Synopsis.pdf |
View full study record |
Document reference: 47861 |
Study title: RESULTS OF CLINICAL USE OF BD 40A DRY SYRUP FOR PEDIATRIC BRONQUIAL-ASTHMA |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 YBDG 3-6 Art45 listing 2011.xls |
View full study record |
Document reference: 47862 |
Study title: Single dose toxicity of formoterol fumarate (D2522) in young rats after oral administration. |
Active substance: FORMOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 47863 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28386 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28387 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28392 |
Study title: Behrendt H et alMitoxantrone is effective in treating childhood T-cell lymphoma/T-cell acute lymphoblastic leukemiaCancer. 1995 Jul 15;76(2):339-42.Behrendt H et alMitoxantrone is effective in treating childhood T-cell lymphoma/T-cell acute lymphoblastic leukemiaCancer. 1995 Jul 15;76(2):339-42. |
Active substance: MITOXANTRONE |
Study summary document link (including results): |
View full study record |
Document reference: 32083 |
Study title: Van Campenhout A, Moens P, Fabry G. Serial bone scintigraphy in Legg-Calvé-Perthes disease: correlation with the Catterall and Herring classification. J Pediatr Orthop B. 2006 Jan;15(1):6-10. Van Campenhout A, Moens P, Fabry G. Serial bone scintigraphy in Legg-Calvé-Perthes disease: correlation with the Catterall and Herring classification. J Pediatr Orthop B. 2006 Jan;15(1):6-10. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43382 |
Study title: van den Oever M, Merrick MV, Scott JH. Bone scintigraphy in symptomatic spondylolysis. J Bone Joint Surg Br. 1987 May;69(3):453-6. van den Oever M, Merrick MV, Scott JH. Bone scintigraphy in symptomatic spondylolysis. J Bone Joint Surg Br. 1987 May;69(3):453-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43865 |
Study title: Generalized soft tissue calcification in children and adolescents with end stage renal failure. van Diemen-Steenvoorde R, Donckerwolcke RA, de Haas G. Eur J Pediatr. 1986 Sep;145(4):293-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43893 |
Study title: Influence of age and gender on quantitative sacroiliac joint scintigraphy. Lin WY, Wang SJ. J Nucl Med. 1998 Jul;39(7):1269-72. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43531 |
Study title: Litchman HM, McCullough RW, Gandsman EJ, Schatz SL. Computerized blood flow analysis for decision making in the treatment of osteochondritis dissecans. J Pediatr Orthop. 1988 Mar-Apr;8(2):208-12. Litchman HM, McCullough RW, Gandsman EJ, Schatz SL. Computerized blood flow analysis for decision making in the treatment of osteochondritis dissecans. J Pediatr Orthop. 1988 Mar-Apr;8(2):208-12. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43824 |
Study title: Liu JX. [Early quantitative detection of vascularity of the reduced femoral head of congenital hip dislocation by scintigraphy] Zhonghua Wai Ke Za Zhi. 1990 May;28(5):292-4, 318. Chinese. Liu JX. [Early quantitative detection of vascularity of the reduced femoral head of congenital hip dislocation by scintigraphy] Zhonghua Wai Ke Za Zhi. 1990 May;28(5):292-4, 318. Chinese. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43764 |
Study title: Hypertrophic pulmonary osteoarthropathy in nasopharyngeal carcinoma: an early sign of pulmonary metastasis. Liu RS, Chen YK, Yen SH, Chu YK, Chu LS, Chen KY, Yeh SH. Nucl Med Commun. 1995 Sep;16(9):785-9. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43591 |
Study title: Liu RS, Chou CS, Yeh SH. Three-phase bone scintigraphy in Pellegrini-Stieda disease. Clin Nucl Med. 1987 Jan;12(1):47-9. Liu RS, Chou CS, Yeh SH. Three-phase bone scintigraphy in Pellegrini-Stieda disease. Clin Nucl Med. 1987 Jan;12(1):47-9. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43877 |
Study title: Primary septic arthritis in heroin users: early diagnosis by radioisotopic imaging and geographic variations in the causative agents. Lopez-Longo FJ, Ménard HA, Carreño L, Cosin J, Ballesteros R, Monteagudo I. J Rheumatol. 1987 Oct;14(5):991-4. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43846 |
Study title: A double blind trial to evaluate the incidence of diarrhea and C. difficile toxin (CDT) folloing therapy with ampicillin (AMP), amoxicillin (AMOX), or trimethoprim-sulfamethoxazole (TMP-SMX) for otitis media.Hyams et al. (Pediatr Infect Dis. 1984 Sep-Oct;3(5):433-6) |
Active substance: AMPICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_30.xlsx |
View full study record |
Document reference: 49029 |
Study title: Hamscho N, Grünwald F. Prognosis of primary osteosarcoma. J Nucl Med. 2003 Jun;44(6):996-7; author reply 997. No abstract available. Hamscho N, Grünwald F. Prognosis of primary osteosarcoma. J Nucl Med. 2003 Jun;44(6):996-7; author reply 997. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43420 |
Study title: Han CS, Wood MB, Bishop AT, Cooney WP 3rd. Vascularized bone transfer. J Bone Joint Surg Am. 1992 Dec;74(10):1441-9. Han CS, Wood MB, Bishop AT, Cooney WP 3rd. Vascularized bone transfer. J Bone Joint Surg Am. 1992 Dec;74(10):1441-9. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43681 |
Study title: Unexpected stomach uptake of technetium-99m-MDP. Spicer JA, Slaton CK, Raveill TG, Baxter KG, Preston DF, Hladik WB. J Nucl Med Technol. 1999 Mar;27(1):43-4. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43508 |
Study title: Spitz J, Becker C, Tittel K, Weigand H. [Clinical relevance of whole body skeletal scintigraphy in multiple injury and polytrauma patients] Unfallchirurgie. 1992 Jun;18(3):133-47. German. Spitz J, Becker C, Tittel K, Weigand H. [Clinical relevance of whole body skeletal scintigraphy in multiple injury and polytrauma patients] Unfallchirurgie. 1992 Jun;18(3):133-47. German. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43695 |
Study title: Spitz J, Lauer I, Tittel K, Wiegand H. Scintimetric evaluation of remodeling after bone fractures in man. J Nucl Med. 1993 Sep;34(9):1403-9. Spitz J, Lauer I, Tittel K, Wiegand H. Scintimetric evaluation of remodeling after bone fractures in man. J Nucl Med. 1993 Sep;34(9):1403-9. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43654 |
Study title: [The age dependence of traumatically induced bone remodeling as studied in the bone scintigram] German Spitz J, Lauer I, Tittel K. Nuklearmedizin. 1991 Oct;30(5):155-60. German. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43726 |
Study title: Springorum HW, Bostel F, Puhl W, Georgi P. [Spinal scintigraphy following Harrington's spondylodesis] Z Orthop Ihre Grenzgeb. 1984 May-Jun;122(3):255-9. German. Springorum HW, Bostel F, Puhl W, Georgi P. [Spinal scintigraphy following Harrington's spondylodesis] Z Orthop Ihre Grenzgeb. 1984 May-Jun;122(3):255-9. German. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44001 |
Study title: Occult fracture of the calcaneus--another toddler's fracture. Starshak RJ, Simons GW, Sty JR. Pediatr Radiol. 1984;14(1):37-40. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44017 |
Study title: Horii T, Tsuchiya H, Tomita K. Presacral tumor associated with the Currarino triad in an adolescent. Arch Orthop Trauma Surg. 2001;121(1-2):114-6. Horii T, Tsuchiya H, Tomita K. Presacral tumor associated with the Currarino triad in an adolescent. Arch Orthop Trauma Surg. 2001;121(1-2):114-6. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43465 |
Study title: Horne T, Mogle P, Finsterbush A, Gordin M. Increased uptake of 99mTc-MDP in calcified synovial sarcoma. Eur J Nucl Med. 1983;8(2):75-6. No abstract available. Horne T, Mogle P, Finsterbush A, Gordin M. Increased uptake of 99mTc-MDP in calcified synovial sarcoma. Eur J Nucl Med. 1983;8(2):75-6. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44054 |
Study title: The technetium phosphate bone scan in the diagnosis of osteomyelitis in childhood. Howie DW, Savage JP, Wilson TG, Paterson D. J Bone Joint Surg Am. 1983 Apr;65(4):431-7. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44041 |
Study title: Multifocal pyomyositis. Diagnosis on technetium-99m MDP bone scan. Howman-Giles R, McCauley D, Brown J. Clin Nucl Med. 1984 Mar;9(3):149-51. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44004 |
Study title: Taylor GA, Shea N, O'Brien T, Hall JE, Treves ST. Osteoid osteoma: localization by intraoperative magnification scintigraphy. Pediatr Radiol. 1986;16(4):313-6. PMID: 3725449 [PubMed - indexed for MEDLINE] Taylor GA, Shea N, O'Brien T, Hall JE, Treves ST. Osteoid osteoma: localization by intraoperative magnification scintigraphy. Pediatr Radiol. 1986;16(4):313-6. PMID: 3725449 [PubMed - indexed for MEDLINE] |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43922 |
Study title: [Osteomyelitis in children: sometimes hard to recognize] Dutch. te Pas AB, Feith SW, Wit JM. Ned Tijdschr Geneeskd. 2002 Aug 17;146(33):1547-50. Dutch. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43438 |
Study title: Teixeira AB, Sá de Camargo Etchebehere EC, Santos AO, Lima MC, Ramos CD, Camargo EE. Scintigraphic findings of dysplasia epiphysealis hemimelica: a case report. Clin Nucl Med. 2001 Feb;26(2):162. No abstract available. Teixeira AB, Sá de Camargo Etchebehere EC, Santos AO, Lima MC, Ramos CD, Camargo EE. Scintigraphic findings of dysplasia epiphysealis hemimelica: a case report. Clin Nucl Med. 2001 Feb;26(2):162. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43460 |
Study title: Rectus femoris muscle bone-image uptake in a sprinter. Telepak RJ, Hartshorne MF, Bauman JM, Cawthon MA. Clin Nucl Med. 1986 May;11(5):365. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43911 |
Study title: Thämmig R, Schulze K, Niederle J. [Display of a primary neuroblastoma in the bone scintigram] Rofo. 1981 Aug;135(2):239-40. German. No abstract available. Thämmig R, Schulze K, Niederle J. [Display of a primary neuroblastoma in the bone scintigram] Rofo. 1981 Aug;135(2):239-40. German. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44116 |
Study title: To investigate the absorption of ampicillin from suppositories.Kida et al. (1983-05-04) |
Active substance: AMPICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_13.xlsx |
View full study record |
Document reference: 49013 |
Study title: To study changes in fecal bacterial flora, including its sensitivity to ampicillin, after rectal and oral administration of ampicillin. Fecal ampicillin concetrations were also studied.Motohiro et al. (1986-10-17) |
Active substance: AMPICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_14.xlsx |
View full study record |
Document reference: 49014 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone -Propionate-FAS30007-ICHE3.pdf |
View full study record |
Document reference: 28393 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28400 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28401 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Study FLIC22 Fluticasone Propionate Fixotide nebules.xls |
View full study record |
Document reference: 28402 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Study FMDT08-Fluticasone Propionate-Flixotide Diskus.xls |
View full study record |
Document reference: 28403 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Study FPC40002-Fluticasone propionate-Cutivate - approved.xls |
View full study record |
Document reference: 28406 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Study FLNT52-Fluticasone_Flixonase.xls |
View full study record |
Document reference: 28410 |